Citrus Sinensis ID: 046714

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-
Protein Sequence
NFSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS
Secondary Structure (PSIPRED)
cccccccccccccEEEcEEEEccEEEEEEEEcccccHHHHHHHccccHHHHHHHHHHHHHHHHHHccccccccccccccEEEcccccEEEcccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHcccccccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccc
Secondary Structure Prediction (SSPRO)
cEEEEEEccccEEEEEEEEcccccEEEEEEEEcccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEHHHHccccccHccccHHHHHcccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHcccHHHcccccc
Coil and Loop (DISEMBL)
nfsfsqfehdNIVQyigtekdeNRLYIFLELVKKgslanlyqkyhlsdsqvsSYTRQILNGLTYLHERNVVHREIKCANILVdasglatttndvksfegtpfwvapevvnlknngyglsADIWSLGCTVlemlthqppyshledMQALFRigrgklpsvpnslsrDARDFILKCLqvnpndrptaaqlmehpfvkrplqts
Flexible Loop (DISEMBL)
nfsfsqfehdNIVQyigtekdeNRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDrptaaqlmehpfvkrplqts
Low Complexity Region (SEG)
NFSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS
Disordered region (IsUnstruct)
*******EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL*********DARDFILKCLQV************************
Disordered Region (DISOPRED)
*FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF*KR*****
Disordered Region (DISEMBL)
NFSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS
Disordered Region (DISPRO)
NFSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
NFSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	201	2.2.26 [Sep-21-2011]
Q39008	608	Mitogen-activated protein	yes	no	0.970	0.320	0.655	1e-73
Q9SZ67	1895	Probable WRKY transcripti	no	no	0.970	0.102	0.610	1e-63
O22040	666	Mitogen-activated protein	no	no	0.920	0.277	0.475	3e-46
Q9FZ36	651	Mitogen-activated protein	no	no	0.925	0.285	0.453	8e-45
Q54R82	942	Mitogen-activated protein	yes	no	0.925	0.197	0.408	4e-44
E9Q3S4	1311	Mitogen-activated protein	yes	no	0.935	0.143	0.412	7e-42
O22042	651	Mitogen-activated protein	no	no	0.925	0.285	0.424	9e-42
P28829	659	Protein kinase byr2 OS=Sc	yes	no	0.930	0.283	0.432	1e-41
Q56UN5	1328	Mitogen-activated protein	no	no	0.935	0.141	0.402	1e-41
Q8T2I8	1167	Serine/threonine-protein	no	no	0.965	0.166	0.410	6e-41

>sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2

 Score =  275 bits (703), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 135/206 (65%), Positives = 161/206 (78%), Gaps = 11/206 (5%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQ +H NIV+Y GT KD + LYIFLELV +GSL  LYQ+Y L DS VS YTRQIL+GL 
Sbjct: 386 LSQLQHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLK 445

Query: 64  YLHERNVVHREIKCANILVDASG--------LATTT--NDVKSFEGTPFWVAPEVVNLKN 113
           YLH++  +HR+IKCANILVDA+G        LA  +  ND+KS +GTPFW+APEV+N K+
Sbjct: 446 YLHDKGFIHRDIKCANILVDANGAVKLADFGLAKVSKFNDIKSCKGTPFWMAPEVINRKD 505

Query: 114 -NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL 172
            +GYG  ADIWSLGCTVLEM T Q PYS LE +QALFRIGRG LP VP++LS DAR FIL
Sbjct: 506 SDGYGSPADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGTLPEVPDTLSLDARLFIL 565

Query: 173 KCLQVNPNDRPTAAQLMEHPFVKRPL 198
           KCL+VNP +RPTAA+L+ HPFV+RPL
Sbjct: 566 KCLKVNPEERPTAAELLNHPFVRRPL 591

Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1

 Score =  242 bits (617), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 124/203 (61%), Positives = 148/203 (72%), Gaps = 8/203 (3%)

Query: 4    FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
             SQ +H NIV+Y GT KDE+ LYIFLELV +GSL  LYQ+  L DS VS YTRQIL+GL 
Sbjct: 1679 LSQLQHQNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRNQLGDSVVSLYTRQILDGLK 1738

Query: 64   YLHERNVVHREIKCANILVDASGLATTTN----DVKSFEGTPFW--VAPEVV-NLKN-NG 115
            YLH++  +HR IKCAN+LVDA+G     +     V S   TP+W  +APEV+ N K+ +G
Sbjct: 1739 YLHDKGFIHRNIKCANVLVDANGTVKLADFGLAKVMSLWRTPYWNWMAPEVILNPKDYDG 1798

Query: 116  YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
            YG  ADIWSLGCTVLEMLT Q PYS LE   AL+ IG GKLP +P+ LS DARDFIL CL
Sbjct: 1799 YGTPADIWSLGCTVLEMLTGQIPYSDLEIGTALYNIGTGKLPKIPDILSLDARDFILTCL 1858

Query: 176  QVNPNDRPTAAQLMEHPFVKRPL 198
            +VNP +RPTAA+L+ HPFV  PL
Sbjct: 1859 KVNPEERPTAAELLNHPFVNMPL 1881

Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity.

Arabidopsis thaliana (taxid: 3702)

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  184 bits (468), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 98/206 (47%), Positives = 138/206 (66%), Gaps = 21/206 (10%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYL 65
             H NIV+Y+GT ++++ L I LE V  GS+++L +K+    +S V +YTRQ+L GL YL
Sbjct: 129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYL 188

Query: 66  HERNVVHREIKCANILVDASG---------------LATTTNDVKSFEGTPFWVAPEVVN 110
           H   ++HR+IK ANILVD  G               LAT T   KS +GTP+W+APEV+ 
Sbjct: 189 HNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTG-AKSMKGTPYWMAPEVI- 246

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSH-LEDMQALFRIGRGKL-PSVPNSLSRDAR 168
               G+  SADIWS+GCTV+EM+T + P+S   +++ A+F IG  K  P +P++LS DA+
Sbjct: 247 -LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDAK 305

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFV 194
           DF+LKCLQ  PN RPTA++L++HPFV
Sbjct: 306 DFLLKCLQEVPNLRPTASELLKHPFV 331

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  179 bits (455), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 93/205 (45%), Positives = 133/205 (64%), Gaps = 19/205 (9%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYL 65
             H NIV+Y+GT +++  L I LE V  GS+++L +K+    +S V +YT Q+L GL YL
Sbjct: 128 LSHPNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESVVRTYTNQLLLGLEYL 187

Query: 66  HERNVVHREIKCANILVDASGLA--------------TTTNDVKSFEGTPFWVAPEVVNL 111
           H   ++HR+IK ANILVD  G                 T +  KS +GTP+W+APEV+  
Sbjct: 188 HNHAIMHRDIKGANILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAPEVI-- 245

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSH-LEDMQALFRIGRGKL-PSVPNSLSRDARD 169
              G+  SADIWS+GCTV+EM+T + P+S   +++ A+F IG  K  P +P+++S DA D
Sbjct: 246 LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISSDAND 305

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFV 194
           F+LKCLQ  PN RPTA++L++HPFV
Sbjct: 306 FLLKCLQQEPNLRPTASELLKHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  177 bits (449), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 83/203 (40%), Positives = 136/203 (66%), Gaps = 17/203 (8%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYL 65
             HDNIV+Y+GT  D++ L +FLE +  GS+++L  K+   S++ +  YT+QIL GL++L
Sbjct: 229 LRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFL 288

Query: 66  HERNVVHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKN 113
           H  +++HR+IK ANIL+D  G+   ++              KS +GTP+W+APEV+  K 
Sbjct: 289 HANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVI--KQ 346

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA-LFRIGRG-KLPSVPNSLSRDARDFI 171
            G+G S+DIWSLGC ++EM T QPP+S++ ++ A ++ I     +P++P+ +S++A DF+
Sbjct: 347 TGHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFL 406

Query: 172 LKCLQVNPNDRPTAAQLMEHPFV 194
             C + +P +RP A QL++HPF+
Sbjct: 407 NLCFKRDPKERPDANQLLKHPFI 429

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus GN=Map3k19 PE=3 SV=1

 Score =  170 bits (430), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 87/211 (41%), Positives = 130/211 (61%), Gaps = 23/211 (10%)

Query: 7    FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYL 65
             +H NIV Y+GT  +EN L IF+E V  GS++++  ++  L +     YTRQIL G+ YL
Sbjct: 1101 LKHVNIVAYLGTCLEENTLSIFMEFVPGGSISSIINRFGPLPEMVFCKYTRQILQGVAYL 1160

Query: 66   HERNVVHREIKCANILVDASGL------------------ATTTNDVKSFEGTPFWVAPE 107
            H+  VVHR+IK  N+++  +G+                   T ++ +KS  GTP+W+APE
Sbjct: 1161 HDNCVVHRDIKGNNVMLMPTGIIKLIDFGCAKRLAWAGLNGTHSDMLKSMRGTPYWMAPE 1220

Query: 108  VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG--RGKLPSVPNSLSR 165
            V+N   +GYG  +DIWS+GCTV EM T +PP + ++ M A+F IG  RG +P +P   S 
Sbjct: 1221 VIN--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRMAAMFYIGAHRGLMPPLPARFSE 1278

Query: 166  DARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
             A DF+  CL  + ++RP+A QL++H F+KR
Sbjct: 1279 PAADFVRLCLTRDQHERPSALQLLKHSFLKR 1309

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  169 bits (429), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 87/205 (42%), Positives = 126/205 (61%), Gaps = 19/205 (9%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYL 65
             H NIV+Y+GT ++ + L I +E V  GS+++L +K+    +  +  YT+Q+L GL YL
Sbjct: 128 LSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQLLLGLEYL 187

Query: 66  HERNVVHREIKCANILVDASGLA--------------TTTNDVKSFEGTPFWVAPEVVNL 111
           H   ++HR+IK ANILVD  G                 T N  KS +GTP+W+APEV+  
Sbjct: 188 HNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEVI-- 245

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYS-HLEDMQALFRIGRGKL-PSVPNSLSRDARD 169
              G+  SADIWS+GCTV+EM T +PP+S   +   A+  IGR K  P +P  LS +A+D
Sbjct: 246 LQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDLSPEAKD 305

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFV 194
           F++KCL   P+ R +A +L++HPFV
Sbjct: 306 FLMKCLHKEPSLRLSATELLQHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1

 Score =  169 bits (427), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 90/208 (43%), Positives = 125/208 (60%), Gaps = 21/208 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTY 64
           +  H++IVQY+G+  + + L IFLE V  GS+A L   Y    ++ V ++ +Q L GL Y
Sbjct: 453 ELSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLLTMYGSFEETLVKNFIKQTLKGLEY 512

Query: 65  LHERNVVHREIKCANILVDASG-----------------LATTTNDVK-SFEGTPFWVAP 106
           LH R +VHR+IK ANILVD  G                  +T T   + SF+G+ FW+AP
Sbjct: 513 LHSRGIVHRDIKGANILVDNKGKIKISDFGISKKLELNSTSTKTGGARPSFQGSSFWMAP 572

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
           EVV  K   +    DIWSLGC V+EMLT + PY + + MQA+FRIG   LP  P+++S  
Sbjct: 573 EVV--KQTMHTEKTDIWSLGCLVIEMLTSKHPYPNCDQMQAIFRIGENILPEFPSNISSS 630

Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A DF+ K   ++ N RPTA++L+ HPFV
Sbjct: 631 AIDFLEKTFAIDCNLRPTASELLSHPFV 658

Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens GN=MAP3K19 PE=2 SV=1

 Score =  169 bits (427), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 85/211 (40%), Positives = 131/211 (62%), Gaps = 23/211 (10%)

Query: 7    FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYL 65
             +H NIV Y+GT   EN + IF+E V  GS++++  ++  L +     YT+QIL G+ YL
Sbjct: 1118 LKHVNIVAYLGTCLQENTVSIFMEFVPGGSISSIINRFGPLPEMVFCKYTKQILQGVAYL 1177

Query: 66   HERNVVHREIKCANILVDASGL------------------ATTTNDVKSFEGTPFWVAPE 107
            HE  VVHR+IK  N+++  +G+                   T ++ +KS  GTP+W+APE
Sbjct: 1178 HENCVVHRDIKGNNVMLMPTGIIKLIDFGCARRLAWAGLNGTHSDMLKSMHGTPYWMAPE 1237

Query: 108  VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG--RGKLPSVPNSLSR 165
            V+N   +GYG  +DIWS+GCTV EM T +PP + ++ M A+F IG  RG +P +P+  S 
Sbjct: 1238 VIN--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRMAAMFYIGAHRGLMPPLPDHFSE 1295

Query: 166  DARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
            +A DF+  CL  + ++RP+A QL++H F++R
Sbjct: 1296 NAADFVRMCLTRDQHERPSALQLLKHSFLER 1326

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8T2I8|SEPA_DICDI Serine/threonine-protein kinase sepA OS=Dictyostelium discoideum GN=sepA PE=2 SV=1

 Score =  167 bits (422), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 85/207 (41%), Positives = 127/207 (61%), Gaps = 13/207 (6%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGL 62
                H NIV+YI   K ++ LYI LE V+ GSL+ + +K+    ++ V  Y RQ+L GL
Sbjct: 69  LKNLNHANIVKYIKYVKTKDNLYIVLEYVENGSLSGIIKKFGKFPETLVCVYIRQVLEGL 128

Query: 63  TYLHERNVVHREIKCANILVDASG--------LATTTNDVKSFE--GTPFWVAPEVVNLK 112
            YLHE+ VVHR+IK ANIL    G        +AT  +D  +    GTP+W+APE++ L 
Sbjct: 129 VYLHEQGVVHRDIKGANILTTKEGKIKLADFGVATKFDDTSAAAVVGTPYWMAPEIIEL- 187

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL 172
            NG    +DIWS+GCTV+E+LT  PPY  L  M ALFRI +   P +P  +S   +D+++
Sbjct: 188 -NGATTKSDIWSVGCTVIELLTGSPPYYDLGQMPALFRIVQDDCPPLPEGISPPLKDWLM 246

Query: 173 KCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
           +C Q +PN R +A +L++H +++  ++
Sbjct: 247 QCFQKDPNLRISAQKLLKHKWIQASIK 273

Serine/threonine-protein kinase involved in the spatial and temporal control system organizing cortical activities in mitotic and postmitotic cells.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	201
356557517	440	PREDICTED: mitogen-activated protein kin	0.970	0.443	0.756	2e-88
255587684	451	Mitogen-activated protein kinase kinase	0.965	0.430	0.745	4e-86
359486016	559	PREDICTED: mitogen-activated protein kin	0.980	0.352	0.724	5e-84
298204644	719	unnamed protein product [Vitis vinifera]	0.980	0.273	0.724	2e-83
255545546	555	Mitogen-activated protein kinase kinase	0.985	0.356	0.730	3e-83
356509460	566	PREDICTED: mitogen-activated protein kin	0.985	0.349	0.725	6e-83
224082218	548	predicted protein [Populus trichocarpa]	0.980	0.359	0.729	1e-82
302141878	273	unnamed protein product [Vitis vinifera]	0.985	0.725	0.721	2e-82
225459451	567	PREDICTED: mitogen-activated protein kin	0.985	0.349	0.721	2e-82
224066881	558	predicted protein [Populus trichocarpa]	0.985	0.354	0.721	1e-81

>gi|356557517|ref|XP_003547062.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  330 bits (845), Expect = 2e-88,   Method: Compositional matrix adjust.
 Identities = 155/205 (75%), Positives = 177/205 (86%), Gaps = 10/205 (4%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQF HDNIV+Y+GT+KD+++LYIFLELV KGSLA+LYQKY L DSQVS+YTRQIL+GL 
Sbjct: 220 LSQFRHDNIVRYLGTDKDDDKLYIFLELVTKGSLASLYQKYRLRDSQVSAYTRQILSGLK 279

Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           YLH+RNVVHR+IKCANILVDA+G           AT  NDVKS +G+P+W+APEVVNL+N
Sbjct: 280 YLHDRNVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSSKGSPYWMAPEVVNLRN 339

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
            GYGL+ADIWSLGCTVLEMLT QPPYSHLE MQALFRIGRG+ P VP SLS DARDFILK
Sbjct: 340 RGYGLAADIWSLGCTVLEMLTRQPPYSHLEGMQALFRIGRGQPPPVPESLSTDARDFILK 399

Query: 174 CLQVNPNDRPTAAQLMEHPFVKRPL 198
           CLQVNPN RPTAA+L++HPFVKRPL
Sbjct: 400 CLQVNPNKRPTAARLLDHPFVKRPL 424

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255587684|ref|XP_002534356.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223525440|gb|EEF28029.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis]

 Score =  322 bits (826), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 152/204 (74%), Positives = 174/204 (85%), Gaps = 10/204 (4%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           FEH+NIV+Y+GTEKDE +LYIFLEL  KGSLA LYQKYHL DS VS+YTRQILNGL YLH
Sbjct: 234 FEHENIVRYLGTEKDEAKLYIFLELATKGSLARLYQKYHLRDSHVSAYTRQILNGLKYLH 293

Query: 67  ERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKNNGY 116
           +RNVVHR+IKCANILVDA+G           ATT NDVKS +GT FW+APEVVNLKN GY
Sbjct: 294 DRNVVHRDIKCANILVDANGSVKLADFGLAKATTMNDVKSCKGTVFWMAPEVVNLKNRGY 353

Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
           GL+ADIWSLGCTVLE+LT +PPYSHLE MQALFRIG+G+ P + +SLS DARDFIL+CLQ
Sbjct: 354 GLAADIWSLGCTVLELLTGRPPYSHLEGMQALFRIGKGEPPPIADSLSTDARDFILRCLQ 413

Query: 177 VNPNDRPTAAQLMEHPFVKRPLQT 200
           VNP +RPTAAQL++HPFVKRP +T
Sbjct: 414 VNPTNRPTAAQLLDHPFVKRPHET 437

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359486016|ref|XP_002264549.2| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Vitis vinifera]

 Score =  315 bits (808), Expect = 5e-84,   Method: Compositional matrix adjust.
 Identities = 150/207 (72%), Positives = 173/207 (83%), Gaps = 10/207 (4%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQFEH+NIV+Y GT+KD+++LYIFLELV KGSL +LYQKY L +SQ S+YTRQILNGL 
Sbjct: 339 LSQFEHENIVRYYGTDKDDSKLYIFLELVTKGSLLSLYQKYDLRESQASAYTRQILNGLK 398

Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           YLHE+NVVHR+IKCANILVD +G           AT  NDVKS +GT FW+APEVVN KN
Sbjct: 399 YLHEQNVVHRDIKCANILVDVNGSVKLADFGLAKATKLNDVKSCKGTVFWMAPEVVNRKN 458

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
            GYGL+ADIWSLGCTVLE+LT +PPYSHLE MQALFRIG+G+ P V NSLS DAR+FILK
Sbjct: 459 KGYGLAADIWSLGCTVLEILTRRPPYSHLEGMQALFRIGKGEPPPVSNSLSSDARNFILK 518

Query: 174 CLQVNPNDRPTAAQLMEHPFVKRPLQT 200
           CLQVNP+DRPTA QL++HPFVKRPL T
Sbjct: 519 CLQVNPSDRPTAGQLLDHPFVKRPLHT 545

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|298204644|emb|CBI23919.3| unnamed protein product [Vitis vinifera]

 Score =  313 bits (803), Expect = 2e-83,   Method: Compositional matrix adjust.
 Identities = 150/207 (72%), Positives = 173/207 (83%), Gaps = 10/207 (4%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQFEH+NIV+Y GT+KD+++LYIFLELV KGSL +LYQKY L +SQ S+YTRQILNGL 
Sbjct: 499 LSQFEHENIVRYYGTDKDDSKLYIFLELVTKGSLLSLYQKYDLRESQASAYTRQILNGLK 558

Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           YLHE+NVVHR+IKCANILVD +G           AT  NDVKS +GT FW+APEVVN KN
Sbjct: 559 YLHEQNVVHRDIKCANILVDVNGSVKLADFGLAKATKLNDVKSCKGTVFWMAPEVVNRKN 618

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
            GYGL+ADIWSLGCTVLE+LT +PPYSHLE MQALFRIG+G+ P V NSLS DAR+FILK
Sbjct: 619 KGYGLAADIWSLGCTVLEILTRRPPYSHLEGMQALFRIGKGEPPPVSNSLSSDARNFILK 678

Query: 174 CLQVNPNDRPTAAQLMEHPFVKRPLQT 200
           CLQVNP+DRPTA QL++HPFVKRPL T
Sbjct: 679 CLQVNPSDRPTAGQLLDHPFVKRPLHT 705

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545546|ref|XP_002513833.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223546919|gb|EEF48416.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis]

 Score =  313 bits (802), Expect = 3e-83,   Method: Compositional matrix adjust.
 Identities = 152/208 (73%), Positives = 172/208 (82%), Gaps = 10/208 (4%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQFEH+NIV+Y GT+KD++ LYIFLELV +GSL NLYQ+YHL DSQVS+YTRQIL+GL 
Sbjct: 336 LSQFEHENIVRYYGTDKDDSNLYIFLELVTQGSLMNLYQRYHLRDSQVSAYTRQILHGLK 395

Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           YLH+RNVVHR+IKCANILVDASG           AT  NDVKS +GT FW+APEVVN K 
Sbjct: 396 YLHDRNVVHRDIKCANILVDASGSVKLADFGLAKATKLNDVKSCKGTAFWMAPEVVNRKT 455

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
           +GYGL ADIWSLGCTVLEMLT Q PYSHLE MQALFRIG+G  P VP+SLS DARDFIL+
Sbjct: 456 HGYGLPADIWSLGCTVLEMLTRQVPYSHLECMQALFRIGKGVPPPVPDSLSNDARDFILQ 515

Query: 174 CLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           CLQVNPN RPTAAQL+EH FV++PL  S
Sbjct: 516 CLQVNPNGRPTAAQLLEHSFVRQPLPMS 543

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356509460|ref|XP_003523467.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max]

 Score =  312 bits (799), Expect = 6e-83,   Method: Compositional matrix adjust.
 Identities = 151/208 (72%), Positives = 170/208 (81%), Gaps = 10/208 (4%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQFEHDNIVQY GTE D+++LYIFLELV KGSL +LYQKY L DSQVS+YTRQIL+GL 
Sbjct: 346 LSQFEHDNIVQYYGTEMDQSKLYIFLELVTKGSLRSLYQKYTLRDSQVSAYTRQILHGLK 405

Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           YLH+RNVVHR+IKCANILVDASG           AT  NDVKS +GT FW+APEVV  KN
Sbjct: 406 YLHDRNVVHRDIKCANILVDASGSVKLADFGLAKATKLNDVKSMKGTAFWMAPEVVKGKN 465

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
            GYGL AD+WSLGCTVLEMLT Q PY  LE MQALFRIG+G+ P +P+SLSRDA+DFIL+
Sbjct: 466 KGYGLPADMWSLGCTVLEMLTGQLPYRDLECMQALFRIGKGERPPIPDSLSRDAQDFILQ 525

Query: 174 CLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           CLQVNPNDRPTAAQL+ H FV+RPL  S
Sbjct: 526 CLQVNPNDRPTAAQLLNHSFVQRPLSQS 553

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224082218|ref|XP_002306607.1| predicted protein [Populus trichocarpa] gi|222856056|gb|EEE93603.1| predicted protein [Populus trichocarpa]

 Score =  310 bits (795), Expect = 1e-82,   Method: Compositional matrix adjust.
 Identities = 151/207 (72%), Positives = 172/207 (83%), Gaps = 10/207 (4%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            S+FEH+NIVQY GT+KDE++LYIFLELV KGSL  LYQ+Y+L DSQVS+YTRQIL+GL 
Sbjct: 329 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLKLYQRYNLRDSQVSAYTRQILHGLK 388

Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           YLH++NVVHR+IKCAN+LVDA+G           AT  NDVKS +GT FW+APEVVN KN
Sbjct: 389 YLHDQNVVHRDIKCANLLVDANGSVKLADFGLAKATKFNDVKSCKGTAFWMAPEVVNNKN 448

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
            GYGL ADIWSLGCTVLEMLT Q PYS LE MQALFRIGRG  P VP+SLS DARDFIL+
Sbjct: 449 QGYGLPADIWSLGCTVLEMLTRQIPYSELESMQALFRIGRGVPPLVPDSLSNDARDFILQ 508

Query: 174 CLQVNPNDRPTAAQLMEHPFVKRPLQT 200
           CLQVNPNDRPTAA L++HPF+KRPL T
Sbjct: 509 CLQVNPNDRPTAAVLLDHPFMKRPLPT 535

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302141878|emb|CBI19081.3| unnamed protein product [Vitis vinifera]

 Score =  310 bits (794), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 150/208 (72%), Positives = 171/208 (82%), Gaps = 10/208 (4%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQF+H+NIVQY GT KDE++LYIFLELV KGSLA+LYQ+Y+L DSQ S+YTRQIL+GL 
Sbjct: 53  LSQFQHENIVQYHGTAKDESKLYIFLELVTKGSLASLYQRYNLGDSQASAYTRQILHGLN 112

Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           YLHERNV+HR+IKCANILV A+G           AT  ND KS +GTPFW+APEVVN K 
Sbjct: 113 YLHERNVIHRDIKCANILVGANGSVKLSDFGLAKATQLNDAKSCKGTPFWMAPEVVNGKG 172

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
            GYGL+ADIWSLGCTVLEMLT + PYSHLE MQALFRIG+G+ P VP+SLS DARDFILK
Sbjct: 173 QGYGLAADIWSLGCTVLEMLTREVPYSHLESMQALFRIGKGEPPPVPDSLSPDARDFILK 232

Query: 174 CLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           CLQV P+DRPTAAQL+ H FVKRP  TS
Sbjct: 233 CLQVIPDDRPTAAQLLNHQFVKRPPPTS 260

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225459451|ref|XP_002284356.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Vitis vinifera]

 Score =  310 bits (794), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 150/208 (72%), Positives = 171/208 (82%), Gaps = 10/208 (4%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQF+H+NIVQY GT KDE++LYIFLELV KGSLA+LYQ+Y+L DSQ S+YTRQIL+GL 
Sbjct: 347 LSQFQHENIVQYHGTAKDESKLYIFLELVTKGSLASLYQRYNLGDSQASAYTRQILHGLN 406

Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           YLHERNV+HR+IKCANILV A+G           AT  ND KS +GTPFW+APEVVN K 
Sbjct: 407 YLHERNVIHRDIKCANILVGANGSVKLSDFGLAKATQLNDAKSCKGTPFWMAPEVVNGKG 466

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
            GYGL+ADIWSLGCTVLEMLT + PYSHLE MQALFRIG+G+ P VP+SLS DARDFILK
Sbjct: 467 QGYGLAADIWSLGCTVLEMLTREVPYSHLESMQALFRIGKGEPPPVPDSLSPDARDFILK 526

Query: 174 CLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           CLQV P+DRPTAAQL+ H FVKRP  TS
Sbjct: 527 CLQVIPDDRPTAAQLLNHQFVKRPPPTS 554

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224066881|ref|XP_002302260.1| predicted protein [Populus trichocarpa] gi|222843986|gb|EEE81533.1| predicted protein [Populus trichocarpa]

 Score =  308 bits (788), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 150/208 (72%), Positives = 172/208 (82%), Gaps = 10/208 (4%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            S+FEH+NIVQY GT+KDE++LYIFLELV KGSL  LYQ+Y+L DSQVSSYTRQIL+GL 
Sbjct: 339 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLQKLYQRYNLRDSQVSSYTRQILHGLK 398

Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           YLH++NVVHR+IKCAN+LVDA+G           AT  NDVKS +GT FW+APEVVN KN
Sbjct: 399 YLHDQNVVHRDIKCANLLVDANGSVKLADFGLAKATKLNDVKSCKGTAFWMAPEVVNNKN 458

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
            GYGL ADIWSLGCTVLEMLT Q PYS LE MQALFRIGRG  P VP+SLS DAR+FIL+
Sbjct: 459 QGYGLPADIWSLGCTVLEMLTRQIPYSELESMQALFRIGRGVPPLVPDSLSNDAREFILQ 518

Query: 174 CLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           C+QVNPNDRPTAA L++HPFVK+ L TS
Sbjct: 519 CIQVNPNDRPTAAVLLDHPFVKKLLPTS 546

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	201
TAIR|locus:2133559	608	MEKK1 "MAPK/ERK kinase kinase	0.965	0.319	0.658	1.7e-66
TAIR|locus:2133539	773	MAPKKK9 "mitogen-activated pro	0.980	0.254	0.600	2.6e-63
TAIR|locus:2133529	560	MEKK3 "MAPK/ERK kinase kinase	0.945	0.339	0.601	9.3e-59
TAIR|locus:2118116	1895	WRKY19 [Arabidopsis thaliana (	0.980	0.103	0.609	4.2e-58
TAIR|locus:2026674	883	YDA "YODA" [Arabidopsis thalia	0.945	0.215	0.5	4.9e-48
TAIR|locus:2024832	609	MAP3KA "mitogen-activated prot	0.945	0.311	0.504	2.6e-47
TAIR|locus:2035989	666	NP1 "NPK1-related protein kina	0.910	0.274	0.485	1.1e-42
TAIR|locus:2174969	716	MAPKKK5 "mitogen-activated pro	0.955	0.268	0.427	1.7e-40
DICTYBASE|DDB_G0283265	1267	mkkA "octicosapeptide/Phox/Bem	0.915	0.145	0.412	3.5e-40
UNIPROTKB|Q40541	690	Q40541 "Protein kinase" [Nicot	0.910	0.265	0.450	8.3e-40

TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 676 (243.0 bits), Expect = 1.7e-66, P = 1.7e-66
 Identities = 135/205 (65%), Positives = 161/205 (78%)

Query:     5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTY 64
             SQ +H NIV+Y GT KD + LYIFLELV +GSL  LYQ+Y L DS VS YTRQIL+GL Y
Sbjct:   387 SQLQHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKY 446

Query:    65 LHERNVVHREIKCANILVDASG--------LATTT--NDVKSFEGTPFWVAPEVVNLKNN 114
             LH++  +HR+IKCANILVDA+G        LA  +  ND+KS +GTPFW+APEV+N K++
Sbjct:   447 LHDKGFIHRDIKCANILVDANGAVKLADFGLAKVSKFNDIKSCKGTPFWMAPEVINRKDS 506

Query:   115 -GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
              GYG  ADIWSLGCTVLEM T Q PYS LE +QALFRIGRG LP VP++LS DAR FILK
Sbjct:   507 DGYGSPADIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGTLPEVPDTLSLDARLFILK 566

Query:   174 CLQVNPNDRPTAAQLMEHPFVKRPL 198
             CL+VNP +RPTAA+L+ HPFV+RPL
Sbjct:   567 CLKVNPEERPTAAELLNHPFVRRPL 591

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046686 "response to cadmium ion" evidence=IGI

GO:0006970 "response to osmotic stress" evidence=IGI;IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009611 "response to wounding" evidence=RCA;IDA

GO:0003677 "DNA binding" evidence=IDA

GO:0019900 "kinase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=IMP;RCA;IPI

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0009620 "response to fungus" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2133539 MAPKKK9 "mitogen-activated protein kinase kinase kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 628 (226.1 bits), Expect = 2.6e-63, Sum P(2) = 2.6e-63
 Identities = 125/208 (60%), Positives = 157/208 (75%)

Query:     5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTY 64
             SQ EH NI++Y GT+KD + LYIFLELV +GSL  LY++Y + DS +S YT+QIL+GL Y
Sbjct:   555 SQLEHQNILRYRGTDKDGSNLYIFLELVTQGSLLELYRRYQIRDSLISLYTKQILDGLKY 614

Query:    65 LHERNVVHREIKCANILVDASG--------LATTT--NDVKSFEGTPFWVAPEVVNLKNN 114
             LH +  +HR+IKCA ILVDA+G        LA  +  ND+KS + T FW+APEV+N K+N
Sbjct:   615 LHHKGFIHRDIKCATILVDANGTVKLADFGLAKVSKLNDIKSRKETLFWMAPEVINRKDN 674

Query:   115 -GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
              GY   ADIWSLGCTVLEM T Q PYS LE ++ALFRI RG LP VP++LS DAR FILK
Sbjct:   675 DGYRSPADIWSLGCTVLEMCTGQIPYSDLEPVEALFRIRRGTLPEVPDTLSLDARHFILK 734

Query:   174 CLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
             CL++NP +RPTA +L+ HPFV+RPL +S
Sbjct:   735 CLKLNPEERPTATELLNHPFVRRPLPSS 762

GO:0005737 "cytoplasm" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0031347 "regulation of defense response" evidence=IMP

TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 603 (217.3 bits), Expect = 9.3e-59, P = 9.3e-59
 Identities = 121/201 (60%), Positives = 151/201 (75%)

Query:     5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTY 64
             SQ +H NIV+Y GT KD ++LYIFLELV +GS+  LY++Y LS + VS YTRQIL GL Y
Sbjct:   357 SQLQHQNIVRYRGTAKDVSKLYIFLELVTQGSVQKLYERYQLSYTVVSLYTRQILAGLNY 416

Query:    65 LHERNVVHREIKCANILVDASGL----------ATTTNDVKSFEGTPFWVAPEVVNLKNN 114
             LH++  VHR+IKCAN+LVDA+G           A+  ND+ S +GT FW+APEV+N K++
Sbjct:   417 LHDKGFVHRDIKCANMLVDANGTVKLADFGLAEASKFNDIMSCKGTLFWMAPEVINRKDS 476

Query:   115 -GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
              G G  ADIWSLGCTVLEM T Q PYS L+ +QA F+IGRG LP VP++LS DAR FIL 
Sbjct:   477 DGNGSPADIWSLGCTVLEMCTGQIPYSDLKPIQAAFKIGRGTLPDVPDTLSLDARHFILT 536

Query:   174 CLQVNPNDRPTAAQLMEHPFV 194
             CL+VNP +RPTAA+L+ HPFV
Sbjct:   537 CLKVNPEERPTAAELLHHPFV 557

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2118116 WRKY19 [Arabidopsis thaliana (taxid:3702)]

 Score = 611 (220.1 bits), Expect = 4.2e-58, P = 4.2e-58
 Identities = 125/205 (60%), Positives = 150/205 (73%)

Query:     5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTY 64
             SQ +H NIV+Y GT KDE+ LYIFLELV +GSL  LYQ+  L DS VS YTRQIL+GL Y
Sbjct:  1680 SQLQHQNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKY 1739

Query:    65 LHERNVVHREIKCANILVDASGLATTTN----DVKSFEGTPFW--VAPEVV-NLKN-NGY 116
             LH++  +HR IKCAN+LVDA+G     +     V S   TP+W  +APEV+ N K+ +GY
Sbjct:  1740 LHDKGFIHRNIKCANVLVDANGTVKLADFGLAKVMSLWRTPYWNWMAPEVILNPKDYDGY 1799

Query:   117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
             G  ADIWSLGCTVLEMLT Q PYS LE   AL+ IG GKLP +P+ LS DARDFIL CL+
Sbjct:  1800 GTPADIWSLGCTVLEMLTGQIPYSDLEIGTALYNIGTGKLPKIPDILSLDARDFILTCLK 1859

Query:   177 VNPNDRPTAAQLMEHPFVKRPLQTS 201
             VNP +RPTAA+L+ HPFV  PL +S
Sbjct:  1860 VNPEERPTAAELLNHPFVNMPLPSS 1884

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003700 "sequence-specific DNA binding transcription factor activity" evidence=IEA;ISS

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005622 "intracellular" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0006952 "defense response" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017111 "nucleoside-triphosphatase activity" evidence=IEA

GO:0043531 "ADP binding" evidence=IEA

GO:0043565 "sequence-specific DNA binding" evidence=IEA

GO:0009941 "chloroplast envelope" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009556 "microsporogenesis" evidence=RCA

GO:0052543 "callose deposition in cell wall" evidence=RCA

TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)]

 Score = 509 (184.2 bits), Expect = 4.9e-48, P = 4.9e-48
 Identities = 102/204 (50%), Positives = 141/204 (69%)

Query:     5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
             S+  H NIVQY G+E  +++LYI+LE V  GS+  L Q+Y    ++ + +YT+QIL+GL 
Sbjct:   455 SRLRHQNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYGQFGENAIRNYTQQILSGLA 514

Query:    64 YLHERNVVHREIKCANILVDASG--------LA---TTTNDVKSFEGTPFWVAPEVVNLK 112
             YLH +N VHR+IK ANILVD  G        +A   T  +   SF+G+P+W+APEV+   
Sbjct:   515 YLHAKNTVHRDIKGANILVDPHGRVKVADFGMAKHITAQSGPLSFKGSPYWMAPEVIK-N 573

Query:   113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK-LPSVPNSLSRDARDFI 171
             +NG  L+ DIWSLGCTVLEM T +PP+S  E + A+F+IG  K LP +P+ LS + +DF+
Sbjct:   574 SNGSNLAVDIWSLGCTVLEMATTKPPWSQYEGVPAMFKIGNSKELPDIPDHLSEEGKDFV 633

Query:   172 LKCLQVNPNDRPTAAQLMEHPFVK 195
              KCLQ NP +RPTAAQL++H FV+
Sbjct:   634 RKCLQRNPANRPTAAQLLDHAFVR 657

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0009793 "embryo development ending in seed dormancy" evidence=IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IMP

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 495 (179.3 bits), Expect = 2.6e-47, P = 2.6e-47
 Identities = 103/204 (50%), Positives = 137/204 (67%)

Query:     5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
             +Q  H NIVQY G+E  E  L ++LE V  GS+  L + Y   ++  + +YTRQIL GL 
Sbjct:   269 NQLCHPNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDYGSFTEPVIQNYTRQILAGLA 328

Query:    64 YLHERNVVHREIKCANILVDASG---LA--------TTTNDVKSFEGTPFWVAPEVVNLK 112
             YLH RN VHR+IK ANILVD +G   LA        T  + + SF+G+P+W+APEVV + 
Sbjct:   329 YLHGRNTVHRDIKGANILVDPNGEIKLADFGMAKHVTAFSTMLSFKGSPYWMAPEVV-MS 387

Query:   113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK-LPSVPNSLSRDARDFI 171
              NGY  + DIWSLGCT+LEM T +PP+S  E + A+F+IG  K  P +P+ LS DA++FI
Sbjct:   388 QNGYTHAVDIWSLGCTILEMATSKPPWSQFEGVAAIFKIGNSKDTPEIPDHLSNDAKNFI 447

Query:   172 LKCLQVNPNDRPTAAQLMEHPFVK 195
               CLQ NP  RPTA+QL+EHPF++
Sbjct:   448 RLCLQRNPTVRPTASQLLEHPFLR 471

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 453 (164.5 bits), Expect = 1.1e-42, P = 1.1e-42
 Identities = 99/204 (48%), Positives = 140/204 (68%)

Query:     9 HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHE 67
             H NIV+Y+GT ++++ L I LE V  GS+++L +K+    +S V +YTRQ+L GL YLH 
Sbjct:   131 HPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYLHN 190

Query:    68 RNVVHREIKCANILVDASG---------------LATTTNDVKSFEGTPFWVAPEVVNLK 112
               ++HR+IK ANILVD  G               LAT T   KS +GTP+W+APEV+ L+
Sbjct:   191 HAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTG-AKSMKGTPYWMAPEVI-LQ 248

Query:   113 NNGYGLSADIWSLGCTVLEMLTHQPPYSH-LEDMQALFRIGRGKL-PSVPNSLSRDARDF 170
               G+  SADIWS+GCTV+EM+T + P+S   +++ A+F IG  K  P +P++LS DA+DF
Sbjct:   249 T-GHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDAKDF 307

Query:   171 ILKCLQVNPNDRPTAAQLMEHPFV 194
             +LKCLQ  PN RPTA++L++HPFV
Sbjct:   308 LLKCLQEVPNLRPTASELLKHPFV 331

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0009908 "flower development" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0007155 "cell adhesion" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 436 (158.5 bits), Expect = 1.7e-40, P = 1.7e-40
 Identities = 92/215 (42%), Positives = 134/215 (62%)

Query:     5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNG 61
             S  +H NIVQY G+E  E+R +I+LE V  GS+ N Y + H   +++S V ++TR IL+G
Sbjct:   401 SNLQHPNIVQYFGSETVEDRFFIYLEYVHPGSI-NKYIRDHCGTMTESVVRNFTRHILSG 459

Query:    62 LTYLHERNVVHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVV 109
             L YLH +  VHR+IK AN+LVDASG+    +            D+ S +G+P+W+APE++
Sbjct:   460 LAYLHNKKTVHRDIKGANLLVDASGVVKLADFGMAKHLTGQRADL-SLKGSPYWMAPELM 518

Query:   110 NL-----KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLS 164
                     N     + DIWSLGCT++EM T +PP+S  E   A+F++ R   P +P S+S
Sbjct:   519 QAVMQKDSNPDLAFAVDIWSLGCTIIEMFTGKPPWSEFEGAAAMFKVMRDS-PPIPESMS 577

Query:   165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
              + +DF+  C Q NP +RPTA+ L+EH F+K  LQ
Sbjct:   578 PEGKDFLRLCFQRNPAERPTASMLLEHRFLKNSLQ 612

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)]

 Score = 440 (159.9 bits), Expect = 3.5e-40, P = 3.5e-40
 Identities = 83/201 (41%), Positives = 136/201 (67%)

Query:     9 HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHE 67
             HDNIV+Y+GT  D++ L +FLE +  GS+++L  K+   S++ +  YT+QIL GL++LH 
Sbjct:   556 HDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLHA 615

Query:    68 RNVVHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNG 115
              +++HR+IK ANIL+D  G+   ++              KS +GTP+W+APEV+  K  G
Sbjct:   616 NSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVI--KQTG 673

Query:   116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA-LFRIGRGK-LPSVPNSLSRDARDFILK 173
             +G S+DIWSLGC ++EM T QPP+S++ ++ A ++ I     +P++P+ +S++A DF+  
Sbjct:   674 HGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFDFLNL 733

Query:   174 CLQVNPNDRPTAAQLMEHPFV 194
             C + +P +RP A QL++HPF+
Sbjct:   734 CFKRDPKERPDANQLLKHPFI 754

GO:0030587 "sorocarp development" evidence=IMP

GO:0009653 "anatomical structure morphogenesis" evidence=IMP

GO:0005938 "cell cortex" evidence=IDA

GO:0004709 "MAP kinase kinase kinase activity" evidence=IEA;ISS

GO:0000186 "activation of MAPKK activity" evidence=IEA;ISS

GO:0000165 "MAPK cascade" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0030435 "sporulation resulting in formation of a cellular spore" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|Q40541 Q40541 "Protein kinase" [Nicotiana tabacum (taxid:4097)]

 Score = 429 (156.1 bits), Expect = 8.3e-40, P = 8.3e-40
 Identities = 92/204 (45%), Positives = 131/204 (64%)

Query:     9 HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHE 67
             H NIV+Y+GT ++   L I LE V  GS+++L  K+    +S +  YT+Q+L GL YLH+
Sbjct:   142 HPNIVRYLGTAREAGSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 201

Query:    68 RNVVHREIKCANILVDASG---------------LATTTNDVKSFEGTPFWVAPEVVNLK 112
               ++HR+IK ANILVD  G               LAT T   KS +GTP+W+APEV+   
Sbjct:   202 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATMTG-AKSMKGTPYWMAPEVI--L 258

Query:   113 NNGYGLSADIWSLGCTVLEMLTHQPPYSH-LEDMQALFRIGRGKL-PSVPNSLSRDARDF 170
               G+  SADIWS+GCT++EM T +PP+S   +++ ALF IG  K  P +P  LS +++DF
Sbjct:   259 QTGHSFSADIWSVGCTIIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEHLSAESKDF 318

Query:   171 ILKCLQVNPNDRPTAAQLMEHPFV 194
             +LKCLQ  P+ R +A+ L++HPFV
Sbjct:   319 LLKCLQKEPHLRHSASNLLQHPFV 342

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	GSVIVG00005840001	SubName- Full=Chromosome chr12 scaffold_159, whole genome shotgun sequence; (552 aa)
		(Vitis vinifera)
Predicted Functional Partners:
	GSVIVG00026919001	SubName- Full=Putative uncharacterized protein (Chromosome chr15 scaffold_40, whole genome shot [...] (375 aa)						•		•	0.800
	GSVIVG00025258001	SubName- Full=Chromosome chr9 scaffold_33, whole genome shotgun sequence; (355 aa)						•		•	0.800
	GSVIVG00016645001	SubName- Full=Putative uncharacterized protein (Chromosome chr11 scaffold_13, whole genome shot [...] (354 aa)						•		•	0.800
	GSVIVG00016514001	SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (354 aa)						•		•	0.800
	GSVIVG00003414001	SubName- Full=Chromosome undetermined scaffold_143, whole genome shotgun sequence; (1088 aa)						•		•	0.800

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	201
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-101
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-86
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-78
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-72
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-66
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-66
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-63
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-62
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-62
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-61
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-60
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-60
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-58
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-54
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-54
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-54
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-53
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-52
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-51
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-50
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-50
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-48
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-46
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-46
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-44
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-43
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-43
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-43
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-42
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-42
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-41
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-40
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-40
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-40
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-40
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-40
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-38
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-38
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-38
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-37
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-37
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-36
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-36
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-36
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-36
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-35
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-35
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-35
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-35
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-35
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-34
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-34
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-34
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-34
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-34
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-34
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-34
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-33
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-33
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-33
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-32
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-32
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-32
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-32
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-31
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-31
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-31
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-31
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-31
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-30
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-30
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-30
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-29
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-29
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-29
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-28
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-28
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-28
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-28
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-27
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-27
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-27
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-27
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-26
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-25
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-25
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-25
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-25
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-24
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-24
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-24
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-24
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-23
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-23
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-23
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-22
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-22
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-22
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-22
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-21
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-21
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-21
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-21
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-21
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-21
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-21
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-21
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-21
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-20
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-20
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-20
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-20
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-20
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-20
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-20
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-20
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-20
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-20
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-20
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-20
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-19
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-19
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-19
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-19
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-19
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-19
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-19
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-19
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-19
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-18
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-18
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-18
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-18
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-18
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-17
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-17
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-16
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-16
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-16
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-16
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-16
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-15
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	1e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-15
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-15
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-15
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	9e-15
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-14
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-14
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-14
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-14
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-14
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-14
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-14
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-14
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-13
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-13
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-13
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-13
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	9e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-12
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-09
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-08
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-04
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.003
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.003

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  292 bits (748), Expect = e-101
 Identities = 118/203 (58%), Positives = 151/203 (74%), Gaps = 14/203 (6%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
           S+ +H NIVQY+GTE++E+ LYIFLELV  GSLA L +KY    +  +  YTRQIL GL 
Sbjct: 57  SKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLE 116

Query: 64  YLHERNVVHREIKCANILVDASG---LA--------TTTNDVKSFEGTPFWVAPEVVNLK 112
           YLH+RN VHR+IK ANILVD +G   LA           +  KSF+G+P+W+APEV+  +
Sbjct: 117 YLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA-Q 175

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK-LPSVPNSLSRDARDFI 171
             GYGL+ADIWSLGCTVLEM T +PP+S LE + A+F+IGR K LP +P+ LS +A+DFI
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235

Query: 172 LKCLQVNPNDRPTAAQLMEHPFV 194
           LKCLQ +P+ RPTAA+L+EHPFV
Sbjct: 236 LKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  254 bits (652), Expect = 3e-86
 Identities = 100/210 (47%), Positives = 135/210 (64%), Gaps = 21/210 (10%)

Query: 4   FSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILN 60
            S  +H NIV+Y G+E+DE  N L IFLE V  GSL++L +K+  L +  +  YTRQIL 
Sbjct: 53  LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE 112

Query: 61  GLTYLHERNVVHREIKCANILVDASGLA--------------TTTNDVKSFEGTPFWVAP 106
           GL YLH   +VHR+IK ANILVD+ G+                T     S  GTP+W+AP
Sbjct: 113 GLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED-MQALFRIGR-GKLPSVPNSLS 164
           EV+      YG +ADIWSLGCTV+EM T +PP+S L + M AL++IG  G+ P +P  LS
Sbjct: 173 EVIR--GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLS 230

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            +A+DF+ KCL+ +P  RPTA +L++HPF+
Sbjct: 231 EEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  234 bits (600), Expect = 2e-78
 Identities = 91/200 (45%), Positives = 128/200 (64%), Gaps = 15/200 (7%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLH 66
           +H NIV+YIG+ +  + LYI LE  + GSL  + +K+    +S V+ Y  Q+L GL YLH
Sbjct: 57  KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH 116

Query: 67  ERNVVHREIKCANILVDAS--------GLATTTNDV----KSFEGTPFWVAPEVVNLKNN 114
           E+ V+HR+IK ANIL            G+AT  NDV     S  GTP+W+APEV+ +   
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS-- 174

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKC 174
           G   ++DIWSLGCTV+E+LT  PPY  L  M ALFRI +   P +P  +S + +DF+++C
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC 234

Query: 175 LQVNPNDRPTAAQLMEHPFV 194
            Q +PN RPTA QL++HP++
Sbjct: 235 FQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  217 bits (555), Expect = 9e-72
 Identities = 75/201 (37%), Positives = 112/201 (55%), Gaps = 17/201 (8%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+     +DE++LY+ +E  + G L +L +K   LS+ +   Y RQIL+ L YLH 
Sbjct: 56  HPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHS 115

Query: 68  RNVVHREIKCANILVDAS--------GLATTTND---VKSFEGTPFWVAPEVVNLKNNGY 116
           + +VHR++K  NIL+D          GLA   +    + +F GTP ++APEV  L   GY
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEV--LLGKGY 173

Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVP---NSLSRDARDFILK 173
           G + DIWSLG  + E+LT +PP+   + +  LF+      P  P     +S +A+D I K
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233

Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L  +P  R TA + ++HPF 
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  202 bits (516), Expect = 7e-66
 Identities = 84/205 (40%), Positives = 123/205 (60%), Gaps = 17/205 (8%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNG 61
             + +H NIV+Y G+   ++ L+I +E    GSL +L +  +  L++SQ++   +++L G
Sbjct: 51  LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKG 110

Query: 62  LTYLHERNVVHREIKCANILV--DAS------GLA---TTTNDVKSFEGTPFWVAPEVVN 110
           L YLH   ++HR+IK ANIL+  D        GL+   + T    +  GTP+W+APEV+N
Sbjct: 111 LEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN 170

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS--LSRDAR 168
            K   Y   ADIWSLG T +E+   +PPYS L  M+ALF+I     P + N    S + +
Sbjct: 171 GK--PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFK 228

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPF 193
           DF+ KCLQ NP  RPTA QL++HPF
Sbjct: 229 DFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  203 bits (518), Expect = 9e-66
 Identities = 77/205 (37%), Positives = 117/205 (57%), Gaps = 15/205 (7%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTY 64
           SQ     I +Y G+    ++L+I +E    GS  +L +   L ++ ++   R++L GL Y
Sbjct: 54  SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEY 113

Query: 65  LHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNLK 112
           LHE   +HR+IK ANIL+   G            L +T +   +F GTPFW+APEV+  K
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI--K 171

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVP-NSLSRDARDFI 171
            +GY   ADIWSLG T +E+   +PP S L  M+ LF I +   PS+  N  S+  +DF+
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFV 231

Query: 172 LKCLQVNPNDRPTAAQLMEHPFVKR 196
             CL  +P +RP+A +L++H F+K+
Sbjct: 232 SLCLNKDPKERPSAKELLKHKFIKK 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  197 bits (502), Expect = 1e-63
 Identities = 92/208 (44%), Positives = 130/208 (62%), Gaps = 21/208 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTY 64
           + +H+NIVQY+G+  D + L IFLE V  GS+A L   Y    ++ V ++ RQIL GL Y
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121

Query: 65  LHERNVVHREIKCANILVDASG-----------------LATTTNDVK-SFEGTPFWVAP 106
           LH R ++HR+IK ANILVD  G                 L+T TN  + S +G+ FW+AP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
           EVV  K   Y   ADIWSLGC V+EMLT + P+     +QA+F+IG    P +P+++S +
Sbjct: 182 EVV--KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239

Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A DF+ K  +++ N RPTAA+L++HPF+
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  193 bits (492), Expect = 4e-62
 Identities = 75/205 (36%), Positives = 116/205 (56%), Gaps = 20/205 (9%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+ I   +D++ LY+ +E  + G L +   +   LS+ +      QIL GL YLH 
Sbjct: 57  HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHS 116

Query: 68  RNVVHREIKCANILVDAS--------GLATTTN----DVKSFEGTPFWVAPEVVNLKNNG 115
             ++HR++K  NIL+D +        GLA         + +F GTP+++APEV+ L  NG
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL-LGGNG 175

Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSH---LEDMQALFRIGRGKLPS---VPNSLSRDARD 169
           YG   D+WSLG  + E+LT +PP+S    L+ +Q + RI    L       +S S +A+D
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFV 194
            I KCL  +P+ RPTA ++++HP+ 
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  192 bits (490), Expect = 8e-62
 Identities = 82/207 (39%), Positives = 125/207 (60%), Gaps = 19/207 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
              +H+ IVQY G  +D+  L IF+E +  GS+ +  + Y  L+++    YTRQIL G+ 
Sbjct: 59  KNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVE 118

Query: 64  YLHERNVVHREIKCANILVDASG---------------LATTTNDVKSFEGTPFWVAPEV 108
           YLH   +VHR+IK ANIL D++G               + ++   +KS  GTP+W++PEV
Sbjct: 119 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL-PSVPNSLSRDA 167
           ++    GYG  AD+WS+GCTV+EMLT +PP++  E M A+F+I      P +P+ +S DA
Sbjct: 179 IS--GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA 236

Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFV 194
           R+F+ +    N   RP+A +L+ H FV
Sbjct: 237 RNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  190 bits (485), Expect = 5e-61
 Identities = 83/206 (40%), Positives = 124/206 (60%), Gaps = 20/206 (9%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLTYLH 66
           +H NIVQY+G E  E  L IFLE V  GS+ +  + Y   + Q V  +T Q+L GL YLH
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 67  ERNVVHREIKCANILVDASG--------LATTTNDV------KSFEGTPFWVAPEVVNLK 112
            + ++HR++K  N+LVDA G        ++  ++D+       S +G+ FW+APEV++  
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK-LPSVP----NSLSRDA 167
           + GY    DIWSLGC VLEM   + P+S  E + A+F++G  +  P +P     +LS  A
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVA 245

Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPF 193
            DF+  C  +NP++RPTA +L++HPF
Sbjct: 246 LDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  188 bits (480), Expect = 3e-60
 Identities = 88/212 (41%), Positives = 128/212 (60%), Gaps = 21/212 (9%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV-SSYTRQILNGL 62
               +H N+V+Y G E    ++YIF+E    G+L  L +   + D  V   YT Q+L GL
Sbjct: 53  LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGL 112

Query: 63  TYLHERNVVHREIKCANILVDASGL--------------ATTT--NDVKSFEGTPFWVAP 106
            YLH   +VHR+IK ANI +D +G+               TTT   +V+S  GTP ++AP
Sbjct: 113 AYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172

Query: 107 EVVNL-KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED-MQALFRIGRGKLPSVPNS-- 162
           EV+   K  G+G +ADIWSLGC VLEM T + P+S L++  Q +F +G G  P +P+S  
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ 232

Query: 163 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           LS + +DF+ +CL+ +P  RPTA++L++HPFV
Sbjct: 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  187 bits (477), Expect = 7e-60
 Identities = 85/209 (40%), Positives = 130/209 (62%), Gaps = 23/209 (11%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYL 65
            +H NIVQY+GT  D+N + IF+E V  GS++++  ++  L +     YT+QIL+G+ YL
Sbjct: 59  LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL 118

Query: 66  HERNVVHREIKCANILVDASGL------------------ATTTNDVKSFEGTPFWVAPE 107
           H   VVHR+IK  N+++  +G+                   T +N +KS  GTP+W+APE
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG--RGKLPSVPNSLSR 165
           V+N   +GYG  +DIWS+GCTV EM T +PP + ++ + A+F IG  RG +P +P+S S 
Sbjct: 179 VIN--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            A DF+  CL  + ++RP+A QL+ H F+
Sbjct: 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  182 bits (465), Expect = 6e-58
 Identities = 84/206 (40%), Positives = 110/206 (53%), Gaps = 23/206 (11%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLH 66
           H NIV Y G+    ++L+I +E    GSL ++YQ     LS+ Q++   R+ L GL YLH
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 67  ERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVV-NLKN 113
           E   +HR+IK ANIL+   G            L  T    KSF GTP+W+APEV    + 
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERK 178

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSL------SRDA 167
            GY    DIW+LG T +E+   QPP   L  M+ALF I +   P  P  L      S   
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP--PPKLKDKEKWSPVF 236

Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPF 193
            DFI KCL  +P  RPTA +L++HPF
Sbjct: 237 HDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  174 bits (444), Expect = 1e-54
 Identities = 76/211 (36%), Positives = 117/211 (55%), Gaps = 19/211 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGL 62
           S+ +H NIV        EN+L+I +E    G+L ++  +    L++ Q+    RQ+L  L
Sbjct: 57  SECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEAL 116

Query: 63  TYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVV- 109
            +LH   V+HR++K  NIL+   G              +T     +F GTP+W+APEVV 
Sbjct: 117 NFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176

Query: 110 --NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSR 165
               K+N Y   ADIWSLG T++E+   +PP+  L  M+ L +I + + P++  P+  S 
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSS 236

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
              DF+  CL  +P+DRPTAA+L++HPFV  
Sbjct: 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  174 bits (442), Expect = 2e-54
 Identities = 84/209 (40%), Positives = 128/209 (61%), Gaps = 19/209 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK----YHLSDSQVSSYTRQILN 60
           S  +H NIVQY+G++ +     IF+E V  GSL+ L +        ++  +  YT+QIL 
Sbjct: 60  SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119

Query: 61  GLTYLHERNVVHREIKCANILVDA-SG------------LATTTNDVKSFEGTPFWVAPE 107
           GL YLH+  +VHR+IK  N+LV+  SG            LA      ++F GT  ++APE
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE 179

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ-ALFRIGRGKL-PSVPNSLSR 165
           V++    GYG  ADIWSLGCT++EM T +PP+  L + Q A+F++G  K+ P +P SLS 
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA 239

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +A++FIL+C + +P+ R +A  L++ PF+
Sbjct: 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  172 bits (439), Expect = 4e-54
 Identities = 75/205 (36%), Positives = 112/205 (54%), Gaps = 18/205 (8%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLT 63
           Q +   IV+Y G+      L+I +E    GS++++ +     L++ ++++   Q L GL 
Sbjct: 54  QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113

Query: 64  YLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL 111
           YLH    +HR+IK  NIL++  G            L  T     +  GTPFW+APEV  +
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV--I 171

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP--SVPNSLSRDARD 169
           +  GY   ADIWSLG T +EM   +PPYS +  M+A+F I     P  S P   S +  D
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFND 231

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFV 194
           F+ KCL  +P +RP+A QL++HPF+
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  172 bits (437), Expect = 2e-53
 Identities = 73/205 (35%), Positives = 113/205 (55%), Gaps = 18/205 (8%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLH 66
           H NIV Y  +    + L++ +E +  GSL ++  +    +++ Q++   R++L GL YLH
Sbjct: 74  HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH 133

Query: 67  ERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNLKNN 114
            +NV+HR+IK  NIL+   G            L    +   S  GTP+W+APEV+  K  
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI--KRK 191

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDARDFIL 172
            YG   DIWSLG   +EM   +PPY     ++ALF I    +P +  P   S + +DF+ 
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251

Query: 173 KCLQVNPNDRPTAAQLMEHPFVKRP 197
           KCL  +P  RP+A +L++HPF+K+ 
Sbjct: 252 KCLVKDPEKRPSAEELLQHPFLKKA 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  166 bits (424), Expect = 7e-52
 Identities = 61/208 (29%), Positives = 114/208 (54%), Gaps = 21/208 (10%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQIL 59
            +  H NI++Y  + +++ +L I +E    G L+   +K         + Q+  +  Q+ 
Sbjct: 54  KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113

Query: 60  NGLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPE 107
             L YLH R ++HR+IK  NI + ++G            L++T +  K+  GTP++++PE
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKLPSVPNSLSRD 166
           +   +N  Y   +DIWSLGC + E+ T + P+   E++  L  +I +G+ P +P+  S +
Sbjct: 174 L--CQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKILKGQYPPIPSQYSSE 230

Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            R+ +   LQ +P +RP+ AQ+++ PF+
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  165 bits (419), Expect = 4e-51
 Identities = 86/211 (40%), Positives = 126/211 (59%), Gaps = 22/211 (10%)

Query: 4   FSQFEHDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILN 60
               +H+ IVQY G  +D  E  L IF+E +  GS+ +  + Y  L++S    YTRQIL 
Sbjct: 58  LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE 117

Query: 61  GLTYLHERNVVHREIKCANILVDASG---------------LATTTNDVKSFEGTPFWVA 105
           G++YLH   +VHR+IK ANIL D++G               +  +   ++S  GTP+W++
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL-PSVPNSLS 164
           PEV++    GYG  AD+WSLGCTV+EMLT +PP++  E M A+F+I      P +P+ +S
Sbjct: 178 PEVIS--GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHIS 235

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             ARDF L C+ V    RP+A +L+ HPF +
Sbjct: 236 EHARDF-LGCIFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  163 bits (415), Expect = 2e-50
 Identities = 71/210 (33%), Positives = 121/210 (57%), Gaps = 24/210 (11%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
           ++  H +I++ +G   +++   +F+E +  GS+++L  KY    ++ + +YT Q+L GL+
Sbjct: 58  ARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLS 117

Query: 64  YLHERNVVHREIKCANILVDASG-------------LATTTNDVKSFE----GTPFWVAP 106
           YLHE  ++HR++K AN+L+D++G             LA        F+    GT  ++AP
Sbjct: 118 YLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRG-KLPSVPNS 162
           EV  L+   YG S D+WS+GC ++EM T +PP+    H   +  +F+I      PS+P  
Sbjct: 178 EV--LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235

Query: 163 LSRDARDFILKCLQVNPNDRPTAAQLMEHP 192
           LS   RD  L+CL++ P DRP + +L++HP
Sbjct: 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  162 bits (411), Expect = 5e-50
 Identities = 86/205 (41%), Positives = 124/205 (60%), Gaps = 22/205 (10%)

Query: 9   HDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYL 65
           HD IVQY G  +D  E +L IF+E +  GS+ +  + Y  L+++    YTRQIL G++YL
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122

Query: 66  HERNVVHREIKCANILVDASG---------------LATTTNDVKSFEGTPFWVAPEVVN 110
           H   +VHR+IK ANIL D++G               +  +   +KS  GTP+W++PEV++
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG-RGKLPSVPNSLSRDARD 169
               GYG  AD+WS+ CTV+EMLT +PP++  E M A+F+I  +   P +P+ +S   RD
Sbjct: 183 --GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFV 194
           F LK + V    RPTA  L+ HPFV
Sbjct: 241 F-LKQIFVEEKRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  157 bits (399), Expect = 6e-48
 Identities = 72/206 (34%), Positives = 114/206 (55%), Gaps = 20/206 (9%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLH 66
           E   +V+  G    E  + I LE +  GSLA+L +K   + +  ++   RQIL GL YLH
Sbjct: 57  ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH 116

Query: 67  -ERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
            +R+++HR+IK +N+L+++ G            L  T +   +F GT  +++PE +  ++
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES 176

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLED---MQALFRIGRGKLPSVP-NSLSRDARD 169
             Y  +ADIWSLG T+LE    + P+         + +  I  G  PS+P    S + RD
Sbjct: 177 YSY--AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVK 195
           FI  CLQ +P  RP+AA+L++HPF+K
Sbjct: 235 FISACLQKDPKKRPSAAELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  155 bits (394), Expect = 2e-47
 Identities = 85/205 (41%), Positives = 121/205 (59%), Gaps = 22/205 (10%)

Query: 9   HDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYL 65
           H+ IVQY G  +D  E  L IF+E +  GS+ +  + Y  L+++    YTRQIL G++YL
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 66  HERNVVHREIKCANILVDASG---------------LATTTNDVKSFEGTPFWVAPEVVN 110
           H   +VHR+IK ANIL D+ G               +  +   +KS  GTP+W++PEV++
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL-PSVPNSLSRDARD 169
               GYG  ADIWS+GCTV+EMLT +PP++  E M A+F+I      P +P  +S   RD
Sbjct: 183 --GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFV 194
           F LK + V    RP+A +L+ H FV
Sbjct: 241 F-LKRIFVEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  152 bits (385), Expect = 2e-46
 Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 48/203 (23%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGL 62
            +  H NIV+  G  +DEN LY+ +E  + GSL +L ++    LS+ ++     QIL GL
Sbjct: 46  KKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGL 105

Query: 63  TYLHERNVVHREIKCANILVDAS---------GLATTTNDVKSFE----GTPFWVAPEVV 109
            YLH   ++HR++K  NIL+D+          GL+      KS      GTP ++APEV+
Sbjct: 106 EYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVL 165

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
                 Y   +DIWSLG  + E+                                 + +D
Sbjct: 166 L-GKGYYSEKSDIWSLGVILYEL--------------------------------PELKD 192

Query: 170 FILKCLQVNPNDRPTAAQLMEHP 192
            I K LQ +P  RP+A +++EH 
Sbjct: 193 LIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  152 bits (385), Expect = 8e-46
 Identities = 69/198 (34%), Positives = 111/198 (56%), Gaps = 14/198 (7%)

Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNV 70
           NI +Y G+     RL+I +E  + GS+  L +   +++  +S   R++L  L Y+H+  V
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGV 122

Query: 71  VHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNLKNNGYGL 118
           +HR+IK ANILV  +G            L   ++   +F GTP+W+APEV+  +   Y  
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI-TEGKYYDT 181

Query: 119 SADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVP-NSLSRDARDFILKCLQV 177
            ADIWSLG T+ EM T  PPYS ++  +A+  I + K P +  N  S+  R+F+  CL  
Sbjct: 182 KADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDE 241

Query: 178 NPNDRPTAAQLMEHPFVK 195
            P +R +A +L++  ++K
Sbjct: 242 EPKERLSAEELLKSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  146 bits (371), Expect = 7e-44
 Identities = 70/214 (32%), Positives = 109/214 (50%), Gaps = 26/214 (12%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL----YQKYHLSDSQVSSYTRQILN 60
           SQ  H N+V+Y  +    + L++ +  +  GSL ++    Y +  L ++ +++  +++L 
Sbjct: 54  SQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLK 113

Query: 61  GLTYLHERNVVHREIKCANILVDASG------------LATTTNDV----KSFEGTPFWV 104
           GL YLH    +HR+IK  NIL+   G            LA   +      K+F GTP W+
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS-- 162
           APEV+  + +GY   ADIWS G T +E+ T   PYS    M+ L    +   PS+     
Sbjct: 174 APEVME-QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD 232

Query: 163 ---LSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
               S+  R  I  CLQ +P+ RPTA +L++H F
Sbjct: 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  145 bits (367), Expect = 3e-43
 Identities = 73/205 (35%), Positives = 112/205 (54%), Gaps = 14/205 (6%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQ +   I +Y G+     +L+I +E +  GS  +L +   L ++ +++  R+IL GL 
Sbjct: 56  LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLD 115

Query: 64  YLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL 111
           YLH    +HR+IK AN+L+   G            L  T     +F GTPFW+APEV+  
Sbjct: 116 YLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-- 173

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFI 171
           K + Y   ADIWSLG T +E+   +PP S L  M+ LF I +   P++    S+  ++F+
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFV 233

Query: 172 LKCLQVNPNDRPTAAQLMEHPFVKR 196
             CL  +P  RPTA +L++H F+ R
Sbjct: 234 EACLNKDPRFRPTAKELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  145 bits (368), Expect = 3e-43
 Identities = 73/214 (34%), Positives = 114/214 (53%), Gaps = 28/214 (13%)

Query: 9   HDNIVQYIG--TEKD----ENRLYIFLELVKKGSLANLYQKYHLSDSQVS----SYT-RQ 57
           H NI  + G   +K+    +++L++ +EL   GS+ +L +       ++     +Y  R+
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 58  ILNGLTYLHERNVVHREIKCANIL---------VD---ASGLATTTNDVKSFEGTPFWVA 105
            L GL YLHE  V+HR+IK  NIL         VD   ++ L +T     +F GTP+W+A
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181

Query: 106 PEVVNLKNN---GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--P 160
           PEV+         Y   +D+WSLG T +E+   +PP   +  M+ALF+I R   P++  P
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241

Query: 161 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            + S+   DFI +CL  N   RP   +L+EHPF+
Sbjct: 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  144 bits (366), Expect = 4e-43
 Identities = 69/203 (33%), Positives = 102/203 (50%), Gaps = 21/203 (10%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLH 66
            H  IV+     + E +LY+ LE    G L +   K    S+ +   Y  +I+  L YLH
Sbjct: 51  NHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH 110

Query: 67  ERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNLKNN 114
              +++R++K  NIL+DA G            L++  +   +F GTP ++APEV  L   
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEV--LLGK 168

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARDFILK 173
           GYG + D WSLG  + EMLT +PP+   ED + ++  I +  L   P  LS +ARD I  
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDPL-RFPEFLSPEARDLISG 226

Query: 174 CLQVNPNDRPT---AAQLMEHPF 193
            LQ +P  R     A ++  HPF
Sbjct: 227 LLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  144 bits (365), Expect = 1e-42
 Identities = 73/208 (35%), Positives = 115/208 (55%), Gaps = 19/208 (9%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYL 65
            H  IV+ +G    + +L+I +E    G++  +  +    L++ Q+    RQ+L  L YL
Sbjct: 67  NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYL 126

Query: 66  HERNVVHREIKCANILVDASG------LATTTNDVK------SFEGTPFWVAPEVV---N 110
           H   ++HR++K  N+L+   G         +  +VK      SF GTP+W+APEVV    
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDAR 168
           +K+  Y   ADIWSLG T++EM   +PP+  L  M+ L +I + + P++  P+  S + R
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           DF+   L  +P  RP+AAQL+EHPFV  
Sbjct: 247 DFLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  143 bits (361), Expect = 2e-42
 Identities = 73/205 (35%), Positives = 116/205 (56%), Gaps = 14/205 (6%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQ +   + +Y G+   + +L+I +E +  GS  +L +   L ++Q+++  R+IL GL 
Sbjct: 56  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLD 115

Query: 64  YLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL 111
           YLH    +HR+IK AN+L+   G            L  T     +F GTPFW+APEV+  
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-- 173

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFI 171
           K + Y   ADIWSLG T +E+   +PP+S L  M+ LF I +   P++  + S+  ++F+
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV 233

Query: 172 LKCLQVNPNDRPTAAQLMEHPFVKR 196
             CL   P+ RPTA +L++H F+ R
Sbjct: 234 EACLNKEPSFRPTAKELLKHKFIVR 258

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  138 bits (351), Expect = 7e-41
 Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 21/207 (10%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLH 66
              IV + G   +   + I +E +  GSL  + ++    + +  +      +L GLTYLH
Sbjct: 58  SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 67  E-RNVVHREIKCANILVDASGL---------ATTTNDV-KSFEGTPFWVAPEVVNLKNNG 115
           E   ++HR++K +NILV++ G              N + K+F GT  ++APE   ++ N 
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPE--RIQGND 175

Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLED-----MQALFRIGRGKLPSVPNS-LSRDARD 169
           Y + +DIWSLG +++E+ T + PY    D      + L  I     P +P+   S D +D
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKR 196
           F+  CL  +P +RP+  +L+EHPF+K+
Sbjct: 236 FVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  139 bits (351), Expect = 1e-40
 Identities = 66/205 (32%), Positives = 115/205 (56%), Gaps = 16/205 (7%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYL 65
            ++H NIV+   +    + L++ +E ++ G+L ++     +++ Q+++    +L  L++L
Sbjct: 72  DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFL 131

Query: 66  HERNVVHREIKCANILVDASG---------LATTTNDV---KSFEGTPFWVAPEVVNLKN 113
           H + V+HR+IK  +IL+ + G          A  + +V   KS  GTP+W+APEV++   
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS--LSRDARDFI 171
             YG   DIWSLG  V+EM+  +PPY +   +QA+ RI     P + N   +S   R F+
Sbjct: 192 --YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFL 249

Query: 172 LKCLQVNPNDRPTAAQLMEHPFVKR 196
            + L  +P  R TAA+L+ HPF+ +
Sbjct: 250 DRMLVRDPAQRATAAELLNHPFLAK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  139 bits (352), Expect = 1e-40
 Identities = 68/204 (33%), Positives = 109/204 (53%), Gaps = 13/204 (6%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLT 63
           Q  H N ++Y G    E+  ++ +E    GS +++ +  K  L + ++++     L GL 
Sbjct: 71  QLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLA 129

Query: 64  YLHERNVVHREIKCANILVDASGL--------ATTTNDVKSFEGTPFWVAPEVVNLKNNG 115
           YLH    +HR+IK  NIL+   G         A+  +   SF GTP+W+APEV+   + G
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEG 189

Query: 116 -YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV-PNSLSRDARDFILK 173
            Y    D+WSLG T +E+   +PP  ++  M AL+ I +   P++  N  S   R+F+  
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDS 249

Query: 174 CLQVNPNDRPTAAQLMEHPFVKRP 197
           CLQ  P DRP++ +L++H FV R 
Sbjct: 250 CLQKIPQDRPSSEELLKHRFVLRE 273

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  137 bits (345), Expect = 6e-40
 Identities = 73/211 (34%), Positives = 115/211 (54%), Gaps = 15/211 (7%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQ +   + +Y G+     +L+I +E +  GS  +L +     + Q+++  ++IL GL 
Sbjct: 56  LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLD 115

Query: 64  YLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL 111
           YLH    +HR+IK AN+L+   G            L  T     +F GTPFW+APEV+  
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-- 173

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFI 171
           + + Y   ADIWSLG T +E+   +PP S +  M+ LF I +   P++    S+  ++FI
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFI 233

Query: 172 LKCLQVNPNDRPTAAQLMEHPF-VKRPLQTS 201
             CL  +P+ RPTA +L++H F VK   +TS
Sbjct: 234 DACLNKDPSFRPTAKELLKHKFIVKNAKKTS 264

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  137 bits (345), Expect = 8e-40
 Identities = 74/206 (35%), Positives = 114/206 (55%), Gaps = 19/206 (9%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL--ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
           +H NIV+ +     EN L+I +E    G++    L  +  L++ Q+    +Q L  L YL
Sbjct: 60  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119

Query: 66  HERNVVHREIKCANILVDASG---------LATTTNDVK---SFEGTPFWVAPEVV---N 110
           HE  ++HR++K  NIL    G          A  T  ++   SF GTP+W+APEVV    
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDAR 168
            K+  Y   AD+WSLG T++EM   +PP+  L  M+ L +I + + P++  P+  S + +
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFV 194
           DF+ KCL+ N + R T  QL++HPFV
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  136 bits (343), Expect = 9e-40
 Identities = 71/202 (35%), Positives = 103/202 (50%), Gaps = 19/202 (9%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----LSDSQVSSYTRQILNGLT 63
           H NI+ Y     D N+L I +E    G L+    K       + + ++     Q+L GL 
Sbjct: 58  HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 64  YLHERNVVHREIKCANILVDASGL----------ATTTNDVKSFEGTPFWVAPEVVNLKN 113
            LHE+ ++HR++K ANIL+ A+ L              N  K+  GTP ++APEV   K 
Sbjct: 118 ALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEV--WKG 175

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL-FRIGRGKLPSVPNSLSRDARDFIL 172
             Y   +DIWSLGC + EM T  PP+     MQ L +++ RGK P +P   S+D ++FI 
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234

Query: 173 KCLQVNPNDRPTAAQLMEHPFV 194
             LQV P  RP   +++  P V
Sbjct: 235 SMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  133 bits (338), Expect = 1e-38
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 40/222 (18%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHE 67
           H  I++   T +DE  LY  LE    G L    +KY  L +     Y  +IL  L YLH 
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 68  RNVVHREIKCANILVD-----------------ASGLATTTNDV---------------K 95
           + ++HR++K  NIL+D                  +    +                    
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 96  SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK 155
           SF GT  +V+PE+  L     G S+D+W+LGC + +MLT +PP+    +     +I + +
Sbjct: 181 SFVGTAEYVSPEL--LNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238

Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTA----AQLMEHPF 193
             S P +   DA+D I K L ++P DR        +L  HPF
Sbjct: 239 Y-SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  133 bits (336), Expect = 2e-38
 Identities = 70/209 (33%), Positives = 115/209 (55%), Gaps = 18/209 (8%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           +H NIV Y+ +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +LH 
Sbjct: 74  KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS 133

Query: 68  RNVVHREIKCANILVDASGLATTT------------NDVKSFEGTPFWVAPEVVNLKNNG 115
             V+HR+IK  NIL+   G    T            +   +  GTP+W+APEVV  K   
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-- 191

Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN--SLSRDARDFILK 173
           YG   DIWSLG   +EM+  +PPY +   ++AL+ I     P + N   LS   RDF+ +
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251

Query: 174 CLQVNPNDRPTAAQLMEHPFVK--RPLQT 200
           CL+++   R +A +L++HPF+K  +PL +
Sbjct: 252 CLEMDVEKRGSAKELLQHPFLKIAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  132 bits (334), Expect = 3e-38
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 32/217 (14%)

Query: 5   SQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQ 57
            + +H NIV+Y     D     LYI +E  + G LA L QK      ++ +  +     Q
Sbjct: 54  RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113

Query: 58  ILNGLTYLHERN-----VVHREIKCANILVDAS--------GLA----TTTNDVKSFEGT 100
           +L  L   H R+     V+HR++K ANI +DA+        GLA      ++  K++ GT
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173

Query: 101 PFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPP---YSHLEDMQALFRIGRGKLP 157
           P++++PE +N  +  Y   +DIWSLGC + E+    PP    + L+      +I  GK  
Sbjct: 174 PYYMSPEQLN--HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS---KIKEGKFR 228

Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            +P   S +  + I   L V+P+ RP+  +L++ P +
Sbjct: 229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  130 bits (329), Expect = 1e-37
 Identities = 75/204 (36%), Positives = 112/204 (54%), Gaps = 18/204 (8%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLH 66
           +H NIV Y G+    ++L+I +E    GSL ++Y     LS+SQ++  +R+ L GL YLH
Sbjct: 64  KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123

Query: 67  ERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL-KN 113
            +  +HR+IK ANIL+  +G            +  T    KSF GTP+W+APEV  + + 
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL--PSVPNSL--SRDARD 169
            GY    DIW++G T +E+   QPP   L  M+ALF + +     P + + +  S     
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243

Query: 170 FILKCLQVNPNDRPTAAQLMEHPF 193
           F+   L  NP  RPTA +L++HPF
Sbjct: 244 FVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  129 bits (326), Expect = 3e-37
 Identities = 76/210 (36%), Positives = 110/210 (52%), Gaps = 18/210 (8%)

Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILN 60
           F   + +H NIV Y G+     +L+I +E    GSL ++Y     LS+ Q++   R+ L 
Sbjct: 58  FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ 117

Query: 61  GLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEV 108
           GL YLH +  +HR+IK ANIL+  +G            +  T    KSF GTP+W+APEV
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177

Query: 109 VNL-KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL--PSVPNSL-- 163
             + KN GY    DIW++G T +E+   QPP   L  M+ALF + +     P + +    
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW 237

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
           S    +F+   L  NP  RPTA +L+ H F
Sbjct: 238 SSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  127 bits (321), Expect = 4e-36
 Identities = 62/220 (28%), Positives = 110/220 (50%), Gaps = 32/220 (14%)

Query: 5   SQFEHDNIVQYIGT--EKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSY-----TRQ 57
              +   IV+Y G   ++  + + I +E  + GSL ++Y+K      ++           
Sbjct: 54  KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAES 113

Query: 58  ILNGLTYLHERNVVHREIKCANILVD-----------ASGLATTTNDVKSFEGTPFWVAP 106
           +L GL+YLH R ++HR+IK +NIL+             SG    +    +F GT F++AP
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-GTFTGTSFYMAP 172

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQ--------PPYSHLEDMQALFRIGRGKL-- 156
           E   ++   Y +++D+WSLG T+LE+  ++        PP   +E +  +  +   +L  
Sbjct: 173 E--RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD 230

Query: 157 -PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
            P      S + +DFI +CL+ +P  RPT   ++EHP++K
Sbjct: 231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  127 bits (319), Expect = 6e-36
 Identities = 69/206 (33%), Positives = 114/206 (55%), Gaps = 18/206 (8%)

Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNV 70
           NIV Y+ +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +LH   V
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQV 136

Query: 71  VHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGL 118
           +HR+IK  NIL+   G    T+               +  GTP+W+APEVV  K   YG 
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGP 194

Query: 119 SADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDARDFILKCLQ 176
             DIWSLG   +EM+  +PPY +   ++AL+ I     P +  P  LS   RDF+ +CL+
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLE 254

Query: 177 VNPNDRPTAAQLMEHPFVK--RPLQT 200
           ++ + R +A +L++HPF+K  +PL +
Sbjct: 255 MDVDRRGSAKELLQHPFLKLAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  126 bits (318), Expect = 6e-36
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 18/203 (8%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             + +H N+V+ +G   +E  LYI +E ++ G L +  +K    LS S + S+  QI  G
Sbjct: 55  MRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPEV 108
           + YL  +N +HR++   N LV  +        GL+     +D     G      W+APE 
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPES 174

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA 167
             LK   +   +D+WS G  + E+ T  + PY  + + + L  +  G     P +   + 
Sbjct: 175 --LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPEL 232

Query: 168 RDFILKCLQVNPNDRPTAAQLME 190
            D +L+C   +P DRPT ++L+E
Sbjct: 233 YDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  126 bits (318), Expect = 9e-36
 Identities = 67/211 (31%), Positives = 117/211 (55%), Gaps = 18/211 (8%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYL 65
           + ++ NIV ++ +    + L++ +E +  GSL ++  +  + ++Q+++  R+ L  L +L
Sbjct: 72  ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFL 131

Query: 66  HERNVVHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKN 113
           H   V+HR+IK  N+L+   G    T+               +  GTP+W+APEVV  K 
Sbjct: 132 HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK- 190

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDARDFI 171
             YG   DIWSLG   +EM+  +PPY +   ++AL+ I     P +  P  LS   RDF+
Sbjct: 191 -AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249

Query: 172 LKCLQVNPNDRPTAAQLMEHPFVK--RPLQT 200
            +CL+++   R +A +L++HPF+K  +PL +
Sbjct: 250 NRCLEMDVEKRGSAKELLQHPFLKLAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  126 bits (317), Expect = 2e-35
 Identities = 70/203 (34%), Positives = 113/203 (55%), Gaps = 13/203 (6%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLT 63
           Q +H N ++Y G    E+  ++ +E    GS ++L +  K  L + ++++ T   L GL 
Sbjct: 77  QLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLA 135

Query: 64  YLHERNVVHREIKCANILVDASGL--------ATTTNDVKSFEGTPFWVAPEVVNLKNNG 115
           YLH  N++HR+IK  NIL+   G         A+ ++   SF GTP+W+APEV+   + G
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEG 195

Query: 116 -YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV-PNSLSRDARDFILK 173
            Y    D+WSLG T +E+   +PP  ++  M AL+ I +   P++  N  +   R F+  
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255

Query: 174 CLQVNPNDRPTAAQLMEHPFVKR 196
           CLQ  P +RP +A+L+ H FV+R
Sbjct: 256 CLQKIPQERPASAELLRHDFVRR 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  125 bits (316), Expect = 2e-35
 Identities = 70/209 (33%), Positives = 116/209 (55%), Gaps = 19/209 (9%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           ++H N+V+   +      L++ +E ++ G+L ++  +  L++ Q+++    +L  L YLH
Sbjct: 75  YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLH 134

Query: 67  ERNVVHREIKCANILVDASG---------LATTTNDV---KSFEGTPFWVAPEVVNLKNN 114
            + V+HR+IK  +IL+   G          A  + DV   KS  GTP+W+APEV++    
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS--RT 192

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS--LSRDARDFIL 172
            YG   DIWSLG  V+EM+  +PPY     +QA+ R+     P + N+  +S   RDF+ 
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE 252

Query: 173 KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           + L   P +R TA +L++HPF+   LQT 
Sbjct: 253 RMLTREPQERATAQELLDHPFL---LQTG 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  124 bits (314), Expect = 3e-35
 Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 21/205 (10%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +  H NIV+ +G       LYI  E +  G L +  +K+   L+   +     QI  G+
Sbjct: 56  KKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTND----VKSFEGTPF---WVAPE 107
            YL  +N VHR++   N LV  +        GL+    +     K   G      W+APE
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR-GGGKLPIKWMAPE 174

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
              LK+  +   +D+WS G  + E+ T  + PY  + + + L  +  G     P +   +
Sbjct: 175 S--LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDE 232

Query: 167 ARDFILKCLQVNPNDRPTAAQLMEH 191
             + +L+C   +P DRPT ++L+E 
Sbjct: 233 LYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  124 bits (315), Expect = 3e-35
 Identities = 67/237 (28%), Positives = 103/237 (43%), Gaps = 58/237 (24%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLT 63
           + +H NIV+ +     E +LY+  E      L     K    LS + + S   Q+L GL 
Sbjct: 54  ELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATT--------TNDVKSFEGTPFWVAPE 107
           Y H   ++HR++K  NIL++          GLA          T++V     T ++ APE
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV----TLWYRAPE 168

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRI------------- 151
           ++ L +  Y  + DIWS+GC   EM+T +P +   S + D   LF+I             
Sbjct: 169 IL-LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQ--LFKIFQILGTPTEESWP 224

Query: 152 GRGKLP---------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
           G  KLP                V   L  +  D + K LQ NP  R +A + ++HP+
Sbjct: 225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  123 bits (311), Expect = 6e-35
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 19/204 (9%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILN 60
             + +H NIV+ +G   +E  L I +E +  G L +  +K     LS S + S+  QI  
Sbjct: 55  MRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ YL  +N +HR++   N LV  +        GL+     +D    +G      W+APE
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE 174

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
              LK   +   +D+WS G  + E+ T  + PY  + + + L  + +G     P +   +
Sbjct: 175 S--LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPE 232

Query: 167 ARDFILKCLQVNPNDRPTAAQLME 190
               +L+C   +P DRPT ++L+E
Sbjct: 233 LYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  124 bits (314), Expect = 1e-34
 Identities = 69/209 (33%), Positives = 108/209 (51%), Gaps = 23/209 (11%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDS-QVSSYTRQILNGLTYLH 66
            H N+V+          + + LE +  GSL       H++D   ++   RQIL+G+ YLH
Sbjct: 130 NHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLH 185

Query: 67  ERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVN--LK 112
            R++VHR+IK +N+L++++             LA T +   S  GT  +++PE +N  L 
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLN 245

Query: 113 NNGY-GLSADIWSLGCTVLEMLTHQPPY--SHLEDMQALF-RIGRGKLPSVPNSLSRDAR 168
           +  Y G + DIWSLG ++LE    + P+      D  +L   I   + P  P + SR+ R
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR 305

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVKRP 197
            FI  CLQ  P  R +A QL++HPF+ R 
Sbjct: 306 HFISCCLQREPAKRWSAMQLLQHPFILRA 334

Length = 353

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  123 bits (310), Expect = 2e-34
 Identities = 70/205 (34%), Positives = 110/205 (53%), Gaps = 13/205 (6%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNG 61
             +  H N +QY G    E+  ++ +E    GS ++L +  K  L + ++++ T   L G
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQG 127

Query: 62  LTYLHERNVVHREIKCANILVDASGL--------ATTTNDVKSFEGTPFWVAPEVVNLKN 113
           L YLH  N++HR++K  NIL+   GL        A+       F GTP+W+APEV+   +
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMD 187

Query: 114 NG-YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV-PNSLSRDARDFI 171
            G Y    D+WSLG T +E+   +PP  ++  M AL+ I + + P++     S   R+F+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247

Query: 172 LKCLQVNPNDRPTAAQLMEHPFVKR 196
             CLQ  P DRPT+  L++H FV R
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  123 bits (310), Expect = 2e-34
 Identities = 71/205 (34%), Positives = 114/205 (55%), Gaps = 13/205 (6%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNG 61
             + +H N ++Y G    E+  ++ +E    GS ++L +  K  L + ++++ T   L G
Sbjct: 79  LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQG 137

Query: 62  LTYLHERNVVHREIKCANILVDASGL--------ATTTNDVKSFEGTPFWVAPEVVNLKN 113
           L YLH  N++HR+IK  NIL+   G         A+  +   SF GTP+W+APEV+   +
Sbjct: 138 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMD 197

Query: 114 NG-YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV-PNSLSRDARDFI 171
            G Y    D+WSLG T +E+   +PP  ++  M AL+ I + + P++  N  S   R+F+
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257

Query: 172 LKCLQVNPNDRPTAAQLMEHPFVKR 196
             CLQ  P DRPT+ +L++H FV R
Sbjct: 258 DSCLQKIPQDRPTSEELLKHMFVLR 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  122 bits (308), Expect = 2e-34
 Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 31/219 (14%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGL 62
            SQ +   +V+   + + +  LY+ +E +  G LA+L +    L +     Y  +I+  L
Sbjct: 47  LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLAL 106

Query: 63  TYLHERNVVHREIKCANILVDASG--------------------LATTTNDVKSFEGTPF 102
            YLH   ++HR++K  NIL+D++G                    L     + K   GTP 
Sbjct: 107 EYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKL--PSV 159
           ++APEV  +   G+  + D WSLGC + E L   PP+ H E  + +F  I  GK+  P  
Sbjct: 167 YIAPEV--ILGQGHSKTVDWWSLGCILYEFLVGIPPF-HGETPEEIFQNILNGKIEWPED 223

Query: 160 PNSLSRDARDFILKCLQVNPNDRPTAA---QLMEHPFVK 195
              +S +A D I K L  +P  R  A    ++  HPF K
Sbjct: 224 VE-VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  122 bits (307), Expect = 2e-34
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 22/205 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY-----QKYHLSDSQVSSYTRQILN 60
           Q +H N+++Y+ +  + N L I LEL   G L+ +      QK  + +  +  Y  Q+ +
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117

Query: 61  GLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEV 108
            L ++H + ++HR+IK AN+ + A+G             ++ T    S  GTP++++PE 
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPP-YSHLEDMQALF-RIGRGKLPSVPNS-LSR 165
           +    NGY   +DIWSLGC + EM   Q P Y    ++ +L  +I +   P +P    S 
Sbjct: 178 I--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSE 235

Query: 166 DARDFILKCLQVNPNDRPTAAQLME 190
           + RD + +C+  +P  RP  + +++
Sbjct: 236 ELRDLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  124 bits (312), Expect = 3e-34
 Identities = 69/229 (30%), Positives = 104/229 (45%), Gaps = 36/229 (15%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH----LSDSQVSSYTRQILNGLTY 64
             NIV+     +DE  LY+ +E V  GSL +L +K      LS+S+      QIL+ L Y
Sbjct: 57  PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116

Query: 65  LHERNVVHREIKCANILVDAS---------GLA----------TTTNDVKSFEGTPFWVA 105
           LH + ++HR+IK  NIL+D           GLA          +      +  GTP ++A
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 106 PEVVNLKNNG-YGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRIGRGKLPSVP 160
           PEV+   +      S+DIWSLG T+ E+LT  PP+    +     Q L  I     PS+ 
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 161 NSLSRD--------ARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           + LS          A D + K L  +P +R +++  + H  +       
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285

Length = 384

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  121 bits (305), Expect = 3e-34
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNG 61
           ++ +   I++Y  +  D+ +L I +E  + G L  L +      L + QV  +  QIL G
Sbjct: 54  AKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG 113

Query: 62  LTYLHERNVVHREIKCANILVD------------ASGLATTTNDVKSFEGTPFWVAPEVV 109
           L +LH + ++HR+IK  N+ +D            A  L+  TN   +  GTP++++PE+ 
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC 173

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDAR 168
             K   Y   +D+W+LG  + E  T + P+    +  AL   I RG  P V    S+   
Sbjct: 174 EDKP--YNEKSDVWALGVVLYECCTGKHPFD-ANNQGALILKIIRGVFPPVSQMYSQQLA 230

Query: 169 DFILKCLQVNPNDRPTAAQLMEHP 192
             I +CL  +   RP   QL+ +P
Sbjct: 231 QLIDQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  122 bits (307), Expect = 4e-34
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 18/206 (8%)

Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNV 70
           NIV Y+ +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +LH   V
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 71  VHREIKCANILVDASGLATTTN----------DVKSFE--GTPFWVAPEVVNLKNNGYGL 118
           +HR+IK  NIL+   G    T+            K     GTP+W+APEVV  K   YG 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGP 195

Query: 119 SADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDARDFILKCLQ 176
             DIWSLG   +EM+  +PPY +   ++AL+ I     P +  P  LS   RDF+ +CL 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 177 VNPNDRPTAAQLMEHPFVK--RPLQT 200
           ++   R +A +L++H F+K  +PL +
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSS 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  120 bits (301), Expect = 1e-33
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 18/207 (8%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILN 60
            ++ +H NIV +  + ++  RL+I +E    G L     +      S+ Q+ S+  QI  
Sbjct: 53  LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL 112

Query: 61  GLTYLHERNVVHREIKCANILVDASGL---------ATTTNDVKSFE----GTPFWVAPE 107
           GL ++H+R ++HR+IK  NI +  +G+         A   ND         GTP++++PE
Sbjct: 113 GLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPE 172

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA 167
           +   +N  Y    DIWSLGC + E+ T + P+      Q + +I +G    +  + SRD 
Sbjct: 173 IC--QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDL 230

Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFV 194
           R  I +  +V+P DRP+   +++ PF+
Sbjct: 231 RSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  119 bits (299), Expect = 3e-33
 Identities = 71/211 (33%), Positives = 108/211 (51%), Gaps = 25/211 (11%)

Query: 9   HDNIVQYIGTEKDEN------RLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQIL 59
           H NI  Y G    +N      +L++ +E    GS+ +L +      L +  ++   R+IL
Sbjct: 62  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121

Query: 60  NGLTYLHERNVVHREIKCANILVD------------ASGLATTTNDVKSFEGTPFWVAPE 107
            GL++LH+  V+HR+IK  N+L+             ++ L  T     +F GTP+W+APE
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 181

Query: 108 VVNLKNN---GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN-SL 163
           V+    N    Y   +D+WSLG T +EM    PP   +  M+ALF I R   P + +   
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 241

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           S+  + FI  CL  N + RPT  QLM+HPF+
Sbjct: 242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  118 bits (298), Expect = 8e-33
 Identities = 71/232 (30%), Positives = 111/232 (47%), Gaps = 46/232 (19%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLT 63
           Q  H+N+V  I   + + RLY+  E V    L +L +KY   L +S+V  Y  QIL G+ 
Sbjct: 56  QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL-EKYPNGLDESRVRKYLFQILRGIE 114

Query: 64  YLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL 111
           + H  N++HR+IK  NILV  SG            LA        +  T ++ APE++ +
Sbjct: 115 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL-V 173

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG----------------- 154
            +  YG + DIW++GC V EMLT +P +    D+  L+ I +                  
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233

Query: 155 ----KLPSVPNSLSRDAR---------DFILKCLQVNPNDRPTAAQLMEHPF 193
               +LP V      + R         D   +CL+++P+DRP+++QL+ H F
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  118 bits (298), Expect = 1e-32
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 18/204 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
               H  +V   G+ +D++ LY+ +E V  G L +  +K       V+  Y  Q++  L 
Sbjct: 56  QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115

Query: 64  YLHERNVVHREIKCANILVDASGLATTT---------NDVKSFEGTPFWVAPEVVNLKNN 114
           YLH  ++V+R++K  N+L+D+ G    T             +  GTP ++APE++  K  
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSK-- 173

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKC 174
           GYG + D W+LG  + EML   PP+     +Q   +I  GK+   P+  S DA+D I   
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV-RFPSFFSPDAKDLIRNL 232

Query: 175 LQVNP-----NDRPTAAQLMEHPF 193
           LQV+      N +     +  HP+
Sbjct: 233 LQVDLTKRLGNLKNGVNDIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  118 bits (296), Expect = 1e-32
 Identities = 67/203 (33%), Positives = 114/203 (56%), Gaps = 16/203 (7%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           + H+N+V    +    + L++ +E ++ G+L ++     +++ Q+++    +L  L+YLH
Sbjct: 76  YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLH 135

Query: 67  ERNVVHREIKCANILVDASG---------LATTTNDV---KSFEGTPFWVAPEVVNLKNN 114
            + V+HR+IK  +IL+ + G          A  + +V   KS  GTP+W+APEV++    
Sbjct: 136 NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVIS--RL 193

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS--LSRDARDFIL 172
            YG   DIWSLG  V+EM+  +PPY +   +QA+ RI     P V +S  +S   R F+ 
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253

Query: 173 KCLQVNPNDRPTAAQLMEHPFVK 195
             L   P+ R TA +L++HPF+K
Sbjct: 254 LMLVREPSQRATAQELLQHPFLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  117 bits (295), Expect = 2e-32
 Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 46/233 (19%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL-YQKYHLSDSQVSSYTRQILNGLTY 64
           Q  H+NIV      + + RLY+  E V++  L  L      L    V SY  Q+L  + Y
Sbjct: 56  QLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAY 115

Query: 65  LHERNVVHREIKCANILVDASGL-------------ATTTNDVKSFEGTPFWVAPEVVNL 111
            H  N++HR+IK  NILV  SG+             A   + +  +  T ++ APE++ +
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL-V 174

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--GKLPS----------- 158
            +  YG   D+W++GC + E+L  +P +    D+  L+ I +  G LP            
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234

Query: 159 ------------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
                              P  +S  A DF+  CL+++P +R T  +L++HP+
Sbjct: 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  116 bits (293), Expect = 3e-32
 Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 17/205 (8%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY---QKYHLSDSQVSSYTRQILN 60
            S  +H NI+ Y     D+N L I +E    G+L +     +     +  V  Y  QI++
Sbjct: 53  LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVS 112

Query: 61  GLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEV 108
            ++Y+H+  ++HR+IK  NI +  +G            L +  +  ++  GTP++++PE+
Sbjct: 113 AVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
              +   Y   +DIW+LGC + E+LT +  +     +  + +I +G    V +  S +  
Sbjct: 173 C--QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELI 230

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPF 193
             +   LQ +P  RPTA ++++ P 
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 9e-32
 Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 51/236 (21%)

Query: 6   QFEHDNIVQYIG--TEKDENRLYIFLELVK---KGSLANLYQKYHLSDSQVSSYTRQILN 60
           +  H NIV+     T K +  +Y+  E +     G L +   +   ++SQ+  Y +Q+L 
Sbjct: 54  KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS--PEVKFTESQIKCYMKQLLE 111

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTP----FWV-APE 107
           GL YLH   ++HR+IK +NIL++          GLA       S + T      W   PE
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRI----------GRG 154
           ++ L    YG   D+WS+GC + E+   +P +   + LE ++ +F +          G  
Sbjct: 172 LL-LGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230

Query: 155 KLP---------SVPNSL--------SRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
           KLP              L           A D + K L ++P  R +A Q ++H +
Sbjct: 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 2e-31
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 27/209 (12%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL----------ANLYQKYHLSDSQVSSY 54
            +  H N+V+ +G   +E  LY+ LE ++ G L              +K  LS   + S+
Sbjct: 51  KKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110

Query: 55  TRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA---TTTNDVKSFEGTPF- 102
             QI  G+ YL  +  VHR++   N LV           GL+      +  +   G    
Sbjct: 111 AIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP 170

Query: 103 --WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSV 159
             W+APE   LK+  +   +D+WS G  + E+ T    PY  L + + L  + +G     
Sbjct: 171 IRWMAPES--LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK 228

Query: 160 PNSLSRDARDFILKCLQVNPNDRPTAAQL 188
           P     +  + +L C Q++P DRPT ++L
Sbjct: 229 PEYCPDELYELMLSCWQLDPEDRPTFSEL 257

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  114 bits (287), Expect = 2e-31
 Identities = 57/190 (30%), Positives = 94/190 (49%), Gaps = 19/190 (10%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H  IV+   T KD+  +Y+ +E    G L   L  +    +     Y   ++    YLH 
Sbjct: 52  HPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN 111

Query: 68  RNVVHREIKCANILVDASGL-----------ATTTNDVKSFEGTPFWVAPEVVNLKNNGY 116
           R +++R++K  N+L+D++G              +     +F GTP +VAPE++   N GY
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEII--LNKGY 169

Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQ-ALFRI---GRGKLPSVPNSLSRDARDFIL 172
             S D WSLG  + E+LT +PP+   ++    ++     G GKL   PN + + A+D I 
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF-PNYIDKAAKDLIK 228

Query: 173 KCLQVNPNDR 182
           + L+ NP +R
Sbjct: 229 QLLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  114 bits (287), Expect = 3e-31
 Identities = 67/214 (31%), Positives = 111/214 (51%), Gaps = 27/214 (12%)

Query: 8   EHDNIVQYIGT-----EKDENRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQ 57
           +H N+V++ G       K+ ++L++ LEL   GS+ +L + +      + +  ++    +
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 58  ILNGLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVA 105
            L GL +LH    +HR++K  NIL+   G            L +T     +  GTPFW+A
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192

Query: 106 PEVVNLK---NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--P 160
           PEV+  +   ++ Y    D+WSLG T +E+    PP + L  M+ALF+I R   P++  P
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP 252

Query: 161 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
              S +  DFI KCL  +   RPT + L++H F+
Sbjct: 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  114 bits (286), Expect = 3e-31
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 19/207 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
            Q E   + +   + + ++ LY+ +E +  G  A+L +    L +     Y  +++ G+ 
Sbjct: 52  IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVE 111

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWVAPEVVNLKNNG 115
            LH+R ++HR+IK  N+L+D +        GL+    + K F GTP ++APE +     G
Sbjct: 112 DLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETIL--GVG 169

Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKL---PSVPNSLSRDARDFI 171
               +D WSLGC + E L   PP+ H E   A+F  I   ++     V    S +A D I
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPF-HAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLI 228

Query: 172 LKCLQVNPNDRPTA---AQLMEHPFVK 195
            + L ++P  R  A    ++  HPF K
Sbjct: 229 NRLLCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  114 bits (286), Expect = 3e-31
 Identities = 72/211 (34%), Positives = 106/211 (50%), Gaps = 25/211 (11%)

Query: 9   HDNIVQYIGT------EKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQIL 59
           H NI  Y G          +++L++ +E    GS+ +L +      L +  ++   R+IL
Sbjct: 72  HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131

Query: 60  NGLTYLHERNVVHREIKCANIL---------VD---ASGLATTTNDVKSFEGTPFWVAPE 107
            GL +LH   V+HR+IK  N+L         VD   ++ L  T     +F GTP+W+APE
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 191

Query: 108 VVNLKNN---GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN-SL 163
           V+    N    Y   +DIWSLG T +EM    PP   +  M+ALF I R   P + +   
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKW 251

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           S+   DFI  CL  N   RP+  QL++HPF+
Sbjct: 252 SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  112 bits (282), Expect = 6e-30
 Identities = 65/243 (26%), Positives = 111/243 (45%), Gaps = 59/243 (24%)

Query: 7   FEHDNIVQ-----YIGTEKDENRLYIFLELVKKGSLANLYQ----KYHLSDSQVSSYTRQ 57
             H+NI+         + +D N +YI  EL++     +L++       L+D  +  +  Q
Sbjct: 56  LRHENIIGLLDILRPPSPEDFNDVYIVTELME----TDLHKVIKSPQPLTDDHIQYFLYQ 111

Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEG--TPFWV--- 104
           IL GL YLH  NV+HR++K +NILV+++        GLA   +  +  +G  T + V   
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 105 --APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRI-------- 151
             APE++ L ++ Y  + DIWS+GC   E+LT +P +    +++ +  +  +        
Sbjct: 172 YRAPELL-LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230

Query: 152 --------------GRGKLPSVPNS-----LSRDARDFILKCLQVNPNDRPTAAQLMEHP 192
                            K P  P S      S +A D + K L  +P  R TA + + HP
Sbjct: 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290

Query: 193 FVK 195
           ++ 
Sbjct: 291 YLA 293

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  110 bits (277), Expect = 8e-30
 Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 22/207 (10%)

Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLY----QKYHLSDSQVSSYTRQILNGLTYLHE 67
           IV + G    E  +Y+ +E +  GSL  LY        + +  +   T  ++ GL +L E
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120

Query: 68  R-NVVHREIKCANILVDASG------LATTTNDVKSFEGTPF----WVAPE---VVNLKN 113
             N++HR++K  N+LV+ +G         + N V S   T      ++APE         
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180

Query: 114 NG-YGLSADIWSLGCTVLEMLTHQ---PPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
           N  Y + +D+WSLG ++LEM   +   PP ++      L  I  G  P++P+  S DA+D
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQD 240

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKR 196
           F+ KCL   PN RPT AQL+EHP++ +
Sbjct: 241 FVAKCLNKIPNRRPTYAQLLEHPWLVK 267

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 9e-30
 Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 55/236 (23%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----KYHLSDSQVSSYTRQILN 60
           +  H NI++ +   + +  LY+  E +      +LY+     +  L +S + SY  Q+L 
Sbjct: 54  ELNHPNIIKLLDVFRHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQLLQ 109

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           GL + H   ++HR++K  N+L++          GLA +         T + V     APE
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRWYRAPE 168

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG------------- 154
           ++ L + GY    DIWS+GC   E+L+ +P +    ++  LF+I R              
Sbjct: 169 LL-LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227

Query: 155 --------KLPS---------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
                     P           PN  S  A D + + L  +P+ R TA Q + HP+
Sbjct: 228 SLARNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  108 bits (272), Expect = 3e-29
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 23/209 (11%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH------LSDSQVSSYTRQ 57
            S  +H NIVQY  + ++   LYI ++  + G   +LY+K +        + Q+  +  Q
Sbjct: 53  LSNMKHPNIVQYQESFEENGNLYIVMDYCEGG---DLYKKINAQRGVLFPEDQILDWFVQ 109

Query: 58  ILNGLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVA 105
           I   L ++H+R ++HR+IK  NI +   G            L +T    ++  GTP++++
Sbjct: 110 ICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLS 169

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           PE+   +N  Y   +DIW+LGC + EM T +  +        + +I RG  P V +  S 
Sbjct: 170 PEIC--ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSY 227

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           D R+ + +  + NP DRP+   ++E  F+
Sbjct: 228 DLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  108 bits (272), Expect = 5e-29
 Identities = 61/204 (29%), Positives = 114/204 (55%), Gaps = 16/204 (7%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           ++H+N+V+   +    + L++ +E ++ G+L ++     +++ Q+++    +L  L+ LH
Sbjct: 74  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLH 133

Query: 67  ERNVVHREIKCANILVDASG---------LATTTNDV---KSFEGTPFWVAPEVVNLKNN 114
            + V+HR+IK  +IL+   G          A  + +V   KS  GTP+W+APE+++    
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS--RL 191

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN--SLSRDARDFIL 172
            YG   DIWSLG  V+EM+  +PPY +   ++A+  I     P + N   +S   + F+ 
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLD 251

Query: 173 KCLQVNPNDRPTAAQLMEHPFVKR 196
           + L  +P  R TAA+L++HPF+ +
Sbjct: 252 RLLVRDPAQRATAAELLKHPFLAK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  108 bits (271), Expect = 6e-29
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 24/213 (11%)

Query: 10  DNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV-----SSYTRQILNGLTY 64
              V + G    E  ++I +E++   SL   Y+K +     +           I+  L Y
Sbjct: 60  PYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118

Query: 65  LHER-NVVHREIKCANILVDASG------LATTTNDVKSFEGT------PFWVAPEVVN- 110
           LH + +V+HR++K +N+L++ +G         +   V S   T      P+ +APE +N 
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPY-MAPERINP 177

Query: 111 -LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-QALFRIGRGKLPSVPN-SLSRDA 167
            L   GY + +D+WSLG T++E+ T + PY   +   Q L ++     P +P    S + 
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237

Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQT 200
           +DF+ KCL+ N  +RP   +L++HPF +  L  
Sbjct: 238 QDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  107 bits (268), Expect = 2e-28
 Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 20/194 (10%)

Query: 22  ENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           + +L++ L+ V  G L  +LYQ+ H ++S+V  Y  +I+  L +LH+  +++R+IK  NI
Sbjct: 77  DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENI 136

Query: 81  LVDASG-------------LATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGC 127
           L+D+ G             LA       SF GT  ++APEV+   + G+  + D WSLG 
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV 196

Query: 128 TVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSRDARDFILKCLQVNPNDR-- 182
              E+LT   P++   +  +   I R  L   P  P ++S +ARDFI K L+ +P  R  
Sbjct: 197 LTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLG 256

Query: 183 -PTAAQLMEHPFVK 195
              A ++  HPF +
Sbjct: 257 ANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  105 bits (264), Expect = 4e-28
 Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 26/211 (12%)

Query: 4   FSQFEHDNIVQYIGT-EKDENRLYIFLELVKKGSLANLYQKYH------LSDSQVSSYTR 56
            SQ +H NIV Y  + E ++  LYI +   + G   +LY K        L ++QV  +  
Sbjct: 53  LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFV 109

Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS--------GLA---TTTNDVKS-FEGTPFWV 104
           QI   L YLHE++++HR++K  N+ +  +        G+A       D+ S   GTP+++
Sbjct: 110 QIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYM 169

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL-FRIGRGKLPSVPNSL 163
           +PE+    N  Y   +D+W+LGC V EM T +  ++  +DM +L +RI  GKLP +P   
Sbjct: 170 SPEL--FSNKPYNYKSDVWALGCCVYEMATLKHAFN-AKDMNSLVYRIIEGKLPPMPKDY 226

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           S +  + I   L   P  RP+   ++  P++
Sbjct: 227 SPELGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 6e-28
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 51/232 (21%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY------HLSDSQVSSYTRQILNG 61
           EH NIV+     ++ + LY   E ++     NLYQ          S+S + S   QIL G
Sbjct: 56  EHPNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQG 111

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFE---GTPFWVAPEVVN 110
           L ++H+    HR++K  N+LV           GLA        +     T ++ APE++ 
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEIL- 170

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI----G--------RG---- 154
           L++  Y    DIW+LGC + E+ T +P +    ++  L++I    G         G    
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230

Query: 155 -----KLPSV-PNSL-------SRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
                + P   P SL       S +A D I   L+ +P  RPTA+Q ++HP+
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  106 bits (265), Expect = 6e-28
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 27/214 (12%)

Query: 9   HDNIVQYIGT--EKDE---NRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQI 58
           H N+V++ G   + D+    +L++ LEL   GS+  L +        L ++ +S      
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 59  LNGLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAP 106
           L GL +LH   ++HR++K  NIL+   G            L +T     +  GTPFW+AP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197

Query: 107 EVVNLK---NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PN 161
           EV+  +   +  Y    D+WSLG T +E+    PP   +  ++ LF+I R   P++  P 
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257

Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
              R    FI +CL  +   RP+   L+EHPF+K
Sbjct: 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  103 bits (258), Expect = 4e-27
 Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 26/200 (13%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY-----QKYHLSDSQVSSYTRQILN 60
           Q  H N+++Y+ +  ++N L I LEL   G L+ +      QK  + +  V  Y  Q+ +
Sbjct: 58  QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 61  GLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEV 108
            + ++H R V+HR+IK AN+ + A+G             ++ T    S  GTP++++PE 
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF----RIGRGKLPSVPNS-L 163
           ++   NGY   +DIWSLGC + EM   Q P+    D   LF    +I +   P +P    
Sbjct: 178 IH--ENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQCDYPPLPTEHY 233

Query: 164 SRDARDFILKCLQVNPNDRP 183
           S   R+ +  C+  +P+ RP
Sbjct: 234 SEKLRELVSMCIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  103 bits (258), Expect = 4e-27
 Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 22/197 (11%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY-----QKYHLSDSQVSSYTRQILN 60
           Q  H NIV+Y  T  + +RLYI ++L++   L   +     +K   ++ ++ +   Q++ 
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 61  GLTYLH-ERNVVHREIKCANILVDAS--------GLATTTND---VKSFEGTPFWVAPEV 108
            L YLH E+ +VHR++   NI++           GLA        + S  GT  +  PE+
Sbjct: 125 ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEI 184

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL-FRIGRGKLPSVPNSL-SRD 166
           V  KN  YG  AD+W+ GC + +M T QPP+ +  +M +L  +I       +P  + S D
Sbjct: 185 V--KNEPYGEKADVWAFGCILYQMCTLQPPF-YSTNMLSLATKIVEAVYEPLPEGMYSED 241

Query: 167 ARDFILKCLQVNPNDRP 183
             D I  CL  +   RP
Sbjct: 242 VTDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  103 bits (260), Expect = 6e-27
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 21/206 (10%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLH 66
           +H  + Q     + ++RL+  +E V  G L    Q+     + +   Y  +I+ GL +LH
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 67  ERNVVHREIKCANILVDASG---LAT-------TTNDVKS--FEGTPFWVAPEVVNLKNN 114
           ER +++R++K  N+L+D+ G   +A            V +  F GTP ++APE+  L   
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEI--LSYQ 171

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKC 174
            YG + D W+LG  + EML  Q P+   +D   LF+         P  LS++A+  +   
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLSKEAKSILKSF 230

Query: 175 LQVNPNDR----PTAAQ-LMEHPFVK 195
           L  NP  R    PT  Q +  HPF +
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  102 bits (255), Expect = 9e-27
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 26/202 (12%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY-----QKYHLSDSQVSSYTRQI 58
             Q  H N+++Y  +  ++N L I LEL   G L+ +      QK  + +  V  Y  Q+
Sbjct: 56  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115

Query: 59  LNGLTYLHERNVVHREIKCANILVDASGL------------ATTTNDVKSFEGTPFWVAP 106
            + L ++H R V+HR+IK AN+ + A+G+            ++ T    S  GTP++++P
Sbjct: 116 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF----RIGRGKLPSVP-N 161
           E ++   NGY   +DIWSLGC + EM   Q P+    D   L+    +I +   P +P +
Sbjct: 176 ERIH--ENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEQCDYPPLPSD 231

Query: 162 SLSRDARDFILKCLQVNPNDRP 183
             S + R  +  C+  +P  RP
Sbjct: 232 HYSEELRQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  101 bits (253), Expect = 2e-26
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 24/208 (11%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLT 63
            +  H  +V    + +DE  +Y+ ++L+  G L  +L QK   S+ QV  +  +I+  L 
Sbjct: 55  QELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALE 114

Query: 64  YLHERNVVHREIKCANILVDASGLATTTN---------DVKSFE--GTPFWVAPEVVNLK 112
           YLH + ++HR+IK  NIL+D  G    T+         D  +    GTP ++APEV+  +
Sbjct: 115 YLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQ 174

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPY-----SHLEDMQALFRIGRGKLPSVPNSLSRDA 167
              Y ++ D WSLG T  E L  + PY     +  + ++A            P + S +A
Sbjct: 175 G--YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ---ETADVLYPATWSTEA 229

Query: 168 RDFILKCLQVNPNDR--PTAAQLMEHPF 193
            D I K L+ +P  R       L  HP+
Sbjct: 230 IDAINKLLERDPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  100 bits (251), Expect = 1e-25
 Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 55/245 (22%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL---YQKYHLSDSQVSSYTRQILNGL 62
           Q +H NI+ Y+ +   ++ LY+   L+  GS  +L   +    L +  ++   + +LN L
Sbjct: 55  QLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNAL 114

Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN-------DVKSFEGTPF------------W 103
            Y+H +  +HR +K ++IL+   G    +                              W
Sbjct: 115 DYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174

Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP------ 157
           ++PEV+     GY   +DI+S+G T  E+     P+  +   Q L    RG +P      
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234

Query: 158 --------------SVPNSLSRDARD-------------FILKCLQVNPNDRPTAAQLME 190
                         S  +  +RD+ D             F+  CLQ +P  RP+A+QL+ 
Sbjct: 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294

Query: 191 HPFVK 195
           H F K
Sbjct: 295 HSFFK 299

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  101 bits (253), Expect = 1e-25
 Identities = 65/246 (26%), Positives = 109/246 (44%), Gaps = 67/246 (27%)

Query: 8   EHDNIVQYIGTEKDENRLYIFL----------ELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
           +H NIV+ +   K EN   I+L           +++   L +++++Y +       Y  Q
Sbjct: 65  DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIM-------Y--Q 115

Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPF------- 102
           +L  L Y+H  NV+HR++K +NIL+++         GLA + ++++     P        
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 103 -WV-APEVVNLKNNGYGLSADIWSLGCTVLEMLT-----------HQ----------PPY 139
            W  APE++ L +  Y    D+WS+GC + EML            +Q          P  
Sbjct: 176 RWYRAPEIL-LGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234

Query: 140 SHLEDMQALF---------RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
             +E +++ F            R  L  +    S DA D + K L  NPN R TA + +E
Sbjct: 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294

Query: 191 HPFVKR 196
           HP+V +
Sbjct: 295 HPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 97.7 bits (243), Expect = 5e-25
 Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 30/213 (14%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----LSDSQVSSYTRQI 58
            S+ +H  IV++  +  + +   I  E  +   L    ++       LS++QV  +  Q+
Sbjct: 56  LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115

Query: 59  LNGLTYLHERNVVHREIKCANI-----------------LVDASGLATTTNDVKSFEGTP 101
           L G+ Y+H+R ++HR++K  NI                 L+ +  LATT      F GTP
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATT------FTGTP 169

Query: 102 FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN 161
           ++++PE   LK+ GY   +DIWSLGC + EM      +     +  + RI  G  PS+P 
Sbjct: 170 YYMSPEA--LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPE 227

Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           + SR     +   L  +P+ RP+AA+++ +PF+
Sbjct: 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 97.2 bits (242), Expect = 7e-25
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 19/206 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNG 61
               H NI++Y     ++  L I +E    G+LA   QK     L +  +  +  QIL  
Sbjct: 54  KLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA 113

Query: 62  LTYLHERNVVHREIKCANILVDA------------SGLATTTNDVKSFEGTPFWVAPEVV 109
           L ++H + ++HR++K  NIL+D             S + ++ +   +  GTP +++PE+ 
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL-FRIGRGKLPSVPNSLSRDAR 168
             K   Y   +DIW+LGC + E+ + +  +    ++ AL  +I  G    + +  S D R
Sbjct: 174 EGKP--YNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKIMSGTFAPISDRYSPDLR 230

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFV 194
             IL  L ++P+ RP  +Q+M  P  
Sbjct: 231 QLILSMLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 97.4 bits (243), Expect = 1e-24
 Identities = 51/157 (32%), Positives = 86/157 (54%), Gaps = 19/157 (12%)

Query: 58  ILNGLTYLHER-NVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWV 104
           I+  L YL E+  V+HR++K +NIL+DASG            L  +    +S  G   ++
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYM 181

Query: 105 APEVVNLKNNG--YGLSADIWSLGCTVLEMLTHQPPYSHLE-DMQALFRIGRGKLPSVPN 161
           APE ++  +    Y + AD+WSLG +++E+ T Q PY + + + + L +I + + PS+P 
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP 241

Query: 162 --SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
               S D   F+  CL  +   RP   +L++HPF++R
Sbjct: 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 1e-24
 Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 53/232 (22%)

Query: 9   HDNIVQYIGTEKDENRLYI---FLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYL 65
           H NIV+ +     EN+LY+   FL+L  K  + +      L    + SY  Q+L G+ Y 
Sbjct: 57  HPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYC 115

Query: 66  HERNVVHREIKCANILVDAS--------GLA--------TTTNDVKSFEGTPFWVAPEVV 109
           H   V+HR++K  N+L+D          GLA        T T++V     T ++ APE++
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 171

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR---------------- 153
            L +  Y    DIWS+GC   EM+  +P +    ++  LFRI R                
Sbjct: 172 -LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230

Query: 154 ------------GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
                         L  V  +L  D  D + K L  +P  R +A   ++HP+
Sbjct: 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 97.5 bits (243), Expect = 2e-24
 Identities = 58/193 (30%), Positives = 90/193 (46%), Gaps = 21/193 (10%)

Query: 22  ENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
            +RLY  +E V  G L    Q+     +     Y  +I  GL +LH + +++R++K  N+
Sbjct: 73  MDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132

Query: 81  LVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           ++DA G     +              ++F GTP ++APE++      YG S D W+ G  
Sbjct: 133 MLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVL 190

Query: 129 VLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR----PT 184
           + EML  QPP+   ED   LF+       S P SLS++A       L  +P  R    PT
Sbjct: 191 LYEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPT 249

Query: 185 AAQ-LMEHPFVKR 196
             + + EH F +R
Sbjct: 250 GERDIREHAFFRR 262

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 96.0 bits (239), Expect = 3e-24
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 26/209 (12%)

Query: 10  DNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLH-E 67
             IV + G   +EN + + +E +  GSL  +Y+K   +    +      ++ GLTYL+  
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122

Query: 68  RNVVHREIKCANILVDASGL---------ATTTNDV-KSFEGTPFWVAPEVVNLKNNGYG 117
             ++HR+IK +NILV++ G              N +  +F GT  +++PE   ++   Y 
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPE--RIQGGKYT 180

Query: 118 LSADIWSLGCTVLEMLTHQPPYSHLED-----------MQALFRIGRGKLPSVPNS-LSR 165
           + +D+WSLG +++E+   + P++               +  L +I +   P +P+S    
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           D RDF+  CL  +P +RPT  QL   P  
Sbjct: 241 DLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 95.2 bits (237), Expect = 8e-24
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 40/218 (18%)

Query: 9   HDNIVQYIG--TEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTY 64
           H+NIV+Y G   +     L + +E +  GSL +  Q++   ++  ++  ++ QI  G+ Y
Sbjct: 65  HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124

Query: 65  LHERNVVHREIKCANILVDAS--------GLATTTND------VKSFEGTP-FWVAPEVV 109
           L  +  +HR++   NILV++         GLA    +      VK    +P FW APE  
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC- 183

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH-----------------LEDMQALFRIG 152
            L+ + +  ++D+WS G T+ E+ T+  P                    +  +  L + G
Sbjct: 184 -LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242

Query: 153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
             +LP  P S   +  D +  C +  P DRP+ A L+ 
Sbjct: 243 -ERLPR-PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 94.0 bits (234), Expect = 2e-23
 Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 44/231 (19%)

Query: 6   QFEHDNIVQYIGTEKDENRLYI---FLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGL 62
           + +H NIV        E+RLY+   FL +  K  L +L +  ++    V SY  QIL G+
Sbjct: 55  ELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114

Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN-----------DVKSFEGTPFWV-APEVVN 110
            + H R V+HR++K  N+L+D  G+    +            V + E    W  APEV+ 
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL- 173

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR-------------GKLP 157
           L +  Y    DIWS+G    EM T +P +    ++  LFRI R               LP
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233

Query: 158 SVPNS---------------LSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
              N+               L  D  D + K L  +P  R +A + + HP+
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 93.7 bits (233), Expect = 2e-23
 Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 53/235 (22%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKG--SLANLYQKYHLSDSQVSSYTRQILNGLT 63
           +  H NIV+ +     EN+LY+  E + +      +      +    + SY  Q+L GL 
Sbjct: 55  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114

Query: 64  YLHERNVVHREIKCANILVDASG----------------LATTTNDVKSFEGTPFWVAPE 107
           + H   V+HR++K  N+L++  G                + T T++V     T ++ APE
Sbjct: 115 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPE 170

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI-------------GRG 154
           ++ L    Y  + DIWSLGC   EM+T +  +    ++  LFRI             G  
Sbjct: 171 IL-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229

Query: 155 KLPS----------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
            LP                 VP  L  D RD + + L  +PN R +A   + HPF
Sbjct: 230 SLPDYKPSFPKWARQDFSKVVPP-LDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 93.1 bits (231), Expect = 8e-23
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 17/203 (8%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD-SQVSSYTRQILNGLTYL 65
           +EH  +     T + +  L+  +E +  G L    Q  H  D  + + Y  +I+ GL +L
Sbjct: 53  WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFL 112

Query: 66  HERNVVHREIKCANILVDASGLATTTN----------DVKS--FEGTPFWVAPEVVNLKN 113
           H + +V+R++K  NIL+D  G     +          D K+  F GTP ++APE+  L  
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI--LLG 170

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             Y  S D WS G  + EML  Q P+ H  D + LF+  R   P  P  L+R+A+D ++K
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPF-HGHDEEELFQSIRMDNPCYPRWLTREAKDILVK 229

Query: 174 CLQVNPNDR-PTAAQLMEHPFVK 195
                P  R      + +HPF +
Sbjct: 230 LFVREPERRLGVKGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 92.6 bits (230), Expect = 1e-22
 Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 21/206 (10%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           +H  IV  I   +   +LY+ LE +  G L  +L ++    +     Y  +I   L +LH
Sbjct: 58  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117

Query: 67  ERNVVHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNN 114
           ++ +++R++K  NIL+DA G    T+               +F GT  ++APE+  L  +
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI--LMRS 175

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKC 174
           G+G + D WSLG  + +MLT  PP++     + + +I +GKL ++P  L+ +ARD + K 
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-NLPPYLTPEARDLLKKL 234

Query: 175 LQVNPNDR-----PTAAQLMEHPFVK 195
           L+ NP+ R       AA++  HPF +
Sbjct: 235 LKRNPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 1e-22
 Identities = 65/231 (28%), Positives = 95/231 (41%), Gaps = 51/231 (22%)

Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNV 70
           IV+   + +DE  LY+ +E +  G L NL  +     +     Y  +++  L  +H+   
Sbjct: 63  IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122

Query: 71  VHREIKCANILVDASG--------LATTTNDVKSFE------------------------ 98
           +HR+IK  NIL+DA G        L    N  K  E                        
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 99  ---------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF 149
                    GTP ++APEV  L+   YGL  D WSLG  + EML   PP+      +   
Sbjct: 183 RRVRANSTVGTPDYIAPEV--LRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240

Query: 150 RIGRGK----LPSVPNSLSRDARDFILKCLQVNPNDRPTAA-QLMEHPFVK 195
           +I   K     P  P  +S +A D I + L  +P DR  +  ++  HPF K
Sbjct: 241 KIINWKESLRFPPDP-PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 92.7 bits (230), Expect = 1e-22
 Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 23/196 (11%)

Query: 22  ENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           E +L++ L+ V  G +  +LYQ+ + S+ +V  Y+ +I+  L +LH+  +V+R+IK  NI
Sbjct: 77  EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENI 136

Query: 81  LVDASGLATTTN-------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGC 127
           L+D+ G    T+                SF GT  ++APE++  K  G+G + D WSLG 
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGI 195

Query: 128 TVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSRDARDFILKCLQVNPNDR-- 182
            + E+LT   P++   +      + R  L   P  P+ +  +A+D + K L+ +P  R  
Sbjct: 196 LIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLG 255

Query: 183 ---PTAAQLMEHPFVK 195
                A+++ EHPF K
Sbjct: 256 AGPQGASEIKEHPFFK 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 92.0 bits (229), Expect = 1e-22
 Identities = 50/230 (21%), Positives = 97/230 (42%), Gaps = 46/230 (20%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYL 65
           +H  +V+ +      +   + +E +    L+ + +     L ++QV SY R +L G+ Y+
Sbjct: 57  QHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115

Query: 66  HERNVVHREIKCANILVDAS--------GLATTTNDVKSFE-----GTPFWVAPEVVNLK 112
           H   ++HR++K AN+L+ A         GLA   ++ +         T ++ APE++   
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL-YG 174

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR------------------- 153
              Y    D+W++GC   E+L   P +    D++ L  + R                   
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234

Query: 154 GKLPSVPN----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
            K+    +            S +A D +   L  +P+ R +AA+ + HP+
Sbjct: 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 91.0 bits (226), Expect = 3e-22
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 17/202 (8%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           EH  +     T + +  L+  +E +  G L  ++       +++   Y  +I+ GL +LH
Sbjct: 54  EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113

Query: 67  ERNVVHREIKCANILVDASG---LA---------TTTNDVKSFEGTPFWVAPEVVNLKNN 114
           ++ +++R++K  N+L+D  G   +A                +F GTP ++APE+  LK  
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEI--LKGQ 171

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKC 174
            Y  S D WS G  + EML  Q P+ H ED   LF       P  P  +S++A+D + K 
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPF-HGEDEDELFDSILNDRPHFPRWISKEAKDCLSKL 230

Query: 175 LQVNPNDR-PTAAQLMEHPFVK 195
            + +P  R      + +HPF +
Sbjct: 231 FERDPTKRLGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 90.5 bits (225), Expect = 4e-22
 Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 44/231 (19%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTY 64
           Q +H N+V  I   + + +L++  E      L  L +    + +  +     Q L  + +
Sbjct: 56  QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115

Query: 65  LHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNLK 112
            H+ N +HR++K  NIL+   G            L    +D   +  T ++ APE++ + 
Sbjct: 116 CHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL-VG 174

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--GKL-------------- 156
           +  YG   D+W++GC   E+LT QP +    D+  L+ I +  G L              
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234

Query: 157 -----PSVPN---------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
                P             ++S  A  F+  CLQ++P +R +  +L+EHP+
Sbjct: 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.1 bits (221), Expect = 1e-21
 Identities = 55/180 (30%), Positives = 87/180 (48%), Gaps = 29/180 (16%)

Query: 43  KYHL--------SDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------G 86
           KYH+         +++   Y  QI+ GL +LH+R +V+R++K  N+L+D          G
Sbjct: 81  KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLG 140

Query: 87  LATTTND---VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY-SHL 142
           LA        +K   GTP ++APEV  L+   Y  S D ++LGCT+ EM+  + P+    
Sbjct: 141 LAVELKGGKKIKGRAGTPGYMAPEV--LQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198

Query: 143 E--DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----PTAAQLMEHPFVK 195
           E  + + L R         P+  S +A+D     LQ +P  R      +A ++ EHP  K
Sbjct: 199 EKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 89.0 bits (221), Expect = 1e-21
 Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 21/194 (10%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYL 65
           H  ++Q       E  +YI  EL+K GSL    Q      L   Q+     Q+ +G+ YL
Sbjct: 60  HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119

Query: 66  HERNVVHREIKCANILVDAS--------GLATT--TNDVKSFEGTPF---WVAPEVVNLK 112
             +N +HR++   N+LV  +        GLA     +  ++ EG  F   W APE     
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY- 178

Query: 113 NNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRDARDF 170
            N + + +D+WS G  + E++T+ + PY  + + + L ++ +G ++P  P    ++  D 
Sbjct: 179 -NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC-PPGCPKELYDI 236

Query: 171 ILKCLQVNPNDRPT 184
           +L C + +P+DRPT
Sbjct: 237 MLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 2e-21
 Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 52/238 (21%)

Query: 7   FEHDNI-----VQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNG 61
           F+H+NI     +    + +  N +YI  EL++   L  L +  HLS+  +  +  QIL G
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRG 118

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLA---TTTNDVKSF----EGTPFWVAP 106
           L Y+H  NV+HR++K +N+L++ +        GLA      +D   F      T ++ AP
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHLED-------------MQALFRI 151
           E++ L + GY  + DIWS+GC + EML+++P  P                    + L  I
Sbjct: 179 EIM-LNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237

Query: 152 ----GRGKLPSVPN----SLSR-------DARDFILKCLQVNPNDRPTAAQLMEHPFV 194
                R  + S+P       ++        A D + K L  NP+ R T  + + HP++
Sbjct: 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 2e-21
 Identities = 58/235 (24%), Positives = 90/235 (38%), Gaps = 52/235 (22%)

Query: 6   QFEHDNIVQ-----YIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQ 57
            FEH NIV+     +      E +L +  E V +  LA    K     L    +    RQ
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQ 115

Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV----- 104
           +L G+ +LH   +VHR++K  NILV +         GLA   +   +   T   V     
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVVTLWYR 173

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI------------- 151
           APEV  L  + Y    D+WS+GC   E+   +P +    +   L +I             
Sbjct: 174 APEV--LLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231

Query: 152 -------------GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
                              S    +  +  D + K L  NP+ R +A + ++HP+
Sbjct: 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 87.8 bits (217), Expect = 3e-21
 Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 20/195 (10%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS---YTRQILNGLT 63
            +HD +V+       E  +YI  E + KGSL +  +    S   +     ++ QI  G+ 
Sbjct: 58  LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTT--NDVKSFEGTPF---WVAPEVVN 110
           ++ +RN +HR+++ ANILV AS        GLA     N+  + EG  F   W APE +N
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
                + + +D+WS G  ++E++T+ + PY  + + + +  + RG     P +   +  +
Sbjct: 177 F--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234

Query: 170 FILKCLQVNPNDRPT 184
            +++C +  P +RPT
Sbjct: 235 IMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 88.3 bits (219), Expect = 4e-21
 Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 63/240 (26%)

Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHE-RN 69
           IV + G    +  + I +E +  GSL  + +K   + ++ +   +  +L GLTYL E   
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK 120

Query: 70  VVHREIKCANILVDASGLATTTNDVK----------------SFEGTPFWVAPEVVNLKN 113
           ++HR++K +NILV++ G      ++K                SF GT  +++PE   L+ 
Sbjct: 121 IMHRDVKPSNILVNSRG------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQG 172

Query: 114 NGYGLSADIWSLGCTVLEMLT-----------------------------HQPPYSHLED 144
             Y + +DIWSLG +++EM                               H+P   H  D
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232

Query: 145 M---QALFR----IGRGKLPSVPNS-LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
                A+F     I     P +P+   S + +DF+ KCL+ NP +R    +L +HPF+KR
Sbjct: 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 88.5 bits (219), Expect = 4e-21
 Identities = 62/189 (32%), Positives = 94/189 (49%), Gaps = 20/189 (10%)

Query: 25  LYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD 83
           LY+  + +  G L  +L ++   S+ +   Y  +++  L +LH+ ++V+R++K  NIL+D
Sbjct: 71  LYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130

Query: 84  ASGLAT-----------TTNDV-KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE 131
           A+G              T N    +F GT  ++APEV+ L   GY    D WSLG  V E
Sbjct: 131 ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL-LDEKGYTKHVDFWSLGVLVFE 189

Query: 132 MLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDR----PTAA 186
           M     P+ + ED Q ++R I  GK+    N LS + R F+   L  NP  R      A 
Sbjct: 190 MCCGWSPF-YAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAV 248

Query: 187 QLMEHPFVK 195
           +L EHPF  
Sbjct: 249 ELKEHPFFA 257

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 88.7 bits (220), Expect = 4e-21
 Identities = 65/250 (26%), Positives = 108/250 (43%), Gaps = 61/250 (24%)

Query: 6   QFEHDNIVQ--------------YIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV 51
           + +HDNIV+               +G+  + N +YI  E ++   LAN+ ++  LS+   
Sbjct: 58  RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHA 116

Query: 52  SSYTRQILNGLTYLHERNVVHREIKCANILVDAS---------GLATTTNDVKSFEG--- 99
             +  Q+L GL Y+H  NV+HR++K AN+ ++           GLA   +   S +G   
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176

Query: 100 ----TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP------------------ 137
               T ++ +P ++ L  N Y  + D+W+ GC   EMLT +P                  
Sbjct: 177 EGLVTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235

Query: 138 PYSHLEDMQALFR-----------IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAA 186
           P    ED   L               R  L  +   ++ +A DF+ + L  NP DR TA 
Sbjct: 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295

Query: 187 QLMEHPFVKR 196
           + + HP++  
Sbjct: 296 EALMHPYMSC 305

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 89.5 bits (222), Expect = 4e-21
 Identities = 48/154 (31%), Positives = 91/154 (59%), Gaps = 18/154 (11%)

Query: 57  QILNGLTYLHERNVVHREIKCANILVDASGL-------------ATTTNDV-KSFEGTPF 102
           Q+L  + ++H ++++HR+IK ANIL+ ++GL             AT ++DV ++F GTP+
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKLPSVPN 161
           +VAPE+   +   Y   AD++SLG  + E+LT + P+   E+M+ +  +   G+   +P 
Sbjct: 211 YVAPEI--WRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYDPLPP 267

Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           S+S + ++ +   L  +P  RP++++L+  P  K
Sbjct: 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICK 301

Length = 496

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 87.6 bits (217), Expect = 5e-21
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 36/215 (16%)

Query: 9   HDNIVQYIG--TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           H+NIV+Y G  +E+    L + +E V  GSL +   K+ L+ +Q+  + +QI  G+ YLH
Sbjct: 65  HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLH 124

Query: 67  ERNVVHREIKCANILVDAS--------GLATTTNDVKSF-------EGTPFWVAPEVVNL 111
            ++ +HR++   N+L+D          GLA    +   +       +   FW A E   L
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC--L 182

Query: 112 KNNGYGLSADIWSLGCTVLEMLTH----QPPYSHLEDM----QALFRIGR--------GK 155
           K N +  ++D+WS G T+ E+LTH    Q P    E+M    Q    + R         +
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242

Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
           LP  P +  ++    +  C +     RPT   L+ 
Sbjct: 243 LPC-PKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 87.9 bits (218), Expect = 6e-21
 Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 31/194 (15%)

Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSS------YTRQILNGLTYLHERNVVHREIK 76
           +RL   +E    G L      +HLS  +V S      Y  +I++ L YLH  +VV+R++K
Sbjct: 68  DRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLK 122

Query: 77  CANILVDASGLATTT------------NDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWS 124
             N+++D  G    T              +K+F GTP ++APEV  L++N YG + D W 
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--LEDNDYGRAVDWWG 180

Query: 125 LGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-- 182
           LG  + EM+  + P+ + +D + LF +   +    P +LS +A+  +   L+ +P  R  
Sbjct: 181 LGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239

Query: 183 ---PTAAQLMEHPF 193
                A ++MEH F
Sbjct: 240 GGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 86.2 bits (214), Expect = 9e-21
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 27/204 (13%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGL 62
           +  HD +VQ      +E  +YI  E + KGSL +  +      L   Q+     QI  G+
Sbjct: 57  KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPEVV 109
            YL  RN +HR++   NILV  +        GLA     ++  + EG  F   W APE  
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG----KLPSVPNSLS 164
           N     + + +D+WS G  + E++T+ + PY  + + + L ++ RG    + P+ P  L 
Sbjct: 177 NY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEEL- 233

Query: 165 RDARDFILKCLQVNPNDRPTAAQL 188
               D +L+C   +P +RPT   L
Sbjct: 234 ---YDLMLQCWDKDPEERPTFEYL 254

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 86.5 bits (215), Expect = 2e-20
 Identities = 58/201 (28%), Positives = 86/201 (42%), Gaps = 53/201 (26%)

Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLAT-------- 89
           L+ + + SY    L GL YLH   ++HR++K  N+L+ +         GLA         
Sbjct: 99  LTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158

Query: 90  -TTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY----SHLED 144
            T   V     T ++ APE++      YG+  D+WS+GC   E+L  + P+    S ++ 
Sbjct: 159 MTHQVV-----TRWYRAPELL-FGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQ 211

Query: 145 MQALFRI----------GRGKLPSV-------PNSL-------SRDARDFILKCLQVNPN 180
           +  +F            G   LP         P  L       S DA D + + L +NPN
Sbjct: 212 LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPN 271

Query: 181 DRPTAAQLMEHP-FVKRPLQT 200
            R TA Q +EHP F   P  T
Sbjct: 272 KRITARQALEHPYFSNDPAPT 292

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 85.8 bits (212), Expect = 2e-20
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 23/204 (11%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL------SDSQVSSYTRQ 57
            ++ +H NIV +  + + +  LYI +E    G   +L QK  L       +  +  +  Q
Sbjct: 52  LAKMKHPNIVAFKESFEADGHLYIVMEYCDGG---DLMQKIKLQRGKLFPEDTILQWFVQ 108

Query: 58  ILNGLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVA 105
           +  G+ ++HE+ V+HR+IK  NI +  +G            L +      ++ GTP++V 
Sbjct: 109 MCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVP 168

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           PE+   +N  Y   +DIWSLGC + E+ T + P+        + ++ +G    +P+  S 
Sbjct: 169 PEI--WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSY 226

Query: 166 DARDFILKCLQVNPNDRPTAAQLM 189
           + R  I +  + NP  RP+A  ++
Sbjct: 227 ELRSLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 86.1 bits (213), Expect = 2e-20
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 23/201 (11%)

Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVV 71
           I+ + G    ENR+ I  E +  GSL ++Y+K  + +  +      ++ GLTYL    ++
Sbjct: 61  IIGFYGAFFVENRISICTEFMDGGSL-DVYRK--IPEHVLGRIAVAVVKGLTYLWSLKIL 117

Query: 72  HREIKCANILVDASG------LATTTNDV----KSFEGTPFWVAPEVVNLKNNGYGLSAD 121
           HR++K +N+LV+  G         +T  V    K++ GT  ++APE   +    YG+ +D
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPE--RISGEQYGIHSD 175

Query: 122 IWSLGCTVLEMLTHQPPYSHLED-------MQALFRIGRGKLPSVPNSL-SRDARDFILK 173
           +WSLG + +E+   + PY  ++        +Q L  I     P +P    S     FI +
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQ 235

Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
           C++  P +RP    LM+HPF+
Sbjct: 236 CMRKQPKERPAPENLMDHPFI 256

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 86.6 bits (215), Expect = 2e-20
 Identities = 64/244 (26%), Positives = 116/244 (47%), Gaps = 59/244 (24%)

Query: 7   FEHDNIV---QYIGTEKDENR-LYIFLELVKKGSLANLYQKYH----LSDSQVSSYTRQI 58
           F+HDNI+     +     + + +Y+ ++L++    ++L+   H    L++  +  +  Q+
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMDLME----SDLHHIIHSDQPLTEEHIRYFLYQL 116

Query: 59  LNGLTYLHERNVVHREIKCANILVD------------ASGLATTTNDVKSFE----GTPF 102
           L GL Y+H  NV+HR++K +N+LV+            A GL+++  + K F      T +
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--P---YSHLEDM----------QA 147
           + APE++ L    Y  + D+WS+GC   EML  +   P   Y H   +          + 
Sbjct: 177 YRAPELL-LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235

Query: 148 LFRIG----RGKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHP 192
           L RIG    R  + ++P              S +A D + + LQ +P +R T  Q ++HP
Sbjct: 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295

Query: 193 FVKR 196
           F+ +
Sbjct: 296 FLAQ 299

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 86.6 bits (214), Expect = 2e-20
 Identities = 61/194 (31%), Positives = 101/194 (52%), Gaps = 31/194 (15%)

Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSS------YTRQILNGLTYLHERNVVHREIK 76
           +RL   +E    G L      +HLS  +V +      Y  +I++ L YLH R+VV+R+IK
Sbjct: 68  DRLCFVMEYANGGELF-----FHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122

Query: 77  CANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWS 124
             N+++D  G    T+             +K+F GTP ++APEV  L++N YG + D W 
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--LEDNDYGRAVDWWG 180

Query: 125 LGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-- 182
           LG  + EM+  + P+ + +D + LF +   +    P +LS +A+  +   L+ +P  R  
Sbjct: 181 LGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239

Query: 183 --PTAAQ-LMEHPF 193
             P+ A+ +MEH F
Sbjct: 240 GGPSDAKEVMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 85.4 bits (211), Expect = 3e-20
 Identities = 53/197 (26%), Positives = 98/197 (49%), Gaps = 22/197 (11%)

Query: 22  ENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           + +L++ L+ +  G L  +L Q+    + +V  Y+ +I+  L +LH+  +++R+IK  NI
Sbjct: 77  DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENI 136

Query: 81  LVDASG-------------LATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGC 127
           L+D++G                      SF GT  ++AP++V   + G+  + D WS+G 
Sbjct: 137 LLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGV 196

Query: 128 TVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSRDARDFILKCLQVNPNDR-- 182
            + E+LT   P++   +  +   I R  L   P  P  +S  A+D I + L  +P  R  
Sbjct: 197 LMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLG 256

Query: 183 --PTAAQ-LMEHPFVKR 196
             P+ A  + +HPF ++
Sbjct: 257 CGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 85.9 bits (213), Expect = 3e-20
 Identities = 66/244 (27%), Positives = 107/244 (43%), Gaps = 61/244 (25%)

Query: 8   EHDNIVQYIGTE----KDENRLYIFLELVKKGSLANLYQKYH----LSDSQVSSYTRQIL 59
            H NI      +     + N LY++ EL++    A+L+Q       L+D+   S+  QIL
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELYLYEELME----ADLHQIIRSGQPLTDAHFQSFIYQIL 115

Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPF--------W 103
            GL Y+H  NV+HR++K  N+LV+A         GLA   ++    E   F        W
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGFMTEYVATRW 174

Query: 104 V-APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF------------- 149
             APE++ L    Y  + D+WS+GC + E+L  +P +   + +  L              
Sbjct: 175 YRAPEIM-LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233

Query: 150 --RIGRGK-------LPSVPN--------SLSRDARDFILKCLQVNPNDRPTAAQLMEHP 192
             RIG  K       LP++P         + +  A D + K L  +P  R +  + +EHP
Sbjct: 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293

Query: 193 FVKR 196
           ++  
Sbjct: 294 YLAI 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 85.9 bits (213), Expect = 4e-20
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHE 67
            + +V+ +   +D+  LY+ +E V  G     L     LS+     Y  ++   +  LHE
Sbjct: 60  SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE 119

Query: 68  RNVVHREIKCANILVDASG--------LAT-TTNDVKSFEGTPFWVAPEVVNLKNNGYGL 118
              +HR++K  N L+DASG        L+        S  G+P ++APEV+  K  GY  
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGK--GYDF 177

Query: 119 SADIWSLGCTVLEMLTHQPPYS---------HLEDMQALFRIGRGKLPSVPNSLSRDARD 169
           + D WSLGC + E L   PP+S         +L+  +   +      P    +LS +A D
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF--NLSDEAWD 235

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKR 196
            I K +        +   +  HPF K 
Sbjct: 236 LITKLINDPSRRFGSLEDIKNHPFFKE 262

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 86.0 bits (213), Expect = 4e-20
 Identities = 54/187 (28%), Positives = 92/187 (49%), Gaps = 13/187 (6%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLTY 64
           +  H  IV  + + +DENR+Y  LE V  G L    +K     + V+  Y  +++    Y
Sbjct: 74  ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEY 133

Query: 65  LHERNVVHREIKCANILVDASGLATTTN-------DVKSFE--GTPFWVAPEVVNLKNNG 115
           LH +++++R++K  N+L+D  G    T+         ++F   GTP ++APEV+  K  G
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSK--G 191

Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
           +G + D W++G  + E +   PP+      +   +I  G+L   PN     ARD +   L
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL-KFPNWFDGRARDLVKGLL 250

Query: 176 QVNPNDR 182
           Q +   R
Sbjct: 251 QTDHTKR 257

Length = 329

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 85.9 bits (212), Expect = 4e-20
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 31/197 (15%)

Query: 20  KDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS------YTRQILNGLTYLHERNVVHR 73
           + ++RL   +E V  G L      +HLS  +V S      Y  +I++ L YLH   +V+R
Sbjct: 65  QTKDRLCFVMEYVNGGELF-----FHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119

Query: 74  EIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSAD 121
           ++K  N+++D  G    T+             +K+F GTP ++APEV  L++N YG + D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV--LEDNDYGRAVD 177

Query: 122 IWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPND 181
            W LG  + EM+  + P+ + +D + LF +   +    P +LS DA+  +   L  +PN 
Sbjct: 178 WWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNK 236

Query: 182 R-----PTAAQLMEHPF 193
           R       A ++M H F
Sbjct: 237 RLGGGPDDAKEIMRHSF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 5e-20
 Identities = 59/188 (31%), Positives = 90/188 (47%), Gaps = 13/188 (6%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLT 63
            +  H  I++   TE D+  LY+ +E V  G L + L      S+S    Y  +I+  L 
Sbjct: 56  KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE 115

Query: 64  YLHERNVVHREIKCANILVDASGLATTT---------NDVKSFEGTPFWVAPEVVNLKNN 114
           YLH + +V+R++K  NIL+D  G    T         +   +  GTP ++APEV  +++ 
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEV--IQSK 173

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKC 174
           G+  + D W+LG  + EML   PP+          +I  GKL   P  L   A+D I K 
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-EFPRHLDLYAKDLIKKL 232

Query: 175 LQVNPNDR 182
           L V+   R
Sbjct: 233 LVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 83.9 bits (208), Expect = 6e-20
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 20/201 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
           +Q +H  IV+ IG  K E  L + +EL   G L    +K   +  S +     Q+  G+ 
Sbjct: 51  AQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMA 109

Query: 64  YLHERNVVHREIKCANILVDASGLAT-----------TTNDVKSFEGT---PF-WVAPEV 108
           YL  ++ VHR++   N+L+     A              +D          P  W APE 
Sbjct: 110 YLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA 167
           +N     +   +D+WS G T+ E  ++   PY  ++  + +  +  G+    P    ++ 
Sbjct: 170 INYGK--FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEI 227

Query: 168 RDFILKCLQVNPNDRPTAAQL 188
              +L C +  P DRPT ++L
Sbjct: 228 YSIMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 85.0 bits (210), Expect = 8e-20
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 27/197 (13%)

Query: 18  TEKDENRLYIFLELVKKGSLANLYQKYHLSDS------QVSSYTRQILNGLTYLHERNVV 71
           T + +  L+  +E +  G L      +H+ D       + + Y  +I+ GL +LH + ++
Sbjct: 64  TFQTKEHLFFVMEFLNGGDLM-----FHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGII 118

Query: 72  HREIKCANILVDASGLATTT------------NDVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           +R++K  N+++D  G                 N   +F GTP ++APE+  L+   Y  S
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI--LQGLKYTFS 176

Query: 120 ADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNP 179
            D WS G  + EML  Q P+ H +D   LF   R   P  P  ++++++D + K  + +P
Sbjct: 177 VDWWSFGVLLYEMLIGQSPF-HGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDP 235

Query: 180 NDR-PTAAQLMEHPFVK 195
             R      +  HPF K
Sbjct: 236 TRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 84.1 bits (208), Expect = 1e-19
 Identities = 68/240 (28%), Positives = 104/240 (43%), Gaps = 58/240 (24%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ--------VSSYTRQ 57
           + +H NIV+       E RLY+  E +      +L  K H+  S         + +Y  Q
Sbjct: 57  EMQHGNIVRLQDVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQ 110

Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS---------GLATTTN-DVKSF--EGTPFWV- 104
           IL G+ Y H   V+HR++K  N+L+D           GLA      V++F  E    W  
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRI---------- 151
           APE++ L +  Y    DIWS+GC   EM+  +P +   S ++++  +FRI          
Sbjct: 171 APEIL-LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWP 229

Query: 152 GRGKLPS----------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           G   LP                 VP  L     D + K L+++P+ R TA   +EH + K
Sbjct: 230 GVTSLPDYKSAFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288

Length = 294

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 84.7 bits (209), Expect = 1e-19
 Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 32/195 (16%)

Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSS------YTRQILNGLTYLH-ERNVVHREI 75
           +RL   +E    G L      +HLS  +V S      Y  +I++ L YLH E+NVV+R++
Sbjct: 68  DRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122

Query: 76  KCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIW 123
           K  N+++D  G    T+             +K+F GTP ++APEV  L++N YG + D W
Sbjct: 123 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV--LEDNDYGRAVDWW 180

Query: 124 SLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR- 182
            LG  + EM+  + P+ + +D + LF +   +    P +LS +A+  +   L+ +P  R 
Sbjct: 181 GLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239

Query: 183 ----PTAAQLMEHPF 193
                 A ++M+H F
Sbjct: 240 GGGPDDAKEIMQHKF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 83.2 bits (206), Expect = 1e-19
 Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 19/201 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILNG 61
           +   H N+VQ +G     N LYI  E + KGSL +  +   +  ++ +Q   +   +  G
Sbjct: 55  TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPF---WVAPEVVN 110
           + YL E+N VHR++   N+LV           GLA   +  +  +       W APE   
Sbjct: 115 MEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS--QGQDSGKLPVKWTAPEA-- 170

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
           L+   +   +D+WS G  + E+ +  + PY  +     +  + +G     P     +   
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYK 230

Query: 170 FILKCLQVNPNDRPTAAQLME 190
            +  C +++P  RPT  QL E
Sbjct: 231 VMKDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 83.5 bits (207), Expect = 2e-19
 Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 52/231 (22%)

Query: 9   HDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLY-----QKYHLSDSQVSSYTRQILNG 61
           H NI++ I    D    RL +  EL+      NLY     +K  L + +V SY  Q+L  
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKS 112

Query: 62  LTYLHERNVVHREIKCANILVDAS-------GLATTTNDVKSFE---GTPFWVAPEVVNL 111
           L ++H   + HR+IK  NIL+          G          +     T ++ APE + L
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECL-L 171

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQP--PYSHLEDMQAL--------------------- 148
            +  YG   DIW++GC   E+L+  P  P ++  D  A                      
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231

Query: 149 ------FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
                  + G G    +PN  S +  D + K L  +P++R TA Q + HP+
Sbjct: 232 MNYNFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 83.5 bits (207), Expect = 2e-19
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 55/211 (26%)

Query: 35  GSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGL------- 87
           G L N      L++SQ+  Y  Q+L G+ YLHE +++HR+IK ANIL+D  G+       
Sbjct: 103 GLLEN--PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160

Query: 88  ----------------ATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE 131
                              T    +   T ++  PE++ L    Y  + DIW +GC   E
Sbjct: 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELL-LGERRYTTAVDIWGIGCVFAE 219

Query: 132 MLTHQPPY---SHLEDMQALFRI----------GRGKLPSVPN----------------S 162
           M T +P     S ++ +  +F++          G   LP                     
Sbjct: 220 MFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGK 279

Query: 163 LSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
           L  +  D + K L ++P  R TA+  +EHP+
Sbjct: 280 LGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 83.9 bits (207), Expect = 2e-19
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 21/192 (10%)

Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           +RLY  +E V  G L  ++ Q     + Q   Y  +I  GL +LH R +++R++K  N++
Sbjct: 74  DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVM 133

Query: 82  VDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D+ G     +              ++F GTP ++APE++  +   YG S D W+ G  +
Sbjct: 134 LDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP--YGKSVDWWAYGVLL 191

Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQ-- 187
            EML  QPP+   ED   LF+       S P SLS++A       +  +P+ R       
Sbjct: 192 YEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEG 250

Query: 188 ---LMEHPFVKR 196
              + EH F +R
Sbjct: 251 ERDIREHAFFRR 262

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 83.7 bits (207), Expect = 2e-19
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 29/201 (14%)

Query: 22  ENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L +LHER +++R++K  N+
Sbjct: 68  ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNV 127

Query: 81  LVDASGLATTTN-----------DVKS-FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           L+DA G    T+           D  S F GTP ++APE+  L+   YG S D W+LG  
Sbjct: 128 LLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEI--LRGEDYGFSVDWWALGVL 185

Query: 129 VLEMLTHQPPY-----SHLEDMQA---LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPN 180
           + EM+  + P+     S   D      LF++   K   +P SLS  A   +   L  +P 
Sbjct: 186 MFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPK 245

Query: 181 DR------PTAAQLMEHPFVK 195
           +R           +  HPF +
Sbjct: 246 ERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 83.3 bits (206), Expect = 2e-19
 Identities = 63/244 (25%), Positives = 103/244 (42%), Gaps = 58/244 (23%)

Query: 6   QFEHDNIVQY--IGTE--------KDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSY 54
           Q  H NIV    I T+        KD+   Y+  E +    +  L     H S+  + S+
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121

Query: 55  TRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPF---- 102
            +Q+L GL Y H++N +HR+IKC+NIL++          GLA   N   S E  P+    
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN---SEESRPYTNKV 178

Query: 103 ---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS---HLEDMQALFRIGRGKL 156
              W  P  + L    YG + D+WS GC + E+ T +P +     L  ++ + R+     
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238

Query: 157 PSV-PNS-------------------------LSRDARDFILKCLQVNPNDRPTAAQLME 190
           P+V P+                          +   A D +   L ++P+ R TA + + 
Sbjct: 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298

Query: 191 HPFV 194
            P++
Sbjct: 299 SPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.8 bits (204), Expect = 2e-19
 Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 21/196 (10%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS---YTRQILNGLT 63
            +HD +V+       E  +YI  E + KGSL +  +        +     ++ QI  G+ 
Sbjct: 58  LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTT--NDVKSFEGTPF---WVAPEVVN 110
           Y+  +N +HR+++ AN+LV  S        GLA     N+  + EG  F   W APE +N
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRDAR 168
                + + +D+WS G  + E++T+ + PY  + +   +  + RG ++P + N    +  
Sbjct: 178 F--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENC-PDELY 234

Query: 169 DFILKCLQVNPNDRPT 184
           D +  C +    +RPT
Sbjct: 235 DIMKTCWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 83.6 bits (206), Expect = 2e-19
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 33/205 (16%)

Query: 20  KDENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           + E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L YLHER +++R++K  
Sbjct: 66  QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 125

Query: 79  NILVDASGLATTTN-----------DVKS-FEGTPFWVAPEVVNLKNNGYGLSADIWSLG 126
           N+L+D+ G    T+           D  S F GTP ++APE+  L+   YG S D W+LG
Sbjct: 126 NVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI--LRGEDYGFSVDWWALG 183

Query: 127 CTVLEMLTHQPPY----------SHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
             + EM+  + P+           + ED   LF++   K   +P SLS  A   +   L 
Sbjct: 184 VLMFEMMAGRSPFDIVGSSDNPDQNTEDY--LFQVILEKQIRIPRSLSVKAASVLKSFLN 241

Query: 177 VNPNDR----PTA--AQLMEHPFVK 195
            +P +R    P    A +  HPF +
Sbjct: 242 KDPKERLGCHPQTGFADIQGHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 82.0 bits (203), Expect = 3e-19
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 23/203 (11%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS---YTRQILNGLTY 64
           +H+N+++  G       + +  EL   GSL +  +K  L    +S+   Y  QI NG+ Y
Sbjct: 54  DHENLIRLYGVVLTHPLMMVT-ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112

Query: 65  LHERNVVHREIKCANILVDAS--------GL--ATTTND---VKSFE-GTPF-WVAPEVV 109
           L  +  +HR++   NIL+ +         GL  A   N+   V       PF W APE  
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE-- 170

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGR-GKLPSVPNSLSRDA 167
           +L+   +  ++D+W  G T+ EM T+ + P++ L   Q L +I + G+    P +  +D 
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDI 230

Query: 168 RDFILKCLQVNPNDRPTAAQLME 190
            + +L+C   NP DRPT A L E
Sbjct: 231 YNVMLQCWAHNPADRPTFAALRE 253

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (204), Expect = 5e-19
 Identities = 57/186 (30%), Positives = 94/186 (50%), Gaps = 19/186 (10%)

Query: 24  RLYIFLELVKKGSLANLYQKYHLSD-SQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +LY+ L  +  G L +  Q+    D S+   YT ++L  L  LH+ NV++R++K  NIL+
Sbjct: 67  KLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL 126

Query: 83  DASGL------------ATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVL 130
           D  G                 +   +F GTP ++APE+  L  +GY  + D W+LG  + 
Sbjct: 127 DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPEL--LLGHGYTKAVDWWTLGVLLY 184

Query: 131 EMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR---PTAAQ 187
           EMLT  PP+ + E++  ++R    +    P+   RDA+D ++  L  +P  R     A +
Sbjct: 185 EMLTGLPPF-YDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQE 243

Query: 188 LMEHPF 193
           +  HPF
Sbjct: 244 IKNHPF 249

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 82.0 bits (202), Expect = 9e-19
 Identities = 51/182 (28%), Positives = 88/182 (48%), Gaps = 21/182 (11%)

Query: 20  KDENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           +  +RL++ +E V  G L  ++ ++  L +     Y  +I   L +LHER +++R++K  
Sbjct: 66  QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLD 125

Query: 79  NILVDASGLATTT------------NDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLG 126
           N+L+DA G    T            +   +F GTP ++APE+  L+   YG S D W+LG
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEI--LRGEEYGFSVDWWALG 183

Query: 127 CTVLEMLTHQPPYSHLED------MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPN 180
             + EM+  + P+  + D         LF++   K   +P  LS  A   +   L  +P 
Sbjct: 184 VLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPK 243

Query: 181 DR 182
           +R
Sbjct: 244 ER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.4 bits (198), Expect = 1e-18
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 18/199 (9%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLT 63
           Q++H NIV+ IG       +YI +ELV  G   +  +K    L   Q+  +      G+ 
Sbjct: 48  QYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMA 107

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTND-VKSFEG---TPF-WVAPEVVN 110
           YL  +N +HR++   N LV  +        G++   +D + S  G    P  W APE +N
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN 167

Query: 111 LKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
                Y   +D+WS G  + E  +    PY  + + QA  ++ +G   S P     D   
Sbjct: 168 YGR--YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYK 225

Query: 170 FILKCLQVNPNDRPTAAQL 188
            + +C    P +RP  ++L
Sbjct: 226 VMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.9 bits (200), Expect = 1e-18
 Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 19/199 (9%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLT 63
           QF+H +IV+ IG   + N ++I +EL   G L +  Q  KY L  + +  Y+ Q+   L 
Sbjct: 63  QFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT----PF-WVAPEVVN 110
           YL  +  VHR+I   N+LV +         GL+    D   ++ +    P  W+APE +N
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
            +   +  ++D+W  G  + E+L     P+  +++   + RI  G+   +P +       
Sbjct: 182 FRR--FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239

Query: 170 FILKCLQVNPNDRPTAAQL 188
            + KC   +P+ RP   +L
Sbjct: 240 LMTKCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 81.7 bits (202), Expect = 1e-18
 Identities = 51/191 (26%), Positives = 83/191 (43%), Gaps = 20/191 (10%)

Query: 22  ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           E+ +   +E    G L         S+ +   Y   ++ GL YLHE  +V+R++K  N+L
Sbjct: 74  EDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLL 133

Query: 82  VDASGLATTT------------NDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D  G                 +   +F GTP ++APEV  L    Y  + D W LG  +
Sbjct: 134 LDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV--LTETSYTRAVDWWGLGVLI 191

Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR----PTA 185
            EML  + P+   +D + +F          P  LSR+A   + + L+ NP  R       
Sbjct: 192 YEMLVGESPFPG-DDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKD 250

Query: 186 AQ-LMEHPFVK 195
           A+ + + PF +
Sbjct: 251 AEDVKKQPFFR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 80.6 bits (199), Expect = 2e-18
 Identities = 54/182 (29%), Positives = 82/182 (45%), Gaps = 20/182 (10%)

Query: 26  YIFLELVKKGSLANLYQKYHLSDSQVSS---YTRQILNGLTYLHERNVVHREIKCANILV 82
           YI  EL++KGSL    +        V+S      Q+  G+ YL E+N +HR++   NILV
Sbjct: 78  YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV 137

Query: 83  DAS--------GLA-TTTNDVKSFEGT--PF-WVAPEVVNLKNNGYGLSADIWSLGCTVL 130
                      GLA     DV        P+ W APE  +     +   +D+WS G  + 
Sbjct: 138 GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT--FSTKSDVWSFGILLY 195

Query: 131 EMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
           EM T+ Q PY  + + +   +I  G ++P  P    ++    +L+C    P DRP+   L
Sbjct: 196 EMFTYGQVPYPGMNNHEVYDQITAGYRMPC-PAKCPQEIYKIMLECWAAEPEDRPSFKAL 254

Query: 189 ME 190
            E
Sbjct: 255 RE 256

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 82.0 bits (202), Expect = 2e-18
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----ANLYQKYHLSDSQVSSYTRQILNGL 62
           +H  IV++    K +++L + +E    G L       L +     + +V     QI+  L
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182

Query: 63  TYLHERNVVHREIKCANILVDASGLA-------------TTTNDV-KSFEGTPFWVAPEV 108
             +H R ++HR++K ANI +  +G+              + + DV  SF GTP+++APE+
Sbjct: 183 DEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPEL 242

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
              K   Y   AD+WSLG  + E+LT   P+      + + ++  GK    P  +S   +
Sbjct: 243 WERKR--YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK 300

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVK 195
             +   L  NP  RPT  QL+   F+K
Sbjct: 301 ALLDPLLSKNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 80.6 bits (199), Expect = 3e-18
 Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 21/190 (11%)

Query: 22  ENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           E +LY+ L+ ++ G L   L ++   ++  V  Y  ++   L +LH   +++R++K  NI
Sbjct: 70  EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 129

Query: 81  LVDASGLATTT------------NDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           L+D  G    T                SF GT  ++APEVVN +  G+  SAD WS G  
Sbjct: 130 LLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVL 187

Query: 129 VLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAA-- 186
           + EMLT   P+   +  + +  I + KL  +P  LS +A+  +    + NP +R  A   
Sbjct: 188 MFEMLTGSLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRALFKRNPANRLGAGPD 246

Query: 187 ---QLMEHPF 193
              ++  HPF
Sbjct: 247 GVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 79.4 bits (196), Expect = 5e-18
 Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 27/210 (12%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL----------ANLYQKYHLSDSQVSS 53
           F +  H N+V+ +G  ++    Y+ LE    G L              +   LS  Q  +
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDVKSFEGTPF------ 102
              QI  G+ +L     VHR++   N LV +       L + + DV + E          
Sbjct: 122 LCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181

Query: 103 --WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLP-S 158
             W+APE V  + + +   +D+WS G  + E+ T  + P+  L D + L R+  GKL   
Sbjct: 182 LRWLAPEAV--QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239

Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
           VP          + +C  VNP DRP+ ++L
Sbjct: 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 80.1 bits (198), Expect = 5e-18
 Identities = 60/240 (25%), Positives = 108/240 (45%), Gaps = 56/240 (23%)

Query: 5   SQFEHDNIVQYIGTEKDENR-----LYIFLELVKKGSLANLYQ----KYHLSDSQVSSYT 55
              +H+N++         +R     +YI  EL+      +L+Q       LSD     + 
Sbjct: 59  RHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD----TDLHQIIRSSQTLSDDHCQYFL 114

Query: 56  RQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEG----TPFW 103
            Q+L GL Y+H  NV+HR++K +N+L++A+        GLA TT++   F      T ++
Sbjct: 115 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWY 174

Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRI--------- 151
            APE++ L  + Y  + D+WS+GC   E+L  +P +    ++  ++ +  +         
Sbjct: 175 RAPELL-LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233

Query: 152 -------GRGKLPSVPN----SLSR-------DARDFILKCLQVNPNDRPTAAQLMEHPF 193
                   R  + S+P     S +R        A D + K L  +P+ R T  + + HP+
Sbjct: 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 78.7 bits (194), Expect = 6e-18
 Identities = 50/196 (25%), Positives = 95/196 (48%), Gaps = 20/196 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGL 62
           Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  G+
Sbjct: 57  QLQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGM 115

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPEVV 109
            ++  +N +HR+++ ANILV  +        GLA     N+  + EG  F   W APE +
Sbjct: 116 AFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
           N     + + +D+WS G  + E++T+ + PY  + + + +  + RG     P++   +  
Sbjct: 176 NYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELY 233

Query: 169 DFILKCLQVNPNDRPT 184
           + +  C +  P +RPT
Sbjct: 234 ELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 7e-18
 Identities = 66/261 (25%), Positives = 105/261 (40%), Gaps = 82/261 (31%)

Query: 9   HDNIV--QYIGTEKDENRLYIFLELVKKGSLANLYQ--KYH-------LSDSQVSSYTRQ 57
           H+N+V    +  E  +  +Y+  +  +     +L+Q  K+H       +  S V S   Q
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116

Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS------------GLATTTND--VKSFEGTP-- 101
           ILNG+ YLH   V+HR++K ANILV               GLA   N       +  P  
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 102 --FWV-APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP-------------PYSHLEDM 145
              W  APE++ L    Y  + DIW++GC   E+LT +P             P+   + +
Sbjct: 177 VTIWYRAPELL-LGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF-QRDQL 234

Query: 146 QALFRI----------GRGKLPSVP-------------NSLSR----------DARDFIL 172
           + +F +             K+P                NSL++             D + 
Sbjct: 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294

Query: 173 KCLQVNPNDRPTAAQLMEHPF 193
           K L+ +P  R TA + +EHP+
Sbjct: 295 KLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 78.3 bits (193), Expect = 8e-18
 Identities = 46/201 (22%), Positives = 77/201 (38%), Gaps = 18/201 (8%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLT 63
           +  H N+VQ  G    +  ++I  E +  G L N  +  K  L    +      +   + 
Sbjct: 55  KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME 114

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTND--VKSFEGTPF---WVAPEVVN 110
           YL     +HR++   N LV           GLA    D    S +GT F   W  PEV +
Sbjct: 115 YLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD 174

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
              + +   +D+WS G  + E+ +  + PY    + + +  +  G     P     +   
Sbjct: 175 Y--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYT 232

Query: 170 FILKCLQVNPNDRPTAAQLME 190
            +  C    P DRP   +L+ 
Sbjct: 233 IMYSCWHEKPEDRPAFKKLLS 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 77.9 bits (192), Expect = 1e-17
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 25/205 (12%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLT 63
           Q++H NIV+ IG    +  +YI +ELV  GSL    +K    L+  ++   +     G+ 
Sbjct: 48  QYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGME 107

Query: 64  YLHERNVVHREIKCANILVD----------------ASGLATTTNDVKSFEGTPF-WVAP 106
           YL  +N +HR++   N LV                   G+ T ++ +K     P  W AP
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI---PIKWTAP 164

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +N     Y   +D+WS G  + E  +    PY  + + Q   RI  G     P     
Sbjct: 165 EALNYGR--YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPE 222

Query: 166 DARDFILKCLQVNPNDRPTAAQLME 190
           +    +L+C   +P +RP+ +++  
Sbjct: 223 EIYRLMLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 78.3 bits (193), Expect = 1e-17
 Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 24/163 (14%)

Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTP 101
           YT QI++GL +LH+R +++R++K  N+L+D  G            L    +  K + GTP
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161

Query: 102 FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRIGRGKLP 157
            ++APE+  L+   Y  S D ++LG T+ EM+  + P+      +E+ +   RI    + 
Sbjct: 162 GFMAPEL--LQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV- 218

Query: 158 SVPNSLSRDARDFILKCLQVNPNDR-----PTAAQLMEHPFVK 195
           + P+  S  ++ F    L  +P  R          L  HP  +
Sbjct: 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 77.8 bits (191), Expect = 2e-17
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 22/197 (11%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL----YQKYHLSDSQVSSYTRQILNG 61
           +  H+ +VQ      +E  +YI  E + KGSL +       KY L   Q+     QI +G
Sbjct: 57  KLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASG 114

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPEV 108
           + Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE 
Sbjct: 115 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA 167
                  + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P       
Sbjct: 175 ALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 232

Query: 168 RDFILKCLQVNPNDRPT 184
            D + +C +  P +RPT
Sbjct: 233 HDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 78.2 bits (193), Expect = 2e-17
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 27/212 (12%)

Query: 10  DNIVQYIGTEKDENRLYIFLELVKKGSLANLY------QKYHLSDSQVSSYTRQILNGLT 63
             IV++ G    E   +I +EL+   SL   Y       K  + +  +       +  L 
Sbjct: 63  PYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121

Query: 64  YLHER-NVVHREIKCANILVDASG------LATTTNDVKSFEGT------PFWVAPEVVN 110
           YL E   ++HR++K +NIL+D +G         +   V S   T      P+ +APE ++
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPY-MAPERID 180

Query: 111 L-KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-QALFRIGRGKLPSVPNSL----S 164
               +GY + +D+WSLG T+ E+ T + PY     +   L ++ +G  P + NS     S
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
               +FI  CL  + + RP   +L+EHPF+K 
Sbjct: 241 PSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 78.7 bits (194), Expect = 2e-17
 Identities = 58/233 (24%), Positives = 95/233 (40%), Gaps = 48/233 (20%)

Query: 6   QFEHDNIVQ----YIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNG 61
              H+NI+     +I   +D   +Y   EL+    L  L     L    +  +  QIL G
Sbjct: 65  HLRHENIISLSDIFISPLED---IYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRG 120

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSFEGTPFWVAPEVVNLK 112
           L Y+H   VVHR++K +NIL++ +        GLA   +  +  +  T ++ APE++ L 
Sbjct: 121 LKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIM-LT 179

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPY------------------------------SHL 142
              Y +  DIWS GC   EML  +P +                              + L
Sbjct: 180 WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239

Query: 143 EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             +Q+L +           +    A D + K L  +P  R +AA+ + HP++ 
Sbjct: 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 77.4 bits (190), Expect = 2e-17
 Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 20/196 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGL 62
           +  HD +V       +E  +YI  E + KGSL +  ++    +L   Q+     QI +G+
Sbjct: 57  KLRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGM 115

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPEVV 109
            Y+   N +HR+++ ANILV  +        GLA     N+  + +G  F   W APE  
Sbjct: 116 AYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
                 + + +D+WS G  + E++T  + PY  + + + L ++ RG     P        
Sbjct: 176 LYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLH 233

Query: 169 DFILKCLQVNPNDRPT 184
           + +  C + +P++RPT
Sbjct: 234 ELMKLCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 77.7 bits (191), Expect = 2e-17
 Identities = 63/197 (31%), Positives = 93/197 (47%), Gaps = 31/197 (15%)

Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSS------YTRQILNGLTYLHERNVVHREIK 76
           ++L   L+L+  G L      YHLS   V S      Y  +I+ GL ++H R VV+R++K
Sbjct: 70  DKLSFILDLMNGGDL-----HYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLK 124

Query: 77  CANILVDAS--------GLATTTNDVKSFE--GTPFWVAPEVVNLKNNGYGLSADIWSLG 126
            ANIL+D          GLA   +  K     GT  ++APEV+  K   Y  SAD +SLG
Sbjct: 125 PANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLG 183

Query: 127 CTVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSRDARDFILKCLQVNPNDR- 182
           C + ++L    P+   +       I R  L     +P+S S + R  +   LQ + N R 
Sbjct: 184 CMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRL 242

Query: 183 ----PTAAQLMEHPFVK 195
                 A ++ EHPF +
Sbjct: 243 GCLGRGAQEVKEHPFFR 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 76.8 bits (189), Expect = 6e-17
 Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 23/195 (11%)

Query: 22  ENRLYIFLELVKKGSLANLYQKYHLSD-SQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           ++RL+  +E V  G L    Q+    D  +   Y  ++   L +LH   V++R++K  NI
Sbjct: 68  KDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNI 127

Query: 81  LVDASG---LA---------TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           L+DA G   LA                +F GTP ++APE+  L+   YG S D W+LG  
Sbjct: 128 LLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEI--LQELEYGPSVDWWALGVL 185

Query: 129 VLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR--PTAA 186
           + EM+  QPP+   ++   LF          P  LS++A   +   +  NPN R    A+
Sbjct: 186 MYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVAS 244

Query: 187 Q-----LMEHPFVKR 196
           Q     + +HPF K 
Sbjct: 245 QGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 75.4 bits (185), Expect = 1e-16
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 20/196 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGL 62
           +  HD +VQ      +E  +YI  E + KGSL +  +      L    +     Q+  G+
Sbjct: 57  KLRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM 115

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPEVV 109
            Y+   N +HR+++ ANILV           GLA     N+  + +G  F   W APE  
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
                 + + +D+WS G  + E++T  + PY  + + + L ++ RG     P        
Sbjct: 176 LYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLH 233

Query: 169 DFILKCLQVNPNDRPT 184
           + +L+C + +P +RPT
Sbjct: 234 ELMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 75.3 bits (185), Expect = 1e-16
 Identities = 53/198 (26%), Positives = 86/198 (43%), Gaps = 18/198 (9%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKY-HLSDSQVSSYTRQILNGLTYLH 66
           H  +VQ  G    +  LYI  E ++ G L N L Q+   LS   + S  + +  G+ YL 
Sbjct: 58  HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117

Query: 67  ERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVNLKN 113
             + +HR++   N LV ++G+   +          ++  S  G  F   W  PEV N   
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-- 175

Query: 114 NGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL 172
           + Y   +D+WS G  + E+ T  + P+    + + +  I RG     P   S    + + 
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY 235

Query: 173 KCLQVNPNDRPTAAQLME 190
            C    P  RPT A+L+ 
Sbjct: 236 SCWHEKPEGRPTFAELLR 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.4 bits (185), Expect = 1e-16
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 36/216 (16%)

Query: 9   HDNIVQYIG--TEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLTY 64
           H+NIV+Y G  TE   N + + +E +  GSL       K  ++  Q   Y  QI  G+ Y
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124

Query: 65  LHERNVVHREIKCANILVDASGL----------ATTTND----VKSFEGTP-FWVAPEVV 109
           L  R  VHR++   N+LV++             A  T+     VK    +P FW APE  
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC- 183

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH----QPPYSHLEDM----QALFRIGR-------G 154
            L  + + +++D+WS G T+ E+LT+      P +    M         + R       G
Sbjct: 184 -LIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242

Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
           K    P +   +    + KC +  P+ R T   L+E
Sbjct: 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 75.8 bits (186), Expect = 2e-16
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 16/158 (10%)

Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           +RLY  +E V  G L   + Q     +     Y  +I  GL +LH + +++R++K  N++
Sbjct: 74  DRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM 133

Query: 82  VDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D+ G     +              K+F GTP ++APE++  +   YG S D W+ G  +
Sbjct: 134 LDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLL 191

Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA 167
            EML  Q P+   ED   LF+       + P S+S++A
Sbjct: 192 YEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEA 228

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 75.2 bits (185), Expect = 2e-16
 Identities = 59/235 (25%), Positives = 97/235 (41%), Gaps = 53/235 (22%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY------HLSDSQVSSYTRQIL 59
           + +H NIV+       + +L +  E   +       +KY       +    V S+  Q+L
Sbjct: 55  ELKHKNIVRLYDVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLL 109

Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSF--EGTPFWVAPEV 108
            GL + H  NV+HR++K  N+L++ +        GLA      V+ +  E    W  P  
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPD 169

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QP--PYSHLED-MQALFRI----------GRG 154
           V      Y  S D+WS GC   E+    +P  P + ++D ++ +FR+          G  
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229

Query: 155 KLPS----------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
           KLP                 VP  L+   RD +   L  NP  R +A + ++HP+
Sbjct: 230 KLPDYKPYPMYPATTSLVNVVPK-LNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 75.2 bits (185), Expect = 2e-16
 Identities = 51/188 (27%), Positives = 76/188 (40%), Gaps = 41/188 (21%)

Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTND----------VK 95
           L    + S+  Q+L G+ + H+  V+HR++K  N+LVD         D          VK
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK 166

Query: 96  SF--EGTPFWV-APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG 152
           S+  E    W  APEV+ L +  Y    DIWS+GC   EM   QP +    ++Q L  I 
Sbjct: 167 SYTHEIVTLWYRAPEVL-LGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225

Query: 153 R-------GKLPSVPN--------------------SLSRDARDFILKCLQVNPNDRPTA 185
           +          P V                       LS +  D + K L+ +P  R +A
Sbjct: 226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA 285

Query: 186 AQLMEHPF 193
              + HP+
Sbjct: 286 KAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 75.0 bits (185), Expect = 3e-16
 Identities = 56/241 (23%), Positives = 108/241 (44%), Gaps = 61/241 (25%)

Query: 6   QFEHDNIV--QYIGTEKDENRLYIFLELVK---KGSLANLYQKYHLSDSQVSSYTRQILN 60
           + +H NIV  + +    + +++Y+ +E V+   K  +  +  K     S+V     Q+L+
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETM--KQPFLQSEVKCLMLQLLS 117

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLAT---------TTNDVKSFEGTPFW 103
           G+ +LH+  ++HR++K +N+L++          GLA          T   V     T ++
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-----TLWY 172

Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRI--------- 151
            APE++ L    Y  + D+WS+GC   E+LT +P +   S ++ +  +F++         
Sbjct: 173 RAPELL-LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231

Query: 152 -GRGKLPSV------------------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP 192
            G  +LP                      SLS +  D + + L  +P  R +A   ++HP
Sbjct: 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHP 291

Query: 193 F 193
           +
Sbjct: 292 Y 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 74.1 bits (182), Expect = 4e-16
 Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 56/237 (23%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----LSDSQVSSYTRQILN 60
           + +H+NIV+       EN+L +  E + K      Y   H     L  + V S+T Q+L 
Sbjct: 54  ELKHENIVRLHDVIHTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLK 111

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--------TTTNDVKSFEGTPFWV 104
           G+ + HE  V+HR++K  N+L++          GLA        T +N+V     T ++ 
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----TLWYR 167

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRI---------- 151
           AP+V+ L +  Y  S DIWS+GC + EM+T +P +   ++ + +  +FRI          
Sbjct: 168 APDVL-LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP 226

Query: 152 GRGKLPSVPN---------------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
           G  +LP                          D + + LQ+NP  R +A   ++HP+
Sbjct: 227 GISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 74.6 bits (184), Expect = 5e-16
 Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 44/191 (23%)

Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTND-VKS 96
           LSD  +     QIL GL Y+H   ++HR++K +NI V+          GLA  T+D +  
Sbjct: 115 LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG 174

Query: 97  FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL 156
           +  T ++ APE++    + Y  + DIWS+GC + E+LT +  +   + +  L RI    L
Sbjct: 175 YVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI--MNL 231

Query: 157 PSVPNS------LSRDARDFIL--------------------------KCLQVNPNDRPT 184
              P+        S  AR++I                           K L ++P+ R T
Sbjct: 232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT 291

Query: 185 AAQLMEHPFVK 195
           AA+ + HP++ 
Sbjct: 292 AAEALAHPYLA 302

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 74.2 bits (182), Expect = 6e-16
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 18/201 (8%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLTYLH 66
            H   V   G+ KDE+ LY+ LE V  G      ++     + V   Y  QI+    YL 
Sbjct: 89  NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ 148

Query: 67  ERNVVHREIKCANILVDASGLATTTN-------DVKSFE--GTPFWVAPEVVNLKNNGYG 117
             N+V+R++K  N+L+D  G    T+       D +++   GTP ++APE+  L N G+G
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEI--LLNVGHG 206

Query: 118 LSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQV 177
            +AD W+LG  + E+L   PP+   E +    +I  G +   P  L  + +  + K L  
Sbjct: 207 KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII-YFPKFLDNNCKHLMKKLLSH 265

Query: 178 N-----PNDRPTAAQLMEHPF 193
           +      N +  A  + EHP+
Sbjct: 266 DLTKRYGNLKKGAQNVKEHPW 286

Length = 340

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 6e-16
 Identities = 46/161 (28%), Positives = 71/161 (44%), Gaps = 21/161 (13%)

Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDASG--------LATTTND---VKSFEGTPF 102
           Y  +I  GL  LH   +V+R++K  NIL+D  G        LA    +   ++   GT  
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVG 166

Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM---QALFRIGRGKLPSV 159
           ++APEVV  KN  Y  S D W LGC + EM+  + P+   ++    + + R  +      
Sbjct: 167 YMAPEVV--KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY 224

Query: 160 PNSLSRDARDFILKCLQVNPNDR-----PTAAQLMEHPFVK 195
               S  AR    + L  +P  R       A ++  HPF +
Sbjct: 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 73.5 bits (180), Expect = 6e-16
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 16/199 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILNG 61
           ++  H N+V+ +G     N LYI +EL+ KG+L N  +   +  +S  Q+  ++  +  G
Sbjct: 54  TKLHHKNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG 112

Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTN------DVKSFEGTPF---WVAPEVVNLK 112
           + YL  + +VHR++   NILV   G+A  ++           + +     W APE   LK
Sbjct: 113 MEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEA--LK 170

Query: 113 NNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFI 171
           +  +   +D+WS G  + E+ ++ + PY  +   +    + +G     P     D    +
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230

Query: 172 LKCLQVNPNDRPTAAQLME 190
             C +  P  RP+  +L E
Sbjct: 231 TSCWETEPKKRPSFHKLRE 249

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 73.1 bits (179), Expect = 7e-16
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 16/200 (8%)

Query: 5   SQFEHDNIVQYIGTEKDEN-RLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILN 60
           +Q  H N+VQ +G   +E   LYI  E + KGSL +  +   +  L    +  ++  +  
Sbjct: 54  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113

Query: 61  GLTYLHERNVVHREIKCANILVDASGLATT-----TNDVKSFEGT---PF-WVAPEVVNL 111
            + YL   N VHR++   N+LV    +A       T +  S + T   P  W APE   L
Sbjct: 114 AMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA--L 171

Query: 112 KNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDF 170
           +   +   +D+WS G  + E+ +  + PY  +     + R+ +G     P+       D 
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV 231

Query: 171 ILKCLQVNPNDRPTAAQLME 190
           + +C  ++   RP+  QL E
Sbjct: 232 MKQCWHLDAATRPSFLQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 73.7 bits (181), Expect = 9e-16
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 35/202 (17%)

Query: 20  KDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKC 77
           +D++ LY+ +E    G L +L  +Y     +     Y  +++  +  +H+   VHR+IK 
Sbjct: 71  QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKP 130

Query: 78  ANILVDASG---------LATTTNDVKSFE----GTPFWVAPEVVNLKNNG----YGLSA 120
            N+L+D +G          A  T +         GTP ++APEV+   N      YG+  
Sbjct: 131 ENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVEC 190

Query: 121 DIWSLGCTVLEMLTHQPP---------YSHLEDMQALFRIGRGKLPSVPNSLSRDARDFI 171
           D WSLG    EM+  + P         Y+++ + Q        K P  P  +S D  D I
Sbjct: 191 DWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL-----KFPEDPK-VSSDFLDLI 244

Query: 172 LKCLQVNPNDRPTAAQLMEHPF 193
              L     +R     L  HPF
Sbjct: 245 QSLL-CGQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 73.1 bits (180), Expect = 9e-16
 Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 36/215 (16%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ----VSSYTR----- 56
           +F   ++V+ +G         + +EL+ KG L + Y +    +++    +   T      
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKS-YLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 57  ---QILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDV-------KSFE 98
              +I +G+ YL  +  VHR++   N +V           G+   T D+       K  +
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM---TRDIYETDYYRKGGK 180

Query: 99  GT-PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGK 155
           G  P  W+APE  +LK+  +   +D+WS G  + EM T  + PY  L + + L  +  G 
Sbjct: 181 GLLPVRWMAPE--SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238

Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
              +P +      + +  C Q NP  RPT  +++ 
Sbjct: 239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 73.9 bits (181), Expect = 1e-15
 Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 41/213 (19%)

Query: 20  KDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN 79
           ++ N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N
Sbjct: 92  EEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN 150

Query: 80  ILVDAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVL 130
           + V+          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + 
Sbjct: 151 LAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMA 209

Query: 131 EMLTHQ---PPYSHLEDMQALFRI----------------GRGKLPSVPNSLSRD----- 166
           E+LT +   P   H++ ++ + R+                 R  + S+      +     
Sbjct: 210 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF 269

Query: 167 ------ARDFILKCLQVNPNDRPTAAQLMEHPF 193
                 A D + K L ++ + R TAAQ + H +
Sbjct: 270 IGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 70.9 bits (174), Expect = 1e-15
 Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 18/176 (10%)

Query: 35  GSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN 92
            SLA++ +     L++ ++ +   Q L  L  LH +      +   + L+   G      
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAFKT 60

Query: 93  DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH----------- 141
             +S    P+++APEV  ++   Y   ADI+SLG T+ E L ++ PY+            
Sbjct: 61  PEQS-RPDPYFMAPEV--IQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEIL 117

Query: 142 LEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP 197
           L  M A     R  L  V  S +R   DF+  C    P  R  A   + H      
Sbjct: 118 LNGMPADDPRDRSNLEGV--SAARSFEDFMRLCASRLPQRREAANHYLAHCRALFA 171

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 73.6 bits (181), Expect = 1e-15
 Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 50/236 (21%)

Query: 7   FEHDNIVQYIGTEKDEN-----RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNG 61
           F+HDN++  +   +  +      +Y+  EL++      +     LS   V  +  QIL G
Sbjct: 56  FKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG 115

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTP-----FWVAPEV 108
           L YLH   ++HR+IK  N+LV+++        GLA      +S   T      ++ APE+
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEI 175

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH------QPPYSHLE---------DMQALFRIGR 153
           + + +  Y  + DIWS+GC   E+L        Q P   L+          ++A+     
Sbjct: 176 L-MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234

Query: 154 G----------KLPSVP------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
           G          K PS+P      +  + +A   + + L  +P+ R +AA  + HP+
Sbjct: 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 72.8 bits (179), Expect = 2e-15
 Identities = 54/196 (27%), Positives = 82/196 (41%), Gaps = 45/196 (22%)

Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSF 97
            S+SQV     Q+L GL YLHE  ++HR++K +N+L+           GLA T       
Sbjct: 105 FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK- 163

Query: 98  EGTPFWV-----APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--------------- 137
             TP  V     APE++ L    Y  + D+W++GC + E+L H+P               
Sbjct: 164 PMTPKVVTLWYRAPELL-LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222

Query: 138 -----PYSHL-EDMQALFRIGRGKLPSVPNS--------LSRDARDFILKCLQVNPNDRP 183
                P   +      L  +G+  LP  P +        LS      +   L  +P  R 
Sbjct: 223 QLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRA 282

Query: 184 TAAQLMEHP-FVKRPL 198
           TA + +E   F ++PL
Sbjct: 283 TAEEALESSYFKEKPL 298

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 72.4 bits (177), Expect = 2e-15
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 34/202 (16%)

Query: 22  ENRLYIFLELVKKGSLANLYQKYHLSDS-----QVSSYTRQILNGLTYLHERNVVHREIK 76
           ++ L + L L+  G L   +  YH+ ++     +   Y  +I  GL  LH+  +V+R++K
Sbjct: 72  KDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLK 129

Query: 77  CANILVDASG--------LATTTND---VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSL 125
             NIL+D  G        LA    +   +K   GT  ++APEVV  KN  Y  S D W+L
Sbjct: 130 PENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTFSPDWWAL 187

Query: 126 GCTVLEMLTHQPPYSH------LEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNP 179
           GC + EM+  Q P+         E+++ L +  + +        S DAR      L  +P
Sbjct: 188 GCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE---KFSPDARSLCKMLLCKDP 244

Query: 180 NDR-----PTAAQLMEHPFVKR 196
            +R       A ++ EHP  K+
Sbjct: 245 KERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 71.6 bits (176), Expect = 2e-15
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 27/207 (13%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLT 63
           QF+H NI++  G       + I  E ++ GSL    ++     +  Q+    R I +G+ 
Sbjct: 61  QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-----PF-WVAPEVV 109
           YL E N VHR++   NILV+++        GL+    D ++   T     P  W APE +
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPS---VPNSLS 164
             +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP     P++L 
Sbjct: 181 AYRK--FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALY 238

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEH 191
           +     +L C Q + N+RPT +Q++  
Sbjct: 239 Q----LMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 72.2 bits (177), Expect = 3e-15
 Identities = 55/192 (28%), Positives = 88/192 (45%), Gaps = 22/192 (11%)

Query: 23  NRLYIFLELVKKGSLANLYQKYHLSD-SQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           +RL+  +E V  G L    QK    D ++   Y  +I + L +LH++ +++R++K  N+L
Sbjct: 69  DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVL 128

Query: 82  VDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D  G     +               +F GTP ++APE+  L+   YG S D W++G  +
Sbjct: 129 LDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI--LQEMLYGPSVDWWAMGVLL 186

Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL- 188
            EML    P+   E+   LF          P  LS+DA D +   +  NP  R  +  L 
Sbjct: 187 YEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLG 245

Query: 189 -----MEHPFVK 195
                + HPF K
Sbjct: 246 GEEAILRHPFFK 257

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 72.4 bits (178), Expect = 3e-15
 Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 65/228 (28%)

Query: 25  LYIFLELVKKGSLANLYQKYHLS-DSQVSSY-TRQILNGLTYLHERNVVHREIKCANILV 82
           +Y+ +EL+     ANL Q   +  D +  SY   Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 96  VYLVMELMD----ANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 151

Query: 83  DAS--------GLATTTNDVKSFEGTPFWV-----APEVVNLKNNGYGLSADIWSLGCTV 129
            +         GLA T     SF  TP+ V     APEV+     GY  + DIWS+GC +
Sbjct: 152 KSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIM 207

Query: 130 LEMLTHQ---------------------PPYSHLEDMQALFRI---GRGKLPS------V 159
            EM+                        P    +  +Q   R     R K          
Sbjct: 208 GEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELF 267

Query: 160 PNSL------------SRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           P+ L            +  ARD + K L ++P  R +    ++HP++ 
Sbjct: 268 PDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 71.6 bits (176), Expect = 3e-15
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 41/228 (17%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTR-------- 56
           S+    NI + +G    +  L + +E ++ G L    QK+    S ++  ++        
Sbjct: 74  SRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLL 133

Query: 57  ----QILNGLTYLHERNVVHREIKCANILVDAS------GLATT----TNDVKSFEGTPF 102
               QI +G+ YL   N VHR++   N LV  +          +    ++D    +G   
Sbjct: 134 YMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAP 193

Query: 103 ----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT--HQPPYSHLEDMQALFRIGRGK- 155
               W+A E V L    +   +D+W+ G T+ E+LT   + PY HL D Q +   G    
Sbjct: 194 LPIRWMAWESVLLGK--FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFR 251

Query: 156 -------LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
                  LP  PN   +D  + +L+C + +  DRPT  ++  H F++R
Sbjct: 252 DDGRQIYLPRPPNC-PKDIYELMLECWRRDEEDRPTFREI--HLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 71.4 bits (175), Expect = 4e-15
 Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 30/208 (14%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL--------ANLYQKYHLSDSQVSSYTR 56
           S F H NIV+ +G        YI +EL++ G L           +    L+  ++     
Sbjct: 54  SNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113

Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS-------------GLATT--TNDVKSFEGTP 101
            +  G  YL + + +HR++   N LV                GLA     +D    EG  
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173

Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+APE  +L +  +   +D+WS G  + E+LT  Q PY  L + + L  +  G  
Sbjct: 174 LLPVRWMAPE--SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR 231

Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPT 184
              P +        +  C   +P++RPT
Sbjct: 232 LQKPENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 71.7 bits (176), Expect = 4e-15
 Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 54/206 (26%)

Query: 43  KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLA---------TTTND 93
           K  L++SQV     QILNGL  LH+   +HR++  ANI +++ G+               
Sbjct: 113 KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYP 172

Query: 94  VKSFEG-----------------TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ 136
             S                    T ++ APE++ +    Y  + D+WS+GC   E+LT +
Sbjct: 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELL-MGAEKYHFAVDMWSVGCIFAELLTGK 231

Query: 137 PPYSHLEDMQALFRIG--RG-----------KLP-------SVPNSL-------SRDARD 169
           P +    ++  L RI    G           KLP         P  L       S DA D
Sbjct: 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAID 291

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVK 195
            +   L++NP +R +A + ++H + K
Sbjct: 292 LLQSLLKLNPLERISAKEALKHEYFK 317

Length = 335

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 70.6 bits (173), Expect = 8e-15
 Identities = 46/208 (22%), Positives = 86/208 (41%), Gaps = 32/208 (15%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---------------KYHLSDS 49
           + F+H+NIV++ G   + +   +  E ++ G L    +                  L+ S
Sbjct: 63  TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATT----------TNDVKSFEG 99
           Q+     QI +G+ YL  ++ VHR++   N LV    +             T D     G
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG 182

Query: 100 TPF----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG 154
                  W+ PE +      +   +D+WS G  + E+ T+ + P+  L + + +  I +G
Sbjct: 183 HTMLPIRWMPPESI--MYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240

Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDR 182
           +L   P +   +  D +L C + +P  R
Sbjct: 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 71.0 bits (174), Expect = 8e-15
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 24/198 (12%)

Query: 20  KDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC 77
           +DEN LY+ ++    G L  L  K+   L +     Y  +++  +  +H+   VHR+IK 
Sbjct: 71  QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKP 130

Query: 78  ANILVDASG---LA--------TTTNDVKSF--EGTPFWVAPEVVNLKNNG---YGLSAD 121
            N+L+D +G   LA             V+S    GTP +++PE++    +G   YG   D
Sbjct: 131 DNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECD 190

Query: 122 IWSLGCTVLEMLTHQPPYSHLEDMQALFRI----GRGKLPSVPNSLSRDARDFILK--CL 175
            WSLG  + EML  + P+     ++   +I       + P     +S +A+D I +  C 
Sbjct: 191 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS 250

Query: 176 QVNPNDRPTAAQLMEHPF 193
                 R       +HPF
Sbjct: 251 PETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 70.8 bits (173), Expect = 9e-15
 Identities = 50/169 (29%), Positives = 73/169 (43%), Gaps = 21/169 (12%)

Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG--------LATTTNDVKSF 97
             + +   Y  +IL GL  LH  N V+R++K  NIL+D  G        LA    + +S 
Sbjct: 99  FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158

Query: 98  EG---TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG 154
            G   T  ++APEV  L N  Y LS D W LGC + EM+  Q P+   ++      + R 
Sbjct: 159 RGRVGTVGYMAPEV--LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR 216

Query: 155 KL---PSVPNSLSRDARDFILKCLQVNPNDR-----PTAAQLMEHPFVK 195
            L          S +A+      L  +P  R       A ++  HPF +
Sbjct: 217 VLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 71.3 bits (174), Expect = 1e-14
 Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 46/234 (19%)

Query: 6   QFEHDNIVQYIGT--EKDENRLYIFLELVKKGSLANLYQKYH-----LSDSQVSSYTRQI 58
           + +H NIV+YI     K   +LYI +E    G L+   QK +     + +  +   TRQ+
Sbjct: 68  ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127

Query: 59  LNGLTYLHE-------RNVVHREIKCANILVDAS-----GLATTTNDVK----------- 95
           L+ L Y H          V+HR++K  NI +         +    N++            
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 96  ------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE 143
                       S  GTP++ +PE++  +   Y   +D+W+LGC + E+ + + P+    
Sbjct: 188 LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247

Query: 144 DM-QALFRIGRGKLPSVP-NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +  Q +  + RG  P +P    S++    I   L ++  +RP+A Q + +  +K
Sbjct: 248 NFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299

Length = 1021

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 70.7 bits (173), Expect = 1e-14
 Identities = 50/189 (26%), Positives = 86/189 (45%), Gaps = 40/189 (21%)

Query: 44  YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DV 94
           + LS+ +V     Q+L GL Y+H   ++HR++K  N+ V+          GLA   + ++
Sbjct: 112 HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM 171

Query: 95  KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY--------------- 139
             +  T ++ APEV+ L    Y  + DIWS+GC + EMLT +  +               
Sbjct: 172 TGYVVTRWYRAPEVI-LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230

Query: 140 ---------SHLEDM------QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT 184
                      LED       ++L +  R    ++    S  A D + K L+++ + R T
Sbjct: 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT 290

Query: 185 AAQLMEHPF 193
           A + +EHP+
Sbjct: 291 ATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 70.6 bits (173), Expect = 2e-14
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 34/212 (16%)

Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVV 71
           IVQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H    +
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFI 164

Query: 72  HREIKCANILVDASG---LATTTNDVKSFE----------GTPFWVAPEVVNLKNNG--- 115
           HR++K  N+L+D SG   LA     +K             GTP +++PEV  LK+ G   
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV--LKSQGGDG 222

Query: 116 -YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSL--------SRD 166
            YG   D WS+G  + EML    P+ + + +   +     K+    NSL        S+ 
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGTY----SKIMDHKNSLTFPDDIEISKQ 277

Query: 167 ARDFILKCLQVNPN--DRPTAAQLMEHPFVKR 196
           A+D I   L        R    ++  HPF K 
Sbjct: 278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 70.4 bits (172), Expect = 2e-14
 Identities = 45/145 (31%), Positives = 71/145 (48%), Gaps = 19/145 (13%)

Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVV 71
           +VQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H   ++
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLI 164

Query: 72  HREIKCANILVDASG---LATTTNDVKSFE----------GTPFWVAPEVVNLKNNG--- 115
           HR++K  N+L+D  G   LA     +K  E          GTP +++PEV  LK+ G   
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV--LKSQGGDG 222

Query: 116 -YGLSADIWSLGCTVLEMLTHQPPY 139
            YG   D WS+G  + EML    P+
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 70.0 bits (171), Expect = 2e-14
 Identities = 61/258 (23%), Positives = 102/258 (39%), Gaps = 69/258 (26%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLT 63
           F H NIV Y  T   +N L++    +  GS  +L   +    +S+  ++   + +L  L 
Sbjct: 56  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALD 115

Query: 64  YLHERNVVHREIKCANILVDA------SGLATTTNDVK--------------SFEGTPFW 103
           Y+H    VHR +K ++IL+        SGL +  + +               S +  P W
Sbjct: 116 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP-W 174

Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP------ 157
           ++PEV+     GY   +DI+S+G T  E+     P+  +   Q L     G +P      
Sbjct: 175 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTT 234

Query: 158 SVPNS-----LSRDARD----------------------------------FILKCLQVN 178
           ++P        SR   +                                  F+ +CLQ N
Sbjct: 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRN 294

Query: 179 PNDRPTAAQLMEHPFVKR 196
           P+ RP+A+ L+ H F K+
Sbjct: 295 PDARPSASTLLNHSFFKQ 312

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.4 bits (170), Expect = 2e-14
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 39/217 (17%)

Query: 8   EHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLT 63
           +HDNIV+Y G      R  L + +E +  GSL +  QK+   L   ++  Y  QI  G+ 
Sbjct: 63  QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGME 122

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTNDVKSF-------EGTPFWVAPEV 108
           YL  +  VHR++   NILV++         GL       K +       E   FW APE 
Sbjct: 123 YLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE- 181

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLEDM-------QALFRI----- 151
            +L  + + +++D+WS G  + E+ T+      PP   +  M         ++ +     
Sbjct: 182 -SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240

Query: 152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
             G+LP  P     +    + +C   +P+ RP+ ++L
Sbjct: 241 NNGRLP-APPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.9 bits (168), Expect = 2e-14
 Identities = 48/199 (24%), Positives = 81/199 (40%), Gaps = 25/199 (12%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLT 63
           Q+ H NIV+ IG    +  +YI +ELV+ G      +     L   ++         G+ 
Sbjct: 49  QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGME 108

Query: 64  YLHERNVVHREIKCANILV----------------DASGLATTTNDVKSFEGTPF-WVAP 106
           YL  ++ +HR++   N LV                +  G+  +T  +K     P  W AP
Sbjct: 109 YLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI---PVKWTAP 165

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +N     Y   +D+WS G  + E  +    PY++L + Q    I +G     P     
Sbjct: 166 EALNYGR--YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPD 223

Query: 166 DARDFILKCLQVNPNDRPT 184
                + +C + +P  RP+
Sbjct: 224 AVYRLMERCWEYDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 69.3 bits (170), Expect = 3e-14
 Identities = 55/196 (28%), Positives = 82/196 (41%), Gaps = 53/196 (27%)

Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG---LA-------------T 89
           LS   V  +  Q+L GL Y H+R V+HR++K  N+L+   G   LA             T
Sbjct: 100 LSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159

Query: 90  TTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLED-M 145
            +N+V +      W  P  V L +  Y  S D+W +GC   EM T +P +   + +ED +
Sbjct: 160 YSNEVVT-----LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL 214

Query: 146 QALFRI----------GRGKLP----------------SVPNSLSR--DARDFILKCLQV 177
             +FR+          G    P                +    L R     +  LK LQ 
Sbjct: 215 HKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQY 274

Query: 178 NPNDRPTAAQLMEHPF 193
            P  R +AA+ M+HP+
Sbjct: 275 EPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 69.4 bits (170), Expect = 3e-14
 Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 20/187 (10%)

Query: 24  RLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +LY  L+ V  G L  +L ++    + +   Y  +I + L YLH  N+++R++K  NIL+
Sbjct: 70  KLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL 129

Query: 83  DASGLATTT-----------NDVKS-FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVL 130
           D+ G    T           +   S F GTP ++APEV  L+   Y  + D W LG  + 
Sbjct: 130 DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV--LRKQPYDRTVDWWCLGAVLY 187

Query: 131 EMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAA---- 186
           EML   PP+ +  D   ++     K   +  ++S  AR  +   LQ +   R  A     
Sbjct: 188 EMLYGLPPF-YSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFL 246

Query: 187 QLMEHPF 193
           ++  H F
Sbjct: 247 EIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 68.5 bits (167), Expect = 3e-14
 Identities = 47/195 (24%), Positives = 84/195 (43%), Gaps = 20/195 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTY 64
           Q ++  IV+ IG  + E+   + +EL + G L    QK  H+++  ++    Q+  G+ Y
Sbjct: 52  QLDNPYIVRMIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKY 110

Query: 65  LHERNVVHREIKCANILVDASGLATTTN--------------DVKSFEGTPF-WVAPEVV 109
           L E N VHR++   N+L+     A  ++                K+    P  W APE +
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
           N     +   +D+WS G  + E  ++ Q PY  ++  +    I  G+    P     +  
Sbjct: 171 NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMY 228

Query: 169 DFILKCLQVNPNDRP 183
           D +  C     ++RP
Sbjct: 229 DLMKLCWTYGVDERP 243

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.9 bits (168), Expect = 5e-14
 Identities = 60/244 (24%), Positives = 102/244 (41%), Gaps = 63/244 (25%)

Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERN- 69
           IV + G    +  + I +E +  GSL  + +K   + +  +   +  ++ GLTYL E++ 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124

Query: 70  VVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           ++HR++K +NILV++ G     +             SF GT  +++PE   L+   Y + 
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 182

Query: 120 ADIWSLGCTVLEM----------------------------------------------- 132
           +DIWS+G +++EM                                               
Sbjct: 183 SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG 242

Query: 133 LTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP 192
              +PP +  E +  +      KLPS       + +DF+ KCL  NP +R    QLM H 
Sbjct: 243 PDSRPPMAIFELLDYIVNEPPPKLPSG--VFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300

Query: 193 FVKR 196
           F+KR
Sbjct: 301 FIKR 304

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 68.6 bits (167), Expect = 6e-14
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 24/198 (12%)

Query: 20  KDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKC 77
           +DEN LY+ ++    G L  L  K+   L +     Y  +++  +  +H+ + VHR+IK 
Sbjct: 71  QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKP 130

Query: 78  ANILVDASG---LATTTNDVKSFE----------GTPFWVAPEVVNLKNNG---YGLSAD 121
            NIL+D +G   LA   + +K  E          GTP +++PE++    +G   YG   D
Sbjct: 131 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECD 190

Query: 122 IWSLGCTVLEMLTHQPPYSHLEDMQALFRI----GRGKLPSVPNSLSRDARDFI--LKCL 175
            WSLG  + EML  + P+     ++   +I     R + P+    +S DA+D I  L C 
Sbjct: 191 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICS 250

Query: 176 QVNPNDRPTAAQLMEHPF 193
           + +   +       +HPF
Sbjct: 251 REHRLGQNGIEDFKQHPF 268

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.0 bits (166), Expect = 7e-14
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 24/204 (11%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLT 63
           QF+H NI+   G       + I  E ++ GSL    +K+    +  Q+    R I +G+ 
Sbjct: 61  QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120

Query: 64  YLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVAPE 107
           YL +   VHR++   NILV+ S L    +D    +  E  P              W APE
Sbjct: 121 YLSDMGYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSR 165
            +  +   +  ++D+WS G  + E++++ + PY  + +   +  I  G +LP+ P     
Sbjct: 180 AIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA-PMDCPA 236

Query: 166 DARDFILKCLQVNPNDRPTAAQLM 189
                +L C Q + N+RP   Q++
Sbjct: 237 ALHQLMLDCWQKDRNERPKFEQIV 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 68.1 bits (166), Expect = 7e-14
 Identities = 64/232 (27%), Positives = 95/232 (40%), Gaps = 48/232 (20%)

Query: 7   FEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQI 58
           FEH N+V+      +     E +L +  E V +  L     K     +    +     Q+
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL 119

Query: 59  LNGLTYLHERNVVHREIKCANILVDASGLATTTN----DVKSFEG-------TPFWVAPE 107
           L GL +LH   VVHR++K  NILV +SG     +     + SF+        T ++ APE
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI----GRGKLPSVPN-- 161
           V  L  + Y    D+WS+GC   EM   +P +    D+  L +I    G       P   
Sbjct: 180 V--LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237

Query: 162 SLSRDA--------------------RDFILKCLQVNPNDRPTAAQLMEHPF 193
           +L R A                    +D +LKCL  NP  R +A   + HP+
Sbjct: 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 68.3 bits (167), Expect = 8e-14
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 45/207 (21%)

Query: 25  LYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD 83
           L + +E V+ G  A L +    L       Y  + +  L YLH   +VHR++K  N+L+ 
Sbjct: 76  LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT 135

Query: 84  ASG--------------LATTTN--------DVKSFE-----GTPFWVAPEVVNLKNNGY 116
           + G              ++ TTN        D + F      GTP ++APEV+     GY
Sbjct: 136 SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI--LRQGY 193

Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL-------PSVPNSLSRDARD 169
           G   D W++G  + E L    P+   +  + LF    G++       P    +L  DA+D
Sbjct: 194 GKPVDWWAMGIILYEFLVGCVPFFG-DTPEELF----GQVISDDIEWPEGDEALPADAQD 248

Query: 170 FILKCLQVNPNDR---PTAAQLMEHPF 193
            I + L+ NP +R     A ++ +H F
Sbjct: 249 LISRLLRQNPLERLGTGGAFEVKQHRF 275

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.7 bits (165), Expect = 8e-14
 Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 29/196 (14%)

Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSS------YTRQILNGLTYLHERNVVHREIK 76
           ++L   L+L+  G L      YHLS   V S      Y  +I+ GL ++H R VV+R++K
Sbjct: 70  DKLCFILDLMNGGDL-----HYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLK 124

Query: 77  CANILVDAS--------GLATTTNDVKSFE--GTPFWVAPEVVNLKNNGYGLSADIWSLG 126
            ANIL+D          GLA   +  K     GT  ++APEV+  K   Y  SAD +SLG
Sbjct: 125 PANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGTAYDSSADWFSLG 183

Query: 127 CTVLEMLTHQPPYSH--LEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-- 182
           C + ++L    P+     +D   + R+       +P+S S + +  +   LQ + + R  
Sbjct: 184 CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLG 243

Query: 183 ---PTAAQLMEHPFVK 195
                A ++ EH F K
Sbjct: 244 CLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 68.1 bits (166), Expect = 9e-14
 Identities = 49/174 (28%), Positives = 85/174 (48%), Gaps = 22/174 (12%)

Query: 20  KDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKC 77
           +DEN LY+ ++    G L  L  K+   L +     Y  +++  +  +H+ + VHR+IK 
Sbjct: 71  QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKP 130

Query: 78  ANILVDASG---LATTTNDVKSFE----------GTPFWVAPEVVNLKNNG---YGLSAD 121
            N+L+D +G   LA   + +K  +          GTP +++PE++    +G   YG   D
Sbjct: 131 DNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 190

Query: 122 IWSLGCTVLEMLTHQPPYSHLEDMQALFRI----GRGKLPSVPNSLSRDARDFI 171
            WSLG  + EML  + P+     ++   +I     R + PS    +S +A+D I
Sbjct: 191 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLI 244

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 1e-13
 Identities = 61/250 (24%), Positives = 94/250 (37%), Gaps = 66/250 (26%)

Query: 8   EHDN--IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTY 64
           E DN  +V+   + +DEN LY+ +E +  G +  L  K    ++ +   Y  + +  +  
Sbjct: 57  EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116

Query: 65  LHERNVVHREIKCANILVDASG--------LAT-----------------TTNDVKSFE- 98
           +H+   +HR+IK  N+L+DA G        L T                   ++   F  
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 99  ------------------------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                                   GTP ++APEV      GY    D WSLG  + EML 
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV--FLQTGYNKECDWWSLGVIMYEMLV 234

Query: 135 HQPPYSHLEDMQALFRIGRGK-----LPSVPNSLSRDARDFILKCLQVNPNDR---PTAA 186
             PP+      +   +I   K        VP  LS +A+D I + L      R       
Sbjct: 235 GYPPFCSDNPQETYRKIINWKETLQFPDEVP--LSPEAKDLIKR-LCCEAERRLGNNGVN 291

Query: 187 QLMEHPFVKR 196
           ++  HPF K 
Sbjct: 292 EIKSHPFFKG 301

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 67.3 bits (164), Expect = 2e-13
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 22/184 (11%)

Query: 37  LANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA 88
           L  L +   LS+ ++     Q+L GL Y+H   ++HR++K  N+ V+          GLA
Sbjct: 106 LGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165

Query: 89  TTTN-DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS---HLED 144
             T+ ++  +  T ++ APEV+ L    Y  + DIWS+GC + EMLT +P +    HL+ 
Sbjct: 166 RQTDSEMTGYVVTRWYRAPEVI-LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ 224

Query: 145 MQALFRI-GRGKLPSVPNSLSRDARDFILKCLQVN--------PNDRPTAAQLMEHPFVK 195
           +  + ++ G      V    S DA++++ K  +          PN  P A  ++E   V 
Sbjct: 225 LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVL 284

Query: 196 RPLQ 199
               
Sbjct: 285 DAES 288

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 66.4 bits (162), Expect = 2e-13
 Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 22/208 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILNGL 62
           + +H N+VQ +G    E   YI  E +  G+L +  +   +  ++   +     QI + +
Sbjct: 58  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPEVV 109
            YL ++N +HR++   N LV  +        GL+   T +   +  G  F   W APE  
Sbjct: 118 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-- 175

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
           +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +G     P        
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVY 235

Query: 169 DFILKCLQVNPNDRPTAAQL---MEHPF 193
           + +  C Q NP+DRP+ A++    E  F
Sbjct: 236 ELMRACWQWNPSDRPSFAEIHQAFETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 66.6 bits (163), Expect = 2e-13
 Identities = 62/253 (24%), Positives = 95/253 (37%), Gaps = 75/253 (29%)

Query: 6   QFEHDNIVQYI--------GTEKDENRLYIFLELVK---KGSLANLYQKYHLSDSQVSSY 54
             +H+N+V  I           + +   Y+  E  +    G L+N   K+ LS  ++   
Sbjct: 67  LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS--EIKKV 124

Query: 55  TRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATT------------TNDV 94
            + +LNGL Y+H   ++HR++K ANIL+           GLA              TN V
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184

Query: 95  KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP----------------- 137
                T ++  PE++ L    YG   D+W  GC + EM T  P                 
Sbjct: 185 V----TLWYRPPELL-LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239

Query: 138 ---------P-------YSHLEDMQALFRIGRGKL-PSVPNSLSRDARDFILKCLQVNPN 180
                    P       +  +E  Q   R  + +L P V +     A D I K L ++P 
Sbjct: 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKD---PHALDLIDKLLVLDPA 296

Query: 181 DRPTAAQLMEHPF 193
            R  A   + H F
Sbjct: 297 KRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 3e-13
 Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 50/197 (25%)

Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG--------LATTTNDV--- 94
           LS+     Y  ++L  L YLH   +V+R++K  NIL+  SG        L+  ++     
Sbjct: 100 LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159

Query: 95  ------------------------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWS 124
                                          SF GT  ++APEV+    +G+G + D W+
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI--SGDGHGSAVDWWT 217

Query: 125 LGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS--LSRDARDFILKCLQVNPNDR 182
           LG  + EML    P+    +    F     K  + P S  +S  ARD I K L  +P+ R
Sbjct: 218 LGILLYEMLYGTTPFKG-SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276

Query: 183 ----PTAAQLMEHPFVK 195
                 AA++ +HPF +
Sbjct: 277 LGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 67.0 bits (163), Expect = 3e-13
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 30/209 (14%)

Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVV 71
           +VQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H    +
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 164

Query: 72  HREIKCANILVDASG---LATTTNDVK----------SFEGTPFWVAPEVVNLKNNG--- 115
           HR++K  N+L+D SG   LA     +K          +  GTP +++PEV  LK+ G   
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV--LKSQGGDG 222

Query: 116 -YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK----LPSVPNSLSRDARDF 170
            YG   D WS+G  + EML    P+     +    +I   K     P   N +S++A++ 
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-DNDISKEAKNL 281

Query: 171 ILKCLQVNPND----RPTAAQLMEHPFVK 195
           I  C  +   +    R    ++  H F K
Sbjct: 282 I--CAFLTDREVRLGRNGVEEIKRHLFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 66.5 bits (162), Expect = 3e-13
 Identities = 39/129 (30%), Positives = 65/129 (50%), Gaps = 15/129 (11%)

Query: 24  RLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +LY  L+ V  G L  +L ++    + +   Y  ++ + + YLH  N+++R++K  NIL+
Sbjct: 70  KLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL 129

Query: 83  DASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVL 130
           D+ G    T+               +F GTP ++APEV  L+   Y  + D W LG  + 
Sbjct: 130 DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV--LRKEPYDRTVDWWCLGAVLY 187

Query: 131 EMLTHQPPY 139
           EML   PP+
Sbjct: 188 EMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 66.6 bits (162), Expect = 3e-13
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 26/178 (14%)

Query: 23  NRLYIFLELVKKGSLANLYQKYHLS------DSQVSSYTRQILNGLTYLHERNVVHREIK 76
           ++LY  L+ +  G L      YHL       + +   Y  +I + L YLH  N+V+R++K
Sbjct: 69  DKLYFVLDYINGGELF-----YHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLK 123

Query: 77  CANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWS 124
             NIL+D+ G    T+               +F GTP ++APEV  L    Y  + D W 
Sbjct: 124 PENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV--LHKQPYDRTVDWWC 181

Query: 125 LGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
           LG  + EML   PP+      +    I    L   PN ++  AR  +   LQ +   R
Sbjct: 182 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN-ITNSARHLLEGLLQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 65.8 bits (160), Expect = 4e-13
 Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 47/231 (20%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYL 65
            + +NIV+     +   +LY+  E V+K  L  L +  + +   +V SY  Q++  + + 
Sbjct: 57  LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116

Query: 66  HERNVVHREIKCANILVD------------ASGLATTTN-DVKSFEGTPFWVAPEVVNLK 112
           H+ ++VHR+IK  N+L+             A  L+  +N +   +  T ++ +PE+  L 
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL--LL 174

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--GKLPSV----------- 159
              YG + D+WS+GC + E+   QP +    ++  LF I +  G LP+            
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234

Query: 160 ----------PNSLSRDAR--------DFILKCLQVNPNDRPTAAQLMEHP 192
                     P SL R           D +   L++NP DR    Q + HP
Sbjct: 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 65.8 bits (160), Expect = 5e-13
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 36/216 (16%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANL------------YQKYHLSDSQVS--- 52
           +H NI+  +G    +  LY+ +E   KG+L               Y    + D Q++   
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 53  --SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
             S T Q+  G+ YL  +  +HR++   N+LV  +        GLA   N++  ++ T  
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 199 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEG 255

Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +  C    P+ RPT  QL+E
Sbjct: 256 HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.8 bits (160), Expect = 5e-13
 Identities = 59/246 (23%), Positives = 106/246 (43%), Gaps = 65/246 (26%)

Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHERN- 69
           IV + G    +  + I +E +  GSL   L +   + +  +   +  +L GL YL E++ 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124

Query: 70  VVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           ++HR++K +NILV++ G     +             SF GT  +++PE   L+   Y + 
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 182

Query: 120 ADIWSLGCTVLEMLT--HQPPYSHLEDMQALFRIGRGKL--------------------- 156
           +DIWS+G +++E+    +  P    ++++A+F  GR  +                     
Sbjct: 183 SDIWSMGLSLVELAIGRYPIPPPDAKELEAIF--GRPVVDGEEGEPHSISPRPRPPGRPV 240

Query: 157 -------------------------PSVPNSL-SRDARDFILKCLQVNPNDRPTAAQLME 190
                                    P +PN + + D ++F+ KCL  NP +R     LM 
Sbjct: 241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300

Query: 191 HPFVKR 196
           H F+KR
Sbjct: 301 HTFIKR 306

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 65.8 bits (160), Expect = 5e-13
 Identities = 41/130 (31%), Positives = 65/130 (50%), Gaps = 15/130 (11%)

Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
            +LY  L+ V  G L  +L ++    + +   Y  +I + L YLH  N+V+R++K  NIL
Sbjct: 69  EKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENIL 128

Query: 82  VDASGLATTT------------NDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D+ G    T            +   +F GTP ++APEV  ++   Y  + D W LG  +
Sbjct: 129 LDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV--IRKQPYDNTVDWWCLGAVL 186

Query: 130 LEMLTHQPPY 139
            EML   PP+
Sbjct: 187 YEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.5 bits (160), Expect = 6e-13
 Identities = 52/217 (23%), Positives = 89/217 (41%), Gaps = 38/217 (17%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL---------ANLYQKY--------HLSDSQ 50
           +H NI+  +G    E  LY+ +E    G+L            Y            L+   
Sbjct: 74  KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S+  Q+  G+ +L  +  +HR++   N+LV           GLA   + +  +  T  
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193

Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP-PYS--HLEDMQALFRIGR 153
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY    +E++  L +   
Sbjct: 194 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK--E 249

Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
           G     P + +++    +  C    P+ RPT  QL+E
Sbjct: 250 GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 65.3 bits (159), Expect = 6e-13
 Identities = 45/197 (22%), Positives = 84/197 (42%), Gaps = 18/197 (9%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLH 66
           H+ +VQ  G    +  +YI  E +  G L N  +++      SQ+    + +  G+ YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE 117

Query: 67  ERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVNLKN 113
            +  +HR++   N LVD  G    +          ++  S  G+ F   W  PEV  L  
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV--LLY 175

Query: 114 NGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL 172
           + +   +D+W+ G  + E+ +  + PY    + + + ++ +G     P+  S      + 
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235

Query: 173 KCLQVNPNDRPTAAQLM 189
            C      +RPT  QL+
Sbjct: 236 SCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 65.8 bits (160), Expect = 7e-13
 Identities = 58/258 (22%), Positives = 100/258 (38%), Gaps = 70/258 (27%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLT 63
           F H NI+         + L++    +  GS  +L + Y    +S++ + +     L GL 
Sbjct: 56  FRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLN 115

Query: 64  YLHERNVVHREIKCANILVDASGLATTTN------------------DVKSFEGTPF-WV 104
           YLH+   +HR IK ++IL+   GL + +                   D   F  +   W+
Sbjct: 116 YLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL 175

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-------------- 150
           +PE++     GY + +DI+S+G T  E+ T + P+  +   Q L +              
Sbjct: 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235

Query: 151 ------------------IG---------------RGKLPSVPNSLSRDARDFILKCLQV 177
                             IG               R + PS   + S   ++ +  CLQ 
Sbjct: 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS-SKTFSPAFQNLVELCLQQ 294

Query: 178 NPNDRPTAAQLMEHPFVK 195
           +P  RP+A+ L+ H F K
Sbjct: 295 DPEKRPSASSLLSHAFFK 312

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 65.0 bits (158), Expect = 8e-13
 Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 21/161 (13%)

Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDASG--------LATTTND---VKSFEGTPF 102
           Y  ++  GL  L    +V+R++K  NIL+D  G        LA    +   V+   GT  
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVG 166

Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM---QALFRIGRGKLPSV 159
           ++APEV+N  N  Y  S D W LGC + EM+  Q P+   ++    + + R  +      
Sbjct: 167 YMAPEVIN--NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY 224

Query: 160 PNSLSRDARDFILKCLQVNPNDR-----PTAAQLMEHPFVK 195
               S DA+      L  NP +R       AA + +HP  K
Sbjct: 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 64.9 bits (159), Expect = 9e-13
 Identities = 52/179 (29%), Positives = 93/179 (51%), Gaps = 18/179 (10%)

Query: 32  VKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS----- 85
           +K G L +L +K   LS+++V    RQ++  L  LH+ N++H +IK  N+L D +     
Sbjct: 91  IKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIY 150

Query: 86  ----GLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY-- 139
               GL         ++GT  + +PE +   N     S D W++G    E+LT + P+  
Sbjct: 151 LCDYGLCKIIGTPSCYDGTLDYFSPEKIKGHNYDV--SFDWWAVGVLTYELLTGKHPFKE 208

Query: 140 SHLEDM--QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-PTAAQLMEHPFVK 195
              E++  ++L +  + KLP    ++S++A DF+   L+ N N R     ++++HPF+K
Sbjct: 209 DEDEELDLESLLKRQQKKLP-FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 64.6 bits (157), Expect = 9e-13
 Identities = 49/196 (25%), Positives = 83/196 (42%), Gaps = 21/196 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLT 63
           Q ++  IV+ IG  + E  L + +E+   G L      +K  ++ S V     Q+  G+ 
Sbjct: 51  QLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMK 109

Query: 64  YLHERNVVHREIKCANILV--------------DASGLATTTNDVKSFEGTPF-WVAPEV 108
           YL  +N VHR++   N+L+               A G   +    +S    P  W APE 
Sbjct: 110 YLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPEC 169

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA 167
           +N +   +   +D+WS G T+ E  ++ Q PY  ++  + +  I +GK    P     + 
Sbjct: 170 INFRK--FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEM 227

Query: 168 RDFILKCLQVNPNDRP 183
              +  C      DRP
Sbjct: 228 YALMKDCWIYKWEDRP 243

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 64.8 bits (158), Expect = 1e-12
 Identities = 52/189 (27%), Positives = 75/189 (39%), Gaps = 55/189 (29%)

Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTP---FWV- 104
           Q+L  L Y+H  NV HR++K  NIL +A         GLA       +F  TP   FW  
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-----AFNDTPTAIFWTD 165

Query: 105 --------APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS-----HLED------- 144
                   APE+     + Y  + DIWS+GC   E+LT +P +      H  D       
Sbjct: 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG 225

Query: 145 ---MQALFRIGRGKL--------PSVPNSLSRD-------ARDFILKCLQVNPNDRPTAA 186
               + + R+   K            P   S+        A   + + L  +P DRPTA 
Sbjct: 226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAE 285

Query: 187 QLMEHPFVK 195
           + +  P+ K
Sbjct: 286 EALADPYFK 294

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 64.2 bits (156), Expect = 2e-12
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 28/200 (14%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGL 62
           QF H NI++  G         I  E ++ G+L + Y + H    S  Q+    R I  G+
Sbjct: 62  QFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGM 120

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT--------PF-WVA 105
            YL + N VHR++   NILV+++        GL+    D    EGT        P  W A
Sbjct: 121 KYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP--EGTYTTSGGKIPIRWTA 178

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E+++  + PY  + + + +  I  G +LP+ P   
Sbjct: 179 PEAIAYRK--FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA-PMDC 235

Query: 164 SRDARDFILKCLQVNPNDRP 183
                  +L+C Q +   RP
Sbjct: 236 PSAVYQLMLQCWQQDRARRP 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 63.6 bits (155), Expect = 3e-12
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 26/203 (12%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTY 64
           +H ++V+ +G      ++ +  +L+  G L + Y + H   +    + ++  QI  G++Y
Sbjct: 67  DHPHVVRLLGICLSS-QVQLITQLMPLGCLLD-YVRNHKDNIGSQYLLNWCVQIAKGMSY 124

Query: 65  LHERNVVHREIKCANILVDAS--------GLA----TTTNDVKSFEG-TPF-WVAPEVVN 110
           L E+ +VHR++   N+LV           GLA        +  +  G  P  W+A E + 
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLE--DMQALFRIGRGKLPSVPNSLSRDA 167
            +   Y   +D+WS G TV E++T    PY  +   ++  L   G  +LP  P   + D 
Sbjct: 185 HRI--YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ERLPQ-PPICTIDV 240

Query: 168 RDFILKCLQVNPNDRPTAAQLME 190
              ++KC  ++   RPT  +L+ 
Sbjct: 241 YMVLVKCWMIDAESRPTFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.4 bits (154), Expect = 3e-12
 Identities = 46/178 (25%), Positives = 83/178 (46%), Gaps = 24/178 (13%)

Query: 25  LYIFLELVKKGSLANLYQKYHLSD-----SQVSSYTRQILNGLTYLHERNVVHREIKCAN 79
           L + + L+  G L   Y  Y++ +      +V  Y+ QI  G+ +LH  ++V+R++K  N
Sbjct: 68  LCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPEN 125

Query: 80  ILVDAS--------GLATTTNDVKSF---EGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           +L+D          GLA    D K+     GT  ++APE+  LK   Y    D +++GC+
Sbjct: 126 VLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEI--LKEEPYSYPVDWFAMGCS 183

Query: 129 VLEMLTHQPPYSHLEDMQALFRIGRGKLPS----VPNSLSRDARDFILKCLQVNPNDR 182
           + EM+  + P+   ++  A   + R  L         + + +++D     L   P DR
Sbjct: 184 IYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 63.9 bits (155), Expect = 3e-12
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 36/216 (16%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANL------------YQKYHLSDSQVS--- 52
           +H NI+  +G    +  LY+ +E   KG+L               Y    + + Q+S   
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 53  --SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
             S   Q+  G+ YL  +  +HR++   N+LV           GLA   + +  ++ T  
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 202 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 258

Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 259 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 63.5 bits (154), Expect = 3e-12
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 36/212 (16%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--------------- 48
            +  +H++IV++ G   D + L +  E +K G L N + + H  D               
Sbjct: 61  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGE 119

Query: 49  ---SQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLAT-----TTNDVKSFE-- 98
              SQ+     QI +G+ YL  ++ VHR++   N LV A+ L        + DV S +  
Sbjct: 120 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179

Query: 99  ------GTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFR 150
                   P  W+ PE +  +   +   +D+WS G  + E+ T+ + P+  L + + +  
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237

Query: 151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
           I +G++   P    ++  D +L C Q  P  R
Sbjct: 238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQR 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 63.8 bits (155), Expect = 3e-12
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 36/216 (16%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANL------------YQKYHLSDSQVS--- 52
           +H NI+  +G    E  LY+ +E   KG+L               +    + + Q+S   
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 53  --SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
             S   Q+  G+ YL  R  +HR++   N+LV           GLA   +D+  ++ T  
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ R G
Sbjct: 196 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-VEELFKLLREG 252

Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P++ + +    + +C    P  RPT  QL+E
Sbjct: 253 HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 63.0 bits (153), Expect = 4e-12
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 36/208 (17%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLT 63
           QF+H NIV+  G     N + I  E +  G+L +  +K+   L   Q+      + +G+ 
Sbjct: 62  QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMK 121

Query: 64  YLHERNVVHREIKCANILVDA------SGLATTTND-------VKSFEGTPFWVAPEVVN 110
           YL E   VH+ +    +LV++      SG      D         S +    W APE + 
Sbjct: 122 YLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPY---SHLEDMQAL---FRIGRGKLPS---VP 160
             +  +  ++D+WS G  + E++++ + PY   S  + ++A+   FR     LP+    P
Sbjct: 182 YHH--FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-----LPAPRNCP 234

Query: 161 NSLSRDARDFILKCLQVNPNDRPTAAQL 188
           N L +     +L C Q    +RP  +Q+
Sbjct: 235 NLLHQ----LMLDCWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.1 bits (153), Expect = 4e-12
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 43/180 (23%)

Query: 57  QILNGLTYLHERNVVHREIKCANILVDA--------SGLA---TTTNDVKSFEGTPFWVA 105
           Q+L GL Y+H ++++HR++K  N+L+           GLA   +  +   S E    W  
Sbjct: 111 QLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYR 170

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRI---------- 151
           P  V L    Y  + DIW  GC  +EML  QP +       E ++ ++ +          
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230

Query: 152 GRGKLPS----------------VPNSLSR--DARDFILKCLQVNPNDRPTAAQLMEHPF 193
           G  KLP+                V   LSR   A D   + L + P DR +A   + HP+
Sbjct: 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 62.7 bits (152), Expect = 5e-12
 Identities = 47/206 (22%), Positives = 89/206 (43%), Gaps = 30/206 (14%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLT 63
           +  H  +VQ  G   + + + +  E ++ G L++    Q+   S   +      +  G+ 
Sbjct: 55  KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA 114

Query: 64  YLHERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVN 110
           YL   NV+HR++   N LV  + +   +          +   S  GT F   W +PEV +
Sbjct: 115 YLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFS 174

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSH------LEDMQALFRIGRGKLPSVPNSL 163
                Y   +D+WS G  + E+ +  + PY +      +E + A FR+ + +L       
Sbjct: 175 FSK--YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLA------ 226

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
           S+   + +  C +  P DRP+ + L+
Sbjct: 227 SQSVYELMQHCWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 63.3 bits (154), Expect = 5e-12
 Identities = 64/253 (25%), Positives = 103/253 (40%), Gaps = 69/253 (27%)

Query: 8   EHDN--IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLTY 64
           E DN  +V+   + +D++ LY  ++ +  G + +L  +  + +  ++  Y  ++   +  
Sbjct: 57  EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIES 116

Query: 65  LHERNVVHREIKCANILVDASG--------LATT---TNDVK-----------SFE---- 98
           +H+   +HR+IK  NIL+D  G        L T    T+D K           S E    
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 99  -----------------------------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
                                        GTP ++APEV  L   GY    D WS+G  +
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEV--LLRTGYTQLCDWWSVGVIL 234

Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGK----LPSVPNSLSRDARDFILKCLQVNPNDR--- 182
            EML  QPP+      +   ++   +    +PS    LSR+A D IL+ L     DR   
Sbjct: 235 YEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAK-LSREASDLILR-LCCGAEDRLGK 292

Query: 183 PTAAQLMEHPFVK 195
             A ++  HPF K
Sbjct: 293 NGADEIKAHPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 5e-12
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 36/216 (16%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANL------------YQKYHLSDSQVS--- 52
           +H NI+  +G    +  LY+ +E   KG+L               +    L + Q++   
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 53  --SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
             S   Q+  G+ YL  +  +HR++   N+LV           GLA   +++  ++ T  
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP-PYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 196 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKLLKEG 252

Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    + +C    P+ RPT  QL+E
Sbjct: 253 HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 63.1 bits (153), Expect = 6e-12
 Identities = 63/248 (25%), Positives = 105/248 (42%), Gaps = 70/248 (28%)

Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILN 60
           H NI+  +       + ++   +Y+ +EL+     ANL Q  H  L   ++S    Q+L 
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLC 134

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     +F  TP+ V     APE
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC--TNFMMTPYVVTRYYRAPE 192

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLT------------------HQPPYSHLEDMQAL- 148
           V+     GY  + DIWS+GC + E++                    Q      E M  L 
Sbjct: 193 VI--LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250

Query: 149 -----FRIGRGKLPSV-----------PNSLSRD------ARDFILKCLQVNPNDRPTAA 186
                +   R + P +           P+   RD      ARD + K L ++P+ R +  
Sbjct: 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310

Query: 187 QLMEHPFV 194
           + + HP++
Sbjct: 311 EALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 62.7 bits (152), Expect = 6e-12
 Identities = 61/230 (26%), Positives = 95/230 (41%), Gaps = 45/230 (19%)

Query: 7   FEHDNIV---QYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            +H NIV     I TEK    ++ +L+   K  L +     ++ +  V  +  Q+L GL 
Sbjct: 61  LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--VKLFLFQLLRGLN 118

Query: 64  YLHERNVVHREIKCANILVDASG---LA--------TTTNDVKSFEGTPFWVAPEVVNLK 112
           Y H R V+HR++K  N+L++  G   LA        +      S E    W  P  + L 
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG 178

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQP--PYSHLED-MQALFRI-GRGKLPSVPNSLSR--- 165
           +  Y    D+W +GC   EM T +P  P S +E+ +  +FRI G     + P  LS    
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238

Query: 166 ----------------------DARDFILKCLQVNPNDRPTAAQLMEHPF 193
                                 D  + + K LQ     R +A + M+HP+
Sbjct: 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 62.4 bits (151), Expect = 7e-12
 Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 33/209 (15%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---------------LSD 48
            +  +H++IV++ G   + + L +  E +K G L N + + H               L+ 
Sbjct: 61  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQ 119

Query: 49  SQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLAT-----TTNDVKSFE----- 98
           SQ+    +QI  G+ YL  ++ VHR++   N LV  + L        + DV S +     
Sbjct: 120 SQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 179

Query: 99  ---GTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGR 153
                P  W+ PE +  +   +   +D+WSLG  + E+ T+ + P+  L + + +  I +
Sbjct: 180 GHTMLPIRWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237

Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDR 182
           G++   P +  ++  D +L C Q  P+ R
Sbjct: 238 GRVLQRPRTCPKEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 62.4 bits (151), Expect = 1e-11
 Identities = 63/248 (25%), Positives = 106/248 (42%), Gaps = 70/248 (28%)

Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       + ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLC 130

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 188

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 189 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 147 ALFRIGRGKLPS---------VPNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R      P           P+SL           +  ARD + K L ++P  R +  
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306

Query: 187 QLMEHPFV 194
           + ++HP++
Sbjct: 307 EALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 62.0 bits (150), Expect = 1e-11
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 41/213 (19%)

Query: 20  KDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN 79
           ++ N +Y+   L+    L N+ +   LSD  V     Q+L GL Y+H   ++HR++K +N
Sbjct: 90  ENFNEVYLVTNLMG-ADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSN 148

Query: 80  ILVDAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVL 130
           + V+          GLA   +D +  +  T ++ APE++ L    Y  + DIWS+GC + 
Sbjct: 149 VAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMA 207

Query: 131 EMLTHQPPYSHLEDMQALFRI-------------------GRGKLPSVPNSLSRD----- 166
           E+L  +  +   + +  L RI                    R  + S+P+   +D     
Sbjct: 208 ELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIF 267

Query: 167 ------ARDFILKCLQVNPNDRPTAAQLMEHPF 193
                 A D + K L ++ + R +A++ + HP+
Sbjct: 268 RGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.8 bits (150), Expect = 2e-11
 Identities = 43/142 (30%), Positives = 61/142 (42%), Gaps = 29/142 (20%)

Query: 56  RQILNGLTYLHERNVVHREIKCANILVD-----------ASGLATTTNDVKSFEGTPFWV 104
           +QIL GL YLH + ++HR++K  NI ++           A+             GT    
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN 223

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLS 164
           APEV  L  + Y   ADIWS G  + EML +  P +  ED            PS P    
Sbjct: 224 APEV--LARDKYNSKADIWSAGIVLFEMLAY--PSTIFEDP-----------PSTPEEYV 268

Query: 165 RDARDFILK---CLQVNPNDRP 183
           +     +LK    L+V+P + P
Sbjct: 269 KSCHSHLLKIISTLKVHPEEFP 290

Length = 357

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 61.2 bits (148), Expect = 2e-11
 Identities = 46/210 (21%), Positives = 87/210 (41%), Gaps = 33/210 (15%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----------------LSDSQV 51
           H NI+  +G  +    LY+ +E    G+L +  +K                   LS  Q+
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 52  SSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDV-----------KSFEGT 100
             +   +  G+ YL ++  +HR++   NILV          D            K+    
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMGRL 173

Query: 101 PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPS 158
           P  W+A E +N   + Y  ++D+WS G  + E+++    PY  +   +   ++ +G    
Sbjct: 174 PVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 231

Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
            P +   +  D + +C +  P +RP+ AQ+
Sbjct: 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.7 bits (145), Expect = 7e-11
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 24/181 (13%)

Query: 25  LYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           L +FL   ++  L        LS  Q+     QI  G++YLH+R V+H++I   N ++D 
Sbjct: 96  LKLFL---QQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE 152

Query: 85  SGLATTTNDVKS---F----------EGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVL 130
                 T++  S   F          E  P  W+A E  +L N  Y  ++D+WS G  + 
Sbjct: 153 ELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALE--SLVNKEYSSASDVWSFGVLLW 210

Query: 131 EMLT-HQPPYSHL--EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQ 187
           E++T  Q PY  +   +M A  + G  +L   P +   +    +  C  ++P +RP+ +Q
Sbjct: 211 ELMTLGQTPYVEIDPFEMAAYLKDGY-RLAQ-PINCPDELFAVMACCWALDPEERPSFSQ 268

Query: 188 L 188
           L
Sbjct: 269 L 269

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 59.2 bits (143), Expect = 8e-11
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)

Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQIL 59
            +    +H  IV+ +G     + L +  +L   GSL +  +++   L   ++ ++  QI 
Sbjct: 61  LAMGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA 119

Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTT----------NDVKSFEG---TPF-WVA 105
            G+ YL E  +VHR +   NIL+ +  +              +D K F     TP  W+A
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYS--HLEDMQALFRIGRGKLPSVPNS 162
            E +      Y   +D+WS G TV EM+++   PY+     ++  L    +G+  + P  
Sbjct: 180 LESILFGR--YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE--KGERLAQPQI 235

Query: 163 LSRDARDFILKCLQVNPNDRPTAAQL 188
            + D    ++KC  ++ N RPT  +L
Sbjct: 236 CTIDVYMVMVKCWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 59.7 bits (144), Expect = 9e-11
 Identities = 43/127 (33%), Positives = 66/127 (51%), Gaps = 23/127 (18%)

Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159

Query: 83  DAS--------GLATTTNDVKSFEGTP-----FWVAPEVVNLKNNGYGLSADIWSLGCTV 129
            +         GLA T     SF  TP     ++ APEV+     GY  + DIWS+GC +
Sbjct: 160 KSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIM 215

Query: 130 LEMLTHQ 136
            EM+   
Sbjct: 216 GEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 59.2 bits (143), Expect = 1e-10
 Identities = 39/120 (32%), Positives = 58/120 (48%), Gaps = 14/120 (11%)

Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG---LA--------TTTNDV 94
           +S   V  +  QIL GL Y H R V+HR++K  N+L++  G   LA        +     
Sbjct: 101 MSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160

Query: 95  KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHLED-MQALFRI 151
            S E    W  P  V L ++ Y    D+W +GC   EM + +P  P S +ED +  +FR+
Sbjct: 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL 220

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 58.8 bits (142), Expect = 1e-10
 Identities = 58/233 (24%), Positives = 93/233 (39%), Gaps = 48/233 (20%)

Query: 6   QFEHDNIVQYIGT-----EKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQI 58
            F+H NIV+ +          E ++ +  E V +     L +     L    +    RQ 
Sbjct: 58  AFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF 117

Query: 59  LNGLTYLHERNVVHREIKCANILVDASGLATTTN----DVKSFEG-------TPFWVAPE 107
           L GL +LH   +VHR++K  NILV + G     +     + S +        T ++ APE
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRI------------- 151
           V  L  + Y    D+WS+GC   EM   +P +   S  + +  +F +             
Sbjct: 178 V--LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235

Query: 152 --GRGKLPS---------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
              RG             VP      A   +L+ L  NP+ R +A + ++HPF
Sbjct: 236 TLPRGAFSPRGPRPVQSVVPEIEESGA-QLLLEMLTFNPHKRISAFRALQHPF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 59.0 bits (143), Expect = 1e-10
 Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 36/217 (16%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYT--------R 56
           S+F H NIV+ IG   +    +I LEL+  G L +  ++      + SS T        R
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 57  QILNGLTYLHERNVVHREIKCANILVDASGLATTTN--D---VKSFEGTPF--------- 102
            +  G  YL E + +HR+I   N L+   G        D    +      +         
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183

Query: 103 ---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQAL-FRIGRGKL- 156
              W+ PE     +  +    D+WS G  + E+ +    PY    + + + F  G G+L 
Sbjct: 184 PIKWMPPEA--FLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241

Query: 157 --PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
                P  + R   D    C Q  P DRP  A ++E 
Sbjct: 242 PPKGCPGPVYRIMTD----CWQHTPEDRPNFATILER 274

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 58.9 bits (142), Expect = 1e-10
 Identities = 47/211 (22%), Positives = 89/211 (42%), Gaps = 33/211 (15%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----------------LSDSQ 50
            H NI+  +G  ++   LYI +E    G+L +  +K                   L+  Q
Sbjct: 61  HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDV-----------KSFEG 99
           +  +   +  G+ YL E+  +HR++   N+LV    LA+   D            K+   
Sbjct: 121 LLQFASDVATGMQYLSEKQFIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVKKTMGR 179

Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLP 157
            P  W+A E +N   + Y   +D+WS G  + E+++    PY  +   +   ++ +G   
Sbjct: 180 LPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM 237

Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
             P +   +  + + +C +  P +RP  AQ+
Sbjct: 238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.1 bits (140), Expect = 2e-10
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 19/162 (11%)

Query: 7   FEHDNIV---QYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            +H NIV     I TE+    ++ +L+   K  L N      +S   V  +  Q+L GL+
Sbjct: 60  LKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNL--MSMHNVKIFMFQLLRGLS 117

Query: 64  YLHERNVVHREIKCANILVDASG---LA--------TTTNDVKSFEGTPFWVAPEVVNLK 112
           Y H+R ++HR++K  N+L++  G   LA        +      S E    W  P  V L 
Sbjct: 118 YCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 177

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQP--PYSHL-EDMQALFRI 151
           +  Y    D+W +GC + EM T +P  P S + E++  +FR+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL 219

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.7 bits (139), Expect = 3e-10
 Identities = 49/214 (22%), Positives = 92/214 (42%), Gaps = 32/214 (14%)

Query: 6   QFEHDNIVQYIGT--EKDENRLY----IFLELVKKGSLAN--LYQKY-----HLSDSQVS 52
           +F+H N+++ IG   +  E+  Y    + L  +K G L +  LY +      +L    + 
Sbjct: 56  EFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLV 115

Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDV----KSFEGTPF------ 102
            +   I +G+ YL  ++ +HR++   N +++ + +     D     K + G  +      
Sbjct: 116 KFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADFGLSKKIYNGDYYRQGRIA 174

Query: 103 -----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKL 156
                W+A E  +L +  Y   +D+WS G T+ E+ T  Q PY  +E+ +    + +G  
Sbjct: 175 KMPVKWIAIE--SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR 232

Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
              P          +  C  +NP DRP+   L  
Sbjct: 233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 57.6 bits (139), Expect = 3e-10
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 24/205 (11%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLT 63
           QF+H NI+   G       + I  E ++ G+L +  ++     +  Q+    R I  G+ 
Sbjct: 61  QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTND-------VKSFEGT-PF-WVAP 106
           YL E N VHR++   NILV+++        GL+    D         S  G  P  W AP
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLS 164
           E +  +   +  ++D+WS G  + E++++ + PY  + +   +  I +  +LP  P    
Sbjct: 181 EAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP-PMDCP 237

Query: 165 RDARDFILKCLQVNPNDRPTAAQLM 189
                 +L C Q + N RP   Q++
Sbjct: 238 TALHQLMLDCWQKDRNARPKFGQIV 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 57.4 bits (138), Expect = 6e-10
 Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 27/168 (16%)

Query: 9   HDNIV---QYIGTEK-DENRLYIFLELVKK--GSLANLYQKYHLSDSQ------VSSYTR 56
           H NI+    Y  TE   +N   IFL +V +      + Y K++  ++       V  Y+ 
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177

Query: 57  QILNGLTYLHERNVVHREIKCANILVD-------------ASGLATTTNDVKSFEGTPFW 103
           Q+   L Y+H + + HR++K  N+L+D             A  L      V S+  + F+
Sbjct: 178 QLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV-SYICSRFY 236

Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI 151
            APE++ L    Y    D+WSLGC + EM+   P +S    +  L RI
Sbjct: 237 RAPELM-LGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283

Length = 440

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 56.7 bits (137), Expect = 7e-10
 Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 23/200 (11%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYH--LSDSQVSSYTRQILNGLTYL 65
           H+NIV  +G       + +  E    G L N L +K    L+   + S++ Q+  G+ +L
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157

Query: 66  HERNVVHREIKCANILVDAS--------GLA-TTTND----VKSFEGTPF-WVAPEVVNL 111
             +N +HR++   N+L+           GLA    ND    VK     P  W+APE  ++
Sbjct: 158 ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE--SI 215

Query: 112 KNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALF--RIGRGKLPSVPNSLSRDAR 168
            N  Y   +D+WS G  + E+ +    PY  +  + + F   I  G   + P     +  
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP-VDSKFYKLIKEGYRMAQPEHAPAEIY 274

Query: 169 DFILKCLQVNPNDRPTAAQL 188
           D +  C   +P  RPT  Q+
Sbjct: 275 DIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 56.7 bits (137), Expect = 7e-10
 Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 36/217 (16%)

Query: 6   QFEHDNIVQYIG---TEKDENRL---YIFLELVKKGSLAN--LY-----QKYHLSDSQVS 52
            F+H N+++ IG         ++    + L  +K G L +  LY         L    + 
Sbjct: 57  DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116

Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPF-- 102
            +   I  G+ YL  RN +HR++   N ++           GL+        +       
Sbjct: 117 KFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 103 ----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLED---MQALFRIGRG 154
               W+A E  +L +  Y   +D+W+ G T+ E+ T  Q PY  +E+      L    R 
Sbjct: 177 MPVKWIAIE--SLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL 234

Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           K P   + L  +  D +  C + +P DRPT  +L E 
Sbjct: 235 KQP--EDCLD-ELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 56.9 bits (137), Expect = 7e-10
 Identities = 47/210 (22%), Positives = 93/210 (44%), Gaps = 31/210 (14%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----------------LSDSQV 51
           H NI+  +G  +    LY+ +E    G+L +  +K                   LS  Q+
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 52  SSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-------DV---KSFEGTP 101
             +   +  G+ YL ++  +HR++   NILV  + +A   +       +V   K+    P
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186

Query: 102 F-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSV 159
             W+A E +N   + Y  ++D+WS G  + E+++    PY  +   +   ++ +G     
Sbjct: 187 VRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 244

Query: 160 PNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           P +   +  D + +C +  P +RP+ AQ++
Sbjct: 245 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 57.2 bits (138), Expect = 8e-10
 Identities = 48/218 (22%), Positives = 80/218 (36%), Gaps = 35/218 (16%)

Query: 5   SQFEHDNIVQYIGT-EKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGL 62
           ++  H NIV  + + E     L+   E V   +L  +      L   +      Q+L+ L
Sbjct: 33  ARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDAL 92

Query: 63  TYLHERNVVHREIKCANILVDASGL----------------------ATTTNDVKSFEGT 100
              H + +VHR++K  NI+V  +G+                        T        GT
Sbjct: 93  ACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGT 152

Query: 101 PFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVP 160
           P + APE   L+      ++D+++ G   LE LT Q         + L++    +L  V 
Sbjct: 153 PTYCAPE--QLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQ----QLSPVD 206

Query: 161 NSL-----SRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
            SL            + K L  +P  R  +A  +   F
Sbjct: 207 VSLPPWIAGHPLGQVLRKALNKDPRQRAASAPALAERF 244

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 56.9 bits (137), Expect = 9e-10
 Identities = 39/141 (27%), Positives = 60/141 (42%), Gaps = 15/141 (10%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER 68
           H +I+Q  GT        + L   K      L  K +++   + +  R +L  + YLHE 
Sbjct: 142 HPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN 201

Query: 69  NVVHREIKCANILVDASG-------------LATTTNDVKSFEGTPFWVAPEVVNLKNNG 115
            ++HR+IK  NI ++  G             +    N    + GT    APE+  L  + 
Sbjct: 202 RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPEL--LARDP 259

Query: 116 YGLSADIWSLGCTVLEMLTHQ 136
           YG + DIWS G  + EM T  
Sbjct: 260 YGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.1 bits (135), Expect = 1e-09
 Identities = 50/213 (23%), Positives = 95/213 (44%), Gaps = 34/213 (15%)

Query: 6   QFEHDNIVQYIGT---EKDENRLYI---FLELVKKGSLANLY-------QKYHLSDSQVS 52
           +F+H N+++ IG     + + RL I    L  +K G L           + + L    + 
Sbjct: 57  EFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV 116

Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDV----KSFEGTPF------ 102
            +   I +G+ YL  +N +HR++   N +++ + +     D     K + G  +      
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 103 -----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQAL-FRIGRGK 155
                W+A E  +L +N Y   +D+W+ G T+ E++T  Q PY+ +E+ +   + I   +
Sbjct: 176 KLPVKWLALE--SLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233

Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
           L   P+ L  D  + + +C    P  RP+   L
Sbjct: 234 LKQPPDCLE-DVYELMCQCWSPEPKCRPSFQHL 265

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 56.6 bits (136), Expect = 1e-09
 Identities = 59/237 (24%), Positives = 90/237 (37%), Gaps = 59/237 (24%)

Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNV 70
           +V+   + +D+  LY+ +E +  G +  L  K   LS+     Y  + +  +  +H+   
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 71  VHREIKCANILVDASG--------LAT--------------TTNDVKSFE---------- 98
           +HR+IK  N+L+DA G        L T              T N    F           
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 99  ---------------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE 143
                          GTP ++APEV      GY    D WSLG  + EML   PP+    
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEV--FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 144 DMQALFRIGRGKL-----PSVPNSLSRDARDFILK-CLQV-NPNDRPTAAQLMEHPF 193
             +   ++   K      P VP  +S  A+D IL+ C    N        ++  HPF
Sbjct: 241 PQETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCTDSENRIGSNGVEEIKSHPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 56.4 bits (136), Expect = 1e-09
 Identities = 49/223 (21%), Positives = 91/223 (40%), Gaps = 42/223 (18%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL------YQKYHLSDSQVS------ 52
           ++F+H NIV+ +G       + +  E +  G L           +  LS S  S      
Sbjct: 63  AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122

Query: 53  -----------SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTND 93
                         +Q+  G+ YL ER  VHR++   N LV  +        GL+     
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182

Query: 94  VKSFEGT-----PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH--QPPYSHLEDM 145
              ++ +     P  W+ PE +    N Y   +D+W+ G  + E+ ++  QP Y  +   
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYYG-MAHE 239

Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
           + ++ +  G + S P++   +  + +  C    P+DRP+ A +
Sbjct: 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 56.2 bits (135), Expect = 1e-09
 Identities = 48/191 (25%), Positives = 75/191 (39%), Gaps = 43/191 (22%)

Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG-----------LATTTNDV 94
           L    V  +  Q+L GL+Y+H+R ++HR++K  N+L+  +G             +  +  
Sbjct: 100 LHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159

Query: 95  KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ-ALFRI-- 151
            S E    W  P  V L +  Y    D+W +GC  +EM+     +  ++D+Q  L RI  
Sbjct: 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFL 219

Query: 152 -----------GRGKLPSVP----------------NSLS--RDARDFILKCLQVNPNDR 182
                      G   LP                   N LS    A D   K LQ  P +R
Sbjct: 220 VLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNR 279

Query: 183 PTAAQLMEHPF 193
            +A   + H +
Sbjct: 280 LSAQAALSHEY 290

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 55.6 bits (134), Expect = 1e-09
 Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 32/192 (16%)

Query: 22  ENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           E+ +++ L+  + G L +   K+ ++ +  V  +  +++  L  LH   +V R++   NI
Sbjct: 57  EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116

Query: 81  LVDASGLATTTNDVKSFEGTP---------FWVAPEVVNLKNNGYGLSADIWSLGCTVLE 131
           L+D  G    T   +  E             + APEV  +       + D WSLG  + E
Sbjct: 117 LLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETE--ACDWWSLGAILFE 174

Query: 132 MLTHQPPYSHLEDMQALFR-----IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAA 186
           +LT           + L       I      ++P  +S +AR  + + LQ NP +R  A 
Sbjct: 175 LLTG----------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224

Query: 187 -----QLMEHPF 193
                 +  HPF
Sbjct: 225 VAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 55.7 bits (134), Expect = 2e-09
 Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 36/220 (16%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ------ 57
           + +  H N++Q +G   +     + LE    G L N  +      +Q++           
Sbjct: 49  YRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACE 108

Query: 58  ILNGLTYLHERNVVHREIKCANILV--DAS------GLATT--------TNDVKSFEGTP 101
           + +GL +LH+ + +H ++   N  +  D S      GLA          T D  +    P
Sbjct: 109 VASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV---P 165

Query: 102 F-WVAPEVV-----NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG 154
             W+APE+V     +L        ++IWSLG T+ E+ T    PY  L D Q L ++ R 
Sbjct: 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE 225

Query: 155 ---KLPSVPNSLSRDARDF-ILKCLQVNPNDRPTAAQLME 190
              KLP     L    R + +++   ++P  RPTA ++ E
Sbjct: 226 QDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 55.4 bits (133), Expect = 2e-09
 Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 44/224 (19%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSL------------------ANLYQKYHLS 47
           Q  H ++++  G    +  L + +E  K GSL                   N    Y  +
Sbjct: 59  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 48  DSQ-------VSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTND------- 93
             +       + S+  QI  G+ YL E  +VHR++   N+LV A G     +D       
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDV 177

Query: 94  ------VKSFEG-TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED 144
                 VK  +G  P  W+A E  +L ++ Y   +D+WS G  + E++T    PY  +  
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235

Query: 145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
            +    +  G     P + S +  + +L C +  P+ RPT A +
Sbjct: 236 ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 55.0 bits (132), Expect = 4e-09
 Identities = 42/169 (24%), Positives = 79/169 (46%), Gaps = 19/169 (11%)

Query: 39  NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-----D 93
           +LY+K  L+   +  Y+ Q+  G+ +L  R  +HR++   NIL+  + +    +     D
Sbjct: 170 DLYKKV-LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD 228

Query: 94  V--------KSFEGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE 143
           +        K     P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++
Sbjct: 229 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286

Query: 144 -DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
            D +   R+  G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 287 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.9 bits (132), Expect = 4e-09
 Identities = 45/162 (27%), Positives = 65/162 (40%), Gaps = 43/162 (26%)

Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSF 97
           L  +QV++  RQ+L+ + Y+H   ++HR+IK  N+LV+          G A       S 
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS- 315

Query: 98  EGTPFWV---------APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL 148
             TPF           APEV  L  + Y  S DIWS G  + E   H           +L
Sbjct: 316 --TPFHYGIAGTVDTNAPEV--LAGDPYTPSVDIWSAGLVIFEAAVHT---------ASL 362

Query: 149 FRIGRGKLPSVPNSLSRDARDF----ILKCLQVNPNDRPTAA 186
           F        S      R   D     I++  QV+ ++ P  A
Sbjct: 363 F--------SASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396

Length = 461

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 54.3 bits (130), Expect = 5e-09
 Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 21/155 (13%)

Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSFEG---- 99
           ++  QI  G++YL E  +VHR++   N+LV +         GLA   + D   +      
Sbjct: 113 NWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172

Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLE--DMQALFRIGRGK 155
            P  W+A E  ++ +  +   +D+WS G TV E++T    PY  +   ++  L   G  +
Sbjct: 173 VPIKWMALE--SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-R 229

Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
           LP  P   + D    ++KC  ++   RP   +L++
Sbjct: 230 LPQPPIC-TIDVYMIMVKCWMIDSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 54.2 bits (130), Expect = 5e-09
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 17/148 (11%)

Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSFEG----TPF- 102
           QI  G+ YL ER +VHR++   N+LV           GLA     D K +       P  
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPN 161
           W+A E  ++ +  Y   +D+WS G TV E++T    PY  +   +    + +G+    P 
Sbjct: 177 WMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234

Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLM 189
             + D    ++KC  ++ + RP   +L+
Sbjct: 235 ICTIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 54.2 bits (130), Expect = 5e-09
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 17/149 (11%)

Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT-PF- 102
           +I +G+ YL+ +  VHR++   N +V        G    T D+       K  +G  P  
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPN 161
           W+APE  +LK+  +  S+D+WS G  + E+ +  + PY  L + Q L  +  G     P+
Sbjct: 187 WMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 244

Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLME 190
           +      D +  C Q NP  RPT  +++ 
Sbjct: 245 NCPERVTDLMRMCWQFNPKMRPTFLEIVN 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.9 bits (129), Expect = 7e-09
 Identities = 55/215 (25%), Positives = 87/215 (40%), Gaps = 68/215 (31%)

Query: 45  HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS------------GLATTTN 92
            L  S V S   QIL+G+ YLH   V+HR++K ANILV               G A   N
Sbjct: 104 QLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Query: 93  -------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP-------- 137
                  D+     T ++ APE++ L    Y  + DIW++GC   E+LT +P        
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELL-LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222

Query: 138 -----PYSHLEDMQALFRI----------GRGKLPSVP---------------------- 160
                P+ H + +  +F +             K+P  P                      
Sbjct: 223 IKTSNPFHH-DQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEK 281

Query: 161 NSLSRDARDFIL--KCLQVNPNDRPTAAQLMEHPF 193
           + +  D++ F+L  K L ++P  R T+ Q ++ P+
Sbjct: 282 HKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.9 bits (129), Expect = 9e-09
 Identities = 50/215 (23%), Positives = 82/215 (38%), Gaps = 57/215 (26%)

Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNV 70
           +V+   + +D+  LY+ +E +  G +  L  K   L++ +   Y  + +  +  +H+   
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 71  VHREIKCANILVDASG--------LATTTNDVKSFE------------------------ 98
           +HR+IK  N+L+D+ G        L T        E                        
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 99  ---------------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE 143
                          GTP ++APEV      GY    D WSLG  + EML   PP+    
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEV--FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 144 DMQALFRIGRGKL-----PSVPNSLSRDARDFILK 173
             +   ++   K      P VP  +S  A+D IL+
Sbjct: 241 PQETYKKVMNWKETLIFPPEVP--ISEKAKDLILR 273

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 53.5 bits (128), Expect = 9e-09
 Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 37/209 (17%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD-----------------S 49
            +H +IV++ G   +   L +  E ++ G L N + + H  D                  
Sbjct: 64  LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLG 122

Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTPF---- 102
           Q+ +   QI +G+ YL   + VHR++   N LV   GL     D    +    T +    
Sbjct: 123 QMLAIASQIASGMVYLASLHFVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYYRVG 181

Query: 103 --------WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGR 153
                   W+ PE +  +   +   +DIWS G  + E+ T+ + P+  L + +A+  I +
Sbjct: 182 GRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239

Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDR 182
           G+    P +   +    +  C Q  P  R
Sbjct: 240 GRELERPRTCPPEVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 47/211 (22%), Positives = 91/211 (43%), Gaps = 30/211 (14%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS------------ 53
           +F   ++V+ +G         + +EL+ +G L + Y +    + + +             
Sbjct: 65  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS-YLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT- 100
              +I +G+ YL+    VHR++   N +V        G    T D+       K  +G  
Sbjct: 124 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 101 PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPS 158
           P  W++PE  +LK+  +   +D+WS G  + E+ T  + PY  + + Q L  +  G L  
Sbjct: 184 PVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD 241

Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
            P++      + +  C Q NP  RP+  +++
Sbjct: 242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 53.1 bits (127), Expect = 1e-08
 Identities = 51/221 (23%), Positives = 94/221 (42%), Gaps = 48/221 (21%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL------ANLYQKYHLSDSQVSSYTR-- 56
           S+ ++ NI++ +G    ++ L +  E ++ G L        +   +  +++ + S +   
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN-IPSVSIAN 130

Query: 57  ------QILNGLTYLHERNVVHREIKCANILVDAS--------GLATT--TNDVKSFEGT 100
                 QI +G+ YL   N VHR++   N LV           G++    + D    +G 
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190

Query: 101 PF----WVAPEVVNLKNNGYGLSADIWSLGCTVLEM--LTHQPPYSHLEDMQAL------ 148
                 W+A E + L    +  ++D+W+ G T+ EM  L  + PYS L D Q +      
Sbjct: 191 AVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEF 248

Query: 149 FR-----IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT 184
           FR     I   + P  P+ +       +++C   +  DRPT
Sbjct: 249 FRNQGRQIYLSQTPLCPSPVF----KLMMRCWSRDIKDRPT 285

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 18/161 (11%)

Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSF 97
           L+   + S+T Q+  G+ +L  +N VHR++   N+L+           GLA       ++
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY 293

Query: 98  --EGTPF----WVAPEVVNLKNNGYGLSADIWSLGCTVLEM--LTHQPPYSHLEDMQALF 149
             +G+ F    W+APE  ++ +N Y   +D+WS G  + E+  L   P    + D     
Sbjct: 294 VSKGSTFLPVKWMAPE--SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351

Query: 150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
           +I  G   + P+  +++  D ++KC    P  RP+   L +
Sbjct: 352 KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.1 bits (127), Expect = 2e-08
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 26/167 (15%)

Query: 46  LSDSQVSSY------TRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTT 91
           +++S   SY      + Q+ NG+ +L  +N VHR++   N+L+           GLA   
Sbjct: 230 INESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDI 289

Query: 92  NDVKSF--EGTPF----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED 144
               ++  +G+ F    W+APE  ++ NN Y   +D+WS G  + E+ T    PY  L  
Sbjct: 290 MRDSNYISKGSTFLPLKWMAPE--SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP- 346

Query: 145 MQALF--RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           M   F   I RG   + P   S +  + + KC +     RP  +QL+
Sbjct: 347 MNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 52.6 bits (126), Expect = 2e-08
 Identities = 54/226 (23%), Positives = 95/226 (42%), Gaps = 43/226 (19%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL------SDSQVSSYTR-- 56
           S+ +  NI++ +      + L +  E ++ G L     ++        +D    SY+   
Sbjct: 74  SRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLI 133

Query: 57  ----QILNGLTYLHERNVVHREIKCANILVDAS--------GLATT--TNDVKSFEGTPF 102
               QI +G+ YL   N VHR++   N LV  +        G++    + D    +G   
Sbjct: 134 FMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAV 193

Query: 103 ----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT--HQPPYSHLEDMQALFRIG---- 152
               W++ E + L    +  ++D+W+ G T+ E+LT   + PYS L D Q +   G    
Sbjct: 194 LPIRWMSWESILLGK--FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFR 251

Query: 153 -RGK---LPSVPNSLSRDARDFILKCLQVNPNDRPT----AAQLME 190
            +G+   LP  P          +L C + N  +RP+     A L+E
Sbjct: 252 DQGRQVYLPK-PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.4 bits (125), Expect = 3e-08
 Identities = 37/147 (25%), Positives = 67/147 (45%), Gaps = 17/147 (11%)

Query: 57  QILNGLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSFEG----TPF- 102
           QI  G+ YL ER +VHR++   N+LV +      T+         D K +       P  
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176

Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPN 161
           W+A E ++ +   +   +D+WS G T+ E++T    PY  +   +    + +G+    P 
Sbjct: 177 WMALECIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 234

Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQL 188
             + D    ++KC  ++ + RP   +L
Sbjct: 235 ICTIDVYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.4 bits (125), Expect = 3e-08
 Identities = 38/114 (33%), Positives = 54/114 (47%), Gaps = 20/114 (17%)

Query: 45  HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS------------GLATTTN 92
            L    V S   QIL+G+ YLH   V+HR++K ANILV               G A   N
Sbjct: 104 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Query: 93  -------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY 139
                  D+     T ++ APE++ L    Y  + DIW++GC   E+LT +P +
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELL-LGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 3e-08
 Identities = 40/152 (26%), Positives = 64/152 (42%), Gaps = 33/152 (21%)

Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD------------ASGLATTTND 93
           L   Q  +  R++L  L YLH R ++HR++K  NI +D            A  L    + 
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241

Query: 94  VKSF--EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI 151
            + +   GT    +PE++ L  + Y    DIWS G  + EM               LF  
Sbjct: 242 PQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVT---------LFGK 290

Query: 152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRP 183
              ++ S  + L       I++C+QV+P + P
Sbjct: 291 ---QVKSSSSQLRS-----IIRCMQVHPLEFP 314

Length = 392

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.9 bits (122), Expect = 6e-08
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 35/204 (17%)

Query: 5   SQFEHDNIVQYIG-TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNG 61
           SQ  H ++V+  G   +DEN   +  E VK G L       K ++S        +Q+ + 
Sbjct: 56  SQLSHKHLVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASA 113

Query: 62  LTYLHERNVVHREIKCANILVDASGLAT-TTNDVK-SFEGTPF-------------WVAP 106
           L YL ++ +VH  +   NILV   GL       +K S  G P              W+AP
Sbjct: 114 LHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAP 173

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL-------FRIGRGKLPSV 159
           E +        ++AD WS G T+LE+ ++       E +  L       F   + +LP +
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEICSNGE-----EPLSTLSSSEKERFYQDQHRLP-M 227

Query: 160 PNSLSRDARDFILKCLQVNPNDRP 183
           P+    +  + I +C   +P  RP
Sbjct: 228 PD--CAELANLINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 51.2 bits (122), Expect = 6e-08
 Identities = 38/106 (35%), Positives = 49/106 (46%), Gaps = 9/106 (8%)

Query: 96  SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIG 152
           S  GTP ++APEV  L   GY    D WS+G  + EML  QPP+   + LE    +    
Sbjct: 207 SLVGTPNYIAPEV--LLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQ 264

Query: 153 RGKLPSVPNSLSRDARDFILKCLQVNPNDR---PTAAQLMEHPFVK 195
                     LS +A D I+K L   P DR     A ++  HPF K
Sbjct: 265 TSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFK 309

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 51.6 bits (123), Expect = 7e-08
 Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 13/99 (13%)

Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTND---VKSFEG--TPF-- 102
           Q  +  +Q+L  + Y+H++ ++HR+IK  NI ++  G      D      FE     F  
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDY 326

Query: 103 -WVAPEVVN----LKNNGYGLSADIWSLGCTVLEMLTHQ 136
            WV     N    L  +GY    DIWS G  +L+ML+H 
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365

Length = 501

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.0 bits (122), Expect = 8e-08
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 18/155 (11%)

Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA----TTTNDVKSFEGT 100
           SY+ Q+  G+ +L  R  +HR++   NIL+  +        GLA       + V+  +  
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 101 -PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGRGKL 156
            P  W+APE +  K   Y   +D+WS G  + E+ +    PY  ++ D +   R+  G  
Sbjct: 237 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR 294

Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P   + +    +L C   NP DRPT ++L+E 
Sbjct: 295 MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.4 bits (120), Expect = 1e-07
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 24/156 (15%)

Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDV--------KSF 97
           Y+ Q+  G+ +L  R  +HR++   NIL+  +        GLA    D+        K  
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA---RDIYKDPDYVRKGS 235

Query: 98  EGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGRG 154
              P  W+APE  ++ +  Y   +D+WS G  + E+ +    PY  ++ + +   R+  G
Sbjct: 236 ARLPLKWMAPE--SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG 293

Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +L C Q +P +RPT + L+E
Sbjct: 294 TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 49.4 bits (118), Expect = 2e-07
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 32/209 (15%)

Query: 5   SQFEHDNIVQYIGTE-KDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNG 61
             F H N++  +G     E    + L  +K G L N  +   ++ +   +  +  Q+  G
Sbjct: 51  KDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKG 110

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATTTND-----VKSFEGTPF---WVA 105
           + YL  +  VHR++   N ++D S        GLA    D     V +  G      W+A
Sbjct: 111 MEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLE--DMQALFRIGRGKLPS---V 159
            E  +L+   +   +D+WS G  + E++T   PPY  ++  D+      GR +L      
Sbjct: 171 LE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-RLLQPEYC 227

Query: 160 PNSLSRDARDFILKCLQVNPNDRPTAAQL 188
           P+ L     + +L C    P  RPT ++L
Sbjct: 228 PDPLY----EVMLSCWHPKPEMRPTFSEL 252

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 2e-07
 Identities = 45/148 (30%), Positives = 67/148 (45%), Gaps = 25/148 (16%)

Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTND-VK-SFEGTPF----------- 102
           +Q+ + L+YL ++N+VH  +   NIL+   GLA  T+  +K S  G  F           
Sbjct: 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVER 183

Query: 103 --WVAPEVVNLKNNGYGLS--ADIWSLGCTVLEML--THQPPYSHLEDMQALFRIGRGKL 156
             W+APE V     G  LS  AD WS G T+LE+      P        +  F   + +L
Sbjct: 184 IPWIAPECV---PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRL 240

Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPT 184
           P  P+   ++    I +CL   P  RP+
Sbjct: 241 PE-PS--CKELATLISQCLTYEPTQRPS 265

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.9 bits (114), Expect = 7e-07
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 37/215 (17%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTR---QILNG 61
            +H NI+Q +G   +     +  E  + G L +    +++H  +SQ+    R   +I  G
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111

Query: 62  LTYLHERNVVHREIKCAN--------ILVDASGLA--------TTTNDVKSFEGTPF-WV 104
           +T++H+ N +H ++   N        + V   G+           T D K     P  W+
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV---PLRWL 168

Query: 105 APEVVNLKNNGYGLSAD------IWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG--- 154
           APE+V   + G  ++A+      +W+LG T+ E+  +   PYSHL D + L  + +    
Sbjct: 169 APELVGEFHGGL-ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV 227

Query: 155 KLPSVPNSLSRDARDF-ILKCLQVNPNDRPTAAQL 188
           KL      L    R + +L+   ++P  R TA ++
Sbjct: 228 KLFKPQLELPYSERWYEVLQFCWLSPEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 47.6 bits (113), Expect = 1e-06
 Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 55/238 (23%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ------------- 50
            S+ +  NI++ +G   DE+ L +  E ++ G L      +HL D +             
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 51  -VSSYTR------QILNGLTYLHERNVVHREIKCANILVDAS--------GLATT--TND 93
              SY+       QI +G+ YL   N VHR++   N LV  +        G++      D
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGD 192

Query: 94  VKSFEGTPF----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT--HQPPYSHLEDMQA 147
               +G       W+A E + +    +  ++D+W+ G T+ E+L    + PY  L D Q 
Sbjct: 193 YYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQV 250

Query: 148 L------FR-----IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +      FR     +   + P  P  L     + +L+C   +  +RP+ + +  H F+
Sbjct: 251 IENAGEFFRDQGRQVYLFRPPPCPQGLY----ELMLQCWSRDCRERPSFSDI--HAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 1e-06
 Identities = 33/101 (32%), Positives = 47/101 (46%), Gaps = 9/101 (8%)

Query: 99  GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR--IGRGKL 156
           GTP ++APE+      GYG   D WSLG  + E L   PP+   E+    +R  I   + 
Sbjct: 210 GTPDYIAPEI--FLQQGYGQECDWWSLGAIMFECLIGWPPFCS-ENSHETYRKIINWRET 266

Query: 157 PSVPN--SLSRDARDFILKCLQVNPN--DRPTAAQLMEHPF 193
              P+   LS +A D I + +    N   R  A ++  HPF
Sbjct: 267 LYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.5 bits (110), Expect = 3e-06
 Identities = 35/103 (33%), Positives = 45/103 (43%), Gaps = 7/103 (6%)

Query: 96  SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRG 154
           S  GTP ++APEV  L   GY    D WS+G  + EML  QPP+      +   + I   
Sbjct: 207 SLVGTPNYIAPEV--LLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWE 264

Query: 155 KLPSVPNS--LSRDARDFILK--CLQVNPNDRPTAAQLMEHPF 193
               +P    LS +A D I K  C       R  A  +  HPF
Sbjct: 265 NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.6 bits (108), Expect = 7e-06
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 6/98 (6%)

Query: 99  GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR--IGRG-K 155
           GTP ++APE+  L    +G + D W+LG  + E LT  PP++  E  Q +F+  + R   
Sbjct: 542 GTPDYLAPEL--LLGKPHGPAVDWWALGVCLFEFLTGIPPFND-ETPQQVFQNILNRDIP 598

Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
            P     LS +A++ I   L ++P  R    +L +HP 
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.8 bits (106), Expect = 9e-06
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 18/152 (11%)

Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA-TTTND----VKSFEG 99
            ++ Q+  G+ +L  +N +HR++   N+L+           GLA    ND    VK    
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275

Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPY-SHLEDMQALFRIGRGKL 156
            P  W+APE  ++ +  Y + +D+WS G  + E+ +  + PY   L + +    + RG  
Sbjct: 276 LPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ 333

Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
            S P+    +    +  C  + P +RPT +Q+
Sbjct: 334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.9 bits (106), Expect = 1e-05
 Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 18/154 (11%)

Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA-TTTND----VKSFEG 99
           S++ Q+  G+++L  +N +HR++   NIL+           GLA    ND    VK    
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277

Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGRGKL 156
            P  W+APE  ++ N  Y   +D+WS G  + E+ +    PY  +  D +    I  G  
Sbjct: 278 LPVKWMAPE--SIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335

Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
              P     +  D +  C   +P  RPT  Q+++
Sbjct: 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 42/168 (25%), Positives = 64/168 (38%), Gaps = 44/168 (26%)

Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFE---------- 98
           +I   + Y+H + V+HR++K  NIL+           G A      +             
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 99  ------------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS------ 140
                       GTP ++APE   L       S DI++LG  + +MLT   PY       
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPE--RLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238

Query: 141 -HLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQ 187
               D   L  I       +P  LS+ A    +K L V+P +R ++ Q
Sbjct: 239 ISYRD-VILSPIEVAPYREIPPFLSQIA----MKALAVDPAERYSSVQ 281

Length = 932

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.5 bits (105), Expect = 1e-05
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 34/217 (15%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTR------Q 57
           +   +H N++Q +G   +     + +E    G L    +    ++      T       +
Sbjct: 49  YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACE 108

Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTP-------F 102
           I  GL +LH+ N +H ++   N L+ A         GL+      + +  TP        
Sbjct: 109 IALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLS-HNKYKEDYYVTPDQLWVPLR 167

Query: 103 WVAPEVV-----NLKNNGYGLSADIWSLGCTVLEM--LTHQPPYSHLEDMQAL---FRIG 152
           W+APE+V     NL        +++WSLG T+ E+  L  Q PY HL D Q L    R  
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQ-PYRHLSDEQVLTYTVREQ 226

Query: 153 RGKLPSVPNSLSRDARDF-ILKCLQVNPNDRPTAAQL 188
           + KLP     L    R + +++   + P  RP+A ++
Sbjct: 227 QLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.5 bits (97), Expect = 1e-04
 Identities = 40/158 (25%), Positives = 66/158 (41%), Gaps = 47/158 (29%)

Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSFEGTPF------------- 102
           +Q+ + L+YL ++++VH  +   NIL+   G+          E  PF             
Sbjct: 112 KQLASALSYLEDKDLVHGNVCTKNILLAREGIDG--------ECGPFIKLSDPGIPITVL 163

Query: 103 ----------WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDM----QA 147
                     W+APE V    N   ++AD WS G T+ E+  + + P   L+D     + 
Sbjct: 164 SRQECVERIPWIAPECVEDSKN-LSIAADKWSFGTTLWEICYNGEIP---LKDKTLAEKE 219

Query: 148 LFRIGRGKL--PSVPNSLSRDARDFILKCLQVNPNDRP 183
            F  G+  L  PS      ++  D +  C+  +PN RP
Sbjct: 220 RFYEGQCMLVTPSC-----KELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.0 bits (96), Expect = 2e-04
 Identities = 21/76 (27%), Positives = 37/76 (48%), Gaps = 1/76 (1%)

Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLTYLHERNV 70
           +V    + +D   LY+ +E +  G L  +  KY      V+  Y  + +  +  +H+   
Sbjct: 63  VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF 122

Query: 71  VHREIKCANILVDASG 86
           +HR+IK  NIL+D  G
Sbjct: 123 IHRDIKPDNILIDRGG 138

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 40.0 bits (93), Expect = 4e-04
 Identities = 49/215 (22%), Positives = 81/215 (37%), Gaps = 42/215 (19%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----------------KYHLS 47
           S+ +H NIV  +G    E  L +         L                      K  L 
Sbjct: 63  SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122

Query: 48  DSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSFE--------- 98
            +       QI  G+ +L   +VVH+++   N+LV    L    +D+  F          
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV-FDKLNVKISDLGLFREVYAADYYK 181

Query: 99  --GTPF----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH--QP--PYSHLEDMQAL 148
             G       W++PE +      + + +DIWS G  + E+ ++  QP   YS+ +D+  +
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVIEM 238

Query: 149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP 183
            R  R  LP  P+         +L+C    P+ RP
Sbjct: 239 IR-NRQVLP-CPDDCPAWVYTLMLECWNEFPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 39.4 bits (92), Expect = 5e-04
 Identities = 46/183 (25%), Positives = 73/183 (39%), Gaps = 40/183 (21%)

Query: 30  ELVKKGSLANLYQKYHLSDSQVS---SYTRQILNGLTYLHERNVVHREIKCANILVDASG 86
           E VK GSL + Y K + +   +S      +Q+   L +L ++ + H  +   N+L+    
Sbjct: 79  EYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREE 137

Query: 87  LATTTNDVKSFEGTPF-----------------------WVAPEVVNLKNNGYGLSADIW 123
              T N        PF                       WV PE +    N   L+AD W
Sbjct: 138 DRKTGN-------PPFIKLSDPGISITVLPKEILLERIPWVPPECIENPQN-LSLAADKW 189

Query: 124 SLGCTVLEMLTH-QPPYSHLEDMQAL-FRIGRGKLPSVPNSLSRDARDFILKCLQVNPND 181
           S G T+ E+ +    P S L+  + L F   R +LP  P     +  + I +C+   P+ 
Sbjct: 190 SFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLP-APKWT--ELANLINQCMDYEPDF 246

Query: 182 RPT 184
           RP+
Sbjct: 247 RPS 249

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 38.8 bits (90), Expect = 9e-04
 Identities = 44/213 (20%), Positives = 75/213 (35%), Gaps = 35/213 (16%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSS--------- 53
            ++  H NIV  +G    E  + +  E + +G L   L  +   SD   SS         
Sbjct: 61  MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120

Query: 54  --------YTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSF 97
                      QI  G+ YL     VH+++   NIL+           GL+        +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY 180

Query: 98  EGTP------FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSHLEDMQALFR 150
              P       W+ PE +      +   +DIWS G  + E+ +    PY    + + +  
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238

Query: 151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP 183
           + + +L              + +C Q  P+ RP
Sbjct: 239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP 271

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 37.6 bits (87), Expect = 0.003
 Identities = 46/203 (22%), Positives = 73/203 (35%), Gaps = 75/203 (36%)

Query: 62  LTYLH-ERNVVHREIKCANILVDASGLATTTNDVKSFEGTP------------------- 101
           L Y H E +++H ++K  NIL++ S    T  D  +    P                   
Sbjct: 244 LDYFHTELHLMHTDLKPENILMETS---DTVVDPVTNRALPPDPCRVRICDLGGCCDERH 300

Query: 102 ---------FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG 152
                     + +PEVV     G+  S D+WS+GC + E+ T +  Y   ++++ L  + 
Sbjct: 301 SRTAIVSTRHYRSPEVV--LGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358

Query: 153 R--GKLPSV-------------------------PNSLSRDAR--------------DFI 171
           +  G+LPS                          P  L+R AR              D I
Sbjct: 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLI 418

Query: 172 LKCLQVNPNDRPTAAQLMEHPFV 194
              L  +   R  A Q+  HP+V
Sbjct: 419 YGLLHYDRQKRLNARQMTTHPYV 441

Length = 467

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 37.7 bits (87), Expect = 0.003
 Identities = 16/36 (44%), Positives = 21/36 (58%)

Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDASG 86
           +    RQ+L GL  LH   +VHR+IK  N+LV   G
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG 346

Length = 507

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	201
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.94
KOG3653	534	consensus Transforming growth factor beta/activin	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.82
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.74
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.73
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.72
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.69
PRK12274	218	serine/threonine protein kinase; Provisional	99.65
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.64
PRK10345	210	hypothetical protein; Provisional	99.64
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.64
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.61
PRK09188	365	serine/threonine protein kinase; Provisional	99.61
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.54
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.54
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.5
KOG1243	690	consensus Protein kinase [General function predict	99.46
PRK14879	211	serine/threonine protein kinase; Provisional	99.41
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.38
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.35
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.35
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.31
smart00090	237	RIO RIO-like kinase.	99.27
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.23
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.15
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.11
COG4248	637	Uncharacterized protein with protein kinase and he	99.11
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.1
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.04
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.9
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.85
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.78
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.77
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.76
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.69
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.66
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.62
KOG3087	229	consensus Serine/threonine protein kinase [General	98.58
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.46
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.35
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.28
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.28
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.26
PRK09902	216	hypothetical protein; Provisional	98.16
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.01
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.97
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.88
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.23
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.2
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.09
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.0
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	96.88
KOG0576	829	consensus Mitogen-activated protein kinase kinase	96.41
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.37
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.58
KOG2268	465	consensus Serine/threonine protein kinase [Signal	94.39
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	94.18
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	93.86
KOG1236	565	consensus Predicted unusual protein kinase [Genera	93.86
PRK05231	319	homoserine kinase; Provisional	93.55
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	93.33
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	93.14
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	92.33
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	91.8
PRK14559	645	putative protein serine/threonine phosphatase; Pro	91.3
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	91.06
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	90.81
PF01636	239	APH: Phosphotransferase enzyme family This family	90.75
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	90.45
PRK12396	409	5-methylribose kinase; Reviewed	90.32
PLN02876	822	acyl-CoA dehydrogenase	90.12
COG4499	434	Predicted membrane protein [Function unknown]	89.89
PHA03111	444	Ser/Thr kinase; Provisional	89.16
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	88.98
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	88.72
COG2334	331	Putative homoserine kinase type II (protein kinase	88.45
PF10140	359	YukC: WXG100 protein secretion system (Wss), prote	87.74
PRK10593	297	hypothetical protein; Provisional	86.95
PRK10271	188	thiK thiamine kinase; Provisional	86.76
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	86.76
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	85.4
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	83.8
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	83.6
KOG2464	246	consensus Serine/threonine kinase (haspin family)	83.29
PLN02756	418	S-methyl-5-thioribose kinase	83.15
PLN02236	344	choline kinase	82.46
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	82.08
KOG2270	520	consensus Serine/threonine protein kinase involved	81.38

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-51  Score=303.39  Aligned_cols=197  Identities=32%  Similarity=0.493  Sum_probs=170.2

Q ss_pred             cccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            2 FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+|++|+|||||+++++|......|+|+||+.||.|.+.+-.. .+.+...+.++.|++.|+.|||++||+||||||+||
T Consensus       228 eILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNI  307 (475)
T KOG0615|consen  228 EILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENI  307 (475)
T ss_pred             HHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceE
Confidence            3789999999999999999999999999999999999987654 488888999999999999999999999999999999


Q ss_pred             EEccC-----------Cceeeec---CccccccCcccccccccccCCCCCc-chhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           81 LVDAS-----------GLATTTN---DVKSFEGTPFWVAPEVVNLKNNGYG-LSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~-----------g~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |+..+           |+++...   ...+.+||+.|.|||++...+.... .++|+||+||+||-+++|.+||.+....
T Consensus       308 Ll~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~  387 (475)
T KOG0615|consen  308 LLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD  387 (475)
T ss_pred             EeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence            99765           5555543   3457889999999999865554444 4899999999999999999999876444


Q ss_pred             H-HHHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          146 Q-ALFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       146 ~-~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      . ..+++..+..+   ..+..++++..++|.+||..||++|||++++|+||||+..-
T Consensus       388 ~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  388 PSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             ccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            3 67777777664   45678999999999999999999999999999999999654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-48  Score=282.55  Aligned_cols=194  Identities=31%  Similarity=0.607  Sum_probs=176.7

Q ss_pred             ccccCCCcceeccceeeeeCC-eEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN-RLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~n   79 (201)
                      +|.+.+|||||.+||.|.+++ ...++|||+++|+|.++++. +.+++....+++.++++||.|||. .+|+||||||+|
T Consensus       130 il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsN  209 (364)
T KOG0581|consen  130 ILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSN  209 (364)
T ss_pred             HHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHH
Confidence            567889999999999999999 49999999999999999886 459999999999999999999995 899999999999


Q ss_pred             EEEccCCceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc-----hH
Q 046714           80 ILVDASGLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL-----ED  144 (201)
Q Consensus        80 ill~~~g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-----~~  144 (201)
                      +|++..|.+++.++.          .++.||..|||||.+  .+..++.++||||||..++|+.+|+.||...     ..
T Consensus       210 lLvNskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi--~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~  287 (364)
T KOG0581|consen  210 LLVNSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERI--SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI  287 (364)
T ss_pred             eeeccCCCEEeccccccHHhhhhhcccccccccccChhhh--cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH
Confidence            999999999888763          457799999999998  5678899999999999999999999999764     56


Q ss_pred             HHHHHHhhcCCCCCCCCC-CCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          145 MQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .+....+..+..|.+|.. +++++++|+..||+++|.+|||+.|+++|||+++-.
T Consensus       288 ~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  288 FELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             HHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            777778888888999987 999999999999999999999999999999998643

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-47  Score=289.86  Aligned_cols=193  Identities=34%  Similarity=0.656  Sum_probs=172.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +-++|+|||||+++++|++.+..|+|.|+|..++|..+.+++ .+++.+++.+++||+.||.|||+.+|+|||||..|++
T Consensus        71 IHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlf  150 (592)
T KOG0575|consen   71 IHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLF  150 (592)
T ss_pred             HHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhhee
Confidence            457899999999999999999999999999999999999864 4999999999999999999999999999999999999


Q ss_pred             EccCCceeeecC------------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTND------------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+-.+++.++            -.+.+|||.|.|||++  ...+.+..+||||+||++|.|+.|++||+...-.+.+.
T Consensus       151 L~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl--~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~  228 (592)
T KOG0575|consen  151 LNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVL--NKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN  228 (592)
T ss_pred             ecCcCcEEecccceeeeecCcccccceecCCCcccChhHh--ccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH
Confidence            987744444332            2356799999999998  46778899999999999999999999999998888888


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ++..... .+|..++.++++||.++|..+|.+|||+++++.|+||+.+.
T Consensus       229 ~Ik~~~Y-~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  229 KIKLNEY-SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             HHHhcCc-ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence            8776654 67779999999999999999999999999999999996543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-46  Score=283.79  Aligned_cols=192  Identities=35%  Similarity=0.625  Sum_probs=172.3

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|.+| .||.|++++..|+|+..+|+|+||+++|+|.++|++.+ |.+..++.++.+|+.||+|||++||+||||||+||
T Consensus       126 ~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENI  205 (604)
T KOG0592|consen  126 ALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENI  205 (604)
T ss_pred             HHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhhe
Confidence            56777 89999999999999999999999999999999998866 99999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc-------------------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC
Q 046714           81 LVDASGLATTTNDV-------------------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH  135 (201)
Q Consensus        81 ll~~~g~~~~~~~~-------------------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g  135 (201)
                      |+|.+|...+.+++                         .+++||-.|++||.+  .....++++|+|+|||++|.|+.|
T Consensus       206 LLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL--~~~~~~~~sDiWAlGCilyQmlaG  283 (604)
T KOG0592|consen  206 LLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELL--NDSPAGPSSDLWALGCILYQMLAG  283 (604)
T ss_pred             eEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHh--cCCCCCcccchHHHHHHHHHHhcC
Confidence            99998755544421                         347788999999998  566778999999999999999999


Q ss_pred             CCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          136 QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       136 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .+||....+--...++..-.. .++.+.++.+.+|++++|..||.+|+|++||.+||||...
T Consensus       284 ~PPFra~NeyliFqkI~~l~y-~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  284 QPPFRAANEYLIFQKIQALDY-EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV  344 (604)
T ss_pred             CCCCccccHHHHHHHHHHhcc-cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence            999998887777777766554 7888999999999999999999999999999999999864

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-46  Score=270.33  Aligned_cols=194  Identities=35%  Similarity=0.577  Sum_probs=178.0

Q ss_pred             cccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            2 FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+|.+++||.|++++..|++....|+|+||+.||.|...+++ +.|++..+.-++.+|+.||.|||++||+||||||+||
T Consensus        77 ~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENI  156 (357)
T KOG0598|consen   77 NILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENI  156 (357)
T ss_pred             HHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHe
Confidence            367889999999999999999999999999999999998885 4599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecC------------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTND------------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      |+|.+|.+.+.++            ..+++||+.|+|||++  .+.+++..+|.||||+++|+|++|..||.........
T Consensus       157 LLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil--~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~  234 (357)
T KOG0598|consen  157 LLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEIL--LGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY  234 (357)
T ss_pred             eecCCCcEEEeccccchhcccCCCccccccCCccccChHHH--hcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH
Confidence            9999987766653            3457899999999998  5678999999999999999999999999999989999


Q ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC----CHhHHhcCccccCc
Q 046714          149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP----TAAQLMEHPFVKRP  197 (201)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~----t~~~il~~~~~~~~  197 (201)
                      ..+.....+..+...+.+.+++++++|+.+|++|.    +++++-+||||...
T Consensus       235 ~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  235 DKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             HHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence            99999887788888999999999999999999995    78999999999864

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-45  Score=277.55  Aligned_cols=193  Identities=30%  Similarity=0.564  Sum_probs=169.7

Q ss_pred             ccccCC-CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFE-HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +++.++ ||||+++++++......++||||+.||+|.+++.. +.+++.++..+++|++.||+|||++||+||||||+|+
T Consensus        72 ~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENi  151 (370)
T KOG0583|consen   72 ILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENI  151 (370)
T ss_pred             HHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHE
Confidence            467788 99999999999999999999999999999999877 5699999999999999999999999999999999999


Q ss_pred             EEccC-CceeeecC------------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           81 LVDAS-GLATTTND------------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~~~-g~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +++.+ +..++.++            ..+.+|++.|+|||++.......+.++||||+|++||.|++|+.||.+......
T Consensus       152 lld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l  231 (370)
T KOG0583|consen  152 LLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL  231 (370)
T ss_pred             EecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH
Confidence            99998 76655543            335668999999999954332446899999999999999999999999777677


Q ss_pred             HHHhhcCCCCCCCCCC-CHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          148 LFRIGRGKLPSVPNSL-SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       148 ~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ...+..+.. .++..+ +++++.++.+|+..+|.+|+|+.++++||||+.
T Consensus       232 ~~ki~~~~~-~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  232 YRKIRKGEF-KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHhcCCc-cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            766665544 667777 999999999999999999999999999999997

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-45  Score=270.55  Aligned_cols=195  Identities=46%  Similarity=0.813  Sum_probs=165.5

Q ss_pred             ccccCCCcceeccceeeeeCC--eEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN--RLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      +|++|+|||||+.+|......  .++++|||+.+|+|.+++.+.+  +++..++.+++||++||+|||++|++|+||||+
T Consensus        67 iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~  146 (313)
T KOG0198|consen   67 ILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPA  146 (313)
T ss_pred             HHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccc
Confidence            588999999999999755444  6999999999999999998865  899999999999999999999999999999999


Q ss_pred             cEEEcc-CCceeeecCc---------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC-
Q 046714           79 NILVDA-SGLATTTNDV---------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH-  141 (201)
Q Consensus        79 nill~~-~g~~~~~~~~---------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-  141 (201)
                      |||++. +|.+++.+++               ..+.||+.|+|||.+.. +....+++||||+||++.+|+||+.||.. 
T Consensus       147 NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~  225 (313)
T KOG0198|consen  147 NILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEF  225 (313)
T ss_pred             eEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence            999999 5766665543               13458889999999943 44445699999999999999999999987 


Q ss_pred             chHHHHHHHhh-cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          142 LEDMQALFRIG-RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       142 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .........+. ....|.++..++.+.++|+.+|+..+|++|||++++|+|||.+...
T Consensus       226 ~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  226 FEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             cchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            34444333433 4456788999999999999999999999999999999999987654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-45  Score=280.43  Aligned_cols=193  Identities=28%  Similarity=0.551  Sum_probs=172.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|+-|.||||+++|+++++...+|+|.||+.||.|.+++- ++++++.++.+++.||+.|+.|||..+|+|+|+||+|++
T Consensus        65 iMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlL  144 (786)
T KOG0588|consen   65 IMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLL  144 (786)
T ss_pred             HHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhh
Confidence            5778899999999999999999999999999999999764 566999999999999999999999999999999999999


Q ss_pred             EccCCceeeecC-----------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           82 VDASGLATTTND-----------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        82 l~~~g~~~~~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +|..+..++.++           ..+.+|++.|.+||++. +....+.++||||.|++||.|++|+.||++..-...+.+
T Consensus       145 Ld~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~-G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlK  223 (786)
T KOG0588|consen  145 LDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVS-GRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLK  223 (786)
T ss_pred             hhcccCEeeeccceeecccCCccccccCCCcccCCchhhc-CCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            998766555443           23567999999999993 444557899999999999999999999998888888888


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      +..+.. ++|..++.++++|+.+|+..||++|+|.+||++|||+..-
T Consensus       224 V~~G~f-~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~  269 (786)
T KOG0588|consen  224 VQRGVF-EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY  269 (786)
T ss_pred             HHcCcc-cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence            887766 7889999999999999999999999999999999998753

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-45  Score=276.82  Aligned_cols=195  Identities=36%  Similarity=0.718  Sum_probs=175.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      +|+..+|+|||++++.|.-++..++||||++||+|.|++....+++.++..+.+++++||+|||.+||+|+|||.+|||+
T Consensus       323 Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL  402 (550)
T KOG0578|consen  323 VMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL  402 (550)
T ss_pred             HHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe
Confidence            57889999999999999998999999999999999999999889999999999999999999999999999999999999


Q ss_pred             ccCCceeeecC------------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTND------------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|.+++.++            ..+.+||+.|+|||.+  ....++++.||||||+++.||+.|+.||-........+.
T Consensus       403 ~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVv--trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL  480 (550)
T KOG0578|consen  403 TMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVV--TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL  480 (550)
T ss_pred             ccCCcEEEeeeeeeeccccccCccccccCCCCccchhhh--hhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH
Confidence            99998877663            2356699999999998  567789999999999999999999999987777777766


Q ss_pred             hhcCCCCCC--CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          151 IGRGKLPSV--PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       151 ~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      +.....+.+  +..+++.+++|+.+||+.|+++|+|+.++|+||||+....
T Consensus       481 Ia~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  481 IATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             HhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence            665555543  5678999999999999999999999999999999977654

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-44  Score=265.64  Aligned_cols=197  Identities=32%  Similarity=0.636  Sum_probs=176.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +++.++||||++.+..|..+..+|+||.++.+|++.++++.   .++++..+..+++++++||.|||++|.+|||||+.|
T Consensus        77 ~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgn  156 (516)
T KOG0582|consen   77 TMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGN  156 (516)
T ss_pred             HhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceeccccccc
Confidence            57889999999999999999999999999999999999975   359999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecC----------------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           80 ILVDASGLATTTND----------------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        80 ill~~~g~~~~~~~----------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      |||+.+|.+++.++                +..+.+++.|+|||.+.....+++.|+||||||+...|+.+|..||..++
T Consensus       157 ILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p  236 (516)
T KOG0582|consen  157 ILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP  236 (516)
T ss_pred             EEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence            99999998887764                24567899999999965567789999999999999999999999999999


Q ss_pred             HHHHHHHhhcCCCCCC---------CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          144 DMQALFRIGRGKLPSV---------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      +.+....-.++..+..         .+..+..+++++..||++||++|||++++++|+||+....
T Consensus       237 PmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  237 PMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             hHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            9998888777766522         2346778999999999999999999999999999997653

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-44  Score=246.80  Aligned_cols=191  Identities=30%  Similarity=0.556  Sum_probs=167.3

Q ss_pred             ccCCCcceeccceeeeeCCeEEEEEEecCCCCHHH-HHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEc
Q 046714            5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD   83 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~   83 (201)
                      ..|+||||+++.+.+.+.+..|+|+|++.|++|.. ..++.-+++..+-.+++||++||.|+|.+||+|||+||+|+++.
T Consensus        65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLA  144 (355)
T KOG0033|consen   65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLA  144 (355)
T ss_pred             HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeee
Confidence            46899999999999999999999999999999955 55666689999999999999999999999999999999999986


Q ss_pred             cC-----------CceeeecCc---cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           84 AS-----------GLATTTNDV---KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        84 ~~-----------g~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ..           |++....+.   ..+.|+|.|+|||++  ....++..+|||+-|++||-++.|..||.+.+..+.++
T Consensus       145 SK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvv--rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye  222 (355)
T KOG0033|consen  145 SKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVL--KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYE  222 (355)
T ss_pred             eccCCCceeecccceEEEeCCccccccccCCCcccCHHHh--hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHH
Confidence            43           333333322   346799999999998  67788999999999999999999999999988889998


Q ss_pred             HhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          150 RIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       150 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ++.++...   ..+++++++.++|+++||..||.+|+|+.|+|+|||+.+.
T Consensus       223 ~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  223 QIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            88877553   3567899999999999999999999999999999998764

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-45  Score=256.98  Aligned_cols=181  Identities=34%  Similarity=0.631  Sum_probs=163.1

Q ss_pred             ccccCCCcceeccce-eeeeCCe-EEEEEEecCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhh--cC--cc
Q 046714            3 SFSQFEHDNIVQYIG-TEKDENR-LYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQILNGLTYLHE--RN--VV   71 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~-~~~~~~~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh~--~~--i~   71 (201)
                      +|++|+||||+++++ .+.+++. ++++||+|.+|+|..+++..     .+++..+++++.|+|.||..||.  ..  ++
T Consensus        71 lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm  150 (375)
T KOG0591|consen   71 LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM  150 (375)
T ss_pred             HHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence            689999999999999 5655555 89999999999999998642     39999999999999999999998  44  99


Q ss_pred             ccCCCCCcEEEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCC
Q 046714           72 HREIKCANILVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY  139 (201)
Q Consensus        72 H~dl~p~nill~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  139 (201)
                      ||||||.||+++.+|.+++++..            .+.+|||.|++||.+  ...+++.++||||+||++|||+.-..||
T Consensus       151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i--~~~~Y~~kSDiWslGCllyEMcaL~~PF  228 (375)
T KOG0591|consen  151 HRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERI--HESGYNFKSDIWSLGCLLYEMCALQSPF  228 (375)
T ss_pred             eccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHH--hcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence            99999999999999999888743            345699999999998  6778999999999999999999999999


Q ss_pred             CCchHHHHHHHhhcCCCCCCC-CCCCHHHHHHHHHHhhcCCCCCCCH
Q 046714          140 SHLEDMQALFRIGRGKLPSVP-NSLSRDARDFILKCLQVNPNDRPTA  185 (201)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~  185 (201)
                      .+..-.+...++..+..+.+| ..++.++.+++..|+..||.+||+.
T Consensus       229 ~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  229 YGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             ccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            999888888889999888888 7789999999999999999999984

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-44  Score=267.28  Aligned_cols=195  Identities=27%  Similarity=0.566  Sum_probs=164.9

Q ss_pred             ccccCC-CcceeccceeeeeCC-eEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFE-HDNIVQYIGTEKDEN-RLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      .|++|+ ||||+++.+++.+.. .+++||||+++ +|..+++.++  |++..+..|+.||++||+|+|++|++|||+||+
T Consensus        61 sL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPE  139 (538)
T KOG0661|consen   61 SLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPE  139 (538)
T ss_pred             HHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChh
Confidence            578899 999999999999887 99999999987 9999998654  999999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecC-----------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           79 NILVDASGLATTTND-----------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        79 nill~~~g~~~~~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |||+..+...++.++           ....+.|.+|+|||++ .....++.+.|+|++||+++|+++-+..|++..+.+.
T Consensus       140 NiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvL-Lrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq  218 (538)
T KOG0661|consen  140 NILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVL-LRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ  218 (538)
T ss_pred             heEecccceeEecccccccccccCCCcchhhhcccccchHHh-hhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH
Confidence            999986555544443           2345578889999998 5677889999999999999999999999999888777


Q ss_pred             HHHhhc--C-------------------CCCC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          148 LFRIGR--G-------------------KLPS--------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       148 ~~~~~~--~-------------------~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      +.++-.  +                   ..+.        +-...++++.++|.+|+.+||.+|||+.|+++||||+...
T Consensus       219 i~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  219 IYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            766410  0                   0111        1123788899999999999999999999999999998765


Q ss_pred             C
Q 046714          199 Q  199 (201)
Q Consensus       199 ~  199 (201)
                      .
T Consensus       299 ~  299 (538)
T KOG0661|consen  299 A  299 (538)
T ss_pred             c
Confidence            4

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=250.81  Aligned_cols=192  Identities=32%  Similarity=0.559  Sum_probs=175.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|+.+.||.++++++.+.+.+..++||||+.||.|..++++ ++|++..++.++.||+.|++|||+.+|++|||||+|||
T Consensus        97 vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiL  176 (355)
T KOG0616|consen   97 VLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLL  176 (355)
T ss_pred             HHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHee
Confidence            68889999999999999999999999999999999999877 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecC---------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           82 VDASGLATTTND---------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        82 l~~~g~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      +|.+|..++.++         ..+.+||+.|+|||++  ...+++.++|-|+||+++|||+.|..||..........++.
T Consensus       177 lD~~G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii--~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~  254 (355)
T KOG0616|consen  177 LDQNGHIKITDFGFAKRVSGRTWTLCGTPEYLAPEII--QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL  254 (355)
T ss_pred             eccCCcEEEEeccceEEecCcEEEecCCccccChHHh--hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH
Confidence            999988776654         3456799999999999  56678899999999999999999999999999999999998


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHhhcCCCCC-----CCHhHHhcCccccCc
Q 046714          153 RGKLPSVPNSLSRDARDFILKCLQVNPNDR-----PTAAQLMEHPFVKRP  197 (201)
Q Consensus       153 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R-----~t~~~il~~~~~~~~  197 (201)
                      .++. .+|...++++++|+.++|+.|-.+|     .-.++|.+||||+..
T Consensus       255 ~~~v-~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  255 EGKV-KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             hCcc-cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence            8875 7889999999999999999999999     356799999999863

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-43  Score=263.57  Aligned_cols=188  Identities=30%  Similarity=0.499  Sum_probs=165.6

Q ss_pred             ccccCCCcceeccceeeeeCC-eEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcC-ccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN-RLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERN-VVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~-i~H~dl~p   77 (201)
                      +|++++||||++++|++.+.. ...+||||+++|+|.+++..   ..++...++.++.||+.||+|||+++ |+|+||||
T Consensus        92 il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~  171 (362)
T KOG0192|consen   92 LLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKS  171 (362)
T ss_pred             HHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccCh
Confidence            577899999999999999987 79999999999999999966   45999999999999999999999999 99999999


Q ss_pred             CcEEEccCC-ceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           78 ANILVDASG-LATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        78 ~nill~~~g-~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      +|+|++.++ .+++.++..            ...||+.|+|||.+......++.++||||||+++||++||+.||.+...
T Consensus       172 ~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  172 DNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             hhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence            999999986 555555321            2458889999999832256789999999999999999999999999887


Q ss_pred             HHHHHHhh-cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQALFRIG-RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ......+. .+..+.++..+++.+..++.+||..+|.+||++.+++.
T Consensus       252 ~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  252 VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            66666654 77778888889999999999999999999999999865

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-43  Score=256.22  Aligned_cols=193  Identities=28%  Similarity=0.592  Sum_probs=166.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++|||||.+++++.+++..++|||||.||+|.++++++ .+++..++.++.||+.|+++||+++|+||||||+|||
T Consensus        62 iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiL  141 (429)
T KOG0595|consen   62 ILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNIL  141 (429)
T ss_pred             HHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEE
Confidence            689999999999999999999999999999999999999876 5999999999999999999999999999999999999


Q ss_pred             EccC-Cc-----eeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           82 VDAS-GL-----ATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        82 l~~~-g~-----~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      ++.. +.     .++.+++           .+.+|++.|||||++  ....++.|+|+||+|+++|++++|+.||.....
T Consensus       142 Ls~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~--~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  142 LSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVI--MSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             eccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHH--HhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            9875 22     2333321           234589999999998  456788999999999999999999999987766


Q ss_pred             HHHHHHhh--cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          145 MQALFRIG--RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       145 ~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .+....+.  ....+..+...+....+++...++.++.+|.++++-+.|++...+
T Consensus       220 ~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  220 KELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             HHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence            66655443  344456667778888899999999999999999999999987764

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-43  Score=264.45  Aligned_cols=186  Identities=26%  Similarity=0.484  Sum_probs=169.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++|+|+|||+++++|..++.++|||||++.|+|.++++.   ..+...+.+.++.|||+|++||++++++||||...|
T Consensus       254 iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARN  333 (468)
T KOG0197|consen  254 IMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARN  333 (468)
T ss_pred             HHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhh
Confidence            68999999999999999999999999999999999999986   238999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccccc-------------cCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKSFE-------------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~~~-------------~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |||+.++.+++.++.-+..             ....|.|||.+  ....++.+|||||||++|+|++| |+.||+.....
T Consensus       334 iLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~--~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~  411 (468)
T KOG0197|consen  334 ILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEAL--NYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE  411 (468)
T ss_pred             eeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHH--hhCCcccccceeehhhhHHHHhccCCCCCCCCCHH
Confidence            9999998888777643322             12349999998  55679999999999999999999 99999999999


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +.+..+..+....-|..+|+++.++|..||..+|++|||++.+..
T Consensus       412 ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  412 EVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            999999999999999999999999999999999999999997643

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=258.76  Aligned_cols=191  Identities=31%  Similarity=0.484  Sum_probs=167.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+++..+++|||+.+++|.+++... .+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus        54 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIl  133 (291)
T cd05612          54 VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENIL  133 (291)
T ss_pred             HHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE
Confidence            578899999999999999999999999999999999988764 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           82 VDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        82 l~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      ++.+|.+++.+...         ...+++.|+|||.+  .+...+.++||||||+++|+|++|+.||...........+.
T Consensus       134 i~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~  211 (291)
T cd05612         134 LDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVI--QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL  211 (291)
T ss_pred             ECCCCCEEEEecCcchhccCCcccccCChhhcCHHHH--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99988777765432         23477889999998  45567899999999999999999999998877666666655


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccC
Q 046714          153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKR  196 (201)
Q Consensus       153 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~  196 (201)
                      .+. ..++..+++.+++++++||+.+|.+|++     ++++++||||+.
T Consensus       212 ~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         212 AGK-LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             hCC-cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence            543 3567778999999999999999999995     999999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.2e-42  Score=261.48  Aligned_cols=192  Identities=27%  Similarity=0.446  Sum_probs=166.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++.+..++..++||||+.+++|.+++... .+++..+..++.||+.||+|||+.||+|+||||+||+
T Consensus        48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIl  127 (323)
T cd05571          48 VLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLM  127 (323)
T ss_pred             HHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEE
Confidence            467899999999999999999999999999999999988664 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|..++.+...            ...|++.|+|||.+  .+..++.++|+||+||++|+|++|+.||..........
T Consensus       128 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~  205 (323)
T cd05571         128 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE  205 (323)
T ss_pred             ECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhh--cCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH
Confidence            99988777665431            23478889999998  45567899999999999999999999998776655555


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                      .+... ...++..+++++.+++.+||+.+|++||     ++.++++||||...
T Consensus       206 ~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         206 LILME-EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             HHHcC-CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            55443 3466778999999999999999999999     89999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.4e-42  Score=261.90  Aligned_cols=191  Identities=28%  Similarity=0.507  Sum_probs=167.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++..+++|||+.+++|.+++... .+++..+..++.||+.||+|||++|++|+||||+||+
T Consensus        71 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIl  150 (329)
T PTZ00263         71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLL  150 (329)
T ss_pred             HHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEE
Confidence            477899999999999999999999999999999999988764 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           82 VDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        82 l~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      ++.+|.+++.+...         ...+++.|+|||.+  .+...+.++|+|||||++|+|++|+.||.+....+....+.
T Consensus       151 l~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  228 (329)
T PTZ00263        151 LDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVI--QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL  228 (329)
T ss_pred             ECCCCCEEEeeccCceEcCCCcceecCChhhcCHHHH--cCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence            99998877765432         23467889999998  45567899999999999999999999998877666666665


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccC
Q 046714          153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKR  196 (201)
Q Consensus       153 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~  196 (201)
                      .+. ..++..++..+++++.+||+.||.+|++     ++++++||||+.
T Consensus       229 ~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        229 AGR-LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             cCC-cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            553 4567778999999999999999999987     799999999986

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-42  Score=258.60  Aligned_cols=192  Identities=30%  Similarity=0.475  Sum_probs=166.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++.+.+++..+++|||+.+++|.+++.+. .+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus        46 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nil  125 (312)
T cd05585          46 VLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENIL  125 (312)
T ss_pred             HHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeE
Confidence            577899999999999999999999999999999999988654 5899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...|++.|+|||.+  .+..++.++|+||+|+++|+|++|+.||......+...
T Consensus       126 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~  203 (312)
T cd05585         126 LDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELL--LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR  203 (312)
T ss_pred             ECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHH--cCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH
Confidence            99988777665421            23478889999998  45667899999999999999999999998776666655


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC---CHhHHhcCccccCc
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP---TAAQLMEHPFVKRP  197 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---t~~~il~~~~~~~~  197 (201)
                      .+... ...++..+++.+.+++.+||+.+|.+||   ++.++++||||+..
T Consensus       204 ~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         204 KILQE-PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHcC-CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            55544 3466778999999999999999999997   57899999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.4e-43  Score=246.54  Aligned_cols=194  Identities=29%  Similarity=0.514  Sum_probs=169.5

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      |+++ .||+|+++.++++++...++|+|.++.|.|.|++... .+++....++++|+.+|++|||.++|+|+||||+||+
T Consensus        76 LRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENIL  155 (411)
T KOG0599|consen   76 LRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENIL  155 (411)
T ss_pred             HHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhhee
Confidence            4444 5999999999999999999999999999999999765 4999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc-----------cccccCccccccccccc----CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           82 VDASGLATTTNDV-----------KSFEGTPFWVAPEVVNL----KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        82 l~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~----~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ++++-..++.++.           ...+||++|.|||.+..    ...+++..+|+|+.|+++|.++.|..||--..+.-
T Consensus       156 lddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml  235 (411)
T KOG0599|consen  156 LDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML  235 (411)
T ss_pred             eccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH
Confidence            9998776666542           23469999999999842    34568899999999999999999999998777777


Q ss_pred             HHHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          147 ALFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       147 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ..+.+..++..   +-+..++...++|+.+||+.||++|.|++|+|+||||.+-
T Consensus       236 MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  236 MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            77777777653   3456789999999999999999999999999999999654

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.5e-42  Score=252.44  Aligned_cols=192  Identities=27%  Similarity=0.455  Sum_probs=172.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++|+||||+.+|++|++.....+||||..+|.|.|++.+++ +++.++..+++||++|+.|||+++++|+|||.+|||
T Consensus       106 IMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENIL  185 (668)
T KOG0611|consen  106 IMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENIL  185 (668)
T ss_pred             HHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhhee
Confidence            6899999999999999999999999999999999999998755 999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           82 VDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        82 l~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +|.++..++.++.           .+++|++.|.+||++++ ...-++.+|.||||++||.+..|..||++.+....+.+
T Consensus       186 LD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG-~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ  264 (668)
T KOG0611|consen  186 LDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNG-TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ  264 (668)
T ss_pred             ecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCC-CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHH
Confidence            9999988777643           46789999999999954 33447899999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      +..+..-+  ..-+....-||+.||-.+|++|.|+++|..|=|++=.
T Consensus       265 Is~GaYrE--P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwg  309 (668)
T KOG0611|consen  265 ISRGAYRE--PETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWG  309 (668)
T ss_pred             hhcccccC--CCCCchHHHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence            88876533  3346778899999999999999999999999887644

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.3e-42  Score=259.69  Aligned_cols=192  Identities=29%  Similarity=0.456  Sum_probs=166.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +++.++||||+++++++.+++..+++|||+.+++|.+++.+. .+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus        84 ~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIL  163 (340)
T PTZ00426         84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLL  163 (340)
T ss_pred             HHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEE
Confidence            567899999999999999999999999999999999998764 5899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           82 VDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        82 l~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      ++.+|.+++.+...         ...|++.|+|||.+  .+..++.++|+||+||++|+|++|+.||...........+.
T Consensus       164 l~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~  241 (340)
T PTZ00426        164 LDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEIL--LNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL  241 (340)
T ss_pred             ECCCCCEEEecCCCCeecCCCcceecCChhhcCHHHH--hCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence            99888777665432         23478889999998  44567889999999999999999999998877666665555


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       153 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                      ... ..++..+++.+.+++++|++.+|++|+     |++++++||||+..
T Consensus       242 ~~~-~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        242 EGI-IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             cCC-CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            443 356777899999999999999999995     89999999999753

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=247.18  Aligned_cols=191  Identities=28%  Similarity=0.581  Sum_probs=161.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .|++|+|||+|.+.++|..++..++|+|||+. ++.+-+++  ++++.+.+.+++.|++.|+.|+|+++++||||||+||
T Consensus        54 mLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENI  132 (396)
T KOG0593|consen   54 MLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENI  132 (396)
T ss_pred             HHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhhe
Confidence            58899999999999999999999999999988 66666655  4599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +|+.+|..++.++.            ...+.|.+|+|||.+ .+...+++.+|||++||++.||++|...|++..+.+..
T Consensus       133 Lit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELL-vGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQL  211 (396)
T KOG0593|consen  133 LITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELL-VGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQL  211 (396)
T ss_pred             EEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhh-cccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHH
Confidence            99999988877653            223357789999998 35578899999999999999999999999998887776


Q ss_pred             HHhhcC--CC-------------------CCC---------CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          149 FRIGRG--KL-------------------PSV---------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       149 ~~~~~~--~~-------------------~~~---------~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      ..+...  ..                   |+.         -..++..+.+|+++||..||.+|++-+|++.||||.
T Consensus       212 y~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  212 YLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             HHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence            655321  11                   000         023456688999999999999999999999999993

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-41  Score=256.85  Aligned_cols=192  Identities=28%  Similarity=0.469  Sum_probs=166.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++.+...+..++||||+.+++|.+++... .+++..+..++.||+.||+|||++|++|+||||+||+
T Consensus        48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIl  127 (323)
T cd05595          48 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM  127 (323)
T ss_pred             HHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEE
Confidence            567899999999999999999999999999999999888654 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+..            ....+++.|+|||.+  .+..++.++|+||+||++|++++|+.||..........
T Consensus       128 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~  205 (323)
T cd05595         128 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE  205 (323)
T ss_pred             EcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccc--cCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9998877766542            123477889999998  45567899999999999999999999998776666555


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                      .+.... ..++..+++++.+++.+||..+|.+|+     ++.++++||||...
T Consensus       206 ~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         206 LILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             HHhcCC-CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence            554433 356778899999999999999999998     89999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-41  Score=248.86  Aligned_cols=193  Identities=30%  Similarity=0.468  Sum_probs=167.1

Q ss_pred             cccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            2 FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      .+|+.++||-++.+|..++.++..+++||||+||+|..+.++++   +++..+..++.+++.||+|||..||++|||||+
T Consensus       129 eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPE  208 (459)
T KOG0610|consen  129 EILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPE  208 (459)
T ss_pred             HHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcc
Confidence            37899999999999999999999999999999999999998755   999999999999999999999999999999999


Q ss_pred             cEEEccCCceeeec------------------------------------------------------------------
Q 046714           79 NILVDASGLATTTN------------------------------------------------------------------   92 (201)
Q Consensus        79 nill~~~g~~~~~~------------------------------------------------------------------   92 (201)
                      ||||..+|...+.+                                                                  
T Consensus       209 NILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~  288 (459)
T KOG0610|consen  209 NILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPT  288 (459)
T ss_pred             eeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCC
Confidence            99997664211100                                                                  


Q ss_pred             --CccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCCCCCCC--CCCHHHH
Q 046714           93 --DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN--SLSRDAR  168 (201)
Q Consensus        93 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  168 (201)
                        ....++||-.|.|||++  .+.+.+.++|-|+||+++|||+.|+.||.+....+....+..... .++.  .++..++
T Consensus       289 ~~RSnSFVGThEYlAPEvI--~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l-~Fp~~~~vs~~ak  365 (459)
T KOG0610|consen  289 GARSNSFVGTHEYLAPEVI--RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL-KFPEEPEVSSAAK  365 (459)
T ss_pred             Cccccccccccccccceee--ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-cCCCCCcchhHHH
Confidence              01234477789999999  677889999999999999999999999999999888888775543 3332  5778999


Q ss_pred             HHHHHHhhcCCCCCCC----HhHHhcCccccCc
Q 046714          169 DFILKCLQVNPNDRPT----AAQLMEHPFVKRP  197 (201)
Q Consensus       169 ~li~~~l~~~p~~R~t----~~~il~~~~~~~~  197 (201)
                      +||+++|.+||++|..    ++||-+||||+..
T Consensus       366 DLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  366 DLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV  398 (459)
T ss_pred             HHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence            9999999999999998    9999999999864

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-42  Score=257.28  Aligned_cols=191  Identities=27%  Similarity=0.528  Sum_probs=164.6

Q ss_pred             cccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            2 FSFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      .+|++|+||||+++.++..+.  +..|+|+||++. +|..++...+  |++.+++-++.||+.||+|||.+|++|||||.
T Consensus       168 ~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~  246 (560)
T KOG0600|consen  168 KILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKG  246 (560)
T ss_pred             HHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccc
Confidence            378999999999999998876  789999999988 9999988764  99999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           78 ANILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      .|||||.+|..++.++.-.             .+-|.+|+|||++ .+...++.++|+||.||+|.||+.|+..|.+..+
T Consensus       247 SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELL-LG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE  325 (560)
T KOG0600|consen  247 SNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELL-LGATSYGTAVDLWSVGCILAELFLGKPILQGRTE  325 (560)
T ss_pred             cceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHh-cCCcccccceeehhhhHHHHHHHcCCCCcCCccH
Confidence            9999999998887775422             2347789999998 5677899999999999999999999999999888


Q ss_pred             HHHHHHhhcC------------CCCC----------------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          145 MQALFRIGRG------------KLPS----------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       145 ~~~~~~~~~~------------~~~~----------------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .+.+..+.+.            +++.                .-...++...+|+..+|+.||.+|.|+.++|+++||
T Consensus       326 veQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  326 VEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             HHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence            8877665321            1110                012467788899999999999999999999999999

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.7e-41  Score=254.91  Aligned_cols=191  Identities=27%  Similarity=0.457  Sum_probs=167.3

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEc
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD   83 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~   83 (201)
                      +++++||||+++++++.+++..++||||+.+++|...+....+++..+..++.||+.||+|||+.|++|+||||+||+++
T Consensus        56 ~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~  135 (324)
T cd05589          56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD  135 (324)
T ss_pred             ccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence            46789999999999999999999999999999999998887899999999999999999999999999999999999999


Q ss_pred             cCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 046714           84 ASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI  151 (201)
Q Consensus        84 ~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  151 (201)
                      .+|..++.+...            ...+++.|+|||.+  .+..++.++|+||||+++|+|++|+.||...........+
T Consensus       136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i  213 (324)
T cd05589         136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL--TETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI  213 (324)
T ss_pred             CCCcEEeCcccCCccCCCCCCcccccccCccccCHhHh--cCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            988777665431            23467889999998  4556788999999999999999999999887766666555


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                      .... ...+..+++.+.+++.+||+.+|.+||     ++.++++||||+..
T Consensus       214 ~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         214 VNDE-VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HhCC-CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            5443 356777899999999999999999999     79999999999763

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.5e-41  Score=256.15  Aligned_cols=192  Identities=28%  Similarity=0.451  Sum_probs=165.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++.+.+++..++||||+.+++|.+.+... .+++.++..++.||+.||+|||++|++|+||||+||+
T Consensus        48 ~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIl  127 (328)
T cd05593          48 VLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLM  127 (328)
T ss_pred             HHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeE
Confidence            467889999999999999999999999999999998888654 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...+++.|+|||.+  .+..++.++|+||+|+++|++++|+.||..........
T Consensus       128 l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  205 (328)
T cd05593         128 LDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE  205 (328)
T ss_pred             ECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhh--cCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH
Confidence            99988777765431            22467889999998  45567899999999999999999999998766655555


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                      .+... ...++..+++++.+++.+||+.+|.+|+     +++++++||||...
T Consensus       206 ~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         206 LILME-DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             HhccC-CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            44433 3356778999999999999999999997     89999999999753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.9e-41  Score=255.41  Aligned_cols=192  Identities=31%  Similarity=0.510  Sum_probs=166.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++.+..++..+++|||+.+++|.+++.+.+ +++..+..++.|++.||+|||++|++|+||||+||+
T Consensus        53 il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil  132 (323)
T cd05584          53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENIL  132 (323)
T ss_pred             HHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence            5788999999999999999999999999999999999887654 788899999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...+++.|+|||.+  .+...+.++||||+|+++|+|++|+.||..........
T Consensus       133 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~  210 (323)
T cd05584         133 LDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL--MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID  210 (323)
T ss_pred             ECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhc--cCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            99988777665431            12467889999998  34557889999999999999999999998877666666


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                      .+..+. ..++..+++.+.+++.+||+.+|++||     +++++++||||+..
T Consensus       211 ~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         211 KILKGK-LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHHcCC-CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            665543 356777899999999999999999999     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9.4e-41  Score=253.01  Aligned_cols=195  Identities=29%  Similarity=0.493  Sum_probs=155.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +++.++||||+++++++..++..++|+||+.+++|.+++..   .++++..+..++.|++.||+|||++|++|+||||+|
T Consensus        52 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~N  131 (327)
T cd08227          52 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASH  131 (327)
T ss_pred             HHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhh
Confidence            46678999999999999999999999999999999999864   348899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCc-------------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Q 046714           80 ILVDASGLATTTNDV-------------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS  140 (201)
Q Consensus        80 ill~~~g~~~~~~~~-------------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  140 (201)
                      |+++.++.....+..                   ....++..|+|||.+......++.++|+||+||++|++++|+.||.
T Consensus       132 il~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  211 (327)
T cd08227         132 ILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK  211 (327)
T ss_pred             EEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            999987755443311                   0112345699999984333567899999999999999999999997


Q ss_pred             CchHHHHHHHhhcCCCC---------------------------------------------CCCCCCCHHHHHHHHHHh
Q 046714          141 HLEDMQALFRIGRGKLP---------------------------------------------SVPNSLSRDARDFILKCL  175 (201)
Q Consensus       141 ~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~li~~~l  175 (201)
                      .............+..+                                             .....+++.+.+++.+||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  291 (327)
T cd08227         212 DMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCL  291 (327)
T ss_pred             CcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHH
Confidence            65443332222211111                                             011234678999999999


Q ss_pred             hcCCCCCCCHhHHhcCccccCc
Q 046714          176 QVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       176 ~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      +.+|++|||++++++||||++.
T Consensus       292 ~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         292 QRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhCchhcCCHHHHhcChhhhhc
Confidence            9999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7e-41  Score=264.83  Aligned_cols=192  Identities=28%  Similarity=0.484  Sum_probs=168.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      .|+.++||||+++++.+..++..++||||+++++|.+++..     .++++..+..++.|++.||+|||+.||+||||||
T Consensus       118 ~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp  197 (478)
T PTZ00267        118 CLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKS  197 (478)
T ss_pred             HHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCH
Confidence            46789999999999999999999999999999999987753     2488999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCc--------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           78 ANILVDASGLATTTNDV--------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~--------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      +||+++.+|.+++.+..              ....|++.|+|||.+  .+..++.++||||+||++|+|++|+.||....
T Consensus       198 ~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~  275 (478)
T PTZ00267        198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELW--ERKRYSKKADMWSLGVILYELLTLHRPFKGPS  275 (478)
T ss_pred             HhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHh--CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999998877665532              122378889999998  45567899999999999999999999998877


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          144 DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      .......+..+.....+..++..+.+++.+||..+|++|||+++++.++|++.
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        276 QREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            77777777666666677788999999999999999999999999999999753

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.9e-41  Score=252.38  Aligned_cols=187  Identities=28%  Similarity=0.487  Sum_probs=163.2

Q ss_pred             CCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccC
Q 046714            7 FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS   85 (201)
Q Consensus         7 l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~   85 (201)
                      .+||||+++++.+.+.+..++||||+.+++|.+++.+. .+++..+..++.|++.||+|||+.|++|+||||+||+++.+
T Consensus        53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~  132 (320)
T cd05590          53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE  132 (320)
T ss_pred             cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC
Confidence            37999999999999999999999999999999988654 58999999999999999999999999999999999999998


Q ss_pred             CceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhc
Q 046714           86 GLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR  153 (201)
Q Consensus        86 g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  153 (201)
                      |.+++.+...            ...|++.|+|||.+  .+..++.++|+||+|+++|+|++|+.||...........+..
T Consensus       133 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~  210 (320)
T cd05590         133 GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL--QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN  210 (320)
T ss_pred             CcEEEeeCCCCeecCcCCCcccccccCccccCHHHH--cCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc
Confidence            8777665431            23367889999998  455678899999999999999999999988777666666654


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH------hHHhcCccccC
Q 046714          154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPTA------AQLMEHPFVKR  196 (201)
Q Consensus       154 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~------~~il~~~~~~~  196 (201)
                      .. ...+..++.++.+++.+||+.+|.+|+++      +++++||||+.
T Consensus       211 ~~-~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         211 DE-VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             CC-CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence            43 35566789999999999999999999998      89999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.2e-40  Score=251.18  Aligned_cols=189  Identities=25%  Similarity=0.481  Sum_probs=162.9

Q ss_pred             cCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEcc
Q 046714            6 QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA   84 (201)
Q Consensus         6 ~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~   84 (201)
                      .++||||+++++.+.+++..++||||+.+++|.+++... .+++..+..++.|++.||+|||+.|++|+||||+||+++.
T Consensus        52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~  131 (316)
T cd05620          52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR  131 (316)
T ss_pred             ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC
Confidence            458999999999999999999999999999999888764 5899999999999999999999999999999999999999


Q ss_pred             CCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           85 SGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        85 ~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      +|.+++.+...            ...++..|+|||.+  .+..++.++|+||+|+++|+|++|+.||...........+.
T Consensus       132 ~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~  209 (316)
T cd05620         132 DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL--QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR  209 (316)
T ss_pred             CCCEEeCccCCCeecccCCCceeccCCCcCccCHHHH--cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            88776665431            23468889999998  45567899999999999999999999998776655555444


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH-hHHhcCccccCc
Q 046714          153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA-AQLMEHPFVKRP  197 (201)
Q Consensus       153 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~-~~il~~~~~~~~  197 (201)
                      . ..+.++..++.++++++.+||+.+|++|+++ +++++||||+..
T Consensus       210 ~-~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         210 V-DTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             h-CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence            3 3356677789999999999999999999998 588999999774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.8e-40  Score=247.42  Aligned_cols=190  Identities=24%  Similarity=0.402  Sum_probs=154.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..++++||+.+ +|.+++...+  ++...+..++.||+.||+|||++|++|+||||+||
T Consensus        56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Ni  134 (288)
T cd07871          56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNL  134 (288)
T ss_pred             HHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence            56789999999999999999999999999986 8988876533  78899999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|..++.+...            ...+++.|+|||.+. ....++.++|+||+|+++|++++|+.||......+..
T Consensus       135 l~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~  213 (288)
T cd07871         135 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL-GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL  213 (288)
T ss_pred             EECCCCCEEECcCcceeeccCCCccccCceecccccChHHhc-CCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999888777665431            223567899999873 3456788999999999999999999999776544433


Q ss_pred             HHhhcCC---------------------CC--------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          149 FRIGRGK---------------------LP--------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       149 ~~~~~~~---------------------~~--------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ..+....                     .+        .....++++..+++.+||+.+|.+|||++|+++||||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         214 HLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             HHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            3221100                     00        0112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=252.45  Aligned_cols=196  Identities=30%  Similarity=0.497  Sum_probs=167.5

Q ss_pred             cccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            2 FSFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      .+|+++.|||||+++++..+.  +..|||+|||..|.+...-.... +++.++++++++++.||+|||.+||+||||||+
T Consensus       160 ailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPs  239 (576)
T KOG0585|consen  160 AILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPS  239 (576)
T ss_pred             HHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchh
Confidence            378999999999999998875  57999999999988866554445 899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCccc-----------------cccCcccccccccccC--CCCCcchhhHHHHHHHHHHHHhCCCCC
Q 046714           79 NILVDASGLATTTNDVKS-----------------FEGTPFWVAPEVVNLK--NNGYGLSADIWSLGCTVLEMLTHQPPY  139 (201)
Q Consensus        79 nill~~~g~~~~~~~~~~-----------------~~~~~~~~aPE~~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~  139 (201)
                      |+|++.+|.+++.++...                 ..||+.|+|||.....  ....+.+.||||+|++||.++.|+.||
T Consensus       240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            999999999888775432                 2489999999998331  233567899999999999999999999


Q ss_pred             CCchHHHHHHHhhcCCCCCCCC--CCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          140 SHLEDMQALFRIGRGKLPSVPN--SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .+....+...++....+ .++.  .+.+.+++||.+||++||++|.++.++..|||.....
T Consensus       320 ~~~~~~~l~~KIvn~pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  320 FDDFELELFDKIVNDPL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             ccchHHHHHHHHhcCcc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            98888888888776554 3333  3689999999999999999999999999999987764

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.3e-41  Score=253.44  Aligned_cols=191  Identities=30%  Similarity=0.551  Sum_probs=159.6

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +.++ +||||+++++++.+.+..++||||+++++|.+++.+ ..+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus        49 l~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil  128 (329)
T cd05588          49 FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVL  128 (329)
T ss_pred             HHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE
Confidence            3445 799999999999999999999999999999988765 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc-------
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL-------  142 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-------  142 (201)
                      ++.+|.+++.+...            ...|+..|+|||.+  .+..++.++|+||+|+++|++++|+.||...       
T Consensus       129 i~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~  206 (329)
T cd05588         129 LDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL--RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD  206 (329)
T ss_pred             ECCCCCEEECcCccccccccCCCccccccCCccccCHHHH--cCCCCCCccceechHHHHHHHHHCCCCccccccccccc
Confidence            99888777665421            23467889999998  4556788999999999999999999999531       


Q ss_pred             -hHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC------HhHHhcCccccC
Q 046714          143 -EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT------AAQLMEHPFVKR  196 (201)
Q Consensus       143 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t------~~~il~~~~~~~  196 (201)
                       .......+........++..++..+.+++.+||+.+|.+|+|      ++++++||||+.
T Consensus       207 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         207 QNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             ccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence             112222333333444667788999999999999999999987      789999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-40  Score=252.27  Aligned_cols=191  Identities=27%  Similarity=0.429  Sum_probs=164.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      .++.++||||+++++.+.+.+..++||||+.+++|.+++... .+++..+..++.||+.||+|||++|++|+||||+||+
T Consensus        49 ~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIl  128 (323)
T cd05575          49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENIL  128 (323)
T ss_pred             HHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeE
Confidence            357799999999999999999999999999999999988754 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|..++.+...            ...+++.|+|||.+  .+..++.++|+||||+++|+|++|+.||......+...
T Consensus       129 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~  206 (323)
T cd05575         129 LDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL--RKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD  206 (323)
T ss_pred             ECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhh--cCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence            99988777665431            12367889999998  45567889999999999999999999998877666665


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH----hHHhcCccccC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA----AQLMEHPFVKR  196 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~----~~il~~~~~~~  196 (201)
                      .+.... ...+..+++.+.+++.+||+.+|.+||++    .++++||||..
T Consensus       207 ~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         207 NILNKP-LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             HHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence            555443 34556689999999999999999999987    69999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-40  Score=247.45  Aligned_cols=194  Identities=25%  Similarity=0.393  Sum_probs=162.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++|+||+++++.+.+++..++++||+.+++|.+++..   ..+++..+..++.|++.||+|||+.|++|+||||+|
T Consensus        53 il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~N  132 (285)
T cd05631          53 ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPEN  132 (285)
T ss_pred             HHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHH
Confidence            56789999999999999999999999999999999887753   248899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---
Q 046714           80 ILVDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM---  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---  145 (201)
                      |+++.++..++.+..           ....++..|+|||.+  .+..++.++||||+|+++|++++|+.||......   
T Consensus       133 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~  210 (285)
T cd05631         133 ILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI--NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR  210 (285)
T ss_pred             EEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhh--cCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH
Confidence            999988777665532           123467889999998  4556789999999999999999999999765332   


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccCcC
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKRPL  198 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~~~  198 (201)
                      .............++..+++.+.+|+++||+.+|.+||+     ++++++||||+...
T Consensus       211 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         211 EEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            222222233344566778999999999999999999997     89999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=252.49  Aligned_cols=193  Identities=29%  Similarity=0.477  Sum_probs=163.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.+++... .+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        54 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil  133 (333)
T cd05600          54 ILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFL  133 (333)
T ss_pred             HHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence            467889999999999999999999999999999999998764 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           82 VDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        82 l~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      ++.+|.+++.+...         ...+++.|+|||.+  .+..++.++||||+||++|+|++|+.||......+....+.
T Consensus       134 ~~~~~~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~  211 (333)
T cd05600         134 IDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVL--RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK  211 (333)
T ss_pred             ECCCCCEEEEeCcCCcccccccCCcccCccccChhHh--cCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH
Confidence            99998887766432         23478889999998  34578899999999999999999999998776655544433


Q ss_pred             cCC----CCCCC---CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          153 RGK----LPSVP---NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       153 ~~~----~~~~~---~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...    .+...   ..+++++.+++.+||..+|.+|||++++++||||+..
T Consensus       212 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         212 YWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             hccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            211    11111   2468999999999999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2e-40  Score=250.33  Aligned_cols=191  Identities=28%  Similarity=0.500  Sum_probs=164.8

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +..+ +||||+++++++.+.+..++||||+.+++|.+.+.+. .+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus        49 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil  128 (318)
T cd05570          49 LALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVL  128 (318)
T ss_pred             HHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeE
Confidence            3334 7999999999999999999999999999999988765 5999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...++..|+|||.+  .+..++.++|+||+|+++|++++|+.||..........
T Consensus       129 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~  206 (318)
T cd05570         129 LDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEIL--SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ  206 (318)
T ss_pred             ECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHh--cCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH
Confidence            99988777665431            12367889999998  45667899999999999999999999998776666555


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH-----hHHhcCccccCc
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA-----AQLMEHPFVKRP  197 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~-----~~il~~~~~~~~  197 (201)
                      .+... ....+..+++.+.+++.+||..+|.+|||+     .++++||||+..
T Consensus       207 ~i~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         207 SILED-EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             HHHcC-CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            55443 345677789999999999999999999999     999999999763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.1e-41  Score=254.27  Aligned_cols=192  Identities=27%  Similarity=0.452  Sum_probs=165.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++.+...+..++||||+.+++|.+++... .+++..+..++.||+.||+|||+ .|++|+||||+||
T Consensus        48 ~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NI  127 (325)
T cd05594          48 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL  127 (325)
T ss_pred             HHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeE
Confidence            467889999999999999999999999999999999888654 58999999999999999999997 7999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|.+++.+...            ...+++.|+|||.+  .+..++.++|+||+|+++|+|++|+.||.........
T Consensus       128 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~  205 (325)
T cd05594         128 MLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF  205 (325)
T ss_pred             EECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHH--ccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH
Confidence            999988777766431            22377889999998  4556789999999999999999999999877665555


Q ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                      ..+... ...++..+++++.+++.+||+.+|++|+     ++.++++||||...
T Consensus       206 ~~i~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         206 ELILME-EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             HHHhcC-CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            544433 3456778899999999999999999997     99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.9e-40  Score=251.29  Aligned_cols=192  Identities=29%  Similarity=0.496  Sum_probs=164.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|..-++|.||++|..|++...+||||||++||++..++.+.+ ++++.+..++.+.+.||+.+|+.|++||||||+|+|
T Consensus       194 iL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlL  273 (550)
T KOG0605|consen  194 ILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLL  273 (550)
T ss_pred             HhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhhee
Confidence            4666789999999999999999999999999999999987655 999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc-----------------------------------------------------------cccccCcc
Q 046714           82 VDASGLATTTNDV-----------------------------------------------------------KSFEGTPF  102 (201)
Q Consensus        82 l~~~g~~~~~~~~-----------------------------------------------------------~~~~~~~~  102 (201)
                      ||..|..++.+++                                                           -..+|||.
T Consensus       274 iD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPD  353 (550)
T KOG0605|consen  274 IDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPD  353 (550)
T ss_pred             ecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCcc
Confidence            9987644433210                                                           01238899


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCC
Q 046714          103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP---SVPNSLSRDARDFILKCLQVNP  179 (201)
Q Consensus       103 ~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p  179 (201)
                      |+|||++  .+.+++..+|.|||||++|||+.|.+||......+.+.++......   .-...+++++++||.+|++ ||
T Consensus       354 YiAPEVl--l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~  430 (550)
T KOG0605|consen  354 YIAPEVL--LGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DP  430 (550)
T ss_pred             ccchHHH--hcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CH
Confidence            9999998  5667899999999999999999999999999998888887654421   2233467999999999999 99


Q ss_pred             CCCC---CHhHHhcCccccCc
Q 046714          180 NDRP---TAAQLMEHPFVKRP  197 (201)
Q Consensus       180 ~~R~---t~~~il~~~~~~~~  197 (201)
                      ++|.   .++||.+||||+..
T Consensus       431 ~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  431 ENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHhcCcccHHHHhcCCccccC
Confidence            9996   59999999999864

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.5e-40  Score=249.19  Aligned_cols=193  Identities=27%  Similarity=0.507  Sum_probs=158.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhc-CccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHER-NVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++..+++|||+.+++|.+++... .+++..+..++.|++.||.|||++ +++|+||||+||
T Consensus        56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Ni  135 (331)
T cd06649          56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI  135 (331)
T ss_pred             HHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhE
Confidence            578899999999999999999999999999999999998764 489999999999999999999986 699999999999


Q ss_pred             EEccCCceeeecCcc----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           81 LVDASGLATTTNDVK----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        81 ll~~~g~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +++.+|.+++.+...          ...++..|+|||.+  .+..++.++|+||+|+++|++++|+.||......+....
T Consensus       136 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~  213 (331)
T cd06649         136 LVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI  213 (331)
T ss_pred             EEcCCCcEEEccCcccccccccccccCCCCcCcCCHhHh--cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999988777665421          23467889999998  445678999999999999999999999975543332211


Q ss_pred             hh----------------------------------------------cCCCCCC-CCCCCHHHHHHHHHHhhcCCCCCC
Q 046714          151 IG----------------------------------------------RGKLPSV-PNSLSRDARDFILKCLQVNPNDRP  183 (201)
Q Consensus       151 ~~----------------------------------------------~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~  183 (201)
                      +.                                              ....+.. ...+++++.+|+.+||+.+|++||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rp  293 (331)
T cd06649         214 FGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERA  293 (331)
T ss_pred             hcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCC
Confidence            11                                              1111111 124678899999999999999999


Q ss_pred             CHhHHhcCccccCc
Q 046714          184 TAAQLMEHPFVKRP  197 (201)
Q Consensus       184 t~~~il~~~~~~~~  197 (201)
                      |++++++||||+..
T Consensus       294 t~~ell~h~~~~~~  307 (331)
T cd06649         294 DLKMLMNHTFIKRS  307 (331)
T ss_pred             CHHHHhcChHHhhc
Confidence            99999999999764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.6e-41  Score=256.55  Aligned_cols=192  Identities=28%  Similarity=0.506  Sum_probs=171.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++.+|+||||+.++++|++....++|+||+.| +|..++.. +.++++.+..++.+++.|+.|||+.+|+|+|+||.||+
T Consensus        54 i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniL  132 (808)
T KOG0597|consen   54 ILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNIL  132 (808)
T ss_pred             HHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceee
Confidence            57899999999999999999999999999988 99999876 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|..++.+++            ....||+.|+|||.+  .+..++..+|+||+||++||+++|++||....-.....
T Consensus       133 l~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv--~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~  210 (808)
T KOG0597|consen  133 LEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELV--EEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVK  210 (808)
T ss_pred             ecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHH--cCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHH
Confidence            9999888877643            223489999999998  57789999999999999999999999998776666666


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .+.... ...+...+..+.+|++.+|.+||.+|.|..+++.|||++...
T Consensus       211 ~I~~d~-v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  211 SILKDP-VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             HHhcCC-CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence            666554 355668999999999999999999999999999999988653

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.8e-40  Score=246.11  Aligned_cols=190  Identities=26%  Similarity=0.480  Sum_probs=153.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++..++..++||||+.++.+..+... ..+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil  132 (287)
T cd07848          53 MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLL  132 (287)
T ss_pred             HHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence            46789999999999999999999999999999776655443 35899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc-------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           82 VDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        82 l~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      ++.+|.+++.+...             ...+++.|+|||.+  .+..++.++|+||+|+++|++++|+.||......+..
T Consensus       133 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~  210 (287)
T cd07848         133 ISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL--LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQL  210 (287)
T ss_pred             EcCCCcEEEeeccCcccccccccccccccccccccCCcHHH--cCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99888776655321             12367789999998  3455788999999999999999999999876543332


Q ss_pred             HHhhcC--C-------------------CC----------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          149 FRIGRG--K-------------------LP----------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       149 ~~~~~~--~-------------------~~----------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ..+...  .                   .+          .....++..+.+++++||+.+|++|||++++++||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         211 FTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             HHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            221110  0                   00          0112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.8e-41  Score=254.27  Aligned_cols=191  Identities=29%  Similarity=0.461  Sum_probs=165.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++.+.+++..++||||+.+++|.+++.+. .+++..+..++.||+.||+|||+.|++|+||||+||+
T Consensus        51 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil  130 (318)
T cd05582          51 ILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENIL  130 (318)
T ss_pred             HHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeE
Confidence            578899999999999999999999999999999999988654 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|..++.+...            ...+++.|+|||.+  .+..++.++|+||||+++|+|++|+.||..........
T Consensus       131 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~  208 (318)
T cd05582         131 LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV--NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT  208 (318)
T ss_pred             ECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHH--cCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH
Confidence            99988777665421            22367789999998  34566889999999999999999999998877666665


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKR  196 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~  196 (201)
                      .+.... ..++..+++.+.+++.+||+.+|++|||     +++++.||||..
T Consensus       209 ~i~~~~-~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         209 MILKAK-LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             HHHcCC-CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence            555443 3566778999999999999999999999     788999999975

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.2e-40  Score=248.29  Aligned_cols=189  Identities=28%  Similarity=0.514  Sum_probs=162.5

Q ss_pred             cCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEcc
Q 046714            6 QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA   84 (201)
Q Consensus         6 ~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~   84 (201)
                      .++||||+++++++.+++..++||||+.+++|.+++... .+++.++..++.|++.||+|||++|++|+||||+||+++.
T Consensus        52 ~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~  131 (316)
T cd05619          52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT  131 (316)
T ss_pred             ccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC
Confidence            368999999999999999999999999999999998764 5899999999999999999999999999999999999999


Q ss_pred             CCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           85 SGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        85 ~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      +|.+++.+...            ...++..|+|||.+  .+..++.++|+||+||++|+|++|+.||......+....+.
T Consensus       132 ~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~  209 (316)
T cd05619         132 DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL--LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR  209 (316)
T ss_pred             CCCEEEccCCcceECCCCCCceeeecCCccccCHHHH--cCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            88776665431            12367889999998  45567899999999999999999999998776665555544


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHh-HHhcCccccCc
Q 046714          153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAA-QLMEHPFVKRP  197 (201)
Q Consensus       153 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~-~il~~~~~~~~  197 (201)
                      .. .+.++..++..+.+++.+||+.+|++|+++. ++++||||+..
T Consensus       210 ~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         210 MD-NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             hC-CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence            33 3455667899999999999999999999996 89999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.2e-40  Score=245.10  Aligned_cols=192  Identities=24%  Similarity=0.421  Sum_probs=159.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      ++++++||||+++.+.+..++..+++|||+++++|.+.+..     ..+++..+..++.||+.||+|||+.|++|+||||
T Consensus        46 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp  125 (280)
T cd05608          46 ILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKP  125 (280)
T ss_pred             HHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence            57889999999999999999999999999999999887732     3489999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           78 ANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      +||+++.+|..++.+...            ...+++.|+|||.+  .+..++.++|+||+|+++|++++|+.||......
T Consensus       126 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  203 (280)
T cd05608         126 ENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL--QGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK  203 (280)
T ss_pred             HHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHh--cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc
Confidence            999999887776655321            12467789999998  3456788999999999999999999999754321


Q ss_pred             ----HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          146 ----QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       146 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                          ....... ......+..+++.+.+++.+||+.+|++||     |++++++||||+..
T Consensus       204 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         204 VENKELKQRIL-NDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             hhHHHHHHhhc-ccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence                1222222 222345667899999999999999999999     88999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.8e-40  Score=232.28  Aligned_cols=192  Identities=29%  Similarity=0.512  Sum_probs=163.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .|+.++||||+.+.++|.+.+...+|+||++. +|..+++...  ++..++..++.++++|++|||++.|+||||||+|+
T Consensus        54 ~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNL  132 (318)
T KOG0659|consen   54 LLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNL  132 (318)
T ss_pred             HHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccce
Confidence            57889999999999999999999999999988 9999998654  89999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDVKSF------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|..++.++.-+.            +.|.+|+|||.+ .+...++..+|+||.||++.||+.|.+.|++..+.+..
T Consensus       133 Lis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELL-fGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL  211 (318)
T KOG0659|consen  133 LISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELL-FGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL  211 (318)
T ss_pred             EEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHh-ccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH
Confidence            99999988887753221            246679999998 56778899999999999999999999999888776666


Q ss_pred             HHhhcC-------CCCC--------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          149 FRIGRG-------KLPS--------------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       149 ~~~~~~-------~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ..+...       ..++                    +-...+.++-+|+.+|+.++|.+|+|+.|+++|+||+.
T Consensus       212 ~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  212 SKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             HHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence            554211       1111                    11235677889999999999999999999999999984

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.3e-40  Score=246.97  Aligned_cols=194  Identities=26%  Similarity=0.420  Sum_probs=153.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.++...++||||+.+ +|.+++..  ..+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus        56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Ni  134 (303)
T cd07869          56 LLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNL  134 (303)
T ss_pred             HHhhCCCCCcCeEEEEEecCCeEEEEEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            56789999999999999999999999999965 77777765  3489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-HH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-QA  147 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~  147 (201)
                      +++.+|..++.+...            ...+++.|+|||.+. ....++.++|+||+||++|+|++|+.||.+.... ..
T Consensus       135 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  213 (303)
T cd07869         135 LISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL-GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ  213 (303)
T ss_pred             EECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence            999888776655431            123567799999973 3445788999999999999999999999765332 11


Q ss_pred             HHHhhc---CC--------------CCC-----CC---------CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          148 LFRIGR---GK--------------LPS-----VP---------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       148 ~~~~~~---~~--------------~~~-----~~---------~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ...+..   ..              .++     .+         ...++.+.+++.+||+.+|++|||++|+++||||+.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~  293 (303)
T cd07869         214 LERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD  293 (303)
T ss_pred             HHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence            111100   00              000     00         123467889999999999999999999999999987


Q ss_pred             cC
Q 046714          197 PL  198 (201)
Q Consensus       197 ~~  198 (201)
                      ..
T Consensus       294 ~~  295 (303)
T cd07869         294 LP  295 (303)
T ss_pred             CC
Confidence            53

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.3e-40  Score=254.49  Aligned_cols=194  Identities=27%  Similarity=0.452  Sum_probs=165.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      +++.++||||+++++.+.+++..++||||+++++|.+++....+++..+..++.||+.||+|||+.||+|+||||+||++
T Consensus        96 il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl  175 (370)
T cd05596          96 IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL  175 (370)
T ss_pred             HHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            46788999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc-------------ccccCcccccccccccC--CCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           83 DASGLATTTNDVK-------------SFEGTPFWVAPEVVNLK--NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        83 ~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +.+|.+++.+...             ...|++.|+|||.+...  ...++.++|+||+||++|+|++|+.||........
T Consensus       176 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~  255 (370)
T cd05596         176 DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT  255 (370)
T ss_pred             cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH
Confidence            9988776665321             23478889999997432  23478899999999999999999999988776666


Q ss_pred             HHHhhcCCC-CCCCC--CCCHHHHHHHHHHhhcCCCC--CCCHhHHhcCccccC
Q 046714          148 LFRIGRGKL-PSVPN--SLSRDARDFILKCLQVNPND--RPTAAQLMEHPFVKR  196 (201)
Q Consensus       148 ~~~~~~~~~-~~~~~--~~~~~~~~li~~~l~~~p~~--R~t~~~il~~~~~~~  196 (201)
                      ...+..... ..++.  .++.++.+++.+||+.+|.+  |+|++++++||||+.
T Consensus       256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         256 YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            666544321 22333  57899999999999998987  999999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.9e-40  Score=249.75  Aligned_cols=187  Identities=28%  Similarity=0.478  Sum_probs=163.1

Q ss_pred             CCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccC
Q 046714            7 FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS   85 (201)
Q Consensus         7 l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~   85 (201)
                      .+||||+++++++.+++..++||||+.+++|.+.+... .+++..+..++.||+.||+|||+.|++|+||||+||+++.+
T Consensus        53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~  132 (321)
T cd05591          53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE  132 (321)
T ss_pred             cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC
Confidence            47999999999999999999999999999999888654 48999999999999999999999999999999999999998


Q ss_pred             CceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhc
Q 046714           86 GLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR  153 (201)
Q Consensus        86 g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  153 (201)
                      |.+++.+...            ...++..|+|||.+  .+..++.++|+||+|+++|+|++|+.||...........+..
T Consensus       133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~  210 (321)
T cd05591         133 GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL--QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH  210 (321)
T ss_pred             CCEEEeecccceecccCCccccccccCccccCHHHH--cCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            8777765431            22367889999998  455678899999999999999999999988877777666655


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-------CHhHHhcCccccC
Q 046714          154 GKLPSVPNSLSRDARDFILKCLQVNPNDRP-------TAAQLMEHPFVKR  196 (201)
Q Consensus       154 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-------t~~~il~~~~~~~  196 (201)
                      .. ...+..+++++.+++.+||+.+|++|+       +++++++||||..
T Consensus       211 ~~-~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         211 DD-VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             CC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            43 345667899999999999999999999       9999999999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-40  Score=229.18  Aligned_cols=191  Identities=30%  Similarity=0.534  Sum_probs=169.6

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      =+.|+||||+++|++|.++...|+++||..+|.+...++.+   .+++.....++.|++.|+.|+|.++++||||||+|+
T Consensus        76 qs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenl  155 (281)
T KOG0580|consen   76 QSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENL  155 (281)
T ss_pred             ecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHh
Confidence            36789999999999999999999999999999999988843   389999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           81 LVDASGLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        81 ll~~~g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      |++..|..+..++.          .+.+||..|.+||.+  .+...+..+|+|++|++.|+++.|..||......+.+.+
T Consensus       156 Llg~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv--~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr  233 (281)
T KOG0580|consen  156 LLGSAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMV--EGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR  233 (281)
T ss_pred             ccCCCCCeeccCCCceeecCCCCceeeecccccCCHhhc--CCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH
Confidence            99988776666543          345588899999998  566778899999999999999999999998887777766


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      +.+-+. .+|..++..+.++|.+|+..+|.+|.+..|++.|||...+
T Consensus       234 I~k~~~-~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  234 IRKVDL-KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHccc-cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            665544 6678899999999999999999999999999999998765

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.9e-40  Score=252.29  Aligned_cols=193  Identities=25%  Similarity=0.419  Sum_probs=159.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++.+.+++..++||||+++++|.+++.+ ..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus        54 il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NIL  133 (363)
T cd05628          54 ILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLL  133 (363)
T ss_pred             HHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeE
Confidence            46788999999999999999999999999999999998865 45899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc-----------------------------------------------ccccCcccccccccccCCC
Q 046714           82 VDASGLATTTNDVK-----------------------------------------------SFEGTPFWVAPEVVNLKNN  114 (201)
Q Consensus        82 l~~~g~~~~~~~~~-----------------------------------------------~~~~~~~~~aPE~~~~~~~  114 (201)
                      ++.+|.+++.+...                                               ...||+.|+|||.+  .+.
T Consensus       134 i~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~--~~~  211 (363)
T cd05628         134 LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF--MQT  211 (363)
T ss_pred             ECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHH--cCC
Confidence            99888776655321                                               23578899999998  455


Q ss_pred             CCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCC-CCCCC--CCCCHHHHHHHHHHhhc--CCCCCCCHhHHh
Q 046714          115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK-LPSVP--NSLSRDARDFILKCLQV--NPNDRPTAAQLM  189 (201)
Q Consensus       115 ~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~--~p~~R~t~~~il  189 (201)
                      .++.++|+||+||++|+|++|+.||......+....+.... ...++  ..+++++++++.++++.  ++..||++++++
T Consensus       212 ~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~  291 (363)
T cd05628         212 GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIK  291 (363)
T ss_pred             CCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHh
Confidence            67889999999999999999999998877666666554422 11222  24688999999987652  233568999999


Q ss_pred             cCccccCc
Q 046714          190 EHPFVKRP  197 (201)
Q Consensus       190 ~~~~~~~~  197 (201)
                      +||||+..
T Consensus       292 ~hp~f~~~  299 (363)
T cd05628         292 TNPFFEGV  299 (363)
T ss_pred             CCCCCCCC
Confidence            99999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.2e-40  Score=240.90  Aligned_cols=190  Identities=46%  Similarity=0.854  Sum_probs=164.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..++++||+++++|.+++... .++...+..++.|++.||++||+.|++|+||+|+||+
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil  138 (267)
T cd06628          59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL  138 (267)
T ss_pred             HHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEE
Confidence            477899999999999999999999999999999999999764 4889999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           82 VDASGLATTTNDVK------------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      ++.++..++.+...                  ...++..|+|||.+  .+..++.++|+||+|+++|++++|+.||....
T Consensus       139 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  216 (267)
T cd06628         139 VDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV--KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT  216 (267)
T ss_pred             EcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHh--ccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence            99887666554321                  12356679999997  34567889999999999999999999998876


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          144 DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .............+..+..++..+.+++++||+.+|.+||++.++++||||
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         217 QLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            666666655565667778889999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=239.03  Aligned_cols=190  Identities=43%  Similarity=0.811  Sum_probs=161.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.++...++++||+++++|.+++... .++...+..++.|++.|+.+||+.|++|+||+|+||+
T Consensus        57 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil  136 (263)
T cd06625          57 LLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL  136 (263)
T ss_pred             HHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            477899999999999999999999999999999999988754 4889999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           82 VDASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        82 l~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ++.++..++.+...               ...++..|+|||.+  .+...+.++|+||+|+++|++++|+.||.......
T Consensus       137 v~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  214 (263)
T cd06625         137 RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI--SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA  214 (263)
T ss_pred             EcCCCCEEEeecccceeccccccccccccCCCcCccccCccee--ccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH
Confidence            99887766554321               12345679999998  34557899999999999999999999997765544


Q ss_pred             HHHHh-hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          147 ALFRI-GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       147 ~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ..... ........+..++..+.+++.+||..+|.+|||+.++++||||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         215 AIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            44333 2333445677889999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.3e-40  Score=250.37  Aligned_cols=195  Identities=25%  Similarity=0.395  Sum_probs=153.6

Q ss_pred             ccccCCCcceeccceeeeeC-----CeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE-----NRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      ++++++||||+++++++...     ...+++|||+. ++|.+++... .+++..+..++.||+.||.|||++|++|+|||
T Consensus        52 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk  130 (338)
T cd07859          52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLK  130 (338)
T ss_pred             HHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            46789999999999987643     35799999996 4898888654 48999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Q 046714           77 CANILVDASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH  141 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  141 (201)
                      |+||+++.+|.+++.+...               ...++..|+|||.+......++.++||||+||++|++++|+.||..
T Consensus       131 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~  210 (338)
T cd07859         131 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG  210 (338)
T ss_pred             HHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999988776655321               1246778999999743335678899999999999999999999976


Q ss_pred             chHHHHHHHh---------------------------hcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          142 LEDMQALFRI---------------------------GRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       142 ~~~~~~~~~~---------------------------~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .........+                           ......   ......++.+.+++.+||+.+|++|||++++++|
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         211 KNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            5432221110                           000000   0112467889999999999999999999999999


Q ss_pred             ccccCcC
Q 046714          192 PFVKRPL  198 (201)
Q Consensus       192 ~~~~~~~  198 (201)
                      |||+...
T Consensus       291 p~f~~~~  297 (338)
T cd07859         291 PYFKGLA  297 (338)
T ss_pred             chhhhcC
Confidence            9997643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=241.18  Aligned_cols=196  Identities=38%  Similarity=0.698  Sum_probs=169.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++||||+++++.+.++...++++||+.+++|.+++....+++..+..++.|++.|+.+||+.+++|+||+|+||++
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i  131 (274)
T cd06609          52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL  131 (274)
T ss_pred             HHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence            46788999999999999999999999999999999999988789999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|...+.+..            ....++..|+|||.+  .+..++.++|+||+|+++|++++|+.||...........
T Consensus       132 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~  209 (274)
T cd06609         132 SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI--KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL  209 (274)
T ss_pred             CCCCCEEEcccccceeecccccccccccCCccccChhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence            998876655432            123356679999998  344588999999999999999999999987766666655


Q ss_pred             hhcCCCCCCCCC-CCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCCC
Q 046714          151 IGRGKLPSVPNS-LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQT  200 (201)
Q Consensus       151 ~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~~  200 (201)
                      +.....+..+.. +++.+.+++.+||..+|++|||++++++||||+...+.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         210 IPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             hhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            555555555555 88999999999999999999999999999999887654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-40  Score=248.83  Aligned_cols=194  Identities=34%  Similarity=0.563  Sum_probs=169.4

Q ss_pred             ccccCC-CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFE-HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|+++. ||||+.+++.+++...+++|||++.||.|.+.+.+..+++..+..++.|++.+++|||+.|++|+|+||+|++
T Consensus        88 il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L  167 (382)
T KOG0032|consen   88 ILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLL  167 (382)
T ss_pred             HHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHee
Confidence            678888 9999999999999999999999999999999887656999999999999999999999999999999999999


Q ss_pred             EccCC----ceeeecC-----------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           82 VDASG----LATTTND-----------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        82 l~~~g----~~~~~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      +....    ..+..++           ....+||+.|+|||.+  ....++..+|+||+|+++|.|++|..||.......
T Consensus       168 ~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl--~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~  245 (382)
T KOG0032|consen  168 LASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVL--GGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE  245 (382)
T ss_pred             eccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhh--cCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH
Confidence            96541    2333332           2345689999999998  45788999999999999999999999999888777


Q ss_pred             HHHHhhcCCC---CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          147 ALFRIGRGKL---PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       147 ~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ....+..+..   .+.+..++..+++++++|+..+|.+|+|+.++|+|||++.+.
T Consensus       246 ~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  246 IFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             HHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence            7777776644   345677899999999999999999999999999999998763

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.9e-40  Score=247.13  Aligned_cols=189  Identities=27%  Similarity=0.516  Sum_probs=162.7

Q ss_pred             cCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEcc
Q 046714            6 QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA   84 (201)
Q Consensus         6 ~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~   84 (201)
                      ..+||||+++++++..++..++||||+.+++|.+++... .+++..+..++.|++.||+|||+.|++|+||||+||+++.
T Consensus        52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~  131 (316)
T cd05592          52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK  131 (316)
T ss_pred             ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC
Confidence            458999999999999999999999999999999988654 4899999999999999999999999999999999999999


Q ss_pred             CCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           85 SGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        85 ~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      +|.+++.+...            ...|++.|+|||.+  .+..++.++|+||+||++|+|++|+.||......+....+.
T Consensus       132 ~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~  209 (316)
T cd05592         132 DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL--KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL  209 (316)
T ss_pred             CCCEEEccCcCCeECCCCCCccccccCCccccCHHHH--cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            88777665431            23468889999998  45567899999999999999999999998877666555544


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHh-HHhcCccccCc
Q 046714          153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAA-QLMEHPFVKRP  197 (201)
Q Consensus       153 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~-~il~~~~~~~~  197 (201)
                      . ..+.++..++.++.+++.+||..+|++||++. ++++||||+..
T Consensus       210 ~-~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         210 N-DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             c-CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence            3 34567778899999999999999999999875 78899999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.3e-40  Score=250.53  Aligned_cols=194  Identities=29%  Similarity=0.443  Sum_probs=160.3

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +++++ +||||+++++.+..++..+++|||+.+++|.+++.+. .+++..+..++.||+.||+|||++|++|+||||+||
T Consensus        57 ~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Ni  136 (332)
T cd05614          57 VLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENI  136 (332)
T ss_pred             HHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHe
Confidence            35566 5999999999999999999999999999999988654 589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch---H
Q 046714           81 LVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE---D  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---~  144 (201)
                      +++.+|.+++.+...             ...|+..|+|||.+. .....+.++||||||+++|+|++|+.||....   .
T Consensus       137 li~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  215 (332)
T cd05614         137 LLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR-GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT  215 (332)
T ss_pred             EECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhc-CCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC
Confidence            999988777665421             234678899999983 33446789999999999999999999996422   1


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                      ............+.++..+++.+.+++.+||+.+|++||     +++++++||||+..
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         216 QSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            222222222334566778899999999999999999999     88899999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-39  Score=242.46  Aligned_cols=188  Identities=19%  Similarity=0.241  Sum_probs=158.8

Q ss_pred             ccccCCCcceeccceeeee----CCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhc-CccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD----ENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHER-NVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~   76 (201)
                      +|++++||||+++++++.+    ....+++|||+++|+|.+++.+. .++......++.|++.|+.+||+. +++|+|||
T Consensus        71 ~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlk  150 (283)
T PHA02988         71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT  150 (283)
T ss_pred             HHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCC
Confidence            5789999999999999877    35689999999999999998764 488999999999999999999985 99999999


Q ss_pred             CCcEEEccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           77 CANILVDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+||+++.+|.+++.+...         ...++..|+|||.+......++.++||||||+++|++++|+.||......+.
T Consensus       151 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~  230 (283)
T PHA02988        151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI  230 (283)
T ss_pred             hhhEEECCCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            9999999998877765432         2346778999999843335788999999999999999999999988776666


Q ss_pred             HHHhh-cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          148 LFRIG-RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       148 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ...+. .......+..+++.+.+++.+||+.+|++|||++++++
T Consensus       231 ~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        231 YDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            55543 33344556578999999999999999999999999976

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.2e-39  Score=237.38  Aligned_cols=190  Identities=28%  Similarity=0.530  Sum_probs=166.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++.+.+++..++++||+.+++|.+++...   .++...+..++.|++.|+.|||+.|++|+||+|+|
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~n  131 (256)
T cd08529          52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLN  131 (256)
T ss_pred             HHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcce
Confidence            467899999999999999999999999999999999998763   48899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           80 ILVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        80 ill~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+++.++..++.+..            ....++..|+|||.+  .+..++.++|+||||++++++++|+.||........
T Consensus       132 ili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  209 (256)
T cd08529         132 LFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC--EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL  209 (256)
T ss_pred             EEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHh--cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999988766665432            112356779999997  345578899999999999999999999988877777


Q ss_pred             HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          148 LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ...+..+..+..+..++..+.+++.+||+.+|++||++.++++|||+
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         210 ILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            77777776667777889999999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.3e-40  Score=249.02  Aligned_cols=189  Identities=31%  Similarity=0.546  Sum_probs=158.4

Q ss_pred             CCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccC
Q 046714            7 FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS   85 (201)
Q Consensus         7 l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~   85 (201)
                      .+||||+++++++.+++..++||||+.+++|..++.. ..+++..+..++.|++.||+|||++|++|+||||+||+++.+
T Consensus        53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~  132 (329)
T cd05618          53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE  132 (329)
T ss_pred             CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC
Confidence            4899999999999999999999999999999888765 459999999999999999999999999999999999999998


Q ss_pred             CceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc--------hHH
Q 046714           86 GLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL--------EDM  145 (201)
Q Consensus        86 g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~--------~~~  145 (201)
                      |.+++.+...            ...++..|+|||.+  .+..++.++|+||+|+++|+|++|+.||...        ...
T Consensus       133 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~  210 (329)
T cd05618         133 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL--RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE  210 (329)
T ss_pred             CCEEEeeCCccccccCCCCccccccCCccccCHHHH--cCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccH
Confidence            8777765431            23467889999998  4556788999999999999999999999521        111


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC------HhHHhcCccccCc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT------AAQLMEHPFVKRP  197 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t------~~~il~~~~~~~~  197 (201)
                      .............++..++..+.+++.+||+.+|.+|+|      ++++++||||+..
T Consensus       211 ~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         211 DYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            222233333444677888999999999999999999998      5899999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-40  Score=253.27  Aligned_cols=192  Identities=28%  Similarity=0.446  Sum_probs=161.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++.+.+++..++||||+.+++|.+++... .+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl  133 (364)
T cd05599          54 ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLL  133 (364)
T ss_pred             HHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeE
Confidence            467889999999999999999999999999999999988764 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc--------------------------------------------------ccccCccccccccccc
Q 046714           82 VDASGLATTTNDVK--------------------------------------------------SFEGTPFWVAPEVVNL  111 (201)
Q Consensus        82 l~~~g~~~~~~~~~--------------------------------------------------~~~~~~~~~aPE~~~~  111 (201)
                      ++.+|.+++.+...                                                  ...||+.|+|||.+  
T Consensus       134 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--  211 (364)
T cd05599         134 LDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF--  211 (364)
T ss_pred             ECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHH--
Confidence            99888766654321                                                  12478899999997  


Q ss_pred             CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCC-CCCC--CCCCHHHHHHHHHHhhcCCCCCCC---H
Q 046714          112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL-PSVP--NSLSRDARDFILKCLQVNPNDRPT---A  185 (201)
Q Consensus       112 ~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~~l~~~p~~R~t---~  185 (201)
                      ....++.++|+||+||++|+|++|..||...........+..... ...+  ..+++.+.+++.+|+. +|.+|++   +
T Consensus       212 ~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~  290 (364)
T cd05599         212 LQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGV  290 (364)
T ss_pred             cCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence            455678999999999999999999999988776665555443221 1222  2468999999999997 8999997   9


Q ss_pred             hHHhcCccccCc
Q 046714          186 AQLMEHPFVKRP  197 (201)
Q Consensus       186 ~~il~~~~~~~~  197 (201)
                      +++++||||+..
T Consensus       291 ~~ll~h~~~~~~  302 (364)
T cd05599         291 NEIKSHPFFKGV  302 (364)
T ss_pred             HHHhcCCCcCCC
Confidence            999999999753

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.3e-40  Score=252.80  Aligned_cols=193  Identities=25%  Similarity=0.421  Sum_probs=158.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++.+.+.+..++||||+++++|.+++.+. .+++..+..++.||+.||+|||+.||+|+||||+||+
T Consensus        54 il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nil  133 (381)
T cd05626          54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL  133 (381)
T ss_pred             HHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEE
Confidence            577899999999999999999999999999999999988764 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc-----------------------------------------------------------ccccCcc
Q 046714           82 VDASGLATTTNDVK-----------------------------------------------------------SFEGTPF  102 (201)
Q Consensus        82 l~~~g~~~~~~~~~-----------------------------------------------------------~~~~~~~  102 (201)
                      ++.+|.+++.+...                                                           ...||..
T Consensus       134 i~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  213 (381)
T cd05626         134 IDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPN  213 (381)
T ss_pred             ECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCcc
Confidence            99887666654321                                                           1357889


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcC-CCCCC--CCCCCHHHHHHHHHHhh--c
Q 046714          103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG-KLPSV--PNSLSRDARDFILKCLQ--V  177 (201)
Q Consensus       103 ~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~li~~~l~--~  177 (201)
                      |+|||.+  .+..++.++||||+||++|+|++|+.||...........+... .....  ...+++++.+++.+|++  .
T Consensus       214 Y~aPE~~--~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~  291 (381)
T cd05626         214 YIAPEVL--LRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAE  291 (381)
T ss_pred             ccCHHHH--cCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcc
Confidence            9999998  4556789999999999999999999999876655544444321 11222  23578999999999664  4


Q ss_pred             CCCCCCCHhHHhcCccccCc
Q 046714          178 NPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       178 ~p~~R~t~~~il~~~~~~~~  197 (201)
                      ++..|++++++++||||+..
T Consensus       292 ~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         292 ERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             cccCCCCHHHHhcCcccCCC
Confidence            55569999999999999763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-40  Score=250.02  Aligned_cols=191  Identities=31%  Similarity=0.608  Sum_probs=174.5

Q ss_pred             ccccCCCcceeccceeeeeCCe-EEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENR-LYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      +++++.||||+.+.+.+..++. .+|+|+||+||++.+.+.+..   ++++.+.+|+.|++.|+.|||+++|+|||||+.
T Consensus        56 lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~  135 (426)
T KOG0589|consen   56 LLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCA  135 (426)
T ss_pred             HHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhh
Confidence            5789999999999999999888 999999999999999986533   999999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           79 NILVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        79 nill~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ||++..++.++++++.            .+..||+.|++||++  .+.+++.++|+|||||++|+|++-+.+|...+-..
T Consensus       136 Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil--~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~  213 (426)
T KOG0589|consen  136 NIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEIL--SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE  213 (426)
T ss_pred             hhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHh--CCCCCCccCcchhhcchHHHHHhcccccCccchHH
Confidence            9999988777665532            345699999999998  67789999999999999999999999999988888


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      ...++.......++..++.+++.+|..|+..+|..||++.++|.+|...
T Consensus       214 Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  214 LILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             HHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence            8888888888889999999999999999999999999999999998765

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-40  Score=254.20  Aligned_cols=191  Identities=28%  Similarity=0.476  Sum_probs=158.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.+++... .+++..+..++.|++.||+|||+.||+|+||||+||+
T Consensus        54 il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIl  133 (377)
T cd05629          54 VLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNIL  133 (377)
T ss_pred             HHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE
Confidence            467899999999999999999999999999999999988754 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc-----------------------------------------------------------ccccCcc
Q 046714           82 VDASGLATTTNDVK-----------------------------------------------------------SFEGTPF  102 (201)
Q Consensus        82 l~~~g~~~~~~~~~-----------------------------------------------------------~~~~~~~  102 (201)
                      ++.+|.+++.+...                                                           ...|++.
T Consensus       134 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  213 (377)
T cd05629         134 IDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD  213 (377)
T ss_pred             ECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCcc
Confidence            99887766654321                                                           1247888


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcC-CCCCCCC--CCCHHHHHHHHHHhhcCC
Q 046714          103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG-KLPSVPN--SLSRDARDFILKCLQVNP  179 (201)
Q Consensus       103 ~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~~p  179 (201)
                      |+|||.+  .+..++.++|+||+||++|+|++|..||...........+... ....++.  .++.++.+++.+|++ +|
T Consensus       214 y~aPE~~--~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~  290 (377)
T cd05629         214 YIAPEIF--LQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NA  290 (377)
T ss_pred             ccCHHHH--ccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CH
Confidence            9999998  4556789999999999999999999999876665555544332 1122232  478899999999998 66


Q ss_pred             CCC---CCHhHHhcCccccC
Q 046714          180 NDR---PTAAQLMEHPFVKR  196 (201)
Q Consensus       180 ~~R---~t~~~il~~~~~~~  196 (201)
                      .+|   +|+.++++||||+.
T Consensus       291 ~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         291 ENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             hhcCCCCCHHHHhcCCCcCC
Confidence            665   69999999999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.6e-39  Score=241.02  Aligned_cols=193  Identities=22%  Similarity=0.361  Sum_probs=158.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++.+.++...+++|||+.+++|.+++...   +++...+..++.|++.||+|||+.|++|+||||+|
T Consensus        46 il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~N  125 (277)
T cd05607          46 ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPEN  125 (277)
T ss_pred             HHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHh
Confidence            578899999999999999999999999999999998887542   37888899999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH----
Q 046714           80 ILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED----  144 (201)
Q Consensus        80 ill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----  144 (201)
                      |+++.++..++.+...           ...++..|+|||.+  .+..++.++|+||+|+++|++++|+.||.....    
T Consensus       126 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~  203 (277)
T cd05607         126 VLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL--KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK  203 (277)
T ss_pred             EEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHH--ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH
Confidence            9999888776655321           23467789999998  344588999999999999999999999975422    


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH----hHHhcCccccCc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA----AQLMEHPFVKRP  197 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~----~~il~~~~~~~~  197 (201)
                      ..................+++++++++.+||+.+|++||++    ++++.||||+..
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         204 EELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             HHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence            22222333333223334688999999999999999999999    678899999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.8e-40  Score=249.81  Aligned_cols=193  Identities=31%  Similarity=0.522  Sum_probs=157.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++|+||+++++++...+..++++||+.+++|.+.   ...++..+..++.||+.||+|||+.|++|+||||+||++
T Consensus       125 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  201 (353)
T PLN00034        125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI  201 (353)
T ss_pred             HHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence            57789999999999999999999999999999998653   225677888999999999999999999999999999999


Q ss_pred             ccCCceeeecCc------------cccccCcccccccccccC---CCCCcchhhHHHHHHHHHHHHhCCCCCCCchH---
Q 046714           83 DASGLATTTNDV------------KSFEGTPFWVAPEVVNLK---NNGYGLSADIWSLGCTVLEMLTHQPPYSHLED---  144 (201)
Q Consensus        83 ~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---  144 (201)
                      +.++.+++.+..            ....++..|+|||.+...   +...+.++|||||||++|++++|+.||.....   
T Consensus       202 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~  281 (353)
T PLN00034        202 NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW  281 (353)
T ss_pred             cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence            998877766542            123467889999987321   23345689999999999999999999964322   


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ......+.....+..+..++.++.+++.+||+.+|++|||+.|+++||||....
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        282 ASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            222223333444556677899999999999999999999999999999999874

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3e-39  Score=241.66  Aligned_cols=195  Identities=32%  Similarity=0.634  Sum_probs=165.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++||||+++++.+...+..++++||+.+++|.+++....+++.++..++.|++.|+++||+.|++|+||+|+||++
T Consensus        69 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili  148 (296)
T cd06655          69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL  148 (296)
T ss_pred             HHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            46789999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|..++.+...            ...++..|+|||.+  .+..++.++|+||||+++|++++|+.||...........
T Consensus       149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~  226 (296)
T cd06655         149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL  226 (296)
T ss_pred             CCCCCEEEccCccchhcccccccCCCcCCCccccCcchh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9888776665321            12356679999997  455678899999999999999999999987665544444


Q ss_pred             hhcCCC--CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          151 IGRGKL--PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       151 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      +.....  ...+..+++.+.+++.+||..+|++|||+.+++.||||+...+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         227 IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            332222  2345568899999999999999999999999999999987544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-39  Score=242.85  Aligned_cols=188  Identities=30%  Similarity=0.515  Sum_probs=152.1

Q ss_pred             cccCCCcceeccceeee-----eCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCC
Q 046714            4 FSQFEHDNIVQYIGTEK-----DENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREI   75 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl   75 (201)
                      +++++||||+++++++.     .....++++||+.+ +|.+++...   .+++..+..++.|++.||+|||++|++|+||
T Consensus        58 l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dl  136 (290)
T cd07862          58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDL  136 (290)
T ss_pred             hcccCCCCcceEEEEEecccCCCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence            44568999999999875     34568999999975 898888653   3889999999999999999999999999999


Q ss_pred             CCCcEEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           76 KCANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      ||+||+++.+|.+++.+...           ...+++.|+|||.+  .+..++.++|+||+|+++|++++|+.||.....
T Consensus       137 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~  214 (290)
T cd07862         137 KPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD  214 (290)
T ss_pred             CHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHH--hCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence            99999999888777665421           23367789999998  345678899999999999999999999987665


Q ss_pred             HHHHHHhhcCCC--------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          145 MQALFRIGRGKL--------------------------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       145 ~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .+....+.....                          ......+++.+.+++.+||+.+|++|||+.++++||||
T Consensus       215 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         215 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            555444321100                          00113467888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.9e-40  Score=254.73  Aligned_cols=191  Identities=27%  Similarity=0.473  Sum_probs=160.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++.+.+++..++||||+++++|.+++.+.+ +++..+..++.||+.||+|||+.||+||||||+||+
T Consensus        54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil  133 (376)
T cd05598          54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNIL  133 (376)
T ss_pred             HHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEE
Confidence            5778999999999999999999999999999999999987654 788999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc-------------------------------------------------------ccccCcccccc
Q 046714           82 VDASGLATTTNDVK-------------------------------------------------------SFEGTPFWVAP  106 (201)
Q Consensus        82 l~~~g~~~~~~~~~-------------------------------------------------------~~~~~~~~~aP  106 (201)
                      ++.+|..++.+...                                                       ...|++.|+||
T Consensus       134 l~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  213 (376)
T cd05598         134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAP  213 (376)
T ss_pred             ECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCH
Confidence            99888776655431                                                       13578889999


Q ss_pred             cccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCC---CCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 046714          107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSRDARDFILKCLQVNPNDRP  183 (201)
Q Consensus       107 E~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~  183 (201)
                      |.+  .+..++.++|+||+||++|+|++|+.||......+....+.....   ......+++.+.+++.+|+ .+|.+|+
T Consensus       214 E~~--~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~  290 (376)
T cd05598         214 EVL--LRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRL  290 (376)
T ss_pred             HHH--cCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence            998  456678999999999999999999999987766555444332211   1223357899999999976 5999999


Q ss_pred             ---CHhHHhcCccccC
Q 046714          184 ---TAAQLMEHPFVKR  196 (201)
Q Consensus       184 ---t~~~il~~~~~~~  196 (201)
                         |++++++||||+.
T Consensus       291 ~~~t~~ell~h~~~~~  306 (376)
T cd05598         291 GKNGADEIKAHPFFKG  306 (376)
T ss_pred             CCCCHHHHhCCCCcCC
Confidence               9999999999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.3e-39  Score=242.26  Aligned_cols=194  Identities=34%  Similarity=0.638  Sum_probs=163.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++||||+++++.+..+...++|+||+.+++|.+++....++..++..++.|++.||+|||+.|++|+||+|+||++
T Consensus        70 ~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill  149 (296)
T cd06654          70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL  149 (296)
T ss_pred             HHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            46788999999999999999999999999999999999987778999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.++.+++.+...            ...+++.|+|||.+  .+...+.++|+||+|+++|++++|+.||...........
T Consensus       150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~  227 (296)
T cd06654         150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL  227 (296)
T ss_pred             cCCCCEEECccccchhccccccccCcccCCccccCHHHH--cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH
Confidence            9888776665421            12466789999997  345678899999999999999999999977655444333


Q ss_pred             hhcCCCC--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          151 IGRGKLP--SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       151 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ......+  ..+..++..+.+++.+||..+|++|||++++++||||....
T Consensus       228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence            3322222  23456788999999999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.9e-39  Score=245.64  Aligned_cols=191  Identities=28%  Similarity=0.471  Sum_probs=163.0

Q ss_pred             cccCCCc-ceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            4 FSQFEHD-NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l~h~-~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +..++|+ +|+++++.+.+.+..++||||+.+++|.+++... .+++..+..++.||+.||+|||++|++|+||||+||+
T Consensus        54 l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nil  133 (324)
T cd05587          54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM  133 (324)
T ss_pred             HHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE
Confidence            4556655 5888999999999999999999999999988654 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...|++.|+|||.+  .+..++.++|+||+|+++|+|++|+.||..........
T Consensus       134 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~  211 (324)
T cd05587         134 LDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ  211 (324)
T ss_pred             EcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhh--cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99988777765431            12368889999998  45567889999999999999999999998877666665


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH-----hHHhcCccccCc
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA-----AQLMEHPFVKRP  197 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~-----~~il~~~~~~~~  197 (201)
                      .+... ...++..+++++.+++.+||..+|.+|++.     +++++||||+..
T Consensus       212 ~i~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         212 SIMEH-NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHHcC-CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            55544 346677899999999999999999999986     899999999764

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.2e-40  Score=253.32  Aligned_cols=192  Identities=27%  Similarity=0.471  Sum_probs=160.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++.+.+++..++||||+++++|.+++.+. .+++..+..++.||+.||+|||++||+|+||||+||+
T Consensus        54 il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NIL  133 (382)
T cd05625          54 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL  133 (382)
T ss_pred             HHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            577899999999999999999999999999999999988764 4889999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc-----------------------------------------------------------ccccCcc
Q 046714           82 VDASGLATTTNDVK-----------------------------------------------------------SFEGTPF  102 (201)
Q Consensus        82 l~~~g~~~~~~~~~-----------------------------------------------------------~~~~~~~  102 (201)
                      ++.+|.+++.+...                                                           ...|++.
T Consensus       134 l~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  213 (382)
T cd05625         134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN  213 (382)
T ss_pred             ECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcc
Confidence            99888776655321                                                           1247788


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCC-C--CCCCCCCHHHHHHHHHHhhcCC
Q 046714          103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL-P--SVPNSLSRDARDFILKCLQVNP  179 (201)
Q Consensus       103 ~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p  179 (201)
                      |+|||.+  .+..++.++|+||+||++|+|++|+.||......+....+..... .  .....+++++.+++.+|+ .+|
T Consensus       214 Y~aPE~~--~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p  290 (382)
T cd05625         214 YIAPEVL--LRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGP  290 (382)
T ss_pred             cCCHHHh--cCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCH
Confidence            9999998  455678999999999999999999999987766555544433211 1  123457899999999875 589


Q ss_pred             CCCCC---HhHHhcCccccCc
Q 046714          180 NDRPT---AAQLMEHPFVKRP  197 (201)
Q Consensus       180 ~~R~t---~~~il~~~~~~~~  197 (201)
                      .+|++   ++++++||||+..
T Consensus       291 ~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         291 EDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             hHcCCCCCHHHHhcCCCcCCc
Confidence            99987   9999999999763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.1e-39  Score=245.22  Aligned_cols=193  Identities=29%  Similarity=0.527  Sum_probs=157.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhc-CccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHER-NVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..+++|||+.+++|.+++... .+++..+..++.|++.|+.|||+. +++|+||||+||
T Consensus        56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Ni  135 (333)
T cd06650          56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI  135 (333)
T ss_pred             HHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhE
Confidence            477899999999999999999999999999999999998764 488999999999999999999975 799999999999


Q ss_pred             EEccCCceeeecCcc----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           81 LVDASGLATTTNDVK----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        81 ll~~~g~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +++.+|.+++.+...          ...++..|+|||.+  .+..++.++|+||+||++|++++|+.||...........
T Consensus       136 li~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~  213 (333)
T cd06650         136 LVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM  213 (333)
T ss_pred             EEcCCCCEEEeeCCcchhhhhhccccCCCCccccCHHHh--cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHH
Confidence            999988777665421          23467789999998  455678899999999999999999999975433222111


Q ss_pred             --------------------------------------------hhcCCCCCCC-CCCCHHHHHHHHHHhhcCCCCCCCH
Q 046714          151 --------------------------------------------IGRGKLPSVP-NSLSRDARDFILKCLQVNPNDRPTA  185 (201)
Q Consensus       151 --------------------------------------------~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~  185 (201)
                                                                  +.....+..+ ...+.++.+|+.+||+.+|++|||+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~  293 (333)
T cd06650         214 FGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADL  293 (333)
T ss_pred             hcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCH
Confidence                                                        1111111111 1357789999999999999999999


Q ss_pred             hHHhcCccccCc
Q 046714          186 AQLMEHPFVKRP  197 (201)
Q Consensus       186 ~~il~~~~~~~~  197 (201)
                      +++++||||+..
T Consensus       294 ~ell~h~~~~~~  305 (333)
T cd06650         294 KQLMVHAFIKRS  305 (333)
T ss_pred             HHHhhCHHHhcC
Confidence            999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-39  Score=247.03  Aligned_cols=191  Identities=28%  Similarity=0.504  Sum_probs=160.2

Q ss_pred             ccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            5 SQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         5 ~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      .++ +||||+++++.+.+.+..++||||+++++|..++.. ..+++..+..++.||+.||+|||++|++|+||||+||++
T Consensus        50 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili  129 (327)
T cd05617          50 EQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL  129 (327)
T ss_pred             HhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            344 699999999999999999999999999999988765 459999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc------hH
Q 046714           83 DASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL------ED  144 (201)
Q Consensus        83 ~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~------~~  144 (201)
                      +.+|..++.+...            ...+++.|+|||.+  .+..++.++|+||+|+++|+|++|+.||...      ..
T Consensus       130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~  207 (327)
T cd05617         130 DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL--RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT  207 (327)
T ss_pred             eCCCCEEEeccccceeccCCCCceecccCCcccCCHHHH--CCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc
Confidence            9988777665421            23467889999998  4566788999999999999999999999532      22


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC------HhHHhcCccccCc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT------AAQLMEHPFVKRP  197 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t------~~~il~~~~~~~~  197 (201)
                      ...............+..++..+.+++.+||..+|.+|++      ++++++||||+..
T Consensus       208 ~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         208 EDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            2333333334444577788999999999999999999997      5799999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.8e-40  Score=248.96  Aligned_cols=191  Identities=28%  Similarity=0.437  Sum_probs=163.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +++.++||||+++++.+..++..++||||+.+++|...+... .+++..+..++.||+.||+|||+.|++|+||||+||+
T Consensus        49 ~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIl  128 (325)
T cd05604          49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENIL  128 (325)
T ss_pred             HHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE
Confidence            467799999999999999999999999999999998887654 5899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|..++.+...            ...+++.|+|||.+  .+..++.++|+||+|+++|+|++|+.||......+...
T Consensus       129 l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~  206 (325)
T cd05604         129 LDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI--RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD  206 (325)
T ss_pred             ECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHH--cCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH
Confidence            99988777665431            22367789999998  45567889999999999999999999998877666665


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH----hHHhcCccccC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA----AQLMEHPFVKR  196 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~----~~il~~~~~~~  196 (201)
                      .+..... ......+..+.+++.+|++.+|.+||++    .++++||||+.
T Consensus       207 ~~~~~~~-~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         207 NILHKPL-VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             HHHcCCc-cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence            5554433 4455688999999999999999999976    58999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.1e-40  Score=251.34  Aligned_cols=194  Identities=26%  Similarity=0.440  Sum_probs=162.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      +++.++||||+++++.+.+++..++||||+.+++|.+++....+++..+..++.||+.||+|||++||+||||||+||++
T Consensus        96 i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl  175 (370)
T cd05621          96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL  175 (370)
T ss_pred             HHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE
Confidence            46788999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCc-------------cccccCcccccccccccCC--CCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           83 DASGLATTTNDV-------------KSFEGTPFWVAPEVVNLKN--NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        83 ~~~g~~~~~~~~-------------~~~~~~~~~~aPE~~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +.+|.+++.+..             ....|++.|+|||.+....  ..++.++|+||+||++|+|++|+.||........
T Consensus       176 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~  255 (370)
T cd05621         176 DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT  255 (370)
T ss_pred             CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH
Confidence            998877766532             1234788999999984322  2367899999999999999999999988776666


Q ss_pred             HHHhhcCCC-CCCCC--CCCHHHHHHHHHHhhcCCCC--CCCHhHHhcCccccC
Q 046714          148 LFRIGRGKL-PSVPN--SLSRDARDFILKCLQVNPND--RPTAAQLMEHPFVKR  196 (201)
Q Consensus       148 ~~~~~~~~~-~~~~~--~~~~~~~~li~~~l~~~p~~--R~t~~~il~~~~~~~  196 (201)
                      ...+..... ..++.  .++..+++++.+|++.++.+  |+|++++++||||+.
T Consensus       256 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         256 YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence            655544321 22333  46889999999999855543  899999999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-40  Score=250.86  Aligned_cols=191  Identities=31%  Similarity=0.474  Sum_probs=161.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++..++||||+++++.+.+++..++||||+.+++|.+++.+. .+++..+..++.||+.||+|||+.|++|+||||+||+
T Consensus        54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIl  133 (350)
T cd05573          54 ILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNIL  133 (350)
T ss_pred             HHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence            467889999999999999999999999999999999998765 5899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc-----------------------------------------cccccCcccccccccccCCCCCcchh
Q 046714           82 VDASGLATTTNDV-----------------------------------------KSFEGTPFWVAPEVVNLKNNGYGLSA  120 (201)
Q Consensus        82 l~~~g~~~~~~~~-----------------------------------------~~~~~~~~~~aPE~~~~~~~~~~~~~  120 (201)
                      ++.+|.+++.+..                                         ....+++.|+|||.+  .+..++.++
T Consensus       134 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~  211 (350)
T cd05573         134 IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL--RGTPYGLEC  211 (350)
T ss_pred             ECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHH--cCCCCCCce
Confidence            9998876665432                                         122467889999998  445788999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhc--CCC-CCCCCCCCHHHHHHHHHHhhcCCCCCCC-HhHHhcCccccC
Q 046714          121 DIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--GKL-PSVPNSLSRDARDFILKCLQVNPNDRPT-AAQLMEHPFVKR  196 (201)
Q Consensus       121 Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t-~~~il~~~~~~~  196 (201)
                      |||||||++|+|++|+.||...........+..  ... ......+++.+.+++.+|+. +|.+|++ ++++++||||+.
T Consensus       212 DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         212 DWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             eeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            999999999999999999988776666555544  111 11222368999999999998 9999999 999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=255.14  Aligned_cols=187  Identities=27%  Similarity=0.504  Sum_probs=170.3

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCc
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGL   87 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~   87 (201)
                      +||.+++++..|+++.++++||||+.||++..+++...|++..+.-|++.++.||.|||++||++||||.+|||+|..|.
T Consensus       427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh  506 (694)
T KOG0694|consen  427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH  506 (694)
T ss_pred             cCCeEeecccccccCCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc
Confidence            79999999999999999999999999999777767677999999999999999999999999999999999999999987


Q ss_pred             eeeecC------------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCC
Q 046714           88 ATTTND------------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK  155 (201)
Q Consensus        88 ~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  155 (201)
                      +++.+.            .++++||+.|+|||++  .+..++..+|-||||++||+|+.|..||.+.++.+....+....
T Consensus       507 ~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil--~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~  584 (694)
T KOG0694|consen  507 VKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVL--TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE  584 (694)
T ss_pred             EEecccccccccCCCCCccccccCChhhcChhhh--ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Confidence            776653            3578899999999998  67789999999999999999999999999988888887776554


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccCc
Q 046714          156 LPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKRP  197 (201)
Q Consensus       156 ~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~~  197 (201)
                       +.+|..++.+..++++++|..+|++|.-     +++|..||||+..
T Consensus       585 -~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  585 -VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             -CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence             5889999999999999999999999975     5789999999864

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.6e-39  Score=238.23  Aligned_cols=197  Identities=36%  Similarity=0.651  Sum_probs=164.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++.+..++..++++||+.+++|.+++.+  .++++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus        55 ~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~ni  134 (282)
T cd06643          55 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNI  134 (282)
T ss_pred             HHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccE
Confidence            46789999999999999999999999999999999887754  4589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc------------cccccCccccccccccc---CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           81 LVDASGLATTTNDV------------KSFEGTPFWVAPEVVNL---KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      +++.+|..++.+..            ....++..|+|||.+..   ....++.++|+||+|+++|++++|+.||......
T Consensus       135 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~  214 (282)
T cd06643         135 LFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM  214 (282)
T ss_pred             EEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH
Confidence            99988876665532            12336778999998732   2344678999999999999999999999877665


Q ss_pred             HHHHHhhcCCCC--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          146 QALFRIGRGKLP--SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       146 ~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      +..........+  ..+..++..+.+++.+||..+|.+|||++++++||||+....
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         215 RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             HHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            555454433222  335567899999999999999999999999999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=249.78  Aligned_cols=188  Identities=32%  Similarity=0.456  Sum_probs=160.3

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG   86 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g   86 (201)
                      +||||+++++.+.+.+..++||||+.+++|.+++.+. .+++..+..++.||+.||+|||++|++|+||||+||+++.+|
T Consensus        54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~  133 (330)
T cd05586          54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG  133 (330)
T ss_pred             CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC
Confidence            7999999999999999999999999999999888654 489999999999999999999999999999999999999988


Q ss_pred             ceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcC
Q 046714           87 LATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG  154 (201)
Q Consensus        87 ~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  154 (201)
                      ..++.+...            ...|+..|+|||.+. ....++.++||||+|+++|+|++|+.||......+....+..+
T Consensus       134 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~  212 (330)
T cd05586         134 HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL-DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG  212 (330)
T ss_pred             CEEEecCCcCcCCCCCCCCccCccCCccccCHHHHc-CCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC
Confidence            776665431            234678899999973 3345788999999999999999999999877666666555554


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCCCCCC----CHhHHhcCccccC
Q 046714          155 KLPSVPNSLSRDARDFILKCLQVNPNDRP----TAAQLMEHPFVKR  196 (201)
Q Consensus       155 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~----t~~~il~~~~~~~  196 (201)
                      ........+++.+.+++.+||+.+|.+||    +++++++||||..
T Consensus       213 ~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         213 KVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence            44333345789999999999999999998    7999999999975

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=247.15  Aligned_cols=192  Identities=28%  Similarity=0.475  Sum_probs=168.1

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      |+-.+||||+++|++......+|+|.|.-++|+|.|+|-+  .++.++.+.+++.||+.|+.|||+.+++|+||||+||.
T Consensus        71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVV  150 (864)
T KOG4717|consen   71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVV  150 (864)
T ss_pred             HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeE
Confidence            4567899999999999999999999999999999999965  46999999999999999999999999999999999986


Q ss_pred             E-ccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 V-DASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l-~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      + .+-|++++.++.           .+.+|+..|-|||++ .+.....+++||||||++||.+.+|+.||....+.+.+-
T Consensus       151 FFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEIL-LGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT  229 (864)
T KOG4717|consen  151 FFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEIL-LGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT  229 (864)
T ss_pred             EeeecCceEeeeccccccCCCcchhhcccchhhccCchhh-hcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh
Confidence            5 456888877642           345688889999998 344555789999999999999999999999888777765


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .+.. ....+|..++.++++||.+||..||++|.|.++|..++|++..
T Consensus       230 mImD-CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  230 MIMD-CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             hhhc-ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence            5543 3447788999999999999999999999999999999999865

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.4e-39  Score=246.10  Aligned_cols=191  Identities=26%  Similarity=0.420  Sum_probs=163.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +++.++||||+++++.+.+.+..++||||+.+++|...+.. ..+++..+..++.||+.||+|||+.|++|+||||+||+
T Consensus        49 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIl  128 (321)
T cd05603          49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENIL  128 (321)
T ss_pred             HHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeE
Confidence            46789999999999999999999999999999999887765 44889999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...+++.|+|||.+  .+..++.++|+||+||++|+|++|+.||..........
T Consensus       129 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  206 (321)
T cd05603         129 LDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL--RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD  206 (321)
T ss_pred             ECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHh--cCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence            99998877765431            12367889999998  45567889999999999999999999998876655555


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH----hHHhcCccccC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA----AQLMEHPFVKR  196 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~----~~il~~~~~~~  196 (201)
                      .+... ...++...+..+.+++.+||+.+|.+|+++    .++++|+||..
T Consensus       207 ~i~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         207 NILHK-PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             HHhcC-CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence            55444 345667788999999999999999999875    59999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-39  Score=246.69  Aligned_cols=191  Identities=27%  Similarity=0.418  Sum_probs=163.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      .++.++||||+++++.+.+.+..+++|||+.+++|.+++... .+++..+..++.||+.||+|||+.|++|+||||+||+
T Consensus        49 ~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nil  128 (325)
T cd05602          49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL  128 (325)
T ss_pred             HHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE
Confidence            357789999999999999999999999999999999988764 4888999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...+++.|+|||.+  .+..++.++|+||+||++|+|++|+.||......+...
T Consensus       129 i~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  206 (325)
T cd05602         129 LDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL--HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD  206 (325)
T ss_pred             ECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHH--cCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH
Confidence            99888777665431            23478889999998  45567889999999999999999999998877666655


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHh----HHhcCccccC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAA----QLMEHPFVKR  196 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~----~il~~~~~~~  196 (201)
                      .+.... ...+..+++.+.+++.+||+.+|.+|+++.    ++++|+||..
T Consensus       207 ~i~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         207 NILNKP-LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             HHHhCC-cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence            554443 345567899999999999999999999876    8999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-39  Score=238.45  Aligned_cols=197  Identities=38%  Similarity=0.686  Sum_probs=166.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++.+.+++..+++|||+++++|.+++.+  ..+++..+..++.|++.|+.|||+.|++|+||+|+||
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni  134 (280)
T cd06611          55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNI  134 (280)
T ss_pred             HHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhE
Confidence            57889999999999999999999999999999999999875  3489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCccccccccccc---CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNL---KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      +++.++..++.+...            ...++..|+|||.+..   ....++.++|+||+|+++|++++|+.||......
T Consensus       135 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~  214 (280)
T cd06611         135 LLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM  214 (280)
T ss_pred             EECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH
Confidence            999888776655321            1235677999998732   2344678999999999999999999999887666


Q ss_pred             HHHHHhhcCCCCC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          146 QALFRIGRGKLPS--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       146 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      .....+.....+.  .+..++..+.+++.+||+.+|.+|||++++++||||....+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (280)
T cd06611         215 RVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD  270 (280)
T ss_pred             HHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence            6665555544332  34567899999999999999999999999999999987643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.5e-39  Score=241.65  Aligned_cols=195  Identities=32%  Similarity=0.598  Sum_probs=163.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      .+++++||||+++++.+...+..++++||+++++|.+++....+++..+..++.||+.|++|||+.|++|+||+|+||++
T Consensus        72 ~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill  151 (292)
T cd06658          72 IMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL  151 (292)
T ss_pred             HHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence            46778999999999999999999999999999999999877778999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.++..++.+...            ...++..|+|||.+  .+..++.++|+||+|+++|++++|+.||...........
T Consensus       152 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~  229 (292)
T cd06658         152 TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI--SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR  229 (292)
T ss_pred             cCCCCEEEccCcchhhcccccccCceeecCccccCHHHH--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9888776655321            12356789999997  455678899999999999999999999977655544444


Q ss_pred             hhcCCCCC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          151 IGRGKLPS--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       151 ~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      +.....+.  .....+..+.+++.+||..+|++|||++++++||||+...+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         230 IRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             HHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence            33222222  22346888999999999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-38  Score=233.81  Aligned_cols=190  Identities=29%  Similarity=0.605  Sum_probs=162.1

Q ss_pred             ccccCCCcceeccceeeee-CCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD-ENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++||||+++++.+.. ++..++++||+++++|.+++...   .+++.++..++.|++.|+++||+.|++|+||+|+
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~  131 (257)
T cd08223          52 LLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQ  131 (257)
T ss_pred             HHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCch
Confidence            4678899999999998764 45689999999999999988652   3899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           79 NILVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        79 nill~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ||+++.++...+.+..            ....+++.|+|||..  .+..++.++|+||+|++++++++|+.||...+...
T Consensus       132 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~  209 (257)
T cd08223         132 NVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF--SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS  209 (257)
T ss_pred             hEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHh--cCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            9999988766555422            123357789999997  45567889999999999999999999998776666


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .......+..+..+..+++.+.+++.+|++.+|++|||+.++++||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         210 LVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            655666666666777889999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=6e-39  Score=237.90  Aligned_cols=194  Identities=35%  Similarity=0.665  Sum_probs=167.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++||||+++++.+.+++..++||||+.+++|.+++....+++.++..++.|++.|+++||+.+++|+||+|+||++
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~  134 (277)
T cd06640          55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL  134 (277)
T ss_pred             HHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE
Confidence            46788999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.++...+.+...            ...++..|+|||.+  .+...+.++|+||||+++|++++|+.||...........
T Consensus       135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~  212 (277)
T cd06640         135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL  212 (277)
T ss_pred             cCCCCEEEcccccceeccCCccccccccCcccccCHhHh--ccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh
Confidence            9887665554321            12345679999997  355678999999999999999999999987766655555


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      +.....+..+..++..+.+++.+||..+|++||+++++++||||....
T Consensus       213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         213 IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence            555555566667889999999999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=252.41  Aligned_cols=196  Identities=38%  Similarity=0.708  Sum_probs=180.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCC-CHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL-SDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      .|.+++++||.+.|+.+..+..++++|||+.||++.++++.+++ .+..+.-++++++.|+.|+|.++.+|+|||+.||+
T Consensus        64 ~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil  143 (467)
T KOG0201|consen   64 VLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANIL  143 (467)
T ss_pred             HHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceeccccccccee
Confidence            57899999999999999999999999999999999999998875 88888999999999999999999999999999999


Q ss_pred             EccCCceeeecC------------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTND------------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      +...|.+++.++            ..++.||+.|||||+++  ...++.++||||||++.++|.+|.+|+.+..+++...
T Consensus       144 ~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~--~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf  221 (467)
T KOG0201|consen  144 LSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIK--QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF  221 (467)
T ss_pred             EeccCcEEEEecceeeeeechhhccccccccccccchhhhc--cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE
Confidence            999888877653            24677999999999994  6678999999999999999999999999999988888


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCCC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQT  200 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~~  200 (201)
                      .+.+...|.+...+++.+++|+..||.++|+.|||+.+++.|+|++..-.+
T Consensus       222 lIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~  272 (467)
T KOG0201|consen  222 LIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKT  272 (467)
T ss_pred             eccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCc
Confidence            888888888999999999999999999999999999999999999875443

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=251.90  Aligned_cols=186  Identities=27%  Similarity=0.579  Sum_probs=167.1

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      |++|+||||+.+.|+|.....++||||||..|.|..+++.+. +.....+.|..+|+.|+.|||...|+|||||.-||||
T Consensus       166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI  245 (904)
T KOG4721|consen  166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI  245 (904)
T ss_pred             HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe
Confidence            789999999999999999999999999999999999998754 8899999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 046714           83 DASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI  151 (201)
Q Consensus        83 ~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  151 (201)
                      ..+..+++.++..           .+.||..|+|||+|  ..++.+.|+||||||+|||+|+||+.||.+.+...++..+
T Consensus       246 s~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvI--rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV  323 (904)
T KOG4721|consen  246 SYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVI--RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV  323 (904)
T ss_pred             eccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHh--hcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec
Confidence            9998888877643           35589999999998  7888999999999999999999999999988776666554


Q ss_pred             hcCCC-CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          152 GRGKL-PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       152 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ..+.+ ..+|..+++-++-|++.||+-.|..||+|.|++.|
T Consensus       324 GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  324 GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            44333 35678899999999999999999999999999988

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.1e-39  Score=241.02  Aligned_cols=195  Identities=33%  Similarity=0.633  Sum_probs=163.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++||||+++++.+..++..++|+||+++++|.+++.+..+++.++..++.|++.|+.|||+.|++|+||+|+||++
T Consensus        69 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili  148 (297)
T cd06656          69 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL  148 (297)
T ss_pred             HHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence            46788999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|.+++.+...            ...+++.|+|||.+  .+..++.++|+||+|+++|++++|+.||...........
T Consensus       149 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~  226 (297)
T cd06656         149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL  226 (297)
T ss_pred             CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHH--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee
Confidence            9888776665421            12356679999997  455678899999999999999999999976544333222


Q ss_pred             hhcCCC--CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          151 IGRGKL--PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       151 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      ......  ...+..++..+.+++.+||..+|++|||++++++||||+...+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence            222211  1234567888999999999999999999999999999986544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-38  Score=235.19  Aligned_cols=190  Identities=42%  Similarity=0.824  Sum_probs=161.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++|+||+++++++.+.+..++++||+.+++|.+++.+ ..+++..+..++.|++.|++|||+.|++|+||+|+||+
T Consensus        55 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil  134 (265)
T cd06631          55 LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVM  134 (265)
T ss_pred             HHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEE
Confidence            46789999999999999999999999999999999999876 45899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           82 VDASGLATTTNDVK------------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      ++.+|..++.+...                  ...++..|+|||.+  .+...+.++|+||+|++++++++|+.||....
T Consensus       135 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  212 (265)
T cd06631         135 LMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI--NESGYGRKSDIWSIGCTVFEMATGKPPLASMD  212 (265)
T ss_pred             ECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhh--cCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence            99887766654321                  22356679999997  44567889999999999999999999997765


Q ss_pred             HHHHHHHhhc--CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          144 DMQALFRIGR--GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       144 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ..........  ...+..+..++..+.+++++||..+|.+|||+.++++||||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         213 RLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             hHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            5444333322  34456777889999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-39  Score=249.71  Aligned_cols=192  Identities=27%  Similarity=0.458  Sum_probs=160.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++.+++||||+++++.+.+++..++||||+++++|.+++.+. .+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        54 ~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIl  133 (360)
T cd05627          54 ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL  133 (360)
T ss_pred             HHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEE
Confidence            467889999999999999999999999999999999998654 5899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc-----------------------------------------------ccccCcccccccccccCCC
Q 046714           82 VDASGLATTTNDVK-----------------------------------------------SFEGTPFWVAPEVVNLKNN  114 (201)
Q Consensus        82 l~~~g~~~~~~~~~-----------------------------------------------~~~~~~~~~aPE~~~~~~~  114 (201)
                      ++.+|.+++.+...                                               ...|++.|+|||.+  .+.
T Consensus       134 i~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~--~~~  211 (360)
T cd05627         134 LDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF--MQT  211 (360)
T ss_pred             ECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHH--cCC
Confidence            99888776655321                                               23478889999998  456


Q ss_pred             CCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCC-CCCCCC--CCCHHHHHHHHHHhhcCCCCCC---CHhHH
Q 046714          115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK-LPSVPN--SLSRDARDFILKCLQVNPNDRP---TAAQL  188 (201)
Q Consensus       115 ~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~li~~~l~~~p~~R~---t~~~i  188 (201)
                      .++.++|+||+||++|+|++|+.||...........+.... ...++.  .+++++++++.+++ .+|.+|+   +++++
T Consensus       212 ~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei  290 (360)
T cd05627         212 GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEI  290 (360)
T ss_pred             CCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHH
Confidence            67899999999999999999999998877666655554321 112232  36889999999976 5899998   58999


Q ss_pred             hcCccccCc
Q 046714          189 MEHPFVKRP  197 (201)
Q Consensus       189 l~~~~~~~~  197 (201)
                      ++||||+..
T Consensus       291 ~~hp~f~~~  299 (360)
T cd05627         291 KSHPFFEGV  299 (360)
T ss_pred             hcCCCCCCC
Confidence            999999863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-39  Score=238.93  Aligned_cols=193  Identities=26%  Similarity=0.399  Sum_probs=161.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++.+.+++..+++|||+.+++|.+++..   ..+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N  132 (285)
T cd05605          53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPEN  132 (285)
T ss_pred             HHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHH
Confidence            56788999999999999999999999999999999988754   248999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           80 ILVDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        80 ill~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      |+++.++.+.+.+..           ....++..|+|||.+  .+..++.++|+||+|+++|++++|+.||.+.......
T Consensus       133 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~  210 (285)
T cd05605         133 ILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV--KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR  210 (285)
T ss_pred             EEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHh--cCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH
Confidence            999988776665532           123467789999998  4556788999999999999999999999875443222


Q ss_pred             ---HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          149 ---FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       149 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                         ...........+..++..+.+++.+||..+|.+||     +++++++||||...
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         211 EEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence               22222333455667899999999999999999999     89999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.5e-39  Score=238.55  Aligned_cols=192  Identities=37%  Similarity=0.694  Sum_probs=164.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++||||+++++.+..++..++|+||+++++|.+++....+++..+..++.|++.|+.|||++|++|+||+|+||++
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i  134 (277)
T cd06642          55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL  134 (277)
T ss_pred             HHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE
Confidence            46789999999999999999999999999999999999988789999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|..++.+...            ...++..|+|||.+  .+..++.++|+||+|++++++++|+.|+...........
T Consensus       135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~  212 (277)
T cd06642         135 SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL  212 (277)
T ss_pred             eCCCCEEEccccccccccCcchhhhcccCcccccCHHHh--CcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh
Confidence            9888776655321            12356679999998  345678899999999999999999999976655555544


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      +.....+......+..+.+++.+||..+|.+|||+.++++|||+..
T Consensus       213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         213 IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             hhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence            4445455556678889999999999999999999999999999864

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.6e-39  Score=241.15  Aligned_cols=193  Identities=25%  Similarity=0.422  Sum_probs=155.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++..++..+++|||+.+ +|.+++...+  ++...+..++.|++.||+|||++|++||||||+||
T Consensus        57 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Ni  135 (309)
T cd07872          57 LLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNL  135 (309)
T ss_pred             HHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            46789999999999999999999999999986 8888776533  78899999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|.+++.+...            ...++..|+|||.+. ....++.++|+||+|+++|+|++|+.||......+..
T Consensus       136 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  214 (309)
T cd07872         136 LINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL-GSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL  214 (309)
T ss_pred             EECCCCCEEECccccceecCCCccccccccccccccCCHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            999888776655421            123567799999873 3456788999999999999999999999766543332


Q ss_pred             HHhhcC---------------------CCCC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          149 FRIGRG---------------------KLPS--------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       149 ~~~~~~---------------------~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ..+...                     ..+.        ....+++++.+++.+||+.+|.+|||++|+++||||+..
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         215 HLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             HHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            222110                     0000        112467889999999999999999999999999999863

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.1e-39  Score=247.08  Aligned_cols=194  Identities=26%  Similarity=0.411  Sum_probs=161.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      +++.++||||+++++.+.+++..++||||+++++|.+++....+++..+..++.||+.||+|||++||+|+||||+||++
T Consensus        96 i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll  175 (371)
T cd05622          96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL  175 (371)
T ss_pred             HHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence            46778999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc-------------ccccCcccccccccccCC--CCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           83 DASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKN--NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        83 ~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +.+|.+++.+...             ...|++.|+|||.+....  ..++.++|+||+||++|+|++|+.||........
T Consensus       176 ~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~  255 (371)
T cd05622         176 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT  255 (371)
T ss_pred             CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH
Confidence            9988776655421             234788899999984322  2367899999999999999999999988776666


Q ss_pred             HHHhhcCCC-CCC--CCCCCHHHHHHHHHHhhcCCCC--CCCHhHHhcCccccC
Q 046714          148 LFRIGRGKL-PSV--PNSLSRDARDFILKCLQVNPND--RPTAAQLMEHPFVKR  196 (201)
Q Consensus       148 ~~~~~~~~~-~~~--~~~~~~~~~~li~~~l~~~p~~--R~t~~~il~~~~~~~  196 (201)
                      ...+..... ..+  ...+++.+++++.+|+..++.+  |++++++++|+||+.
T Consensus       256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         256 YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             HHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence            555543321 122  2358899999999999854443  789999999999976

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.7e-40  Score=240.47  Aligned_cols=193  Identities=30%  Similarity=0.496  Sum_probs=159.8

Q ss_pred             ccccCCCcceeccceeeeeCC-----eEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccc
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN-----RLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVH   72 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H   72 (201)
                      +|++++||||+++..+|....     ...+||||++. +|.++++.     ..++...++-+..||+.|+.|||+.||+|
T Consensus        70 im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcH  148 (364)
T KOG0658|consen   70 IMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICH  148 (364)
T ss_pred             HHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCccc
Confidence            578999999999988876432     45689999987 99999873     45888899999999999999999999999


Q ss_pred             cCCCCCcEEEccC-CceeeecCccccc-----------cCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Q 046714           73 REIKCANILVDAS-GLATTTNDVKSFE-----------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS  140 (201)
Q Consensus        73 ~dl~p~nill~~~-g~~~~~~~~~~~~-----------~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  140 (201)
                      |||||.|+|+|.+ |..++.+++++..           .+..|+|||.+ .+...++.+.||||.||++.||+.|++.|+
T Consensus       149 RDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELi-fga~~Yt~~IDiWSaGCV~aELl~g~plFp  227 (364)
T KOG0658|consen  149 RDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELI-FGATEYTTSIDIWSAGCVMAELLKGQPLFP  227 (364)
T ss_pred             CCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHH-cCccccCceeEEhhhhHHHHHHhcCCcccC
Confidence            9999999999987 7777777655433           45569999999 567788999999999999999999999998


Q ss_pred             CchHHHHHHHhhcC-------------------CCC---------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          141 HLEDMQALFRIGRG-------------------KLP---------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       141 ~~~~~~~~~~~~~~-------------------~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                      +.+..+....+.+-                   ..+         .+....+++..+|+.++|+++|.+|.++.|++.||
T Consensus       228 G~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~  307 (364)
T KOG0658|consen  228 GDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP  307 (364)
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence            87766655443110                   000         13345789999999999999999999999999999


Q ss_pred             cccCc
Q 046714          193 FVKRP  197 (201)
Q Consensus       193 ~~~~~  197 (201)
                      ||.+-
T Consensus       308 fFdel  312 (364)
T KOG0658|consen  308 FFDEL  312 (364)
T ss_pred             hhHHh
Confidence            99864

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.5e-38  Score=236.63  Aligned_cols=195  Identities=32%  Similarity=0.613  Sum_probs=165.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++||||+++++.+...+..++++||+.+++|.+++....++...+..++.|++.|+++||+.|++|+||+|+||++
T Consensus        69 ~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~  148 (285)
T cd06648          69 IMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL  148 (285)
T ss_pred             HHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE
Confidence            46778999999999999999999999999999999999988779999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|..++.+...            ...++..|+|||..  .+..++.++|+||+|++++++++|+.||...........
T Consensus       149 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~  226 (285)
T cd06648         149 TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI--SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR  226 (285)
T ss_pred             cCCCcEEEcccccchhhccCCcccccccCCccccCHHHh--cCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH
Confidence            9988776655321            12366779999997  445578899999999999999999999977666555555


Q ss_pred             hhcCCCCCC--CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          151 IGRGKLPSV--PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       151 ~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      +.....+..  +..++..+.+++.+||+.+|++|||+.++++||||+...+
T Consensus       227 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         227 IRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence            544432222  2337889999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.7e-38  Score=234.28  Aligned_cols=186  Identities=23%  Similarity=0.454  Sum_probs=158.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++..++..++||||+++++|.+++...  .+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        59 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~ni  138 (266)
T cd05064          59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKV  138 (266)
T ss_pred             HHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhE
Confidence            467889999999999999999999999999999999998763  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.++..++.+....             ..++..|+|||.+  .+..++.++|+||+|+++|++++ |+.||......+
T Consensus       139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~  216 (266)
T cd05064         139 LVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAI--QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD  216 (266)
T ss_pred             EEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHH--hhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence            9998877665543211             1123569999987  45667899999999999999775 999998877766


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ....+..+.....+..++..+.+++.+||+.+|.+|||++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         217 VIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            66666665555667788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.1e-38  Score=237.21  Aligned_cols=190  Identities=32%  Similarity=0.517  Sum_probs=153.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK----YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++||||+++++++.+++..++|+||+.+ +|.+++..    ..+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~  130 (285)
T cd07861          52 LLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQ  130 (285)
T ss_pred             HHHhcCCCCEeeeEEEEeeCCeEEEEEecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHH
Confidence            46788999999999999999999999999975 88887754    34899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           79 NILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        79 nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ||+++.+|.+++.+...            ...+++.|+|||.+. ....++.++|+||+|++++++++|+.||.......
T Consensus       131 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~  209 (285)
T cd07861         131 NLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLL-GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID  209 (285)
T ss_pred             HEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhc-CCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            99999998777665431            123467799999873 33456889999999999999999999997654332


Q ss_pred             HHHHhhc----------------------------CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          147 ALFRIGR----------------------------GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       147 ~~~~~~~----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .......                            .........+++++.+++++||+.+|.+|||+.++++||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         210 QLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            2221110                            00011123478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.6e-38  Score=232.97  Aligned_cols=190  Identities=29%  Similarity=0.559  Sum_probs=166.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++.+...+..++++||+.+++|.+++...   .+++.++..++.|++.|+.+||++|++|+||+|+|
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~n  131 (256)
T cd08218          52 VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQN  131 (256)
T ss_pred             HHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence            578899999999999999999999999999999999988653   37899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           80 ILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        80 ill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+++.++...+.+...            ...++..|+|||..  .+...+.++|+||+|++++++++|+.||......+.
T Consensus       132 il~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~  209 (256)
T cd08218         132 IFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC--ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL  209 (256)
T ss_pred             EEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHh--CCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH
Confidence            9999887666554321            12356679999997  345577899999999999999999999988777777


Q ss_pred             HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          148 LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ...+..+..+..+...+.++.+++.+||+.+|.+||++.++++||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         210 VLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            77777777777778889999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.1e-39  Score=241.78  Aligned_cols=186  Identities=26%  Similarity=0.461  Sum_probs=161.7

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG   86 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g   86 (201)
                      +||+|+++++.+.+.+..++||||+.+++|.+.+.. ..+++..+..++.||+.||+|||+.|++|+||||+||+++.+|
T Consensus        59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~  138 (323)
T cd05616          59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG  138 (323)
T ss_pred             CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC
Confidence            689999999999999999999999999999988865 4589999999999999999999999999999999999999998


Q ss_pred             ceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcC
Q 046714           87 LATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG  154 (201)
Q Consensus        87 ~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  154 (201)
                      ..++.+...            ...|++.|+|||.+  .+..++.++|+||+||++|+|++|+.||...........+...
T Consensus       139 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~  216 (323)
T cd05616         139 HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH  216 (323)
T ss_pred             cEEEccCCCceecCCCCCccccCCCChhhcCHHHh--cCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            777665431            23467889999998  4556789999999999999999999999887776666665544


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH-----hHHhcCccccC
Q 046714          155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTA-----AQLMEHPFVKR  196 (201)
Q Consensus       155 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~-----~~il~~~~~~~  196 (201)
                      . ..++..+++++.+++.+|++.+|.+|++.     .++++||||+.
T Consensus       217 ~-~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         217 N-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             C-CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            3 35677889999999999999999999984     89999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-38  Score=234.46  Aligned_cols=192  Identities=29%  Similarity=0.516  Sum_probs=163.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++.+.+++..++++||+++++|.+++.+. .++...+..++.|++.|++|||+.|++|+||+|+||+
T Consensus        46 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nil  125 (262)
T cd05572          46 ILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLL  125 (262)
T ss_pred             HHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEE
Confidence            467899999999999999999999999999999999998764 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch--HHHHH
Q 046714           82 VDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE--DMQAL  148 (201)
Q Consensus        82 l~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~~~~  148 (201)
                      ++.+|.+++.+...           ...++..|++||.+  ....++.++|+||+|+++|++++|..||....  .....
T Consensus       126 v~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  203 (262)
T cd05572         126 LDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEII--LNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY  203 (262)
T ss_pred             EcCCCCEEEeeCCcccccCcccccccccCCcCccChhHh--cCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH
Confidence            99988776655321           12356779999997  34567889999999999999999999997665  44444


Q ss_pred             HHhhc-CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccC
Q 046714          149 FRIGR-GKLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKR  196 (201)
Q Consensus       149 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~  196 (201)
                      ..+.. ......+...++++.+++.+||+.+|.+||+     ++|+++||||+.
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         204 NDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             HHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence            44442 3344566667899999999999999999999     999999999985

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-38  Score=246.29  Aligned_cols=192  Identities=25%  Similarity=0.375  Sum_probs=151.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++..+...++++|++.+ +|.+++.. ..++...++.++.||+.||+|||++||+|+||||+||+
T Consensus       136 il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIl  214 (391)
T PHA03212        136 ILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIF  214 (391)
T ss_pred             HHHhCCCCCCCCEeEEEEECCeeEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEE
Confidence            57889999999999999999999999999965 78777754 45899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc-------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch-----
Q 046714           82 VDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE-----  143 (201)
Q Consensus        82 l~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-----  143 (201)
                      ++.+|.+++.+...             ...+|+.|+|||.+  .+..++.++|+||+|+++|++++|+.||....     
T Consensus       215 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~  292 (391)
T PHA03212        215 INHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGD  292 (391)
T ss_pred             EcCCCCEEEEeCCcccccccccccccccccCccCCCChhhh--cCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccccc
Confidence            99888776665432             12478889999998  44567899999999999999999997763321     


Q ss_pred             --HHHHHHHh--------------------------hcCC--CC-CC-----CCCCCHHHHHHHHHHhhcCCCCCCCHhH
Q 046714          144 --DMQALFRI--------------------------GRGK--LP-SV-----PNSLSRDARDFILKCLQVNPNDRPTAAQ  187 (201)
Q Consensus       144 --~~~~~~~~--------------------------~~~~--~~-~~-----~~~~~~~~~~li~~~l~~~p~~R~t~~~  187 (201)
                        .......+                          ....  .+ ..     ...++.++.+++.+||+.+|.+|||++|
T Consensus       293 ~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~e  372 (391)
T PHA03212        293 CDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEA  372 (391)
T ss_pred             CchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHH
Confidence              00000000                          0000  00 00     0124668899999999999999999999


Q ss_pred             HhcCccccCc
Q 046714          188 LMEHPFVKRP  197 (201)
Q Consensus       188 il~~~~~~~~  197 (201)
                      +++||||+..
T Consensus       373 lL~hp~f~~~  382 (391)
T PHA03212        373 LLDFAAFQDI  382 (391)
T ss_pred             HhcChhhccC
Confidence            9999999874

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=239.65  Aligned_cols=192  Identities=30%  Similarity=0.480  Sum_probs=161.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +++.++||||+++++.+.+.+..++++||+.+++|.+++...   .+++..+..++.|++.||+|||+.|++|+||||+|
T Consensus        54 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  133 (316)
T cd05574          54 ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPEN  133 (316)
T ss_pred             HHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHH
Confidence            467889999999999999999999999999999999998753   48999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc-----------------------------------------ccccCcccccccccccCCCCCcc
Q 046714           80 ILVDASGLATTTNDVK-----------------------------------------SFEGTPFWVAPEVVNLKNNGYGL  118 (201)
Q Consensus        80 ill~~~g~~~~~~~~~-----------------------------------------~~~~~~~~~aPE~~~~~~~~~~~  118 (201)
                      |+++.+|.+.+.+...                                         ...++..|+|||.+  .+..++.
T Consensus       134 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~  211 (316)
T cd05574         134 ILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI--SGDGHGS  211 (316)
T ss_pred             eEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHH--cCCCCCc
Confidence            9999887665544211                                         12356679999998  4556788


Q ss_pred             hhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCCCCCCC--CCCHHHHHHHHHHhhcCCCCCCC----HhHHhcCc
Q 046714          119 SADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN--SLSRDARDFILKCLQVNPNDRPT----AAQLMEHP  192 (201)
Q Consensus       119 ~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~t----~~~il~~~  192 (201)
                      ++|+||||+++|++++|+.||...........+..... ..+.  ..++.+.+++.+||+.+|++|||    ++++++||
T Consensus       212 ~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~  290 (316)
T cd05574         212 AVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEV-TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP  290 (316)
T ss_pred             hHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCc-cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence            99999999999999999999987766665555443322 2222  36899999999999999999999    99999999


Q ss_pred             cccCc
Q 046714          193 FVKRP  197 (201)
Q Consensus       193 ~~~~~  197 (201)
                      ||+..
T Consensus       291 ~~~~~  295 (316)
T cd05574         291 FFRGV  295 (316)
T ss_pred             hhhcC
Confidence            99864

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.8e-38  Score=237.95  Aligned_cols=193  Identities=25%  Similarity=0.425  Sum_probs=156.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+++++||||+++++++..++..++++||+.+ +|.+++...  .+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus        57 ~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Ni  135 (301)
T cd07873          57 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNL  135 (301)
T ss_pred             HHHhcCCCCcceEEEEEecCCeEEEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHE
Confidence            46789999999999999999999999999975 888887653  488999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.++..++.+...            ...+++.|+|||.+. ....++.++|+||+|+++|+|++|+.||......+..
T Consensus       136 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~  214 (301)
T cd07873         136 LINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL-GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL  214 (301)
T ss_pred             EECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHh-CCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999988776655421            123466799999873 3445788999999999999999999999776544333


Q ss_pred             HHhhc---C------------------CCC--------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          149 FRIGR---G------------------KLP--------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       149 ~~~~~---~------------------~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ..+..   .                  ..+        .....+++.+++++.+||+.+|.+|||++++++||||+..
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         215 HFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             HHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            22110   0                  000        0113467889999999999999999999999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.4e-39  Score=245.65  Aligned_cols=193  Identities=26%  Similarity=0.403  Sum_probs=162.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +++.++||||+++++.+.+.+..++||||+++++|.+++.+.  .+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus        54 i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NI  133 (330)
T cd05601          54 ILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV  133 (330)
T ss_pred             HHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHhe
Confidence            467789999999999999999999999999999999999764  589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-------------ccccCcccccccccccC----CCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           81 LVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLK----NNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      +++.+|.+++.+...             ...+++.|+|||.+...    ...++.++||||+|+++|+|++|+.||....
T Consensus       134 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~  213 (330)
T cd05601         134 LIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT  213 (330)
T ss_pred             EECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence            999988777765431             12467889999997421    3456789999999999999999999998776


Q ss_pred             HHHHHHHhhcCCC-CCCC--CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          144 DMQALFRIGRGKL-PSVP--NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       144 ~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      .......+..... ..++  ..+++.+.+++.+|++ +|.+|||++++++||||..
T Consensus       214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         214 SAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            6665555443221 1222  3578999999999998 9999999999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.6e-38  Score=234.45  Aligned_cols=195  Identities=36%  Similarity=0.684  Sum_probs=168.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      .+++++||||+++++.+..++..++|+||+.+++|.+++....++...+..++.|++.++.+||+.|++|+||+|+||++
T Consensus        55 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i  134 (277)
T cd06641          55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL  134 (277)
T ss_pred             HHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE
Confidence            46788999999999999999999999999999999999988789999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|...+.+...            ...++..|+|||.+  ....++.++|+||+|++++++++|..||...........
T Consensus       135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  212 (277)
T cd06641         135 SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL  212 (277)
T ss_pred             CCCCCEEEeecccceecccchhhhccccCCccccChhhh--ccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH
Confidence            9888766654321            12356679999997  345678899999999999999999999987766666555


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      +.....+.+...++..+.+++.+||..+|.+||++.++++||||+....
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         213 IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             HhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence            5555556667778999999999999999999999999999999986544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6e-38  Score=234.17  Aligned_cols=196  Identities=37%  Similarity=0.664  Sum_probs=161.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+++++||||+++++.+..++..+++|||+++++|..++.+  ..+++..+..++.|++.++.+||+.|++|+||+|+||
T Consensus        62 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Ni  141 (292)
T cd06644          62 ILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNV  141 (292)
T ss_pred             HHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceE
Confidence            46789999999999999999999999999999999887753  4589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCccccccccccc---CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNL---KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      +++.+|..++.+...            ...++..|+|||.+..   ....++.++|+||+|+++|++++|+.||......
T Consensus       142 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  221 (292)
T cd06644         142 LLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM  221 (292)
T ss_pred             EEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH
Confidence            999887766655421            1224667999998732   2334678999999999999999999999776655


Q ss_pred             HHHHHhhcCCCC--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          146 QALFRIGRGKLP--SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       146 ~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ...........+  ..+..++.++.+++.+||..+|++||+++++++||||....
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         222 RVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             HHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            555454443332  23456788999999999999999999999999999997644

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.6e-38  Score=235.98  Aligned_cols=192  Identities=30%  Similarity=0.522  Sum_probs=164.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+++..+++|||+.+++|.+++... .+++..+..++.|++.||++||+.|++|+||+|.||+
T Consensus        54 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nil  133 (290)
T cd05580          54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLL  133 (290)
T ss_pred             HHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE
Confidence            478899999999999999999999999999999999998664 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           82 VDASGLATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        82 l~~~g~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      ++.+|..++.+..         ....+++.|+|||.+  .+...+.++|+||+|+++|++++|+.||...........+.
T Consensus       134 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  211 (290)
T cd05580         134 LDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEII--LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL  211 (290)
T ss_pred             ECCCCCEEEeeCCCccccCCCCCCCCCCccccChhhh--cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence            9998877665432         122366789999997  34567889999999999999999999998776555555544


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       153 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                      .+ ...++...++.+++++.+||+.+|.+|+     +++++++||||+..
T Consensus       212 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         212 EG-KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             cC-CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence            33 3456677899999999999999999999     99999999999764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-38  Score=237.18  Aligned_cols=193  Identities=27%  Similarity=0.425  Sum_probs=160.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++|++|+++++.+.+++..+++|||+.+++|.+++...   ++++..+..++.|++.||.|||+.|++|+||||+|
T Consensus        53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~N  132 (285)
T cd05630          53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPEN  132 (285)
T ss_pred             HHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHH
Confidence            567899999999999999999999999999999999988542   48999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---
Q 046714           80 ILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM---  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---  145 (201)
                      |+++.++...+.+...           ...++..|+|||.+  .+..++.++|+||+|+++|++++|+.||......   
T Consensus       133 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~  210 (285)
T cd05630         133 ILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR  210 (285)
T ss_pred             EEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHH--cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH
Confidence            9999888776655321           12467789999998  4456788999999999999999999999764321   


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccCc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKRP  197 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~~  197 (201)
                      ..............+..+++.+.+++.+||+.+|++|||     ++++++||||++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         211 EEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            222222222233456678899999999999999999999     8999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-38  Score=249.71  Aligned_cols=193  Identities=25%  Similarity=0.418  Sum_probs=151.0

Q ss_pred             ccccCCCcceeccceeeeeC--------CeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--------NRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERN   69 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~   69 (201)
                      +|++++||||+++++++...        ...+++|||+.+ ++.+++..     ..+++..+..++.||+.||+|||+.|
T Consensus       112 il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~  190 (440)
T PTZ00036        112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF  190 (440)
T ss_pred             HHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            57889999999998876432        246789999986 77776642     34899999999999999999999999


Q ss_pred             ccccCCCCCcEEEccCC-ceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCC
Q 046714           70 VVHREIKCANILVDASG-LATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        70 i~H~dl~p~nill~~~g-~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      |+||||||+||+++.++ .+++.+...           ...+++.|+|||.+. ....++.++|+||+||++|+|++|..
T Consensus       191 IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlGvil~elltG~~  269 (440)
T PTZ00036        191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELML-GATNYTTHIDLWSLGCIIAEMILGYP  269 (440)
T ss_pred             EecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhc-CCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999998664 455554321           234677899999872 34467899999999999999999999


Q ss_pred             CCCCchHHHHHHHhhcC-------------------CC---------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          138 PYSHLEDMQALFRIGRG-------------------KL---------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       138 p~~~~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                      ||.+....+....+...                   ..         ..++...++++.+|+.+||+++|.+|||+.|++
T Consensus       270 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l  349 (440)
T PTZ00036        270 IFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL  349 (440)
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            99876544433332110                   00         012345678999999999999999999999999


Q ss_pred             cCccccCc
Q 046714          190 EHPFVKRP  197 (201)
Q Consensus       190 ~~~~~~~~  197 (201)
                      +||||...
T Consensus       350 ~hp~f~~~  357 (440)
T PTZ00036        350 ADPFFDDL  357 (440)
T ss_pred             CChhHHhh
Confidence            99999753

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.1e-38  Score=230.17  Aligned_cols=190  Identities=39%  Similarity=0.720  Sum_probs=158.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+++++||||+++++.+.++...++++||+.+++|.+++..  ..+++..+..++.|++.|+.|||+.|++|+||+|+||
T Consensus        51 ~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni  130 (256)
T cd06612          51 ILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNI  130 (256)
T ss_pred             HHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceE
Confidence            46788999999999999999999999999999999999864  3489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|..++.+...            ...++..|+|||.+  .+..++.++|+||+|++++++++|+.||.........
T Consensus       131 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~  208 (256)
T cd06612         131 LLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI--QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI  208 (256)
T ss_pred             EECCCCcEEEcccccchhcccCccccccccCCccccCHHHH--hcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh
Confidence            999988776655321            12256679999997  3456788999999999999999999999876555544


Q ss_pred             HHhhcCCCC--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          149 FRIGRGKLP--SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       149 ~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .........  ..+..++..+.+++.+||+.+|++|||+.++++||||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         209 FMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             hhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            443332222  2234567899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.8e-38  Score=232.49  Aligned_cols=192  Identities=41%  Similarity=0.750  Sum_probs=156.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CC--CHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HL--SDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~--~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++|+||+++++.+..++..++++||+.+++|.+++...  .+  +...+..++.|++.|++|||++|++|+||+|+
T Consensus        58 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~  137 (268)
T cd06624          58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGD  137 (268)
T ss_pred             HHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence            467899999999999999999999999999999999998753  34  77888899999999999999999999999999


Q ss_pred             cEEEcc-CCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           79 NILVDA-SGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        79 nill~~-~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      ||+++. ++..++.+..            ....++..|+|||.+......++.++|+||+|+++|++++|+.||......
T Consensus       138 nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~  217 (268)
T cd06624         138 NVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP  217 (268)
T ss_pred             HEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            999976 4444444321            112357789999998444445788999999999999999999999754322


Q ss_pred             H--HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          146 Q--ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       146 ~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .  ..........+.++..+++++.+++.+||..+|.+|||+++++.||||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         218 QAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             hhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            2  222222334456677889999999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.8e-39  Score=230.91  Aligned_cols=193  Identities=27%  Similarity=0.466  Sum_probs=161.1

Q ss_pred             cccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            2 FSFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      ++|.+++|||||.+-.+....  +..|+||||+.+ +|..++...  +|...+++-++.|+++|++|||.+.|+||||||
T Consensus       127 niLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~  205 (419)
T KOG0663|consen  127 NILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKT  205 (419)
T ss_pred             HHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccch
Confidence            367889999999999986643  569999999988 999999754  499999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           78 ANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      +|+|+...|..++.++.-            ..+-|.+|+|||.+ .....++.+.|+||+||++.+++++++.|++....
T Consensus       206 SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELL-LG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~  284 (419)
T KOG0663|consen  206 SNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELL-LGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI  284 (419)
T ss_pred             hheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHh-cCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH
Confidence            999999998887776532            22346789999998 56678899999999999999999999999988877


Q ss_pred             HHHHHhhcCC-------CC--------------C---------CCC-CCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          146 QALFRIGRGK-------LP--------------S---------VPN-SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       146 ~~~~~~~~~~-------~~--------------~---------~~~-~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      +.+.++....       .+              .         ++. ..++...+|+..+|.+||.+|.|++|+|+|+||
T Consensus       285 dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F  364 (419)
T KOG0663|consen  285 DQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF  364 (419)
T ss_pred             HHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc
Confidence            7766653110       00              0         001 145788899999999999999999999999999


Q ss_pred             cC
Q 046714          195 KR  196 (201)
Q Consensus       195 ~~  196 (201)
                      .+
T Consensus       365 ~e  366 (419)
T KOG0663|consen  365 RE  366 (419)
T ss_pred             cc
Confidence            87

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2e-38  Score=244.18  Aligned_cols=193  Identities=27%  Similarity=0.484  Sum_probs=155.4

Q ss_pred             ccccCCCcceeccceeeeeCC-----eEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN-----RLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +|+.++||||+++++++...+     ..++++||+.+ +|.+.+.. ..++...+..++.||+.||+|||+.|++|+|||
T Consensus        52 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlk  130 (372)
T cd07853          52 MLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIK  130 (372)
T ss_pred             HHHhCCCCCcCCHhheecCCCccccceEEEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence            467899999999999998776     78999999975 78777654 458999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc-------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           77 CANILVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      |+||+++.+|.+++.+...             ...++..|+|||.+. ....++.++|+||+||++|+|++|+.||....
T Consensus       131 p~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  209 (372)
T cd07853         131 PGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM-GSRHYTSAVDIWSVGCIFAELLGRRILFQAQS  209 (372)
T ss_pred             hHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHc-CCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence            9999999988777665431             123567799999973 33456889999999999999999999997665


Q ss_pred             HHHHHHHhhc------------------------C-CCC------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          144 DMQALFRIGR------------------------G-KLP------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       144 ~~~~~~~~~~------------------------~-~~~------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                      .......+..                        . ..+      ......++++.+++.+||+.||++|||++++++||
T Consensus       210 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  289 (372)
T cd07853         210 PIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP  289 (372)
T ss_pred             HHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence            4433322211                        0 000      12334678899999999999999999999999999


Q ss_pred             cccCc
Q 046714          193 FVKRP  197 (201)
Q Consensus       193 ~~~~~  197 (201)
                      ||+..
T Consensus       290 ~~~~~  294 (372)
T cd07853         290 YLDEG  294 (372)
T ss_pred             hhCCC
Confidence            99873

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.9e-38  Score=236.86  Aligned_cols=195  Identities=29%  Similarity=0.538  Sum_probs=155.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.+.+..++++||+.+++|.+++...   .+++..+..++.|++.||+|||+.||+|+||+|+|
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~N  131 (314)
T cd08216          52 TSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASH  131 (314)
T ss_pred             HHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcce
Confidence            467889999999999999999999999999999999998753   48899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCc-------------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Q 046714           80 ILVDASGLATTTNDV-------------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS  140 (201)
Q Consensus        80 ill~~~g~~~~~~~~-------------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  140 (201)
                      |+++.+|.+++.+..                   ....++..|+|||.+......++.++|+||+|++++++++|+.||.
T Consensus       132 ili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~  211 (314)
T cd08216         132 ILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK  211 (314)
T ss_pred             EEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence            999988766554421                   1122455699999984333457889999999999999999999998


Q ss_pred             CchHHHHHHHhhcCCCC---------------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhH
Q 046714          141 HLEDMQALFRIGRGKLP---------------------------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQ  187 (201)
Q Consensus       141 ~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~  187 (201)
                      .............+..+                                 .....++.++.+++.+||+.+|++|||+++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~  291 (314)
T cd08216         212 DMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ  291 (314)
T ss_pred             CCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence            65443332221111100                                 001123467889999999999999999999


Q ss_pred             HhcCccccCc
Q 046714          188 LMEHPFVKRP  197 (201)
Q Consensus       188 il~~~~~~~~  197 (201)
                      +++||||+..
T Consensus       292 ll~~p~~~~~  301 (314)
T cd08216         292 LLNHSFFKQC  301 (314)
T ss_pred             HhcCchHhhh
Confidence            9999999865

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.1e-38  Score=234.16  Aligned_cols=186  Identities=25%  Similarity=0.466  Sum_probs=160.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--------------CCHHHHHHHHHHHHHHHHHHhhc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--------------LSDSQVSSYTRQILNGLTYLHER   68 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~i~~~l~~lh~~   68 (201)
                      ++++++||||+++++++...+..++++||+.+++|.+++...+              +++..+..++.|++.||+|||++
T Consensus        60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~  139 (288)
T cd05093          60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ  139 (288)
T ss_pred             HHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4678999999999999999999999999999999999986432              79999999999999999999999


Q ss_pred             CccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh
Q 046714           69 NVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT  134 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~  134 (201)
                      |++|+||||+||+++.++..++.+....              ..++..|+|||.+  .+..++.++|+||||+++|+|++
T Consensus       140 ~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDiwslG~il~~l~t  217 (288)
T cd05093         140 HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSLGVVLWEIFT  217 (288)
T ss_pred             CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHh--ccCCCCchhhHHHHHHHHHHHHh
Confidence            9999999999999999887766553211              1124569999997  44567889999999999999998


Q ss_pred             -CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          135 -HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       135 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                       |..||......+....+..+.....+..++.++.+++.+||+.+|.+|||+++++.
T Consensus       218 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         218 YGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             99999887776777777776666667778999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.1e-38  Score=232.10  Aligned_cols=190  Identities=45%  Similarity=0.857  Sum_probs=157.4

Q ss_pred             ccccCCCcceeccceeeee--CCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.+  .+..++++||+.+++|.+++... .++......++.|++.||++||+.|++|+||+|+|
T Consensus        57 ~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~n  136 (266)
T cd06651          57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGAN  136 (266)
T ss_pred             HHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence            5788999999999998875  36788999999999999988764 48899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           80 ILVDASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        80 ill~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      |+++.++.+++.+...               ...++..|+|||.+  .+..++.++|+||+|+++|++++|+.||.....
T Consensus       137 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~  214 (266)
T cd06651         137 ILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI--SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA  214 (266)
T ss_pred             EEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHh--CCCCCCchhhhHHHHHHHHHHHHCCCCccccch
Confidence            9999887666554321               12356679999998  455678999999999999999999999987655


Q ss_pred             HHHHHHh-hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          145 MQALFRI-GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       145 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      ....... .....+.++..+++.+++++ +|+..+|++|||++++++||||+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         215 MAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            4444333 23334566677889999998 67778999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.5e-38  Score=229.98  Aligned_cols=190  Identities=27%  Similarity=0.531  Sum_probs=162.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++||||+++++.+..++..++|+||+++++|.+++...   .+++..+..++.|++.++++||++|++|+||+|+|
T Consensus        52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~n  131 (256)
T cd08220          52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQN  131 (256)
T ss_pred             HHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            578899999999999999999999999999999999998753   27899999999999999999999999999999999


Q ss_pred             EEEccCCc-eeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           80 ILVDASGL-ATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        80 ill~~~g~-~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+++.++. .++.+..           ....++..|+|||.+  .+...+.++|+||+|++++++++|+.||........
T Consensus       132 il~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~  209 (256)
T cd08220         132 ILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC--EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL  209 (256)
T ss_pred             EEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhc--cCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH
Confidence            99986543 3343321           112356679999998  345578899999999999999999999988776666


Q ss_pred             HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          148 LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ............+..+++.+.+++.+||..+|.+|||+.++++|||+
T Consensus       210 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         210 VLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            66666665566677789999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.9e-38  Score=238.26  Aligned_cols=187  Identities=29%  Similarity=0.491  Sum_probs=160.7

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG   86 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g   86 (201)
                      +|++|+++++.+.+.+..++||||+++++|.+++... .+++.++..++.|++.||+|||++|++|+||||+||+++.+|
T Consensus        59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~  138 (323)
T cd05615          59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG  138 (323)
T ss_pred             CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC
Confidence            4677888999999999999999999999999988764 589999999999999999999999999999999999999988


Q ss_pred             ceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcC
Q 046714           87 LATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG  154 (201)
Q Consensus        87 ~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  154 (201)
                      ..++.+...            ...+++.|+|||.+  .+..++.++|+||+|+++|+|++|+.||...........+...
T Consensus       139 ~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~  216 (323)
T cd05615         139 HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII--AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH  216 (323)
T ss_pred             CEEEeccccccccCCCCccccCccCCccccCHHHH--cCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            777665431            22367889999998  4456788999999999999999999999887766666665544


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccCc
Q 046714          155 KLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKRP  197 (201)
Q Consensus       155 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~~  197 (201)
                      . ...+..++..+.+++.+||+.+|.+|++     .+++++||||+..
T Consensus       217 ~-~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         217 N-VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             C-CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            3 3567778999999999999999999997     4789999999863

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1e-37  Score=228.64  Aligned_cols=190  Identities=28%  Similarity=0.557  Sum_probs=165.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++|+||+++++++.+.+..++++||+++++|.+++.+.   .++..++..++.|++.++.|||+.|++|+||+|+|
T Consensus        52 ~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~n  131 (256)
T cd08221          52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLN  131 (256)
T ss_pred             HHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHh
Confidence            578899999999999999999999999999999999998764   38999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           80 ILVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        80 ill~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+++.++.+++.+..            ....+++.|.|||.+  .+..++.++|+||+|++++++++|..||......+.
T Consensus       132 i~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~--~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~  209 (256)
T cd08221         132 IFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC--QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL  209 (256)
T ss_pred             EEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhc--CCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            999988876665432            123467789999997  344577899999999999999999999988776666


Q ss_pred             HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          148 LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ...+..+.....+..++.++.+++.+||..+|.+|||++++++++|+
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         210 VVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            66666666656667789999999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-38  Score=244.42  Aligned_cols=192  Identities=23%  Similarity=0.321  Sum_probs=153.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++.+...+..+++||++.+ +|.+++.. ..+++..+..++.||+.||+|||++||+|+||||+||+
T Consensus       139 il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nil  217 (392)
T PHA03207        139 ILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIF  217 (392)
T ss_pred             HHHhcCCCCccceeeeEeeCCEEEEEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence            57889999999999999999999999999965 78887754 45899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH---
Q 046714           82 VDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED---  144 (201)
Q Consensus        82 l~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---  144 (201)
                      ++.+|.+++.+...              ...++..|+|||.+  ....++.++||||+||++|+|++|+.||.....   
T Consensus       218 l~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~  295 (392)
T PHA03207        218 LDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELL--ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS  295 (392)
T ss_pred             EcCCCCEEEccCccccccCcccccccccccccccCccCHhHh--cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc
Confidence            99988777665421              23478889999998  455678899999999999999999999855321   


Q ss_pred             HHHHHHhh--------------------------cCCCCCC-------CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          145 MQALFRIG--------------------------RGKLPSV-------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       145 ~~~~~~~~--------------------------~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ......+.                          ....+..       ....+.++.+++.+||..+|++|||+.++++|
T Consensus       296 ~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        296 SSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            11111100                          0000000       12346678899999999999999999999999


Q ss_pred             ccccCc
Q 046714          192 PFVKRP  197 (201)
Q Consensus       192 ~~~~~~  197 (201)
                      |||++.
T Consensus       376 p~f~~~  381 (392)
T PHA03207        376 PLFTKE  381 (392)
T ss_pred             chhhcc
Confidence            999853

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5e-38  Score=233.55  Aligned_cols=187  Identities=22%  Similarity=0.385  Sum_probs=161.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLTYL   65 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~l   65 (201)
                      .+++++||||+++++++.+.+..++++||+.+++|.+++...                 .++...+..++.|++.||+||
T Consensus        61 ~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l  140 (283)
T cd05048          61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL  140 (283)
T ss_pred             HHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999999999999999998652                 367888999999999999999


Q ss_pred             hhcCccccCCCCCcEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHH
Q 046714           66 HERNVVHREIKCANILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE  131 (201)
Q Consensus        66 h~~~i~H~dl~p~nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~  131 (201)
                      |+.|++|+||||+||+++.++.+++.+...              ...+++.|+|||.+  ....++.++|+||||+++|+
T Consensus       141 H~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDv~slG~il~e  218 (283)
T cd05048         141 SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI--LYGKFTTESDIWSFGVVLWE  218 (283)
T ss_pred             HhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHh--ccCcCchhhhHHHHHHHHHH
Confidence            999999999999999999887766655321              11235669999987  34567899999999999999


Q ss_pred             HHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          132 MLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       132 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +++ |..||.+....+....+..+..+..+..+++++.+++.+||+.+|.+|||+.+++++
T Consensus       219 l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         219 IFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            998 999998877777777777777677788899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.2e-38  Score=235.60  Aligned_cols=193  Identities=32%  Similarity=0.632  Sum_probs=163.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++||||+++++.+..++..++++||+++++|.+++....+++..+..++.|++.|+++||+.|++|+||+|+||++
T Consensus        71 ~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill  150 (297)
T cd06659          71 IMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL  150 (297)
T ss_pred             HHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE
Confidence            46788999999999999999999999999999999999887779999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|..++.+..            ....++..|+|||.+  .+..++.++|+||+|++++++++|+.||...........
T Consensus       151 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  228 (297)
T cd06659         151 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI--SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR  228 (297)
T ss_pred             ccCCcEEEeechhHhhcccccccccceecCccccCHHHH--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            988877666532            123366789999998  345678899999999999999999999977665555444


Q ss_pred             hhcCCC--CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          151 IGRGKL--PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       151 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      +.....  .......+..+.+++.+||+.+|++|||++++++||||.+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         229 LRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             HhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence            433222  12234578899999999999999999999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3e-38  Score=235.25  Aligned_cols=188  Identities=29%  Similarity=0.500  Sum_probs=150.4

Q ss_pred             cccCCCcceeccceeeee-----CCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCC
Q 046714            4 FSQFEHDNIVQYIGTEKD-----ENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREI   75 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl   75 (201)
                      +++++||||+++++++..     ....++++|++.+ +|.+++...   .+++..+..++.|++.||+|||+.|++|+||
T Consensus        56 l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~di  134 (288)
T cd07863          56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDL  134 (288)
T ss_pred             hhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            345689999999998764     3458999999986 888887653   3899999999999999999999999999999


Q ss_pred             CCCcEEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           76 KCANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      ||+||+++.+|..++.+...           ...++..|+|||.+  .+..++.++|+||+|+++|+|++|+.||.....
T Consensus       135 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~  212 (288)
T cd07863         135 KPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE  212 (288)
T ss_pred             CHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHh--hCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence            99999999988777665321           22356779999998  455678999999999999999999999976654


Q ss_pred             HHHHHHhhcCC------------------C--------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          145 MQALFRIGRGK------------------L--------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       145 ~~~~~~~~~~~------------------~--------~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ......+....                  .        ......+++.+.+++.+||+.||++|||++++++||||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         213 ADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             HHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            44333321100                  0        01123467888999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-38  Score=232.97  Aligned_cols=191  Identities=35%  Similarity=0.659  Sum_probs=161.0

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCc
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGL   87 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~   87 (201)
                      .||||+++++++..+...++++||+.+++|.++++...+++..+..++.|++.|+.|||+.|++|+||+|+||+++.+|.
T Consensus        60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~  139 (277)
T cd06917          60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN  139 (277)
T ss_pred             CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC
Confidence            49999999999999999999999999999999998878999999999999999999999999999999999999998877


Q ss_pred             eeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCC
Q 046714           88 ATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK  155 (201)
Q Consensus        88 ~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  155 (201)
                      ..+.+..            ....++..|+|||.+. .+..++.++|+||+|+++|++++|+.||................
T Consensus       140 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~  218 (277)
T cd06917         140 VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT-EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK  218 (277)
T ss_pred             EEEccCCceeecCCCccccccccCCcceeCHHHhc-cCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCC
Confidence            6665532            1123566799999873 34557889999999999999999999998776555444433333


Q ss_pred             CCCCCC-CCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          156 LPSVPN-SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       156 ~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      .+.++. ..+.++.+++.+||..+|.+|||+.+++.|+||+....
T Consensus       219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         219 PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence            344443 37889999999999999999999999999999987653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.3e-38  Score=231.32  Aligned_cols=185  Identities=28%  Similarity=0.491  Sum_probs=154.8

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG   86 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g   86 (201)
                      +||||+++++.+...+..++||||+++++|.+++... .+++.++..++.|+++|+++||+.|++|+||+|+||+++.++
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~  146 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK  146 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC
Confidence            7999999999999999999999999999999998775 689999999999999999999999999999999999999887


Q ss_pred             -ceeeecCc--------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHHHhhc
Q 046714           87 -LATTTNDV--------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ----ALFRIGR  153 (201)
Q Consensus        87 -~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~  153 (201)
                       ...+.+..        ....++..|+|||.+  .+..++.++|+||+|+++|++++|+.||.......    ...... 
T Consensus       147 ~~~~l~dfg~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-  223 (267)
T PHA03390        147 DRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKI--KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-  223 (267)
T ss_pred             CeEEEecCccceecCCCccCCCCCcccChhhh--cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-
Confidence             55554432        223467789999998  34567889999999999999999999997543222    111112 


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-HhHHhcCcccc
Q 046714          154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPT-AAQLMEHPFVK  195 (201)
Q Consensus       154 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-~~~il~~~~~~  195 (201)
                      ......+...++.+.+++.+||+.+|.+|++ ++++++||||+
T Consensus       224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        224 QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            2233455578999999999999999999995 69999999996

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.8e-38  Score=229.07  Aligned_cols=191  Identities=60%  Similarity=1.067  Sum_probs=162.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      .+++++||||+++++.+.++...++++||+++++|.+++.+.+ +++..+..++.|++.|+++||+.|++|+||+|+||+
T Consensus        55 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~  134 (258)
T cd06632          55 LLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANIL  134 (258)
T ss_pred             HHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence            4678899999999999999999999999999999999987655 899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           82 VDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        82 l~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      ++.++..++.+..           ....++..|++||.+. ....++.++|+||+|+++|++++|+.||...........
T Consensus       135 ~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~-~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~  213 (258)
T cd06632         135 VDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA-QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK  213 (258)
T ss_pred             ECCCCCEEEccCccceeccccccccccCCCcceeCHHHhc-CCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH
Confidence            9988877665532           2233567799999973 222478899999999999999999999977665444444


Q ss_pred             hhc-CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          151 IGR-GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       151 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ... ...+..+..+++.+.+++.+||+.+|.+|||+++++.|||+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         214 IGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            333 44556677789999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.2e-38  Score=234.56  Aligned_cols=192  Identities=27%  Similarity=0.421  Sum_probs=160.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +++.++||||+++++.+..++..+++|||+.|++|.++++.. .+++..+..++.|++.|++|||+.|++|+||+|+||+
T Consensus        54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIl  133 (305)
T cd05609          54 ILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLL  133 (305)
T ss_pred             HHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEE
Confidence            467889999999999999999999999999999999998764 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCccc---------------------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh
Q 046714           82 VDASGLATTTNDVKS---------------------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT  134 (201)
Q Consensus        82 l~~~g~~~~~~~~~~---------------------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~  134 (201)
                      ++.+|.+++.+....                           ..++..|+|||.+  .....+.++|+||||+++|++++
T Consensus       134 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~vl~el~~  211 (305)
T cd05609         134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI--LRQGYGKPVDWWAMGIILYEFLV  211 (305)
T ss_pred             ECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhc--cCCCCCchhhHHHHHHHHHHHHh
Confidence            998887666553311                           1245679999997  44567899999999999999999


Q ss_pred             CCCCCCCchHHHHHHHhhcCCC--CCCCCCCCHHHHHHHHHHhhcCCCCCCC---HhHHhcCccccC
Q 046714          135 HQPPYSHLEDMQALFRIGRGKL--PSVPNSLSRDARDFILKCLQVNPNDRPT---AAQLMEHPFVKR  196 (201)
Q Consensus       135 g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~t---~~~il~~~~~~~  196 (201)
                      |+.||.+....+..........  +.....++..+.+++.+||+.+|++||+   +.++++||||..
T Consensus       212 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         212 GCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            9999987766665555444322  2223367899999999999999999998   789999999854

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-39  Score=233.03  Aligned_cols=192  Identities=30%  Similarity=0.570  Sum_probs=157.5

Q ss_pred             ccccCCCcceeccceeeee-----CCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD-----ENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      .|+.++|+||+.+++++..     -+..|+|+|++.. +|...++.+. ++.+.+...+.||+.|++|+|+.+++|||||
T Consensus        74 lLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLK  152 (359)
T KOG0660|consen   74 LLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLK  152 (359)
T ss_pred             HHHHhcCCCcceEEeecccccccccceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccc
Confidence            4678899999999999876     2468999999955 9999999887 9999999999999999999999999999999


Q ss_pred             CCcEEEccC--------CceeeecC------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc
Q 046714           77 CANILVDAS--------GLATTTND------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL  142 (201)
Q Consensus        77 p~nill~~~--------g~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  142 (201)
                      |.|++++.+        |++...+.      .+..+.|.+|+|||+. .....++...||||+||++.||++|+..|++.
T Consensus       153 PsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPEll-l~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~  231 (359)
T KOG0660|consen  153 PSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELL-LNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK  231 (359)
T ss_pred             hhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHH-hccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence            999999876        44444321      2344567889999998 56778999999999999999999999999877


Q ss_pred             hHHHHHHHhhc-------------------------CCCCC-----CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          143 EDMQALFRIGR-------------------------GKLPS-----VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       143 ~~~~~~~~~~~-------------------------~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                      +....+..+..                         ...+.     .-.+.++.+.+|+.+||..||.+|+|++|+|+||
T Consensus       232 d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  232 DYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             chHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence            65444433211                         11111     1135788999999999999999999999999999


Q ss_pred             cccC
Q 046714          193 FVKR  196 (201)
Q Consensus       193 ~~~~  196 (201)
                      |+..
T Consensus       312 Yl~~  315 (359)
T KOG0660|consen  312 YLAP  315 (359)
T ss_pred             hhhh
Confidence            9864

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6e-38  Score=232.81  Aligned_cols=191  Identities=28%  Similarity=0.406  Sum_probs=159.0

Q ss_pred             ccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEc
Q 046714            5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD   83 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~   83 (201)
                      ...+||||+.+++.+..++..++||||+.+++|.+++... .+++..+..++.|++.||+|||+.|++|+||||+||+++
T Consensus        52 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~  131 (279)
T cd05633          52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD  131 (279)
T ss_pred             hhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC
Confidence            3457999999999999999999999999999999988654 489999999999999999999999999999999999999


Q ss_pred             cCCceeeecCcc----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHh
Q 046714           84 ASGLATTTNDVK----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED--MQALFRI  151 (201)
Q Consensus        84 ~~g~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~  151 (201)
                      .++..++.+...          ...++..|+|||.+. .+..++.++|+||+|+++|++++|..||.....  .......
T Consensus       132 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  210 (279)
T cd05633         132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM  210 (279)
T ss_pred             CCCCEEEccCCcceeccccCccCcCCCcCccCHHHhc-CCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH
Confidence            888766655331          224678899999873 345578899999999999999999999965322  2222233


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccC
Q 046714          152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKR  196 (201)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~  196 (201)
                      .......++..++.++.+++.+||..+|.+|+     |++++++||||+.
T Consensus       211 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         211 TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence            33334456777899999999999999999999     6999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.3e-38  Score=240.79  Aligned_cols=190  Identities=23%  Similarity=0.449  Sum_probs=150.3

Q ss_pred             ccccCCCcceeccceeeeeCC------eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN------RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      ++++++||||+++++++...+      ..+++|||+.+ ++...+.. .++...+..++.|++.||+|||+.|++|+|||
T Consensus        73 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlk  150 (359)
T cd07876          73 LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  150 (359)
T ss_pred             HHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            467899999999999986543      47999999976 66666543 47889999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           77 CANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |+||+++.+|.+++.+...           ...++..|+|||.+  .+..++.++|+||+|+++|+|++|+.||...+..
T Consensus       151 p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~  228 (359)
T cd07876         151 PSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI  228 (359)
T ss_pred             HHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhc--cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999998887766432           12357789999998  4556788999999999999999999999765443


Q ss_pred             HHHHHhhc---------------------CCCC--------------------CCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 046714          146 QALFRIGR---------------------GKLP--------------------SVPNSLSRDARDFILKCLQVNPNDRPT  184 (201)
Q Consensus       146 ~~~~~~~~---------------------~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~R~t  184 (201)
                      ..+.....                     ...+                    ......++.+++++.+||+.+|++|||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t  308 (359)
T cd07876         229 DQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS  308 (359)
T ss_pred             HHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCC
Confidence            32211100                     0000                    011224577899999999999999999


Q ss_pred             HhHHhcCccccC
Q 046714          185 AAQLMEHPFVKR  196 (201)
Q Consensus       185 ~~~il~~~~~~~  196 (201)
                      +.|+++||||+.
T Consensus       309 ~~e~l~hp~~~~  320 (359)
T cd07876         309 VDEALRHPYITV  320 (359)
T ss_pred             HHHHhcCchhhh
Confidence            999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.8e-38  Score=249.71  Aligned_cols=192  Identities=24%  Similarity=0.449  Sum_probs=164.9

Q ss_pred             ccccCCCcceeccceeeeeCC--------eEEEEEEecCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN--------RLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQILNGLTYLHERN   69 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~~   69 (201)
                      .|..++|+||+++++.+....        ..++||||+.+++|.+++...     .+++..+..++.|++.||+|||+.|
T Consensus        84 ~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~  163 (496)
T PTZ00283         84 CLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH  163 (496)
T ss_pred             HHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            366789999999988765432        368999999999999988642     4889999999999999999999999


Q ss_pred             ccccCCCCCcEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC
Q 046714           70 VVHREIKCANILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH  135 (201)
Q Consensus        70 i~H~dl~p~nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g  135 (201)
                      ++|+||||+||+++.+|.+++.+...              ...|++.|+|||.+  .+..++.++||||||+++|++++|
T Consensus       164 IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~--~~~~~s~k~DVwSlGvilyeLltG  241 (496)
T PTZ00283        164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW--RRKPYSKKADMFSLGVLLYELLTL  241 (496)
T ss_pred             EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHh--CCCCCCcHHHHHHHHHHHHHHHHC
Confidence            99999999999999988777665431              23478889999998  455678999999999999999999


Q ss_pred             CCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          136 QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       136 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      +.||..............+.....+..+++++.+++.+||+.+|.+|||+.++++|||++.
T Consensus       242 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        242 KRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            9999888777777777777666778889999999999999999999999999999998764

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-38  Score=241.89  Aligned_cols=191  Identities=24%  Similarity=0.351  Sum_probs=148.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++...+..++|+|++.+ +|.+++..  ..+++..+..++.||+.||.|||++||+|+||||+||
T Consensus       110 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Ni  188 (357)
T PHA03209        110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENI  188 (357)
T ss_pred             HHHhCCCCCCcChhheEEeCCeeEEEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            57889999999999999999999999999965 88887754  3489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCC-CCchHH---
Q 046714           81 LVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY-SHLEDM---  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~-~~~~~~---  145 (201)
                      +++.++.+++.+...           ...++..|+|||.+  .+..++.++|+||+||++|+++++..++ ......   
T Consensus       189 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~  266 (357)
T PHA03209        189 FINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVL--ARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE  266 (357)
T ss_pred             EECCCCCEEEecCccccccccCcccccccccccccCCeec--CCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHH
Confidence            999888777665432           12367889999998  4456789999999999999999854443 321100   


Q ss_pred             ------HHHHHhhc---CCCCCC------------------------------CCCCCHHHHHHHHHHhhcCCCCCCCHh
Q 046714          146 ------QALFRIGR---GKLPSV------------------------------PNSLSRDARDFILKCLQVNPNDRPTAA  186 (201)
Q Consensus       146 ------~~~~~~~~---~~~~~~------------------------------~~~~~~~~~~li~~~l~~~p~~R~t~~  186 (201)
                            ........   .....+                              ...++..+.++|.+||+.+|.+|||++
T Consensus       267 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~  346 (357)
T PHA03209        267 YVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAE  346 (357)
T ss_pred             HHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHH
Confidence                  00111000   000000                              113466777899999999999999999


Q ss_pred             HHhcCccccC
Q 046714          187 QLMEHPFVKR  196 (201)
Q Consensus       187 ~il~~~~~~~  196 (201)
                      |+++||||+.
T Consensus       347 e~l~hp~f~~  356 (357)
T PHA03209        347 EILNYPMFAQ  356 (357)
T ss_pred             HHhcCchhcc
Confidence            9999999985

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8.2e-38  Score=233.35  Aligned_cols=186  Identities=25%  Similarity=0.464  Sum_probs=160.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-----------------CCHHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----------------LSDSQVSSYTRQILNGLTYL   65 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------------~~~~~~~~~~~~i~~~l~~l   65 (201)
                      ++++++||||+++++++...+..+++|||+++++|.+++...+                 +++..++.++.||+.|++||
T Consensus        60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l  139 (291)
T cd05094          60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL  139 (291)
T ss_pred             HHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999999999999999986532                 68889999999999999999


Q ss_pred             hhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHH
Q 046714           66 HERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE  131 (201)
Q Consensus        66 h~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~  131 (201)
                      |++|++|+||||+||+++.++.+++.+....              ..++..|+|||.+  .+..++.++|+||||+++|+
T Consensus       140 H~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~e  217 (291)
T cd05094         140 ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWE  217 (291)
T ss_pred             HhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHh--ccCCCCchhhHHHHHHHHHH
Confidence            9999999999999999998887666553211              1234569999987  45567889999999999999


Q ss_pred             HHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          132 MLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       132 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +++ |+.||...........+..+.....+...+..+.+++.+||+.+|++|||+.++++
T Consensus       218 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         218 IFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            998 99999887777777667666666667778999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.3e-38  Score=239.18  Aligned_cols=195  Identities=27%  Similarity=0.479  Sum_probs=154.5

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++.++||||+++++++..++..++++||+.++++.+++.+.   ++++..+..++.|++.||+|||++|++|+||||+||
T Consensus        53 ~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Ni  132 (328)
T cd08226          53 SHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHI  132 (328)
T ss_pred             HHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            45689999999999999999999999999999999988753   488999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-------------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Q 046714           81 LVDASGLATTTNDVK-------------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH  141 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  141 (201)
                      +++.++..+..+...                   ...++..|+|||.+......++.++|+||+|+++|++++|+.||..
T Consensus       133 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~  212 (328)
T cd08226         133 LISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD  212 (328)
T ss_pred             EEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999887665443210                   0112345999999843335578999999999999999999999976


Q ss_pred             chHHHHHHHhhcCCC----------------------------------------------CCCCCCCCHHHHHHHHHHh
Q 046714          142 LEDMQALFRIGRGKL----------------------------------------------PSVPNSLSRDARDFILKCL  175 (201)
Q Consensus       142 ~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~li~~~l  175 (201)
                      ...............                                              ......+++.+.+++++||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  292 (328)
T cd08226         213 MLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCL  292 (328)
T ss_pred             cChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHc
Confidence            644333322211100                                              0112235677899999999


Q ss_pred             hcCCCCCCCHhHHhcCccccCcC
Q 046714          176 QVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       176 ~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      +.+|++|||++++++||||+...
T Consensus       293 ~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         293 QQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             cCCcccCCCHHHHhhCHHHHHHH
Confidence            99999999999999999997543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.5e-38  Score=234.13  Aligned_cols=195  Identities=32%  Similarity=0.549  Sum_probs=162.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY----HLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p   77 (201)
                      ++++++||||+++++.+...+..++++||+++++|..++...    .+++..+..++.|++.|+.|||+ .|++|+||+|
T Consensus        52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p  131 (286)
T cd06622          52 ILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKP  131 (286)
T ss_pred             HHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCH
Confidence            467899999999999999999999999999999999988764    68999999999999999999997 5999999999


Q ss_pred             CcEEEccCCceeeecCcc----------ccccCcccccccccccCC----CCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           78 ANILVDASGLATTTNDVK----------SFEGTPFWVAPEVVNLKN----NGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~----------~~~~~~~~~aPE~~~~~~----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      +||+++.++..++.+...          ...++..|+|||.+....    ..++.++|+||+|+++|++++|+.||....
T Consensus       132 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  211 (286)
T cd06622         132 TNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET  211 (286)
T ss_pred             HHEEECCCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc
Confidence            999999988776665431          123566799999874321    235789999999999999999999996644


Q ss_pred             HHHH---HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          144 DMQA---LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       144 ~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ....   ...+..+..+..+..+++++.+++.+||+.+|.+||+++++++||||...
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         212 YANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             hhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence            3332   22344455566677799999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.1e-38  Score=231.32  Aligned_cols=192  Identities=32%  Similarity=0.596  Sum_probs=161.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~n   79 (201)
                      .+++++||||+++++.+..++..++++||+.+++|.+++...  .+++..+..++.|++.|+++||+ .|++|+||+|+|
T Consensus        52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~n  131 (265)
T cd06605          52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN  131 (265)
T ss_pred             HHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHH
Confidence            467789999999999999999999999999999999998753  58999999999999999999999 999999999999


Q ss_pred             EEEccCCceeeecCcc----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc-----hH
Q 046714           80 ILVDASGLATTTNDVK----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL-----ED  144 (201)
Q Consensus        80 ill~~~g~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-----~~  144 (201)
                      |+++.+|..++.+...          ...++..|+|||.+  .+..++.++|+||+|++++++++|+.||...     ..
T Consensus       132 i~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  209 (265)
T cd06605         132 ILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERI--QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI  209 (265)
T ss_pred             EEECCCCCEEEeecccchhhHHHHhhcccCChhccCHHHH--cCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH
Confidence            9999988776665422          13456789999998  3447789999999999999999999999654     22


Q ss_pred             HHHHHHhhcCCCCCCCCC-CCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          145 MQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ............+..+.. +++.+.+++.+||..+|++|||+.+++.||||+.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         210 FELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            233333444444455554 8899999999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.2e-38  Score=235.14  Aligned_cols=193  Identities=30%  Similarity=0.555  Sum_probs=156.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++.+.+++..++++||+++++|.+++++. .+++..+..++.|++.||.|||+ .+++|+||+|+||
T Consensus        52 ~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~ni  131 (308)
T cd06615          52 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNI  131 (308)
T ss_pred             HHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHE
Confidence            477899999999999999999999999999999999998764 48999999999999999999997 5999999999999


Q ss_pred             EEccCCceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           81 LVDASGLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        81 ll~~~g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +++.+|..++.+..          ....++..|+|||.+  .+..++.++|+||+|++++++++|+.||...........
T Consensus       132 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~  209 (308)
T cd06615         132 LVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL--QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM  209 (308)
T ss_pred             EEecCCcEEEccCCCcccccccccccCCCCcCccChhHh--cCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHh
Confidence            99988877665532          123467789999987  345578899999999999999999999865433222211


Q ss_pred             hh------------------------------------cCCCCCCC-CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcc
Q 046714          151 IG------------------------------------RGKLPSVP-NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF  193 (201)
Q Consensus       151 ~~------------------------------------~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~  193 (201)
                      ..                                    ....+..+ ..++.++++++.+||..+|++|||++++++|||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             hcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            11                                    01111111 136778999999999999999999999999999


Q ss_pred             ccCc
Q 046714          194 VKRP  197 (201)
Q Consensus       194 ~~~~  197 (201)
                      |...
T Consensus       290 ~~~~  293 (308)
T cd06615         290 IKRA  293 (308)
T ss_pred             hhhc
Confidence            9764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.1e-38  Score=228.82  Aligned_cols=194  Identities=31%  Similarity=0.551  Sum_probs=161.2

Q ss_pred             ccccCCCcc-eeccceeeeeCC------eEEEEEEecCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcCc
Q 046714            3 SFSQFEHDN-IVQYIGTEKDEN------RLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQILNGLTYLHERNV   70 (201)
Q Consensus         3 ~l~~l~h~~-I~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~~i   70 (201)
                      +|++++|+| |+++++++.+.+      ..++|+||.+. +|..++...     +++...++.++.||+.||+|||+++|
T Consensus        63 llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~I  141 (323)
T KOG0594|consen   63 LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGI  141 (323)
T ss_pred             HHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            478899999 999999998877      89999999977 999998753     47888999999999999999999999


Q ss_pred             cccCCCCCcEEEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCC
Q 046714           71 VHREIKCANILVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPP  138 (201)
Q Consensus        71 ~H~dl~p~nill~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p  138 (201)
                      +||||||+|++|+.+|..++.++.            .....|.+|+|||.+ .....++...|+||+||++.+|++++.-
T Consensus       142 lHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvL-lGs~~Ys~~vDiWs~GcIfaEm~~~~~L  220 (323)
T KOG0594|consen  142 LHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVL-LGSTSYSTSVDIWSLGCIFAEMFTRRPL  220 (323)
T ss_pred             ecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHh-cCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence            999999999999999988777653            223367789999998 4455789999999999999999999999


Q ss_pred             CCCchHHHHHHHhhcC-------CCC----------CC------------CCCCCHHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          139 YSHLEDMQALFRIGRG-------KLP----------SV------------PNSLSRDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       139 ~~~~~~~~~~~~~~~~-------~~~----------~~------------~~~~~~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                      |++..+.+....+..-       ..+          .+            .+..+++..+++.+||+++|.+|.|++.++
T Consensus       221 FpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al  300 (323)
T KOG0594|consen  221 FPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGAL  300 (323)
T ss_pred             CCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHh
Confidence            9988777666554210       000          00            012345788999999999999999999999


Q ss_pred             cCccccCcC
Q 046714          190 EHPFVKRPL  198 (201)
Q Consensus       190 ~~~~~~~~~  198 (201)
                      .||||...-
T Consensus       301 ~h~yf~~~~  309 (323)
T KOG0594|consen  301 THPYFSELP  309 (323)
T ss_pred             cChhhcccc
Confidence            999998763

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-38  Score=234.52  Aligned_cols=186  Identities=27%  Similarity=0.498  Sum_probs=155.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      .+++++||||++++|++...+..++|+||+.+++|.+++...   .+++..+..++.||+.||+|||+++++|++|+++|
T Consensus        54 ~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~n  133 (259)
T PF07714_consen   54 ILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSN  133 (259)
T ss_dssp             HHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGG
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            467889999999999999888899999999999999999876   59999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           80 ILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      |+++.++.+++.+..-.              ......|.|||.+  ....++.++||||||+++|++++ |+.||.+...
T Consensus       134 ill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~  211 (259)
T PF07714_consen  134 ILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVL--KDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN  211 (259)
T ss_dssp             EEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHH--HHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence            99999988777654211              1134469999997  34457899999999999999999 7899998888


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .+....+..+.....+..++..+.+++.+||..+|.+|||+.++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  212 EEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            8877777777777778889999999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.8e-38  Score=238.37  Aligned_cols=186  Identities=24%  Similarity=0.469  Sum_probs=150.4

Q ss_pred             ccccC-CCcceeccceeeeeC-CeEEEEEEecCCCCHHHHHHhc------------------------------------
Q 046714            3 SFSQF-EHDNIVQYIGTEKDE-NRLYIFLELVKKGSLANLYQKY------------------------------------   44 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~------------------------------------   44 (201)
                      +|+++ +||||+++++.+... +..+++|||+++|+|.+++...                                    
T Consensus        63 ~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (338)
T cd05102          63 ILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQA  142 (338)
T ss_pred             HHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccC
Confidence            35566 899999999988764 4588999999999999988642                                    


Q ss_pred             ---------------------------CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCccc-
Q 046714           45 ---------------------------HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS-   96 (201)
Q Consensus        45 ---------------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~-   96 (201)
                                                 .+++..+..++.||+.||+|||++|++|+||||+||+++.++.+++.+.... 
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~  222 (338)
T cd05102         143 SVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR  222 (338)
T ss_pred             CccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeeccccc
Confidence                                       2667788899999999999999999999999999999998887766654311 


Q ss_pred             -------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH-HHHHHhhcCCCCCCCC
Q 046714           97 -------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM-QALFRIGRGKLPSVPN  161 (201)
Q Consensus        97 -------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~-~~~~~~~~~~~~~~~~  161 (201)
                                   ..++..|+|||.+  .+..++.++||||||+++|++++ |..||...... ........+.....+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  300 (338)
T cd05102         223 DIYKDPDYVRKGSARLPLKWMAPESI--FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPE  300 (338)
T ss_pred             ccccCcchhcccCCCCCccccCcHHh--hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCC
Confidence                         1234579999997  45567899999999999999997 99999775432 2333344444455667


Q ss_pred             CCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          162 SLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       162 ~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .+++.+.+++.+||+.+|.+|||+.++++
T Consensus       301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         301 NATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            78999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-38  Score=229.37  Aligned_cols=191  Identities=41%  Similarity=0.708  Sum_probs=157.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++.+.+++..+++|||+.+++|.+++...  .+++..+..++.|++.|++|||+.|++|+||+|+||
T Consensus        53 ~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni  132 (262)
T cd06613          53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANI  132 (262)
T ss_pred             HHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhE
Confidence            467899999999999999999999999999999999988654  589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLK-NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +++.+|..++.+...            ...++..|+|||.+... ...++.++|+||+|+++|+|++|+.||........
T Consensus       133 ~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~  212 (262)
T cd06613         133 LLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA  212 (262)
T ss_pred             EECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999988776665321            12356679999997321 12677899999999999999999999987665554


Q ss_pred             HHHhhcCCC----CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcc
Q 046714          148 LFRIGRGKL----PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF  193 (201)
Q Consensus       148 ~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~  193 (201)
                      .........    ......++.++.+++.+||..+|.+|||+++++.|+|
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         213 LFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            444333311    1123345788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-38  Score=238.59  Aligned_cols=194  Identities=25%  Similarity=0.408  Sum_probs=158.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++.+.+++..++||||+.+++|.+++.+  ..+++..+..++.||+.||+|||++|++|+||||+||
T Consensus        54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni  133 (331)
T cd05597          54 VLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNV  133 (331)
T ss_pred             HHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHE
Confidence            45678999999999999999999999999999999999875  3489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-------------ccccCcccccccccccC---CCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           81 LVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLK---NNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      +++.+|.+++.+...             ...+++.|+|||.+...   ...++.++|+||+||++|+|++|+.||.....
T Consensus       134 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~  213 (331)
T cd05597         134 LLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL  213 (331)
T ss_pred             EECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence            999888776655321             12368889999998421   23467899999999999999999999987665


Q ss_pred             HHHHHHhhcCC----CCCCCCCCCHHHHHHHHHHhhcCCCC--CCCHhHHhcCccccC
Q 046714          145 MQALFRIGRGK----LPSVPNSLSRDARDFILKCLQVNPND--RPTAAQLMEHPFVKR  196 (201)
Q Consensus       145 ~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~--R~t~~~il~~~~~~~  196 (201)
                      .+....+....    .+.....+++.+++++++|++.++++  |++++++++||||..
T Consensus       214 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         214 VETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             HHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            55554443221    12223457899999999998764443  789999999999975

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-38  Score=240.60  Aligned_cols=193  Identities=25%  Similarity=0.450  Sum_probs=154.7

Q ss_pred             ccccCCCcceeccceeeeeC------CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE------NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +|++++||||+++++++...      ...+++++++ +++|.++++...+++..+..++.|++.||+|||+.|++|+|||
T Consensus        67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdik  145 (343)
T cd07878          67 LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLK  145 (343)
T ss_pred             HHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence            57889999999999987643      3578999988 6699998887789999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           77 CANILVDASGLATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+||+++.+|.+++.+..         ....++..|+|||.+. ....++.++|+||+|+++|+|++|+.||........
T Consensus       146 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  224 (343)
T cd07878         146 PSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ  224 (343)
T ss_pred             hhhEEECCCCCEEEcCCccceecCCCcCCccccccccCchHhc-CCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence            999999998877766543         2234678899999983 334678899999999999999999999976544333


Q ss_pred             HHHhhcC----------------------CCCC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGRG----------------------KLPS--------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~----------------------~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+...                      ..+.        .....++.+.+++.+||..+|.+|||+.++++||||...
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         225 LKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             HHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence            2221110                      0000        112356778899999999999999999999999999764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1e-37  Score=232.29  Aligned_cols=193  Identities=37%  Similarity=0.724  Sum_probs=163.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+++++|+||+++++.+...+..++++||+.+++|.+++...  .++...+..++.|++.|+++||+.|++|+||+|+||
T Consensus        68 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni  147 (286)
T cd06614          68 IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNI  147 (286)
T ss_pred             HHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhE
Confidence            467889999999999999999999999999999999999876  699999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|..++.+..            ....++..|++||.+  .+..++.++|+||+|+++|++++|+.||.........
T Consensus       148 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~  225 (286)
T cd06614         148 LLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI--KRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL  225 (286)
T ss_pred             EEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHh--cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99988877665532            112355679999987  3456788999999999999999999999877665554


Q ss_pred             HHhhcCCCCCCC--CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          149 FRIGRGKLPSVP--NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       149 ~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ..+.....+...  ..++..+.+++.+||+.+|.+|||+.++++|+||+..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             HHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence            444433333222  2378899999999999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.7e-37  Score=227.55  Aligned_cols=186  Identities=25%  Similarity=0.474  Sum_probs=159.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++..++..+++|||+++++|.+++...  .+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni  131 (256)
T cd05114          52 VMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNC  131 (256)
T ss_pred             HHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceE
Confidence            578899999999999999999999999999999999988643  488999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.++..++.+....             ..++..|+|||.+  ....++.++|+||+|+++|++++ |+.||......+
T Consensus       132 ~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~  209 (256)
T cd05114         132 LVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVF--NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE  209 (256)
T ss_pred             EEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhc--ccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9998887666553211             1123469999998  34567889999999999999999 899998877777


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ....+..+.....+...+..+.+++.+||+.+|++|||++++++
T Consensus       210 ~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         210 VVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            77777666655566677899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.2e-37  Score=229.64  Aligned_cols=191  Identities=39%  Similarity=0.713  Sum_probs=155.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +++.++||||+++++.+...+..++++||+.+++|.+++... .+++.++..++.|++.|++|||+.|++|+||+|+||+
T Consensus        59 ~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil  138 (267)
T cd06645          59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANIL  138 (267)
T ss_pred             HHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence            467889999999999999999999999999999999988654 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc------------cccccCccccccccccc-CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           82 VDASGLATTTNDV------------KSFEGTPFWVAPEVVNL-KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        82 l~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      ++.+|..++.+..            ....++..|+|||.+.. ....++.++|+||+|+++|++++|+.||.........
T Consensus       139 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~  218 (267)
T cd06645         139 LTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL  218 (267)
T ss_pred             ECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH
Confidence            9988766554422            12346778999998732 2345778999999999999999999998655443333


Q ss_pred             HHhhcCCC--CCC--CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcc
Q 046714          149 FRIGRGKL--PSV--PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF  193 (201)
Q Consensus       149 ~~~~~~~~--~~~--~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~  193 (201)
                      ........  +..  ...++..+.+++.+||+.+|++|||++++++|||
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         219 FLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            33222211  111  1246788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.1e-38  Score=240.48  Aligned_cols=190  Identities=24%  Similarity=0.436  Sum_probs=151.6

Q ss_pred             ccccCCCcceeccceeeeeC------CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE------NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +++.++||||+++++++...      ...++||||+.+ +|.+.+.. .++...+..++.|++.||+|||++|++|+|||
T Consensus        76 ~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlk  153 (364)
T cd07875          76 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  153 (364)
T ss_pred             HHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCC
Confidence            46788999999999987643      357999999976 77776653 47889999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           77 CANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |+||+++.+|.+++.+...           ...++..|+|||.+  .+..++.++|+|||||++|+|++|+.||......
T Consensus       154 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  231 (364)
T cd07875         154 PSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI  231 (364)
T ss_pred             HHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHH--hCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999988777766432           23467789999998  4566789999999999999999999999876554


Q ss_pred             HHHHHhhcCC---------------------CC--------------------CCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 046714          146 QALFRIGRGK---------------------LP--------------------SVPNSLSRDARDFILKCLQVNPNDRPT  184 (201)
Q Consensus       146 ~~~~~~~~~~---------------------~~--------------------~~~~~~~~~~~~li~~~l~~~p~~R~t  184 (201)
                      .....+....                     .+                    ......+..+.+++.+||+.||.+|||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t  311 (364)
T cd07875         232 DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS  311 (364)
T ss_pred             HHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCC
Confidence            4433322100                     00                    011123467899999999999999999


Q ss_pred             HhHHhcCccccC
Q 046714          185 AAQLMEHPFVKR  196 (201)
Q Consensus       185 ~~~il~~~~~~~  196 (201)
                      ++++++||||+.
T Consensus       312 ~~e~L~hp~~~~  323 (364)
T cd07875         312 VDEALQHPYINV  323 (364)
T ss_pred             HHHHhcCccccc
Confidence            999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-37  Score=232.00  Aligned_cols=191  Identities=27%  Similarity=0.532  Sum_probs=154.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++.+..+...++++||+++++|..++... .+++..+..++.|++.||+|||+.|++|+||+|+||+
T Consensus        53 ~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil  132 (286)
T cd07847          53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENIL  132 (286)
T ss_pred             HHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEE
Confidence            467899999999999999999999999999998888776543 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...++..|+|||.+. ....++.++|+||+|++++++++|+.||.+....+...
T Consensus       133 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~  211 (286)
T cd07847         133 ITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV-GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY  211 (286)
T ss_pred             EcCCCcEEECccccceecCCCcccccCcccccccCCHHHHh-CCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            99888766655321            123456799999973 33456789999999999999999999998765444333


Q ss_pred             HhhcC---------------------CCCC---------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          150 RIGRG---------------------KLPS---------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       150 ~~~~~---------------------~~~~---------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .+...                     ..+.         ....++..+.+++.+||+.+|++|||+.+++.||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         212 LIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             HHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            22110                     0000         012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-37  Score=231.99  Aligned_cols=191  Identities=25%  Similarity=0.473  Sum_probs=154.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++..++..++|+||+ +++|.+++..  ..+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus        52 ~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni  130 (286)
T cd07832          52 ALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANL  130 (286)
T ss_pred             HHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHE
Confidence            467889999999999999999999999999 8899998864  3489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc-------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           81 LVDASGLATTTNDV-------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~~~g~~~~~~~~-------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +++.+|...+.+..             ....++..|+|||.+. ....++.++|+||+|++++++++|..+|........
T Consensus       131 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~  209 (286)
T cd07832         131 LISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY-GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ  209 (286)
T ss_pred             EEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeee-ccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH
Confidence            99988766555421             1233567799999873 344568899999999999999999888876554444


Q ss_pred             HHHhhcCCC-----------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          148 LFRIGRGKL-----------------------------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       148 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      ...+.....                             .......+..+.+++.+||..+|++|||++++++||||.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         210 LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             HHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            333221000                             011124578899999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.8e-38  Score=238.62  Aligned_cols=194  Identities=26%  Similarity=0.414  Sum_probs=160.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++.+++|+||+++++.+.+.+..++||||+.+++|.+++.+  ..+++..+..++.|++.|++|||+.|++||||||+||
T Consensus        54 ~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Ni  133 (332)
T cd05623          54 VLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI  133 (332)
T ss_pred             HHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence            45678999999999999999999999999999999999976  3489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-------------ccccCccccccccccc---CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           81 LVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNL---KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      +++.+|.+++.+...             ...|++.|+|||.+..   ....++.++|+||+|+++|+|++|+.||.....
T Consensus       134 li~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~  213 (332)
T cd05623         134 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL  213 (332)
T ss_pred             EECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence            999888776665431             1347888999999742   134578899999999999999999999988776


Q ss_pred             HHHHHHhhcCC----CCCCCCCCCHHHHHHHHHHhhcCCCC--CCCHhHHhcCccccC
Q 046714          145 MQALFRIGRGK----LPSVPNSLSRDARDFILKCLQVNPND--RPTAAQLMEHPFVKR  196 (201)
Q Consensus       145 ~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~--R~t~~~il~~~~~~~  196 (201)
                      .+....+....    .+.....+++++++++++|++.++.+  |++++++++||||..
T Consensus       214 ~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         214 VETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             HHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            66665554332    22233467899999999999765444  689999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=228.66  Aligned_cols=192  Identities=29%  Similarity=0.467  Sum_probs=161.2

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ....+||||+++++.+..++..++++||+.+++|.++++.. .+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus        51 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~  130 (260)
T cd05611          51 MIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI  130 (260)
T ss_pred             hhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence            34568999999999999999999999999999999998764 58999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCc--------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcC
Q 046714           83 DASGLATTTNDV--------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG  154 (201)
Q Consensus        83 ~~~g~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  154 (201)
                      +.++.+++.+..        ....++..|+|||...  +..++.++|+||+|+++|++++|..||...............
T Consensus       131 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  208 (260)
T cd05611         131 DQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETIL--GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR  208 (260)
T ss_pred             CCCCcEEEeecccceeccccccCCCCcCccChhhhc--CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence            988877665532        2234677899999973  344788999999999999999999999877666655554333


Q ss_pred             CC---CCCCCCCCHHHHHHHHHHhhcCCCCCC---CHhHHhcCccccCc
Q 046714          155 KL---PSVPNSLSRDARDFILKCLQVNPNDRP---TAAQLMEHPFVKRP  197 (201)
Q Consensus       155 ~~---~~~~~~~~~~~~~li~~~l~~~p~~R~---t~~~il~~~~~~~~  197 (201)
                      ..   ......+++.+.+++.+||+.+|.+||   +++|++.||||+..
T Consensus       209 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         209 RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence            22   233446789999999999999999999   55799999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.6e-37  Score=227.78  Aligned_cols=187  Identities=22%  Similarity=0.460  Sum_probs=159.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++......+++|||+.+++|.+++...  .+++..+..++.|++.|++|||+.|++|+||+|+||
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni  131 (256)
T cd05113          52 VMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNC  131 (256)
T ss_pred             HHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceE
Confidence            477899999999999999998999999999999999998753  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.++.+++.+....             ..++..|+|||.+  .+..++.++|+||||+++|++++ |+.||.......
T Consensus       132 li~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~--~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~  209 (256)
T cd05113         132 LVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL--LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE  209 (256)
T ss_pred             EEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHH--hcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence            9998887766553211             1123469999997  34457889999999999999998 999998777666


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ....+........+...++.+.+++.+||..+|.+|||+.+++.+
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         210 TVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            666666665555666778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-37  Score=228.30  Aligned_cols=186  Identities=25%  Similarity=0.454  Sum_probs=159.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      .+++++||||+++++++..++..++++||+.+++|.+++...   .+++..+..++.|++.||+|||++|++|+||+|+|
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~n  134 (263)
T cd05052          55 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN  134 (263)
T ss_pred             HHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcce
Confidence            467899999999999999999999999999999999998653   38889999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcccc-------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKSF-------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~~-------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.++.+++.+.....             ..+..|+|||.+  .+..++.++|+||||+++|++++ |..||......
T Consensus       135 il~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~  212 (263)
T cd05052         135 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  212 (263)
T ss_pred             EEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHh--ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999988877666532111             123469999987  45567889999999999999998 99999887766


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +.............+..+++++.+++.+||+.+|++|||+.++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         213 QVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            666666666566777889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.1e-37  Score=231.17  Aligned_cols=192  Identities=28%  Similarity=0.453  Sum_probs=159.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++||||+++++++...+..++++||+++++|.+++.+.   .+++..+..++.|++.|+.|||+.|++|+||+|+|
T Consensus        46 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~N  125 (277)
T cd05577          46 ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPEN  125 (277)
T ss_pred             HHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence            578899999999999999999999999999999999988653   48999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH---H
Q 046714           80 ILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED---M  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~  145 (201)
                      |+++.++..++.+...           ...++..|+|||.+  .+..++.++|+||+|++++++++|+.||.....   .
T Consensus       126 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  203 (277)
T cd05577         126 VLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL--QGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK  203 (277)
T ss_pred             EEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHh--cCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH
Confidence            9999988776655321           12345679999997  344478899999999999999999999966533   1


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccC
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKR  196 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~  196 (201)
                      ..............+...++.+.+++.+||+.+|.+||     ++.++++||||+.
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         204 EELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             HHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence            22222222333455667899999999999999999999     8888999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=269.73  Aligned_cols=198  Identities=41%  Similarity=0.725  Sum_probs=173.3

Q ss_pred             cccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            2 FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++|.-++|||+++.||+-.++...+|.||||++|+|.++++.++ .++.....+..|++.|+.|||+.|||||||||.||
T Consensus      1286 ~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI 1365 (1509)
T KOG4645|consen 1286 KVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANI 1365 (1509)
T ss_pred             HHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccce
Confidence            45777899999999999999999999999999999999998876 45555667899999999999999999999999999


Q ss_pred             EEccCCceeeecCccc----------------cccCcccccccccccCC-CCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           81 LVDASGLATTTNDVKS----------------FEGTPFWVAPEVVNLKN-NGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~----------------~~~~~~~~aPE~~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      +++.+|..+..++++.                ..||+.|+|||.+.+.. .+...+.||||+|||+.||+||+.||...+
T Consensus      1366 ~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1366 LLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred             eeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence            9999998877765432                33899999999995433 556789999999999999999999998764


Q ss_pred             -HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          144 -DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       144 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                       +-.+.+.+..+..|.+|..++.+.++|+..||+.||++|+++.|+++|.|-+...+
T Consensus      1446 ne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1446 NEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred             chhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence             44566778899999999999999999999999999999999999999998765543

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2e-37  Score=226.70  Aligned_cols=186  Identities=24%  Similarity=0.462  Sum_probs=156.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++...+..++++||+.+++|.+++...  .+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus        46 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~ni  125 (252)
T cd05084          46 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNC  125 (252)
T ss_pred             HHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheE
Confidence            578899999999999999999999999999999999998653  378999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc--------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVKSF--------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~--------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      +++.++..++.+.....              ..+..|+|||.+  .+...+.++|+||+|+++|++++ |..||......
T Consensus       126 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~  203 (252)
T cd05084         126 LVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL--NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ  203 (252)
T ss_pred             EEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhh--cCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH
Confidence            99988877666542211              112359999997  34457889999999999999998 88999776665


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+........+..++..+.+++.+||+.+|++|||+.++++
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         204 QTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            555555555555667778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2e-37  Score=229.97  Aligned_cols=191  Identities=28%  Similarity=0.523  Sum_probs=155.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++||||+++++.+..++..++++||+++++|..+   ..+++..+..++.|++.|+.|||+.|++|+||+|+||++
T Consensus        52 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill  128 (279)
T cd06619          52 ILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV  128 (279)
T ss_pred             HHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE
Confidence            46789999999999999999999999999999998654   237888999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-------
Q 046714           83 DASGLATTTNDVK----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-------  145 (201)
Q Consensus        83 ~~~g~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------  145 (201)
                      +.+|..++.+...          ...++..|+|||.+  .+..++.++|+||+|+++|++++|+.||......       
T Consensus       129 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~  206 (279)
T cd06619         129 NTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERI--SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL  206 (279)
T ss_pred             CCCCCEEEeeCCcceecccccccCCCCChhhcCceee--cCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH
Confidence            9988777766432          23467789999998  3456789999999999999999999999643211       


Q ss_pred             HHHHHhhcCCCCCC-CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          146 QALFRIGRGKLPSV-PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       146 ~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ...........+.. ....++++.+++.+|++.+|.+||+++++++||||....
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         207 QLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             HHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence            11222222222222 345788999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.5e-37  Score=228.86  Aligned_cols=191  Identities=35%  Similarity=0.659  Sum_probs=159.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY----HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      +++.++|+||+++++.+..++..++++|++.+++|.+++...    .+++..+..++.|++.|+++||+.|++|+||+|+
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~  131 (267)
T cd06610          52 AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAG  131 (267)
T ss_pred             HHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            467899999999999999999999999999999999998652    3789999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCc----------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc
Q 046714           79 NILVDASGLATTTNDV----------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL  142 (201)
Q Consensus        79 nill~~~g~~~~~~~~----------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  142 (201)
                      ||+++.++..++.+..                ....++..|+|||.+. .....+.++|+||+|++++++++|+.||...
T Consensus       132 ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~  210 (267)
T cd06610         132 NILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME-QVHGYDFKADIWSFGITAIELATGAAPYSKY  210 (267)
T ss_pred             hEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHc-cccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence            9999988766555421                1123567799999973 2346788999999999999999999999877


Q ss_pred             hHHHHHHHhhcCCCCCCC-----CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          143 EDMQALFRIGRGKLPSVP-----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ..............+...     ..+++.+.+++.+||..+|++|||++++++||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         211 PPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            665555444443333222     2567899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.9e-37  Score=227.31  Aligned_cols=190  Identities=31%  Similarity=0.621  Sum_probs=161.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++|+||+++++.+.+.+..++++||+.+++|.+++.+.   .+++..+..++.|++.|+.|||+.+++|+||+|+|
T Consensus        52 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~n  131 (257)
T cd08225          52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQN  131 (257)
T ss_pred             HHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHH
Confidence            467889999999999999999999999999999999988653   27899999999999999999999999999999999


Q ss_pred             EEEccCCce-eeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           80 ILVDASGLA-TTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        80 ill~~~g~~-~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      |+++.++.. ++.+..            ....++..|+|||..  ....++.++|+||+|++++++++|..||......+
T Consensus       132 il~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  209 (257)
T cd08225         132 IFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC--QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ  209 (257)
T ss_pred             EEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHH--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            999887543 333221            112356679999987  34567889999999999999999999998776666


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .................+..+.+++.+|+..+|++|||+.++++||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         210 LVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            666666666666667788999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-38  Score=232.52  Aligned_cols=191  Identities=37%  Similarity=0.632  Sum_probs=156.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+....+++||++.+++|.+++. ...++...+..++.|++.||++||+.|++|+||+|+||+
T Consensus        51 ~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl  130 (260)
T PF00069_consen   51 ILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENIL  130 (260)
T ss_dssp             HHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4567899999999999999999999999999999999997 566999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc---hHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL---EDMQ  146 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~---~~~~  146 (201)
                      ++.+|...+.+...            ...++..|.|||.+. .+...+.++|+||+|+++++|++|..||...   ....
T Consensus       131 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~  209 (260)
T PF00069_consen  131 LDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQ-QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE  209 (260)
T ss_dssp             ESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHT-TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccchhhhh
Confidence            99887766654322            233677899999983 3667889999999999999999999999886   2222


Q ss_pred             HHHHhhcCCCCC---CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          147 ALFRIGRGKLPS---VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       147 ~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ............   .....++.+.+++.+||+.+|++|||+.++++||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  210 IIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             hhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            222222211110   111123899999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.8e-38  Score=257.73  Aligned_cols=195  Identities=26%  Similarity=0.490  Sum_probs=155.7

Q ss_pred             ccccCCCcceeccceeeee--CCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc-------
Q 046714            3 SFSQFEHDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHER-------   68 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~-------   68 (201)
                      +|++|+||||+++++++.+  ...+++||||+.+++|.+++..     ..+++..++.++.||+.||.|||+.       
T Consensus        65 IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k  144 (1021)
T PTZ00266         65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGE  144 (1021)
T ss_pred             HHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccC
Confidence            5788999999999998854  4568999999999999998865     3489999999999999999999984       


Q ss_pred             CccccCCCCCcEEEccC-----------------CceeeecCc-----------cccccCcccccccccccCCCCCcchh
Q 046714           69 NVVHREIKCANILVDAS-----------------GLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSA  120 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~-----------------g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~  120 (201)
                      +|+|+||||+|||++.+                 +.+++.++.           ....+++.|+|||.+......++.++
T Consensus       145 ~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KS  224 (1021)
T PTZ00266        145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKS  224 (1021)
T ss_pred             CceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchh
Confidence            49999999999999642                 223444332           12347889999999844445678899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          121 DIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       121 Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      |||||||++|+|++|+.||........................+.++.+||..||..+|.+|||+.|++.|||++..
T Consensus       225 DVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        225 DMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             HHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            99999999999999999997655444433333222222234578999999999999999999999999999999744

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.9e-37  Score=231.52  Aligned_cols=194  Identities=30%  Similarity=0.590  Sum_probs=162.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      .+++++||||+++++.+...+..++++||+++++|.+++....+++..+..++.|++.|++|||+.|++|+||+|+||++
T Consensus        70 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv  149 (292)
T cd06657          70 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL  149 (292)
T ss_pred             HHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence            46788999999999999999999999999999999999877778999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|...+.+..            ....++..|++||.+  ....++.++|+||+|+++|++++|..||...........
T Consensus       150 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~--~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~  227 (292)
T cd06657         150 THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI--SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM  227 (292)
T ss_pred             CCCCCEEEcccccceecccccccccccccCccccCHHHh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            988766554422            112356779999987  445678899999999999999999999977655544443


Q ss_pred             hhcCCCCC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          151 IGRGKLPS--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       151 ~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      +.......  ....+++.+.+++.+||+.+|.+||+++++++||||....
T Consensus       228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         228 IRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             HHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence            33222222  2345788999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.5e-37  Score=229.41  Aligned_cols=186  Identities=24%  Similarity=0.451  Sum_probs=160.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---------------CCCHHHHHHHHHHHHHHHHHHhh
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---------------HLSDSQVSSYTRQILNGLTYLHE   67 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~lh~   67 (201)
                      +|++++||||+++++++...+..+++|||+++++|.+++...               .+++..+..++.|++.|+.+||+
T Consensus        61 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~  140 (280)
T cd05049          61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS  140 (280)
T ss_pred             HHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence            577899999999999999999999999999999999998653               26788899999999999999999


Q ss_pred             cCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHH
Q 046714           68 RNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML  133 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~  133 (201)
                      +|++|+||+|+||+++.++..++.+....              ..+++.|+|||.+  .+..++.++|+||+|+++|+++
T Consensus       141 ~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~e~~  218 (280)
T cd05049         141 QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVVLWEIF  218 (280)
T ss_pred             CCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhh--ccCCcchhhhHHHHHHHHHHHH
Confidence            99999999999999998887766554211              1124569999998  4556788999999999999999


Q ss_pred             h-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          134 T-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       134 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      + |+.||......+....+..+.....+..++..+.+++.+||+.+|.+|||++++++
T Consensus       219 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         219 TYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             hcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            8 99999887777777777777666667788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.6e-38  Score=230.80  Aligned_cols=190  Identities=31%  Similarity=0.482  Sum_probs=161.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      .+++++||||+++++.+.+++..++++||+.+++|.+++... .+++..+..++.|+++|+.|||+.|++|+||+|+||+
T Consensus        53 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil  132 (258)
T cd05578          53 ILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNIL  132 (258)
T ss_pred             HHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence            467899999999999999999999999999999999999766 6999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHH
Q 046714           82 VDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED--MQAL  148 (201)
Q Consensus        82 l~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~  148 (201)
                      ++.++..++.+..           ....++..|.|||.+  .....+.++|+||+|+++|++++|+.||.....  ....
T Consensus       133 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  210 (258)
T cd05578         133 LDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVL--CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI  210 (258)
T ss_pred             EcCCCCEEEeecccccccCCCccccccCCChhhcCHHHH--cccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH
Confidence            9998877665532           123356679999998  344578899999999999999999999976653  2222


Q ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH--hHHhcCccc
Q 046714          149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA--AQLMEHPFV  194 (201)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~--~~il~~~~~  194 (201)
                      ...........+...+..+.+++.+||..+|.+||++  .++++||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         211 RAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            3333334456677789999999999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-37  Score=226.35  Aligned_cols=187  Identities=20%  Similarity=0.421  Sum_probs=159.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++...+..++++||+++++|.+++...  .+++..+..++.|++.|++|||+.|++|+||+|+||
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni  131 (256)
T cd05059          52 VMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNC  131 (256)
T ss_pred             HHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhE
Confidence            567899999999999999999999999999999999998653  478999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc-------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKSF-------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~-------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.+|..++.+.....             ..+..|+|||.+  .+..++.++|+||+|+++|++++ |+.||......+
T Consensus       132 ~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  209 (256)
T cd05059         132 LVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVF--DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE  209 (256)
T ss_pred             EECCCCcEEECCcccceecccccccccCCCCCCccccCHHHh--ccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH
Confidence            99998877666542111             112359999997  34567889999999999999999 899998777777


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ....+........+...+..+.+++.+||..+|++|||+.++++.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         210 VVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            666666665556677789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.2e-38  Score=241.88  Aligned_cols=191  Identities=31%  Similarity=0.595  Sum_probs=164.9

Q ss_pred             ccccCCCcceeccceeeeeCC--eEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhc--CccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN--RLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHER--NVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~--~i~H~dl~p   77 (201)
                      .|+.|+||||+++|+++.+..  ...+|+|.+..|+|+.|+++.+ +....++.|++||++||.|||++  -|+|||||-
T Consensus        94 lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKC  173 (632)
T KOG0584|consen   94 LLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKC  173 (632)
T ss_pred             HHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCcccccccc
Confidence            588999999999999988765  4889999999999999998865 89999999999999999999988  599999999


Q ss_pred             CcEEEccC-Cceeeec----------CccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc-hHH
Q 046714           78 ANILVDAS-GLATTTN----------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL-EDM  145 (201)
Q Consensus        78 ~nill~~~-g~~~~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~  145 (201)
                      +||+|+.+ |.+++++          ......|||.|||||..   .+.+...+||||||++++||.|+..||... ...
T Consensus       174 DNIFinG~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmY---EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A  250 (632)
T KOG0584|consen  174 DNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMY---EENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA  250 (632)
T ss_pred             ceEEEcCCcCceeecchhHHHHhhccccceeccCccccChHHH---hhhcchhhhhhhhhHHHHHHHhccCChhhhCCHH
Confidence            99999876 4444443          22345799999999997   477899999999999999999999999876 556


Q ss_pred             HHHHHhhcCCCCC-CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          146 QALFRIGRGKLPS-VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       146 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .++.++..+..|. +.+--++++++||.+||.. .+.|+|+.|+|+||||...
T Consensus       251 QIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  251 QIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            6667788887764 3444579999999999999 9999999999999999874

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=226.78  Aligned_cols=188  Identities=31%  Similarity=0.499  Sum_probs=154.2

Q ss_pred             CCCcceeccceeeee----CCeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            7 FEHDNIVQYIGTEKD----ENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         7 l~h~~I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      -.|||||+++++|.+    ...+.+|||.+.||.|...++.++   |++.++..+++||+.|+.|||+.+|.||||||+|
T Consensus       112 s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpEN  191 (400)
T KOG0604|consen  112 SGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPEN  191 (400)
T ss_pred             cCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhh
Confidence            469999999998764    467899999999999999988755   9999999999999999999999999999999999


Q ss_pred             EEEccC-----------Cceeeec---CccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH-
Q 046714           80 ILVDAS-----------GLATTTN---DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED-  144 (201)
Q Consensus        80 ill~~~-----------g~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-  144 (201)
                      +|....           |.++...   ...+.+.|+.|.|||.+  +.+.++...|+||+|+++|-|++|..||..... 
T Consensus       192 LLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevl--g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~  269 (400)
T KOG0604|consen  192 LLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVL--GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL  269 (400)
T ss_pred             eeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHh--CchhcCCCCCccchhHHHHHhhcCCCcccccCCc
Confidence            998654           3333322   22345578899999998  667789999999999999999999999965432 


Q ss_pred             ---HHHHHHhhcCCC---CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          145 ---MQALFRIGRGKL---PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       145 ---~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                         .....++..+..   .+-+..+++..+++|+.+|..+|++|.|++++++|||++.
T Consensus       270 aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~  327 (400)
T KOG0604|consen  270 AISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ  327 (400)
T ss_pred             cCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence               112233333332   2335668999999999999999999999999999999875

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-37  Score=243.04  Aligned_cols=191  Identities=25%  Similarity=0.384  Sum_probs=149.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++..++..++++|++.+ +|.+++...  .+++..+..++.|++.||+|||++||+|+||||+||
T Consensus       213 iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NI  291 (461)
T PHA03211        213 LLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENV  291 (461)
T ss_pred             HHHHCCCCCCCcEEEEEEECCEEEEEEEccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHE
Confidence            57889999999999999999999999999965 888877643  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch---
Q 046714           81 LVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE---  143 (201)
Q Consensus        81 ll~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---  143 (201)
                      +++.++.+++.+...              ...|+..|+|||.+  .+..++.++|||||||++|++++|..++....   
T Consensus       292 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~--~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~  369 (461)
T PHA03211        292 LVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVL--AGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD  369 (461)
T ss_pred             EECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHH--cCCCCCchHHHHHHHHHHHHHHHcCCCcccCCccc
Confidence            999887666655321              12478889999998  45567899999999999999999775442211   


Q ss_pred             -----HHHHHHHhhcCCC--CCCC-------------------------------CCCCHHHHHHHHHHhhcCCCCCCCH
Q 046714          144 -----DMQALFRIGRGKL--PSVP-------------------------------NSLSRDARDFILKCLQVNPNDRPTA  185 (201)
Q Consensus       144 -----~~~~~~~~~~~~~--~~~~-------------------------------~~~~~~~~~li~~~l~~~p~~R~t~  185 (201)
                           .......+.....  ..++                               ...+..+.+|+.+||+.||.+|||+
T Consensus       370 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa  449 (461)
T PHA03211        370 ERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA  449 (461)
T ss_pred             ccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH
Confidence                 1111111111000  0000                               1245678999999999999999999


Q ss_pred             hHHhcCccccC
Q 046714          186 AQLMEHPFVKR  196 (201)
Q Consensus       186 ~~il~~~~~~~  196 (201)
                      +|+|+||||+.
T Consensus       450 ~elL~hp~f~~  460 (461)
T PHA03211        450 AELLRLPLFQS  460 (461)
T ss_pred             HHHhhCcccCC
Confidence            99999999975

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.8e-37  Score=232.16  Aligned_cols=194  Identities=27%  Similarity=0.472  Sum_probs=156.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++|+||+++++++.+.+..++||||+ +++|.+++....  +++..+..++.||++||.|||++|++|+||+|+||
T Consensus        55 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~ni  133 (298)
T cd07841          55 LLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNL  133 (298)
T ss_pred             HHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhE
Confidence            467899999999999999999999999999 889999997654  89999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|.+++.+...            ...++..|+|||.+. ....++.++|+||+|++++++++|..+|......+..
T Consensus       134 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~  212 (298)
T cd07841         134 LIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLF-GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL  212 (298)
T ss_pred             EEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHh-CCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH
Confidence            999988776655321            112355699999872 3455788999999999999999998887655443333


Q ss_pred             HHhhcCC-------------C--------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          149 FRIGRGK-------------L--------------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       149 ~~~~~~~-------------~--------------~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .......             .              .......+..+.+++.+||..+|++|||++++++||||+..-
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         213 GKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             HHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence            2221100             0              001134567899999999999999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.2e-38  Score=249.20  Aligned_cols=185  Identities=25%  Similarity=0.487  Sum_probs=165.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC---------------CCHHHHHHHHHHHHHHHHHHhh
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---------------LSDSQVSSYTRQILNGLTYLHE   67 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~i~~~l~~lh~   67 (201)
                      .|..|+|||||+++|+|..++..++|+||+..|+|..++....               ++..+.+.++.||+.|++||-+
T Consensus       542 Lla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~  621 (774)
T KOG1026|consen  542 LLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS  621 (774)
T ss_pred             HHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            4788999999999999999999999999999999999985321               6677899999999999999999


Q ss_pred             cCccccCCCCCcEEEccCCceeeecCccccc--------------cCcccccccccccCCCCCcchhhHHHHHHHHHHHH
Q 046714           68 RNVVHREIKCANILVDASGLATTTNDVKSFE--------------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML  133 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g~~~~~~~~~~~~--------------~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~  133 (201)
                      +.+|||||-..|+||..+-.+++.+..-...              -...|||||.|  .-.+++.+|||||+|++|||++
T Consensus       622 ~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI--ly~kFTteSDVWs~GVvLWEIF  699 (774)
T KOG1026|consen  622 HHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI--LYGKFTTESDVWSFGVVLWEIF  699 (774)
T ss_pred             CcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHh--hcCcccchhhhhhhhhhhhhhh
Confidence            9999999999999998877777666432111              12459999999  4567999999999999999999


Q ss_pred             h-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          134 T-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       134 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                      + |+.||.+....++++.+.++..-+.|.++|.++++||..||+.+|++||+|.||-
T Consensus       700 syG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  700 SYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             ccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            9 9999999999999999999999999999999999999999999999999999983

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1e-37  Score=233.09  Aligned_cols=194  Identities=35%  Similarity=0.660  Sum_probs=161.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      .+++++||||+++++.+...+..++|+||+++++|.+++.+..++...+..++.|++.|+.+||+.|++|+||+|+||++
T Consensus        69 ~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili  148 (293)
T cd06647          69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL  148 (293)
T ss_pred             HHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE
Confidence            46789999999999999999999999999999999999988788999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.++..++.+...            ...++..|++||.+  ....++.++|+||+|+++|++++|+.||...........
T Consensus       149 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~  226 (293)
T cd06647         149 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL  226 (293)
T ss_pred             cCCCCEEEccCcceecccccccccccccCChhhcCchhh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee
Confidence            9887766654321            12355679999997  345678899999999999999999999976654433332


Q ss_pred             hhcCCCCC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          151 IGRGKLPS--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       151 ~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ......+.  .+..++..+.+++.+||..+|++||++.+++.|+||+...
T Consensus       227 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         227 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             hhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            22222222  2345678899999999999999999999999999998765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.8e-38  Score=232.90  Aligned_cols=190  Identities=26%  Similarity=0.446  Sum_probs=150.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+.+..++++||+.+ +|.+++..  ..+++..+..++.||++||.|||+.|++|+||+|+||
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~ni  130 (284)
T cd07839          52 LLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNL  130 (284)
T ss_pred             HHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence            46788999999999999999999999999976 78777654  3489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH-LEDMQA  147 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~  147 (201)
                      +++.+|.+++.+...            ...++..|+|||.+. ....++.++|+||+|+++|+|++|..|+.. ......
T Consensus       131 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~  209 (284)
T cd07839         131 LINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF-GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ  209 (284)
T ss_pred             EEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHh-CCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH
Confidence            999888776655321            123467799999873 334568899999999999999999888533 222222


Q ss_pred             HHHhhc-------------------CCCC---------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          148 LFRIGR-------------------GKLP---------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       148 ~~~~~~-------------------~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ...+..                   ...+         .....+++++.+++.+||+.+|.+|||++++++||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         210 LKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             HHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            111100                   0000         1123467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-37  Score=228.57  Aligned_cols=191  Identities=35%  Similarity=0.752  Sum_probs=156.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      .++.++||||+++++++.+.+..++++||+.+++|.+++.+. .+++..+..++.|++.||++||++|++|+||+|+||+
T Consensus        56 ~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil  135 (268)
T cd06630          56 LMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLL  135 (268)
T ss_pred             HHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            467789999999999999999999999999999999998764 4889999999999999999999999999999999999


Q ss_pred             EccCCc-eeeecCcc----------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           82 VDASGL-ATTTNDVK----------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        82 l~~~g~-~~~~~~~~----------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      ++.+|. .++.+...                ...++..|+|||.+  .+..++.++|+||+|++++++++|+.||.....
T Consensus       136 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~--~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  213 (268)
T cd06630         136 IDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL--RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH  213 (268)
T ss_pred             EcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHh--ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            987653 34433211                12356679999997  445678899999999999999999999965432


Q ss_pred             H---HHHHHh-hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          145 M---QALFRI-GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       145 ~---~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      .   ...... .....+..+...++.+.+++.+|+..+|.+|||+.++++||||+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         214 SNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             cchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            1   222121 22334556677889999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.4e-38  Score=239.07  Aligned_cols=191  Identities=24%  Similarity=0.435  Sum_probs=150.5

Q ss_pred             ccccCCCcceeccceeeeeC------CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE------NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +++.++||||+++++++...      ...+++|||+.+ ++.+.+.. .++...+..++.|++.||+|||++|++|+|||
T Consensus        69 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDik  146 (355)
T cd07874          69 LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  146 (355)
T ss_pred             HHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            46778999999999988654      357999999977 67666653 48889999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           77 CANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |+||+++.+|.+++.+...           ...++..|+|||.+  .+..++.++|+||+|+++|+|++|+.||......
T Consensus       147 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  224 (355)
T cd07874         147 PSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI  224 (355)
T ss_pred             hHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHH--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999988777765421           23467789999998  4556789999999999999999999999765543


Q ss_pred             HHHHHhhcC---------------------CC--------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 046714          146 QALFRIGRG---------------------KL--------------------PSVPNSLSRDARDFILKCLQVNPNDRPT  184 (201)
Q Consensus       146 ~~~~~~~~~---------------------~~--------------------~~~~~~~~~~~~~li~~~l~~~p~~R~t  184 (201)
                      .........                     ..                    ...+...+..+.+++.+||..+|++|||
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps  304 (355)
T cd07874         225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS  304 (355)
T ss_pred             HHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCC
Confidence            332211100                     00                    0011223567899999999999999999


Q ss_pred             HhHHhcCccccCc
Q 046714          185 AAQLMEHPFVKRP  197 (201)
Q Consensus       185 ~~~il~~~~~~~~  197 (201)
                      +.|+++||||+..
T Consensus       305 ~~ell~hp~~~~~  317 (355)
T cd07874         305 VDEALQHPYINVW  317 (355)
T ss_pred             HHHHhcCcchhcc
Confidence            9999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2e-37  Score=228.51  Aligned_cols=191  Identities=39%  Similarity=0.671  Sum_probs=154.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++..++..++++||+.+++|.+++.. ..+++..+..++.|++.|++|||+.|++|+|++|+||+
T Consensus        59 ~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil  138 (267)
T cd06646          59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANIL  138 (267)
T ss_pred             HHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence            46788999999999999999999999999999999998865 45899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc------------cccccCccccccccccc-CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           82 VDASGLATTTNDV------------KSFEGTPFWVAPEVVNL-KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        82 l~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      ++.+|..++.+..            ....++..|+|||.+.. ....++.++|+||+|+++|++++|+.||.........
T Consensus       139 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~  218 (267)
T cd06646         139 LTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL  218 (267)
T ss_pred             ECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh
Confidence            9988876655432            12235677999998732 2344678999999999999999999998655433332


Q ss_pred             HHhhcCCC--C--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcc
Q 046714          149 FRIGRGKL--P--SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF  193 (201)
Q Consensus       149 ~~~~~~~~--~--~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~  193 (201)
                      ........  +  .....++..+.+++++||+.+|++|||++++++|+|
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         219 FLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             eeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            22211111  1  112346789999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.9e-37  Score=231.04  Aligned_cols=187  Identities=22%  Similarity=0.446  Sum_probs=157.9

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLTY   64 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~   64 (201)
                      +++++ +||||+++++++...+..++++||+++++|.+++.+.                 .++...+..++.|++.|++|
T Consensus        55 ~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~  134 (297)
T cd05089          55 VLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQY  134 (297)
T ss_pred             HHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHH
Confidence            35567 7999999999999999999999999999999998653                 27788999999999999999


Q ss_pred             HhhcCccccCCCCCcEEEccCCceeeecCcccc-----------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHH
Q 046714           65 LHERNVVHREIKCANILVDASGLATTTNDVKSF-----------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML  133 (201)
Q Consensus        65 lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~~-----------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~  133 (201)
                      ||+.|++|+||||+||+++.++..++.+.....           ..+..|+|||.+  ....++.++||||||+++|+|+
T Consensus       135 lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwSlG~il~el~  212 (297)
T cd05089         135 LSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESL--NYSVYTTKSDVWSFGVLLWEIV  212 (297)
T ss_pred             HHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhh--ccCCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999988777666543211           113459999987  4456788999999999999999


Q ss_pred             h-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          134 T-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       134 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      + |..||......+.......+.....+..++..+.+++.+||..+|.+|||++++++.
T Consensus       213 t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         213 SLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7 999998877777666666665556677789999999999999999999999999654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.3e-37  Score=227.55  Aligned_cols=193  Identities=36%  Similarity=0.638  Sum_probs=164.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++.+...+..++++||+.+++|.+++.. ..+++..+..++.|++.|+++||+ .|++|+||+|+||
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni  131 (264)
T cd06623          52 TLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNL  131 (264)
T ss_pred             HHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHE
Confidence            46788999999999999999999999999999999999876 558999999999999999999999 9999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc---hHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL---EDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~---~~~  145 (201)
                      +++.+|...+.+...            ...++..|.|||.+  ....++.++|+||||+++|++++|+.||...   ...
T Consensus       132 ~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~--~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~  209 (264)
T cd06623         132 LINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI--QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF  209 (264)
T ss_pred             EECCCCCEEEccCccceecccCCCcccceeecccccCHhhh--CCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHH
Confidence            999988776654321            12345679999997  4456788999999999999999999999776   344


Q ss_pred             HHHHHhhcCCCCCCCCC-CCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          146 QALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      +....+.....+..+.. ++..+.+++.+|+..+|++|||++++++|||++..
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         210 ELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            44455555555556666 89999999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-37  Score=228.11  Aligned_cols=192  Identities=42%  Similarity=0.821  Sum_probs=157.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      .+++++||||+++++++...+..++|+||+.+++|.+++.+. .++...+..++.|++.|+.+||+.|++|+||+|+||+
T Consensus        61 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil  140 (272)
T cd06629          61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLL  140 (272)
T ss_pred             HHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEE
Confidence            467889999999999999999999999999999999988764 4889999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           82 VDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        82 l~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ++.++..++.+...              ...++..|+|||.+......++.++|+||+|++++++++|..||........
T Consensus       141 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  220 (272)
T cd06629         141 VDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA  220 (272)
T ss_pred             EcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH
Confidence            99887666654321              1235667999999843334578899999999999999999999976555444


Q ss_pred             HHHhhc-CCCC----CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          148 LFRIGR-GKLP----SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       148 ~~~~~~-~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ...... ....    .....++..+.+++.+||..+|.+|||++++++|||+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         221 MFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             HHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            333221 1111    2233568899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-37  Score=226.12  Aligned_cols=187  Identities=28%  Similarity=0.514  Sum_probs=162.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHhhcCccc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY----------HLSDSQVSSYTRQILNGLTYLHERNVVH   72 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lh~~~i~H   72 (201)
                      .++.++|+||+++++++.+.+..++++||+++++|.+++...          .+++..+..++.|++.||++||++|++|
T Consensus        49 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H  128 (262)
T cd00192          49 VMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVH  128 (262)
T ss_pred             HHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCccc
Confidence            467889999999999999999999999999999999998763          4899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCC
Q 046714           73 REIKCANILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQP  137 (201)
Q Consensus        73 ~dl~p~nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~  137 (201)
                      +||+|+||+++.++..++.+...              ...++..|+|||.+  ....++.++|+||+|+++|++++ |..
T Consensus       129 ~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~g~~  206 (262)
T cd00192         129 RDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL--KDGIFTSKSDVWSFGVLLWEIFTLGAT  206 (262)
T ss_pred             CccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHh--ccCCcchhhccHHHHHHHHHHHhcCCC
Confidence            99999999999988776665321              12245679999997  34478899999999999999999 699


Q ss_pred             CCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          138 PYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       138 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ||..............+.....+..+++++.+++.+||+.+|.+|||+++++++
T Consensus       207 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         207 PYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            998887777777777666667778889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.2e-37  Score=230.15  Aligned_cols=192  Identities=33%  Similarity=0.620  Sum_probs=155.4

Q ss_pred             cccC-CCcceeccceeeeeC-----CeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccc
Q 046714            4 FSQF-EHDNIVQYIGTEKDE-----NRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVH   72 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H   72 (201)
                      +.++ +||||+++++++...     +..++++||+.+++|.++++.     ..+++..+..++.|++.|+++||+.|++|
T Consensus        72 l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH  151 (291)
T cd06639          72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIH  151 (291)
T ss_pred             HHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            4455 799999999998753     368999999999999998753     34899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceeeecCcc------------ccccCcccccccccccCC---CCCcchhhHHHHHHHHHHHHhCCC
Q 046714           73 REIKCANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKN---NGYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        73 ~dl~p~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~---~~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      +||+|+||+++.++.+++.+...            ...++..|+|||.+....   ..++.++|+||+|+++|++++|+.
T Consensus       152 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~  231 (291)
T cd06639         152 RDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP  231 (291)
T ss_pred             cCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCC
Confidence            99999999999888776655321            123566799999874221   236789999999999999999999


Q ss_pred             CCCCchHHHHHHHhhcCCCCC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          138 PYSHLEDMQALFRIGRGKLPS--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       138 p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      ||.................+.  .+...+..+.+++.+||+.+|++|||+.++++||||+
T Consensus       232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         232 PLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            998776655555544443322  2345678899999999999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=228.65  Aligned_cols=192  Identities=36%  Similarity=0.704  Sum_probs=155.5

Q ss_pred             ccccC-CCcceeccceeeeeCC------eEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCc
Q 046714            3 SFSQF-EHDNIVQYIGTEKDEN------RLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNV   70 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i   70 (201)
                      +++++ +||||+++++.+....      ..++++||+.+++|.+++..     ..+++..+..++.|++.||+|||+.|+
T Consensus        55 ~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i  134 (275)
T cd06608          55 ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKV  134 (275)
T ss_pred             HHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCc
Confidence            35666 7999999999987644      48999999999999998754     348999999999999999999999999


Q ss_pred             cccCCCCCcEEEccCCceeeecCc------------cccccCcccccccccccC---CCCCcchhhHHHHHHHHHHHHhC
Q 046714           71 VHREIKCANILVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLK---NNGYGLSADIWSLGCTVLEMLTH  135 (201)
Q Consensus        71 ~H~dl~p~nill~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~---~~~~~~~~Dv~slG~~l~~l~~g  135 (201)
                      +|+||+|+||+++.++..++.+..            ....++..|+|||.+...   ...++.++|+||+|++++++++|
T Consensus       135 ~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g  214 (275)
T cd06608         135 IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG  214 (275)
T ss_pred             ccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhC
Confidence            999999999999988876665432            123356679999987322   23467889999999999999999


Q ss_pred             CCCCCCchHHHHHHHhhcCCCCCC--CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          136 QPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       136 ~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      +.||...........+.....+..  +..++..+.+++.+||..+|++|||++++++|||+
T Consensus       215 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         215 KPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            999987655555555544433222  22367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.3e-37  Score=230.32  Aligned_cols=193  Identities=25%  Similarity=0.382  Sum_probs=161.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++|+||+++.+.+..++..++++||+.+++|.+++...   .+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus        53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~N  132 (285)
T cd05632          53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPEN  132 (285)
T ss_pred             HHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHH
Confidence            577899999999999999999999999999999998887542   48999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           80 ILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        80 ill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      |+++.++.+++.+...           ...++..|+|||.+  .+..++.++|+||+|+++|++++|+.||.........
T Consensus       133 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~  210 (285)
T cd05632         133 ILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL--NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR  210 (285)
T ss_pred             EEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHh--cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999887776665331           23467789999998  4456788999999999999999999999775443222


Q ss_pred             HH---hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccCc
Q 046714          149 FR---IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKRP  197 (201)
Q Consensus       149 ~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~~  197 (201)
                      ..   .........+..+++.+.+++.+|++.+|++|||     ++++++|+||+..
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         211 EEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            22   2222233456678899999999999999999999     8899999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.6e-37  Score=234.36  Aligned_cols=190  Identities=27%  Similarity=0.456  Sum_probs=142.6

Q ss_pred             ccccCCCcceeccceeeee--CCeEEEEEEecCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHhhcCc
Q 046714            3 SFSQFEHDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKY----------HLSDSQVSSYTRQILNGLTYLHERNV   70 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lh~~~i   70 (201)
                      +|++++||||+++++++..  +...++++||+.+ +|.+++...          .+++..+..++.||+.||+|||++|+
T Consensus        51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i  129 (317)
T cd07868          51 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWV  129 (317)
T ss_pred             HHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            5788999999999998864  4568999999966 888876521          37888999999999999999999999


Q ss_pred             cccCCCCCcEEEc----cCCceeeecCc---------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHH
Q 046714           71 VHREIKCANILVD----ASGLATTTNDV---------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE  131 (201)
Q Consensus        71 ~H~dl~p~nill~----~~g~~~~~~~~---------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~  131 (201)
                      +|+||||+||+++    .++.+++.+..               ....+++.|+|||.+. ....++.++|+||+||++|+
T Consensus       130 vHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~e  208 (317)
T cd07868         130 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAE  208 (317)
T ss_pred             EcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHc-CCCCcCchhhHHHHHHHHHH
Confidence            9999999999994    33445544432               1234577899999983 33457889999999999999


Q ss_pred             HHhCCCCCCCchHH---------HHHHHhhc--C-----------CCC------------------------CCCCCCCH
Q 046714          132 MLTHQPPYSHLEDM---------QALFRIGR--G-----------KLP------------------------SVPNSLSR  165 (201)
Q Consensus       132 l~~g~~p~~~~~~~---------~~~~~~~~--~-----------~~~------------------------~~~~~~~~  165 (201)
                      |++|+.||......         .....+..  +           ..+                        ......+.
T Consensus       209 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (317)
T cd07868         209 LLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS  288 (317)
T ss_pred             HHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCCh
Confidence            99999998532210         00000000  0           000                        00112345


Q ss_pred             HHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          166 DARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       166 ~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .+.+++.+||+.||.+|||++|+++||||
T Consensus       289 ~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         289 KAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            68899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.6e-37  Score=226.48  Aligned_cols=190  Identities=32%  Similarity=0.588  Sum_probs=162.9

Q ss_pred             ccccCCCcceeccceeeee--CCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh-----hcCc
Q 046714            3 SFSQFEHDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLH-----ERNV   70 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh-----~~~i   70 (201)
                      ++++++||||+++++.+..  +...++++||+++++|.+++..     ..+++..++.++.|++.|+++||     +.++
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i  131 (265)
T cd08217          52 ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTV  131 (265)
T ss_pred             HHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcc
Confidence            4678999999999997754  4568999999999999998864     34889999999999999999999     8899


Q ss_pred             cccCCCCCcEEEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCC
Q 046714           71 VHREIKCANILVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPP  138 (201)
Q Consensus        71 ~H~dl~p~nill~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p  138 (201)
                      +|+||+|+||+++.++..++.+..            ....++..|+|||.+  .+...+.++|+||||++++++++|+.|
T Consensus       132 ~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~--~~~~~~~~~Dv~slG~il~~l~~g~~p  209 (265)
T cd08217         132 LHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL--NHMSYDEKSDIWSLGCLIYELCALSPP  209 (265)
T ss_pred             eecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhh--cCCCCCchhHHHHHHHHHHHHHHCCCc
Confidence            999999999999988776655432            123467789999998  344578899999999999999999999


Q ss_pred             CCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          139 YSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      |...........+..+..+.++...+..+.+++.+|+..+|.+|||++++++|||+
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         210 FTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            98877666666677776677788889999999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-39  Score=249.21  Aligned_cols=194  Identities=42%  Similarity=0.786  Sum_probs=166.1

Q ss_pred             ccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CC--CHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HL--SDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~--~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +.|+|.|||+++|.+..+++.-++||..+||+|.+++...  ++  .+.++-.+.+||++||+|||.+.|||||||-+||
T Consensus       627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNV  706 (1226)
T KOG4279|consen  627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNV  706 (1226)
T ss_pred             HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcE
Confidence            5689999999999999999999999999999999999763  35  7778889999999999999999999999999999


Q ss_pred             EEcc-CCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           81 LVDA-SGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~~-~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +|+. .|.+++.++..            ++.||..|+|||++..+..+++.++|||||||.+.||.||++||-+.+....
T Consensus       707 LvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA  786 (1226)
T KOG4279|consen  707 LVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA  786 (1226)
T ss_pred             EEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH
Confidence            9975 46666665432            3558899999999988888999999999999999999999999977644333


Q ss_pred             H-HHh-hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          148 L-FRI-GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       148 ~-~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      . .++ .-..-|++|..++.+++.||.+|+.++|.+||++.++|++||++.+.
T Consensus       787 AMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  787 AMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             hhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence            2 222 22233577888999999999999999999999999999999998763

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.9e-37  Score=227.98  Aligned_cols=192  Identities=32%  Similarity=0.528  Sum_probs=162.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++.+..++..++++||+.+++|.+++.+ ..+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus        46 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil  125 (265)
T cd05579          46 ILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL  125 (265)
T ss_pred             HHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeE
Confidence            46788999999999999999999999999999999999876 45899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc--------------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Q 046714           82 VDASGLATTTNDVK--------------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH  141 (201)
Q Consensus        82 l~~~g~~~~~~~~~--------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  141 (201)
                      ++.++..++.+...                    ...++..|++||..  .....+.++|+||||++++++++|+.||..
T Consensus       126 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~--~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~  203 (265)
T cd05579         126 IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI--LGQGHSKTVDWWSLGCILYEFLVGIPPFHG  203 (265)
T ss_pred             EcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHh--cCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            99988776654321                    12345679999997  344478899999999999999999999987


Q ss_pred             chHHHHHHHhhcCCCCCCCCC--CCHHHHHHHHHHhhcCCCCCCCH---hHHhcCccccCc
Q 046714          142 LEDMQALFRIGRGKLPSVPNS--LSRDARDFILKCLQVNPNDRPTA---AQLMEHPFVKRP  197 (201)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~R~t~---~~il~~~~~~~~  197 (201)
                      ............+.. ..+..  .+..+.+++.+||+.+|.+|||+   .++++||||+..
T Consensus       204 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         204 ETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             CCHHHHHHHHhcCCc-CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            776666655554332 23333  38999999999999999999999   999999999854

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.7e-37  Score=227.06  Aligned_cols=191  Identities=35%  Similarity=0.658  Sum_probs=154.6

Q ss_pred             cccC-CCcceeccceeeeeC------CeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCcccc
Q 046714            4 FSQF-EHDNIVQYIGTEKDE------NRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHR   73 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~   73 (201)
                      ++++ +||||+++++.+...      ...++++||+.+++|.+++...   .+++..+..++.|++.|++|||+.|++|+
T Consensus        56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~  135 (272)
T cd06637          56 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR  135 (272)
T ss_pred             HHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence            4555 699999999998753      4689999999999999988752   38899999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceeeecCcc------------ccccCcccccccccccC---CCCCcchhhHHHHHHHHHHHHhCCCC
Q 046714           74 EIKCANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLK---NNGYGLSADIWSLGCTVLEMLTHQPP  138 (201)
Q Consensus        74 dl~p~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p  138 (201)
                      ||+|+||+++.++.+++.+...            ...++..|+|||.+...   ...++.++|+||+|+++|++++|+.|
T Consensus       136 dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p  215 (272)
T cd06637         136 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP  215 (272)
T ss_pred             CCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999887766655321            12356779999997422   33577899999999999999999999


Q ss_pred             CCCchHHHHHHHhhcCC-CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          139 YSHLEDMQALFRIGRGK-LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       139 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      |................ .......++..+.+++.+||..+|.+|||+.+++.||||
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         216 LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            97665544444333222 222344578899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4e-37  Score=228.50  Aligned_cols=186  Identities=23%  Similarity=0.413  Sum_probs=158.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHh
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY----------------HLSDSQVSSYTRQILNGLTYLH   66 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh   66 (201)
                      ++++++||||+++++++.+.+..++++||+.+++|.+++...                .+++..+..++.|++.|++|||
T Consensus        60 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH  139 (280)
T cd05092          60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA  139 (280)
T ss_pred             HHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999999999999999998653                2788899999999999999999


Q ss_pred             hcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHH
Q 046714           67 ERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEM  132 (201)
Q Consensus        67 ~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l  132 (201)
                      +.|++|+||||+||+++.++.+++.+....              ..+++.|+|||.+  .+..++.++|+||||+++|++
T Consensus       140 ~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el  217 (280)
T cd05092         140 SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDIWSFGVVLWEI  217 (280)
T ss_pred             HCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHh--ccCCcCchhhHHHHHHHHHHH
Confidence            999999999999999998877666553211              1124569999987  455678999999999999999


Q ss_pred             Hh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          133 LT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       133 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ++ |+.||......+.......+.....+..+++.+.+++.+||+.+|++||+++++++
T Consensus       218 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         218 FTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            98 99999877766666666666555667788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.2e-37  Score=226.01  Aligned_cols=188  Identities=27%  Similarity=0.530  Sum_probs=161.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++.+.+++..++++||+++++|.+++..   ..+++..+..++.|++.|+.+||+.|++|+||+|+|
T Consensus        51 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~n  130 (255)
T cd08219          51 LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKN  130 (255)
T ss_pred             HHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcce
Confidence            46788999999999999999999999999999999998764   237899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           80 ILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        80 ill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+++.++...+.+...            ...++..|+|||.+  .+...+.++|+||+|+++|++++|+.||........
T Consensus       131 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~  208 (255)
T cd08219         131 IFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW--ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL  208 (255)
T ss_pred             EEECCCCcEEEcccCcceeecccccccccccCCccccCHHHH--ccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence            9999887666554321            23356679999997  445678899999999999999999999988776666


Q ss_pred             HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          148 LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                      ......+.....+..++..+.+++.+||+.+|.+|||+.+++..-
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         209 ILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             HHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence            666666666667778899999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.6e-37  Score=225.60  Aligned_cols=192  Identities=43%  Similarity=0.820  Sum_probs=158.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++|+||+++++.+.+.+..++++||+.+++|.+++...+ +++..+..++.|++.|++|||+.|++|+||+|+||+
T Consensus        52 ~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil  131 (264)
T cd06626          52 VLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIF  131 (264)
T ss_pred             HHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence            5778999999999999999999999999999999999987654 788899999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc----------------ccccCcccccccccccCC-CCCcchhhHHHHHHHHHHHHhCCCCCCCch-
Q 046714           82 VDASGLATTTNDVK----------------SFEGTPFWVAPEVVNLKN-NGYGLSADIWSLGCTVLEMLTHQPPYSHLE-  143 (201)
Q Consensus        82 l~~~g~~~~~~~~~----------------~~~~~~~~~aPE~~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-  143 (201)
                      ++.++.+++.+...                ...++..|+|||.+.... ...+.++|+||+|++++++++|+.||.... 
T Consensus       132 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~  211 (264)
T cd06626         132 LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN  211 (264)
T ss_pred             ECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc
Confidence            99988766655321                123466799999984322 337889999999999999999999997653 


Q ss_pred             HHHHHHHhhcCCCCCCCCCC--CHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          144 DMQALFRIGRGKLPSVPNSL--SRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .......+.....+.++...  ++.+.+++.+||+.+|.+|||+++++.|||+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         212 EFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             hHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            23333333334444444444  8999999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-37  Score=227.10  Aligned_cols=186  Identities=24%  Similarity=0.456  Sum_probs=156.7

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLTY   64 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~   64 (201)
                      +++++ +||||+++++.+...+..+++|||+++++|.+++...                 .++..++..++.|++.|++|
T Consensus        48 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~  127 (270)
T cd05047          48 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY  127 (270)
T ss_pred             HHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHH
Confidence            35677 7999999999999999999999999999999998653                 26888999999999999999


Q ss_pred             HhhcCccccCCCCCcEEEccCCceeeecCccc-----------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHH
Q 046714           65 LHERNVVHREIKCANILVDASGLATTTNDVKS-----------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML  133 (201)
Q Consensus        65 lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~-----------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~  133 (201)
                      ||+.|++|+||||+||+++.++.+++.+....           ...+..|+|||.+  ....++.++|+||||+++++++
T Consensus       128 lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slG~il~el~  205 (270)
T cd05047         128 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV  205 (270)
T ss_pred             HHHCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHH--ccCCCCchhhHHHHHHHHHHHH
Confidence            99999999999999999998887766654321           1123459999987  4556788999999999999999


Q ss_pred             h-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          134 T-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       134 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      + |..||......+....+........+...+.++.+++.+||..+|.+|||+.++++
T Consensus       206 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         206 SLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             cCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            7 99999877666666666555555566678899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.2e-37  Score=226.09  Aligned_cols=190  Identities=42%  Similarity=0.785  Sum_probs=157.1

Q ss_pred             ccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++.+.+.  ...++++||+++++|.+++.+. .+++..+..++.|++.||++||++|++|+||+|+|
T Consensus        57 ~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~n  136 (265)
T cd06652          57 LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGAN  136 (265)
T ss_pred             HHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence            47789999999999988763  5688999999999999998764 47889999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           80 ILVDASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        80 ill~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      |+++.+|..++.+...               ...++..|+|||.+  .+..++.++|+||||+++|++++|+.||.....
T Consensus       137 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  214 (265)
T cd06652         137 ILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI--SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA  214 (265)
T ss_pred             EEecCCCCEEECcCccccccccccccccccccCCCCccccChhhh--cCCCCCcchhHHHHHHHHHHHhhCCCCCCccch
Confidence            9999888776655321               12356679999997  345678999999999999999999999977654


Q ss_pred             HHHHHHhh-cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          145 MQALFRIG-RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       145 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      ........ ....+..+...+..+.+++.+|+. +|++|||++++++|||++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         215 MAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            44444333 223345566778889999999995 899999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.1e-37  Score=228.10  Aligned_cols=187  Identities=25%  Similarity=0.452  Sum_probs=156.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcCccccC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--------HLSDSQVSSYTRQILNGLTYLHERNVVHRE   74 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d   74 (201)
                      ++++++|+||+++++++.+.+..++++||+.+++|.+++...        .+++..+..++.||+.|++|||++|++|+|
T Consensus        62 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~d  141 (277)
T cd05036          62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRD  141 (277)
T ss_pred             HHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence            467899999999999999999999999999999999998653        378889999999999999999999999999


Q ss_pred             CCCCcEEEccCC---ceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CC
Q 046714           75 IKCANILVDASG---LATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQ  136 (201)
Q Consensus        75 l~p~nill~~~g---~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~  136 (201)
                      |+|+||+++.+|   .+++.+....              ...+..|+|||.+  .+..++.++|+|||||++|++++ |.
T Consensus       142 lkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~~g~  219 (277)
T cd05036         142 IAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF--LDGIFTSKTDVWSFGVLLWEIFSLGY  219 (277)
T ss_pred             cchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHH--hcCCcCchhHHHHHHHHHHHHHcCCC
Confidence            999999998754   2344332211              1113469999997  44568899999999999999997 99


Q ss_pred             CCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          137 PPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .||...........+........+..++..+.+++.+|++.+|++|||+.+++++
T Consensus       220 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         220 MPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            9998876666665565555556677889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.8e-37  Score=225.19  Aligned_cols=182  Identities=25%  Similarity=0.369  Sum_probs=150.9

Q ss_pred             cCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEcc
Q 046714            6 QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA   84 (201)
Q Consensus         6 ~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~   84 (201)
                      ...||||+++++++.+.+..+++|||+.+++|.+++.+. ++++..+..++.|++.||+|||++|++|+||||+||+++.
T Consensus        41 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~  120 (237)
T cd05576          41 PHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD  120 (237)
T ss_pred             hcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC
Confidence            456999999999999999999999999999999987653 5899999999999999999999999999999999999999


Q ss_pred             CCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCC
Q 046714           85 SGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK  155 (201)
Q Consensus        85 ~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  155 (201)
                      +|..++.+...         ...++..|+|||..  ....++.++|+||+|+++|++++|+.|+......     .....
T Consensus       121 ~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~  193 (237)
T cd05576         121 RGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVG--GISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHT  193 (237)
T ss_pred             CCCEEEecccchhccccccccCCcCccccCCccc--CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccccc
Confidence            88776655321         22345669999987  4456788999999999999999999877543211     11111


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCCCCCCCH-----hHHhcCccc
Q 046714          156 LPSVPNSLSRDARDFILKCLQVNPNDRPTA-----AQLMEHPFV  194 (201)
Q Consensus       156 ~~~~~~~~~~~~~~li~~~l~~~p~~R~t~-----~~il~~~~~  194 (201)
                      ....+..+++.+++++.+|++.+|++|+|+     +++++||||
T Consensus       194 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         194 TLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            123556788999999999999999999985     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8e-37  Score=227.74  Aligned_cols=193  Identities=23%  Similarity=0.418  Sum_probs=161.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-----------CCHHHHHHHHHHHHHHHHHHhhcCcc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----------LSDSQVSSYTRQILNGLTYLHERNVV   71 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~i~~~l~~lh~~~i~   71 (201)
                      .++.++||||+++++++.+.+..+++|||+.+++|.+++....           .+...+..++.|++.||.|||++|++
T Consensus        62 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~  141 (288)
T cd05061          62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFV  141 (288)
T ss_pred             HHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Confidence            4678899999999999999999999999999999999986421           35567889999999999999999999


Q ss_pred             ccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CC
Q 046714           72 HREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQ  136 (201)
Q Consensus        72 H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~  136 (201)
                      |+||||+||+++.++.+++.+....              ..++..|+|||.+  .+..++.++|+||+|+++|++++ |.
T Consensus       142 H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~--~~~~~~~~~DvwslG~~l~el~~~~~  219 (288)
T cd05061         142 HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAE  219 (288)
T ss_pred             CCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHh--ccCCCChHhHHHHHHHHHHHHHhCCC
Confidence            9999999999998887766554311              1124569999997  34567889999999999999998 78


Q ss_pred             CCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc------CccccCc
Q 046714          137 PPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME------HPFVKRP  197 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~------~~~~~~~  197 (201)
                      .||......+....+..+.....+...++.+.+++.+||+.+|++|||+.++++      ||||+..
T Consensus       220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         220 QPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence            899877666666555555555666778899999999999999999999999987      8998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5e-37  Score=224.83  Aligned_cols=190  Identities=30%  Similarity=0.633  Sum_probs=165.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      .+++++|||++++.+.+..+...++++|++++++|.+++.+     ..++...+..++.+++.|+.+||+.|++|+||+|
T Consensus        52 ~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~  131 (258)
T cd08215          52 ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKP  131 (258)
T ss_pred             HHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCCh
Confidence            46788999999999999999999999999999999998865     4489999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           78 ANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      +||+++.++..++.+...            ...+++.|+|||..  .....+.++|+||+|++++++++|+.||......
T Consensus       132 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~--~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~  209 (258)
T cd08215         132 QNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC--QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL  209 (258)
T ss_pred             HHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHh--ccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH
Confidence            999999887766654321            12356679999987  4455788999999999999999999999887777


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      +.............+...+..+.+++.+||..+|++|||++++++||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         210 ELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            7766666666777777889999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.6e-37  Score=227.33  Aligned_cols=187  Identities=21%  Similarity=0.401  Sum_probs=158.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHhhcCcc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------HLSDSQVSSYTRQILNGLTYLHERNVV   71 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~lh~~~i~   71 (201)
                      ++++++||||+++++++..++..++++||+.+++|.+++...           .++...+..++.|++.|++|||+.|++
T Consensus        62 ~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~v  141 (277)
T cd05062          62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFV  141 (277)
T ss_pred             HHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            467889999999999999999999999999999999998652           146678889999999999999999999


Q ss_pred             ccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CC
Q 046714           72 HREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQ  136 (201)
Q Consensus        72 H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~  136 (201)
                      |+||||+||+++.++.+++.+....              ..++..|+|||.+  .+..++.++|+||||+++|++++ |.
T Consensus       142 H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~~~  219 (277)
T cd05062         142 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAE  219 (277)
T ss_pred             cCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHh--hcCCcCchhHHHHHHHHHHHHHcCCC
Confidence            9999999999999887766654321              1124569999998  34567899999999999999999 78


Q ss_pred             CCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          137 PPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .||....................+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         220 QPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9998877766666666666666777889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3e-37  Score=229.49  Aligned_cols=190  Identities=30%  Similarity=0.532  Sum_probs=152.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.+++..++++||+.+ +|.+++..   ..+++..+..++.|++.|++|||+.|++|+||+|+|
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~n  130 (284)
T cd07860          52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN  130 (284)
T ss_pred             HHHhcCCCCCcchhhhcccCCcEEEEeecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence            46789999999999999999999999999964 88888754   348899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           80 ILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        80 ill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+++.++..++.+...            ...++..|+|||.+. ....++.++|+||||+++|++++|+.||........
T Consensus       131 ill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~  209 (284)
T cd07860         131 LLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL-GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ  209 (284)
T ss_pred             EEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEe-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            9999988776654321            112456799999873 334467899999999999999999999976554333


Q ss_pred             HHHhhcCC----------------------------CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          148 LFRIGRGK----------------------------LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       148 ~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ..+.....                            .......+++.+++++.+||+.+|.+|||++++++||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         210 LFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            32211100                            001123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.3e-37  Score=227.63  Aligned_cols=193  Identities=29%  Similarity=0.411  Sum_probs=160.4

Q ss_pred             ccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEc
Q 046714            5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD   83 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~   83 (201)
                      +..+||+|+++++.+.+.+..++|+||+.|++|.+++... .+++..+..++.|++.|++|||+.+++|+||+|+||+++
T Consensus        52 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~  131 (278)
T cd05606          52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD  131 (278)
T ss_pred             HhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC
Confidence            3468999999999999999999999999999999888654 489999999999999999999999999999999999999


Q ss_pred             cCCceeeecCcc----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHh
Q 046714           84 ASGLATTTNDVK----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED--MQALFRI  151 (201)
Q Consensus        84 ~~g~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~  151 (201)
                      .++.+++.+...          ...++..|+|||.+. .+..++.++|+||+|+++|++++|+.||.....  .......
T Consensus       132 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~  210 (278)
T cd05606         132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM  210 (278)
T ss_pred             CCCCEEEccCcCccccCccCCcCcCCCcCCcCcHHhc-CCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Confidence            888776655321          234677899999983 234578899999999999999999999976521  1222223


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCcC
Q 046714          152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRPL  198 (201)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~~  198 (201)
                      ........+..+++.+.+++.+|+..+|.+|+     +++++++||||+...
T Consensus       211 ~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         211 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             hhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            33334556677899999999999999999999     999999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.1e-37  Score=224.40  Aligned_cols=190  Identities=35%  Similarity=0.602  Sum_probs=165.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      ++++++||||+++++++.+....++++||+++++|.+++.+     ..+++..+..++.|++.|+++||+.|++|+||+|
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~  131 (256)
T cd08530          52 ILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKS  131 (256)
T ss_pred             HHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCc
Confidence            46788999999999999999999999999999999998865     3488899999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           78 ANILVDASGLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +||+++.++..++.+..          ....++..|++||.+  .+..++.++|+||+|++++++++|+.||...+..+.
T Consensus       132 ~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~--~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~  209 (256)
T cd08530         132 ANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVW--KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL  209 (256)
T ss_pred             ceEEEecCCcEEEeeccchhhhccCCcccccCCccccCHHHH--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999988766665532          122356789999998  445677899999999999999999999988877666


Q ss_pred             HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          148 LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ...+..+..+..+...+.++.+++.+|++.+|.+|||++++++||++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         210 RYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            66666676677777889999999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.8e-37  Score=224.26  Aligned_cols=185  Identities=24%  Similarity=0.425  Sum_probs=156.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.. ...++++||+.+++|.+++... .+++..+..++.|++.|+++||++|++|+||||.||+
T Consensus        49 ~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nil  127 (257)
T cd05116          49 VMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVL  127 (257)
T ss_pred             HHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEE
Confidence            4678899999999998864 4568999999999999988653 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCccc---------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           82 VDASGLATTTNDVKS---------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        82 l~~~g~~~~~~~~~~---------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      ++.++.+++.+....               ..++..|+|||.+  .....+.++|+||||+++|++++ |+.||......
T Consensus       128 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  205 (257)
T cd05116         128 LVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN  205 (257)
T ss_pred             EcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHh--ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            998876666543211               0123579999987  34567889999999999999998 99999887776


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+..+..+..+..+++++.+++.+||+.+|++|||+.+|.+
T Consensus       206 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         206 EVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            777777766666778889999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=222.76  Aligned_cols=190  Identities=45%  Similarity=0.852  Sum_probs=164.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++|||++++++++.+++..++++|++.+++|.+++.. ..+++..+..++.|++.|+.+||+.|++|+||+|+||+
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~  131 (254)
T cd06627          52 LLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANIL  131 (254)
T ss_pred             HHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEE
Confidence            46788999999999999999999999999999999998876 45899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|..++.+..            ....++..|+|||...  +...+.++|+|++|++++++++|..||..........
T Consensus       132 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~  209 (254)
T cd06627         132 TTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE--MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF  209 (254)
T ss_pred             ECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence            9988776665532            1223566799999973  3447889999999999999999999998766655555


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .......+..+..+++.+.+++.+||..+|++|||+++++.||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         210 RIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            555555666777889999999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.3e-37  Score=224.47  Aligned_cols=186  Identities=25%  Similarity=0.468  Sum_probs=159.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.+.+..+++|||+.+++|.+++...   .++...+..++.|++.|+.|||+.|++|+||+|+|
T Consensus        55 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~n  134 (261)
T cd05148          55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARN  134 (261)
T ss_pred             HHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcce
Confidence            478899999999999999999999999999999999999752   37899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           80 ILVDASGLATTTNDVKS------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      |+++.++..++.+....            ..++..|++||.+  ....++.++|+||||+++|++++ |+.||......+
T Consensus       135 ilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~--~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~  212 (261)
T cd05148         135 ILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA--SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE  212 (261)
T ss_pred             EEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHH--ccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            99998887766543211            1234569999997  34567889999999999999998 899998877767


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ....+........+...++.+.+++.+||+.+|++|||+.++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         213 VYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            76666666556667788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.4e-37  Score=227.93  Aligned_cols=191  Identities=35%  Similarity=0.651  Sum_probs=153.8

Q ss_pred             cccC-CCcceeccceeeee------CCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCcccc
Q 046714            4 FSQF-EHDNIVQYIGTEKD------ENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHR   73 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~   73 (201)
                      ++++ +||||+++++++..      ....+++|||+.+++|.+++...   .+++..+..++.|++.|+.|||+.|++|+
T Consensus        66 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~  145 (282)
T cd06636          66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHR  145 (282)
T ss_pred             HHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            3445 79999999998853      45789999999999999988653   37888899999999999999999999999


Q ss_pred             CCCCCcEEEccCCceeeecCcc------------ccccCcccccccccccC---CCCCcchhhHHHHHHHHHHHHhCCCC
Q 046714           74 EIKCANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLK---NNGYGLSADIWSLGCTVLEMLTHQPP  138 (201)
Q Consensus        74 dl~p~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p  138 (201)
                      ||+|+||+++.++..++.+...            ...++..|+|||.+...   ...++.++|+||+|+++|++++|+.|
T Consensus       146 dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p  225 (282)
T cd06636         146 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP  225 (282)
T ss_pred             CCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCC
Confidence            9999999999988776655321            23356779999987321   34567899999999999999999999


Q ss_pred             CCCchHHHHHHHhhcCCCC-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          139 YSHLEDMQALFRIGRGKLP-SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      |.................+ .....++..+.+++.+||..+|.+|||+.++++||||
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         226 LCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            9766554444333332222 2334578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=9.7e-37  Score=223.81  Aligned_cols=185  Identities=25%  Similarity=0.419  Sum_probs=157.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.. ...++|+||+++++|.+++..  ..+++..+..++.|++.|++|||++|++|+||||+||
T Consensus        48 ~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni  126 (257)
T cd05115          48 IMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNV  126 (257)
T ss_pred             HHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheE
Confidence            4678999999999998864 467999999999999998864  3489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc---------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           81 LVDASGLATTTNDVKSF---------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~---------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      +++.++.+++.+.....               .++..|+|||.+  ....++.++|+||||+++|++++ |..||.....
T Consensus       127 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  204 (257)
T cd05115         127 LLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG  204 (257)
T ss_pred             EEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHH--ccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH
Confidence            99988776665532110               113569999987  34557889999999999999996 9999988877


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ......+..+.....+...++++.+++.+||..+|++||++.++.+
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         205 PEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7777777777767777888999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.1e-37  Score=230.83  Aligned_cols=187  Identities=24%  Similarity=0.457  Sum_probs=156.3

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLTY   64 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~   64 (201)
                      ++.++ +||||+++++++.+++.+++++||+++++|.+++.+.                 .++..++..++.|++.|++|
T Consensus        60 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~  139 (303)
T cd05088          60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY  139 (303)
T ss_pred             HHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHH
Confidence            35677 8999999999999999999999999999999998643                 36888999999999999999


Q ss_pred             HhhcCccccCCCCCcEEEccCCceeeecCcccc-----------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHH
Q 046714           65 LHERNVVHREIKCANILVDASGLATTTNDVKSF-----------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML  133 (201)
Q Consensus        65 lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~~-----------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~  133 (201)
                      ||++|++|+||||+||+++.++..++.+.....           ..+..|+|||.+  ....++.++|+||||+++|+++
T Consensus       140 LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ell  217 (303)
T cd05088         140 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV  217 (303)
T ss_pred             HHhCCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHH--hccCCcccccchhhhhHHHHHH
Confidence            999999999999999999988877666543221           123469999987  4455788999999999999999


Q ss_pred             h-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          134 T-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       134 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      + |..||......+.............+...++.+.+++.+||+.+|++|||++++++.
T Consensus       218 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         218 SLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             hcCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8 999997766655555554444445566788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-36  Score=226.70  Aligned_cols=195  Identities=29%  Similarity=0.529  Sum_probs=159.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++.+...+.+++++||+++++|.+++.+. .+++..+..++.+++.|+.|||+ .|++|+||+|+||
T Consensus        56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~ni  135 (284)
T cd06620          56 IMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNI  135 (284)
T ss_pred             HHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHE
Confidence            467889999999999999999999999999999999988764 48999999999999999999997 5899999999999


Q ss_pred             EEccCCceeeecCcc----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-----
Q 046714           81 LVDASGLATTTNDVK----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-----  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----  145 (201)
                      +++.++.+.+.+...          ...++..|+|||.+  .+..++.++|+||+|+++|++++|+.||......     
T Consensus       136 l~~~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~  213 (284)
T cd06620         136 LVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERI--QGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD  213 (284)
T ss_pred             EECCCCcEEEccCCcccchhhhccCccccCcccCCHHHH--ccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh
Confidence            999887766654321          23467789999997  3446788999999999999999999999754331     


Q ss_pred             ------HHHHHhhcCCCCCCCCC-CCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          146 ------QALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       146 ------~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                            .....+.....+.++.. ++..+.+++.+|+..+|.+|||++++++++||.+..+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~  274 (284)
T cd06620         214 DPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR  274 (284)
T ss_pred             hhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                  22223333333333333 7789999999999999999999999999999876543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1e-36  Score=226.58  Aligned_cols=187  Identities=20%  Similarity=0.385  Sum_probs=158.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc------------------CCCHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY------------------HLSDSQVSSYTRQILNGLTY   64 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~~i~~~l~~   64 (201)
                      .+++++||||+++++++..++..+++|||+.+++|.+++...                  .+++.++..++.|++.|++|
T Consensus        60 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~  139 (283)
T cd05090          60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEY  139 (283)
T ss_pred             HHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence            578899999999999999999999999999999999988522                  26778889999999999999


Q ss_pred             HhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHH
Q 046714           65 LHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVL  130 (201)
Q Consensus        65 lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~  130 (201)
                      ||++|++|+||||+||+++.++.+++.+....              ..++..|+|||.+  .+..++.++|+||||+++|
T Consensus       140 lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~  217 (283)
T cd05090         140 LSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI--MYGKFSSDSDIWSFGVVLW  217 (283)
T ss_pred             HHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHh--ccCCCCchhhhHHHHHHHH
Confidence            99999999999999999998877666553211              1234469999987  3455789999999999999


Q ss_pred             HHHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          131 EMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       131 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ++++ |..||...........+........+..+++.+.+++.+||+.+|.+||++.+++++
T Consensus       218 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         218 EIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            9998 999997776666666666666666777889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.1e-36  Score=222.99  Aligned_cols=190  Identities=52%  Similarity=0.971  Sum_probs=160.1

Q ss_pred             ccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++.+.+.  +..++++|++.+++|.+++... .+++..+..++.|++.|++|||+.|++|+||+|+|
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~n  131 (260)
T cd06606          52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGAN  131 (260)
T ss_pred             HHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHH
Confidence            46788999999999999988  8999999999999999998765 58999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCc--------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch-H
Q 046714           80 ILVDASGLATTTNDV--------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE-D  144 (201)
Q Consensus        80 ill~~~g~~~~~~~~--------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-~  144 (201)
                      |+++.+|..++.+..              ....++..|.|||.+  .....+.++|+||+|++++++++|..||.... .
T Consensus       132 i~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  209 (260)
T cd06606         132 ILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI--RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP  209 (260)
T ss_pred             EEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Confidence            999988766555421              123356679999997  44457899999999999999999999997765 2


Q ss_pred             HHHHHHhh-cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          145 MQALFRIG-RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       145 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ........ ....+..+...+..+.+++.+|++.+|.+|||+.++++||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         210 MAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            22222222 234456677789999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1e-36  Score=224.63  Aligned_cols=187  Identities=26%  Similarity=0.464  Sum_probs=159.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++.+...+..++++||+.+++|.+++...  .+++..+..++.|++.|++|||+.|++|+||+|+||
T Consensus        58 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ni  137 (266)
T cd05033          58 IMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI  137 (266)
T ss_pred             HHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence            467899999999999999999999999999999999998653  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      +++.++..++.+....              ..++..|+|||.+  ....++.++|+||+|+++|++++ |..||......
T Consensus       138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~--~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~  215 (266)
T cd05033         138 LVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI--AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ  215 (266)
T ss_pred             EEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhh--ccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence            9999887666553211              1123569999997  44567899999999999999998 99999877776


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +....+........+..+++.+.+++.+||+.+|++||++++++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         216 DVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            6666666655555667789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.8e-37  Score=228.24  Aligned_cols=190  Identities=25%  Similarity=0.476  Sum_probs=153.2

Q ss_pred             ccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++||||+++++++...  +..++++||+.+ +|.+++...  .+++..+..++.|++.||+|||++|++|+||+|+
T Consensus        57 ~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~  135 (293)
T cd07843          57 ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTS  135 (293)
T ss_pred             HHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHH
Confidence            46788999999999998877  889999999976 998888653  3899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           79 NILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        79 nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ||+++.+|.+++.+...            ...++..|+|||.+. .....+.++|+||+|++++++++|..||.......
T Consensus       136 nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~  214 (293)
T cd07843         136 NLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLL-GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID  214 (293)
T ss_pred             HEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhc-CCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            99999988777665321            122456799999873 33346889999999999999999999997765544


Q ss_pred             HHHHhhcCC------------------------------CCCCCCC-CCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          147 ALFRIGRGK------------------------------LPSVPNS-LSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       147 ~~~~~~~~~------------------------------~~~~~~~-~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ...++....                              ...++.. +++.+.+++++||+.+|++|||++|+++||||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         215 QLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             HHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            433221100                              0112222 57889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.4e-37  Score=234.72  Aligned_cols=195  Identities=24%  Similarity=0.382  Sum_probs=159.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++..++|+||+++++.+.+++..++||||+.+++|.+++.+  ..+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        54 ~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Ni  133 (331)
T cd05624          54 VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV  133 (331)
T ss_pred             HHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHE
Confidence            45678999999999999999999999999999999999976  3589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-------------ccccCcccccccccccCC---CCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           81 LVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKN---NGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      +++.+|.+++.+...             ...|++.|+|||.+....   ..++.++|+||+|+++|+|++|+.||.....
T Consensus       134 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~  213 (331)
T cd05624         134 LLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL  213 (331)
T ss_pred             EEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence            999888776655421             134788899999974311   3467899999999999999999999987766


Q ss_pred             HHHHHHhhcCC----CCCCCCCCCHHHHHHHHHHhhcCCCC--CCCHhHHhcCccccCc
Q 046714          145 MQALFRIGRGK----LPSVPNSLSRDARDFILKCLQVNPND--RPTAAQLMEHPFVKRP  197 (201)
Q Consensus       145 ~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~--R~t~~~il~~~~~~~~  197 (201)
                      .+....+....    .+.....+++.+++++.+|++.++.+  |++++++++||||+..
T Consensus       214 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         214 VETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             HHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            66555544322    12223446899999999999876544  5699999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-37  Score=226.05  Aligned_cols=186  Identities=23%  Similarity=0.402  Sum_probs=158.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHhhcCcc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------HLSDSQVSSYTRQILNGLTYLHERNVV   71 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~lh~~~i~   71 (201)
                      ++++++||||+++++++......++++||+++++|.+++...           .+++..+..++.|++.|+.|||+.|++
T Consensus        62 ~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  141 (277)
T cd05032          62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFV  141 (277)
T ss_pred             HHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            467889999999999999999999999999999999988642           156778999999999999999999999


Q ss_pred             ccCCCCCcEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CC
Q 046714           72 HREIKCANILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQ  136 (201)
Q Consensus        72 H~dl~p~nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~  136 (201)
                      |+||+|+||+++.+|..++.+...              ...++..|+|||.+  .....+.++|+||||+++|++++ |+
T Consensus       142 H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~t~g~  219 (277)
T cd05032         142 HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL--KDGVFTTKSDVWSFGVVLWEMATLAE  219 (277)
T ss_pred             ccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHH--hcCCCCcccchHHHHHHHHHhhccCC
Confidence            999999999999988776655321              11235579999987  34567889999999999999998 99


Q ss_pred             CCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          137 PPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .||......+.......+.....+..++..+.+++.+||+.+|++|||+.++++
T Consensus       220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         220 QPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            999877766666666666566677788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-36  Score=225.71  Aligned_cols=195  Identities=32%  Similarity=0.592  Sum_probs=154.6

Q ss_pred             ccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVHREI   75 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl   75 (201)
                      ++++++||||+++++++.+.  +..+++|||+++++|.+++..     ..++...+..++.|++.||.|||+.|++|+||
T Consensus        52 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl  131 (287)
T cd06621          52 INKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDI  131 (287)
T ss_pred             HHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence            56789999999999988653  478999999999999887653     33788999999999999999999999999999


Q ss_pred             CCCcEEEccCCceeeecCcc----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch--
Q 046714           76 KCANILVDASGLATTTNDVK----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE--  143 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--  143 (201)
                      +|+||+++.++.+.+.+...          ...++..|+|||.+  .+..++.++|+||+|+++|++++|+.||....  
T Consensus       132 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  209 (287)
T cd06621         132 KPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERI--QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP  209 (287)
T ss_pred             CHHHEEEecCCeEEEeeccccccccccccccccCCccccCHHHh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence            99999999887766655321          22356679999997  44567889999999999999999999997541  


Q ss_pred             ---HHHHHHHhhcCCCCCCC------CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          144 ---DMQALFRIGRGKLPSVP------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       144 ---~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                         ..+..........+..+      ...++.+.+++.+||..+|.+|||+.|++.||||+....
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         210 PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             CCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence               22222222222222222      234578999999999999999999999999999976544

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-36  Score=226.01  Aligned_cols=187  Identities=20%  Similarity=0.359  Sum_probs=159.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----------------YHLSDSQVSSYTRQILNGLTYL   65 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~l   65 (201)
                      ++++++||||+++++++.+....++++||+.+++|.+++..                 ..++...+..++.|++.||+|+
T Consensus        61 ~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l  140 (283)
T cd05091          61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL  140 (283)
T ss_pred             HHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999999999999998852                 2367888999999999999999


Q ss_pred             hhcCccccCCCCCcEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHH
Q 046714           66 HERNVVHREIKCANILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE  131 (201)
Q Consensus        66 h~~~i~H~dl~p~nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~  131 (201)
                      |+.|++|+||||+||++++++.+++.+...              ...+++.|+|||.+  ....++.++|+||+|+++|+
T Consensus       141 H~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~~l~e  218 (283)
T cd05091         141 SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI--MYGKFSIDSDIWSYGVVLWE  218 (283)
T ss_pred             HHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHH--hcCCCCcchhHHHHHHHHHH
Confidence            999999999999999999887776665431              11234579999997  34557889999999999999


Q ss_pred             HHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          132 MLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       132 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +++ |..||......+....+........+..++..+.+++.+||+.+|.+||++++++..
T Consensus       219 l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         219 VFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            998 888998877777777777776666778899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1e-36  Score=224.01  Aligned_cols=186  Identities=23%  Similarity=0.458  Sum_probs=156.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +++.++||||+++++.+.+.+..++++||+.+++|.+++.+.   .++...+..++.|++.|++|||+.|++|+||+|+|
T Consensus        54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~n  133 (261)
T cd05072          54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAAN  133 (261)
T ss_pred             HHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhh
Confidence            467899999999999999999999999999999999998652   37888999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.++..++.+....             ..++..|+|||.+  ....++.++|+||||+++|++++ |+.||......
T Consensus       134 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~  211 (261)
T cd05072         134 VLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS  211 (261)
T ss_pred             EEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHh--ccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence            99998887665543211             1124469999997  34557889999999999999998 99999887666


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+...........++.++.+++.+|+..+|++|||++++.+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         212 DVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            666666555544555678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-36  Score=221.87  Aligned_cols=189  Identities=42%  Similarity=0.785  Sum_probs=159.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+++++||||+++++.+...+..++++||+.+++|.+++...  .+++..+..++.|++.|+++||..|++|+||+|+||
T Consensus        50 ~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni  129 (253)
T cd05122          50 ILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANI  129 (253)
T ss_pred             HHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHE
Confidence            467889999999999999999999999999999999998765  689999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           81 LVDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        81 ll~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      +++.++..++.+..           ....++..|+|||.+  .+...+.++|+||+|++++++++|+.||..........
T Consensus       130 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  207 (253)
T cd05122         130 LLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVI--NGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF  207 (253)
T ss_pred             EEccCCeEEEeeccccccccccccccceecCCcccCHHHH--cCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence            99988776665432           123356679999998  34457889999999999999999999998775555444


Q ss_pred             HhhcCCCCCCCCCC--CHHHHHHHHHHhhcCCCCCCCHhHHhcCcc
Q 046714          150 RIGRGKLPSVPNSL--SRDARDFILKCLQVNPNDRPTAAQLMEHPF  193 (201)
Q Consensus       150 ~~~~~~~~~~~~~~--~~~~~~li~~~l~~~p~~R~t~~~il~~~~  193 (201)
                      .......+..+...  +..+.+++.+||+.+|++|||+.++++|||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         208 KIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            44434333443333  889999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-37  Score=227.00  Aligned_cols=190  Identities=30%  Similarity=0.539  Sum_probs=153.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      .+++++||||+++++++.+++..++++||+. ++|.+++....   +++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        51 ~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~n  129 (283)
T cd07835          51 LLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQN  129 (283)
T ss_pred             HHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHH
Confidence            4678899999999999999999999999996 48999887643   8999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           80 ILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        80 ill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+++.++...+.+...            ...++..|+|||.+. ....++.++|+||+|+++|++++|+.||........
T Consensus       130 il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  208 (283)
T cd07835         130 LLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL-GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ  208 (283)
T ss_pred             EEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceee-cCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999988776655321            112356799999873 334568899999999999999999999976654333


Q ss_pred             HHHhhcC----------------------------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          148 LFRIGRG----------------------------KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       148 ~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ...+...                            ........++..+.+++.+|++.+|.+|||++++++||||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         209 LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            2221110                            0011234567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=9e-37  Score=224.20  Aligned_cols=189  Identities=30%  Similarity=0.604  Sum_probs=161.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      ++++++||||+++++.+.+....++++||+++++|.+++..     ..+++..+..++.|++.|+.|||+.|++|+||+|
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~  134 (260)
T cd08222          55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKA  134 (260)
T ss_pred             HHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCCh
Confidence            46788999999999999999999999999999999988753     3489999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           78 ANILVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      +||+++.+ ..++.+..            ....++..|+|||..  ....++.++|+||+|++++++++|..||......
T Consensus       135 ~nili~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~  211 (260)
T cd08222         135 KNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL--KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL  211 (260)
T ss_pred             hheEeecC-CEeecccCceeecCCCcccccCCCCCcCccCHHHH--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence            99999754 33333321            123356779999987  3455678999999999999999999999877666


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ........+..+..+..++.++.+++.+|+..+|++||+++++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         212 SVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            6666666666667778889999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-37  Score=237.89  Aligned_cols=195  Identities=37%  Similarity=0.705  Sum_probs=175.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|...+||+|+++++.|..++.++++.|||.||....++-.  +++.+.++..+..|++.||.|||+++|+|+|||..||
T Consensus        82 ILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNi  161 (1187)
T KOG0579|consen   82 ILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNI  161 (1187)
T ss_pred             hhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccce
Confidence            68889999999999999999999999999999999887754  4599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc------------cccccCccccccccccc---CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           81 LVDASGLATTTNDV------------KSFEGTPFWVAPEVVNL---KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |+.-+|-.++.+++            .++.||+.|+|||++..   ...++..++||||||+.|.+|..+.+|-.....+
T Consensus       162 L~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM  241 (1187)
T KOG0579|consen  162 LLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM  241 (1187)
T ss_pred             EEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH
Confidence            99999877766643            35679999999998732   3456888999999999999999999999999999


Q ss_pred             HHHHHhhcCCCCCC--CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          146 QALFRIGRGKLPSV--PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       146 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      +++.++.+...|.+  |...+..+.+|+.+||..+|..||++.++++||||+..
T Consensus       242 RVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  242 RVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             HHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            99999988877653  66788999999999999999999999999999999843

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=222.05  Aligned_cols=185  Identities=25%  Similarity=0.475  Sum_probs=156.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.. +..++++||+.+++|.+++...+ +++..+..++.|++.|+++||..|++|+||+|+||+
T Consensus        49 ~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nil  127 (257)
T cd05060          49 VMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVL  127 (257)
T ss_pred             HHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEE
Confidence            4678899999999998764 45799999999999999997755 899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcccc---------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           82 VDASGLATTTNDVKSF---------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        82 l~~~g~~~~~~~~~~~---------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      ++.++..++.+.....               .++..|+|||.+  .+..++.++|+||||+++|++++ |..||......
T Consensus       128 i~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~  205 (257)
T cd05060         128 LVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI--NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA  205 (257)
T ss_pred             EcCCCcEEeccccccceeecCCcccccccCccccccccCHHHh--cCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            9998876665432110               012469999987  44567889999999999999998 99999887766


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +....+........+..+++.+++++.+||..+|++|||+.++++
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         206 EVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            666666666555667788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.4e-36  Score=225.59  Aligned_cols=188  Identities=28%  Similarity=0.499  Sum_probs=149.4

Q ss_pred             cccC-CCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            4 FSQF-EHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      +.++ +||||+++++++.++  +..++++||+.+ ++.+.+..  ..+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus        51 l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~  129 (282)
T cd07831          51 LRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPE  129 (282)
T ss_pred             HhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHH
Confidence            4556 499999999999987  889999999976 77777764  34899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           79 NILVDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        79 nill~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ||+++. |..++.+..           ....++..|+|||.+. .+...+.++|+||+|+++|++++|+.||......+.
T Consensus       130 ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~  207 (282)
T cd07831         130 NILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLL-TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ  207 (282)
T ss_pred             HEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhh-cCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH
Confidence            999998 776665532           1223566799999863 334568899999999999999999999977654433


Q ss_pred             HHHhhcC---------------CC--CC-----------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          148 LFRIGRG---------------KL--PS-----------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       148 ~~~~~~~---------------~~--~~-----------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .......               ..  ..           ....++..+.+++.+||.++|++|||++++++||||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         208 IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            3222110               00  00           112467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.5e-37  Score=231.87  Aligned_cols=190  Identities=26%  Similarity=0.435  Sum_probs=142.0

Q ss_pred             ccccCCCcceeccceeeee--CCeEEEEEEecCCCCHHHHHHh----------cCCCHHHHHHHHHHHHHHHHHHhhcCc
Q 046714            3 SFSQFEHDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQK----------YHLSDSQVSSYTRQILNGLTYLHERNV   70 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~~i   70 (201)
                      +|++++||||+++++++..  +...++++||+.+ +|.+++..          ..+++..+..++.|++.||+|||+.|+
T Consensus        51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i  129 (317)
T cd07867          51 LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWV  129 (317)
T ss_pred             HHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            5778999999999998853  5678999999976 78777642          137888899999999999999999999


Q ss_pred             cccCCCCCcEEEc----cCCceeeecCc---------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHH
Q 046714           71 VHREIKCANILVD----ASGLATTTNDV---------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE  131 (201)
Q Consensus        71 ~H~dl~p~nill~----~~g~~~~~~~~---------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~  131 (201)
                      +|+||||+||++.    .+|..++.+..               ....++..|+|||.+. ....++.++|+||+|+++|+
T Consensus       130 vH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlG~il~e  208 (317)
T cd07867         130 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAE  208 (317)
T ss_pred             EcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhc-CCCccCcHHHHHhHHHHHHH
Confidence            9999999999994    34444444421               1223577799999973 33457889999999999999


Q ss_pred             HHhCCCCCCCchHH---------HHHHHhhc--C--------------C---------------------CCCCCCCCCH
Q 046714          132 MLTHQPPYSHLEDM---------QALFRIGR--G--------------K---------------------LPSVPNSLSR  165 (201)
Q Consensus       132 l~~g~~p~~~~~~~---------~~~~~~~~--~--------------~---------------------~~~~~~~~~~  165 (201)
                      +++|+.||......         ........  +              .                     ........+.
T Consensus       209 l~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (317)
T cd07867         209 LLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDS  288 (317)
T ss_pred             HHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCCh
Confidence            99999998543210         00000000  0              0                     0001112356


Q ss_pred             HHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          166 DARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       166 ~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .+.+++.+||+.||.+|||++|+++||||
T Consensus       289 ~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         289 KVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            68899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-36  Score=223.59  Aligned_cols=186  Identities=23%  Similarity=0.401  Sum_probs=147.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.++...++++||+.+++|..++..  ..+++..+..++.||++||+|||++|++|+||||+||
T Consensus        57 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni  136 (262)
T cd05077          57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNI  136 (262)
T ss_pred             HHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccE
Confidence            46789999999999999999999999999999999888865  3489999999999999999999999999999999999


Q ss_pred             EEccCCc-------eeeecCc--------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHH-hCCCCCCCchH
Q 046714           81 LVDASGL-------ATTTNDV--------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML-THQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~-------~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~-~g~~p~~~~~~  144 (201)
                      +++.+|.       .++.+..        ....++..|+|||.+. ....++.++||||||+++|+++ .|..|+.....
T Consensus       137 ll~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~  215 (262)
T cd05077         137 LLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVE-DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL  215 (262)
T ss_pred             EEecCCccCCCCceeEeCCCCCCccccCcccccccccccChhhhc-CCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence            9986653       2333322        1223567799999872 3456788999999999999997 58888876543


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .+.. ....... ......++++.+++.+||+.+|.+||++.+++++
T Consensus       216 ~~~~-~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         216 AEKE-RFYEGQC-MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             hHHH-HHHhcCc-cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            3322 2222211 2233346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.8e-37  Score=228.53  Aligned_cols=191  Identities=35%  Similarity=0.630  Sum_probs=153.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +++.++||||+++++++.+++..++++||+++++|..+.... .+++..+..++.|++.|++|||+.|++|+||+|+||+
T Consensus        53 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~  132 (286)
T cd07846          53 MLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENIL  132 (286)
T ss_pred             HHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence            467889999999999999999999999999998888876543 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.++..++.+...            ...++..|+|||.+. ....++.++|+||+|++++++++|+.||......+...
T Consensus       133 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~  211 (286)
T cd07846         133 VSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV-GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY  211 (286)
T ss_pred             ECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhc-cccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHH
Confidence            99988766654321            123566799999973 33456789999999999999999999987654433222


Q ss_pred             Hhhc---------------------CCCC---------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          150 RIGR---------------------GKLP---------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       150 ~~~~---------------------~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .+..                     ...+         .....++..+.+++.+||..+|.+|||+.++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         212 HIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             HHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            2110                     0000         0123567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.9e-36  Score=222.09  Aligned_cols=186  Identities=25%  Similarity=0.476  Sum_probs=157.6

Q ss_pred             ccccCCCcceeccceeee-eCCeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEK-DENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++|+||+++++++. .++..++++||+++++|.++++...   +++..+..++.|++.||++||++|++|+||+|+
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~  131 (256)
T cd05082          52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAAR  131 (256)
T ss_pred             HHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchh
Confidence            467899999999999754 5567899999999999999987543   788899999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCccc---------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH
Q 046714           79 NILVDASGLATTTNDVKS---------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQAL  148 (201)
Q Consensus        79 nill~~~g~~~~~~~~~~---------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~  148 (201)
                      ||+++.+|..++.+....         ...+..|+|||.+  ....++.++|+||+|+++|++++ |+.||......+..
T Consensus       132 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~  209 (256)
T cd05082         132 NVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV  209 (256)
T ss_pred             eEEEcCCCcEEecCCccceeccccCCCCccceeecCHHHH--ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999988777664321         1234469999997  45567889999999999999998 99999877666666


Q ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..+.....+..+..+++.+.+++.+|++.+|.+|||+.++++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         210 PRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            666666666677788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.9e-36  Score=225.86  Aligned_cols=186  Identities=25%  Similarity=0.431  Sum_probs=157.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-------------------------CCCHHHHHHHHHH
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-------------------------HLSDSQVSSYTRQ   57 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------------------~~~~~~~~~~~~~   57 (201)
                      ++++++||||+++++.+..++..++++||+.+++|.+++...                         .+++..+..++.|
T Consensus        56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~  135 (290)
T cd05045          56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQ  135 (290)
T ss_pred             HHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHH
Confidence            467899999999999999999999999999999999988642                         3678889999999


Q ss_pred             HHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHH
Q 046714           58 ILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIW  123 (201)
Q Consensus        58 i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~  123 (201)
                      ++.||+|||+.|++|+||+|+||++++++.+++.+....              ..++..|+|||.+  .+..++.++|+|
T Consensus       136 i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~  213 (290)
T cd05045         136 ISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL--FDHIYTTQSDVW  213 (290)
T ss_pred             HHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH--ccCCcchHhHHH
Confidence            999999999999999999999999998887766553221              1234569999987  455678999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          124 SLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       124 slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      |||++++++++ |..||......+.............+..++..+.+++.+||+.+|++||++.++++
T Consensus       214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            99999999998 99999887766666665555555567778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-36  Score=226.48  Aligned_cols=191  Identities=34%  Similarity=0.628  Sum_probs=153.1

Q ss_pred             cccC-CCcceeccceeee-----eCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccc
Q 046714            4 FSQF-EHDNIVQYIGTEK-----DENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVH   72 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H   72 (201)
                      ++++ +||||+++++++.     +++..+++|||+++++|.+++..     ..+++..+..++.|++.|+.|||+.+++|
T Consensus        68 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  147 (286)
T cd06638          68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIH  147 (286)
T ss_pred             HHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            5566 6999999999874     44678999999999999988752     23788899999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceeeecCcc------------ccccCccccccccccc---CCCCCcchhhHHHHHHHHHHHHhCCC
Q 046714           73 REIKCANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNL---KNNGYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        73 ~dl~p~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      +||+|+||+++.+|.+++.+...            ...++..|+|||.+..   ....++.++|+||+|+++|++++|+.
T Consensus       148 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~  227 (286)
T cd06638         148 RDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP  227 (286)
T ss_pred             cCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCC
Confidence            99999999999888766554321            1236678999998742   12446789999999999999999999


Q ss_pred             CCCCchHHHHHHHhhcCCCC--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          138 PYSHLEDMQALFRIGRGKLP--SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       138 p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ||.................+  ..+..++..+.+++.+||+.+|++|||+.++++|+||
T Consensus       228 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         228 PLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            99776554444433322221  1234467889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-36  Score=223.72  Aligned_cols=186  Identities=23%  Similarity=0.363  Sum_probs=148.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.++...++||||+++++|..++.+  ..+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        69 ~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Ni  148 (274)
T cd05076          69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNI  148 (274)
T ss_pred             HHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccE
Confidence            46789999999999999999999999999999999998864  3489999999999999999999999999999999999


Q ss_pred             EEccCCc-------eeeecCc--------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHH-hCCCCCCCchH
Q 046714           81 LVDASGL-------ATTTNDV--------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML-THQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~-------~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~-~g~~p~~~~~~  144 (201)
                      +++..|.       .++.+..        ....++..|+|||.+. ....++.++|+||||+++|+++ +|+.||.....
T Consensus       149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         149 LLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVP-GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             EEeccCcccCccceeeecCCccccccccccccccCCcccCchhhc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            9986543       2222221        1123567799999873 3356789999999999999985 68999876544


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .........  ....+...++.+.+++.+||+.+|++|||+++++++
T Consensus       228 ~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         228 SEKERFYEK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHHHHHh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            333222221  123344456789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.8e-36  Score=220.37  Aligned_cols=186  Identities=26%  Similarity=0.498  Sum_probs=157.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++...+..+++|||+.+++|.+++...  .+++..+..++.|++.|+.|+|+.|++|+||+|+||
T Consensus        45 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~ni  124 (250)
T cd05085          45 ILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNC  124 (250)
T ss_pred             HHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheE
Confidence            467889999999999999999999999999999999988653  378999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.++.+++.+....             ..++..|+|||.+  ....++.++|+||+|+++|++++ |..||.......
T Consensus       125 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~  202 (250)
T cd05085         125 LVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEAL--NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ  202 (250)
T ss_pred             EEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHh--ccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence            9998887666554211             1123459999997  34567889999999999999998 999998776666


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ....+........+..++..+.+++.+|+..+|++|||+.++++
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         203 AREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            66666555555667778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-36  Score=222.11  Aligned_cols=186  Identities=27%  Similarity=0.503  Sum_probs=157.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++...+..++++||+.+++|.+++...   .++...+..++.|++.|+.+||+.|++|+||+|+|
T Consensus        54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~N  133 (261)
T cd05068          54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARN  133 (261)
T ss_pred             HHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcce
Confidence            467899999999999999999999999999999999998753   38999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc----------ccc---CcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS----------FEG---TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~----------~~~---~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.+|..++.+....          ..+   ...|+|||.+  ....++.++|+||||++++++++ |+.||......
T Consensus       134 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  211 (261)
T cd05068         134 VLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA--LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA  211 (261)
T ss_pred             EEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCcccc--ccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999887666553211          111   2369999987  45567889999999999999999 99999887766


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+........+...+..+.+++.+|++.+|.+||+++++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         212 EVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            666666555444556678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.9e-37  Score=235.91  Aligned_cols=186  Identities=23%  Similarity=0.461  Sum_probs=151.5

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-------------------------------------
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-------------------------------------   44 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------------------------------   44 (201)
                      +++++ +||||+++++.+...+..+++|||+++++|.+++...                                     
T Consensus        94 il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (374)
T cd05106          94 ILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGF  173 (374)
T ss_pred             HHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccc
Confidence            45677 8999999999999999999999999999999987532                                     


Q ss_pred             ----------------------------------CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceee
Q 046714           45 ----------------------------------HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATT   90 (201)
Q Consensus        45 ----------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~   90 (201)
                                                        ++++..+.+++.||+.||+|||++|++|+||||+||+++.++.+++
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL  253 (374)
T cd05106         174 SSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKI  253 (374)
T ss_pred             cccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEE
Confidence                                              2577788999999999999999999999999999999998876666


Q ss_pred             ecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHHh-hcC
Q 046714           91 TNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRI-GRG  154 (201)
Q Consensus        91 ~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~-~~~  154 (201)
                      .+....              ..++..|+|||.+  ....++.++|+||+|+++|++++ |+.||............ ..+
T Consensus       254 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~  331 (374)
T cd05106         254 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESI--FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG  331 (374)
T ss_pred             eeceeeeeccCCcceeeccCCCCccceeCHHHh--cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc
Confidence            553211              1123469999997  44567899999999999999997 99999776544333333 333


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       155 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..+..+...++++.+++.+||+.+|.+|||++++++
T Consensus       332 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         332 YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            334455667899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-36  Score=225.67  Aligned_cols=190  Identities=29%  Similarity=0.494  Sum_probs=153.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY----HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++||||+++++.+.+.+..++++||+.+ +|.+++...    .+++..+..++.|++.|++|||+.|++|+||+|+
T Consensus        51 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~  129 (284)
T cd07836          51 LMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQ  129 (284)
T ss_pred             HHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHH
Confidence            56789999999999999999999999999986 888887653    3899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           79 NILVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        79 nill~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ||+++.+|..++.+..            ....++..|++||.+. ....++.++|+||+|+++|++++|+.||......+
T Consensus       130 ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~  208 (284)
T cd07836         130 NLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL-GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED  208 (284)
T ss_pred             HEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            9999988877665532            1223466799999873 33456889999999999999999999997655443


Q ss_pred             HHHHhhcC-------------C----CCC-----------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          147 ALFRIGRG-------------K----LPS-----------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       147 ~~~~~~~~-------------~----~~~-----------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ........             .    ...           .....+..+.+++.+|++.+|.+|||++++++||||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         209 QLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             HHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            33222110             0    000           112457788999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.3e-36  Score=227.14  Aligned_cols=195  Identities=33%  Similarity=0.626  Sum_probs=160.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+++++||||+++++++.+++..++|+||+.+ ++.+++..  ..+++..+..++.|++.|+.|||+.|++|+||+|+||
T Consensus        68 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nI  146 (307)
T cd06607          68 FLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNI  146 (307)
T ss_pred             HHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccE
Confidence            46789999999999999999999999999976 77776643  4589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc--------cccccCccccccccccc-CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 046714           81 LVDASGLATTTNDV--------KSFEGTPFWVAPEVVNL-KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI  151 (201)
Q Consensus        81 ll~~~g~~~~~~~~--------~~~~~~~~~~aPE~~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  151 (201)
                      +++.+|..++.+..        ....++..|+|||.+.. ....++.++|+||||+++|++++|+.||...........+
T Consensus       147 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~  226 (307)
T cd06607         147 LLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  226 (307)
T ss_pred             EECCCCCEEEeecCcceecCCCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH
Confidence            99998877666532        22345678999998732 2345788999999999999999999999876665555544


Q ss_pred             hcCCCCCC-CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          152 GRGKLPSV-PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       152 ~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .....+.. ...++..+.+++.+||+.+|++|||+.+++.||||....
T Consensus       227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         227 AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             hcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            44333333 334678999999999999999999999999999997654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=221.32  Aligned_cols=189  Identities=34%  Similarity=0.542  Sum_probs=162.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++.+.+++..+++||++.+++|.+++... .+++..+..++.|++.|+.+||+.+++|+||+|+||+
T Consensus        46 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~  125 (250)
T cd05123          46 ILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENIL  125 (250)
T ss_pred             HHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEE
Confidence            467889999999999999999999999999999999998765 5899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.++...+.+...            ...++..|+|||.+  .+...+.++|+||||+++|++++|..||...+......
T Consensus       126 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~--~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~  203 (250)
T cd05123         126 LDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL--LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE  203 (250)
T ss_pred             EcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHh--CCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            99988766554321            22356679999997  34557889999999999999999999998776655555


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH---hHHhcCccc
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA---AQLMEHPFV  194 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~---~~il~~~~~  194 (201)
                      .+.. ....++...+..+.+++++||..+|++|||+   +++++||||
T Consensus       204 ~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         204 KILK-DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            5544 3346677789999999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.5e-36  Score=221.69  Aligned_cols=186  Identities=22%  Similarity=0.358  Sum_probs=149.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++..+...++||||+.+++|.++++..+  +++..+..++.||+.|++|||++|++|+||||+||
T Consensus        52 ~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~ni  131 (258)
T cd05078          52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNV  131 (258)
T ss_pred             HHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            4678899999999999999899999999999999999987543  78999999999999999999999999999999999


Q ss_pred             EEccCCce--------eeecCc--------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC-CCCCCCch
Q 046714           81 LVDASGLA--------TTTNDV--------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLE  143 (201)
Q Consensus        81 ll~~~g~~--------~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~  143 (201)
                      +++.++..        ++.+..        ....++..|+|||.+. ....++.++|+||+|+++|++++| ..|+....
T Consensus       132 li~~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~  210 (258)
T cd05078         132 LLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIE-NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD  210 (258)
T ss_pred             EEecccccccCCCceEEecccccccccCCchhccccCCccCchhcc-CCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc
Confidence            99876543        333321        1234567799999983 334568899999999999999998 46665554


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          144 DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ........  .....++...+.++.+++.+||+.+|++|||++++++.
T Consensus       211 ~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         211 SQKKLQFY--EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHH--HccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            43332222  12334566677899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.9e-36  Score=227.74  Aligned_cols=193  Identities=26%  Similarity=0.409  Sum_probs=154.0

Q ss_pred             ccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++|+||+++++++.+.  +..++|+||+.+ +|.+++..  ..+++.++..++.|++.||+|||+.|++|+||+|+
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~  137 (309)
T cd07845          59 LLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVS  137 (309)
T ss_pred             HHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            46789999999999998765  568999999976 88888765  34899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCccc------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           79 NILVDASGLATTTNDVKS------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        79 nill~~~g~~~~~~~~~~------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ||+++.+|.+++.+....            ..++..|+|||.+. ....++.++|+||+|+++|++++|+.||.......
T Consensus       138 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~  216 (309)
T cd07845         138 NLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL-GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE  216 (309)
T ss_pred             HEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhc-CCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999887766553211            12355699999873 34557889999999999999999999998766655


Q ss_pred             HHHHhhcCCC------------------CCC-----------CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          147 ALFRIGRGKL------------------PSV-----------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       147 ~~~~~~~~~~------------------~~~-----------~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ....+.....                  ...           ....++.+.+++.+||+.||++|||++++++||||+..
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         217 QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             HHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            5443322100                  000           01247888999999999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=226.13  Aligned_cols=190  Identities=28%  Similarity=0.460  Sum_probs=150.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..++|+||+.+ +|.+++...  .+++..+..++.|+++||.|||+.|++|+||+|+||
T Consensus        56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~ni  134 (291)
T cd07844          56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNL  134 (291)
T ss_pred             HHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHE
Confidence            46789999999999999999999999999986 898887653  478999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch-HHHH
Q 046714           81 LVDASGLATTTNDVKS------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE-DMQA  147 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-~~~~  147 (201)
                      +++.+|.+++.+....            ..++..|+|||.+. ....++.++|+||+|+++|++++|+.||.... ..+.
T Consensus       135 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~  213 (291)
T cd07844         135 LISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL-GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ  213 (291)
T ss_pred             EEcCCCCEEECccccccccCCCCccccccccccccCCcHHhh-cCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence            9999887777654311            12356799999873 33457889999999999999999999996554 1111


Q ss_pred             HHHhhc---CC------------------CC--------CCCCCCC--HHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          148 LFRIGR---GK------------------LP--------SVPNSLS--RDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       148 ~~~~~~---~~------------------~~--------~~~~~~~--~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ...+..   ..                  ..        .....++  ..+.+++.+|++.+|++|||+.++++||||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         214 LHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             HHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            111100   00                  00        0001233  778899999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.8e-36  Score=222.56  Aligned_cols=186  Identities=25%  Similarity=0.455  Sum_probs=155.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcCccccC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--------HLSDSQVSSYTRQILNGLTYLHERNVVHRE   74 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d   74 (201)
                      ++++++||||+++++++...+..++++||+++++|.+++...        .+++..+..++.|++.|++|||+.+++|+|
T Consensus        52 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~d  131 (269)
T cd05044          52 LMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRD  131 (269)
T ss_pred             HHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            467899999999999999999999999999999999988642        267888999999999999999999999999


Q ss_pred             CCCCcEEEccCC-----ceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-
Q 046714           75 IKCANILVDASG-----LATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-  134 (201)
Q Consensus        75 l~p~nill~~~g-----~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-  134 (201)
                      |+|+||+++.++     ..++.+...              ...++..|+|||.+  .+..++.++|+||||+++|++++ 
T Consensus       132 l~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~ellt~  209 (269)
T cd05044         132 LAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESL--LDGKFTTQSDVWSFGVLMWEILTL  209 (269)
T ss_pred             CChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHH--ccCCcccchhHHHHHHHHHHHHHc
Confidence            999999998876     444443221              11234579999997  44567899999999999999998 


Q ss_pred             CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          135 HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       135 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      |+.||......+....+..+.....+..+++.+.+++.+||..+|++|||++++++
T Consensus       210 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         210 GQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             CCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            99999877666666555555555667778999999999999999999999999865

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-36  Score=234.29  Aligned_cols=187  Identities=24%  Similarity=0.431  Sum_probs=151.4

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-------------------------------------
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-------------------------------------   44 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------------------------------   44 (201)
                      +|+++ +||||+++++.+.+.+..++||||+++|+|.+++...                                     
T Consensus        91 il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  170 (375)
T cd05104          91 VLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMD  170 (375)
T ss_pred             HHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhh
Confidence            35566 8999999999999999999999999999999988542                                     


Q ss_pred             ---------------------------------------CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccC
Q 046714           45 ---------------------------------------HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS   85 (201)
Q Consensus        45 ---------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~   85 (201)
                                                             .+++..+..++.||+.||+|||+.|++|+||||+||+++.+
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~  250 (375)
T cd05104         171 MKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG  250 (375)
T ss_pred             cCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC
Confidence                                                   25677888999999999999999999999999999999988


Q ss_pred             CceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHH-
Q 046714           86 GLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALF-  149 (201)
Q Consensus        86 g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~-  149 (201)
                      +.+++.+....              ..++..|+|||.+  .+..++.++|+||||+++|++++ |..||.......... 
T Consensus       251 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~  328 (375)
T cd05104         251 RITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESI--FNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK  328 (375)
T ss_pred             CcEEEecCccceeccCcccccccCCCCCCcceeChhHh--cCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHH
Confidence            76666554311              1123469999997  45567899999999999999998 889997764433333 


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .+..+.....+...+.++.+++.+||+.+|++|||+.++++.
T Consensus       329 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            333343444556678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.7e-36  Score=226.53  Aligned_cols=186  Identities=25%  Similarity=0.413  Sum_probs=149.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--------------------CCHHHHHHHHHHHHHHH
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--------------------LSDSQVSSYTRQILNGL   62 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~i~~~l   62 (201)
                      +|.+++||||+++++++.+.+..+++|||+.+++|.+++....                    ++...+..++.||+.||
T Consensus        72 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al  151 (304)
T cd05096          72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGM  151 (304)
T ss_pred             HHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999999999999999886432                    56678899999999999


Q ss_pred             HHHhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHH
Q 046714           63 TYLHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT  128 (201)
Q Consensus        63 ~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~  128 (201)
                      .|||+.|++|+||||+||+++.++.+++.+....              ..++..|+|||.+  ....++.++|+||||++
T Consensus       152 ~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~~  229 (304)
T cd05096         152 KYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI--LMGKFTTASDVWAFGVT  229 (304)
T ss_pred             HHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH--hcCCCCchhhhHHHHHH
Confidence            9999999999999999999999887777664321              1125579999997  34567899999999999


Q ss_pred             HHHHHh--CCCCCCCchHHHHHHHhhc-------CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          129 VLEMLT--HQPPYSHLEDMQALFRIGR-------GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       129 l~~l~~--g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +|++++  +..||..............       ......+..+++.+.+++.+||+.+|++|||++++.+
T Consensus       230 l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         230 LWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             HHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            999987  5678876554444332211       1112234567899999999999999999999999843

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-37  Score=236.59  Aligned_cols=186  Identities=30%  Similarity=0.435  Sum_probs=156.5

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE-
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV-   82 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill-   82 (201)
                      +.--+||||+++.+++.++...++|||.++|+-+.+.+...+....++..|+++|+.|+.|||.+|++||||||+|||+ 
T Consensus       370 ~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~  449 (612)
T KOG0603|consen  370 LLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD  449 (612)
T ss_pred             hhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec
Confidence            3445799999999999999999999999999888887766554447788899999999999999999999999999999 


Q ss_pred             ccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHHHhh
Q 046714           83 DASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-QALFRIG  152 (201)
Q Consensus        83 ~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~  152 (201)
                      ++.|...+.++..         ..+-|..|.|||..  ....++.++|+||||++||+|++|+.||...+.. +...++.
T Consensus       450 ~~~g~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl--~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~  527 (612)
T KOG0603|consen  450 GSAGHLRLTYFGFWSELERSCDTPALTLQYVAPEVL--AIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ  527 (612)
T ss_pred             CCCCcEEEEEechhhhCchhhcccchhhcccChhhh--ccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc
Confidence            5777666665432         22346679999998  4778899999999999999999999999877665 3333333


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       153 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .   +.+...+|..+++|++.||+.+|.+|+++.++..|||+
T Consensus       528 ~---~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  528 M---PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             C---CccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            2   34457899999999999999999999999999999999

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-36  Score=219.84  Aligned_cols=186  Identities=26%  Similarity=0.488  Sum_probs=159.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++|+||+++++++.+.+..++++||+.+++|.++++..   .+++..+..++.|++.|+.|||+.|++|+||+|+|
T Consensus        53 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~N  132 (256)
T cd05039          53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARN  132 (256)
T ss_pred             HHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccce
Confidence            567899999999999999999999999999999999998764   38999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcccc---------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHH
Q 046714           80 ILVDASGLATTTNDVKSF---------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALF  149 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~~---------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~  149 (201)
                      |+++.+|..++.+.....         ..+..|.|||.+  ....++.++|+||+|++++++++ |..||..........
T Consensus       133 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~  210 (256)
T cd05039         133 VLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP  210 (256)
T ss_pred             EEEeCCCCEEEcccccccccccccccCCCcccccCchhh--cCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999998887766543211         123459999987  34567889999999999999997 999998877766666


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..........+...++.+.+++.+||..+|++|||++++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         211 HVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            66555555667778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.7e-36  Score=225.60  Aligned_cols=194  Identities=34%  Similarity=0.650  Sum_probs=159.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++|||++++++++.+....++++||+.+ ++.+++..  ..+++.++..++.|++.|+.|||+.|++|+||+|+||
T Consensus        74 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~ni  152 (313)
T cd06633          74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI  152 (313)
T ss_pred             HHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhE
Confidence            46789999999999999999999999999976 77777654  3488999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc--------cccccCccccccccccc-CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 046714           81 LVDASGLATTTNDV--------KSFEGTPFWVAPEVVNL-KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI  151 (201)
Q Consensus        81 ll~~~g~~~~~~~~--------~~~~~~~~~~aPE~~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  151 (201)
                      +++.+|..++.+..        ....++..|+|||.+.. ....++.++|+||+|+++|++++|..||............
T Consensus       153 li~~~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~  232 (313)
T cd06633         153 LLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  232 (313)
T ss_pred             EECCCCCEEEeecCCCcccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99988876665532        22345677999999732 2345788999999999999999999999876655555554


Q ss_pred             hcCCCCC-CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          152 GRGKLPS-VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       152 ~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .....+. ....++..+.+++.+||+.+|.+||++.++++||||+..
T Consensus       233 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         233 AQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            4333332 234567889999999999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=224.74  Aligned_cols=191  Identities=32%  Similarity=0.620  Sum_probs=153.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++|+||+++++++.+++..++++||+.++.+..+..+ ..++...+..++.|++.|+.|||+.|++|+||+|+||+
T Consensus        53 ~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~  132 (288)
T cd07833          53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENIL  132 (288)
T ss_pred             HHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence            46789999999999999999999999999998777666554 34899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc-------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           82 VDASGLATTTNDV-------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        82 l~~~g~~~~~~~~-------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      ++.++.+++.+..             ....++..|+|||.+. ....++.++|+||+|+++|++++|+.||......+..
T Consensus       133 ~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~  211 (288)
T cd07833         133 VSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV-GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL  211 (288)
T ss_pred             ECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhc-CCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9998877665532             1233456799999983 2336788999999999999999999999765443332


Q ss_pred             HHhhcC---------------------CCC----------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          149 FRIGRG---------------------KLP----------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       149 ~~~~~~---------------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ......                     ..+          .++..+++++.+++++||..+|++|||++++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         212 YLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             HHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            221100                     000          1223358889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-36  Score=231.68  Aligned_cols=191  Identities=25%  Similarity=0.423  Sum_probs=150.2

Q ss_pred             cccCC-CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            4 FSQFE-HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         4 l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      |.+|+ |.+|++++++-..++.+|+|||+-+. +|..+++++.  .+...+..+..|++.||.+.|..||||.||||.|+
T Consensus       413 L~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANF  491 (677)
T KOG0596|consen  413 LNKLKGHDKIIQLYDYEVTDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANF  491 (677)
T ss_pred             HHHhcCCceEEEEeeeeccCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccE
Confidence            34454 88999999999999999999999866 9999998765  45458899999999999999999999999999999


Q ss_pred             EEccCCceeeecCc--------------cccccCcccccccccccCCC---------CCcchhhHHHHHHHHHHHHhCCC
Q 046714           81 LVDASGLATTTNDV--------------KSFEGTPFWVAPEVVNLKNN---------GYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        81 ll~~~g~~~~~~~~--------------~~~~~~~~~~aPE~~~~~~~---------~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      ++-+ |..++.+++              ...+||+.|++||.+.....         +.++++||||+||+||+|+.|+.
T Consensus       492 LlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgkt  570 (677)
T KOG0596|consen  492 LLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKT  570 (677)
T ss_pred             EEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCC
Confidence            8854 333333321              23458999999999842222         26789999999999999999999


Q ss_pred             CCCCchHHHHHHHhhcCCCC--CCCCCCCHH-HHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          138 PYSHLEDMQALFRIGRGKLP--SVPNSLSRD-ARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       138 p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ||..+...............  +++..-+.. +.++++.||.+||++|||+.++|+|||++.
T Consensus       571 Pf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  571 PFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             chHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            99887644333332222222  444443333 899999999999999999999999999886

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.3e-37  Score=238.04  Aligned_cols=183  Identities=32%  Similarity=0.510  Sum_probs=149.9

Q ss_pred             ceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC-
Q 046714           11 NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG-   86 (201)
Q Consensus        11 ~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g-   86 (201)
                      |||+++++|...++.++|+|.+.. +|.++++.+   +++...++.++.||+.||.+||+.||+|+||||+|||+.+-+ 
T Consensus       249 n~Vrm~d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r  327 (586)
T KOG0667|consen  249 NIVRMLDYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR  327 (586)
T ss_pred             eEEEeeeccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc
Confidence            899999999999999999999966 999999875   489999999999999999999999999999999999997654 


Q ss_pred             -ceeeecCcccc---------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhc--C
Q 046714           87 -LATTTNDVKSF---------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--G  154 (201)
Q Consensus        87 -~~~~~~~~~~~---------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~  154 (201)
                       .+++++++++.         ..+..|+|||++  .+..++.+.|||||||+++||++|.+.|++..+.+.+..+..  +
T Consensus       328 ~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVI--LGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG  405 (586)
T KOG0667|consen  328 SRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVI--LGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG  405 (586)
T ss_pred             CceeEEecccccccCCcceeeeeccccccchhh--ccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence             33445544332         245569999998  778899999999999999999999999988777666555411  0


Q ss_pred             CC---------------------CC----------------------------CC-----------CCCCHHHHHHHHHH
Q 046714          155 KL---------------------PS----------------------------VP-----------NSLSRDARDFILKC  174 (201)
Q Consensus       155 ~~---------------------~~----------------------------~~-----------~~~~~~~~~li~~~  174 (201)
                      ..                     +.                            .+           ......+.+|+++|
T Consensus       406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~  485 (586)
T KOG0667|consen  406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC  485 (586)
T ss_pred             CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence            00                     00                            00           11234578999999


Q ss_pred             hhcCCCCCCCHhHHhcCccccC
Q 046714          175 LQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       175 l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      |.+||.+|+|..|+++|||+..
T Consensus       486 L~~dP~~R~tp~qal~Hpfl~~  507 (586)
T KOG0667|consen  486 LEWDPAERITPAQALNHPFLTG  507 (586)
T ss_pred             hccCchhcCCHHHHhcCccccc
Confidence            9999999999999999999983

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.6e-36  Score=226.20  Aligned_cols=186  Identities=25%  Similarity=0.463  Sum_probs=156.3

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLTY   64 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~   64 (201)
                      +++++ +||||+++++++.+++..++++||+.+++|.+++...                 .++..++..++.|++.||.|
T Consensus        70 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~  149 (314)
T cd05099          70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEY  149 (314)
T ss_pred             HHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHH
Confidence            34566 6999999999999999999999999999999998652                 27788899999999999999


Q ss_pred             HhhcCccccCCCCCcEEEccCCceeeecCcccc--------------ccCcccccccccccCCCCCcchhhHHHHHHHHH
Q 046714           65 LHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVL  130 (201)
Q Consensus        65 lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~~--------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~  130 (201)
                      ||++|++|+||||+||+++.++..++.+.....              .++..|+|||.+  .+..++.++|+||||+++|
T Consensus       150 lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslG~~l~  227 (314)
T cd05099         150 LESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGILMW  227 (314)
T ss_pred             HHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHH--ccCCcCccchhhHHHHHHH
Confidence            999999999999999999988877666533211              122469999997  3456788999999999999


Q ss_pred             HHHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          131 EMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       131 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ++++ |..||...........+........+..++.++.+++.+||..+|++|||+.++++
T Consensus       228 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         228 EIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            9999 89999887766666666665555667778899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.5e-36  Score=221.36  Aligned_cols=186  Identities=25%  Similarity=0.455  Sum_probs=155.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..+++|||+++++|.+++.+.  .++..++..++.|++.|+.+||++|++|+||+|+||
T Consensus        58 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~ni  137 (267)
T cd05066          58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI  137 (267)
T ss_pred             HHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcE
Confidence            467889999999999999999999999999999999998764  378999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc---------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           81 LVDASGLATTTNDVKS---------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~---------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      +++.++..++.+....               ...+..|+|||.+  .+..++.++|+||+|+++|++++ |..||.....
T Consensus       138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~--~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~  215 (267)
T cd05066         138 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN  215 (267)
T ss_pred             EECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHh--ccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence            9998876665543211               0113469999998  44567899999999999999887 9999987766


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .+....+........+..+++.+.+++.+|++.+|.+|||+.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         216 QDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            5555555555444555668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.2e-36  Score=223.31  Aligned_cols=186  Identities=27%  Similarity=0.479  Sum_probs=149.2

Q ss_pred             ccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++...  ...+++|||+.+++|.+++....+++..+..++.|++.|++|||++|++|+||||+||
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Ni  138 (283)
T cd05080          59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNV  138 (283)
T ss_pred             HHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheE
Confidence            57889999999999987653  4689999999999999999888899999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc---------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVKS---------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~---------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      +++.++..++.+....               ..++..|+|||.+  .....+.++|+||||++++++++|..|+......
T Consensus       139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~--~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~  216 (283)
T cd05080         139 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL--KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK  216 (283)
T ss_pred             EEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHh--cccCCCcccccHHHHHHHHHHHhCCCCCCCCcch
Confidence            9998877666543211               1134458999987  3456788999999999999999999987543211


Q ss_pred             ---------------HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 ---------------QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                                     ..............+..++..+.+++.+||+.+|++|||++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         217 FEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                           001111112222345667899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=215.51  Aligned_cols=188  Identities=29%  Similarity=0.479  Sum_probs=148.3

Q ss_pred             cccCCCcceeccceeeeeC-----CeEEEEEEecCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcC--cc
Q 046714            4 FSQFEHDNIVQYIGTEKDE-----NRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQILNGLTYLHERN--VV   71 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~~--i~   71 (201)
                      -++++|||++++++....+     ...|++++|+..|+|.+.++..     .+++.+++.++.+|++||++||...  +.
T Consensus        72 ~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yA  151 (302)
T KOG2345|consen   72 HRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYA  151 (302)
T ss_pred             HHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCccc
Confidence            3689999999999976543     3599999999999999988642     3899999999999999999999998  99


Q ss_pred             ccCCCCCcEEEccCCceeeecCccc---------------------cccCccccccccccc-CCCCCcchhhHHHHHHHH
Q 046714           72 HREIKCANILVDASGLATTTNDVKS---------------------FEGTPFWVAPEVVNL-KNNGYGLSADIWSLGCTV  129 (201)
Q Consensus        72 H~dl~p~nill~~~g~~~~~~~~~~---------------------~~~~~~~~aPE~~~~-~~~~~~~~~Dv~slG~~l  129 (201)
                      |+||||.||++.+.|...+.+..+.                     ...|..|+|||.+.. .+...+.++|||||||++
T Consensus       152 H~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtL  231 (302)
T KOG2345|consen  152 HRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTL  231 (302)
T ss_pred             ccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHH
Confidence            9999999999999887776665432                     225788999999853 345678999999999999


Q ss_pred             HHHHhCCCCCCCchHHHH--HHHhhcCCCC-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          130 LEMLTHQPPYSHLEDMQA--LFRIGRGKLP-SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       130 ~~l~~g~~p~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      |.|+.|..||+...+...  ...+..+... .....+++.+.++++.|++.||.+||++.+++.+
T Consensus       232 Ya~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  232 YAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             HHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            999999999965322111  0111111110 1122389999999999999999999999998763

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.1e-36  Score=221.38  Aligned_cols=185  Identities=25%  Similarity=0.429  Sum_probs=153.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.. ...++++||+.+++|.+++...  .+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        62 ~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~ni  140 (279)
T cd05111          62 AMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNI  140 (279)
T ss_pred             HHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceE
Confidence            4678999999999998764 4578899999999999998653  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      +++.++.+++.+....              ..++..|+|||.+  .+..++.++|+||||+++|++++ |+.||.+....
T Consensus       141 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~--~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~  218 (279)
T cd05111         141 LLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI--LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH  218 (279)
T ss_pred             EEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHh--ccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9998877766553211              1234579999997  34557899999999999999998 99999877655


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+..+.....+..++..+.+++.+||..+|.+|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         219 EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            555555555555556667889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.3e-36  Score=231.20  Aligned_cols=191  Identities=25%  Similarity=0.436  Sum_probs=151.0

Q ss_pred             ccccCCCcceeccceeeeeC------CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE------NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      ++++++||||+++++++...      ...++|+||+.+ +|.+.+... ++...+..++.|++.||+|||+.|++|+|||
T Consensus        68 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlk  145 (353)
T cd07850          68 LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  145 (353)
T ss_pred             HHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence            46788999999999987644      357999999976 888877654 8999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           77 CANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |+||+++.+|..++.+...           ...++..|+|||.+  .+..++.++|+||+|+++|+|++|+.||...+..
T Consensus       146 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~  223 (353)
T cd07850         146 PSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI  223 (353)
T ss_pred             HHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHH--hCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence            9999999988776665422           12356679999998  4566789999999999999999999999765443


Q ss_pred             HHHHHhhcCC---------------------CC---------------------CCCCCCCHHHHHHHHHHhhcCCCCCC
Q 046714          146 QALFRIGRGK---------------------LP---------------------SVPNSLSRDARDFILKCLQVNPNDRP  183 (201)
Q Consensus       146 ~~~~~~~~~~---------------------~~---------------------~~~~~~~~~~~~li~~~l~~~p~~R~  183 (201)
                      .....+....                     .+                     ..+...++.+.+++.+||+.+|++||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  303 (353)
T cd07850         224 DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI  303 (353)
T ss_pred             HHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc
Confidence            3322211000                     00                     00123456789999999999999999


Q ss_pred             CHhHHhcCccccCc
Q 046714          184 TAAQLMEHPFVKRP  197 (201)
Q Consensus       184 t~~~il~~~~~~~~  197 (201)
                      |+.|+++||||+..
T Consensus       304 t~~eiL~~~~~~~~  317 (353)
T cd07850         304 SVDDALQHPYINVW  317 (353)
T ss_pred             CHHHHhcChhHhhc
Confidence            99999999998753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.3e-36  Score=237.94  Aligned_cols=189  Identities=23%  Similarity=0.359  Sum_probs=145.1

Q ss_pred             CCcceeccceeeeeC-CeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCcEEEcc
Q 046714            8 EHDNIVQYIGTEKDE-NRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCANILVDA   84 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~nill~~   84 (201)
                      +|++|+++++++..+ +..++|+|++ +++|.+++.+ +.+++..+..++.||+.||+|||+ .||+|+||||+||+++.
T Consensus       189 ~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~  267 (467)
T PTZ00284        189 DRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMET  267 (467)
T ss_pred             cCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEec
Confidence            456789999988765 5788999988 5588887765 458999999999999999999998 59999999999999987


Q ss_pred             CCc----------------eeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCC
Q 046714           85 SGL----------------ATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY  139 (201)
Q Consensus        85 ~g~----------------~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  139 (201)
                      +|.                +++.+..         ....+++.|+|||.+  .+..++.++|||||||++|+|++|+.||
T Consensus       268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~--~~~~~~~~~DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVV--LGLGWMYSTDMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             CCcccccccccccCCCCceEEECCCCccccCccccccccCCccccCcHHh--hcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            653                3444332         134578899999998  4567889999999999999999999999


Q ss_pred             CCchHHHHHHHhhc--CCCC------------------------CC---------------CCCCCHHHHHHHHHHhhcC
Q 046714          140 SHLEDMQALFRIGR--GKLP------------------------SV---------------PNSLSRDARDFILKCLQVN  178 (201)
Q Consensus       140 ~~~~~~~~~~~~~~--~~~~------------------------~~---------------~~~~~~~~~~li~~~l~~~  178 (201)
                      ......+....+..  +..+                        ..               ....++.+.+||.+||++|
T Consensus       346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  425 (467)
T PTZ00284        346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD  425 (467)
T ss_pred             CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence            77654433222111  0000                        00               0012356779999999999


Q ss_pred             CCCCCCHhHHhcCccccCcCC
Q 046714          179 PNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       179 p~~R~t~~~il~~~~~~~~~~  199 (201)
                      |++|||++|+++||||++-..
T Consensus       426 P~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        426 RQKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             hhhCCCHHHHhcCccccccCC
Confidence            999999999999999987543

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.1e-36  Score=225.31  Aligned_cols=186  Identities=24%  Similarity=0.457  Sum_probs=156.5

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHH
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLTYL   65 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~l   65 (201)
                      ++++ +||||+++++++...+..++++||+.+++|.+++...                 .++..++..++.|++.||+||
T Consensus        77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l  156 (307)
T cd05098          77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL  156 (307)
T ss_pred             HHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence            4556 7999999999999999999999999999999998653                 267888999999999999999


Q ss_pred             hhcCccccCCCCCcEEEccCCceeeecCcccc--------------ccCcccccccccccCCCCCcchhhHHHHHHHHHH
Q 046714           66 HERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE  131 (201)
Q Consensus        66 h~~~i~H~dl~p~nill~~~g~~~~~~~~~~~--------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~  131 (201)
                      |+.|++|+||||+||+++.++.+++.+.....              .++..|+|||.+  .+..++.++|+||+|+++|+
T Consensus       157 H~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~~l~e  234 (307)
T cd05098         157 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWE  234 (307)
T ss_pred             HHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHh--ccCCCCcHHHHHHHHHHHHH
Confidence            99999999999999999988877665532211              123469999987  34567889999999999999


Q ss_pred             HHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          132 MLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       132 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      |++ |..||......+....+........+...+.++.+++.+||..+|.+|||+.+++++
T Consensus       235 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         235 IFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            998 889998776666665555555556677789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9.5e-36  Score=218.95  Aligned_cols=187  Identities=22%  Similarity=0.429  Sum_probs=152.6

Q ss_pred             ccccCCCcceeccceeee-eCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEK-DENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +++.++||||+++++++. .++..++++||+.+++|.+++.+..  .+...+..++.|+++|++|||+.+++|+||+|+|
T Consensus        49 ~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~n  128 (262)
T cd05058          49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARN  128 (262)
T ss_pred             HHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcce
Confidence            467899999999999765 4556899999999999999987533  5777888999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc----------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCc
Q 046714           80 ILVDASGLATTTNDVKS----------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHL  142 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~----------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~  142 (201)
                      |+++.++.+++.+....                ..++..|+|||.+  ....++.++|+||||+++|++++ |..||...
T Consensus       129 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~  206 (262)
T cd05058         129 CMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  206 (262)
T ss_pred             EEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHh--ccCccchHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99998877666553221                1134569999987  34567889999999999999999 56677766


Q ss_pred             hHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          143 EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ...........+.....+...++.+.+++.+||..+|++||++.++++.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         207 DSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             CHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            6655555555555555566678999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.2e-36  Score=224.18  Aligned_cols=186  Identities=24%  Similarity=0.452  Sum_probs=156.3

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHH
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLTYL   65 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~l   65 (201)
                      ++.+ +||||+++++.+...+..+++|||+.+++|.+++...                 .++...+..++.|++.||.||
T Consensus        74 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L  153 (304)
T cd05101          74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL  153 (304)
T ss_pred             HHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH
Confidence            5567 7999999999999999999999999999999998653                 266778899999999999999


Q ss_pred             hhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHH
Q 046714           66 HERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE  131 (201)
Q Consensus        66 h~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~  131 (201)
                      |+.|++|+||||+||+++.+|..++.+....              ..++..|+|||.+  .+..++.++|+||||+++|+
T Consensus       154 H~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~e  231 (304)
T cd05101         154 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMWE  231 (304)
T ss_pred             HHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh--ccCCCCchhhHHHHHHHHHH
Confidence            9999999999999999998877666553211              1134569999987  34567889999999999999


Q ss_pred             HHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          132 MLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       132 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +++ |..||......+....+........+..++..+.+++.+||..+|.+|||+.++++.
T Consensus       232 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         232 IFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            998 888888777767666666655555667789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.7e-36  Score=228.03  Aligned_cols=193  Identities=26%  Similarity=0.454  Sum_probs=155.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++..++..++++||+.+ +|.+++... .+++..+..++.|++.||++||+.|++|+||+|+||+
T Consensus        73 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nil  151 (335)
T PTZ00024         73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIF  151 (335)
T ss_pred             HHHhCCCcceeeeeEEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeE
Confidence            46789999999999999999999999999975 888888653 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCccc--------------------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC
Q 046714           82 VDASGLATTTNDVKS--------------------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH  135 (201)
Q Consensus        82 l~~~g~~~~~~~~~~--------------------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g  135 (201)
                      ++.+|..++.+....                          ..++..|+|||.+. .....+.++|+||+|+++|++++|
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~el~tg  230 (335)
T PTZ00024        152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLM-GAEKYHFAVDMWSVGCIFAELLTG  230 (335)
T ss_pred             ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcc-cCCCCCcHHHHHHHHHHHHHHHhC
Confidence            998887665543211                          12355699999973 334568899999999999999999


Q ss_pred             CCCCCCchHHHHHHHhhcC---CCC------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHH
Q 046714          136 QPPYSHLEDMQALFRIGRG---KLP------------------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQL  188 (201)
Q Consensus       136 ~~p~~~~~~~~~~~~~~~~---~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~i  188 (201)
                      +.||......+....+...   ...                        ......+..+.+++.+||..+|++|||++++
T Consensus       231 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~  310 (335)
T PTZ00024        231 KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA  310 (335)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence            9999877655444332110   000                        0112457789999999999999999999999


Q ss_pred             hcCccccCc
Q 046714          189 MEHPFVKRP  197 (201)
Q Consensus       189 l~~~~~~~~  197 (201)
                      +.||||+..
T Consensus       311 l~~~~~~~~  319 (335)
T PTZ00024        311 LKHEYFKSD  319 (335)
T ss_pred             hcCcccCCC
Confidence            999999864

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.1e-36  Score=225.00  Aligned_cols=186  Identities=23%  Similarity=0.464  Sum_probs=157.5

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHH
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLTYL   65 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~l   65 (201)
                      ++++ +||||+++++++..++..+++|||+.+++|.++++..                 .+++..+..++.|++.|++||
T Consensus        69 l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L  148 (293)
T cd05053          69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL  148 (293)
T ss_pred             HHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence            4566 7999999999999999999999999999999998642                 378889999999999999999


Q ss_pred             hhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHH
Q 046714           66 HERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE  131 (201)
Q Consensus        66 h~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~  131 (201)
                      |+.|++|+||+|+||+++.++..++.+....              ..++..|+|||.+  .+..++.++|+||||+++|+
T Consensus       149 H~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~e  226 (293)
T cd05053         149 ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLLWE  226 (293)
T ss_pred             HHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHh--ccCCcCcccceeehhhHHHH
Confidence            9999999999999999999887766654321              1123469999987  45567889999999999999


Q ss_pred             HHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          132 MLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       132 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +++ |..||......+.......+.....+...+..+.+++.+||..+|++|||+++++++
T Consensus       227 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         227 IFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            997 999998877666666666665556677788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.1e-36  Score=225.10  Aligned_cols=193  Identities=28%  Similarity=0.493  Sum_probs=151.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.+++..++|+||+++ +|.+.+....   +++..+..++.||+.||+|||++|++|+||+|+|
T Consensus        54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~n  132 (294)
T PLN00009         54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQN  132 (294)
T ss_pred             HHHhccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcce
Confidence            46789999999999999999999999999965 7877765432   5778888999999999999999999999999999


Q ss_pred             EEEccCC-ceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           80 ILVDASG-LATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        80 ill~~~g-~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      |+++.++ .+++.+..            ....++..|+|||.+. ....++.++|+||+|+++|++++|+.||......+
T Consensus       133 ill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~  211 (294)
T PLN00009        133 LLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL-GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID  211 (294)
T ss_pred             EEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9998644 33443321            1122456799999873 33457889999999999999999999997765544


Q ss_pred             HHHHhhcC---C-----------------CC--------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          147 ALFRIGRG---K-----------------LP--------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       147 ~~~~~~~~---~-----------------~~--------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+....   .                 .+        ......++.+.+++.+|++.+|++||+++++++||||...
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        212 ELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             HHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence            44332110   0                 00        0123467889999999999999999999999999999864

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-36  Score=228.94  Aligned_cols=194  Identities=29%  Similarity=0.524  Sum_probs=152.9

Q ss_pred             ccccCCCcceeccceeeeeC-----CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE-----NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      ++++++||||+++++++...     ...++++||+.+ +|.+++....+++..+..++.|++.||++||+.|++|+||||
T Consensus        56 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp  134 (336)
T cd07849          56 ILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKP  134 (336)
T ss_pred             HHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence            56789999999999987654     357999999976 888888877899999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc
Q 046714           78 ANILVDASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL  142 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  142 (201)
                      +||+++.+|..++.+...               ...++..|+|||.+. ....++.++|+||+|+++|++++|+.||...
T Consensus       135 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DvwslGvil~el~~G~~~f~~~  213 (336)
T cd07849         135 SNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNRPLFPGK  213 (336)
T ss_pred             HHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999887666554321               123567799999862 3456788999999999999999999999765


Q ss_pred             hHHHHHHHhhc----------------------C---CCC-----CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          143 EDMQALFRIGR----------------------G---KLP-----SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       143 ~~~~~~~~~~~----------------------~---~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                      ........+..                      .   ...     ......++.+.+++.+||+.+|++|||+.++++||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp  293 (336)
T cd07849         214 DYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP  293 (336)
T ss_pred             CHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence            43222111100                      0   000     01124578899999999999999999999999999


Q ss_pred             cccCcC
Q 046714          193 FVKRPL  198 (201)
Q Consensus       193 ~~~~~~  198 (201)
                      ||+...
T Consensus       294 ~~~~~~  299 (336)
T cd07849         294 YLEQYH  299 (336)
T ss_pred             cccccC
Confidence            998654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=218.40  Aligned_cols=186  Identities=27%  Similarity=0.498  Sum_probs=158.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.++...++++||+.+++|.+++...   .++...+..++.|++.|+.|||++|++|+||+|+|
T Consensus        54 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~n  133 (261)
T cd05034          54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARN  133 (261)
T ss_pred             HHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchhe
Confidence            467899999999999999989999999999999999998653   38899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.++..++.+....             ...+..|+|||.+  .+...+.++|+||+|++++++++ |+.||......
T Consensus       134 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  211 (261)
T cd05034         134 ILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA--NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR  211 (261)
T ss_pred             EEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHh--ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999887776654211             1123469999987  45567899999999999999998 99999887776


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..............+...+..+.+++.+|++.+|.+|||++++.+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         212 EVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            666666665555556677899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-37  Score=237.83  Aligned_cols=194  Identities=29%  Similarity=0.487  Sum_probs=169.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +++.++||||++++.+...+..+|+||||+.++.+.+++.+.+ +.+..+..++.|++.|++|||+++|+|+|||.+|++
T Consensus       108 imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNil  187 (596)
T KOG0586|consen  108 IMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENIL  187 (596)
T ss_pred             HHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcc
Confidence            5788999999999999999999999999999999999998765 777899999999999999999999999999999999


Q ss_pred             EccCCceeeecC-----------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           82 VDASGLATTTND-----------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        82 l~~~g~~~~~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      ++.+-..++.++           ..+++|++.|.|||++++ ....++++|+||+|+++|.+..|..||++....+...+
T Consensus       188 L~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g-~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r  266 (596)
T KOG0586|consen  188 LDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNG-KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR  266 (596)
T ss_pred             cccccceeeeccccceeecccccccccCCCCCccChHhhcC-cccCCcceehhhhhhhheeeeecccccCCcccccccch
Confidence            998876665543           235678999999999954 44668999999999999999999999998776666666


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ...+.. .++..++.+++++|+++|..+|.+|++.+|++.|.|.+...
T Consensus       267 vl~gk~-rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  267 VLRGKY-RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             heeeee-cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence            555544 56677889999999999999999999999999999987654

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-35  Score=219.32  Aligned_cols=186  Identities=24%  Similarity=0.428  Sum_probs=156.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++.+++.+.+..+++|||+.+++|.+++...  .+++.++..++.|++.|++|||+.|++|+||+|+||
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni  138 (268)
T cd05063          59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNI  138 (268)
T ss_pred             HHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence            467899999999999999999999999999999999998653  488999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc---------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           81 LVDASGLATTTNDVKSF---------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~---------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      +++.++..++.+.....               ..+..|+|||.+  ....++.++|+||+|+++|++++ |+.||.....
T Consensus       139 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~  216 (268)
T cd05063         139 LVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI--AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN  216 (268)
T ss_pred             EEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHh--hcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence            99988766655432111               012359999997  34567889999999999999997 9999977766


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ......+........+...+..+.+++.+||+.+|++||++.++++
T Consensus       217 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         217 HEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            6666666555444555668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-36  Score=217.63  Aligned_cols=186  Identities=26%  Similarity=0.494  Sum_probs=156.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+.+..++++||+.+++|.+++...  .++...+..++.+++.|+++||++|++|+||+|+||
T Consensus        45 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~ni  124 (251)
T cd05041          45 ILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNC  124 (251)
T ss_pred             HHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceE
Confidence            468899999999999999999999999999999999998653  378889999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc--------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVKSF--------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~--------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      +++.++.+++.+.....              ..+..|+|||.+  .+..++.++|+||+|+++|++++ |..||......
T Consensus       125 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~  202 (251)
T cd05041         125 LVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL--NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ  202 (251)
T ss_pred             EEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhh--ccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH
Confidence            99988877665532111              113359999997  34567899999999999999999 88999877666


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+........+...+..+.+++.+||+.+|.+|||++++++
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         203 QTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            655555555444556778899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-35  Score=217.96  Aligned_cols=185  Identities=29%  Similarity=0.520  Sum_probs=154.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.+ +..++++||+.+++|.+.+...   .+++..+..++.|++.||+|||++|++|+||+|+|
T Consensus        49 ~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~n  127 (257)
T cd05040          49 IMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARN  127 (257)
T ss_pred             HHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCccc
Confidence            5788999999999999888 8899999999999999998764   38899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCch
Q 046714           80 ILVDASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE  143 (201)
Q Consensus        80 ill~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~  143 (201)
                      |+++.++..++.+...               ...++..|+|||.+  .+..++.++|+||+|+++++|++ |+.||....
T Consensus       128 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  205 (257)
T cd05040         128 ILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL--RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS  205 (257)
T ss_pred             EEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHh--cccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999888766655321               11244579999987  45567889999999999999998 999997765


Q ss_pred             HHHHHHHhh-cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          144 DMQALFRIG-RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       144 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..+....+. .......+...+..+.+++.+|++.+|++|||+.++++
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         206 GSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            555544443 22333345567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9.8e-36  Score=218.75  Aligned_cols=185  Identities=25%  Similarity=0.478  Sum_probs=155.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.. ...+++|||+.+++|.+++...   .+++..+..++.|++.|++|||+.|++|+||+|+|
T Consensus        54 ~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~N  132 (260)
T cd05070          54 IMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSAN  132 (260)
T ss_pred             HHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccce
Confidence            5788999999999998754 5578999999999999998653   38899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.++.+++.+....             ..++..|+|||..  ....++.++|+||||+++|++++ |+.||......
T Consensus       133 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~  210 (260)
T cd05070         133 ILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR  210 (260)
T ss_pred             EEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHH--hcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99998876655543211             1123469999987  44567889999999999999999 89999887776


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +....+........+...+..+.+++.+|+..+|.+|||+.++.+
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         211 EVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            766666665555667778999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-35  Score=218.59  Aligned_cols=185  Identities=24%  Similarity=0.467  Sum_probs=154.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.. +..+++|||+.+++|.+++...   .+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        54 ~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~N  132 (260)
T cd05069          54 IMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAAN  132 (260)
T ss_pred             HHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcce
Confidence            5778999999999998754 5678999999999999998653   27888999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |++++++..++.+....             ..++..|+|||..  .+...+.++|+||||+++|++++ |+.||.+....
T Consensus       133 ill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  210 (260)
T cd05069         133 ILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR  210 (260)
T ss_pred             EEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHh--ccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99998887666543211             1134569999987  44567889999999999999999 99999887666


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +....+........+...+..+.+++.+||..+|.+||+++++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         211 EVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            666666555555556678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.5e-36  Score=223.04  Aligned_cols=189  Identities=34%  Similarity=0.590  Sum_probs=160.1

Q ss_pred             ccccCC-CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFE-HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++ ||||+++++++.+++..+++||++.+++|.+++.+. .+++..+..++.|++.||.+||+.|++|+||+|+||
T Consensus        54 ~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni  133 (280)
T cd05581          54 VLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENI  133 (280)
T ss_pred             HHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence            456777 999999999999999999999999999999998776 589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc--------------------------------ccccCcccccccccccCCCCCcchhhHHHHHHH
Q 046714           81 LVDASGLATTTNDVK--------------------------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT  128 (201)
Q Consensus        81 ll~~~g~~~~~~~~~--------------------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~  128 (201)
                      +++.+|...+.+...                                ...++..|+|||..  .....+.++|+||+|++
T Consensus       134 ~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~--~~~~~~~~~Di~slG~~  211 (280)
T cd05581         134 LLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL--NEKPAGKSSDLWALGCI  211 (280)
T ss_pred             EECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHh--CCCCCChhhhHHHHHHH
Confidence            999887655544221                                12245679999987  34557889999999999


Q ss_pred             HHHHHhCCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH----hHHhcCccc
Q 046714          129 VLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA----AQLMEHPFV  194 (201)
Q Consensus       129 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~----~~il~~~~~  194 (201)
                      ++++++|+.||............... ....+..+++.+.+++.+||+.+|.+|||+    +++++||||
T Consensus       212 l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         212 IYQMLTGKPPFRGSNEYLTFQKILKL-EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHhCCCCCCCccHHHHHHHHHhc-CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            99999999999877655554444332 335566789999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.8e-36  Score=222.66  Aligned_cols=190  Identities=27%  Similarity=0.410  Sum_probs=148.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+++++|+||+++++++.+++..++++||+.+ ++.+.+..  ..++...+..++.|++.||+|||+.|++|+||||+||
T Consensus        56 ~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni  134 (291)
T cd07870          56 LLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNL  134 (291)
T ss_pred             HHHhcCCCCEeEEEEEEecCCeEEEEEecccC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence            46789999999999999999999999999965 77666543  3478888999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-HH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-QA  147 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~  147 (201)
                      +++.+|..++.+...            ...++..|+|||.+. ....++.++|+||+|+++|++++|+.||...... +.
T Consensus       135 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~  213 (291)
T cd07870         135 LISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL-GATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ  213 (291)
T ss_pred             EEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceee-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH
Confidence            999888776665431            122467799999973 3345678999999999999999999999765432 11


Q ss_pred             HHHhhc-----------------CCCCCC------------C--CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          148 LFRIGR-----------------GKLPSV------------P--NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       148 ~~~~~~-----------------~~~~~~------------~--~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ......                 ...+..            .  ...+..+.+++.+|+..+|.+|||++|++.||||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         214 LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             HHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            111100                 000000            0  1135688999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.3e-36  Score=226.05  Aligned_cols=186  Identities=22%  Similarity=0.397  Sum_probs=155.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++... ..++++||+.+++|.+++...  .++...+..++.|++.||+|||++|++|+||||+||
T Consensus        62 ~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Ni  140 (316)
T cd05108          62 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNV  140 (316)
T ss_pred             HHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhhe
Confidence            57889999999999998875 467999999999999998764  378889999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc--------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVKSF--------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~--------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      +++.++.+++.+.....              ..+..|+|||.+  .+..++.++|+||||+++|++++ |+.||.+....
T Consensus       141 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~  218 (316)
T cd05108         141 LVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  218 (316)
T ss_pred             EecCCCcEEEccccccccccCCCcceeccCCccceeecChHHh--ccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99988877666542211              123469999997  45567899999999999999998 99999877665


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +.............+..++..+.+++.+||..+|.+|||+.+++.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         219 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            5554455554445566788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-36  Score=223.56  Aligned_cols=190  Identities=28%  Similarity=0.566  Sum_probs=154.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..++++||+.+ ++.+++...  .+++..+..++.|++.|+++||+.|++|+||+|+||
T Consensus        51 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ni  129 (283)
T cd05118          51 LLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENL  129 (283)
T ss_pred             HHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHE
Confidence            56788999999999999999999999999976 888877654  589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.++..++.+..            ....++..|+|||.+. ....++.++|+||+|+++|++++|+.||......+..
T Consensus       130 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~  208 (283)
T cd05118         130 LINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL-GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL  208 (283)
T ss_pred             EECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHh-cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99988876665432            1123556799999973 3336789999999999999999999999776554443


Q ss_pred             HHhhcCCC-----------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          149 FRIGRGKL-----------------------------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       149 ~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ........                             ......++.++.+++.+||..+|.+||++++++.||||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         209 FKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             HHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            33211000                             01122467889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.9e-36  Score=223.26  Aligned_cols=186  Identities=23%  Similarity=0.459  Sum_probs=152.7

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      +++++ +||||+++++.+...+..++++||+.+++|.++++...   +++.++..++.|++.|++|||++|++|+||+|+
T Consensus        91 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~  170 (302)
T cd05055          91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  170 (302)
T ss_pred             HHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccc
Confidence            45677 79999999999999999999999999999999987532   799999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCch
Q 046714           79 NILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE  143 (201)
Q Consensus        79 nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~  143 (201)
                      ||+++.++.+++.+....              ..++..|+|||.+  ....++.++|+||+|+++|++++ |..||....
T Consensus       171 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~  248 (302)
T cd05055         171 NVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI--FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP  248 (302)
T ss_pred             eEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhh--ccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence            999998876655543211              1234569999987  34557889999999999999998 999987655


Q ss_pred             HHHHHHH-hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          144 DMQALFR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       144 ~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ....... ...+.....+...++.+.+++.+|+..+|++|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         249 VDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             chHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            4433333 3333344455667899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.5e-36  Score=222.97  Aligned_cols=195  Identities=29%  Similarity=0.564  Sum_probs=156.5

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc-CccccCCCC
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHER-NVVHREIKC   77 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~p   77 (201)
                      ++.++||||+++++.+..++..++++||+++ +|.+++..     ..+++..+..++.|++.|++|||++ +++|+||+|
T Consensus        54 ~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp  132 (283)
T cd06617          54 MRSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKP  132 (283)
T ss_pred             HHHcCCCCeeeeeEEEecCCcEEEEhhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCH
Confidence            5668999999999999999999999999975 88777754     2489999999999999999999997 999999999


Q ss_pred             CcEEEccCCceeeecCcc-----------ccccCcccccccccccC--CCCCcchhhHHHHHHHHHHHHhCCCCCCCch-
Q 046714           78 ANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLK--NNGYGLSADIWSLGCTVLEMLTHQPPYSHLE-  143 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-  143 (201)
                      +||+++.++..++.+...           ...++..|+|||.+...  ...++.++|+||+|+++|++++|+.||.... 
T Consensus       133 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  212 (283)
T cd06617         133 SNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT  212 (283)
T ss_pred             HHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc
Confidence            999999988777665421           12356679999987321  1346789999999999999999999996532 


Q ss_pred             HHHHHHHhhcCCCCCCC-CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          144 DMQALFRIGRGKLPSVP-NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      ..+..........+..+ ..+++++.+++.+||..+|.+|||++++++||||+....
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         213 PFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             CHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence            22233333333333333 357899999999999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=8.2e-36  Score=222.86  Aligned_cols=191  Identities=29%  Similarity=0.481  Sum_probs=149.8

Q ss_pred             ccccC-CCcceeccceeeeeCCe-----EEEEEEecCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcCc
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENR-----LYIFLELVKKGSLANLYQK------YHLSDSQVSSYTRQILNGLTYLHERNV   70 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~i   70 (201)
                      +++++ +||||+++++++.....     .++++||+.+ +|.+++..      ..+++..+..++.||+.||.|||+.|+
T Consensus        53 ~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i  131 (295)
T cd07837          53 LLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGV  131 (295)
T ss_pred             HHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            35566 46999999999887665     8999999987 78887753      237899999999999999999999999


Q ss_pred             cccCCCCCcEEEcc-CCceeeecCccc------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCC
Q 046714           71 VHREIKCANILVDA-SGLATTTNDVKS------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        71 ~H~dl~p~nill~~-~g~~~~~~~~~~------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      +|+||+|+||+++. ++.+++.+....            ..+++.|+|||.+. ....++.++|+||+|+++|+|++|..
T Consensus       132 ~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~  210 (295)
T cd07837         132 MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLL-GSTHYSTPVDIWSVGCIFAEMSRKQP  210 (295)
T ss_pred             eecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhh-CCCCCCchHHHHHHHHHHHHHHcCCC
Confidence            99999999999998 666666553211            12456799999873 34457889999999999999999999


Q ss_pred             CCCCchHHHHHHHhhcCC-------------------CC--------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          138 PYSHLEDMQALFRIGRGK-------------------LP--------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       138 p~~~~~~~~~~~~~~~~~-------------------~~--------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ||...........+....                   .+        .....+++++.+++.+||.++|.+|||+++++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         211 LFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            997765544433321100                   00        011347888999999999999999999999999


Q ss_pred             Ccccc
Q 046714          191 HPFVK  195 (201)
Q Consensus       191 ~~~~~  195 (201)
                      ||||+
T Consensus       291 ~~~~~  295 (295)
T cd07837         291 HPYFD  295 (295)
T ss_pred             CCCcC
Confidence            99985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.4e-35  Score=222.53  Aligned_cols=196  Identities=34%  Similarity=0.624  Sum_probs=161.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+++++|||++++++++.+++..++++||+.+ ++.+.+..  ..+++.++..++.|++.|+.|||+.|++|+||+|+||
T Consensus        78 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Ni  156 (317)
T cd06635          78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI  156 (317)
T ss_pred             HHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccE
Confidence            46788999999999999999999999999976 77776643  4489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc--------cccccCccccccccccc-CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 046714           81 LVDASGLATTTNDV--------KSFEGTPFWVAPEVVNL-KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI  151 (201)
Q Consensus        81 ll~~~g~~~~~~~~--------~~~~~~~~~~aPE~~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  151 (201)
                      +++.++..++.+..        ....++..|+|||.+.. .....+.++|+||+|+++|++++|+.||...........+
T Consensus       157 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~  236 (317)
T cd06635         157 LLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  236 (317)
T ss_pred             EECCCCCEEEecCCCccccCCcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            99988877665542        22346678999999732 2345788999999999999999999999776665555555


Q ss_pred             hcCCCC-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          152 GRGKLP-SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       152 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      .....+ .....+++.+.+++.+||+.+|.+|||+.++++|+|+.....
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         237 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            444333 234457889999999999999999999999999999866543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.6e-35  Score=217.08  Aligned_cols=187  Identities=21%  Similarity=0.447  Sum_probs=157.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+++++||||+++++++......++++||+.+++|.+++...  .+++..+..++.|++.++++||+.|++|+||+|+||
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni  131 (256)
T cd05112          52 VMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNC  131 (256)
T ss_pred             HHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceE
Confidence            467899999999999999999999999999999999988653  378999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.++..++.+....             ...+..|+|||.+  .+..++.++|+||+|+++|++++ |+.||.......
T Consensus       132 ~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~--~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  209 (256)
T cd05112         132 LVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVF--SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE  209 (256)
T ss_pred             EEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHh--ccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            9998876665543211             1123469999987  34567889999999999999998 999998777666


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .......+.....+...+..+.+++.+||+.+|++|||++++++.
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         210 VVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            666665554545566678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-35  Score=219.55  Aligned_cols=187  Identities=22%  Similarity=0.413  Sum_probs=153.8

Q ss_pred             ccccCCCcceeccceeeeeC------CeEEEEEEecCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE------NRLYIFLELVKKGSLANLYQK-------YHLSDSQVSSYTRQILNGLTYLHERN   69 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~   69 (201)
                      ++++++||||+++++.+...      ...++++||+.+++|.+++..       ..+++..+..++.|++.|++|||++|
T Consensus        53 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  132 (272)
T cd05075          53 CMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS  132 (272)
T ss_pred             HHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            46788999999999976432      247899999999999887732       22788999999999999999999999


Q ss_pred             ccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-
Q 046714           70 VVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-  134 (201)
Q Consensus        70 i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-  134 (201)
                      ++|+||||+||+++.++..++.+....              ...++.|++||..  .+..++.++|+||+|+++|++++ 
T Consensus       133 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~Di~slG~il~el~~~  210 (272)
T cd05075         133 FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL--ADRVYTTKSDVWSFGVTMWEIATR  210 (272)
T ss_pred             eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHc--cCCCcChHHHHHHHHHHHHHHHcC
Confidence            999999999999998876666553211              1134569999987  45567899999999999999999 


Q ss_pred             CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          135 HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       135 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      |+.||...........+..+.....+..++..+.+++.+||+.+|.+|||++++++.
T Consensus       211 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         211 GQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            899998877766666666665556667788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=217.86  Aligned_cols=189  Identities=42%  Similarity=0.782  Sum_probs=158.3

Q ss_pred             ccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++.+.+.  +..++++||+++++|.+++.. ..+++..+..++.|++.|+.|||+.|++|+||+|+|
T Consensus        57 ~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~n  136 (264)
T cd06653          57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGAN  136 (264)
T ss_pred             HHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence            47789999999999988764  568899999999999998876 448899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           80 ILVDASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        80 ill~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      |+++.++...+.+...               ...++..|+|||.+  .+..++.++|+||+|++++++++|+.||.....
T Consensus       137 i~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  214 (264)
T cd06653         137 ILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI--SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA  214 (264)
T ss_pred             EEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhh--cCCCCCccccHHHHHHHHHHHHhCCCCCCccCH
Confidence            9999887666554321               12356779999997  345678899999999999999999999987765


Q ss_pred             HHHHHHhh-cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          145 MQALFRIG-RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       145 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ........ ....+.++..+++.+.+++.+|+.. |.+|||+.+++.|||+
T Consensus       215 ~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~~-~~~r~~~~~~~~~~~~  264 (264)
T cd06653         215 MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVE-EKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhcC-cccCccHHHHhcCCCC
Confidence            55554443 3344567888999999999999995 7999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.7e-36  Score=224.36  Aligned_cols=190  Identities=27%  Similarity=0.499  Sum_probs=147.2

Q ss_pred             ccccCCCcceeccceeeeeCC--------eEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccc
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN--------RLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVH   72 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H   72 (201)
                      ++++++||||+++++++....        ..++++||+.+ +|.+.+...  .+++.++..++.|++.||+|||+.|++|
T Consensus        64 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H  142 (310)
T cd07865          64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILH  142 (310)
T ss_pred             HHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            467899999999999887653        45999999976 888877654  4899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceeeecCcc----------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCC
Q 046714           73 REIKCANILVDASGLATTTNDVK----------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        73 ~dl~p~nill~~~g~~~~~~~~~----------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                      +||+|+||+++.+|.+++.+...                ...++..|+|||.+. ....++.++|+||+|+++|++++|.
T Consensus       143 ~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~~l~el~t~~  221 (310)
T cd07865         143 RDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL-GERDYGPPIDMWGAGCIMAEMWTRS  221 (310)
T ss_pred             cCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhc-CCcccCchhhhHHHHHHHHHHHhCC
Confidence            99999999999888776654321                122456699999873 3344678999999999999999999


Q ss_pred             CCCCCchHHHHHHHhhc--CC-CC---------------CC-------------CCCCCHHHHHHHHHHhhcCCCCCCCH
Q 046714          137 PPYSHLEDMQALFRIGR--GK-LP---------------SV-------------PNSLSRDARDFILKCLQVNPNDRPTA  185 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~--~~-~~---------------~~-------------~~~~~~~~~~li~~~l~~~p~~R~t~  185 (201)
                      .||...........+..  +. .+               ..             +...+..+.+++.+||..+|.+|||+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~  301 (310)
T cd07865         222 PIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA  301 (310)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH
Confidence            99876544332221111  00 00               00             11235677899999999999999999


Q ss_pred             hHHhcCccc
Q 046714          186 AQLMEHPFV  194 (201)
Q Consensus       186 ~~il~~~~~  194 (201)
                      +++++||||
T Consensus       302 ~e~l~h~~f  310 (310)
T cd07865         302 DTALNHDFF  310 (310)
T ss_pred             HHHhcCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-35  Score=219.22  Aligned_cols=187  Identities=24%  Similarity=0.435  Sum_probs=149.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH------LSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      .++.++||||+++++.+.+....+++|||+.+++|.+++....      .++..+..++.||+.|++|||++|++|+|||
T Consensus        48 ~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk  127 (269)
T cd05042          48 PYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLA  127 (269)
T ss_pred             HHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEeccccc
Confidence            3567899999999999999999999999999999999986532      3567788999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCccc--------------cccCcccccccccccC-----CCCCcchhhHHHHHHHHHHHHh-CC
Q 046714           77 CANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLK-----NNGYGLSADIWSLGCTVLEMLT-HQ  136 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~-----~~~~~~~~Dv~slG~~l~~l~~-g~  136 (201)
                      |+||+++.++..++.+....              ..++..|+|||.+...     ....+.++|+||+|+++|++++ |.
T Consensus       128 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~  207 (269)
T cd05042         128 LRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAAD  207 (269)
T ss_pred             HhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCC
Confidence            99999999887766654321              1124569999987422     2356789999999999999999 78


Q ss_pred             CCCCCchHHHHHHHhhcCCC-----CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          137 PPYSHLEDMQALFRIGRGKL-----PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .||......+..........     +..+..+++...+++..|+ .+|.+|||++++++
T Consensus       208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         208 QPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             CCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            89987765555444333222     2334467888999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.4e-36  Score=227.86  Aligned_cols=191  Identities=28%  Similarity=0.497  Sum_probs=149.2

Q ss_pred             ccccCCCcceeccceeeeeC--------------CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--------------NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER   68 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   68 (201)
                      ++++++||||+++++++...              ...++++||+.+ +|.+++....+++..+..++.||++|++|||+.
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~  133 (342)
T cd07854          55 IIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSA  133 (342)
T ss_pred             HHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            47789999999999876654              357899999975 899888877799999999999999999999999


Q ss_pred             CccccCCCCCcEEEccCC-ceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHH
Q 046714           69 NVVHREIKCANILVDASG-LATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEM  132 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~g-~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l  132 (201)
                      |++|+||||+||+++..+ ..++.+...               ...++..|+|||.+. ....++.++|+|||||++|++
T Consensus       134 givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwSlGvil~el  212 (342)
T cd07854         134 NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEM  212 (342)
T ss_pred             CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHh-CccccCchhhHHHHHHHHHHH
Confidence            999999999999997543 333332211               123466799999862 345678899999999999999


Q ss_pred             HhCCCCCCCchHHHHHHHhhcC------------------------CCC-----CCCCCCCHHHHHHHHHHhhcCCCCCC
Q 046714          133 LTHQPPYSHLEDMQALFRIGRG------------------------KLP-----SVPNSLSRDARDFILKCLQVNPNDRP  183 (201)
Q Consensus       133 ~~g~~p~~~~~~~~~~~~~~~~------------------------~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~  183 (201)
                      ++|+.||...............                        ...     .....++.++.+++.+||+.+|.+||
T Consensus       213 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  292 (342)
T cd07854         213 LTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL  292 (342)
T ss_pred             HhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc
Confidence            9999999765443332222110                        000     01234678899999999999999999


Q ss_pred             CHhHHhcCcccc
Q 046714          184 TAAQLMEHPFVK  195 (201)
Q Consensus       184 t~~~il~~~~~~  195 (201)
                      |++++++||||+
T Consensus       293 t~~ell~h~~~~  304 (342)
T cd07854         293 TAEEALMHPYMS  304 (342)
T ss_pred             CHHHHhCCCccc
Confidence            999999999997

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.6e-35  Score=217.30  Aligned_cols=185  Identities=23%  Similarity=0.369  Sum_probs=147.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++.+.. ...++++||+.+++|.+++...+  ++...+..++.||+.||+|||++|++|+||||+||
T Consensus        54 ~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Ni  132 (259)
T cd05037          54 LMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNI  132 (259)
T ss_pred             HHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceE
Confidence            5788999999999999888 77899999999999999987544  89999999999999999999999999999999999


Q ss_pred             EEccCC-------ceeeecCcc--------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           81 LVDASG-------LATTTNDVK--------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g-------~~~~~~~~~--------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      +++.++       ..++.+...        ...++..|+|||.+......++.++|+||+|++++++++ |..|+.....
T Consensus       133 ll~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~  212 (259)
T cd05037         133 LVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS  212 (259)
T ss_pred             EEecCccccCCceeEEeCCCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence            999877       445544322        123466799999984333477899999999999999999 5777766543


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..........  ...+......+.+++.+||..+|.+|||+.++++
T Consensus       213 ~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         213 SEKERFYQDQ--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             hhHHHHHhcC--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            3322222211  1222233478999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.8e-35  Score=218.03  Aligned_cols=187  Identities=29%  Similarity=0.562  Sum_probs=152.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      +++.++||||+++++.+.+.+..++++||+++++|.+++..     ..+++..+..++.|++.|++|||++|++|+||+|
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~  134 (267)
T cd08228          55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKP  134 (267)
T ss_pred             HHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCH
Confidence            46788999999999999999999999999999999988742     2378899999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch--
Q 046714           78 ANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE--  143 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--  143 (201)
                      +||+++.++...+.+...            ...++..|+|||.+  .+..++.++|+||+|+++|++++|+.||....  
T Consensus       135 ~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~  212 (267)
T cd08228         135 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN  212 (267)
T ss_pred             HHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhh--ccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc
Confidence            999999888766655321            12466779999997  34567889999999999999999999985542  


Q ss_pred             HHHHHHHhhcCCCCC-CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          144 DMQALFRIGRGKLPS-VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .......+.....+. .....+..+.+++.+||..+|++|||++++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         213 LFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            223333333322222 234577899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.8e-35  Score=222.38  Aligned_cols=195  Identities=34%  Similarity=0.630  Sum_probs=159.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +++.++|+|++++++++...+..++|+||+.+ ++.+.+..  ..++...+..++.|++.|+.|||+.|++|+||+|+||
T Consensus        68 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni  146 (308)
T cd06634          68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI  146 (308)
T ss_pred             HHHhCCCCCcccEEEEEEcCCeeEEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhE
Confidence            46788999999999999999999999999975 78776643  3488999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc--------ccccCccccccccccc-CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 046714           81 LVDASGLATTTNDVK--------SFEGTPFWVAPEVVNL-KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI  151 (201)
Q Consensus        81 ll~~~g~~~~~~~~~--------~~~~~~~~~aPE~~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  151 (201)
                      +++.+|..++.+...        ...++..|+|||.+.. .....+.++|+||+|+++|++++|..||............
T Consensus       147 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  226 (308)
T cd06634         147 LLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  226 (308)
T ss_pred             EECCCCcEEECCcccceeecCcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH
Confidence            999888776655431        2335678999999732 2345678999999999999999999998776555554444


Q ss_pred             hcCCCCC-CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          152 GRGKLPS-VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       152 ~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .....+. ....++..+.+++.+||..+|.+||+++++++|||+....
T Consensus       227 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             hhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            4443333 2446788999999999999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-35  Score=219.55  Aligned_cols=187  Identities=24%  Similarity=0.440  Sum_probs=156.9

Q ss_pred             ccccCCCcceeccceeeeeCCe------EEEEEEecCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENR------LYIFLELVKKGSLANLYQKY-------HLSDSQVSSYTRQILNGLTYLHERN   69 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~   69 (201)
                      .+++++||||+++++++.....      .++++||+++++|..++...       .+++..+..++.|++.||+|||+.|
T Consensus        54 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~  133 (273)
T cd05035          54 CMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN  133 (273)
T ss_pred             HHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4677899999999998765443      79999999999999887432       3788999999999999999999999


Q ss_pred             ccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-
Q 046714           70 VVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-  134 (201)
Q Consensus        70 i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-  134 (201)
                      ++|+||||+||+++.++.+++.+....              ...+..|+|||..  ....++.++|+||+|+++|++++ 
T Consensus       134 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~Dv~SlG~il~el~~~  211 (273)
T cd05035         134 FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATR  211 (273)
T ss_pred             eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhc--ccCCCCcccchHHHHHHHHHHHhC
Confidence            999999999999998877666553221              1123469999987  45667889999999999999999 


Q ss_pred             CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          135 HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       135 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      |..||......+.......+.....+..+++.+.+++.+||+.+|++|||+.+++++
T Consensus       212 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         212 GQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899998877777776666666667778899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.2e-35  Score=216.17  Aligned_cols=185  Identities=26%  Similarity=0.512  Sum_probs=155.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++.+..++ .++++||+.+++|.+++...   .++...+..++.|++.|+.|||+.|++|+||+|+|
T Consensus        52 ~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~n  130 (254)
T cd05083          52 VMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARN  130 (254)
T ss_pred             HHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcce
Confidence            467899999999999987654 68999999999999998753   37888999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc---------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHH
Q 046714           80 ILVDASGLATTTNDVKS---------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALF  149 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~---------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~  149 (201)
                      |+++.+|.+++.+....         ......|+|||.+  .+..++.++|+||+|+++|++++ |+.||......+...
T Consensus       131 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~--~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  208 (254)
T cd05083         131 ILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEAL--KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE  208 (254)
T ss_pred             EEEcCCCcEEECCCccceeccccCCCCCCCceecCHHHh--ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence            99999887777664321         1123469999987  44567889999999999999998 999998877666666


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .+..+.....+..+++.+.+++.+||+.+|++|||++++++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         209 CVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            66665555566778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=246.48  Aligned_cols=186  Identities=25%  Similarity=0.490  Sum_probs=167.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcCccccC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--------HLSDSQVSSYTRQILNGLTYLHERNVVHRE   74 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d   74 (201)
                      +|++++||||+++.|++.+...+++++||+.||+|..++++.        .+++...+.++.||++|++||++++++|||
T Consensus       748 ~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRD  827 (1025)
T KOG1095|consen  748 LMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRD  827 (1025)
T ss_pred             HHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcc
Confidence            588999999999999999999999999999999999999865        289999999999999999999999999999


Q ss_pred             CCCCcEEEccCCceeeecCcccc--------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCC
Q 046714           75 IKCANILVDASGLATTTNDVKSF--------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPY  139 (201)
Q Consensus        75 l~p~nill~~~g~~~~~~~~~~~--------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~  139 (201)
                      |...|+|++....+++.++.-..              .-...|+|||.+  ....++.++||||||+++||++| |..||
T Consensus       828 LAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl--~d~iFtskSDvWsFGVllWEifslG~~PY  905 (1025)
T KOG1095|consen  828 LAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESL--KDGIFTSKSDVWSFGVLLWEIFSLGATPY  905 (1025)
T ss_pred             hhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHH--hhcccccccchhhhHHHHHHHHhCCCCCC
Confidence            99999999988777776653221              112459999998  45789999999999999999999 99999


Q ss_pred             CCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          140 SHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +...+.+.......+-..+.|..++..++++|..||+.+|++||++..+++
T Consensus       906 ~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  906 PSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            999999998877777777889999999999999999999999999999987

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.5e-35  Score=220.85  Aligned_cols=186  Identities=24%  Similarity=0.454  Sum_probs=156.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------------------CCCHHHHHHHHHHHH
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------------HLSDSQVSSYTRQIL   59 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------------~~~~~~~~~~~~~i~   59 (201)
                      .+++++||||+++++++.++...++++||+.+++|.+++...                       .++...+..++.|++
T Consensus        61 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~  140 (288)
T cd05050          61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVA  140 (288)
T ss_pred             HHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHH
Confidence            467889999999999999999999999999999999998642                       257778899999999


Q ss_pred             HHHHHHhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHH
Q 046714           60 NGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSL  125 (201)
Q Consensus        60 ~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~sl  125 (201)
                      .||++||++|++|+||+|+||+++.++..++.+....              ...+..|+|||.+  .+..++.++|+|||
T Consensus       141 ~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~sl  218 (288)
T cd05050         141 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI--FYNRYTTESDVWAY  218 (288)
T ss_pred             HHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHH--hcCCCCchhHHHHH
Confidence            9999999999999999999999998887666553221              1123459999987  44567899999999


Q ss_pred             HHHHHHHHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          126 GCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       126 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      |+++|++++ |..||......+....+..+.....+...+.++.+++.+||+.+|++|||++|+++
T Consensus       219 G~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         219 GVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            999999998 88898776666666666666555556678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-37  Score=242.52  Aligned_cols=185  Identities=25%  Similarity=0.448  Sum_probs=152.8

Q ss_pred             ccccCC-Ccceecccee-eee---C---CeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcC--
Q 046714            3 SFSQFE-HDNIVQYIGT-EKD---E---NRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERN--   69 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~-~~~---~---~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~--   69 (201)
                      +|++|. |+|||.++|. ...   .   -.+.|+||||.|+.|-|++..   .+|++.++++|+.++|+||.+||..+  
T Consensus        87 ~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pP  166 (738)
T KOG1989|consen   87 IMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPP  166 (738)
T ss_pred             HHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCc
Confidence            577887 9999999993 221   1   257899999999999999874   34999999999999999999999997  


Q ss_pred             ccccCCCCCcEEEccCCceeeecCcccc---------------------ccCccccccccccc-CCCCCcchhhHHHHHH
Q 046714           70 VVHREIKCANILVDASGLATTTNDVKSF---------------------EGTPFWVAPEVVNL-KNNGYGLSADIWSLGC  127 (201)
Q Consensus        70 i~H~dl~p~nill~~~g~~~~~~~~~~~---------------------~~~~~~~aPE~~~~-~~~~~~~~~Dv~slG~  127 (201)
                      |+|||||-+||||+.+|.-++.++++..                     ..|+.|+|||+|.. .+..++.|+|||+|||
T Consensus       167 iIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGc  246 (738)
T KOG1989|consen  167 IIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGC  246 (738)
T ss_pred             cchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHH
Confidence            9999999999999999988888765432                     15788999999863 5678999999999999


Q ss_pred             HHHHHHhCCCCCCCchHHHHHHHhhcCCCCC-CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          128 TVLEMLTHQPPYSHLEDMQALFRIGRGKLPS-VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       128 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +||-||..+.||++.+...+    ..+...- ....++..+++||+.||+.+|.+||+|.|++..
T Consensus       247 lLYkLCy~t~PFe~sg~laI----lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  247 LLYKLCYFTTPFEESGKLAI----LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             HHHHHHHhCCCcCcCcceeE----EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            99999999999987644322    2332211 124688999999999999999999999998865

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-36  Score=228.20  Aligned_cols=194  Identities=26%  Similarity=0.437  Sum_probs=156.8

Q ss_pred             ccccCCCcceeccceeeeeCCe------EEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENR------LYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      ++++++||||+++++++...+.      .++++||+ +++|.+++....+++..+..++.|++.|+.+||+.|++|+||+
T Consensus        67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlk  145 (343)
T cd07851          67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLK  145 (343)
T ss_pred             HHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            4678899999999998776554      89999999 5599999988789999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           77 CANILVDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+||+++.+|.+++.+...         ...++..|+|||.+. .....+.++|+||+|+++|++++|+.||........
T Consensus       146 p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~  224 (343)
T cd07851         146 PSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ  224 (343)
T ss_pred             HHHeEECCCCCEEEccccccccccccccCCcccccccCHHHHh-CCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            9999999988776665321         233567799999873 234678899999999999999999999976655444


Q ss_pred             HHHhhcCCC------------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGRGKL------------------------------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+.....                              .......++.+.+++.+||+.+|++|||+.++++||||++.
T Consensus       225 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         225 LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             HHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence            333221100                              01112458899999999999999999999999999999765


Q ss_pred             C
Q 046714          198 L  198 (201)
Q Consensus       198 ~  198 (201)
                      .
T Consensus       305 ~  305 (343)
T cd07851         305 H  305 (343)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.9e-35  Score=216.58  Aligned_cols=186  Identities=28%  Similarity=0.523  Sum_probs=160.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      .+++++|+||+++++.+.+.+..+++||++++++|.+++....   +++..+..++.|++.|+++||+.|++|+||+|+|
T Consensus        54 ~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~n  133 (258)
T smart00219       54 IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARN  133 (258)
T ss_pred             HHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccce
Confidence            4567899999999999999999999999999999999986533   8999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.++...+.+....             ..++..|+|||.+  ....++.++|+||+|++++++++ |..||......
T Consensus       134 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~--~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~  211 (258)
T smart00219      134 CLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESL--KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE  211 (258)
T ss_pred             EEEccCCeEEEcccCCceecccccccccccCCCcccccChHHh--ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999886665543211             1144679999987  45567899999999999999998 88999877777


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..............+...+..+.+++.+|+..+|++|||+.++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      212 EVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            777777666666777778999999999999999999999999975

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-36  Score=224.96  Aligned_cols=190  Identities=29%  Similarity=0.469  Sum_probs=147.6

Q ss_pred             ccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcCccccC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQK------YHLSDSQVSSYTRQILNGLTYLHERNVVHRE   74 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d   74 (201)
                      ++++++||||+++++++.+.  +..++|+||+.+ ++.+++..      ..+++..+..++.|++.||+|||+.|++|+|
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~d  133 (316)
T cd07842          55 LLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRD  133 (316)
T ss_pred             HHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCC
Confidence            46789999999999999988  789999999976 67676642      1478899999999999999999999999999


Q ss_pred             CCCCcEEEcc----CCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC
Q 046714           75 IKCANILVDA----SGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH  135 (201)
Q Consensus        75 l~p~nill~~----~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g  135 (201)
                      |+|+||+++.    +|..++.+...               ...++..|+|||.+. ....++.++|+||||++++++++|
T Consensus       134 lkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~~l~~l~~~  212 (316)
T cd07842         134 LKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLL-GARHYTKAIDIWAIGCIFAELLTL  212 (316)
T ss_pred             CCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHh-CCCCCCcHHHHHHHHHHHHHHHhc
Confidence            9999999998    67666655321               112456799999872 334578899999999999999999


Q ss_pred             CCCCCCchHHH---------HHHHhh-------------------------cCCCCCCC-----------CCCCHHHHHH
Q 046714          136 QPPYSHLEDMQ---------ALFRIG-------------------------RGKLPSVP-----------NSLSRDARDF  170 (201)
Q Consensus       136 ~~p~~~~~~~~---------~~~~~~-------------------------~~~~~~~~-----------~~~~~~~~~l  170 (201)
                      +.||.......         ....+.                         .......+           ...+..+.++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (316)
T cd07842         213 EPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL  292 (316)
T ss_pred             CCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHH
Confidence            99996543221         000000                         00000111           1466789999


Q ss_pred             HHHHhhcCCCCCCCHhHHhcCccc
Q 046714          171 ILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       171 i~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      +.+||+.+|++|||+.++++||||
T Consensus       293 i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         293 LRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHhcCCcccCcCHHHHhcCCCC
Confidence            999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.5e-35  Score=216.89  Aligned_cols=185  Identities=26%  Similarity=0.463  Sum_probs=153.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++.+.. ...+++|||+.+++|.+++.+.   .+++..+..++.|++.||++||+.|++|+||+|+|
T Consensus        54 ~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~N  132 (262)
T cd05071          54 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN  132 (262)
T ss_pred             HHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCccc
Confidence            4678899999999998754 4578999999999999998752   37889999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.++..++.+....             ..++..|+|||..  ....++.++|+||+|+++|++++ |..||......
T Consensus       133 ill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~  210 (262)
T cd05071         133 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  210 (262)
T ss_pred             EEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHh--ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence            99998887666543211             1134469999987  44567899999999999999999 88899877666


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+........+..+++.+.+++.+|++.+|.+|||++++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         211 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            666665554444456678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=216.46  Aligned_cols=192  Identities=30%  Similarity=0.533  Sum_probs=154.9

Q ss_pred             CCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccC
Q 046714            7 FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS   85 (201)
Q Consensus         7 l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~   85 (201)
                      -.|+||++++++|+++...|+|||-+.||+|...|+++ .|++.++.++..+|+.||.|||.+||.|||+||+|||-.+.
T Consensus       133 qgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~p  212 (463)
T KOG0607|consen  133 QGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESP  212 (463)
T ss_pred             cCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCC
Confidence            46999999999999999999999999999998888654 59999999999999999999999999999999999996543


Q ss_pred             Cce---eeec-------------------CccccccCccccccccccc---CCCCCcchhhHHHHHHHHHHHHhCCCCCC
Q 046714           86 GLA---TTTN-------------------DVKSFEGTPFWVAPEVVNL---KNNGYGLSADIWSLGCTVLEMLTHQPPYS  140 (201)
Q Consensus        86 g~~---~~~~-------------------~~~~~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  140 (201)
                      +.+   ++.+                   ...+.+|+-.|||||.+..   ....+..+.|.||||+++|-|++|+.||.
T Consensus       213 n~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFv  292 (463)
T KOG0607|consen  213 NKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFV  292 (463)
T ss_pred             CCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCcc
Confidence            211   1111                   1223446667999998632   23457789999999999999999999995


Q ss_pred             Cch---------------HHHHHHHhhcCCCCCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          141 HLE---------------DMQALFRIGRGKLPSVP----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       141 ~~~---------------~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      +..               +....+.+..+.. ++|    ..++.+.++++..++..++.+|.++.++++|||++.-.+
T Consensus       293 G~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  293 GHCGADCGWDRGEVCRVCQNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             CccCCcCCccCCCccHHHHHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            432               2333444555554 444    358999999999999999999999999999999987544

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2e-35  Score=218.16  Aligned_cols=186  Identities=25%  Similarity=0.478  Sum_probs=154.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+++++||||+++++++.+++..++++||+.+++|.+++...  .++..++..++.|++.|++|||++|++|+||+|+||
T Consensus        58 ~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ni  137 (269)
T cd05065          58 IMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNI  137 (269)
T ss_pred             HHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheE
Confidence            467899999999999999999999999999999999998753  388999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-----------c---c-c--CcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCc
Q 046714           81 LVDASGLATTTNDVKS-----------F---E-G--TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHL  142 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-----------~---~-~--~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~  142 (201)
                      +++.++..++.+....           .   . +  +..|+|||.+  ....++.++|+||+|+++|++++ |..||...
T Consensus       138 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~  215 (269)
T cd05065         138 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWDM  215 (269)
T ss_pred             EEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHh--ccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence            9998876655543211           0   0 1  2359999997  44567889999999999999886 99999877


Q ss_pred             hHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          143 EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ...+....+........+..++..+.+++.+||..+|.+||++++++.
T Consensus       216 ~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         216 SNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            666655555444444455678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.2e-35  Score=224.32  Aligned_cols=187  Identities=24%  Similarity=0.450  Sum_probs=157.0

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLTY   64 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~   64 (201)
                      +++++ +||||+++++.+..++..++++||+.+++|.+++.+.                 .++..++..++.|++.||+|
T Consensus        70 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~  149 (334)
T cd05100          70 MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEY  149 (334)
T ss_pred             HHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence            35567 7999999999999999999999999999999998642                 26677889999999999999


Q ss_pred             HhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHH
Q 046714           65 LHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVL  130 (201)
Q Consensus        65 lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~  130 (201)
                      ||++|++|+||+|+||+++.++..++.+....              ..++..|+|||.+  .+..++.++|+||||+++|
T Consensus       150 LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~  227 (334)
T cd05100         150 LASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLLW  227 (334)
T ss_pred             HHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHh--ccCCcCchhhhHHHHHHHH
Confidence            99999999999999999998887766553211              1123459999997  4556788999999999999


Q ss_pred             HHHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          131 EMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       131 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +|++ |..||......+....+........+...+..+.+++.+||..+|.+|||+.+++++
T Consensus       228 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         228 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            9998 889998877666666666655556677788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.1e-35  Score=218.08  Aligned_cols=186  Identities=25%  Similarity=0.455  Sum_probs=156.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+. ..++++||+++++|.+++.+..  ++...+..++.|++.|++|||+.|++|+||+|+||
T Consensus        60 ~l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~ni  138 (270)
T cd05056          60 IMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNV  138 (270)
T ss_pred             HHHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheE
Confidence            46789999999999998764 4679999999999999997643  89999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.++.+++.+....             ..+...|+|||.+  ....++.++|+||||++++++++ |..||......+
T Consensus       139 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~  216 (270)
T cd05056         139 LVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND  216 (270)
T ss_pred             EEecCCCeEEccCceeeecccccceecCCCCccccccChhhh--ccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            9998877666553211             1123469999987  44567899999999999999986 999998877766


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ....+..+.....+..++..+.+++.+|+..+|.+|||+.+++..
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         217 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            666666666666777889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2e-35  Score=217.13  Aligned_cols=185  Identities=23%  Similarity=0.471  Sum_probs=154.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      .+++++||||+++++++. .+..++++||+.+++|.+++..   ..++..++..++.|++.||+|||+.|++|+||+|+|
T Consensus        54 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~n  132 (260)
T cd05067          54 LMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAAN  132 (260)
T ss_pred             HHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHh
Confidence            467899999999999874 4568999999999999998864   237889999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.++...+.+....             ..++..|+|||.+  ....++.++|+||||+++|++++ |+.||......
T Consensus       133 i~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  210 (260)
T cd05067         133 ILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP  210 (260)
T ss_pred             EEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHh--ccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence            99998887666553211             1234569999987  34557889999999999999999 99999877766


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..............+...+.++.+++.+|+..+|++|||++++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         211 EVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            666666555555667778899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-35  Score=225.92  Aligned_cols=194  Identities=29%  Similarity=0.483  Sum_probs=154.1

Q ss_pred             ccccC-CCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQF-EHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +++++ +||||+++++++...  ...++|+||+.+ +|..++....+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        59 ~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~n  137 (337)
T cd07852          59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSN  137 (337)
T ss_pred             HHHHhcCCCCccceeeeeccCCCceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence            45678 999999999988653  468999999975 99998887778899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc-----------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc
Q 046714           80 ILVDASGLATTTNDVK-----------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL  142 (201)
Q Consensus        80 ill~~~g~~~~~~~~~-----------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  142 (201)
                      |+++.+|..++.+...                 ...++..|+|||.+. .....+.++|+||+|+++|++++|+.||...
T Consensus       138 ill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~sDi~slG~~l~el~tg~~pf~~~  216 (337)
T cd07852         138 ILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILL-GSTRYTKGVDMWSVGCILGEMLLGKPLFPGT  216 (337)
T ss_pred             EEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeee-ccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence            9999998776655321                 123566799999873 3455678999999999999999999999765


Q ss_pred             hHHHHHHHhhcC------------------------------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          143 EDMQALFRIGRG------------------------------KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       143 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                      ............                              ........++.++.+++.+||+.+|.+|||+.++++||
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~  296 (337)
T cd07852         217 STLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP  296 (337)
T ss_pred             ChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence            443332221110                              00111233688899999999999999999999999999


Q ss_pred             cccCcC
Q 046714          193 FVKRPL  198 (201)
Q Consensus       193 ~~~~~~  198 (201)
                      |++.-.
T Consensus       297 ~~~~~~  302 (337)
T cd07852         297 YVAQFH  302 (337)
T ss_pred             hhhhhc
Confidence            997643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=220.60  Aligned_cols=190  Identities=30%  Similarity=0.534  Sum_probs=154.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+.+..++++|++.+ +|.+++.+.  .+++..+..++.|++.||++||+.|++|+||+|+||
T Consensus        51 ~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni  129 (282)
T cd07829          51 LLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNI  129 (282)
T ss_pred             HHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheE
Confidence            46788999999999999999999999999985 999999875  589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|.+++.+...            ....+..|+|||.+. .....+.++|+||+|++++++++|+.||.........
T Consensus       130 ~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~  208 (282)
T cd07829         130 LINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILL-GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL  208 (282)
T ss_pred             EEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhc-CCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence            999988777665321            112345699999973 3346788999999999999999999999766544333


Q ss_pred             HHhhc--------------------CCCC--------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          149 FRIGR--------------------GKLP--------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       149 ~~~~~--------------------~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ..+..                    ...+        ......+..+.+++.+||..+|++||+++++++||||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         209 FKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            22211                    0000        0112347789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=232.77  Aligned_cols=186  Identities=26%  Similarity=0.529  Sum_probs=167.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||++++|+...+..+++|||+|+||+|.+++++.+  ++..+...++.+.+.||+|||+++++||||-..|+
T Consensus       214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNc  293 (474)
T KOG0194|consen  214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNC  293 (474)
T ss_pred             HHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHh
Confidence            4678999999999999999999999999999999999999875  99999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccccc------------CcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHH
Q 046714           81 LVDASGLATTTNDVKSFEG------------TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~~~------------~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~  147 (201)
                      |++.++.+++.++.....+            ...|+|||.++  ...++.++||||||+++||+++ |..||.+....+.
T Consensus       294 L~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~--~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v  371 (474)
T KOG0194|consen  294 LYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLN--TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV  371 (474)
T ss_pred             eecCCCeEEeCccccccCCcceeeccccccCcceecChhhhc--cCccccccchhheeeeEEeeeccCCCCCCCCCHHHH
Confidence            9999888777776543333            24599999984  3488999999999999999999 8889999999888


Q ss_pred             HHHh-hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          148 LFRI-GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       148 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ...+ ..+.....+...+..+..++.+||..+|++|||+.++.+
T Consensus       372 ~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  372 KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            8888 667777888889999999999999999999999998754

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7e-36  Score=227.01  Aligned_cols=193  Identities=26%  Similarity=0.465  Sum_probs=152.1

Q ss_pred             ccccCCCcceeccceeeee----CCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD----ENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      +|++++||||+++++++..    ....++++||+.+ +|.+++... .+++..+..++.|++.||.|||+.|++|+||+|
T Consensus        57 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp  135 (334)
T cd07855          57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKP  135 (334)
T ss_pred             HHHhcCCCCccCHHHhccccCCCCceEEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence            5788999999999998763    3568999999965 888888643 489999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCcc----------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Q 046714           78 ANILVDASGLATTTNDVK----------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH  141 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~----------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  141 (201)
                      +||+++.+|..++.+...                ...++..|+|||.+. .....+.++|+||+|+++|++++|+.||..
T Consensus       136 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~~Di~slG~~l~el~~g~~pf~~  214 (334)
T cd07855         136 SNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL-SLPEYTTAIDMWSVGCIFAEMLGRRQLFPG  214 (334)
T ss_pred             HHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhc-CCcccccccchHHHHHHHHHHHcCCCccCC
Confidence            999999988776654321                124566799999973 334578899999999999999999999976


Q ss_pred             chHHHHHHHhh-------------------------cCCCCC-----CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          142 LEDMQALFRIG-------------------------RGKLPS-----VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       142 ~~~~~~~~~~~-------------------------~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .+.......+.                         ......     .....++++.+++++||+.+|.+|||+++++.|
T Consensus       215 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         215 KNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             CChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            54322211100                         000011     123468899999999999999999999999999


Q ss_pred             ccccCc
Q 046714          192 PFVKRP  197 (201)
Q Consensus       192 ~~~~~~  197 (201)
                      |||+..
T Consensus       295 ~~~~~~  300 (334)
T cd07855         295 PFLAQY  300 (334)
T ss_pred             hhhhhc
Confidence            999653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.7e-35  Score=218.60  Aligned_cols=186  Identities=24%  Similarity=0.443  Sum_probs=154.0

Q ss_pred             ccccCCCcceeccceeeee-CCeEEEEEEecCCCCHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHhhcCccc
Q 046714            3 SFSQFEHDNIVQYIGTEKD-ENRLYIFLELVKKGSLANLYQK---------YHLSDSQVSSYTRQILNGLTYLHERNVVH   72 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H   72 (201)
                      ++++++||||+++++++.. +...+++++|+.+++|.+++..         ..+++..+..++.|++.||+|||+.|++|
T Consensus        61 ~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H  140 (280)
T cd05043          61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIH  140 (280)
T ss_pred             HHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence            4678899999999998765 4678999999999999999865         23789999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCC
Q 046714           73 REIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQP  137 (201)
Q Consensus        73 ~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~  137 (201)
                      +||+|+||+++.++..++.+....              ..++..|+|||.+  .+..++.++||||+|+++|++++ |+.
T Consensus       141 ~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slG~~l~el~~~g~~  218 (280)
T cd05043         141 KDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL--VNKEYSSASDVWSFGVLLWELMTLGQT  218 (280)
T ss_pred             cccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHH--hcCCCCchhhHHHhHHHHHHHhcCCCC
Confidence            999999999998877666543211              1234469999987  45567899999999999999999 999


Q ss_pred             CCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          138 PYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       138 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ||......+....+..+.....+..+++++.+++.+||..+|++|||+.++++
T Consensus       219 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         219 PYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99877666655555555444455667899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.4e-35  Score=219.98  Aligned_cols=196  Identities=26%  Similarity=0.415  Sum_probs=158.7

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +++++ +|+||+++++.+..++..++++||+.+++|.+++... ++++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus        57 ~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~ni  136 (290)
T cd05613          57 VLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENI  136 (290)
T ss_pred             HHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHe
Confidence            35566 5999999999999999999999999999999988654 488999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH---
Q 046714           81 LVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED---  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---  144 (201)
                      +++.+|..++.+...             ...++..|+|||.+.......+.++|+||+|+++|++++|..||.....   
T Consensus       137 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~  216 (290)
T cd05613         137 LLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS  216 (290)
T ss_pred             EECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc
Confidence            999888776655321             1235677999999843334567899999999999999999999864321   


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCcC
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRPL  198 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~~  198 (201)
                      ............+..+..+++.+.+++.+||..+|.+|+     ++++++.||||+...
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         217 QAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            111222222233455677899999999999999999997     899999999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=219.88  Aligned_cols=190  Identities=26%  Similarity=0.503  Sum_probs=152.7

Q ss_pred             ccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++|||++++++++.+.  +..++++||+.+ +|.+++...  .+++..+..++.|++.|+++||+.|++|+||+|+
T Consensus        51 ~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~  129 (287)
T cd07840          51 LLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGS  129 (287)
T ss_pred             HHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHH
Confidence            46788999999999999988  889999999976 888888654  5899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCc-------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           79 NILVDASGLATTTNDV-------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        79 nill~~~g~~~~~~~~-------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      ||+++.+|..++.+..             ....++..|+|||.+. ....++.++|+||||++++++++|+.||......
T Consensus       130 nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~  208 (287)
T cd07840         130 NILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL-GATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL  208 (287)
T ss_pred             HeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeE-ccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            9999998877665432             1122456699999863 3345788999999999999999999999776544


Q ss_pred             HHHHHhhcCC-------CC-----------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          146 QALFRIGRGK-------LP-----------------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       146 ~~~~~~~~~~-------~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .....+....       .+                       .+...+++.+.+++++||+.+|.+|||++++++||||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         209 EQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             HHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            3333221100       00                       0011137889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-35  Score=234.93  Aligned_cols=193  Identities=23%  Similarity=0.359  Sum_probs=147.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC------CCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH------LSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +|++++||||+++++++.+.+..+++++++.+ +|.+++....      .....+..++.||+.||+|||++||+|+|||
T Consensus       216 il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLK  294 (501)
T PHA03210        216 ALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIK  294 (501)
T ss_pred             HHHhCCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            57789999999999999999999999999965 7777664432      3456778899999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc-------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCC-CCCc
Q 046714           77 CANILVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPP-YSHL  142 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p-~~~~  142 (201)
                      |+||+++.+|.+++.+...             ...|+..|+|||.+  .+..++.++|||||||++|+|++|..+ +...
T Consensus       295 P~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~  372 (501)
T PHA03210        295 LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEIL--AGDGYCEITDIWSCGLILLDMLSHDFCPIGDG  372 (501)
T ss_pred             HHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhh--cCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence            9999999888777665422             13478889999998  455688999999999999999998753 4321


Q ss_pred             --hHHHHHHHhhcC----------------------CCCCC---------CCCCCHHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          143 --EDMQALFRIGRG----------------------KLPSV---------PNSLSRDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       143 --~~~~~~~~~~~~----------------------~~~~~---------~~~~~~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                        ........+...                      .....         ....+.++.+++.+||++||++|||+.|++
T Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL  452 (501)
T PHA03210        373 GGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL  452 (501)
T ss_pred             CCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence              111111111100                      00000         113456778889999999999999999999


Q ss_pred             cCccccCcC
Q 046714          190 EHPFVKRPL  198 (201)
Q Consensus       190 ~~~~~~~~~  198 (201)
                      .||||....
T Consensus       453 ~hp~f~~~~  461 (501)
T PHA03210        453 ALPLFSAEE  461 (501)
T ss_pred             hChhhhcCC
Confidence            999998643

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.7e-35  Score=217.11  Aligned_cols=186  Identities=30%  Similarity=0.572  Sum_probs=151.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      +++.++||||+++++.+.+++..++++||+.+++|.+++..     ..+++..+..++.|++.|+.|||++|++|+||+|
T Consensus        55 ~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p  134 (267)
T cd08229          55 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKP  134 (267)
T ss_pred             HHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence            46778999999999999999999999999999999998863     2378999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH-
Q 046714           78 ANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED-  144 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-  144 (201)
                      +||+++.+|..++.+...            ...++..|+|||.+  .+...+.++|+||+|+++|++++|..||..... 
T Consensus       135 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  212 (267)
T cd08229         135 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN  212 (267)
T ss_pred             HHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHh--cCCCccchhhHHHHHHHHHHHHhCCCCcccccch
Confidence            999999888776655321            22466779999997  345678899999999999999999999864322 


Q ss_pred             -HHHHHHhhcCCCC-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 -MQALFRIGRGKLP-SVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 -~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                       ......+.....+ ..+...++.+.+++.+||..+|++|||++++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         213 LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence             2222223322222 233457889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4e-35  Score=217.11  Aligned_cols=187  Identities=28%  Similarity=0.489  Sum_probs=153.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHhhcCccc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY----------HLSDSQVSSYTRQILNGLTYLHERNVVH   72 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lh~~~i~H   72 (201)
                      ++++++||||+++++++.+....++++||+.+++|.+++...          .+++..+..++.|++.||+|||+.|++|
T Consensus        61 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H  140 (275)
T cd05046          61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVH  140 (275)
T ss_pred             HHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCccc
Confidence            578899999999999999999999999999999999998653          3899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceeeecCcc-------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCC
Q 046714           73 REIKCANILVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPP  138 (201)
Q Consensus        73 ~dl~p~nill~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p  138 (201)
                      +||||+||+++.++...+.+...             ...++..|+|||.+.  +...+.++|+||+|+++|++++ |..|
T Consensus       141 ~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~Di~slG~~l~~l~~~~~~p  218 (275)
T cd05046         141 RDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ--EDDFSTKSDVWSFGVLMWEVFTQGELP  218 (275)
T ss_pred             CcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999887665543211             112345599999873  4456789999999999999998 8889


Q ss_pred             CCCchHHHHHHHhhcCCC-CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          139 YSHLEDMQALFRIGRGKL-PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      |................. ...+..++..+.+++.+||+.+|.+|||+.+++..
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         219 FYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             ccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            977665555555443322 23355688999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.2e-35  Score=227.51  Aligned_cols=186  Identities=25%  Similarity=0.450  Sum_probs=150.8

Q ss_pred             ccccCC-CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-------------------------------------
Q 046714            3 SFSQFE-HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-------------------------------------   44 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------------------------------   44 (201)
                      +|+++. ||||+++++++.+.+..++||||+.+++|.+++...                                     
T Consensus        93 ~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (400)
T cd05105          93 IMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFE  172 (400)
T ss_pred             HHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhc
Confidence            466775 999999999999999999999999999999887542                                     


Q ss_pred             ------------------------------------------------------------CCCHHHHHHHHHHHHHHHHH
Q 046714           45 ------------------------------------------------------------HLSDSQVSSYTRQILNGLTY   64 (201)
Q Consensus        45 ------------------------------------------------------------~~~~~~~~~~~~~i~~~l~~   64 (201)
                                                                                  .+++..+..++.|++.||+|
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~  252 (400)
T cd05105         173 NKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEF  252 (400)
T ss_pred             ccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHH
Confidence                                                                        25677788999999999999


Q ss_pred             HhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHH
Q 046714           65 LHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVL  130 (201)
Q Consensus        65 lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~  130 (201)
                      ||+.|++|+||||+||+++.++.+++.+....              ..++..|+|||.+  .+..++.++||||||+++|
T Consensus       253 LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwSlGvil~  330 (400)
T cd05105         253 LASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI--FDNLYTTLSDVWSYGILLW  330 (400)
T ss_pred             HHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh--cCCCCCchhhHHHHHHHHH
Confidence            99999999999999999998877666553211              1234569999987  4456788999999999999


Q ss_pred             HHHh-CCCCCCCchHHHH-HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          131 EMLT-HQPPYSHLEDMQA-LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       131 ~l~~-g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ++++ |..||........ ...+..+.....+..++..+.+++.+||+.+|++|||+.++.+
T Consensus       331 ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         331 EIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            9997 9999876543322 2333444444556678899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-35  Score=226.14  Aligned_cols=193  Identities=25%  Similarity=0.448  Sum_probs=151.7

Q ss_pred             ccccCCCcceeccceeeeeC-----CeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE-----NRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +++.++||||+++++++...     ...++++||+. ++|.+++... .+++..+..++.|++.||+|||++|++|+||+
T Consensus        57 ~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlk  135 (337)
T cd07858          57 LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLK  135 (337)
T ss_pred             HHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence            46788999999999987654     34799999996 4888888654 48999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           77 CANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      |+||+++.++..++.+...            ...++..|+|||.+. ....++.++|+||+|+++|++++|+.||...+.
T Consensus       136 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  214 (337)
T cd07858         136 PSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL-NCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY  214 (337)
T ss_pred             HHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHh-cCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence            9999999888776655321            123566799999873 234578899999999999999999999976433


Q ss_pred             HHHHHHhhc---------------------------CC---CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          145 MQALFRIGR---------------------------GK---LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       145 ~~~~~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ......+..                           ..   .......+++.+.+++++||+.+|++|||++++++||||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~  294 (337)
T cd07858         215 VHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL  294 (337)
T ss_pred             HHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence            221111100                           00   001123578889999999999999999999999999999


Q ss_pred             cCc
Q 046714          195 KRP  197 (201)
Q Consensus       195 ~~~  197 (201)
                      ...
T Consensus       295 ~~~  297 (337)
T cd07858         295 ASL  297 (337)
T ss_pred             hhh
Confidence            764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.3e-35  Score=215.42  Aligned_cols=186  Identities=29%  Similarity=0.613  Sum_probs=153.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      ++++++|+||+++++.+...+..+++|||+++++|.+++..     ..++...+..++.+++.|+.|||+.|++|+||+|
T Consensus        55 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p  134 (267)
T cd08224          55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKP  134 (267)
T ss_pred             HHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcCh
Confidence            46788999999999999999999999999999999998853     2378999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch--
Q 046714           78 ANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE--  143 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--  143 (201)
                      +||+++.+|...+.+...            ...++..|.|||.+  .+..++.++|+||+|+++|++++|+.||....  
T Consensus       135 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  212 (267)
T cd08224         135 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN  212 (267)
T ss_pred             hhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHh--ccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc
Confidence            999999888766654321            12356679999997  45567889999999999999999999985432  


Q ss_pred             HHHHHHHhhcCCCCCCCC-CCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          144 DMQALFRIGRGKLPSVPN-SLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..+.......+..+..+. .++..+.+++.+||..+|++|||+.++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         213 LYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            223333344444444444 67889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.8e-35  Score=217.18  Aligned_cols=185  Identities=21%  Similarity=0.378  Sum_probs=154.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +++.++||||+++++++... ..++++||+++++|.+++...  .+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        62 ~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Ni  140 (279)
T cd05109          62 VMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNV  140 (279)
T ss_pred             HHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence            46778999999999998764 467999999999999998753  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc--------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVKSF--------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~--------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      ++++++.+++.+.....              .++..|+|||..  .+..++.++|+||||+++|++++ |..||......
T Consensus       141 l~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  218 (279)
T cd05109         141 LVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI--LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR  218 (279)
T ss_pred             EEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHh--ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99888777665543211              123469999997  44567889999999999999998 89999877666


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+........+...+.++.+++.+||..+|++|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         219 EIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            555555555555566778999999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=225.07  Aligned_cols=195  Identities=28%  Similarity=0.467  Sum_probs=156.0

Q ss_pred             ccccCCCcceeccceeeeeCC-----eEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN-----RLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      ++++++||||+++++++....     ..++++||+.+ +|.+++.+. .+++..+..++.|++.||++||+.|++|+|||
T Consensus        52 ~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlk  130 (330)
T cd07834          52 LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLK  130 (330)
T ss_pred             HHHhcCCcchhhhhhhhcccCcccccceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            467889999999999988775     78999999975 888888764 58999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCc---------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Q 046714           77 CANILVDASGLATTTNDV---------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH  141 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~---------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  141 (201)
                      |+||+++.+|.+++.+..               ....++..|+|||.+.. ....+.++|+||+|++++++++|+.||..
T Consensus       131 p~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~sDi~slG~il~~l~~g~~pf~~  209 (330)
T cd07834         131 PSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS-SSRYTKAIDIWSVGCIFAELLTRKPLFPG  209 (330)
T ss_pred             HHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeec-ccCCCcchhHHHHHHHHHHHHcCCCCcCC
Confidence            999999988776665421               12234667999999832 33778999999999999999999999977


Q ss_pred             chHHHHHHHhhcCCC------------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          142 LEDMQALFRIGRGKL------------------------------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       142 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ....+....+.....                              .......++.+.+++.+||+.+|.+|||++++++|
T Consensus       210 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         210 RDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             CCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            655443333221000                              00123367889999999999999999999999999


Q ss_pred             ccccCcCC
Q 046714          192 PFVKRPLQ  199 (201)
Q Consensus       192 ~~~~~~~~  199 (201)
                      |||+...+
T Consensus       290 ~~~~~~~~  297 (330)
T cd07834         290 PYLAQLHD  297 (330)
T ss_pred             ccHHhhcc
Confidence            99976543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.3e-35  Score=218.98  Aligned_cols=194  Identities=30%  Similarity=0.458  Sum_probs=156.5

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +++++ +||||+++++.+..++..++||||+.+++|.+++.. ..+++..+..++.|++.+|.+||+.|++|+||+|+||
T Consensus        57 ~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~ni  136 (288)
T cd05583          57 VLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENI  136 (288)
T ss_pred             HHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence            35566 599999999999999999999999999999998765 4589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch----
Q 046714           81 LVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE----  143 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----  143 (201)
                      +++.++...+.+...             ...++..|++||.+.......+.++|+||+|++++++++|..||....    
T Consensus       137 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~  216 (288)
T cd05583         137 LLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS  216 (288)
T ss_pred             EECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch
Confidence            999887766555321             123567799999974333346789999999999999999999985322    


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC---HhHHhcCccccCc
Q 046714          144 DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT---AAQLMEHPFVKRP  197 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t---~~~il~~~~~~~~  197 (201)
                      ..+...... ...+..+..++..+.+++.+||+.+|++|||   +.++++||||+..
T Consensus       217 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         217 QSEISRRIL-KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             HHHHHHHHH-ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            122222222 3334566678899999999999999999998   4677999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.6e-35  Score=215.00  Aligned_cols=187  Identities=21%  Similarity=0.354  Sum_probs=149.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      .++.++||||+++++.+.+....+++|||+.+++|.+++.+.     ..+...+..++.||+.||+|||+.+++|+||||
T Consensus        48 ~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp  127 (268)
T cd05086          48 PYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLAL  127 (268)
T ss_pred             HHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCcc
Confidence            356789999999999999999999999999999999988653     256667889999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCccc--------------cccCcccccccccccC-----CCCCcchhhHHHHHHHHHHHHh-CCC
Q 046714           78 ANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLK-----NNGYGLSADIWSLGCTVLEMLT-HQP  137 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~-----~~~~~~~~Dv~slG~~l~~l~~-g~~  137 (201)
                      +||+++.++..++.+....              ..++..|+|||.+...     ....+.++|+||||+++|++++ |..
T Consensus       128 ~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~  207 (268)
T cd05086         128 RNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQ  207 (268)
T ss_pred             ceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCC
Confidence            9999998887766654321              2245679999987321     2235678999999999999997 577


Q ss_pred             CCCCchHHHHHHHhhcCCC-----CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          138 PYSHLEDMQALFRIGRGKL-----PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       138 p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ||......+..........     +.....+++.+.+++..|| .+|.+|||++++++
T Consensus       208 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         208 PYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            8877666555554433322     3344557888999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.1e-35  Score=218.69  Aligned_cols=186  Identities=27%  Similarity=0.423  Sum_probs=151.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHhhcCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY------------HLSDSQVSSYTRQILNGLTYLHERNV   70 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~i~~~l~~lh~~~i   70 (201)
                      ++++++||||+++++++..++..++++|++.+++|.+++.+.            .+++..+..++.|++.||+|||+.|+
T Consensus        72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i  151 (296)
T cd05051          72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF  151 (296)
T ss_pred             HHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCc
Confidence            468899999999999999999999999999999999998654            37899999999999999999999999


Q ss_pred             cccCCCCCcEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh--
Q 046714           71 VHREIKCANILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT--  134 (201)
Q Consensus        71 ~H~dl~p~nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~--  134 (201)
                      +|+||||+||+++.++.+.+.+...              ...++..|+|||.+  ....++.++||||||+++|++++  
T Consensus       152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~~l~el~~~~  229 (296)
T cd05051         152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV--LLGKFTTKSDVWAFGVTLWEILTLC  229 (296)
T ss_pred             cccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh--hcCCCCccchhhhhHHHHHHHHhcC
Confidence            9999999999999887666554321              11234579999997  34467899999999999999998  


Q ss_pred             CCCCCCCchHHHHHHHhhcC-------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          135 HQPPYSHLEDMQALFRIGRG-------KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       135 g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +..||...............       .....+..++.++.+++.+||+.+|++|||+.++++
T Consensus       230 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         230 REQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            77888776555554443321       111234456789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-35  Score=216.34  Aligned_cols=185  Identities=23%  Similarity=0.427  Sum_probs=156.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.. ...++++||+.+++|.+++...  .+++..+..++.|++.|++|||+.|++|+||+|+||
T Consensus        62 ~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~ni  140 (279)
T cd05057          62 VMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNV  140 (279)
T ss_pred             HHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceE
Confidence            5678999999999999887 6789999999999999998763  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc--------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVKSF--------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~--------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      +++.++.+++.+.....              .++..|+|||.+  ....++.++|+||+|++++++++ |+.||......
T Consensus       141 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  218 (279)
T cd05057         141 LVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV  218 (279)
T ss_pred             EEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHh--hcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence            99988877665543111              013469999987  34567889999999999999998 99999887776


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +....+..+.....+...+..+.+++.+||..+|++|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         219 EIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            666666666555666678899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-35  Score=225.29  Aligned_cols=194  Identities=25%  Similarity=0.446  Sum_probs=152.7

Q ss_pred             ccccCCCcceeccceeeeeC------CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE------NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      ++++++||||+++++++...      ..+++++||+.. +|.++.. ..+++..+..++.|++.||+|||+.|++|+||+
T Consensus        67 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlk  144 (342)
T cd07879          67 LLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG-HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLK  144 (342)
T ss_pred             HHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            46788999999999998754      346899999965 7776653 358999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCccc---------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           77 CANILVDASGLATTTNDVKS---------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~~---------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+||+++.+|.+++.+....         ..++..|+|||.+. ....++.++|+||+|+++|++++|+.||........
T Consensus       145 p~NIll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~  223 (342)
T cd07879         145 PGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVIL-NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ  223 (342)
T ss_pred             HHHEEECCCCCEEEeeCCCCcCCCCCCCCceeeecccChhhhc-CccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999988777664321         23466799999973 334578899999999999999999999987654333


Q ss_pred             HHHhhcC----------------------CCCC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGRG----------------------KLPS--------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~----------------------~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+...                      ..+.        .....++.+.+++.+||+.+|++|||+++++.||||+..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         224 LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            3222110                      0000        112467789999999999999999999999999999876


Q ss_pred             CC
Q 046714          198 LQ  199 (201)
Q Consensus       198 ~~  199 (201)
                      .+
T Consensus       304 ~~  305 (342)
T cd07879         304 RD  305 (342)
T ss_pred             cc
Confidence            54

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.2e-35  Score=218.37  Aligned_cols=195  Identities=28%  Similarity=0.494  Sum_probs=152.0

Q ss_pred             ccccCC-CcceeccceeeeeCCeEEEEEEecCCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHhhc-CccccC
Q 046714            3 SFSQFE-HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ------KYHLSDSQVSSYTRQILNGLTYLHER-NVVHRE   74 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~------~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~d   74 (201)
                      ++.++. ||||+++++++..++..++++|++.. ++.++..      ...+++..+..++.|++.|++|||+. |++|+|
T Consensus        55 ~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~d  133 (288)
T cd06616          55 VVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD  133 (288)
T ss_pred             HHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccC
Confidence            355665 99999999999999999999999865 6554332      24489999999999999999999975 999999


Q ss_pred             CCCCcEEEccCCceeeecCcc-----------ccccCcccccccccccCC-CCCcchhhHHHHHHHHHHHHhCCCCCCCc
Q 046714           75 IKCANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKN-NGYGLSADIWSLGCTVLEMLTHQPPYSHL  142 (201)
Q Consensus        75 l~p~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  142 (201)
                      |+|+||+++.+|..++.+...           ...++..|+|||.+.... ..++.++|+||+|+++|++++|+.||...
T Consensus       134 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  213 (288)
T cd06616         134 VKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW  213 (288)
T ss_pred             CCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence            999999999888766655321           123567899999983221 36788999999999999999999999765


Q ss_pred             hH-HHHHHHhhcCCCCCC----CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          143 ED-MQALFRIGRGKLPSV----PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       143 ~~-~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .. .....+......+..    +..++.++.+|+.+||+.+|.+|||++++++||||+...
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         214 NSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             chHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            42 222222222222222    234788999999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.8e-35  Score=221.84  Aligned_cols=193  Identities=26%  Similarity=0.432  Sum_probs=153.3

Q ss_pred             ccccCCCcceeccceeeee-CCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKD-ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.. .+..++++||+. ++|.++++...+++..+..++.|+++||++||+.|++|+||+|+||+
T Consensus        62 ~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nil  140 (328)
T cd07856          62 LLKHLRHENIISLSDIFISPLEDIYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNIL  140 (328)
T ss_pred             HHHhcCCCCeeeEeeeEecCCCcEEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEe
Confidence            4678999999999999875 567899999984 58999988778899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           82 VDASGLATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        82 l~~~g~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      ++.+|..++.+..         ....++..|+|||.+. ....++.++|+||+|+++|++++|+.||.............
T Consensus       141 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~  219 (328)
T cd07856         141 INENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIML-TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIIT  219 (328)
T ss_pred             ECCCCCEEeCccccccccCCCcCCCcccccccCceeee-ccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9988877665532         1223566799999872 33567899999999999999999999997654322111100


Q ss_pred             --------------------------c-CCC---CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          153 --------------------------R-GKL---PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       153 --------------------------~-~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                                                . ...   ......+++.+.+++++||+.+|++|||+++++.||||...
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~  294 (328)
T cd07856         220 DLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY  294 (328)
T ss_pred             HHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence                                      0 000   01113467899999999999999999999999999999643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-35  Score=218.03  Aligned_cols=188  Identities=29%  Similarity=0.493  Sum_probs=151.1

Q ss_pred             cccCCCcceeccceeeeeCCe-----EEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCC
Q 046714            4 FSQFEHDNIVQYIGTEKDENR-----LYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREI   75 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl   75 (201)
                      +++++||||+++++.+.+...     .++++|++.+ +|.+++...   .+++..+..++.|++.||.+||+.|++|+||
T Consensus        55 l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l  133 (287)
T cd07838          55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDL  133 (287)
T ss_pred             hhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccC
Confidence            456689999999999988776     9999999976 888887653   3899999999999999999999999999999


Q ss_pred             CCCcEEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           76 KCANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      +|+||+++.++.+++.+...           ...++..|+|||.+  .+..++.++|+||+|+++|+|++|+.||.....
T Consensus       134 ~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~--~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~  211 (287)
T cd07838         134 KPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL--LQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE  211 (287)
T ss_pred             ChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHh--ccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence            99999999998776665321           12245679999998  445678899999999999999999999977655


Q ss_pred             HHHHHHhhcCCC--------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          145 MQALFRIGRGKL--------------------------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       145 ~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .+....+.....                          .......++.+.+++.+||+.+|.+||+++++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         212 ADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             HHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            544433321100                          00011345778899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.5e-35  Score=222.21  Aligned_cols=187  Identities=25%  Similarity=0.460  Sum_probs=150.2

Q ss_pred             ccccC-CCcceeccceeeeeC-CeEEEEEEecCCCCHHHHHHh-------------------------------------
Q 046714            3 SFSQF-EHDNIVQYIGTEKDE-NRLYIFLELVKKGSLANLYQK-------------------------------------   43 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~-------------------------------------   43 (201)
                      ++.++ +||||+++++.+... ...++++||+++++|.+++..                                     
T Consensus        63 ~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (337)
T cd05054          63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSS  142 (337)
T ss_pred             HHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccc
Confidence            34566 799999999987654 568899999999999998753                                     


Q ss_pred             -------------------------cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCccc--
Q 046714           44 -------------------------YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS--   96 (201)
Q Consensus        44 -------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--   96 (201)
                                               .++++..+..++.|++.||+|||++||+|+||||+||+++.++.+++.+....  
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~  222 (337)
T cd05054         143 ASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD  222 (337)
T ss_pred             cccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchh
Confidence                                     14688889999999999999999999999999999999998887766654321  


Q ss_pred             ------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH-HHHHhhcCCCCCCCCC
Q 046714           97 ------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ-ALFRIGRGKLPSVPNS  162 (201)
Q Consensus        97 ------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~-~~~~~~~~~~~~~~~~  162 (201)
                                  ..++..|+|||.+  .+..++.++|+||+||++|++++ |..||......+ ....+..+.....+..
T Consensus       223 ~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  300 (337)
T cd05054         223 IYKDPDYVRKGDARLPLKWMAPESI--FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEY  300 (337)
T ss_pred             cccCcchhhccCCCCCccccCcHHh--cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCcc
Confidence                        1234569999987  45678899999999999999998 999997643322 2223333344455667


Q ss_pred             CCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          163 LSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       163 ~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .++++.+++.+||+.+|++|||+++++++
T Consensus       301 ~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         301 ATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            88999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.6e-35  Score=215.05  Aligned_cols=187  Identities=24%  Similarity=0.405  Sum_probs=146.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY------HLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      ++++++||||+++++.+.+....+++|||+++++|.+++...      ..+...+..++.|++.|++|||+.|++|+|||
T Consensus        48 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlk  127 (269)
T cd05087          48 PYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLA  127 (269)
T ss_pred             HHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccC
Confidence            467899999999999999999999999999999999998642      24566778899999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCccc--------------cccCcccccccccccCC-----CCCcchhhHHHHHHHHHHHHh-CC
Q 046714           77 CANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKN-----NGYGLSADIWSLGCTVLEMLT-HQ  136 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~-----~~~~~~~Dv~slG~~l~~l~~-g~  136 (201)
                      |+||+++.++.+++.+....              ..++..|+|||.+....     ..++.++|+||+|+++|++++ |+
T Consensus       128 p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~  207 (269)
T cd05087         128 LRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGS  207 (269)
T ss_pred             cceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCC
Confidence            99999998877766653211              12345699999974221     235789999999999999996 99


Q ss_pred             CCCCCchHHHHHHHhhcCC-----CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          137 PPYSHLEDMQALFRIGRGK-----LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .||......+.........     .+......++.+.+++.+|+ .+|++|||+++++.
T Consensus       208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         208 QPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            9998765554433322211     12233356788999999998 58999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.6e-35  Score=214.05  Aligned_cols=185  Identities=24%  Similarity=0.504  Sum_probs=154.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++|+||+++++.+.+ ...++++||+++++|.+++.+.   .++...+..++.|++.|+.+||+.|++|+||+|+|
T Consensus        54 ~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~n  132 (260)
T cd05073          54 VMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN  132 (260)
T ss_pred             HHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcce
Confidence            5788999999999999887 7789999999999999998753   26788899999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.++..++.+....             ..++..|+|||.+  ....++.++|+||||+++|++++ |+.||......
T Consensus       133 i~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~  210 (260)
T cd05073         133 ILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP  210 (260)
T ss_pred             EEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHh--ccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999887766553211             1123459999998  34567889999999999999998 99999877666


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+..+.....+...+.++.+++.+|+..+|++||++.+++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         211 EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            666655555555566778899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4e-35  Score=219.84  Aligned_cols=190  Identities=28%  Similarity=0.536  Sum_probs=150.9

Q ss_pred             ccccCCCcceeccceeeeeCC----------eEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN----------RLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNV   70 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i   70 (201)
                      ++++++||||+++++++.+..          ..++++||+++ ++.+.+...  .+++..+..++.|++.||+|||+.|+
T Consensus        59 ~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  137 (302)
T cd07864          59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNF  137 (302)
T ss_pred             HHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            467889999999999887654          78999999987 777776643  48999999999999999999999999


Q ss_pred             cccCCCCCcEEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCC
Q 046714           71 VHREIKCANILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        71 ~H~dl~p~nill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      +|+||+|+||+++.++.+++.+....             ..++..|+|||.+. .....+.++|+||+|++++++++|+.
T Consensus       138 ~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~~Di~slG~~~~el~~g~~  216 (302)
T cd07864         138 LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLL-GEERYGPAIDVWSCGCILGELFTKKP  216 (302)
T ss_pred             ecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhc-CCCCCCchhHHHHHHHHHHHHHhCCC
Confidence            99999999999999887766553211             12355699999873 33456889999999999999999999


Q ss_pred             CCCCchHHHHHHHhhc---CCCC--------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHH
Q 046714          138 PYSHLEDMQALFRIGR---GKLP--------------------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQL  188 (201)
Q Consensus       138 p~~~~~~~~~~~~~~~---~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~i  188 (201)
                      ||...........+..   ...+                          .....++..+.+++.+||..+|.+|||++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  296 (302)
T cd07864         217 IFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA  296 (302)
T ss_pred             CCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            9976554443333221   1000                          0112468899999999999999999999999


Q ss_pred             hcCccc
Q 046714          189 MEHPFV  194 (201)
Q Consensus       189 l~~~~~  194 (201)
                      ++||||
T Consensus       297 l~~~~~  302 (302)
T cd07864         297 LNSPWL  302 (302)
T ss_pred             hcCCCC
Confidence            999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=232.44  Aligned_cols=195  Identities=35%  Similarity=0.653  Sum_probs=175.2

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      |.+++|||++.+-|.|..+...++|||||-| +-.|++.  +.++.+.++..+..+.+.||+|||+.+.+|+|||..||+
T Consensus        80 L~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNIL  158 (948)
T KOG0577|consen   80 LRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNIL  158 (948)
T ss_pred             HHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceE
Confidence            6789999999999999999999999999977 8888874  567999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc--------cccccCccccccccccc-CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           82 VDASGLATTTNDV--------KSFEGTPFWVAPEVVNL-KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        82 l~~~g~~~~~~~~--------~~~~~~~~~~aPE~~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      +...|.+++.+++        .+++|||.|+|||++-. ....++-++||||||+++.++...++|+.....+..++.+.
T Consensus       159 Lse~g~VKLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA  238 (948)
T KOG0577|consen  159 LSEPGLVKLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA  238 (948)
T ss_pred             ecCCCeeeeccccchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH
Confidence            9999988887764        45789999999999843 34457889999999999999999999999999999999999


Q ss_pred             cCCCCCCCC-CCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          153 RGKLPSVPN-SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       153 ~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      .+..|.++. ..+..+++|+..||+.-|++|||.++++.|+|+....+
T Consensus       239 QNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  239 QNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             hcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence            888777654 57899999999999999999999999999999876543

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-35  Score=218.17  Aligned_cols=189  Identities=29%  Similarity=0.562  Sum_probs=151.1

Q ss_pred             cccCC-CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            4 FSQFE-HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         4 l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +++++ ||||+++++++.+++..+++|||+ +++|.+.+...   .+++..+..++.|++.++.|||++|++|+||+|+|
T Consensus        51 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~n  129 (283)
T cd07830          51 LRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPEN  129 (283)
T ss_pred             HHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhh
Confidence            55778 999999999999999999999999 66898877653   48999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           80 ILVDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        80 ill~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      |+++.++...+.+..           ....++..|+|||.+. ....++.++|+||||++++++++|+.||......+..
T Consensus       130 i~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~  208 (283)
T cd07830         130 LLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILL-RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL  208 (283)
T ss_pred             EEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeee-cCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH
Confidence            999998877665532           1223566799999873 3445788999999999999999999999765443333


Q ss_pred             HHhhcC---------------------C--------CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          149 FRIGRG---------------------K--------LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       149 ~~~~~~---------------------~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ......                     .        ........+..+.+++.+||+.+|++|||++|++.||||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         209 YKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             HHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            221110                     0        000111236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=8e-35  Score=217.77  Aligned_cols=191  Identities=31%  Similarity=0.543  Sum_probs=153.0

Q ss_pred             cCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCcEEE
Q 046714            6 QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCANILV   82 (201)
Q Consensus         6 ~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~nill   82 (201)
                      ..+||||+++++++.+++..++++||+.+ ++.+++..  ..+++..+..++.|++.|++|||+ .|++|+||+|+||++
T Consensus        70 ~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill  148 (296)
T cd06618          70 SHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL  148 (296)
T ss_pred             ccCCCchHhhheeeecCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE
Confidence            34699999999999999999999999865 78777654  348899999999999999999997 599999999999999


Q ss_pred             ccCCceeeecCccc-----------cccCcccccccccccCC--CCCcchhhHHHHHHHHHHHHhCCCCCCCchH-HHHH
Q 046714           83 DASGLATTTNDVKS-----------FEGTPFWVAPEVVNLKN--NGYGLSADIWSLGCTVLEMLTHQPPYSHLED-MQAL  148 (201)
Q Consensus        83 ~~~g~~~~~~~~~~-----------~~~~~~~~aPE~~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~  148 (201)
                      +.++..++.+....           ..++..|+|||.+....  ..++.++|+||||+++|++++|+.||..... .+..
T Consensus       149 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  228 (296)
T cd06618         149 DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL  228 (296)
T ss_pred             cCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH
Confidence            98887776654221           12456799999984322  3477899999999999999999999976433 2333


Q ss_pred             HHhhcCCCCCCC--CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          149 FRIGRGKLPSVP--NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       149 ~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ........+..+  ..++.++.+++.+||..+|.+|||++++++||||+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         229 TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             HHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            333333333333  2468899999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-35  Score=224.08  Aligned_cols=193  Identities=24%  Similarity=0.443  Sum_probs=155.0

Q ss_pred             ccccCCCcceeccceeeeeCC------eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN------RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +|++++||||+++++++....      ..++++|++ +++|.+++....+++..+..++.|++.||+|||+.|++|+||+
T Consensus        67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlk  145 (343)
T cd07880          67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLK  145 (343)
T ss_pred             HHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            478899999999999987654      458999998 6699999887789999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           77 CANILVDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+||+++.+|..++.+...         ...++..|+|||.+. .....+.++|+||+|+++|++++|+.||........
T Consensus       146 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  224 (343)
T cd07880         146 PGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVIL-NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ  224 (343)
T ss_pred             HHHEEEcCCCCEEEeecccccccccCccccccCCcccCHHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999888776655321         233567799999973 224578899999999999999999999976544333


Q ss_pred             HHHhhcC------------------------------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGRG------------------------------KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .......                              ........+++.+.+++.+|++.+|++|||+.++++||||+.-
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         225 LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            2221110                              0001224567889999999999999999999999999999764

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-36  Score=223.12  Aligned_cols=194  Identities=26%  Similarity=0.416  Sum_probs=167.7

Q ss_pred             cccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            2 FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      .+|++++.+.||.+-.-|++++.+++|+..++||+|.-+|-.   .+|+++.++.++.+|+.||++||+.+||+||+||+
T Consensus       237 ~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPe  316 (591)
T KOG0986|consen  237 QILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPE  316 (591)
T ss_pred             HHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChh
Confidence            368889999999999999999999999999999999777643   25999999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecC-----------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--
Q 046714           79 NILVDASGLATTTND-----------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--  145 (201)
Q Consensus        79 nill~~~g~~~~~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--  145 (201)
                      |||+|+.|.+.+++-           .....||.+|+|||++  .+..++...|-||+||++|+|+.|..||......  
T Consensus       317 NILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl--~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk  394 (591)
T KOG0986|consen  317 NILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVL--QNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK  394 (591)
T ss_pred             heeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHH--cCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh
Confidence            999999998776652           2344689999999998  4455899999999999999999999999655433  


Q ss_pred             -HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          146 -QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       146 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                       +.+.+.+.....+++...+++++++.+.+|+.+|++|.     .++++.+||||+..
T Consensus       395 ~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  395 REEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             HHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence             33445556666788899999999999999999999996     57799999999874

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-35  Score=217.36  Aligned_cols=186  Identities=25%  Similarity=0.387  Sum_probs=149.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHhhcC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-------------HLSDSQVSSYTRQILNGLTYLHERN   69 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~lh~~~   69 (201)
                      ++++++||||+++++++...+..+++|||+.+++|.+++...             .+++..+..++.|++.||.|||+.|
T Consensus        70 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~  149 (295)
T cd05097          70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN  149 (295)
T ss_pred             HHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC
Confidence            467899999999999999999999999999999999988643             2577888999999999999999999


Q ss_pred             ccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-
Q 046714           70 VVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-  134 (201)
Q Consensus        70 i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-  134 (201)
                      ++|+||||+||+++.++.+++.+....              ..++..|+|||.+  ....++.++|+||||++++++++ 
T Consensus       150 i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwSlG~~l~el~~~  227 (295)
T cd05097         150 FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI--LLGKFTTASDVWAFGVTLWEMFTL  227 (295)
T ss_pred             eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh--ccCCcCchhhHHHHHHHHHHHHHc
Confidence            999999999999998877666553211              1124569999987  34567899999999999999998 


Q ss_pred             -CCCCCCCchHHHHHHHhh-------cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          135 -HQPPYSHLEDMQALFRIG-------RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       135 -g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                       +..||.............       .......+...++.+.+++.+||+.+|++|||++++++
T Consensus       228 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         228 CKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             CCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence             667887655444433221       11112334557899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.8e-35  Score=220.11  Aligned_cols=190  Identities=29%  Similarity=0.546  Sum_probs=147.2

Q ss_pred             ccccCCCcceeccceeeeeC--------CeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccc
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--------NRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVH   72 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H   72 (201)
                      ++++++||||+++++++...        ...++++||+.+ ++...+..  ..+++..+..++.|+++||+|||+.|++|
T Consensus        60 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H  138 (311)
T cd07866          60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILH  138 (311)
T ss_pred             HHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            47789999999999987543        346999999976 67666654  34999999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceeeecCccc-----------------------cccCcccccccccccCCCCCcchhhHHHHHHHH
Q 046714           73 REIKCANILVDASGLATTTNDVKS-----------------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV  129 (201)
Q Consensus        73 ~dl~p~nill~~~g~~~~~~~~~~-----------------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l  129 (201)
                      +||+|+||+++.+|..++.+....                       ..+++.|+|||.+. ....++.++|+||+|+++
T Consensus       139 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Dv~slG~il  217 (311)
T cd07866         139 RDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLL-GERRYTTAVDIWGIGCVF  217 (311)
T ss_pred             CCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhh-CCCccCchhHhHHHHHHH
Confidence            999999999999887666543211                       12355699999873 344578899999999999


Q ss_pred             HHHHhCCCCCCCchHHHHHHHhhcCCC-------------CC---------C-------CCCCCHHHHHHHHHHhhcCCC
Q 046714          130 LEMLTHQPPYSHLEDMQALFRIGRGKL-------------PS---------V-------PNSLSRDARDFILKCLQVNPN  180 (201)
Q Consensus       130 ~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------~~---------~-------~~~~~~~~~~li~~~l~~~p~  180 (201)
                      |++++|+.||.+.........+.....             +.         .       ....++.+.+++.+||+.+|.
T Consensus       218 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  297 (311)
T cd07866         218 AEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY  297 (311)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcc
Confidence            999999999976655443333211000             00         0       023446788999999999999


Q ss_pred             CCCCHhHHhcCccc
Q 046714          181 DRPTAAQLMEHPFV  194 (201)
Q Consensus       181 ~R~t~~~il~~~~~  194 (201)
                      +|||+.+++.||||
T Consensus       298 ~R~t~~ell~~~~f  311 (311)
T cd07866         298 KRLTASDALEHPYF  311 (311)
T ss_pred             cCcCHHHHhcCCCC
Confidence            99999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.8e-35  Score=216.08  Aligned_cols=187  Identities=26%  Similarity=0.473  Sum_probs=147.7

Q ss_pred             ccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++||||+++++++.+.  ...++++||+++++|.+++.+.  .+++..+..++.|++.||+|||++|++|+||||+
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~  138 (284)
T cd05079          59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR  138 (284)
T ss_pred             HHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchh
Confidence            47889999999999998875  5689999999999999998654  3789999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc-
Q 046714           79 NILVDASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL-  142 (201)
Q Consensus        79 nill~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-  142 (201)
                      ||+++.+|..++.+...               ...++..|+|||.+  .+..++.++|+||+|+++|+++++..|.... 
T Consensus       139 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~--~~~~~~~~~Di~slG~il~ellt~~~~~~~~~  216 (284)
T cd05079         139 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL--IQSKFYIASDVWSFGVTLYELLTYCDSESSPM  216 (284)
T ss_pred             eEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHh--ccCCCCccccchhhhhhhhhhhcCCCCCcccc
Confidence            99999888766654321               12234569999987  4456788999999999999999976553211 


Q ss_pred             --------------hHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          143 --------------EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       143 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                                    ...........+.....+..++..+.+++.+||+.+|++|||++++++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         217 TLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             chhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                          0111112222333334456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-34  Score=216.65  Aligned_cols=186  Identities=24%  Similarity=0.400  Sum_probs=148.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC------------CCHHHHHHHHHHHHHHHHHHhhcCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH------------LSDSQVSSYTRQILNGLTYLHERNV   70 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~i~~~l~~lh~~~i   70 (201)
                      ++++++||||+++++++.+.+..++++||+.+++|.+++....            ++...+..++.|++.|++|||+.|+
T Consensus        72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i  151 (296)
T cd05095          72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF  151 (296)
T ss_pred             HHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4678999999999999999999999999999999999986532            5567899999999999999999999


Q ss_pred             cccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh--
Q 046714           71 VHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT--  134 (201)
Q Consensus        71 ~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~--  134 (201)
                      +|+||||+||+++.++.+++.+....              ...+..|++||..  ....++.++|+||||+++|++++  
T Consensus       152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~~DiwSlG~~l~el~~~~  229 (296)
T cd05095         152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI--LLGKFTTASDVWAFGVTLWEILTLC  229 (296)
T ss_pred             ecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH--hcCCccchhhhhHHHHHHHHHHHhC
Confidence            99999999999998877666553221              1123569999986  34567899999999999999998  


Q ss_pred             CCCCCCCchHHHHHHHhh-------cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          135 HQPPYSHLEDMQALFRIG-------RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       135 g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      |..||......+......       .......+..+++.+.+++.+||+.+|++|||+.++.+
T Consensus       230 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         230 KEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             CCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            778887655444433221       11111234567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=231.73  Aligned_cols=187  Identities=24%  Similarity=0.479  Sum_probs=157.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .|++-+|.||+-+.|++..+.. .+|+.+|.|.+|+.+++-  -.|.+...++|++||++|+.|||.++|+|+|||.+||
T Consensus       441 ~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNI  519 (678)
T KOG0193|consen  441 VLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNI  519 (678)
T ss_pred             HHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccce
Confidence            5788999999999999999987 999999999999998864  3489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc--------------ccccCcccccccccccC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLK-NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      ++.+++.+++.++.-              ...+...|+|||++... ..++++.+||||||+|+|||++|..||......
T Consensus       520 Fl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d  599 (678)
T KOG0193|consen  520 FLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD  599 (678)
T ss_pred             EEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh
Confidence            999887777666431              22356679999998643 457899999999999999999999999965555


Q ss_pred             HHHHHhhcCCCC----CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLP----SVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .++..+..+...    .....+++++++|+..||.+++++||.+.+|+.
T Consensus       600 qIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  600 QIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             heEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            666555555321    233457789999999999999999999999887

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-36  Score=209.87  Aligned_cols=193  Identities=30%  Similarity=0.532  Sum_probs=162.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhc-CccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHER-NVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~p~n   79 (201)
                      ++++.++|+|++.+|+|..+...++.||.+.. .+..++++  +++++..+-++...+++||.||..+ |++|||+||+|
T Consensus       144 v~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSN  222 (391)
T KOG0983|consen  144 VLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN  222 (391)
T ss_pred             HhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccc
Confidence            45667899999999999999999999999855 66666654  4589988889999999999999966 89999999999


Q ss_pred             EEEccCCceeeecCcc-----------ccccCcccccccccccC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCc-hHHH
Q 046714           80 ILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLK-NNGYGLSADIWSLGCTVLEMLTHQPPYSHL-EDMQ  146 (201)
Q Consensus        80 ill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~~  146 (201)
                      ||+|..|..++.++.-           ...|.+.|+|||.+... ..++..++||||||+.++++.||..||.+. .+.+
T Consensus       223 ILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe  302 (391)
T KOG0983|consen  223 ILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE  302 (391)
T ss_pred             eEEccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH
Confidence            9999999988876531           23367789999998543 456788999999999999999999999874 4556


Q ss_pred             HHHHhhcCCCCCCCC--CCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          147 ALFRIGRGKLPSVPN--SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ..-++.....|.++.  ..++.+.+|+..||+.|+.+||...++++|||+..
T Consensus       303 ~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~  354 (391)
T KOG0983|consen  303 VLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR  354 (391)
T ss_pred             HHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence            666666665565554  37999999999999999999999999999999864

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.2e-35  Score=221.74  Aligned_cols=193  Identities=26%  Similarity=0.431  Sum_probs=152.3

Q ss_pred             ccccCCCcceeccceeeeeC------CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE------NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      ++++++||||+++++++...      +..+++++++ +++|.++++...+++..+..++.|++.|++|||+.|++|+||+
T Consensus        69 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk  147 (345)
T cd07877          69 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK  147 (345)
T ss_pred             HHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence            46788999999999987643      3467888877 6699998887779999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           77 CANILVDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+||+++.+|.+++.+...         ...++..|+|||.+. ....++.++|+||+|+++|++++|+.||........
T Consensus       148 p~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~  226 (345)
T cd07877         148 PSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ  226 (345)
T ss_pred             hHHEEEcCCCCEEEecccccccccccccccccCCCccCHHHHh-CccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999988777665421         223567799999873 334578899999999999999999999975543332


Q ss_pred             HHHhhcC-------------------------CC-----CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGRG-------------------------KL-----PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~-------------------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+...                         ..     .......++.+.+++.+|++.+|.+|||+.++++||||++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence            2211100                         00     01112457889999999999999999999999999999854

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=238.83  Aligned_cols=188  Identities=31%  Similarity=0.447  Sum_probs=163.1

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG   86 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g   86 (201)
                      +.+=|++++..|++++++|+||||++||+|..++.++. +++..+..|+..|+.||.-+|+.|+|||||||+|||+|..|
T Consensus       133 ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G  212 (1317)
T KOG0612|consen  133 NSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG  212 (1317)
T ss_pred             CcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC
Confidence            45568889999999999999999999999999999887 99999999999999999999999999999999999999999


Q ss_pred             ceeeecCc-------------cccccCcccccccccccCC---CCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           87 LATTTNDV-------------KSFEGTPFWVAPEVVNLKN---NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        87 ~~~~~~~~-------------~~~~~~~~~~aPE~~~~~~---~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      ..++.+++             ...+|||.|.|||+++..+   ..+++.+|-||+|+++|+|+.|..||....-.+.+.+
T Consensus       213 HikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~K  292 (1317)
T KOG0612|consen  213 HIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGK  292 (1317)
T ss_pred             cEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHH
Confidence            88777653             3456999999999986433   4488999999999999999999999988888888777


Q ss_pred             hhcCCC-CCCC--CCCCHHHHHHHHHHhhcCCCCCCC---HhHHhcCccccC
Q 046714          151 IGRGKL-PSVP--NSLSRDARDFILKCLQVNPNDRPT---AAQLMEHPFVKR  196 (201)
Q Consensus       151 ~~~~~~-~~~~--~~~~~~~~~li~~~l~~~p~~R~t---~~~il~~~~~~~  196 (201)
                      +..... -.+|  ..+|+++++||++.++. |+.|..   ++++..||||..
T Consensus       293 Im~hk~~l~FP~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  293 IMNHKESLSFPDETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             HhchhhhcCCCcccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccC
Confidence            765421 1333  45899999999999886 888988   999999999974

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.8e-34  Score=211.24  Aligned_cols=185  Identities=30%  Similarity=0.553  Sum_probs=153.2

Q ss_pred             ccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCC
Q 046714            5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCA   78 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~   78 (201)
                      +.++||||+++++++..++..++++||+.+++|.+++..     ..+++..++.++.|++.++.+||. .|++|+||+|+
T Consensus        64 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~  143 (269)
T cd08528          64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPN  143 (269)
T ss_pred             hcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHH
Confidence            458999999999999999999999999999999988742     248899999999999999999996 78999999999


Q ss_pred             cEEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           79 NILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        79 nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ||+++.++..++.+...           ...++..|++||.+  .+..++.++|+||||+++|++++|+.||........
T Consensus       144 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~--~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~  221 (269)
T cd08528         144 NIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV--KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL  221 (269)
T ss_pred             HEEECCCCcEEEecccceeecccccccccccCcccCcChhhh--cCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH
Confidence            99999888776665331           23356779999998  345578999999999999999999999977665555


Q ss_pred             HHHhhcCCCCCCC-CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          148 LFRIGRGKLPSVP-NSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       148 ~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ............+ ..+++.+.+++.+||+.+|.+|||+.|+..+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         222 ATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            5554444333333 3678999999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.8e-34  Score=215.48  Aligned_cols=186  Identities=22%  Similarity=0.413  Sum_probs=151.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++... ..++++||+++++|.+++...  .+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        62 ~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Ni  140 (303)
T cd05110          62 IMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNV  140 (303)
T ss_pred             HHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeecccccccee
Confidence            46788999999999998765 467899999999999998764  378899999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      +++.++.+++.+....              ..++..|+|||.+  .+..++.++|+||||+++|++++ |..||.+....
T Consensus       141 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~--~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~  218 (303)
T cd05110         141 LVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR  218 (303)
T ss_pred             eecCCCceEEccccccccccCcccccccCCCccccccCCHHHh--ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9988876666553211              1124569999987  45667899999999999999997 89999776554


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ........+.....+...+..+.+++.+||..+|++||+++++++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         219 EIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4444444444444556678899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-36  Score=214.85  Aligned_cols=193  Identities=28%  Similarity=0.481  Sum_probs=171.0

Q ss_pred             cccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            2 FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      -.|+.-+||.+..+...|+...++++||||+.||.|.-.+.+ ..+++.....+..+|+.||.|||+++|++||+|.+|.
T Consensus       220 RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENL  299 (516)
T KOG0690|consen  220 RVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENL  299 (516)
T ss_pred             HHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhh
Confidence            457788999999999999999999999999999999776654 5599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecC------------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTND------------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      ++|.+|..++.++            .++++||+.|.|||.+  ...+++.++|-|++|+++|+|++|+.||...+.....
T Consensus       300 lLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVl--eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF  377 (516)
T KOG0690|consen  300 LLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVL--EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF  377 (516)
T ss_pred             eeccCCceEeeecccchhcccccceeccccCChhhcCchhh--ccccccceeehhhhhHHHHHHHhccCcccccchhHHH
Confidence            9999987665543            4578899999999998  6778999999999999999999999999888776666


Q ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                      .-+..... .+|..++++.+.|+..+|..+|.+|.     .+.+|.+|+||...
T Consensus       378 eLIl~ed~-kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v  430 (516)
T KOG0690|consen  378 ELILMEDL-KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV  430 (516)
T ss_pred             HHHHhhhc-cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence            65555443 78899999999999999999999996     58899999999764

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.9e-34  Score=219.00  Aligned_cols=191  Identities=28%  Similarity=0.483  Sum_probs=147.6

Q ss_pred             cccC-CCcceeccceeeee----CCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            4 FSQF-EHDNIVQYIGTEKD----ENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      ++++ +||||+++++.+..    ....+++++++.+ +|.+.+.. ..+++..+..++.||+.||+|||+.|++|+||||
T Consensus        55 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp  133 (332)
T cd07857          55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKP  133 (332)
T ss_pred             HHHhcCCCChheeeeeeeeccccCCcEEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence            4556 59999999987442    2457888998864 88887754 4589999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCcc----------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Q 046714           78 ANILVDASGLATTTNDVK----------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH  141 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~----------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  141 (201)
                      +||+++.+|.+++.+...                ...++..|+|||... ....++.++|+||+|+++|++++|+.||..
T Consensus       134 ~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~~Di~slGv~l~~l~~g~~pf~~  212 (332)
T cd07857         134 GNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIML-SFQSYTKAIDVWSVGCILAELLGRKPVFKG  212 (332)
T ss_pred             HHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence            999999888766655321                124677899999872 345678899999999999999999999976


Q ss_pred             chHHHHHHHhhc---------------------------C---CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          142 LEDMQALFRIGR---------------------------G---KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       142 ~~~~~~~~~~~~---------------------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ............                           .   .........+..+.+++.+|++.+|++|||+.+++.|
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         213 KDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            543222211100                           0   0011123457889999999999999999999999999


Q ss_pred             ccccC
Q 046714          192 PFVKR  196 (201)
Q Consensus       192 ~~~~~  196 (201)
                      ||+++
T Consensus       293 ~~~~~  297 (332)
T cd07857         293 PYLAI  297 (332)
T ss_pred             hhhhh
Confidence            99973

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-35  Score=225.46  Aligned_cols=185  Identities=23%  Similarity=0.433  Sum_probs=165.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|+.++|||+++++|+|..+...|||+||+..|+|.+++.+..   ++.-..+.++.||.+|++||.+++++||||...|
T Consensus       316 vMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARN  395 (1157)
T KOG4278|consen  316 VMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARN  395 (1157)
T ss_pred             HHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhh
Confidence            5789999999999999999999999999999999999998754   6777788899999999999999999999999999


Q ss_pred             EEEccCCceeeecCcccc----------c---cCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKSF----------E---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~~----------~---~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      +|+..+.++++.++....          .   ..+.|+|||-+  .-..++.++|||+||++||++.| |-.||++.+..
T Consensus       396 CLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsL--AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS  473 (1157)
T KOG4278|consen  396 CLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  473 (1157)
T ss_pred             ccccccceEEeeccchhhhhcCCceecccCccCcccccCcccc--cccccccchhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence            999998887776653221          1   23459999997  56779999999999999999999 88999999999


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                      .++.-..++...+-+..+++.+++||+.||+++|.+||++.++-
T Consensus       474 qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  474 QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence            99888899999999999999999999999999999999999873

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.2e-34  Score=221.25  Aligned_cols=187  Identities=27%  Similarity=0.453  Sum_probs=152.3

Q ss_pred             ccccCC-CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-------------------------------------
Q 046714            3 SFSQFE-HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-------------------------------------   44 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------------------------------   44 (201)
                      +|.++. ||||+++++.+...+..++|+||+.+|+|.+++.+.                                     
T Consensus        93 ~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (401)
T cd05107          93 IMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGS  172 (401)
T ss_pred             HHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhh
Confidence            466787 999999999999999999999999999999988642                                     


Q ss_pred             --------------------------------------------------------------CCCHHHHHHHHHHHHHHH
Q 046714           45 --------------------------------------------------------------HLSDSQVSSYTRQILNGL   62 (201)
Q Consensus        45 --------------------------------------------------------------~~~~~~~~~~~~~i~~~l   62 (201)
                                                                                    .++...+..++.|++.||
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL  252 (401)
T cd05107         173 ESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGM  252 (401)
T ss_pred             ccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHH
Confidence                                                                          145567788999999999


Q ss_pred             HHHhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHH
Q 046714           63 TYLHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT  128 (201)
Q Consensus        63 ~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~  128 (201)
                      +|||+.|++|+||||+||+++.++.+++.+....              ..++..|+|||.+  ....++.++|+||+|++
T Consensus       253 ~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslGvi  330 (401)
T cd05107         253 EFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI--FNNLYTTLSDVWSFGIL  330 (401)
T ss_pred             HHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh--cCCCCCcHhHHHHHHHH
Confidence            9999999999999999999998776655543211              1234569999998  34567889999999999


Q ss_pred             HHHHHh-CCCCCCCchHHHHHHH-hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          129 VLEMLT-HQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       129 l~~l~~-g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +|++++ |..||......+.... +..+..+..+..++..+.+++.+||..+|.+||++.++++.
T Consensus       331 l~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         331 LWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999998 8899977654444333 34444455667789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3e-34  Score=235.63  Aligned_cols=185  Identities=23%  Similarity=0.292  Sum_probs=146.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHhhcCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY------------HLSDSQVSSYTRQILNGLTYLHERNV   70 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~i~~~l~~lh~~~i   70 (201)
                      ++++++||||+++++++.+++..+++|||++|++|.+++...            ..+...+..++.||+.||+|||+.|+
T Consensus        55 ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GI  134 (932)
T PRK13184         55 IAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGV  134 (932)
T ss_pred             HHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            467899999999999999999999999999999999988631            24556778899999999999999999


Q ss_pred             cccCCCCCcEEEccCCceeeecCcc------------------------------ccccCcccccccccccCCCCCcchh
Q 046714           71 VHREIKCANILVDASGLATTTNDVK------------------------------SFEGTPFWVAPEVVNLKNNGYGLSA  120 (201)
Q Consensus        71 ~H~dl~p~nill~~~g~~~~~~~~~------------------------------~~~~~~~~~aPE~~~~~~~~~~~~~  120 (201)
                      +||||||+||+++.+|.+++.+...                              ...|++.|+|||.+  .+...+.++
T Consensus       135 IHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l--~g~~~S~kS  212 (932)
T PRK13184        135 LHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL--LGVPASEST  212 (932)
T ss_pred             cccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh--cCCCCCcHh
Confidence            9999999999999877655543211                              13478899999997  455678999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCCCC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          121 DIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPS--VPNSLSRDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       121 Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                      |+||+||++|+|++|+.||...................  ....+++.+.+++.+|+..+|++|++..+.+
T Consensus       213 DIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        213 DIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             HHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999999999997754433332211111111  1236788999999999999999998765544

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.2e-34  Score=207.65  Aligned_cols=193  Identities=27%  Similarity=0.487  Sum_probs=151.2

Q ss_pred             ccccCCCcceeccceeeee-CCeEEEEEEecCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcCccccCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD-ENRLYIFLELVKKGSLANLYQKY------HLSDSQVSSYTRQILNGLTYLHERNVVHREI   75 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl   75 (201)
                      .+++++||||+.+..++.. +...++++||++. +|...|+-.      .++...+..++.||+.|+.|||++-++||||
T Consensus        80 L~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDL  158 (438)
T KOG0666|consen   80 LLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDL  158 (438)
T ss_pred             HHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccC
Confidence            4678999999999999887 8899999999988 998888532      3888999999999999999999999999999


Q ss_pred             CCCcEEEccC----CceeeecCc---------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCC
Q 046714           76 KCANILVDAS----GLATTTNDV---------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        76 ~p~nill~~~----g~~~~~~~~---------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                      ||.||++..+    |.+++.+-.               ...+-|.+|+|||.+ .+...++++.|+|+.||++.||++.+
T Consensus       159 KPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELL-LGa~hYT~AiDvWAiGCIfaElLtl~  237 (438)
T KOG0666|consen  159 KPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELL-LGARHYTKAIDVWAIGCIFAELLTLE  237 (438)
T ss_pred             CcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHh-cccccccchhhhHHHHHHHHHHHccC
Confidence            9999999887    666555421               123357789999998 56778999999999999999999988


Q ss_pred             CCCCCchH------------HHHHHHhhc----CCC------CCC-----------------------CCCCCHHHHHHH
Q 046714          137 PPYSHLED------------MQALFRIGR----GKL------PSV-----------------------PNSLSRDARDFI  171 (201)
Q Consensus       137 ~p~~~~~~------------~~~~~~~~~----~~~------~~~-----------------------~~~~~~~~~~li  171 (201)
                      +.|.+.+.            ...+..+.-    ...      |+.                       .+.-++...+|+
T Consensus       238 PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL  317 (438)
T KOG0666|consen  238 PLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLL  317 (438)
T ss_pred             ccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHH
Confidence            77744322            111111100    000      010                       112355588999


Q ss_pred             HHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          172 LKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       172 ~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .++|++||.+|+|++|+++|+||.+-
T Consensus       318 ~klL~yDP~kRIta~qAleh~yF~~d  343 (438)
T KOG0666|consen  318 QKLLTYDPIKRITAEQALEHPYFTED  343 (438)
T ss_pred             HHHhccCchhhccHHHHhcccccccC
Confidence            99999999999999999999999863

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=7.9e-34  Score=205.86  Aligned_cols=190  Identities=37%  Similarity=0.676  Sum_probs=157.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      .+++++|+||+++++.+......++++|++.+++|.+++.... ++...+..++.+++.++.+||+.|++|+||+|+||+
T Consensus        40 ~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~  119 (244)
T smart00220       40 ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENIL  119 (244)
T ss_pred             HHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeE
Confidence            4677899999999999999999999999999999999987655 899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHH
Q 046714           82 VDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH-LEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~  149 (201)
                      ++.++...+.+..           ....++..|++||..  .....+.++|+|++|++++++++|..||.. ........
T Consensus       120 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~--~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~  197 (244)
T smart00220      120 LDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL--LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFK  197 (244)
T ss_pred             ECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            9988766655432           223356679999997  355677899999999999999999999977 33333433


Q ss_pred             HhhcCCCCCCCCC--CCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          150 RIGRGKLPSVPNS--LSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       150 ~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .............  ++..+.+++.+|+..+|++||++.++++||||
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      198 KIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             HHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            3333333222222  88999999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-33  Score=210.34  Aligned_cols=186  Identities=25%  Similarity=0.440  Sum_probs=144.4

Q ss_pred             ccccCCCcceeccceeeee--CCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++||||+++++++..  ....++++||+.+++|.+++...  .+++..+..++.|++.||+|||++|++|+||||+
T Consensus        58 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~  137 (284)
T cd05081          58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATR  137 (284)
T ss_pred             HHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHh
Confidence            4678999999999998653  35689999999999999998753  3889999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCcccc---------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           79 NILVDASGLATTTNDVKSF---------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        79 nill~~~g~~~~~~~~~~~---------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      ||+++.++.+++.+.....               .+...|+|||..  .+..++.++|+||+|++++++++|..++....
T Consensus       138 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~  215 (284)
T cd05081         138 NILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYSDKSCSPP  215 (284)
T ss_pred             hEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHh--ccCCcChHHHHHHHHHHHHHHhhcCCcCCCcc
Confidence            9999988876665532111               012248999997  44567889999999999999999876653321


Q ss_pred             HHH----------------HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          144 DMQ----------------ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       144 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ...                .............+..++..+.+++.+||..+|++|||+.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         216 AEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             hhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            110                01111222222345567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=214.35  Aligned_cols=194  Identities=38%  Similarity=0.700  Sum_probs=169.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++.+.+.|+++++||.+-....+++|||||..|++.|.++-  ..++++++..+++.-++||+|||...-+|||||..||
T Consensus        81 IMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNI  160 (502)
T KOG0574|consen   81 IMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNI  160 (502)
T ss_pred             HHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccE
Confidence            56788999999999998888889999999999999998864  4599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|.+++.++.            .+..||+.|+|||+++  .-++..++|+||||+...+|..|++||.+..+.+.+
T Consensus       161 LLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~--EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI  238 (502)
T KOG0574|consen  161 LLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIE--EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI  238 (502)
T ss_pred             EEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHH--HhccchhhhHhhhcchhhhhhcCCCCccccccccee
Confidence            99999988776643            3456899999999994  345778999999999999999999999999888887


Q ss_pred             HHhhcCCCCCC--CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          149 FRIGRGKLPSV--PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       149 ~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ..+-....|.+  |...+.++.+|+++||...|++|.|+.++++|||.+..-
T Consensus       239 FMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  239 FMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             EeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            76665555544  335688899999999999999999999999999998653

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-35  Score=224.95  Aligned_cols=185  Identities=25%  Similarity=0.488  Sum_probs=164.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++.|+|.+.. .++|||.++-|.|.++++.+.  ++......++.||+.|+.|||+.+++||||...||
T Consensus       444 iMrnfdHphIikLIGv~~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNi  522 (974)
T KOG4257|consen  444 IMRNFDHPHIIKLIGVCVEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNI  522 (974)
T ss_pred             HHHhCCCcchhheeeeeeccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhhe
Confidence            688999999999999998764 699999999999999998654  88899999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc-----------cc--CcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKSF-----------EG--TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~-----------~~--~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      ++.....+++.+++-+.           .+  ...|+|||.++.  ..++.++|||.||+++||++. |..||.+..+.+
T Consensus       523 LVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD  600 (974)
T KOG4257|consen  523 LVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD  600 (974)
T ss_pred             eecCcceeeecccchhhhccccchhhccccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence            99988777776654221           11  235999999854  468899999999999999888 999999999999


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ++..+.++.....|..+|+.++.++.+||.++|.+||++.++..
T Consensus       601 VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  601 VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            99999999999999999999999999999999999999988753

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.6e-34  Score=211.71  Aligned_cols=186  Identities=27%  Similarity=0.500  Sum_probs=149.0

Q ss_pred             ccccCCCcceeccceeeee--CCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      .+++++||||+++++++..  +...++++||+.+++|.+++....  ++...+..++.|++.||+|||+.|++|+||+|+
T Consensus        59 ~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~  138 (284)
T cd05038          59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAAR  138 (284)
T ss_pred             HHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            4678999999999999887  567899999999999999997655  899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCccc---------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           79 NILVDASGLATTTNDVKS---------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        79 nill~~~g~~~~~~~~~~---------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      ||+++.++..++.+....               ..++..|.+||.+  ....++.++|+||||++++++++|..|+....
T Consensus       139 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~--~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~  216 (284)
T cd05038         139 NILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL--RTSKFSSASDVWSFGVTLYELFTYGDPSQSPP  216 (284)
T ss_pred             hEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHH--ccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence            999999887766653211               1123358999987  34567889999999999999999998875432


Q ss_pred             HHH---------------HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          144 DMQ---------------ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       144 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ...               .............+..++.++.+++.+||..+|++|||+.++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         217 AEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             chhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            111               11122222223334567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-35  Score=221.98  Aligned_cols=192  Identities=28%  Similarity=0.485  Sum_probs=174.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|.+.+.|.|+++|-.|.+++..|++||-|-||.|+..+..++ |...++..++.-+++|++|||++||++|||||+|.+
T Consensus       473 Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENll  552 (732)
T KOG0614|consen  473 IMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLL  552 (732)
T ss_pred             HHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhee
Confidence            5677889999999999999999999999999999999887654 999999999999999999999999999999999999


Q ss_pred             EccCCceeeecC-----------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           82 VDASGLATTTND-----------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        82 l~~~g~~~~~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      ++.+|.+++.++           .++++||+.|.|||++  ...+...++|.||||+++||+++|++||...++...+..
T Consensus       553 Ld~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEII--LnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~  630 (732)
T KOG0614|consen  553 LDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEII--LNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL  630 (732)
T ss_pred             eccCCceEEeehhhHHHhccCCceeeecCCcccccchhh--hccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence            999998877663           4678999999999998  667778999999999999999999999999999998888


Q ss_pred             hhcCCC-CCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccC
Q 046714          151 IGRGKL-PSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKR  196 (201)
Q Consensus       151 ~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~  196 (201)
                      +.++-. ..+|..++....++++++-..+|.+|.-     +.+|-+|.||..
T Consensus       631 ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  631 ILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             HHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            776643 3678899999999999999999999975     889999999963

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-33  Score=214.82  Aligned_cols=187  Identities=24%  Similarity=0.466  Sum_probs=148.5

Q ss_pred             ccccC-CCcceeccceeeeeC-CeEEEEEEecCCCCHHHHHHhc------------------------------------
Q 046714            3 SFSQF-EHDNIVQYIGTEKDE-NRLYIFLELVKKGSLANLYQKY------------------------------------   44 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~------------------------------------   44 (201)
                      +|.++ +||||+++++.+... +..++++||+++++|.+++...                                    
T Consensus        63 ~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (343)
T cd05103          63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSIT  142 (343)
T ss_pred             HHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccc
Confidence            35566 689999999987654 5678999999999999988542                                    


Q ss_pred             --------------------------------CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeec
Q 046714           45 --------------------------------HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN   92 (201)
Q Consensus        45 --------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~   92 (201)
                                                      .++...+..++.|++.||+|||++|++|+||||+||+++.++.+++.+
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~d  222 (343)
T cd05103         143 SSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICD  222 (343)
T ss_pred             cccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEe
Confidence                                            256777888999999999999999999999999999999888776665


Q ss_pred             Cccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH-HHHHHhhcCCC
Q 046714           93 DVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM-QALFRIGRGKL  156 (201)
Q Consensus        93 ~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~-~~~~~~~~~~~  156 (201)
                      ....              ..++..|+|||.+  .+..++.++|+||||+++|++++ |..||...... ........+..
T Consensus       223 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~  300 (343)
T cd05103         223 FGLARDIYKDPDYVRKGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR  300 (343)
T ss_pred             cccccccccCcchhhcCCCCCCcceECcHHh--cCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC
Confidence            4311              1124569999987  34567889999999999999997 99998765432 22233334444


Q ss_pred             CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       157 ~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ...+...++++.+++.+||+.+|++|||+.+++++
T Consensus       301 ~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         301 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            45556678899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-35  Score=230.47  Aligned_cols=186  Identities=26%  Similarity=0.466  Sum_probs=166.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|.|++||||+++-|+....+...+|+||+..|+|+.+++.+  .|...+...+++.|+.|++||-+.|+|||||...||
T Consensus       683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNI  762 (996)
T KOG0196|consen  683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNI  762 (996)
T ss_pred             hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhhe
Confidence            789999999999999999999999999999999999999764  399999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc---------cccC------cccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           81 LVDASGLATTTNDVKS---------FEGT------PFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~---------~~~~------~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      |++.+=.++..++.-+         ...|      ..|+|||.|  ...+++.++||||+|+++||.++ |+.||=+..+
T Consensus       763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAI--a~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN  840 (996)
T KOG0196|consen  763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAI--AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN  840 (996)
T ss_pred             eeccceEEEeccccceeecccCCCccccccCCccceeecChhHh--hhcccCchhhccccceEEEEecccCCCcccccch
Confidence            9987755544443221         1111      359999999  55679999999999999999887 9999999999


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .+++..+..+.....|..+|..+.+|+..||++|-.+||++.||+.
T Consensus       841 QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  841 QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            9999999999999999999999999999999999999999999976

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-34  Score=216.40  Aligned_cols=186  Identities=25%  Similarity=0.405  Sum_probs=144.3

Q ss_pred             ccccCCCcceeccceeeeeCC-eEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcC---ccccCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN-RLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERN---VVHREI   75 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~---i~H~dl   75 (201)
                      +|++++|||+++++|+|.+.+ ...+|+||+..|+|.+.+...   .++|..+.+|+.+++.||+|||...   |+||||
T Consensus       124 ~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDi  203 (361)
T KOG1187|consen  124 ILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDI  203 (361)
T ss_pred             HHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCC
Confidence            578999999999999999998 599999999999999998653   6799999999999999999999854   999999


Q ss_pred             CCCcEEEccCCceeeecCcc----cc---------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc
Q 046714           76 KCANILVDASGLATTTNDVK----SF---------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL  142 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~~~~----~~---------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  142 (201)
                      |+.|||+|.+..+++.++.-    ..         .||.+|++||++  .....+.++||||||++++|+++|+.+.+..
T Consensus       204 KssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~--~~g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  204 KSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYA--STGKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             CHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhh--ccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence            99999999887776655321    11         688899999998  3356789999999999999999999877542


Q ss_pred             h---H---HHHH-HHhhcCCCC-----CCC-CCCC--HH---HHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          143 E---D---MQAL-FRIGRGKLP-----SVP-NSLS--RD---ARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       143 ~---~---~~~~-~~~~~~~~~-----~~~-~~~~--~~---~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .   .   .+.. ..+..+...     .+. ...+  ..   +..+..+|++.+|+.||++.|+++
T Consensus       282 ~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  282 RPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            1   1   1111 111121111     111 2223  22   456778999999999999999754

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.2e-33  Score=205.14  Aligned_cols=187  Identities=22%  Similarity=0.437  Sum_probs=150.3

Q ss_pred             ccccCCCcceeccceeeeeCC------eEEEEEEecCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN------RLYIFLELVKKGSLANLYQKY-------HLSDSQVSSYTRQILNGLTYLHERN   69 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~   69 (201)
                      ++++++||||+++++++....      ..++++||+.+++|.+++...       .++...+..++.|++.|++|||++|
T Consensus        54 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~  133 (273)
T cd05074          54 CMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN  133 (273)
T ss_pred             HHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            578899999999999876532      347889999999998876421       3688899999999999999999999


Q ss_pred             ccccCCCCCcEEEccCCceeeecCcccc--------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-
Q 046714           70 VVHREIKCANILVDASGLATTTNDVKSF--------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-  134 (201)
Q Consensus        70 i~H~dl~p~nill~~~g~~~~~~~~~~~--------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-  134 (201)
                      ++|+||||+||+++.++.+++.+.....              .+.+.|++||.+  .....+.++|+||+|+++|++++ 
T Consensus       134 i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~--~~~~~~~~sDi~slG~il~el~~~  211 (273)
T cd05074         134 FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESL--ADNVYTTHSDVWAFGVTMWEIMTR  211 (273)
T ss_pred             EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHH--hcCccchhhhhHHHHHHHHHHhhC
Confidence            9999999999999988777665532211              123568899987  34557789999999999999999 


Q ss_pred             CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          135 HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       135 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      |+.||...........+........+...+..+.+++.+||..+|.+|||+.++++.
T Consensus       212 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         212 GQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899998776655555555444444556678999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=211.86  Aligned_cols=185  Identities=24%  Similarity=0.397  Sum_probs=144.3

Q ss_pred             eeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCc-
Q 046714           12 IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGL-   87 (201)
Q Consensus        12 I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~-   87 (201)
                      ++.+.++|.-.++.++|+|.+ |.++.|+++.+.   ++...+..++.|++++|+|||+.+++|.||||+||++.+... 
T Consensus       153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence            677788899999999999999 559999998754   899999999999999999999999999999999999865311 


Q ss_pred             -------------------eeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCC
Q 046714           88 -------------------ATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY  139 (201)
Q Consensus        88 -------------------~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  139 (201)
                                         .++.++++         ..+.|..|+|||++  .+.+++.++||||+||+|+|+++|...|
T Consensus       232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEVi--LgLGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVI--LGLGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             EEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchhe--eccCcCCccCceeeeeEEEEeeccceec
Confidence                               11222221         12357789999998  7889999999999999999999999999


Q ss_pred             CCchHHHHHHHh--hcCCCCC------------------CC-------------------------CCCCHHHHHHHHHH
Q 046714          140 SHLEDMQALFRI--GRGKLPS------------------VP-------------------------NSLSRDARDFILKC  174 (201)
Q Consensus       140 ~~~~~~~~~~~~--~~~~~~~------------------~~-------------------------~~~~~~~~~li~~~  174 (201)
                      ...++.+.....  ..+..|.                  .+                         +..-..+.+|+++|
T Consensus       310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m  389 (415)
T KOG0671|consen  310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM  389 (415)
T ss_pred             ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence            777655533221  1111110                  00                         01112477999999


Q ss_pred             hhcCCCCCCCHhHHhcCccccCcCC
Q 046714          175 LQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       175 l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      |.+||.+|+|+.|++.||||+...+
T Consensus       390 L~fDP~~RiTl~EAL~HpFF~~~~~  414 (415)
T KOG0671|consen  390 LEFDPARRITLREALSHPFFARLTP  414 (415)
T ss_pred             HccCccccccHHHHhcCHHhhcCCC
Confidence            9999999999999999999987653

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=208.01  Aligned_cols=186  Identities=30%  Similarity=0.514  Sum_probs=163.3

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG   86 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g   86 (201)
                      +-|.+++++..|++-+++|+||||+.||+|.-.+++.+ +.+..++.++.+|+-||-|||++||++||||.+||++|..|
T Consensus       408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG  487 (683)
T KOG0696|consen  408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG  487 (683)
T ss_pred             CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC
Confidence            34677888888999999999999999999988887754 99999999999999999999999999999999999999998


Q ss_pred             ceeeecC------------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcC
Q 046714           87 LATTTND------------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG  154 (201)
Q Consensus        87 ~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  154 (201)
                      ..++.+.            ..+++||+.|+|||++  .-.+++.++|-||+|++||||+.|..||++.++.+....+...
T Consensus       488 HiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi--~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh  565 (683)
T KOG0696|consen  488 HIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH  565 (683)
T ss_pred             ceEeeecccccccccCCcceeeecCCCcccccceE--EecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc
Confidence            8776653            2467899999999998  5567889999999999999999999999998877777666544


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH-----hHHhcCccccC
Q 046714          155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTA-----AQLMEHPFVKR  196 (201)
Q Consensus       155 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~-----~~il~~~~~~~  196 (201)
                       ...+|+.++.+..++.+..+...|.+|.-.     .+|..||||+.
T Consensus       566 -nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  566 -NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             -cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence             458899999999999999999999999643     47899999974

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=2.7e-33  Score=233.36  Aligned_cols=189  Identities=16%  Similarity=0.257  Sum_probs=139.4

Q ss_pred             cccCCC-cceeccceeee-------eCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCcccc
Q 046714            4 FSQFEH-DNIVQYIGTEK-------DENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHR   73 (201)
Q Consensus         4 l~~l~h-~~I~~~~~~~~-------~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~   73 (201)
                      .+.++| +||+++++.+.       .....+.++|++.+ +|.+++...  .+++.+++.++.||+.||+|||++||+||
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr  104 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDV-SLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH  104 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccCCc-cHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            456778 78999999872       33457788898844 999999653  48999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCce-------------------eeecCcc----------------------------ccccCcccccc
Q 046714           74 EIKCANILVDASGLA-------------------TTTNDVK----------------------------SFEGTPFWVAP  106 (201)
Q Consensus        74 dl~p~nill~~~g~~-------------------~~~~~~~----------------------------~~~~~~~~~aP  106 (201)
                      ||||+|||++..|..                   ++.++..                            ...+|+.|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            999999999643221                   1111110                            12356779999


Q ss_pred             cccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHh
Q 046714          107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAA  186 (201)
Q Consensus       107 E~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~  186 (201)
                      |.+  .+..++.++|||||||++|||++|..|+.....  ..........+.......+....++.+||+++|.+|||+.
T Consensus       185 E~~--~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~  260 (793)
T PLN00181        185 EED--NGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMS  260 (793)
T ss_pred             hhh--ccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChH
Confidence            998  445678999999999999999999887654321  1111111111111112245667889999999999999999


Q ss_pred             HHhcCccccCc
Q 046714          187 QLMEHPFVKRP  197 (201)
Q Consensus       187 ~il~~~~~~~~  197 (201)
                      |+++||||..+
T Consensus       261 eil~h~~~~~~  271 (793)
T PLN00181        261 ELLQSEFINEP  271 (793)
T ss_pred             HHhhchhhhhh
Confidence            99999999764

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.7e-33  Score=236.79  Aligned_cols=185  Identities=22%  Similarity=0.337  Sum_probs=142.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHh---hcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH---ERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.+++..++||||+++++|.++++.  +++..+.+++.|+++|++|||   +.+++|||+||+|
T Consensus       736 ~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~N  813 (968)
T PLN00113        736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK  813 (968)
T ss_pred             HHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHh
Confidence            46789999999999999999999999999999999999875  789999999999999999999   6699999999999


Q ss_pred             EEEccCCceeeecC-------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH----HHHH
Q 046714           80 ILVDASGLATTTND-------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED----MQAL  148 (201)
Q Consensus        80 ill~~~g~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~  148 (201)
                      |+++.++.......       .....++..|+|||.+  .+..++.++||||||+++||+++|+.||.....    ...+
T Consensus       814 il~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~  891 (968)
T PLN00113        814 IIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETR--ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW  891 (968)
T ss_pred             EEECCCCceEEEeccccccccCCCccccccccCcccc--cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHH
Confidence            99998765543311       1122456889999997  455688999999999999999999999843211    1111


Q ss_pred             HH-hhcCC------CCCC------CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          149 FR-IGRGK------LPSV------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       149 ~~-~~~~~------~~~~------~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .+ .....      .+..      +.....++.+++.+||+.+|++|||++|+++.
T Consensus       892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            11 00000      0111      11112356788999999999999999999764

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.2e-32  Score=221.38  Aligned_cols=83  Identities=22%  Similarity=0.452  Sum_probs=76.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +++.++||||+++++++...+..++||||+.+++|.+++... .+++..++.++.||+.||+|||..||+|+||||+||+
T Consensus        57 ~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NIL  136 (669)
T cd05610          57 ALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNML  136 (669)
T ss_pred             HHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEE
Confidence            456789999999999999999999999999999999998764 4789999999999999999999999999999999999


Q ss_pred             EccC
Q 046714           82 VDAS   85 (201)
Q Consensus        82 l~~~   85 (201)
                      ++.+
T Consensus       137 l~~~  140 (669)
T cd05610         137 ISNE  140 (669)
T ss_pred             EcCC
Confidence            9643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8e-32  Score=201.41  Aligned_cols=182  Identities=19%  Similarity=0.315  Sum_probs=141.1

Q ss_pred             cccCCCcceeccceeeeeCC----eEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            4 FSQFEHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      +..++|+||+++++.+....    ..+++++++.. ++.+.++... .++..+..++.|++.|++|||+.+++||||||+
T Consensus        77 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~  155 (294)
T PHA02882         77 IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPE  155 (294)
T ss_pred             hccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            45679999999998766543    34678888754 6777666543 688889999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCcc-------------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCC
Q 046714           79 NILVDASGLATTTNDVK-------------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY  139 (201)
Q Consensus        79 nill~~~g~~~~~~~~~-------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  139 (201)
                      ||+++.++.+.+.++..                   ...+|+.|+|||..  .+..++.++||||+|++++++++|+.||
T Consensus       156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~--~~~~~~~~~DiwSlG~~l~el~~g~~P~  233 (294)
T PHA02882        156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH--NGACVTRRGDLESLGYCMLKWAGIKLPW  233 (294)
T ss_pred             HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHh--CCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            99998876665554321                   13478889999997  4566889999999999999999999999


Q ss_pred             CCchHHH---------HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          140 SHLEDMQ---------ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       140 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .......         ....+..+.  ......++.+.+++..|+..+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        234 KGFGHNGNLIHAAKCDFIKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             CccccchHHHHHhHHHHHHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            7663211         112222221  123456889999999999999999999999875

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-33  Score=184.46  Aligned_cols=194  Identities=27%  Similarity=0.478  Sum_probs=157.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++|.||++++++..+++..-+|+|||.. +|..+...  +.+..+.+..++.|++.|+.|+|+.++.|+|+||.|.
T Consensus        54 llkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnl  132 (292)
T KOG0662|consen   54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNL  132 (292)
T ss_pred             HHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceE
Confidence            47889999999999999999999999999976 88888764  3489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHH
Q 046714           81 LVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~  147 (201)
                      +|+.+|..++.++.            +...-|..|++|..+ .+..-++...|+||.||++.|+.. |++.|++.+-.+.
T Consensus       133 lin~ngelkladfglarafgipvrcysaevvtlwyrppdvl-fgakly~tsidmwsagcifaelanagrplfpg~dvddq  211 (292)
T KOG0662|consen  133 LINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL-FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ  211 (292)
T ss_pred             EeccCCcEEecccchhhhcCCceEeeeceeeeeeccCccee-eeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH
Confidence            99999877766542            233457789999998 456678899999999999999988 7777877665555


Q ss_pred             HHHhhc-------CCCCC------------CC---------CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          148 LFRIGR-------GKLPS------------VP---------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       148 ~~~~~~-------~~~~~------------~~---------~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ..++..       ...|.            ++         ...+...++++++++.-+|.+|++++++++||||.+-.
T Consensus       212 lkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  212 LKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             HHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            444321       11111            11         12344578999999999999999999999999998754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3e-33  Score=221.45  Aligned_cols=183  Identities=34%  Similarity=0.526  Sum_probs=140.8

Q ss_pred             CCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--C---CHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            7 FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--L---SDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         7 l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~---~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      =+||||+++|+.-+++.+.|+..|.|.. +|.|+++..+  .   .....+..+.|+++||++||+.+|+||||||.|||
T Consensus       560 D~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNIL  638 (903)
T KOG1027|consen  560 DEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNIL  638 (903)
T ss_pred             cCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEE
Confidence            4799999999999999999999999988 9999998632  1   11345778999999999999999999999999999


Q ss_pred             Ecc---CC----------ceeeecC-------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCC
Q 046714           82 VDA---SG----------LATTTND-------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYS  140 (201)
Q Consensus        82 l~~---~g----------~~~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~  140 (201)
                      |+.   +|          +++....       .+...||.+|+|||++.  ....+.++|+||+||++|+.++ |.+||+
T Consensus       639 I~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~--~~~~~~avDiFslGCvfyYvltgG~HpFG  716 (903)
T KOG1027|consen  639 ISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLR--EDRKTQAVDIFSLGCVFYYVLTGGSHPFG  716 (903)
T ss_pred             EEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHh--ccccCcccchhhcCceEEEEecCCccCCC
Confidence            986   23          2221111       12334788999999984  4444669999999999999998 499998


Q ss_pred             CchHHHHHHHhhcCCCC--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          141 HLEDMQALFRIGRGKLP--SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       141 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      +.-..+.  .+..+...  .+......++.+||.+|+.++|..||++.++|.||+|
T Consensus       717 d~~~R~~--NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF  770 (903)
T KOG1027|consen  717 DSLERQA--NILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF  770 (903)
T ss_pred             chHHhhh--hhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence            7544322  23333221  1222222289999999999999999999999999987

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=197.55  Aligned_cols=189  Identities=25%  Similarity=0.462  Sum_probs=149.0

Q ss_pred             ccccCCCcceeccceeeeeCC------eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN------RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      .++.++|+||++++.++.-..      ..|+|||++.. +|..++. ..+.-+.+..+..|++.|+++||+.||+|||||
T Consensus        68 l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLk  145 (369)
T KOG0665|consen   68 LMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLK  145 (369)
T ss_pred             hhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccC
Confidence            467789999999999987653      57999999976 9998887 346788899999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           77 CANILVDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |+||++..++..++.++.           +....+..|+|||++.  +..+...+||||+||++.+|++|+..|.+....
T Consensus       146 Psnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil--~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~i  223 (369)
T KOG0665|consen  146 PSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVIL--GMGYKENVDIWSVGCIMGELILGTVLFPGKDHI  223 (369)
T ss_pred             cccceecchhheeeccchhhcccCcccccCchhheeeccCchhee--ccCCcccchhhhhhhHHHHHhhceEEecCchHH
Confidence            999999887766655432           2233455699999984  444889999999999999999999999776655


Q ss_pred             HHHHHhhcC---------------------CCCC---------CC-----------CCCCHHHHHHHHHHhhcCCCCCCC
Q 046714          146 QALFRIGRG---------------------KLPS---------VP-----------NSLSRDARDFILKCLQVNPNDRPT  184 (201)
Q Consensus       146 ~~~~~~~~~---------------------~~~~---------~~-----------~~~~~~~~~li~~~l~~~p~~R~t  184 (201)
                      +.+.++...                     ..+.         ++           ..-...+++++.+||..+|++|.|
T Consensus       224 dQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris  303 (369)
T KOG0665|consen  224 DQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS  303 (369)
T ss_pred             HHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc
Confidence            544433110                     0000         01           112245789999999999999999


Q ss_pred             HhHHhcCcccc
Q 046714          185 AAQLMEHPFVK  195 (201)
Q Consensus       185 ~~~il~~~~~~  195 (201)
                      ++++|+|||++
T Consensus       304 v~daL~HPY~~  314 (369)
T KOG0665|consen  304 VDDALRHPYIK  314 (369)
T ss_pred             HHHHhcCCeee
Confidence            99999999997

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-32  Score=214.46  Aligned_cols=192  Identities=25%  Similarity=0.426  Sum_probs=165.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|.+|+|||++++||+..+ ....+|+|.+.+|+|.+.+.+   ..|.......++.||+.|+.||..++++||||-..|
T Consensus       164 ~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARN  242 (1039)
T KOG0199|consen  164 HMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARN  242 (1039)
T ss_pred             HHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhh
Confidence            4778999999999999998 567899999999999998876   238888899999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcccc--------c-------cCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCch
Q 046714           80 ILVDASGLATTTNDVKSF--------E-------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE  143 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~~--------~-------~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~  143 (201)
                      +++.....+++.++....        +       -...|.|||.+  ....++.++|||++|+.+|||++ |+.||.+..
T Consensus       243 lllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsL--rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~  320 (1039)
T KOG0199|consen  243 LLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESL--RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR  320 (1039)
T ss_pred             heecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHh--ccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence            999776666665543211        1       12249999998  56789999999999999999999 899999999


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          144 DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...++..+..+....-++.++++++++++.||..+|++||||..|.+.-+..+.
T Consensus       321 g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea  374 (1039)
T KOG0199|consen  321 GIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA  374 (1039)
T ss_pred             HHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence            999999999888888899999999999999999999999999999766554443

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=7.2e-33  Score=194.59  Aligned_cols=194  Identities=29%  Similarity=0.479  Sum_probs=163.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHhhc-CccccCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ------KYHLSDSQVSSYTRQILNGLTYLHER-NVVHREI   75 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~------~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl   75 (201)
                      ++++-++|||+++||..-.++..++.||.++- ++..+.+      +..+++...-++..-.+.||.||... .|+|||+
T Consensus       116 ~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDv  194 (361)
T KOG1006|consen  116 VMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDV  194 (361)
T ss_pred             HHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccC
Confidence            46777899999999998888889999999965 7766543      34589988888999999999999965 8999999


Q ss_pred             CCCcEEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch-
Q 046714           76 KCANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE-  143 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-  143 (201)
                      ||+|||++..|.+++.++.-           ...|...|+|||.+.....++..++|+||||++|||+.||+.|+..+. 
T Consensus       195 KPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s  274 (361)
T KOG1006|consen  195 KPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS  274 (361)
T ss_pred             ChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence            99999999999998887531           223677899999997666678999999999999999999999998874 


Q ss_pred             HHHHHHHhhcCCCCCCC-----CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          144 DMQALFRIGRGKLPSVP-----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ..+.+.++..+..+.+.     .+++..+..++..|+.++...||+..+++.+||++.-
T Consensus       275 vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  275 VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            45666677777766543     2378899999999999999999999999999998753

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=3.2e-32  Score=190.28  Aligned_cols=195  Identities=27%  Similarity=0.522  Sum_probs=153.5

Q ss_pred             ccccCCCcceeccceeeeeC--------CeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccc
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--------NRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVH   72 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H   72 (201)
                      +|..|+|+|++.+.++|...        ...|+||++|.. +|..++...  .++..++.+++.+++.||.|+|+..|+|
T Consensus        69 iL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilH  147 (376)
T KOG0669|consen   69 ILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILH  147 (376)
T ss_pred             HHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHh
Confidence            57789999999999987642        358999999988 888888654  4899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceeeecCccc----------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCC
Q 046714           73 REIKCANILVDASGLATTTNDVKS----------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        73 ~dl~p~nill~~~g~~~~~~~~~~----------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                      ||+|+.|++|+.+|..++.++...                .+-|.+|++||.+ .+...++++.|+|+.||++.+|+++.
T Consensus       148 RDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEll-LG~r~yg~~iDiWgAgCimaeMwtrs  226 (376)
T KOG0669|consen  148 RDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELL-LGDREYGPPIDIWGAGCIMAEMWTRS  226 (376)
T ss_pred             hcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHh-hcccccCCcchhHhHHHHHHHHHccC
Confidence            999999999999987766654322                1136789999998 45667899999999999999999999


Q ss_pred             CCCCCchHHHHHHHhh-------cCCCC--------------CCCC-------------CCCHHHHHHHHHHhhcCCCCC
Q 046714          137 PPYSHLEDMQALFRIG-------RGKLP--------------SVPN-------------SLSRDARDFILKCLQVNPNDR  182 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~-------~~~~~--------------~~~~-------------~~~~~~~~li~~~l~~~p~~R  182 (201)
                      +.+.+..+...+..+.       ..-.|              .++.             .-+++..+|+..++..||.+|
T Consensus       227 pimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR  306 (376)
T KOG0669|consen  227 PIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKR  306 (376)
T ss_pred             ccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccC
Confidence            8887765544433321       11011              0111             124467799999999999999


Q ss_pred             CCHhHHhcCcccc-CcCC
Q 046714          183 PTAAQLMEHPFVK-RPLQ  199 (201)
Q Consensus       183 ~t~~~il~~~~~~-~~~~  199 (201)
                      +++.++++|.||. +|.+
T Consensus       307 ~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  307 IDADQALNHDFFWKDPMP  324 (376)
T ss_pred             cchHhhhchhhhhcCCcc
Confidence            9999999999864 4433

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=4.3e-33  Score=212.01  Aligned_cols=192  Identities=28%  Similarity=0.443  Sum_probs=162.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|.++.||+|+.+-.+|++.+..++|||-+.|.-|.-.+.  ++.+++.....++.||+.||.|||-++|+|+||||+||
T Consensus       616 ILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENV  695 (888)
T KOG4236|consen  616 ILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENV  695 (888)
T ss_pred             HHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchhe
Confidence            6889999999999999999999999999998854444443  35699999999999999999999999999999999999


Q ss_pred             EEccC-----------Cceeeec---CccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH-H
Q 046714           81 LVDAS-----------GLATTTN---DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED-M  145 (201)
Q Consensus        81 ll~~~-----------g~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~  145 (201)
                      ++.+.           |.+.+..   +..+.+||+.|.|||.+  ...++...-|+||+|+++|--++|..||.+.++ .
T Consensus       696 LLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVL--rnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn  773 (888)
T KOG4236|consen  696 LLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVL--RNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN  773 (888)
T ss_pred             eeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHH--hhccccccccceeeeEEEEEEecccccCCCccchh
Confidence            99754           4444433   23456799999999998  567788999999999999999999999976543 3


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      +.+........+..+..+++...+||..+|+..-.+|-|+++.+.|||++.
T Consensus       774 dQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  774 DQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             HHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence            333334445566778899999999999999999999999999999999875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.3e-31  Score=207.59  Aligned_cols=191  Identities=27%  Similarity=0.455  Sum_probs=155.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ||.+-+++=||++|..|+++..+|+||||++||++..++-+.+ |++..+..++.++..|+++.|+.|++||||||+|||
T Consensus       682 ILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNIL  761 (1034)
T KOG0608|consen  682 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNIL  761 (1034)
T ss_pred             hHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceE
Confidence            5677788999999999999999999999999999999877666 889999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc------------------------------------------------------cccccCccccccc
Q 046714           82 VDASGLATTTNDV------------------------------------------------------KSFEGTPFWVAPE  107 (201)
Q Consensus        82 l~~~g~~~~~~~~------------------------------------------------------~~~~~~~~~~aPE  107 (201)
                      ||.+|..++.++.                                                      ...+||+.|+|||
T Consensus       762 IDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiape  841 (1034)
T KOG0608|consen  762 IDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPE  841 (1034)
T ss_pred             EccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChH
Confidence            9998766555421                                                      0112788899999


Q ss_pred             ccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcC---CCCCCCCCCCHHHHHHHHHHhhcCCCCCC-
Q 046714          108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG---KLPSVPNSLSRDARDFILKCLQVNPNDRP-  183 (201)
Q Consensus       108 ~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~-  183 (201)
                      ++  ...+++..+|.||.|++||+|+.|+.||-.....+...++..-   .--....++++++.++|.++ +.++..|. 
T Consensus       842 vl--~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kL-c~sad~RLG  918 (1034)
T KOG0608|consen  842 VL--ARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKL-CCSADSRLG  918 (1034)
T ss_pred             Hh--cccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHH-hcChhhhhc
Confidence            98  5667889999999999999999999999766554443333211   11133456899999999875 55678885 


Q ss_pred             --CHhHHhcCccccC
Q 046714          184 --TAAQLMEHPFVKR  196 (201)
Q Consensus       184 --t~~~il~~~~~~~  196 (201)
                        -.+|+-.||||+.
T Consensus       919 kng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  919 KNGADQVKAHPFFKG  933 (1034)
T ss_pred             ccchhhhhcCccccc
Confidence              4678999999985

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=200.63  Aligned_cols=197  Identities=24%  Similarity=0.405  Sum_probs=156.4

Q ss_pred             ccccCCCcceeccceeeee-CCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhc--CccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD-ENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHER--NVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~--~i~H~dl~p~   78 (201)
                      +-+.|+||.||++|+++.- ....+.|+|||+|.+|.-+++... +++.++..++.||+.||.||...  .|+|-||||.
T Consensus       520 IHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPg  599 (775)
T KOG1151|consen  520 IHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPG  599 (775)
T ss_pred             hhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCc
Confidence            3468999999999999874 457899999999999999998765 89999999999999999999976  5999999999


Q ss_pred             cEEEccC-----------CceeeecCc-----------cccccCcccccccccccC--CCCCcchhhHHHHHHHHHHHHh
Q 046714           79 NILVDAS-----------GLATTTNDV-----------KSFEGTPFWVAPEVVNLK--NNGYGLSADIWSLGCTVLEMLT  134 (201)
Q Consensus        79 nill~~~-----------g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~--~~~~~~~~Dv~slG~~l~~l~~  134 (201)
                      |||+.++           |+.++.++.           +...||.+|.+||.+.-+  ...++.++||||+|+++|.++.
T Consensus       600 NILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY  679 (775)
T KOG1151|consen  600 NILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY  679 (775)
T ss_pred             cEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence            9998543           444443321           223478899999998544  3457789999999999999999


Q ss_pred             CCCCCCCch-HHHHHHH--hhcCCCCCCC--CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          135 HQPPYSHLE-DMQALFR--IGRGKLPSVP--NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       135 g~~p~~~~~-~~~~~~~--~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      |+.||+... ..+++..  +.+.....+|  ..++.+.++||++||++..++|....++..||+|..+..
T Consensus       680 GrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~r  749 (775)
T KOG1151|consen  680 GRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIR  749 (775)
T ss_pred             cCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhh
Confidence            999997653 3333322  2222222233  347899999999999999999999999999999976543

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.2e-31  Score=211.78  Aligned_cols=181  Identities=27%  Similarity=0.517  Sum_probs=158.8

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-----------------CCHHHHHHHHHHHHHHHHHHhhcCc
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----------------LSDSQVSSYTRQILNGLTYLHERNV   70 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------------~~~~~~~~~~~~i~~~l~~lh~~~i   70 (201)
                      +||||+.++|.+..++..++|+||+..|+|.++++...                 ++......++.||+.|++||++.++
T Consensus       360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~  439 (609)
T KOG0200|consen  360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPC  439 (609)
T ss_pred             CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCc
Confidence            59999999999999999999999999999999998766                 8889999999999999999999999


Q ss_pred             cccCCCCCcEEEccCCceeeecCcccc----------c---c--CcccccccccccCCCCCcchhhHHHHHHHHHHHHh-
Q 046714           71 VHREIKCANILVDASGLATTTNDVKSF----------E---G--TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-  134 (201)
Q Consensus        71 ~H~dl~p~nill~~~g~~~~~~~~~~~----------~---~--~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-  134 (201)
                      +||||-..||++..+..++..++....          .   +  ...|+|||.+  ....++.++||||+|++|||+++ 
T Consensus       440 vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl--~~~~ft~kSDVWSfGI~L~EifsL  517 (609)
T KOG0200|consen  440 VHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESL--FDRVFTSKSDVWSFGILLWEIFTL  517 (609)
T ss_pred             cchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHh--ccCcccccchhhHHHHHHHHHhhC
Confidence            999999999999988666655543221          0   1  1239999998  44789999999999999999999 


Q ss_pred             CCCCCCCch-HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          135 HQPPYSHLE-DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       135 g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      |..||++.. ..+....+..+...+.|..++++++++++.||..+|++||++.++.+
T Consensus       518 G~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  518 GGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             CCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            899999865 55666678888898999999999999999999999999999998864

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=193.08  Aligned_cols=187  Identities=29%  Similarity=0.547  Sum_probs=163.5

Q ss_pred             CCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccC
Q 046714            7 FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS   85 (201)
Q Consensus         7 l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~   85 (201)
                      -+||.++-++..|+++..+++|.||.+||+|.-.+++ +.++++.+..+..+|+.||.|||++||+++|||.+||++|..
T Consensus       308 sn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae  387 (593)
T KOG0695|consen  308 SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE  387 (593)
T ss_pred             cCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC
Confidence            4799999999999999999999999999999766654 559999999999999999999999999999999999999988


Q ss_pred             Cceeeec------------CccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCC-------CchHHH
Q 046714           86 GLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS-------HLEDMQ  146 (201)
Q Consensus        86 g~~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~-------~~~~~~  146 (201)
                      |..++.+            ..++++||+.|.|||++  .+..++..+|-|+||+++++|+.|+.||+       +...++
T Consensus       388 ghikltdygmcke~l~~gd~tstfcgtpnyiapeil--rgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nted  465 (593)
T KOG0695|consen  388 GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL--RGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTED  465 (593)
T ss_pred             CceeecccchhhcCCCCCcccccccCCCcccchhhh--cccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhH
Confidence            7665543            35678899999999998  67888999999999999999999999993       334455


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC------CHhHHhcCcccc
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP------TAAQLMEHPFVK  195 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~------t~~~il~~~~~~  195 (201)
                      ...++.......+|..++-....+++..|.+||++|.      .+.++-.|+||+
T Consensus       466 ylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr  520 (593)
T KOG0695|consen  466 YLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR  520 (593)
T ss_pred             HHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence            6666666666788888999999999999999999995      478999999997

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=205.09  Aligned_cols=186  Identities=26%  Similarity=0.407  Sum_probs=155.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++|+||||+.++|+|..++.+++++||+..|+|..++.+..   .......+++.||++|++||.+.+++|||+.+.|
T Consensus       588 iLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rN  667 (807)
T KOG1094|consen  588 ILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRN  667 (807)
T ss_pred             HHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccc
Confidence            5889999999999999999999999999999999999998764   2445567799999999999999999999999999


Q ss_pred             EEEccCCceeeecCcccc--------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh--CCCCCCCch
Q 046714           80 ILVDASGLATTTNDVKSF--------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT--HQPPYSHLE  143 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~~--------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~--g~~p~~~~~  143 (201)
                      +|++.++.+++.++.-..              .-...|+|+|.+  .-.+++.++|+|+||+++||+++  ...||....
T Consensus       668 cLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsi--llgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt  745 (807)
T KOG1094|consen  668 CLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESI--LLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT  745 (807)
T ss_pred             eeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHH--HhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence            999999888877652111              123569999998  55678999999999999999776  788999888


Q ss_pred             HHHHHHHhhcC-------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          144 DMQALFRIGRG-------KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       144 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ++...+....-       .....|..++..+.+++.+||..+.++|||++++-.
T Consensus       746 ~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  746 DEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            77776653211       112456778999999999999999999999999843

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-31  Score=209.19  Aligned_cols=193  Identities=33%  Similarity=0.639  Sum_probs=167.9

Q ss_pred             cccCCCcceeccceeeee-----CCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCC
Q 046714            4 FSQFEHDNIVQYIGTEKD-----ENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREI   75 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl   75 (201)
                      ...-+|||++.+|+++..     ++.+++|||||.||+..|+++.   ..+.++.+..+++.++.|+.+||+..++|+|+
T Consensus        70 ~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDi  149 (953)
T KOG0587|consen   70 KKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDI  149 (953)
T ss_pred             HhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecc
Confidence            344579999999998764     4579999999999999999975   34899999999999999999999999999999


Q ss_pred             CCCcEEEccCCceeeecCc------------cccccCccccccccccc---CCCCCcchhhHHHHHHHHHHHHhCCCCCC
Q 046714           76 KCANILVDASGLATTTNDV------------KSFEGTPFWVAPEVVNL---KNNGYGLSADIWSLGCTVLEMLTHQPPYS  140 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  140 (201)
                      |-+||++..+|-+++.++.            .++.||+.|+|||++..   ....++.++|+||||++..+|.-|.+|+.
T Consensus       150 kG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~  229 (953)
T KOG0587|consen  150 KGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC  229 (953)
T ss_pred             cCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence            9999999999887776642            34668999999999843   34457789999999999999999999999


Q ss_pred             CchHHHHHHHhhcCCCCCC--CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          141 HLEDMQALFRIGRGKLPSV--PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      +..+......+.....|.+  +...++++.++|..||..+..+||+..++++|||.++
T Consensus       230 DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  230 DMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             CcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            9999888888776666544  4567899999999999999999999999999999874

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=4.9e-30  Score=205.58  Aligned_cols=177  Identities=23%  Similarity=0.302  Sum_probs=125.2

Q ss_pred             eeCCeEEEEEEecCCCCHHHHHHhcCC---------------------CHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714           20 KDENRLYIFLELVKKGSLANLYQKYHL---------------------SDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus        20 ~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ..+...++++||+.+++|.+++....+                     ....+..++.|++.||+|||+.||+|+||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            345678999999999999998875432                     12345679999999999999999999999999


Q ss_pred             cEEEcc-CCceeeecCcc-------------ccccCcccccccccccCCC--------------------CCcchhhHHH
Q 046714           79 NILVDA-SGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNN--------------------GYGLSADIWS  124 (201)
Q Consensus        79 nill~~-~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~--------------------~~~~~~Dv~s  124 (201)
                      |||++. ++.+++.++..             ...+++.|+|||.+.....                    .+..++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            999986 45566555432             2346778999997532221                    1234569999


Q ss_pred             HHHHHHHHHhCCCCCCCchHHHHHHH-hh-------------cCC-CC------CCCCCCCHHHHHHHHHHhhcCCCCCC
Q 046714          125 LGCTVLEMLTHQPPYSHLEDMQALFR-IG-------------RGK-LP------SVPNSLSRDARDFILKCLQVNPNDRP  183 (201)
Q Consensus       125 lG~~l~~l~~g~~p~~~~~~~~~~~~-~~-------------~~~-~~------~~~~~~~~~~~~li~~~l~~~p~~R~  183 (201)
                      +||++|+|+++..++....  ..... +.             ... .+      ...+..+...++|+.+||+.||++||
T Consensus       365 lGviL~el~~~~~~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~  442 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSNL--IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI  442 (566)
T ss_pred             HHHHHHHHHhCcCCCchHH--HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence            9999999999776654321  11111 00             000 00      01111234566899999999999999


Q ss_pred             CHhHHhcCccccCcC
Q 046714          184 TAAQLMEHPFVKRPL  198 (201)
Q Consensus       184 t~~~il~~~~~~~~~  198 (201)
                      |+.++++||||+...
T Consensus       443 ta~e~L~Hpff~~~~  457 (566)
T PLN03225        443 SAKAALAHPYFDREG  457 (566)
T ss_pred             CHHHHhCCcCcCCCC
Confidence            999999999998643

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=7.6e-30  Score=188.06  Aligned_cols=185  Identities=20%  Similarity=0.390  Sum_probs=159.2

Q ss_pred             cccCCCcceeccceeeeeC-CeEEEEEEecCCCCHHHHHHhc---------CCCHHHHHHHHHHHHHHHHHHhhcCcccc
Q 046714            4 FSQFEHDNIVQYIGTEKDE-NRLYIFLELVKKGSLANLYQKY---------HLSDSQVSSYTRQILNGLTYLHERNVVHR   73 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~   73 (201)
                      |--+.|||+.++.+++..+ ..+++++.+..-|+|..++...         .++..+.+.++.|++.|++|||+.|++|.
T Consensus       341 ly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHk  420 (563)
T KOG1024|consen  341 LYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHK  420 (563)
T ss_pred             HhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence            4456899999999997754 5688899999989999999721         16777889999999999999999999999


Q ss_pred             CCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCC
Q 046714           74 EIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPP  138 (201)
Q Consensus        74 dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p  138 (201)
                      ||...|++||+.-.+++.+..-+              ......|++||.+  ....++.++|+||||+++||++| |+.|
T Consensus       421 DiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal--~n~~yssasDvWsfGVllWELmtlg~~P  498 (563)
T KOG1024|consen  421 DIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEAL--QNSHYSSASDVWSFGVLLWELMTLGKLP  498 (563)
T ss_pred             hhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHH--hhhhhcchhhhHHHHHHHHHHHhcCCCC
Confidence            99999999998754444442111              1133459999998  56788999999999999999999 9999


Q ss_pred             CCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          139 YSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +.+.++.+....+..+.....|.++|.++..++..||...|++||+++|+..
T Consensus       499 yaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  499 YAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            9999999999999999999999999999999999999999999999999875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=2.3e-31  Score=201.97  Aligned_cols=183  Identities=29%  Similarity=0.470  Sum_probs=146.3

Q ss_pred             ceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC
Q 046714           11 NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH----LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG   86 (201)
Q Consensus        11 ~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g   86 (201)
                      |+++++-.|...+++++|||.+.- +|.+++++++    +....+..|+.|+..||..|.+.|++|.||||+|||++.+.
T Consensus       495 Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  495 HCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc
Confidence            789999999999999999999966 9999999875    77888999999999999999999999999999999998764


Q ss_pred             c-eeeecCccccc----------cCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHh--hc
Q 046714           87 L-ATTTNDVKSFE----------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI--GR  153 (201)
Q Consensus        87 ~-~~~~~~~~~~~----------~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~--~~  153 (201)
                      + .++.++.+...          -+..|.|||++  .+..++...|+||+||+||+++||+..|++..+...+.-.  .+
T Consensus       574 ~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIi--LG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K  651 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENEITPYLVSRFYRAPEII--LGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK  651 (752)
T ss_pred             ceeeeccCccccccccccccHHHHHHhccCccee--ecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence            3 34454443221          23359999998  6788899999999999999999999999887654443222  12


Q ss_pred             CCCCC------------------------------------------------------CCCC---CCHHHHHHHHHHhh
Q 046714          154 GKLPS------------------------------------------------------VPNS---LSRDARDFILKCLQ  176 (201)
Q Consensus       154 ~~~~~------------------------------------------------------~~~~---~~~~~~~li~~~l~  176 (201)
                      +..|.                                                      ++..   .-..+++|+..||.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence            22110                                                      0000   11347789999999


Q ss_pred             cCCCCCCCHhHHhcCccccC
Q 046714          177 VNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       177 ~~p~~R~t~~~il~~~~~~~  196 (201)
                      .||++|.|..|+|.||||+.
T Consensus       732 LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  732 LDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             cChhhcCCHHHHhcCCcccC
Confidence            99999999999999999986

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=4.2e-30  Score=178.41  Aligned_cols=153  Identities=28%  Similarity=0.395  Sum_probs=117.3

Q ss_pred             CCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCc------cccccCcccccc
Q 046714           35 GSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDV------KSFEGTPFWVAP  106 (201)
Q Consensus        35 ~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~------~~~~~~~~~~aP  106 (201)
                      |+|.+++..  .++++..++.++.|++.||+|||+.+      ||+||+++.++..+. .+.      ....+++.|+||
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~-fG~~~~~~~~~~~g~~~y~aP   73 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL-DGSVAFKTPEQSRVDPYFMAP   73 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee-ccceEeeccccCCCcccccCh
Confidence            589999875  34999999999999999999999998      999999998876655 211      123578899999


Q ss_pred             cccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHHHhhcCCCCC------CCCCCCH--HHHHHHHHHhhc
Q 046714          107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-QALFRIGRGKLPS------VPNSLSR--DARDFILKCLQV  177 (201)
Q Consensus       107 E~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~------~~~~~~~--~~~~li~~~l~~  177 (201)
                      |.+  .+..++.++||||+|+++|++++|+.||...... .............      .+..++.  .+.+++.+||..
T Consensus        74 E~~--~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~  151 (176)
T smart00750       74 EVI--QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASR  151 (176)
T ss_pred             HHh--cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhc
Confidence            998  4556788999999999999999999999654332 2222222111111      1122333  689999999999


Q ss_pred             CCCCCCCHhHHhcCccccC
Q 046714          178 NPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       178 ~p~~R~t~~~il~~~~~~~  196 (201)
                      +|.+|||+.++++|+|+..
T Consensus       152 ~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      152 LPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ccccccCHHHHHHHHHHHH
Confidence            9999999999999998653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=5e-30  Score=177.05  Aligned_cols=192  Identities=26%  Similarity=0.483  Sum_probs=142.9

Q ss_pred             ccccCC-CcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFE-HDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|..|. ||||++++++..+.  ..+.+++||+...+...+...  ++...+..++.++++||.|||+.||.|||+||.|
T Consensus        85 IL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t--l~d~dIryY~~elLkALdyCHS~GImHRDVKPhN  162 (338)
T KOG0668|consen   85 ILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT--LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHN  162 (338)
T ss_pred             HHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh--hchhhHHHHHHHHHHHHhHHHhcCcccccCCcce
Confidence            456666 99999999998875  568999999988776665444  7888999999999999999999999999999999


Q ss_pred             EEEccC---------Cceeeec---CccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCC-CchHHH
Q 046714           80 ILVDAS---------GLATTTN---DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS-HLEDMQ  146 (201)
Q Consensus        80 ill~~~---------g~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~-~~~~~~  146 (201)
                      ++||..         |++....   ..+....+..|.-||.+. .-..+...-|+|||||.+..|+..+.||. +.++.+
T Consensus       163 vmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLV-dy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D  241 (338)
T KOG0668|consen  163 VMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD  241 (338)
T ss_pred             eeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchhee-echhccccHHHHHHHHHHHHHHhccCcccCCCCCHH
Confidence            999875         2222211   122233455678899872 34457788999999999999999998873 222222


Q ss_pred             HHHHhh----------------cCCCC--------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          147 ALFRIG----------------RGKLP--------------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       147 ~~~~~~----------------~~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ...++.                ....+                    +...-.++++.+|+.++|.+|-++|+|+.|++.
T Consensus       242 QLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  242 QLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            221110                00000                    011225688999999999999999999999999


Q ss_pred             CccccCc
Q 046714          191 HPFVKRP  197 (201)
Q Consensus       191 ~~~~~~~  197 (201)
                      ||||...
T Consensus       322 HpyF~~~  328 (338)
T KOG0668|consen  322 HPYFAPV  328 (338)
T ss_pred             CchHHHH
Confidence            9999754

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=7.7e-31  Score=204.97  Aligned_cols=139  Identities=27%  Similarity=0.505  Sum_probs=118.0

Q ss_pred             ccccCCCcceeccceeeeeCC------eEEEEEEecCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcCccc
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN------RLYIFLELVKKGSLANLYQK----YHLSDSQVSSYTRQILNGLTYLHERNVVH   72 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H   72 (201)
                      +|++|+|||||+++++-.+..      ...++||||.||+|...+.+    +|+++.+.+.++..++.|+.|||.+||+|
T Consensus        64 ilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvH  143 (732)
T KOG4250|consen   64 ILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVH  143 (732)
T ss_pred             HHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCcee
Confidence            689999999999999866543      57899999999999999965    46999999999999999999999999999


Q ss_pred             cCCCCCcEEEccC------------CceeeecC---ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCC
Q 046714           73 REIKCANILVDAS------------GLATTTND---VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        73 ~dl~p~nill~~~------------g~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      |||||.||++-.+            |.++-.++   +.+.+||..|.+||... ....++..+|.|||||++|+++||+.
T Consensus       144 RDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E-~q~~y~~tVDLWS~GvtlY~caTG~l  222 (732)
T KOG4250|consen  144 RDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYE-RQKKYTATVDLWSFGVTLYECATGEL  222 (732)
T ss_pred             ccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHh-hccCcCceeehhhhhhHHHHHhccCC
Confidence            9999999998433            33433332   34567999999999983 24678889999999999999999999


Q ss_pred             CCCCc
Q 046714          138 PYSHL  142 (201)
Q Consensus       138 p~~~~  142 (201)
                      ||-..
T Consensus       223 PF~p~  227 (732)
T KOG4250|consen  223 PFIPF  227 (732)
T ss_pred             CCCcC
Confidence            99544

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=9.9e-29  Score=194.24  Aligned_cols=186  Identities=19%  Similarity=0.245  Sum_probs=133.1

Q ss_pred             eeccceeeee--------CCeEEEEEEecCCCCHHHHHHhc-------------------------CCCHHHHHHHHHHH
Q 046714           12 IVQYIGTEKD--------ENRLYIFLELVKKGSLANLYQKY-------------------------HLSDSQVSSYTRQI   58 (201)
Q Consensus        12 I~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~-------------------------~~~~~~~~~~~~~i   58 (201)
                      +++++++|..        ++..++|+||+.+++|.++++..                         .+++..+..++.|+
T Consensus       239 ~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql  318 (507)
T PLN03224        239 CAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQV  318 (507)
T ss_pred             hhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHH
Confidence            4666666543        35689999999999999987631                         12456688899999


Q ss_pred             HHHHHHHhhcCccccCCCCCcEEEccCCceeeecCccc-------------cccCcccccccccccCCC-----------
Q 046714           59 LNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNN-----------  114 (201)
Q Consensus        59 ~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~-----------  114 (201)
                      +.+|.|||+.+++|+||||+||+++.++..++.+....             ..+++.|+|||.+.....           
T Consensus       319 ~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~  398 (507)
T PLN03224        319 LTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAA  398 (507)
T ss_pred             HHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhh
Confidence            99999999999999999999999998877766554221             113678999998732211           


Q ss_pred             ---------CCcchhhHHHHHHHHHHHHhCCC-CCCCchHHH-----------HHHHhhcCC-CCCCCCCCCHHHHHHHH
Q 046714          115 ---------GYGLSADIWSLGCTVLEMLTHQP-PYSHLEDMQ-----------ALFRIGRGK-LPSVPNSLSRDARDFIL  172 (201)
Q Consensus       115 ---------~~~~~~Dv~slG~~l~~l~~g~~-p~~~~~~~~-----------~~~~~~~~~-~~~~~~~~~~~~~~li~  172 (201)
                               ....+.|+||+||++++|+++.. |+.......           .+....... .....+..++..++++.
T Consensus       399 ~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~  478 (507)
T PLN03224        399 LLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLAC  478 (507)
T ss_pred             hhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHH
Confidence                     11234799999999999999875 664321111           111111111 11234557899999999


Q ss_pred             HHhhcCC---CCCCCHhHHhcCccccCc
Q 046714          173 KCLQVNP---NDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       173 ~~l~~~p---~~R~t~~~il~~~~~~~~  197 (201)
                      +||..+|   .+|+|++|+|+||||..-
T Consensus       479 ~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        479 KLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             HHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            9999766   689999999999999753

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=9.8e-30  Score=201.81  Aligned_cols=186  Identities=24%  Similarity=0.452  Sum_probs=162.5

Q ss_pred             cccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            2 FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      .+|.+++|||++++++++.... ..||++|++.|+|.|+++..  .+..+..+.|..||++|+.|||.++++||||-..|
T Consensus       750 l~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRN  828 (1177)
T KOG1025|consen  750 LRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARN  828 (1177)
T ss_pred             HHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhh
Confidence            3678999999999999999877 78999999999999998754  48888999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccccc------------c--CcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           80 ILVDASGLATTTNDVKSFE------------G--TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~~~------------~--~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      ||+.....++..++.....            +  .+.|+|-|.+  ....+++++||||||+.+||++| |..|+.+...
T Consensus       829 VLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i--~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~  906 (1177)
T KOG1025|consen  829 VLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESI--RIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA  906 (1177)
T ss_pred             eeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHh--hccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence            9998877666665433222            1  2348888887  56678999999999999999999 9999999998


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .++-.-+..+.....|..++.+++-++.+||-.|+..||+++++..
T Consensus       907 ~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  907 EEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            8888888888888889999999999999999999999999998754

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=6.6e-29  Score=203.59  Aligned_cols=170  Identities=28%  Similarity=0.513  Sum_probs=132.6

Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCCC--HHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecC-------
Q 046714           23 NRLYIFLELVKKGSLANLYQKYHLS--DSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTND-------   93 (201)
Q Consensus        23 ~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~-------   93 (201)
                      ...||=||||...++.+++.++.+.  ...+++++++|++||.|+|++||+||||||.||+++.++.++++++       
T Consensus       669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~  748 (1351)
T KOG1035|consen  669 LILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLK  748 (1351)
T ss_pred             eEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhh
Confidence            4578889999998888888887764  7889999999999999999999999999999999998765554432       


Q ss_pred             -----------------------ccccccCcccccccccccCC-CCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHH
Q 046714           94 -----------------------VKSFEGTPFWVAPEVVNLKN-NGYGLSADIWSLGCTVLEMLTHQPPYSH-LEDMQAL  148 (201)
Q Consensus        94 -----------------------~~~~~~~~~~~aPE~~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~  148 (201)
                                             .....||-.|+|||.+.... ..++.|+|+||||++++||+.-   |.. .+....+
T Consensus       749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsMERa~iL  825 (1351)
T KOG1035|consen  749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSMERASIL  825 (1351)
T ss_pred             hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCchHHHHHHH
Confidence                                   12344777899999984332 2689999999999999999963   433 3344444


Q ss_pred             HHhhcCCCCCC---CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          149 FRIGRGKLPSV---PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       149 ~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      .....+..|..   ....-+.-.++|+.|++.||.+|||+.|+|++.||-
T Consensus       826 ~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  826 TNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            44444444433   333335567899999999999999999999999986

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-27  Score=180.38  Aligned_cols=73  Identities=29%  Similarity=0.485  Sum_probs=64.5

Q ss_pred             CcceeccceeeeeC----CeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc-CccccCCCCCcE
Q 046714            9 HDNIVQYIGTEKDE----NRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHER-NVVHREIKCANI   80 (201)
Q Consensus         9 h~~I~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~p~ni   80 (201)
                      -.+||++++.|...    .++++|+|++ |.+|..+|++   ++++...++.|++|++.||.|||++ ||+|.||||+||
T Consensus       141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENv  219 (590)
T KOG1290|consen  141 KKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENV  219 (590)
T ss_pred             CceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCccee
Confidence            34799999998754    5799999999 5588888875   3599999999999999999999965 999999999999


Q ss_pred             EE
Q 046714           81 LV   82 (201)
Q Consensus        81 ll   82 (201)
                      |+
T Consensus       220 Ll  221 (590)
T KOG1290|consen  220 LL  221 (590)
T ss_pred             ee
Confidence            98

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=9.5e-27  Score=165.05  Aligned_cols=157  Identities=38%  Similarity=0.665  Sum_probs=136.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .++.++|++|+++++.+......++++|++.+++|.+++...  .++...+..++.+++.++++||+.|++|+||+|.||
T Consensus        44 ~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni  123 (215)
T cd00180          44 ILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENI  123 (215)
T ss_pred             HHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhE
Confidence            467889999999999999999999999999989999999876  689999999999999999999999999999999999


Q ss_pred             EEcc-CCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           81 LVDA-SGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~~-~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +++. ++...+.+..            ....+...|.+||.... ....+.+.|+|++|++++++               
T Consensus       124 ~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~~D~~~lg~~~~~l---------------  187 (215)
T cd00180         124 LLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG-KGYYSEKSDIWSLGVILYEL---------------  187 (215)
T ss_pred             EEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcc-cCCCCchhhhHHHHHHHHHH---------------
Confidence            9998 6655554421            12335667999999732 23678899999999999998               


Q ss_pred             HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          148 LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                                       ..+.+++.+|++.+|.+||++.++++++
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                             7888999999999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=3.9e-27  Score=160.34  Aligned_cols=158  Identities=27%  Similarity=0.505  Sum_probs=130.4

Q ss_pred             cccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHH----hc-CCCHHHHHHHHHHHHHHHHHHhhc-CccccCC
Q 046714            2 FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ----KY-HLSDSQVSSYTRQILNGLTYLHER-NVVHREI   75 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~-~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl   75 (201)
                      .+++...+|.++.+||-..+.+..++.||.+.. +|..+-+    ++ .+++.-+-+++..++.|++|||++ .++|||+
T Consensus        97 i~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDv  175 (282)
T KOG0984|consen   97 IIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDV  175 (282)
T ss_pred             hhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccC
Confidence            456777899999999998899999999999966 8866543    33 389999999999999999999977 8999999


Q ss_pred             CCCcEEEccCCceeeecCccc-----------cccCcccccccccccC--CCCCcchhhHHHHHHHHHHHHhCCCCCCCc
Q 046714           76 KCANILVDASGLATTTNDVKS-----------FEGTPFWVAPEVVNLK--NNGYGLSADIWSLGCTVLEMLTHQPPYSHL  142 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~~~~~-----------~~~~~~~~aPE~~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  142 (201)
                      ||+||||+.+|.++..++.-+           ..|...|+|||.+...  ...++.++||||||+.+.||.+++.||+.+
T Consensus       176 KPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  176 KPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             CcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            999999999999988775321           2367789999998532  336889999999999999999999999886


Q ss_pred             -hHHHHHHHhhcCCCCCCC
Q 046714          143 -EDMQALFRIGRGKLPSVP  160 (201)
Q Consensus       143 -~~~~~~~~~~~~~~~~~~  160 (201)
                       .+.+.+.++.....|.++
T Consensus       256 ~tpF~qLkqvVeep~P~Lp  274 (282)
T KOG0984|consen  256 GTPFQQLKQVVEEPSPQLP  274 (282)
T ss_pred             CCHHHHHHHHhcCCCCCCc
Confidence             566677777766655544

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.5e-28  Score=170.26  Aligned_cols=193  Identities=27%  Similarity=0.518  Sum_probs=148.9

Q ss_pred             ccccCCCcceeccceeeeeCC-----eEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN-----RLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +|+.++|.|++..+++.+..+     ..|+++|.+.. +|...|-. ..++.+.++-.+.||+.|++|||+.||.|||||
T Consensus       105 mLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIK  183 (449)
T KOG0664|consen  105 MLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIK  183 (449)
T ss_pred             HHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCC
Confidence            578899999999999887654     36788888866 78776643 558999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCccccc-------------cCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           77 CANILVDASGLATTTNDVKSFE-------------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~~~~-------------~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      |.|.+++.+...++.++.....             -|..|+|||++ ++...++.+.||||+||++.|++.++..|.-..
T Consensus       184 PGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiL-MGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~  262 (449)
T KOG0664|consen  184 PGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELL-MGARRYTGAVDIWSVGCIFAELLQRKILFQAAG  262 (449)
T ss_pred             CccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHh-hcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence            9999999987777766543322             35569999998 567788999999999999999999888885444


Q ss_pred             HHHHHHHhh-----------------------cC--CCCCCC--------CCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          144 DMQALFRIG-----------------------RG--KLPSVP--------NSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       144 ~~~~~~~~~-----------------------~~--~~~~~~--------~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..+...-+.                       .+  +.+.++        ..-..+...++..++.++|.+|.+.++++.
T Consensus       263 PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~  342 (449)
T KOG0664|consen  263 PIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ  342 (449)
T ss_pred             hHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence            433332221                       11  111111        122234667788899999999999999999


Q ss_pred             CccccCc
Q 046714          191 HPFVKRP  197 (201)
Q Consensus       191 ~~~~~~~  197 (201)
                      |++..+.
T Consensus       343 ~~~~~e~  349 (449)
T KOG0664|consen  343 HRYLEEG  349 (449)
T ss_pred             ccccccc
Confidence            9998664

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-27  Score=183.02  Aligned_cols=135  Identities=26%  Similarity=0.476  Sum_probs=118.8

Q ss_pred             cCCCcceeccceeeeeCCeEEEEEEec-CCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEc
Q 046714            6 QFEHDNIVQYIGTEKDENRLYIFLELV-KKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD   83 (201)
Q Consensus         6 ~l~h~~I~~~~~~~~~~~~~~lv~e~~-~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~   83 (201)
                      +=.|+||++++++|++++.+|++||-. +|-+|.++|...+ +.+.++..+++|++.|+++||++||+|||||-+||.++
T Consensus       625 ~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd  704 (772)
T KOG1152|consen  625 KHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD  704 (772)
T ss_pred             hcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEe
Confidence            334999999999999999999999975 5678899998654 99999999999999999999999999999999999999


Q ss_pred             cCCceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Q 046714           84 ASGLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH  141 (201)
Q Consensus        84 ~~g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  141 (201)
                      .+|.+++.++.          ..++||..|.|||.+ .+....+..-|||++|++||.+...+.||..
T Consensus       705 ~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl-~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  705 SNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVL-GGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             cCCeEEEeeccchhhhcCCCcceeeeeccccchhhh-CCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99999887753          456789999999998 3444557789999999999999999998854

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=1.5e-26  Score=171.59  Aligned_cols=188  Identities=31%  Similarity=0.515  Sum_probs=141.3

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccC--
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--   85 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~--   85 (201)
                      .+.||+++.+.+..++...+|+||+++....++...  ++..++..+++.++.||+++|++||+||||||.|++.+..  
T Consensus        93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~  170 (418)
T KOG1167|consen   93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ  170 (418)
T ss_pred             cchhhhcchhhhccCCeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC
Confidence            477999999999999999999999999998888766  6788899999999999999999999999999999987532  


Q ss_pred             -------Ccee--------------------e-ec----------------------C-----ccccccCcccccccccc
Q 046714           86 -------GLAT--------------------T-TN----------------------D-----VKSFEGTPFWVAPEVVN  110 (201)
Q Consensus        86 -------g~~~--------------------~-~~----------------------~-----~~~~~~~~~~~aPE~~~  110 (201)
                             |++.                    . .+                      .     .....||++|+|||++ 
T Consensus       171 rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL-  249 (418)
T KOG1167|consen  171 RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVL-  249 (418)
T ss_pred             CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHH-
Confidence                   1110                    0 00                      0     0112389999999998 


Q ss_pred             cCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch-HHHHHHH--------------hhcCC--------------------
Q 046714          111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE-DMQALFR--------------IGRGK--------------------  155 (201)
Q Consensus       111 ~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-~~~~~~~--------------~~~~~--------------------  155 (201)
                      ..-...++++||||.|+++..++++..||.... +......              ...+.                    
T Consensus       250 ~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~  329 (418)
T KOG1167|consen  250 FRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFE  329 (418)
T ss_pred             hhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchh
Confidence            345566889999999999999999999983211 1000000              00000                    


Q ss_pred             -----------C-----CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          156 -----------L-----PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       156 -----------~-----~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                                 .     .......+..+.+++.+|++.+|.+|.|++++|.||||.+.-
T Consensus       330 s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  330 TLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence                       0     000122345788999999999999999999999999998653

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=9.7e-26  Score=168.46  Aligned_cols=183  Identities=25%  Similarity=0.445  Sum_probs=134.9

Q ss_pred             CCCcceeccceeeeeC----CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc--------CccccC
Q 046714            7 FEHDNIVQYIGTEKDE----NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER--------NVVHRE   74 (201)
Q Consensus         7 l~h~~I~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------~i~H~d   74 (201)
                      |+|+||+.+.+.-..+    ..+++|++|.+.|+|.|++.+..++.+...+++..++.||++||..        .|.|||
T Consensus       262 LRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRD  341 (513)
T KOG2052|consen  262 LRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRD  341 (513)
T ss_pred             hccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccc
Confidence            6899999998864433    3689999999999999999999999999999999999999999942        499999


Q ss_pred             CCCCcEEEccCCceeeec----------------CccccccCcccccccccccCC----CCCcchhhHHHHHHHHHHHHh
Q 046714           75 IKCANILVDASGLATTTN----------------DVKSFEGTPFWVAPEVVNLKN----NGYGLSADIWSLGCTVLEMLT  134 (201)
Q Consensus        75 l~p~nill~~~g~~~~~~----------------~~~~~~~~~~~~aPE~~~~~~----~~~~~~~Dv~slG~~l~~l~~  134 (201)
                      ||..||++.++|.+.+.+                .....+||..|+|||++...-    -..-..+||||||.++||+.-
T Consensus       342 lKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  342 LKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             cccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            999999999997654433                234567999999999984211    111247899999999999876


Q ss_pred             C----------CCCCCCc----hHHHHHHHh--hcCCCCCCCCCCC-----HHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          135 H----------QPPYSHL----EDMQALFRI--GRGKLPSVPNSLS-----RDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       135 g----------~~p~~~~----~~~~~~~~~--~~~~~~~~~~~~~-----~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                      +          ..||.+.    +..+....+  .....|..|....     ..+..+|+.||..+|..|.|+-.+.
T Consensus       422 Rc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  422 RCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             HhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence            2          3455332    222222221  2233333333321     3466789999999999999876553

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-25  Score=169.17  Aligned_cols=183  Identities=22%  Similarity=0.361  Sum_probs=136.4

Q ss_pred             cccCCCcceeccceeeeeCC----eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhh---------cCc
Q 046714            4 FSQFEHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHE---------RNV   70 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---------~~i   70 (201)
                      +--++|+||+++++.-....    .+++|++|.+.|+|.++++.+-+++....+++..++.||+|||.         ..|
T Consensus       258 lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~I  337 (534)
T KOG3653|consen  258 LPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPI  337 (534)
T ss_pred             ccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcc
Confidence            34578999999999765544    79999999999999999999999999999999999999999994         359


Q ss_pred             cccCCCCCcEEEccCCceeeecCc--------------cccccCcccccccccccCC----CCCcchhhHHHHHHHHHHH
Q 046714           71 VHREIKCANILVDASGLATTTNDV--------------KSFEGTPFWVAPEVVNLKN----NGYGLSADIWSLGCTVLEM  132 (201)
Q Consensus        71 ~H~dl~p~nill~~~g~~~~~~~~--------------~~~~~~~~~~aPE~~~~~~----~~~~~~~Dv~slG~~l~~l  132 (201)
                      +|||||..||||..++.+.+.++.              ...+||..|+|||.+.+.-    ...-.+.||||+|.++||+
T Consensus       338 aHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi  417 (534)
T KOG3653|consen  338 AHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEI  417 (534)
T ss_pred             ccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHH
Confidence            999999999999988655554432              2355899999999984321    1122578999999999999


Q ss_pred             HhCCCC------------CC----CchHH-HHHHH-hhcCCCCCCCCC-----CCHHHHHHHHHHhhcCCCCCCCHh
Q 046714          133 LTHQPP------------YS----HLEDM-QALFR-IGRGKLPSVPNS-----LSRDARDFILKCLQVNPNDRPTAA  186 (201)
Q Consensus       133 ~~g~~p------------~~----~~~~~-~~~~~-~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~R~t~~  186 (201)
                      +++-.-            |.    ..+.. +...- +.+..+|.++..     ....+++.+..||..|++.|.|+.
T Consensus       418 ~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  418 ASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             HhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence            985322            21    00011 11111 223334444433     235688999999999999999976

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.3e-25  Score=157.14  Aligned_cols=187  Identities=22%  Similarity=0.439  Sum_probs=156.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcC--ccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERN--VVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~--i~H~dl~p   77 (201)
                      .|+-+.||||+++++-|.....+.++..|++.++|..++++..   ....++++.+.+++.|++|||+..  |.--.|+.
T Consensus       240 ~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns  319 (448)
T KOG0195|consen  240 ALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNS  319 (448)
T ss_pred             ceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhccc
Confidence            4677899999999999999999999999999999999998754   677789999999999999999863  55567889


Q ss_pred             CcEEEccCCceee-------ecCccccccCcccccccccccCCCCCc-chhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           78 ANILVDASGLATT-------TNDVKSFEGTPFWVAPEVVNLKNNGYG-LSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        78 ~nill~~~g~~~~-------~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ..|+||.+--+++       ........-.+.|++||.++....+.. .++|+|||++++||+-|.+.||.+..+.+...
T Consensus       320 ~hvmidedltarismad~kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm  399 (448)
T KOG0195|consen  320 KHVMIDEDLTARISMADTKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM  399 (448)
T ss_pred             ceEEecchhhhheecccceeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh
Confidence            9999998743332       222233345678999999865544433 47899999999999999999999999999888


Q ss_pred             Hhh-cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          150 RIG-RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       150 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                      ++. .+..+.+|.+++..+..++.-|+..||.+||.+++++
T Consensus       400 kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  400 KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            764 6677788999999999999999999999999998864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=9.9e-27  Score=186.51  Aligned_cols=191  Identities=22%  Similarity=0.367  Sum_probs=151.2

Q ss_pred             ccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEc
Q 046714            5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD   83 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~   83 (201)
                      +.|.|||++.....+.+.....-.||||++ +|..++... .+...++--++.|++.||+|+|..|+.|+|+|++|+++.
T Consensus       376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~  454 (601)
T KOG0590|consen  376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT  454 (601)
T ss_pred             ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe
Confidence            568999999988888777666666999999 999998876 688999999999999999999999999999999999999


Q ss_pred             cCCceeeecCcc----------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           84 ASGLATTTNDVK----------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        84 ~~g~~~~~~~~~----------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      .+|..++.++..                ...|+..|+|||.+. ..+......||||.|+++..|.+|+.||......+.
T Consensus       455 ~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~-~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~  533 (601)
T KOG0590|consen  455 ENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLT-GKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN  533 (601)
T ss_pred             cCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccc-ccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence            998877766432                233677799999983 333334578999999999999999999855433222


Q ss_pred             H--HHhhc------CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 L--FRIGR------GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~--~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .  .....      .....+...++...+.+|.+||+.+|.+|.|+++|++++||+..
T Consensus       534 ~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  534 SFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             chhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            1  11000      01112234467788999999999999999999999999999864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=8.8e-26  Score=175.89  Aligned_cols=197  Identities=38%  Similarity=0.648  Sum_probs=165.5

Q ss_pred             cccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            2 FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+++..+||||+.+++.+......++.||||.||+|.+.-+ .+++++.++....+..+++++|||..|=+|||||-.||
T Consensus        64 ~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGani  143 (829)
T KOG0576|consen   64 GMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANI  143 (829)
T ss_pred             eeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccce
Confidence            35778899999999999999999999999999999988765 35599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecC------------ccccccCcccccccccc-cCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           81 LVDASGLATTTND------------VKSFEGTPFWVAPEVVN-LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~~~g~~~~~~~------------~~~~~~~~~~~aPE~~~-~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ++.+.|-+++.++            ..++.||+.|+|||+-. .....+...+|+|++|+...++-.-..|-.+..+.+.
T Consensus       144 lltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~  223 (829)
T KOG0576|consen  144 LLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA  223 (829)
T ss_pred             eecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH
Confidence            9999887776654            24577999999999853 2345678899999999999998887777767667676


Q ss_pred             HHHhhcCCCCC----CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          148 LFRIGRGKLPS----VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       148 ~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ..-..+.....    -+...++.+.+|++.++..+|++|||++.++.|||....+
T Consensus       224 l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l  278 (829)
T KOG0576|consen  224 LFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTL  278 (829)
T ss_pred             HHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccch
Confidence            66555433221    2345788999999999999999999999999999988764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=6.4e-26  Score=160.26  Aligned_cols=189  Identities=21%  Similarity=0.307  Sum_probs=142.7

Q ss_pred             CCcceecccee-eeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC
Q 046714            8 EHDNIVQYIGT-EKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG   86 (201)
Q Consensus         8 ~h~~I~~~~~~-~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g   86 (201)
                      -|.||+.-|++ |++.+.+++++||++.|+|..-+...++-+....+++.|+++|+.|||++++||||||.+||||-..+
T Consensus        79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d  158 (378)
T KOG1345|consen   79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD  158 (378)
T ss_pred             cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC
Confidence            58899998885 88888999999999999999998888999999999999999999999999999999999999996543


Q ss_pred             --ceeeecCccc-ccc--------CcccccccccccC---CCCCcchhhHHHHHHHHHHHHhCCCCCCCch----HHHHH
Q 046714           87 --LATTTNDVKS-FEG--------TPFWVAPEVVNLK---NNGYGLSADIWSLGCTVLEMLTHQPPYSHLE----DMQAL  148 (201)
Q Consensus        87 --~~~~~~~~~~-~~~--------~~~~~aPE~~~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~~~~~  148 (201)
                        -+++.+++.+ ..|        +..|.+||.....   .....+.+|+|.||+++|++++|+.||....    .--.+
T Consensus       159 f~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~  238 (378)
T KOG1345|consen  159 FYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW  238 (378)
T ss_pred             ccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHH
Confidence              3344444322 222        2347888875322   2345678999999999999999999996321    11222


Q ss_pred             HHhhcCCCCCCC---CCCCHHHHHHHHHHhhcCCCCC---CCHhHHhcCccccC
Q 046714          149 FRIGRGKLPSVP---NSLSRDARDFILKCLQVNPNDR---PTAAQLMEHPFVKR  196 (201)
Q Consensus       149 ~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R---~t~~~il~~~~~~~  196 (201)
                      .+...+..+..|   ...++.+.++.++-|..++++|   .+...-....|...
T Consensus       239 ~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  239 EQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             HHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            333444444444   4468889999999999999999   55555555555443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.92  E-value=4e-24  Score=153.44  Aligned_cols=151  Identities=37%  Similarity=0.589  Sum_probs=124.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+.+++|+|++++++.+......++++|++.+++|.+++....  ++...+..++.+++.++.+||+.+++|+|++|.||
T Consensus        50 ~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni  129 (225)
T smart00221       50 ILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENI  129 (225)
T ss_pred             HHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            4567899999999999999999999999999999999997654  78999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc-------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC-chHH-
Q 046714           81 LVDASGLATTTNDV-------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH-LEDM-  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~-------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~-  145 (201)
                      +++.++...+.+..             ....+...|++||... ....++.++|+|++|++++++++|+.||.. .... 
T Consensus       130 ~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~  208 (225)
T smart00221      130 LLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTS  208 (225)
T ss_pred             EEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHH
Confidence            99987766554421             2233556699999974 555677799999999999999999999977 4444 


Q ss_pred             HHHHHhhcC
Q 046714          146 QALFRIGRG  154 (201)
Q Consensus       146 ~~~~~~~~~  154 (201)
                      .....+..+
T Consensus       209 ~~~~~~~~~  217 (225)
T smart00221      209 LLSDVWSFG  217 (225)
T ss_pred             HHHHHHhcC
Confidence            444444444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=1.6e-25  Score=182.71  Aligned_cols=184  Identities=20%  Similarity=0.270  Sum_probs=137.6

Q ss_pred             ccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEc
Q 046714            5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD   83 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~   83 (201)
                      ...+|||++++.-+...++..|+|-+|..+ +|.|.+..++ +..-+.+.++.||+.||..+|+.||+|||||.+||||.
T Consensus        76 ~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT  154 (1431)
T KOG1240|consen   76 ALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT  154 (1431)
T ss_pred             HhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe
Confidence            346899999998888888889999999988 9999998777 67778888999999999999999999999999999997


Q ss_pred             cCCceeeec-------------------CccccccCcccccccccccCC--------CC-CcchhhHHHHHHHHHHHHh-
Q 046714           84 ASGLATTTN-------------------DVKSFEGTPFWVAPEVVNLKN--------NG-YGLSADIWSLGCTVLEMLT-  134 (201)
Q Consensus        84 ~~g~~~~~~-------------------~~~~~~~~~~~~aPE~~~~~~--------~~-~~~~~Dv~slG~~l~~l~~-  134 (201)
                      .=+.+.+.+                   ++.+...-..|.|||.+....        .. .+++.||||+||+++|+++ 
T Consensus       155 SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~E  234 (1431)
T KOG1240|consen  155 SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLE  234 (1431)
T ss_pred             eechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhc
Confidence            654433332                   222223344699999984321        11 5679999999999999999 


Q ss_pred             CCCCCCCchHHHHHHHhhcCCCC--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          135 HQPPYSHLEDMQALFRIGRGKLP--SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       135 g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      |+++|.-. +.-.++... ...+  .+....+..++.++..|++.||.+|.++++.|+.
T Consensus       235 g~PlF~LS-QL~aYr~~~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  235 GRPLFTLS-QLLAYRSGN-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CCCcccHH-HHHhHhccC-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            67777322 111111110 0000  1122345688999999999999999999999875

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=6.7e-23  Score=152.18  Aligned_cols=180  Identities=23%  Similarity=0.372  Sum_probs=138.3

Q ss_pred             cCCCcceeccceeeee---------------------------CCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHH
Q 046714            6 QFEHDNIVQYIGTEKD---------------------------ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQI   58 (201)
Q Consensus         6 ~l~h~~I~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i   58 (201)
                      --+||||+++++.|.+                           ....|+||..+++ +|..++-.+..+.....-++.|+
T Consensus       272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQL  350 (598)
T ss_pred             cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHH
Confidence            3579999999987654                           2367999999977 99999988888999999999999


Q ss_pred             HHHHHHHhhcCccccCCCCCcEEEcc--CCceee----------ecC----------ccccccCcccccccccccCCCC-
Q 046714           59 LNGLTYLHERNVVHREIKCANILVDA--SGLATT----------TND----------VKSFEGTPFWVAPEVVNLKNNG-  115 (201)
Q Consensus        59 ~~~l~~lh~~~i~H~dl~p~nill~~--~g~~~~----------~~~----------~~~~~~~~~~~aPE~~~~~~~~-  115 (201)
                      ++|+.|||++|+.|+|+|.+||++.-  ++...+          .+.          .....|+-..+|||+......+ 
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            99999999999999999999999843  322111          111          1122255568999997322111 


Q ss_pred             ---CcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHh
Q 046714          116 ---YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA-LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAA  186 (201)
Q Consensus       116 ---~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~  186 (201)
                         .-.++|.|+.|.+.||++....||...+..-. .....+...|.++..+++.+++++..+|+.+|++|++..
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence               12489999999999999999999977433221 122455667888999999999999999999999998853

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=1.4e-20  Score=145.78  Aligned_cols=187  Identities=26%  Similarity=0.471  Sum_probs=142.7

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCc-cccCCCCCcE
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNV-VHREIKCANI   80 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i-~H~dl~p~ni   80 (201)
                      |+++.|.|+.+++|.+.++.....|.+||..|+|.|.+....  +..--...++++|++|++|+|...| .|+.++..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            678999999999999999999999999999999999998755  4555566678999999999998865 9999999999


Q ss_pred             EEccCCceeeecCccccc--------------cCcccccccccccCC-CC----CcchhhHHHHHHHHHHHHhCCCCCCC
Q 046714           81 LVDASGLATTTNDVKSFE--------------GTPFWVAPEVVNLKN-NG----YGLSADIWSLGCTVLEMLTHQPPYSH  141 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~~--------------~~~~~~aPE~~~~~~-~~----~~~~~Dv~slG~~l~~l~~g~~p~~~  141 (201)
                      ++|..-..++.+..-...              ....|.|||.+.... ..    .+++.|+||+|++++++++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999876555544322111              123499999985421 11    46789999999999999999999965


Q ss_pred             c----hHHHHHHHhhc-CC---CCCCC--CCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          142 L----EDMQALFRIGR-GK---LPSVP--NSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       142 ~----~~~~~~~~~~~-~~---~~~~~--~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .    ...+....+.. +.   .|...  ...++.+..++.+||..+|.+||+++++..
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            2    22344444433 22   12222  134567889999999999999999998854

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=2.1e-19  Score=135.40  Aligned_cols=195  Identities=34%  Similarity=0.497  Sum_probs=151.7

Q ss_pred             ccccCCCc-ceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHD-NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY----HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~-~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      ++.++.|+ +|+++.+.+...+..+++++++.++++.+++...    .++......++.|++.+++++|+.|++|+|+||
T Consensus        50 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp  129 (384)
T COG0515          50 ILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKP  129 (384)
T ss_pred             HHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence            35678888 7999999998888889999999999999887765    589999999999999999999999999999999


Q ss_pred             CcEEEccCC-ceeeecCc------------------cccccCcccccccccccCC-CCCcchhhHHHHHHHHHHHHhCCC
Q 046714           78 ANILVDASG-LATTTNDV------------------KSFEGTPFWVAPEVVNLKN-NGYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        78 ~nill~~~g-~~~~~~~~------------------~~~~~~~~~~aPE~~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      +||+++..+ ...+.+..                  ....++..|++||.+.... ...+...|+|++|++++++++|..
T Consensus       130 ~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~  209 (384)
T COG0515         130 ENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP  209 (384)
T ss_pred             HHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCC
Confidence            999999876 34443322                  2344677899999983221 567889999999999999999999


Q ss_pred             CCCCchH----HHHHHHhhcCCCC----CCCCCC----CHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          138 PYSHLED----MQALFRIGRGKLP----SVPNSL----SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       138 p~~~~~~----~~~~~~~~~~~~~----~~~~~~----~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ||.....    ......+.....+    ......    ...+.+++.+++..+|..|.+..+...+++....
T Consensus       210 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         210 PFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             CCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            9876653    3333333333322    111111    1578899999999999999999988887665443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.6e-21  Score=151.65  Aligned_cols=184  Identities=26%  Similarity=0.384  Sum_probs=153.2

Q ss_pred             ccCC-CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            5 SQFE-HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         5 ~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ...+ ||.+++++..++.++..+++.++..|+.+...+.... +.......+...++-+++++|+.+++|+|+|++||++
T Consensus        51 ~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill  130 (612)
T KOG0603|consen   51 AFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL  130 (612)
T ss_pred             hhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee
Confidence            3344 9999999999999999999999999988877665544 7777888899999999999999999999999999999


Q ss_pred             ccCCceeeecCc--------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcC
Q 046714           83 DASGLATTTNDV--------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG  154 (201)
Q Consensus        83 ~~~g~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  154 (201)
                      +.+|..+..++.        ...+|+..|+|||+++    .....+|-||+|++++++++|..||..    +....+.. 
T Consensus       131 d~~Ghi~~tdfglske~v~~~~~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~-  201 (612)
T KOG0603|consen  131 LLEGHIKLTDFGLSKEAVKEKIACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK-  201 (612)
T ss_pred             cccCccccCCchhhhHhHhhhhcccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh-
Confidence            999966665542        2236799999999984    457789999999999999999999987    33333333 


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccCc
Q 046714          155 KLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKRP  197 (201)
Q Consensus       155 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~~  197 (201)
                      .....|...+..+++++..++..+|..|.-     ..++.+|+||+..
T Consensus       202 ~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i  249 (612)
T KOG0603|consen  202 AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI  249 (612)
T ss_pred             hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence            234677888999999999999999999964     5789999998764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.82  E-value=1.1e-20  Score=138.02  Aligned_cols=152  Identities=22%  Similarity=0.293  Sum_probs=99.9

Q ss_pred             EEEEEEecCCCCHHHHHHh---cC-----CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCccc
Q 046714           25 LYIFLELVKKGSLANLYQK---YH-----LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS   96 (201)
Q Consensus        25 ~~lv~e~~~~~~L~~~~~~---~~-----~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~   96 (201)
                      .+++|+-+.+ +|.+++.-   ..     ........+..|+++.+++||..|++|+||+|+|++++.+|...+.+....
T Consensus       114 ~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~  192 (288)
T PF14531_consen  114 RFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL  192 (288)
T ss_dssp             EEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred             hhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence            4778888866 88887642   21     223344566789999999999999999999999999999998877764321


Q ss_pred             ---------cccCcccccccccccC------CCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCCCCCCC
Q 046714           97 ---------FEGTPFWVAPEVVNLK------NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN  161 (201)
Q Consensus        97 ---------~~~~~~~~aPE~~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  161 (201)
                               ...+..|.+||.....      ....+.+.|.|++|+++|.++++..||...........    ...... 
T Consensus       193 ~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----~f~~C~-  267 (288)
T PF14531_consen  193 VRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----DFSRCR-  267 (288)
T ss_dssp             EETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----GGTTSS-
T ss_pred             eecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----cchhcC-
Confidence                     1234558888876321      12467899999999999999999999976543222111    122223 


Q ss_pred             CCCHHHHHHHHHHhhcCCCCC
Q 046714          162 SLSRDARDFILKCLQVNPNDR  182 (201)
Q Consensus       162 ~~~~~~~~li~~~l~~~p~~R  182 (201)
                      .+|+.++.||..+|+++|.+|
T Consensus       268 ~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  268 DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ---HHHHHHHHHHT-SSGGGS
T ss_pred             CcCHHHHHHHHHHccCCcccC
Confidence            789999999999999999987

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.76  E-value=3.2e-17  Score=124.04  Aligned_cols=178  Identities=25%  Similarity=0.299  Sum_probs=132.9

Q ss_pred             cceeccceee-eeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccC
Q 046714           10 DNIVQYIGTE-KDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS   85 (201)
Q Consensus        10 ~~I~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~   85 (201)
                      +++..+++.. ..+...++||+.+ |.+|.++....   .++..++..++.|++.+|+++|+.|++||||||+|+++...
T Consensus        80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~  158 (322)
T KOG1164|consen   80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQS  158 (322)
T ss_pred             CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCC
Confidence            5888888888 5778899999999 66999988543   39999999999999999999999999999999999999754


Q ss_pred             -------------Ccee--e-e-cC----------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCC
Q 046714           86 -------------GLAT--T-T-ND----------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPP  138 (201)
Q Consensus        86 -------------g~~~--~-~-~~----------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p  138 (201)
                                   |++.  . . ..          ...+.||..|.++..-  .+...+++.|+||++.++.++..|..|
T Consensus       159 ~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H--~~~e~~r~DDles~~Y~l~el~~g~LP  236 (322)
T KOG1164|consen  159 SRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVH--LGIEQGRRDDLESLFYMLLELLKGSLP  236 (322)
T ss_pred             CCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHh--CCCccCCchhhhhHHHHHHHHhcCCCC
Confidence                         2222  1 0 00          1124478889998875  566788999999999999999999999


Q ss_pred             CCCchHHHHHHH---hhcCCCCC-CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          139 YSHLEDMQALFR---IGRGKLPS-VPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       139 ~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      |...........   ........ .....+..+..+...+-..+...+|....+..
T Consensus       237 W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  237 WEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             CccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            966543222222   11111111 33445677888877777788899998876643

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.74  E-value=6.1e-18  Score=138.56  Aligned_cols=137  Identities=29%  Similarity=0.478  Sum_probs=112.2

Q ss_pred             HHHHHHHhhcCccccCCCCCcEEEccCCceeeecC---------------------------ccccccCccccccccccc
Q 046714           59 LNGLTYLHERNVVHREIKCANILVDASGLATTTND---------------------------VKSFEGTPFWVAPEVVNL  111 (201)
Q Consensus        59 ~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~---------------------------~~~~~~~~~~~aPE~~~~  111 (201)
                      +.+++|+|+.||+|+|+||+|.+|..-|..++.++                           ....++|+.|+|||++  
T Consensus       153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi--  230 (1205)
T KOG0606|consen  153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI--  230 (1205)
T ss_pred             hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh--
Confidence            78999999999999999999999987655444432                           1234589999999998  


Q ss_pred             CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCC--CCCCCCCCHHHHHHHHHHhhcCCCCC---CCHh
Q 046714          112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL--PSVPNSLSRDARDFILKCLQVNPNDR---PTAA  186 (201)
Q Consensus       112 ~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R---~t~~  186 (201)
                      ..++++..+|.|++|+++|+.+.|..||.+...++....+.....  ++-....++++++++.++|..+|..|   ...-
T Consensus       231 lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~  310 (1205)
T KOG0606|consen  231 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL  310 (1205)
T ss_pred             hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence            667889999999999999999999999999888777766654432  23345578999999999999999999   4566


Q ss_pred             HHhcCccccCc
Q 046714          187 QLMEHPFVKRP  197 (201)
Q Consensus       187 ~il~~~~~~~~  197 (201)
                      ++.+|+||+.-
T Consensus       311 evk~h~ff~~L  321 (1205)
T KOG0606|consen  311 EVKQHGFFQLL  321 (1205)
T ss_pred             hhhhccceeec
Confidence            88999999753

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.73  E-value=2.6e-18  Score=131.64  Aligned_cols=162  Identities=24%  Similarity=0.453  Sum_probs=119.8

Q ss_pred             eEEEEEEecCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeec-------
Q 046714           24 RLYIFLELVKKGSLANLYQKYH----LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-------   92 (201)
Q Consensus        24 ~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~-------   92 (201)
                      ..++.|++|...+|.+++..+.    .+......++.|+..|++|   +|.+|+|+||.||+...++..++.+       
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            5789999999999999997433    6777889999999999999   9999999999999987664332222       


Q ss_pred             -C----------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC-CCCCCCchHHHHHHHhhcCCCC-CC
Q 046714           93 -D----------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLP-SV  159 (201)
Q Consensus        93 -~----------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~-~~  159 (201)
                       .          .....+|..|++||.+  .+..++.++|||+||.++++++.- ...+   ........+..+..+ .+
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi--~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip~~~  481 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQI--RGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIPPEF  481 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHH--hhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCChHH
Confidence             1          1234478899999998  678899999999999999999972 1111   111222223344443 22


Q ss_pred             CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          160 PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       160 ~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .... +.-..|++.++..+|.+||++.+.-.|+|.
T Consensus       482 ~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  482 LQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            2233 445689999999999999988777777664

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=1.2e-17  Score=121.71  Aligned_cols=181  Identities=27%  Similarity=0.418  Sum_probs=134.5

Q ss_pred             cccCCCcceeccceeeeeCC-----eEEEEEEecCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHhhc--Ccc
Q 046714            4 FSQFEHDNIVQYIGTEKDEN-----RLYIFLELVKKGSLANLYQKYH-----LSDSQVSSYTRQILNGLTYLHER--NVV   71 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~i~~~l~~lh~~--~i~   71 (201)
                      |-++.|.||++++.++.+.+     ...+++||+..+++..++++..     +......+|..||+.||.|||+.  -|+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            34678999999999877654     5789999999999999997532     77788899999999999999987  599


Q ss_pred             ccCCCCCcEEEccCCceeeecCcc----------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC
Q 046714           72 HREIKCANILVDASGLATTTNDVK----------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH  135 (201)
Q Consensus        72 H~dl~p~nill~~~g~~~~~~~~~----------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g  135 (201)
                      |+++.-+.|++..+|+.+......                ...+-++|.+||.=  .....+-++|||++|++..++..+
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg--~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG--TTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC--cccccccchhhhhhhHHHHHHHHh
Confidence            999999999999999887654211                11134568888872  344556789999999999999987


Q ss_pred             CCCCCCch----HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcc
Q 046714          136 QPPYSHLE----DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF  193 (201)
Q Consensus       136 ~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~  193 (201)
                      +.--....    ..+.+.....+    +   ....-+.++.+|++.+|+.||++..++.||.
T Consensus       279 Eiq~tnseS~~~~ee~ia~~i~~----l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpl  333 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIANVIIG----L---ENGLQRGSITKCLEGEPNGRPDARLLLFHPL  333 (458)
T ss_pred             eeccCCCcceeehhhhhhhheee----c---cCccccCcCcccccCCCCCCcchhhhhcCce
Confidence            65422211    11111111111    1   1122346789999999999999999999995

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.69  E-value=1.2e-17  Score=118.79  Aligned_cols=121  Identities=15%  Similarity=0.205  Sum_probs=87.1

Q ss_pred             ccccCCCcceeccceeeeeC--------CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--------NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHRE   74 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d   74 (201)
                      .+.++.||+|..+.+++...        +..+++|||++|.+|.++..   +++    ....+++.++..+|+.|++|+|
T Consensus        88 ~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~D  160 (232)
T PRK10359         88 QTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGD  160 (232)
T ss_pred             HHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCC
Confidence            36778999999998886643        35889999999999988732   333    3456999999999999999999


Q ss_pred             CCCCcEEEccCCceeeecCccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHH
Q 046714           75 IKCANILVDASGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML  133 (201)
Q Consensus        75 l~p~nill~~~g~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~  133 (201)
                      ++|+||+++.+| ..+.+.... ..+..-.|-+.+ .....+..++|+|+||+.+..+.
T Consensus       161 ikp~Nili~~~g-i~liDfg~~-~~~~e~~a~d~~-vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        161 PHKGNFIVSKNG-LRIIDLSGK-RCTAQRKAKDRI-DLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CChHHEEEeCCC-EEEEECCCc-ccccchhhHHHH-HHHhHhcccccccceeEeehHHH
Confidence            999999999988 666664322 222111111222 12233457899999999987654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.65  E-value=1e-15  Score=107.00  Aligned_cols=129  Identities=15%  Similarity=0.103  Sum_probs=93.9

Q ss_pred             ccccCC-CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCC-CCCcE
Q 046714            3 SFSQFE-HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREI-KCANI   80 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl-~p~ni   80 (201)
                      +|++|. |++|++++++    +..+++|||+.|.+|......      ....++.|++.+++++|+.|++|+|| ||+||
T Consensus        54 iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NI  123 (218)
T PRK12274         54 ALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANW  123 (218)
T ss_pred             HHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceE
Confidence            577885 4778888886    346899999999988654322      12357889999999999999999999 79999


Q ss_pred             EEccCCceeeecCccccc-------------------------cCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC
Q 046714           81 LVDASGLATTTNDVKSFE-------------------------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH  135 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~~-------------------------~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g  135 (201)
                      +++.+|.+.+.++.....                         .++.+.+|+........--.+.+.++.|.-+|.++|+
T Consensus       124 Lv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~  203 (218)
T PRK12274        124 LVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTR  203 (218)
T ss_pred             EEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhc
Confidence            999888776665432221                         2344556655433333323677899999999999999


Q ss_pred             CCCCCC
Q 046714          136 QPPYSH  141 (201)
Q Consensus       136 ~~p~~~  141 (201)
                      ..+.-+
T Consensus       204 ~~~~~~  209 (218)
T PRK12274        204 RVLHWE  209 (218)
T ss_pred             cCCccc
Confidence            887633

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.64  E-value=1.1e-15  Score=107.16  Aligned_cols=171  Identities=19%  Similarity=0.316  Sum_probs=120.7

Q ss_pred             ceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccC---
Q 046714           11 NIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS---   85 (201)
Q Consensus        11 ~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~---   85 (201)
                      +|..+..+..++....+|||.+ |.+|.++..-  +.++..+++-++-|++.-++|+|.++++|+||||+|++..-+   
T Consensus        72 GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~  150 (341)
T KOG1163|consen   72 GIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHC  150 (341)
T ss_pred             CCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccccc
Confidence            5666777788888899999999 7799998863  459999999999999999999999999999999999998543   


Q ss_pred             --------CceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-
Q 046714           86 --------GLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-  145 (201)
Q Consensus        86 --------g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-  145 (201)
                              |+++..-+.           ....||-.|.+--..  .+...+.+-|+-|+|.++.++--|..||.+.... 
T Consensus       151 ~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh--~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t  228 (341)
T KOG1163|consen  151 NKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAH--LGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT  228 (341)
T ss_pred             ceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhh--hhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence                    433322111           112256667665443  3344577889999999999999999999876432 


Q ss_pred             --HHHHHhhcC----CCCCCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 046714          146 --QALFRIGRG----KLPSVPNSLSRDARDFILKCLQVNPNDRPT  184 (201)
Q Consensus       146 --~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~t  184 (201)
                        ...+++.+.    ....+..+.|.++.-.+.-|-..-=++.|+
T Consensus       229 k~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd  273 (341)
T KOG1163|consen  229 KKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD  273 (341)
T ss_pred             HHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence              223333322    222344567777766666664444444454

>PRK10345 hypothetical protein; Provisional

Probab=99.64  E-value=6.4e-16  Score=109.35  Aligned_cols=85  Identities=20%  Similarity=0.363  Sum_probs=67.5

Q ss_pred             CCcceeccceeeeeCC---e-EEEEEEe--cCCCCHHHHHHhcCCCHHHHHHHHHHHHHHH-HHHhhcCccccCCCCCcE
Q 046714            8 EHDNIVQYIGTEKDEN---R-LYIFLEL--VKKGSLANLYQKYHLSDSQVSSYTRQILNGL-TYLHERNVVHREIKCANI   80 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~---~-~~lv~e~--~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l-~~lh~~~i~H~dl~p~ni   80 (201)
                      +||||+++++++.++.   . +.+|+||  +.+++|.+++++..+++.  ..++.+++.++ +|||+.+|+|+||||+||
T Consensus        59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NI  136 (210)
T PRK10345         59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNI  136 (210)
T ss_pred             CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence            6899999999999873   3 3378999  557899999987666665  35678888777 999999999999999999


Q ss_pred             EEccCC----ceeeecCc
Q 046714           81 LVDASG----LATTTNDV   94 (201)
Q Consensus        81 ll~~~g----~~~~~~~~   94 (201)
                      +++..+    ...+.+++
T Consensus       137 Ll~~~~~~~~~~~LiDg~  154 (210)
T PRK10345        137 LCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEeccCCCCCcEEEEECC
Confidence            997532    45555544

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=2.3e-17  Score=132.91  Aligned_cols=187  Identities=30%  Similarity=0.418  Sum_probs=150.2

Q ss_pred             CcceeccceeeeeCCeEEEEEEecCCCCHHHHH-Hhc--CCCHHHHHHHHHHHHHHHHHHh-hcCccccCCCCCcEEEcc
Q 046714            9 HDNIVQYIGTEKDENRLYIFLELVKKGSLANLY-QKY--HLSDSQVSSYTRQILNGLTYLH-ERNVVHREIKCANILVDA   84 (201)
Q Consensus         9 h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~~--~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~dl~p~nill~~   84 (201)
                      |+|++.+++...+....+++.++..|+++.+.+ ...  +.+...+..++.|+..++.|+| ..++.|+|++|+|.+++.
T Consensus        80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~  159 (601)
T KOG0590|consen   80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE  159 (601)
T ss_pred             cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc
Confidence            999999999999999999999999999998887 432  5778889999999999999999 999999999999999998


Q ss_pred             CC-ceeeecC---------------cccccc-CcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           85 SG-LATTTND---------------VKSFEG-TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        85 ~g-~~~~~~~---------------~~~~~~-~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      .| ..+..+.               .....| ++.|.|||... ......+..|+||.|+++..+.+|..|+........
T Consensus       160 s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~-~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~  238 (601)
T KOG0590|consen  160 SGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLS-GKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG  238 (601)
T ss_pred             CCCcccCCCchhhccccccCCcceeeecccCCCCCCCCccccc-chhhcCCCcccccccccccccccCCCCccccccccc
Confidence            87 3222221               112336 88899999973 224557889999999999999999999866544332


Q ss_pred             HHHhhcCC----CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          148 LFRIGRGK----LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       148 ~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ........    ....+..++....+++.+++..+|..|.+++++..++|+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  239 RYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            22211111    23456678889999999999999999999999999999887

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.61  E-value=6.5e-15  Score=107.64  Aligned_cols=162  Identities=20%  Similarity=0.341  Sum_probs=120.2

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccC
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS   85 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~   85 (201)
                      ..++|...|.+.+.+.+..+|+|.+ |.+|.|+..-.  .|+..+++.++.|++.-++++|.+.+++|||||+|+||..-
T Consensus        82 g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp  160 (449)
T KOG1165|consen   82 GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRP  160 (449)
T ss_pred             CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCC
Confidence            4688999999999998999999999 77999988743  49999999999999999999999999999999999999653


Q ss_pred             -------------CceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Q 046714           86 -------------GLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH  141 (201)
Q Consensus        86 -------------g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  141 (201)
                                   |+++...+.           .+..||-.|++--.-  .+...+.+-|+-|||-++++.+-|..||.+
T Consensus       161 ~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTH--lGrEQSRRDDLEaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  161 GTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             CCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeecc--ccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence                         333332221           122367778875543  455678899999999999999999999976


Q ss_pred             c---hHHHHHHHhhcCCCC----CCCCCCCHHHHHHHH
Q 046714          142 L---EDMQALFRIGRGKLP----SVPNSLSRDARDFIL  172 (201)
Q Consensus       142 ~---~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~  172 (201)
                      .   ...+..+++...+..    ++..++|.++..-+.
T Consensus       239 LKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~  276 (449)
T KOG1165|consen  239 LKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLR  276 (449)
T ss_pred             ccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHH
Confidence            4   344455555433322    223345555444333

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.61  E-value=1.1e-15  Score=116.19  Aligned_cols=82  Identities=15%  Similarity=0.141  Sum_probs=63.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCC-CCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREI-KCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl-~p~nil   81 (201)
                      +|++++|+||++.+..   .+..+++|||+.|++|... ..  ..   ...++.|++++|++||+.||+|||| ||+||+
T Consensus        74 iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NIL  144 (365)
T PRK09188         74 ALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWL  144 (365)
T ss_pred             HHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEE
Confidence            5788999999863322   2457999999999999632 11  11   2467899999999999999999999 999999


Q ss_pred             EccCCceeeecC
Q 046714           82 VDASGLATTTND   93 (201)
Q Consensus        82 l~~~g~~~~~~~   93 (201)
                      ++.+|..++.++
T Consensus       145 v~~~~~ikLiDF  156 (365)
T PRK09188        145 MGPDGEAAVIDF  156 (365)
T ss_pred             EcCCCCEEEEEC
Confidence            988776666654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.54  E-value=1.2e-14  Score=101.77  Aligned_cols=89  Identities=15%  Similarity=0.158  Sum_probs=66.3

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHH-HHhcCCCHHHHHHHHHHHHHHHHHH-hhcCccccCCCCCcEE
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL-YQKYHLSDSQVSSYTRQILNGLTYL-HERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~-~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~H~dl~p~nil   81 (201)
                      |+++.++++.....+...  ..++||||+.|+++... +...+++...+..++.|++.+|.++ |+.|++|+||||+||+
T Consensus        73 l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIl  150 (190)
T cd05147          73 LKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLL  150 (190)
T ss_pred             HHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEE
Confidence            445556665333222222  23899999998777554 4556789999999999999999999 7999999999999999


Q ss_pred             EccCCceeeecCcc
Q 046714           82 VDASGLATTTNDVK   95 (201)
Q Consensus        82 l~~~g~~~~~~~~~   95 (201)
                      ++. |...+.++..
T Consensus       151 i~~-~~v~LiDFG~  163 (190)
T cd05147         151 YHD-GKLYIIDVSQ  163 (190)
T ss_pred             EEC-CcEEEEEccc
Confidence            984 5566666554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=1.1e-14  Score=120.82  Aligned_cols=124  Identities=20%  Similarity=0.237  Sum_probs=99.1

Q ss_pred             ceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccC----
Q 046714           11 NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS----   85 (201)
Q Consensus        11 ~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~----   85 (201)
                      .|+.+...+...+.-++|+||.+.|+|.+++... .+.+..+..++.|++..|+.||..+|+||||||+|++|...    
T Consensus       755 ~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~  834 (974)
T KOG1166|consen  755 SIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICAD  834 (974)
T ss_pred             chHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCC
Confidence            4555555555566678999999999999999854 38898999999999999999999999999999999999542    


Q ss_pred             -Cc--eeeec--------------CccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCC
Q 046714           86 -GL--ATTTN--------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        86 -g~--~~~~~--------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                       +.  ..+++              .+....+|-.+..+|+.  .+..|+.+.|.|+++.+++.|+.|+
T Consensus       835 ~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~--~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  835 SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMR--EGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHh--cCCCCchhhhhHHHHHHHHHHHHHH
Confidence             11  11222              12334466778899997  6889999999999999999999985

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.50  E-value=7.1e-14  Score=98.08  Aligned_cols=89  Identities=11%  Similarity=0.155  Sum_probs=67.2

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHH-HHHhcCCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCcEE
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~nil   81 (201)
                      +.++.|++|.....+....  .++||||+.|+++.. .+....++......++.|++.++.++|. .|++|+||||+||+
T Consensus        73 l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl  150 (190)
T cd05145          73 LKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL  150 (190)
T ss_pred             HHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence            4456666664433333222  489999999875533 4555668888999999999999999999 99999999999999


Q ss_pred             EccCCceeeecCcc
Q 046714           82 VDASGLATTTNDVK   95 (201)
Q Consensus        82 l~~~g~~~~~~~~~   95 (201)
                      ++ +|...+.+...
T Consensus       151 l~-~~~~~liDFG~  163 (190)
T cd05145         151 YH-DGKPYIIDVSQ  163 (190)
T ss_pred             EE-CCCEEEEEccc
Confidence            98 66666665543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.46  E-value=1.3e-12  Score=103.59  Aligned_cols=126  Identities=25%  Similarity=0.412  Sum_probs=96.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHh-hcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH-ERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~dl~p~nil   81 (201)
                      .|+-++||||+++++.+..++..|+|+|.+  ..|..++++.+  .......+.||+.||.||| +.+++|++|.-+.|+
T Consensus        62 ~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~--~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVf  137 (690)
T KOG1243|consen   62 RLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG--KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVF  137 (690)
T ss_pred             HhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH--HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEE
Confidence            477899999999999999999999999998  36777777643  6667777999999999997 668999999999999


Q ss_pred             EccCCceeeecCccc------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCC
Q 046714           82 VDASGLATTTNDVKS------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        82 l~~~g~~~~~~~~~~------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                      ++..|--++.+....            ......|..|+.+.  ...  -..|.|.|||++++++.|.
T Consensus       138 Vn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~--~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  138 VNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID--PSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             EcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC--ccc--cchhhhhHHHHHHHHhCcc
Confidence            999876555432110            01122356666541  111  3469999999999999983

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.41  E-value=9.4e-13  Score=93.89  Aligned_cols=88  Identities=15%  Similarity=0.171  Sum_probs=72.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++..+.|++|.....++.+.+..+++|||++|++|.+++....  . ....++.+++.++.++|+.|++|+|++|.||++
T Consensus        52 ~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~--~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~  128 (211)
T PRK14879         52 IMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG--M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL  128 (211)
T ss_pred             HHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc--H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE
Confidence            3456778888777777777778899999999999999887532  2 788999999999999999999999999999999


Q ss_pred             ccCCceeeecCc
Q 046714           83 DASGLATTTNDV   94 (201)
Q Consensus        83 ~~~g~~~~~~~~   94 (201)
                      + ++...+.+..
T Consensus       129 ~-~~~~~liDf~  139 (211)
T PRK14879        129 S-GGKIYLIDFG  139 (211)
T ss_pred             E-CCCEEEEECC
Confidence            8 5555555543

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.38  E-value=1.8e-12  Score=93.97  Aligned_cols=89  Identities=21%  Similarity=0.262  Sum_probs=67.3

Q ss_pred             cccCCCcce--eccceeeeeC-C---eEEEEEEecCC-CCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            4 FSQFEHDNI--VQYIGTEKDE-N---RLYIFLELVKK-GSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         4 l~~l~h~~I--~~~~~~~~~~-~---~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +.+|+|++|  ++.+++...+ +   ..++|+|+++| .+|.+++....++..    .+.+++.++.+||+.||+|+|||
T Consensus        94 l~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlk  169 (239)
T PRK01723         94 LAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLN  169 (239)
T ss_pred             HHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCC
Confidence            456777774  5666654332 2   23599999997 799998877666654    35789999999999999999999


Q ss_pred             CCcEEEccCCceeeecCccc
Q 046714           77 CANILVDASGLATTTNDVKS   96 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~~   96 (201)
                      |+||+++.++.+.+.+....
T Consensus       170 p~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        170 AHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             chhEEEcCCCCEEEEECCCc
Confidence            99999998886666665543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.35  E-value=3e-12  Score=103.29  Aligned_cols=84  Identities=14%  Similarity=0.184  Sum_probs=70.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++|++|+....++.+....+++|||++|++|.+++.       ....++.+++.++.+||+.|++|+|+||+||++
T Consensus       389 ~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl  461 (535)
T PRK09605        389 LLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV  461 (535)
T ss_pred             HHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE
Confidence            4677899999887777777777899999999999998875       356789999999999999999999999999999


Q ss_pred             ccCCceeeecCc
Q 046714           83 DASGLATTTNDV   94 (201)
Q Consensus        83 ~~~g~~~~~~~~   94 (201)
                       .++...+.+..
T Consensus       462 -~~~~~~liDFG  472 (535)
T PRK09605        462 -RDDRLYLIDFG  472 (535)
T ss_pred             -ECCcEEEEeCc
Confidence             45555555544

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.35  E-value=2.7e-12  Score=90.72  Aligned_cols=84  Identities=17%  Similarity=0.199  Sum_probs=66.2

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEc
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD   83 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~   83 (201)
                      ++.+.|+++.....++...+..+++|||++|++|.+++.....      .++.+++.++.++|+.|++|+|++|+||+++
T Consensus        51 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~  124 (199)
T TIGR03724        51 LSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR  124 (199)
T ss_pred             HHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE
Confidence            4556777665555555566667899999999999988765321      7899999999999999999999999999998


Q ss_pred             cCCceeeecCc
Q 046714           84 ASGLATTTNDV   94 (201)
Q Consensus        84 ~~g~~~~~~~~   94 (201)
                       ++...+.+..
T Consensus       125 -~~~~~liDfg  134 (199)
T TIGR03724       125 -DDKLYLIDFG  134 (199)
T ss_pred             -CCcEEEEECC
Confidence             6666665544

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.31  E-value=4.7e-12  Score=104.77  Aligned_cols=186  Identities=26%  Similarity=0.376  Sum_probs=144.1

Q ss_pred             cceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCce
Q 046714           10 DNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLA   88 (201)
Q Consensus        10 ~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~   88 (201)
                      |-++.....+......+++++|+.+++|...++.-+ .+.+.+......++.+.++||...+.|+|++|.|.++..+|..
T Consensus       864 P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~  943 (1205)
T KOG0606|consen  864 PAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHR  943 (1205)
T ss_pred             CceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCc
Confidence            344443333444566889999999999988887755 6666677788889999999999999999999999998655321


Q ss_pred             eeec--------------C-----------------------------ccccccCcccccccccccCCCCCcchhhHHHH
Q 046714           89 TTTN--------------D-----------------------------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSL  125 (201)
Q Consensus        89 ~~~~--------------~-----------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~sl  125 (201)
                      ....              +                             -....+++.|.+||..  .+....+.+|.|++
T Consensus       944 ~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~--lg~~hgs~ad~~~~ 1021 (1205)
T KOG0606|consen  944 PLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEIL--LGRRHGSAADWWSS 1021 (1205)
T ss_pred             ccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccc--ccccCCCcchhhhh
Confidence            1100              0                             0122367889999997  55566788999999


Q ss_pred             HHHHHHHHhCCCCCCCchHHHHHHHhhcCCCC--CCCCCCCHHHHHHHHHHhhcCCCCCCCHh---HHhcCccccCc
Q 046714          126 GCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP--SVPNSLSRDARDFILKCLQVNPNDRPTAA---QLMEHPFVKRP  197 (201)
Q Consensus       126 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~t~~---~il~~~~~~~~  197 (201)
                      |.++++.++|..||......+..+.+..+..+  .-+...+...++++.+.+..++.+|..+.   ++-.|+||+..
T Consensus      1022 g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             hhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence            99999999999999988888887777665543  34456788999999999999999998887   88889999864

>smart00090 RIO RIO-like kinase

Probab=99.27  E-value=6.5e-12  Score=90.96  Aligned_cols=70  Identities=19%  Similarity=0.249  Sum_probs=57.0

Q ss_pred             eEEEEEEecCCCCHHHHH-HhcCCCHHHHHHHHHHHHHHHHHHhhcC-ccccCCCCCcEEEccCCceeeecCc
Q 046714           24 RLYIFLELVKKGSLANLY-QKYHLSDSQVSSYTRQILNGLTYLHERN-VVHREIKCANILVDASGLATTTNDV   94 (201)
Q Consensus        24 ~~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~-i~H~dl~p~nill~~~g~~~~~~~~   94 (201)
                      ..++||||+.|.+|.... ........++..++.|++.++++||+.| ++|+|+||+||+++ ++...+.+..
T Consensus       122 ~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg  193 (237)
T smart00090      122 RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVS  193 (237)
T ss_pred             CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEECh
Confidence            358999999998886654 3444666677899999999999999999 99999999999998 5555555543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.23  E-value=1.6e-11  Score=96.18  Aligned_cols=185  Identities=25%  Similarity=0.251  Sum_probs=137.2

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHH----HHHHHhhcCccccCCCCCcEE
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILN----GLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~----~l~~lh~~~i~H~dl~p~nil   81 (201)
                      .|+|.++.+..+...+..++-+|.+. .+|..+....  .++....+....+...    |+.++|..+++|-|++|.||+
T Consensus       176 ~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~  254 (524)
T KOG0601|consen  176 SHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIF  254 (524)
T ss_pred             ccccccccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhhee
Confidence            48888888888999999999999996 5887776543  2888899999999999    999999999999999999999


Q ss_pred             EccC-CceeeecCc--------c---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           82 VDAS-GLATTTNDV--------K---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        82 l~~~-g~~~~~~~~--------~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      ...+ ......++.        .         ...+...|++||..   ..-.+...|+|++|.++.+-.++-.......
T Consensus       255 ~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~---~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~  331 (524)
T KOG0601|consen  255 TTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL---NGLATFASDIFSLGEVILEAILGSHLPSVGK  331 (524)
T ss_pred             cccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh---ccccchHhhhcchhhhhHhhHhhcccccCCC
Confidence            9887 333322211        0         01245569999996   3446789999999999999888765442210


Q ss_pred             HHHHHHHhhcCC-CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          144 DMQALFRIGRGK-LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       144 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                       ...+.++..+. ..++....+.++...+..|+..+|..|++.+.+.++++...+
T Consensus       332 -~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  332 -NSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             -CCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence             01122222222 223444566777789999999999999999999999887643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.15  E-value=1.8e-11  Score=97.58  Aligned_cols=148  Identities=21%  Similarity=0.271  Sum_probs=105.6

Q ss_pred             HHHHHHHHHHHHHHHHHhhc-CccccCCCCCcEEEccCCceeeecCcc-------------c--------cccCcccccc
Q 046714           49 SQVSSYTRQILNGLTYLHER-NVVHREIKCANILVDASGLATTTNDVK-------------S--------FEGTPFWVAP  106 (201)
Q Consensus        49 ~~~~~~~~~i~~~l~~lh~~-~i~H~dl~p~nill~~~g~~~~~~~~~-------------~--------~~~~~~~~aP  106 (201)
                      +....-+.+.+.|+.|+|+. +++|++|.|++|.++.+|.-++.++..             .        ......|.||
T Consensus        99 e~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap  178 (700)
T KOG2137|consen   99 EDGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP  178 (700)
T ss_pred             cHhhhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence            34444466677999999976 899999999999999887544433210             0        0023349999


Q ss_pred             cccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHH---hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCC
Q 046714          107 EVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFR---IGRGKLPSVPNSLSRDARDFILKCLQVNPNDR  182 (201)
Q Consensus       107 E~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  182 (201)
                      |.+  .....++++|+||+|+++|.++. |+..+...........   ............+++++++=+.+++..++..|
T Consensus       179 E~~--~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~r  256 (700)
T KOG2137|consen  179 EYL--LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVR  256 (700)
T ss_pred             hhh--ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccC
Confidence            998  44667899999999999999884 5554433322111111   11112223457789999999999999999999


Q ss_pred             CCHhHHhcCccccCcC
Q 046714          183 PTAAQLMEHPFVKRPL  198 (201)
Q Consensus       183 ~t~~~il~~~~~~~~~  198 (201)
                      |++..+...|||.++.
T Consensus       257 p~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  257 PTLDLLLSIPFFSDPG  272 (700)
T ss_pred             cchhhhhcccccCCch
Confidence            9999999999998763

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.11  E-value=1e-10  Score=82.65  Aligned_cols=68  Identities=18%  Similarity=0.197  Sum_probs=56.1

Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCcc
Q 046714           23 NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVK   95 (201)
Q Consensus        23 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~   95 (201)
                      +..+++|||+.|++|.++...     .....++.+++.++.++|+.|++|+||+|+||+++.++...+.+...
T Consensus       104 ~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~  171 (198)
T cd05144         104 NRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQ  171 (198)
T ss_pred             CCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCc
Confidence            345899999999998766431     34567889999999999999999999999999999888777766543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.11  E-value=1.1e-09  Score=83.53  Aligned_cols=163  Identities=19%  Similarity=0.268  Sum_probs=113.6

Q ss_pred             EEEEEEecCCC-CHHHHHH------hcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCc--
Q 046714           25 LYIFLELVKKG-SLANLYQ------KYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDV--   94 (201)
Q Consensus        25 ~~lv~e~~~~~-~L~~~~~------~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~--   94 (201)
                      ..++|..++|. .+.++..      ..+ ..++-.++.++.++.+.+-||..|.+-||++++|+|+++++.+.+.+.-  
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            67888888764 2333331      111 6788899999999999999999999999999999999999988776532  


Q ss_pred             ---------cccccCccccccccccc---CCCCCcchhhHHHHHHHHHHHHhC-CCCCCCchHHH----HHH-HhhcC--
Q 046714           95 ---------KSFEGTPFWVAPEVVNL---KNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQ----ALF-RIGRG--  154 (201)
Q Consensus        95 ---------~~~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~~~----~~~-~~~~~--  154 (201)
                               ...++...|++||.-..   .+..-+...|.|.||+++++++.| ++||.+.....    ..+ .+..+  
T Consensus       165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence                     22346778999998531   233456789999999999998885 99996543211    000 11111  


Q ss_pred             ---------CCC---C-CCCCCCHHHHHHHHHHhhcC--CCCCCCHhH
Q 046714          155 ---------KLP---S-VPNSLSRDARDFILKCLQVN--PNDRPTAAQ  187 (201)
Q Consensus       155 ---------~~~---~-~~~~~~~~~~~li~~~l~~~--p~~R~t~~~  187 (201)
                               ..+   + ...-+++++..++.+|++..  +.-|||++.
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence                     110   0 11236789999999999754  567999763

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.10  E-value=1.2e-10  Score=78.24  Aligned_cols=85  Identities=16%  Similarity=0.292  Sum_probs=67.9

Q ss_pred             cccCCC--cceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc---CccccCCCCC
Q 046714            4 FSQFEH--DNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER---NVVHREIKCA   78 (201)
Q Consensus         4 l~~l~h--~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~H~dl~p~   78 (201)
                      +..+.|  .+++++++....++..++++||+.+..+..+      +......++.+++.+++.+|..   +++|+|++|+
T Consensus        45 ~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~  118 (155)
T cd05120          45 LQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPG  118 (155)
T ss_pred             HHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcc
Confidence            344554  5788888888887889999999998777544      5566778899999999999984   7999999999


Q ss_pred             cEEEccCCceeeecCc
Q 046714           79 NILVDASGLATTTNDV   94 (201)
Q Consensus        79 nill~~~g~~~~~~~~   94 (201)
                      ||+++..+...+.+..
T Consensus       119 Nil~~~~~~~~l~Df~  134 (155)
T cd05120         119 NILVDDGKILGIIDWE  134 (155)
T ss_pred             eEEEECCcEEEEEecc
Confidence            9999986666655543

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.04  E-value=4.4e-09  Score=81.90  Aligned_cols=172  Identities=16%  Similarity=0.187  Sum_probs=116.6

Q ss_pred             ccccCCCcceeccceeeee----CCeEEEEEEecCC-CCHHHHHH----------------hcCCCHHHHHHHHHHHHHH
Q 046714            3 SFSQFEHDNIVQYIGTEKD----ENRLYIFLELVKK-GSLANLYQ----------------KYHLSDSQVSSYTRQILNG   61 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~----~~~~~lv~e~~~~-~~L~~~~~----------------~~~~~~~~~~~~~~~i~~~   61 (201)
                      +++++.|+|+|++.+++..    +...++|++|.++ ++|.++--                ....++..+|.++.|+..|
T Consensus       326 ~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaa  405 (655)
T KOG3741|consen  326 AWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAA  405 (655)
T ss_pred             HHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHH
Confidence            4789999999999999884    3468999999875 57766541                1126788999999999999


Q ss_pred             HHHHhhcCccccCCCCCcEEEccCCceeeecCccccccCcccccc-cccccCCCCCcchhhHHHHHHHHHHHHhCCCC-C
Q 046714           62 LTYLHERNVVHREIKCANILVDASGLATTTNDVKSFEGTPFWVAP-EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPP-Y  139 (201)
Q Consensus        62 l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~~~~~~~~~aP-E~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p-~  139 (201)
                      |.++|+.|+.-+-|.|.+|+++.+-...+....-...  . .-.| +.+     .--.+-|.-.||.+++.|.+|..- +
T Consensus       406 L~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dv--l-~~d~~~~l-----e~~Qq~D~~~lG~ll~aLAt~~~ns~  477 (655)
T KOG3741|consen  406 LYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDV--L-QEDPTEPL-----ESQQQNDLRDLGLLLLALATGTENSN  477 (655)
T ss_pred             HHHHHhcCceeecccHhHeEeeCcceEEEecccceee--e-cCCCCcch-----hHHhhhhHHHHHHHHHHHhhcccccc
Confidence            9999999999999999999998764222222111000  0 0011 111     112467999999999999998542 1


Q ss_pred             C-CchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          140 S-HLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       140 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      . +........        .+...++.++++++.-.....+.+ -++++++.+
T Consensus       478 ~~d~~~~s~~~--------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  478 RTDSTQSSHLT--------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             cccchHHHHHH--------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            1 111111121        223457788888888888877776 677777653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.90  E-value=4.3e-09  Score=73.57  Aligned_cols=70  Identities=21%  Similarity=0.274  Sum_probs=52.0

Q ss_pred             eEEEEEEecCCCCHHH-HHHhcCCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCcEEEccCCceeeecCcc
Q 046714           24 RLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCANILVDASGLATTTNDVK   95 (201)
Q Consensus        24 ~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~nill~~~g~~~~~~~~~   95 (201)
                      ..+++|||+.++.+.. .+...... ..+..++.+++.++.++|. .|++|+||+|+||+++ ++...+.+...
T Consensus        89 ~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~  160 (187)
T cd05119          89 RHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQ  160 (187)
T ss_pred             CCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcc
Confidence            3589999999843321 11211111 6678899999999999999 9999999999999999 66666655443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.85  E-value=1.6e-09  Score=85.10  Aligned_cols=186  Identities=24%  Similarity=0.249  Sum_probs=127.8

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG   86 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g   86 (201)
                      .|.+++.....+......++=-||+.++++...+. ...+.+...+++..|++.++.++|+..++|.|++|+||++..+|
T Consensus       324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~  403 (524)
T KOG0601|consen  324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG  403 (524)
T ss_pred             cccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch
Confidence            36666665555554444568888998888766542 22378888999999999999999999999999999999999864


Q ss_pred             c-eeeecCcc---------ccccCcccc-cccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCC
Q 046714           87 L-ATTTNDVK---------SFEGTPFWV-APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK  155 (201)
Q Consensus        87 ~-~~~~~~~~---------~~~~~~~~~-aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  155 (201)
                      . ..+.+...         .....-.+. ..|+. ...+.+..+.|+++||.-+.+.+++...-...   ..+..+..+.
T Consensus       404 ~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~-~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---~~~~~i~~~~  479 (524)
T KOG0601|consen  404 FFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEIL-LEDYPHLSKADIFSLGLSVDEAITGSPLSESG---VQSLTIRSGD  479 (524)
T ss_pred             hhhhccccccccccceecccccccccccccchhh-ccccccccccccccccccccccccCcccCccc---ccceeeeccc
Confidence            2 22222111         111222333 24554 24566778999999999999999987543322   2233344444


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       156 ~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .+..+..- .++..+.+.++..++..|+.+.++..++=|....
T Consensus       480 ~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~  521 (524)
T KOG0601|consen  480 TPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS  521 (524)
T ss_pred             ccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence            44444433 7778888999999999999999998887555433

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.78  E-value=2.6e-08  Score=68.06  Aligned_cols=65  Identities=17%  Similarity=0.291  Sum_probs=53.0

Q ss_pred             eeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCcee
Q 046714           19 EKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLAT   89 (201)
Q Consensus        19 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~   89 (201)
                      ..+.....++|||+.|..|.+++...      ...++..+-.-+.-||+.||+||||.++|+++..++...
T Consensus        68 dvD~~~~~I~me~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~~  132 (204)
T COG3642          68 DVDPDNGLIVMEYIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYF  132 (204)
T ss_pred             EEcCCCCEEEEEEeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEEE
Confidence            34555668999999999999998775      245667777778899999999999999999998877443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.77  E-value=8.3e-08  Score=70.68  Aligned_cols=61  Identities=13%  Similarity=0.174  Sum_probs=52.8

Q ss_pred             eEEEEEEecCCC-CHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEcc
Q 046714           24 RLYIFLELVKKG-SLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA   84 (201)
Q Consensus        24 ~~~lv~e~~~~~-~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~   84 (201)
                      ..++|+|++.+. +|.+++..   ...+......++.+++..+.-||..|++|+|+++.||+++.
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~  173 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHL  173 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEec
Confidence            468999999885 79888753   33566677899999999999999999999999999999985

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.76  E-value=3.8e-08  Score=68.86  Aligned_cols=71  Identities=17%  Similarity=0.248  Sum_probs=52.2

Q ss_pred             CeEEEEEEecCCCCHH-HHHHhcCCCHHHHHHHHHHHHHHHHHH-hhcCccccCCCCCcEEEccCCceeeecCc
Q 046714           23 NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYL-HERNVVHREIKCANILVDASGLATTTNDV   94 (201)
Q Consensus        23 ~~~~lv~e~~~~~~L~-~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~H~dl~p~nill~~~g~~~~~~~~   94 (201)
                      +..++||||+.+..+. ..++...++......+..+++.++..| |+.|++||||++.||+++. |...+.+..
T Consensus        97 ~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~-~~v~iIDF~  169 (197)
T cd05146          97 KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD-GKVWFIDVS  169 (197)
T ss_pred             cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC-CcEEEEECC
Confidence            3458999999764332 233433456666778889999999998 8999999999999999975 444455444

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.69  E-value=1.4e-07  Score=66.99  Aligned_cols=63  Identities=29%  Similarity=0.463  Sum_probs=54.8

Q ss_pred             eEEEEEEecCC-CCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC
Q 046714           24 RLYIFLELVKK-GSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG   86 (201)
Q Consensus        24 ~~~lv~e~~~~-~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g   86 (201)
                      ..++|+|++++ .+|.+++... ..+......++.++...+.-||..|++|+|+++.|||++.++
T Consensus        91 ~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~  155 (206)
T PF06293_consen   91 RSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDD  155 (206)
T ss_pred             eEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCC
Confidence            45899999987 4789988762 256777889999999999999999999999999999999887

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.66  E-value=2.9e-08  Score=68.18  Aligned_cols=63  Identities=17%  Similarity=0.157  Sum_probs=46.7

Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCc-----cccCCCCCcEEEccCCceeeecCc
Q 046714           24 RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNV-----VHREIKCANILVDASGLATTTNDV   94 (201)
Q Consensus        24 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i-----~H~dl~p~nill~~~g~~~~~~~~   94 (201)
                      ..++|||+++|.++.+.    .   ......+.+++.++..||+.++     +|+|++|.||+++ ++...+.+..
T Consensus        65 ~~~lv~e~i~G~~l~~~----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~  132 (170)
T cd05151          65 TGVLITEFIEGSELLTE----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWE  132 (170)
T ss_pred             CCeEEEEecCCCccccc----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecc
Confidence            35799999999887543    1   1123456789999999999885     9999999999998 4444444443

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.62  E-value=1.2e-07  Score=74.82  Aligned_cols=68  Identities=13%  Similarity=0.120  Sum_probs=52.2

Q ss_pred             eEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHH-HHHHHhhcCccccCCCCCcEEEccCCceeeecCc
Q 046714           24 RLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILN-GLTYLHERNVVHREIKCANILVDASGLATTTNDV   94 (201)
Q Consensus        24 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~-~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~   94 (201)
                      ..+++|||++|.+|.++....  +.   ....++.+++. .+..+|..|++|+|++|.||+++.+|...+.+..
T Consensus       232 ~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG  302 (437)
T TIGR01982       232 ERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFG  302 (437)
T ss_pred             CceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCC
Confidence            468999999999998876432  22   23455666665 4688999999999999999999988877666654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.58  E-value=3.4e-07  Score=62.67  Aligned_cols=72  Identities=18%  Similarity=0.323  Sum_probs=56.6

Q ss_pred             eeeeCCeEEEEEEecCC-CCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCcee
Q 046714           18 TEKDENRLYIFLELVKK-GSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLAT   89 (201)
Q Consensus        18 ~~~~~~~~~lv~e~~~~-~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~   89 (201)
                      ++.+...-.++|||++| .++.+++...-   ...+.....+.+|-+.+.-||..+++||||..+||++..+|.-.
T Consensus        78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~  153 (229)
T KOG3087|consen   78 IFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQI  153 (229)
T ss_pred             EEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcC
Confidence            45566666899999977 57788876532   33334478899999999999999999999999999998877543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.46  E-value=6.2e-07  Score=63.49  Aligned_cols=61  Identities=16%  Similarity=0.381  Sum_probs=47.8

Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeee
Q 046714           24 RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTT   91 (201)
Q Consensus        24 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~   91 (201)
                      ..+++|||++|..|.++..   +++    .+...+.+++.-+|+.|++|||.+|.|+++++++...+.
T Consensus       117 ~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~i~iID  177 (229)
T PF06176_consen  117 SYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNGIRIID  177 (229)
T ss_pred             EEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCcEEEEE
Confidence            4568999999988866532   232    344667788999999999999999999999988855443

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.35  E-value=1.7e-06  Score=73.77  Aligned_cols=187  Identities=21%  Similarity=0.289  Sum_probs=118.3

Q ss_pred             ccccCCCcceeccceeeeeCCeE----EEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRL----YIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~----~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      .+.++.|+|+..++.+...+...    .+..+++...++...++. ...+....+.+..++.+|+.++|+....|.-+..
T Consensus       235 ~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~  314 (1351)
T KOG1035|consen  235 SLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSA  314 (1351)
T ss_pred             HHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEec
Confidence            46788999999999887654332    245678888888887765 4488889999999999999999988544433332


Q ss_pred             C---cEEEccCCceeee--cC-cc----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Q 046714           78 A---NILVDASGLATTT--ND-VK----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH  141 (201)
Q Consensus        78 ~---nill~~~g~~~~~--~~-~~----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  141 (201)
                      .   +.-.+..+.....  +. ..          .......+.++|.......+.+...|+|++|.....+..+..+-..
T Consensus       315 s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~  394 (1351)
T KOG1035|consen  315 SSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEK  394 (1351)
T ss_pred             ccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccc
Confidence            2   1111111211111  00 00          1112233566666533334445567999999999999887543221


Q ss_pred             chHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          142 LEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      ...       ...   .++............+|+..++++|+++.+++.|+|.+.+.+
T Consensus       395 ~~~-------~~~---~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~  442 (1351)
T KOG1035|consen  395 SAV-------PVS---LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTD  442 (1351)
T ss_pred             ccc-------hhh---hhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence            110       000   111112226677888999999999999999999999876644

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.28  E-value=1.3e-06  Score=62.61  Aligned_cols=56  Identities=18%  Similarity=0.245  Sum_probs=36.4

Q ss_pred             ceeccceeeeeC---CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHh
Q 046714           11 NIVQYIGTEKDE---NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH   66 (201)
Q Consensus        11 ~I~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   66 (201)
                      .+.+++.+....   +..+++||+++|.++.+.+....++......++.++++++..||
T Consensus        58 ~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH  116 (223)
T cd05154          58 PVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLRPELSPEERRALARALADTLAALH  116 (223)
T ss_pred             CCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Confidence            356666665553   36789999999988866543233555566666666666666666

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.28  E-value=6.7e-07  Score=62.36  Aligned_cols=67  Identities=25%  Similarity=0.306  Sum_probs=43.6

Q ss_pred             EEEEEecC--CCCHHHHHHhcCCCHHHHHHHHHHHHHHHHH-HhhcCccccCCCCCcEEEccCCceeeecCc
Q 046714           26 YIFLELVK--KGSLANLYQKYHLSDSQVSSYTRQILNGLTY-LHERNVVHREIKCANILVDASGLATTTNDV   94 (201)
Q Consensus        26 ~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~-lh~~~i~H~dl~p~nill~~~g~~~~~~~~   94 (201)
                      .+||||+.  |..+..+.. ..++......+..+++..+.. +|+.|++|||+++.||+++.+ .+.+.+..
T Consensus        82 ~ivME~I~~~G~~~~~l~~-~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~  151 (188)
T PF01163_consen   82 VIVMEYIGEDGVPLPRLKD-VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG  151 (188)
T ss_dssp             EEEEE--EETTEEGGCHHH-CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred             EEEEEecCCCccchhhHHh-ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence            79999998  655544433 223345566777888885555 579999999999999999877 34444443

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.26  E-value=2e-06  Score=69.17  Aligned_cols=61  Identities=10%  Similarity=0.084  Sum_probs=40.2

Q ss_pred             eEEEEEEecCCCCHHHH--HHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC
Q 046714           24 RLYIFLELVKKGSLANL--YQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG   86 (201)
Q Consensus        24 ~~~lv~e~~~~~~L~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g   86 (201)
                      ..+++|||+.|+.+.++  +...+...........+  .-+..+...|++|+|+||.||+++.+|
T Consensus       235 ~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~--~~~~Qif~~GffHaDpHPGNIlv~~~g  297 (537)
T PRK04750        235 ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE--VFFTQVFRDGFFHADMHPGNIFVSYDP  297 (537)
T ss_pred             CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH--HHHHHHHhCCeeeCCCChHHeEEecCC
Confidence            45799999999999875  33333332222211111  112334568999999999999999887

>PRK09902 hypothetical protein; Provisional

Probab=98.16  E-value=1.7e-05  Score=56.08  Aligned_cols=71  Identities=20%  Similarity=0.164  Sum_probs=57.0

Q ss_pred             eEEEEEEecCC-CCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCc--eeeecCc
Q 046714           24 RLYIFLELVKK-GSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGL--ATTTNDV   94 (201)
Q Consensus        24 ~~~lv~e~~~~-~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~--~~~~~~~   94 (201)
                      ..+||+|-+.| .+|.+++....   .+......++.+++.++.-||+.|+.|+|+.+.||+++.+|.  +.+.+..
T Consensus        99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902         99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            46899997753 58888887644   466777899999999999999999999999999999987664  4444433

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.01  E-value=1.4e-05  Score=55.87  Aligned_cols=85  Identities=19%  Similarity=0.180  Sum_probs=65.6

Q ss_pred             cccCCC-cceeccceeeeeCCeEEEEEEecCCCCHHH----HHHhcCCCHHHHHHHHHHHHHHHHHHhh---cCccccCC
Q 046714            4 FSQFEH-DNIVQYIGTEKDENRLYIFLELVKKGSLAN----LYQKYHLSDSQVSSYTRQILNGLTYLHE---RNVVHREI   75 (201)
Q Consensus         4 l~~l~h-~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~----~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~H~dl   75 (201)
                      |+.+.+ +++++++|.|.+    .+++||...+++..    +.+-...++..+.+++.++++.+++++.   ..+.-.|+
T Consensus        13 l~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv   88 (188)
T PF12260_consen   13 LQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDV   88 (188)
T ss_pred             HHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeec
Confidence            444555 589999999966    68999998665532    1122236899999999999999999997   34667999


Q ss_pred             CCCcEEEccCCceeeec
Q 046714           76 KCANILVDASGLATTTN   92 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~   92 (201)
                      +++|+-++.+|.++..+
T Consensus        89 ~~~nfgv~~~~~lk~iD  105 (188)
T PF12260_consen   89 SPDNFGVNDDGRLKLID  105 (188)
T ss_pred             chHHeEEeCCCcEEEEe
Confidence            99999999887766655

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.97  E-value=1.6e-05  Score=62.87  Aligned_cols=154  Identities=21%  Similarity=0.335  Sum_probs=95.7

Q ss_pred             ccccCCCcceeccceeeeeC-CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDE-NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      .++.+.|+|.-..+++.... .+..+|+|++.. ++.|....+........              ..|+.|-     |++
T Consensus        35 ~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~l~~~s~~--------------~~~~~~~-----~~~   94 (725)
T KOG1093|consen   35 YLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGNLKDESLL--------------AHGVLHL-----NII   94 (725)
T ss_pred             HHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcccchhhhc--------------cccccee-----hhh
Confidence            46788999998888876544 347788999955 99998876542221111              1222211     111


Q ss_pred             EccCCceeeecCccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCCCC---
Q 046714           82 VDASGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPS---  158 (201)
Q Consensus        82 l~~~g~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---  158 (201)
                      ...+       ...+..       |       ....+++|||++|.++.+++.|..-+......+....+.+-....   
T Consensus        95 ~~td-------~~~t~~-------~-------~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~  153 (725)
T KOG1093|consen   95 YITD-------HFLTKY-------P-------SPIGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQEL  153 (725)
T ss_pred             hccc-------cccccC-------C-------CCCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhH
Confidence            1111       111100       1       112369999999999999999987766555555444433222111   


Q ss_pred             --------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          159 --------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       159 --------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                              +...+++....+..+|+...|..||...++.+++-|.+.
T Consensus       154 ~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  154 LSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence                    112356667788899999999999999999998877653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.88  E-value=2.5e-05  Score=56.94  Aligned_cols=68  Identities=24%  Similarity=0.260  Sum_probs=51.6

Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCc
Q 046714           23 NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDV   94 (201)
Q Consensus        23 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~   94 (201)
                      +...++||++.|..|...-    +..+....++..|+.-+.-.-..|++|||+++-||+++.+|-....+..
T Consensus       180 nRHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwP  247 (304)
T COG0478         180 NRHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWP  247 (304)
T ss_pred             ccceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCc
Confidence            4557999999997775542    2344455666677777777778999999999999999999877666544

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.73  E-value=0.00033  Score=49.39  Aligned_cols=76  Identities=18%  Similarity=0.326  Sum_probs=60.1

Q ss_pred             cCCCcceeccceeeeeCCeEEEEEEecCC------CCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            6 QFEHDNIVQYIGTEKDENRLYIFLELVKK------GSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         6 ~l~h~~I~~~~~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ...+.+|.+++|+.+++....+|+|.+.+      .||.++++...++. .....   +-+-.++|-+.+|+.+|++|.|
T Consensus        73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~N  148 (199)
T PF10707_consen   73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHN  148 (199)
T ss_pred             CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHHH---HHHHHHHHHHcCCeecCCCccc
Confidence            45688999999999999999999998643      47888988777766 33333   3444567888999999999999


Q ss_pred             EEEccC
Q 046714           80 ILVDAS   85 (201)
Q Consensus        80 ill~~~   85 (201)
                      |++...
T Consensus       149 Iv~~~~  154 (199)
T PF10707_consen  149 IVVQRR  154 (199)
T ss_pred             EEEEec
Confidence            999764

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.23  E-value=0.0015  Score=52.70  Aligned_cols=69  Identities=14%  Similarity=0.215  Sum_probs=48.9

Q ss_pred             CeEEEEEEecCCCCHHHH--HHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecC
Q 046714           23 NRLYIFLELVKKGSLANL--YQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTND   93 (201)
Q Consensus        23 ~~~~lv~e~~~~~~L~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~   93 (201)
                      +...++|||+.|-.+.+.  ++..+++...+.....+..  +..+-..|++|+|.+|.||+++.+|.....+.
T Consensus       239 ~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDf  309 (517)
T COG0661         239 TRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDF  309 (517)
T ss_pred             CCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcC
Confidence            345899999999999887  4566666444433333222  34555689999999999999999876655544

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.20  E-value=0.0011  Score=53.37  Aligned_cols=70  Identities=14%  Similarity=0.144  Sum_probs=48.3

Q ss_pred             eeccceeeeeCCeEEEEEEecCCCCHHH--HHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccC
Q 046714           12 IVQYIGTEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS   85 (201)
Q Consensus        12 I~~~~~~~~~~~~~~lv~e~~~~~~L~~--~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~   85 (201)
                      |.+++..+...  ..++|||+.|..+.|  .+.+.+++...+...+.+..  .+.+-..|++|+|=+|.||+++.+
T Consensus       266 VP~Vy~~~st~--RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~  337 (538)
T KOG1235|consen  266 VPKVYWDLSTK--RVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPN  337 (538)
T ss_pred             CCeehhhcCcc--eEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecC
Confidence            44444444333  589999999988865  56777888875544433332  234456789999999999999953

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.09  E-value=0.0027  Score=46.30  Aligned_cols=28  Identities=18%  Similarity=0.252  Sum_probs=21.1

Q ss_pred             eeccceeeeeCCeEEEEEEecCCCCHHH
Q 046714           12 IVQYIGTEKDENRLYIFLELVKKGSLAN   39 (201)
Q Consensus        12 I~~~~~~~~~~~~~~lv~e~~~~~~L~~   39 (201)
                      +.++++.....+..++|||+++|.++..
T Consensus        54 vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150          54 VPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             CCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            5566666666667899999999987753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.00  E-value=0.0057  Score=44.19  Aligned_cols=25  Identities=20%  Similarity=0.191  Sum_probs=19.4

Q ss_pred             eeccceeeeeCCeEEEEEEecCCCC
Q 046714           12 IVQYIGTEKDENRLYIFLELVKKGS   36 (201)
Q Consensus        12 I~~~~~~~~~~~~~~lv~e~~~~~~   36 (201)
                      +.+.+++..+.+...++||++.|.+
T Consensus        56 vP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172        56 TPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             CCceEEEEecCCeeeeeeeecCCcc
Confidence            3556777777777889999999963

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=96.88  E-value=0.0024  Score=46.31  Aligned_cols=69  Identities=17%  Similarity=0.228  Sum_probs=49.4

Q ss_pred             EEEEEEecCCCCH-HHHHHhcCCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCcEEEccCCceeeecCc
Q 046714           25 LYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCANILVDASGLATTTNDV   94 (201)
Q Consensus        25 ~~lv~e~~~~~~L-~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~nill~~~g~~~~~~~~   94 (201)
                      ..++|||+..... .-.++.-+++..++..+..++++.+.-|-. .+++|+||+.-|||+. +|...+.+-.
T Consensus       141 nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~  211 (268)
T COG1718         141 NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVS  211 (268)
T ss_pred             CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECc
Confidence            3799999965311 112333344555788888999999999887 8999999999999998 5554444433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=96.41  E-value=0.00017  Score=58.50  Aligned_cols=185  Identities=26%  Similarity=0.303  Sum_probs=105.2

Q ss_pred             ccccCCCcc-eeccceeeeeCCeEEEEEEecCCC-CHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDN-IVQYIGTEKDENRLYIFLELVKKG-SLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~-I~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      .|.|.+||| .+..++-++.+....+.++++.++ +..+...  +-.+..-+.....+.=.++++++|+.-=+|+|    
T Consensus       286 LLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----  361 (829)
T KOG0576|consen  286 LLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----  361 (829)
T ss_pred             HHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----
Confidence            478899999 677777777788899999999876 2222111  11133334445566667888999987667777    


Q ss_pred             cEEEccCCcee--------eec--CccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           79 NILVDASGLAT--------TTN--DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        79 nill~~~g~~~--------~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      ||+........        +..  ......+++.++|||..  ....+..+.|+|++|.--.++.-|-.|-....  ...
T Consensus       362 ~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~--~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~  437 (829)
T KOG0576|consen  362 NILGSEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVI--QENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVL  437 (829)
T ss_pred             cccccccccccccccCCcccCcccccccCCCCCCCCCchhh--cccccccCCCccCCCcchhhcCCCCCCCCCCc--ccc
Confidence            66655432111        111  23445578889999987  45567788999999976555665655432200  000


Q ss_pred             HHhhcCC-CCCCC--CCCCHHHH-HHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          149 FRIGRGK-LPSVP--NSLSRDAR-DFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       149 ~~~~~~~-~~~~~--~~~~~~~~-~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      ..+..+. .+.+.  ...++... ++...|+...|..|+..-.++-|.+|+
T Consensus       438 ~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfn  488 (829)
T KOG0576|consen  438 PMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFN  488 (829)
T ss_pred             CCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhc
Confidence            0000000 00000  00011111 255566777777777766666666554

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.37  E-value=0.031  Score=40.24  Aligned_cols=95  Identities=18%  Similarity=0.153  Sum_probs=61.1

Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhh--cCccccCCCCCcEEEccCCceeeecCccccccC
Q 046714           23 NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHE--RNVVHREIKCANILVDASGLATTTNDVKSFEGT  100 (201)
Q Consensus        23 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--~~i~H~dl~p~nill~~~g~~~~~~~~~~~~~~  100 (201)
                      -.+.++.|+|-....        ...   -.+.+ =++++.-.|+  .+.+|||..|+||+=|+.|..++.+...-....
T Consensus       127 ~~yGvIlE~Cy~~~i--------~~~---N~i~a-gi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~~  194 (308)
T PF07387_consen  127 YKYGVILERCYKIKI--------NFS---NFITA-GIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLENQ  194 (308)
T ss_pred             ceeEEEEeeccCccc--------chh---HHHHH-hHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhhhhe
Confidence            357888898844211        111   11111 2345677784  479999999999999999999999887665555


Q ss_pred             cccccccccccCCCCCcchhhHHHHHHHHHHHHh
Q 046714          101 PFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT  134 (201)
Q Consensus       101 ~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~  134 (201)
                      .-|.--|+.     ..++++.+-+|-.-++++..
T Consensus       195 V~~vN~~Y~-----~lT~~aE~~~fv~s~l~~v~  223 (308)
T PF07387_consen  195 VNMVNIEYE-----SLTQEAEVKVFVKSCLKLVE  223 (308)
T ss_pred             eeEEeeecc-----ccChHHHHHHHHHHHHHHHH
Confidence            556553332     34566666666655666554

The function of this family is unknown.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.58  E-value=0.002  Score=57.86  Aligned_cols=189  Identities=14%  Similarity=0.008  Sum_probs=109.4

Q ss_pred             ccCCCcceeccceeeee--CCeEEEEEEecCCCCHHHHHHhcC----CCHHHHHHHHHHH-HHHHHHHhhc-C----ccc
Q 046714            5 SQFEHDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKYH----LSDSQVSSYTRQI-LNGLTYLHER-N----VVH   72 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~i-~~~l~~lh~~-~----i~H   72 (201)
                      ++..|+++...+.-...  ....+..++++.+|.+.+.+-++-    ...+.......++ +.+..-+|+. +    -+|
T Consensus      1284 ~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~ 1363 (2724)
T KOG1826|consen 1284 REAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVS 1363 (2724)
T ss_pred             hhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchh
Confidence            34577777665543332  234578888999999999885532    1222233333343 5555665643 2    588


Q ss_pred             cCCCCCcEEEccCC--------ceeeec----CccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Q 046714           73 REIKCANILVDASG--------LATTTN----DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS  140 (201)
Q Consensus        73 ~dl~p~nill~~~g--------~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  140 (201)
                      .++++-|.+|..+-        +.++..    ..+...+++.|++|++.+  .-.++.++|+|..|+.+|....|..+|-
T Consensus      1364 ~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N--~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1364 KSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN--EIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             hhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH--HHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence            99999999987653        333111    223344566688888763  3346677999999999998887766652


Q ss_pred             CchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          141 HLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      ...+......+..+...+.+.-.|.+.......++-..-..||.-...+..+.+-
T Consensus      1442 ~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1442 FFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            2222111111222222233444444444444555555567778777776665543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=94.39  E-value=0.034  Score=42.36  Aligned_cols=66  Identities=17%  Similarity=0.234  Sum_probs=46.0

Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecC
Q 046714           23 NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTND   93 (201)
Q Consensus        23 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~   93 (201)
                      +..++|||++.|.+|...-+-  -..   ..+...+..-+--|-+.|++|||.+--||+++.++....+++
T Consensus       181 ~RH~Vvmelv~g~Pl~~v~~v--~d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDF  246 (465)
T KOG2268|consen  181 NRHCVVMELVDGYPLRQVRHV--EDP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDF  246 (465)
T ss_pred             cceeeHHHhhcccceeeeeec--CCh---HHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeec
Confidence            456789999999887655321  122   233344455566778899999999999999998776655554

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=94.18  E-value=0.057  Score=39.16  Aligned_cols=28  Identities=18%  Similarity=0.152  Sum_probs=21.1

Q ss_pred             cCccccCCCCCcEEEccCCceeeecCcc
Q 046714           68 RNVVHREIKCANILVDASGLATTTNDVK   95 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g~~~~~~~~~   95 (201)
                      .+++|+|+.+.||+++.++...+.+...
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~  191 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGC  191 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcc
Confidence            3589999999999998766555555443

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=93.86  E-value=0.14  Score=38.81  Aligned_cols=26  Identities=23%  Similarity=0.390  Sum_probs=21.2

Q ss_pred             cCccccCCCCCcEEEccCCceeeecC
Q 046714           68 RNVVHREIKCANILVDASGLATTTND   93 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g~~~~~~~   93 (201)
                      .+++|+|+++.||+++.++...+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDf  212 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDF  212 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeec
Confidence            68999999999999998875555543

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=93.86  E-value=0.23  Score=39.18  Aligned_cols=61  Identities=16%  Similarity=0.180  Sum_probs=47.1

Q ss_pred             EEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHh-hcCccccCCCCCcEEEccC
Q 046714           25 LYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH-ERNVVHREIKCANILVDAS   85 (201)
Q Consensus        25 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~dl~p~nill~~~   85 (201)
                      ..++=+|..|..+..+++....++....+++.-.+.|+-.|- -.+++|.|++|.||++..+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            356666888889999998777777777777777777755443 5689999999999999643

>PRK05231 homoserine kinase; Provisional

Probab=93.55  E-value=0.2  Score=38.12  Aligned_cols=27  Identities=22%  Similarity=0.349  Sum_probs=21.1

Q ss_pred             cCccccCCCCCcEEEccCCceeeecCc
Q 046714           68 RNVVHREIKCANILVDASGLATTTNDV   94 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g~~~~~~~~   94 (201)
                      .|++|+|++|+||+++.++...+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~  213 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFY  213 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecc
Confidence            489999999999999876655555543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=93.33  E-value=0.14  Score=38.42  Aligned_cols=26  Identities=27%  Similarity=0.433  Sum_probs=20.7

Q ss_pred             cCccccCCCCCcEEEccCCceeeecC
Q 046714           68 RNVVHREIKCANILVDASGLATTTND   93 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g~~~~~~~   93 (201)
                      .+++|+|++|.||+++.++...+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDf  200 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDF  200 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeeh
Confidence            47999999999999998766545544

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=93.14  E-value=0.2  Score=36.22  Aligned_cols=25  Identities=12%  Similarity=0.208  Sum_probs=18.9

Q ss_pred             cCccccCCCCCcEEEcc-CCceeeec
Q 046714           68 RNVVHREIKCANILVDA-SGLATTTN   92 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~-~g~~~~~~   92 (201)
                      .+++|+|+.+.||+++. ++...+.+
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lID  195 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFID  195 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEE
Confidence            36899999999999997 34444444

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=92.33  E-value=0.42  Score=36.14  Aligned_cols=19  Identities=26%  Similarity=0.473  Sum_probs=16.4

Q ss_pred             cCccccCCCCCcEEEccCC
Q 046714           68 RNVVHREIKCANILVDASG   86 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g   86 (201)
                      .+++|||+++.||+++.++
T Consensus       187 ~~liHgD~~~~Nil~~~~~  205 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKDNE  205 (313)
T ss_pred             CceEcCCCCcccEEEeCCc
Confidence            4789999999999998743

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=91.80  E-value=0.99  Score=35.32  Aligned_cols=99  Identities=19%  Similarity=0.198  Sum_probs=62.3

Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc-CccccCCCCCcEEEccCCceeeecCcccccc---
Q 046714           24 RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER-NVVHREIKCANILVDASGLATTTNDVKSFEG---   99 (201)
Q Consensus        24 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~p~nill~~~g~~~~~~~~~~~~~---   99 (201)
                      ..|++|++. |+++... +  ....+++..++.+.+..+.-+.++ ..-|+|+..+||+|+ .|.+.+.+.......   
T Consensus       300 y~yl~~kdh-gt~is~i-k--~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q  374 (488)
T COG5072         300 YLYLHFKDH-GTPISII-K--ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQ  374 (488)
T ss_pred             EEEEEEecC-Cceeeee-e--cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecccCC
Confidence            456677775 4344222 2  145667788888888877777755 789999999999999 888877765433221   


Q ss_pred             -Ccc---cccccccccCCCCCcchhhHHHHHHHHH
Q 046714          100 -TPF---WVAPEVVNLKNNGYGLSADIWSLGCTVL  130 (201)
Q Consensus       100 -~~~---~~aPE~~~~~~~~~~~~~Dv~slG~~l~  130 (201)
                       ...   .--|..++  +. .+.+.+||-+.-.+.
T Consensus       375 ~~isy~rldhp~lF~--G~-dd~QFeIYrlMr~l~  406 (488)
T COG5072         375 GIISYNRLDHPDLFN--GV-DDYQFEIYRLMRRLL  406 (488)
T ss_pred             ceeeccccCchhhhc--Cc-cceeeeHHHHHHHHh
Confidence             222   33455553  22 256777777554443

>PRK14559 putative protein serine/threonine phosphatase; Provisional

Probab=91.30  E-value=1.1  Score=37.78  Aligned_cols=81  Identities=19%  Similarity=0.151  Sum_probs=64.2

Q ss_pred             cCCCcceeccceeeeeCCeEEEEEEecCC-CCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEcc
Q 046714            6 QFEHDNIVQYIGTEKDENRLYIFLELVKK-GSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA   84 (201)
Q Consensus         6 ~l~h~~I~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~   84 (201)
                      ...+.||.++|+.+..++...+++|+... .+|.+.-.....+..+.+.|+-||++--.-|...|+.-.=|.++|+.++.
T Consensus       176 ~~~~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~~~~~~~l~~l~Wl~q~~~LW~~l~~~~~~~sll~~~nlrv~~  255 (645)
T PRK14559        176 DQFPTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQDQTLPTLQILYWLNQMTQLWKALEPWGCCQSLLELENLRVDE  255 (645)
T ss_pred             ccccccCcchheeecCCCCcEEEeCCCCCCchHHHHhhhcCCcHHHHHHHHHHHHHHHHHHHhcCeehhccchhheeeCC
Confidence            34455699999999988888888898643 34444444444567888999999999999999999999999999999985


Q ss_pred             CC
Q 046714           85 SG   86 (201)
Q Consensus        85 ~g   86 (201)
                      +.
T Consensus       256 ~~  257 (645)
T PRK14559        256 DQ  257 (645)
T ss_pred             Cc
Confidence            43

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=91.06  E-value=0.75  Score=32.69  Aligned_cols=66  Identities=21%  Similarity=0.211  Sum_probs=44.8

Q ss_pred             cccCCCcce--eccceeeeeC------------------CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHH
Q 046714            4 FSQFEHDNI--VQYIGTEKDE------------------NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT   63 (201)
Q Consensus         4 l~~l~h~~I--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~   63 (201)
                      |++..+.++  ++++|+..-.                  ....||.||.+...        .++..    -+.+|.+-+.
T Consensus       111 Lke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~----~~~~~~~dl~  178 (207)
T PF13095_consen  111 LKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIR----DIPQMLRDLK  178 (207)
T ss_pred             HHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchh----HHHHHHHHHH
Confidence            455566666  7888875211                  13467888876633        23333    3456677788


Q ss_pred             HHhhcCccccCCCCCcEE
Q 046714           64 YLHERNVVHREIKCANIL   81 (201)
Q Consensus        64 ~lh~~~i~H~dl~p~nil   81 (201)
                      .+|+.||+-+|+++.|..
T Consensus       179 ~~~k~gI~~~Dv~~~ny~  196 (207)
T PF13095_consen  179 ILHKLGIVPRDVKPRNYR  196 (207)
T ss_pred             HHHHCCeeeccCcccccc
Confidence            899999999999999975

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=90.81  E-value=0.48  Score=35.96  Aligned_cols=25  Identities=20%  Similarity=0.171  Sum_probs=21.0

Q ss_pred             CccccCCCCCcEEEccCCceeeecC
Q 046714           69 NVVHREIKCANILVDASGLATTTND   93 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~g~~~~~~~   93 (201)
                      +++|+|+.++||+++.+|...+.+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDf  221 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINF  221 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEh
Confidence            7999999999999998876666553

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=90.75  E-value=0.16  Score=36.24  Aligned_cols=55  Identities=18%  Similarity=0.218  Sum_probs=0.0

Q ss_pred             HHHHH-HHHHHHHHHHHHhhcCccccCCCCCcEEEc-cCCceeeecCccccccCccc
Q 046714           49 SQVSS-YTRQILNGLTYLHERNVVHREIKCANILVD-ASGLATTTNDVKSFEGTPFW  103 (201)
Q Consensus        49 ~~~~~-~~~~i~~~l~~lh~~~i~H~dl~p~nill~-~~g~~~~~~~~~~~~~~~~~  103 (201)
                      ..+.. +...+...+.--....++|+|+.|.||+++ .+|...+.+......+.+.|
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~~~~~  202 (239)
T PF01636_consen  146 EELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWGDPAY  202 (239)
T ss_dssp             HHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEEETHH
T ss_pred             HHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceECCHHH

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=90.45  E-value=0.43  Score=35.63  Aligned_cols=26  Identities=19%  Similarity=0.334  Sum_probs=18.8

Q ss_pred             CccccCCCCCcEEEccCC-ceeeecCc
Q 046714           69 NVVHREIKCANILVDASG-LATTTNDV   94 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~g-~~~~~~~~   94 (201)
                      .++|+|++|.||+++.+| ...+.+-.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe  212 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWT  212 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcH
Confidence            489999999999998743 33344433

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK12396 5-methylribose kinase; Reviewed

Probab=90.32  E-value=0.56  Score=36.97  Aligned_cols=34  Identities=12%  Similarity=0.309  Sum_probs=23.1

Q ss_pred             hcCccccCCCCCcEEEccCCceeeecCccccccCc
Q 046714           67 ERNVVHREIKCANILVDASGLATTTNDVKSFEGTP  101 (201)
Q Consensus        67 ~~~i~H~dl~p~nill~~~g~~~~~~~~~~~~~~~  101 (201)
                      ....+|||++|.||+++.++.. +.+..-.+.|.+
T Consensus       226 ~~aLlHGDlHtGSI~v~~~~~k-vIDpEFAfyGP~  259 (409)
T PRK12396        226 AQALIHGDLHTGSVFVKNDSTK-VIDPEFAFYGPM  259 (409)
T ss_pred             chhhccCcCCCCCEEecCCceE-EEcccccccCCc
Confidence            3468999999999999987643 344333444443

>PLN02876 acyl-CoA dehydrogenase

Probab=90.12  E-value=0.36  Score=41.87  Aligned_cols=63  Identities=11%  Similarity=0.143  Sum_probs=37.8

Q ss_pred             cccCC-Ccce--eccceeeeeC---CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhh
Q 046714            4 FSQFE-HDNI--VQYIGTEKDE---NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHE   67 (201)
Q Consensus         4 l~~l~-h~~I--~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   67 (201)
                      |+.+. |+++  .+++.++.+.   +..++|||+++|..+.+-. -...+..+...+..+++.+|..||+
T Consensus        92 l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~-~~~~~~~~r~~l~~~l~~~La~LH~  160 (822)
T PLN02876         92 LRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPK-LPGVAPERRRAIYRATAKVLAALHS  160 (822)
T ss_pred             HHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCcc-CCCCCHHHHHHHHHHHHHHHHHHhC
Confidence            44453 5554  7777777664   5688999999986543210 0123455555666666666665553

>COG4499 Predicted membrane protein [Function unknown]

Probab=89.89  E-value=0.48  Score=36.57  Aligned_cols=105  Identities=10%  Similarity=0.035  Sum_probs=61.6

Q ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCccccccCcc
Q 046714           23 NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSFEGTPF  102 (201)
Q Consensus        23 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~~~~~~~  102 (201)
                      +.+.+-++..  .....+-.-..+.....++++.|.+..|..+... -.|-=+.|+||+++.++.......+....-.|.
T Consensus        61 Ds~vIsy~i~--~~~~~F~~~k~~~k~~Klr~a~~~I~~l~e~~~t-r~~~~laPeNilf~~~l~p~~vH~Glk~~lpPy  137 (434)
T COG4499          61 DSFVISYPIP--EAAKSFASAKRKEKTRKLRLALQNIATLSELNNT-RYTFFLAPENILFDGGLTPFFVHRGLKNSLPPY  137 (434)
T ss_pred             ceeEEEecCc--cccchHHHHHHHHHHHHHHHHHHHHHHHHHhhcc-ceeEEecchheEEcCCCceEEEecchhccCCCC
Confidence            3344444433  3343443333356667777788888887765433 345567899999998776655544333222333


Q ss_pred             cccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc
Q 046714          103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL  142 (201)
Q Consensus       103 ~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  142 (201)
                      =+.||.+            .-.+-+++.+++.|+.+|...
T Consensus       138 e~tee~f------------~~~ykA~~~~~fn~k~~Fe~l  165 (434)
T COG4499         138 EMTEERF------------LKEYKALAIYAFNGKFSFESL  165 (434)
T ss_pred             CCCHHHH------------HHHHHHHHHHHHcCCccHHHH
Confidence            3444443            224557777888999988543

>PHA03111 Ser/Thr kinase; Provisional

Probab=89.16  E-value=0.67  Score=35.68  Aligned_cols=62  Identities=19%  Similarity=0.097  Sum_probs=35.0

Q ss_pred             eEEEEEEecCC--CCHHH-HHHhcCC-CH-HHHHHHHHHHHHHHHHHh----hcCccccCCCCCcEEEccC
Q 046714           24 RLYIFLELVKK--GSLAN-LYQKYHL-SD-SQVSSYTRQILNGLTYLH----ERNVVHREIKCANILVDAS   85 (201)
Q Consensus        24 ~~~lv~e~~~~--~~L~~-~~~~~~~-~~-~~~~~~~~~i~~~l~~lh----~~~i~H~dl~p~nill~~~   85 (201)
                      ...+|++.+.+  ..+.. ...+.++ +. +-++.+..|++.-.-...    -.+++|.||||+|||+-+.
T Consensus       249 GnIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        249 GNIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             CcEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            34677887654  12211 2233343 32 234445667665442332    2358999999999999665

>TIGR02721 ycfN_thiK thiamine kinase

Probab=88.98  E-value=0.34  Score=35.62  Aligned_cols=19  Identities=26%  Similarity=0.555  Sum_probs=16.9

Q ss_pred             CccccCCCCCcEEEccCCc
Q 046714           69 NVVHREIKCANILVDASGL   87 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~g~   87 (201)
                      .++|+|+.|.||+++.+|.
T Consensus       147 ~l~H~Dl~~~Nil~~~~~~  165 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQGL  165 (256)
T ss_pred             eeecCCCCcCcEEEeCCCC
Confidence            4899999999999998774

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=88.72  E-value=1  Score=33.97  Aligned_cols=17  Identities=24%  Similarity=0.362  Sum_probs=15.4

Q ss_pred             CccccCCCCCcEEEccC
Q 046714           69 NVVHREIKCANILVDAS   85 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~   85 (201)
                      .++|+|+.+.||+++.+
T Consensus       180 ~lcH~Dl~~~Nil~~~~  196 (302)
T cd05156         180 VFCHNDLQEGNILLLNP  196 (302)
T ss_pred             eEEecCCCcCeEEecCC
Confidence            57999999999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=88.45  E-value=0.89  Score=34.95  Aligned_cols=25  Identities=16%  Similarity=0.224  Sum_probs=19.7

Q ss_pred             ccccCCCCCcEEEccCCc-eeeecCc
Q 046714           70 VVHREIKCANILVDASGL-ATTTNDV   94 (201)
Q Consensus        70 i~H~dl~p~nill~~~g~-~~~~~~~   94 (201)
                      ++|+|+.|+||+++.++. +...++.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFd  224 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFD  224 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcc
Confidence            999999999999998874 4444443

>PF10140 YukC: WXG100 protein secretion system (Wss), protein YukC; InterPro: IPR018778 Members of this family are associated with type VII secretion of WXG100 family targets in the Firmicutes, but not in the Actinobacteria

Probab=87.74  E-value=2.7  Score=32.74  Aligned_cols=117  Identities=13%  Similarity=0.136  Sum_probs=54.8

Q ss_pred             cCCCcceeccceeeeeCCeEEEEEEecCC-CCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEcc
Q 046714            6 QFEHDNIVQYIGTEKDENRLYIFLELVKK-GSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA   84 (201)
Q Consensus         6 ~l~h~~I~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~   84 (201)
                      +..||+.++. .+-.+++.+.+-++.-.. .++.. ++  .++..++++++.+| .+|.. |...-+|--++|+|++++.
T Consensus        19 ~~~~~~f~~~-~i~~~ed~~~~~y~~~~~~~~f~~-i~--~~~~~eklr~~~ni-~~l~~-~~~~~~~f~l~P~Nl~fd~   92 (359)
T PF10140_consen   19 KEHDPYFLPQ-EIEEDEDELTFTYQIPESYQSFEE-IK--KLDKSEKLRLLINI-AALKE-HLNSRYTFILHPENLVFDK   92 (359)
T ss_dssp             GS--TTB--E-EEEE-SSEEEEEE---TTSEEGGG-GG--GS-HHHHHHHHHHG-GGGGG-GGGSSEE---SGGGEEE-T
T ss_pred             hccCcccCCc-eEEEeCCEEEEEEEcCcccCcHHH-HH--hcCHHHHHHHHHHH-HHHHH-HhcCceeEEEechheEEcC
Confidence            3467888873 555666665555554432 23322 22  36788888888884 44432 2234678889999999999


Q ss_pred             CCceeeecCccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Q 046714           85 SGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS  140 (201)
Q Consensus        85 ~g~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  140 (201)
                      ++.+.....     |-..-++|..       .+...=.-.+=|++..++.++..|.
T Consensus        93 ~~~p~i~hr-----Gi~~~l~P~~-------~~ee~fl~qyKali~~ll~~k~~Fe  136 (359)
T PF10140_consen   93 NLMPKILHR-----GIKEILPPYE-------LDEEDFLKQYKALIIALLDPKYSFE  136 (359)
T ss_dssp             TS-EEES-------EETTTBS------------HHHHHHHHHHHHHHHH-TT--HH
T ss_pred             CCCEEEEEc-----CCcCCCCCCC-------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            988766533     2222233322       1222224455667777777777763

This protein is designated YukC in Bacillus subtilis and EssB is Staphylococcus aureus. ; PDB: 4ANN_A.

>PRK10593 hypothetical protein; Provisional

Probab=86.95  E-value=1.4  Score=33.33  Aligned_cols=54  Identities=17%  Similarity=0.167  Sum_probs=36.6

Q ss_pred             ceeccceeeee---CCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc
Q 046714           11 NIVQYIGTEKD---ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER   68 (201)
Q Consensus        11 ~I~~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   68 (201)
                      .+.++++++.+   .+..++|||++.|.++.+.    .........+..++++++.-||+.
T Consensus        71 pVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         71 RMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             CcCcEEEEeccCCcCCCeEEEEeccCCEecCCC----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            46666766654   4668999999999877651    123344556667777888888863

>PRK10271 thiK thiamine kinase; Provisional

Probab=86.76  E-value=0.63  Score=32.59  Aligned_cols=24  Identities=25%  Similarity=0.390  Sum_probs=18.9

Q ss_pred             CccccCCCCCcEEEccCCceeeecC
Q 046714           69 NVVHREIKCANILVDASGLATTTND   93 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~g~~~~~~~   93 (201)
                      -.+|+|+.|.|+++.++|.. +.+-
T Consensus        78 ~p~H~D~~~~N~~~~~~~~~-lIDw  101 (188)
T PRK10271         78 APLHMDVHAGNLVHSASGLR-LIDW  101 (188)
T ss_pred             eeecCCCCCccEEEECCCEE-EEeC
Confidence            35999999999999988844 5543

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=86.76  E-value=0.6  Score=35.64  Aligned_cols=33  Identities=18%  Similarity=0.266  Sum_probs=25.6

Q ss_pred             CccccCCCCCcEEEccCCceeeecCccccccCc
Q 046714           69 NVVHREIKCANILVDASGLATTTNDVKSFEGTP  101 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~g~~~~~~~~~~~~~~~  101 (201)
                      .++|||+++.|++++.++...+.+....-.|.|
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            489999999999999988866666555555544

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=85.40  E-value=2.3  Score=29.92  Aligned_cols=19  Identities=16%  Similarity=0.256  Sum_probs=16.0

Q ss_pred             cCccccCCCCCcEEEccCC
Q 046714           68 RNVVHREIKCANILVDASG   86 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g   86 (201)
                      ..++|||+.++|+++..++
T Consensus       120 ~vl~HgD~~~~N~~~~~~~  138 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDD  138 (196)
T ss_pred             eEEeeCCCCccceeeccCC
Confidence            4689999999999998543

subfamily of choline kinases

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=83.80  E-value=2.4  Score=31.62  Aligned_cols=39  Identities=13%  Similarity=0.163  Sum_probs=25.9

Q ss_pred             HHHHHHHHHHhhc--CccccCCCCCcEEEccCCceeeecCc
Q 046714           56 RQILNGLTYLHER--NVVHREIKCANILVDASGLATTTNDV   94 (201)
Q Consensus        56 ~~i~~~l~~lh~~--~i~H~dl~p~nill~~~g~~~~~~~~   94 (201)
                      ..+-.++.-.+..  -++|+|+.|+|++.++.|...+.+-.
T Consensus       139 ~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWE  179 (269)
T COG0510         139 KELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWE  179 (269)
T ss_pred             HHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecc
Confidence            3333444444433  48999999999999996666666543

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=83.60  E-value=0.66  Score=35.85  Aligned_cols=60  Identities=22%  Similarity=0.098  Sum_probs=32.6

Q ss_pred             EEEEEEecCCCCHHH----HHHhcCCC--HHHHHHHHHHHHHHHHHH---h-hcCccccCCCCCcEEEccC
Q 046714           25 LYIFLELVKKGSLAN----LYQKYHLS--DSQVSSYTRQILNGLTYL---H-ERNVVHREIKCANILVDAS   85 (201)
Q Consensus        25 ~~lv~e~~~~~~L~~----~~~~~~~~--~~~~~~~~~~i~~~l~~l---h-~~~i~H~dl~p~nill~~~   85 (201)
                      ..+|++.+.+ +-..    ...+.|+.  .+-++.+..|++.-.--.   - -.+++|.||||+|||+-+.
T Consensus       246 nIIIfPLA~~-Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  315 (434)
T PF05445_consen  246 NIIIFPLARC-SADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDS  315 (434)
T ss_pred             cEEEEehhhc-chhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecC
Confidence            3577887654 2222    12233332  222344555655432112   1 2368999999999999654

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>KOG2464 consensus Serine/threonine kinase (haspin family) [Cell cycle control, cell division, chromosome partitioning]

Probab=83.29  E-value=2.9  Score=30.70  Aligned_cols=41  Identities=27%  Similarity=0.371  Sum_probs=35.8

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhhc-CccccCCCCCcEEEccCC
Q 046714           46 LSDSQVSSYTRQILNGLTYLHER-NVVHREIKCANILVDASG   86 (201)
Q Consensus        46 ~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~p~nill~~~g   86 (201)
                      .+..++..++.|+...++-..+. ++.|+|+.+.||+++..|
T Consensus       134 ~~~~~~~si~~q~~~~l~i~~~~~~~~hrdl~~gnili~k~~  175 (246)
T KOG2464|consen  134 ESKNQALSIFWQLVLSLAIAEKSLGFEHRDLHLGNILIKKTG  175 (246)
T ss_pred             ccHHHHHHHHHHHHHHHHHhhhhhcccccccCcCcEEEeccc
Confidence            56778888999999988888865 899999999999999866

>PLN02756 S-methyl-5-thioribose kinase

Probab=83.15  E-value=2.6  Score=33.52  Aligned_cols=20  Identities=15%  Similarity=0.461  Sum_probs=17.4

Q ss_pred             cCccccCCCCCcEEEccCCc
Q 046714           68 RNVVHREIKCANILVDASGL   87 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g~   87 (201)
                      ...+|||+.|.||++..++.
T Consensus       230 ~~L~HGDl~~g~i~~~~~~~  249 (418)
T PLN02756        230 QALVHGDLHTGSVMVTPDST  249 (418)
T ss_pred             cceeecCCCCCcEEEcCCCc
Confidence            35899999999999998773

>PLN02236 choline kinase

Probab=82.46  E-value=2.3  Score=32.96  Aligned_cols=24  Identities=21%  Similarity=0.458  Sum_probs=17.9

Q ss_pred             CccccCCCCCcEEEccC-Cceeeec
Q 046714           69 NVVHREIKCANILVDAS-GLATTTN   92 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~-g~~~~~~   92 (201)
                      .++|+|+++.||+++.. +...+.+
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID  225 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIID  225 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEe
Confidence            58999999999999863 4344443

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=82.08  E-value=1.1  Score=34.98  Aligned_cols=22  Identities=14%  Similarity=0.369  Sum_probs=18.0

Q ss_pred             hcCccccCCCCCcEEEccCCce
Q 046714           67 ERNVVHREIKCANILVDASGLA   88 (201)
Q Consensus        67 ~~~i~H~dl~p~nill~~~g~~   88 (201)
                      ...++|||+.+.||+++.++..
T Consensus       191 ~~~llHGDl~~gNi~~~~~~~~  212 (370)
T TIGR01767       191 AETLLHGDLHSGSIFVSEHETK  212 (370)
T ss_pred             cceeeeccCCcccEEEcCCCCE
Confidence            3468999999999999876644

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=81.38  E-value=2.7  Score=33.16  Aligned_cols=63  Identities=19%  Similarity=0.242  Sum_probs=47.0

Q ss_pred             EEEEEEecCCCCH-HHHHHhcCCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCcEEEccCCc
Q 046714           25 LYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCANILVDASGL   87 (201)
Q Consensus        25 ~~lv~e~~~~~~L-~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~nill~~~g~   87 (201)
                      ..|||+++.+..- .-.++...++...+..+-.|++.-+.-|.+ +++||.||+--|+|+-.+.+
T Consensus       239 hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~l  303 (520)
T KOG2270|consen  239 HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGKL  303 (520)
T ss_pred             ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCEE
Confidence            4799999954221 224455567877888888888888888764 58999999999999976543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	201
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-37
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-36
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-35
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-35
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-35
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-35
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-34
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-33
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-33
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-32
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-32
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-32
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-32
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-31
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-30
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-29
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-29
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-29
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-29
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-29
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-29
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-29
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-29
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-28
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-27
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-27
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-27
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-25
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-25
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-25
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-25
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-25
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-25
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-23
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-23
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-23
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-23
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-23
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-23
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-23
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-22
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-22
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-22
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-22
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-22
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-21
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-21
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-21
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-21
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-21
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-21
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-21
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-21
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-21
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-21
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-21
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-21
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-21
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-21
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-21
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-21
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-21
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-21
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-21
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-21
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-21
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-21
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-21
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-21
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-20
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-20
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-20
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-20
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-20
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-20
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-20
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-20
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-20
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-20
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-20
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-20
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-20
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-20
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-20
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-20
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-20
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-20
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-20
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-20
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-20
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-19
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-19
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-19
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-19
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-19
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-19
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-19
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-19
3soa_A	444	Full-Length Human Camkii Length = 444		5e-19
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-18
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-18
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-18
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-18
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-18
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-18
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-18
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-18
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-18
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-18
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-18
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-18
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-18
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-18
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-18
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-18
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-18
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-18
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-18
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-18
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-18
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-18
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-18
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-18
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-18
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-18
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-18
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-18
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-18
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		9e-18
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-18
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		9e-18
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-17
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-17
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-17
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-17
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-17
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-17
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-17
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-17
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-17
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-17
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-17
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-17
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-17
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-17
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-17
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-17
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-17
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-17
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-17
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-17
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-17
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-17
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-17
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-17
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-17
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-17
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-17
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-17
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-17
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-17
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-17
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-17
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-17
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-17
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-17
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-17
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-17
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-17
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-17
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-17
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-17
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-17
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-17
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-17
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-17
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-17
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-17
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-17
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-17
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-17
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-17
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-17
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-17
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-17
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-17
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-17
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-17
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-17
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-17
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-17
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-17
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-16
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-16
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-16
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-16
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-16
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-16
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-16
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-16
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-16
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-16
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-16
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-16
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-16
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-16
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-16
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-16
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-16
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-16
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-16
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-16
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-16
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-16
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-16
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-16
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-16
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-16
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-16
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-16
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-16
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-16
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-16
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-16
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-16
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-16
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-16
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-16
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-16
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-16
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-16
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-16
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-16
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-16
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-16
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-16
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-16
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-16
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-16
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-16
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-16
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-16
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-16
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-16
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-16
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-16
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-15
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-15
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-15
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-15
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-15
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-15
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-15
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-15
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-15
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-15
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-15
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-15
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-15
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-15
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-15
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-15
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-15
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-15
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-15
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-15
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-15
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-15
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-15
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-15
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-15
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-15
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-14
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-14
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-14
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-14
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-14
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-14
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-14
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-14
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-14
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-13
3gni_B	389	Structure Of Strad And Mo25 Length = 389		1e-13
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-13
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-13
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-13
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-13
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-13
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-13
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-13
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-13
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-13
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-13
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-13
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-13
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-13
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-13
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-13
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-13
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-13
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-13
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-13
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-13
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-13
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-13
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-13
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-13
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-13
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-13
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-13
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-12
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-12
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-12
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-12
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-12
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-12
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-12
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-12
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-12
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		8e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-12
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-11
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-11
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-11
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-11
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		4e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-11
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		4e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-11
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		7e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-10
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-10
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-10
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-10
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-10
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-10
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-10
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-10
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-10
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-10
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-10
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-10
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-10
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-10
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-10
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-10
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		8e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-09
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-09
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-09
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		6e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-09
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		6e-09
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		6e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-09
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		6e-09
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		7e-09
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		7e-09
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-09
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-09
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		7e-09
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		7e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-09
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		7e-09
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		7e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		8e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-09
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		8e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-07
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-07
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-07

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  149 bits (377), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 83/208 (39%), Positives = 127/208 (61%), Gaps = 19/208 (9%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQ--VSSYTRQILNGL 62
            +H NIVQY+G+  +   + IF+E V  GSL+ L +     L D++  +  YT+QIL GL
Sbjct: 76  LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 63  TYLHERNVVHREIKCANILVDA-SG------------LATTTNDVKSFEGTPFWVAPEVV 109
            YLH+  +VHR+IK  N+L++  SG            LA      ++F GT  ++APE++
Sbjct: 136 KYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 195
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ-ALFRIGRGKL-PSVPNSLSRDA 167
           +    GYG +ADIWSLGCT++EM T +PP+  L + Q A+F++G  K+ P +P S+S +A
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255
Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           + FILKC + +P+ R  A  L+   F+K
Sbjct: 256 KAFILKCFEPDPDKRACANDLLVDEFLK 283

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  149 bits (376), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 83/209 (39%), Positives = 127/209 (60%), Gaps = 19/209 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQ--VSSYTRQILNG 61
             +H NIVQY+G+  +   + IF+E V  GSL+ L +     L D++  +  YT+QIL G
Sbjct: 61  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 120
Query: 62  LTYLHERNVVHREIKCANILVDA-SG------------LATTTNDVKSFEGTPFWVAPEV 108
           L YLH+  +VHR+IK  N+L++  SG            LA      ++F GT  ++APE+
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEI 180
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ-ALFRIGRGKL-PSVPNSLSRD 166
           ++    GYG +ADIWSLGCT++EM T +PP+  L + Q A+F++G  K+ P +P S+S +
Sbjct: 181 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAE 240
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           A+ FILKC + +P+ R  A  L+   F+K
Sbjct: 241 AKAFILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  144 bits (364), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 116/205 (56%), Gaps = 14/205 (6%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQ +   + +Y G+   + +L+I +E +  GS  +L +   L ++Q+++  R+IL GL 
Sbjct: 79  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLD 138
Query: 64  YLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL 111
           YLH    +HR+IK AN+L+   G            L  T     +F GTPFW+APEV+  
Sbjct: 139 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-- 196
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFI 171
           K + Y   ADIWSLG T +E+   +PP+S L  M+ LF I +   P++  + S+  ++F+
Sbjct: 197 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV 256
Query: 172 LKCLQVNPNDRPTAAQLMEHPFVKR 196
             CL   P+ RPTA +L++H F+ R
Sbjct: 257 EACLNKEPSFRPTAKELLKHKFILR 281

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  144 bits (363), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 116/205 (56%), Gaps = 14/205 (6%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQ +   + +Y G+   + +L+I +E +  GS  +L +   L ++Q+++  R+IL GL 
Sbjct: 59  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLD 118
Query: 64  YLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL 111
           YLH    +HR+IK AN+L+   G            L  T     +F GTPFW+APEV+  
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-- 176
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFI 171
           K + Y   ADIWSLG T +E+   +PP+S L  M+ LF I +   P++  + S+  ++F+
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV 236
Query: 172 LKCLQVNPNDRPTAAQLMEHPFVKR 196
             CL   P+ RPTA +L++H F+ R
Sbjct: 237 EACLNKEPSFRPTAKELLKHKFILR 261

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  143 bits (361), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 115/205 (56%), Gaps = 14/205 (6%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQ +   + +Y G+   + +L+I +E +  GS  +L +   L ++Q+++  R+IL GL 
Sbjct: 59  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLD 118
Query: 64  YLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL 111
           YLH    +HR+IK AN+L+   G            L  T      F GTPFW+APEV+  
Sbjct: 119 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-- 176
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFI 171
           K + Y   ADIWSLG T +E+   +PP+S L  M+ LF I +   P++  + S+  ++F+
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV 236
Query: 172 LKCLQVNPNDRPTAAQLMEHPFVKR 196
             CL   P+ RPTA +L++H F+ R
Sbjct: 237 EACLNKEPSFRPTAKELLKHKFILR 261

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  143 bits (361), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 115/205 (56%), Gaps = 14/205 (6%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQ +   + +Y G+   + +L+I +E +  GS  +L +   L ++Q+++  R+IL GL 
Sbjct: 74  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLD 133
Query: 64  YLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL 111
           YLH    +HR+IK AN+L+   G            L  T      F GTPFW+APEV+  
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-- 191
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFI 171
           K + Y   ADIWSLG T +E+   +PP+S L  M+ LF I +   P++  + S+  ++F+
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFV 251
Query: 172 LKCLQVNPNDRPTAAQLMEHPFVKR 196
             CL   P+ RPTA +L++H F+ R
Sbjct: 252 EACLNKEPSFRPTAKELLKHKFILR 276

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  140 bits (352), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 111/205 (54%), Gaps = 14/205 (6%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQ +   I +Y G+     +L+I +E +  GS  +L +   L ++ +++  R+IL GL 
Sbjct: 71  LSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLD 130
Query: 64  YLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL 111
           YLH    +HR+IK AN+L+   G            L  T      F GTPFW+APEV+  
Sbjct: 131 YLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-- 188
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFI 171
           K + Y   ADIWSLG T +E+   +PP S L  M+ LF I +   P++    S+  ++F+
Sbjct: 189 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFV 248
Query: 172 LKCLQVNPNDRPTAAQLMEHPFVKR 196
             CL  +P  RPTA +L++H F+ R
Sbjct: 249 EACLNKDPRFRPTAKELLKHKFITR 273

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  137 bits (345), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 117/210 (55%), Gaps = 19/210 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNG 61
            +  +H  IV+ +G    + +L+I +E    G++  +  +    L++ Q+    RQ+L  
Sbjct: 62  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 121
Query: 62  LTYLHERNVVHREIKCANILVDASG------LATTTNDVK------SFEGTPFWVAPEVV 109
           L +LH + ++HR++K  N+L+   G         +  ++K      SF GTP+W+APEVV
Sbjct: 122 LNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 181
Query: 110 ---NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLS 164
               +K+  Y   ADIWSLG T++EM   +PP+  L  M+ L +I +   P++  P+  S
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 241
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            + RDF+   L  NP  RP+AAQL+EHPFV
Sbjct: 242 VEFRDFLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  137 bits (345), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 117/210 (55%), Gaps = 19/210 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNG 61
            +  +H  IV+ +G    + +L+I +E    G++  +  +    L++ Q+    RQ+L  
Sbjct: 70  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 62  LTYLHERNVVHREIKCANILVDASG------LATTTNDVK------SFEGTPFWVAPEVV 109
           L +LH + ++HR++K  N+L+   G         +  ++K      SF GTP+W+APEVV
Sbjct: 130 LNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 110 ---NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLS 164
               +K+  Y   ADIWSLG T++EM   +PP+  L  M+ L +I +   P++  P+  S
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWS 249
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            + RDF+   L  NP  RP+AAQL+EHPFV
Sbjct: 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  135 bits (339), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 112/203 (55%), Gaps = 14/203 (6%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
            SQ +   + +Y G+    ++L+I +E +  GS  +L +     + Q+++  ++IL GL 
Sbjct: 75  LSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLD 134
Query: 64  YLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL 111
           YLH    +HR+IK AN+L+   G            L  T     +F GTPFW+APEV+  
Sbjct: 135 YLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-- 192
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFI 171
           + + Y   ADIWSLG T +E+   +PP S +  M+ LF I +   P++    ++  ++FI
Sbjct: 193 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFI 252
Query: 172 LKCLQVNPNDRPTAAQLMEHPFV 194
             CL  +P+ RPTA +L++H F+
Sbjct: 253 DACLNKDPSFRPTAKELLKHKFI 275

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  132 bits (333), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 73/210 (34%), Positives = 118/210 (56%), Gaps = 19/210 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNG 61
            +  +H NIV+ +     EN L+I +E    G++  +  +    L++SQ+    +Q L+ 
Sbjct: 88  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 147
Query: 62  LTYLHERNVVHREIKCANILVDASG---------LATTTNDVK---SFEGTPFWVAPEVV 109
           L YLH+  ++HR++K  NIL    G          A  T  ++   SF GTP+W+APEVV
Sbjct: 148 LNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 207
Query: 110 ---NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLS 164
                K+  Y   AD+WSLG T++EM   +PP+  L  M+ L +I + + P++  P+  S
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 267
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            + +DF+ KCL+ N + R T +QL++HPFV
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  132 bits (333), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 73/210 (34%), Positives = 118/210 (56%), Gaps = 19/210 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNG 61
            +  +H NIV+ +     EN L+I +E    G++  +  +    L++SQ+    +Q L+ 
Sbjct: 88  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 147
Query: 62  LTYLHERNVVHREIKCANILVDASG---------LATTTNDVK---SFEGTPFWVAPEVV 109
           L YLH+  ++HR++K  NIL    G          A  T  ++   SF GTP+W+APEVV
Sbjct: 148 LNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVV 207
Query: 110 ---NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLS 164
                K+  Y   AD+WSLG T++EM   +PP+  L  M+ L +I + + P++  P+  S
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 267
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            + +DF+ KCL+ N + R T +QL++HPFV
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  130 bits (328), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 117/210 (55%), Gaps = 19/210 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNG 61
            +  +H NIV+ +     EN L+I +E    G++  +  +    L++SQ+    +Q L+ 
Sbjct: 88  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 147
Query: 62  LTYLHERNVVHREIKCANILVDASG---------LATTTNDVK---SFEGTPFWVAPEVV 109
           L YLH+  ++HR++K  NIL    G          A  T  ++    F GTP+W+APEVV
Sbjct: 148 LNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVV 207
Query: 110 ---NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLS 164
                K+  Y   AD+WSLG T++EM   +PP+  L  M+ L +I + + P++  P+  S
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 267
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            + +DF+ KCL+ N + R T +QL++HPFV
Sbjct: 268 SNFKDFLKKCLEKNVDARWTTSQLLQHPFV 297

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  126 bits (316), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 114/208 (54%), Gaps = 18/208 (8%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNG 61
             Q +  ++V+Y G+      L+I +E    GS++++ +  +  L++ ++++  +  L G
Sbjct: 78  MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG 137
Query: 62  LTYLHERNVVHREIKCANILVDASG--------LATTTNDVKSFE----GTPFWVAPEVV 109
           L YLH    +HR+IK  NIL++  G        +A    D  +      GTPFW+APEV+
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI 197
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDA 167
             +  GY   ADIWSLG T +EM   +PPY+ +  M+A+F I     P+   P   S + 
Sbjct: 198 --QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNF 255
Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFVK 195
            DF+ +CL  +P  R TA QL++HPFV+
Sbjct: 256 TDFVKQCLVKSPEQRATATQLLQHPFVR 283

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  125 bits (313), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNG 61
             +  H N +QY G    E+  ++ +E    GS ++L +  K  L + ++++ T   L G
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQG 166
Query: 62  LTYLHERNVVHREIKCANILVDASGL--------ATTTNDVKSFEGTPFWVAPEVVNLKN 113
           L YLH  N++HR++K  NIL+   GL        A+       F GTP+W+APEV+   +
Sbjct: 167 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMD 226
Query: 114 NG-YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS-LSRDARDFI 171
            G Y    D+WSLG T +E+   +PP  ++  M AL+ I + + P++ +   S   R+F+
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286
Query: 172 LKCLQVNPNDRPTAAQLMEHPFVKR 196
             CLQ  P DRPT+  L++H FV R
Sbjct: 287 DSCLQKIPQDRPTSEVLLKHRFVLR 311

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  124 bits (312), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNG 61
             +  H N +QY G    E+  ++ +E    GS ++L +  K  L + ++++ T   L G
Sbjct: 69  LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 62  LTYLHERNVVHREIKCANILVDASGL--------ATTTNDVKSFEGTPFWVAPEVVNLKN 113
           L YLH  N++HR++K  NIL+   GL        A+       F GTP+W+APEV+   +
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMD 187
Query: 114 NG-YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS-LSRDARDFI 171
            G Y    D+WSLG T +E+   +PP  ++  M AL+ I + + P++ +   S   R+F+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 172 LKCLQVNPNDRPTAAQLMEHPFVKR 196
             CLQ  P DRPT+  L++H FV R
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLR 272

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  124 bits (311), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 18/206 (8%)
Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNV 70
           NIV Y+ +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +LH   V
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 71  VHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGL 118
           +HR+IK  NIL+   G    T+                  GTP+W+APEVV  K   YG 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRK--AYGP 195
Query: 119 SADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDARDFILKCLQ 176
             DIWSLG   +EM+  +PPY +   ++AL+ I     P +  P  LS   RDF+ +CL+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255
Query: 177 VNPNDRPTAAQLMEHPFVK--RPLQT 200
           ++   R +A +L++H F+K  +PL +
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSS 281

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  124 bits (311), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 18/206 (8%)
Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNV 70
           NIV Y+ +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +LH   V
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 138
Query: 71  VHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGL 118
           +HR+IK  NIL+   G    T+                  GTP+W+APEVV  K   YG 
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRK--AYGP 196
Query: 119 SADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDARDFILKCLQ 176
             DIWSLG   +EM+  +PPY +   ++AL+ I     P +  P  LS   RDF+ +CL+
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 256
Query: 177 VNPNDRPTAAQLMEHPFVK--RPLQT 200
           ++   R +A +L++H F+K  +PL +
Sbjct: 257 MDVEKRGSAKELIQHQFLKIAKPLSS 282

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  124 bits (311), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 18/206 (8%)
Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNV 70
           NIV Y+ +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +LH   V
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 71  VHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGL 118
           +HR+IK  NIL+   G    T+               +  GTP+W+APEVV  K   YG 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGP 195
Query: 119 SADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDARDFILKCLQ 176
             DIWSLG   +EM+  +PPY +   ++AL+ I     P +  P  LS   RDF+ +CL 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 177 VNPNDRPTAAQLMEHPFVK--RPLQT 200
           ++   R +A +L++H F+K  +PL +
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSS 281

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  124 bits (310), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 18/206 (8%)
Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNV 70
           NIV Y+ +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +LH   V
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 138
Query: 71  VHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGL 118
           +HR IK  NIL+   G    T+               +  GTP+W+APEVV  K   YG 
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK--AYGP 196
Query: 119 SADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDARDFILKCLQ 176
             DIWSLG   +EM+  +PPY +   ++AL+ I     P +  P  LS   RDF+ +CL+
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 256
Query: 177 VNPNDRPTAAQLMEHPFVK--RPLQT 200
           ++   R +A +L++H F+K  +PL +
Sbjct: 257 MDVEKRGSAKELIQHQFLKIAKPLSS 282

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  124 bits (310), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 113/202 (55%), Gaps = 16/202 (7%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           ++H N+V+   +      L++ +E ++ G+L ++  +  L++ Q+++    +L  L YLH
Sbjct: 99  YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLH 158
Query: 67  ERNVVHREIKCANILVDASG---------LATTTNDV---KSFEGTPFWVAPEVVNLKNN 114
            + V+HR+IK  +IL+   G          A  + DV   K   GTP+W+APEV++   +
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVIS--RS 216
Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS--LSRDARDFIL 172
            Y    DIWSLG  V+EM+  +PPY     +QA+ R+     P + NS  +S   RDF+ 
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276
Query: 173 KCLQVNPNDRPTAAQLMEHPFV 194
           + L  +P +R TA +L++HPF+
Sbjct: 277 RMLVRDPQERATAQELLDHPFL 298

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  123 bits (309), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 110/206 (53%), Gaps = 18/206 (8%)
Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNV 70
           NIV Y+ +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +LH   V
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 71  VHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGL 118
           +HR+IK  NIL+   G    T+                  GTP+W+APEVV  K   YG 
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRK--AYGP 195
Query: 119 SADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDARDFILKCLQ 176
             DIWSLG   +EM+  +PPY +   ++AL+ I     P +  P  LS   RDF+ +CL 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 177 VNPNDRPTAAQLMEHPFVK--RPLQT 200
           ++   R +A +L++H F+K  +PL +
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSS 281

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  120 bits (300), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 108/212 (50%), Gaps = 25/212 (11%)
Query: 9   HDNIVQYIGTEKDEN------RLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQIL 59
           H NI  Y G    +N      +L++ +E    GS+ +L +      L +  ++   R+IL
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 60  NGLTYLHERNVVHREIKCANILVD------------ASGLATTTNDVKSFEGTPFWVAPE 107
            GL++LH+  V+HR+IK  N+L+             ++ L  T     +F GTP+W+APE
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199
Query: 108 VVNLKNN---GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN-SL 163
           V+    N    Y   +D+WSLG T +EM    PP   +  M+ALF I R   P + +   
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 259
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           S+  + FI  CL  N + RP   QLM+HPF++
Sbjct: 260 SKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  118 bits (296), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 111/203 (54%), Gaps = 16/203 (7%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           + HDN+V    +    + L++ +E ++ G+L ++     +++ Q+++    +L  L+YLH
Sbjct: 99  YHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLH 158
Query: 67  ERNVVHREIKCANILVDASG---------LATTTNDV---KSFEGTPFWVAPEVVNLKNN 114
            + V+HR+IK  +IL+ + G          A  + +V   K   GTP+W+APEV++    
Sbjct: 159 NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVIS--RL 216
Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN--SLSRDARDFIL 172
            YG   DIWSLG  V+EM+  +PPY +   +QA+ RI     P V +   +S   R F+ 
Sbjct: 217 PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLD 276
Query: 173 KCLQVNPNDRPTAAQLMEHPFVK 195
             L   P+ R TA +L+ HPF+K
Sbjct: 277 LMLVREPSQRATAQELLGHPFLK 299

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  118 bits (296), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 115/229 (50%), Gaps = 36/229 (15%)
Query: 3   SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL---------YQKYHLSDSQVSS 53
           + SQ  H NIV Y  +   ++ L++ ++L+  GS+ ++         ++   L +S +++
Sbjct: 61  AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 120
Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDASG------------LAT----TTNDV-KS 96
             R++L GL YLH+   +HR++K  NIL+   G            LAT    T N V K+
Sbjct: 121 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 180
Query: 97  FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL 156
           F GTP W+APEV+  +  GY   ADIWS G T +E+ T   PY     M+ L    +   
Sbjct: 181 FVGTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 239
Query: 157 PSVPNSL---------SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           PS+   +          +  R  I  CLQ +P  RPTAA+L+ H F ++
Sbjct: 240 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  118 bits (296), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 115/229 (50%), Gaps = 36/229 (15%)
Query: 3   SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL---------YQKYHLSDSQVSS 53
           + SQ  H NIV Y  +   ++ L++ ++L+  GS+ ++         ++   L +S +++
Sbjct: 66  AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDASG------------LAT----TTNDV-KS 96
             R++L GL YLH+   +HR++K  NIL+   G            LAT    T N V K+
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 97  FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL 156
           F GTP W+APEV+  +  GY   ADIWS G T +E+ T   PY     M+ L    +   
Sbjct: 186 FVGTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244
Query: 157 PSVPNSL---------SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           PS+   +          +  R  I  CLQ +P  RPTAA+L+ H F ++
Sbjct: 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  110 bits (276), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 113/204 (55%), Gaps = 16/204 (7%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           ++H+N+V+   +    + L++ +E ++ G+L ++     +++ Q+++    +L  L+ LH
Sbjct: 83  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 142
Query: 67  ERNVVHREIKCANILVDASG---------LATTTNDV---KSFEGTPFWVAPEVVNLKNN 114
            + V+HR+IK  +IL+   G          A  + +V   K   GTP+W+APE+++    
Sbjct: 143 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS--RL 200
Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN--SLSRDARDFIL 172
            YG   DIWSLG  V+EM+  +PPY +   ++A+  I     P + N   +S   + F+ 
Sbjct: 201 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 260
Query: 173 KCLQVNPNDRPTAAQLMEHPFVKR 196
           + L  +P  R TAA+L++HPF+ +
Sbjct: 261 RLLVRDPAQRATAAELLKHPFLAK 284

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  110 bits (276), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 113/204 (55%), Gaps = 16/204 (7%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           ++H+N+V+   +    + L++ +E ++ G+L ++     +++ Q+++    +L  L+ LH
Sbjct: 85  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 144
Query: 67  ERNVVHREIKCANILVDASG---------LATTTNDV---KSFEGTPFWVAPEVVNLKNN 114
            + V+HR+IK  +IL+   G          A  + +V   K   GTP+W+APE+++    
Sbjct: 145 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS--RL 202
Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN--SLSRDARDFIL 172
            YG   DIWSLG  V+EM+  +PPY +   ++A+  I     P + N   +S   + F+ 
Sbjct: 203 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 262
Query: 173 KCLQVNPNDRPTAAQLMEHPFVKR 196
           + L  +P  R TAA+L++HPF+ +
Sbjct: 263 RLLVRDPAQRATAAELLKHPFLAK 286

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  110 bits (276), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 113/204 (55%), Gaps = 16/204 (7%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           ++H+N+V+   +    + L++ +E ++ G+L ++     +++ Q+++    +L  L+ LH
Sbjct: 78  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 137
Query: 67  ERNVVHREIKCANILVDASG---------LATTTNDV---KSFEGTPFWVAPEVVNLKNN 114
            + V+HR+IK  +IL+   G          A  + +V   K   GTP+W+APE+++    
Sbjct: 138 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS--RL 195
Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN--SLSRDARDFIL 172
            YG   DIWSLG  V+EM+  +PPY +   ++A+  I     P + N   +S   + F+ 
Sbjct: 196 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 255
Query: 173 KCLQVNPNDRPTAAQLMEHPFVKR 196
           + L  +P  R TAA+L++HPF+ +
Sbjct: 256 RLLVRDPAQRATAAELLKHPFLAK 279

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  110 bits (275), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 113/204 (55%), Gaps = 16/204 (7%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           ++H+N+V+   +    + L++ +E ++ G+L ++     +++ Q+++    +L  L+ LH
Sbjct: 74  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 133
Query: 67  ERNVVHREIKCANILVDASG---------LATTTNDV---KSFEGTPFWVAPEVVNLKNN 114
            + V+HR+IK  +IL+   G          A  + +V   K   GTP+W+APE+++    
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS--RL 191
Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN--SLSRDARDFIL 172
            YG   DIWSLG  V+EM+  +PPY +   ++A+  I     P + N   +S   + F+ 
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 251
Query: 173 KCLQVNPNDRPTAAQLMEHPFVKR 196
           + L  +P  R TAA+L++HPF+ +
Sbjct: 252 RLLVRDPAQRATAAELLKHPFLAK 275

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  110 bits (275), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 113/204 (55%), Gaps = 16/204 (7%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           ++H+N+V+   +    + L++ +E ++ G+L ++     +++ Q+++    +L  L+ LH
Sbjct: 128 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 187
Query: 67  ERNVVHREIKCANILVDASG---------LATTTNDV---KSFEGTPFWVAPEVVNLKNN 114
            + V+HR+IK  +IL+   G          A  + +V   K   GTP+W+APE+++    
Sbjct: 188 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS--RL 245
Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN--SLSRDARDFIL 172
            YG   DIWSLG  V+EM+  +PPY +   ++A+  I     P + N   +S   + F+ 
Sbjct: 246 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 305
Query: 173 KCLQVNPNDRPTAAQLMEHPFVKR 196
           + L  +P  R TAA+L++HPF+ +
Sbjct: 306 RLLVRDPAQRATAAELLKHPFLAK 329

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  110 bits (274), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 113/204 (55%), Gaps = 16/204 (7%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           ++H+N+V+   +    + L++ +E ++ G+L ++     +++ Q+++    +L  L+ LH
Sbjct: 205 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLH 264
Query: 67  ERNVVHREIKCANILVDASG---------LATTTNDV---KSFEGTPFWVAPEVVNLKNN 114
            + V+HR+IK  +IL+   G          A  + +V   K   GTP+W+APE+++    
Sbjct: 265 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS--RL 322
Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN--SLSRDARDFIL 172
            YG   DIWSLG  V+EM+  +PPY +   ++A+  I     P + N   +S   + F+ 
Sbjct: 323 PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 382
Query: 173 KCLQVNPNDRPTAAQLMEHPFVKR 196
           + L  +P  R TAA+L++HPF+ +
Sbjct: 383 RLLVRDPAQRATAAELLKHPFLAK 406

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  104 bits (260), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHE 67
           H ++V + G  +D + +++ LEL ++ SL  L+++   L++ +   Y RQI+ G  YLH 
Sbjct: 80  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 139
Query: 68  RNVVHREIKCANILVDAS--------GLATTT----NDVKSFEGTPFWVAPEVVNLKNNG 115
             V+HR++K  N+ ++          GLAT         K+  GTP ++APEV  L   G
Sbjct: 140 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEV--LSKKG 197
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
           +    D+WS+GC +  +L  +PP+      +   RI + +  S+P  ++  A   I K L
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKML 256
Query: 176 QVNPNDRPTAAQLMEHPF 193
           Q +P  RPT  +L+   F
Sbjct: 257 QTDPTARPTINELLNDEF 274

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHE 67
           H ++V + G  +D + +++ LEL ++ SL  L+++   L++ +   Y RQI+ G  YLH 
Sbjct: 76  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 68  RNVVHREIKCANILVDAS--------GLATTT----NDVKSFEGTPFWVAPEVVNLKNNG 115
             V+HR++K  N+ ++          GLAT         K+  GTP ++APEV  L   G
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEV--LSKKG 193
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
           +    D+WS+GC +  +L  +PP+      +   RI + +  S+P  ++  A   I K L
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKML 252
Query: 176 QVNPNDRPTAAQLMEHPF 193
           Q +P  RPT  +L+   F
Sbjct: 253 QTDPTARPTINELLNDEF 270

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 16/198 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHE 67
           H ++V + G  +D + +++ LEL ++ SL  L+++   L++ +   Y RQI+ G  YLH 
Sbjct: 76  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 68  RNVVHREIKCANILVDAS--------GLATTT----NDVKSFEGTPFWVAPEVVNLKNNG 115
             V+HR++K  N+ ++          GLAT         K+  GTP ++APEV  L   G
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEV--LSKKG 193
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
           +    D+WS+GC +  +L  +PP+      +   RI + +  S+P  ++  A   I K L
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKML 252
Query: 176 QVNPNDRPTAAQLMEHPF 193
           Q +P  RPT  +L+   F
Sbjct: 253 QTDPTARPTINELLNDEF 270

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  103 bits (256), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHE 67
           H ++V + G  +D + +++ LEL ++ SL  L+++   L++ +   Y RQI+ G  YLH 
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 68  RNVVHREIKCANILVDAS--------GLATTT----NDVKSFEGTPFWVAPEVVNLKNNG 115
             V+HR++K  N+ ++          GLAT         K   GTP ++APEV  L   G
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV--LSKKG 191
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
           +    D+WS+GC +  +L  +PP+      +   RI + +  S+P  ++  A   I K L
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKML 250
Query: 176 QVNPNDRPTAAQLMEHPF 193
           Q +P  RPT  +L+   F
Sbjct: 251 QTDPTARPTINELLNDEF 268

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  103 bits (256), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 108/207 (52%), Gaps = 19/207 (9%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H +I+  I + +  + +++  +L++KG L + L +K  LS+ +  S  R +L  +++LH 
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 68  RNVVHREIKCANILVDASGLATTTN-----------DVKSFEGTPFWVAPEVVNLKNN-- 114
            N+VHR++K  NIL+D +     ++            ++   GTP ++APE++    +  
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278
Query: 115 --GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP-SVP--NSLSRDARD 169
             GYG   D+W+ G  +  +L   PP+ H   +  L  I  G+   S P  +  S   +D
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338
Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKR 196
            I + LQV+P  R TA Q ++HPF +R
Sbjct: 339 LISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  103 bits (256), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHE 67
           H ++V + G  +D + +++ LEL ++ SL  L+++   L++ +   Y RQI+ G  YLH 
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 68  RNVVHREIKCANILVDAS--------GLATTT----NDVKSFEGTPFWVAPEVVNLKNNG 115
             V+HR++K  N+ ++          GLAT         K   GTP ++APEV  L   G
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV--LSKKG 217
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
           +    D+WS+GC +  +L  +PP+      +   RI + +  S+P  ++  A   I K L
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKML 276
Query: 176 QVNPNDRPTAAQLMEHPF 193
           Q +P  RPT  +L+   F
Sbjct: 277 QTDPTARPTINELLNDEF 294

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  103 bits (256), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHE 67
           H ++V + G  +D + +++ LEL ++ SL  L+++   L++ +   Y RQI+ G  YLH 
Sbjct: 98  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 157
Query: 68  RNVVHREIKCANILVDAS--------GLATTT----NDVKSFEGTPFWVAPEVVNLKNNG 115
             V+HR++K  N+ ++          GLAT         K   GTP ++APEV  L   G
Sbjct: 158 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV--LSKKG 215
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
           +    D+WS+GC +  +L  +PP+      +   RI + +  S+P  ++  A   I K L
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-SIPKHINPVAASLIQKML 274
Query: 176 QVNPNDRPTAAQLMEHPF 193
           Q +P  RPT  +L+   F
Sbjct: 275 QTDPTARPTINELLNDEF 292

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 110/211 (52%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H NI++     +D +  YI  EL   G L + + ++   S+   +   +Q+ +G+
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 63  TYLHERNVVHREIKCANILVDAS-----------GLATT---TNDVKSFEGTPFWVAPEV 108
           TY+H+ N+VHR++K  NIL+++            GL+T       +K   GT +++APEV
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP-SVPN--SLSR 165
           +      Y    D+WS G  +  +L+  PP+    +   L R+  GK    +P   ++S 
Sbjct: 195 L---RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251
Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           DA+D I K L  +P+ R TA Q +EHP++++
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 110/211 (52%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H NI++     +D +  YI  EL   G L + + ++   S+   +   +Q+ +G+
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 63  TYLHERNVVHREIKCANILVDAS-----------GLATT---TNDVKSFEGTPFWVAPEV 108
           TY+H+ N+VHR++K  NIL+++            GL+T       +K   GT +++APEV
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP-SVPN--SLSR 165
           +      Y    D+WS G  +  +L+  PP+    +   L R+  GK    +P   ++S 
Sbjct: 195 L---RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251
Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           DA+D I K L  +P+ R TA Q +EHP++++
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 110/211 (52%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H NI++     +D +  YI  EL   G L + + ++   S+   +   +Q+ +G+
Sbjct: 75  LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 63  TYLHERNVVHREIKCANILVDAS-----------GLATT---TNDVKSFEGTPFWVAPEV 108
           TY+H+ N+VHR++K  NIL+++            GL+T       +K   GT +++APEV
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP-SVPN--SLSR 165
           +      Y    D+WS G  +  +L+  PP+    +   L R+  GK    +P   ++S 
Sbjct: 195 L---RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251
Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           DA+D I K L  +P+ R TA Q +EHP++++
Sbjct: 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  102 bits (253), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 22/200 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY-----QKYHLSDSQVSSYTRQI 58
             Q  H N+++Y  +  ++N L I LEL   G L+ +      QK  + +  V  Y  Q+
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 59  LNGLTYLHERNVVHREIKCANILVDASGL------------ATTTNDVKSFEGTPFWVAP 106
            + L ++H R V+HR+IK AN+ + A+G+            ++ T    S  GTP++++P
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPP-YSHLEDMQALF-RIGRGKLPSVPNS-L 163
           E ++   NGY   +DIWSLGC + EM   Q P Y    ++ +L  +I +   P +P+   
Sbjct: 206 ERIH--ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263
Query: 164 SRDARDFILKCLQVNPNDRP 183
           S + R  +  C+  +P  RP
Sbjct: 264 SEELRQLVNMCINPDPEKRP 283

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  101 bits (251), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 23/208 (11%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYL 65
            +H NI++     +D+   Y+ +E  K G L + +  +   ++   +   +Q+L+G+TYL
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152
Query: 66  HERNVVHREIKCANILVDAS-----------GLATTTNDVKSFE---GTPFWVAPEVVNL 111
           H+ N+VHR++K  N+L+++            GL+    + K  +   GT +++APEV+  
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK 212
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL----PSVPNSLSRDA 167
           K   Y    D+WS+G  +  +L   PP+    D + L ++ +GK     P   N +S  A
Sbjct: 213 K---YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN-VSEGA 268
Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +D I + LQ +   R +A Q +EHP++K
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIK 296

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE   +G +    QK    D Q  ++Y  ++ N L+
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALS 127
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++      GT  ++ PE++  + 
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMI--EG 185
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 244
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 245 LLKHNPSQRPMLREVLEHPWI 265

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYL 65
            ++ ++V + G  +D++ +Y+ LE+ ++ SL  L+++   +++ +   + RQ + G+ YL
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 66  HERNVVHREIKCANILVDAS--------GLATTT----NDVKSFEGTPFWVAPEVVNLKN 113
           H   V+HR++K  N+ ++          GLAT         K+  GTP ++APEV  L  
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEV--LCK 216
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
            G+    DIWSLGC +  +L  +PP+      +   RI + +  SVP  ++  A   I +
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY-SVPRHINPVASALIRR 275
Query: 174 CLQVNPNDRPTAAQLMEHPF 193
            L  +P  RP+ A+L+   F
Sbjct: 276 MLHADPTLRPSVAELLTDEF 295

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 109/206 (52%), Gaps = 19/206 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL---SDSQVSSYTRQILNGL 62
           Q +H +I++     +D N +Y+ LE+   G + N Y K  +   S+++   +  QI+ G+
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTN----DVKSFEGTPFWVAPEVVN 110
            YLH   ++HR++  +N+L+  +        GLAT          +  GTP +++PE+  
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDF 170
              + +GL +D+WSLGC    +L  +PP+        L ++       +P+ LS +A+D 
Sbjct: 186 --RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY-EMPSFLSIEAKDL 242
Query: 171 ILKCLQVNPNDRPTAAQLMEHPFVKR 196
           I + L+ NP DR + + +++HPF+ R
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFMSR 268

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 98.2 bits (243), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE   +G +    QK    D Q  ++Y  ++ N L+
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALS 127
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EG 185
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 244
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 245 LLKHNPSQRPMLREVLEHPWI 265

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYL 65
            ++ ++V + G  +D++ +Y+ LE+ ++ SL  L+++   +++ +   + RQ + G+ YL
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 66  HERNVVHREIKCANILVDAS--------GLATTT----NDVKSFEGTPFWVAPEVVNLKN 113
           H   V+HR++K  N+ ++          GLAT         K   GTP ++APEV  L  
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEV--LCK 216
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
            G+    DIWSLGC +  +L  +PP+      +   RI + +  SVP  ++  A   I +
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY-SVPRHINPVASALIRR 275
Query: 174 CLQVNPNDRPTAAQLMEHPF 193
            L  +P  RP+ A+L+   F
Sbjct: 276 MLHADPTLRPSVAELLTDEF 295

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYL 65
            ++ ++V + G  +D++ +Y+ LE+ ++ SL  L+++   +++ +   + RQ + G+ YL
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 66  HERNVVHREIKCANILVDAS--------GLATTT----NDVKSFEGTPFWVAPEVVNLKN 113
           H   V+HR++K  N+ ++          GLAT         K   GTP ++APEV  L  
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEV--LCK 216
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
            G+    DIWSLGC +  +L  +PP+      +   RI + +  SVP  ++  A   I +
Sbjct: 217 KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY-SVPRHINPVASALIRR 275
Query: 174 CLQVNPNDRPTAAQLMEHPF 193
            L  +P  RP+ A+L+   F
Sbjct: 276 MLHADPTLRPSVAELLTDEF 295

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL---ANLYQKYHLSDSQVSSYTRQILN 60
            +  +H NIVQY  + ++   LYI ++  + G L    N  +     + Q+  +  QI  
Sbjct: 77  LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL 136
Query: 61  GLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEV 108
            L ++H+R ++HR+IK  NI +   G            L +T    ++  GTP++++PE+
Sbjct: 137 ALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
              +N  Y   +DIW+LGC + E+ T +  +        + +I  G  P V    S D R
Sbjct: 197 C--ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLR 254
Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
             + +  + NP DRP+   ++E  F+ + ++
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYL 65
            ++ ++V + G  +D++ +Y+ LE+ ++ SL  L+++   +++ +   + RQ + G+ YL
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 142
Query: 66  HERNVVHREIKCANILVDAS--------GLATTT----NDVKSFEGTPFWVAPEVVNLKN 113
           H   V+HR++K  N+ ++          GLAT         K   GTP ++APEV  L  
Sbjct: 143 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEV--LCK 200
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
            G+    DIWSLGC +  +L  +PP+      +   RI + +  SVP  ++  A   I +
Sbjct: 201 KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY-SVPRHINPVASALIRR 259
Query: 174 CLQVNPNDRPTAAQLMEHPF 193
            L  +P  RP+ A+L+   F
Sbjct: 260 MLHADPTLRPSVAELLTDEF 279

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 97.8 bits (242), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/211 (35%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNGLTYL 65
           +H NI+       D   +Y+  EL+K G L +  L QK+  S+ + S+    I   + YL
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREASAVLFTITKTVEYL 132
Query: 66  HERNVVHREIKCANIL-VDASG-----------LATTTNDVKSFEGTPFW----VAPEVV 109
           H + VVHR++K +NIL VD SG            A           TP +    VAPEV 
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV- 191
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED---MQALFRIGRGKLP---SVPNSL 163
            L+  GY  + DIWSLG  +  MLT   P+++  D    + L RIG GK        NS+
Sbjct: 192 -LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           S  A+D + K L V+P+ R TAA ++ HP++
Sbjct: 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 97.1 bits (240), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G              ++   +  GT  ++ PE++  + 
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMI--EG 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 240
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 241 LLKHNPSQRPMLREVLEHPWI 261

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 97.1 bits (240), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 64  YLHERNVVHREIKCANILVDASGLATTTNDVKSFE----------GTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G     N   S            GT  ++ PE++  + 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI--EG 183
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 242
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 243 LLKHNPSQRPMLREVLEHPWI 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 97.1 bits (240), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI--EG 180
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 239
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 240 LLKHNPSQRPMLREVLEHPWI 260

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 97.1 bits (240), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 122 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EG 179
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 180 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 238
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 239 LLKHNPSQRPMLREVLEHPWI 259

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 97.1 bits (240), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EG 180
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 239
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 240 LLKHNPSQRPMLREVLEHPWI 260

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 97.1 bits (240), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 120 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EG 177
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 178 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 236
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 237 LLKHNPSQRPMLREVLEHPWI 257

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EG 183
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 242
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 243 LLKHNPSQRPMLREVLEHPWI 263

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMI--EG 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 240
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 241 LLKHNPSQRPMLREVLEHPWI 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EG 183
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 242
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 243 LLKHNPSQRPMLREVLEHPWI 263

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI--EG 183
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 242
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 243 LLKHNPSQRPMLREVLEHPWI 263

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 64  YLHERNVVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G     N             +  GT  ++ PE++  + 
Sbjct: 125 YCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI--EG 182
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 241
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 242 LLKHNPSQRPMLREVLEHPWI 262

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EG 184
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 243
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 244 LLKHNPSQRPMLREVLEHPWI 264

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 149 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EG 206
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 265
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 266 LLKHNPSQRPMLREVLEHPWI 286

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EG 185
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 244
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 245 LLKHNPSQRPMLREVLEHPWI 265

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 96.7 bits (239), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 80  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 140 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EG 197
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 198 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 256
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 257 LLKHNPSQRPMLREVLEHPWI 277

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE +  + 
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXI--EG 185
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 186 RXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 244
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 245 LLKHNPSQRPXLREVLEHPWI 265

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 63  SHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 123 YCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMI--EG 180
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+          RI R +  + P+ ++  ARD I +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEF-TFPDFVTEGARDLISR 239
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 240 LLKHNPSQRPMLREVLEHPWI 260

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++      GT  ++ PE++  + 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMI--EG 183
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 242
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 243 LLKHNPSQRPMLREVLEHPWI 263

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++      GT  ++ PE++  + 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMI--EG 180
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 239
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 240 LLKHNPSQRPMLREVLEHPWI 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++      GT  ++ PE++  + 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI--EG 180
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 239
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 240 LLKHNPSQRPMLREVLEHPWI 260

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++      GT  ++ PE++  + 
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EG 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 240
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 241 LLKHNPSQRPMLREVLEHPWI 261

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++      GT  ++ PE++  + 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI--EG 183
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 242
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 243 LLKHNPSQRPMLREVLEHPWI 263

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++      GT  ++ PE++  + 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMI--EG 180
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 239
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 240 LLKHNPSQRPMLREVLEHPWI 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++      GT  ++ PE++  + 
Sbjct: 125 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI--EG 182
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 241
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 242 LLKHNPSQRPMLREVLEHPWI 262

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++      GT  ++ PE++  + 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EG 180
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 239
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 240 LLKHNPSQRPMLREVLEHPWI 260

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++      GT  ++ PE++  + 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EG 180
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 239
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 240 LLKHNPSQRPMLREVLEHPWI 260

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++      GT  ++ PE++  + 
Sbjct: 128 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EG 185
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 244
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 245 LLKHNPSQRPMLREVLEHPWI 265

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++      GT  ++ PE++  + 
Sbjct: 149 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMI--EG 206
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 207 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 265
Query: 174 CLQVNPNDRPTAAQLMEHPFV 194
            L+ NP+ RP   +++EHP++
Sbjct: 266 LLKHNPSQRPMLREVLEHPWI 286

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NI+Q   T +     ++  +L+KKG L + L +K  LS+ +     R +L  +  LH+
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 68  RNVVHREIKCANILVDASGLATTTN-----------DVKSFEGTPFWVAPEVVNLKNN-- 114
            N+VHR++K  NIL+D       T+            ++S  GTP ++APE++    N  
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDN 202
Query: 115 --GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP-SVP--NSLSRDARD 169
             GYG   D+WS G  +  +L   PP+ H + M  L  I  G      P  +  S   +D
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 262
Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKR 196
            + + L V P  R TA + + HPF ++
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALS 126
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EG 184
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L   PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEF-TFPDFVTEGARDLISR 243
Query: 174 CLQVNPNDRPTAAQLMEHPFVK 195
            L+ N + R T A+++EHP++K
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIK 265

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK    D Q  ++Y  ++ N L+
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALS 126
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++G          +   ++   +  GT  ++ PE++  + 
Sbjct: 127 YCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMI--EG 184
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L   PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEF-TFPDFVTEGARDLISR 243
Query: 174 CLQVNPNDRPTAAQLMEHPFVK 195
            L+ N + R T A+++EHP++K
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIK 265

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/211 (34%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNGLTYL 65
           +H NI+       D   +Y+  EL K G L +  L QK+  S+ + S+    I   + YL
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF-FSEREASAVLFTITKTVEYL 132
Query: 66  HERNVVHREIKCANIL-VDASG-----------LATTTNDVKSFEGTPFW----VAPEVV 109
           H + VVHR++K +NIL VD SG            A           TP +    VAPEV 
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEV- 191
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED---MQALFRIGRGKLP---SVPNSL 163
            L+  GY  + DIWSLG  +   LT   P+++  D    + L RIG GK        NS+
Sbjct: 192 -LERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           S  A+D + K L V+P+ R TAA ++ HP++
Sbjct: 251 SDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN---LYQKYHLSDSQVSSYTRQILN 60
             Q +H NI++     +D+   Y+ +E+ + G L +   L QK+   D+ V    +Q+L+
Sbjct: 75  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV--IMKQVLS 132
Query: 61  GLTYLHERNVVHREIKCANILVDAS-----------GLAT---TTNDVKSFEGTPFWVAP 106
           G TYLH+ N+VHR++K  N+L+++            GL+        +K   GT +++AP
Sbjct: 133 GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAP 192
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVP---NSL 163
           EV+  K   Y    D+WS G  +  +L   PP+    D + L R+ +GK    P     +
Sbjct: 193 EVLRKK---YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQV 249
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           S +A+  +   L   P+ R +A + + HP++
Sbjct: 250 SDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NI+Q   T +     ++  +L+KKG L + L +K  LS+ +     R +L  +  LH+
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 129
Query: 68  RNVVHREIKCANILVDASGLATTTN-----------DVKSFEGTPFWVAPEVVNLKNN-- 114
            N+VHR++K  NIL+D       T+            ++   GTP ++APE++    N  
Sbjct: 130 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 189
Query: 115 --GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP-SVP--NSLSRDARD 169
             GYG   D+WS G  +  +L   PP+ H + M  L  I  G      P  +  S   +D
Sbjct: 190 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 249
Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKR 196
            + + L V P  R TA + + HPF ++
Sbjct: 250 LVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NI+Q   T +     ++  +L+KKG L + L +K  LS+ +     R +L  +  LH+
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 68  RNVVHREIKCANILVDASGLATTTN-----------DVKSFEGTPFWVAPEVVNLKNN-- 114
            N+VHR++K  NIL+D       T+            ++   GTP ++APE++    N  
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 202
Query: 115 --GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP-SVP--NSLSRDARD 169
             GYG   D+WS G  +  +L   PP+ H + M  L  I  G      P  +  S   +D
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 262
Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKR 196
            + + L V P  R TA + + HPF ++
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 94.0 bits (232), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN---LYQKYHLSDSQVSSYTRQILN 60
             Q +H NI++     +D+   Y+ +E+ + G L +   L QK+   D+ V    +Q+L+
Sbjct: 58  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV--IMKQVLS 115
Query: 61  GLTYLHERNVVHREIKCANILVDAS-----------GLAT---TTNDVKSFEGTPFWVAP 106
           G TYLH+ N+VHR++K  N+L+++            GL+        +K   GT +++AP
Sbjct: 116 GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAP 175
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVP---NSL 163
           EV+  K   Y    D+WS G  +  +L   PP+    D + L R+ +GK    P     +
Sbjct: 176 EVLRKK---YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQV 232
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           S +A+  +   L   P+ R +A + + HP++
Sbjct: 233 SDEAKQLVKLMLTYEPSKRISAEEALNHPWI 263

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNGLTYL 65
           +H NI+       D   +Y+  EL++ G L +  L QK+  S+ + S     I   + YL
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGKTVEYL 137
Query: 66  HERNVVHREIKCANIL-VDASG-----------LATTTNDVKSFEGTPFW----VAPEVV 109
           H + VVHR++K +NIL VD SG            A           TP +    VAPEV 
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEV- 196
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED---MQALFRIGRGKLPSVP---NSL 163
            LK  GY    DIWSLG  +  ML    P+++       + L RIG GK        N++
Sbjct: 197 -LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTV 255
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           S  A+D + K L V+P+ R TA Q+++HP+V +
Sbjct: 256 SETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNGLTYL 65
           +H NI+       D   +Y+  EL++ G L +  L QK+  S+ + S     I   + YL
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGKTVEYL 137
Query: 66  HERNVVHREIKCANIL-VDASG-----------LATTTNDVKSFEGTPFW----VAPEVV 109
           H + VVHR++K +NIL VD SG            A           TP +    VAPEV 
Sbjct: 138 HSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEV- 196
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED---MQALFRIGRGKLPSVP---NSL 163
            LK  GY    DIWSLG  +  ML    P+++       + L RIG GK        N++
Sbjct: 197 -LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTV 255
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           S  A+D + K L V+P+ R TA Q+++HP+V
Sbjct: 256 SETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 4   FSQFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLY-----QKYHLSDSQVSSYTR 56
             + +H NIV+Y     ++    LYI +E  + G LA++      ++ +L +  V     
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 57  QILNGLTYLHERN-----VVHREIKCANILVDAS--------GLATTTND----VKSFEG 99
           Q+   L   H R+     V+HR++K AN+ +D          GLA   N      K+F G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 178
Query: 100 TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV 159
           TP++++PE +N     Y   +DIWSLGC + E+    PP++     +   +I  GK   +
Sbjct: 179 TPYYMSPEQMN--RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236
Query: 160 PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           P   S +  + I + L +    RP+  +++E+P +
Sbjct: 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 4   FSQFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLY-----QKYHLSDSQVSSYTR 56
             + +H NIV+Y     ++    LYI +E  + G LA++      ++ +L +  V     
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 57  QILNGLTYLHERN-----VVHREIKCANILVDAS--------GLATTTND----VKSFEG 99
           Q+   L   H R+     V+HR++K AN+ +D          GLA   N      K+F G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 100 TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV 159
           TP++++PE +N     Y   +DIWSLGC + E+    PP++     +   +I  GK   +
Sbjct: 179 TPYYMSPEQMN--RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236
Query: 160 PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           P   S +  + I + L +    RP+  +++E+P +
Sbjct: 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 4   FSQFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLY-----QKYHLSDSQVSSYTR 56
             + +H NIV+Y     ++    LYI +E  + G LA++      ++ +L +  V     
Sbjct: 59  LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 57  QILNGLTYLHERN-----VVHREIKCANILVDAS--------GLATTTND----VKSFEG 99
           Q+   L   H R+     V+HR++K AN+ +D          GLA   N      K F G
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVG 178
Query: 100 TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV 159
           TP++++PE +N     Y   +DIWSLGC + E+    PP++     +   +I  GK   +
Sbjct: 179 TPYYMSPEQMN--RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236
Query: 160 PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           P   S +  + I + L +    RP+  +++E+P +
Sbjct: 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 108/208 (51%), Gaps = 23/208 (11%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
            +H NIV+   +  +E   Y+  +LV  G L  ++  + + S++  S   +QIL  + + 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 137
Query: 66  HERNVVHREIKCANILVDAS-----------GLATTTNDVK----SFEGTPFWVAPEVVN 110
           H+  VVHR++K  N+L+ +            GLA      +     F GTP +++PEV  
Sbjct: 138 HQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV-- 195
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF---RIGRGKLPSVP-NSLSRD 166
           L+ + YG   D+W+ G  +  +L   PP+   ED   L+   + G    PS   ++++ +
Sbjct: 196 LRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPE 254
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+D I K L +NP+ R TAA+ ++HP++
Sbjct: 255 AKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD-SQVSSYTRQILNGLTYL 65
           +EH  +     T + +  L+  +E +  G L    Q  H  D S+ + Y  +I+ GL +L
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 135
Query: 66  HERNVVHREIKCANILVDASGLATTTN----------DVKS--FEGTPFWVAPEVVNLKN 113
           H + +V+R++K  NIL+D  G     +          D K+  F GTP ++APE+  L  
Sbjct: 136 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEI--LLG 193
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             Y  S D WS G  + EML  Q P+ H +D + LF   R   P  P  L ++A+D ++K
Sbjct: 194 QKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 252
Query: 174 CLQVNPNDR-PTAAQLMEHPFVK 195
                P  R      + +HP  +
Sbjct: 253 LFVREPEKRLGVRGDIRQHPLFR 275

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD-SQVSSYTRQILNGLTYL 65
           +EH  +     T + +  L+  +E +  G L    Q  H  D S+ + Y  +I+ GL +L
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 66  HERNVVHREIKCANILVDASGLATTTN----------DVKS--FEGTPFWVAPEVVNLKN 113
           H + +V+R++K  NIL+D  G     +          D K+  F GTP ++APE+  L  
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEI--LLG 192
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             Y  S D WS G  + EML  Q P+ H +D + LF   R   P  P  L ++A+D ++K
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 251
Query: 174 CLQVNPNDR-PTAAQLMEHPFVK 195
                P  R      + +HP  +
Sbjct: 252 LFVREPEKRLGVRGDIRQHPLFR 274

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 23/208 (11%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
            +H NIV+   +  +E   Y+  +LV  G L  ++  + + S++  S   +QIL  + + 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 66  HERNVVHREIKCANILVDAS-----------GLATTTNDVK----SFEGTPFWVAPEVVN 110
           H+  VVHR +K  N+L+ +            GLA      +     F GTP +++PEV  
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV-- 184
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF---RIGRGKLPSVP-NSLSRD 166
           L+ + YG   D+W+ G  +  +L   PP+   ED   L+   + G    PS   ++++ +
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPE 243
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+D I K L +NP+ R TAA+ ++HP++
Sbjct: 244 AKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 44/235 (18%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV-SSYTRQILNGL 62
             Q  H+N+V  +   K + R Y+  E V    L +L    +  D QV   Y  QI+NG+
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN-----------DVKSFE-GTPFWVAPEVVN 110
            + H  N++HR+IK  NILV  SG+    +           +V   E  T ++ APE++ 
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL- 196
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI------------------- 151
           + +  YG + D+W++GC V EM   +P +    D+  L+ I                   
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256
Query: 152 --GRGKLPSVPN---------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                +LP +            LS    D   KCL ++P+ RP  A+L+ H F +
Sbjct: 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 90.1 bits (222), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 99/195 (50%), Gaps = 20/195 (10%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDS---QVSSYTRQILNGLT 63
            +HD +V+       E  +YI  E + KGSL +  +    S     ++  ++ QI  G+ 
Sbjct: 67  LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 125
Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTT--NDVKSFEGTPF---WVAPEVVN 110
           ++ +RN +HR+++ ANILV AS        GLA     N+  + EG  F   W APE +N
Sbjct: 126 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 185
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
                + + +D+WS G  ++E++T+ + PY  + + + +  + RG     P +   +  +
Sbjct: 186 F--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 243
Query: 170 FILKCLQVNPNDRPT 184
            +++C +  P +RPT
Sbjct: 244 IMMRCWKNRPEERPT 258

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 99/195 (50%), Gaps = 20/195 (10%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDS---QVSSYTRQILNGLT 63
            +HD +V+       E  +YI  E + KGSL +  +    S     ++  ++ QI  G+ 
Sbjct: 240 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTT--NDVKSFEGTPF---WVAPEVVN 110
           ++ +RN +HR+++ ANILV AS        GLA     N+  + EG  F   W APE +N
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 358
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
                + + +D+WS G  ++E++T+ + PY  + + + +  + RG     P +   +  +
Sbjct: 359 F--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 416
Query: 170 FILKCLQVNPNDRPT 184
            +++C +  P +RPT
Sbjct: 417 IMMRCWKNRPEERPT 431

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           + +H+NIV      +  N LY+ ++LV  G L + + +K   ++   S+  RQ+L+ + Y
Sbjct: 76  KIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYY 135
Query: 65  LHERNVVHREIKCAN-----------ILVDASGLATT--TNDVKSFE-GTPFWVAPEVVN 110
           LH   +VHR++K  N           I++   GL+      DV S   GTP +VAPEV  
Sbjct: 136 LHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEV-- 193
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP-SVP--NSLSRDA 167
           L    Y  + D WS+G     +L   PP+    D +   +I + +     P  + +S  A
Sbjct: 194 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSA 253
Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +DFI   ++ +PN R T  Q   HP++
Sbjct: 254 KDFIRNLMEKDPNKRYTCEQAARHPWI 280

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY----HLSDSQVSSYTRQIL 59
             +  H NIV ++G       L I  E + +GSL  L  K      L + +  S    + 
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 60  NGLTYLHERN--VVHREIKCANILVDAS--------GL----ATTTNDVKSFEGTPFWVA 105
            G+ YLH RN  +VHR +K  N+LVD          GL    A+T    KS  GTP W+A
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG-RGKLPSVPNSLS 164
           PEV  L++      +D++S G  + E+ T Q P+ +L   Q +  +G + K   +P +L+
Sbjct: 208 PEV--LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 265
Query: 165 RDARDFILKCLQVNPNDRPTAAQLME--HPFVK 195
                 I  C    P  RP+ A +M+   P +K
Sbjct: 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 99/189 (52%), Gaps = 21/189 (11%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+R+IK  N++
Sbjct: 78  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137
Query: 82  VDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D  G    T+             +K+F GTP ++APEV  L++N YG + D W LG  +
Sbjct: 138 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--LEDNDYGRAVDWWGLGVVM 195
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----PT 184
            EM+  + P+ + +D + LF +   +    P +LS +A+  +   L+ +P  R       
Sbjct: 196 YEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 185 AAQLMEHPF 193
           A ++MEH F
Sbjct: 255 AKEVMEHRF 263

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 99/189 (52%), Gaps = 21/189 (11%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+R+IK  N++
Sbjct: 78  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137
Query: 82  VDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D  G    T+             +K+F GTP ++APEV  L++N YG + D W LG  +
Sbjct: 138 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--LEDNDYGRAVDWWGLGVVM 195
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----PT 184
            EM+  + P+ + +D + LF +   +    P +LS +A+  +   L+ +P  R       
Sbjct: 196 YEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 185 AAQLMEHPF 193
           A ++MEH F
Sbjct: 255 AKEVMEHRF 263

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 99/189 (52%), Gaps = 21/189 (11%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+R+IK  N++
Sbjct: 81  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 140
Query: 82  VDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D  G    T+             +K+F GTP ++APEV  L++N YG + D W LG  +
Sbjct: 141 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--LEDNDYGRAVDWWGLGVVM 198
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----PT 184
            EM+  + P+ + +D + LF +   +    P +LS +A+  +   L+ +P  R       
Sbjct: 199 YEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 257
Query: 185 AAQLMEHPF 193
           A ++MEH F
Sbjct: 258 AKEVMEHRF 266

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 98/189 (51%), Gaps = 21/189 (11%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+R+IK  N++
Sbjct: 78  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137
Query: 82  VDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D  G    T+             +K F GTP ++APEV  L++N YG + D W LG  +
Sbjct: 138 LDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV--LEDNDYGRAVDWWGLGVVM 195
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----PT 184
            EM+  + P+ + +D + LF +   +    P +LS +A+  +   L+ +P  R       
Sbjct: 196 YEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 185 AAQLMEHPF 193
           A ++MEH F
Sbjct: 255 AKEVMEHRF 263

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 98/189 (51%), Gaps = 21/189 (11%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+R+IK  N++
Sbjct: 83  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 142
Query: 82  VDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D  G    T+             +K F GTP ++APEV  L++N YG + D W LG  +
Sbjct: 143 LDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV--LEDNDYGRAVDWWGLGVVM 200
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----PT 184
            EM+  + P+ + +D + LF +   +    P +LS +A+  +   L+ +P  R       
Sbjct: 201 YEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 259
Query: 185 AAQLMEHPF 193
           A ++MEH F
Sbjct: 260 AKEVMEHRF 268

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 98/189 (51%), Gaps = 21/189 (11%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+R+IK  N++
Sbjct: 78  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137
Query: 82  VDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D  G    T+             +K F GTP ++APEV  L++N YG + D W LG  +
Sbjct: 138 LDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV--LEDNDYGRAVDWWGLGVVM 195
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----PT 184
            EM+  + P+ + +D + LF +   +    P +LS +A+  +   L+ +P  R       
Sbjct: 196 YEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 185 AAQLMEHPF 193
           A ++MEH F
Sbjct: 255 AKEVMEHRF 263

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 98/189 (51%), Gaps = 21/189 (11%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+R+IK  N++
Sbjct: 78  DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137
Query: 82  VDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D  G    T+             +K F GTP ++APEV  L++N YG + D W LG  +
Sbjct: 138 LDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV--LEDNDYGRAVDWWGLGVVM 195
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----PT 184
            EM+  + P+ + +D + LF +   +    P +LS +A+  +   L+ +P  R       
Sbjct: 196 YEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254
Query: 185 AAQLMEHPF 193
           A ++MEH F
Sbjct: 255 AKEVMEHRF 263

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 20/195 (10%)
Query: 21  DENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN 79
           D    YI LEL++ G L + +     L ++    Y  Q+L  + YLHE  ++HR++K  N
Sbjct: 85  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 144
Query: 80  ILVDA--------------SGLATTTNDVKSFEGTPFWVAPEV-VNLKNNGYGLSADIWS 124
           +L+ +              S +   T+ +++  GTP ++APEV V++   GY  + D WS
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 125 LGCTVLEMLTHQPPYS-HLEDMQALFRIGRGK---LPSVPNSLSRDARDFILKCLQVNPN 180
           LG  +   L+  PP+S H   +    +I  GK   +P V   +S  A D + K L V+P 
Sbjct: 205 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 181 DRPTAAQLMEHPFVK 195
            R T  + + HP+++
Sbjct: 265 ARFTTEEALRHPWLQ 279

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 20/195 (10%)
Query: 21  DENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN 79
           D    YI LEL++ G L + +     L ++    Y  Q+L  + YLHE  ++HR++K  N
Sbjct: 85  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 144
Query: 80  ILVDA--------------SGLATTTNDVKSFEGTPFWVAPEV-VNLKNNGYGLSADIWS 124
           +L+ +              S +   T+ +++  GTP ++APEV V++   GY  + D WS
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 125 LGCTVLEMLTHQPPYS-HLEDMQALFRIGRGK---LPSVPNSLSRDARDFILKCLQVNPN 180
           LG  +   L+  PP+S H   +    +I  GK   +P V   +S  A D + K L V+P 
Sbjct: 205 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 181 DRPTAAQLMEHPFVK 195
            R T  + + HP+++
Sbjct: 265 ARFTTEEALRHPWLQ 279

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 20/195 (10%)
Query: 21  DENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN 79
           D    YI LEL++ G L + +     L ++    Y  Q+L  + YLHE  ++HR++K  N
Sbjct: 85  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 144
Query: 80  ILVDA--------------SGLATTTNDVKSFEGTPFWVAPEV-VNLKNNGYGLSADIWS 124
           +L+ +              S +   T+ +++  GTP ++APEV V++   GY  + D WS
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 125 LGCTVLEMLTHQPPYS-HLEDMQALFRIGRGK---LPSVPNSLSRDARDFILKCLQVNPN 180
           LG  +   L+  PP+S H   +    +I  GK   +P V   +S  A D + K L V+P 
Sbjct: 205 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 181 DRPTAAQLMEHPFVK 195
            R T  + + HP+++
Sbjct: 265 ARFTTEEALRHPWLQ 279

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 20/195 (10%)
Query: 21  DENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN 79
           D    YI LEL++ G L + +     L ++    Y  Q+L  + YLHE  ++HR++K  N
Sbjct: 84  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 143
Query: 80  ILVDA--------------SGLATTTNDVKSFEGTPFWVAPEV-VNLKNNGYGLSADIWS 124
           +L+ +              S +   T+ +++  GTP ++APEV V++   GY  + D WS
Sbjct: 144 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 203
Query: 125 LGCTVLEMLTHQPPYS-HLEDMQALFRIGRGK---LPSVPNSLSRDARDFILKCLQVNPN 180
           LG  +   L+  PP+S H   +    +I  GK   +P V   +S  A D + K L V+P 
Sbjct: 204 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 263
Query: 181 DRPTAAQLMEHPFVK 195
            R T  + + HP+++
Sbjct: 264 ARFTTEEALRHPWLQ 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 20/195 (10%)
Query: 21  DENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN 79
           D    YI LEL++ G L + +     L ++    Y  Q+L  + YLHE  ++HR++K  N
Sbjct: 91  DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 150
Query: 80  ILVDA--------------SGLATTTNDVKSFEGTPFWVAPEV-VNLKNNGYGLSADIWS 124
           +L+ +              S +   T+ +++  GTP ++APEV V++   GY  + D WS
Sbjct: 151 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 210
Query: 125 LGCTVLEMLTHQPPYS-HLEDMQALFRIGRGK---LPSVPNSLSRDARDFILKCLQVNPN 180
           LG  +   L+  PP+S H   +    +I  GK   +P V   +S  A D + K L V+P 
Sbjct: 211 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 270
Query: 181 DRPTAAQLMEHPFVK 195
            R T  + + HP+++
Sbjct: 271 ARFTTEEALRHPWLQ 285

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 88.2 bits (217), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 20/195 (10%)
Query: 21  DENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN 79
           D    YI LEL++ G L + +     L ++    Y  Q+L  + YLHE  ++HR++K  N
Sbjct: 224 DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 283
Query: 80  ILVDA--------------SGLATTTNDVKSFEGTPFWVAPEV-VNLKNNGYGLSADIWS 124
           +L+ +              S +   T+ +++  GTP ++APEV V++   GY  + D WS
Sbjct: 284 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 343
Query: 125 LGCTVLEMLTHQPPYS-HLEDMQALFRIGRGK---LPSVPNSLSRDARDFILKCLQVNPN 180
           LG  +   L+  PP+S H   +    +I  GK   +P V   +S  A D + K L V+P 
Sbjct: 344 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 403
Query: 181 DRPTAAQLMEHPFVK 195
            R T  + + HP+++
Sbjct: 404 ARFTTEEALRHPWLQ 418

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 23/208 (11%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
            +H NIV+   +  +E   Y+  +LV  G L  ++  + + S++  S    QIL  + ++
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHI 146
Query: 66  HERNVVHREIKCANILVDAS-----------GLATTTNDVK----SFEGTPFWVAPEVVN 110
           H+ ++VHR++K  N+L+ +            GLA      +     F GTP +++PEV  
Sbjct: 147 HQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEV-- 204
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF---RIGRGKLPSVP-NSLSRD 166
           L+ + YG   DIW+ G  +  +L   PP+   ED   L+   + G    PS   ++++ +
Sbjct: 205 LRKDPYGKPVDIWACGVILYILLVGYPPFWD-EDQHKLYQQIKAGAYDFPSPEWDTVTPE 263
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A++ I + L +NP  R TA Q ++HP+V
Sbjct: 264 AKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNG 61
            +Q  H  ++      +D+  + + LE +  G L +    + Y +S+++V +Y RQ   G
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161
Query: 62  LTYLHERNVVHREIKCANILVDAS----------GLATTTND---VKSFEGTPFWVAPEV 108
           L ++HE ++VH +IK  NI+ +            GLAT  N    VK    T  + APE+
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSR 165
           V+      G   D+W++G     +L+   P++  +D++ L  + R          +S+S 
Sbjct: 222 VD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279
Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +A+DFI   LQ  P  R T    +EHP++K
Sbjct: 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 87.8 bits (216), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 20/195 (10%)
Query: 21  DENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN 79
           D    YI LEL++ G L + +     L ++    Y  Q+L  + YLHE  ++HR++K  N
Sbjct: 210 DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 269
Query: 80  ILVDA--------------SGLATTTNDVKSFEGTPFWVAPEV-VNLKNNGYGLSADIWS 124
           +L+ +              S +   T+ +++  GTP ++APEV V++   GY  + D WS
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 329
Query: 125 LGCTVLEMLTHQPPYS-HLEDMQALFRIGRGK---LPSVPNSLSRDARDFILKCLQVNPN 180
           LG  +   L+  PP+S H   +    +I  GK   +P V   +S  A D + K L V+P 
Sbjct: 330 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 389
Query: 181 DRPTAAQLMEHPFVK 195
            R T  + + HP+++
Sbjct: 390 ARFTTEEALRHPWLQ 404

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 19/200 (9%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV-SSYTRQILNGLTYLHERN- 69
           IV + G    +  + I +E +  GSL  + +K      Q+    +  ++ GLTYL E++ 
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 128
Query: 70  VVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           ++HR++K +NILV++ G     +              F GT  +++PE   L+   Y + 
Sbjct: 129 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPE--RLQGTHYSVQ 186
Query: 120 ADIWSLGCTVLEMLTHQ---PPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
           +DIWS+G +++EM   +   PP +  E +  +      KLPS   SL  + +DF+ KCL 
Sbjct: 187 SDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSL--EFQDFVNKCLI 244
Query: 177 VNPNDRPTAAQLMEHPFVKR 196
            NP +R    QLM H F+KR
Sbjct: 245 KNPAERADLKQLMVHAFIKR 264

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV-SSYTRQILNGLTYLHERN- 69
           IV + G    +  + I +E +  GSL  + +K      Q+    +  ++ GLTYL E++ 
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 144
Query: 70  VVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           ++HR++K +NILV++ G     +             SF GT  +++PE   L+   Y + 
Sbjct: 145 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 202
Query: 120 ADIWSLGCTVLEMLTHQPPYSHLEDMQALFR----IGRGKLPSVPNSL-SRDARDFILKC 174
           +DIWS+G +++EM   + P        A+F     I     P +P+ + S + +DF+ KC
Sbjct: 203 SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 262
Query: 175 LQVNPNDRPTAAQLMEHPFVKR 196
           L  NP +R    QLM H F+KR
Sbjct: 263 LIKNPAERADLKQLMVHAFIKR 284

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q +H NI++     +D+   Y+  E+   G L + +  +   S+   +   RQ+L+G+
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 145
Query: 63  TYLHERNVVHREIKCANILVDAS-----------GLAT---TTNDVKSFEGTPFWVAPEV 108
           TY+H+  +VHR++K  N+L+++            GL+T    +  +K   GT +++APEV
Sbjct: 146 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 205
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK----LPSVPNSLS 164
           +   +  Y    D+WS G  +  +L+  PP++   +   L ++ +GK    LP     +S
Sbjct: 206 L---HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW-KKVS 261
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+D I K L   P+ R +A   ++H +++
Sbjct: 262 ESAKDLIRKMLTYVPSMRISARDALDHEWIQ 292

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 21/209 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           +  H NI+      +++  + + LELV  G L + L +K  L++ + + + +QIL+G+ Y
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 65  LHERNVVHREIKCANI-LVDAS-----------GLA---TTTNDVKSFEGTPFWVAPEVV 109
           LH + + H ++K  NI L+D +           G+A      N+ K+  GTP +VAPE+V
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLSRD 166
           N +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S  
Sbjct: 184 NYEP--LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           A+DFI + L  +P  R T AQ +EH ++K
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 95/185 (51%), Gaps = 10/185 (5%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDS---QVSSYTRQILNGLT 63
            +HD +V+       E  +YI  E + KGSL +  +    S     ++  ++ QI  G+ 
Sbjct: 234 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 292
Query: 64  YLHERNVVHREIKCANILVDASGLATTTNDVKSFEGTPF---WVAPEVVNLKNNGYGLSA 120
           ++ +RN +HR+++ ANILV AS +    +   +  G  F   W APE +N     + + +
Sbjct: 293 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWTAPEAINF--GSFTIKS 350
Query: 121 DIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNP 179
           D+WS G  ++E++T+ + PY  + + + +  + RG     P +   +  + +++C +  P
Sbjct: 351 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRP 410
Query: 180 NDRPT 184
            +RPT
Sbjct: 411 EERPT 415

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTY 64
           + +H NIV+   + ++E+  Y+  +LV  G L  ++  +   S++  S   +QIL  + Y
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 65  LHERNVVHREIKCANILVDAS-----------GLATTTNDVKS---FEGTPFWVAPEVVN 110
            H   +VHR +K  N+L+ +            GLA   ND ++   F GTP +++PEV  
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-- 178
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF---RIGRGKLPSVP-NSLSRD 166
           LK + Y    DIW+ G  +  +L   PP+   ED   L+   + G    PS   ++++ +
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPE 237
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+  I   L VNP  R TA Q ++ P++
Sbjct: 238 AKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTY 64
           + +H NIV+   + ++E+  Y+  +LV  G L  ++  +   S++  S   +QIL  + Y
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 65  LHERNVVHREIKCANILVDAS-----------GLATTTNDVKS---FEGTPFWVAPEVVN 110
            H   +VHR +K  N+L+ +            GLA   ND ++   F GTP +++PEV  
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-- 178
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF---RIGRGKLPSVP-NSLSRD 166
           LK + Y    DIW+ G  +  +L   PP+   ED   L+   + G    PS   ++++ +
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPE 237
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+  I   L VNP  R TA Q ++ P++
Sbjct: 238 AKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 87.0 bits (214), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTY 64
           + +H NIV+   + ++E+  Y+  +LV  G L  ++  +   S++  S   +QIL  + Y
Sbjct: 60  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 119
Query: 65  LHERNVVHREIKCANILVDAS-----------GLATTTNDVKS---FEGTPFWVAPEVVN 110
            H   +VHR +K  N+L+ +            GLA   ND ++   F GTP +++PEV  
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-- 177
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF---RIGRGKLPSVP-NSLSRD 166
           LK + Y    DIW+ G  +  +L   PP+   ED   L+   + G    PS   ++++ +
Sbjct: 178 LKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPE 236
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+  I   L VNP  R TA Q ++ P++
Sbjct: 237 AKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 87.0 bits (214), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 107/210 (50%), Gaps = 21/210 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q +H NI++     +D+   Y+  E+   G L + +  +   S+   +   RQ+L+G+
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 63  TYLHERNVVHREIKCANILVDAS-----------GLAT---TTNDVKSFEGTPFWVAPEV 108
           TY+H+  +VHR++K  N+L+++            GL+T    +  +K   GT +++APEV
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 199
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP-SVP--NSLSR 165
           +   +  Y    D+WS G  +  +L+  PP++   +   L ++ +GK    +P    +S 
Sbjct: 200 L---HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256
Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
            A+D I K L   P+ R +A   ++H +++
Sbjct: 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQ 286

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTY 64
           + +H NIV+   + ++E+  Y+  +LV  G L  ++  +   S++  S   +QIL  + Y
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 143
Query: 65  LHERNVVHREIKCANILVDAS-----------GLATTTNDVKS---FEGTPFWVAPEVVN 110
            H   +VHR +K  N+L+ +            GLA   ND ++   F GTP +++PEV  
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-- 201
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF---RIGRGKLPSVP-NSLSRD 166
           LK + Y    DIW+ G  +  +L   PP+   ED   L+   + G    PS   ++++ +
Sbjct: 202 LKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPE 260
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+  I   L VNP  R TA Q ++ P++
Sbjct: 261 AKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 86.7 bits (213), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q +H NI++     +D+   Y+  E+   G L + +  +   S+   +   RQ+L+G+
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 163
Query: 63  TYLHERNVVHREIKCANILVDAS-----------GLAT---TTNDVKSFEGTPFWVAPEV 108
           TY+H+  +VHR++K  N+L+++            GL+T    +  +K   GT +++APEV
Sbjct: 164 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 223
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK----LPSVPNSLS 164
           +   +  Y    D+WS G  +  +L+  PP++   +   L ++ +GK    LP     +S
Sbjct: 224 L---HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK-VS 279
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+D I K L   P+ R +A   ++H +++
Sbjct: 280 ESAKDLIRKMLTYVPSMRISARDALDHEWIQ 310

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 86.7 bits (213), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q +H NI++     +D+   Y+  E+   G L + +  +   S+   +   RQ+L+G+
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 162
Query: 63  TYLHERNVVHREIKCANILVDAS-----------GLAT---TTNDVKSFEGTPFWVAPEV 108
           TY+H+  +VHR++K  N+L+++            GL+T    +  +K   GT +++APEV
Sbjct: 163 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 222
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK----LPSVPNSLS 164
           +   +  Y    D+WS G  +  +L+  PP++   +   L ++ +GK    LP     +S
Sbjct: 223 L---HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK-VS 278
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+D I K L   P+ R +A   ++H +++
Sbjct: 279 ESAKDLIRKMLTYVPSMRISARDALDHEWIQ 309

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 23/208 (11%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
            +H NIV+   +  +E   Y+  +LV  G L  ++  + + S++  S   +QIL  + + 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 66  HERNVVHREIKCANILV--DASGLATTTNDVK-------------SFEGTPFWVAPEVVN 110
           H   +VHR++K  N+L+   + G A    D                F GTP +++PEV  
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEV-- 177
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF---RIGRGKLPSVP-NSLSRD 166
           L+ + YG   D+W+ G  +  +L   PP+   ED   L+   + G    PS   ++++ +
Sbjct: 178 LRKDPYGKPVDMWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPE 236
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+D I K L +NP  R TA++ ++HP++
Sbjct: 237 AKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 86.7 bits (213), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           Q  H NI+      ++   + + LELV  G L + L QK  LS+ + +S+ +QIL+G+ Y
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 65  LHERNVVHREIKCANI-LVDAS-----------GLATTTNDVKSFE---GTPFWVAPEVV 109
           LH + + H ++K  NI L+D +           GLA    D   F+   GTP +VAPE+V
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLSRD 166
           N +    GL AD+WS+G     +L+   P+   +  E +  +  +         +  S  
Sbjct: 191 NYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+DFI K L      R T  + + HP++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 4   FSQFEHDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNG 61
             + +H N+V+ +    D  E+ LY+  ELV +G +  +     LS+ Q   Y + ++ G
Sbjct: 90  LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKG 149
Query: 62  LTYLHERNVVHREIKCANILVDASGLAT-----TTNDVKSFE-------GTPFWVAPEVV 109
           + YLH + ++HR+IK +N+LV   G         +N+ K  +       GTP ++APE +
Sbjct: 150 IEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESL 209
Query: 110 NLKNNGY-GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL--PSVPNSLSRD 166
           +     + G + D+W++G T+   +  Q P+     M    +I    L  P  P+ ++ D
Sbjct: 210 SETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPD-IAED 268
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
            +D I + L  NP  R    ++  HP+V R
Sbjct: 269 LKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
            +H NIV+   +  +E   Y+  +LV  G L  ++  + + S++  S   +QIL  + + 
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 66  HERNVVHREIKCANILV--DASGLATTTNDVK-------------SFEGTPFWVAPEVVN 110
           H+  VVHR++K  N+L+     G A    D                F GTP +++PEV  
Sbjct: 120 HQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEV-- 177
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF---RIGRGKLPSVP-NSLSRD 166
           L+   YG   DIW+ G  +  +L   PP+   ED   L+   + G    PS   ++++ +
Sbjct: 178 LRKEAYGKPVDIWACGVILYILLVGYPPFWD-EDQHKLYQQIKAGAYDFPSPEWDTVTPE 236
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A++ I + L +NP  R TA + ++HP+V
Sbjct: 237 AKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 23/208 (11%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
            +H NIV+   +  +E   Y+  +LV  G L  ++  + + S++  S   +QIL  + + 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 66  HERNVVHREIKCANILV--DASGLATTTNDVK-------------SFEGTPFWVAPEVVN 110
           H   +VHR++K  N+L+   + G A    D                F GTP +++PEV  
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEV-- 177
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF---RIGRGKLPSVP-NSLSRD 166
           L+ + YG   D+W+ G  +  +L   PP+   ED   L+   + G    PS   ++++ +
Sbjct: 178 LRKDPYGKPVDMWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPE 236
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+D I K L +NP  R TA++ ++HP++
Sbjct: 237 AKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           Q  H N++      ++   + + LELV  G L + L QK  LS+ + +S+ +QIL+G+ Y
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 65  LHERNVVHREIKCANI-LVDAS-----------GLATTTNDVKSFE---GTPFWVAPEVV 109
           LH + + H ++K  NI L+D +           GLA    D   F+   GTP +VAPE+V
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLSRD 166
           N +    GL AD+WS+G     +L+   P+   +  E +  +  +         +  S  
Sbjct: 191 NYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+DFI K L      R T  + + HP++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           Q  H N++      ++   + + LELV  G L + L QK  LS+ + +S+ +QIL+G+ Y
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 65  LHERNVVHREIKCANI-LVDAS-----------GLATTTNDVKSFE---GTPFWVAPEVV 109
           LH + + H ++K  NI L+D +           GLA    D   F+   GTP +VAPE+V
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLSRD 166
           N +    GL AD+WS+G     +L+   P+   +  E +  +  +         +  S  
Sbjct: 191 NYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+DFI K L      R T  + + HP++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           Q  H N++      ++   + + LELV  G L + L QK  LS+ + +S+ +QIL+G+ Y
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 65  LHERNVVHREIKCANI-LVDAS-----------GLATTTNDVKSFE---GTPFWVAPEVV 109
           LH + + H ++K  NI L+D +           GLA    D   F+   GTP +VAPE+V
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLSRD 166
           N +    GL AD+WS+G     +L+   P+   +  E +  +  +         +  S  
Sbjct: 191 NYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+DFI K L      R T  + + HP++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY----HLSDSQVSSYTRQIL 59
             +  H NIV ++G       L I  E + +GSL  L  K      L + +  S    + 
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 60  NGLTYLHERN--VVHREIKCANILVDAS--------GL----ATTTNDVKSFEGTPFWVA 105
            G+ YLH RN  +VHR++K  N+LVD          GL    A+     K   GTP W+A
Sbjct: 148 KGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMA 207
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG-RGKLPSVPNSLS 164
           PEV  L++      +D++S G  + E+ T Q P+ +L   Q +  +G + K   +P +L+
Sbjct: 208 PEV--LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN 265
Query: 165 RDARDFILKCLQVNPNDRPTAAQLME--HPFVK 195
                 I  C    P  RP+ A +M+   P +K
Sbjct: 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           Q  H N++      ++   + + LELV  G L + L QK  LS+ + +S+ +QIL+G+ Y
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 65  LHERNVVHREIKCANI-LVDAS-----------GLATTTNDVKSFE---GTPFWVAPEVV 109
           LH + + H ++K  NI L+D +           GLA    D   F+   GTP +VAPE+V
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLSRD 166
           N +    GL AD+WS+G     +L+   P+   +  E +  +  +         +  S  
Sbjct: 191 NYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+DFI K L      R T  + + HP++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           Q  H N++      ++   + + LELV  G L + L QK  LS+ + +S+ +QIL+G+ Y
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 65  LHERNVVHREIKCANI-LVDAS-----------GLATTTNDVKSFE---GTPFWVAPEVV 109
           LH + + H ++K  NI L+D +           GLA    D   F+   GTP +VAPE+V
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLSRD 166
           N +    GL AD+WS+G     +L+   P+   +  E +  +  +         +  S  
Sbjct: 191 NYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+DFI K L      R T  + + HP++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 33/203 (16%)
Query: 22  ENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L YLHER +++R++K  N+
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184
Query: 81  LVDASGLATTT------------NDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           L+D+ G    T            +   +F GTP ++APE+  L+   YG S D W+LG  
Sbjct: 185 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI--LRGEDYGFSVDWWALGVL 242
Query: 129 VLEMLTHQPPYS----------HLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVN 178
           + EM+  + P+           + ED   LF++   K   +P SLS  A   +   L  +
Sbjct: 243 MFEMMAGRSPFDIVGSSDNPDQNTEDY--LFQVILEKQIRIPRSLSVKAASVLKSFLNKD 300
Query: 179 PNDRPTA------AQLMEHPFVK 195
           P +R         A +  HPF +
Sbjct: 301 PKERLGCHPQTGFADIQGHPFFR 323

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S   H NI++      D  R+Y+ LE   +G L    QK+   D Q S+ +  ++ + L 
Sbjct: 70  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 129
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y HER V+HR+IK  N+L+   G          +   +   +   GT  ++ PE++  K 
Sbjct: 130 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKT 189
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
           +      D+W  G    E L   PP+      +   RI    L   P  LS  ++D I K
Sbjct: 190 HDE--KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-KFPPFLSDGSKDLISK 246
Query: 174 CLQVNPNDRPTAAQLMEHPFVK 195
            L+ +P  R     +MEHP+VK
Sbjct: 247 LLRYHPPQRLPLKGVMEHPWVK 268

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 63  TYLHERNVVHREIKCANI-LVDAS-----------GLATTT---NDVKSFEGTPFWVAPE 107
            YLH   + H ++K  NI L+D +           GLA      N+ K+  GTP +VAPE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLS 164
           +VN +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S
Sbjct: 188 IVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+DFI + L  +P  R T    ++HP++K
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S   H NI++      D  R+Y+ LE   +G L    QK+   D Q S+ +  ++ + L 
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 64  YLHERNVVHREIKCANILVDASG----------LATTTNDVKSFEGTPFWVAPEVVNLKN 113
           Y HER V+HR+IK  N+L+   G          +   +   +   GT  ++ PE++  K 
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKT 188
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
           +      D+W  G    E L   PP+      +   RI    L   P  LS  ++D I K
Sbjct: 189 HDE--KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-KFPPFLSDGSKDLISK 245
Query: 174 CLQVNPNDRPTAAQLMEHPFVK 195
            L+ +P  R     +MEHP+VK
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVK 267

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           +  H NI+      +++  + + LELV  G L + L +K  L++ + + + +QIL+G+ Y
Sbjct: 85  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 144
Query: 65  LHERNVVHREIKCANI-LVDAS-----------GLA---TTTNDVKSFEGTPFWVAPEVV 109
           LH + + H ++K  NI L+D +           G+A      N+ K+  GTP +VAPE+V
Sbjct: 145 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 204
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLSRD 166
           N +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S  
Sbjct: 205 NYEP--LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 262
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           A+DFI + L  +P  R   AQ +EH ++K
Sbjct: 263 AKDFIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           +  H NI+      +++  + + LELV  G L + L +K  L++ + + + +QIL+G+ Y
Sbjct: 71  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 130
Query: 65  LHERNVVHREIKCANI-LVDAS-----------GLA---TTTNDVKSFEGTPFWVAPEVV 109
           LH + + H ++K  NI L+D +           G+A      N+ K+  GTP +VAPE+V
Sbjct: 131 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 190
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLSRD 166
           N +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S  
Sbjct: 191 NYEP--LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 248
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           A+DFI + L  +P  R   AQ +EH ++K
Sbjct: 249 AKDFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 63  TYLHERNVVHREIKCANI-LVDAS-----------GLATTT---NDVKSFEGTPFWVAPE 107
            YLH   + H ++K  NI L+D +           GLA      N+ K+  GTP +VAPE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLS 164
           +VN +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S
Sbjct: 187 IVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+DFI + L  +P  R T    ++HP++K
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 29/206 (14%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDS-----QVSSYTRQILNGLT 63
           H NI+ ++G    +N L I  +  +  SL   Y+  H+ ++     Q+    RQ   G+ 
Sbjct: 91  HVNILLFMGYMTKDN-LAIVTQWCEGSSL---YKHLHVQETKFQMFQLIDIARQTAQGMD 146
Query: 64  YLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVV 109
           YLH +N++HR++K  NI +           GLAT       +  V+   G+  W+APEV+
Sbjct: 147 YLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI 206
Query: 110 NLK-NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-QALFRIGRG----KLPSVPNSL 163
            ++ NN +   +D++S G  + E++T + PYSH+ +  Q +F +GRG     L  +  + 
Sbjct: 207 RMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC 266
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
            +  +  +  C++    +RP   Q++
Sbjct: 267 PKAMKRLVADCVKKVKEERPLFPQIL 292

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 63  TYLHERNVVHREIKCANI-LVDAS-----------GLATTT---NDVKSFEGTPFWVAPE 107
            YLH   + H ++K  NI L+D +           GLA      N+ K+  GTP +VAPE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLS 164
           +VN +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S
Sbjct: 188 IVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+DFI + L  +P  R T    ++HP++K
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 63  TYLHERNVVHREIKCANI-LVDAS-----------GLATTT---NDVKSFEGTPFWVAPE 107
            YLH   + H ++K  NI L+D +           GLA      N+ K+  GTP +VAPE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLS 164
           +VN +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S
Sbjct: 188 IVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+DFI + L  +P  R T    ++HP++K
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 25/208 (12%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV-SSYTRQILNGLTYLHERN- 69
           IV + G    +  + I +E +  GSL  + +K      Q+    +  ++ GLTYL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 70  VVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           ++HR++K +NILV++ G     +             SF GT  +++PE   L+   Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 183
Query: 120 ADIWSLGCTVLEMLTHQ---PPYSHLEDMQ---ALFR----IGRGKLPSVPNSL-SRDAR 168
           +DIWS+G +++EM   +   PP    ED +   A+F     I     P +P+ + S + +
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 243
Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           DF+ KCL  NP +R    QLM H F+KR
Sbjct: 244 DFVNKCLIKNPAERADLKQLMVHAFIKR 271

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 63  TYLHERNVVHREIKCANI-LVDAS-----------GLATTT---NDVKSFEGTPFWVAPE 107
            YLH   + H ++K  NI L+D +           GLA      N+ K+  GTP +VAPE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLS 164
           +VN +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S
Sbjct: 188 IVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+DFI + L  +P  R T    ++HP++K
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 63  TYLHERNVVHREIKCANI-LVDAS-----------GLATTT---NDVKSFEGTPFWVAPE 107
            YLH   + H ++K  NI L+D +           GLA      N+ K+  GTP +VAPE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLS 164
           +VN +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S
Sbjct: 188 IVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+DFI + L  +P  R T    ++HP++K
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 33/203 (16%)
Query: 22  ENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L YLHER +++R++K  N+
Sbjct: 82  ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 141
Query: 81  LVDASGLATTTN-----------DVKS-FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           L+D+ G    T+           D  S F GTP ++APE+  L+   YG S D W+LG  
Sbjct: 142 LLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEI--LRGEDYGFSVDWWALGVL 199
Query: 129 VLEMLTHQPPYS----------HLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVN 178
           + EM+  + P+           + ED   LF++   K   +P SLS  A   +   L  +
Sbjct: 200 MFEMMAGRSPFDIVGSSDNPDQNTEDY--LFQVILEKQIRIPRSLSVKAASVLKSFLNKD 257
Query: 179 PNDRPTA------AQLMEHPFVK 195
           P +R         A +  HPF +
Sbjct: 258 PKERLGCHPQTGFADIQGHPFFR 280

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 63  TYLHERNVVHREIKCANI-LVDAS-----------GLATTT---NDVKSFEGTPFWVAPE 107
            YLH   + H ++K  NI L+D +           GLA      N+ K+  GTP +VAPE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLS 164
           +VN +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S
Sbjct: 188 IVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+DFI + L  +P  R T    ++HP++K
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 33/203 (16%)
Query: 22  ENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L YLHER +++R++K  N+
Sbjct: 78  ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 137
Query: 81  LVDASGLATTTN-----------DVKS-FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           L+D+ G    T+           D  S F GTP ++APE+  L+   YG S D W+LG  
Sbjct: 138 LLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEI--LRGEDYGFSVDWWALGVL 195
Query: 129 VLEMLTHQPPYS----------HLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVN 178
           + EM+  + P+           + ED   LF++   K   +P SLS  A   +   L  +
Sbjct: 196 MFEMMAGRSPFDIVGSSDNPDQNTEDY--LFQVILEKQIRIPRSLSVKAASVLKSFLNKD 253
Query: 179 PNDRPTA------AQLMEHPFVK 195
           P +R         A +  HPF +
Sbjct: 254 PKERLGCHPQTGFADIQGHPFFR 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+
Sbjct: 67  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 63  TYLHERNVVHREIKCANI-LVDAS-----------GLATTT---NDVKSFEGTPFWVAPE 107
            YLH   + H ++K  NI L+D +           GLA      N+ K+  GTP +VAPE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLS 164
           +VN +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S
Sbjct: 187 IVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+DFI + L  +P  R T    ++HP++K
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 63  TYLHERNVVHREIKCANI-LVDAS-----------GLATTT---NDVKSFEGTPFWVAPE 107
            YLH   + H ++K  NI L+D +           GLA      N+ K+  GTP +VAPE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLS 164
           +VN +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S
Sbjct: 188 IVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+DFI + L  +P  R T    ++HP++K
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 63  TYLHERNVVHREIKCANI-LVDAS-----------GLATTT---NDVKSFEGTPFWVAPE 107
            YLH   + H ++K  NI L+D +           GLA      N+ K+  GTP +VAPE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLS 164
           +VN +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S
Sbjct: 188 IVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+DFI + L  +P  R T    ++HP++K
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 63  TYLHERNVVHREIKCANI-LVDAS-----------GLATTT---NDVKSFEGTPFWVAPE 107
            YLH   + H ++K  NI L+D +           GLA      N+ K+  GTP +VAPE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLS 164
           +VN +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S
Sbjct: 188 IVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+DFI + L  +P  R T    ++HP++K
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           + +H+NIV      +     Y+ ++LV  G L + + ++   ++   S   +Q+L+ + Y
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 65  LHERNVVHREIKCANILV----DASGLATTTNDVKSFE---------GTPFWVAPEVVNL 111
           LHE  +VHR++K  N+L     + S +  T   +   E         GTP +VAPEV  L
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEV--L 179
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSRDAR 168
               Y  + D WS+G     +L   PP+    + +   +I  G         + +S  A+
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239
Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFV 194
           DFI   L+ +PN+R T  + + HP++
Sbjct: 240 DFICHLLEKDPNERYTCEKALSHPWI 265

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 63  TYLHERNVVHREIKCANI-LVDAS-----------GLATTT---NDVKSFEGTPFWVAPE 107
            YLH   + H ++K  NI L+D +           GLA      N+ K+  GTP +VAPE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLS 164
           +VN +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S
Sbjct: 188 IVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+DFI + L  +P  R T    ++HP++K
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 63  TYLHERNVVHREIKCANI-LVDAS-----------GLATTT---NDVKSFEGTPFWVAPE 107
            YLH   + H ++K  NI L+D +           GLA      N+ K+  GTP +VAPE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLS 164
           +VN +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S
Sbjct: 188 IVNYEP--LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+DFI + L  +P  R T    ++HP++K
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           +H NI++     +D+   Y+  E  + G L   +  ++   +   ++  +QIL+G+ YLH
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH 163
Query: 67  ERNVVHREIKCANILVDAS-----------GLAT-TTNDVKSFE--GTPFWVAPEVVNLK 112
           + N+VHR+IK  NIL++             GL++  + D K  +  GT +++APEV+  K
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK 223
Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN---SLSRDARD 169
              Y    D+WS G  +  +L   PP+    D   + ++ +GK     N   ++S +A++
Sbjct: 224 ---YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKE 280
Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKR 196
            I   L  + N R TA + +   ++K+
Sbjct: 281 LIKLMLTYDYNKRCTAEEALNSRWIKK 307

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 21/192 (10%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           +RLY  +E V  G L  ++ Q     + Q   Y  +I  GL +LH+R +++R++K  N++
Sbjct: 93  DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVM 152
Query: 82  VDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D+ G     +              + F GTP ++APE++  +   YG S D W+ G  +
Sbjct: 153 LDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQP--YGKSVDWWAYGVLL 210
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR----PTA 185
            EML  QPP+   ED   LF+       S P SLS++A       +  +P  R    P  
Sbjct: 211 YEMLAGQPPFDG-EDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPAKRLGCGPEG 269
Query: 186 AQ-LMEHPFVKR 196
            + + EH F +R
Sbjct: 270 ERDVREHAFFRR 281

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 14/194 (7%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+     + E  LY+ +E    G + + L     + + +  +  RQI++ + Y H+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 68  RNVVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPFWVAPEVVNLKNNGY 116
           + +VHR++K  N+L+DA           S   T  N + +F G+P + APE+   K    
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD- 190
Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
           G   D+WSLG  +  +++   P+      +   R+ RGK   +P  +S D  + + K L 
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLI 249
Query: 177 VNPNDRPTAAQLME 190
           +NP+ R T  Q+M+
Sbjct: 250 LNPSKRGTLEQIMK 263

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 14/194 (7%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+     + E  LY+ +E    G + + L     + + +  +  RQI++ + Y H+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 68  RNVVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPFWVAPEVVNLKNNGY 116
           + +VHR++K  N+L+DA           S   T  N + +F G+P + APE+   K    
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD- 190
Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
           G   D+WSLG  +  +++   P+      +   R+ RGK   +P  +S D  + + K L 
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLI 249
Query: 177 VNPNDRPTAAQLME 190
           +NP+ R T  Q+M+
Sbjct: 250 LNPSKRGTLEQIMK 263

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 33/203 (16%)
Query: 22  ENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L YLHER +++R++K  N+
Sbjct: 93  ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 152
Query: 81  LVDASGLATTTN-----------DVKS-FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           L+D+ G    T+           D  S F GTP ++APE+  L+   YG S D W+LG  
Sbjct: 153 LLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEI--LRGEDYGFSVDWWALGVL 210
Query: 129 VLEMLTHQPPYS----------HLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVN 178
           + EM+  + P+           + ED   LF++   K   +P S+S  A   +   L  +
Sbjct: 211 MFEMMAGRSPFDIVGSSDNPDQNTEDY--LFQVILEKQIRIPRSMSVKAASVLKSFLNKD 268
Query: 179 PNDRPTA------AQLMEHPFVK 195
           P +R         A +  HPF +
Sbjct: 269 PKERLGCLPQTGFADIQGHPFFR 291

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 14/194 (7%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+     + E  LY+ +E    G + + L     + + +  +  RQI++ + Y H+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 68  RNVVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPFWVAPEVVNLKNNGY 116
           + +VHR++K  N+L+DA           S   T  N + +F G+P + APE+   K    
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD- 190
Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
           G   D+WSLG  +  +++   P+      +   R+ RGK   +P  +S D  + + K L 
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLI 249
Query: 177 VNPNDRPTAAQLME 190
           +NP+ R T  Q+M+
Sbjct: 250 LNPSKRGTLEQIMK 263

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 22/197 (11%)
Query: 22  ENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           E +L++ L+ +  G L  +L Q+   ++ +V  Y  +I+  L +LH+  +++R+IK  NI
Sbjct: 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 190
Query: 81  LVDASG-------------LATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGC 127
           L+D++G             +A  T     F GT  ++AP++V   ++G+  + D WSLG 
Sbjct: 191 LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 250
Query: 128 TVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSRDARDFILKCLQVNPNDR-- 182
            + E+LT   P++   +  +   I R  L   P  P  +S  A+D I + L  +P  R  
Sbjct: 251 LMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLG 310
Query: 183 ---PTAAQLMEHPFVKR 196
                A ++ EH F ++
Sbjct: 311 CGPRDADEIKEHLFFQK 327

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q +H NI +     +D+   Y+  E+   G L + +  +   S+   +   RQ+L+G+
Sbjct: 80  LKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 63  TYLHERNVVHREIKCANILVDAS-----------GLAT---TTNDVKSFEGTPFWVAPEV 108
           TY H+  +VHR++K  N+L+++            GL+T    +   K   GT +++APEV
Sbjct: 140 TYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEV 199
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK----LPSVPNSLS 164
           +   +  Y    D+WS G  +  +L+  PP++   +   L ++ +GK    LP     +S
Sbjct: 200 L---HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK-VS 255
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+D I K L   P+ R +A   ++H +++
Sbjct: 256 ESAKDLIRKXLTYVPSXRISARDALDHEWIQ 286

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 14/194 (7%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+     + E  LY+ +E    G + + L     + + +  +  RQI++ + Y H+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 68  RNVVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPFWVAPEVVNLKNNGY 116
           + +VHR++K  N+L+DA           S   T  N + +F G P + APE+   K    
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD- 190
Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
           G   D+WSLG  +  +++   P+      +   R+ RGK   +P  +S D  + + K L 
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLI 249
Query: 177 VNPNDRPTAAQLME 190
           +NP+ R T  Q+M+
Sbjct: 250 LNPSKRGTLEQIMK 263

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 7   FEHDNIVQYI----GTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV-SSYTRQILNG 61
            +H NIV++      T K +  + +  EL   G+L    +++ +   +V  S+ RQIL G
Sbjct: 82  LQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKG 141
Query: 62  LTYLHERN--VVHREIKCANILVDAS---------GLATTTND--VKSFEGTPFWVAPEV 108
           L +LH R   ++HR++KC NI +            GLAT       K+  GTP + APE 
Sbjct: 142 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEX 201
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKLPSVPNSLS-RD 166
              K   Y  S D+++ G   LE  T + PYS  ++   ++ R+  G  P+  + ++  +
Sbjct: 202 YEEK---YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPF 193
            ++ I  C++ N ++R +   L+ H F
Sbjct: 259 VKEIIEGCIRQNKDERYSIKDLLNHAF 285

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 14/194 (7%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+     + E  LY+ +E    G + + L     + + +  +  RQI++ + Y H+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 68  RNVVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPFWVAPEVVNLKNNGY 116
           + +VHR++K  N+L+DA           S   T  N +  F G+P + APE+   K    
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYD- 190
Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
           G   D+WSLG  +  +++   P+      +   R+ RGK   +P  +S D  + + K L 
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLI 249
Query: 177 VNPNDRPTAAQLME 190
           +NP+ R T  Q+M+
Sbjct: 250 LNPSKRGTLEQIMK 263

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 84.0 bits (206), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 99/190 (52%), Gaps = 22/190 (11%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLH-ERNVVHREIKCANI 80
           +RL   +E    G L  +L ++   S+ +   Y  +I++ L YLH E+NVV+R++K  N+
Sbjct: 224 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 283
Query: 81  LVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           ++D  G    T+             +K+F GTP ++APEV  L++N YG + D W LG  
Sbjct: 284 MLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV--LEDNDYGRAVDWWGLGVV 341
Query: 129 VLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----P 183
           + EM+  + P+ + +D + LF +   +    P +L  +A+  +   L+ +P  R      
Sbjct: 342 MYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSE 400
Query: 184 TAAQLMEHPF 193
            A ++M+H F
Sbjct: 401 DAKEIMQHRF 410

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 84.0 bits (206), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 14/194 (7%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+     + E  LY+ +E    G + + L     + + +  +  RQI++ + Y H+
Sbjct: 65  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 68  RNVVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPFWVAPEVVNLKNNGY 116
           + +VHR++K  N+L+DA           S   T  N + +F G+P + APE+   K    
Sbjct: 125 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD- 183
Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
           G   D+WSLG  +  +++   P+      +   R+ RGK   +P  +S D  + + K L 
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLI 242
Query: 177 VNPNDRPTAAQLME 190
           +NP+ R T  Q+M+
Sbjct: 243 LNPSKRGTLEQIMK 256

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYL 65
           F H +I++           ++ +E V  G L +   K+  + + +     +QIL+ + Y 
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 66  HERNVVHREIKCANILVDAS--------GLATTTND---VKSFEGTPFWVAPEVVNLKNN 114
           H   VVHR++K  N+L+DA         GL+   +D   +++  G+P + APEV++ +  
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKC 174
             G   DIWS G  +  +L    P+   E +  LF+  RG +  +P  L+R     ++  
Sbjct: 188 A-GPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNRSVATLLMHM 245
Query: 175 LQVNPNDRPTAAQLMEHPFVKRPL 198
           LQV+P  R T   + EH + K+ L
Sbjct: 246 LQVDPLKRATIKDIREHEWFKQDL 269

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 83.6 bits (205), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 99/190 (52%), Gaps = 22/190 (11%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLH-ERNVVHREIKCANI 80
           +RL   +E    G L  +L ++   S+ +   Y  +I++ L YLH E+NVV+R++K  N+
Sbjct: 221 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 280
Query: 81  LVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           ++D  G    T+             +K+F GTP ++APEV  L++N YG + D W LG  
Sbjct: 281 MLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV--LEDNDYGRAVDWWGLGVV 338
Query: 129 VLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----P 183
           + EM+  + P+ + +D + LF +   +    P +L  +A+  +   L+ +P  R      
Sbjct: 339 MYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSE 397
Query: 184 TAAQLMEHPF 193
            A ++M+H F
Sbjct: 398 DAKEIMQHRF 407

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+     + E  LY+ +E    G + + L     + + +  S  RQI++ + Y H+
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 68  RNVVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPFWVAPEVVNLKNNGY 116
           + +VHR++K  N+L+DA           S   T    + +F G+P + APE+   K    
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYD- 188
Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
           G   D+WSLG  +  +++   P+      +   R+ RGK   +P  +S D  + + + L 
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKRFLV 247
Query: 177 VNPNDRPTAAQLMEHPFV 194
           +NP  R T  Q+M+  ++
Sbjct: 248 LNPIKRGTLEQIMKDRWI 265

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 54/242 (22%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 135
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 196 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 254
Query: 148 LFRIG----------RGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +  +           + K+P     PN+ S+ A D + K L  NP+ R    Q + HP++
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 195 KR 196
           ++
Sbjct: 314 EQ 315

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 83.6 bits (205), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 113/241 (46%), Gaps = 52/241 (21%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 133
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 194 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 252
Query: 148 LFRI-GRGKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +  +  R  L S+P+           +    A D + K L  NP+ R    Q + HP+++
Sbjct: 253 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 312
Query: 196 R 196
           +
Sbjct: 313 Q 313

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 54/242 (22%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 85  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 143
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 144 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 204 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 262
Query: 148 LFRIG----------RGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +  +           + K+P     PN+ S+ A D + K L  NP+ R    Q + HP++
Sbjct: 263 IINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 321
Query: 195 KR 196
           ++
Sbjct: 322 EQ 323

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 54/242 (22%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 135
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 196 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 254
Query: 148 LFRIG----------RGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +  +           + K+P     PN+ S+ A D + K L  NP+ R    Q + HP++
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 195 KR 196
           ++
Sbjct: 314 EQ 315

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 54/242 (22%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 139
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 200 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 148 LFRIG----------RGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +  +           + K+P     PN+ S+ A D + K L  NP+ R    Q + HP++
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 195 KR 196
           ++
Sbjct: 318 EQ 319

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 113/241 (46%), Gaps = 52/241 (21%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 79  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 137
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 198 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 256
Query: 148 LFRI-GRGKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +  +  R  L S+P+           +    A D + K L  NP+ R    Q + HP+++
Sbjct: 257 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 316
Query: 196 R 196
           +
Sbjct: 317 Q 317

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 54/242 (22%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 133
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 194 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNC 252
Query: 148 LFRIG----------RGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +  +           + K+P     PN+ S+ A D + K L  NP+ R    Q + HP++
Sbjct: 253 IINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 311
Query: 195 KR 196
           ++
Sbjct: 312 EQ 313

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 113/241 (46%), Gaps = 52/241 (21%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 135
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 196 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 254
Query: 148 LFRI-GRGKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +  +  R  L S+P+           +    A D + K L  NP+ R    Q + HP+++
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 314
Query: 196 R 196
           +
Sbjct: 315 Q 315

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 54/242 (22%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 139
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 200 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 148 LFRIG----------RGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +  +           + K+P     PN+ S+ A D + K L  NP+ R    Q + HP++
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 195 KR 196
           ++
Sbjct: 318 EQ 319

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 62  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVK--SFEGTPF---WVAPE 107
           G+ ++ ERN +HR+++ ANILV  +        GLA    D +  + EG  F   W APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPE 180
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   +
Sbjct: 181 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 167 ARDFILKCLQVNPNDRPT 184
               +  C +  P DRPT
Sbjct: 239 LYQLMRLCWKERPEDRPT 256

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 54/242 (22%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 140
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 201 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 259
Query: 148 LFRIG----------RGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +  +           + K+P     PN+ S+ A D + K L  NP+ R    Q + HP++
Sbjct: 260 IINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 318
Query: 195 KR 196
           ++
Sbjct: 319 EQ 320

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 54/242 (22%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 83  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 141
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 142 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 202 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 260
Query: 148 LFRIG----------RGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +  +           + K+P     PN+ S+ A D + K L  NP+ R    Q + HP++
Sbjct: 261 IINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 319
Query: 195 KR 196
           ++
Sbjct: 320 EQ 321

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 54/242 (22%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 74  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 132
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 133 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 193 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 251
Query: 148 LFRIG----------RGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +  +           + K+P     PN+ S+ A D + K L  NP+ R    Q + HP++
Sbjct: 252 IINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 310
Query: 195 KR 196
           ++
Sbjct: 311 EQ 312

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 113/241 (46%), Gaps = 52/241 (21%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 155
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 216 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 274
Query: 148 LFRI-GRGKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +  +  R  L S+P+           +    A D + K L  NP+ R    Q + HP+++
Sbjct: 275 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334
Query: 196 R 196
           +
Sbjct: 335 Q 335

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 54/242 (22%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 139
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 200 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 148 LFRIG----------RGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +  +           + K+P     PN+ S+ A D + K L  NP+ R    Q + HP++
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 195 KR 196
           ++
Sbjct: 318 EQ 319

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 54/242 (22%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 135
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 196 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNX 254
Query: 148 LFRIG----------RGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +  +           + K+P     PN+ S+ A D + K L  NP+ R    Q + HP++
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 195 KR 196
           ++
Sbjct: 314 EQ 315

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+     + E  LY+ +E    G + + L     + + +  S  RQI++ + Y H+
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 68  RNVVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPFWVAPEVVNLKNNGY 116
           + +VHR++K  N+L+DA           S   T    + +F G P + APE+   K    
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD- 191
Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
           G   D+WSLG  +  +++   P+      +   R+ RGK   +P  +S D  + + + L 
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKRFLV 250
Query: 177 VNPNDRPTAAQLMEHPFV 194
           +NP  R T  Q+M+  ++
Sbjct: 251 LNPIKRGTLEQIMKDRWI 268

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 83.2 bits (204), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 98/190 (51%), Gaps = 22/190 (11%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLH-ERNVVHREIKCANI 80
           +RL   +E    G L  +L ++   S+ +   Y  +I++ L YLH E+NVV+R++K  N+
Sbjct: 83  DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 142
Query: 81  LVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           ++D  G    T+             +K F GTP ++APEV  L++N YG + D W LG  
Sbjct: 143 MLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV--LEDNDYGRAVDWWGLGVV 200
Query: 129 VLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----P 183
           + EM+  + P+ + +D + LF +   +    P +L  +A+  +   L+ +P  R      
Sbjct: 201 MYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSE 259
Query: 184 TAAQLMEHPF 193
            A ++M+H F
Sbjct: 260 DAKEIMQHRF 269

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 54/242 (22%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 139
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 200 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 148 LFRIG----------RGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +  +           + K+P     PN+ S+ A D + K L  NP+ R    Q + HP++
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 195 KR 196
           ++
Sbjct: 318 EQ 319

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 83.2 bits (204), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 98/190 (51%), Gaps = 22/190 (11%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLH-ERNVVHREIKCANI 80
           +RL   +E    G L  +L ++   S+ +   Y  +I++ L YLH E+NVV+R++K  N+
Sbjct: 82  DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 141
Query: 81  LVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           ++D  G    T+             +K F GTP ++APEV  L++N YG + D W LG  
Sbjct: 142 MLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV--LEDNDYGRAVDWWGLGVV 199
Query: 129 VLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----P 183
           + EM+  + P+ + +D + LF +   +    P +L  +A+  +   L+ +P  R      
Sbjct: 200 MYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSE 258
Query: 184 TAAQLMEHPF 193
            A ++M+H F
Sbjct: 259 DAKEIMQHRF 268

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 83.2 bits (204), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 98/190 (51%), Gaps = 22/190 (11%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLH-ERNVVHREIKCANI 80
           +RL   +E    G L  +L ++   S+ +   Y  +I++ L YLH E+NVV+R++K  N+
Sbjct: 81  DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 140
Query: 81  LVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           ++D  G    T+             +K F GTP ++APEV  L++N YG + D W LG  
Sbjct: 141 MLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV--LEDNDYGRAVDWWGLGVV 198
Query: 129 VLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----P 183
           + EM+  + P+ + +D + LF +   +    P +L  +A+  +   L+ +P  R      
Sbjct: 199 MYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSE 257
Query: 184 TAAQLMEHPF 193
            A ++M+H F
Sbjct: 258 DAKEIMQHRF 267

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 54/242 (22%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 135
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 196 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNX 254
Query: 148 LFRIG----------RGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +  +           + K+P     PN+ S+ A D + K L  NP+ R    Q + HP++
Sbjct: 255 IINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 195 KR 196
           ++
Sbjct: 314 EQ 315

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
            +  QF+H +IV+ IG    EN ++I +EL   G L +  Q  K+ L  + +  Y  Q+ 
Sbjct: 63  LTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLS 121
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT----PF-WVAP 106
             L YL  +  VHR+I   N+LV A+        GL+    D   ++ +    P  W+AP
Sbjct: 122 TALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +N +   +  ++D+W  G  + E+L H   P+  +++   + RI  G+   +P +   
Sbjct: 182 ESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 239
Query: 166 DARDFILKCLQVNPNDRPTAAQL 188
                + KC   +P+ RP   +L
Sbjct: 240 TLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 14/204 (6%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYL 65
           F H +I++           ++ +E V  G L +   K+  + + +     +QIL+ + Y 
Sbjct: 68  FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 66  HERNVVHREIKCANILVDAS--------GLATTTND---VKSFEGTPFWVAPEVVNLKNN 114
           H   VVHR++K  N+L+DA         GL+   +D   ++   G+P + APEV++ +  
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187
Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKC 174
             G   DIWS G  +  +L    P+   E +  LF+  RG +  +P  L+R     ++  
Sbjct: 188 A-GPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLNRSVATLLMHM 245
Query: 175 LQVNPNDRPTAAQLMEHPFVKRPL 198
           LQV+P  R T   + EH + K+ L
Sbjct: 246 LQVDPLKRATIKDIREHEWFKQDL 269

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 71  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 129
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ ++ ERN +HR+++ ANILV  +        GLA     N+  + EG  F   W APE
Sbjct: 130 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 189
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   +
Sbjct: 190 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 247
Query: 167 ARDFILKCLQVNPNDRPT 184
               +  C +  P DRPT
Sbjct: 248 LYQLMRLCWKERPEDRPT 265

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 63  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 121
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ ++ ERN +HR+++ ANILV  +        GLA     N+  + EG  F   W APE
Sbjct: 122 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 181
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   +
Sbjct: 182 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 239
Query: 167 ARDFILKCLQVNPNDRPT 184
               +  C +  P DRPT
Sbjct: 240 LYQLMRLCWKERPEDRPT 257

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 62  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ ++ ERN +HR+++ ANILV  +        GLA     N+  + EG  F   W APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 180
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   +
Sbjct: 181 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 167 ARDFILKCLQVNPNDRPT 184
               +  C +  P DRPT
Sbjct: 239 LYQLMRLCWKERPEDRPT 256

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 62  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ ++ ERN +HR+++ ANILV  +        GLA     N+  + EG  F   W APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 180
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   +
Sbjct: 181 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 167 ARDFILKCLQVNPNDRPT 184
               +  C +  P DRPT
Sbjct: 239 LYQLMRLCWKERPEDRPT 256

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 64  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 122
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ ++ ERN +HR+++ ANILV  +        GLA     N+  + EG  F   W APE
Sbjct: 123 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 182
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   +
Sbjct: 183 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 240
Query: 167 ARDFILKCLQVNPNDRPT 184
               +  C +  P DRPT
Sbjct: 241 LYQLMRLCWKERPEDRPT 258

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 68  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 126
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ ++ ERN +HR+++ ANILV  +        GLA     N+  + EG  F   W APE
Sbjct: 127 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 186
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   +
Sbjct: 187 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 244
Query: 167 ARDFILKCLQVNPNDRPT 184
               +  C +  P DRPT
Sbjct: 245 LYQLMRLCWKERPEDRPT 262

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 68  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 126
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ ++ ERN +HR+++ ANILV  +        GLA     N+  + EG  F   W APE
Sbjct: 127 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 186
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   +
Sbjct: 187 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 244
Query: 167 ARDFILKCLQVNPNDRPT 184
               +  C +  P DRPT
Sbjct: 245 LYQLMRLCWKERPEDRPT 262

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 57  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 115
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ ++ ERN +HR+++ ANILV  +        GLA     N+  + EG  F   W APE
Sbjct: 116 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 175
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   +
Sbjct: 176 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 233
Query: 167 ARDFILKCLQVNPNDRPT 184
               +  C +  P DRPT
Sbjct: 234 LYQLMRLCWKERPEDRPT 251

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
            +  QF+H +IV+ IG    EN ++I +EL   G L +  Q  KY L  + +  Y  Q+ 
Sbjct: 91  LTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 149
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT----PF-WVAP 106
             L YL  +  VHR+I   N+LV ++        GL+    D   ++ +    P  W+AP
Sbjct: 150 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 209
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +N +   +  ++D+W  G  + E+L H   P+  +++   + RI  G+   +P +   
Sbjct: 210 ESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 267
Query: 166 DARDFILKCLQVNPNDRPTAAQL 188
                + KC   +P+ RP   +L
Sbjct: 268 TLYSLMTKCWAYDPSRRPRFTEL 290

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 70  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 128
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ ++ ERN +HR+++ ANILV  +        GLA     N+  + EG  F   W APE
Sbjct: 129 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 188
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   +
Sbjct: 189 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 246
Query: 167 ARDFILKCLQVNPNDRPT 184
               +  C +  P DRPT
Sbjct: 247 LYQLMRLCWKERPEDRPT 264

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
            +  QF+H +IV+ IG    EN ++I +EL   G L +  Q  KY L  + +  Y  Q+ 
Sbjct: 63  LTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 121
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT----PF-WVAP 106
             L YL  +  VHR+I   N+LV ++        GL+    D   ++ +    P  W+AP
Sbjct: 122 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +N +   +  ++D+W  G  + E+L H   P+  +++   + RI  G+   +P +   
Sbjct: 182 ESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 239
Query: 166 DARDFILKCLQVNPNDRPTAAQL 188
                + KC   +P+ RP   +L
Sbjct: 240 TLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 67  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 125
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ ++ ERN +HR+++ ANILV  +        GLA     N+  + EG  F   W APE
Sbjct: 126 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 185
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   +
Sbjct: 186 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 243
Query: 167 ARDFILKCLQVNPNDRPT 184
               +  C +  P DRPT
Sbjct: 244 LYQLMRLCWKERPEDRPT 261

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
            +  QF+H +IV+ IG    EN ++I +EL   G L +  Q  KY L  + +  Y  Q+ 
Sbjct: 63  LTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 121
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT----PF-WVAP 106
             L YL  +  VHR+I   N+LV ++        GL+    D   ++ +    P  W+AP
Sbjct: 122 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +N +   +  ++D+W  G  + E+L H   P+  +++   + RI  G+   +P +   
Sbjct: 182 ESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 239
Query: 166 DARDFILKCLQVNPNDRPTAAQL 188
                + KC   +P+ RP   +L
Sbjct: 240 TLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 72  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 130
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ ++ ERN +HR+++ ANILV  +        GLA     N+  + EG  F   W APE
Sbjct: 131 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 190
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   +
Sbjct: 191 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 248
Query: 167 ARDFILKCLQVNPNDRPT 184
               +  C +  P DRPT
Sbjct: 249 LYQLMRLCWKERPEDRPT 266

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 62  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ ++ ERN +HR+++ ANILV  +        GLA     N+  + EG  F   W APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   +
Sbjct: 181 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 167 ARDFILKCLQVNPNDRPT 184
               +  C +  P DRPT
Sbjct: 239 LYQLMRLCWKERPEDRPT 256

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
            +  QF+H +IV+ IG    EN ++I +EL   G L +  Q  KY L  + +  Y  Q+ 
Sbjct: 68  LTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT----PF-WVAP 106
             L YL  +  VHR+I   N+LV ++        GL+    D   ++ +    P  W+AP
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 186
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +N +   +  ++D+W  G  + E+L H   P+  +++   + RI  G+   +P +   
Sbjct: 187 ESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 244
Query: 166 DARDFILKCLQVNPNDRPTAAQL 188
                + KC   +P+ RP   +L
Sbjct: 245 TLYSLMTKCWAYDPSRRPRFTEL 267

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
            +  QF+H +IV+ IG    EN ++I +EL   G L +  Q  KY L  + +  Y  Q+ 
Sbjct: 60  LTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT----PF-WVAP 106
             L YL  +  VHR+I   N+LV ++        GL+    D   ++ +    P  W+AP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +N +   +  ++D+W  G  + E+L H   P+  +++   + RI  G+   +P +   
Sbjct: 179 ESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236
Query: 166 DARDFILKCLQVNPNDRPTAAQL 188
                + KC   +P+ RP   +L
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTEL 259

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
            +  QF+H +IV+ IG    EN ++I +EL   G L +  Q  KY L  + +  Y  Q+ 
Sbjct: 65  LTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 123
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT----PF-WVAP 106
             L YL  +  VHR+I   N+LV ++        GL+    D   ++ +    P  W+AP
Sbjct: 124 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 183
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +N +   +  ++D+W  G  + E+L H   P+  +++   + RI  G+   +P +   
Sbjct: 184 ESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 241
Query: 166 DARDFILKCLQVNPNDRPTAAQL 188
                + KC   +P+ RP   +L
Sbjct: 242 TLYSLMTKCWAYDPSRRPRFTEL 264

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 113/241 (46%), Gaps = 52/241 (21%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKCQHLSNDHICYFLYQILR 139
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 200 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 148 LFRI-GRGKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +  +  R  L S+P+           +    A D + K L  NP+ R    Q + HP+++
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
Query: 196 R 196
           +
Sbjct: 319 Q 319

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
            +  QF+H +IV+ IG    EN ++I +EL   G L +  Q  KY L  + +  Y  Q+ 
Sbjct: 66  LTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 124
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT----PF-WVAP 106
             L YL  +  VHR+I   N+LV ++        GL+    D   ++ +    P  W+AP
Sbjct: 125 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 184
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +N +   +  ++D+W  G  + E+L H   P+  +++   + RI  G+   +P +   
Sbjct: 185 ESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 242
Query: 166 DARDFILKCLQVNPNDRPTAAQL 188
                + KC   +P+ RP   +L
Sbjct: 243 TLYSLMTKCWAYDPSRRPRFTEL 265

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 111/240 (46%), Gaps = 52/240 (21%)
Query: 7   FEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNG 61
           F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL G
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG 138
Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVAP 106
           L Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ AP
Sbjct: 139 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQAL 148
           E++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  +
Sbjct: 199 EIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 149 FRI-GRGKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
             +  R  L S+P+           +    A D + K L  NP+ R    Q + HP++ +
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
            +  QF+H +IV+ IG    EN ++I +EL   G L +  Q  K+ L  + +  Y  Q+ 
Sbjct: 443 LTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLS 501
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT----PF-WVAP 106
             L YL  +  VHR+I   N+LV A+        GL+    D   ++ +    P  W+AP
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +N +   +  ++D+W  G  + E+L H   P+  +++   + RI  G+   +P +   
Sbjct: 562 ESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619
Query: 166 DARDFILKCLQVNPNDRPTAAQL 188
                + KC   +P+ RP   +L
Sbjct: 620 TLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 112/241 (46%), Gaps = 52/241 (21%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 139
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEG-------TPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA   +      G       T ++ A
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 200 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258
Query: 148 LFRI-GRGKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +  +  R  L S+P+           +    A D + K L  NP+ R    Q + HP+++
Sbjct: 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
Query: 196 R 196
           +
Sbjct: 319 Q 319

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 112/241 (46%), Gaps = 52/241 (21%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 140
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEG-------TPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA   +      G       T ++ A
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 201 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 259
Query: 148 LFRI-GRGKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +  +  R  L S+P+           +    A D + K L  NP+ R    Q + HP+++
Sbjct: 260 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 319
Query: 196 R 196
           +
Sbjct: 320 Q 320

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
            +H NI++   T +D   +Y+ +EL   G L   +  K    +S  +   + +L+ + Y 
Sbjct: 80  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 139
Query: 66  HERNVVHREIKCAN--ILVDAS---------GLATTTNDVKSFE---GTPFWVAPEVVNL 111
           H+ NV HR++K  N   L D+          GLA      K      GTP++V+P+V+  
Sbjct: 140 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-- 197
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN----SLSRDA 167
               YG   D WS G  +  +L   PP+S   D + + +I  G   + P     ++S  A
Sbjct: 198 -EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTF-TFPEKDWLNVSPQA 255
Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
              I + L  +P  R T+ Q +EH + ++ L +S
Sbjct: 256 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 289

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
            +H NI++   T +D   +Y+ +EL   G L   +  K    +S  +   + +L+ + Y 
Sbjct: 63  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 66  HERNVVHREIKCAN--ILVDAS---------GLATTTNDVKSFE---GTPFWVAPEVVNL 111
           H+ NV HR++K  N   L D+          GLA      K      GTP++V+P+V+  
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-- 180
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN----SLSRDA 167
               YG   D WS G  +  +L   PP+S   D + + +I  G   + P     ++S  A
Sbjct: 181 -EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTF-TFPEKDWLNVSPQA 238
Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
              I + L  +P  R T+ Q +EH + ++ L +S
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 111/241 (46%), Gaps = 52/241 (21%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+N++         T +    +YI  +L++   L  L +   LS+  +  +  QIL 
Sbjct: 97  RFRHENVIGIRDILRASTLEAMRDVYIVQDLMET-DLYKLLKSQQLSNDHICYFLYQILR 155
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEG-------TPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA   +      G       T ++ A
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRA 215
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 216 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 274
Query: 148 LFRI-GRGKLPSVPNSLS-----------RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +  +  R  L S+P+                A D + + L  NPN R T  + + HP+++
Sbjct: 275 IINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLE 334
Query: 196 R 196
           +
Sbjct: 335 Q 335

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             + +H N++      +++  + +  ELV  G L + L +K  L++ + + + +QILNG+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 63  TYLHERNVVHREIKCANI-LVDAS-----------GLATTT---NDVKSFEGTPFWVAPE 107
            YLH   + H ++K  NI L+D +           GLA      N+ K+  GTP +VAPE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLS 164
           +VN +    GL AD+WS+G     +L+   P+   +  E +  +  +         ++ S
Sbjct: 188 IVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+DFI + L  +P  R T    ++HP++K
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNG 61
            +H +IV+ + T   +  LY+  E +    L     K     +  S++  S Y RQIL  
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 62  LTYLHERNVVHREIKCANILVDAS-----------GLATTTND----VKSFEGTPFWVAP 106
           L Y H+ N++HR++K  N+L+ +            G+A    +         GTP ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVP---NS 162
           EVV  K   YG   D+W  G  +  +L+   P+   +  + LF  I +GK    P   + 
Sbjct: 203 EVV--KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNPRQWSH 258
Query: 163 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +S  A+D + + L ++P +R T  + + HP++K
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 58  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 116
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ ++ ERN +HR ++ ANILV  +        GLA     N+  + EG  F   W APE
Sbjct: 117 GMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 176
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   +
Sbjct: 177 AINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 234
Query: 167 ARDFILKCLQVNPNDRPT 184
               +  C +  P DRPT
Sbjct: 235 LYQLMRLCWKERPEDRPT 252

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 52/241 (21%)
Query: 6   QFEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI+         T +    +Y+   L+    L  L +  HLS+  +  +  QIL 
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQHLSNDHICYFLYQILR 155
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVA 105
           GL Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ A
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHL----------------EDMQA 147
           PE++ L + GY  S DIWS+GC + EML+++P  P  H                 ED+  
Sbjct: 216 PEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 274
Query: 148 LFRI-GRGKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +  +  R  L S+P+           +    A D + K L  NP+ R    Q + HP+++
Sbjct: 275 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 334
Query: 196 R 196
           +
Sbjct: 335 Q 335

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   E +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADEPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 87/174 (50%), Gaps = 16/174 (9%)
Query: 22  ENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           E +LY+ L+ ++ G L   L ++   ++  V  Y  ++  GL +LH   +++R++K  NI
Sbjct: 102 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENI 161
Query: 81  LVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
           L+D  G    T+               SF GT  ++APEVVN    G+  SAD WS G  
Sbjct: 162 LLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN--RQGHSHSADWWSYGVL 219
Query: 129 VLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
           + EMLT   P+   +  + +  I + KL  +P  LS +A+  +    + NP +R
Sbjct: 220 MFEMLTGSLPFQGKDRKETMTLILKAKL-GMPQFLSTEAQSLLRALFKRNPANR 272

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 26/204 (12%)
Query: 13  VQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQILNGLTYLHE 67
           V + G    E  ++I +EL+   SL   Y++       + +  +      I+  L +LH 
Sbjct: 69  VTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 68  R-NVVHREIKCANILVDASG-------------LATTTNDVKSFEGTPFWVAPEVVN--L 111
           + +V+HR++K +N+L++A G             +     D+ +  G   ++APE +N  L
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GCKPYMAPERINPEL 185
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPY-SHLEDMQALFRIGRGKLPSVP-NSLSRDARD 169
              GY + +DIWSLG T++E+   + PY S     Q L ++     P +P +  S +  D
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 245
Query: 170 FILKCLQVNPNDRPTAAQLMEHPF 193
           F  +CL+ N  +RPT  +LM+HPF
Sbjct: 246 FTSQCLKKNSKERPTYPELMQHPF 269

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 3   SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILN 60
           + S   H  +V      +D+N + +  E +  G L       H  +S+ +   Y RQ+  
Sbjct: 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 61  GLTYLHERNVVHREIKCANILVDAS----------GLAT---TTNDVKSFEGTPFWVAPE 107
           GL ++HE N VH ++K  NI+              GL         VK   GT  + APE
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 326
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLS 164
           V   K  GY    D+WS+G     +L+   P+    D + L  +         S  + +S
Sbjct: 327 VAEGKPVGY--YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 384
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            D +DFI K L  +PN R T  Q +EHP++
Sbjct: 385 EDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 3   SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILN 60
           + S   H  +V      +D+N + +  E +  G L       H  +S+ +   Y RQ+  
Sbjct: 101 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 160
Query: 61  GLTYLHERNVVHREIKCANILVDAS----------GLAT---TTNDVKSFEGTPFWVAPE 107
           GL ++HE N VH ++K  NI+              GL         VK   GT  + APE
Sbjct: 161 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 220
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLS 164
           V   K  GY    D+WS+G     +L+   P+    D + L  +         S  + +S
Sbjct: 221 VAEGKPVGY--YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 278
Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            D +DFI K L  +PN R T  Q +EHP++
Sbjct: 279 EDGKDFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 81.3 bits (199), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVS-----SYTRQILNGL 62
            H NI+ ++G    + +L I  +  +  SL   Y   H+ +++          RQ   G+
Sbjct: 67  RHVNILLFMGYST-KPQLAIVTQWCEGSSL---YHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEV 108
            YLH ++++HR++K  NI +           GLAT       ++  +   G+  W+APEV
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 182
Query: 109 VNLKN-NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-QALFRIGRG----KLPSVPNS 162
           + +++ N Y   +D+++ G  + E++T Q PYS++ +  Q +F +GRG     L  V ++
Sbjct: 183 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 242
Query: 163 LSRDARDFILKCLQVNPNDRPTAAQLM 189
             +  +  + +CL+   ++RP   Q++
Sbjct: 243 CPKAMKRLMAECLKKKRDERPLFPQIL 269

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           + +H NIV      +    LY+ ++LV  G L + + +K   ++   S    Q+L+ + Y
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 65  LHERNVVHREIKCAN-----------ILVDASGLATTTND---VKSFEGTPFWVAPEVVN 110
           LH+  +VHR++K  N           I++   GL+   +    + +  GTP +VAPEV  
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV-- 189
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP-SVP--NSLSRDA 167
           L    Y  + D WS+G     +L   PP+    D +   +I + +     P  + +S  A
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +DFI   ++ +P  R T  Q ++HP++
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVS-----SYTRQILNGL 62
            H NI+ ++G    + +L I  +  +  SL   Y   H+ +++          RQ   G+
Sbjct: 64  RHVNILLFMGYST-KPQLAIVTQWCEGSSL---YHHLHIIETKFEMIKLIDIARQTAQGM 119
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEV 108
            YLH ++++HR++K  NI +           GLAT       ++  +   G+  W+APEV
Sbjct: 120 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 179
Query: 109 VNLKN-NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-QALFRIGRG----KLPSVPNS 162
           + +++ N Y   +D+++ G  + E++T Q PYS++ +  Q +F +GRG     L  V ++
Sbjct: 180 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 239
Query: 163 LSRDARDFILKCLQVNPNDRPTAAQLM 189
             +  +  + +CL+   ++RP   Q++
Sbjct: 240 CPKAMKRLMAECLKKKRDERPLFPQIL 266

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 92/177 (51%), Gaps = 25/177 (14%)
Query: 38  ANLYQKYHLSDSQVS-----SYTRQILNGLTYLHERNVVHREIKCANILVDAS------- 85
           ++LY   H+ +++          RQ   G+ YLH ++++HR++K  NI +          
Sbjct: 115 SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGD 174
Query: 86  -GLATT------TNDVKSFEGTPFWVAPEVVNLKN-NGYGLSADIWSLGCTVLEMLTHQP 137
            GLAT       ++  +   G+  W+APEV+ +++ N Y   +D+++ G  + E++T Q 
Sbjct: 175 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 234
Query: 138 PYSHLEDM-QALFRIGRG----KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           PYS++ +  Q +F +GRG     L  V ++  +  +  + +CL+   ++RP   Q++
Sbjct: 235 PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 291

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           + +H NIV      +    LY+ ++LV  G L + + +K   ++   S    Q+L+ + Y
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 65  LHERNVVHREIKCAN-----------ILVDASGLATTTND---VKSFEGTPFWVAPEVVN 110
           LH+  +VHR++K  N           I++   GL+   +    + +  GTP +VAPEV  
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV-- 189
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP-SVP--NSLSRDA 167
           L    Y  + D WS+G     +L   PP+    D +   +I + +     P  + +S  A
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +DFI   ++ +P  R T  Q ++HP++
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 104/206 (50%), Gaps = 29/206 (14%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVS-----SYTRQILNGLT 63
           H NI+ ++G    + +L I  +  +  SL   Y   H+ +++          RQ   G+ 
Sbjct: 63  HVNILLFMGYST-KPQLAIVTQWCEGSSL---YHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 64  YLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVV 109
           YLH ++++HR++K  NI +           GLAT       ++  +   G+  W+APEV+
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 110 NLKN-NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-QALFRIGRG----KLPSVPNSL 163
            +++ N Y   +D+++ G  + E++T Q PYS++ +  Q +F +GRG     L  V ++ 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
            +  +  + +CL+   ++RP   Q++
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHER 68
           IVQ  GT      ++I +EL+  G+ A   +K     + +  +   T  I+  L YL E+
Sbjct: 86  IVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 69  -NVVHREIKCANILVDASG--------LATTTNDVKSFE---GTPFWVAPEVVNLKNN-- 114
             V+HR++K +NIL+D  G        ++    D K+ +   G   ++APE ++  +   
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 115 -GYGLSADIWSLGCTVLEMLTHQPPYSHLE-DMQALFRIGRGKLPSVPNSL--SRDARDF 170
             Y + AD+WSLG +++E+ T Q PY + + D + L ++ + + P +P  +  S D + F
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSF 263
Query: 171 ILKCLQVNPNDRPTAAQLMEHPFVKR 196
           +  CL  +   RP   +L+EH F+KR
Sbjct: 264 VKDCLTKDHRKRPKYNKLLEHSFIKR 289

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 92/177 (51%), Gaps = 25/177 (14%)
Query: 38  ANLYQKYHLSDSQVS-----SYTRQILNGLTYLHERNVVHREIKCANILVDAS------- 85
           ++LY   H+ +++          RQ   G+ YLH ++++HR++K  NI +          
Sbjct: 116 SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGD 175
Query: 86  -GLATT------TNDVKSFEGTPFWVAPEVVNLKN-NGYGLSADIWSLGCTVLEMLTHQP 137
            GLAT       ++  +   G+  W+APEV+ +++ N Y   +D+++ G  + E++T Q 
Sbjct: 176 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 235
Query: 138 PYSHLEDM-QALFRIGRG----KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           PYS++ +  Q +F +GRG     L  V ++  +  +  + +CL+   ++RP   Q++
Sbjct: 236 PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 292

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 104/206 (50%), Gaps = 29/206 (14%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVS-----SYTRQILNGLT 63
           H NI+ ++G    + +L I  +  +  SL   Y   H+ +++          RQ   G+ 
Sbjct: 68  HVNILLFMGYST-KPQLAIVTQWCEGSSL---YHHLHIIETKFEMIKLIDIARQTAQGMD 123
Query: 64  YLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVV 109
           YLH ++++HR++K  NI +           GLAT       ++  +   G+  W+APEV+
Sbjct: 124 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183
Query: 110 NLKN-NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-QALFRIGRG----KLPSVPNSL 163
            +++ N Y   +D+++ G  + E++T Q PYS++ +  Q +F +GRG     L  V ++ 
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 243
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
            +  +  + +CL+   ++RP   Q++
Sbjct: 244 PKAMKRLMAECLKKKRDERPLFPQIL 269

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 92/177 (51%), Gaps = 25/177 (14%)
Query: 38  ANLYQKYHLSDSQVS-----SYTRQILNGLTYLHERNVVHREIKCANILVDAS------- 85
           ++LY   H+ +++          RQ   G+ YLH ++++HR++K  NI +          
Sbjct: 88  SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGD 147
Query: 86  -GLATT------TNDVKSFEGTPFWVAPEVVNLKN-NGYGLSADIWSLGCTVLEMLTHQP 137
            GLAT       ++  +   G+  W+APEV+ +++ N Y   +D+++ G  + E++T Q 
Sbjct: 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207
Query: 138 PYSHLEDM-QALFRIGRG----KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           PYS++ +  Q +F +GRG     L  V ++  +  +  + +CL+   ++RP   Q++
Sbjct: 208 PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 52/240 (21%)
Query: 7   FEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNG 61
           F H+NI+         T +    +YI  +L++   L  L +  HLS+  +  +  QIL G
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRG 138
Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATT-------TNDVKSFEGTPFWVAP 106
           L Y+H  NV+HR++K +N+L++ +        GLA         T  +  +  T ++ AP
Sbjct: 139 LKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 198
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS---HLEDMQALFRI------------ 151
           E++ L + GY  S DIWS+GC + EML+++P +    +L+ +  +  I            
Sbjct: 199 EIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCG 257
Query: 152 ----GRGKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
                R  L S+P+           +    A D + K L  NP+ R    Q + HP++ +
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           + +H NIV      +    LY+ ++LV  G L + + +K   ++   S    Q+L+ + Y
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 65  LHERNVVHREIKCAN-----------ILVDASGLATTTND---VKSFEGTPFWVAPEVVN 110
           LH+  +VHR++K  N           I++   GL+   +    + +  GTP +VAPEV  
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV-- 189
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP-SVP--NSLSRDA 167
           L    Y  + D WS+G     +L   PP+    D +   +I + +     P  + +S  A
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +DFI   ++ +P  R T  Q ++HP++
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 13  VQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQILNGLTYLHE 67
           V + G    E  ++I +EL+   SL   Y++       + +  +      I+  L +LH 
Sbjct: 113 VTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 171
Query: 68  R-NVVHREIKCANILVDASGLATTTN----------DVKSFE-GTPFWVAPEVVN--LKN 113
           + +V+HR++K +N+L++A G     +            K+ + G   ++APE +N  L  
Sbjct: 172 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPY-SHLEDMQALFRIGRGKLPSVP-NSLSRDARDFI 171
            GY + +DIWSLG T++E+   + PY S     Q L ++     P +P +  S +  DF 
Sbjct: 232 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 291
Query: 172 LKCLQVNPNDRPTAAQLMEHPF 193
            +CL+ N  +RPT  +LM+HPF
Sbjct: 292 SQCLKKNSKERPTYPELMQHPF 313

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           + +H NIV      +    LY+ ++LV  G L + + +K   ++   S    Q+L+ + Y
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 65  LHERNVVHREIKCAN-----------ILVDASGLATTTND---VKSFEGTPFWVAPEVVN 110
           LH+  +VHR++K  N           I++   GL+   +    + +  GTP +VAPEV  
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV-- 189
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP-SVP--NSLSRDA 167
           L    Y  + D WS+G     +L   PP+    D +   +I + +     P  + +S  A
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 249
Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +DFI   ++ +P  R T  Q ++HP++
Sbjct: 250 KDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
            +  QF+H +IV+ IG    EN ++I +EL   G L +  Q  K+ L  + +  Y  Q+ 
Sbjct: 443 LTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLS 501
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT----PF-WVAP 106
             L YL  +  VHR+I   N+LV ++        GL+    D   ++ +    P  W+AP
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +N +   +  ++D+W  G  + E+L H   P+  +++   + RI  G+   +P +   
Sbjct: 562 ESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619
Query: 166 DARDFILKCLQVNPNDRPTAAQL 188
                + KC   +P+ RP   +L
Sbjct: 620 TLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 97  KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 156
Query: 79  NILVDASGLATTTN-----DVK----SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK    +  GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 157 NLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 214
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 215 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 266

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 132 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 191
Query: 79  NILVDASGLATTTN-----DVK----SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK    +  GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 249
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 250 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 92/177 (51%), Gaps = 25/177 (14%)
Query: 38  ANLYQKYHLSDSQVS-----SYTRQILNGLTYLHERNVVHREIKCANILVDAS------- 85
           ++LY   H+ +++          RQ   G+ YLH ++++HR++K  NI +          
Sbjct: 108 SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGD 167
Query: 86  -GLATT------TNDVKSFEGTPFWVAPEVVNLKN-NGYGLSADIWSLGCTVLEMLTHQP 137
            GLAT       ++  +   G+  W+APEV+ +++ N Y   +D+++ G  + E++T Q 
Sbjct: 168 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 227
Query: 138 PYSHLEDM-QALFRIGRG----KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           PYS++ +  Q +F +GRG     L  V ++  +  +  + +CL+   ++RP   Q++
Sbjct: 228 PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 284

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 79  NILVDASGLATTTN-----DVK----SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK    +  GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 229
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 104/206 (50%), Gaps = 29/206 (14%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVS-----SYTRQILNGLT 63
           H NI+ ++G    + +L I  +  +  SL   Y   H+ +++          RQ   G+ 
Sbjct: 63  HVNILLFMGYST-KPQLAIVTQWCEGSSL---YHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 64  YLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVV 109
           YLH ++++HR++K  NI +           GLAT       ++  +   G+  W+APEV+
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 110 NLKN-NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-QALFRIGRG----KLPSVPNSL 163
            +++ N Y   +D+++ G  + E++T Q PYS++ +  Q +F +GRG     L  V ++ 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
            +  +  + +CL+   ++RP   Q++
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQIL 264

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 92/177 (51%), Gaps = 25/177 (14%)
Query: 38  ANLYQKYHLSDSQVS-----SYTRQILNGLTYLHERNVVHREIKCANILVDAS------- 85
           ++LY   H+ +++          RQ   G+ YLH ++++HR++K  NI +          
Sbjct: 116 SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGD 175
Query: 86  -GLATT------TNDVKSFEGTPFWVAPEVVNLKN-NGYGLSADIWSLGCTVLEMLTHQP 137
            GLAT       ++  +   G+  W+APEV+ +++ N Y   +D+++ G  + E++T Q 
Sbjct: 176 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 235
Query: 138 PYSHLEDM-QALFRIGRG----KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           PYS++ +  Q +F +GRG     L  V ++  +  +  + +CL+   ++RP   Q++
Sbjct: 236 PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 292

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 92/191 (48%), Gaps = 16/191 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H  IV+     + E +LY+ L+ ++ G L   L ++   ++  V  Y  ++   L +LH 
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 68  RNVVHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNG 115
             +++R++K  NIL+D  G    T+               SF GT  ++APEVVN    G
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN--RRG 202
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
           +  SAD WS G  + EMLT   P+   +  + +  I + KL  +P  LS +A+  +    
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRMLF 261
Query: 176 QVNPNDRPTAA 186
           + NP +R  A 
Sbjct: 262 KRNPANRLGAG 272

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 98  KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 157
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 158 NLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 215
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 216 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 267

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 92/191 (48%), Gaps = 16/191 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H  IV+     + E +LY+ L+ ++ G L   L ++   ++  V  Y  ++   L +LH 
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 68  RNVVHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNG 115
             +++R++K  NIL+D  G    T+               SF GT  ++APEVVN    G
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN--RRG 202
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
           +  SAD WS G  + EMLT   P+   +  + +  I + KL  +P  LS +A+  +    
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRMLF 261
Query: 176 QVNPNDRPTAA 186
           + NP +R  A 
Sbjct: 262 KRNPANRLGAG 272

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 92/191 (48%), Gaps = 16/191 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H  IV+     + E +LY+ L+ ++ G L   L ++   ++  V  Y  ++   L +LH 
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 145
Query: 68  RNVVHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNG 115
             +++R++K  NIL+D  G    T+               SF GT  ++APEVVN    G
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN--RRG 203
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
           +  SAD WS G  + EMLT   P+   +  + +  I + KL  +P  LS +A+  +    
Sbjct: 204 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRMLF 262
Query: 176 QVNPNDRPTAA 186
           + NP +R  A 
Sbjct: 263 KRNPANRLGAG 273

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 111/229 (48%), Gaps = 44/229 (19%)
Query: 11  NIVQYIGTEKDENRLYIFLELVKKGS-LANLYQKYHLSDSQVSSYTRQILNGLTYLHERN 69
           NI++ I   +D+ R Y+  E ++ GS LA++ ++ H ++ + S   R +   L +LH + 
Sbjct: 72  NILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG 131
Query: 70  VVHREIKCANILVDA---------------SGLA-------TTTNDVKSFEGTPFWVAPE 107
           + HR++K  NIL ++               SG+         TT ++ +  G+  ++APE
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 108 VVNL---KNNGYGLSADIWSLGCTVLEMLTHQPPY-SHLE-----DMQALFRIGRGKL-- 156
           VV +   +   Y    D+WSLG  +  ML+  PP+  H       D   + R+ + KL  
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 251
Query: 157 ------PSVPNS----LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                    P+     +S +A+D I K L  +   R +AAQ+++HP+V+
Sbjct: 252 SIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 112 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 229
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
            +  QF+H +IV+ IG    EN ++I +EL   G L +  Q  K+ L  + +  Y  Q+ 
Sbjct: 63  LTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLS 121
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTND---VKSFEGT-PF-WVAP 106
             L YL  +  VHR+I   N+LV ++        GL+    D    K+ +G  P  W+AP
Sbjct: 122 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAP 181
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +N +   +  ++D+W  G  + E+L H   P+  +++   + RI  G+   +P +   
Sbjct: 182 ESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 239
Query: 166 DARDFILKCLQVNPNDRPTAAQL 188
                + KC   +P+ RP   +L
Sbjct: 240 TLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 104 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 163
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 164 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 221
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 222 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 132 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 191
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 249
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 250 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 229
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 229
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 80.1 bits (196), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           +  H NI++     +    + + LELV  G L + + +K + S+   +   +QIL  + Y
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 65  LHERNVVHREIKCANIL-----------VDASGLATTTND---VKSFEGTPFWVAPEVVN 110
           LHE  +VHR++K  N+L           +   GL+        +K+  GTP + APE+  
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI-- 221
Query: 111 LKNNGYGLSADIWSLG-CTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVP---NSLSRD 166
           L+   YG   D+WS+G  T + +   +P Y    D     RI   +   +    + +S +
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           A+D + K + ++P  R T  Q ++HP+V
Sbjct: 282 AKDLVRKLIVLDPKKRLTTFQALQHPWV 309

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 229
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 229
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 109/248 (43%), Gaps = 61/248 (24%)
Query: 6   QFEHDNIVQY--------------IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV 51
           + +HDNIV+               +G+  + N +YI  E ++   LAN+ ++  L +   
Sbjct: 64  RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHA 122
Query: 52  SSYTRQILNGLTYLHERNVVHREIKCANILVDAS---------GLATTTNDVKSFEG--- 99
             +  Q+L GL Y+H  NV+HR++K AN+ ++           GLA   +   S +G   
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 100 ----TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP------------------ 137
               T ++ +P ++ L  N Y  + D+W+ GC   EMLT +                   
Sbjct: 183 EGLVTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241
Query: 138 PYSHLEDMQALFRI-----------GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAA 186
           P  H ED Q L  +               L  +   +SR+A DF+ + L  +P DR TA 
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301
Query: 187 QLMEHPFV 194
           + + HP++
Sbjct: 302 EALSHPYM 309

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+++D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIISK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L +      L+      + SY  Q+L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 175 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 86/169 (50%), Gaps = 13/169 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVN 178
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVD 276

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 175 L-LGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL++ H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 115 GLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 175 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    ++     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 63  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 121
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 181
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 182 L-LGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 240
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 241 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 175
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 176 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 174 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI +E + KGSL +  +     +L   Q+     QI +
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 126 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPE 185
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 186 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C + +P +RPT
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 175 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 175 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 173
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 174 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            +M    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YQMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 178 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 177 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 178 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 175 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 176 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGL 62
             + +H  IV  I   +   +LY+ LE +  G L   L ++    +     Y  +I   L
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVN 110
            +LH++ +++R++K  NI+++  G    T+               +F GT  ++APE+  
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI-- 192
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDF 170
           L  +G+  + D WSLG  + +MLT  PP++     + + +I + KL ++P  L+++ARD 
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQEARDL 251
Query: 171 ILKCLQVNPNDR-----PTAAQLMEHPFVK 195
           + K L+ N   R       A ++  HPF +
Sbjct: 252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 175 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 176 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 175 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 174 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 60  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 118
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 119 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 178
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 179 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 237
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 238 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 178 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 176 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI +E + KGSL +  +     +L   Q+     QI +
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 126 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 186 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C + +P +RPT
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 177 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E +    L +      L+      + SY  Q+L 
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 177 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 175 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 58  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 117 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 177 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 236 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 174
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 175 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 174 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 173
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 174 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 60  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 118
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 119 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 178
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 179 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 237
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 238 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNG 61
            +H +IV+ + T   +  LY+  E +    L     K     +  S++  S Y RQIL  
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 62  LTYLHERNVVHREIK-----------CANILVDASGLATTTND----VKSFEGTPFWVAP 106
           L Y H+ N++HR++K            A + +   G+A    +         GTP ++AP
Sbjct: 145 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 204
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVP---NS 162
           EVV  K   YG   D+W  G  +  +L+   P+   +  + LF  I +GK    P   + 
Sbjct: 205 EVV--KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNPRQWSH 260
Query: 163 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +S  A+D + + L ++P +R T  + + HP++K
Sbjct: 261 ISESAKDLVRRMLMLDPAERITVYEALNHPWLK 293

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILNGLT 63
            +HD +V+       E  +YI  E + KGSL +  +          ++  ++ QI  G+ 
Sbjct: 65  LQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 124
Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTT--NDVKSFEGTPF---WVAPEVVN 110
           Y+  +N +HR+++ AN+LV  S        GLA     N+  + EG  F   W APE +N
Sbjct: 125 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 184
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRDAR 168
                + + +D+WS G  + E++T+ + PY    +   +  + +G ++P V N    +  
Sbjct: 185 F--GCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENC-PDELY 241
Query: 169 DFILKCLQVNPNDRPT 184
           D +  C +    +RPT
Sbjct: 242 DIMKMCWKEKAEERPT 257

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 28/213 (13%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNG 61
            +H +IV+ + T   +  LY+  E +    L     K     +  S++  S Y RQIL  
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 62  LTYLHERNVVHREIKCANILVDAS-----------GLATTTND----VKSFEGTPFWVAP 106
           L Y H+ N++HR++K   +L+ +            G+A    +         GTP ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVP---NS 162
           EVV  K   YG   D+W  G  +  +L+   P+   +  + LF  I +GK    P   + 
Sbjct: 203 EVV--KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNPRQWSH 258
Query: 163 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +S  A+D + + L ++P +R T  + + HP++K
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E +    L +      L+      + SY  Q+L 
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 178 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E + +  L        L+      + SY  Q+L 
Sbjct: 63  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 121
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 181
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 182 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 240
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 241 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E V +  L        L+      + SY  Q+L 
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 174 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 97/235 (41%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E V +  L        L+      + SY  Q+L 
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 178 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++R++K  
Sbjct: 132 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 191
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 249
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 250 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++R++K  
Sbjct: 106 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 165
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 166 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 223
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 224 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 275

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 96/235 (40%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E +    L        L+      + SY  Q+L 
Sbjct: 59  LKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 118 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 178 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 237 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++R++K  
Sbjct: 104 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 163
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 164 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 221
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 222 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP  +APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEALAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G     +      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 96/235 (40%), Gaps = 45/235 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILN 60
             +  H NIV+ +     EN+LY+  E +    L        L+      + SY  Q+L 
Sbjct: 57  LKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEV 108
           GL + H   V+HR++K  N+L++  G     +          V+++  E    W  APE+
Sbjct: 116 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR--------------- 153
           + L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R               
Sbjct: 176 L-LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 154 --GKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                PS P             L  D R  + + L  +PN R +A   + HPF +
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +     +     Y  QI+    YLH  ++++R++K  
Sbjct: 112 KDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 229
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGL 62
             + +H  IV  I   +   +LY+ LE +  G L   L ++    +     Y  +I   L
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVN 110
            +LH++ +++R++K  NI+++  G    T+                F GT  ++APE+  
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEI-- 192
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDF 170
           L  +G+  + D WSLG  + +MLT  PP++     + + +I + KL ++P  L+++ARD 
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQEARDL 251
Query: 171 ILKCLQVNPNDR-----PTAAQLMEHPFVK 195
           + K L+ N   R       A ++  HPF +
Sbjct: 252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 13/203 (6%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
             H +I++     K ++ + + +E         + Q+  +S+ +   + +QI++ + Y H
Sbjct: 70  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 129
Query: 67  ERNVVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPFWVAPEVVNLKNNG 115
              +VHR++K  N+L+D            S + T  N +K+  G+P + APEV++ K   
Sbjct: 130 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 189
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
            G   D+WS G  +  ML  + P+   E +  LF+     + ++P  LS  A   I + L
Sbjct: 190 -GPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRML 247
Query: 176 QVNPNDRPTAAQLMEHPFVKRPL 198
            VNP +R +  ++M+  + K  L
Sbjct: 248 IVNPLNRISIHEIMQDDWFKVDL 270

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
             H +I++     K ++ + + +E         + Q+  +S+ +   + +QI++ + Y H
Sbjct: 61  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 120
Query: 67  ERNVVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPFWVAPEVVNLKNNG 115
              +VHR++K  N+L+D            S + T  N +K+  G+P + APEV++ K   
Sbjct: 121 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 180
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
            G   D+WS G  +  ML  + P+   E +  LF+     + ++P  LS  A   I + L
Sbjct: 181 -GPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRML 238
Query: 176 QVNPNDRPTAAQLMEHPFVK 195
            VNP +R +  ++M+  + K
Sbjct: 239 IVNPLNRISIHEIMQDDWFK 258

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 110/235 (46%), Gaps = 47/235 (20%)
Query: 4   FSQFEHDNIVQYI-----GTEKDE-NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
               +H+N++  +      T  +E N +Y+   L+    L N+ +   L+D  V     Q
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQ 162
Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTND-VKSFEGTPFWVAPEV 108
           IL GL Y+H  +++HR++K +N+ V+          GLA  T+D +  +  T ++ APE+
Sbjct: 163 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEI 222
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQ---PPYSHLEDMQALFRI-------------- 151
           + L    Y ++ DIWS+GC + E+LT +   P   H+  +Q + R+              
Sbjct: 223 M-LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPS 281
Query: 152 --GRGKLPSVPNSLSRD-----------ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              R  + S+P    R+           A D + K L ++ + R TA++ + HP+
Sbjct: 282 HEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPY 336

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+     QI +
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 126 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 186 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C + +P +RPT
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
             H +I++     K ++ + + +E         + Q+  +S+ +   + +QI++ + Y H
Sbjct: 65  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 124
Query: 67  ERNVVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPFWVAPEVVNLKNNG 115
              +VHR++K  N+L+D            S + T  N +K+  G+P + APEV++ K   
Sbjct: 125 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 184
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
            G   D+WS G  +  ML  + P+   E +  LF+     + ++P  LS  A   I + L
Sbjct: 185 -GPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRML 242
Query: 176 QVNPNDRPTAAQLMEHPFVK 195
            VNP +R +  ++M+  + K
Sbjct: 243 IVNPLNRISIHEIMQDDWFK 262

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E    G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+++D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E    G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+++D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E    G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 112 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+++D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 229
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E    G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 112 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+++D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 229
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+     QI +
Sbjct: 58  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 116
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 117 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 176
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 177 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 234
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C + +P +RPT
Sbjct: 235 LHDLMCQCWRKDPEERPT 252

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E V  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G    T+      VK       GTP ++AP ++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPAIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 13/203 (6%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
             H +I++     K ++ + + +E         + Q+  +S+ +   + +QI++ + Y H
Sbjct: 71  LRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 130
Query: 67  ERNVVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPFWVAPEVVNLKNNG 115
              +VHR++K  N+L+D            S + T  N +K+  G+P + APEV++ K   
Sbjct: 131 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYA 190
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
            G   D+WS G  +  ML  + P+   E +  LF+     + ++P  LS  A   I + L
Sbjct: 191 -GPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYTLPKFLSPGAAGLIKRML 248
Query: 176 QVNPNDRPTAAQLMEHPFVKRPL 198
            VNP +R +  ++M+  + K  L
Sbjct: 249 IVNPLNRISIHEIMQDDWFKVDL 271

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E    G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 112 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+++D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 229
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E    G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+++D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+     QI +
Sbjct: 56  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 114
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 115 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 174
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 175 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 232
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C + +P +RPT
Sbjct: 233 LHDLMCQCWRKDPEERPT 250

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E    G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+++D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 14/194 (7%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+     + E  LY+  E    G + + L       + +  +  RQI++ + Y H+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQ 131
Query: 68  RNVVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPFWVAPEVVNLKNNGY 116
           + +VHR++K  N+L+DA           S   T  N + +F G P + APE+   K    
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD- 190
Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
           G   D+WSLG  +  +++   P+      +   R+ RGK   +P   S D  + + K L 
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYXSTDCENLLKKFLI 249
Query: 177 VNPNDRPTAAQLME 190
           +NP+ R T  Q+ +
Sbjct: 250 LNPSKRGTLEQIXK 263

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 92/177 (51%), Gaps = 25/177 (14%)
Query: 38  ANLYQKYHLSDSQVS-----SYTRQILNGLTYLHERNVVHREIKCANILVDAS------- 85
           ++LY   H S+++          RQ   G+ YLH ++++HR++K  NI +          
Sbjct: 92  SSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGD 151
Query: 86  -GLATT------TNDVKSFEGTPFWVAPEVVNLKN-NGYGLSADIWSLGCTVLEMLTHQP 137
            GLAT       ++  +   G+  W+APEV+ +++ N Y   +D+++ G  + E++T Q 
Sbjct: 152 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 211
Query: 138 PYSHLEDM-QALFRIGRGK----LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           PYS++ +  Q +  +GRG     L  V ++  +  +  + +CL+   ++RP+  +++
Sbjct: 212 PYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 268

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+     QI +
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 126 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 186 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C + +P +RPT
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+     QI +
Sbjct: 67  MKKIRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 126 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 186 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C + +P +RPT
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI +E + KG L +  +     +L   Q+     QI +
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 126 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 186 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C + +P +RPT
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 92/177 (51%), Gaps = 25/177 (14%)
Query: 38  ANLYQKYHLSDSQVS-----SYTRQILNGLTYLHERNVVHREIKCANILVDAS------- 85
           ++LY   H S+++          RQ   G+ YLH ++++HR++K  NI +          
Sbjct: 104 SSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGD 163
Query: 86  -GLATT------TNDVKSFEGTPFWVAPEVVNLKN-NGYGLSADIWSLGCTVLEMLTHQP 137
            GLAT       ++  +   G+  W+APEV+ +++ N Y   +D+++ G  + E++T Q 
Sbjct: 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223
Query: 138 PYSHLEDM-QALFRIGRGK----LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           PYS++ +  Q +  +GRG     L  V ++  +  +  + +CL+   ++RP+  +++
Sbjct: 224 PYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+   + QI +
Sbjct: 64  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIAS 122
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 123 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 182
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 183 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 240
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C +  P +RPT
Sbjct: 241 LHDLMCQCWRKEPEERPT 258

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 92/177 (51%), Gaps = 25/177 (14%)
Query: 38  ANLYQKYHLSDSQVS-----SYTRQILNGLTYLHERNVVHREIKCANILVDAS------- 85
           ++LY   H S+++          RQ   G+ YLH ++++HR++K  NI +          
Sbjct: 104 SSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGD 163
Query: 86  -GLATT------TNDVKSFEGTPFWVAPEVVNLKN-NGYGLSADIWSLGCTVLEMLTHQP 137
            GLAT       ++  +   G+  W+APEV+ +++ N Y   +D+++ G  + E++T Q 
Sbjct: 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223
Query: 138 PYSHLEDM-QALFRIGRGK----LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           PYS++ +  Q +  +GRG     L  V ++  +  +  + +CL+   ++RP+  +++
Sbjct: 224 PYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ LE    G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 112 KDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G     +      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 172 NLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 229
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLTYLHE 67
           H  I++  GT +D  ++++ ++ ++ G L +L +K     + V+  Y  ++   L YLH 
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 68  RNVVHREIKCANILVDAS--------GLATTTNDVK-SFEGTPFWVAPEVVNLKNNGYGL 118
           +++++R++K  NIL+D +        G A    DV     GTP ++APEVV+ K   Y  
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTK--PYNK 182
Query: 119 SADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVN 178
           S D WS G  + EML    P+     M+   +I   +L   P   + D +D + + +  +
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLITRD 241
Query: 179 PNDRPTAAQ-----LMEHPFVK 195
            + R    Q     +  HP+ K
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFK 263

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 25/197 (12%)
Query: 25  LYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I +E ++ G L +  Q+      ++ + +   R I   + +LH  N+ HR++K  N+L
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 82  VDAS-----------GLA--TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
             +            G A  TT N +++   TP++VAPEV  L    Y  S D+WSLG  
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGVI 218
Query: 129 VLEMLTHQPP-YSHL-----EDMQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPND 181
           +  +L   PP YS+        M+   R+G+   P+   S +S DA+  I   L+ +P +
Sbjct: 219 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 278
Query: 182 RPTAAQLMEHPFVKRPL 198
           R T  Q M HP++ + +
Sbjct: 279 RLTITQFMNHPWINQSM 295

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+     QI +
Sbjct: 60  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 118
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 119 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 178
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 179 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 236
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C +  P +RPT
Sbjct: 237 LHDLMCQCWRKEPEERPT 254

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 25/197 (12%)
Query: 25  LYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I +E ++ G L +  Q+      ++ + +   R I   + +LH  N+ HR++K  N+L
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 82  VDAS-----------GLA--TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT 128
             +            G A  TT N +++   TP++VAPEV  L    Y  S D+WSLG  
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGVI 199
Query: 129 VLEMLTHQPP-YSHLED-----MQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPND 181
           +  +L   PP YS+        M+   R+G+   P+   S +S DA+  I   L+ +P +
Sbjct: 200 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 259
Query: 182 RPTAAQLMEHPFVKRPL 198
           R T  Q M HP++ + +
Sbjct: 260 RLTITQFMNHPWINQSM 276

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E +  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G     +      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E +  G + ++L +    S+     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+L+D  G     +      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+   + QI +
Sbjct: 64  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIAS 122
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 123 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPE 182
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 183 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 240
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C +  P +RPT
Sbjct: 241 LHDLMCQCWRKEPEERPT 258

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 36/219 (16%)
Query: 9   HDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           H++I++Y G  +D  E  L + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 67  ERNVVHREIKCANILVDAS--------GLATTTND------VKSFEGTP-FWVAPEVVNL 111
            ++ +HR +   N+L+D          GLA    +      V+    +P FW APE   L
Sbjct: 135 SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC--L 192
Query: 112 KNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE------DMQALFRIG----RGKL 156
           K   +  ++D+WS G T+ E+LTH      PP   LE          + R+     RG+ 
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 252
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
              P+    +    +  C +   + RPT   L+  P +K
Sbjct: 253 LPRPDKCPCEVYHLMKNCWETEASFRPTFENLI--PILK 289

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 36/219 (16%)
Query: 9   HDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           H++I++Y G  +D  E  L + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 67  ERNVVHREIKCANILVDAS--------GLATTTND------VKSFEGTP-FWVAPEVVNL 111
            ++ +HR +   N+L+D          GLA    +      V+    +P FW APE   L
Sbjct: 135 AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC--L 192
Query: 112 KNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE------DMQALFRIG----RGKL 156
           K   +  ++D+WS G T+ E+LTH      PP   LE          + R+     RG+ 
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 252
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
              P+    +    +  C +   + RPT   L+  P +K
Sbjct: 253 LPRPDKCPCEVYHLMKNCWETEASFRPTFENLI--PILK 289

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+     QI +
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR++  ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 126 GMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 186 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C + +P +RPT
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 89/198 (44%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+     QI +
Sbjct: 234 MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 292
Query: 61  GLTYLHERNVVHREIKCANILVDAS----------GLATTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +          G     N+  + +G  F   W APE
Sbjct: 293 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPE 352
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 353 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 410
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C + +P +RPT
Sbjct: 411 LHDLMCQCWRKDPEERPT 428

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+     QI +
Sbjct: 233 MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 352 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 409
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C +  P +RPT
Sbjct: 410 LHDLMCQCWRKEPEERPT 427

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQ-VSSYTRQILNGLT 63
           +   H NI++      D  R+Y+ LE   +G L    QK    D Q  ++   ++ + L 
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALM 137
Query: 64  YLHERNVVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+   G     +            K+  GT  ++ PE++  + 
Sbjct: 138 YCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMI--EG 195
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+W +G    E+L   PP+      +   RI +  L   P S+   A+D I K
Sbjct: 196 RMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDL-KFPASVPTGAQDLISK 254
Query: 174 CLQVNPNDRPTAAQLMEHPFVK 195
            L+ NP++R   AQ+  HP+V+
Sbjct: 255 LLRHNPSERLPLAQVSAHPWVR 276

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+     QI +
Sbjct: 233 MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 352 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 409
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C +  P +RPT
Sbjct: 410 LHDLMCQCWRKEPEERPT 427

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 93/196 (47%), Gaps = 21/196 (10%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD---SQVSSYTRQILNGLT 63
            +HD +V+       E  +YI  E + KGSL +  +          ++  ++ QI  G+ 
Sbjct: 64  LQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 123
Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTT--NDVKSFEGTPF---WVAPEVVN 110
           Y+  +N +HR+++ AN+LV  S        GLA     N+  + EG  F   W APE +N
Sbjct: 124 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRDAR 168
                + + +++WS G  + E++T+ + PY    +   +  + +G ++P + N    +  
Sbjct: 184 F--GCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENC-PDELY 240
Query: 169 DFILKCLQVNPNDRPT 184
           D +  C +    +RPT
Sbjct: 241 DIMKMCWKEKAEERPT 256

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+     QI +
Sbjct: 316 MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 435 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 492
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C +  P +RPT
Sbjct: 493 LHDLMCQCWRKEPEERPT 510

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E    G + ++L +     +     Y  QI+    YLH  ++++R++K  
Sbjct: 111 KDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 170
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+++D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 171 NLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 228
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 229 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 13/173 (7%)
Query: 20  KDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           KD + LY+ +E    G + ++L +     +     Y  QI+    YLH  ++++R++K  
Sbjct: 112 KDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPE 171
Query: 79  NILVDASGLATTTN-----DVKS----FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           N+++D  G    T+      VK       GTP ++APE++  K  GY  + D W+LG  +
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSK--GYNKAVDWWALGVLI 229
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EM    PP+   + +Q   +I  GK+   P+  S D +D +   LQV+   R
Sbjct: 230 YEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KG L +  +     +L   Q+     QI +
Sbjct: 67  MKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIAS 125
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 126 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 185
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 186 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 243
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C + +P +RPT
Sbjct: 244 LHDLMCQCWRKDPEERPT 261

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 48/236 (20%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNG 61
             + +H NIV+       + RL +  E + +  L  L    +  L      S+  Q+LNG
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 62  LTYLHERNVVHREIKCANILVDASG-LATTTNDVKSFEGTP-----------FWVAPEVV 109
           + Y H+R V+HR++K  N+L++  G L      +    G P           ++ AP+V+
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS------- 162
            + +  Y  + DIWS+GC   EM+   P +  + +   L RI R  +   PNS       
Sbjct: 173 -MGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFR--ILGTPNSKNWPNVT 229
Query: 163 -----------------------LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                                  L     D + K L+++PN R TA Q +EH + K
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 36/219 (16%)
Query: 9   HDNIVQYIGTEKDEN--RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           H++I++Y G  +D     L + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 67  ERNVVHREIKCANILVDAS--------GLATTTND------VKSFEGTP-FWVAPEVVNL 111
            ++ +HR++   N+L+D          GLA    +      V+    +P FW APE   L
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC--L 209
Query: 112 KNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE------DMQALFRIG----RGKL 156
           K   +  ++D+WS G T+ E+LTH      PP   LE          + R+     RG+ 
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
              P+    +    +  C +   + RPT   L+  P +K
Sbjct: 270 LPRPDKCPAEVYHLMKNCWETEASFRPTFENLI--PILK 306

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 48/236 (20%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNG 61
             + +H NIV+       + RL +  E + +  L  L    +  L      S+  Q+LNG
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 62  LTYLHERNVVHREIKCANILVDASG-LATTTNDVKSFEGTP-----------FWVAPEVV 109
           + Y H+R V+HR++K  N+L++  G L      +    G P           ++ AP+V+
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS------- 162
            + +  Y  + DIWS+GC   EM+   P +  + +   L RI R  +   PNS       
Sbjct: 173 -MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR--ILGTPNSKNWPNVT 229
Query: 163 -----------------------LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                                  L     D + K L+++PN R TA Q +EH + K
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 48/236 (20%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNG 61
             + +H NIV+       + RL +  E + +  L  L    +  L      S+  Q+LNG
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 62  LTYLHERNVVHREIKCANILVDASG-LATTTNDVKSFEGTP-----------FWVAPEVV 109
           + Y H+R V+HR++K  N+L++  G L      +    G P           ++ AP+V+
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS------- 162
            + +  Y  + DIWS+GC   EM+   P +  + +   L RI R  +   PNS       
Sbjct: 173 -MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR--ILGTPNSKNWPNVT 229
Query: 163 -----------------------LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                                  L     D + K L+++PN R TA Q +EH + K
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVK--SFEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   +  SF GT  +V+PE++
Sbjct: 147 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 206
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 207 TEKSASK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 263
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+     QI +
Sbjct: 233 MKKLRHEKLVQLYAVVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 352 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 409
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C +  P +RPT
Sbjct: 410 LHDLMCQCWRKEPEERPT 427

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 20/154 (12%)
Query: 58  ILNGLTYLHER-NVVHREIKCANILVDASG-------------LATTTNDVKSFEGTPFW 103
           I+  L +LH + +V+HR++K +N+L++A G             +     D+ +  G   +
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA--GCKPY 202
Query: 104 VAPEVVN--LKNNGYGLSADIWSLGCTVLEMLTHQPPY-SHLEDMQALFRIGRGKLPSVP 160
            APE +N  L   GY + +DIWSLG T +E+   + PY S     Q L ++     P +P
Sbjct: 203 XAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP 262
Query: 161 -NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
            +  S +  DF  +CL+ N  +RPT  +L +HPF
Sbjct: 263 ADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPF 296

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYL 65
           EH N+++Y  TEKD    YI +EL        + QK   HL    ++   +Q  +GL +L
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT-LLQQTTSGLAHL 134
Query: 66  HERNVVHREIKCANILV---DASG--------------LATTTNDVKSFEGTP---FWVA 105
           H  N+VHR++K  NIL+   +A G              LA   +      G P    W+A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 106 PEVV--NLKNNGYGLSADIWSLGCTVLEMLTHQP-PYSHLEDMQALFRIGRGKLPSVPNS 162
           PE++  + K N    + DI+S GC    +++    P+      QA   +G   L  +   
Sbjct: 195 PEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 163 LSRD--ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              D  AR+ I K + ++P  RP+A  +++HPF
Sbjct: 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 43/234 (18%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGL 62
             +  H NIV  I     E  L +  E ++K     L + K  L DSQ+  Y  Q+L G+
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEVVN 110
            + H+  ++HR++K  N+L+++ G     +          V+S+  E    W  AP+V+ 
Sbjct: 133 AHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL- 191
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED-------------------------- 144
           + +  Y  S DIWS+GC   EM+T +P +  + D                          
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251
Query: 145 --MQALFRIGRGK-LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
              Q  F++   K   S+     ++  D +   L  +PN R +A   M HP+ K
Sbjct: 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 43/234 (18%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGL 62
             +  H NIV  I     E  L +  E ++K     L + K  L DSQ+  Y  Q+L G+
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN---------DVKSF--EGTPFWV-APEVVN 110
            + H+  ++HR++K  N+L+++ G     +          V+S+  E    W  AP+V+ 
Sbjct: 133 AHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL- 191
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED-------------------------- 144
           + +  Y  S DIWS+GC   EM+T +P +  + D                          
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251
Query: 145 --MQALFRIGRGK-LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
              Q  F++   K   S+     ++  D +   L  +PN R +A   M HP+ K
Sbjct: 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 143
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVK--SFEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   +  SF GT  +V+PE++
Sbjct: 144 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 203
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 204 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 260
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 261 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 88  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 147
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVK--SFEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   +  SF GT  +V+PE++
Sbjct: 148 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 207
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 208 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 264
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 265 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 147 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 207 TEKSAXK--SSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARD 263
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 90  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 149
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 150 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 209
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P +    ARD
Sbjct: 210 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPAAFFPKARD 266
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 267 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 298

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHE 67
           H  + Q     +  +RL+  +E V  G L    QK     +++   Y  +I++ L +LH+
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 68  RNVVHREIKCANILVDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNG 115
           + +++R++K  N+L+D  G     +               +F GTP ++APE+  L+   
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI--LQEML 200
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCL 175
           YG + D W++G  + EML    P+   E+   LF          P  L  DA   +   +
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILNDEVVYPTWLHEDATGILKSFM 259
Query: 176 QVNPNDR-PTAAQLMEHPFVKRPL 198
             NP  R  +  Q  EH  ++ P 
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPF 283

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 23/168 (13%)
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS----------GLATTTNDVKSFE-- 98
           +S+  RQI + L YLH + + HR+IK  N L   +          GL+     + + E  
Sbjct: 170 ISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 99  ------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG 152
                 GTP++VAPEV+N  N  YG   D WS G  +  +L    P+  + D   + ++ 
Sbjct: 230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL 289
Query: 153 RGKL----PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
             KL    P+  N LS  ARD +   L  N ++R  A + ++HP++ +
Sbjct: 290 NKKLCFENPNY-NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 121
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 122 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 181
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 182 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 238
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPF 193
            + K L ++   R    +      L  HPF
Sbjct: 239 LVEKLLVLDATKRLGCEEMEGYGPLKAHPF 268

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 143
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 144 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 203
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 204 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 260
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 261 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 182
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 183 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 239
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPF 193
            + K L ++   R    +      L  HPF
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 65  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 124
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 125 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 184
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 185 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 241
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPF 193
            + K L ++   R    +      L  HPF
Sbjct: 242 LVEKLLVLDATKRLGCEEMEGYGPLKAHPF 271

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 147 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 207 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 263
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 147 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 207 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 263
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
           F+  +H NI+   G    E  L + +E  + G L  +     +    + ++  QI  G+ 
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMN 119
Query: 64  YLHERNVV---HREIKCANILV-------DAS---------GLATTTNDVK--SFEGTPF 102
           YLH+  +V   HR++K +NIL+       D S         GLA   +     S  G   
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA 179
Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP-SVPN 161
           W+APEV+  + + +   +D+WS G  + E+LT + P+  ++ +   + +   KL   +P+
Sbjct: 180 WMAPEVI--RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           +        +  C   +P+ RP+   +++ 
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 144
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVK--SFEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   +  +F GT  +V+PE++
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL 204
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 205 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 261
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 144
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 205 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 261
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 144
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 205 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 261
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 147 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 207 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARD 263
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 88  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 147
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 148 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 207
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 208 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 264
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 265 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 296

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 146
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 147 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 207 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 263
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 64  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 123
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 124 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 183
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 184 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 240
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPF 193
            + K L ++   R    +      L  HPF
Sbjct: 241 LVEKLLVLDATKRLGCEEMEGYGPLKAHPF 270

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 144
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 205 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 261
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 69  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 128
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 129 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 188
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 189 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 245
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPF 193
            + K L ++   R    +      L  HPF
Sbjct: 246 LVEKLLVLDATKRLGCEEMEGYGPLKAHPF 275

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-----ANLYQKYHLSDSQVSSYTRQILNG 61
            +H NI++     +D + +YI +E  + G L     +   +   LS+  V+   +Q++N 
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 62  LTYLHERNVVHREIKCANILV-DAS----------GLA---TTTNDVKSFEGTPFWVAPE 107
           L Y H ++VVH+++K  NIL  D S          GLA    +     +  GT  ++APE
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY--SHLEDMQALFRIGRGKLPSVPNSLSR 165
           V            DIWS G  +  +LT   P+  + LE++Q                L+ 
Sbjct: 197 VF---KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP 253
Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
            A D + + L  +P  RP+AAQ++ H + K+
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLT 63
           SQ  H NIV  I  +++++  Y+ +E ++  +L+   + +  LS     ++T QIL+G+ 
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 64  YLHERNVVHREIKCANILVDAS--------GLA-----TTTNDVKSFEGTPFWVAPEVVN 110
           + H+  +VHR+IK  NIL+D++        G+A     T+        GT  + +PE   
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE--Q 183
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA--- 167
            K        DI+S+G  + EML  +PP++    +    +  +  +P+V   + +D    
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 168 -RDFILKCLQVNPNDRPTAAQLME 190
             + IL+  + +  +R    Q M+
Sbjct: 244 LSNVILRATEKDKANRYKTIQEMK 267

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
             +  H+ +VQ      +E  + I  E + KGSL +  +     +L   Q+     QI +
Sbjct: 57  MKKLRHEKLVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 115
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA     N+  + +G  F   W APE
Sbjct: 116 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPE 175
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P      
Sbjct: 176 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 233
Query: 167 ARDFILKCLQVNPNDRPT 184
             D + +C +  P +RPT
Sbjct: 234 LHDLMCQCWRKEPEERPT 251

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  F  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  F  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDFGLARHTDDEMAGFVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 20/198 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILN 60
             + +HD +VQ      +E  +YI  E + KGSL +  +      L    +     Q+  
Sbjct: 58  MKKLKHDKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 116
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ Y+   N +HR+++ ANILV           GLA     N+  + +G  F   W APE
Sbjct: 117 GMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPE 176
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
                   + + +D+WS G  + E++T  + PY  + + + L ++ RG     P      
Sbjct: 177 AALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS 234
Query: 167 ARDFILKCLQVNPNDRPT 184
             + ++ C + +P +RPT
Sbjct: 235 LHELMIHCWKKDPEERPT 252

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 21/191 (10%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           +RLY  +E V  G L  ++ Q     +     Y  +I  GL +L  + +++R++K  N++
Sbjct: 94  DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 153
Query: 82  VDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D+ G     +              K F GTP ++APE++  +   YG S D W+ G  +
Sbjct: 154 LDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLL 211
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR----PTA 185
            EML  Q P+   ED   LF+       + P S+S++A       +  +P  R    P  
Sbjct: 212 YEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEG 270
Query: 186 AQ-LMEHPFVK 195
            + + EH F +
Sbjct: 271 ERDIKEHAFFR 281

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYL 65
            EH  +V    + +DE  +++ ++L+  G L  +L Q  H  +  V  +  +++  L YL
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131
Query: 66  HERNVVHREIKCANILVDASGLATTTN-----------DVKSFEGTPFWVAPEVV-NLKN 113
             + ++HR++K  NIL+D  G    T+            + +  GT  ++APE+  + K 
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLE---DMQALFRIGRGKLPSVPNSLSRDARDF 170
            GY  + D WSLG T  E+L  + PY H+      + +       + + P++ S++    
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPY-HIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSL 250
Query: 171 ILKCLQVNPNDR 182
           + K L+ NP+ R
Sbjct: 251 LKKLLEPNPDQR 262

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 104/242 (42%), Gaps = 61/242 (25%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV-SSYTRQILNGLTYLHERN- 69
           IV + G    +  + I +E +  GSL  + +K      Q+    +  ++ GLTYL E++ 
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 187
Query: 70  VVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           ++HR++K +NILV++ G     +             SF GT  +++PE   L+   Y + 
Sbjct: 188 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 245
Query: 120 ADIWSLGCTVLEM---------------------------------------------LT 134
           +DIWS+G +++EM                                             + 
Sbjct: 246 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 305
Query: 135 HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            +PP +  E +  +      KLPS   SL  + +DF+ KCL  NP +R    QLM H F+
Sbjct: 306 SRPPMAIFELLDYIVNEPPPKLPSAVFSL--EFQDFVNKCLIKNPAERADLKQLMVHAFI 363
Query: 195 KR 196
           KR
Sbjct: 364 KR 365

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 109/235 (46%), Gaps = 47/235 (20%)
Query: 4   FSQFEHDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
               +H+N++  +       + ++ N +Y+   L+    L N+ +   L+D  V     Q
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQ 129
Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTND-VKSFEGTPFWVAPEV 108
           IL GL Y+H  +++HR++K +N+ V+          GLA  T+D +  F  T ++ APE+
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRAPEI 189
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQ---PPYSHLEDMQALFRI----GRGKLPSVPN 161
           + L    Y  + DIWS+GC + E+LT +   P   H++ ++ + R+    G   L  + +
Sbjct: 190 M-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 162 SLSRD-----------------------ARDFILKCLQVNPNDRPTAAQLMEHPF 193
             +R+                       A D + K L ++ + R TAAQ + H +
Sbjct: 249 ESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 61/242 (25%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV-SSYTRQILNGLTYLHERN- 69
           IV + G    +  + I +E +  GSL  + +K      Q+    +  ++ GLTYL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 70  VVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           ++HR++K +NILV++ G     +             SF GT  +++PE   L+   Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 183
Query: 120 ADIWSLGCTVLEM---------------------------------------------LT 134
           +DIWS+G +++EM                                             + 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 135 HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            +PP +  E +  +      KLPS     S + +DF+ KCL  NP +R    QLM H F+
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 195 KR 196
           KR
Sbjct: 302 KR 303

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 28/200 (14%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+      D+   ++ +EL+  G L   + +K H S+++ S   R++++ ++++H+
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 68  RNVVHREIKCANIL------------VDASGLATTTNDVKSFEGTPF---WVAPEVVNLK 112
             VVHR++K  N+L            +D         D +  +   F   + APE++N  
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN-- 182
Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPY-SHLEDM------QALFRIGRGKLP---SVPNS 162
            NGY  S D+WSLG  +  ML+ Q P+ SH   +      + + +I +G          +
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242
Query: 163 LSRDARDFILKCLQVNPNDR 182
           +S++A+D I   L V+PN R
Sbjct: 243 VSQEAKDLIQGLLTVDPNKR 262

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 61/242 (25%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV-SSYTRQILNGLTYLHERN- 69
           IV + G    +  + I +E +  GSL  + +K      Q+    +  ++ GLTYL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 70  VVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           ++HR++K +NILV++ G     +             SF GT  +++PE   L+   Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 183
Query: 120 ADIWSLGCTVLEM---------------------------------------------LT 134
           +DIWS+G +++EM                                             + 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 135 HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            +PP +  E +  +      KLPS     S + +DF+ KCL  NP +R    QLM H F+
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 195 KR 196
           KR
Sbjct: 302 KR 303

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 19/168 (11%)
Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS-----------GLATTTN-- 92
           +S++ V    +QIL G+ YLH+ N+VH ++K  NIL+ +            G++      
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 93  -DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI 151
            +++   GTP ++APE++N   +    + D+W++G     +LTH  P+   ++ +    I
Sbjct: 188 CELREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245
Query: 152 GRGKL---PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
            +  +       +S+S+ A DFI   L  NP  RPTA   + H ++++
Sbjct: 246 SQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 61/242 (25%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV-SSYTRQILNGLTYLHERN- 69
           IV + G    +  + I +E +  GSL  + +K      Q+    +  ++ GLTYL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 70  VVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           ++HR++K +NILV++ G     +             SF GT  +++PE   L+   Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 183
Query: 120 ADIWSLGCTVLEM---------------------------------------------LT 134
           +DIWS+G +++EM                                             + 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 135 HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            +PP +  E +  +      KLPS     S + +DF+ KCL  NP +R    QLM H F+
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 195 KR 196
           KR
Sbjct: 302 KR 303

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 61/242 (25%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV-SSYTRQILNGLTYLHERN- 69
           IV + G    +  + I +E +  GSL  + +K      Q+    +  ++ GLTYL E++ 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 70  VVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           ++HR++K +NILV++ G     +             SF GT  +++PE   L+   Y + 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 183
Query: 120 ADIWSLGCTVLEM---------------------------------------------LT 134
           +DIWS+G +++EM                                             + 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 135 HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            +PP +  E +  +      KLPS     S + +DF+ KCL  NP +R    QLM H F+
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
Query: 195 KR 196
           KR
Sbjct: 302 KR 303

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNAMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 61/242 (25%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV-SSYTRQILNGLTYLHERN- 69
           IV + G    +  + I +E +  GSL  + +K      Q+    +  ++ GLTYL E++ 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 70  VVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           ++HR++K +NILV++ G     +             SF GT  +++PE   L+   Y + 
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE--RLQGTHYSVQ 210
Query: 120 ADIWSLGCTVLEM---------------------------------------------LT 134
           +DIWS+G +++EM                                             + 
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 135 HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
            +PP +  E +  +      KLPS     S + +DF+ KCL  NP +R    QLM H F+
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328
Query: 195 KR 196
           KR
Sbjct: 329 KR 330

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DA--------SGLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +         +GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDAGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 19/200 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILNGL 62
           + +H N+VQ +G    E   YI +E +  G+L +  +   +  +S   +     QI + +
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 122
Query: 63  TYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPEVV 109
            YL ++N +HR++   N LV  + L            T +   +  G  F   W APE  
Sbjct: 123 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE-- 180
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
           +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P        
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY 240
Query: 169 DFILKCLQVNPNDRPTAAQL 188
           + +  C Q NP+DRP+ A++
Sbjct: 241 ELMRACWQWNPSDRPSFAEI 260

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 73.2 bits (178), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 21/191 (10%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           +RLY  +E V  G L  ++ Q     +     Y  +I  GL +L  + +++R++K  N++
Sbjct: 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 474
Query: 82  VDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D+ G     +              K F GTP ++APE++  +   YG S D W+ G  +
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP--YGKSVDWWAFGVLL 532
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR----PTA 185
            EML  Q P+   ED   LF+       + P S+S++A       +  +P  R    P  
Sbjct: 533 YEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEG 591
Query: 186 AQ-LMEHPFVK 195
            + + EH F +
Sbjct: 592 ERDIKEHAFFR 602

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 9   HDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           H++IV+Y G  +D  E  + + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH
Sbjct: 70  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 67  ERNVVHREIKCANILVDAS--------GLATTTND------VKSFEGTP-FWVAPEVVNL 111
            ++ +HR +   N+L+D          GLA    +      V+    +P FW APE   L
Sbjct: 130 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC--L 187
Query: 112 KNNGYGLSADIWSLGCTVLEMLTH----QPPYS-------HLEDMQALFRIG----RGKL 156
           K   +  ++D+WS G T+ E+LT+    Q P++       H +    + R+     RG+ 
Sbjct: 188 KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGER 247
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
              P+    +    +  C +   + RPT   L+
Sbjct: 248 LPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 280

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 73.2 bits (178), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 6   QFEHDNIVQYIGT--EKDENRLYIFLELVKKG--SLANLYQKYHLSDSQVSSYTRQILNG 61
           +  H N++Q +     +++ ++Y+ +E    G   + +   +      Q   Y  Q+++G
Sbjct: 62  RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 62  LTYLHERNVVHREIKCANIL--------VDASGLA------TTTNDVKSFEGTPFWVAPE 107
           L YLH + +VH++IK  N+L        + A G+A         +  ++ +G+P +  PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRD 166
           + N  +   G   DIWS G T+  + T   P+   +++  LF  IG+G   ++P      
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY-AIPGDCGPP 239
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
             D +   L+  P  R +  Q+ +H + ++
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 9   HDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           H++IV+Y G  +D  E  + + +E V  GSL +   ++ +  +Q+  + +QI  G+ YLH
Sbjct: 69  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 67  ERNVVHREIKCANILVDAS--------GLATTTND------VKSFEGTP-FWVAPEVVNL 111
            ++ +HR +   N+L+D          GLA    +      V+    +P FW APE   L
Sbjct: 129 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC--L 186
Query: 112 KNNGYGLSADIWSLGCTVLEMLTH----QPPYS-------HLEDMQALFRIG----RGKL 156
           K   +  ++D+WS G T+ E+LT+    Q P++       H +    + R+     RG+ 
Sbjct: 187 KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGER 246
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
              P+    +    +  C +   + RPT   L+
Sbjct: 247 LPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 279

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 102/258 (39%), Gaps = 69/258 (26%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL---SDSQVSSYTRQILNGLT 63
           F H NIV Y  T   +N L++    +  GS  +L   + +   ++  ++   + +L  L 
Sbjct: 67  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 126
Query: 64  YLHERNVVHREIKCANILVDA------SGLATTTNDVK--------------SFEGTPFW 103
           Y+H    VHR +K ++IL+        SGL +  + +               S +  P W
Sbjct: 127 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP-W 185
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP------ 157
           ++PEV+     GY   +DI+S+G T  E+     P+  +   Q L     G +P      
Sbjct: 186 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 245
Query: 158 -------------SVPNSLSRDA--------------------------RDFILKCLQVN 178
                        SV NS   D+                            F+ +CLQ N
Sbjct: 246 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 305
Query: 179 PNDRPTAAQLMEHPFVKR 196
           P+ RP+A+ L+ H F K+
Sbjct: 306 PDARPSASTLLNHSFFKQ 323

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 102/258 (39%), Gaps = 69/258 (26%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL---SDSQVSSYTRQILNGLT 63
           F H NIV Y  T   +N L++    +  GS  +L   + +   ++  ++   + +L  L 
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 64  YLHERNVVHREIKCANILVDA------SGLATTTNDVK--------------SFEGTPFW 103
           Y+H    VHR +K ++IL+        SGL +  + +               S +  P W
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP-W 201
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP------ 157
           ++PEV+     GY   +DI+S+G T  E+     P+  +   Q L     G +P      
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261
Query: 158 -------------SVPNSLSRDA--------------------------RDFILKCLQVN 178
                        SV NS   D+                            F+ +CLQ N
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321
Query: 179 PNDRPTAAQLMEHPFVKR 196
           P+ RP+A+ L+ H F K+
Sbjct: 322 PDARPSASTLLNHSFFKQ 339

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLATTTNDV 94
           L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG        
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 166
Query: 95  KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM---QALFRI 151
             F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   Q  FR 
Sbjct: 167 TDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR- 224
Query: 152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                      +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 225 ---------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 106 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 165 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 223
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 224 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 283
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 284 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 313

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 106 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 165 NEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 223
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 224 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 283
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 284 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 313

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 102 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 161 NEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 219
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 220 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 279
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 280 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 309

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 111 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 169
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 170 NEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 228
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 229 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 288
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 289 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 318

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 112 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 170
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 171 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 229
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 230 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 289
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 290 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 319

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 111 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 169
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 170 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 228
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 229 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 288
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 289 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 318

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 109/235 (46%), Gaps = 47/235 (20%)
Query: 4   FSQFEHDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
               +H+N++  +       + ++ N +Y+   L+    L N+ +   L+D  V     Q
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQ 138
Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTND-VKSFEGTPFWVAPEV 108
           IL GL Y+H  +++HR++K +N+ V+          GLA  T+D +  +  T ++ APE+
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEI 198
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQ---PPYSHLEDMQALFRI----GRGKLPSVPN 161
           + L    Y  + DIWS+GC + E+LT +   P   H++ ++ + R+    G   L  + +
Sbjct: 199 M-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 162 SLSRD-----------------------ARDFILKCLQVNPNDRPTAAQLMEHPF 193
             +R+                       A D + K L ++ + R TAAQ + H +
Sbjct: 258 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 312

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 123 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 181
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 182 NEDCELKILDFGLARHTDDEMXGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 240
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 241 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 300
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 301 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 330

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DA--------SGLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDGGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 105 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 164 NEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 222
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 223 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 282
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 283 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 312

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 112 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 170
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 171 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 229
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 230 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 289
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 290 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 319

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 112 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 170
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 171 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 229
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 230 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 289
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 290 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 319

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILGFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 102 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 161 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 219
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 220 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 279
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 280 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 309

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 106 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 165 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 223
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 224 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 283
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 284 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 313

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 120 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 178
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 179 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 237
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 238 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 297
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 298 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 327

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDRGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 106 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 165 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 223
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 224 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGA 283
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 284 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 313

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 105 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 164 NEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 222
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 223 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 282
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 283 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 312

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 102 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 161 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 219
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 220 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 279
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 280 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 309

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 94/194 (48%), Gaps = 14/194 (7%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+     + E  LY+ +E    G + + L     + + +  +  RQI++ + Y H+
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 68  RNVVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPFWVAPEVVNLKNNGY 116
           + +VHR++K  N+L+D            S   T  N + +F G+P + APE+   K    
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYD- 191
Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
           G   D+WSLG  +  +++   P+      +   R+ RGK   +P  +S D  + + K L 
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKLLV 250
Query: 177 VNPNDRPTAAQLME 190
           +NP  R +  Q+M+
Sbjct: 251 LNPIKRGSLEQIMK 264

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+     +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 92  SRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 151
Query: 64  YLHERNVVHREIKCANILVD------------ASGLATTTNDVKS--FEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++            A  L+  +   ++  F GT  +V+PE++
Sbjct: 152 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 211
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             K+     S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 212 TEKSACK--SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARD 268
Query: 170 FILKCLQVNPNDRPTAAQ------LMEHPFVK 195
            + K L ++   R    +      L  HPF +
Sbjct: 269 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 300

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 107 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 166 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 224
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 225 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 284
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 285 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDYGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 109/235 (46%), Gaps = 47/235 (20%)
Query: 4   FSQFEHDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
               +H+N++  +       + ++ N +Y+   L+    L N+ +   L+D  V     Q
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQ 131
Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTND-VKSFEGTPFWVAPEV 108
           IL GL Y+H  +++HR++K +N+ V+          GLA  T+D +  +  T ++ APE+
Sbjct: 132 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEI 191
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQ---PPYSHLEDMQALFRI----GRGKLPSVPN 161
           + L    Y  + DIWS+GC + E+LT +   P   H++ ++ + R+    G   L  + +
Sbjct: 192 M-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 250
Query: 162 SLSRD-----------------------ARDFILKCLQVNPNDRPTAAQLMEHPF 193
             +R+                       A D + K L ++ + R TAAQ + H +
Sbjct: 251 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 305

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 105 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 164 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 222
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 223 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 282
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 283 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 312

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 99  NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 157
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 158 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 216
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 217 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 276
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 277 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 306

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 110 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 168
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 169 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 227
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 228 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGA 287
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 288 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 317

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 109/235 (46%), Gaps = 47/235 (20%)
Query: 4   FSQFEHDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
               +H+N++  +       + ++ N +Y+   L+    L N+ +   L+D  V     Q
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCAKLTDDHVQFLIYQ 129
Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTND-VKSFEGTPFWVAPEV 108
           IL GL Y+H  +++HR++K +N+ V+          GLA  T+D +  +  T ++ APE+
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEI 189
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQ---PPYSHLEDMQALFRI----GRGKLPSVPN 161
           + L    Y  + DIWS+GC + E+LT +   P   H++ ++ + R+    G   L  + +
Sbjct: 190 M-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 162 SLSRD-----------------------ARDFILKCLQVNPNDRPTAAQLMEHPF 193
             +R+                       A D + K L ++ + R TAAQ + H +
Sbjct: 249 ESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 120 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 178
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 179 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 237
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 238 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGA 297
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 298 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 327

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 123 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 181
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 182 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 240
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 241 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 300
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 301 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 330

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 102 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 161 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 219
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 220 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 279
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 280 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 309

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 119 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 177
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 178 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 236
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 237 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 296
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 297 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 326

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 97  NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 155
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 156 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 214
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 215 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 274
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 275 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 304

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 119 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 177
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 178 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 236
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 237 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGA 296
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 297 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 326

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 109/235 (46%), Gaps = 47/235 (20%)
Query: 4   FSQFEHDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
               +H+N++  +       + ++ N +Y+   L+    L N+ +   L+D  V     Q
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQ 129
Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTND-VKSFEGTPFWVAPEV 108
           IL GL Y+H  +++HR++K +N+ V+          GLA  T+D +  +  T ++ APE+
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEI 189
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQ---PPYSHLEDMQALFRI----GRGKLPSVPN 161
           + L    Y  + DIWS+GC + E+LT +   P   H++ ++ + R+    G   L  + +
Sbjct: 190 M-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 162 SLSRD-----------------------ARDFILKCLQVNPNDRPTAAQLMEHPF 193
             +R+                       A D + K L ++ + R TAAQ + H +
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILN 60
             + +H N+VQ +G    E   YI +E +  G+L +  +   +  +S   +     QI +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 183 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 241 VYELMRACWQWNPSDRPSFAEI 262

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 97  NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 155
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 156 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 214
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 215 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 274
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 275 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 304

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 96  NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 155 NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 213
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 214 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGA 273
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 274 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 303

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILN 60
             + +H N+VQ +G    E   YI +E +  G+L +  +   +  +S   +     QI +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 183 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 241 VYELMRACWQWNPSDRPSFAEI 262

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLATTTNDV 94
           L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG        
Sbjct: 110 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 169
Query: 95  KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM---QALFRI 151
             F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   Q  FR 
Sbjct: 170 TDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR- 227
Query: 152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                      +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 228 ---------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 262

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 105 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 164
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 165 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 223
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 224 QVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 263

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 106 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 165
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 166 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 224
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 225 QVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 128 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 187
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +      +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 188 LKDTVYTDFDGTRVYSPPEWIRYHRY-HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 246
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 247 QVFFR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 286

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLATTTNDV 94
           L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG        
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 166
Query: 95  KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM---QALFRI 151
             F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   Q  FR 
Sbjct: 167 TDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR- 224
Query: 152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                      +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 225 ---------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 106 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 165
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 166 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 224
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 225 QVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 105 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 164
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 165 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 223
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 224 QVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 263

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GL   T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDSELKILDFGLCRHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 106 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 165
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 166 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 224
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 225 QVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 264

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLATTTNDV 94
           L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG        
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 166
Query: 95  KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM---QALFRI 151
             F+GT  +  PE +      +G SA +WSLG  + +M+    P+ H E++   Q  FR 
Sbjct: 167 TDFDGTRVYSPPEWIRYHRY-HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR- 224
Query: 152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                      +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 225 ---------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 75/145 (51%), Gaps = 19/145 (13%)
Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTP 101
           YT QI++GL +LH+RN+++R++K  N+L+D  G            L       K + GTP
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 102 FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRIGRGKLP 157
            ++APE+  L    Y  S D ++LG T+ EM+  + P+      +E+ +   R+    + 
Sbjct: 354 GFMAPEL--LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV- 410
Query: 158 SVPNSLSRDARDFILKCLQVNPNDR 182
           + P+  S  ++DF    LQ +P  R
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 121 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 180
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 181 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 239
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 240 QVFFR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 279

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 120 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 179
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 180 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 238
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 239 QVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 278

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 120 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 179
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 180 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 238
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 239 QVFFR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 278

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 75/145 (51%), Gaps = 19/145 (13%)
Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTP 101
           YT QI++GL +LH+RN+++R++K  N+L+D  G            L       K + GTP
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 102 FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRIGRGKLP 157
            ++APE+  L    Y  S D ++LG T+ EM+  + P+      +E+ +   R+    + 
Sbjct: 354 GFMAPEL--LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV- 410
Query: 158 SVPNSLSRDARDFILKCLQVNPNDR 182
           + P+  S  ++DF    LQ +P  R
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 121 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 180
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 181 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 239
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 240 QVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 279

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 75/145 (51%), Gaps = 19/145 (13%)
Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTP 101
           YT QI++GL +LH+RN+++R++K  N+L+D  G            L       K + GTP
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 102 FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRIGRGKLP 157
            ++APE+  L    Y  S D ++LG T+ EM+  + P+      +E+ +   R+    + 
Sbjct: 354 GFMAPEL--LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV- 410
Query: 158 SVPNSLSRDARDFILKCLQVNPNDR 182
           + P+  S  ++DF    LQ +P  R
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 107 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 83  DAS--------GLAT-TTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T +++  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 166 NEDCELKILDFGLARHTADEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 224
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 225 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 284
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 285 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  +   +  +S   +     QI +
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 181 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEK 238
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 239 VYELMRACWQWNPSDRPSFAEI 260

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 148 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 207
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 208 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 266
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 267 QVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 148 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 207
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 208 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 266
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 267 QVFFR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 19/200 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILNGL 62
           + +H N+VQ +G    E   YI  E +  G+L +  +   +  +S   +     QI + +
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 122
Query: 63  TYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPEVV 109
            YL ++N +HR++   N LV  + L            T +   +  G  F   W APE  
Sbjct: 123 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPE-- 180
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
           +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P        
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKVY 240
Query: 169 DFILKCLQVNPNDRPTAAQL 188
           + +  C Q NP+DRP+ A++
Sbjct: 241 ELMRACWQWNPSDRPSFAEI 260

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLATTTNDV 94
           L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG        
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 213
Query: 95  KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM---QALFRI 151
             F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   Q  FR 
Sbjct: 214 TDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR- 271
Query: 152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                      +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 272 ---------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 306

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 107 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 83  DAS--------GLAT-TTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T +++  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 166 NEDCELKILDFGLARHTADEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 224
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 225 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 284
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 285 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 140 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +      +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 200 LKDTVYTDFDGTRVYSPPEWIRYHRY-HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 258
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 259 QVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 107 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 83  DAS--------GLAT-TTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T +++  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 166 NEDCELKILDFGLARHTADEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 224
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 225 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 284
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 285 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 314

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 133 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 192
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 193 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 251
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 252 QVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 134 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 193
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 194 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 252
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 253 QVFFR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 102/246 (41%), Gaps = 62/246 (25%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----------LSDSQVS 52
             + +H+NIV+       EN+L +  E      + N  +KY            L  + V 
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEF-----MDNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGT 100
            +  Q+L GL + HE  ++HR++K  N+L++  G                 N   S   T
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 101 PFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED---MQALFRI----GR 153
            ++ AP+V+ + +  Y  S DIWS GC + EM+T +P +    D   ++ +F I      
Sbjct: 172 LWYRAPDVL-MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230
Query: 154 GKLPSV-------PNSLSRDAR-------------------DFILKCLQVNPNDRPTAAQ 187
              PSV       PN   R  R                   DF+   LQ+NP+ R +A Q
Sbjct: 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ 290
Query: 188 LMEHPF 193
            + HP+
Sbjct: 291 ALHHPW 296

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 133 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 192
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 193 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 251
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 252 QVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 133 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 192
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 193 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 251
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 252 QVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 9   HDNIVQYIG--TEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLTY 64
           H+NIV+Y G  TE   N + + +E +  GSL       K  ++  Q   Y  QI  G+ Y
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 65  LHERNVVHREIKCANILVDAS--------GL--ATTTND----VKSFEGTP-FWVAPEVV 109
           L  R  VHR++   N+LV++         GL  A  T+     VK    +P FW APE  
Sbjct: 142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC- 200
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH---------------QPPYSHLEDMQALFRIGRG 154
            L  + + +++D+WS G T+ E+LT+                P +  +   + +  +  G
Sbjct: 201 -LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
           K    P +   +    + KC +  P++R +   L+E
Sbjct: 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 134 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 193
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 194 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 252
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 253 QVFFR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 133 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 192
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 193 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 251
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 252 QVFFR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 291

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 75/145 (51%), Gaps = 19/145 (13%)
Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTP 101
           YT QI++GL +LH+RN+++R++K  N+L+D  G            L       K + GTP
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 102 FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRIGRGKLP 157
            ++APE+  L    Y  S D ++LG T+ EM+  + P+      +E+ +   R+    + 
Sbjct: 354 GFMAPEL--LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV- 410
Query: 158 SVPNSLSRDARDFILKCLQVNPNDR 182
           + P+  S  ++DF    LQ +P  R
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 134 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 193
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 194 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 252
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 253 QVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 153 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 212
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +      +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 213 LKDTVYTDFDGTRVYSPPEWIRYHRY-HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 271
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 272 QVFFR----------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 311

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 134 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 193
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 194 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGG 252
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P+DRPT  ++  HP+++
Sbjct: 253 QVFFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 292

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 3   SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILN 60
           +    +H N+++  G       + +  EL   GSL +  +K+  H     +S Y  Q+  
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 61  GLTYLHERNVVHREIKCANILVDASGL----------ATTTND----VKSFEGTPF-WVA 105
           G+ YL  +  +HR++   N+L+    L          A   ND    ++     PF W A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGR-GKLPSVPNSL 163
           PE  +LK   +  ++D W  G T+ EM T+ Q P+  L   Q L +I + G+    P   
Sbjct: 183 PE--SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP 197
            +D  + +++C    P DRPT   L +     +P
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 274

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 71/145 (48%), Gaps = 19/145 (13%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVV 71
           +VQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H   ++
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLI 196
Query: 72  HREIKCANILVDASG---LATTTNDVKSFE----------GTPFWVAPEVVNLKNNG--- 115
           HR++K  N+L+D  G   LA     +K  E          GTP +++PEV  LK+ G   
Sbjct: 197 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEV--LKSQGGDG 254
Query: 116 -YGLSADIWSLGCTVLEMLTHQPPY 139
            YG   D WS+G  + EML    P+
Sbjct: 255 YYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 9   HDNIVQYIG--TEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLTY 64
           H+NIV+Y G  TE   N + + +E +  GSL       K  ++  Q   Y  QI  G+ Y
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY 129
Query: 65  LHERNVVHREIKCANILVDAS--------GL--ATTTND----VKSFEGTP-FWVAPEVV 109
           L  R  VHR++   N+LV++         GL  A  T+     VK    +P FW APE  
Sbjct: 130 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC- 188
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH---------------QPPYSHLEDMQALFRIGRG 154
            L  + + +++D+WS G T+ E+LT+                P +  +   + +  +  G
Sbjct: 189 -LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 247
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
           K    P +   +    + KC +  P++R +   L+E
Sbjct: 248 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 3   SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILN 60
           +    +H N+++  G       + +  EL   GSL +  +K+  H     +S Y  Q+  
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 61  GLTYLHERNVVHREIKCANILVDASGL----------ATTTND----VKSFEGTPF-WVA 105
           G+ YL  +  +HR++   N+L+    L          A   ND    ++     PF W A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 182
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGR-GKLPSVPNSL 163
           PE  +LK   +  ++D W  G T+ EM T+ Q P+  L   Q L +I + G+    P   
Sbjct: 183 PE--SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP 197
            +D  + +++C    P DRPT   L +     +P
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 274

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 3   SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILN 60
           +    +H N+++  G       + +  EL   GSL +  +K+  H     +S Y  Q+  
Sbjct: 74  AMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 132
Query: 61  GLTYLHERNVVHREIKCANILVDASGL----------ATTTND----VKSFEGTPF-WVA 105
           G+ YL  +  +HR++   N+L+    L          A   ND    ++     PF W A
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGR-GKLPSVPNSL 163
           PE  +LK   +  ++D W  G T+ EM T+ Q P+  L   Q L +I + G+    P   
Sbjct: 193 PE--SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP 197
            +D  + +++C    P DRPT   L +     +P
Sbjct: 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 3   SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILN 60
           +    +H N+++  G       + +  EL   GSL +  +K+  H     +S Y  Q+  
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 61  GLTYLHERNVVHREIKCANILVDASGL----------ATTTND----VKSFEGTPF-WVA 105
           G+ YL  +  +HR++   N+L+    L          A   ND    ++     PF W A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGR-GKLPSVPNSL 163
           PE  +LK   +  ++D W  G T+ EM T+ Q P+  L   Q L +I + G+    P   
Sbjct: 183 PE--SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 164 SRDARDFILKCLQVNPNDRPTAAQL 188
            +D  + +++C    P DRPT   L
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH------LSDSQVSSYTRQILNGLTYL 65
           IVQ+ G    E   +I +EL+   S    Y+  +      + +  +   T   +  L +L
Sbjct: 83  IVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 66  HER-NVVHREIKCANILVDASG------LATTTNDVKSFE-----GTPFWVAPEVVN--L 111
            E   ++HR+IK +NIL+D SG         +   V S       G   ++APE ++   
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 201
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-QALFRIGRGKLPSVPNSLSRDAR-- 168
              GY + +D+WSLG T+ E+ T + PY     +   L ++ +G  P + NS  R+    
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPS 261
Query: 169 --DFILKCLQVNPNDRPTAAQLMEHPFV 194
             +F+  CL  + + RP   +L++HPF+
Sbjct: 262 FINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 3   SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILN 60
           +    +H N+++  G       + +  EL   GSL +  +K+  H     +S Y  Q+  
Sbjct: 68  AMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 126
Query: 61  GLTYLHERNVVHREIKCANILVDASGL----------ATTTND----VKSFEGTPF-WVA 105
           G+ YL  +  +HR++   N+L+    L          A   ND    ++     PF W A
Sbjct: 127 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGR-GKLPSVPNSL 163
           PE  +LK   +  ++D W  G T+ EM T+ Q P+  L   Q L +I + G+    P   
Sbjct: 187 PE--SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 244
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP 197
            +D  + +++C    P DRPT   L +     +P
Sbjct: 245 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 278

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 25/170 (14%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + ++  L +    S+  Q+L  + + H   V+HR+IK  NIL+D            SG  
Sbjct: 121 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 180
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--- 145
                   F+GT  +  PE +   +  +G SA +WSLG  + +M+    P+ H E++   
Sbjct: 181 LKDTVYTDFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 239
Query: 146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           Q  FR            +S + +  I  CL + P DRPT  ++  HP+++
Sbjct: 240 QVFFR----------QRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQ 279

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--SQVSSY-TRQILN 60
             + +H N+VQ +G    E   YI +E +  G+L +  ++ +  +  + V  Y   QI +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 188 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 245
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 246 VYELMRACWQWNPSDRPSFAEI 267

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 22/214 (10%)
Query: 3   SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILN 60
           +    +H N+++  G       + +  EL   GSL +  +K+  H     +S Y  Q+  
Sbjct: 74  AMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 132
Query: 61  GLTYLHERNVVHREIKCANILVDASGL----------ATTTND----VKSFEGTPF-WVA 105
           G+ YL  +  +HR++   N+L+    L          A   ND    ++     PF W A
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 192
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGR-GKLPSVPNSL 163
           PE  +LK   +  ++D W  G T+ EM T+ Q P+  L   Q L +I + G+    P   
Sbjct: 193 PE--SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 250
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP 197
            +D  + +++C    P DRPT   L +     +P
Sbjct: 251 PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--SQVSSY-TRQILN 60
             + +H N+VQ +G    E   YI +E +  G+L +  ++ +  +  + V  Y   QI +
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 183
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 184 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 241
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 242 VYELMRACWQWNPSDRPSFAEI 263

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 3   SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILN 60
           +    +H N+++  G       + +  EL   GSL +  +K+  H     +S Y  Q+  
Sbjct: 68  AMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 126
Query: 61  GLTYLHERNVVHREIKCANILVDASGL----------ATTTND----VKSFEGTPF-WVA 105
           G+ YL  +  +HR++   N+L+    L          A   ND    ++     PF W A
Sbjct: 127 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGR-GKLPSVPNSL 163
           PE  +LK   +  ++D W  G T+ EM T+ Q P+  L   Q L +I + G+    P   
Sbjct: 187 PE--SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 244
Query: 164 SRDARDFILKCLQVNPNDRPTAAQL 188
            +D  + +++C    P DRPT   L
Sbjct: 245 PQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  +   +  +S   +     QI +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 183 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 241 VYELMRACWQWNPSDRPSFAEI 262

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 94/191 (49%), Gaps = 19/191 (9%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           ++L   L+L+  G L  +L Q    S++ +  Y  +I+ GL ++H R VV+R++K ANIL
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324
Query: 82  VDAS--------GLATTTNDVKSFE--GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE 131
           +D          GLA   +  K     GT  ++APEV+  K   Y  SAD +SLGC + +
Sbjct: 325 LDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFK 383
Query: 132 MLTHQPPYSH--LEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----PT 184
           +L    P+     +D   + R+       +P+S S + R  +   LQ + N R       
Sbjct: 384 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 185 AAQLMEHPFVK 195
           A ++ E PF +
Sbjct: 444 AQEVKESPFFR 454

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 94/191 (49%), Gaps = 19/191 (9%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           ++L   L+L+  G L  +L Q    S++ +  Y  +I+ GL ++H R VV+R++K ANIL
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324
Query: 82  VDAS--------GLATTTNDVKSFE--GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE 131
           +D          GLA   +  K     GT  ++APEV+  K   Y  SAD +SLGC + +
Sbjct: 325 LDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFK 383
Query: 132 MLTHQPPYSH--LEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----PT 184
           +L    P+     +D   + R+       +P+S S + R  +   LQ + N R       
Sbjct: 384 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 185 AAQLMEHPFVK 195
           A ++ E PF +
Sbjct: 444 AQEVKESPFFR 454

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 94/191 (49%), Gaps = 19/191 (9%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           ++L   L+L+  G L  +L Q    S++ +  Y  +I+ GL ++H R VV+R++K ANIL
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 324
Query: 82  VDAS--------GLATTTNDVKSFE--GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE 131
           +D          GLA   +  K     GT  ++APEV+  K   Y  SAD +SLGC + +
Sbjct: 325 LDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFK 383
Query: 132 MLTHQPPYSH--LEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----PT 184
           +L    P+     +D   + R+       +P+S S + R  +   LQ + N R       
Sbjct: 384 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 185 AAQLMEHPFVK 195
           A ++ E PF +
Sbjct: 444 AQEVKESPFFR 454

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 4   FSQFEHDNIVQYIGTEKDE-NRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQIL 59
            +Q  H N+VQ +G   +E   LYI  E + KGSL +  +   +  L    +  ++  + 
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 299
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATT-----TNDVKSFEGT---PF-WVAPEVVN 110
             + YL   N VHR++   N+LV    +A       T +  S + T   P  W APE   
Sbjct: 300 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA-- 357
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
           L+   +   +D+WS G  + E+ +  + PY  +     + R+ +G     P+       D
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYD 417
Query: 170 FILKCLQVNPNDRPTAAQLMEH 191
            +  C  ++   RPT  QL E 
Sbjct: 418 VMKNCWHLDAATRPTFLQLREQ 439

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYL 65
           F H +I++        + +++ +E V  G L + + +   L + +     +QIL+G+ Y 
Sbjct: 73  FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYC 132
Query: 66  HERNVVHREIKCANILVDAS--------GLATTTND---VKSFEGTPFWVAPEVVNLKNN 114
           H   VVHR++K  N+L+DA         GL+   +D   ++   G+P + APEV++ +  
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLY 192
Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKC 174
             G   DIWS G  +  +L    P+   + +  LF+     +   P  L+      +   
Sbjct: 193 A-GPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYLNPSVISLLKHM 250
Query: 175 LQVNPNDRPTAAQLMEHPFVKRPL 198
           LQV+P  R T   + EH + K+ L
Sbjct: 251 LQVDPMKRATIKDIREHEWFKQDL 274

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  +   +  +S   +     QI +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 127
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 188 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 245
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 246 VYELMRACWQWNPSDRPSFAEI 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  +   +  +S   +     QI +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 183 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 241 VYELMRACWQWNPSDRPSFAEI 262

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 94/191 (49%), Gaps = 19/191 (9%)
Query: 23  NRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           ++L   L+L+  G L  +L Q    S++ +  Y  +I+ GL ++H R VV+R++K ANIL
Sbjct: 264 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 323
Query: 82  VDAS--------GLATTTNDVKSFE--GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE 131
           +D          GLA   +  K     GT  ++APEV+  K   Y  SAD +SLGC + +
Sbjct: 324 LDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFK 382
Query: 132 MLTHQPPYSH--LEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-----PT 184
           +L    P+     +D   + R+       +P+S S + R  +   LQ + N R       
Sbjct: 383 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 442
Query: 185 AAQLMEHPFVK 195
           A ++ E PF +
Sbjct: 443 AQEVKESPFFR 453

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSF-------EGTPFWVAPE 107
            YL  +  +HR++   NILV+          GL       K F       E   FW APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 188 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 246 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 108/235 (45%), Gaps = 47/235 (20%)
Query: 4   FSQFEHDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
               +H+N++  +       + ++ N +Y+   L+    L N+ +   L+D  V     Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTND-VKSFEGTPFWVAPEV 108
           IL GL Y+H  +++HR++K +N+ V+          GLA  T+D +     T ++ APE+
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATRWYRAPEI 193
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQ---PPYSHLEDMQALFRI----GRGKLPSVPN 161
           + L    Y  + DIWS+GC + E+LT +   P   H++ ++ + R+    G   L  + +
Sbjct: 194 M-LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 162 SLSRD-----------------------ARDFILKCLQVNPNDRPTAAQLMEHPF 193
             +R+                       A D + K L ++ + R TAAQ + H +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 120 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 178
Query: 83  DAS--------GLATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +          GLA  T+D +     T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 179 NEDCELKILDFGLARHTDDEMXGXVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 237
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 238 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGA 297
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 298 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 327

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 46/233 (19%)
Query: 7   FEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
           FEH N+V+      +     E +L +  E V +     L +  +  +    +     Q+L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTN----DVKSFEG-------TPFWVAPEV 108
            GL +LH   VVHR++K  NILV +SG     +     + SF+        T ++ APEV
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI-------GRGKLP---S 158
             L  + Y    D+WS+GC   EM   +P +    D+  L +I       G    P   +
Sbjct: 191 --LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 159 VP----------------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +P                  +    +D +LKCL  NP  R +A   + HP+ +
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 46/233 (19%)
Query: 7   FEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
           FEH N+V+      +     E +L +  E V +     L +  +  +    +     Q+L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTN----DVKSFEG-------TPFWVAPEV 108
            GL +LH   VVHR++K  NILV +SG     +     + SF+        T ++ APEV
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI-------GRGKLP---S 158
             L  + Y    D+WS+GC   EM   +P +    D+  L +I       G    P   +
Sbjct: 191 --LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 159 VP----------------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +P                  +    +D +LKCL  NP  R +A   + HP+ +
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 46/233 (19%)
Query: 7   FEHDNIVQY-----IGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
           FEH N+V+      +     E +L +  E V +     L +  +  +    +     Q+L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTN----DVKSFEG-------TPFWVAPEV 108
            GL +LH   VVHR++K  NILV +SG     +     + SF+        T ++ APEV
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI-------GRGKLP---S 158
             L  + Y    D+WS+GC   EM   +P +    D+  L +I       G    P   +
Sbjct: 191 --LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 248
Query: 159 VP----------------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +P                  +    +D +LKCL  NP  R +A   + HP+ +
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 40/187 (21%)
Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKS 96
            S+ ++     Q+L GL Y+H   VVHR++K  N+ V+          GLA   + ++  
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
Query: 97  FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS---HLEDMQALFRI-- 151
           +  T ++ APEV+ L    Y  + DIWS+GC + EMLT +  +    +L+ +  + ++  
Sbjct: 183 YVVTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241
Query: 152 --------------GRGKLPSVPNSLSRD-----------ARDFILKCLQVNPNDRPTAA 186
                          +  + S+P +  +D           A D + K L+++ + R TAA
Sbjct: 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 301
Query: 187 QLMEHPF 193
           Q + HPF
Sbjct: 302 QALTHPF 308

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 41/219 (18%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTY 64
            EH N++++IG    + RL    E +K G+L  + +        SQ  S+ + I +G+ Y
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 65  LHERNVVHREIKCANILVDAS--------GLATTTNDVK------------------SFE 98
           LH  N++HR++   N LV  +        GLA    D K                  +  
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 99  GTPFWVAPEVVNLKNNGYGLSADIWSLG---CTVLEMLTHQPPY-SHLEDMQALFR--IG 152
           G P+W+APE++N     Y    D++S G   C ++  +   P Y     D     R  + 
Sbjct: 184 GNPYWMAPEMIN--GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           R   P+ P S         ++C  ++P  RP+  +L EH
Sbjct: 242 RYCPPNCPPSFF----PITVRCCDLDPEKRPSFVKL-EH 275

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 71/145 (48%), Gaps = 19/145 (13%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVV 71
           +VQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H    +
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 72  HREIKCANILVDASG---LATTTNDVK----------SFEGTPFWVAPEVVNLKNNG--- 115
           HR++K  N+L+D SG   LA     +K          +  GTP +++PEV  LK+ G   
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV--LKSQGGDG 248
Query: 116 -YGLSADIWSLGCTVLEMLTHQPPY 139
            YG   D WS+G  + EML    P+
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 71/145 (48%), Gaps = 19/145 (13%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVV 71
           +VQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H    +
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 195
Query: 72  HREIKCANILVDASG---LATTTNDVK----------SFEGTPFWVAPEVVNLKNNG--- 115
           HR++K  N+L+D SG   LA     +K          +  GTP +++PEV  LK+ G   
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV--LKSQGGDG 253
Query: 116 -YGLSADIWSLGCTVLEMLTHQPPY 139
            YG   D WS+G  + EML    P+
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--SQVSSY-TRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  ++ +  +  + V  Y   QI +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 183 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 241 VYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--SQVSSY-TRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  ++ +  +  + V  Y   QI +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 183 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 241 VYELMRACWQWNPSDRPSFAEI 262

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--SQVSSY-TRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  ++ +  +  + V  Y   QI +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 188 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 245
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 246 VYELMRACWQWNPSDRPSFAEI 267

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 40/187 (21%)
Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKS 96
            S+ ++     Q+L GL Y+H   VVHR++K  N+ V+          GLA   + ++  
Sbjct: 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 200
Query: 97  FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS---HLEDMQALFRI-- 151
           +  T ++ APEV+ L    Y  + DIWS+GC + EMLT +  +    +L+ +  + ++  
Sbjct: 201 YVVTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259
Query: 152 --------------GRGKLPSVPNSLSRD-----------ARDFILKCLQVNPNDRPTAA 186
                          +  + S+P +  +D           A D + K L+++ + R TAA
Sbjct: 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 319
Query: 187 QLMEHPF 193
           Q + HPF
Sbjct: 320 QALTHPF 326

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--SQVSSY-TRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  ++ +  +  + V  Y   QI +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 188 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 245
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 246 VYELMRACWQWNPSDRPSFAEI 267

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 71/145 (48%), Gaps = 19/145 (13%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVV 71
           +VQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H    +
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 195
Query: 72  HREIKCANILVDASG---LATTTNDVK----------SFEGTPFWVAPEVVNLKNNG--- 115
           HR++K  N+L+D SG   LA     +K          +  GTP +++PEV  LK+ G   
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV--LKSQGGDG 253
Query: 116 -YGLSADIWSLGCTVLEMLTHQPPY 139
            YG   D WS+G  + EML    P+
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 101/235 (42%), Gaps = 48/235 (20%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL--YQKYHLSDSQVSSYTRQILNG 61
             Q +H N+V  +   + + RL++  E      L  L  YQ+  + +  V S T Q L  
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQA 114
Query: 62  LTYLHERNVVHREIKCANILVDA-----------SGLATTTNDVKSFE-GTPFWVAPEVV 109
           + + H+ N +HR++K  NIL+             + L T  +D    E  T ++ +PE++
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL 174
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG--------------- 154
            + +  YG   D+W++GC   E+L+  P +    D+  L+ I +                
Sbjct: 175 -VGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 155 ------KLP----------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
                 K+P            PN +S  A   +  CL ++P +R T  QL+ HP+
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPN-ISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--SQVSSY-TRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  ++ +  +  + V  Y   QI +
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 126
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 187 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 245 VYELMRACWQWNPSDRPSFAEI 266

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--SQVSSY-TRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  ++ +  +  + V  Y   QI +
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 185 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 242
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 243 VYELMRACWQWNPSDRPSFAEI 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--SQVSSY-TRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  ++ +  +  + V  Y   QI +
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 135
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 136 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 195
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 196 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 253
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 254 VYELMRACWQWNPSDRPSFAEI 275

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--SQVSSY-TRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  ++ +  +  + V  Y   QI +
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 185 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 242
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 243 VYELMRACWQWNPSDRPSFAEI 264

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--SQVSSY-TRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  ++ +  +  + V  Y   QI +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 188 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 245
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 246 VYELMRACWQWNPSDRPSFAEI 267

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 24/198 (12%)
Query: 20  KDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKC 77
           +D+N LY+ ++    G L  L  K+   L +     Y  +++  +  +H+ + VHR+IK 
Sbjct: 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKP 203
Query: 78  ANILVDASG---LATTTNDVKSFE----------GTPFWVAPEVVNLKNNG---YGLSAD 121
            NIL+D +G   LA   + +K  E          GTP +++PE++     G   YG   D
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECD 263
Query: 122 IWSLGCTVLEMLTHQPPYSHLEDMQALFRI----GRGKLPSVPNSLSRDARDFI--LKCL 175
            WSLG  + EML  + P+     ++   +I     R + P+    +S +A+D I  L C 
Sbjct: 264 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICS 323
Query: 176 QVNPNDRPTAAQLMEHPF 193
           + +   +       +HPF
Sbjct: 324 REHRLGQNGIEDFKKHPF 341

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 25  LYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HR++K  N+L
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 154
Query: 82  VDAS-----------GLATTTNDVKSFEG---TPFWVAPEVVNLKNNGYGLSADIWSLGC 127
             +            G A  T    S      TP++VAPEV  L    Y  S D+WSLG 
Sbjct: 155 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 212
Query: 128 TVLEMLTHQPPY------SHLEDMQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPN 180
            +  +L   PP+      +    M+   R+G+ + P+   S +S + +  I   L+  P 
Sbjct: 213 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 272
Query: 181 DRPTAAQLMEHPFV-------KRPLQTS 201
            R T  + M HP++       + PL TS
Sbjct: 273 QRMTITEFMNHPWIMQSTKVPQTPLHTS 300

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 25  LYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HR++K  N+L
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 155
Query: 82  VDAS-----------GLATTTNDVKSFEG---TPFWVAPEVVNLKNNGYGLSADIWSLGC 127
             +            G A  T    S      TP++VAPEV  L    Y  S D+WSLG 
Sbjct: 156 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 213
Query: 128 TVLEMLTHQPPY------SHLEDMQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPN 180
            +  +L   PP+      +    M+   R+G+ + P+   S +S + +  I   L+  P 
Sbjct: 214 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 273
Query: 181 DRPTAAQLMEHPFV-------KRPLQTS 201
            R T  + M HP++       + PL TS
Sbjct: 274 QRMTITEFMNHPWIMQSTKVPQTPLHTS 301

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILNGL 62
           + +H N+VQ +G    E   YI  E +  G+L +  +   +  +S   +     QI + +
Sbjct: 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 63  TYLHERNVVHREIKCANILVDASGLAT----------TTNDVKSFEGTPF---WVAPEVV 109
            YL ++N +HR +   N LV  + L            T +   +  G  F   W APE  
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-- 389
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
           +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P        
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 449
Query: 169 DFILKCLQVNPNDRPTAAQL 188
           + +  C Q NP+DRP+ A++
Sbjct: 450 ELMRACWQWNPSDRPSFAEI 469

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 25  LYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HR++K  N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 82  VDAS-----------GLATTTNDVKSFEG---TPFWVAPEVVNLKNNGYGLSADIWSLGC 127
             +            G A  T    S      TP++VAPEV  L    Y  S D+WSLG 
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 207
Query: 128 TVLEMLTHQPPY------SHLEDMQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPN 180
            +  +L   PP+      +    M+   R+G+ + P+   S +S + +  I   L+  P 
Sbjct: 208 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 267
Query: 181 DRPTAAQLMEHPFV-------KRPLQTS 201
            R T  + M HP++       + PL TS
Sbjct: 268 QRMTITEFMNHPWIMQSTKVPQTPLHTS 295

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 25  LYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HR++K  N+L
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 153
Query: 82  VDAS-----------GLA---TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGC 127
             +            G A   T+ N + +   TP++VAPEV  L    Y  S D+WSLG 
Sbjct: 154 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 211
Query: 128 TVLEMLTHQPPY------SHLEDMQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPN 180
            +  +L   PP+      +    M+   R+G+ + P+   S +S + +  I   L+  P 
Sbjct: 212 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 271
Query: 181 DRPTAAQLMEHPFV-------KRPLQTS 201
            R T  + M HP++       + PL TS
Sbjct: 272 QRMTITEFMNHPWIMQSTKVPQTPLHTS 299

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 25  LYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HR++K  N+L
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 82  VDAS-----------GLATTTNDVKSFEG---TPFWVAPEVVNLKNNGYGLSADIWSLGC 127
             +            G A  T    S      TP++VAPEV  L    Y  S D+WSLG 
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 251
Query: 128 TVLEMLTHQPPY------SHLEDMQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPN 180
            +  +L   PP+      +    M+   R+G+ + P+   S +S + +  I   L+  P 
Sbjct: 252 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 311
Query: 181 DRPTAAQLMEHPFV-------KRPLQTS 201
            R T  + M HP++       + PL TS
Sbjct: 312 QRMTITEFMNHPWIMQSTKVPQTPLHTS 339

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 41/210 (19%)
Query: 23  NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           N +Y+   L+    L N+ +   L+D  V     QIL GL Y+H  +++HR++K +N+ V
Sbjct: 100 NDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 83  DASG--------LATTTND-VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML 133
           +           LA  T+D +  +  T ++ APE++ L    Y  + DIWS+GC + E+L
Sbjct: 159 NEDCELKILDFYLARHTDDEMTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 217
Query: 134 THQ---PPYSHLEDMQALFRI----GRGKLPSVPNSLSRD-------------------- 166
           T +   P   H++ ++ + R+    G   L  + +  +R+                    
Sbjct: 218 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 277
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPF 193
              A D + K L ++ + R TAAQ + H +
Sbjct: 278 NPLAVDLLEKMLVLDSDKRITAAQALAHAY 307

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 25  LYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HR++K  N+L
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 163
Query: 82  VDAS-----------GLATTTNDVKSFEG---TPFWVAPEVVNLKNNGYGLSADIWSLGC 127
             +            G A  T    S      TP++VAPEV  L    Y  S D+WSLG 
Sbjct: 164 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 221
Query: 128 TVLEMLTHQPPY------SHLEDMQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPN 180
            +  +L   PP+      +    M+   R+G+ + P+   S +S + +  I   L+  P 
Sbjct: 222 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 281
Query: 181 DRPTAAQLMEHPFV-------KRPLQTS 201
            R T  + M HP++       + PL TS
Sbjct: 282 QRMTITEFMNHPWIMQSTKVPQTPLHTS 309

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 25  LYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HR++K  N+L
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 82  VDAS-----------GLATTTNDVKSFEG---TPFWVAPEVVNLKNNGYGLSADIWSLGC 127
             +            G A  T    S      TP++VAPEV  L    Y  S D+WSLG 
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 205
Query: 128 TVLEMLTHQPPY------SHLEDMQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPN 180
            +  +L   PP+      +    M+   R+G+ + P+   S +S + +  I   L+  P 
Sbjct: 206 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 265
Query: 181 DRPTAAQLMEHPFV-------KRPLQTS 201
            R T  + M HP++       + PL TS
Sbjct: 266 QRMTITEFMNHPWIMQSTKVPQTPLHTS 293

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNG 61
            +Q +H N++Q     + +N + + +E V  G L +  + + Y+L++     + +QI  G
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 62  LTYLHERNVVHREIKCANILV---DAS-------GLATTTNDVKSFE---GTPFWVAPEV 108
           + ++H+  ++H ++K  NIL    DA        GLA      +  +   GTP ++APEV
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV 259
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI--GRGKLPSVP-NSLSR 165
           VN   +      D+WS+G     +L+   P+    D + L  I   R  L       +S 
Sbjct: 260 VNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317
Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           +A++FI K L    + R +A++ ++HP++
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 25  LYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HR++K  N+L
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 199
Query: 82  VDAS-----------GLATTTNDVKSFEG---TPFWVAPEVVNLKNNGYGLSADIWSLGC 127
             +            G A  T    S      TP++VAPEV  L    Y  S D+WSLG 
Sbjct: 200 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 257
Query: 128 TVLEMLTHQPPY------SHLEDMQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPN 180
            +  +L   PP+      +    M+   R+G+ + P+   S +S + +  I   L+  P 
Sbjct: 258 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 317
Query: 181 DRPTAAQLMEHPFV-------KRPLQTS 201
            R T  + M HP++       + PL TS
Sbjct: 318 QRMTITEFMNHPWIMQSTKVPQTPLHTS 345

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 25  LYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HR++K  N+L
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 148
Query: 82  VDAS-----------GLATTTNDVKSFEG---TPFWVAPEVVNLKNNGYGLSADIWSLGC 127
             +            G A  T    S      TP++VAPEV  L    Y  S D+WSLG 
Sbjct: 149 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 206
Query: 128 TVLEMLTHQPPY------SHLEDMQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPN 180
            +  +L   PP+      +    M+   R+G+ + P+   S +S + +  I   L+  P 
Sbjct: 207 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 266
Query: 181 DRPTAAQLMEHPFV-------KRPLQTS 201
            R T  + M HP++       + PL TS
Sbjct: 267 QRMTITEFMNHPWIMQSTKVPQTPLHTS 294

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 25  LYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HR++K  N+L
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 82  VDAS-----------GLATTTNDVKSFEG---TPFWVAPEVVNLKNNGYGLSADIWSLGC 127
             +            G A  T    S      TP++VAPEV  L    Y  S D+WSLG 
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 205
Query: 128 TVLEMLTHQPPY------SHLEDMQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPN 180
            +  +L   PP+      +    M+   R+G+ + P+   S +S + +  I   L+  P 
Sbjct: 206 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 265
Query: 181 DRPTAAQLMEHPFV-------KRPLQTS 201
            R T  + M HP++       + PL TS
Sbjct: 266 QRMTITEFMNHPWIMQSTKVPQTPLHTS 293

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 33/208 (15%)
Query: 25  LYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HR++K  N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 82  VDAS-----------GLATTTNDVKSFEG---TPFWVAPEVVNLKNNGYGLSADIWSLGC 127
             +            G A  T    S      TP++VAPEV  L    Y  S D+WSLG 
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDMWSLGV 207
Query: 128 TVLEMLTHQPPY------SHLEDMQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPN 180
            +  +L   PP+      +    M+   R+G+ + P+   S +S + +  I   L+  P 
Sbjct: 208 IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 267
Query: 181 DRPTAAQLMEHPFV-------KRPLQTS 201
            R T  + M HP++       + PL TS
Sbjct: 268 QRMTITEFMNHPWIMQSTKVPQTPLHTS 295

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--SQVSSY-TRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  ++ +  +  + V  Y   QI +
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 183
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 184 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 241
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 242 VYELMRACWQWNPSDRPSFAEI 263

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--SQVSSY-TRQILN 60
             + +H N+VQ +G    E   YI  E +  G+L +  ++ +  +  + V  Y   QI +
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 61  GLTYLHERNVVHREIKCANILVDASGLA----------TTTNDVKSFEGTPF---WVAPE 107
            + YL ++N +HR++   N LV  + L            T +   +  G  F   W APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 184
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
             +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P      
Sbjct: 185 --SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 242
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             + +  C Q NP+DRP+ A++
Sbjct: 243 VYELMRACWQWNPSDRPSFAEI 264

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 22/178 (12%)
Query: 20  KDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKC 77
           +DEN LY+ ++    G L  L  K+   L +     Y  +++  +  +H+ + VHR+IK 
Sbjct: 160 QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKP 219
Query: 78  ANILVDASG---LAT-----TTNDVKSFE-----GTPFWVAPEVVNLKNNG---YGLSAD 121
            N+L+D +G   LA        ND  + +     GTP +++PE++    +G   YG   D
Sbjct: 220 DNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 279
Query: 122 IWSLGCTVLEMLTHQPPYSHLEDMQALFRI----GRGKLPSVPNSLSRDARDFILKCL 175
            WSLG  + EML  + P+     ++   +I     R + PS    +S +A+D I + +
Sbjct: 280 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLI 337

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 102/223 (45%), Gaps = 31/223 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY----HLSDSQVSSYTRQIL 59
            S+  H NIV+  G     N + + +E  + GSL N+        + + +   S+  Q  
Sbjct: 56  LSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 113
Query: 60  NGLTYLHE---RNVVHREIKCANILVDASGLA------TTTNDVKSF----EGTPFWVAP 106
            G+ YLH    + ++HR++K  N+L+ A G         T  D+++     +G+  W+AP
Sbjct: 114 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAP 173
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL--EDMQALFRIGRGKLPSVPNSLS 164
           EV   + + Y    D++S G  + E++T + P+  +     + ++ +  G  P +  +L 
Sbjct: 174 EV--FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 231
Query: 165 RDARDFILKCLQVNPNDRPTA---AQLMEH-----PFVKRPLQ 199
           +     + +C   +P+ RP+     ++M H     P    PLQ
Sbjct: 232 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 274

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 22/178 (12%)
Query: 20  KDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKC 77
           +DEN LY+ ++    G L  L  K+   L +     Y  +++  +  +H+ + VHR+IK 
Sbjct: 144 QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKP 203
Query: 78  ANILVDASG---LAT-----TTNDVKSFE-----GTPFWVAPEVVNLKNNG---YGLSAD 121
            N+L+D +G   LA        ND  + +     GTP +++PE++    +G   YG   D
Sbjct: 204 DNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 263
Query: 122 IWSLGCTVLEMLTHQPPYSHLEDMQALFRI----GRGKLPSVPNSLSRDARDFILKCL 175
            WSLG  + EML  + P+     ++   +I     R + PS    +S +A+D I + +
Sbjct: 264 WWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLI 321

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 102/223 (45%), Gaps = 31/223 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY----HLSDSQVSSYTRQIL 59
            S+  H NIV+  G     N + + +E  + GSL N+        + + +   S+  Q  
Sbjct: 55  LSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 60  NGLTYLHE---RNVVHREIKCANILVDASGLA------TTTNDVKSF----EGTPFWVAP 106
            G+ YLH    + ++HR++K  N+L+ A G         T  D+++     +G+  W+AP
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAP 172
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL--EDMQALFRIGRGKLPSVPNSLS 164
           EV   + + Y    D++S G  + E++T + P+  +     + ++ +  G  P +  +L 
Sbjct: 173 EV--FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 230
Query: 165 RDARDFILKCLQVNPNDRPTA---AQLMEH-----PFVKRPLQ 199
           +     + +C   +P+ RP+     ++M H     P    PLQ
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 10  DNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYL 65
           D IV+Y G      R  L + +E +  G L +  Q++   L  S++  Y+ QI  G+ YL
Sbjct: 72  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 131
Query: 66  HERNVVHREIKCANILVDAS--------GLATTTNDVKSF-------EGTPFWVAPEVVN 110
             R  VHR++   NILV++         GLA      K +       +   FW APE  +
Sbjct: 132 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE--S 189
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHL------EDMQALFR----IGRGK 155
           L +N +   +D+WS G  + E+ T+      P    L       D+ AL R    +  G+
Sbjct: 190 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQ 249
Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
               P +   +  + +  C   +P DRP+ + L
Sbjct: 250 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 282

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 69  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 128
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSF-------EGTPFWVAPE 107
            YL  +  +HR +   NILV+          GL       K +       E   FW APE
Sbjct: 129 EYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 188
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 189 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 246
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 247 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 283

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 50/234 (21%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVS--------SYTRQIL 59
           +H N+++Y  +E  +  LYI LEL    +L +L +  ++SD  +         S  RQI 
Sbjct: 67  DHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 60  NGLTYLHERNVVHREIKCANILVDA-----------------------------SGLATT 90
           +G+ +LH   ++HR++K  NILV                               SG ++ 
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 91  TNDVKSFEGTPFWVAPEVVNLKNN-----GYGLSADIWSLGCTVLEMLTHQP-----PYS 140
             ++ +  GT  W APE++   NN         S DI+S+GC    +L+         YS
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 141 HLED-MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
              + ++ +F +   K      SL  +A D I + +  +P  RPTA +++ HP 
Sbjct: 246 RESNIIRGIFSLDEMKCLH-DRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 30/200 (15%)
Query: 22  ENRLYIFLELVKKGSLANLYQKYHLS-----DSQVSSYTRQILNGLTYLHERNVVHREIK 76
           ++ L + L L+  G L   +  YH+      +++   Y  +I  GL  LH   +V+R++K
Sbjct: 256 KDALCLVLTLMNGGDLK--FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLK 313
Query: 77  CANILVDASGLATTTN-----------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSL 125
             NIL+D  G    ++            +K   GT  ++APEVV  KN  Y  S D W+L
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTFSPDWWAL 371
Query: 126 GCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSR----DARDFILKCLQVNPND 181
           GC + EM+  Q P+   +       + R  +  VP   S      AR    + L  +P +
Sbjct: 372 GCLLYEMIAGQSPFQQRKKKIKREEVER-LVKEVPEEYSERFSPQARSLCSQLLCKDPAE 430
Query: 182 R-----PTAAQLMEHPFVKR 196
           R      +A ++ EHP  K+
Sbjct: 431 RLGCRGGSAREVKEHPLFKK 450

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 30/200 (15%)
Query: 22  ENRLYIFLELVKKGSLANLYQKYHLS-----DSQVSSYTRQILNGLTYLHERNVVHREIK 76
           ++ L + L L+  G L   +  YH+      +++   Y  +I  GL  LH   +V+R++K
Sbjct: 256 KDALCLVLTLMNGGDLK--FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLK 313
Query: 77  CANILVDASGLATTTN-----------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSL 125
             NIL+D  G    ++            +K   GT  ++APEVV  KN  Y  S D W+L
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTFSPDWWAL 371
Query: 126 GCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSR----DARDFILKCLQVNPND 181
           GC + EM+  Q P+   +       + R  +  VP   S      AR    + L  +P +
Sbjct: 372 GCLLYEMIAGQSPFQQRKKKIKREEVER-LVKEVPEEYSERFSPQARSLCSQLLCKDPAE 430
Query: 182 R-----PTAAQLMEHPFVKR 196
           R      +A ++ EHP  K+
Sbjct: 431 RLGCRGGSAREVKEHPLFKK 450

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 81/165 (49%), Gaps = 13/165 (7%)
Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-----------ASGLA 88
           + +K  +++ +   + +QI+  + Y H   +VHR++K  N+L+D            S + 
Sbjct: 99  IVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158
Query: 89  TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL 148
           T  N +K+  G+P + APEV+N K    G   D+WS G  +  ML  + P+   E +  L
Sbjct: 159 TDGNFLKTSCGSPNYAAPEVINGKLYA-GPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNL 216
Query: 149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
           F+     +  +P+ LS  A+  I + +  +P  R T  ++   P+
Sbjct: 217 FKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 10  DNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYL 65
           D IV+Y G      R  L + +E +  G L +  Q++   L  S++  Y+ QI  G+ YL
Sbjct: 71  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 130
Query: 66  HERNVVHREIKCANILVDAS--------GLATTTNDVKSF-------EGTPFWVAPEVVN 110
             R  VHR++   NILV++         GLA      K +       +   FW APE  +
Sbjct: 131 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE--S 188
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHL------EDMQALFR----IGRGK 155
           L +N +   +D+WS G  + E+ T+      P    L       D+ AL R    +  G+
Sbjct: 189 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQ 248
Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
               P +   +  + +  C   +P DRP+ + L
Sbjct: 249 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 90/200 (45%), Gaps = 19/200 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSD--SQVSSY-TRQILNGL 62
           + +H N+VQ +G    E   YI  E +  G+L +  ++ +  +  + V  Y   QI + +
Sbjct: 311 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 370
Query: 63  TYLHERNVVHREIKCANILVDASGLAT----------TTNDVKSFEGTPF---WVAPEVV 109
            YL ++N +HR +   N LV  + L            T +   +  G  F   W APE  
Sbjct: 371 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-- 428
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
           +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P        
Sbjct: 429 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 488
Query: 169 DFILKCLQVNPNDRPTAAQL 188
           + +  C Q NP+DRP+ A++
Sbjct: 489 ELMRACWQWNPSDRPSFAEI 508

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 10  DNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYL 65
           D IV+Y G      R  L + +E +  G L +  Q++   L  S++  Y+ QI  G+ YL
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143
Query: 66  HERNVVHREIKCANILVDAS--------GLATTTNDVKSF-------EGTPFWVAPEVVN 110
             R  VHR++   NILV++         GLA      K +       +   FW APE  +
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE--S 201
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHL------EDMQALFR----IGRGK 155
           L +N +   +D+WS G  + E+ T+      P    L       D+ AL R    +  G+
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261
Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
               P +   +  + +  C   +P DRP+ + L
Sbjct: 262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 18/164 (10%)
Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLAT-----------TTNDV 94
           L ++QV  Y R  L  L +LH + +VH ++K ANI +   G              T    
Sbjct: 154 LPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213
Query: 95  KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG 154
           +  EG P ++APE++      YG +AD++SLG T+LE+  +       E  Q L    +G
Sbjct: 214 EVQEGDPRYMAPELL---QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLR---QG 267
Query: 155 KL-PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP 197
            L P     LS + R  ++  L+ +P  R TA  L+  P +++P
Sbjct: 268 YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP 311

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 99  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTP-FWVAPE 107
            YL  +  +HR++   NILV+          GL            VK    +P FW APE
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 219 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 277 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 313

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G       + I  E ++ GSL +  +K+    +  Q+    R I +G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT------PF-WVAP 106
           + YL +   VHR++   NIL++++        GLA    D      T      P  W +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLS 164
           E +  +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP  P    
Sbjct: 220 EAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCP 276
Query: 165 RDARDFILKCLQVNPNDRPTAAQLM 189
                 +L C Q + N+RP   Q++
Sbjct: 277 AALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTP-FWVAPE 107
            YL  +  +HR++   NILV+          GL            VK    +P FW APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 188 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 246 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL    QK+   +   ++  YT QI  G+
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGM 130
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSF-------EGTPFWVAPE 107
            YL  +  +HR++   NILV+          GL       K         E   FW APE
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 191 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 248
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 249 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTP-FWVAPE 107
            YL  +  +HR++   NILV+          GL            VK    +P FW APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 188 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 246 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 67  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 126
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTP-FWVAPE 107
            YL  +  +HR++   NILV+          GL            VK    +P FW APE
Sbjct: 127 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 187 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 244
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 245 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 281

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 86  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 145
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTP-FWVAPE 107
            YL  +  +HR++   NILV+          GL            VK    +P FW APE
Sbjct: 146 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 206 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 263
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 264 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 10  DNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYL 65
           D IV+Y G      R  L + +E +  G L +  Q++   L  S++  Y+ QI  G+ YL
Sbjct: 68  DFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 127
Query: 66  HERNVVHREIKCANILVDAS--------GLA------TTTNDVKSFEGTP-FWVAPEVVN 110
             R  VHR++   NILV++         GLA           V+    +P FW APE  +
Sbjct: 128 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPE--S 185
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHL------EDMQALFR----IGRGK 155
           L +N +   +D+WS G  + E+ T+      P    L       D+ AL R    +  G+
Sbjct: 186 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQ 245
Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
               P +   +  + +  C   +P DRP+ + L
Sbjct: 246 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 278

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 66  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 125
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSF-------EGTPFWVAPE 107
            YL  +  +HR++   NILV+          GL       K         E   FW APE
Sbjct: 126 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 186 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 243
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 244 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 280

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 73  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 132
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTP-FWVAPE 107
            YL  +  +HR++   NILV+          GL            VK    +P FW APE
Sbjct: 133 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 193 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 250
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 251 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 287

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 75  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 134
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTP-FWVAPE 107
            YL  +  +HR++   NILV+          GL            VK    +P FW APE
Sbjct: 135 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 194
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 195 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 252
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 253 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 289

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 72  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 131
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSF-------EGTPFWVAPE 107
            YL  +  +HR++   NILV+          GL       K         E   FW APE
Sbjct: 132 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 191
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 192 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 249
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 250 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 286

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 74  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 133
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSF-------EGTPFWVAPE 107
            YL  +  +HR++   NILV+          GL       K         E   FW APE
Sbjct: 134 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 194 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 251
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 252 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 288

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 130
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTP-FWVAPE 107
            YL  +  +HR++   NILV+          GL            VK    +P FW APE
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 191 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 248
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 249 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  QK+   +   ++  YT QI  G+
Sbjct: 86  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 145
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTP-FWVAPE 107
            YL  +  +HR++   NILV+          GL            VK    +P FW APE
Sbjct: 146 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 206 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 263
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 264 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 300

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G       + I  E ++ GSL +  +K+    +  Q+    R I +G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL +   VHR++   NIL++ S L    +D    +  E  P              W +
Sbjct: 160 MKYLSDMGAVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP  P   
Sbjct: 219 PEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDC 275
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q + N+RP   Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 105/250 (42%), Gaps = 60/250 (24%)
Query: 4   FSQFEHDNIVQYIGTEKDE-----NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQI 58
              F+H+NI+     ++ +     N +YI  EL++   L  +     LSD  +  +  Q 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQT 121
Query: 59  LNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKS-------------- 96
           L  +  LH  NV+HR++K +N+L++++        GLA   ++  +              
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 97  FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE-DMQALFRIGRGK 155
           F  T ++ APEV+ L +  Y  + D+WS GC + E+   +P +   +   Q L   G   
Sbjct: 182 FVATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240
Query: 156 LPSVPNSL----SRDARDFI--------------------------LKCLQVNPNDRPTA 185
            P   N L    S  AR++I                           + L  +P  R TA
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300
Query: 186 AQLMEHPFVK 195
            + +EHP+++
Sbjct: 301 KEALEHPYLQ 310

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 16/173 (9%)
Query: 23  NRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           ++LY  L+ +  G L  +L ++    + +   Y  +I + L YLH  N+V+R++K  NIL
Sbjct: 112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL 171
Query: 82  VDASGLATTTN------------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +D+ G    T+               +F GTP ++APEV  L    Y  + D W LG  +
Sbjct: 172 LDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV--LHKQPYDRTVDWWCLGAVL 229
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            EML   PP+      +    I    L   PN ++  AR  +   LQ +   R
Sbjct: 230 YEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN-ITNSARHLLEGLLQKDRTKR 281

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 4   FSQFEHDNIVQYIGTEKDE-NRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQIL 59
            +Q  H N+VQ +G   +E   LYI  E + KGSL +  +   +  L    +  ++  + 
Sbjct: 53  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 112
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATT-----TNDVKSFEGT---PF-WVAPEVVN 110
             + YL   N VHR++   N+LV    +A       T +  S + T   P  W APE   
Sbjct: 113 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA-- 170
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
           L+   +   +D+WS G  + E+ +  + PY  +     + R+ +G     P+       +
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 230
Query: 170 FILKCLQVNPNDRPTAAQLMEH 191
            +  C  ++   RP+  QL E 
Sbjct: 231 VMKNCWHLDAAMRPSFLQLREQ 252

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 4   FSQFEHDNIVQYIGTEKDE-NRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQIL 59
            +Q  H N+VQ +G   +E   LYI  E + KGSL +  +   +  L    +  ++  + 
Sbjct: 59  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 118
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATT-----TNDVKSFEGT---PF-WVAPEVVN 110
             + YL   N VHR++   N+LV    +A       T +  S + T   P  W APE   
Sbjct: 119 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA-- 176
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
           L+   +   +D+WS G  + E+ +  + PY  +     + R+ +G     P+       +
Sbjct: 177 LREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 236
Query: 170 FILKCLQVNPNDRPTAAQLMEH 191
            +  C  ++   RP+  QL E 
Sbjct: 237 VMKNCWHLDAAMRPSFLQLREQ 258

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 4   FSQFEHDNIVQYIGTEKDE-NRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQIL 59
            +Q  H N+VQ +G   +E   LYI  E + KGSL +  +   +  L    +  ++  + 
Sbjct: 68  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 127
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATT-----TNDVKSFEGT---PF-WVAPEVVN 110
             + YL   N VHR++   N+LV    +A       T +  S + T   P  W APE   
Sbjct: 128 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA-- 185
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
           L+   +   +D+WS G  + E+ +  + PY  +     + R+ +G     P+       +
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 245
Query: 170 FILKCLQVNPNDRPTAAQLMEH 191
            +  C  ++   RP+  QL E 
Sbjct: 246 VMKNCWHLDAAMRPSFLQLREQ 267

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G       + I  E ++ GSL +  +K+    +  Q+    R I +G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL +   VHR++   NIL++ S L    +D    +  E  P              W +
Sbjct: 160 MKYLSDMGFVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP  P   
Sbjct: 219 PEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDC 275
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q + N+RP   Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 50/234 (21%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVS--------SYTRQIL 59
           +H N+++Y  +E  +  LYI LEL    +L +L +  ++SD  +         S  RQI 
Sbjct: 67  DHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTND---------VKSF------------- 97
           +G+ +LH   ++HR++K  NILV  S   T             +  F             
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 98  -------EGTPFWVAPEVVNLKNN-----GYGLSADIWSLGCTVLEMLTHQP-----PYS 140
                   GT  W APE++   NN         S DI+S+GC    +L+         YS
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 141 HLEDM-QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
              ++ + +F +   K      SL  +A D I + +  +P  RPTA +++ HP 
Sbjct: 246 RESNIIRGIFSLDEMKCLH-DRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
             H NIV++         L I +E    G L   +      S+ +   + +Q+++G++Y 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYA 131
Query: 66  HERNVVHREIKCANILVDAS----------GLATTT---NDVKSFEGTPFWVAPEVVNLK 112
           H   V HR++K  N L+D S          G +  +   +  KS  GTP ++APEV+ LK
Sbjct: 132 HAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVL-LK 190
Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLED----MQALFRIGRGKLPSVPN--SLSRD 166
               G  AD+WS G T+  ML    P+   E+     + + RI   +  ++P+   +S +
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY-AIPDYVHISPE 249
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEH 191
            R  I +    +P  R +  ++  H
Sbjct: 250 CRHLISRIFVADPAKRISIPEIRNH 274

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
             H NIV++         L I +E    G L   +      S+ +   + +Q+++G++Y 
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 130
Query: 66  HERNVVHREIKCANILVDAS----------GLATTT---NDVKSFEGTPFWVAPEVVNLK 112
           H   V HR++K  N L+D S          G + ++   +  KS  GTP ++APEV+ LK
Sbjct: 131 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-LK 189
Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLED----MQALFRIGRGKLPSVPN--SLSRD 166
               G  AD+WS G T+  ML    P+   E+     + + RI   +  ++P+   +S +
Sbjct: 190 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY-AIPDYVHISPE 248
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEH 191
            R  I +    +P  R +  ++  H
Sbjct: 249 CRHLISRIFVADPAKRISIPEIRNH 273

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G       + I  E ++ GSL +  +K+    +  Q+    R I +G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL +   VHR++   NIL++ S L    +D    +  E  P              W +
Sbjct: 160 MKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP  P   
Sbjct: 219 PEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDC 275
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q + N+RP   Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
             H NIV++         L I +E    G L   +      S+ +   + +Q+++G++Y 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 66  HERNVVHREIKCANILVDAS----------GLATTT---NDVKSFEGTPFWVAPEVVNLK 112
           H   V HR++K  N L+D S          G + ++   +  KS  GTP ++APEV+ LK
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVL-LK 190
Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLED----MQALFRIGRGKLPSVPN--SLSRD 166
               G  AD+WS G T+  ML    P+   E+     + + RI   +  ++P+   +S +
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY-AIPDYVHISPE 249
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEH 191
            R  I +    +P  R +  ++  H
Sbjct: 250 CRHLISRIFVADPAKRISIPEIRNH 274

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G       + I  E ++ GSL +  +K+    +  Q+    R I +G
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL +   VHR++   NIL++ S L    +D    +  E  P              W +
Sbjct: 131 MKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP  P   
Sbjct: 190 PEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDC 246
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q + N+RP   Q++
Sbjct: 247 PAALYQLMLDCWQKDRNNRPKFEQIV 272

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
             H NIV++         L I +E    G L   +      S+ +   + +Q+++G++Y 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 66  HERNVVHREIKCANILVDAS----------GLATTT---NDVKSFEGTPFWVAPEVVNLK 112
           H   V HR++K  N L+D S          G + ++   +  KS  GTP ++APEV+ LK
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-LK 190
Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLED----MQALFRIGRGKLPSVPN--SLSRD 166
               G  AD+WS G T+  ML    P+   E+     + + RI   +  ++P+   +S +
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY-AIPDYVHISPE 249
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEH 191
            R  I +    +P  R +  ++  H
Sbjct: 250 CRHLISRIFVADPAKRISIPEIRNH 274

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G       + I  E ++ GSL +  +K+    +  Q+    R I +G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL +   VHR++   NIL++ S L    +D    +  E  P              W +
Sbjct: 160 MKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP  P   
Sbjct: 219 PEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDC 275
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q + N+RP   Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G       + I  E ++ GSL +  +K+    +  Q+    R I +G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL +   VHR++   NIL++ S L    +D    +  E  P              W +
Sbjct: 160 MKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP  P   
Sbjct: 219 PEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDC 275
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q + N+RP   Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G       + I  E ++ GSL +  +K+    +  Q+    R I +G
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 147
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL +   VHR++   NIL++ S L    +D    +  E  P              W +
Sbjct: 148 MKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 206
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP  P   
Sbjct: 207 PEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDC 263
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q + N+RP   Q++
Sbjct: 264 PAALYQLMLDCWQKDRNNRPKFEQIV 289

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H N+V   G       + I +E ++ G+L    +K+    +  Q+    R I  G
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAG 157
Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATTTND----VKSFEGTPF---WVAP 106
           + YL +   VHR++   NILV+++        GL+    D    V +  G      W AP
Sbjct: 158 MRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAP 217
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +  +   +  ++D+WS G  + E++++ + PY  + +   +  I  G     P     
Sbjct: 218 EAIQYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPA 275
Query: 166 DARDFILKCLQVNPNDRPTAAQLM 189
                +L C Q    +RP   Q++
Sbjct: 276 GLHQLMLDCWQKERAERPKFEQIV 299

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G       + I  E ++ GSL +  +K+    +  Q+    R I +G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL +   VHR++   NIL++ S L    +D    +  E  P              W +
Sbjct: 160 MKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP  P   
Sbjct: 219 PEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDC 275
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q + N+RP   Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G       + I  E ++ GSL +  +K+    +  Q+    R I +G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL +   VHR++   NIL++ S L    +D    +  E  P              W +
Sbjct: 160 MKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP  P   
Sbjct: 219 PEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDC 275
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q + N+RP   Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF H NI++  G       + I  E ++ G+L    ++     S  Q+    R I  G
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATTTND------VKSFEGTPF-WVAP 106
           + YL   N VHR++   NILV+++        GL+    D        S    P  W AP
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLS 164
           E ++ +   +  ++D+WS G  + E++T+ + PY  L + + +  I  G +LP+ P    
Sbjct: 220 EAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-PMDCP 276
Query: 165 RDARDFILKCLQVNPNDRPTAAQLM 189
                 +++C Q     RP  A ++
Sbjct: 277 SAIYQLMMQCWQQERARRPKFADIV 301

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G       + I  E ++ GSL +  +K+    +  Q+    R I +G
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL +   VHR++   NIL++ S L    +D    +  E  P              W +
Sbjct: 160 MKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 218
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP  P   
Sbjct: 219 PEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDC 275
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q + N+RP   Q++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G       + I  E ++ GSL +  +K+    +  Q+    R I +G
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 157
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL +   VHR++   NIL++ S L    +D    +  E  P              W +
Sbjct: 158 MKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 216
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP  P   
Sbjct: 217 PEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDC 273
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q + N+RP   Q++
Sbjct: 274 PAALYQLMLDCWQKDRNNRPKFEQIV 299

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
             H NIV++         L I +E    G L   +      S+ +   + +Q+L+G++Y 
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 66  HERNVVHREIKCANILVDAS----------GLATTT---NDVKSFEGTPFWVAPEVVNLK 112
           H   + HR++K  N L+D S          G + ++   +  KS  GTP ++APEV+ L+
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL-LR 191
Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR---- 168
               G  AD+WS G T+  ML    P+   E+ +  +R    ++ SV  S+  D R    
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVKYSIPDDIRISPE 250
Query: 169 --DFILKCLQVNPNDRPTAAQLMEH 191
               I +    +P  R +  ++  H
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTH 275

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/249 (23%), Positives = 110/249 (44%), Gaps = 61/249 (24%)
Query: 4   FSQFEHDNIVQYIGTEK------DENRLYIFLELVKKGSLANLYQKYH----LSDSQVSS 53
              F+HDNI+      +      +   +Y+ L+L++    ++L+Q  H    L+   V  
Sbjct: 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME----SDLHQIIHSSQPLTLEHVRY 162
Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVD------------ASGLATTTND----VKSF 97
           +  Q+L GL Y+H   V+HR++K +N+LV+            A GL T+  +    +  +
Sbjct: 163 FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 222
Query: 98  EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ---PPYSHLEDMQALFRIGRG 154
             T ++ APE++ L  + Y  + D+WS+GC   EML  +   P  +++  +Q +  +   
Sbjct: 223 VATRWYRAPELM-LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 281
Query: 155 KLPSVPNSLS---------------------------RDARDFILKCLQVNPNDRPTAAQ 187
             P+V  ++                            R A   + + L+  P+ R +AA 
Sbjct: 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 341
Query: 188 LMEHPFVKR 196
            + HPF+ +
Sbjct: 342 ALRHPFLAK 350

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G       + I  E ++ GSL +  +K+    +  Q+    R I +G
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL +   VHR++   NIL++ S L    +D    +  E  P              W +
Sbjct: 131 MKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTS 189
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP  P   
Sbjct: 190 PEAIAYRK--FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDC 246
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q + N+RP   Q++
Sbjct: 247 PAALYQLMLDCWQKDRNNRPKFEQIV 272

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 105/250 (42%), Gaps = 60/250 (24%)
Query: 4   FSQFEHDNIVQYIGTEKDE-----NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQI 58
              F+H+NI+     ++ +     N +YI  EL++   L  +     LSD  +  +  Q 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQT 121
Query: 59  LNGLTYLHERNVVHREIKCANILVDAS--------GLATTTND--------------VKS 96
           L  +  LH  NV+HR++K +N+L++++        GLA   ++              +  
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 97  FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE-DMQALFRIGRGK 155
           +  T ++ APEV+ L +  Y  + D+WS GC + E+   +P +   +   Q L   G   
Sbjct: 182 YVATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240
Query: 156 LPSVPNSL----SRDARDFI--------------------------LKCLQVNPNDRPTA 185
            P   N L    S  AR++I                           + L  +P  R TA
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300
Query: 186 AQLMEHPFVK 195
            + +EHP+++
Sbjct: 301 KEALEHPYLQ 310

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/249 (23%), Positives = 110/249 (44%), Gaps = 61/249 (24%)
Query: 4   FSQFEHDNIVQYIGTEK------DENRLYIFLELVKKGSLANLYQKYH----LSDSQVSS 53
              F+HDNI+      +      +   +Y+ L+L++    ++L+Q  H    L+   V  
Sbjct: 108 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME----SDLHQIIHSSQPLTLEHVRY 163
Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVD------------ASGLATTTND----VKSF 97
           +  Q+L GL Y+H   V+HR++K +N+LV+            A GL T+  +    +  +
Sbjct: 164 FLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 223
Query: 98  EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ---PPYSHLEDMQALFRIGRG 154
             T ++ APE++ L  + Y  + D+WS+GC   EML  +   P  +++  +Q +  +   
Sbjct: 224 VATRWYRAPELM-LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 282
Query: 155 KLPSVPNSLS---------------------------RDARDFILKCLQVNPNDRPTAAQ 187
             P+V  ++                            R A   + + L+  P+ R +AA 
Sbjct: 283 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 342
Query: 188 LMEHPFVKR 196
            + HPF+ +
Sbjct: 343 ALRHPFLAK 351

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 108/232 (46%), Gaps = 46/232 (19%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGS-LANLYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H N+++ I   ++E+R Y+  E ++ GS L++++++ H ++ + S   + + + L +LH 
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 68  RNVVHREIKCANILVD---------------ASGLA-------TTTNDVKSFEGTPFWVA 105
           + + HR++K  NIL +                SG+         +T ++ +  G+  ++A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 106 PEVVNL---KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS 162
           PEVV     + + Y    D+WSLG  +  +L+  PP+         +  G    P+  N 
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA-CPACQNM 248
Query: 163 L-------------------SRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           L                   S  A+D I K L  +   R +AAQ+++HP+V+
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 108/232 (46%), Gaps = 46/232 (19%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGS-LANLYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H N+++ I   ++E+R Y+  E ++ GS L++++++ H ++ + S   + + + L +LH 
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 68  RNVVHREIKCANILVD---------------ASGLA-------TTTNDVKSFEGTPFWVA 105
           + + HR++K  NIL +                SG+         +T ++ +  G+  ++A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 106 PEVVNL---KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS 162
           PEVV     + + Y    D+WSLG  +  +L+  PP+         +  G    P+  N 
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA-CPACQNM 248
Query: 163 L-------------------SRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           L                   S  A+D I K L  +   R +AAQ+++HP+V+
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 34/211 (16%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----------------KYHL 46
            +  +H++IV++ G   D + L +  E +K G L    +                 K  L
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 47  SDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATT-----TNDVKSFE--- 98
             SQ+     QI +G+ YL  ++ VHR++   N LV A+ L        + DV S +   
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 190
Query: 99  -----GTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRI 151
                  P  W+ PE +  +   +   +D+WS G  + E+ T+ + P+  L + + +  I
Sbjct: 191 VGGHTMLPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248
Query: 152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
            +G++   P    ++  D +L C Q  P  R
Sbjct: 249 TQGRVLERPRVCPKEVYDVMLGCWQREPQQR 279

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK-RR 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            K L  NP+ R T   + +  +  +PL+  
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLKKG 271

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 39/218 (17%)
Query: 7   FEHDNIVQYIGTEKDENR--LYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +HDNIV+Y G      R  L + +E +  GSL +  Q +   +   ++  YT QI  G+
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGM 130
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTP-FWVAPE 107
            YL  +  +HR++   NILV+          GL            VK    +P FW APE
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-----QPPYSHLE----DMQALFRI------- 151
             +L  + + +++D+WS G  + E+ T+      PP   +     D Q    +       
Sbjct: 191 --SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 248
Query: 152 -GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              G+LP  P+    +    + +C   N N RP+   L
Sbjct: 249 KNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 285

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 22/202 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGL 62
           +  H  +V++ G    E  +YI  E +  G L N Y + H   L  SQ+      +  G+
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTNDVK-----------SFEGTPF---WVAPEV 108
            +L     +HR++   N LVD   L    +D             S  GT F   W APEV
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV 176
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA 167
            +     Y   +D+W+ G  + E+ +  + PY    + + + ++ +G     P+  S   
Sbjct: 177 FHYFK--YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI 234
Query: 168 RDFILKCLQVNPNDRPTAAQLM 189
              +  C    P  RPT  QL+
Sbjct: 235 YQIMYSCWHELPEKRPTFQQLL 256

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 41/218 (18%)
Query: 16  IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYT---------RQILNGLTYLH 66
           I T  DE  +YI  E ++  S+    + + + D   + +          + +LN  +Y+H
Sbjct: 111 IITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH 168
Query: 67  -ERNVVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKNNG 115
            E+N+ HR++K +NIL+D +G    ++           +K   GT  ++ PE  + +++ 
Sbjct: 169 NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSY 228
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVP--------------- 160
            G   DIWSLG  +  M  +  P+S    +  LF   R K    P               
Sbjct: 229 NGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKS 288
Query: 161 ----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
               N LS +  DF+   L+ NP +R T+   ++H ++
Sbjct: 289 TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 31/213 (14%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY---QKYHLSDSQVSSYT-RQIL 59
            S+ EH NI++ +  +  EN+ +  L + K GS  +L+    ++   D  ++SY  RQ++
Sbjct: 83  LSRVEHANIIKVL--DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS------------FEGTPFWVAPE 107
           + + YL  ++++HR+IK  NI++ A        D  S            F GT  + APE
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE 199
Query: 108 VVNLKNNGY-GLSADIWSLGCTVLEMLTHQPPYSHLED-MQALFRIGRGKLPSVPNSLSR 165
           V  L  N Y G   ++WSLG T+  ++  + P+  LE+ ++A            P  +S+
Sbjct: 200 V--LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIH--------PPYLVSK 249
Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 198
           +    +   LQ  P  R T  +L+  P+V +P+
Sbjct: 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 104/250 (41%), Gaps = 60/250 (24%)
Query: 4   FSQFEHDNIVQYIGTEKDE-----NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQI 58
              F+H+NI+     ++ +     N +YI  EL++   L  +     LSD  +  +  Q 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQT 121
Query: 59  LNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTP--------- 101
           L  +  LH  NV+HR++K +N+L++++        GLA   ++  +    P         
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 102 -----FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE-DMQALFRIGRGK 155
                ++ APEV+ L +  Y  + D+WS GC + E+   +P +   +   Q L   G   
Sbjct: 182 XVATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240
Query: 156 LPSVPNSL----SRDARDFI--------------------------LKCLQVNPNDRPTA 185
            P   N L    S  AR++I                           + L  +P  R TA
Sbjct: 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300
Query: 186 AQLMEHPFVK 195
            + +EHP+++
Sbjct: 301 KEALEHPYLQ 310

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTY 64
            +H +IV+ IG  ++E   +I +EL   G L +  +  K  L    +  Y+ QI   + Y
Sbjct: 82  LDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 140
Query: 65  LHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT----PF-WVAPEVVNL 111
           L   N VHR+I   NILV +         GL+    D   ++ +    P  W++PE +N 
Sbjct: 141 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 200
Query: 112 KNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDF 170
           +   +  ++D+W     + E+L+  + P+  LE+   +  + +G     P+         
Sbjct: 201 RR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTL 258
Query: 171 ILKCLQVNPNDRPTAAQLM 189
           + +C   +P+DRP   +L+
Sbjct: 259 MTRCWDYDPSDRPRFTELV 277

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYL 65
             H NIV++         L I +E    G L   +      S+ +   + +Q+++G++Y 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 66  HERNVVHREIKCANILVDAS----------GLATTT---NDVKSFEGTPFWVAPEVVNLK 112
           H   V HR++K  N L+D S          G + ++   +  K   GTP ++APEV+ LK
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVL-LK 190
Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLED----MQALFRIGRGKLPSVPN--SLSRD 166
               G  AD+WS G T+  ML    P+   E+     + + RI   +  ++P+   +S +
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY-AIPDYVHISPE 249
Query: 167 ARDFILKCLQVNPNDRPTAAQLMEH 191
            R  I +    +P  R +  ++  H
Sbjct: 250 CRHLISRIFVADPAKRISIPEIRNH 274

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q ++  IV+ IG  + E+ + + +E+ + G L   L Q  H+ D  +     Q+  G+
Sbjct: 66  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 124
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN---------DVKSFEGTPF------WVAPE 107
            YL E N VHR++   N+L+     A  ++         D   ++          W APE
Sbjct: 125 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE 184
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     +   +D+WS G  + E  ++ Q PY  ++  +    + +G+    P    R+
Sbjct: 185 CINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 242
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             D +  C   +  +RP  A +
Sbjct: 243 MYDLMNLCWTYDVENRPGFAAV 264

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 21/196 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLT 63
           Q ++  IV+ IG  + E  L + +E+   G L      ++  +  S V+    Q+  G+ 
Sbjct: 66  QLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 124
Query: 64  YLHERNVVHREIKCANILV--------------DASGLATTTNDVKSFEGTPF-WVAPEV 108
           YL E+N VHR++   N+L+               A G   +    +S    P  W APE 
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 184
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA 167
           +N +   +   +D+WS G T+ E L++ Q PY  ++  + +  I +GK    P     + 
Sbjct: 185 INFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 242
Query: 168 RDFILKCLQVNPNDRP 183
              +  C      DRP
Sbjct: 243 YALMSDCWIYKWEDRP 258

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTY 64
            +H +IV+ IG  ++E   +I +EL   G L +  +  K  L    +  Y+ QI   + Y
Sbjct: 66  LDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 124
Query: 65  LHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT----PF-WVAPEVVNL 111
           L   N VHR+I   NILV +         GL+    D   ++ +    P  W++PE +N 
Sbjct: 125 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 184
Query: 112 KNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDF 170
           +   +  ++D+W     + E+L+  + P+  LE+   +  + +G     P+         
Sbjct: 185 RR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTL 242
Query: 171 ILKCLQVNPNDRPTAAQLM 189
           + +C   +P+DRP   +L+
Sbjct: 243 MTRCWDYDPSDRPRFTELV 261

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTY 64
            +H +IV+ IG  ++E   +I +EL   G L +  +  K  L    +  Y+ QI   + Y
Sbjct: 70  LDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 65  LHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT----PF-WVAPEVVNL 111
           L   N VHR+I   NILV +         GL+    D   ++ +    P  W++PE +N 
Sbjct: 129 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 112 KNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDF 170
           +   +  ++D+W     + E+L+  + P+  LE+   +  + +G     P+         
Sbjct: 189 RR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTL 246
Query: 171 ILKCLQVNPNDRPTAAQLM 189
           + +C   +P+DRP   +L+
Sbjct: 247 MTRCWDYDPSDRPRFTELV 265

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK-RR 182
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            K L  NP+ R T   + +  +  +PL+  
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKG 272

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILNGL 62
           + +H N+VQ +G    E   YI  E +  G+L +  +   +  ++   +     QI + +
Sbjct: 84  EIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAM 143
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPEVV 109
            YL ++N +HR++   N LV  +        GL+   T +   +  G  F   W APE  
Sbjct: 144 EYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE-- 201
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
           +L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +G     P        
Sbjct: 202 SLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVY 261
Query: 169 DFILKCLQVNPNDRPTAAQ 187
           + +  C + +P DRP+ A+
Sbjct: 262 ELMRACWKWSPADRPSFAE 280

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLX 137
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 195
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 196 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 147 ALFR---IGRGKLPSV------PNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R     R K   +      P+SL           +  ARD + K L ++P  R +  
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 314 DALQHPYI 321

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 105/246 (42%), Gaps = 65/246 (26%)
Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHERN- 69
           IV + G    +  + I +E +  GSL   L +   + +  +   +  +L GL YL E++ 
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 135
Query: 70  VVHREIKCANILVDASGLATTTN----------DVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           ++HR++K +NILV++ G     +             SF GT  ++APE   L+   Y + 
Sbjct: 136 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPE--RLQGTHYSVQ 193
Query: 120 ADIWSLGCTVLEMLTHQPPY--SHLEDMQALFRIGRGKL--------------------- 156
           +DIWS+G +++E+   + P      ++++A+F  GR  +                     
Sbjct: 194 SDIWSMGLSLVELAVGRYPIPPPDAKELEAIF--GRPVVDGEEGEPHSISPRPRPPGRPV 251
Query: 157 -------------------------PSVPNSL-SRDARDFILKCLQVNPNDRPTAAQLME 190
                                    P +PN + + D ++F+ KCL  NP +R     L  
Sbjct: 252 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLTN 311
Query: 191 HPFVKR 196
           H F+KR
Sbjct: 312 HTFIKR 317

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK-RR 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            K L  NP+ R T   + +  +  +PL+  
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLKKG 271

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNG 61
             QF+H NI+   G       + I  E ++ GSL    +K     +  Q+    R I +G
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 143
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL + + VHR++   NILV+ S L    +D    +  E  P              W A
Sbjct: 144 MKYLSDMSAVHRDLAARNILVN-SNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 202
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  I  G +LP  P   
Sbjct: 203 PEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPP-PMDC 259
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q   +DRP   Q++
Sbjct: 260 PIALHQLMLDCWQKERSDRPKFGQIV 285

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 9   HDNIVQYIGTEKDENRLYIFLE--LVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
           H  +++ +   + +    + LE  L  +     + +K  L +     +  Q++  + + H
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 67  ERNVVHREIKCANILVD-----------ASGLATTTNDVKSFEGTPFWVAPEVVNLKNNG 115
            R VVHR+IK  NIL+D            SG          F+GT  +  PE ++ ++  
Sbjct: 157 SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWIS-RHQY 215
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSH-LEDMQALFRIGRGKLPSVPNSLSRDARDFILKC 174
           + L A +WSLG  + +M+    P+    E ++A            P  +S D    I +C
Sbjct: 216 HALPATVWSLGILLYDMVCGDIPFERDQEILEAELHF--------PAHVSPDCCALIRRC 267
Query: 175 LQVNPNDRPTAAQLMEHPFVKRPLQ 199
           L   P+ RP+  +++  P+++ P +
Sbjct: 268 LAPKPSSRPSLEEILLDPWMQTPAE 292

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK-RR 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
            K L  NP+ R T   + +  +  +PL+
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q ++  IV+ IG  + E+ + + +E+ + G L   L Q  H+ D  +     Q+  G+
Sbjct: 80  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 138
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN---------DVKSFEGTPF------WVAPE 107
            YL E N VHR++   N+L+     A  ++         D   ++          W APE
Sbjct: 139 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 198
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     +   +D+WS G  + E  ++ Q PY  ++  +    + +G+    P    R+
Sbjct: 199 CINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 256
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             D +  C   +  +RP  A +
Sbjct: 257 MYDLMNLCWTYDVENRPGFAAV 278

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q ++  IV+ IG  + E+ + + +E+ + G L   L Q  H+ D  +     Q+  G+
Sbjct: 82  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 140
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN---------DVKSFEGTPF------WVAPE 107
            YL E N VHR++   N+L+     A  ++         D   ++          W APE
Sbjct: 141 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     +   +D+WS G  + E  ++ Q PY  ++  +    + +G+    P    R+
Sbjct: 201 CINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 258
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             D +  C   +  +RP  A +
Sbjct: 259 MYDLMNLCWTYDVENRPGFAAV 280

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK-RR 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            K L  NP+ R T   + +  +  +PL+  
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLKKG 271

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q ++  IV+ IG  + E+ + + +E+ + G L   L Q  H+ D  +     Q+  G+
Sbjct: 82  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 140
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN---------DVKSFEGTPF------WVAPE 107
            YL E N VHR++   N+L+     A  ++         D   ++          W APE
Sbjct: 141 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     +   +D+WS G  + E  ++ Q PY  ++  +    + +G+    P    R+
Sbjct: 201 CINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 258
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             D +  C   +  +RP  A +
Sbjct: 259 MYDLMNLCWTYDVENRPGFAAV 280

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLX 137
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 195
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 196 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 147 ALFR---IGRGKLPSV------PNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R     R K   +      P+SL           +  ARD + K L ++P  R +  
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 314 DALQHPYI 321

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q ++  IV+ IG  + E+ + + +E+ + G L   L Q  H+ D  +     Q+  G+
Sbjct: 72  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN---------DVKSFEGTPF------WVAPE 107
            YL E N VHR++   N+L+     A  ++         D   ++          W APE
Sbjct: 131 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     +   +D+WS G  + E  ++ Q PY  ++  +    + +G+    P    R+
Sbjct: 191 CINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 248
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             D +  C   +  +RP  A +
Sbjct: 249 MYDLMNLCWTYDVENRPGFAAV 270

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q ++  IV+ IG  + E+ + + +E+ + G L   L Q  H+ D  +     Q+  G+
Sbjct: 66  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 124
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN---------DVKSFEGTPF------WVAPE 107
            YL E N VHR++   N+L+     A  ++         D   ++          W APE
Sbjct: 125 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 184
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     +   +D+WS G  + E  ++ Q PY  ++  +    + +G+    P    R+
Sbjct: 185 CINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 242
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             D +  C   +  +RP  A +
Sbjct: 243 MYDLMNLCWTYDVENRPGFAAV 264

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLX 130
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 188
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 189 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 147 ALFRIGRGKLPS---------VPNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R      P           P+SL           +  ARD + K L ++P  R +  
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 307 DALQHPYI 314

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q ++  IV+ IG  + E+ + + +E+ + G L   L Q  H+ D  +     Q+  G+
Sbjct: 60  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 118
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN---------DVKSFEGTPF------WVAPE 107
            YL E N VHR++   N+L+     A  ++         D   ++          W APE
Sbjct: 119 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 178
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     +   +D+WS G  + E  ++ Q PY  ++  +    + +G+    P    R+
Sbjct: 179 CINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 236
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             D +  C   +  +RP  A +
Sbjct: 237 MYDLMNLCWTYDVENRPGFAAV 258

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L                  N   +  ++   
Sbjct: 99  KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA   N++  ++ T  
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 219 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEG 275
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +  C    P+ RPT  QL+E
Sbjct: 276 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L                  N   +  ++   
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA   N++  ++ T  
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFR-IGRG 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF+ +  G
Sbjct: 219 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEG 275
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +  C    P+ RPT  QL+E
Sbjct: 276 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 84/196 (42%), Gaps = 21/196 (10%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLT 63
           Q ++  IV+ IG  + E  L + +E+   G L      ++  +  S V+    Q+  G+ 
Sbjct: 392 QLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 450
Query: 64  YLHERNVVHREIKCANILV--------------DASGLATTTNDVKSFEGTPF-WVAPEV 108
           YL E+N VHR +   N+L+               A G   +    +S    P  W APE 
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA 167
           +N +   +   +D+WS G T+ E L++ Q PY  ++  + +  I +GK    P     + 
Sbjct: 511 INFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 568
Query: 168 RDFILKCLQVNPNDRP 183
              +  C      DRP
Sbjct: 569 YALMSDCWIYKWEDRP 584

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  H  L   ++S    Q+L 
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLC 137
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     +F  TP+ V     APE
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYRAPE 195
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEML------------------THQPPYSHLEDMQAL- 148
           V+     GY  + DIWS+GC + E++                    Q      E M AL 
Sbjct: 196 VI--LGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQ 253
Query: 149 -----FRIGRGKLPSV-----------PNSLSRD------ARDFILKCLQVNPNDRPTAA 186
                +   R K P +           P+   RD      ARD + K L ++P+ R +  
Sbjct: 254 PTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVD 313
Query: 187 QLMEHPFV 194
           + + HP++
Sbjct: 314 EALRHPYI 321

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 93/236 (39%), Gaps = 47/236 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
             + +H NI++        +RL++  E  +      + +   +S   + S+  Q++NG+ 
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 64  YLHERNVVHREIKCANILVDAS-------------GLATTTN-DVKSF--EGTPFWVAPE 107
           + H R  +HR++K  N+L+  S             GLA      ++ F  E    W  P 
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPP 206
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI-------------GRG 154
            + L +  Y  S DIWS+ C   EML   P +    ++  LF+I             G  
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266
Query: 155 KLPSVPNSLSRDARDFILK-----------------CLQVNPNDRPTAAQLMEHPF 193
            LP    S  +  R   LK                  L+++P  R +A   +EHP+
Sbjct: 267 ALPDWKQSFPK-FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q ++  IV+ IG  + E+ + + +E+ + G L   L Q  H+ D  +     Q+  G+
Sbjct: 62  MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN---------DVKSFEGTPF------WVAPE 107
            YL E N VHR++   N+L+     A  ++         D   ++          W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     +   +D+WS G  + E  ++ Q PY  ++  +    + +G+    P    R+
Sbjct: 181 CINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 238
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             D +  C   +  +RP  A +
Sbjct: 239 MYDLMNLCWTYDVENRPGFAAV 260

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q ++  IV+ IG  + E+ + + +E+ + G L   L Q  H+ D  +     Q+  G+
Sbjct: 424 MQQLDNPYIVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 482
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN--------------DVKSFEGTPF-WVAPE 107
            YL E N VHR++   N+L+     A  ++                ++    P  W APE
Sbjct: 483 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 542
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     +   +D+WS G  + E  ++ Q PY  ++  +    + +G+    P    R+
Sbjct: 543 CINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 600
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             D +  C   +  +RP  A +
Sbjct: 601 MYDLMNLCWTYDVENRPGFAAV 622

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 54/234 (23%)
Query: 11  NIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER 68
           NI++ I T KD       +  E +       LYQ   L+D  +  Y  ++L  L Y H +
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQI--LTDFDIRFYMYELLKALDYCHSK 156
Query: 69  NVVHREIKCANILVDAS---------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGY 116
            ++HR++K  N+++D           GLA   +  + +     + ++  PE++ +    Y
Sbjct: 157 GIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELL-VDYQMY 215
Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLED-MQALFRIGR--------GKL--------PSV 159
             S D+WSLGC +  M+  + P+ H +D    L RI +        G L        P  
Sbjct: 216 DYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHF 275
Query: 160 PNSLSRDAR--------------------DFILKCLQVNPNDRPTAAQLMEHPF 193
            + L + +R                    D + K L+ +   R TA + MEHP+
Sbjct: 276 NDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 329

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             Q ++  IV+ IG  + E+ + + +E+ + G L   L Q  H+ D  +     Q+  G+
Sbjct: 425 MQQLDNPYIVRMIGICEAESWMLV-MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 483
Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN--------------DVKSFEGTPF-WVAPE 107
            YL E N VHR++   N+L+     A  ++                ++    P  W APE
Sbjct: 484 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 543
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            +N     +   +D+WS G  + E  ++ Q PY  ++  +    + +G+    P    R+
Sbjct: 544 CINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 601
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
             D +  C   +  +RP  A +
Sbjct: 602 MYDLMNLCWTYDVENRPGFAAV 623

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L                  N   +  ++   
Sbjct: 88  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA   N++  ++ T  
Sbjct: 148 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 208 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEG 264
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +  C    P+ RPT  QL+E
Sbjct: 265 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L                  N   +  ++   
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA   N++  ++ T  
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 219 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEG 275
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +  C    P+ RPT  QL+E
Sbjct: 276 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L                  N   +  ++   
Sbjct: 91  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA   N++  ++ T  
Sbjct: 151 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 211 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEG 267
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +  C    P+ RPT  QL+E
Sbjct: 268 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L                  N   +  ++   
Sbjct: 86  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA   N++  ++ T  
Sbjct: 146 LVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 206 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEG 262
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +  C    P+ RPT  QL+E
Sbjct: 263 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 54/234 (23%)
Query: 11  NIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER 68
           NI++ I T KD       +  E +       LYQ   L+D  +  Y  ++L  L Y H +
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQI--LTDFDIRFYMYELLKALDYCHSK 151
Query: 69  NVVHREIKCANILVDAS---------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGY 116
            ++HR++K  N+++D           GLA   +  + +     + ++  PE++ +    Y
Sbjct: 152 GIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELL-VDYQMY 210
Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLED-MQALFRIGR--------GKL--------PSV 159
             S D+WSLGC +  M+  + P+ H +D    L RI +        G L        P  
Sbjct: 211 DYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHF 270
Query: 160 PNSLSRDAR--------------------DFILKCLQVNPNDRPTAAQLMEHPF 193
            + L + +R                    D + K L+ +   R TA + MEHP+
Sbjct: 271 NDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 324

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L                  N   +  ++   
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA   N++  ++ T  
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFR-IGRG 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF+ +  G
Sbjct: 219 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEG 275
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +  C    P+ RPT  QL+E
Sbjct: 276 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----------------KYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L    Q                 +  LS   
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S   Q+  G+ YL  +  +HR++   N+LV           GLA   + +  ++ T  
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 212 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 268
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 269 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----------------KYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L    Q                 +  LS   
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S   Q+  G+ YL  +  +HR++   N+LV           GLA   + +  ++ T  
Sbjct: 137 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 197 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 253
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 254 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----------------KYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L    Q                 +  LS   
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S   Q+  G+ YL  +  +HR++   N+LV           GLA   + +  ++ T  
Sbjct: 141 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 200
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 201 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 257
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 258 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 293

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 18/214 (8%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLT 63
           +   H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ 
Sbjct: 60  AMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 64  YLHERNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVV 109
           YLH   + HR+IK  N+L+D          GLAT          +    GT  +VAPE++
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             +   +    D+WS G  +  ML  + P+    D    +   + K   +      D+  
Sbjct: 180 K-RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 170 FIL--KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
             L  K L  NP+ R T   + +  +  +PL+  
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPLKKG 272

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLC 137
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 195
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 196 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 147 ALFRIGRGKLPS---------VPNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R      P           P+SL           +  ARD + K L ++P  R +  
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 314 DALQHPYI 321

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----------------KYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L    Q                 +  LS   
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S   Q+  G+ YL  +  +HR++   N+LV           GLA   + +  ++ T  
Sbjct: 145 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 204
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 205 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 261
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 262 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 297

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L                  N   +  ++   
Sbjct: 99  KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA   N++  ++ T  
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 219 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEG 275
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +  C    P+ RPT  QL+E
Sbjct: 276 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----------------KYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L    Q                 +  LS   
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S   Q+  G+ YL  +  +HR++   N+LV           GLA   + +  ++ T  
Sbjct: 144 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 203
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 204 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 260
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 261 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 296

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----------------KYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L    Q                 +  LS   
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S   Q+  G+ YL  +  +HR++   N+LV           GLA   + +  ++ T  
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 212 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 268
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 269 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L                  N   +  ++   
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA   N++  ++ T  
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 265 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEG 321
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +  C    P+ RPT  QL+E
Sbjct: 322 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----------------KYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L    Q                 +  LS   
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S   Q+  G+ YL  +  +HR++   N+LV           GLA   + +  ++ T  
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 212 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 268
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 269 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----------------KYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L    Q                 +  LS   
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S   Q+  G+ YL  +  +HR++   N+LV           GLA   + +  ++ T  
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 253 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 309
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 310 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 46/230 (20%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVS--------SYTRQIL 59
           +H N+++Y  +E  +  LYI LEL    +L +L +  ++SD  +         S  RQI 
Sbjct: 85  DHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTND---------VKSF------------- 97
           +G+ +LH   ++HR++K  NILV  S   T             +  F             
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 98  -------EGTPFWVAPEVVNLKNNG-YGLSADIWSLGCTVLEMLTHQP-----PYSHLED 144
                   GT  W APE++          S DI+S+GC    +L+         YS   +
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 145 M-QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
           + + +F +   K      SL  +A D I + +  +P  RPTA +++ HP 
Sbjct: 264 IIRGIFSLDEMKCLH-DRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNG 61
             QF+H NI+   G       + I  E ++ GSL    +K     +  Q+    R I +G
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 122
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL + + VHR++   NILV+ S L    +D    +  E  P              W A
Sbjct: 123 MKYLSDMSYVHRDLAARNILVN-SNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 181
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  I  G +LP  P   
Sbjct: 182 PEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPP-PMDC 238
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q   +DRP   Q++
Sbjct: 239 PIALHQLMLDCWQKERSDRPKFGQIV 264

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 46/230 (20%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVS--------SYTRQIL 59
           +H N+++Y  +E  +  LYI LEL    +L +L +  ++SD  +         S  RQI 
Sbjct: 85  DHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTND---------VKSF------------- 97
           +G+ +LH   ++HR++K  NILV  S   T             +  F             
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 98  -------EGTPFWVAPEVVNLKNNG-YGLSADIWSLGCTVLEMLTHQP-----PYSHLED 144
                   GT  W APE++          S DI+S+GC    +L+         YS   +
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 145 M-QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
           + + +F +   K      SL  +A D I + +  +P  RPTA +++ HP 
Sbjct: 264 IIRGIFSLDEMKCLH-DRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 312

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            K L  NP+ R T   + +  +  +PL+  
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLKKG 271

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLC 138
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 196
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 197 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 147 ALFR---IGRGKLPSV------PNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R     R K   +      P+SL           +  ARD + K L ++P  R +  
Sbjct: 255 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 314
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 315 DALQHPYI 322

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 182
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            K L  NP+ R T   + +  +  +PL+  
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKG 272

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNG 61
             QF+H NI+   G       + I  E ++ GSL    +K     +  Q+    R I +G
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 128
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL + + VHR++   NILV+ S L    +D    +  E  P              W A
Sbjct: 129 MKYLSDMSYVHRDLAARNILVN-SNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 187
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  I  G +LP  P   
Sbjct: 188 PEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPP-PMDC 244
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q   +DRP   Q++
Sbjct: 245 PIALHQLMLDCWQKERSDRPKFGQIV 270

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLC 175
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 233
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 234 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 147 ALFR---IGRGKLPSV------PNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R     R K   +      P+SL           +  ARD + K L ++P  R +  
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 352 DALQHPYI 359

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            K L  NP+ R T   + +  +  +PL+  
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLKKG 271

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
            K L  NP+ R T   + +  +  +PL+
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
            K L  NP+ R T   + +  +  +PL+
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLK 269

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLC 137
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 195
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 196 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 147 ALFRIGRGKLPS---------VPNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R      P           P+SL           +  ARD + K L ++P  R +  
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 314 DALQHPYI 321

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 182
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
            K L  NP+ R T   + +  +  +PL+
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLK 270

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLC 138
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 196
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 197 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 147 ALFRIGRGKLPS---------VPNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R      P           P+SL           +  ARD + K L ++P  R +  
Sbjct: 255 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 314
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 315 DALQHPYI 322

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLC 137
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 195
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 196 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 147 ALFRIGRGKLPS---------VPNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R      P           P+SL           +  ARD + K L ++P  R +  
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 314 DALQHPYI 321

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--------------HLSDS 49
            +  +H++IV++ G   + + L +  E +K G L    + +               L+ S
Sbjct: 69  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQS 128
Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATT-----TNDVKSFE------ 98
           Q+    +QI  G+ YL  ++ VHR++   N LV  + L        + DV S +      
Sbjct: 129 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 188
Query: 99  --GTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG 154
               P  W+ PE +  +   +   +D+WSLG  + E+ T+ + P+  L + + +  I +G
Sbjct: 189 HTMLPIRWMPPESIMYRK--FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDR 182
           ++   P +  ++  + +L C Q  P+ R
Sbjct: 247 RVLQRPRTCPQEVYELMLGCWQREPHMR 274

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 182
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            K L  NP+ R T   + +  +  +PL+  
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKG 272

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 182
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            K L  NP+ R T   + +  +  +PL+  
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKG 272

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            K L  NP+ R T   + +  +  +PL+  
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLKKG 271

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 180
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            K L  NP+ R T   + +  +  +PL+  
Sbjct: 241 HKILVENPSARITIPDIKKDRWYNKPLKKG 270

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 182
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            K L  NP+ R T   + +  +  +PL+  
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKG 272

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            K L  NP+ R T   + +  +  +PL+  
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLKKG 271

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            K L  NP+ R T   + +  +  +PL+  
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLKKG 271

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 81  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLC 136
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 137 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 194
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 195 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 252
Query: 147 ALFRIGRGKLPS---------VPNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R      P           P+SL           +  ARD + K L ++P  R +  
Sbjct: 253 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 312
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 313 DALQHPYI 320

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 24/200 (12%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNG 61
             QF+H NI+   G       + I  E ++ GSL    +K     +  Q+    R I  G
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAG 136
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL +   VHR++   NIL++ S L    +D    +  E  P              W A
Sbjct: 137 MKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 195
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           PE +  +   +  ++D+WS G  + E++++ + PY  + +   +  +  G +LPS P   
Sbjct: 196 PEAIAFRK--FTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPS-PMDC 252
Query: 164 SRDARDFILKCLQVNPNDRP 183
                  +L C Q   N RP
Sbjct: 253 PAALYQLMLDCWQKERNSRP 272

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLC 175
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 233
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 234 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 147 ALFR---IGRGKLPSV------PNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R     R K   +      P+SL           +  ARD + K L ++P  R +  
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 351
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 352 DALQHPYI 359

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 107/248 (43%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLC 137
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 195
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 196 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 147 ALFR---IGRGKLPSV------PNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R     R K   +      P+SL           +  ARD + K L ++P  R +  
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 313
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 314 DALQHPYI 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLC 131
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 189
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 190 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 147 ALFRIGRGKLPS---------VPNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R      P           P+SL           +  ARD + K L ++P  R +  
Sbjct: 248 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 307
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 308 DALQHPYI 315

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLC 131
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 189
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 190 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 147 ALFRIGRGKLPS---------VPNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R      P           P+SL           +  ARD + K L ++P  R +  
Sbjct: 248 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 307
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 308 DALQHPYI 315

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 105/248 (42%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q+L 
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLC 130
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     APE
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 188
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + EM+ H+                     P    ++ +Q
Sbjct: 189 VI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 147 ALFRIGRGKLPS---------VPNSL-----------SRDARDFILKCLQVNPNDRPTAA 186
              R      P           P+SL           +  ARD + K L ++P  R +  
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 187 QLMEHPFV 194
             ++HP++
Sbjct: 307 DALQHPYI 314

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 27  IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS- 85
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HR++K  N+L+D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEH 168
Query: 86  --------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                   GLA   +  + +     + ++  PE++ +    Y  S D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 135 HQPPYSHLED-MQALFRI----GRGKL------------PSVPNSLSRDAR--------- 168
            + P+ H  D    L RI    G   L            P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 169 -----------DFILKCLQVNPNDRPTAAQLMEHPF 193
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 96/242 (39%), Gaps = 63/242 (26%)
Query: 4   FSQFEHDNIV---QYIGTEKDENRLYIFLE------LVKKGSLANLYQKYHLSDSQVSSY 54
               +H NIV     I TEK    ++ +L+      L   G++ N++         V  +
Sbjct: 54  LKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHN--------VKLF 105
Query: 55  TRQILNGLTYLHERNVVHREIKCANILVDASG--------------LATTTNDVKSFEGT 100
             Q+L GL Y H + V+HR++K  N+L++  G              + T T D    E  
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV 162
Query: 101 PFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--PYSHLED-MQALFRI-GRGKL 156
             W  P  + L +  Y    D+W +GC   EM T +P  P S +E+ +  +FRI G    
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE 222
Query: 157 PSVPNSLSR-------------------------DARDFILKCLQVNPNDRPTAAQLMEH 191
            + P  LS                          D  D + K LQ    +R +A   M+H
Sbjct: 223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282
Query: 192 PF 193
           PF
Sbjct: 283 PF 284

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 182
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPL 198
            K L  NP+ R T   + +  +  +PL
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 18/207 (8%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLTYLHE 67
           H+N+V++ G  ++ N  Y+FLE    G L +  +    + +     +  Q++ G+ YLH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 68  RNVVHREIKCANILVDAS--------GLATT------TNDVKSFEGTPFWVAPEVVNLKN 113
             + HR+IK  N+L+D          GLAT          +    GT  +VAPE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RR 181
Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL- 172
             +    D+WS G  +  ML  + P+    D    +   + K   +      D+    L 
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 173 -KCLQVNPNDRPTAAQLMEHPFVKRPL 198
            K L  NP+ R T   + +  +  +PL
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 20/204 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G         I  E ++ GSL    + +    +  Q+    R +  G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT------PF-WVAP 106
           + YL +   VHR++   N+LVD++        GL+    D      T      P  W AP
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAP 223
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           E +  +   +  ++D+WS G  + E+L + + PY ++ +   +  +  G     P     
Sbjct: 224 EAIAFRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH 281
Query: 166 DARDFILKCLQVNPNDRPTAAQLM 189
                +L C   +   RP  +Q++
Sbjct: 282 ALHQLMLDCWHKDRAQRPRFSQIV 305

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----------------KYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L    Q                 +  LS   
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S   Q+  G+ YL  +  +HR++   N+LV           GLA   + +   + T  
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 212 GRLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEG 268
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P++ + +    +  C    P+ RPT  QL+E
Sbjct: 269 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 91/187 (48%), Gaps = 21/187 (11%)
Query: 4   FSQFEHDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
               +H+N++  +       + +D + +Y+   L+    L N+ +   LSD  V     Q
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKSQALSDEHVQFLVYQ 139
Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSFEGTPFWVAPEV 108
           +L GL Y+H   ++HR++K +N+ V+          GLA   + ++  +  T ++ APE+
Sbjct: 140 LLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPEI 199
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQ---PPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           + L    Y  + DIWS+GC + E+L  +   P   +++ ++ +  +     P V   +S 
Sbjct: 200 M-LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISS 258
Query: 166 D-ARDFI 171
           + AR +I
Sbjct: 259 EHARTYI 265

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L                  N   +  ++   
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA   N++   + T  
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFR-IGRG 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF+ +  G
Sbjct: 219 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEG 275
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +  C    P+ RPT  QL+E
Sbjct: 276 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 90/232 (38%), Gaps = 43/232 (18%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNG 61
             + +H NIV+       + +L +  E   +  L   +   +  L    V S+  Q+L G
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTN-----------DVKSFEGTPFWVAPEVVN 110
           L + H RNV+HR++K  N+L++ +G     N              S E    W  P  V 
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED----MQALFRI----------GRGKL 156
                Y  S D+WS GC   E+     P     D    ++ +FR+             KL
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 157 P---------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
           P               +V   L+   RD +   L+ NP  R +A + ++HP+
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L                  N   +  ++   
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA   N++   + T  
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 219 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEG 275
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +  C    P+ RPT  QL+E
Sbjct: 276 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 27  IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS- 85
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HR++K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 86  --------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                   GLA   +  + +     + ++  PE++ +    Y  S D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 135 HQPPYSHLED-MQALFRI----GRGKL------------PSVPNSLSRDAR--------- 168
            + P+ H  D    L RI    G   L            P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 169 -----------DFILKCLQVNPNDRPTAAQLMEHPF 193
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 27  IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS- 85
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HR++K  N+++D   
Sbjct: 109 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 166
Query: 86  --------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                   GLA   +  + +     + ++  PE++ +    Y  S D+WSLGC +  M+ 
Sbjct: 167 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 225
Query: 135 HQPPYSHLED-MQALFRI----GRGKL------------PSVPNSLSRDAR--------- 168
            + P+ H  D    L RI    G   L            P   + L R +R         
Sbjct: 226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 285
Query: 169 -----------DFILKCLQVNPNDRPTAAQLMEHPF 193
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 286 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 27  IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS- 85
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HR++K  N+++D   
Sbjct: 110 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 167
Query: 86  --------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                   GLA   +  + +     + ++  PE++ +    Y  S D+WSLGC +  M+ 
Sbjct: 168 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 226
Query: 135 HQPPYSHLED-MQALFRI----GRGKL------------PSVPNSLSRDAR--------- 168
            + P+ H  D    L RI    G   L            P   + L R +R         
Sbjct: 227 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 286
Query: 169 -----------DFILKCLQVNPNDRPTAAQLMEHPF 193
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 287 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 27  IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS- 85
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HR++K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 86  --------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                   GLA   +  + +     + ++  PE++ +    Y  S D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 135 HQPPYSHLED-MQALFRI----GRGKL------------PSVPNSLSRDAR--------- 168
            + P+ H  D    L RI    G   L            P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 169 -----------DFILKCLQVNPNDRPTAAQLMEHPF 193
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 27  IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS- 85
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HR++K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 86  --------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                   GLA   +  + +     + ++  PE++ +    Y  S D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 135 HQPPYSHLED-MQALFRI----GRGKL------------PSVPNSLSRDAR--------- 168
            + P+ H  D    L RI    G   L            P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 169 -----------DFILKCLQVNPNDRPTAAQLMEHPF 193
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 27  IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS- 85
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HR++K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 86  --------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                   GLA   +  + +     + ++  PE++ +    Y  S D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 135 HQPPYSHLED-MQALFRI----GRGKL------------PSVPNSLSRDAR--------- 168
            + P+ H  D    L RI    G   L            P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 169 -----------DFILKCLQVNPNDRPTAAQLMEHPF 193
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 27  IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS- 85
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HR++K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 86  --------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                   GLA   +  + +     + ++  PE++ +    Y  S D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 135 HQPPYSHLED-MQALFRI----GRGKL------------PSVPNSLSRDAR--------- 168
            + P+ H  D    L RI    G   L            P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 169 -----------DFILKCLQVNPNDRPTAAQLMEHPF 193
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 27  IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS- 85
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HR++K  N+++D   
Sbjct: 110 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 167
Query: 86  --------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                   GLA   +  + +     + ++  PE++ +    Y  S D+WSLGC +  M+ 
Sbjct: 168 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 226
Query: 135 HQPPYSHLED-MQALFRI----GRGKL------------PSVPNSLSRDAR--------- 168
            + P+ H  D    L RI    G   L            P   + L R +R         
Sbjct: 227 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 286
Query: 169 -----------DFILKCLQVNPNDRPTAAQLMEHPF 193
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 287 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 22/206 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H N++   G       + I  E ++ GSL +  ++     +  Q+    R I  G
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 147
Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATTTND-------VKSFEG-TPF-WV 104
           + YL + N VHR++   NILV+++        GL+    D         +  G  P  W 
Sbjct: 148 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSL 163
           APE +  +   +  ++D+WS G  + E++++ + PY  + +   +  I +      P   
Sbjct: 208 APEAIQYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC 265
Query: 164 SRDARDFILKCLQVNPNDRPTAAQLM 189
                  +L C Q + N RP   Q++
Sbjct: 266 PSALHQLMLDCWQKDRNHRPKFGQIV 291

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 27  IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS- 85
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HR++K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 86  --------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                   GLA   +  + +     + ++  PE++ +    Y  S D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 135 HQPPYSHLED-MQALFRI----GRGKL------------PSVPNSLSRDAR--------- 168
            + P+ H  D    L RI    G   L            P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 169 -----------DFILKCLQVNPNDRPTAAQLMEHPF 193
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 23/199 (11%)
Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERN 69
            IV   G  ++   + IF+EL++ GSL  L ++   L + +   Y  Q L GL YLH R 
Sbjct: 146 RIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR 205
Query: 70  VVHREIKCANILVDASGLATTTNDV------------KSF------EGTPFWVAPEVVNL 111
           ++H ++K  N+L+ + G      D             KS        GT   +APEVV  
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP--SVPNSLSRDARD 169
           ++       D+WS  C +L ML    P++         +I     P   +P S +     
Sbjct: 266 RS--CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQ 323
Query: 170 FILKCLQVNPNDRPTAAQL 188
            I + L+  P  R +AA+L
Sbjct: 324 AIQEGLRKEPIHRVSAAEL 342

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 27  IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS- 85
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HR++K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 86  --------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                   GLA   +  + +     + ++  PE++ +    Y  S D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 135 HQPPYSHLED-MQALFRI----GRGKL------------PSVPNSLSRDAR--------- 168
            + P+ H  D    L RI    G   L            P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 169 -----------DFILKCLQVNPNDRPTAAQLMEHPF 193
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 23/199 (11%)
Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERN 69
            IV   G  ++   + IF+EL++ GSL  L ++   L + +   Y  Q L GL YLH R 
Sbjct: 127 RIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR 186
Query: 70  VVHREIKCANILVDASGLATTTNDVKS------------------FEGTPFWVAPEVVNL 111
           ++H ++K  N+L+ + G      D                       GT   +APEVV  
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP--SVPNSLSRDARD 169
           ++       D+WS  C +L ML    P++         +I     P   +P S +     
Sbjct: 247 RS--CDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQ 304
Query: 170 FILKCLQVNPNDRPTAAQL 188
            I + L+  P  R +AA+L
Sbjct: 305 AIQEGLRKEPIHRVSAAEL 323

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVS-----SYTRQI 58
             QFEH NI++  G   +   + I  E ++ G+L +  +   L+D Q +        R I
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGI 127
Query: 59  LNGLTYLHERNVVHREIKCANILVDAS--------GL-------ATTTNDVKSFEG-TPF 102
            +G+ YL E + VHR++   NILV+++        GL       ++   +  S  G  P 
Sbjct: 128 ASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPI 187
Query: 103 -WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSV 159
            W APE +  +   +  ++D WS G  + E+++  + PY  + +   +  I +  +LP  
Sbjct: 188 RWTAPEAIAFRK--FTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPP 245
Query: 160 PNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           P+  +      +L C Q + N RP   Q++
Sbjct: 246 PDCPT-SLHQLMLDCWQKDRNARPRFPQVV 274

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 27  IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS- 85
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HR++K  N+++D   
Sbjct: 116 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 173
Query: 86  --------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                   GLA   +  + +     + ++  PE++ +    Y  S D+WSLGC +  M+ 
Sbjct: 174 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 232
Query: 135 HQPPYSHLED-MQALFRI----GRGKL------------PSVPNSLSRDAR--------- 168
            + P+ H  D    L RI    G   L            P   + L R +R         
Sbjct: 233 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 292
Query: 169 -----------DFILKCLQVNPNDRPTAAQLMEHPF 193
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 293 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 328

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 27  IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS- 85
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HR++K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 86  --------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                   GLA   +  + +     + ++  PE++ +    Y  S D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 135 HQPPYSHLED-MQALFRI----GRGKL------------PSVPNSLSRDAR--------- 168
            + P+ H  D    L RI    G   L            P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 169 -----------DFILKCLQVNPNDRPTAAQLMEHPF 193
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 66/130 (50%), Gaps = 29/130 (22%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 83  DAS--------GLATTTNDVKSFEGTPFWVAPEVVN--------LKNNGYGLSADIWSLG 126
            +         GLA T        GT F + PEVV         +   GY  + DIWS+G
Sbjct: 160 KSDCTLKILDFGLARTA-------GTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVG 212
Query: 127 CTVLEMLTHQ 136
           C + EM+ H+
Sbjct: 213 CIMGEMVCHK 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/127 (34%), Positives = 68/127 (53%), Gaps = 23/127 (18%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 109 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 164
Query: 83  DAS--------GLATTTNDVKSFEGTPFWV-----APEVVNLKNNGYGLSADIWSLGCTV 129
            +         GLA T     SF  TP+ V     APEV+     GY  + D+WS+GC +
Sbjct: 165 KSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVI--LGMGYKENVDLWSVGCIM 220
Query: 130 LEMLTHQ 136
            EM+ H+
Sbjct: 221 GEMVCHK 227

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 22/205 (10%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H NI++  G         I  E ++ GSL    + +    +  Q+    R +  G
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTP-------------FWVA 105
           + YL +   VHR++   N+LVD S L    +D    +  E  P              W A
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLS 164
           PE +  +   +  ++D+WS G  + E+L + + PY ++ +   +  +  G     P    
Sbjct: 223 PEAIAFRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP 280
Query: 165 RDARDFILKCLQVNPNDRPTAAQLM 189
                 +L C   +   RP  +Q++
Sbjct: 281 HALHQLMLDCWHKDRAQRPRFSQIV 305

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 89/221 (40%), Gaps = 45/221 (20%)
Query: 17  GTEKDENRLYIFLELVK----KGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVH 72
           G +KDE  L + LE V     + S      K  +    +  Y  Q+L  L Y+H   + H
Sbjct: 105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICH 164
Query: 73  REIKCANILVDASGLATTTNDVKS----FEGTP--------FWVAPEVVNLKNNGYGLSA 120
           R+IK  N+L+D         D  S      G P        ++ APE++    N Y  + 
Sbjct: 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATN-YTTNI 223
Query: 121 DIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR-------------------GKLPSV-P 160
           DIWS GC + E++  QP +     +  L  I +                    K P + P
Sbjct: 224 DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRP 283
Query: 161 NSLSR--------DARDFILKCLQVNPNDRPTAAQLMEHPF 193
           +  S+        DA D I + L+  P+ R TA + + HPF
Sbjct: 284 HPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 52/216 (24%)
Query: 27  IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS- 85
           +  E V       LYQ   L+D  +  Y  +IL  L Y H   ++HR++K  N+++D   
Sbjct: 111 LVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 86  --------GLATTTNDVKSFE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT 134
                   GLA   +  + +     + ++  PE++ +    Y  S D+WSLGC +  M+ 
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIF 227
Query: 135 HQPPYSHLED-MQALFRI----GRGKL------------PSVPNSLSRDAR--------- 168
            + P+ H  D    L RI    G   L            P   + L R +R         
Sbjct: 228 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 287
Query: 169 -----------DFILKCLQVNPNDRPTAAQLMEHPF 193
                      DF+ K L+ +   R TA + MEHP+
Sbjct: 288 ENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 30/169 (17%)
Query: 4   FSQFEHDNIVQYI---GTEKDENRLYIFLE-----LVKKGSLANLYQKYHLSDSQVSSYT 55
             +  H NI+  +   G + + + ++ F+E     ++K  SL        L+ S + +Y 
Sbjct: 66  LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-------LTPSHIKAYM 118
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTND--VKSFEGTP-----------F 102
              L GL YLH+  ++HR++K  N+L+D +G+    +    KSF G+P           +
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVVTRW 177
Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI 151
           + APE++      YG+  D+W++GC + E+L   P      D+  L RI
Sbjct: 178 YRAPELL-FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 225

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/127 (34%), Positives = 68/127 (53%), Gaps = 23/127 (18%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 98  VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 153
Query: 83  DAS--------GLATTTNDVKSFEGTPFWV-----APEVVNLKNNGYGLSADIWSLGCTV 129
            +         GLA T     SF  TP+ V     APEV+     GY  + D+WS+GC +
Sbjct: 154 KSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVI--LGMGYKENVDLWSVGCIM 209
Query: 130 LEMLTHQ 136
            EM+ H+
Sbjct: 210 GEMVCHK 216

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 91/187 (48%), Gaps = 21/187 (11%)
Query: 4   FSQFEHDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
               +H+N++  +       + +D + +Y+   L+    L N+ +   LSD  V     Q
Sbjct: 73  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQFLVYQ 131
Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSFEGTPFWVAPEV 108
           +L GL Y+H   ++HR++K +N+ V+          GLA   + ++  +  T ++ APE+
Sbjct: 132 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATRWYRAPEI 191
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQ---PPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           + L    Y  + DIWS+GC + E+L  +   P   +++ ++ +  +     P V   +S 
Sbjct: 192 M-LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISS 250
Query: 166 D-ARDFI 171
           + AR +I
Sbjct: 251 EHARTYI 257

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 91/187 (48%), Gaps = 21/187 (11%)
Query: 4   FSQFEHDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
               +H+N++  +       + +D + +Y+   L+    L N+ +   LSD  V     Q
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMG-ADLNNIVKCQALSDEHVQFLVYQ 139
Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSFEGTPFWVAPEV 108
           +L GL Y+H   ++HR++K +N+ V+          GLA   + ++  +  T ++ APE+
Sbjct: 140 LLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPEI 199
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQ---PPYSHLEDMQALFRIGRGKLPSVPNSLSR 165
           + L    Y  + DIWS+GC + E+L  +   P   +++ ++ +  +     P V   +S 
Sbjct: 200 M-LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISS 258
Query: 166 D-ARDFI 171
           + AR +I
Sbjct: 259 EHARTYI 265

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYT--RQILNGLTY 64
            E  N V+ +   K ++ L+I +E  + G+L +L    +L+  +   +   RQIL  L+Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 65  LHERNVVHREIKCANILVDAS--------GLAT------------------TTNDVKSFE 98
           +H + ++HR++K  NI +D S        GLA                   +++++ S  
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 99  GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL-- 156
           GT  +VA EV++     Y    D++SLG    EM+   P  + +E +  L ++    +  
Sbjct: 192 GTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVSIEF 248
Query: 157 -PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
            P   ++  +  +  I   +  +PN RP A  L+
Sbjct: 249 PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +    KG+L                  N   +  ++   
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA   N++  ++ T  
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 219 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEG 275
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +  C    P+ RPT  QL+E
Sbjct: 276 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 90/232 (38%), Gaps = 43/232 (18%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNG 61
             + +H NIV+       + +L +  E   +  L   +   +  L    V S+  Q+L G
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTN-----------DVKSFEGTPFWVAPEVVN 110
           L + H RNV+HR++K  N+L++ +G     +              S E    W  P  V 
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED----MQALFRI----------GRGKL 156
                Y  S D+WS GC   E+     P     D    ++ +FR+             KL
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 157 P---------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
           P               +V   L+   RD +   L+ NP  R +A + ++HP+
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 105/248 (42%), Gaps = 70/248 (28%)
Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILN 60
           H NI+  +       T ++   +Y+ +EL+     ANL Q  H  L   ++S    Q+L 
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLC 135
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-----APE 107
           G+ +LH   ++HR++K +NI+V +         GLA T +   +F  TP+ V     APE
Sbjct: 136 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAS--TNFMMTPYVVTRYYRAPE 193
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQ---------------------PPYSHLEDMQ 146
           V+     GY  + DIWS+GC + E++                        P    +  +Q
Sbjct: 194 VI--LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQ 251
Query: 147 ALFR---IGRGKLPSV-----------PNSLSRD------ARDFILKCLQVNPNDRPTAA 186
              R     R   P +           P+   RD      ARD + K L ++P+ R +  
Sbjct: 252 PTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVD 311
Query: 187 QLMEHPFV 194
           + + HP++
Sbjct: 312 EALRHPYI 319

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVS-----SYTRQI 58
             QFEH NI++  G   +   + I  E ++ G+L +  +   L+D Q +        R I
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGI 125
Query: 59  LNGLTYLHERNVVHREIKCANILVDASGLATTTND----------------VKSFEG-TP 101
            +G+ YL E + VHR++   NILV+ S L    +D                  S  G  P
Sbjct: 126 ASGMRYLAEMSYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIP 184
Query: 102 F-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPS 158
             W APE +  +   +  ++D WS G  + E+++  + PY  + +   +  I +  +LP 
Sbjct: 185 IRWTAPEAIAFRK--FTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPP 242
Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
            P+  +      +L C Q + N RP   Q++
Sbjct: 243 PPDCPT-SLHQLMLDCWQKDRNARPRFPQVV 272

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
             QF+H N++   G       + I  E ++ GSL +  ++     +  Q+    R I  G
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 121
Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATTTND-------VKSFEG-TPF-WV 104
           + YL + N VHR +   NILV+++        GL+    D         +  G  P  W 
Sbjct: 122 MKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNS 162
           APE +  +   +  ++D+WS G  + E++++ + PY  + +   +  I +  +LP  P  
Sbjct: 182 APEAIQYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP-PMD 238
Query: 163 LSRDARDFILKCLQVNPNDRPTAAQLM 189
                   +L C Q + N RP   Q++
Sbjct: 239 CPSALHQLMLDCWQKDRNHRPKFGQIV 265

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 9   HDNIVQYIGT-EKDENRLYIFLELVKKGSLA--------------NLYQKYHLSDSQVSS 53
           H N+V  +G   K    L + +E  K G+L+              +LY+ + L+   +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF-LTLEHLIC 148
Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-----DV--------KSFEGT 100
           Y+ Q+  G+ +L  R  +HR++   NIL+    +    +     D+        K     
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 101 PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGRGKLP 157
           P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++ D +   R+  G   
Sbjct: 209 PLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 266
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
             P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 267 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 84/208 (40%), Gaps = 33/208 (15%)
Query: 25  LYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I  E +  G L +  Q       ++ + S   + I   + YLH  N+ HR++K  N+L
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 82  VDAS-----------GLATTTNDVKSFEG---TPFWVAPEVVNLKNNGYGLSADIWSLGC 127
             +            G A  T    S      TP++VAPEV  L    Y  S D WSLG 
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV--LGPEKYDKSCDXWSLGV 251
Query: 128 TVLEMLTHQPPYSHLEDM------QALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPN 180
               +L   PP+     +      +   R G+ + P+   S +S + +  I   L+  P 
Sbjct: 252 IXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLIRNLLKTEPT 311
Query: 181 DRPTAAQLMEHPFVKR-------PLQTS 201
            R T  +   HP++ +       PL TS
Sbjct: 312 QRXTITEFXNHPWIXQSTKVPQTPLHTS 339

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +    KG+L                  N   +  ++   
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGT-- 100
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA   N++  ++ T  
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 101 ---PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE   L +  Y   +D+WS G  + E+ T    PY  +  ++ LF++ + G
Sbjct: 219 GRLPVKWMAPEA--LFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKEG 275
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P + + +    +  C    P+ RPT  QL+E
Sbjct: 276 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 66/130 (50%), Gaps = 29/130 (22%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 83  DAS--------GLATTTNDVKSFEGTPFWVAPEVVN--------LKNNGYGLSADIWSLG 126
            +         GLA T        GT F + PEVV         +   GY  + D+WS+G
Sbjct: 160 KSDCTLKILDFGLARTA-------GTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVG 212
Query: 127 CTVLEMLTHQ 136
           C + EM+ H+
Sbjct: 213 CIMGEMVCHK 222

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/193 (23%), Positives = 88/193 (45%), Gaps = 16/193 (8%)
Query: 7   FEHDNIVQYIGTEKDENRLY--IFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNG 61
           F H N++  +G  +     +  +    +  GSL N+  +   + +  SQ   +   +  G
Sbjct: 64  FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARG 123
Query: 62  LTYLH--ERNVVHREIKCANILVDASGLA-TTTNDVK-SFEG-----TPFWVAPEVVNLK 112
           + +LH  E  +    +   ++++D    A  +  DVK SF+       P WVAPE +  K
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKK 183
Query: 113 -NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG-RGKLPSVPNSLSRDARDF 170
             +    SAD+WS    + E++T + P++ L +M+   ++   G  P++P  +S      
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKL 243
Query: 171 ILKCLQVNPNDRP 183
           +  C+  +P  RP
Sbjct: 244 MKICMNEDPAKRP 256

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 9   HDNIVQYIGT-EKDENRLYIFLELVKKGSLA--------------NLYQKYHLSDSQVSS 53
           H N+V  +G   K    L + +E  K G+L+              +LY+ + L+   +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF-LTLEHLIX 148
Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-----DV--------KSFEGT 100
           Y+ Q+  G+ +L  R  +HR++   NIL+    +    +     D+        K     
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 101 PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGRGKLP 157
           P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++ D +   R+  G   
Sbjct: 209 PLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRM 266
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
             P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 267 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 88/190 (46%), Gaps = 23/190 (12%)
Query: 26  YIFLELVKKGSLANL-YQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           YI +E V   +L ++ + +  ++  +           L + H+  ++HR++K ANIL+ A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISA 151
Query: 85  S--------GLATTTND-------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +        G+A    D         +  GT  +++PE    + +     +D++SLGC +
Sbjct: 152 TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVL 209
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS----LSRDARDFILKCLQVNPNDRPTA 185
            E+LT +PP++    +   ++  R + P  P++    LS D    +LK L  NP +R   
Sbjct: 210 YEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 268
Query: 186 AQLMEHPFVK 195
           A  M    V+
Sbjct: 269 AAEMRADLVR 278

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/124 (37%), Positives = 68/124 (54%), Gaps = 23/124 (18%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 104 VYIVMELMD----ANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVV 159
Query: 83  --DAS------GLATTTNDVKSFEGTPFWV-----APEVVNLKNNGYGLSADIWSLGCTV 129
             DA+      GLA T     SF  TP+ V     APEV+     GY  + DIWS+GC +
Sbjct: 160 KSDATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIM 215
Query: 130 LEML 133
            EM+
Sbjct: 216 GEMI 219

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/124 (37%), Positives = 68/124 (54%), Gaps = 23/124 (18%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 104 VYIVMELMD----ANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 83  --DAS------GLATTTNDVKSFEGTPFWV-----APEVVNLKNNGYGLSADIWSLGCTV 129
             DA+      GLA T     SF  TP+ V     APEV+     GY  + DIWS+GC +
Sbjct: 160 KSDATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIM 215
Query: 130 LEML 133
            EM+
Sbjct: 216 GEMI 219

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 82/200 (41%), Gaps = 26/200 (13%)
Query: 20  KDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC 77
           +DEN LY+ +E    G L  L  K+   +       Y  +I+  +  +H    VHR+IK 
Sbjct: 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190
Query: 78  ANILVDASG---LAT--------TTNDVKSF--EGTPFWVAPEVVNLKNNGYGL-----S 119
            NIL+D  G   LA             V+S    GTP +++PE++     G G       
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE 250
Query: 120 ADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK----LPSVPNSLSRDARDFI--LK 173
            D W+LG    EM   Q P+      +   +I   K    LP V   +  +ARDFI  L 
Sbjct: 251 CDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL 310
Query: 174 CLQVNPNDRPTAAQLMEHPF 193
           C       R  A     HPF
Sbjct: 311 CPPETRLGRGGAGDFRTHPF 330

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 5   SQFEHDNIVQYIGTEKDENRL----YIFLELVKKGSLANL-YQKYHLSDSQVSSYTRQIL 59
           +   H  IV    T + E       YI +E V   +L ++ + +  ++  +         
Sbjct: 67  AALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTND-------VKSFEGTPFWV 104
             L + H+  ++HR++K ANI++ A+        G+A    D         +  GT  ++
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS-- 162
           +PE    + +     +D++SLGC + E+LT +PP++    +   ++  R + P  P++  
Sbjct: 187 SPE--QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARH 243
Query: 163 --LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             LS D    +LK L  NP +R   A  M    V+
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/124 (37%), Positives = 68/124 (54%), Gaps = 23/124 (18%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 104 VYIVMELMD----ANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 83  --DAS------GLATTTNDVKSFEGTPFWV-----APEVVNLKNNGYGLSADIWSLGCTV 129
             DA+      GLA T     SF  TP+ V     APEV+     GY  + DIWS+GC +
Sbjct: 160 KSDATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIM 215
Query: 130 LEML 133
            EM+
Sbjct: 216 GEMI 219

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 95/217 (43%), Gaps = 37/217 (17%)
Query: 9   HDNIVQYIGT-EKDENRLYIFLELVKKGSLA-----------------NLYQKYHLSDSQ 50
           H N+V  +G   K    L + +E  K G+L+                 +LY+ + L+   
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDF-LTLEH 149
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVD------------ASGLATTTNDVKSFE 98
           +  Y+ Q+  G+ +L  R  +HR++   NIL+             A  +    + V+  +
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 99  GT-PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGRG 154
              P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++ D +   R+  G
Sbjct: 210 ARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
                P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 9   HDNIVQYIGT-EKDENRLYIFLELVKKGSLA----------------NLYQKYHLSDSQV 51
           H N+V  +G   K    L + +E  K G+L+                +LY+ + L+   +
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDF-LTLEHL 150
Query: 52  SSYTRQILNGLTYLHERNVVHREIKCANILVD------------ASGLATTTNDVKSFEG 99
             Y+ Q+  G+ +L  R  +HR++   NIL+             A  +    + V+  + 
Sbjct: 151 IXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 100 T-PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGRGK 155
             P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++ D +   R+  G 
Sbjct: 211 RLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268
Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
               P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 88/190 (46%), Gaps = 23/190 (12%)
Query: 26  YIFLELVKKGSLANL-YQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           YI +E V   +L ++ + +  ++  +           L + H+  ++HR++K ANI++ A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 85  S--------GLATTTND-------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +        G+A    D         +  GT  +++PE    + +     +D++SLGC +
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVL 209
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS----LSRDARDFILKCLQVNPNDRPTA 185
            E+LT +PP++    +   ++  R + P  P++    LS D    +LK L  NP +R   
Sbjct: 210 YEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 268
Query: 186 AQLMEHPFVK 195
           A  M    V+
Sbjct: 269 AAEMRADLVR 278

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 88/190 (46%), Gaps = 23/190 (12%)
Query: 26  YIFLELVKKGSLANL-YQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           YI +E V   +L ++ + +  ++  +           L + H+  ++HR++K ANI++ A
Sbjct: 109 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 168
Query: 85  S--------GLATTTND-------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +        G+A    D         +  GT  +++PE    + +     +D++SLGC +
Sbjct: 169 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVL 226
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS----LSRDARDFILKCLQVNPNDRPTA 185
            E+LT +PP++    +   ++  R + P  P++    LS D    +LK L  NP +R   
Sbjct: 227 YEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 285
Query: 186 AQLMEHPFVK 195
           A  M    V+
Sbjct: 286 AAEMRADLVR 295

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/215 (20%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQIL 59
            ++ Q  H+N+V ++G       L I   L K  +L ++ +  K  L  ++     ++I+
Sbjct: 81  MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSFEGT-------------PFW--- 103
            G+ YLH + ++H+++K  N+  D   +  T   + S  G                W   
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 104 VAPEVVNLKNNG-------YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL 156
           +APE++   +         +   +D+++LG    E+   + P+        ++++G G  
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260
Query: 157 PSVPN-SLSRDARDFILKCLQVNPNDRPTAAQLME 190
           P++    + ++  D +L C      +RPT  +LM+
Sbjct: 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 9   HDNIVQYIGT-EKDENRLYIFLELVKKGSLA------------------NLYQKYHLSDS 49
           H N+V  +G   K    L + +E  K G+L+                  +LY+ + L+  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLE 148
Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-----DV--------KS 96
            +  Y+ Q+  G+ +L  R  +HR++   NIL+    +    +     D+        K 
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 97  FEGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGR 153
               P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++ D +   R+  
Sbjct: 209 DARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 9   HDNIVQYIGT-EKDENRLYIFLELVKKGSLA------------------NLYQKYHLSDS 49
           H N+V  +G   K    L + +E  K G+L+                  +LY+ + L+  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLE 148
Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-----DV--------KS 96
            +  Y+ Q+  G+ +L  R  +HR++   NIL+    +    +     D+        K 
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 97  FEGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGR 153
               P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++ D +   R+  
Sbjct: 209 DARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 66/124 (53%), Gaps = 23/124 (18%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 104 VYIVMELMD----ANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 83  DAS--------GLATTTNDVKSFEGTPFWV-----APEVVNLKNNGYGLSADIWSLGCTV 129
            +         GLA T     SF  TP+ V     APEV+     GY  + DIWS+GC +
Sbjct: 160 KSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIM 215
Query: 130 LEML 133
            EM+
Sbjct: 216 GEMI 219

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 9   HDNIVQYIGT-EKDENRLYIFLELVKKGSLA------------------NLYQKYHLSDS 49
           H N+V  +G   K    L + +E  K G+L+                  +LY+ + L+  
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLE 185
Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-----DV--------KS 96
            +  Y+ Q+  G+ +L  R  +HR++   NIL+    +    +     D+        K 
Sbjct: 186 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 97  FEGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGR 153
               P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++ D +   R+  
Sbjct: 246 DARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 303
Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 304 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 38/218 (17%)
Query: 9   HDNIVQYIGT-EKDENRLYIFLELVKKGSLA------------------NLYQKYHLSDS 49
           H N+V  +G   K    L + +E  K G+L+                  +LY+ + L+  
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLE 139
Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVD------------ASGLATTTNDVKSF 97
            +  Y+ Q+  G+ +L  R  +HR++   NIL+             A  +    + V+  
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 98  EGT-PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGR 153
           +   P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++ D +   R+  
Sbjct: 200 DARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 257
Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 258 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 88/190 (46%), Gaps = 23/190 (12%)
Query: 26  YIFLELVKKGSLANL-YQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           YI +E V   +L ++ + +  ++  +           L + H+  ++HR++K ANI++ A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 85  S--------GLATTTND-------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +        G+A    D         +  GT  +++PE    + +     +D++SLGC +
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVL 209
Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS----LSRDARDFILKCLQVNPNDRPTA 185
            E+LT +PP++    +   ++  R + P  P++    LS D    +LK L  NP +R   
Sbjct: 210 YEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 268
Query: 186 AQLMEHPFVK 195
           A  M    V+
Sbjct: 269 AAEMRADLVR 278

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 66/124 (53%), Gaps = 23/124 (18%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 83  DAS--------GLATTTNDVKSFEGTPFWV-----APEVVNLKNNGYGLSADIWSLGCTV 129
            +         GLA T     SF  TP+ V     APEV+     GY  + DIWS+GC +
Sbjct: 160 KSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIM 215
Query: 130 LEML 133
            EM+
Sbjct: 216 GEMI 219

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 38/218 (17%)
Query: 9   HDNIVQYIGT-EKDENRLYIFLELVKKGSLA------------------NLYQKYHLSDS 49
           H N+V  +G   K    L + +E  K G+L+                  +LY+ + L+  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLE 148
Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVD------------ASGLATTTNDVKSF 97
            +  Y+ Q+  G+ +L  R  +HR++   NIL+             A  +    + V+  
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 98  EGT-PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGR 153
           +   P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++ D +   R+  
Sbjct: 209 DARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 267 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 66/124 (53%), Gaps = 23/124 (18%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 105 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 160
Query: 83  DAS--------GLATTTNDVKSFEGTPFWV-----APEVVNLKNNGYGLSADIWSLGCTV 129
            +         GLA T     SF  TP+ V     APEV+     GY  + DIWS+GC +
Sbjct: 161 KSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIM 216
Query: 130 LEML 133
            EM+
Sbjct: 217 GEMI 220

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 66/124 (53%), Gaps = 23/124 (18%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 83  DAS--------GLATTTNDVKSFEGTPFWV-----APEVVNLKNNGYGLSADIWSLGCTV 129
            +         GLA T     SF  TP+ V     APEV+     GY  + DIWS+GC +
Sbjct: 160 KSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIM 215
Query: 130 LEML 133
            EM+
Sbjct: 216 GEMI 219

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 9   HDNIVQYIGT-EKDENRLYIFLELVKKGSLA------------------NLYQKYHLSDS 49
           H N+V  +G   K    L + +E  K G+L+                  +LY+ + L+  
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDF-LTLE 150
Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-----DV--------KS 96
            +  Y+ Q+  G+ +L  R  +HR++   NIL+    +    +     D+        K 
Sbjct: 151 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 97  FEGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGR 153
               P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++ D +   R+  
Sbjct: 211 DARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 268
Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 269 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 34/211 (16%)
Query: 4   FSQFEHDNIVQYIGTE---KDENRL---YIFLELVKKGSLANLY-------QKYHLSDSQ 50
             +F+H ++ + +G     + + RL    + L  +K G L             ++L    
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDV----KSFEGTPF---- 102
           +  +   I  G+ YL  RN +HR++   N ++ A  +     D     K + G  +    
Sbjct: 139 LVRFMVDIACGMEYLSSRNFIHRDLAARNCML-AEDMTVCVADFGLSRKIYSGDYYRQGC 197
Query: 103 -------WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQAL-FRIGR 153
                  W+A E  +L +N Y + +D+W+ G T+ E++T  Q PY+ +E+ +   + IG 
Sbjct: 198 ASKLPVKWLALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255
Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPT 184
            +L   P  +  +  D + +C   +P  RP+
Sbjct: 256 NRLKQPPECME-EVYDLMYQCWSADPKQRPS 285

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 65/124 (52%), Gaps = 23/124 (18%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 106 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 161
Query: 83  DAS--------GLATTTNDVKSFEGTPFWV-----APEVVNLKNNGYGLSADIWSLGCTV 129
            +         GLA T     SF   PF V     APEV+     GY  + DIWS+GC +
Sbjct: 162 KSDCTLKILDFGLARTAG--TSFMMVPFVVTRYYRAPEVI--LGMGYKENVDIWSVGCIM 217
Query: 130 LEML 133
            EM+
Sbjct: 218 GEMI 221

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 46/234 (19%)
Query: 7   FEHDNIVQYI---GTEKDENRLYIFLELVKKGSLANLY----QKYHLSDSQVSSYTRQIL 59
           FEH N+V+ +    T + +  + + L           Y        L    +    RQ L
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTN----DVKSFEGTPFWV-------APEV 108
            GL +LH   +VHR++K  NILV + G     +     + S++   F V       APEV
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEV 182
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALF---------------R 150
             L  + Y    D+WS+GC   EM   +P +   S  + +  +F                
Sbjct: 183 --LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS 240
Query: 151 IGRGKLP--------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           + RG  P        SV   +       +L+ L  NP+ R +A + ++H ++ +
Sbjct: 241 LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 75/200 (37%), Gaps = 23/200 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNG 61
             Q+ H NIV+ IG    +  +YI +ELV+ G        +   L    +         G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 62  LTYLHERNVVHREIKCANILV----------------DASGLATTTNDVKSFEGTPFWVA 105
           + YL  +  +HR++   N LV                +A G+   +  ++       W A
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVK--WTA 283
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLS 164
           PE +N     Y   +D+WS G  + E  +    PY +L + Q    + +G     P    
Sbjct: 284 PEALNYGR--YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP 341
Query: 165 RDARDFILKCLQVNPNDRPT 184
                 + +C    P  RP+
Sbjct: 342 DAVFRLMEQCWAYEPGQRPS 361

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 71/148 (47%), Gaps = 17/148 (11%)
Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT-PF- 102
           +I +G+ YL+ +  VHR++   N +V        G    T D+       K  +G  P  
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPN 161
           W+APE  +LK+  +  S+D+WS G  + E+ +  + PY  L + Q L  +  G     P+
Sbjct: 198 WMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLM 189
           +      D +  C Q NPN RPT  +++
Sbjct: 256 NCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 28/157 (17%)
Query: 7   FEHDNIVQYIGTEKDE----NR-------LYIFLELVKKGSLANLYQKYHLSDSQVSSYT 55
            +H+N+V  I   + +    NR       ++ F E    G L+N+  K+ LS  ++    
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS--EIKRVM 130
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPF----- 102
           + +LNGL Y+H   ++HR++K AN+L+           GLA   +  K+ +   +     
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 103 --WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
             W  P  + L    YG   D+W  GC + EM T  P
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 28/157 (17%)
Query: 7   FEHDNIVQYIGTEKDE----NR-------LYIFLELVKKGSLANLYQKYHLSDSQVSSYT 55
            +H+N+V  I   + +    NR       ++ F E    G L+N+  K+ LS  ++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS--EIKRVM 131
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPF----- 102
           + +LNGL Y+H   ++HR++K AN+L+           GLA   +  K+ +   +     
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 103 --WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
             W  P  + L    YG   D+W  GC + EM T  P
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 81/197 (41%), Gaps = 50/197 (25%)
Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS---------GLATTTNDVKS 96
           L+D  +  Y  +IL  L Y H   ++HR++K  N+++D           GLA   +  + 
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 187
Query: 97  FE---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED-MQALFRI- 151
           +     + ++  PE++ +    Y  S D+WSLGC +  M+  + P+ H  D    L RI 
Sbjct: 188 YNVRVASRYFKGPELL-VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 152 ---GRGKL------------PSVPNSLSRDAR--------------------DFILKCLQ 176
              G   L            P   + L R +R                    DF+ K L+
Sbjct: 247 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 306
Query: 177 VNPNDRPTAAQLMEHPF 193
            +   R TA + MEHP+
Sbjct: 307 YDHQSRLTAREAMEHPY 323

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/124 (34%), Positives = 66/124 (53%), Gaps = 23/124 (18%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 83  DAS--------GLATTTNDVKSFEGTP-----FWVAPEVVNLKNNGYGLSADIWSLGCTV 129
            +         GLA T     SF  TP     ++ APEV+     GY  + DIWS+GC +
Sbjct: 160 KSDCTLKILDFGLARTAG--TSFMMTPEVVTRYYRAPEVI--LGMGYKENVDIWSVGCIM 215
Query: 130 LEML 133
            EM+
Sbjct: 216 GEMI 219

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 9   HDNIVQYIGT-EKDENRLYIFLELVKKGSLA------------------NLYQKYHLSDS 49
           H N+V  +G   K    L +  E  K G+L+                  +LY+ + L+  
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLE 139
Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVD------------ASGLATTTNDVKSF 97
            +  Y+ Q+  G+ +L  R  +HR++   NIL+             A  +    + V+  
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 98  EGT-PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGR 153
           +   P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++ D +   R+  
Sbjct: 200 DARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 257
Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 258 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 86/196 (43%), Gaps = 40/196 (20%)
Query: 37  LANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA 88
           L  L +   L + ++     Q+L GL Y+H   ++HR++K  N+ V+          GLA
Sbjct: 116 LGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175
Query: 89  TTTN-DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS---HLED 144
              + ++     T ++ APEV+ L    Y  + DIWS+GC + EM+T +  +    HL+ 
Sbjct: 176 RQADSEMXGXVVTRWYRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234
Query: 145 MQALFRI----------------GRGKLPSVPNSLSRD-----------ARDFILKCLQV 177
           ++ + ++                 +  +  +P    +D           A + + K L +
Sbjct: 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 294
Query: 178 NPNDRPTAAQLMEHPF 193
           +   R TA + + HP+
Sbjct: 295 DAEQRVTAGEALAHPY 310

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 38/218 (17%)
Query: 9   HDNIVQYIGT-EKDENRLYIFLELVKKGSLA------------------NLYQKYHLSDS 49
           H N+V  +G   K    L +  E  K G+L+                  +LY+ + L+  
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLE 139
Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-----DV--------KS 96
            +  Y+ Q+  G+ +L  R  +HR++   NIL+    +    +     D+        K 
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 97  FEGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGR 153
               P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++ D +   R+  
Sbjct: 200 DARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 257
Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 258 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 38/218 (17%)
Query: 9   HDNIVQYIGT-EKDENRLYIFLELVKKGSLA------------------NLYQKYHLSDS 49
           H N+V  +G   K    L +  E  K G+L+                  +LY+ + L+  
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLE 139
Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-----DV--------KS 96
            +  Y+ Q+  G+ +L  R  +HR++   NIL+    +    +     D+        K 
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 97  FEGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGR 153
               P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++ D +   R+  
Sbjct: 200 DARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 257
Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 258 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 84/189 (44%), Gaps = 21/189 (11%)
Query: 26  YIFLELVKKGSLANL-YQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           YI +E V   +L ++ + +  ++  +           L + H+  ++HR++K ANI++ A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 85  S--------GLATTTND-------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
           +        G+A    D         +  GT  +++PE    + +     +D++SLGC +
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--QARGDSVDARSDVYSLGCVL 209
Query: 130 LEMLTHQPPYS-HLEDMQALFRIGRGKLPSVP--NSLSRDARDFILKCLQVNPNDRPTAA 186
            E+LT +PP++    D  A   +    +P       LS D    +LK L  NP +R   A
Sbjct: 210 YEVLTGEPPFTGDSPDSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 269
Query: 187 QLMEHPFVK 195
             M    V+
Sbjct: 270 AEMRADLVR 278

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 28/157 (17%)
Query: 7   FEHDNIVQYIGTEKDE----NR-------LYIFLELVKKGSLANLYQKYHLSDSQVSSYT 55
            +H+N+V  I   + +    NR       ++ F E    G L+N+  K+ LS  ++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS--EIKRVM 131
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPF----- 102
           + +LNGL Y+H   ++HR++K AN+L+           GLA   +  K+ +   +     
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 103 --WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
             W  P  + L    YG   D+W  GC + EM T  P
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 28/157 (17%)
Query: 7   FEHDNIVQYIGTEKDE----NR-------LYIFLELVKKGSLANLYQKYHLSDSQVSSYT 55
            +H+N+V  I   + +    NR       ++ F E    G L+N+  K+ LS  ++    
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLS--EIKRVM 131
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPF----- 102
           + +LNGL Y+H   ++HR++K AN+L+           GLA   +  K+ +   +     
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 103 --WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
             W  P  + L    YG   D+W  GC + EM T  P
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 78/215 (36%), Gaps = 30/215 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS--------YT 55
            S+F H NIV+ IG        +I LEL+  G L +  ++     SQ SS          
Sbjct: 79  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 138
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTP 101
           R I  G  YL E + +HR+I   N L+   G       +  F               G  
Sbjct: 139 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK-IGDFGMARDIYRASYYRKGGCA 197
Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+ PE        +    D WS G  + E+ +    PY    + + L  +  G  
Sbjct: 198 MLPVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 255
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P +        + +C Q  P DRP  A ++E 
Sbjct: 256 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 290

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 26/194 (13%)
Query: 25  LYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           L I +E +  G L +  Q       ++ + S   + I   + YLH  N+ HR++K  N+L
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 82  VDASGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY-- 139
                  T+       + T F  A E    K   Y  S D+WSLG  +  +L   PP+  
Sbjct: 150 Y------TSKRPNAILKLTDFGFAKETTGEK---YDKSCDMWSLGVIMYILLCGYPPFYS 200
Query: 140 ----SHLEDMQALFRIGRGKLPSVPNS-LSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
               +    M+   R+G+ + P+   S +S + +  I   L+  P  R T  + M HP++
Sbjct: 201 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260
Query: 195 -------KRPLQTS 201
                  + PL TS
Sbjct: 261 MQSTKVPQTPLHTS 274

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 78/215 (36%), Gaps = 30/215 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS--------YT 55
            S+F H NIV+ IG        +I LEL+  G L +  ++     SQ SS          
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTP 101
           R I  G  YL E + +HR+I   N L+   G       +  F               G  
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK-IGDFGMARDIYRASYYRKGGCA 205
Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+ PE        +    D WS G  + E+ +    PY    + + L  +  G  
Sbjct: 206 MLPVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P +        + +C Q  P DRP  A ++E 
Sbjct: 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 75/200 (37%), Gaps = 23/200 (11%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNG 61
             Q+ H NIV+ IG    +  +YI +ELV+ G        +   L    +         G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 62  LTYLHERNVVHREIKCANILV----------------DASGLATTTNDVKSFEGTPFWVA 105
           + YL  +  +HR++   N LV                +A G+   +  ++       W A
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK--WTA 283
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLS 164
           PE +N     Y   +D+WS G  + E  +    PY +L + Q    + +G     P    
Sbjct: 284 PEALNYGR--YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCP 341
Query: 165 RDARDFILKCLQVNPNDRPT 184
                 + +C    P  RP+
Sbjct: 342 DAVFRLMEQCWAYEPGQRPS 361

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 78/215 (36%), Gaps = 30/215 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS--------YT 55
            S+F H NIV+ IG        +I LEL+  G L +  ++     SQ SS          
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTP 101
           R I  G  YL E + +HR+I   N L+   G       +  F               G  
Sbjct: 148 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK-IGDFGMARDIYRASYYRKGGCA 206
Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+ PE        +    D WS G  + E+ +    PY    + + L  +  G  
Sbjct: 207 MLPVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 264
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P +        + +C Q  P DRP  A ++E 
Sbjct: 265 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 299

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 78/215 (36%), Gaps = 30/215 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS--------YT 55
            S+F H NIV+ IG        +I LEL+  G L +  ++     SQ SS          
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTP 101
           R I  G  YL E + +HR+I   N L+   G       +  F               G  
Sbjct: 148 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK-IGDFGMAQDIYRASYYRKGGCA 206
Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+ PE        +    D WS G  + E+ +    PY    + + L  +  G  
Sbjct: 207 MLPVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 264
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P +        + +C Q  P DRP  A ++E 
Sbjct: 265 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 299

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT-PF- 102
           +I +G+ YL+ +  VHR +   N +V        G    T D+       K  +G  P  
Sbjct: 138 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPN 161
           W+APE  +LK+  +  S+D+WS G  + E+ +  + PY  L + Q L  +  G     P+
Sbjct: 198 WMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLM 189
           +      D +  C Q NPN RPT  +++
Sbjct: 256 NCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 46/234 (19%)
Query: 7   FEHDNIVQYI---GTEKDENRLYIFLELVKKGSLANLY----QKYHLSDSQVSSYTRQIL 59
           FEH N+V+ +    T + +  + + L           Y        L    +    RQ L
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTN----DVKSFEG--TPFWV-----APEV 108
            GL +LH   +VHR++K  NILV + G     +     + S++   TP  V     APEV
Sbjct: 131 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEV 190
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALF---------------R 150
             L  + Y    D+WS+GC   EM   +P +   S  + +  +F                
Sbjct: 191 --LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS 248
Query: 151 IGRGKLP--------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           + RG  P        SV   +       +L+ L  NP+ R +A + ++H ++ +
Sbjct: 249 LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 67/150 (44%), Gaps = 21/150 (14%)
Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERN 69
            IV   G  ++   + IF+EL++ GSL  L ++   L + +   Y  Q L GL YLH R 
Sbjct: 125 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 184
Query: 70  VVHREIKCANILVDASGLATTTNDV------------KSF------EGTPFWVAPEVVNL 111
           ++H ++K  N+L+ + G      D             KS        GT   +APEVV  
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSH 141
           K        DIWS  C +L ML    P++ 
Sbjct: 245 KP--CDAKVDIWSSCCMMLHMLNGCHPWTQ 272

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 78/215 (36%), Gaps = 30/215 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS--------YT 55
            S+F H NIV+ IG        +I LEL+  G L +  ++     SQ SS          
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTP 101
           R I  G  YL E + +HR+I   N L+   G       +  F               G  
Sbjct: 162 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK-IGDFGMARDIYRASYYRKGGCA 220
Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+ PE        +    D WS G  + E+ +    PY    + + L  +  G  
Sbjct: 221 MLPVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 278
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P +        + +C Q  P DRP  A ++E 
Sbjct: 279 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 313

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT-PF- 102
           +I +G+ YL+ +  VHR +   N +V        G    T D+       K  +G  P  
Sbjct: 139 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPN 161
           W+APE  +LK+  +  S+D+WS G  + E+ +  + PY  L + Q L  +  G     P+
Sbjct: 199 WMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 256
Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLM 189
           +      D +  C Q NPN RPT  +++
Sbjct: 257 NCPERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 67/150 (44%), Gaps = 21/150 (14%)
Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERN 69
            IV   G  ++   + IF+EL++ GSL  L ++   L + +   Y  Q L GL YLH R 
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 70  VVHREIKCANILVDASGLATTTNDV------------KSF------EGTPFWVAPEVVNL 111
           ++H ++K  N+L+ + G      D             KS        GT   +APEVV  
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSH 141
           K        DIWS  C +L ML    P++ 
Sbjct: 231 KP--CDAKVDIWSSCCMMLHMLNGCHPWTQ 258

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 46/234 (19%)
Query: 7   FEHDNIVQYI---GTEKDENRLYIFL--ELVKKGSLANLYQKY--HLSDSQVSSYTRQIL 59
           FEH N+V+ +    T + +  + + L  E V +     L +     L    +    RQ L
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTN----DVKSFEG-------TPFWVAPEV 108
            GL +LH   +VHR++K  NILV + G     +     + S++        T ++ APEV
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEV 182
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALF---------------R 150
             L  + Y    D+WS+GC   EM   +P +   S  + +  +F                
Sbjct: 183 --LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS 240
Query: 151 IGRGKLP--------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           + RG  P        SV   +       +L+ L  NP+ R +A + ++H ++ +
Sbjct: 241 LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 78/215 (36%), Gaps = 30/215 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS--------YT 55
            S+F H NIV+ IG        +I LEL+  G L +  ++     SQ SS          
Sbjct: 94  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 153
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTP 101
           R I  G  YL E + +HR+I   N L+   G       +  F               G  
Sbjct: 154 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK-IGDFGMARDIYRASYYRKGGCA 212
Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+ PE        +    D WS G  + E+ +    PY    + + L  +  G  
Sbjct: 213 MLPVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 270
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P +        + +C Q  P DRP  A ++E 
Sbjct: 271 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 305

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 84/200 (42%), Gaps = 18/200 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLT 63
           +  H  +VQ  G   ++  + +  E ++ G L++    Q+   +   +      +  G+ 
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 117
Query: 64  YLHERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVN 110
           YL E +V+HR++   N LV  + +   +          +   S  GT F   W +PEV +
Sbjct: 118 YLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 177
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
                Y   +D+WS G  + E+ +  + PY +  + + +  I  G     P   S     
Sbjct: 178 FSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 235
Query: 170 FILKCLQVNPNDRPTAAQLM 189
            +  C +  P DRP  ++L+
Sbjct: 236 IMNHCWKERPEDRPAFSRLL 255

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 78/215 (36%), Gaps = 30/215 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS--------YT 55
            S+F H NIV+ IG        +I LEL+  G L +  ++     SQ SS          
Sbjct: 104 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 163
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTP 101
           R I  G  YL E + +HR+I   N L+   G       +  F               G  
Sbjct: 164 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK-IGDFGMARDIYRASYYRKGGCA 222
Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+ PE        +    D WS G  + E+ +    PY    + + L  +  G  
Sbjct: 223 MLPVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 280
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P +        + +C Q  P DRP  A ++E 
Sbjct: 281 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 315

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 46/234 (19%)
Query: 7   FEHDNIVQYI---GTEKDENRLYIFL--ELVKKGSLANLYQKY--HLSDSQVSSYTRQIL 59
           FEH N+V+ +    T + +  + + L  E V +     L +     L    +    RQ L
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTN----DVKSFEG-------TPFWVAPEV 108
            GL +LH   +VHR++K  NILV + G     +     + S++        T ++ APEV
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEV 182
Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALF---------------R 150
             L  + Y    D+WS+GC   EM   +P +   S  + +  +F                
Sbjct: 183 --LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS 240
Query: 151 IGRGKLP--------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           + RG  P        SV   +       +L+ L  NP+ R +A + ++H ++ +
Sbjct: 241 LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 294

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 67/150 (44%), Gaps = 21/150 (14%)
Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERN 69
            IV   G  ++   + IF+EL++ GSL  L ++   L + +   Y  Q L GL YLH R 
Sbjct: 127 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 186
Query: 70  VVHREIKCANILVDASGLATTTNDV------------KSF------EGTPFWVAPEVVNL 111
           ++H ++K  N+L+ + G      D             KS        GT   +APEVV  
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSH 141
           K        DIWS  C +L ML    P++ 
Sbjct: 247 KP--CDAKVDIWSSCCMMLHMLNGCHPWTQ 274

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 78/215 (36%), Gaps = 30/215 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS--------YT 55
            S+F H NIV+ IG        +I LEL+  G L +  ++     SQ SS          
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTP 101
           R I  G  YL E + +HR+I   N L+   G       +  F               G  
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK-IGDFGMARDIYRAGYYRKGGCA 246
Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+ PE        +    D WS G  + E+ +    PY    + + L  +  G  
Sbjct: 247 MLPVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P +        + +C Q  P DRP  A ++E 
Sbjct: 305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 78/215 (36%), Gaps = 30/215 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS--------YT 55
            S+F H NIV+ IG        +I LEL+  G L +  ++     SQ SS          
Sbjct: 105 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 164
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTP 101
           R I  G  YL E + +HR+I   N L+   G       +  F               G  
Sbjct: 165 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK-IGDFGMARDIYRAGYYRKGGCA 223
Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+ PE        +    D WS G  + E+ +    PY    + + L  +  G  
Sbjct: 224 MLPVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 281
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P +        + +C Q  P DRP  A ++E 
Sbjct: 282 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 316

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 78/215 (36%), Gaps = 30/215 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS--------YT 55
            S+F H NIV+ IG        +I LEL+  G L +  ++     SQ SS          
Sbjct: 114 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 173
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTP 101
           R I  G  YL E + +HR+I   N L+   G       +  F               G  
Sbjct: 174 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK-IGDFGMARDIYRASYYRKGGCA 232
Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+ PE        +    D WS G  + E+ +    PY    + + L  +  G  
Sbjct: 233 MLPVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 290
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P +        + +C Q  P DRP  A ++E 
Sbjct: 291 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 325

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYL 65
           Q   D I++    E  +  +Y+ +E       + L +K  +   +  SY + +L  +  +
Sbjct: 84  QQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 66  HERNVVHREIKCANIL-VDAS------GLAT-----TTNDVKSFE-GTPFWVAPEVV--- 109
           H+  +VH ++K AN L VD        G+A      TT+ VK  + GT  ++ PE +   
Sbjct: 144 HQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 110 -NLKNNG-----YGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRIGRG-KLPS 158
            + + NG         +D+WSLGC +  M   + P+    + +  + A+       + P 
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263
Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +P    +D +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 264 IP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYL 65
           Q   D I++    E  +  +Y+ +E       + L +K  +   +  SY + +L  +  +
Sbjct: 68  QQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 127
Query: 66  HERNVVHREIKCANIL-VDAS------GLAT-----TTNDVKSFE-GTPFWVAPEVV--- 109
           H+  +VH ++K AN L VD        G+A      TT+ VK  + GT  ++ PE +   
Sbjct: 128 HQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 187
Query: 110 -NLKNNG-----YGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRIGRG-KLPS 158
            + + NG         +D+WSLGC +  M   + P+    + +  + A+       + P 
Sbjct: 188 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 247
Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +P    +D +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 248 IP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYL 65
           Q   D I++    E  +  +Y+ +E       + L +K  +   +  SY + +L  +  +
Sbjct: 64  QQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 123
Query: 66  HERNVVHREIKCANIL-VDAS------GLAT-----TTNDVKSFE-GTPFWVAPEVV--- 109
           H+  +VH ++K AN L VD        G+A      TT+ VK  + GT  ++ PE +   
Sbjct: 124 HQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 183
Query: 110 -NLKNNG-----YGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRIGRG-KLPS 158
            + + NG         +D+WSLGC +  M   + P+    + +  + A+       + P 
Sbjct: 184 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 243
Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +P    +D +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 244 IP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYL 65
           Q   D I++    E  +  +Y+ +E       + L +K  +   +  SY + +L  +  +
Sbjct: 65  QQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 66  HERNVVHREIKCANIL-VDAS------GLAT-----TTNDVKSFE-GTPFWVAPEVV--- 109
           H+  +VH ++K AN L VD        G+A      TT+ VK  + GT  ++ PE +   
Sbjct: 125 HQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 110 -NLKNNG-----YGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRIGRG-KLPS 158
            + + NG         +D+WSLGC +  M   + P+    + +  + A+       + P 
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +P    +D +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 245 IP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYL 65
           Q   D I++    E  +  +Y+ +E       + L +K  +   +  SY + +L  +  +
Sbjct: 112 QQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 66  HERNVVHREIKCANIL-VDAS------GLAT-----TTNDVKSFE-GTPFWVAPEVV--- 109
           H+  +VH ++K AN L VD        G+A      TT+ VK  + GT  ++ PE +   
Sbjct: 172 HQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 231
Query: 110 -NLKNNG-----YGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRIGRG-KLPS 158
            + + NG         +D+WSLGC +  M   + P+    + +  + A+       + P 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +P    +D +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 292 IP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 78/215 (36%), Gaps = 30/215 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS--------YT 55
            S+F H NIV+ IG        +I +EL+  G L +  ++     SQ SS          
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTP 101
           R I  G  YL E + +HR+I   N L+   G       +  F               G  
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK-IGDFGMARDIYRASYYRKGGCA 205
Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+ PE        +    D WS G  + E+ +    PY    + + L  +  G  
Sbjct: 206 MLPVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P +        + +C Q  P DRP  A ++E 
Sbjct: 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 93/210 (44%), Gaps = 31/210 (14%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----------------LSDSQV 51
           H NI+  +G  +    LY+ +E    G+L +  +K                   LS  Q+
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 52  SSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-------DV---KSFEGTP 101
             +   +  G+ YL ++  +HR++   NILV  + +A   +       +V   K+    P
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 194
Query: 102 F-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSV 159
             W+A E +N   + Y  ++D+WS G  + E+++    PY  +   +   ++ +G     
Sbjct: 195 VRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 252
Query: 160 PNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           P +   +  D + +C +  P +RP+ AQ++
Sbjct: 253 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 93/210 (44%), Gaps = 31/210 (14%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----------------LSDSQV 51
           H NI+  +G  +    LY+ +E    G+L +  +K                   LS  Q+
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 52  SSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-------DV---KSFEGTP 101
             +   +  G+ YL ++  +HR++   NILV  + +A   +       +V   K+    P
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 102 F-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSV 159
             W+A E +N   + Y  ++D+WS G  + E+++    PY  +   +   ++ +G     
Sbjct: 205 VRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 262
Query: 160 PNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           P +   +  D + +C +  P +RP+ AQ++
Sbjct: 263 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 78/215 (36%), Gaps = 30/215 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS--------YT 55
            S+F H NIV+ IG        +I +EL+  G L +  ++     SQ SS          
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTP 101
           R I  G  YL E + +HR+I   N L+   G       +  F               G  
Sbjct: 162 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK-IGDFGMARDIYRASYYRKGGCA 220
Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+ PE        +    D WS G  + E+ +    PY    + + L  +  G  
Sbjct: 221 MLPVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 278
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P +        + +C Q  P DRP  A ++E 
Sbjct: 279 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 313

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYL 65
           Q   D I++    E  +  +Y+ +E       + L +K  +   +  SY + +L  +  +
Sbjct: 112 QQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 66  HERNVVHREIKCANIL-VDAS------GLAT-----TTNDVKSFE-GTPFWVAPEVV--- 109
           H+  +VH ++K AN L VD        G+A      TT+ VK  + GT  ++ PE +   
Sbjct: 172 HQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 231
Query: 110 -NLKNNG-----YGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRIGRG-KLPS 158
            + + NG         +D+WSLGC +  M   + P+    + +  + A+       + P 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +P    +D +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 292 IP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 34/214 (15%)
Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYT--RQILNGLTY 64
            E  N V+ +   K ++ L+I +E  +  +L +L    +L+  +   +   RQIL  L+Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 65  LHERNVVHREIKCANILVDAS--------GLAT------------------TTNDVKSFE 98
           +H + ++HR++K  NI +D S        GLA                   +++++ S  
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 99  GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL-- 156
           GT  +VA EV++     Y    D++SLG    EM+   P  + +E +  L ++    +  
Sbjct: 192 GTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVSIEF 248
Query: 157 -PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
            P   ++  +  +  I   +  +PN RP A  L+
Sbjct: 249 PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/197 (21%), Positives = 81/197 (41%), Gaps = 18/197 (9%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLH 66
           H+ +VQ  G    +  ++I  E +  G L N  +  ++     Q+    + +   + YL 
Sbjct: 63  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 122
Query: 67  ERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVNLKN 113
            +  +HR++   N LV+  G+   +          ++  S  G+ F   W  PEV  L  
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEV--LMY 180
Query: 114 NGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL 172
           + +   +DIW+ G  + E+ +  + PY    + +    I +G     P+  S      + 
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 240
Query: 173 KCLQVNPNDRPTAAQLM 189
            C     ++RPT   L+
Sbjct: 241 SCWHEKADERPTFKILL 257

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 83/200 (41%), Gaps = 18/200 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLT 63
           +  H  +VQ  G   ++  + +  E ++ G L++    Q+   +   +      +  G+ 
Sbjct: 78  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 137
Query: 64  YLHERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVN 110
           YL E  V+HR++   N LV  + +   +          +   S  GT F   W +PEV +
Sbjct: 138 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 197
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
                Y   +D+WS G  + E+ +  + PY +  + + +  I  G     P   S     
Sbjct: 198 FSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 255
Query: 170 FILKCLQVNPNDRPTAAQLM 189
            +  C +  P DRP  ++L+
Sbjct: 256 IMNHCWKERPEDRPAFSRLL 275

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 19/169 (11%)
Query: 39  NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-----D 93
           +LY+ + L+   +  Y+ Q+  G+ +L  R  +HR++   NIL+    +    +     D
Sbjct: 182 DLYKDF-LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 240
Query: 94  V--------KSFEGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE 143
           +        K     P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++
Sbjct: 241 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 298
Query: 144 -DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
            D +   R+  G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 299 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 347

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 19/169 (11%)
Query: 39  NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-----D 93
           +LY+ + L+   +  Y+ Q+  G+ +L  R  +HR++   NIL+    +    +     D
Sbjct: 184 DLYKDF-LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 94  V--------KSFEGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE 143
           +        K     P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 144 -DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
            D +   R+  G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 83/200 (41%), Gaps = 18/200 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLT 63
           +  H  +VQ  G   ++  + +  E ++ G L++    Q+   +   +      +  G+ 
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 64  YLHERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVN 110
           YL E  V+HR++   N LV  + +   +          +   S  GT F   W +PEV +
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
                Y   +D+WS G  + E+ +  + PY +  + + +  I  G     P   S     
Sbjct: 176 FSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 233
Query: 170 FILKCLQVNPNDRPTAAQLM 189
            +  C +  P DRP  ++L+
Sbjct: 234 IMNHCWKERPEDRPAFSRLL 253

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 19/169 (11%)
Query: 39  NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-----D 93
           +LY+ + L+   +  Y+ Q+  G+ +L  R  +HR++   NIL+    +    +     D
Sbjct: 189 DLYKDF-LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 247
Query: 94  V--------KSFEGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE 143
           +        K     P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++
Sbjct: 248 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 305
Query: 144 -DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
            D +   R+  G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 306 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 354

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 83/200 (41%), Gaps = 18/200 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLT 63
           +  H  +VQ  G   ++  + +  E ++ G L++    Q+   +   +      +  G+ 
Sbjct: 61  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 120
Query: 64  YLHERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVN 110
           YL E  V+HR++   N LV  + +   +          +   S  GT F   W +PEV +
Sbjct: 121 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 180
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
                Y   +D+WS G  + E+ +  + PY +  + + +  I  G     P   S     
Sbjct: 181 FSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 238
Query: 170 FILKCLQVNPNDRPTAAQLM 189
            +  C +  P DRP  ++L+
Sbjct: 239 IMNHCWRERPEDRPAFSRLL 258

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 83/200 (41%), Gaps = 18/200 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLT 63
           +  H  +VQ  G   ++  + +  E ++ G L++    Q+   +   +      +  G+ 
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 117
Query: 64  YLHERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVN 110
           YL E  V+HR++   N LV  + +   +          +   S  GT F   W +PEV +
Sbjct: 118 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 177
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
                Y   +D+WS G  + E+ +  + PY +  + + +  I  G     P   S     
Sbjct: 178 FSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 235
Query: 170 FILKCLQVNPNDRPTAAQLM 189
            +  C +  P DRP  ++L+
Sbjct: 236 IMNHCWKERPEDRPAFSRLL 255

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 19/169 (11%)
Query: 39  NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-----D 93
           +LY+ + L+   +  Y+ Q+  G+ +L  R  +HR++   NIL+    +    +     D
Sbjct: 191 DLYKDF-LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 249
Query: 94  V--------KSFEGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE 143
           +        K     P  W+APE +   +  Y + +D+WS G  + E+ +    PY  ++
Sbjct: 250 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 307
Query: 144 -DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
            D +   R+  G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 308 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 356

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 98/216 (45%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKY----HLSDSQVSSYTRQILNGL 62
           +H ++V+Y     +++ + I  E    GSLA+ + + Y    +  ++++     Q+  GL
Sbjct: 65  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 124
Query: 63  TYLHERNVVHREIKCANILVDAS---------------------------GLATTTNDVK 95
            Y+H  ++VH +IK +NI +  +                           G  T  +  +
Sbjct: 125 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 184
Query: 96  SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK 155
             EG   ++A EV+  +N  +   ADI++L  TV+     +P   + +       I +G+
Sbjct: 185 VEEGDSRFLANEVLQ-ENYTHLPKADIFALALTVVXAAGAEPLPRNGDQWH---EIRQGR 240
Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           LP +P  LS++  + +   +  +P  RP+A  L++H
Sbjct: 241 LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 276

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT-PF- 102
           +I +G+ YL+ +  VHR++   N +V        G    T D+       K  +G  P  
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR 197
Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPN 161
           W+APE  +LK+  +  S+D+WS G  + E+ +  + PY  L + Q L  +  G     P+
Sbjct: 198 WMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLM 189
           +      D +  C Q NP  RPT  +++
Sbjct: 256 NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT-PF- 102
           +I +G+ YL+ +  VHR++   N +V        G    T D+       K  +G  P  
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPN 161
           W+APE  +LK+  +  S+D+WS G  + E+ +  + PY  L + Q L  +  G     P+
Sbjct: 198 WMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLM 189
           +      D +  C Q NP  RPT  +++
Sbjct: 256 NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT-PF- 102
           +I +G+ YL+ +  VHR++   N +V        G    T D+       K  +G  P  
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPN 161
           W+APE  +LK+  +  S+D+WS G  + E+ +  + PY  L + Q L  +  G     P+
Sbjct: 197 WMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 254
Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLM 189
           +      D +  C Q NP  RPT  +++
Sbjct: 255 NCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT-PF- 102
           +I +G+ YL+ +  VHR++   N +V        G    T D+       K  +G  P  
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPN 161
           W+APE  +LK+  +  S+D+WS G  + E+ +  + PY  L + Q L  +  G     P+
Sbjct: 198 WMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLM 189
           +      D +  C Q NP  RPT  +++
Sbjct: 256 NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/197 (21%), Positives = 81/197 (41%), Gaps = 18/197 (9%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLH 66
           H+ +VQ  G    +  ++I  E +  G L N  +  ++     Q+    + +   + YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 67  ERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVNLKN 113
            +  +HR++   N LV+  G+   +          ++  S  G+ F   W  PEV  L  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV--LMY 175
Query: 114 NGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL 172
           + +   +DIW+ G  + E+ +  + PY    + +    I +G     P+  S      + 
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235
Query: 173 KCLQVNPNDRPTAAQLM 189
            C     ++RPT   L+
Sbjct: 236 SCWHEKADERPTFKILL 252

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/197 (21%), Positives = 81/197 (41%), Gaps = 18/197 (9%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLH 66
           H+ +VQ  G    +  ++I  E +  G L N  +  ++     Q+    + +   + YL 
Sbjct: 62  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 121
Query: 67  ERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVNLKN 113
            +  +HR++   N LV+  G+   +          ++  S  G+ F   W  PEV  L  
Sbjct: 122 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV--LMY 179
Query: 114 NGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL 172
           + +   +DIW+ G  + E+ +  + PY    + +    I +G     P+  S      + 
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 239
Query: 173 KCLQVNPNDRPTAAQLM 189
            C     ++RPT   L+
Sbjct: 240 SCWHEKADERPTFKILL 256

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT-PF- 102
           +I +G+ YL+ +  VHR++   N +V        G    T D+       K  +G  P  
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPN 161
           W+APE  +LK+  +  S+D+WS G  + E+ +  + PY  L + Q L  +  G     P+
Sbjct: 195 WMAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 252
Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLM 189
           +      D +  C Q NP  RPT  +++
Sbjct: 253 NCPERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----------------LSDSQV 51
           H NI+  +G  +    LY+ +E    G+L +  +K                   LS  Q+
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 52  SSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTN-------DV---KSFEGTP 101
             +   +  G+ YL ++  +HR +   NILV  + +A   +       +V   K+    P
Sbjct: 142 LHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 201
Query: 102 F-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSV 159
             W+A E +N   + Y  ++D+WS G  + E+++    PY  +   +   ++ +G     
Sbjct: 202 VRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 259
Query: 160 PNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           P +   +  D + +C +  P +RP+ AQ++
Sbjct: 260 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/197 (21%), Positives = 81/197 (41%), Gaps = 18/197 (9%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLH 66
           H+ +VQ  G    +  ++I  E +  G L N  +  ++     Q+    + +   + YL 
Sbjct: 63  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 122
Query: 67  ERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVNLKN 113
            +  +HR++   N LV+  G+   +          ++  S  G+ F   W  PEV  L  
Sbjct: 123 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV--LMY 180
Query: 114 NGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL 172
           + +   +DIW+ G  + E+ +  + PY    + +    I +G     P+  S      + 
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 240
Query: 173 KCLQVNPNDRPTAAQLM 189
            C     ++RPT   L+
Sbjct: 241 SCWHEKADERPTFKILL 257

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/124 (36%), Positives = 67/124 (54%), Gaps = 23/124 (18%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 104 VYIVMELMD----ANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVV 159
Query: 83  --DAS------GLATTTNDVKSFEGTPFWV-----APEVVNLKNNGYGLSADIWSLGCTV 129
             DA+      GLA T     SF  TP+ V     APEV+     GY  + DIWS+G  +
Sbjct: 160 KSDATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGVIM 215
Query: 130 LEML 133
            EM+
Sbjct: 216 GEMI 219

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/197 (21%), Positives = 81/197 (41%), Gaps = 18/197 (9%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLH 66
           H+ +VQ  G    +  ++I  E +  G L N  +  ++     Q+    + +   + YL 
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 67  ERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVNLKN 113
            +  +HR++   N LV+  G+   +          ++  S  G+ F   W  PEV  L  
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV--LMY 195
Query: 114 NGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL 172
           + +   +DIW+ G  + E+ +  + PY    + +    I +G     P+  S      + 
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 255
Query: 173 KCLQVNPNDRPTAAQLM 189
            C     ++RPT   L+
Sbjct: 256 SCWHEKADERPTFKILL 272

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/197 (21%), Positives = 81/197 (41%), Gaps = 18/197 (9%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLH 66
           H+ +VQ  G    +  ++I  E +  G L N  +  ++     Q+    + +   + YL 
Sbjct: 69  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 128
Query: 67  ERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVNLKN 113
            +  +HR++   N LV+  G+   +          ++  S  G+ F   W  PEV  L  
Sbjct: 129 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV--LMY 186
Query: 114 NGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL 172
           + +   +DIW+ G  + E+ +  + PY    + +    I +G     P+  S      + 
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 246
Query: 173 KCLQVNPNDRPTAAQLM 189
            C     ++RPT   L+
Sbjct: 247 SCWHEKADERPTFKILL 263

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 83/200 (41%), Gaps = 18/200 (9%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLT 63
           +  H  +VQ  G   ++  + +  E ++ G L++    Q+   +   +      +  G+ 
Sbjct: 59  KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 118
Query: 64  YLHERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVN 110
           YL E  V+HR++   N LV  + +   +          +   S  GT F   W +PEV +
Sbjct: 119 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 178
Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
                Y   +D+WS G  + E+ +  + PY +  + + +  I  G     P   S     
Sbjct: 179 FSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 236
Query: 170 FILKCLQVNPNDRPTAAQLM 189
            +  C +  P DRP  ++L+
Sbjct: 237 IMNHCWRERPEDRPAFSRLL 256

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/124 (36%), Positives = 67/124 (54%), Gaps = 23/124 (18%)
Query: 25  LYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV 82
           +YI +EL+     ANL Q  +  L   ++S    Q+L G+ +LH   ++HR++K +NI+V
Sbjct: 104 VYIVMELMD----ANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVV 159
Query: 83  --DAS------GLATTTNDVKSFEGTPFWV-----APEVVNLKNNGYGLSADIWSLGCTV 129
             DA+      GLA T     SF  TP+ V     APEV+     GY  + DIWS+G  +
Sbjct: 160 KSDATLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGVIM 215
Query: 130 LEML 133
            EM+
Sbjct: 216 GEMI 219

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 97/237 (40%), Gaps = 47/237 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH------------------ 45
             Q  H ++++  G    +  L + +E  K GSL    ++                    
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 46  -------LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTND----- 93
                  L+   + S+  QI  G+ YL E ++VHR++   NILV A G     +D     
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILV-AEGRKMKISDFGLSR 198
Query: 94  --------VKSFEG-TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHL 142
                   VK  +G  P  W+A E  +L ++ Y   +D+WS G  + E++T    PY  +
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 143 EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL---MEHPFVKR 196
              +    +  G     P++ S +    +L+C +  P+ RP  A +   +E   VKR
Sbjct: 257 PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/197 (21%), Positives = 81/197 (41%), Gaps = 18/197 (9%)
Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYLH 66
           H+ +VQ  G    +  ++I  E +  G L N  +  ++     Q+    + +   + YL 
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 67  ERNVVHREIKCANILVDASGLATTT----------NDVKSFEGTPF---WVAPEVVNLKN 113
            +  +HR++   N LV+  G+   +          ++  S  G+ F   W  PEV  L  
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEV--LMY 195
Query: 114 NGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL 172
           + +   +DIW+ G  + E+ +  + PY    + +    I +G     P+  S      + 
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 255
Query: 173 KCLQVNPNDRPTAAQLM 189
            C     ++RPT   L+
Sbjct: 256 SCWHEKADERPTFKILL 272

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 60/240 (25%)
Query: 11  NIVQYIGTEKDENRLY--IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER 68
           NIV+ +   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 144
Query: 69  NVVHREIKCANILVDAS---------GLATTTNDVKSFE---GTPFWVAPE-VVNLKNNG 115
            ++HR++K  N+++D           GLA   +  K +     + ++  PE +V+L++  
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-- 202
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLED------------------------------- 144
           Y  S D+WSLGC    M+  + P+ +  D                               
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 145 MQALFRIGRG------KLPSVPNS--LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           ++AL  +GR       K  +  N   +S +A DF+ K L+ +  +R TA + M HP+ ++
Sbjct: 263 LEAL--VGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 77/215 (35%), Gaps = 30/215 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS--------YT 55
            S+  H NIV+ IG        +I LEL+  G L +  ++     SQ SS          
Sbjct: 102 ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTP 101
           R I  G  YL E + +HR+I   N L+   G       +  F               G  
Sbjct: 162 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK-IGDFGMARDIYRASYYRKGGCA 220
Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+ PE        +    D WS G  + E+ +    PY    + + L  +  G  
Sbjct: 221 MLPVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 278
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P +        + +C Q  P DRP  A ++E 
Sbjct: 279 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 313

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 77/215 (35%), Gaps = 30/215 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS--------YT 55
            S+  H NIV+ IG        +I LEL+  G L +  ++     SQ SS          
Sbjct: 88  ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSF--------------EGTP 101
           R I  G  YL E + +HR+I   N L+   G       +  F               G  
Sbjct: 148 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK-IGDFGMARDIYRASYYRKGGCA 206
Query: 102 F----WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKL 156
                W+ PE        +    D WS G  + E+ +    PY    + + L  +  G  
Sbjct: 207 MLPVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 264
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P +        + +C Q  P DRP  A ++E 
Sbjct: 265 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 299

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 60/240 (25%)
Query: 11  NIVQYIGTEKDENRLY--IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER 68
           NIV+ +   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 144
Query: 69  NVVHREIKCANILVDAS---------GLATTTNDVKSFE---GTPFWVAPE-VVNLKNNG 115
            ++HR++K  N+++D           GLA   +  K +     + ++  PE +V+L++  
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-- 202
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLED------------------------------- 144
           Y  S D+WSLGC    M+  + P+ +  D                               
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 145 MQALFRIGRG------KLPSVPNS--LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           ++AL  +GR       K  +  N   +S +A DF+ K L+ +  +R TA + M HP+ ++
Sbjct: 263 LEAL--VGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 60/240 (25%)
Query: 11  NIVQYIGTEKDENRLY--IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER 68
           NIV+ +   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 144
Query: 69  NVVHREIKCANILVDAS---------GLATTTNDVKSFE---GTPFWVAPE-VVNLKNNG 115
            ++HR++K  N+++D           GLA   +  K +     + ++  PE +V+L++  
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-- 202
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLED------------------------------- 144
           Y  S D+WSLGC    M+  + P+ +  D                               
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 145 MQALFRIGRG------KLPSVPNS--LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           ++AL  +GR       K  +  N   +S +A DF+ K L+ +  +R TA + M HP+ ++
Sbjct: 263 LEAL--VGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYL 65
           Q   D I++    E  +  +Y+ +E       + L +K  +   +  SY + +L  +  +
Sbjct: 112 QQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 66  HERNVVHREIKCANIL-VDAS------GLAT-----TTNDVKSFE-GTPFWVAPEVV--- 109
           H+  +VH ++K AN L VD        G+A      TT+ VK  + G   ++ PE +   
Sbjct: 172 HQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 110 -NLKNNG-----YGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRIGRG-KLPS 158
            + + NG         +D+WSLGC +  M   + P+    + +  + A+       + P 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +P    +D +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 292 IP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 60/240 (25%)
Query: 11  NIVQYIGTEKDENRLY--IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER 68
           NIV+ +   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 145
Query: 69  NVVHREIKCANILVDAS---------GLATTTNDVKSFE---GTPFWVAPE-VVNLKNNG 115
            ++HR++K  N+++D           GLA   +  K +     + ++  PE +V+L++  
Sbjct: 146 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-- 203
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLED------------------------------- 144
           Y  S D+WSLGC    M+  + P+ +  D                               
Sbjct: 204 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 263
Query: 145 MQALFRIGRG------KLPSVPNS--LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           ++AL  +GR       K  +  N   +S +A DF+ K L+ +  +R TA + M HP+ ++
Sbjct: 264 LEAL--VGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 60/240 (25%)
Query: 11  NIVQYIGTEKDENRLY--IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER 68
           NIV+ +   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 146
Query: 69  NVVHREIKCANILVDAS---------GLATTTNDVKSFE---GTPFWVAPE-VVNLKNNG 115
            ++HR++K  N+++D           GLA   +  K +     + ++  PE +V+L++  
Sbjct: 147 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-- 204
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLED------------------------------- 144
           Y  S D+WSLGC    M+  + P+ +  D                               
Sbjct: 205 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 264
Query: 145 MQALFRIGRG------KLPSVPNS--LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           ++AL  +GR       K  +  N   +S +A DF+ K L+ +  +R TA + M HP+ ++
Sbjct: 265 LEAL--VGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 322

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 60/240 (25%)
Query: 11  NIVQYIGTEKDENRLY--IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER 68
           NIV+ +   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 145
Query: 69  NVVHREIKCANILVDAS---------GLATTTNDVKSFE---GTPFWVAPE-VVNLKNNG 115
            ++HR++K  N+++D           GLA   +  K +     + ++  PE +V+L++  
Sbjct: 146 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-- 203
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLED------------------------------- 144
           Y  S D+WSLGC    M+  + P+ +  D                               
Sbjct: 204 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 263
Query: 145 MQALFRIGRG------KLPSVPNS--LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           ++AL  +GR       K  +  N   +S +A DF+ K L+ +  +R TA + M HP+ ++
Sbjct: 264 LEAL--VGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 321

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 60/240 (25%)
Query: 11  NIVQYIGTEKDENRLY--IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER 68
           NIV+ +   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 144
Query: 69  NVVHREIKCANILVDAS---------GLATTTNDVKSFE---GTPFWVAPE-VVNLKNNG 115
            ++HR++K  N+++D           GLA   +  K +     + ++  PE +V+L++  
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-- 202
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLED------------------------------- 144
           Y  S D+WSLGC    M+  + P+ +  D                               
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 145 MQALFRIGRG------KLPSVPNS--LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           ++AL  +GR       K  +  N   +S +A DF+ K L+ +  +R TA + M HP+ ++
Sbjct: 263 LEAL--VGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 60/240 (25%)
Query: 11  NIVQYIGTEKDENRLY--IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER 68
           NIV+ +   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 144
Query: 69  NVVHREIKCANILVDAS---------GLATTTNDVKSFE---GTPFWVAPE-VVNLKNNG 115
            ++HR++K  N+++D           GLA   +  K +     + ++  PE +V+L++  
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-- 202
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLED------------------------------- 144
           Y  S D+WSLGC    M+  + P+ +  D                               
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 145 MQALFRIGRG------KLPSVPNS--LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           ++AL  +GR       K  +  N   +S +A DF+ K L+ +  +R TA + M HP+ ++
Sbjct: 263 LEAL--VGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 60/240 (25%)
Query: 11  NIVQYIGTEKDENRLY--IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER 68
           NIV+ +   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 144
Query: 69  NVVHREIKCANILVDAS---------GLATTTNDVKSFE---GTPFWVAPE-VVNLKNNG 115
            ++HR++K  N+++D           GLA   +  K +     + ++  PE +V+L++  
Sbjct: 145 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-- 202
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLED------------------------------- 144
           Y  S D+WSLGC    M+  + P+ +  D                               
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 145 MQALFRIGRG------KLPSVPNS--LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           ++AL  +GR       K  +  N   +S +A DF+ K L+ +  +R TA + M HP+ ++
Sbjct: 263 LEAL--VGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 320

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 60/240 (25%)
Query: 11  NIVQYIGTEKDENRLY--IFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER 68
           NIV+ +   +D++     +  E V       LY    L+D  +  Y  ++L  L Y H +
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ 165
Query: 69  NVVHREIKCANILVDAS---------GLATTTNDVKSFE---GTPFWVAPE-VVNLKNNG 115
            ++HR++K  N+++D           GLA   +  K +     + ++  PE +V+L++  
Sbjct: 166 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-- 223
Query: 116 YGLSADIWSLGCTVLEMLTHQPPYSHLED------------------------------- 144
           Y  S D+WSLGC    M+  + P+ +  D                               
Sbjct: 224 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDPQ 283
Query: 145 MQALFRIGRG------KLPSVPNS--LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           ++AL  +GR       K  +  N   +S +A DF+ K L+ +  +R TA + M HP+ ++
Sbjct: 284 LEAL--VGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQ 341

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 47/237 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH------------------ 45
             Q  H ++++  G    +  L + +E  K GSL    ++                    
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 46  -------LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTND----- 93
                  L+   + S+  QI  G+ YL E  +VHR++   NILV A G     +D     
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV-AEGRKMKISDFGLSR 198
Query: 94  --------VKSFEG-TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHL 142
                   VK  +G  P  W+A E  +L ++ Y   +D+WS G  + E++T    PY  +
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 143 EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL---MEHPFVKR 196
              +    +  G     P++ S +    +L+C +  P+ RP  A +   +E   VKR
Sbjct: 257 PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQIL 59
            +    +H +IV+ +G     + L +  + +  GSL +  +++   L    + ++  QI 
Sbjct: 67  LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTN---------DVK----SFEGTPF-WVA 105
            G+ YL E  +VHR +   N+L+ +       +         D K    S   TP  W+A
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLS 164
            E ++     Y   +D+WS G TV E++T    PY+ L   +    + +G+  + P   +
Sbjct: 186 LESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICT 243
Query: 165 RDARDFILKCLQVNPNDRPTAAQL 188
            D    ++KC  ++ N RPT  +L
Sbjct: 244 IDVYMVMVKCWMIDENIRPTFKEL 267

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 98/216 (45%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKY----HLSDSQVSSYTRQILNGL 62
           +H ++V+Y     +++ + I  E    GSLA+ + + Y    +  ++++     Q+  GL
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 63  TYLHERNVVHREIKCANILVDAS---------------------------GLATTTNDVK 95
            Y+H  ++VH +IK +NI +  +                           G  T  +  +
Sbjct: 127 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 186
Query: 96  SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK 155
             EG   ++A EV+  +N  +   ADI++L  TV+     +P   + +       I +G+
Sbjct: 187 VEEGDSRFLANEVLQ-ENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIRQGR 242
Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           LP +P  LS++  + +   +  +P  RP+A  L++H
Sbjct: 243 LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 278

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 98/216 (45%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKY----HLSDSQVSSYTRQILNGL 62
           +H ++V+Y     +++ + I  E    GSLA+ + + Y    +  ++++     Q+  GL
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 63  TYLHERNVVHREIKCANILVDAS---------------------------GLATTTNDVK 95
            Y+H  ++VH +IK +NI +  +                           G  T  +  +
Sbjct: 127 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 186
Query: 96  SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK 155
             EG   ++A EV+  +N  +   ADI++L  TV+     +P   + +       I +G+
Sbjct: 187 VEEGDSRFLANEVLQ-ENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIRQGR 242
Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           LP +P  LS++  + +   +  +P  RP+A  L++H
Sbjct: 243 LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 278

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 47/237 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH------------------ 45
             Q  H ++++  G    +  L + +E  K GSL    ++                    
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 46  -------LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTND----- 93
                  L+   + S+  QI  G+ YL E  +VHR++   NILV A G     +D     
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV-AEGRKMKISDFGLSR 198
Query: 94  --------VKSFEG-TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHL 142
                   VK  +G  P  W+A E  +L ++ Y   +D+WS G  + E++T    PY  +
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 143 EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL---MEHPFVKR 196
              +    +  G     P++ S +    +L+C +  P+ RP  A +   +E   VKR
Sbjct: 257 PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 92/220 (41%), Gaps = 43/220 (19%)
Query: 9   HDNIVQY-----IGTEKDENRLYIFLELVK--KGSLANLYQKYH----LSDSQVSSYTRQ 57
           H NIVQ+     IG E+ +     FL L +  KG L    +K      LS   V     Q
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 58  ILNGLTYLHERN--VVHREIKCANILVDASGL--------ATTTNDVKSFE--------- 98
               + ++H +   ++HR++K  N+L+   G         ATT +    +          
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 99  -------GTPFWVAPEVVNLKNN-GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR 150
                   TP +  PE+++L +N   G   DIW+LGC +  +   Q P+   ED  A  R
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF---ED-GAKLR 260
Query: 151 IGRGKLPSVPNSLSRDA-RDFILKCLQVNPNDRPTAAQLM 189
           I  GK    P+          I   LQVNP +R + A+++
Sbjct: 261 IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 35/213 (16%)
Query: 6   QFEHDNIVQ--YIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQ-------VSSYT 55
           + +H NIV+  Y      E +  ++L LV     A +Y+   H S ++       V  Y 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSL 163
            APE++      Y  S D+WS GC + E+L  QP +     +  L  I +         L
Sbjct: 189 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK--------VL 239
Query: 164 SRDARDFILKCLQVNPNDRPTA-AQLMEHPFVK 195
               R+ I    ++NPN    A  Q+  HP+ K
Sbjct: 240 GTPTREQI---REMNPNYTEFAFPQIKAHPWTK 269

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 98/216 (45%), Gaps = 36/216 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKY----HLSDSQVSSYTRQILNGL 62
           +H ++V+Y     +++ + I  E    GSLA+ + + Y    +  ++++     Q+  GL
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 63  TYLHERNVVHREIKCANILVDAS---------------------------GLATTTNDVK 95
            Y+H  ++VH +IK +NI +  +                           G  T  +  +
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 96  SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK 155
             EG   ++A EV+  +N  +   ADI++L  TV+     +P   + +       I +G+
Sbjct: 189 VEEGDSRFLANEVLQ-ENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIRQGR 244
Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           LP +P  LS++  + +   +  +P  RP+A  L++H
Sbjct: 245 LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL-----------SDSQVS 52
             +F   ++V+ +G         + +EL+ +G L +  +               S S++ 
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT 100
               +I +G+ YL+    VHR++   N +V        G    T D+       K  +G 
Sbjct: 127 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGL 186
Query: 101 -PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLP 157
            P  W++PE  +LK+  +   +D+WS G  + E+ T  + PY  L + Q L  +  G L 
Sbjct: 187 LPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 244
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P++      + +  C Q NP  RP+  +++
Sbjct: 245 DKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQIL 59
            +    +H +IV+ +G     + L +  + +  GSL +  +++   L    + ++  QI 
Sbjct: 85  LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 143
Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTN---------DVK----SFEGTPF-WVA 105
            G+ YL E  +VHR +   N+L+ +       +         D K    S   TP  W+A
Sbjct: 144 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLS 164
            E ++     Y   +D+WS G TV E++T    PY+ L   +    + +G+  + P   +
Sbjct: 204 LESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICT 261
Query: 165 RDARDFILKCLQVNPNDRPTAAQL 188
            D    ++KC  ++ N RPT  +L
Sbjct: 262 IDVYMVMVKCWMIDENIRPTFKEL 285

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL-----------SDSQVS 52
             +F   ++V+ +G         + +EL+ +G L +  +               S S++ 
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT 100
               +I +G+ YL+    VHR++   N +V        G    T D+       K  +G 
Sbjct: 133 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 192
Query: 101 -PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLP 157
            P  W++PE  +LK+  +   +D+WS G  + E+ T  + PY  L + Q L  +  G L 
Sbjct: 193 LPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 250
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P++      + +  C Q NP  RP+  +++
Sbjct: 251 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL-----------SDSQVS 52
             +F   ++V+ +G         + +EL+ +G L +  +               S S++ 
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT 100
               +I +G+ YL+    VHR++   N +V        G    T D+       K  +G 
Sbjct: 136 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGL 195
Query: 101 -PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLP 157
            P  W++PE  +LK+  +   +D+WS G  + E+ T  + PY  L + Q L  +  G L 
Sbjct: 196 LPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 253
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P++      + +  C Q NP  RP+  +++
Sbjct: 254 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL-----------SDSQVS 52
             +F   ++V+ +G         + +EL+ +G L +  +               S S++ 
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT 100
               +I +G+ YL+    VHR++   N +V        G    T D+       K  +G 
Sbjct: 132 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 191
Query: 101 -PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLP 157
            P  W++PE  +LK+  +   +D+WS G  + E+ T  + PY  L + Q L  +  G L 
Sbjct: 192 LPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 249
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P++      + +  C Q NP  RP+  +++
Sbjct: 250 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL-----------SDSQVS 52
             +F   ++V+ +G         + +EL+ +G L +  +               S S++ 
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT 100
               +I +G+ YL+    VHR++   N +V        G    T D+       K  +G 
Sbjct: 135 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 194
Query: 101 -PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLP 157
            P  W++PE  +LK+  +   +D+WS G  + E+ T  + PY  L + Q L  +  G L 
Sbjct: 195 LPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 252
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P++      + +  C Q NP  RP+  +++
Sbjct: 253 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL-----------SDSQVS 52
             +F   ++V+ +G         + +EL+ +G L +  +               S S++ 
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT 100
               +I +G+ YL+    VHR++   N +V        G    T D+       K  +G 
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 101 -PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLP 157
            P  W++PE  +LK+  +   +D+WS G  + E+ T  + PY  L + Q L  +  G L 
Sbjct: 202 LPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P++      + +  C Q NP  RP+  +++
Sbjct: 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL-----------SDSQVS 52
             +F   ++V+ +G         + +EL+ +G L +  +               S S++ 
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT 100
               +I +G+ YL+    VHR++   N +V        G    T D+       K  +G 
Sbjct: 164 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 223
Query: 101 -PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLP 157
            P  W++PE  +LK+  +   +D+WS G  + E+ T  + PY  L + Q L  +  G L 
Sbjct: 224 LPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 281
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P++      + +  C Q NP  RP+  +++
Sbjct: 282 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL-----------SDSQVS 52
             +F   ++V+ +G         + +EL+ +G L +  +               S S++ 
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT 100
               +I +G+ YL+    VHR++   N +V        G    T D+       K  +G 
Sbjct: 136 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 195
Query: 101 -PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLP 157
            P  W++PE  +LK+  +   +D+WS G  + E+ T  + PY  L + Q L  +  G L 
Sbjct: 196 LPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 253
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P++      + +  C Q NP  RP+  +++
Sbjct: 254 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL-----------SDSQVS 52
             +F   ++V+ +G         + +EL+ +G L +  +               S S++ 
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT 100
               +I +G+ YL+    VHR++   N +V        G    T D+       K  +G 
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 101 -PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLP 157
            P  W++PE  +LK+  +   +D+WS G  + E+ T  + PY  L + Q L  +  G L 
Sbjct: 202 LPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P++      + +  C Q NP  RP+  +++
Sbjct: 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL-----------SDSQVS 52
             +F   ++V+ +G         + +EL+ +G L +  +               S S++ 
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT 100
               +I +G+ YL+    VHR++   N +V        G    T D+       K  +G 
Sbjct: 129 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 188
Query: 101 -PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLP 157
            P  W++PE  +LK+  +   +D+WS G  + E+ T  + PY  L + Q L  +  G L 
Sbjct: 189 LPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 246
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P++      + +  C Q NP  RP+  +++
Sbjct: 247 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 278

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL-----------SDSQVS 52
             +F   ++V+ +G         + +EL+ +G L +  +               S S++ 
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT 100
               +I +G+ YL+    VHR++   N +V        G    T D+       K  +G 
Sbjct: 135 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 194
Query: 101 -PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLP 157
            P  W++PE  +LK+  +   +D+WS G  + E+ T  + PY  L + Q L  +  G L 
Sbjct: 195 LPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 252
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P++      + +  C Q NP  RP+  +++
Sbjct: 253 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/172 (22%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 44  YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTT------------ 91
           + L++ ++ SY  Q+   L +LH  N+ H +I+  NI+      +T              
Sbjct: 97  FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156
Query: 92  -NDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR 150
            ++ +     P + APEV   +++    + D+WSLG  V  +L+   P+    + Q +  
Sbjct: 157 GDNFRLLFTAPEYYAPEV--HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN 214
Query: 151 IGRGKL---PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
           I   +          +S +A DF+ + L      R TA++ ++HP++K+ ++
Sbjct: 215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 189 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 70  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 129
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 130 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 189
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 190 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 222

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 189 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 82  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 141
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 142 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 201
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 202 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 234

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 189 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 88/213 (41%), Gaps = 35/213 (16%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSL 163
            APE++      Y  S D+WS GC + E+L  QP +     +  L  I +         L
Sbjct: 189 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK--------VL 239
Query: 164 SRDARDFILKCLQVNPNDRPTA-AQLMEHPFVK 195
               R+ I    ++NPN    A  Q+  HP+ K
Sbjct: 240 GTPTREQI---REMNPNYTEFAFPQIKAHPWTK 269

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 189 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 88  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 147
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 148 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 207
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 208 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 240

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 73  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 132
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 133 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 192
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 193 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 225

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 81  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 140
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 141 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 200
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 201 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 81  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 140
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 141 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 200
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 201 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 233

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 77  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 136
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 137 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 196
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 197 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 229

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 82/196 (41%), Gaps = 22/196 (11%)
Query: 9   HDNIVQYIGTE-KDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQILNGLTYL 65
           H N++  IG     E   ++ L  +  G L    +  + + +   + S+  Q+  G+ YL
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 66  HERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPF--------WVAPEVV 109
            E+  VHR++   N ++D S        GLA    D + +             W A E  
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE-- 198
Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
           +L+   +   +D+WS G  + E+LT   PPY H++       + +G+    P        
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY 258
Query: 169 DFILKCLQVNPNDRPT 184
             + +C + +P  RPT
Sbjct: 259 QVMQQCWEADPAVRPT 274

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 222
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 223 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 222
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 223 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 105 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 164
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 165 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 224
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 225 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 257

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 97  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 156
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 157 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 216
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 217 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 249

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 148 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 207
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 208 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 267
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 268 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 300

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 64/230 (27%)
Query: 19  EKDENRLYIFLELVKKGSLANLY-QKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC 77
           E   ++LY+  EL++      ++ Q+  +S   +  +   IL GL  LHE  VVHR++  
Sbjct: 103 EPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHP 162
Query: 78  ANILVDASGLAT----------TTNDVKSFEGTPFWV-APEVVNLKNNGYGLSADIWSLG 126
            NIL+  +   T          T +  K+   T  W  APE+V ++  G+    D+WS G
Sbjct: 163 GNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV-MQFKGFTKLVDMWSAG 221
Query: 127 CTVLEMLTHQPPYSHLEDMQALFR--------------IGRGKLPSVPNSLSRDARDF-- 170
           C + EM           + +ALFR              +G  K+  V    S  ARD+  
Sbjct: 222 CVMAEMF----------NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLR 271
Query: 171 -------------------------ILKCLQVNPNDRPTAAQLMEHPFVK 195
                                    I K L+ NP  R +  Q + HP+ +
Sbjct: 272 NSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 74  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 133
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 134 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 193
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 194 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 226

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 67/154 (43%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQY------IGTEKDENRLYIFLELVKKG--SLANLYQ--KYHLSDSQVSSYT 55
           + +H NIV+        G +KDE  L + L+ V +    +A  Y   K  L    V  Y 
Sbjct: 107 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 166
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 167 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 226
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 227 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 259

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 50/223 (22%)
Query: 19  EKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK 76
           E   ++LY+  EL++   LA +   Q+  +S   +  +   IL GL  LHE  VVHR++ 
Sbjct: 103 EPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLH 161
Query: 77  CANILVDASGLAT----------TTNDVKSFEGTPFWV-APEVVNLKNNGYGLSADIWSL 125
             NIL+  +   T          T +  K+   T  W  APE+V ++  G+    D+WS 
Sbjct: 162 PGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV-MQFKGFTKLVDMWSA 220
Query: 126 GCTVLEMLTHQPP------YSHLEDMQALFRIGRGKLPSVPNSLSRDARDF--------- 170
           GC + EM   +        Y+ L  +  +  +G  K+  V    S  ARD+         
Sbjct: 221 GCVMAEMFNRKALFRGSTFYNQLNKIVEV--VGTPKIEDVVMFSSPSARDYLRNSLSNVP 278
Query: 171 ------------------ILKCLQVNPNDRPTAAQLMEHPFVK 195
                             I K L+ NP  R +  Q + HP+ +
Sbjct: 279 ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 90/212 (42%), Gaps = 28/212 (13%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHL-----------SDSQVS 52
             +F   ++V+ +G         + +EL+ +G L +  +               S S++ 
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS-----GLATTTNDV-------KSFEGT 100
               +I +G+ YL+    VHR++   N  V        G    T D+       K  +G 
Sbjct: 129 QMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 188
Query: 101 -PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLP 157
            P  W++PE  +LK+  +   +D+WS G  + E+ T  + PY  L + Q L  +  G L 
Sbjct: 189 LPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 246
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P++      + +  C Q NP  RP+  +++
Sbjct: 247 DKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 97/217 (44%), Gaps = 30/217 (13%)
Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYL 65
           Q   D I++    E  +  +Y+ +E       + L +K  +   +  SY + +L  +  +
Sbjct: 84  QQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 66  HERNVVHREIKCANIL-VDAS------GLATTTND-----VKSFE-GTPFWVAPEVV--- 109
           H+  +VH ++K AN L VD        G+A          VK  + GT  ++ PE +   
Sbjct: 144 HQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDM 203
Query: 110 -NLKNNG-----YGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRIGRG-KLPS 158
            + + NG         +D+WSLGC +  M   + P+    + +  + A+       + P 
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263
Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +P    +D +D +  CL+ +P  R +  +L+ HP+V+
Sbjct: 264 IP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 87/206 (42%), Gaps = 34/206 (16%)
Query: 1   NFSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F+ S F+ D  +  +  E+D +  Y                K  ++   + SY+ Q+  
Sbjct: 167 SFASSGFQEDKSLSDVEEEEDSDGFY----------------KEPITMEDLISYSFQVAR 210
Query: 61  GLTYLHERNVVHREIKCANILVDASGLATTTN-----DV--------KSFEGTPF-WVAP 106
           G+ +L  R  +HR++   NIL+  + +    +     D+        K     P  W+AP
Sbjct: 211 GMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAP 270
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGRGKLPSVPNSLS 164
           E  ++ +  Y   +D+WS G  + E+ +    PY  ++ D     R+  G     P   +
Sbjct: 271 E--SIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMRMRAPEYST 328
Query: 165 RDARDFILKCLQVNPNDRPTAAQLME 190
            +    +L C   +P +RP  A+L+E
Sbjct: 329 PEIYQIMLDCWHRDPKERPRFAELVE 354

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 66/154 (42%), Gaps = 23/154 (14%)
Query: 6   QFEHDNIVQ--YIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQ-------VSSYT 55
           + +H NIV+  Y      E +  ++L LV       +Y+   H S ++       V  Y 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS----FEGTP--------FW 103
            Q+   L Y+H   + HR+IK  N+L+D         D  S      G P        ++
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
            APE++      Y  S D+WS GC + E+L  QP
Sbjct: 189 RAPELI-FGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 53/111 (47%), Gaps = 20/111 (18%)
Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS------------GLATTTN- 92
           L    V S   QIL+G+ YLH   V+HR++K ANILV               G A   N 
Sbjct: 125 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 93  ------DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
                 D+     T ++ APE++ L    Y  + DIW++GC   E+LT +P
Sbjct: 185 PLKPLADLDPVVVTFWYRAPELL-LGARHYTKAIDIWAIGCIFAELLTSEP 234

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/212 (21%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDS-------------- 49
            +  +H +IV++ G   +   L +  E ++ G L N + + H  D+              
Sbjct: 74  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPL 132
Query: 50  ---QVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTPF- 102
              Q+ +   Q+  G+ YL   + VHR++   N LV   GL     D    +    T + 
Sbjct: 133 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYY 191
Query: 103 -----------WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFR 150
                      W+ PE +  +   +   +D+WS G  + E+ T+ + P+  L + +A+  
Sbjct: 192 RVGGRTMLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 249
Query: 151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
           I +G+    P +   +    +  C Q  P  R
Sbjct: 250 ITQGRELERPRACPPEVYAIMRGCWQREPQQR 281

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/212 (21%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDS-------------- 49
            +  +H +IV++ G   +   L +  E ++ G L N + + H  D+              
Sbjct: 68  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPL 126
Query: 50  ---QVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTPF- 102
              Q+ +   Q+  G+ YL   + VHR++   N LV   GL     D    +    T + 
Sbjct: 127 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYY 185
Query: 103 -----------WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFR 150
                      W+ PE +  +   +   +D+WS G  + E+ T+ + P+  L + +A+  
Sbjct: 186 RVGGRTMLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 243
Query: 151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
           I +G+    P +   +    +  C Q  P  R
Sbjct: 244 ITQGRELERPRACPPEVYAIMRGCWQREPQQR 275

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/212 (21%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDS-------------- 49
            +  +H +IV++ G   +   L +  E ++ G L N + + H  D+              
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPL 155
Query: 50  ---QVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDV---KSFEGTPF- 102
              Q+ +   Q+  G+ YL   + VHR++   N LV   GL     D    +    T + 
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYY 214
Query: 103 -----------WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFR 150
                      W+ PE +  +   +   +D+WS G  + E+ T+ + P+  L + +A+  
Sbjct: 215 RVGGRTMLPIRWMPPESILYRK--FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272
Query: 151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
           I +G+    P +   +    +  C Q  P  R
Sbjct: 273 ITQGRELERPRACPPEVYAIMRGCWQREPQQR 304

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/202 (22%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
            +  +H ++V+ +G       + +  +L+  G L     ++  ++    + ++  QI  G
Sbjct: 94  MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKG 152
Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLAT-TTNDVKSFEG----TPF-WVAPE 107
           + YL ER +VHR++   N+LV +         GLA     D K +       P  W+A E
Sbjct: 153 MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 212
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            ++ +   +   +D+WS G T+ E++T    PY  +   +    + +G+    P   + D
Sbjct: 213 CIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID 270
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
               ++KC  ++ + RP   +L
Sbjct: 271 VYMVMVKCWMIDADSRPKFKEL 292

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 81/179 (45%), Gaps = 21/179 (11%)
Query: 25  LYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI- 80
           L+I +E   KG+L    +K     L          QI  G+ Y+H + ++HR++K +NI 
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIF 168
Query: 81  LVDAS-------GLATT-TNDVKSF--EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVL 130
           LVD         GL T+  ND K    +GT  +++PE ++ ++  YG   D+++LG  + 
Sbjct: 169 LVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD--YGKEVDLYALGLILA 226
Query: 131 EMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           E+L                R G      + +   +  +  + K L   P DRP  ++++
Sbjct: 227 ELLHVCDTAFETSKFFTDLRDG-----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 280

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 37/217 (17%)
Query: 3   SFSQFEHDNIVQYIG-----------TEKDENR-----LYIFLELVKKGSLANLYQKYH- 45
           + ++ +H NIV Y G           + K+ +R     L+I +E   KG+L    +K   
Sbjct: 57  ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 46  --LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI-LVDAS-------GLATT-TNDV 94
             L          QI  G+ Y+H + +++R++K +NI LVD         GL T+  ND 
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 95  KSF--EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG 152
           K    +GT  +++PE ++ ++  YG   D+++LG  + E+L                R G
Sbjct: 177 KRXRSKGTLRYMSPEQISSQD--YGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234
Query: 153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
                 + +   +  +  + K L   P DRP  ++++
Sbjct: 235 -----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/202 (21%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
            +  +H ++V+ +G       + +  +L+  G L     ++  ++    + ++  QI  G
Sbjct: 71  MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKG 129
Query: 62  LTYLHERNVVHREIKCANILVDASGLATTTN---------DVKSFEG----TPF-WVAPE 107
           + YL ER +VHR++   N+LV +      T+         D K +       P  W+A E
Sbjct: 130 MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 189
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
            ++ +   +   +D+WS G T+ E++T    PY  +   +    + +G+    P   + D
Sbjct: 190 CIHYRK--FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID 247
Query: 167 ARDFILKCLQVNPNDRPTAAQL 188
               ++KC  ++ + RP   +L
Sbjct: 248 VYMVMVKCWMIDADSRPKFKEL 269

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 79/165 (47%), Gaps = 33/165 (20%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELV----KKGSLANLYQKYHLSDSQVSSYTRQ 57
           +S    +H+NI+Q+IG EK    + + L L+    +KGSL++  +   +S +++      
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAET 129
Query: 58  ILNGLTYLHER----------NVVHREIKCANILVDAS--------GLA------TTTND 93
           +  GL YLHE            + HR+IK  N+L+  +        GLA       +  D
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 94  VKSFEGTPFWVAPEV----VNLKNNGYGLSADIWSLGCTVLEMLT 134
                GT  ++APEV    +N + + + L  D++++G  + E+ +
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAF-LRIDMYAMGLVLWELAS 233

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/221 (20%), Positives = 88/221 (39%), Gaps = 42/221 (19%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH------LSDSQVSS---- 53
            ++F++ NIV+ +G       + +  E +  G L    +         LS S +S+    
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 54  ---------------YTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATT 90
                            RQ+  G+ YL ER  VHR++   N LV  +        GL+  
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 91  TNDVKSF-----EGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSHLE 143
                 +     +  P  W+ PE  ++  N Y   +D+W+ G  + E+ ++   PY  + 
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281
Query: 144 DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT 184
             + ++ +  G + + P +   +  + +  C    P DRP+
Sbjct: 282 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPS 322

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 64/132 (48%), Gaps = 16/132 (12%)
Query: 22  ENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           + +LY+   L+    LA  L ++  L+  +  +  RQI + L   H     HR++K  NI
Sbjct: 106 DGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165
Query: 81  LVDAS--------GLATTTNDVKSFE-----GTPFWVAPEVVNLKNNGYGLSADIWSLGC 127
           LV A         G+A+ T D K  +     GT ++ APE  +  +  Y   ADI++L C
Sbjct: 166 LVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATY--RADIYALTC 223
Query: 128 TVLEMLTHQPPY 139
            + E LT  PPY
Sbjct: 224 VLYECLTGSPPY 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 21/164 (12%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN----LYQKYHLSDSQVSSYTRQIL 59
            ++ +H+N+V+ +G   D + L +    +  GSL +    L     LS        +   
Sbjct: 84  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 143
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKS------FEGTPFWVA 105
           NG+ +LHE + +HR+IK ANIL+D +        GLA  +             GT  ++A
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMA 203
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF 149
           PE +          +DI+S G  +LE++T  P      + Q L 
Sbjct: 204 PEAL---RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 21/164 (12%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN----LYQKYHLSDSQVSSYTRQIL 59
            ++ +H+N+V+ +G   D + L +    +  GSL +    L     LS        +   
Sbjct: 78  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 137
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKS------FEGTPFWVA 105
           NG+ +LHE + +HR+IK ANIL+D +        GLA  +             GT  ++A
Sbjct: 138 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMA 197
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF 149
           PE +          +DI+S G  +LE++T  P      + Q L 
Sbjct: 198 PEAL---RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 238

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 21/164 (12%)
Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN----LYQKYHLSDSQVSSYTRQIL 59
            ++ +H+N+V+ +G   D + L +    +  GSL +    L     LS        +   
Sbjct: 84  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 143
Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKS------FEGTPFWVA 105
           NG+ +LHE + +HR+IK ANIL+D +        GLA  +             GT  ++A
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMA 203
Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF 149
           PE +          +DI+S G  +LE++T  P      + Q L 
Sbjct: 204 PEAL---RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 35/214 (16%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANL------------YQKYHLSDSQVSS-- 53
           +H+NIV  +G       + +  E    G L N             Y   H  + Q+SS  
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRD 167
Query: 54  ---YTRQILNGLTYLHERNVVHREIKCANIL--------VDASGLA-TTTND----VKSF 97
              ++ Q+  G+ +L  +N +HR++   N+L        +   GLA    ND    VK  
Sbjct: 168 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 227
Query: 98  EGTPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-G 154
              P  W+APE  ++ +  Y + +D+WS G  + E+ +    PY  +      +++ + G
Sbjct: 228 ARLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG 285
Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
              + P    ++    +  C  + P  RPT  Q+
Sbjct: 286 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 319

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 104/271 (38%), Gaps = 91/271 (33%)
Query: 9   HDNIVQYIGTEKDENRLYIFLEL------VKKGSLANLYQKYHLSDSQVSSYTRQILNGL 62
           H+NIV  +   + +N   ++L        +     AN+ +  H    Q   Y  Q++  +
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH---KQYVVY--QLIKVI 122
Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATT-------TNDV------------- 94
            YLH   ++HR++K +NIL++A         GL+ +       TN++             
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 95  -----KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF 149
                  +  T ++ APE++ L +  Y    D+WSLGC + E+L  +P +     M  L 
Sbjct: 183 DQPILTDYVATRWYRAPEIL-LGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 150 R-IGRGKLPS------------------------VPNSLSRD------------------ 166
           R IG    PS                        +  S  RD                  
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 167 ---ARDFILKCLQVNPNDRPTAAQLMEHPFV 194
              A D + K LQ NPN R +A   ++HPFV
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFV 332

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 89/238 (37%), Gaps = 77/238 (32%)
Query: 30  ELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA---SG 86
           EL+KK    N +Q + L    V  +   IL  L  LH+  ++H ++K  NIL+     SG
Sbjct: 187 ELIKK----NKFQGFSLP--LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 87  LATTTNDVKSFE--------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP- 137
           +         +E         + F+ APEV+      YG+  D+WSLGC + E+LT  P 
Sbjct: 241 IKVIDFGSSCYEHQRVYTXIQSRFYRAPEVI--LGARYGMPIDMWSLGCILAELLTGYPL 298
Query: 138 --------------------------------------------PYSHLEDMQALFRIG- 152
                                                         + L D   +   G 
Sbjct: 299 LPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGR 358
Query: 153 --RGKLPSVPNSLS-----RDARD-----FILKCLQVNPNDRPTAAQLMEHPFVKRPL 198
             RGKL   P S       +   D     F+ +CL+ +P  R T  Q + HP+++R L
Sbjct: 359 SRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 88/238 (36%), Gaps = 77/238 (32%)
Query: 30  ELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA---SG 86
           EL+KK    N +Q + L    V  +   IL  L  LH+  ++H ++K  NIL+     SG
Sbjct: 187 ELIKK----NKFQGFSLP--LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 87  LATTTNDVKSFE--------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP- 137
           +         +E         + F+ APEV+      YG+  D+WSLGC + E+LT  P 
Sbjct: 241 IKVIDFGSSCYEHQRVYXXIQSRFYRAPEVI--LGARYGMPIDMWSLGCILAELLTGYPL 298
Query: 138 -------------------PYSHLEDMQALF----------------------------R 150
                              P   L D                                 R
Sbjct: 299 LPGEDEGDQLACMIELLGMPXQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGR 358
Query: 151 IGRGKLPSVPNSLS-----RDARD-----FILKCLQVNPNDRPTAAQLMEHPFVKRPL 198
             RGKL   P S       +   D     F+ +CL+ +P  R T  Q + HP+++R L
Sbjct: 359 SRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 57/119 (47%), Gaps = 19/119 (15%)
Query: 30  ELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA---SG 86
           EL+KK    N +Q + L    V  +   IL  L  LH+  ++H ++K  NIL+     SG
Sbjct: 187 ELIKK----NKFQGFSLP--LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 87  LATTTNDVKSFE--------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
           +         +E         + F+ APEV+      YG+  D+WSLGC + E+LT  P
Sbjct: 241 IKVIDFGSSCYEHQRVYTXIQSRFYRAPEVI--LGARYGMPIDMWSLGCILAELLTGYP 297

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 78/203 (38%), Gaps = 23/203 (11%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVS-SYTRQIL 59
           F  S   H NIV+  G   +  R+   +E V  G L + L  K H     V       I 
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 60  NGLTYLHERN--VVHREIKCANILV--------------DASGLATTTNDVKSFEGTPFW 103
            G+ Y+  +N  +VHR+++  NI +              D S    + + V    G   W
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLGNFQW 192
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF---RIGRGKLPSVP 160
           +APE +  +   Y   AD +S    +  +LT + P+      +  F       G  P++P
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252
Query: 161 NSLSRDARDFILKCLQVNPNDRP 183
                  R+ I  C   +P  RP
Sbjct: 253 EDCPPRLRNVIELCWSGDPKKRP 275

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 92/212 (43%), Gaps = 33/212 (15%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK----------YHLSDSQVSS---- 53
           +H+NIV  +G       + +  E    G L N  ++          + +++S +S+    
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 54  -YTRQILNGLTYLHERNVVHREIKCANIL--------VDASGLA-TTTND----VKSFEG 99
            ++ Q+  G+ +L  +N +HR++   N+L        +   GLA    ND    VK    
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-GKL 156
            P  W+APE  ++ +  Y + +D+WS G  + E+ +    PY  +      +++ + G  
Sbjct: 228 LPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ 285
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
            + P    ++    +  C  + P  RPT  Q+
Sbjct: 286 MAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 86/180 (47%), Gaps = 19/180 (10%)
Query: 27  IFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHR++   N+LV  
Sbjct: 93  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152
Query: 85  S--------GLATTTN-DVKSF--EG--TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVL 130
                    GLA     + K +  EG   P  W+A E  ++ +  Y   +D+WS G TV 
Sbjct: 153 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVW 210
Query: 131 EMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           E++T    PY  +   +    + +G+    P   + D    ++KC  ++ + RP   +L+
Sbjct: 211 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 77/184 (41%), Gaps = 41/184 (22%)
Query: 23  NRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL 81
           + LYI LE +    L  L++    L++  + +    +L G  ++HE  ++HR++K AN L
Sbjct: 103 DELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL 161
Query: 82  VDAS--------GLATTTNDVK--------------------------SFEGTPFWVAPE 107
           ++          GLA T N  K                          S   T ++ APE
Sbjct: 162 LNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE 221
Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI--GRGKLPSVPNSLSR 165
           ++ L+ N Y  S DIWS GC   E+L      SH+ D    F +  G    P  P+  S+
Sbjct: 222 LILLQEN-YTKSIDIWSTGCIFAELLNML--QSHINDPTNRFPLFPGSSCFPLSPDRNSK 278
Query: 166 DARD 169
              +
Sbjct: 279 KVHE 282

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 86/180 (47%), Gaps = 19/180 (10%)
Query: 27  IFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHR++   N+LV  
Sbjct: 94  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 153
Query: 85  S--------GLATTTN-DVKSF--EG--TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVL 130
                    GLA     + K +  EG   P  W+A E  ++ +  Y   +D+WS G TV 
Sbjct: 154 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVW 211
Query: 131 EMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           E++T    PY  +   +    + +G+    P   + D    ++KC  ++ + RP   +L+
Sbjct: 212 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 82/189 (43%), Gaps = 37/189 (19%)
Query: 7   FEHDNI---VQYIGTEKD-ENRLYIFLELVKKGSLANLYQKYH-----LSDSQVSSYTRQ 57
           F H NI   V Y   E+  ++  ++ L   K+G+L N  ++       L++ Q+      
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 58  ILNGLTYLHERNVVHREIKCANIL---------------------VDASGLATTTNDVKS 96
           I  GL  +H +   HR++K  NIL                     V+ S  A T  D  +
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 97  FEGTPFWVAPEVVNLKNNGY-GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK 155
              T  + APE+ +++++       D+WSLGC +  M+  + PY    DM  +F+ G   
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY----DM--VFQKGDSV 256
Query: 156 LPSVPNSLS 164
             +V N LS
Sbjct: 257 ALAVQNQLS 265

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 85/180 (47%), Gaps = 19/180 (10%)
Query: 27  IFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHR++   N+LV  
Sbjct: 95  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 154
Query: 85  S--------GLATTTN-DVKSF--EGTPF---WVAPEVVNLKNNGYGLSADIWSLGCTVL 130
                    GLA     + K +  EG      W+A E  ++ +  Y   +D+WS G TV 
Sbjct: 155 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVW 212
Query: 131 EMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           E++T    PY  +   +    + +G+    P   + D    ++KC  ++ + RP   +L+
Sbjct: 213 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 86/180 (47%), Gaps = 19/180 (10%)
Query: 27  IFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHR++   N+LV  
Sbjct: 100 LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 159
Query: 85  S--------GLATTTN-DVKSF--EG--TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVL 130
                    GLA     + K +  EG   P  W+A E  ++ +  Y   +D+WS G TV 
Sbjct: 160 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVW 217
Query: 131 EMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           E++T    PY  +   +    + +G+    P   + D    ++KC  ++ + RP   +L+
Sbjct: 218 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 86/180 (47%), Gaps = 19/180 (10%)
Query: 27  IFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHR++   N+LV  
Sbjct: 94  LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 153
Query: 85  S--------GLATTTN-DVKSF--EG--TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVL 130
                    GLA     + K +  EG   P  W+A E  ++ +  Y   +D+WS G TV 
Sbjct: 154 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVW 211
Query: 131 EMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           E++T    PY  +   +    + +G+    P   + D    ++KC  ++ + RP   +L+
Sbjct: 212 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 85/180 (47%), Gaps = 19/180 (10%)
Query: 27  IFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHR++   N+LV  
Sbjct: 96  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 155
Query: 85  S--------GLATTTN-DVKSF--EGTPF---WVAPEVVNLKNNGYGLSADIWSLGCTVL 130
                    GLA     + K +  EG      W+A E  ++ +  Y   +D+WS G TV 
Sbjct: 156 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVW 213
Query: 131 EMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           E++T    PY  +   +    + +G+    P   + D    ++KC  ++ + RP   +L+
Sbjct: 214 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 79/203 (38%), Gaps = 23/203 (11%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVS-SYTRQIL 59
           F  S   H NIV+  G   +  R+   +E V  G L + L  K H     V       I 
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 60  NGLTYLHERN--VVHREIKCANILVDA-----------SGLATTTNDVKSFEGTPF---W 103
            G+ Y+  +N  +VHR+++  NI + +           +   T+   V S  G      W
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGNFQW 192
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF---RIGRGKLPSVP 160
           +APE +  +   Y   AD +S    +  +LT + P+      +  F       G  P++P
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252
Query: 161 NSLSRDARDFILKCLQVNPNDRP 183
                  R+ I  C   +P  RP
Sbjct: 253 EDCPPRLRNVIELCWSGDPKKRP 275

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 86/180 (47%), Gaps = 19/180 (10%)
Query: 27  IFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHR++   N+LV  
Sbjct: 97  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 156
Query: 85  S--------GLATTTN-DVKSF--EG--TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVL 130
                    GLA     + K +  EG   P  W+A E  ++ +  Y   +D+WS G TV 
Sbjct: 157 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVW 214
Query: 131 EMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           E++T    PY  +   +    + +G+    P   + D    ++KC  ++ + RP   +L+
Sbjct: 215 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 18/154 (11%)
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA-TTTND----VKSFEG 99
           S++ Q+  G+ +L  +N +HR++   NIL+           GLA    ND    VK    
Sbjct: 167 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 226
Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFR-IGRGKL 156
            P  W+APE  ++ N  Y   +D+WS G  + E+ +    PY  +      ++ I  G  
Sbjct: 227 LPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 284
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
              P     +  D +  C   +P  RPT  Q+++
Sbjct: 285 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 318

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 18/154 (11%)
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA-TTTND----VKSFEG 99
           S++ Q+  G+ +L  +N +HR++   NIL+           GLA    ND    VK    
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 231
Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFR-IGRGKL 156
            P  W+APE  ++ N  Y   +D+WS G  + E+ +    PY  +      ++ I  G  
Sbjct: 232 LPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 289
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
              P     +  D +  C   +P  RPT  Q+++
Sbjct: 290 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 18/154 (11%)
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLAT-TTND----VKSFEG 99
           S++ Q+  G+ +L  +N +HR++   NIL+           GLA    ND    VK    
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNAR 231
Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFR-IGRGKL 156
            P  W+APE  ++ N  Y   +D+WS G  + E+ +    PY  +      ++ I  G  
Sbjct: 232 LPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 289
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
              P     +  D +  C   +P  RPT  Q+++
Sbjct: 290 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 91/212 (42%), Gaps = 33/212 (15%)
Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK----------YHLSDSQVSS---- 53
           +H+NIV  +G       + +  E    G L N  ++          + +++S  S+    
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 54  -YTRQILNGLTYLHERNVVHREIKCANIL--------VDASGLA-TTTND----VKSFEG 99
            ++ Q+  G+ +L  +N +HR++   N+L        +   GLA    ND    VK    
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGR-GKL 156
            P  W+APE  ++ +  Y + +D+WS G  + E+ +    PY  +      +++ + G  
Sbjct: 228 LPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ 285
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
            + P    ++    +  C  + P  RPT  Q+
Sbjct: 286 MAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 85/180 (47%), Gaps = 19/180 (10%)
Query: 27  IFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHR++   N+LV  
Sbjct: 97  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 156
Query: 85  SGLATTTN---------DVKSF--EG--TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVL 130
                 T+         + K +  EG   P  W+A E  ++ +  Y   +D+WS G TV 
Sbjct: 157 PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVW 214
Query: 131 EMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           E++T    PY  +   +    + +G+    P   + D    ++KC  ++ + RP   +L+
Sbjct: 215 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 18/154 (11%)
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA-TTTND----VKSFEG 99
           S++ Q+  G+ +L  +N +HR++   NIL+           GLA    ND    VK    
Sbjct: 165 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 224
Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFR-IGRGKL 156
            P  W+APE  ++ N  Y   +D+WS G  + E+ +    PY  +      ++ I  G  
Sbjct: 225 LPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 282
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
              P     +  D +  C   +P  RPT  Q+++
Sbjct: 283 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 18/154 (11%)
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA-TTTND----VKSFEG 99
           S++ Q+  G+ +L  +N +HR++   NIL+           GLA    ND    VK    
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFR-IGRGKL 156
            P  W+APE  ++ N  Y   +D+WS G  + E+ +    PY  +      ++ I  G  
Sbjct: 209 LPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266
Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
              P     +  D +  C   +P  RPT  Q+++
Sbjct: 267 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 17/152 (11%)
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSF--EG-- 99
           ++  QI  G+ YL +R +VHR++   N+LV           GLA     + K +  EG  
Sbjct: 115 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLP 157
            P  W+A E  ++ +  Y   +D+WS G TV E++T    PY  +   +    + +G+  
Sbjct: 175 VPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 232
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P   + D    ++KC  ++ + RP   +L+
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 264

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 21/163 (12%)
Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN----LYQKYHLSDSQVSSYTRQILN 60
           ++ +H+N+V+ +G   D + L +       GSL +    L     LS        +   N
Sbjct: 76  AKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAAN 135
Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKS------FEGTPFWVAP 106
           G+ +LHE + +HR+IK ANIL+D +        GLA  +             GT  + AP
Sbjct: 136 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF 149
           E +          +DI+S G  +LE++T  P      + Q L 
Sbjct: 196 EAL---RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 235

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 80/203 (39%), Gaps = 23/203 (11%)
Query: 2   FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVS-SYTRQIL 59
           F  S   H NIV+  G   +  R+   +E V  G L + L  K H     V       I 
Sbjct: 75  FIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 60  NGLTYLHERN--VVHREIKCANILVDA-------------SGLAT-TTNDVKSFEGTPFW 103
            G+ Y+  +N  +VHR+++  NI + +              GL+  + + V    G   W
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQW 192
Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF---RIGRGKLPSVP 160
           +APE +  +   Y   AD +S    +  +LT + P+      +  F       G  P++P
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252
Query: 161 NSLSRDARDFILKCLQVNPNDRP 183
                  R+ I  C   +P  RP
Sbjct: 253 EDCPPRLRNVIELCWSGDPKKRP 275

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 17/152 (11%)
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSF--EG-- 99
           ++  QI  G+ YL +R +VHR++   N+LV           GLA     + K +  EG  
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLP 157
            P  W+A E  ++ +  Y   +D+WS G TV E++T    PY  +   +    + +G+  
Sbjct: 181 VPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P   + D    ++KC  ++ + RP   +L+
Sbjct: 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/180 (22%), Positives = 84/180 (46%), Gaps = 19/180 (10%)
Query: 27  IFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           + ++L+  G L +  +++  ++    + ++  QI  G+ YL +R +VHR++   N+LV  
Sbjct: 95  LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 154
Query: 85  SGLATTTN---------DVKSF--EGTPF---WVAPEVVNLKNNGYGLSADIWSLGCTVL 130
                 T+         + K +  EG      W+A E  ++ +  Y   +D+WS G TV 
Sbjct: 155 PQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE--SILHRIYTHQSDVWSYGVTVW 212
Query: 131 EMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           E++T    PY  +   +    + +G+    P   + D    ++KC  ++ + RP   +L+
Sbjct: 213 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 17/152 (11%)
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSF--EG-- 99
           ++  QI  G+ YL +R +VHR++   N+LV           GLA     + K +  EG  
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLP 157
            P  W+A E  ++ +  Y   +D+WS G TV E++T    PY  +   +    + +G+  
Sbjct: 181 VPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P   + D    ++KC  ++ + RP   +L+
Sbjct: 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 17/152 (11%)
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSF--EGTP 101
           ++  QI  G+ YL +R +VHR++   N+LV           GLA     + K +  EG  
Sbjct: 146 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 205
Query: 102 F---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLP 157
               W+A E  ++ +  Y   +D+WS G TV E++T    PY  +   +    + +G+  
Sbjct: 206 VPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 263
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P   + D    ++KC  ++ + RP   +L+
Sbjct: 264 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 295

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 17/152 (11%)
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSF--EG-- 99
           ++  QI  G+ YL +R +VHR++   N+LV           GLA     + K +  EG  
Sbjct: 127 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 186
Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLP 157
            P  W+A E  ++ +  Y   +D+WS G TV E++T    PY  +   +    + +G+  
Sbjct: 187 VPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 244
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P   + D    ++KC  ++ + RP   +L+
Sbjct: 245 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 276

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 17/152 (11%)
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSF--EGTP 101
           ++  QI  G+ YL +R +VHR++   N+LV           GLA     + K +  EG  
Sbjct: 123 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 102 F---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLP 157
               W+A E  ++ +  Y   +D+WS G TV E++T    PY  +   +    + +G+  
Sbjct: 183 VPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P   + D    ++KC  ++ + RP   +L+
Sbjct: 241 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 17/152 (11%)
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSF--EG-- 99
           ++  QI  G+ YL +R +VHR++   N+LV           GLA     + K +  EG  
Sbjct: 128 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLP 157
            P  W+A E  ++ +  Y   +D+WS G TV E++T    PY  +   +    + +G+  
Sbjct: 188 VPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 245
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P   + D    ++KC  ++ + RP   +L+
Sbjct: 246 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 17/152 (11%)
Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTN-DVKSF--EG-- 99
           ++  QI  G+ YL +R +VHR++   N+LV           GLA     + K +  EG  
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 100 TPF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLP 157
            P  W+A E  ++ +  Y   +D+WS G TV E++T    PY  +   +    + +G+  
Sbjct: 181 VPIKWMALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
             P   + D    ++KC  ++ + RP   +L+
Sbjct: 239 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	201
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-105
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-94
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-89
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-83
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-78
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-71
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-70
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-69
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-68
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-68
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-68
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-68
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-68
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-68
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-67
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-66
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-66
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-64
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-64
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-61
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-59
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-59
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-57
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-57
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-57
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-57
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-56
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-55
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-54
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-54
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-53
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-52
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-50
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-50
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-49
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-49
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-47
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-46
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-45
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-45
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-45
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-45
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-45
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-45
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-44
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-44
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-44
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-44
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-44
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-44
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-43
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-43
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-43
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-43
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-43
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-43
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-43
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-43
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-42
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-42
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-42
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-42
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-42
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-42
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-42
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-42
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-42
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-41
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-41
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-41
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-41
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-41
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-41
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-40
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-40
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-39
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-39
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-39
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-39
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-38
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-38
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-38
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-38
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-37
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-37
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-37
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-37
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-37
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-36
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-36
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-36
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-35
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-35
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-35
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-35
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-35
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-34
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-34
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-34
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-34
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-34
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-34
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-33
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-33
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-33
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-33
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-33
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-32
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-32
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-32
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-32
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-32
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-31
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-31
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-31
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-31
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-31
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-31
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-31
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-30
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-30
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-30
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-30
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-30
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-30
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-30
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-30
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-30
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-30
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-30
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-29
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-29
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-29
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-29
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-29
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-29
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-29
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-29
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-29
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-28
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-28
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-28
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-28
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-28
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-28
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-28
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-28
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-27
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-27
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-27
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-27
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-26
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-26
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-26
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-26
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-26
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-25
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-25
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-25
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-25
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-25
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-23
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-23
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-23
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-22
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-22
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-21
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-21
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-21
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-20
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-20
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-20
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-20
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-20
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-18
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-18
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-17
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-14
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-06
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-05

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  304 bits (782), Expect = e-105
 Identities = 77/216 (35%), Positives = 124/216 (57%), Gaps = 19/216 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH----LSDSQVSSYTRQILN 60
              +H NIVQY+G+  +   + IF+E V  GSL+ L +        ++  +  YT+QIL 
Sbjct: 74  KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE 133

Query: 61  GLTYLHERNVVHREIKCANILVDAS---------GLATTTNDV----KSFEGTPFWVAPE 107
           GL YLH+  +VHR+IK  N+L++           G +     +    ++F GT  ++APE
Sbjct: 134 GLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 193

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED-MQALFRIGRGKL-PSVPNSLSR 165
           +++    GYG +ADIWSLGCT++EM T +PP+  L +   A+F++G  K+ P +P S+S 
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           +A+ FILKC + +P+ R  A  L+   F+K   +  
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  278 bits (712), Expect = 1e-94
 Identities = 52/214 (24%), Positives = 83/214 (38%), Gaps = 23/214 (10%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
           +      IV   G  ++   + IF+EL++ GSL  L ++   L + +   Y  Q L GL 
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE 164

Query: 64  YLHERNVVHREIKCANILVDASG------------------LATTTNDVKSFEGTPFWVA 105
           YLH R ++H ++K  N+L+ + G                  L  +        GT   +A
Sbjct: 165 YLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK--LPSVPNSL 163
           PEVV           DIWS  C +L ML    P++         +I      +  +P S 
Sbjct: 225 PEVV--MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC 282

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP 197
           +      I + L+  P  R +A +L         
Sbjct: 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  263 bits (674), Expect = 2e-89
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)

Query: 5   SQFEHDNIVQYIG----TEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQIL 59
              +H NIV++      T K +  + +  EL+  G+L    +++  +    + S+ RQIL
Sbjct: 80  KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 139

Query: 60  NGLTYLHERN--VVHREIKCANILVDAS---------GLAT--TTNDVKSFEGTPFWVAP 106
            GL +LH R   ++HR++KC NI +            GLAT    +  K+  GTP ++AP
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAP 199

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP--SVPNSLS 164
           E+       Y  S D+++ G  +LEM T + PYS  ++   ++R     +   S      
Sbjct: 200 EMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
            + ++ I  C++ N ++R +   L+ H F + 
Sbjct: 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  247 bits (633), Expect = 2e-83
 Identities = 48/224 (21%), Positives = 97/224 (43%), Gaps = 36/224 (16%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQIL 59
              +H ++V+Y     +++ + I  E    GSLA+   +      +  ++++     Q+ 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 60  NGLTYLHERNVVHREIKCANILVDAS---------------------------GLATTTN 92
            GL Y+H  ++VH +IK +NI +  +                           G  T  +
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185

Query: 93  DVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG 152
             +  EG   ++A EV+  +N  +   ADI++L  TV+     +P   + +       I 
Sbjct: 186 SPQVEEGDSRFLANEVLQ-ENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIR 241

Query: 153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           +G+LP +P  LS++  + +   +  +P  RP+A  L++H  +  
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  236 bits (604), Expect = 1e-78
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 21/207 (10%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
              +H   V+     ++   LY+  EL    SL    + +   L ++QV  Y R  L  L
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLAT---TTNDVKSFEGTPFWVAPEVVNL 111
            +LH + +VH ++K ANI +           GL     T    +  EG P ++APE++  
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ- 229

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL-PSVPNSLSRDARDF 170
               YG +AD++SLG T+LE+  +       E  Q L +   G L P     LS + R  
Sbjct: 230 --GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ---GYLPPEFTAGLSSELRSV 284

Query: 171 ILKCLQVNPNDRPTAAQLMEHPFVKRP 197
           ++  L+ +P  R TA  L+  P +++P
Sbjct: 285 LVMMLEPDPKLRATAEALLALPVLRQP 311

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  216 bits (553), Expect = 6e-71
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 22/217 (10%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQIL 59
            Q  H N+++Y  +  ++N L I LEL   G L+ + + +      + +  V  Y  Q+ 
Sbjct: 87  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146

Query: 60  NGLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPE 107
           + L ++H R V+HR+IK AN+ + A+G             ++ T    S  GTP++++PE
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY-SHLEDMQALF-RIGRGKLPSVP-NSLS 164
            +    NGY   +DIWSLGC + EM   Q P+     ++ +L  +I +   P +P +  S
Sbjct: 207 RI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            + R  +  C+  +P  RP    + +          S
Sbjct: 265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  214 bits (548), Expect = 4e-70
 Identities = 73/204 (35%), Positives = 116/204 (56%), Gaps = 14/204 (6%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTY 64
           SQ +   + +Y G+   + +L+I +E +  GS  +L +   L ++Q+++  R+IL GL Y
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDY 134

Query: 65  LHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNLK 112
           LH    +HR+IK AN+L+   G            L  T     +F GTPFW+APEV+  K
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--K 192

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL 172
            + Y   ADIWSLG T +E+   +PP+S L  M+ LF I +   P++  + S+  ++F+ 
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 252

Query: 173 KCLQVNPNDRPTAAQLMEHPFVKR 196
            CL   P+ RPTA +L++H F+ R
Sbjct: 253 ACLNKEPSFRPTAKELLKHKFILR 276

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  215 bits (548), Expect = 4e-69
 Identities = 47/213 (22%), Positives = 92/213 (43%), Gaps = 26/213 (12%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
            D I++    E  +  +Y+ +E      L + L +K  +   +  SY + +L  +  +H+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 68  RNVVHREIKCANILVDAS-------GLA------TTTNDVKSFEGTPFWVAPEVVNLKNN 114
             +VH ++K AN L+          G+A      TT+    S  G   ++ PE +   ++
Sbjct: 174 HGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 115 G---------YGLSADIWSLGCTVLEMLTHQPPYSHLED-MQALFRIGRGKLP-SVPNSL 163
                         +D+WSLGC +  M   + P+  + + +  L  I         P+  
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 293

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
            +D +D +  CL+ +P  R +  +L+ HP+V+ 
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  212 bits (541), Expect = 1e-68
 Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 17/210 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNG 61
           +  +H NIVQY  + ++   LYI ++  + G L             + Q+  +  QI   
Sbjct: 78  ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA 137

Query: 62  LTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVV 109
           L ++H+R ++HR+IK  NI +   G            L +T    ++  GTP++++PE+ 
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI- 196

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
             +N  Y   +DIW+LGC + E+ T +  +        + +I  G  P V    S D R 
Sbjct: 197 -CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRS 255

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
            + +  + NP DRP+   ++E  F+ + ++
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  209 bits (535), Expect = 2e-68
 Identities = 65/211 (30%), Positives = 111/211 (52%), Gaps = 16/211 (7%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTY 64
            + ++ NIV Y+ +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEF 131

Query: 65  LHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNLK 112
           LH   V+HR+IK  NIL+   G            +    +   +  GTP+W+APEVV   
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV--T 189

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDARDF 170
              YG   DIWSLG   +EM+  +PPY +   ++AL+ I     P +  P  LS   RDF
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249

Query: 171 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           + +CL+++   R +A +L++H F+K     S
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  210 bits (536), Expect = 3e-68
 Identities = 62/211 (29%), Positives = 111/211 (52%), Gaps = 16/211 (7%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTY 64
             ++H N+V+   +      L++ +E ++ G+L ++  +  L++ Q+++    +L  L Y
Sbjct: 97  RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAY 156

Query: 65  LHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNLK 112
           LH + V+HR+IK  +IL+   G            ++      KS  GTP+W+APEV+   
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI--S 214

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDARDF 170
            + Y    DIWSLG  V+EM+  +PPY     +QA+ R+     P +   + +S   RDF
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDF 274

Query: 171 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           + + L  +P +R TA +L++HPF+ +     
Sbjct: 275 LERMLVRDPQERATAQELLDHPFLLQTGLPE 305

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  209 bits (535), Expect = 3e-68
 Identities = 72/216 (33%), Positives = 114/216 (52%), Gaps = 19/216 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGL 62
           +  +H  IV+ +G    + +L+I +E    G++  +  +    L++ Q+    RQ+L  L
Sbjct: 71  ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 130

Query: 63  TYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVV- 109
            +LH + ++HR++K  N+L+   G               T     SF GTP+W+APEVV 
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 110 --NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSR 165
              +K+  Y   ADIWSLG T++EM   +PP+  L  M+ L +I +   P++  P+  S 
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           + RDF+   L  NP  RP+AAQL+EHPFV       
Sbjct: 251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  209 bits (534), Expect = 5e-68
 Identities = 72/213 (33%), Positives = 114/213 (53%), Gaps = 18/213 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGL 62
            Q +  ++V+Y G+      L+I +E    GS++++ +  +  L++ ++++  +  L GL
Sbjct: 79  QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGL 138

Query: 63  TYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVN 110
            YLH    +HR+IK  NIL++  G            L  T     +  GTPFW+APEV+ 
Sbjct: 139 EYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI- 197

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDAR 168
            +  GY   ADIWSLG T +EM   +PPY+ +  M+A+F I     P+   P   S +  
Sbjct: 198 -QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT 256

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           DF+ +CL  +P  R TA QL++HPFV+     S
Sbjct: 257 DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  210 bits (536), Expect = 7e-68
 Identities = 47/213 (22%), Positives = 92/213 (43%), Gaps = 26/213 (12%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHE 67
            D I++    E  +  +Y+ +E      L +  +K   +   +  SY + +L  +  +H+
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 68  RNVVHREIKCANILVDAS-------GLA------TTTNDVKSFEGTPFWVAPEVVNLKNN 114
             +VH ++K AN L+          G+A      TT+    S  GT  ++ PE +   ++
Sbjct: 127 HGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 115 ---------GYGLSADIWSLGCTVLEMLTHQPPYSHLED-MQALFRIGRGKLP-SVPNSL 163
                         +D+WSLGC +  M   + P+  + + +  L  I         P+  
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
            +D +D +  CL+ +P  R +  +L+ HP+V+ 
Sbjct: 247 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  207 bits (530), Expect = 2e-67
 Identities = 47/213 (22%), Positives = 92/213 (43%), Gaps = 26/213 (12%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHE 67
            D I++    E  +  +Y+ +E      L +  +K   +   +  SY + +L  +  +H+
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 68  RNVVHREIKCANILVDAS-------GLA------TTTNDVKSFEGTPFWVAPEVVNLKNN 114
             +VH ++K AN L+          G+A      TT+    S  GT  ++ PE +   ++
Sbjct: 146 HGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205

Query: 115 ---------GYGLSADIWSLGCTVLEMLTHQPPYSHLED-MQALFRIGRGKLP-SVPNSL 163
                         +D+WSLGC +  M   + P+  + + +  L  I         P+  
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
            +D +D +  CL+ +P  R +  +L+ HP+V+ 
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  205 bits (524), Expect = 5e-66
 Identities = 68/209 (32%), Positives = 111/209 (53%), Gaps = 13/209 (6%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGL 62
            +  H N +QY G    E+  ++ +E    GS ++L + +   L + ++++ T   L GL
Sbjct: 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGL 167

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWVAPEVV-NLKN 113
            YLH  N++HR++K  NIL+           G A+      SF GTP+W+APEV+  +  
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDE 227

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS-LSRDARDFIL 172
             Y    D+WSLG T +E+   +PP  ++  M AL+ I + + P++ +   S   R+F+ 
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 287

Query: 173 KCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            CLQ  P DRPT+  L++H FV R    +
Sbjct: 288 SCLQKIPQDRPTSEVLLKHRFVLRERPPT 316

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  208 bits (530), Expect = 5e-66
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYL 65
           EH N+++Y  TEKD    YI +EL    +L    ++  +     +  +  +Q  +GL +L
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134

Query: 66  HERNVVHREIKCANILVDAS-------------GLA-------TTTNDVKSFEGTPFWVA 105
           H  N+VHR++K  NIL+                GL         + +      GT  W+A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 106 PEVVNLKNN-GYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKL--PSVPN 161
           PE+++         + DI+S GC    +++    P+      QA   +G   L       
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK 254

Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP 197
                AR+ I K + ++P  RP+A  +++HPF    
Sbjct: 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  200 bits (511), Expect = 2e-64
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 25/218 (11%)

Query: 9   HDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQIL 59
           H NI  Y G          +++L++ +E    GS+ +L +      L +  ++   R+IL
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 60  NGLTYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPE 107
            GL++LH+  V+HR+IK  N+L+  +             L  T     +F GTP+W+APE
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199

Query: 108 VVNLKNN---GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV-PNSL 163
           V+    N    Y   +D+WSLG T +EM    PP   +  M+ALF I R   P +     
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 259

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           S+  + FI  CL  N + RP   QLM+HPF++      
Sbjct: 260 SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER 297

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  198 bits (506), Expect = 6e-64
 Identities = 69/232 (29%), Positives = 109/232 (46%), Gaps = 36/232 (15%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---------LSDSQVSSYT 55
           SQ  H NIV Y  +   ++ L++ ++L+  GS+ ++ +            L +S +++  
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127

Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASG---LA--------TTTNDV------KSFE 98
           R++L GL YLH+   +HR++K  NIL+   G   +A         T  D+      K+F 
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 99  GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI------- 151
           GTP W+APEV+  +  GY   ADIWS G T +E+ T   PY     M+ L          
Sbjct: 188 GTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246

Query: 152 --GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
                +   +     +  R  I  CLQ +P  RPTAA+L+ H F ++     
Sbjct: 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  194 bits (494), Expect = 3e-61
 Identities = 56/259 (21%), Positives = 94/259 (36%), Gaps = 67/259 (25%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNG 61
             F H NIV Y  T   +N L++    +  GS  +L   +    +++  ++   + +L  
Sbjct: 81  KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140

Query: 62  LTYLHERNVVHREIKCANILVDASG---LA----------------TTTNDVKSFEGTPF 102
           L Y+H    VHR +K ++IL+   G   L+                   +  K       
Sbjct: 141 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200

Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPS---- 158
           W++PEV+     GY   +DI+S+G T  E+     P+  +   Q L     G +P     
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260

Query: 159 -----------------------------------------VPNSLSRDARDFILKCLQV 177
                                                       + S     F+ +CLQ 
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320

Query: 178 NPNDRPTAAQLMEHPFVKR 196
           NP+ RP+A+ L+ H F K+
Sbjct: 321 NPDARPSASTLLNHSFFKQ 339

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  187 bits (476), Expect = 1e-59
 Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 39/223 (17%)

Query: 5   SQFEHDNIVQYIG----------------TEKDENRLYIFLELVKKGSLANLYQKY---H 45
           ++ +H NIV Y G                +      L+I +E   KG+L    +K     
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 46  LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATT---TNDV 94
           L          QI  G+ Y+H + +++R++K +NI +  +        GL T+       
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178

Query: 95  KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGR 153
              +GT  +++PE   + +  YG   D+++LG  + E+L          +    F  +  
Sbjct: 179 TRSKGTLRYMSPEQ--ISSQDYGKEVDLYALGLILAELLHVCDTAF---ETSKFFTDLRD 233

Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           G +        +  +  + K L   P DRP  ++++    V +
Sbjct: 234 GIISD---IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  186 bits (474), Expect = 3e-59
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 28/220 (12%)

Query: 5   SQFEHDNIVQYIGT--EKDENRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQ 57
            + +H NIV+Y     ++    LYI +E  + G LA++  K      +L +  V     Q
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119

Query: 58  ILNGLTYLHERN-----VVHREIKCANILVDASG------------LATTTNDVKSFEGT 100
           +   L   H R+     V+HR++K AN+ +D               L   T+  K+F GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179

Query: 101 PFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKLPSV 159
           P++++PE   +    Y   +DIWSLGC + E+    PP++     + L  +I  GK   +
Sbjct: 180 PYYMSPEQ--MNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRRI 236

Query: 160 PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
           P   S +  + I + L +    RP+  +++E+P +     
Sbjct: 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  182 bits (463), Expect = 4e-57
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 34/225 (15%)

Query: 1   NFSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH------LSDSQVSSY 54
           +      +   IVQ+ G    E   +I +EL+   S    Y+  +      + +  +   
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKI 130

Query: 55  TRQILNGLTYLH-ERNVVHREIKCANILVDASG------------LATT---TNDVKSFE 98
           T   +  L +L     ++HR+IK +NIL+D SG            L  +   T D     
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA---- 186

Query: 99  GTPFWVAPEVVN--LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-QALFRIGRGK 155
           G   ++APE ++      GY + +D+WSLG T+ E+ T + PY     +   L ++ +G 
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246

Query: 156 LPSVPNSL----SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
            P + NS     S    +F+  CL  + + RP   +L++HPF+  
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  180 bits (460), Expect = 4e-57
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 22/217 (10%)

Query: 1   NFSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----LSDSQVSSYT 55
           + S    +    V + G    E  ++I +EL+   SL   Y++       + +  +    
Sbjct: 57  DISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIA 115

Query: 56  RQILNGLTYLH-ERNVVHREIKCANILVDASG---LA--------TTTNDVKSFEGTPFW 103
             I+  L +LH + +V+HR++K +N+L++A G   +                   G   +
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPY 175

Query: 104 VAPEVVN--LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE-DMQALFRIGRGKLPSVP 160
           +APE +N  L   GY + +DIWSLG T++E+   + PY       Q L ++     P +P
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP 235

Query: 161 -NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
            +  S +  DF  +CL+ N  +RPT  +LM+HPF   
Sbjct: 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  181 bits (461), Expect = 5e-57
 Identities = 52/241 (21%), Positives = 95/241 (39%), Gaps = 47/241 (19%)

Query: 5   SQFEHDNIVQYIGTEKDENR-------------LYIFLELVKKGSLANL--YQKYHLSDS 49
           +   H  +V+Y     +                L+I +E  + G+L +L   +  +    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDV------- 94
           +     RQIL  L+Y+H + ++HR++K  NI +D S        GLA   +         
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 95  -----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE 143
                       S  GT  +VA EV++   + Y    D++SLG    EM+   P  + +E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGH-YNEKIDMYSLGIIFFEMIY--PFSTGME 233

Query: 144 DMQALFRIGRGKL---PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQT 200
            +  L ++    +   P   ++  +  +  I   +  +PN RP A  L+   ++    Q 
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293

Query: 201 S 201
            
Sbjct: 294 E 294

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  181 bits (460), Expect = 7e-57
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 21/216 (9%)

Query: 1   NFSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQI 58
           +      +   IVQ  GT      ++I +EL+   +   L ++    + +  +   T  I
Sbjct: 75  DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK-LKKRMQGPIPERILGKMTVAI 133

Query: 59  LNGLTYLH-ERNVVHREIKCANILVDASG---LA--------TTTNDVKSFEGTPFWVAP 106
           +  L YL  +  V+HR++K +NIL+D  G   L                   G   ++AP
Sbjct: 134 VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAP 193

Query: 107 EVVN---LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE-DMQALFRIGRGKLPSVPNS 162
           E ++        Y + AD+WSLG +++E+ T Q PY + + D + L ++ + + P +P  
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH 253

Query: 163 L--SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           +  S D + F+  CL  +   RP   +L+EH F+KR
Sbjct: 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  177 bits (450), Expect = 2e-55
 Identities = 49/232 (21%), Positives = 90/232 (38%), Gaps = 44/232 (18%)

Query: 5   SQFEHDNIVQYIGTEKDENR------------LYIFLELVKKGSLANLYQK----YHLSD 48
           ++ EH  IV+Y     ++N             LYI ++L +K +L +             
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117

Query: 49  SQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFE-- 98
           S       QI   + +LH + ++HR++K +NI             GL T  +  +  +  
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

Query: 99  --------------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED 144
                         GT  +++PE   +  N Y    DI+SLG  + E+L   P  + +E 
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQ--IHGNSYSHKVDIFSLGLILFELLY--PFSTQMER 233

Query: 145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           ++ L  +   K P +           +   L  +P +RP A  ++E+   + 
Sbjct: 234 VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  172 bits (439), Expect = 4e-54
 Identities = 55/207 (26%), Positives = 107/207 (51%), Gaps = 19/207 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            Q +H +I++     +D N +Y+ LE+   G +    +      S+++   +  QI+ G+
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFE----GTPFWVAPEVVN 110
            YLH   ++HR++  +N+L+  +        GLAT             GTP +++PE+  
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKLPSVPNSLSRDARD 169
              + +GL +D+WSLGC    +L  +PP+   + ++    ++       +P+ LS +A+D
Sbjct: 186 --RSAHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLADY-EMPSFLSIEAKD 241

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKR 196
            I + L+ NP DR + + +++HPF+ R
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFMSR 268

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  173 bits (440), Expect = 4e-54
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 18/206 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
               H ++V + G  +D + +++ LEL ++ SL  L+++   L++ +   Y RQI+ G  
Sbjct: 70  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFE----GTPFWVAPEVVNL 111
           YLH   V+HR++K  N+ ++          GLAT        +    GTP ++APEV  L
Sbjct: 130 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV--L 187

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKLPSVPNSLSRDARDF 170
              G+    D+WS+GC +  +L  +PP+     ++  + RI + +  S+P  ++  A   
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEY-SIPKHINPVAASL 245

Query: 171 ILKCLQVNPNDRPTAAQLMEHPFVKR 196
           I K LQ +P  RPT  +L+   F   
Sbjct: 246 IQKMLQTDPTARPTINELLNDEFFTS 271

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  172 bits (439), Expect = 2e-53
 Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 18/206 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
               H ++V + G  +D + +++ LEL ++ SL  L+++   L++ +   Y RQI+ G  
Sbjct: 96  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFE----GTPFWVAPEVVNL 111
           YLH   V+HR++K  N+ ++          GLAT        +    GTP ++APEV++ 
Sbjct: 156 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS- 214

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKLPSVPNSLSRDARDF 170
              G+    D+WS+GC +  +L  +PP+     ++  + RI + +  S+P  ++  A   
Sbjct: 215 -KKGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEY-SIPKHINPVAASL 271

Query: 171 ILKCLQVNPNDRPTAAQLMEHPFVKR 196
           I K LQ +P  RPT  +L+   F   
Sbjct: 272 IQKMLQTDPTARPTINELLNDEFFTS 297

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  167 bits (426), Expect = 4e-52
 Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 14/203 (6%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK     + + ++Y  ++ N L+
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTNDVK--SFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++        G +      +     GT  ++ PE++    
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIE--G 181

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +  + P+ ++  ARD I +
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARDLISR 240

Query: 174 CLQVNPNDRPTAAQLMEHPFVKR 196
            L+ NP+ RP   +++EHP++  
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITA 263

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  165 bits (418), Expect = 4e-50
 Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 57/247 (23%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLT 63
            +     IV + G    +  + I +E +  GSL  + +K   + +  +   +  ++ GLT
Sbjct: 86  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 145

Query: 64  YLH-ERNVVHREIKCANILVDASG---LA-------TTTNDVKSFEGTPFWVAPEVVNLK 112
           YL  +  ++HR++K +NILV++ G   L           +   SF GT  +++PE   L+
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPER--LQ 203

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPY--------------------------------- 139
              Y + +DIWS+G +++EM   + P                                  
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263

Query: 140 -----SHLEDMQALF----RIGRGKLPSVPNSL-SRDARDFILKCLQVNPNDRPTAAQLM 189
                       A+F     I     P +P+ + S + +DF+ KCL  NP +R    QLM
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 323

Query: 190 EHPFVKR 196
            H F+KR
Sbjct: 324 VHAFIKR 330

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  165 bits (420), Expect = 9e-50
 Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 48/237 (20%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYT--------RQIL 59
           +H N+++Y  +E  +  LYI LEL    +L +L +  ++SD  +            RQI 
Sbjct: 67  DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125

Query: 60  NGLTYLHERNVVHREIKCANILVDAS---------------------GLA--------TT 90
           +G+ +LH   ++HR++K  NILV  S                     GL         + 
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185

Query: 91  TNDVKSFEGTPFWVAPEVVN-----LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLED 144
             ++ +  GT  W APE++              S DI+S+GC    +L+  + P+     
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245

Query: 145 MQALFRIGRGKLPSVP----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP 197
            ++    G   L  +      SL  +A D I + +  +P  RPTA +++ HP     
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  162 bits (411), Expect = 3e-49
 Identities = 43/219 (19%), Positives = 83/219 (37%), Gaps = 32/219 (14%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL--YQKYH--LSDSQVSSYTRQILN 60
             F   N V  +     +  LYI ++L +K +L +    +                QI  
Sbjct: 116 DPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE 175

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFE-------------- 98
            + +LH + ++HR++K +NI             GL T  +  +  +              
Sbjct: 176 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235

Query: 99  --GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL 156
             GT  +++PE   +  N Y    DI+SLG  + E+L      + +E ++ +  +   K 
Sbjct: 236 QVGTKLYMSPEQ--IHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDVRNLKF 291

Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           P +           +   L  +P +RP A  ++E+   +
Sbjct: 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  160 bits (407), Expect = 4e-49
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 16/204 (7%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
           S   H NI++      D  R+Y+ LE   +G L    QK+    + + +++  ++ + L 
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTNDVK--SFEGTPFWVAPEVVNLKN 113
           Y HER V+HR+IK  N+L+           G +     ++  +  GT  ++ PE++    
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIE--G 186

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKLPSVPNSLSRDARDFIL 172
             +    D+W  G    E L   PP+           RI    L   P  LS  ++D I 
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVNVDL-KFPPFLSDGSKDLIS 244

Query: 173 KCLQVNPNDRPTAAQLMEHPFVKR 196
           K L+ +P  R     +MEHP+VK 
Sbjct: 245 KLLRYHPPQRLPLKGVMEHPWVKA 268

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  157 bits (398), Expect = 3e-47
 Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 25/211 (11%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NI+       D   +Y+  EL+K G L + + ++   S+ + S+    I   + YLH 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134

Query: 68  RNVVHREIKCANILV-----DAS-------GLATTTNDVKSFE----GTPFWVAPEVVNL 111
           + VVHR++K +NIL      +         G A               T  +VAPEV  L
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV--L 192

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--QALF-RIGRGKL--PSVP-NSLSR 165
           +  GY  + DIWSLG  +  MLT   P+++  D   + +  RIG GK        NS+S 
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
            A+D + K L V+P+ R TAA ++ HP++  
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  152 bits (387), Expect = 6e-46
 Identities = 47/226 (20%), Positives = 88/226 (38%), Gaps = 33/226 (14%)

Query: 5   SQFEHDNIVQYIGTEKDE----NRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYT 55
             F H NI++ +     E    +  ++ L   K+G+L N  ++       L++ Q+    
Sbjct: 81  RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140

Query: 56  RQILNGLTYLHERNVVHREIKCANILVDASGL---------------------ATTTNDV 94
             I  GL  +H +   HR++K  NIL+   G                      A T  D 
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200

Query: 95  KSFEGTPFWVAPEVVNLK-NNGYGLSADIWSLGCTVLEMLTHQPPY-SHLEDMQALFRIG 152
            +   T  + APE+ +++ +       D+WSLGC +  M+  + PY    +   ++    
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260

Query: 153 RGKLPSVPNS-LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP 197
           + +L    +   S      +   + V+P+ RP    L+      +P
Sbjct: 261 QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  151 bits (383), Expect = 2e-45
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 21/209 (10%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLH 66
            H NI+Q   T +     ++  +L+KKG L + L +K  LS+ +     R +L  +  LH
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141

Query: 67  ERNVVHREIKCANILVDAS--------GLATTTNDVKSFE---GTPFWVAPEV----VNL 111
           + N+VHR++K  NIL+D          G +   +  +      GTP ++APE+    +N 
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 201

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDA 167
            + GYG   D+WS G  +  +L   PP+ H      + R I  G     S   +  S   
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTV 260

Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           +D + + L V P  R TA + + HPF ++
Sbjct: 261 KDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  150 bits (381), Expect = 3e-45
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 22/209 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           + +H NIV+   + ++E+  Y+  +LV  G L   +  +   S++  S   +QIL  + Y
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120

Query: 65  LHERNVVHREIKCANILV-----DAS------GLATTTNDVKSFE---GTPFWVAPEVVN 110
            H   +VHR +K  N+L+      A+      GLA   ND +++    GTP +++PEV  
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-- 178

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRD 166
           LK + Y    DIW+ G  +  +L   PP+   ED   L+  I  G    PS   ++++ +
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPE 237

Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           A+  I   L VNP  R TA Q ++ P++ 
Sbjct: 238 AKSLIDSMLTVNPKKRITADQALKVPWIC 266

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  153 bits (388), Expect = 4e-45
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 21/210 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           +  H  I++       E+  YI LEL++ G L + +     L ++    Y  Q+L  + Y
Sbjct: 196 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254

Query: 65  LHERNVVHREIKCANILVDAS-----------GLATTTNDVKSFE---GTPFWVAPEVV- 109
           LHE  ++HR++K  N+L+ +            G +    +        GTP ++APEV+ 
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 314

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKL--PSVP-NSLSR 165
           ++   GY  + D WSLG  +   L+  PP+S      +L  +I  GK          +S 
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
            A D + K L V+P  R T  + + HP+++
Sbjct: 375 KALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  151 bits (384), Expect = 4e-45
 Identities = 49/230 (21%), Positives = 96/230 (41%), Gaps = 39/230 (16%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL---------ANLYQKYHLSDSQVSSYT 55
           +  +++  +   G   + + +YI  E ++  S+          +      +    +    
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 56  RQILNGLTYLH-ERNVVHREIKCANILVDAS--------GLATTTND--VKSFEGTPFWV 104
           + +LN  +Y+H E+N+ HR++K +NIL+D +        G +    D  +K   GT  ++
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFM 217

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKL------- 156
            PE  + +++  G   DIWSLG  +  M  +  P+S    +  LF  I    +       
Sbjct: 218 PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRN 277

Query: 157 -----------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                          N LS +  DF+   L+ NP +R T+   ++H ++ 
Sbjct: 278 HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  151 bits (383), Expect = 7e-45
 Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 21/208 (10%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H +I+  I + +  + +++  +L++KG L + L +K  LS+ +  S  R +L  +++LH 
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218

Query: 68  RNVVHREIKCANILVDAS--------GLATTTNDVKSFE---GTPFWVAPEV----VNLK 112
            N+VHR++K  NIL+D +        G +      +      GTP ++APE+    ++  
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDET 278

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDAR 168
           + GYG   D+W+ G  +  +L   PP+ H      + R I  G+    S   +  S   +
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPEWDDRSSTVK 337

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           D I + LQV+P  R TA Q ++HPF +R
Sbjct: 338 DLISRLLQVDPEARLTAEQALQHPFFER 365

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  151 bits (383), Expect = 8e-45
 Identities = 33/215 (15%), Positives = 64/215 (29%), Gaps = 31/215 (14%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLEL-VKKGSLANLY--------QKYHLSDSQVSSYTRQI 58
           +   +++    E+D   L  F      + +L                L        T Q+
Sbjct: 156 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 215

Query: 59  LNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWVAPEVVN 110
           +  L  LH   +VH  ++  +I++D                        +  +  PE+  
Sbjct: 216 IRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEA 275

Query: 111 ---------LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN 161
                     +      S D W+LG  +  +     P +    +     I R        
Sbjct: 276 RRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS-----CK 330

Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           ++ +  R  +   L+    DR    Q ME P  ++
Sbjct: 331 NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  148 bits (377), Expect = 1e-44
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 26/212 (12%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSL-----ANLYQKYHLSDSQVSSYTRQILN 60
             +H NI++     +D + +YI +E  + G L     +   +   LS+  V+   +Q++N
Sbjct: 76  SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135

Query: 61  GLTYLHERNVVHREIKCANILVDAS-----------GLATTTNDVKSFE---GTPFWVAP 106
            L Y H ++VVH+++K  NIL   +           GLA      +      GT  ++AP
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVPNSL 163
           EV            DIWS G  +  +LT   P+     ++ + +     +         L
Sbjct: 196 EVFK---RDVTFKCDIWSAGVVMYFLLTGCLPF-TGTSLEEVQQKATYKEPNYAVECRPL 251

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +  A D + + L  +P  RP+AAQ++ H + K
Sbjct: 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  150 bits (380), Expect = 1e-44
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 28/213 (13%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+      D+   ++ +EL+  G L   + +K H S+++ S   R++++ ++++H+
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124

Query: 68  RNVVHREIKCANILV-----DAS------GLATTTND----VKSFEGTPFWVAPEVVNLK 112
             VVHR++K  N+L      +        G A         +K+   T  + APE+  L 
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL--LN 182

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPP-YSHLEDM-----QALF-RIGRGKL--PSVP-NS 162
            NGY  S D+WSLG  +  ML+ Q P  SH   +       +  +I +G          +
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242

Query: 163 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +S++A+D I   L V+PN R   + L  + +++
Sbjct: 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  150 bits (381), Expect = 1e-44
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 22/206 (10%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+   + ++E+  Y+  +LV  G L   +  +   S++  S   +QIL  + Y H 
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 146

Query: 68  RNVVHREIKCANILV-----DAS------GLATTTNDVKSFE---GTPFWVAPEVVNLKN 113
             +VHR +K  N+L+      A+      GLA   ND +++    GTP +++PEV  LK 
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV--LKK 204

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDARD 169
           + Y    DIW+ G  +  +L   PP+   ED   L+  I  G    PS   ++++ +A+ 
Sbjct: 205 DPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVK 195
            I   L VNP  R TA Q ++ P++ 
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWIC 289

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  149 bits (378), Expect = 2e-44
 Identities = 58/251 (23%), Positives = 93/251 (37%), Gaps = 64/251 (25%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSL------------------------------- 37
           H NI +     +DE  + + +EL   G L                               
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146

Query: 38  ----------ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS-- 85
                           +   +  +S+  RQI + L YLH + + HR+IK  N L   +  
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206

Query: 86  --------GLATTTNDVKSFE--------GTPFWVAPEVVNLKNNGYGLSADIWSLGCTV 129
                   GL+     + + E        GTP++VAPEV+N  N  YG   D WS G  +
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 130 LEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDARDFILKCLQVNPNDRPTA 185
             +L    P+    +       +   KL   +   N LS  ARD +   L  N ++R  A
Sbjct: 267 HLLLMGAVPFPG-VNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325

Query: 186 AQLMEHPFVKR 196
            + ++HP++ +
Sbjct: 326 MRALQHPWISQ 336

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  147 bits (373), Expect = 4e-44
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 23/207 (11%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NI+      +++  + + LELV  G L + L +K  L++ + + + +QIL+G+ YLH 
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126

Query: 68  RNVVHREIKCANILVDAS------------GLATTTNDVKSFE---GTPFWVAPEVVNLK 112
           + + H ++K  NI++               G+A        F+   GTP +VAPE+  + 
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI--VN 184

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDAR 168
               GL AD+WS+G     +L+   P+   E  Q     I            ++ S  A+
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSNTSELAK 243

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVK 195
           DFI + L  +P  R T AQ +EH ++K
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  147 bits (373), Expect = 7e-44
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 21/205 (10%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H+NIV      +     Y+ ++LV  G L + + ++   ++   S   +Q+L+ + YLHE
Sbjct: 65  HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE 124

Query: 68  RNVVHREIKCANILV-----DAS------GLATTTND--VKSFEGTPFWVAPEVVNLKNN 114
             +VHR++K  N+L      ++       GL+    +  + +  GTP +VAPEV  L   
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEV--LAQK 182

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDARDF 170
            Y  + D WS+G     +L   PP+   E    LF  I  G     S   + +S  A+DF
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESAKDF 241

Query: 171 ILKCLQVNPNDRPTAAQLMEHPFVK 195
           I   L+ +PN+R T  + + HP++ 
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWID 266

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  147 bits (373), Expect = 2e-43
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NI++     +    + + LELV  G L + + +K + S+   +   +QIL  + YLHE
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166

Query: 68  RNVVHREIKCANILV-----DAS------GLATTTNDVKSFE---GTPFWVAPEVVNLKN 113
             +VHR++K  N+L      DA       GL+         +   GTP + APE+  L+ 
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI--LRG 224

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDARD 169
             YG   D+WS+G     +L    P+      Q +FR I   +    S   + +S +A+D
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVK 195
            + K + ++P  R T  Q ++HP+V 
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWVT 310

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  145 bits (368), Expect = 2e-43
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 23/215 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
             +H NI++   T +D   +Y+ +EL   G L   +  K    +S  +   + +L+ + Y
Sbjct: 62  SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121

Query: 65  LHERNVVHREIKCANILVDAS-----------GLATTTNDVKSFE---GTPFWVAPEVVN 110
            H+ NV HR++K  N L               GLA      K      GTP++V+P+V+ 
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE 181

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRD 166
                YG   D WS G  +  +L   PP+        +   I  G    P     ++S  
Sbjct: 182 ---GLYGPECDEWSAGVMMYVLLCGYPPF-SAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237

Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           A   I + L  +P  R T+ Q +EH + ++ L +S
Sbjct: 238 AESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  145 bits (369), Expect = 4e-43
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 21/210 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           +  H  I++       E+  YI LEL++ G L + +     L ++    Y  Q+L  + Y
Sbjct: 71  KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129

Query: 65  LHERNVVHREIKCANILVDAS-----------GLATTTNDVKSFE---GTPFWVAPEV-V 109
           LHE  ++HR++K  N+L+ +            G +    +        GTP ++APEV V
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSR 165
           ++   GY  + D WSLG  +   L+  PP+S      +L   I  GK          +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
            A D + K L V+P  R T  + + HP+++
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  145 bits (367), Expect = 4e-43
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 23/206 (11%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NI++     +D +  YI  EL   G L + + ++   S+   +   +Q+ +G+TY+H+
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139

Query: 68  RNVVHREIKCANILVDAS-----------GLATTTNDVKSFE---GTPFWVAPEVVNLKN 113
            N+VHR++K  NIL+++            GL+T        +   GT +++APEV  L+ 
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV--LRG 197

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDARD 169
             Y    D+WS G  +  +L+  PP+   ++   + + +  GK         ++S DA+D
Sbjct: 198 T-YDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKD 255

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVK 195
            I K L  +P+ R TA Q +EHP+++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQ 281

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  145 bits (368), Expect = 5e-43
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 21/206 (10%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H N++      ++   + + LELV  G L + L QK  LS+ + +S+ +QIL+G+ YLH 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133

Query: 68  RNVVHREIKCANILVDAS------------GLATTTNDVKSFE---GTPFWVAPEVVNLK 112
           + + H ++K  NI++               GLA    D   F+   GTP +VAPE+  + 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI--VN 191

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL--PSVP-NSLSRDARD 169
               GL AD+WS+G     +L+   P+      + L  I            +  S  A+D
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKD 251

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVK 195
           FI K L      R T  + + HP++ 
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWIT 277

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  146 bits (370), Expect = 6e-43
 Identities = 28/214 (13%), Positives = 53/214 (24%), Gaps = 26/214 (12%)

Query: 9   HDNIVQYIGTEKDENRLYIFLEL-VKKGSLANLY--------QKYHLSDSQVSSYTRQIL 59
                Q    + D       L +      L  L+         +       +   T Q++
Sbjct: 145 QPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLI 204

Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-APEVVN 110
                L  + +VH      N+ +                          P      E +N
Sbjct: 205 RLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLN 264

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYS-------HLEDMQALFRIGRGKLP-SVPNS 162
                +  + + W LG ++  +     P+              +L   G   L       
Sbjct: 265 ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTP 324

Query: 163 LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           L    +  I + L  +   R    + ME P   +
Sbjct: 325 LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  148 bits (375), Expect = 7e-43
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 23/207 (11%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV+   +  +E   Y+  +LV  G L   +  + + S++  S   +QIL  + + H+
Sbjct: 69  HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128

Query: 68  RNVVHREIKCANILV-----DAS------GLATTTND----VKSFEGTPFWVAPEVVNLK 112
             VVHR +K  N+L+      A+      GLA            F GTP +++PEV  L+
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV--LR 186

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDAR 168
            + YG   D+W+ G  +  +L   PP+   ED   L++ I  G    PS   ++++ +A+
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVK 195
           D I K L +NP+ R TAA+ ++HP++ 
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWIS 272

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  148 bits (375), Expect = 9e-43
 Identities = 52/212 (24%), Positives = 103/212 (48%), Gaps = 23/212 (10%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NI++     +D+   Y+  E+   G L + +  +   S+   +   RQ+L+G+TY+H+
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144

Query: 68  RNVVHREIKCANILVDAS-----------GLATTTNDVKSFE---GTPFWVAPEVVNLKN 113
             +VHR++K  N+L+++            GL+T     K  +   GT +++APEV++   
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH--- 201

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDARD 169
             Y    D+WS G  +  +L+  PP+ +  +   + + + +GK          +S  A+D
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
            I K L   P+ R +A   ++H +++   +  
Sbjct: 261 LIRKMLTYVPSMRISARDALDHEWIQTYTKEQ 292

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  144 bits (366), Expect = 1e-42
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 23/207 (11%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H N++      +++  + + LELV  G L + L +K  L++ + + + +QILNG+ YLH 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132

Query: 68  RNVVHREIKCANILVDAS------------GLATTTNDVKSFE---GTPFWVAPEVVNLK 112
             + H ++K  NI++               GLA   +    F+   GTP +VAPE+  + 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI--VN 190

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDAR 168
               GL AD+WS+G     +L+   P+   +  Q     +            ++ S  A+
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSNTSALAK 249

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVK 195
           DFI + L  +P  R T    ++HP++K
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  147 bits (374), Expect = 1e-42
 Identities = 58/211 (27%), Positives = 107/211 (50%), Gaps = 21/211 (9%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NI++     +D+   Y+ +E  K G L + +  +   ++   +   +Q+L+G+TYLH+
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154

Query: 68  RNVVHREIKCANILVDAS-----------GLATTTNDVKSFE---GTPFWVAPEVVNLKN 113
            N+VHR++K  N+L+++            GL+    + K  +   GT +++APEV+    
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR--- 211

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL--PSVP-NSLSRDARDF 170
             Y    D+WS+G  +  +L   PP+    D + L ++ +GK    S    ++S  A+D 
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271

Query: 171 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           I + LQ +   R +A Q +EHP++K      
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  142 bits (361), Expect = 2e-42
 Identities = 47/210 (22%), Positives = 92/210 (43%), Gaps = 24/210 (11%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT 63
           F+  +H NI+   G    E  L + +E  + G L  +     +    + ++  QI  G+ 
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMN 119

Query: 64  YLHERN---VVHREIKCANILVDAS----------------GLAT--TTNDVKSFEGTPF 102
           YLH+     ++HR++K +NIL+                   GLA         S  G   
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA 179

Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL-PSVPN 161
           W+APEV  ++ + +   +D+WS G  + E+LT + P+  ++ +   + +   KL   +P+
Sbjct: 180 WMAPEV--IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237

Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           +        +  C   +P+ RP+   +++ 
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  145 bits (367), Expect = 2e-42
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 23/207 (11%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NI+      ++   + + LELV  G L + L QK  LS+ + +S+ +QIL+G+ YLH 
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133

Query: 68  RNVVHREIKCANILVDAS------------GLATTTNDVKSFE---GTPFWVAPEVVNLK 112
           + + H ++K  NI++               GLA    D   F+   GTP +VAPE+  + 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI--VN 191

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDAR 168
               GL AD+WS+G     +L+   P+   +  Q     I            +  S  A+
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFSQTSELAK 250

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVK 195
           DFI K L      R T  + + HP++ 
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWIT 277

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  144 bits (366), Expect = 2e-42
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 28/211 (13%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSL-----ANLYQKYHLSDSQVSSYTRQILNGLT 63
           H +IV+ + T   +  LY+  E +    L           +  S++  S Y RQIL  L 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 64  YLHERNVVHREIKCANILV-----DAS------GLATTTND----VKSFEGTPFWVAPEV 108
           Y H+ N++HR++K   +L+      A       G+A    +         GTP ++APEV
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLS 164
             +K   YG   D+W  G  +  +L+   P+      + LF  I +GK        + +S
Sbjct: 205 --VKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMNPRQWSHIS 260

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
             A+D + + L ++P +R T  + + HP++K
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  143 bits (363), Expect = 2e-42
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 20/208 (9%)

Query: 7   FEHDNIVQ-Y-IGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTY 64
            +H N+V+   +  + +E+ LY+  ELV +G +  +     LS+ Q   Y + ++ G+ Y
Sbjct: 93  LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEY 152

Query: 65  LHERNVVHREIKCANILVDAS--------GLATTTND----VKSFEGTPFWVAPEVVNLK 112
           LH + ++HR+IK +N+LV           G++         + +  GTP ++APE ++  
Sbjct: 153 LHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSET 212

Query: 113 NNGY-GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRG--KLPSVPNSLSRDAR 168
              + G + D+W++G T+   +  Q P+   E +  L   I     + P  P+ ++ D +
Sbjct: 213 RKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKIKSQALEFPDQPD-IAEDLK 270

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           D I + L  NP  R    ++  HP+V R
Sbjct: 271 DLITRMLDKNPESRIVVPEIKLHPWVTR 298

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  142 bits (361), Expect = 4e-42
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 23/208 (11%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL----YQKYHLSDSQVSSYTRQIL 59
             +  H NIV ++G       L I  E + +GSL  L      +  L + +  S    + 
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147

Query: 60  NGLTYLHERN--VVHREIKCANILVDAS--------GLAT----TTNDVKSFEGTPFWVA 105
            G+ YLH RN  +VHR +K  N+LVD          GL+     T    KS  GTP W+A
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVL-EMLTHQPPYSHLEDMQALFRIGRGKL-PSVPNSL 163
           PEV  L++      +D++S G  +L E+ T Q P+ +L   Q +  +G       +P +L
Sbjct: 208 PEV--LRDEPSNEKSDVYSFG-VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL 264

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEH 191
           +      I  C    P  RP+ A +M+ 
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDL 292

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  147 bits (372), Expect = 4e-42
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 23/207 (11%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NI++     +D+   Y+  E  + G L   +  ++   +   ++  +QIL+G+ YLH+
Sbjct: 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK 164

Query: 68  RNVVHREIKCANILVDAS-----------GLAT---TTNDVKSFEGTPFWVAPEVVNLKN 113
            N+VHR+IK  NIL++             GL++       ++   GT +++APEV  LK 
Sbjct: 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV--LKK 222

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDARD 169
             Y    D+WS G  +  +L   PP+   ++ Q + + + +GK         ++S +A++
Sbjct: 223 K-YNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKE 280

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKR 196
            I   L  + N R TA + +   ++K+
Sbjct: 281 LIKLMLTYDYNKRCTAEEALNSRWIKK 307

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  146 bits (371), Expect = 5e-42
 Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 23/206 (11%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NI++     +D +  YI  EL   G L + + ++   S+   +   +Q+ +G+TY+H+
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139

Query: 68  RNVVHREIKCANILVDAS-----------GLATTTNDVKSFE---GTPFWVAPEVVNLKN 113
            N+VHR++K  NIL+++            GL+T        +   GT +++APEV  L+ 
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV--LRG 197

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDARD 169
             Y    D+WS G  +  +L+  PP+ + ++   + + +  GK         ++S DA+D
Sbjct: 198 T-YDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVK 195
            I K L  +P+ R TA Q +EHP+++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQ 281

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  142 bits (359), Expect = 2e-41
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 40/229 (17%)

Query: 9   HDNIVQYIGT----EKDENRLYIFLELVKKGSL-----ANLYQKYHLSDSQVSSYTRQIL 59
             +IV  +         +  L I +E ++ G L         Q +  ++ + +   R I 
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF--TEREAAEIMRDIG 138

Query: 60  NGLTYLHERNVVHREIKCANILV-----DAS------GLAT--TTNDVKSFEGTPFWVAP 106
             + +LH  N+ HR++K  N+L      DA       G A   T N +++   TP++VAP
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAP 198

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALF-RIGRGKL--PSVP 160
           EV  L    Y  S D+WSLG  +  +L   PP+   +       +  RI  G+   P+  
Sbjct: 199 EV--LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256

Query: 161 -NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK-------RPLQTS 201
            + +S DA+  I   L+ +P +R T  Q M HP++         PL T+
Sbjct: 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTA 305

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  141 bits (358), Expect = 2e-41
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 30/212 (14%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSL-----ANLYQKYHLSDSQVSSYTRQILNGLT 63
              ++      ++ + + + LE    G +       L +   +S++ V    +QIL G+ 
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE--MVSENDVIRLIKQILEGVY 145

Query: 64  YLHERNVVHREIKCANILVDAS-----------GLATTTNDVKSFE---GTPFWVAPEVV 109
           YLH+ N+VH ++K  NIL+ +            G++             GTP ++APE+ 
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI- 204

Query: 110 NLKNNGYGLSADIWSLGCTVLE--MLTHQPPYSHLEDMQALFRIGRGKL--PSVP-NSLS 164
            L  +    + D+W++G  ++   +LTH  P+   ++ +    I +  +       +S+S
Sbjct: 205 -LNYDPITTATDMWNIG--IIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS 261

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           + A DFI   L  NP  RPTA   + H ++++
Sbjct: 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  140 bits (356), Expect = 3e-41
 Identities = 57/241 (23%), Positives = 103/241 (42%), Gaps = 49/241 (20%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H N+++ I   ++E+R Y+  E ++ GS+ + ++++ H ++ + S   + + + L +LH 
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129

Query: 68  RNVVHREIKCANILV-----DAS------GLATTTNDVKSFE-----------GTPFWVA 105
           + + HR++K  NIL       +        L +                    G+  ++A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 106 PEVVNLKNN---GYGLSADIWSLGCTVLEMLTHQPP--------------YSHLEDMQAL 148
           PEVV   +     Y    D+WSLG  +  +L+  PP               +       L
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249

Query: 149 F-RIGRGKL--PSVP-NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK-----RPLQ 199
           F  I  GK   P      +S  A+D I K L  +   R +AAQ+++HP+V+       L 
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309

Query: 200 T 200
           T
Sbjct: 310 T 310

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  142 bits (360), Expect = 3e-41
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 20/208 (9%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNGLT 63
           Q  H  ++      +D+  + + LE +  G L +    + Y +S+++V +Y RQ   GL 
Sbjct: 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 163

Query: 64  YLHERNVVHREIKCANILVDAS----------GLATTTNDVKSFE---GTPFWVAPEVVN 110
           ++HE ++VH +IK  NI+ +            GLAT  N  +  +    T  + APE+V+
Sbjct: 164 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 223

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL--PSVP-NSLSRDA 167
                 G   D+W++G     +L+   P++  +D++ L  + R          +S+S +A
Sbjct: 224 --REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 281

Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +DFI   LQ  P  R T    +EHP++K
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEHPWLK 309

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  140 bits (356), Expect = 3e-41
 Identities = 47/208 (22%), Positives = 87/208 (41%), Gaps = 22/208 (10%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNGLTYLH 66
           H NI+    + +    L +  E +    +        + L++ ++ SY  Q+   L +LH
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 67  ERNVVHREIKCANILVDAS----------GLATTTNDVKSFE---GTPFWVAPEVVNLKN 113
             N+ H +I+  NI+              G A       +F      P + APEV   ++
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV--HQH 177

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL--PSVP-NSLSRDARD 169
           +    + D+WSLG  V  +L+   P+   E  Q +   I   +          +S +A D
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKRP 197
           F+ + L      R TA++ ++HP++K+ 
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWLKQK 264

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  140 bits (356), Expect = 3e-41
 Identities = 43/214 (20%), Positives = 93/214 (43%), Gaps = 26/214 (12%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL--YQKYHLSDSQVSSYTRQILNG 61
           + Q  H+N+V ++G       L I   L K  +L ++    K  L  ++     ++I+ G
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142

Query: 62  LTYLHERNVVHREIKCANILVDAS-------GLAT---------TTNDVKSFEGTPFWVA 105
           + YLH + ++H+++K  N+  D         GL +           + ++   G    +A
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

Query: 106 PEVVNLKNNG-------YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPS 158
           PE++   +         +   +D+++LG    E+   + P+        ++++G G  P+
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262

Query: 159 VPN-SLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           +    + ++  D +L C      +RPT  +LM+ 
Sbjct: 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  139 bits (352), Expect = 7e-41
 Identities = 50/211 (23%), Positives = 102/211 (48%), Gaps = 25/211 (11%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL--YQKYHLSDSQVSSYTRQILNG 61
             +  H NI+ ++G       L I  +  +  SL +     +      ++    RQ   G
Sbjct: 74  LRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLAT------TTNDVKSFEGTPFWVAPE 107
           + YLH ++++HR++K  NI +           GLAT       ++  +   G+  W+APE
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192

Query: 108 VVNLKNNG-YGLSADIWSLGCTVL-EMLTHQPPYSHLEDM-QALFRIGRGKL----PSVP 160
           V+ ++++  Y   +D+++ G  VL E++T Q PYS++ +  Q +  +GRG L      V 
Sbjct: 193 VIRMQDSNPYSFQSDVYAFG-IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251

Query: 161 NSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           ++  +  +  + +CL+   ++RP+  +++  
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAE 282

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  141 bits (357), Expect = 1e-40
 Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 41/230 (17%)

Query: 9   HDNIVQYIGTEKD----ENRLYIFLELVKKGSL-----ANLYQKYHLSDSQVSSYTRQIL 59
             +IV+ +   ++       L I +E +  G L         Q +  ++ + S   + I 
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREASEIMKSIG 171

Query: 60  NGLTYLHERNVVHREIKCANILV-----DAS------GLATTTNDVKSFE---GTPFWVA 105
             + YLH  N+ HR++K  N+L      +A       G A  T    S      TP++VA
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALF-RIGRGKL--PSV 159
           PEV  L    Y  S D+WSLG  +  +L   PP+     L     +  RI  G+   P+ 
Sbjct: 232 PEV--LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289

Query: 160 P-NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK-------RPLQTS 201
             + +S + +  I   L+  P  R T  + M HP++         PL TS
Sbjct: 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 339

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  142 bits (359), Expect = 5e-40
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 22/209 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSL--ANLYQKYHLSDSQVSSYTRQILNGLT 63
              H  +V      +D+N + +  E +  G L      +   +S+ +   Y RQ+  GL 
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269

Query: 64  YLHERNVVHREIKCANILVDAS----------GLATTTNDVKSFE---GTPFWVAPEVVN 110
           ++HE N VH ++K  NI+              GL    +  +S +   GT  + APEV  
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 329

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGK--LPSVP-NSLSRD 166
            K    G   D+WS+G     +L+   P+   E+     R +      +     + +S D
Sbjct: 330 GKP--VGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDDSAFSGISED 386

Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
            +DFI K L  +PN R T  Q +EHP++ 
Sbjct: 387 GKDFIRKLLLADPNTRMTIHQALEHPWLT 415

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  138 bits (350), Expect = 6e-40
 Identities = 52/210 (24%), Positives = 101/210 (48%), Gaps = 24/210 (11%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNGLT 63
           Q +H N++Q     + +N + + +E V  G L +  + + Y+L++     + +QI  G+ 
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIR 201

Query: 64  YLHERNVVHREIKCANILVDAS----------GLATTTNDVKSFE---GTPFWVAPEVVN 110
           ++H+  ++H ++K  NIL              GLA      +  +   GTP ++APEVVN
Sbjct: 202 HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261

Query: 111 LKNNGYGLSADIWSLGCTVLE--MLTHQPPYSHLEDMQALFRIGRGKL--PSVP-NSLSR 165
              +      D+WS+G  V+   +L+   P+    D + L  I   +          +S 
Sbjct: 262 --YDFVSFPTDMWSVG--VIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           +A++FI K L    + R +A++ ++HP++ 
Sbjct: 318 EAKEFISKLLIKEKSWRISASEALKHPWLS 347

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  134 bits (340), Expect = 3e-39
 Identities = 45/209 (21%), Positives = 82/209 (39%), Gaps = 23/209 (11%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNG 61
            S   H NIV+  G   +     + +E V  G L +    + + +  S        I  G
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134

Query: 62  LTYLHERN--VVHREIKCANILVDAS-------------GLA-TTTNDVKSFEGTPFWVA 105
           + Y+  +N  +VHR+++  NI + +              GL+  + + V    G   W+A
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMA 194

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG---RGKLPSVPNS 162
           PE +  +   Y   AD +S    +  +LT + P+      +  F       G  P++P  
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254

Query: 163 LSRDARDFILKCLQVNPNDRPTAAQLMEH 191
                R+ I  C   +P  RP  + +++ 
Sbjct: 255 CPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  135 bits (341), Expect = 4e-39
 Identities = 47/242 (19%), Positives = 81/242 (33%), Gaps = 55/242 (22%)

Query: 6   QFEHDNIVQYIGTEKDEN--RLYIFLELVKKGSLANLYQK----YHLSDSQVSSYTRQIL 59
           +  H NIV+    E++       + +E    GSL  + ++    Y L +S+     R ++
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 60  NGLTYLHERNVVHREIKCANILVDAS------------GLATTTND---VKSFEGTPFWV 104
            G+ +L E  +VHR IK  NI+                G A    D     S  GT  ++
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182

Query: 105 APEVV------NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE----DMQALFRIGRG 154
            P++             YG + D+WS+G T     T   P+   E    + + +++I  G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 155 KL------------------------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
           K                          S+   L       +   L+ +        Q   
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 191 HP 192
             
Sbjct: 303 ET 304

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  133 bits (337), Expect = 7e-39
 Identities = 39/205 (19%), Positives = 81/205 (39%), Gaps = 18/205 (8%)

Query: 4   FSQFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQI 58
              F H N++  +G           +    +  GSL N+  +   + +  SQ   +   +
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120

Query: 59  LNGLTYLHERN--VVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWVAPEV 108
             G+ +LH     +    +   ++++D           +  +          P WVAPE 
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-PGRMYAPAWVAPEA 179

Query: 109 VNLK-NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL-PSVPNSLSRD 166
           +  K  +    SAD+WS    + E++T + P++ L +M+   ++    L P++P  +S  
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239

Query: 167 ARDFILKCLQVNPNDRPTAAQLMEH 191
               +  C+  +P  RP    ++  
Sbjct: 240 VSKLMKICMNEDPAKRPKFDMIVPI 264

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  134 bits (339), Expect = 8e-39
 Identities = 46/216 (21%), Positives = 81/216 (37%), Gaps = 32/216 (14%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL--YQKYHLSDSQVSSYTRQILNGL 62
              EH N++++IG    + RL    E +K G+L  +          SQ  S+ + I +G+
Sbjct: 62  RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA------------------TTTNDVKS 96
            YLH  N++HR++   N LV  +        GLA                         +
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 97  FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG--RG 154
             G P+W+APE+  +    Y    D++S G  + E++               F +     
Sbjct: 182 VVGNPYWMAPEM--INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239

Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                P +         ++C  ++P  RP+  +L  
Sbjct: 240 LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  134 bits (338), Expect = 2e-38
 Identities = 52/233 (22%), Positives = 88/233 (37%), Gaps = 45/233 (19%)

Query: 7   FEHDNIVQYIGTE-------KDENRLYIFLELVKKGSLA----NLYQKYHLSDSQVSSYT 55
             H NIVQ+                 ++ L  + KG L      +  +  LS   V    
Sbjct: 83  SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142

Query: 56  RQILNGLTYLHERN--VVHREIKCANILVDAS--------GLATTTNDVKSFE------- 98
            Q    + ++H +   ++HR++K  N+L+           G ATT +    +        
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 99  ---------GTPFWVAPEVVNLKNN-GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL 148
                     TP +  PE+++L +N   G   DIW+LGC +  +   Q P+    +  A 
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAK 258

Query: 149 FRIGRGK--LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
            RI  GK  +P    +        I   LQVNP +R + A+++         +
Sbjct: 259 LRIVNGKYSIPPHD-TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  132 bits (334), Expect = 3e-38
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 20/211 (9%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYL 65
             H+N+V++ G  ++ N  Y+FLE    G L + +     + +     +  Q++ G+ YL
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121

Query: 66  HERNVVHREIKCANILVDAS--------GLATTTNDVKSFE------GTPFWVAPEVVNL 111
           H   + HR+IK  N+L+D          GLAT               GT  +VAPE+  L
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL--L 179

Query: 112 KNNGY-GLSADIWSLGCTVLEMLTHQPPYSHLED-MQALFRIGRGKLPSVP-NSLSRDAR 168
           K   +     D+WS G  +  ML  + P+    D  Q        K    P   +     
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
             + K L  NP+ R T   + +  +  +PL+
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLK 270

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  132 bits (334), Expect = 4e-38
 Identities = 45/207 (21%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK----YHLSDSQVSSYTRQIL 59
            S+  H NIV+  G   +   + + +E  + GSL N+        + + +   S+  Q  
Sbjct: 55  LSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 60  NGLTYLHERN---VVHREIKCANILVDAS---------GLATTTNDVKSFE-GTPFWVAP 106
            G+ YLH      ++HR++K  N+L+ A          G A       +   G+  W+AP
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAP 172

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED--MQALFRIGRGKLPSVPNSLS 164
           EV   + + Y    D++S G  + E++T + P+  +     + ++ +  G  P +  +L 
Sbjct: 173 EV--FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 230

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEH 191
           +     + +C   +P+ RP+  ++++ 
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIVKI 257

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  131 bits (333), Expect = 6e-38
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 26/211 (12%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS-YTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K    D   +  YT +I++ L 
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 144

Query: 64  YLHERNVVHREIKCANILVDAS--------GLA------TTTNDVKSFEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++          G A      +      SF GT  +V+PE+ 
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL- 203

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKLPSVPNSLSRDAR 168
            L       S+D+W+LGC + +++   PP+    +   +F +I + +    P      AR
Sbjct: 204 -LTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEY-DFPEKFFPKAR 260

Query: 169 DFILKCLQVNPNDRPT------AAQLMEHPF 193
           D + K L ++   R           L  HPF
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  130 bits (329), Expect = 1e-37
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 24/209 (11%)

Query: 7   FEHDNIVQ-Y--IGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
           F H +I++ Y  I T  D    ++ +E V  G L + + +   + + +     +QIL+ +
Sbjct: 68  FRHPHIIKLYQVISTPTD---FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTND---VKSFEGTPFWVAPEVVNL 111
            Y H   VVHR++K  N+L+DA         GL+   +D   +++  G+P + APEV++ 
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 184

Query: 112 KNNGY-GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARD 169
           +   Y G   DIWS G  +  +L    P+   E +  LF+ I  G    +P  L+R    
Sbjct: 185 R--LYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVF-YIPEYLNRSVAT 240

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKRPL 198
            ++  LQV+P  R T   + EH + K+ L
Sbjct: 241 LLMHMLQVDPLKRATIKDIREHEWFKQDL 269

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  131 bits (332), Expect = 1e-37
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 24/207 (11%)

Query: 7   FEHDNIV---QYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             H NIV   + I TEK    LY+ +E    G + + L     + + +  S  RQI++ +
Sbjct: 71  LNHPNIVKLFEVIETEKT---LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV 127

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTND---VKSFEGTPFWVAPEVVNL 111
            Y H++ +VHR++K  N+L+DA         G +        + +F G P + APE+   
Sbjct: 128 QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL--F 185

Query: 112 KNNGY-GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKLPSVPNSLSRDARD 169
           +   Y G   D+WSLG  +  +++   P+   ++++ L  R+ RGK   +P  +S D  +
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR-IPFYMSTDCEN 243

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKR 196
            + + L +NP  R T  Q+M+  ++  
Sbjct: 244 LLKRFLVLNPIKRGTLEQIMKDRWINA 270

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  130 bits (329), Expect = 3e-37
 Identities = 47/209 (22%), Positives = 88/209 (42%), Gaps = 23/209 (11%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGS--LANLYQKYHLSDSQVSSYTRQILNGL 62
           +   H  +++ +   + +    + LE           + +K  L +     +  Q++  +
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152

Query: 63  TYLHERNVVHREIKCANILVDAS---------GLATTTND--VKSFEGTPFWVAPEVVNL 111
            + H R VVHR+IK  NIL+D           G     +D     F+GT  +  PE ++ 
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISR 212

Query: 112 KNNGY-GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDF 170
               Y  L A +WSLG  + +M+    P+   +       I   +L   P  +S D    
Sbjct: 213 H--QYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAEL-HFPAHVSPDCCAL 263

Query: 171 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
           I +CL   P+ RP+  +++  P+++ P +
Sbjct: 264 IRRCLAPKPSSRPSLEEILLDPWMQTPAE 292

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  132 bits (332), Expect = 4e-37
 Identities = 33/218 (15%), Positives = 68/218 (31%), Gaps = 33/218 (15%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVK----KGSLANLYQ--------KYHLSDSQVSSY 54
            +     + I    DE  +++          + +L    +           L        
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216

Query: 55  TRQILNGLTYLHERNVVHREIKCANILVDASGL-------------ATTTNDVKSFEGTP 101
           T Q++  L  LH   +VH  ++  +I++D  G              A+  + +      P
Sbjct: 217 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPP 276

Query: 102 FWVAPEVVNLKNNG---YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPS 158
              A  ++    +       + D W+LG  +  +     P +    +     I R     
Sbjct: 277 ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS---- 332

Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
              ++ +  R  +   L+    DR    Q ME P  ++
Sbjct: 333 -CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  130 bits (328), Expect = 4e-37
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 20/210 (9%)

Query: 7   FEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYL 65
             H+N+V++ G  ++ N  Y+FLE    G L + +     + +     +  Q++ G+ YL
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121

Query: 66  HERNVVHREIKCANILVDAS--------GLATTTNDVKSFE------GTPFWVAPEVVNL 111
           H   + HR+IK  N+L+D          GLAT               GT  +VAPE+  L
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL--L 179

Query: 112 KNNGY-GLSADIWSLGCTVLEMLTHQPPYSHLED-MQALFRIGRGKLPSVP-NSLSRDAR 168
           K   +     D+WS G  +  ML  + P+    D  Q        K    P   +     
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVKRPL 198
             + K L  NP+ R T   + +  +  +PL
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPL 269

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  127 bits (322), Expect = 2e-36
 Identities = 49/211 (23%), Positives = 96/211 (45%), Gaps = 25/211 (11%)

Query: 7   FEHDNIVQ-Y--IGTEKDENRLYIFLELVKKGS--LANLYQKYHLSDSQVSSYTRQILNG 61
             H N++Q    +  E ++ ++Y+ +E    G   + +   +      Q   Y  Q+++G
Sbjct: 63  LRHKNVIQLVDVLYNE-EKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFE------GTPFWVAPE 107
           L YLH + +VH++IK  N+L+           G+A   +   + +      G+P +  PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 108 VVNLKNNGY-GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSR 165
           + N   + + G   DIWS G T+  + T   P+   +++  LF  IG+G   ++P     
Sbjct: 182 IAN-GLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY-AIPGDCGP 238

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
              D +   L+  P  R +  Q+ +H + ++
Sbjct: 239 PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  129 bits (325), Expect = 4e-36
 Identities = 47/241 (19%), Positives = 81/241 (33%), Gaps = 55/241 (22%)

Query: 6   QFEHDNIVQYIGTEKDEN--RLYIFLELVKKGSLANLYQK----YHLSDSQVSSYTRQIL 59
           +  H NIV+    E++       + +E    GSL  + ++    Y L +S+     R ++
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 60  NGLTYLHERNVVHREIKCANILVDAS------------GLATTTND---VKSFEGTPFWV 104
            G+ +L E  +VHR IK  NI+                G A    D     S  GT  ++
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182

Query: 105 APEVV------NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE----DMQALFRIGRG 154
            P++             YG + D+WS+G T     T   P+   E    + + +++I  G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 155 KLP------------------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
           K                          S+   L       +   L+ +        Q   
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 191 H 191
            
Sbjct: 303 E 303

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  127 bits (320), Expect = 6e-36
 Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 23/202 (11%)

Query: 11  NIVQYIGTEKDENRLYIFLELVK-KGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHER 68
            +++ +   +  +   + LE  +    L + + ++  L +    S+  Q+L  + + H  
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 168

Query: 69  NVVHREIKCANILVDAS---------GLATTTND--VKSFEGTPFWVAPEVVNLKNNGY- 116
            V+HR+IK  NIL+D +         G      D     F+GT  +  PE +      Y 
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH--RYH 226

Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
           G SA +WSLG  + +M+    P+ H E       I RG++      +S + +  I  CL 
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQV-FFRQRVSSECQHLIRWCLA 279

Query: 177 VNPNDRPTAAQLMEHPFVKRPL 198
           + P+DRPT  ++  HP+++  L
Sbjct: 280 LRPSDRPTFEEIQNHPWMQDVL 301

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  126 bits (319), Expect = 1e-35
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 23/208 (11%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGS--LANLYQKYHLSDSQVSSYTRQILNGL 62
           S+ EH NI++ +   +++    + +E    G    A + +   L +   S   RQ+++ +
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFE---GTPFWVAPEVVNL 111
            YL  ++++HR+IK  NI++           G A      K F    GT  + APEV  L
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV--L 201

Query: 112 KNNGY-GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDF 170
             N Y G   ++WSLG T+  ++  + P+  LE            +   P  +S++    
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAI-HPPYLVSKELMSL 254

Query: 171 ILKCLQVNPNDRPTAAQLMEHPFVKRPL 198
           +   LQ  P  R T  +L+  P+V +P+
Sbjct: 255 VSGLLQPVPERRTTLEKLVTDPWVTQPV 282

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  127 bits (321), Expect = 1e-35
 Identities = 49/206 (23%), Positives = 93/206 (45%), Gaps = 18/206 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLT 63
              EH  +V    + +DE  +++ ++L+  G L   L Q  H  +  V  +  +++  L 
Sbjct: 70  QGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129

Query: 64  YLHERNVVHREIKCANILVDASG--------LATTTND---VKSFEGTPFWVAPEVVNLK 112
           YL  + ++HR++K  NIL+D  G        +A        + +  GT  ++APE+ + +
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189

Query: 113 N-NGYGLSADIWSLGCTVLEMLTHQPPY--SHLEDMQALFR-IGRGKLPSVPNSLSRDAR 168
              GY  + D WSLG T  E+L  + PY        + +        +   P++ S++  
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT-YPSAWSQEMV 248

Query: 169 DFILKCLQVNPNDR-PTAAQLMEHPF 193
             + K L+ NP+ R    + +   P+
Sbjct: 249 SLLKKLLEPNPDQRFSQLSDVQNFPY 274

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  126 bits (318), Expect = 2e-35
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 20/205 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLT 63
                  +V+   + KD + LY+ +E V  G + ++L +    S+     Y  QI+    
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155

Query: 64  YLHERNVVHREIKCANILVDASG--------LATTTNDV-KSFEGTPFWVAPEVVNLKNN 114
           YLH  ++++R++K  N+L+D  G         A        +  GTP  +APE+  + + 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEI--ILSK 213

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARDFILK 173
           GY  + D W+LG  + EM    PP+   +    ++  I  GK+   P+  S D +D +  
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRN 271

Query: 174 CLQVNPNDR-----PTAAQLMEHPF 193
            LQV+   R          +  H +
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKW 296

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  123 bits (312), Expect = 8e-35
 Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 38/218 (17%)

Query: 9   HDNIVQYIG----TEKDENRLYIFLELVKKGSL-----ANLYQKYHLSDSQVSSYTRQIL 59
             +IV+ +            L I +E +  G L         Q +  ++ + S   + I 
Sbjct: 70  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TEREASEIMKSIG 127

Query: 60  NGLTYLHERNVVHREIKCANILVDASGLATTTND--VKSFEGTPFWVAPEVVNLKNNGYG 117
             + YLH  N+ HR++K  N+L       +   +  +K    T F  A E        Y 
Sbjct: 128 EAIQYLHSINIAHRDVKPENLL-----YTSKRPNAILK---LTDFGFAKETTG---EKYD 176

Query: 118 LSADIWSLGCTVLEMLTHQPPY---SHLEDMQALF-RIGRGKL--PSVP-NSLSRDARDF 170
            S D+WSLG  +  +L   PP+     L     +  RI  G+   P+   + +S + +  
Sbjct: 177 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 236

Query: 171 ILKCLQVNPNDRPTAAQLMEHPFVK-------RPLQTS 201
           I   L+  P  R T  + M HP++         PL TS
Sbjct: 237 IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 274

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  123 bits (311), Expect = 2e-34
 Identities = 62/238 (26%), Positives = 93/238 (39%), Gaps = 58/238 (24%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----KYHLSDSQVSSYTRQILN 60
           Q  H+N+V  +   K + R Y+  E V       +          L    V  Y  QI+N
Sbjct: 80  QLRHENLVNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQIIN 135

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA-TTTNDVKSFEGTPFWV-----AP 106
           G+ + H  N++HR+IK  NILV  S        G A T     + +            AP
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRAP 193

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR------------- 153
           E++ + +  YG + D+W++GC V EM   +P +    D+  L+ I               
Sbjct: 194 ELL-VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252

Query: 154 GKLPS------------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
            K P                    P  LS    D   KCL ++P+ RP  A+L+ H F
Sbjct: 253 NKNPVFAGVRLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  126 bits (317), Expect = 2e-34
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 24/209 (11%)

Query: 7   FEHDNIV---QYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
           F H +I+   Q I T  D   +++ +E V  G L + + +   L + +     +QIL+G+
Sbjct: 73  FRHPHIIKLYQVISTPSD---IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTND---VKSFEGTPFWVAPEVVNL 111
            Y H   VVHR++K  N+L+DA         GL+   +D   +++  G+P + APEV++ 
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 189

Query: 112 KNNGY-GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARD 169
           +   Y G   DIWS G  +  +L    P+   + +  LF+ I  G     P  L+     
Sbjct: 190 R--LYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIF-YTPQYLNPSVIS 245

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKRPL 198
            +   LQV+P  R T   + EH + K+ L
Sbjct: 246 LLKHMLQVDPMKRATIKDIREHEWFKQDL 274

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  122 bits (309), Expect = 3e-34
 Identities = 50/238 (21%), Positives = 90/238 (37%), Gaps = 58/238 (24%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----KYHLSDSQVSSYTRQILN 60
           Q +H N+V  +   + + RL++  E         +       +  + +  V S T Q L 
Sbjct: 58  QLKHPNLVNLLEVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQ 113

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA-TTTNDVKSFEGTPFWV-----AP 106
            + + H+ N +HR++K  NIL+           G A   T     +            +P
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSP 171

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR------------- 153
           E++ + +  YG   D+W++GC   E+L+  P +    D+  L+ I +             
Sbjct: 172 ELL-VGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230

Query: 154 GKLPS------------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
                                   PN +S  A   +  CL ++P +R T  QL+ HP+
Sbjct: 231 STNQYFSGVKIPDPEDMEPLELKFPN-ISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  122 bits (308), Expect = 4e-34
 Identities = 49/202 (24%), Positives = 93/202 (46%), Gaps = 20/202 (9%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLH 66
            H  I++  GT +D  ++++ ++ ++ G L +L +K     +     Y  ++   L YLH
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123

Query: 67  ERNVVHREIKCANILVDASG--------LATTTNDV-KSFEGTPFWVAPEVVNLKNNGYG 117
            +++++R++K  NIL+D +G         A    DV  +  GTP ++APEV  +    Y 
Sbjct: 124 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEV--VSTKPYN 181

Query: 118 LSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKLPSVPNSLSRDARDFILKCLQ 176
            S D WS G  + EML    P+    +    + +I   +L   P   + D +D + + + 
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLIT 239

Query: 177 VNPNDR-----PTAAQLMEHPF 193
            + + R          +  HP+
Sbjct: 240 RDLSQRLGNLQNGTEDVKNHPW 261

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  126 bits (319), Expect = 4e-34
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 21/201 (10%)

Query: 12  IVQYIGTEKDENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNV 70
           IV         ++L   L+L+  G L  +L Q    S++ +  Y  +I+ GL ++H R V
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 313

Query: 71  VHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSA 120
           V+R++K ANIL+D          GLA   +     +  GT  ++APEV+  K   Y  SA
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSA 372

Query: 121 DIWSLGCTVLEMLTHQPP-YSHLE-DMQALFR-IGRGKLPSVPNSLSRDARDFILKCLQV 177
           D +SLGC + ++L    P   H   D   + R      +  +P+S S + R  +   LQ 
Sbjct: 373 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELRSLLEGLLQR 431

Query: 178 NPNDR-----PTAAQLMEHPF 193
           + N R       A ++ E PF
Sbjct: 432 DVNRRLGCLGRGAQEVKESPF 452

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  122 bits (309), Expect = 4e-34
 Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 25/206 (12%)

Query: 7   FEHDNIV---QYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             H +I+     I T  D   + + +E    G L + + +K  +++ +   + +QI+  +
Sbjct: 66  LRHPHIIKLYDVITTPTD---IVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAI 121

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTND---VKSFEGTPFWVAPEVVNL 111
            Y H   +VHR++K  N+L+D +        GL+    D   +K+  G+P + APEV  +
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV--I 179

Query: 112 KNNGY-GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARD 169
               Y G   D+WS G  +  ML  + P+   E +  LF+ +       +P+ LS  A+ 
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVY-VMPDFLSPGAQS 237

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVK 195
            I + +  +P  R T  ++   P+  
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWFN 263

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  121 bits (305), Expect = 1e-33
 Identities = 56/194 (28%), Positives = 97/194 (50%), Gaps = 29/194 (14%)

Query: 22  ENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
             +LY+ LE +  G L   L ++    +     Y  +I   L +LH++ +++R++K  NI
Sbjct: 93  GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENI 152

Query: 81  LVDASG---LA------------TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSL 125
           +++  G   L             T T+   +F GT  ++APE+  L  +G+  + D WSL
Sbjct: 153 MLNHQGHVKLTDFGLCKESIHDGTVTH---TFCGTIEYMAPEI--LMRSGHNRAVDWWSL 207

Query: 126 GCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-- 182
           G  + +MLT  PP++  E+ +     I + KL  +P  L+++ARD + K L+ N   R  
Sbjct: 208 GALMYDMLTGAPPFTG-ENRKKTIDKILKCKLN-LPPYLTQEARDLLKKLLKRNAASRLG 265

Query: 183 --PT-AAQLMEHPF 193
             P  A ++  HPF
Sbjct: 266 AGPGDAGEVQAHPF 279

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  120 bits (304), Expect = 2e-33
 Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 29/194 (14%)

Query: 22  ENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           E +LY+ L+ ++ G L   L ++   ++  V  Y  ++   L +LH   +++R++K  NI
Sbjct: 98  EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 157

Query: 81  LVDASG---LA------------TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSL 125
           L+D  G   L                    SF GT  ++APEV  +   G+  SAD WS 
Sbjct: 158 LLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEV--VNRRGHTQSADWWSF 212

Query: 126 GCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-- 182
           G  + EMLT   P+   +D +     I + KL  +P  LS +A+  +    + NP +R  
Sbjct: 213 GVLMFEMLTGTLPFQG-KDRKETMTMILKAKL-GMPQFLSPEAQSLLRMLFKRNPANRLG 270

Query: 183 --PT-AAQLMEHPF 193
             P    ++  H F
Sbjct: 271 AGPDGVEEIKRHSF 284

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  124 bits (311), Expect = 4e-33
 Identities = 41/219 (18%), Positives = 71/219 (32%), Gaps = 26/219 (11%)

Query: 6   QFEHDNIVQYIGTEKDENRL------YIFLELVKKGSLANLYQK----YHLSDSQVSSYT 55
           +  H N+V          +L       + +E  + G L     +      L +  + +  
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127

Query: 56  RQILNGLTYLHERNVVHREIKCANILVDAS-----------GLATTTND---VKSFEGTP 101
             I + L YLHE  ++HR++K  NI++              G A   +       F GT 
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL 187

Query: 102 FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPN 161
            ++APE+  L+   Y ++ D WS G    E +T   P+             R K      
Sbjct: 188 QYLAPEL--LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245

Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQT 200
                        +   PN            +++  L  
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW 284

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  120 bits (302), Expect = 6e-33
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 32/217 (14%)

Query: 7   FEHDNIVQY---IGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGL 62
             H NIV++   I T      L I +E    G L   +      S+ +   + +Q+L+G+
Sbjct: 73  LRHPNIVRFKEVILTPTH---LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGV 129

Query: 63  TYLHERNVVHREIKCANILVDAS----------GLATTTND---VKSFEGTPFWVAPEVV 109
           +Y H   + HR++K  N L+D S          G + ++      KS  GTP ++APEV 
Sbjct: 130 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV- 188

Query: 110 NLKNNGY-GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-----IGRGK--LPSVPN 161
            L    Y G  AD+WS G T+  ML    P+    +    +R     I   K  +P    
Sbjct: 189 -LLRQEYDGKIADVWSCGVTLYVMLVGAYPFED-PEEPRDYRKTIQRILSVKYSIPDDIR 246

Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL 198
            +S +    I +    +P  R +  ++  H +  + L
Sbjct: 247 -ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  119 bits (301), Expect = 8e-33
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 30/199 (15%)

Query: 21  DENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN 79
            E +L++ L+ +  G L   L Q+   ++ +V  Y  +I+  L +LH+  +++R+IK  N
Sbjct: 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLEN 189

Query: 80  ILVDASG---LA-------------TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIW 123
           IL+D++G   L                      F GT  ++AP++V   ++G+  + D W
Sbjct: 190 ILLDSNGHVVLTDFGLSKEFVADETERAY---DFCGTIEYMAPDIVRGGDSGHDKAVDWW 246

Query: 124 SLGCTVLEMLTHQPPY---SHLEDMQALFR-IGRGKLPSVPNSLSRDARDFILKCLQVNP 179
           SLG  + E+LT   P+           + R I + + P  P  +S  A+D I + L  +P
Sbjct: 247 SLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-YPQEMSALAKDLIQRLLMKDP 305

Query: 180 NDR----PT-AAQLMEHPF 193
             R    P  A ++ EH F
Sbjct: 306 KKRLGCGPRDADEIKEHLF 324

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  118 bits (299), Expect = 1e-32
 Identities = 58/194 (29%), Positives = 100/194 (51%), Gaps = 29/194 (14%)

Query: 22  ENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
            +RL   +E    G L  +L ++   ++ +   Y  +I++ L YLH R+VV+R+IK  N+
Sbjct: 77  HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 136

Query: 81  LVDASG---LA------------TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSL 125
           ++D  G   +              T     +F GTP ++APEV  L++N YG + D W L
Sbjct: 137 MLDKDGHIKITDFGLCKEGISDGATMK---TFCGTPEYLAPEV--LEDNDYGRAVDWWGL 191

Query: 126 GCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-- 182
           G  + EM+  + P+ + +D + LF  I   ++   P +LS +A+  +   L+ +P  R  
Sbjct: 192 GVVMYEMMCGRLPFYN-QDHERLFELILMEEIR-FPRTLSPEAKSLLAGLLKKDPKQRLG 249

Query: 183 --PTAAQ-LMEHPF 193
             P+ A+ +MEH F
Sbjct: 250 GGPSDAKEVMEHRF 263

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  121 bits (306), Expect = 2e-32
 Identities = 54/199 (27%), Positives = 87/199 (43%), Gaps = 34/199 (17%)

Query: 22  ENRLYIFLELVKKGSLANLYQKYHL--------SDSQVSSYTRQILNGLTYLHERNVVHR 73
           ++ L + L L+  G L     K+H+         +++   Y  +I  GL  LH   +V+R
Sbjct: 256 KDALCLVLTLMNGGDL-----KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310

Query: 74  EIKCANILVDAS--------GLA---TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADI 122
           ++K  NIL+D          GLA        +K   GT  ++APEV  +KN  Y  S D 
Sbjct: 311 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV--VKNERYTFSPDW 368

Query: 123 WSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNP 179
           W+LGC + EM+  Q P+         + + R+ +          S  AR    + L  +P
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDP 428

Query: 180 NDR-----PTAAQLMEHPF 193
            +R      +A ++ EHP 
Sbjct: 429 AERLGCRGGSAREVKEHPL 447

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  118 bits (298), Expect = 2e-32
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 30/195 (15%)

Query: 22  ENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
            +RL+  +E V  G L  ++ +     +++   Y  +I++ L +LH++ +++R++K  N+
Sbjct: 96  PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNV 155

Query: 81  LVDASG---LA------------TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSL 125
           L+D  G   LA             TT    +F GTP ++APE+  L+   YG + D W++
Sbjct: 156 LLDHEGHCKLADFGMCKEGICNGVTTA---TFCGTPDYIAPEI--LQEMLYGPAVDWWAM 210

Query: 126 GCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-- 182
           G  + EML    P+   E+   LF  I   ++   P  L  DA   +   +  NP  R  
Sbjct: 211 GVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV-VYPTWLHEDATGILKSFMTKNPTMRLG 268

Query: 183 --PTAA--QLMEHPF 193
                    ++ HPF
Sbjct: 269 SLTQGGEHAILRHPF 283

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  120 bits (303), Expect = 3e-32
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 37/204 (18%)

Query: 22  ENRLYIFLELVKKGSLANLYQKYHL----------SDSQVSSYTRQILNGLTYLHERNVV 71
           +  L + + ++  G +     +YH+           + +   YT QI++GL +LH+RN++
Sbjct: 257 KTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311

Query: 72  HREIKCANILVDAS--------GLA----TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           +R++K  N+L+D          GLA          K + GTP ++APE+  L    Y  S
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL--LLGEEYDFS 369

Query: 120 ADIWSLGCTVLEMLTHQPP-YSHLE--DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQ 176
            D ++LG T+ EM+  + P  +  E  + + L +    +  + P+  S  ++DF    LQ
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429

Query: 177 VNPNDR-----PTAAQLMEHPFVK 195
            +P  R      +   L  HP  +
Sbjct: 430 KDPEKRLGFRDGSCDGLRTHPLFR 453

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  117 bits (296), Expect = 5e-32
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 38/198 (19%)

Query: 22  ENRLYIFLELVKKGSLANLYQKYHLSDSQVSS------YTRQILNGLTYLHERNVVHREI 75
            ++LY  L+ +  G L      YHL   +         Y  +I + L YLH  N+V+R++
Sbjct: 111 ADKLYFVLDYINGGELF-----YHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165

Query: 76  KCANILVDASG---LA------------TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSA 120
           K  NIL+D+ G   L             +TT+   +F GTP ++APEV  L    Y  + 
Sbjct: 166 KPENILLDSQGHIVLTDFGLCKENIEHNSTTS---TFCGTPEYLAPEV--LHKQPYDRTV 220

Query: 121 DIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARDFILKCLQVNP 179
           D W LG  + EML   PP+    +   ++  I    L  +  +++  AR  +   LQ + 
Sbjct: 221 DWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL-QLKPNITNSARHLLEGLLQKDR 278

Query: 180 NDR----PTAAQLMEHPF 193
             R        ++  H F
Sbjct: 279 TKRLGAKDDFMEIKSHVF 296

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  115 bits (290), Expect = 1e-31
 Identities = 53/245 (21%), Positives = 93/245 (37%), Gaps = 59/245 (24%)

Query: 2   FSFSQFEHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
           ++     H+NI+ +I ++        +L++     + GSL +  Q   L           
Sbjct: 54  YNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS 113

Query: 58  ILNGLTYLHER--------NVVHREIKCANILVDAS--------GLA--------TTTND 93
           I +GL +LH           + HR++K  NILV  +        GLA             
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173

Query: 94  VKSFEGTPFWVAPEV----VNLKNNGYGLSADIWSLGCTVL-EMLT----------HQPP 138
                GT  ++APEV    + +         DIW+ G  VL E+            ++PP
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG-LVLWEVARRMVSNGIVEDYKPP 232

Query: 139 YSHL-------EDMQALFRIGRGKL-PSVPNSLSRDA-----RDFILKCLQVNPNDRPTA 185
           +  +       EDM+ +  +   +  P++PN    D         + +C   NP+ R TA
Sbjct: 233 FYDVVPNDPSFEDMRKV--VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290

Query: 186 AQLME 190
            ++ +
Sbjct: 291 LRIKK 295

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  115 bits (291), Expect = 2e-31
 Identities = 55/239 (23%), Positives = 97/239 (40%), Gaps = 57/239 (23%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTY 64
           + +H NI++        +RL++  E  +   L     K   +S   + S+  Q++NG+ +
Sbjct: 89  ELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147

Query: 65  LHERNVVHREIKCANILVDAS-------------GLA--------TTTNDVKSFEGTPFW 103
            H R  +HR++K  N+L+  S             GLA          T+++     T ++
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII----TLWY 203

Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI------------ 151
             PE++ L +  Y  S DIWS+ C   EML   P +    ++  LF+I            
Sbjct: 204 RPPEIL-LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262

Query: 152 -GRGKLP----------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
            G   LP                 +   L  +  D +   L+++P  R +A   +EHP+
Sbjct: 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  115 bits (291), Expect = 2e-31
 Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 25/190 (13%)

Query: 22  ENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           +  L+  +E +  G L  ++   +    S+ + Y  +I+ GL +LH + +V+R++K  NI
Sbjct: 90  KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149

Query: 81  LVDASG---LA------------TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSL 125
           L+D  G   +A              TN   +F GTP ++APE+  L    Y  S D WS 
Sbjct: 150 LLDKDGHIKIADFGMCKENMLGDAKTN---TFCGTPDYIAPEI--LLGQKYNHSVDWWSF 204

Query: 126 GCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT 184
           G  + EML  Q P+ H +D + LF  I        P  L ++A+D ++K     P  R  
Sbjct: 205 GVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPF-YPRWLEKEAKDLLVKLFVREPEKRLG 262

Query: 185 AAQ-LMEHPF 193
               + +HP 
Sbjct: 263 VRGDIRQHPL 272

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  115 bits (290), Expect = 3e-31
 Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 29/194 (14%)

Query: 22  ENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
            +RLY  +E V  G L  ++ Q     +     Y  +I  GL +L  + +++R++K  N+
Sbjct: 93  MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 152

Query: 81  LVDASG---LA------------TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSL 125
           ++D+ G   +A             TT    +F GTP ++APE+  +    YG S D W+ 
Sbjct: 153 MLDSEGHIKIADFGMCKENIWDGVTTK---TFCGTPDYIAPEI--IAYQPYGKSVDWWAF 207

Query: 126 GCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-- 182
           G  + EML  Q P+   ED   LF+ I    + + P S+S++A       +  +P  R  
Sbjct: 208 GVLLYEMLAGQAPF-EGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLG 265

Query: 183 --PTAAQ-LMEHPF 193
             P   + + EH F
Sbjct: 266 CGPEGERDIKEHAF 279

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  115 bits (289), Expect = 3e-31
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 35/202 (17%)

Query: 22  ENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L YLHER +++R++K  N+
Sbjct: 82  ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 141

Query: 81  LVDASG---LA------------TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSL 125
           L+D+ G   L              TT+   +F GTP ++APE+  L+   YG S D W+L
Sbjct: 142 LLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYIAPEI--LRGEDYGFSVDWWAL 196

Query: 126 GCTVLEMLTHQPPYSHL--------EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQV 177
           G  + EM+  + P+  +             LF++   K   +P SLS  A   +   L  
Sbjct: 197 GVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNK 256

Query: 178 NPNDR------PTAAQLMEHPF 193
           +P +R         A +  HPF
Sbjct: 257 DPKERLGCHPQTGFADIQGHPF 278

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  114 bits (288), Expect = 4e-31
 Identities = 54/243 (22%), Positives = 91/243 (37%), Gaps = 55/243 (22%)

Query: 2   FSFSQFEHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
           +      H+NI+ +I  +        +LY+  +  + GSL +  +   L    +      
Sbjct: 83  YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYS 142

Query: 58  ILNGLTYLHERN--------VVHREIKCANILVDAS--------GLATTTNDVKSFE--- 98
            ++GL +LH           + HR++K  NILV  +        GLA       +     
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202

Query: 99  -----GTPFWVAPEV----VNLKNNGYGLSADIWSLGCTVL-EMLT----------HQPP 138
                GT  ++ PEV    +N  +    + AD++S G  +L E+            +Q P
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL-ILWEVARRCVSGGIVEEYQLP 261

Query: 139 YSHLEDMQALFR-----IGRGKL-PSVPNSLSRDA-----RDFILKCLQVNPNDRPTAAQ 187
           Y  L      +      +   KL PS PN  S D         + +C   NP  R TA +
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321

Query: 188 LME 190
           + +
Sbjct: 322 VKK 324

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  114 bits (288), Expect = 1e-30
 Identities = 56/250 (22%), Positives = 84/250 (33%), Gaps = 75/250 (30%)

Query: 6   QFEHDNIVQ--YI----GTEKDENRLYIFLELVKKGSLANLYQ--------KYHLSDSQV 51
           + +H NIV+  Y     G +KDE  L + L+ V +     +Y+        K  L    V
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYV 158

Query: 52  SSYTRQILNGLTYLHERNVVHREIKCANILVDAS---------GLATTTNDVKSFEGTPF 102
             Y  Q+   L Y+H   + HR+IK  N+L+D           G A      K       
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA------KQLVRGEP 212

Query: 103 WV---------APEVVNLKNNGYGLSADIWSLGCTVLEMLT-----------HQ------ 136
            V         APE++      Y  S D+WS GC + E+L             Q      
Sbjct: 213 NVSYICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271

Query: 137 ----PPYSHLEDMQALFRIGRGKLPSVP---------NSLSRDARDFILKCLQVNPNDRP 183
               P    + +M   +     K P +               +A     + L+  P  R 
Sbjct: 272 VLGTPTREQIREMNPNYT--EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329

Query: 184 TAAQLMEHPF 193
           T  +   H F
Sbjct: 330 TPLEACAHSF 339

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  114 bits (287), Expect = 1e-30
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 35/202 (17%)

Query: 22  ENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
           E+RL+  +E V  G L  ++ ++  L +     Y+ +I   L YLHER +++R++K  N+
Sbjct: 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184

Query: 81  LVDASG---LA------------TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSL 125
           L+D+ G   L              TT+   +F GTP ++APE+  L+   YG S D W+L
Sbjct: 185 LLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYIAPEI--LRGEDYGFSVDWWAL 239

Query: 126 GCTVLEMLTHQPPYSHL--------EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQV 177
           G  + EM+  + P+  +             LF++   K   +P SLS  A   +   L  
Sbjct: 240 GVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNK 299

Query: 178 NPNDR------PTAAQLMEHPF 193
           +P +R         A +  HPF
Sbjct: 300 DPKERLGCHPQTGFADIQGHPF 321

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  111 bits (281), Expect = 3e-30
 Identities = 56/239 (23%), Positives = 88/239 (36%), Gaps = 58/239 (24%)

Query: 5   SQFEHDNIVQ-----YIGTEKDENRLYI---FLELVKKGSLANLYQKYHLSDSQVSSYTR 56
             FEH N+V+            E ++ +    ++   +  L        L    +    R
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-PPPGLPAETIKDLMR 127

Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS--------GLA-------TTTNDVKSFEGTP 101
           Q L GL +LH   +VHR++K  NILV +         GLA         T  V     T 
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV----TL 183

Query: 102 FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI---------- 151
           ++ APEV  L  + Y    D+WS+GC   EM   +P +    +   L +I          
Sbjct: 184 WYRAPEV--LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241

Query: 152 ---GRGKLPS--------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
                  LP               VP  +       +L+ L  NP+ R +A + ++H +
Sbjct: 242 DWPRDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  113 bits (285), Expect = 3e-30
 Identities = 58/247 (23%), Positives = 92/247 (37%), Gaps = 71/247 (28%)

Query: 7   FEHDNIVQ--YI----GTEKDENRLYIFLELVKKGSLANLYQ--------KYHLSDSQVS 52
            +H N+V         G +KDE  L + LE V +     +Y+        K  +    + 
Sbjct: 89  VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE----TVYRASRHYAKLKQTMPMLLIK 144

Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS---------GLATTTNDVKSFEGTPFW 103
            Y  Q+L  L Y+H   + HR+IK  N+L+D           G A      K        
Sbjct: 145 LYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA------KILIAGEPN 198

Query: 104 V---------APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRI 151
           V         APE++      Y  + DIWS GC + E++  QP +   S ++ +  + ++
Sbjct: 199 VSYICSRYYRAPELI-FGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257

Query: 152 ----------------GRGKLPSVP---------NSLSRDARDFILKCLQVNPNDRPTAA 186
                              K P +               DA D I + L+  P+ R TA 
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317

Query: 187 QLMEHPF 193
           + + HPF
Sbjct: 318 EALCHPF 324

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  112 bits (282), Expect = 3e-30
 Identities = 54/244 (22%), Positives = 97/244 (39%), Gaps = 57/244 (23%)

Query: 2   FSFSQFEHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
           +      H+NI+ +I  +  +N    +L++  +  + GSL +   +Y ++   +      
Sbjct: 88  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS 147

Query: 58  ILNGLTYLHER--------NVVHREIKCANILVDAS--------GLA--------TTTND 93
             +GL +LH           + HR++K  NILV  +        GLA        T    
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207

Query: 94  VKSFEGTPFWVAPEV----VNLKNNGYGLSADIWSLGCTVLEMLT----------HQPPY 139
                GT  ++APEV    +N+K+      ADI+++G    E+            +Q PY
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267

Query: 140 SHL-------EDMQALFRIGRGKL-PSVPNSLSRDA-----RDFILKCLQVNPNDRPTAA 186
             L       E+M+ +  +   KL P++PN              + +C   N   R TA 
Sbjct: 268 YDLVPSDPSVEEMRKV--VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325

Query: 187 QLME 190
           ++ +
Sbjct: 326 RIKK 329

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  112 bits (282), Expect = 4e-30
 Identities = 36/222 (16%), Positives = 67/222 (30%), Gaps = 38/222 (17%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH------LSDSQVSSYTRQILNGL 62
               +++      +N   +  EL   G+L N    Y       +    V S+  ++L  +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185

Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN----------------DVKSFE-------- 98
             +H+  ++H +IK  N ++    L                     D+K F         
Sbjct: 186 EQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 99  -GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP 157
             T  +   E+  L N  +    D + +  TV  ML         E  +        +LP
Sbjct: 246 CETSGFQCVEM--LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303

Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
            +         +F    L +       +  L+     K   Q
Sbjct: 304 HLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  111 bits (281), Expect = 4e-30
 Identities = 61/239 (25%), Positives = 94/239 (39%), Gaps = 58/239 (24%)

Query: 5   SQFEHDNIVQ-----YIGTEKDENRLYI---FLELVKKGSLANLYQKYHLSDSQVSSYTR 56
             FEH N+V+      +     E +L +    ++      L  +  +  +    +     
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMF 127

Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS--------GLA-------TTTNDVKSFEGTP 101
           Q+L GL +LH   VVHR++K  NILV +S        GLA         T+ V     T 
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV----TL 183

Query: 102 FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI---------- 151
           ++ APEV  L  + Y    D+WS+GC   EM   +P +    D+  L +I          
Sbjct: 184 WYRAPEV--LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241

Query: 152 ---GRGKLPS--------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
                  LP               V + +    +D +LKCL  NP  R +A   + HP+
Sbjct: 242 DWPRDVALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  111 bits (279), Expect = 4e-30
 Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 52/234 (22%)

Query: 6   QFEHDNIVQYIGTEKDENRLYI---FLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGL 62
           + +H NIV+       + RL +    L+   K  L     +  L      S+  Q+LNG+
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGI 113

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA-TTTNDVKSFEGTPFWV-----APEV 108
            Y H+R V+HR++K  N+L++          GLA      V+ +  T   V     AP+V
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDV 171

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI-------------GRGK 155
           + + +  Y  + DIWS+GC   EM+   P +  + +   L RI                +
Sbjct: 172 L-MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 156 LP----------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
           LP                 +   L     D + K L+++PN R TA Q +EH +
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKG-LDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  113 bits (285), Expect = 5e-30
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 38/199 (19%)

Query: 22  ENRLYIFLELVKKGSLANLYQKYHLSDSQVSS------YTRQILNGLTYLH-ERNVVHRE 74
            +RL   +E    G L      +HLS  +V S      Y  +I++ L YLH E+NVV+R+
Sbjct: 220 HDRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274

Query: 75  IKCANILVDASG---LA------------TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLS 119
           +K  N+++D  G   +              T     +F GTP ++APEV  L++N YG +
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMK---TFCGTPEYLAPEV--LEDNDYGRA 329

Query: 120 ADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNP 179
            D W LG  + EM+  + P+ + +D + LF +   +    P +L  +A+  +   L+ +P
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 388

Query: 180 NDR----PT-AAQLMEHPF 193
             R       A ++M+H F
Sbjct: 389 KQRLGGGSEDAKEIMQHRF 407

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  112 bits (282), Expect = 5e-30
 Identities = 52/246 (21%), Positives = 86/246 (34%), Gaps = 61/246 (24%)

Query: 6   QFEHDNIVQYIG--------TEKDENRLYI---FLELVKKGSLANLYQKYHLSDSQVSSY 54
             +H+N+V  I           + +  +Y+   F E    G L+N       + S++   
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRV 129

Query: 55  TRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPF---- 102
            + +LNGL Y+H   ++HR++K AN+L+           GLA   +  K+ +   +    
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189

Query: 103 ---WV-APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI------- 151
              W   PE++ L    YG   D+W  GC + EM T  P      +   L  I       
Sbjct: 190 VTLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248

Query: 152 ------GRGKLPSV---------PNSL---------SRDARDFILKCLQVNPNDRPTAAQ 187
                                     +            A D I K L ++P  R  +  
Sbjct: 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308

Query: 188 LMEHPF 193
            + H F
Sbjct: 309 ALNHDF 314

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  111 bits (280), Expect = 5e-30
 Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 53/235 (22%)

Query: 6   QFEHDNIVQYIGTEKDENRLYI---FLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGL 62
           +  H NIV  I     E  L +   F+E   K  L     K  L DSQ+  Y  Q+L G+
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGV 132

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA-TTTNDVKSFEGTPFWV-----APEV 108
            + H+  ++HR++K  N+L+++         GLA      V+S+  T   V     AP+V
Sbjct: 133 AHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDV 190

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI-------------GRGK 155
           + + +  Y  S DIWS+GC   EM+T +P +  + D   L +I                +
Sbjct: 191 L-MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249

Query: 156 LP-----------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
           LP                  +P    ++  D +   L  +PN R +A   M HP+
Sbjct: 250 LPLWKQRTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  114 bits (286), Expect = 1e-29
 Identities = 53/194 (27%), Positives = 88/194 (45%), Gaps = 29/194 (14%)

Query: 22  ENRLYIFLELVKKGSL-ANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI 80
            +RLY  +E V  G L  ++ Q     +     Y  +I  GL +L  + +++R++K  N+
Sbjct: 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 473

Query: 81  LVDASG---LA------------TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSL 125
           ++D+ G   +A             TT    +F GTP ++APE+  +    YG S D W+ 
Sbjct: 474 MLDSEGHIKIADFGMCKENIWDGVTTK---TFCGTPDYIAPEI--IAYQPYGKSVDWWAF 528

Query: 126 GCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDR-- 182
           G  + EML  Q P+   ED   LF+ I    + + P S+S++A       +  +P  R  
Sbjct: 529 GVLLYEMLAGQAPF-EGEDEDELFQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLG 586

Query: 183 ---PTAAQLMEHPF 193
                   + EH F
Sbjct: 587 CGPEGERDIKEHAF 600

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  110 bits (277), Expect = 1e-29
 Identities = 63/250 (25%), Positives = 108/250 (43%), Gaps = 61/250 (24%)

Query: 6   QFEHDNIV--------------QYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQV 51
           + +HDNIV                +G+  + N +YI  E ++   LAN+ ++  L +   
Sbjct: 64  RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHA 122

Query: 52  SSYTRQILNGLTYLHERNVVHREIKCANILVDAS---------GLATTTNDVKSFEG--- 99
             +  Q+L GL Y+H  NV+HR++K AN+ ++           GLA   +   S +G   
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 100 ----TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHL---------- 142
               T ++ +P ++ L  N Y  + D+W+ GC   EMLT +  +     L          
Sbjct: 183 EGLVTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241

Query: 143 -----EDMQALFRIGRGKLPSVPN-----------SLSRDARDFILKCLQVNPNDRPTAA 186
                ED Q L  +    + +               +SR+A DF+ + L  +P DR TA 
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301

Query: 187 QLMEHPFVKR 196
           + + HP++  
Sbjct: 302 EALSHPYMSI 311

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  112 bits (281), Expect = 1e-29
 Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 26/211 (12%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYL 65
           +   I       +D+N LY+ ++    G L  L  K+   L +     Y  +++  +  +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191

Query: 66  HERNVVHREIKCANILVDASG-------------LATTTNDVKSFEGTPFWVAPEVVNLK 112
           H+ + VHR+IK  NIL+D +G             +   T       GTP +++PE++   
Sbjct: 192 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251

Query: 113 ---NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGK----LPSVPNSLS 164
                 YG   D WSLG  + EML  + P+ + E +   + +I   K     P+    +S
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQFPTQVTDVS 310

Query: 165 RDARDFILKCLQVNPN--DRPTAAQLMEHPF 193
            +A+D I + +    +   +       +HPF
Sbjct: 311 ENAKDLIRRLICSREHRLGQNGIEDFKKHPF 341

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  113 bits (284), Expect = 2e-29
 Identities = 45/196 (22%), Positives = 83/196 (42%), Gaps = 27/196 (13%)

Query: 8   EHDNIVQ-Y-IGTEKDEN---RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGL 62
            H +IVQ +      D +     YI +E V   SL     +  L  ++  +Y  +IL  L
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPAL 195

Query: 63  TYLHERNVVHREIKCANILVDAS-------GLATTTNDVKSFEGTPFWVAPEVVNLKNNG 115
           +YLH   +V+ ++K  NI++          G  +  N      GTP + APE+V     G
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGYLYGTPGFQAPEIV---RTG 252

Query: 116 YGLSADIWSLGCTVLEMLTHQPPYS--HLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             ++ DI+++G T+  +    P  +  +++ +          +    +S  R     + +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE-----DDPVLKTYDSYGR----LLRR 303

Query: 174 CLQVNPNDRPTAAQLM 189
            +  +P  R T A+ M
Sbjct: 304 AIDPDPRQRFTTAEEM 319

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  110 bits (278), Expect = 2e-29
 Identities = 58/252 (23%), Positives = 98/252 (38%), Gaps = 70/252 (27%)

Query: 6   QFEHDNIVQYI------GTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQ 57
              H NI+  +       + ++   +YI +EL+     ANL Q  +  L   ++S    Q
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQ 135

Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV----- 104
           +L G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYR 193

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--------------------------- 137
           APEV  +   GY  + DIWS+GC + EM+                               
Sbjct: 194 APEV--ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251

Query: 138 -------------PYSHLEDMQALFR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP 183
                        P       + LF  +            +  ARD + K L ++ + R 
Sbjct: 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311

Query: 184 TAAQLMEHPFVK 195
           +  + ++HP++ 
Sbjct: 312 SVDEALQHPYIN 323

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  109 bits (274), Expect = 2e-29
 Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 57/237 (24%)

Query: 6   QFEHDNIVQYIGTEKDENRLYI---FLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGL 62
           + +H NIV+       + +L +   F +   K    +      L    V S+  Q+L GL
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGL 114

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA--------TTTNDVKSFEGTPFWVAP 106
            + H RNV+HR++K  N+L++ +        GLA          + +V     T ++  P
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYRPP 170

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRI----------G 152
           +V+      Y  S D+WS GC   E+     P        + ++ +FR+           
Sbjct: 171 DVL-FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229

Query: 153 RGKLP----------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
             KLP                 VP  L+   RD +   L+ NP  R +A + ++HP+
Sbjct: 230 MTKLPDYKPYPMYPATTSLVNVVPK-LNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  110 bits (278), Expect = 3e-29
 Identities = 57/201 (28%), Positives = 80/201 (39%), Gaps = 30/201 (14%)

Query: 21  DENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA 78
           DEN LY+ +E    G L  L  K+   +       Y  +I+  +  +H    VHR+IK  
Sbjct: 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPD 191

Query: 79  NILVDASG-------------LATTTNDVKSFEGTPFWVAPEVVNLKNNG-----YGLSA 120
           NIL+D  G              A  T       GTP +++PE++     G     YG   
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPEC 251

Query: 121 DIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKL----PSVPNSLSRDARDFILKCL 175
           D W+LG    EM   Q P+ + +     +  I   K     P V   +  +ARDFI + L
Sbjct: 252 DWWALGVFAYEMFYGQTPF-YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL 310

Query: 176 QVNPNDR---PTAAQLMEHPF 193
              P  R     A     HPF
Sbjct: 311 C-PPETRLGRGGAGDFRTHPF 330

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  109 bits (274), Expect = 3e-29
 Identities = 63/245 (25%), Positives = 98/245 (40%), Gaps = 70/245 (28%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELV----KK--GSLANLYQKYHLSDSQVSSYTRQILNGL 62
           H+NIV+       EN+L +  E +    KK   S         L  + V  +  Q+L GL
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA--------TTTNDVKSFEGTPFWV-- 104
            + HE  ++HR++K  N+L++          GLA        T +++V         V  
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV---------VTL 172

Query: 105 ---APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI---------- 151
              AP+V+ + +  Y  S DIWS GC + EM+T +P +    D + L  I          
Sbjct: 173 WYRAPDVL-MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231

Query: 152 ---GRGKLP--------------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQL 188
                 KLP                         L  +  DF+   LQ+NP+ R +A Q 
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291

Query: 189 MEHPF 193
           + HP+
Sbjct: 292 LHHPW 296

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  109 bits (274), Expect = 4e-29
 Identities = 56/234 (23%), Positives = 87/234 (37%), Gaps = 57/234 (24%)

Query: 9   HDNIVQYIGTEKDENRLYI---FLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYL 65
           H NIV        E  L +   +L+   K  L +      ++   V  +  Q+L GL Y 
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYC 116

Query: 66  HERNVVHREIKCANILVDAS--------GLA--------TTTNDVKSFEGTPFWVAPEVV 109
           H + V+HR++K  N+L++          GLA        T  N+V     T ++  P+++
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----TLWYRPPDIL 172

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI-------------GRGKL 156
            L +  Y    D+W +GC   EM T +P +      + L  I             G    
Sbjct: 173 -LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231

Query: 157 P-----------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
                               P  L  D  D + K LQ    +R +A   M+HPF
Sbjct: 232 EEFKTYNYPKYRAEALLSHAPR-LDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  109 bits (275), Expect = 5e-29
 Identities = 56/241 (23%), Positives = 97/241 (40%), Gaps = 60/241 (24%)

Query: 6   QFEHDNIVQYI------GTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQ 57
             +H+N++  +       + ++    Y+ +  ++     +L +      S+ ++     Q
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGLKFSEEKIQYLVYQ 134

Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV----- 104
           +L GL Y+H   VVHR++K  N+ V+          GLA   +       T + V     
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYR 190

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP------PYSHLE---------DMQALF 149
           APEV+ L    Y  + DIWS+GC + EMLT +           L            + + 
Sbjct: 191 APEVI-LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249

Query: 150 RIGRGK-------LPSVP--------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
           ++           LP  P           S  A D + K L+++ + R TAAQ + HPF 
Sbjct: 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

Query: 195 K 195
           +
Sbjct: 310 E 310

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  109 bits (273), Expect = 1e-28
 Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 24/204 (11%)

Query: 12  IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVV 71
           +VQ     +D+  LY+ +E +  G L NL   Y + +     YT +++  L  +H    +
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 190

Query: 72  HREIKCANILVDASG-------------LATTTNDVKSFEGTPFWVAPEVVNLK--NNGY 116
           HR++K  N+L+D SG                      +  GTP +++PEV+  +  +  Y
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY 250

Query: 117 GLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-RIGRGKLP-SVPNS--LSRDARDFIL 172
           G   D WS+G  + EML    P+   + +   + +I   K   + P+   +S++A++ I 
Sbjct: 251 GRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI- 308

Query: 173 KCLQVNPNDR---PTAAQLMEHPF 193
                +   R       ++  H F
Sbjct: 309 CAFLTDREVRLGRNGVEEIKRHLF 332

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  107 bits (270), Expect = 2e-28
 Identities = 55/243 (22%), Positives = 101/243 (41%), Gaps = 55/243 (22%)

Query: 2   FSFSQFEHDNIVQYIGTEK----DENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQ 57
           +S    +H+NI+Q+IG EK     +  L++     +KGSL++  +   +S +++      
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAET 129

Query: 58  ILNGLTYLHER----------NVVHREIKCANILVDAS--------GLA------TTTND 93
           +  GL YLHE            + HR+IK  N+L+  +        GLA       +  D
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 94  VKSFEGTPFWVAPEVVN---LKNNGYGLSADIWSLGCTVLEMLT-----------HQPPY 139
                GT  ++APEV+           L  D++++G  + E+ +           +  P+
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249

Query: 140 SH-------LEDMQALFRIGRGKLPSVPNSLSRDA-----RDFILKCLQVNPNDRPTAAQ 187
                    LEDMQ +  + + K P + +   + A      + I +C   +   R +A  
Sbjct: 250 EEEIGQHPSLEDMQEV-VVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308

Query: 188 LME 190
           + E
Sbjct: 309 VGE 311

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  109 bits (274), Expect = 2e-28
 Identities = 60/252 (23%), Positives = 97/252 (38%), Gaps = 70/252 (27%)

Query: 6   QFEHDNIVQYI------GTEKDENRLYIFLELVKKGSLANLYQ--KYHLSDSQVSSYTRQ 57
              H NI+  +       T ++   +Y+ +EL+     ANL Q  +  L   ++S    Q
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQ 172

Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV----- 104
           +L G+ +LH   ++HR++K +NI+V +         GLA T     SF  TP+ V     
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYR 230

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--------------------------- 137
           APEV  +   GY  + DIWS+GC + EM+ H+                            
Sbjct: 231 APEV--ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288

Query: 138 -------------PYSHLEDMQALF-RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP 183
                        P         LF               +  ARD + K L ++P  R 
Sbjct: 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348

Query: 184 TAAQLMEHPFVK 195
           +    ++HP++ 
Sbjct: 349 SVDDALQHPYIN 360

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  107 bits (270), Expect = 2e-28
 Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 50/237 (21%)

Query: 9   HDNIVQYIGTEKDENRLYI---FLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYL 65
           H NI+  +     ++ + +   F+E   +  + +      L+ S + +Y    L GL YL
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 66  HERNVVHREIKCANILVDAS--------GLATTTND-VKSFEGTPFWV-----APEVVNL 111
           H+  ++HR++K  N+L+D +        GLA +     +++  T   V     APE++  
Sbjct: 129 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELL-F 185

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI-------------GRGKLP- 157
               YG+  D+W++GC + E+L   P      D+  L RI                 LP 
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245

Query: 158 --SVPN-----------SLSRDARDFILKCLQVNPNDRPTAAQLMEHP-FVKRPLQT 200
             +  +           +   D  D I      NP  R TA Q ++   F  RP  T
Sbjct: 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 302

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  107 bits (269), Expect = 2e-28
 Identities = 57/237 (24%), Positives = 93/237 (39%), Gaps = 56/237 (23%)

Query: 9   HDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
             NI+      KD       +  E V       LYQ   L+D  +  Y  +IL  L Y H
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCH 147

Query: 67  ERNVVHREIKCANILVDAS---------GLATTTNDVKSFEG---TPFWVAPEV-VNLKN 113
              ++HR++K  N+++D           GLA   +  + +     + ++  PE+ V+ + 
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLED-MQALFRIGR------------------- 153
             Y  S D+WSLGC +  M+  + P+ H  D    L RI +                   
Sbjct: 208 --YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265

Query: 154 -------GKLPSVP----------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
                  G+               + +S +A DF+ K L+ +   R TA + MEHP+
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  107 bits (270), Expect = 3e-28
 Identities = 56/244 (22%), Positives = 94/244 (38%), Gaps = 61/244 (25%)

Query: 6   QFEHDNIVQ----YIGTEKDE-NRLYIFLELVKKGSLANLYQ-----KYHLSDSQVSSYT 55
            F H NI+     ++  E+   ++LY+  EL++     +L Q     +  +S   +  + 
Sbjct: 85  HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQHIQYFM 140

Query: 56  RQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV--- 104
             IL GL  LHE  VVHR++   NIL+  +         LA           T +     
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTA--DANKTHYVTHRW 198

Query: 105 --APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--P---YSH-------------LED 144
             APE+V ++  G+    D+WS GC + EM   +       + +             +ED
Sbjct: 199 YRAPELV-MQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257

Query: 145 MQAL--------FRIGRGKLPSVP-----NSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           +            R     +P+        +    A D I K L+ NP  R +  Q + H
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317

Query: 192 PFVK 195
           P+ +
Sbjct: 318 PYFE 321

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  106 bits (266), Expect = 3e-28
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 38/208 (18%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
           H NIV  I  +++++  Y+ +E ++  +L+  +     LS     ++T QIL+G+ + H+
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129

Query: 68  RNVVHREIKCANILVDAS--------GLA--------TTTNDVKSFEGTPFWVAPEVVNL 111
             +VHR+IK  NIL+D++        G+A        T TN V    GT  + +PE    
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL---GTVQYFSPEQA-- 184

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYS----------HLEDMQALFRIGRGKLPSVPN 161
           K        DI+S+G  + EML  +PP++          H++D  ++  +       +P 
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--SVPNVTTDVRKDIPQ 242

Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLM 189
           SL     + IL+  + +  +R    Q M
Sbjct: 243 SL----SNVILRATEKDKANRYKTIQEM 266

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  107 bits (269), Expect = 4e-28
 Identities = 44/225 (19%), Positives = 83/225 (36%), Gaps = 57/225 (25%)

Query: 20  KDENRLYIFLELV----KKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREI 75
                L + +E V     K   + +     +  + +S Y  Q+   + ++H   + HR+I
Sbjct: 108 SQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDI 167

Query: 76  KCANILVDAS---------GLATTTNDVKSFEGTPFWV---------APEVVNLKNNGYG 117
           K  N+LV++          G A      K    +   V         APE++ L    Y 
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSA------KKLIPSEPSVAYICSRFYRAPELM-LGATEYT 220

Query: 118 LSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRI----------------GRGKLPS 158
            S D+WS+GC   E++  +P +   + ++ +  + +I                   + P+
Sbjct: 221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPT 280

Query: 159 ---------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
                    +P      A D + + L+  P+ R    + M HPF 
Sbjct: 281 LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  107 bits (268), Expect = 8e-28
 Identities = 56/261 (21%), Positives = 88/261 (33%), Gaps = 77/261 (29%)

Query: 9   HDNIVQYIG--TEKDENRLYI---FLE------LVKKGSLANLYQKYHLSDSQVSSYTRQ 57
           H N++          + ++++   + E      +    +     +   L    V S   Q
Sbjct: 77  HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136

Query: 58  ILNGLTYLHERNVVHREIKCANILVDAS------------GLATTTND-VKSFEGTPFWV 104
           IL+G+ YLH   V+HR++K ANILV               G A   N  +K        V
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 105 ------APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP---------PYSHLEDMQALF 149
                 APE++ L    Y  + DIW++GC   E+LT +P           S+      L 
Sbjct: 197 VTFWYRAPELL-LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255

Query: 150 RI-------------GRGKLPSVPN------------------------SLSRDARDFIL 172
           RI                K+P                                 A   + 
Sbjct: 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 315

Query: 173 KCLQVNPNDRPTAAQLMEHPF 193
           K L ++P  R T+ Q M+ P+
Sbjct: 316 KLLTMDPIKRITSEQAMQDPY 336

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  106 bits (266), Expect = 9e-28
 Identities = 54/235 (22%), Positives = 106/235 (45%), Gaps = 47/235 (20%)

Query: 6   QFEHDNIVQYI------GTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQIL 59
             +H+N++  +       + ++ N +Y+   L+    L N+ +   L+D  V     QIL
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQIL 142

Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLA-TTTNDVKSFEGTPFWVAPEVVN 110
            GL Y+H  +++HR++K +N+ V+          GLA  T +++  +  T ++ APE++ 
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIM- 201

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHL---------------EDMQAL---- 148
           L    Y  + DIWS+GC + E+LT +  +    H+               E ++ +    
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261

Query: 149 ---FRIGRGKLPSVP-----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
              +     ++P +         +  A D + K L ++ + R TAAQ + H +  
Sbjct: 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  106 bits (266), Expect = 1e-27
 Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 47/235 (20%)

Query: 6   QFEHDNIVQYI------GTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQIL 59
              H+N++  +       T  D    Y+ +  +    L  L +   L + ++     Q+L
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQML 138

Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLA-TTTNDVKSFEGTPFWVAPEVVN 110
            GL Y+H   ++HR++K  N+ V+          GLA    +++  +  T ++ APEV+ 
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVI- 197

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHL---------------EDMQAL---- 148
           L    Y  + DIWS+GC + EM+T +  +    HL               E +Q L    
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257

Query: 149 ---FRIGRGKLPSVP-----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
              +  G  +L          + S  A + + K L ++   R TA + + HP+ +
Sbjct: 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  104 bits (262), Expect = 1e-27
 Identities = 52/227 (22%), Positives = 86/227 (37%), Gaps = 47/227 (20%)

Query: 5   SQFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILN 60
              +HDNIV+Y G         L + +E +  GSL +  QK+   +   ++  YT QI  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA----------TTTNDVKSFEGTP- 101
           G+ YL  +  +HR++   NILV+          GL                 +S    P 
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES----PI 181

Query: 102 FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH----------------QPPYSHLEDM 145
           FW APE   L  + + +++D+WS G  + E+ T+                      +   
Sbjct: 182 FWYAPES--LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239

Query: 146 QALFRIGRGK-LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
             +  +     LP  P+    +    + +C   N N RP+   L   
Sbjct: 240 HLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  105 bits (263), Expect = 2e-27
 Identities = 46/206 (22%), Positives = 87/206 (42%), Gaps = 26/206 (12%)

Query: 6   QFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNG 61
             ++ ++ + +G         + +  +L+  G L +     K ++    + ++  QI  G
Sbjct: 73  SVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLA---TTTNDVKSFEGTPF---WVAPE 107
           + YL +R +VHR++   N+LV           GLA            EG      W+A E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSR 165
            +   +  Y   +D+WS G TV E++T    PY  +   +    + +G +LP  P   + 
Sbjct: 190 SIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-PPICTI 246

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEH 191
           D    + KC  ++ + RP   +L+  
Sbjct: 247 DVYMIMRKCWMIDADSRPKFRELIIE 272

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  105 bits (264), Expect = 2e-27
 Identities = 46/253 (18%), Positives = 84/253 (33%), Gaps = 69/253 (27%)

Query: 5   SQFEHDNIVQ-------YIGTEKDENRLYIFLELV----KKGSLANLYQKYHLSDSQVSS 53
           +   H NIVQ           ++ +  L + +E V     +       ++       +  
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV 133

Query: 54  YTRQILNGLTYLHER--NVVHREIKCANILVDAS---------GLATTTNDVKSFEGTPF 102
           +  Q++  +  LH    NV HR+IK  N+LV+ +         G A      K    +  
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA------KKLSPSEP 187

Query: 103 WV---------APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP---------------- 137
            V         APE++   N  Y  + DIWS+GC   EM+  +P                
Sbjct: 188 NVAYICSRYYRAPELI-FGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246

Query: 138 ---------------PYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDR 182
                           ++ ++   +                +++A D +   LQ  P +R
Sbjct: 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306

Query: 183 PTAAQLMEHPFVK 195
               + + HP+  
Sbjct: 307 MKPYEALCHPYFD 319

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  105 bits (263), Expect = 3e-27
 Identities = 66/242 (27%), Positives = 109/242 (45%), Gaps = 56/242 (23%)

Query: 6   QFEHDNI-----VQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
           +F H+NI     +    T +    +YI  +L++   L  L +  HLS+  +  +  QIL 
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR 139

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV-------- 104
           GL Y+H  NV+HR++K +N+L++ +        GLA   +     + T F          
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP--DHDHTGFLTEYVATRWY 197

Query: 105 -APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY---SHL---------------EDM 145
            APE++ L + GY  S DIWS+GC + EML+++P +    +L               ED+
Sbjct: 198 RAPEIM-LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256

Query: 146 QALF-RIGRGKLPSVPNS-----------LSRDARDFILKCLQVNPNDRPTAAQLMEHPF 193
             +     R  L S+P+                A D + K L  NP+ R    Q + HP+
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316

Query: 194 VK 195
           ++
Sbjct: 317 LE 318

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  105 bits (263), Expect = 3e-27
 Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 23/204 (11%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY---QKYHLSDSQVSSYTRQILNGL 62
           Q+ H NIV+ IG    +  +YI +ELV+ G     +   +   L    +         G+
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGM 226

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF----WVAPEV 108
            YL  +  +HR++   N LV           G++         +  G       W APE 
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRD 166
             L    Y   +D+WS G  + E  +    PY +L + Q    + +G +LP  P      
Sbjct: 287 --LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC-PELCPDA 343

Query: 167 ARDFILKCLQVNPNDRPTAAQLME 190
               + +C    P  RP+ + + +
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIYQ 367

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  103 bits (260), Expect = 3e-27
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 44/223 (19%)

Query: 5   SQFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGL 62
               H++I++Y G   +     L + +E V  GSL +   ++ +  +Q+  + +QI  G+
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 147

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA----------TTTNDVKSFEGTP-FW 103
            YLH ++ +HR++   N+L+D          GLA              D  S    P FW
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS----PVFW 203

Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH---------------QPPYSHLEDMQAL 148
            APE   LK   +  ++D+WS G T+ E+LTH                     +  ++  
Sbjct: 204 YAPEC--LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261

Query: 149 FRIGRGK-LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
             + RG+ LP  P+    +    +  C +   + RPT   L+ 
Sbjct: 262 ELLERGERLPR-PDKCPAEVYHLMKNCWETEASFRPTFENLIP 303

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  103 bits (260), Expect = 4e-27
 Identities = 50/205 (24%), Positives = 84/205 (40%), Gaps = 34/205 (16%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
             ++V      + + +LY+ + L+    LA  L ++  L+  +  +  RQI + L   H 
Sbjct: 93  EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA 152

Query: 68  RNVVHREIKCANILVDAS--------GLATTTNDVK-----SFEGTPFWVAPEVVNLKNN 114
               HR++K  NILV A         G+A+ T D K     +  GT +++APE      +
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF--SES 210

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYS---------HL-EDMQALFRIGRGKLPSVPNSLS 164
                ADI++L C + E LT  PPY          H+ + +           P +P +  
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRP----STVRPGIPVAF- 265

Query: 165 RDARDFILKCLQVNPNDRPTAAQLM 189
                 I + +  NP DR      +
Sbjct: 266 ---DAVIARGMAKNPEDRYVTCGDL 287

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  104 bits (261), Expect = 4e-27
 Identities = 57/249 (22%), Positives = 106/249 (42%), Gaps = 62/249 (24%)

Query: 6   QFEHDNI-----VQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
            F+H+NI     +Q   + ++ N +YI  EL++   L  +     LSD  +  +  Q L 
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLR 123

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA-----TTTNDVKSFEGTPFW---V 104
            +  LH  NV+HR++K +N+L++++        GLA     +  ++ +           V
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 105 ------APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--------------------P 138
                 APEV+ L +  Y  + D+WS GC + E+   +P                    P
Sbjct: 184 ATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242

Query: 139 YSHLEDMQALF-RIGRGKLPSVPNS-----------LSRDARDFILKCLQVNPNDRPTAA 186
           +S   D++ +     R  + S+P             ++    D + + L  +P  R TA 
Sbjct: 243 HSD-NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301

Query: 187 QLMEHPFVK 195
           + +EHP+++
Sbjct: 302 EALEHPYLQ 310

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  102 bits (257), Expect = 9e-27
 Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 47/215 (21%)

Query: 9   HDNIVQ-Y-IGTEKDENRL--YIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLT 63
           H  IV  Y  G  +       YI +E V   +L + ++ +  ++  +           L 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130

Query: 64  YLHERNVVHREIKCANILVDAS--------GLA----------TTTNDVKSFEGTPFWVA 105
           + H+  ++HR++K ANI++ A+        G+A          T T  V    GT  +++
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI---GTAQYLS 187

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS----------HL-EDMQALFRIGRG 154
           PE    + +     +D++SLGC + E+LT +PP++          H+ ED          
Sbjct: 188 PEQA--RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP----SA 241

Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM 189
           +   +   L       +LK L  NP +R   A  M
Sbjct: 242 RHEGLSADL----DAVVLKALAKNPENRYQTAAEM 272

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  102 bits (257), Expect = 1e-26
 Identities = 55/219 (25%), Positives = 85/219 (38%), Gaps = 36/219 (16%)

Query: 6   QFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNG 61
               D IV+Y G         L + +E +  G L +  Q++   L  S++  Y+ QI  G
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLA---TTTNDV-KSFEGT--P-FWVAP 106
           + YL  R  VHR++   NILV++         GLA       D     E    P FW AP
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPS--VPNSL 163
           E   L +N +   +D+WS G  + E+ T+     S   +   +    R       +   L
Sbjct: 200 ES--LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257

Query: 164 SRDAR------------DFILKCLQVNPNDRPTAAQLME 190
               R            + +  C   +P DRP+ + L  
Sbjct: 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  102 bits (256), Expect = 1e-26
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 46/226 (20%)

Query: 5   SQFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILN 60
               H+NIV+Y G  TE   N + + +E +  GSL     K    ++  Q   Y  QI  
Sbjct: 78  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA----------TTTNDVKSFEGTP- 101
           G+ YL  R  VHR++   N+LV++         GL           T  +D  S    P 
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS----PV 193

Query: 102 FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH---------------QPPYSHLEDMQ 146
           FW APE   L  + + +++D+WS G T+ E+LT+                P +  +   +
Sbjct: 194 FWYAPEC--LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251

Query: 147 ALFRIGRGK-LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
            +  +  GK LP  P +   +    + KC +  P++R +   L+E 
Sbjct: 252 LVNTLKEGKRLPC-PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  102 bits (255), Expect = 2e-26
 Identities = 50/254 (19%), Positives = 80/254 (31%), Gaps = 66/254 (25%)

Query: 2   FSFSQFEHDNIVQYIG-----TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTR 56
           +     EHDNI ++I      T        + +E    GSL      +            
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH 118

Query: 57  QILNGLTYLHE---------RNVVHREIKCANILVDAS--------GLATTTNDVKSFE- 98
            +  GL YLH            + HR++   N+LV           GL+      +    
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178

Query: 99  -----------GTPFWVAPEV----VNLKNNG-YGLSADIWSLGCTVLEMLT-------- 134
                      GT  ++APEV    VNL++        D+++LG    E+          
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238

Query: 135 -----HQPPYSH-------LEDMQALFRIGRGKLPSVPNSLSRDA------RDFILKCLQ 176
                +Q  +          EDMQ L      + P  P +   ++      ++ I  C  
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLV-SREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297

Query: 177 VNPNDRPTAAQLME 190
            +   R TA    E
Sbjct: 298 QDAEARLTAQXAEE 311

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  100 bits (252), Expect = 2e-26
 Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 20/203 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +  H  +V++ G    E  +YI  E +  G L N  + +   L  SQ+      +  G+
Sbjct: 58  MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPEVV 109
            +L     +HR++   N LVD          G+      +   S  GT F   W APEV 
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV- 176

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRDA 167
                 Y   +D+W+ G  + E+ +  + PY    + + + ++ +G +L   P+  S   
Sbjct: 177 -FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-PHLASDTI 234

Query: 168 RDFILKCLQVNPNDRPTAAQLME 190
              +  C    P  RPT  QL+ 
Sbjct: 235 YQIMYSCWHELPEKRPTFQQLLS 257

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (255), Expect = 2e-26
 Identities = 52/226 (23%), Positives = 86/226 (38%), Gaps = 47/226 (20%)

Query: 5   SQFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILN 60
              +HDNIV+Y G         L + +E +  GSL +  QK+   +   ++  YT QI  
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA----------TTTNDVKSFEGTP- 101
           G+ YL  +  +HR++   NILV+          GL                 +S    P 
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES----PI 212

Query: 102 FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH----------------QPPYSHLEDM 145
           FW APE   L  + + +++D+WS G  + E+ T+                      +   
Sbjct: 213 FWYAPES--LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270

Query: 146 QALFRIGRGK-LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
             +  +     LP  P+    +    + +C   N N RP+   L  
Sbjct: 271 HLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  100 bits (251), Expect = 3e-26
 Identities = 45/203 (22%), Positives = 84/203 (41%), Gaps = 20/203 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGL 62
            +  H  +VQ  G   ++  + +  E ++ G L++  +      +   +      +  G+
Sbjct: 58  MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 117

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPEVV 109
            YL E  V+HR++   N LV  +        G+      +   S  GT F   W +PEV 
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV- 176

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRDA 167
               + Y   +D+WS G  + E+ +  + PY +  + + +  I  G +L   P   S   
Sbjct: 177 -FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHV 234

Query: 168 RDFILKCLQVNPNDRPTAAQLME 190
              +  C +  P DRP  ++L+ 
Sbjct: 235 YQIMNHCWRERPEDRPAFSRLLR 257

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  100 bits (251), Expect = 5e-26
 Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 22/203 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
           Q ++  IV+ IG  + E    + +E+ + G L   L Q  H+ D  +     Q+  G+ Y
Sbjct: 74  QLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 132

Query: 65  LHERNVVHREIKCANILVDAS--------GLA----TTTNDVKSFEGTPF---WVAPEVV 109
           L E N VHR++   N+L+           GL+       N  K+     +   W APE +
Sbjct: 133 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGK-LPSVPNSLSRDA 167
           N     +   +D+WS G  + E  ++ Q PY  ++  +    + +G+ +   P    R+ 
Sbjct: 193 NYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-PAGCPREM 249

Query: 168 RDFILKCLQVNPNDRPTAAQLME 190
            D +  C   +  +RP  A +  
Sbjct: 250 YDLMNLCWTYDVENRPGFAAVEL 272

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  101 bits (254), Expect = 5e-26
 Identities = 50/236 (21%), Positives = 85/236 (36%), Gaps = 71/236 (30%)

Query: 29  LELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH-ERNVVHREIKCANILVDASGL 87
           L L+KK      ++   L    V   ++Q+L GL Y+H    ++H +IK  N+L++    
Sbjct: 117 LALIKK----YEHRGIPLI--YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170

Query: 88  ATTTNDVK-------SFEG--------TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEM 132
                 +K        +          T  + +PEV  L    +G  ADIWS  C + E+
Sbjct: 171 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEV--LLGAPWGCGADIWSTACLIFEL 228

Query: 133 LTHQP------------PYSHLEDMQALF-------------------------RIGRGK 155
           +T                  H+  +  L                           I + K
Sbjct: 229 ITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK 288

Query: 156 LPSVPNSLSR-------DAR---DFILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
              + + L+        +A+   DF+   LQ++P  R  A  L+ HP++K  L   
Sbjct: 289 FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 344

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  102 bits (255), Expect = 9e-26
 Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 26/205 (12%)

Query: 6   QFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
           +  H+ +VQ     +E+    +YI  E + KGSL +  +     +L   Q+     QI +
Sbjct: 235 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTND----VKSFEGTPF-WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA    D     +     P  W APE
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSR 165
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG ++P  P     
Sbjct: 352 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPE 408

Query: 166 DARDFILKCLQVNPNDRPTAAQLME 190
              D + +C +  P +RPT   L  
Sbjct: 409 SLHDLMCQCWRKEPEERPTFEYLQA 433

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  100 bits (252), Expect = 1e-25
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 22/205 (10%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            QF+H NI++  G       + I  E ++ GSL +  +K+    +  Q+    R I +G+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTND----VKSFEGTPF---WVAPE 107
            YL +   VHR++   NIL++++        GL     D      +  G      W +PE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSR 165
            +      +  ++D+WS G  + E++++ + PY  + +   +  +  G +LP  P     
Sbjct: 221 AIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-PMDCPA 277

Query: 166 DARDFILKCLQVNPNDRPTAAQLME 190
                +L C Q + N+RP   Q++ 
Sbjct: 278 ALYQLMLDCWQKDRNNRPKFEQIVS 302

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 99.2 bits (248), Expect = 1e-25
 Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 23/205 (11%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            Q ++  IV+ IG  + E  L + +E+   G L          +  S V+    Q+  G+
Sbjct: 65  HQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA----TTTNDVKSFEGTPF---WVAPE 107
            YL E+N VHR++   N+L+           GL+       +   +     +   W APE
Sbjct: 124 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGK-LPSVPNSLSR 165
            +N +   +   +D+WS G T+ E L++ Q PY  ++  + +  I +GK +   P     
Sbjct: 184 CINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPP 240

Query: 166 DARDFILKCLQVNPNDRPTAAQLME 190
           +    +  C      DRP    + +
Sbjct: 241 ELYALMSDCWIYKWEDRPDFLTVEQ 265

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  100 bits (250), Expect = 1e-25
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 22/205 (10%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            QF H NI++  G       + I  E ++ G+L    ++     S  Q+    R I  G+
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSF----EGTPF---WVAPE 107
            YL   N VHR++   NILV+++        GL+    D         G      W APE
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSR 165
            ++     +  ++D+WS G  + E++T+ + PY  L + + +  I  G +LP+ P     
Sbjct: 221 AIS--YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-PMDCPS 277

Query: 166 DARDFILKCLQVNPNDRPTAAQLME 190
                +++C Q     RP  A ++ 
Sbjct: 278 AIYQLMMQCWQQERARRPKFADIVS 302

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 99.7 bits (249), Expect = 2e-25
 Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 22/204 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLT 63
           QF+H NI++  G         I  E ++ GSL    + +    +  Q+    R +  G+ 
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTND----VKSFEGTPF---WVAPEV 108
           YL +   VHR++   N+LVD++        GL+    D      +  G      W APE 
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRD 166
           +      +  ++D+WS G  + E+L + + PY ++ +   +  +  G +LP+ P      
Sbjct: 226 IA--FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA-PMGCPHA 282

Query: 167 ARDFILKCLQVNPNDRPTAAQLME 190
               +L C   +   RP  +Q++ 
Sbjct: 283 LHQLMLDCWHKDRAQRPRFSQIVS 306

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 98.9 bits (247), Expect = 2e-25
 Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 21/204 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL---YQKYHLSDSQVSSYTRQILNGL 62
           + +H N+VQ +G    E   YI  E +  G+L +      +  +S   +     QI + +
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPEVV 109
            YL ++N +HR++   N LV  +        GL+   T +   +  G  F   W APE  
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES- 183

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRDA 167
            L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +  ++   P       
Sbjct: 184 -LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-PEGCPEKV 241

Query: 168 RDFILKCLQVNPNDRPTAAQLMEH 191
            + +  C Q NP+DRP+ A++ + 
Sbjct: 242 YELMRACWQWNPSDRPSFAEIHQA 265

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 98.8 bits (247), Expect = 2e-25
 Identities = 44/204 (21%), Positives = 84/204 (41%), Gaps = 20/204 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGL 62
               H+ +VQ  G    +  ++I  E +  G L N  ++  +     Q+    + +   +
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPEVV 109
            YL  +  +HR++   N LV+          GL+     ++  S  G+ F   W  PEV 
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV- 192

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRDA 167
            L  + +   +DIW+ G  + E+ +  + PY    + +    I +G +L   P+  S   
Sbjct: 193 -LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKV 250

Query: 168 RDFILKCLQVNPNDRPTAAQLMEH 191
              +  C     ++RPT   L+ +
Sbjct: 251 YTIMYSCWHEKADERPTFKILLSN 274

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 98.9 bits (247), Expect = 2e-25
 Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 28/207 (13%)

Query: 6   QFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNG 61
             +H N+++  G         + +  EL   GSL +     + H     +S Y  Q+  G
Sbjct: 77  SLDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLA----TTTNDVKSFEGTPF---WVAP 106
           + YL  +  +HR++   N+L+           GL        +     E       W AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG--KLPSVPNSL 163
           E +      +  ++D W  G T+ EM T+ Q P+  L   Q L +I +   +LP  P   
Sbjct: 194 ESLK--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-PEDC 250

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLME 190
            +D  + +++C    P DRPT   L +
Sbjct: 251 PQDIYNVMVQCWAHKPEDRPTFVALRD 277

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 99.3 bits (248), Expect = 2e-25
 Identities = 46/206 (22%), Positives = 88/206 (42%), Gaps = 26/206 (12%)

Query: 6   QFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNG 61
             ++ ++ + +G         + +  +L+  G L +     K ++    + ++  QI  G
Sbjct: 73  SVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLA---TTTNDVKSFEGTPF---WVAPE 107
           + YL +R +VHR++   N+LV           GLA            EG      W+A E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSR 165
            +   +  Y   +D+WS G TV E++T    PY  +   +    + +G +LP  P   + 
Sbjct: 190 SIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ-PPICTI 246

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEH 191
           D    ++KC  ++ + RP   +L+  
Sbjct: 247 DVYMIMVKCWMIDADSRPKFRELIIE 272

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  101 bits (253), Expect = 2e-25
 Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 26/205 (12%)

Query: 6   QFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
           +  H+ +VQ     +E+    +YI  E + KGSL +  +     +L   Q+     QI +
Sbjct: 318 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTND----VKSFEGTPF-WVAPE 107
           G+ Y+   N VHR+++ ANILV  +        GLA    D     +     P  W APE
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSR 165
                   + + +D+WS G  + E+ T  + PY  + + + L ++ RG ++P  P     
Sbjct: 435 AALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPE 491

Query: 166 DARDFILKCLQVNPNDRPTAAQLME 190
              D + +C +  P +RPT   L  
Sbjct: 492 SLHDLMCQCWRKEPEERPTFEYLQA 516

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 98.5 bits (246), Expect = 5e-25
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 22/204 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNGLT 63
             +H +IV+ +G       L +  + +  GSL +     +  L    + ++  QI  G+ 
Sbjct: 71  SLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129

Query: 64  YLHERNVVHREIKCANILVDAS--------GLA---TTTNDVKSFEGTPF---WVAPEVV 109
           YL E  +VHR +   N+L+ +         G+A      +    +        W+A E +
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRDA 167
           +     Y   +D+WS G TV E++T    PY+ L   +    + +G +L   P   + D 
Sbjct: 190 H--FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ-PQICTIDV 246

Query: 168 RDFILKCLQVNPNDRPTAAQLMEH 191
              ++KC  ++ N RPT  +L   
Sbjct: 247 YMVMVKCWMIDENIRPTFKELANE 270

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  100 bits (250), Expect = 5e-25
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 21/204 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL---YQKYHLSDSQVSSYTRQILNGL 62
           + +H N+VQ +G    E   YI  E +  G+L +      +  +S   +     QI + +
Sbjct: 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLATTTND---VKSFEGT-PF-WVAPEVV 109
            YL ++N +HR +   N LV  +        GL+                P  W APE  
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES- 390

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRDA 167
            L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +  ++   P       
Sbjct: 391 -LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-PEGCPEKV 448

Query: 168 RDFILKCLQVNPNDRPTAAQLMEH 191
            + +  C Q NP+DRP+ A++ + 
Sbjct: 449 YELMRACWQWNPSDRPSFAEIHQA 472

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 97.3 bits (243), Expect = 6e-25
 Identities = 48/203 (23%), Positives = 87/203 (42%), Gaps = 22/203 (10%)

Query: 6   QFEHDNIVQYIGT-EKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILNG 61
           Q  H N+VQ +G   +++  LYI  E + KGSL +  +   +  L    +  ++  +   
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPF---WVAPEVVN 110
           + YL   N VHR++   N+LV           GL        + +       W APE   
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKLPVKWTAPEA-- 185

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRDAR 168
           L+   +   +D+WS G  + E+ +  + PY  +     + R+ +G K+ + P+       
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-PDGCPPAVY 244

Query: 169 DFILKCLQVNPNDRPTAAQLMEH 191
           + +  C  ++   RP+  QL E 
Sbjct: 245 EVMKNCWHLDAAMRPSFLQLREQ 267

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.4 bits (243), Expect = 6e-25
 Identities = 44/207 (21%), Positives = 79/207 (38%), Gaps = 26/207 (12%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
           S+  H ++V   G     +   +  E VK GSL    +K    ++        +Q+   +
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAM 126

Query: 63  TYLHERNVVHREIKCANILVDASGLATTTN-------------DVKSFEGTPF---WVAP 106
            +L E  ++H  +   NIL+       T N              V   +       WV P
Sbjct: 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPP 186

Query: 107 EVVNLKNNG-YGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSL 163
           E   ++N     L+ D WS G T+ E+ +    P S L+  + L       +LP+   + 
Sbjct: 187 EC--IENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAA- 243

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLME 190
             +  + I  C+   P+ RP+   ++ 
Sbjct: 244 --ELANLINNCMDYEPDHRPSFRAIIR 268

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 96.9 bits (242), Expect = 8e-25
 Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 25/205 (12%)

Query: 5   SQFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILN 60
            QF+H +IV+ IG  TE   N ++I +EL   G L +    +KY L  + +  Y  Q+  
Sbjct: 71  RQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
            L YL  +  VHR+I   N+LV ++        GL+     +             W+APE
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 187

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSR 165
              +    +  ++D+W  G  + E+L H   P+  +++   + RI  G +LP  P +   
Sbjct: 188 S--INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-PPNCPP 244

Query: 166 DARDFILKCLQVNPNDRPTAAQLME 190
                + KC   +P+ RP   +L  
Sbjct: 245 TLYSLMTKCWAYDPSRRPRFTELKA 269

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 99.6 bits (248), Expect = 1e-24
 Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 23/204 (11%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNGLT 63
           Q ++  IV+ IG  + E  L + +E+   G L    + ++  +  S V+    Q+  G+ 
Sbjct: 392 QLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 450

Query: 64  YLHERNVVHREIKCANILVDAS--------GLA----TTTNDVKSFEGTPF---WVAPEV 108
           YL E+N VHR +   N+L+           GL+       +   +     +   W APE 
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGK-LPSVPNSLSRD 166
           +N +   +   +D+WS G T+ E L++ Q PY  ++  + +  I +GK +   P     +
Sbjct: 511 INFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPE 567

Query: 167 ARDFILKCLQVNPNDRPTAAQLME 190
               +  C      DRP    + +
Sbjct: 568 LYALMSDCWIYKWEDRPDFLTVEQ 591

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 96.1 bits (240), Expect = 2e-24
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 25/205 (12%)

Query: 5   SQFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILN 60
              +H +IV+ IG   E+     +I +EL   G L +  ++    L    +  Y+ QI  
Sbjct: 68  KNLDHPHIVKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICK 124

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
            + YL   N VHR+I   NILV +         GL+      D      T     W++PE
Sbjct: 125 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 184

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSR 165
              +    +  ++D+W     + E+L+  + P+  LE+   +  + +G +LP  P+    
Sbjct: 185 S--INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPP 241

Query: 166 DARDFILKCLQVNPNDRPTAAQLME 190
                + +C   +P+DRP   +L+ 
Sbjct: 242 VLYTLMTRCWDYDPSDRPRFTELVC 266

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 95.4 bits (238), Expect = 4e-24
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 26/206 (12%)

Query: 6   QFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILN 60
           Q +H  +V+     T+     +YI  E ++ GSL +  +      L+ +++     QI  
Sbjct: 64  QLQHQRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPE 107
           G+ ++ ERN +HR+++ ANILV  +        GLA     N+  + EG  F   W APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSR 165
              +    + + +D+WS G  + E++TH + PY  + + + +  + RG ++   P++   
Sbjct: 181 A--INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPE 237

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEH 191
           +    +  C +  P DRPT   L   
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSV 263

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 96.6 bits (241), Expect = 8e-24
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 26/204 (12%)

Query: 6   QFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLY----QKYHLSDSQVSSYTRQIL 59
           Q  H N+VQ +G    +++  LYI  E + KGSL + Y     +  L    +  ++  + 
Sbjct: 242 QLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVC 299

Query: 60  NGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPF---WVAPEV 108
             + YL   N VHR++   N+LV           GL    +  +  +       W APE 
Sbjct: 300 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEA 357

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSRD 166
             L+   +   +D+WS G  + E+ +  + PY  +     + R+ +G K+ + P+     
Sbjct: 358 --LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-PDGCPPA 414

Query: 167 ARDFILKCLQVNPNDRPTAAQLME 190
             D +  C  ++   RPT  QL E
Sbjct: 415 VYDVMKNCWHLDAATRPTFLQLRE 438

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 94.0 bits (234), Expect = 1e-23
 Identities = 21/192 (10%), Positives = 49/192 (25%), Gaps = 24/192 (12%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTY 64
           S+ +   + + +          +  E ++ GSL  +      S        + +      
Sbjct: 86  SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRAMQSLAAAADA 144

Query: 65  LHERNVVHREIKCANILVDASGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWS 124
            H   V       + + V   G              P  +                DI  
Sbjct: 145 AHRAGVALSIDHPSRVRVSIDGDVVL--------AYPATMPDA---------NPQDDIRG 187

Query: 125 LGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLP---SVPNSLSRDARDFILKCLQVN 178
           +G ++  +L ++ P         +    R   G+      +   +         + +Q +
Sbjct: 188 IGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGD 247

Query: 179 PNDRPTAAQLME 190
              R  +  L  
Sbjct: 248 GGIRSASTLLNL 259

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 93.9 bits (234), Expect = 2e-23
 Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 22/207 (10%)

Query: 5   SQFEHDNIVQYIGT-EKDENRLYIFLELVKKGSLAN--LYQKYHLSDSQVSSYTRQILNG 61
               H N++  IG     E   ++ L  +  G L       + + +   + S+  Q+  G
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLA-----TTTNDVKSFEGTPF---WVA 105
           + YL E+  VHR++   N ++D S        GLA          V+          W A
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLS 164
            E  +L+   +   +D+WS G  + E+LT   PPY H++       + +G+    P    
Sbjct: 197 LE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCP 254

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEH 191
                 + +C + +P  RPT   L+  
Sbjct: 255 DSLYQVMQQCWEADPAVRPTFRVLVGE 281

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 95.7 bits (238), Expect = 2e-23
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 19/202 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            QF+H +IV+ IG   +   ++I +EL   G L +  Q     L  + +  Y  Q+   L
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF---WVAPEVV 109
            YL  +  VHR+I   N+LV ++        GL+     +             W+APE  
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES- 563

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
            +    +  ++D+W  G  + E+L H   P+  +++   + RI  G+   +P +      
Sbjct: 564 -INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 622

Query: 169 DFILKCLQVNPNDRPTAAQLME 190
             + KC   +P+ RP   +L  
Sbjct: 623 SLMTKCWAYDPSRRPRFTELKA 644

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 94.4 bits (235), Expect = 3e-23
 Identities = 57/272 (20%), Positives = 98/272 (36%), Gaps = 89/272 (32%)

Query: 8   EHDNIVQY--IGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGL 62
            H+NIV    +    ++  +Y+  + ++     +L+       L          Q++  +
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYME----TDLHAVIRANILEPVHKQYVVYQLIKVI 122

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA----------------TTTNDVKSFE 98
            YLH   ++HR++K +NIL++A         GL+                   N     +
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182

Query: 99  GTPFW---V------APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP--P---YSH--- 141
             P     V      APE++ L +  Y    D+WSLGC + E+L  +P  P     +   
Sbjct: 183 DQPILTDYVATRWYRAPEIL-LGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241

Query: 142 ----------LEDMQAL-------------------FRIGRGKLPSVPNSL--------- 163
                      ED++++                       R       N L         
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301

Query: 164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           + +A D + K LQ NPN R +A   ++HPFV 
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFVS 333

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 92.0 bits (229), Expect = 1e-22
 Identities = 44/215 (20%), Positives = 86/215 (40%), Gaps = 30/215 (13%)

Query: 5   SQFEHDNIVQYIG--TEKD----ENRLYIFLELVKKGSLAN-------LYQKYHLSDSQV 51
            +F+H ++ + +G               + L  +K G L             ++L    +
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139

Query: 52  SSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDV-KSFEGT 100
             +   I  G+ YL  RN +HR++   N ++           GL+    + D  +    +
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199

Query: 101 PF---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKL 156
                W+A E  +L +N Y + +D+W+ G T+ E++T  Q PY+ +E+ +    +  G  
Sbjct: 200 KLPVKWLALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257

Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P     +  D + +C   +P  RP+   L   
Sbjct: 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 93.2 bits (232), Expect = 1e-22
 Identities = 54/205 (26%), Positives = 105/205 (51%), Gaps = 26/205 (12%)

Query: 6   QFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANL---YQKYHLSDSQVSSYTRQILN 60
             +HD +V+     T++    +YI  E + KGSL +     +       ++  ++ QI  
Sbjct: 239 TLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295

Query: 61  GLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVK--SFEGTPF---WVAPE 107
           G+ ++ +RN +HR+++ ANILV AS        GLA    D +  + EG  F   W APE
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 355

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRG-KLPSVPNSLSR 165
            +N  +  + + +D+WS G  ++E++T+ + PY  + + + +  + RG ++P  P +   
Sbjct: 356 AINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-PENCPE 412

Query: 166 DARDFILKCLQVNPNDRPTAAQLME 190
           +  + +++C +  P +RPT   +  
Sbjct: 413 ELYNIMMRCWKNRPEERPTFEYIQS 437

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 89.6 bits (223), Expect = 7e-22
 Identities = 44/207 (21%), Positives = 83/207 (40%), Gaps = 22/207 (10%)

Query: 5   SQFEHDNIVQYIGT-EKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNG 61
             F H N++  +G   + E    + L  +K G L N  +   ++ +   +  +  Q+  G
Sbjct: 81  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 140

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDVKSFEGTPF------WVA 105
           + YL  +  VHR++   N ++D          GLA      +  S            W+A
Sbjct: 141 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLS 164
            E  +L+   +   +D+WS G  + E++T   PPY  +        + +G+    P    
Sbjct: 201 LE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 258

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEH 191
               + +LKC       RP+ ++L+  
Sbjct: 259 DPLYEVMLKCWHPKAEMRPSFSELVSR 285

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 91.0 bits (226), Expect = 7e-22
 Identities = 55/293 (18%), Positives = 91/293 (31%), Gaps = 108/293 (36%)

Query: 6   QFEHDNIVQYIGTEKDENR-----LYIFLELVKKGSLANLYQ----KYHLSDSQVSSYTR 56
           + + D I++       ++      LYI LE+      ++L +       L++  + +   
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD----SDLKKLFKTPIFLTEEHIKTILY 136

Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV---- 104
            +L G  ++HE  ++HR++K AN L++          GLA T N  K             
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196

Query: 105 ----------------------APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSH 141
                                 APE++ L    Y  S DIWS GC   E+L       + 
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255

Query: 142 LEDMQALFRIGRGKLPSVPNSL--------------------------------SRDARD 169
             +   LF  G    P  P+                                    +   
Sbjct: 256 PTNRFPLFP-GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIK 314

Query: 170 FIL--------------------------KCLQVNPNDRPTAAQLMEHPFVKR 196
           +I                             L+ NPN R T  Q ++HP++K 
Sbjct: 315 YIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 89.9 bits (223), Expect = 2e-21
 Identities = 53/301 (17%), Positives = 92/301 (30%), Gaps = 116/301 (38%)

Query: 6   QFEHDNIVQ-----YIGTEKDENRLYIFLELVKKGSLANLYQ----KYHLSDSQVSSYTR 56
           +  HD++V+          +  + LY+ LE+      ++  +      +L++  + +   
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVYLTELHIKTLLY 163

Query: 57  QILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWV---- 104
            +L G+ Y+H   ++HR++K AN LV+          GLA T +  ++            
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 105 ---------------------------APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
                                      APE++ L    Y  + D+WS+GC   E+L    
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI-LLQENYTEAIDVWSIGCIFAELLNMIK 282

Query: 138 PYSHLEDM-QALFRIGRGKLPSVPNSL--------------------------------- 163
                      LF  G    P  P+                                   
Sbjct: 283 ENVAYHADRGPLFP-GSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341

Query: 164 --SRDARDFIL--------------------------KCLQVNPNDRPTAAQLMEHPFVK 195
               DA+ +I                           + L  NPN R T  + + HPF K
Sbjct: 342 LEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401

Query: 196 R 196
            
Sbjct: 402 E 402

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 88.1 bits (219), Expect = 2e-21
 Identities = 44/214 (20%), Positives = 82/214 (38%), Gaps = 29/214 (13%)

Query: 5   SQFEHDNIVQYIG--TEKD---ENRLYIFLELVKKGSLAN-------LYQKYHLSDSQVS 52
             F H N+++ +G   E       +  + L  +K G L              H+    + 
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150

Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDV-KSFEGTP 101
            +   I  G+ YL  RN +HR++   N ++           GL+    + D  +      
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210

Query: 102 F---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLP 157
               W+A E  +L +  Y   +D+W+ G T+ E+ T    PY  +++ +    +  G   
Sbjct: 211 MPVKWIAIE--SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL 268

Query: 158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
             P     +  + +  C + +P DRPT + L   
Sbjct: 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 87.7 bits (218), Expect = 3e-21
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 34/218 (15%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLS 47
           +  +H++IV++ G   D + L +  E +K G L                      K  L 
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 48  DSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDV-KS 96
            SQ+     QI +G+ YL  ++ VHR++   N LV A+        G++    + D  + 
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191

Query: 97  FEGTPF---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIG 152
              T     W+ PE   +    +   +D+WS G  + E+ T+ + P+  L + + +  I 
Sbjct: 192 GGHTMLPIRWMPPES--IMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 249

Query: 153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
           +G++   P    ++  D +L C Q  P  R    ++ +
Sbjct: 250 QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 88.7 bits (220), Expect = 3e-21
 Identities = 44/207 (21%), Positives = 85/207 (41%), Gaps = 22/207 (10%)

Query: 5   SQFEHDNIVQYIGT-EKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNG 61
             F H N++  +G   + E    + L  +K G L N  +   ++ +   +  +  Q+  G
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 204

Query: 62  LTYLHERNVVHREIKCANILVDAS--------GLA-----TTTNDVKSFEGTPF---WVA 105
           + +L  +  VHR++   N ++D          GLA        + V +  G      W+A
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLS 164
            E  +L+   +   +D+WS G  + E++T   PPY  +        + +G+    P    
Sbjct: 265 LE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 322

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEH 191
               + +LKC       RP+ ++L+  
Sbjct: 323 DPLYEVMLKCWHPKAEMRPSFSELVSR 349

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 87.0 bits (216), Expect = 9e-21
 Identities = 49/213 (23%), Positives = 76/213 (35%), Gaps = 28/213 (13%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN--------LYQKYHLSDSQVSSYTR 56
           S+F H NIV+ IG        +I +EL+  G L +          Q   L+   +    R
Sbjct: 88  SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147

Query: 57  QILNGLTYLHERNVVHREIKCANILVDASGLATT--------TNDV------KSFEGTPF 102
            I  G  YL E + +HR+I   N L+   G              D+      +       
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207

Query: 103 ---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPS 158
              W+ PE        +    D WS G  + E+ +    PY    + + L  +  G    
Sbjct: 208 PVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 265

Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
            P +        + +C Q  P DRP  A ++E 
Sbjct: 266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 86.6 bits (215), Expect = 1e-20
 Identities = 47/220 (21%), Positives = 87/220 (39%), Gaps = 42/220 (19%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------ANLYQKYHLSDSQVSS 53
            +F   ++V+ +G         + +EL+ +G L           AN       S S++  
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142

Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA----------TTTND-- 93
              +I +G+ YL+    VHR++   N +V           G+                  
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202

Query: 94  -VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRI 151
            V+       W++PE  +LK+  +   +D+WS G  + E+ T  + PY  L + Q L  +
Sbjct: 203 PVR-------WMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253

Query: 152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
             G L   P++      + +  C Q NP  RP+  +++  
Sbjct: 254 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 87.0 bits (216), Expect = 1e-20
 Identities = 54/250 (21%), Positives = 94/250 (37%), Gaps = 90/250 (36%)

Query: 25  LYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
           LY   E++ +    N Y  +H+    +  Y  +IL  L YL + ++ H ++K  NIL+D 
Sbjct: 122 LY---EIITR----NNYNGFHIE--DIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172

Query: 85  SGLATTT-------------------NDVK-------SFEG--------TPFWVAPEVVN 110
                +                      +K       +F+         T  + APEV+ 
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVI- 231

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQP------PYSHLEDMQAL---------------- 148
           L N G+ +S+D+WS GC + E+ T            HL  M+++                
Sbjct: 232 L-NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTN 290

Query: 149 ----FRIGRGKLPSVPNSLSRDAR-------------------DFILKCLQVNPNDRPTA 185
                     KL    N+ S ++                    DF+   LQ++P  RP+ 
Sbjct: 291 GSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP 350

Query: 186 AQLMEHPFVK 195
           A+L++H F++
Sbjct: 351 AELLKHKFLE 360

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 85.8 bits (213), Expect = 2e-20
 Identities = 42/218 (19%), Positives = 82/218 (37%), Gaps = 33/218 (15%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL----------------ANLYQKYHLSD 48
           +  +H +IV++ G   +   L +  E ++ G L                        L  
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157

Query: 49  SQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDV-KSF 97
            Q+ +   Q+  G+ YL   + VHR++   N LV           G++    + D  +  
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217

Query: 98  EGTPF---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGR 153
             T     W+ PE   +    +   +D+WS G  + E+ T+ + P+  L + +A+  I +
Sbjct: 218 GRTMLPIRWMPPES--ILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275

Query: 154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           G+    P +   +    +  C Q  P  R +   +   
Sbjct: 276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 86.3 bits (214), Expect = 3e-20
 Identities = 50/213 (23%), Positives = 75/213 (35%), Gaps = 28/213 (13%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL--------ANLYQKYHLSDSQVSSYTR 56
           S+F H NIV+ IG        +I LEL+  G L            Q   L+   +    R
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188

Query: 57  QILNGLTYLHERNVVHREIKCANILVDASGLATT--------TNDV------KSFEGTPF 102
            I  G  YL E + +HR+I   N L+   G              D+      +       
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 248

Query: 103 ---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPS 158
              W+ PE        +    D WS G  + E+ +    PY    + + L  +  G    
Sbjct: 249 PVKWMPPEA--FMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 306

Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
            P +        + +C Q  P DRP  A ++E 
Sbjct: 307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 85.4 bits (212), Expect = 3e-20
 Identities = 44/245 (17%), Positives = 77/245 (31%), Gaps = 84/245 (34%)

Query: 25  LYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
            Y   + +K+    N +  + L    +     QI   + +LH   + H ++K  NIL   
Sbjct: 103 TY---DFIKE----NGFLPFRLD--HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQ 153

Query: 85  SGLATTTN-------------DVK-------SFEG--------TPFWVAPEVV-NLKNNG 115
           S      N             D+K       +++         T  + APEV+  L   G
Sbjct: 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILAL---G 210

Query: 116 YGLSADIWSLGCTVLEMLT------------H---------QPPYSHLEDMQALFRIGRG 154
           +    D+WS+GC ++E               H           P   ++  +        
Sbjct: 211 WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHD 270

Query: 155 KLPSVPNSLSRDAR----------------------DFILKCLQVNPNDRPTAAQLMEHP 192
           +L    +S +                          D I K L+ +P  R T  + ++HP
Sbjct: 271 RLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHP 330

Query: 193 FVKRP 197
           F    
Sbjct: 331 FFDLL 335

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 84.6 bits (210), Expect = 4e-20
 Identities = 42/219 (19%), Positives = 76/219 (34%), Gaps = 34/219 (15%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLS 47
           ++ +H N+V  +G    +  L +       G L                  +   K  L 
Sbjct: 67  ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 48  DSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDV-KS 96
                    QI  G+ YL   +VVH+++   N+LV           GL       D  K 
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186

Query: 97  FEGTPF---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIG 152
              +     W+APE   +    + + +DIWS G  + E+ ++   PY    +   +  I 
Sbjct: 187 LGNSLLPIRWMAPE--AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 244

Query: 153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
             ++   P+         +++C    P+ RP    +   
Sbjct: 245 NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 83.9 bits (208), Expect = 1e-19
 Identities = 50/249 (20%), Positives = 81/249 (32%), Gaps = 90/249 (36%)

Query: 25  LYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA 84
            +   E +K+    N +Q Y L    V     Q+ + L +LHE  + H ++K  NIL   
Sbjct: 108 TF---EFLKE----NNFQPYPLP--HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158

Query: 85  SGLATTTN-------------DVK-------SFEG--------TPFWVAPEVVNLKNNGY 116
           S   T  N              ++       +F+         T  +  PEV+ L   G+
Sbjct: 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVI-L-ELGW 216

Query: 117 GLSADIWSLGCTVLEMLTHQP------PYSHLEDMQALFRIGRGKLPS------------ 158
               D+WS+GC + E               HL  M+ +     G +PS            
Sbjct: 217 AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL----GPIPSHMIHRTRKQKYF 272

Query: 159 --------VPNSLSRDAR---------------------DFILKCLQVNPNDRPTAAQLM 189
                     +S  R  +                     D + + L+ +P  R T A+ +
Sbjct: 273 YKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332

Query: 190 EHPFVKRPL 198
            HPF     
Sbjct: 333 LHPFFAGLT 341

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 81.1 bits (201), Expect = 1e-18
 Identities = 49/227 (21%), Positives = 87/227 (38%), Gaps = 42/227 (18%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL-------------------------AN 39
            Q  H ++++  G    +  L + +E  K GSL                          +
Sbjct: 81  KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA--T 89
              +  L+   + S+  QI  G+ YL E  +VHR++   NILV           GL+   
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200

Query: 90  TTNDV-KSFEGTPF---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLED 144
              D             W+A E  +L ++ Y   +D+WS G  + E++T    PY  +  
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258

Query: 145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
            +    +  G     P++ S +    +L+C +  P+ RP  A + + 
Sbjct: 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 80.4 bits (199), Expect = 2e-18
 Identities = 51/216 (23%), Positives = 85/216 (39%), Gaps = 34/216 (15%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L                  N   +  ++   
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDV-KSFEG 99
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA      D  K    
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218

Query: 100 TPF---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGK 155
                 W+APE   L +  Y   +D+WS G  + E+ T    PY  +   +    +  G 
Sbjct: 219 GRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 276

Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
               P + + +    +  C    P+ RPT  QL+E 
Sbjct: 277 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 80.5 bits (199), Expect = 3e-18
 Identities = 51/216 (23%), Positives = 85/216 (39%), Gaps = 34/216 (15%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L                  N   +  ++   
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDV-KSFEG 99
           + S T Q+  G+ YL  +  +HR++   N+LV  +        GLA      D  K    
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264

Query: 100 TPF---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGK 155
                 W+APE   L +  Y   +D+WS G  + E+ T    PY  +   +    +  G 
Sbjct: 265 GRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 322

Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
               P + + +    +  C    P+ RPT  QL+E 
Sbjct: 323 RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 79.6 bits (197), Expect = 4e-18
 Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 73/233 (31%)

Query: 5   SQFEHDNIVQYIG--TEKDENRL-YIFLELVKKGSLANLYQKYHLSDSQVSSY-----TR 56
           S   H ++V  IG   E++E  L Y   + ++ G+L       HL  S + +       R
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIY---KYMENGNLKR-----HLYGSDLPTMSMSWEQR 141

Query: 57  -QIL----NGLTYLHERNVVHREIKCANILVDAS--------GLATTTND---------V 94
            +I      GL YLH R ++HR++K  NIL+D +        G++    +         V
Sbjct: 142 LEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV 201

Query: 95  KSFEGTPFWVAPEVVNLKNNGYGLS------ADIWSLGCTVLEMLTHQPP--YSHLEDMQ 146
           K   GT  ++ PE        Y +       +D++S G  + E+L  +     S   +M 
Sbjct: 202 K---GTLGYIDPE--------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250

Query: 147 -----ALFRIGRGKLPSV----------PNSLSRDARDFILKCLQVNPNDRPT 184
                A+     G+L  +          P SL +   D  +KCL ++  DRP+
Sbjct: 251 NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK-FGDTAVKCLALSSEDRPS 302

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 79.2 bits (196), Expect = 4e-18
 Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 38/219 (17%)

Query: 8   EHDNIVQYIG--TEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSD 48
            H N+V  +G  T+     L + +E  K G+L                      K  L+ 
Sbjct: 89  HHLNVVNLLGACTKPGG-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 49  SQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDV-KSF 97
             +  Y+ Q+  G+ +L  R  +HR++   NIL+           GLA     +      
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207

Query: 98  EGTPF---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFR-IG 152
                   W+APE   + +  Y + +D+WS G  + E+ +    PY  ++  +   R + 
Sbjct: 208 GDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265

Query: 153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
            G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 266 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 79.8 bits (197), Expect = 6e-18
 Identities = 62/267 (23%), Positives = 94/267 (35%), Gaps = 89/267 (33%)

Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----KYH-LSDSQVSSYTRQILNGLTY 64
           N++  +      N + +  EL+      NLY+     K+   S   V  +   IL  L  
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM----NLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215

Query: 65  LHERNVVHREIKCANILVDASGLATTTNDVK-------SFEGTP--------FWVAPEVV 109
           LH+  ++H ++K  NIL+   G     + +K        +E           F+ APEV 
Sbjct: 216 LHKNRIIHCDLKPENILLKQQG----RSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEV- 270

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPP------YSHLEDMQALF-------------- 149
            +    YG+  D+WSLGC + E+LT  P          L  M  L               
Sbjct: 271 -ILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA 329

Query: 150 ----------------------------RIGRGKLPSVPNSLS-------RDARDFI--- 171
                                       R  RGKL   P S          D   F+   
Sbjct: 330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL 389

Query: 172 LKCLQVNPNDRPTAAQLMEHPFVKRPL 198
            +CL+ +P  R T  Q + HP+++R L
Sbjct: 390 KQCLEWDPAVRMTPGQALRHPWLRRRL 416

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 78.8 bits (195), Expect = 6e-18
 Identities = 45/219 (20%), Positives = 77/219 (35%), Gaps = 37/219 (16%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-------------------ANLYQKYHLSD 48
            H NIV  +G         +  E    G L                        +  L  
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 49  SQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDV-KSF 97
             + S++ Q+  G+ +L  +N +HR++   NIL+           GLA     +      
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 98  EGTPF---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFR-IG 152
                   W+APE  ++ N  Y   +D+WS G  + E+ +    PY  +      ++ I 
Sbjct: 205 GNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262

Query: 153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
            G     P     +  D +  C   +P  RPT  Q+++ 
Sbjct: 263 EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 78.9 bits (195), Expect = 9e-18
 Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 34/216 (15%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
           +H NI+  +G    +  LY+ +E   KG+L                  +   +  LS   
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA--TTTNDV-KSFEG 99
           + S   Q+  G+ YL  +  +HR++   N+LV           GLA      D  K    
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252

Query: 100 TPF---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGK 155
                 W+APE   L +  Y   +D+WS G  + E+ T    PY  +   +    +  G 
Sbjct: 253 GRLPVKWMAPE--ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 310

Query: 156 LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
               P++ + +    +  C    P+ RPT  QL+E 
Sbjct: 311 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 77.7 bits (192), Expect = 2e-17
 Identities = 42/217 (19%), Positives = 80/217 (36%), Gaps = 37/217 (17%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL---------------ANLYQKYHLSDSQVS 52
           +H+NIV  +G       + +  E    G L               A        S   + 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 53  SYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA---TTTNDVKSFEGTP 101
            ++ Q+  G+ +L  +N +HR++   N+L+           GLA      ++        
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 102 F---WVAPEVVNLKNNGYGLSADIWSLGCTVL--EMLT--HQPPYSHLEDMQALFRIGRG 154
               W+APE  ++ +  Y + +D+WS G  +L  E+ +    P    L + +    +  G
Sbjct: 228 LPVKWMAPE--SIFDCVYTVQSDVWSYG--ILLWEIFSLGLNPYPGILVNSKFYKLVKDG 283

Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              + P    ++    +  C  + P  RPT  Q+   
Sbjct: 284 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 77.7 bits (192), Expect = 2e-17
 Identities = 45/234 (19%), Positives = 88/234 (37%), Gaps = 56/234 (23%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSL-------------------------AN 39
           ++F++ NIV+ +G       + +  E +  G L                          +
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164

Query: 40  LYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA--- 88
                 LS ++     RQ+  G+ YL ER  VHR++   N LV  +        GL+   
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224

Query: 89  -------TTTND---VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QP 137
                     ND   ++       W+ PE  ++  N Y   +D+W+ G  + E+ ++   
Sbjct: 225 YSADYYKADGNDAIPIR-------WMPPE--SIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275

Query: 138 PYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           PY  +   + ++ +  G + + P +   +  + +  C    P DRP+   +   
Sbjct: 276 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 77.2 bits (191), Expect = 2e-17
 Identities = 50/227 (22%), Positives = 92/227 (40%), Gaps = 65/227 (28%)

Query: 5   SQFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSS----YTRQ- 57
           ++ +H+N+V+ +G  ++  ++   ++   +  GSL +      LS    +     + R  
Sbjct: 85  AKCQHENLVELLGFSSD-GDDLCLVY-VYMPNGSLLD-----RLSCLDGTPPLSWHMRCK 137

Query: 58  ----ILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFE------- 98
                 NG+ +LHE + +HR+IK ANIL+D +        GLA      ++ E       
Sbjct: 138 IAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA------RASEKFAQTVM 191

Query: 99  -----GTPFWVAPEVVNLKNNGYGLS--ADIWSLGCTVLEMLTHQPPYSHLEDMQAL--- 148
                GT  ++APE +     G  ++  +DI+S G  +LE++T  P      + Q L   
Sbjct: 192 TSRIVGTTAYMAPEAL----RGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246

Query: 149 ---FRIGRGKL-----PSVPNSLSRDARDFI---LKCLQVNPNDRPT 184
                     +       + ++ S           +CL    N RP 
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 76.9 bits (190), Expect = 4e-17
 Identities = 44/213 (20%), Positives = 84/213 (39%), Gaps = 31/213 (14%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL-----------------ANLYQKYHLSDSQ 50
            H NI+  +G  +    LY+ +E    G+L                         LS  Q
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPF 102
           +  +   +  G+ YL ++  +HR++   NILV  +        GL+              
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 203

Query: 103 ---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPS 158
              W+A E   L  + Y  ++D+WS G  + E+++    PY  +   +   ++ +G    
Sbjct: 204 PVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 261

Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
            P +   +  D + +C +  P +RP+ AQ++  
Sbjct: 262 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 74.3 bits (183), Expect = 4e-16
 Identities = 42/224 (18%), Positives = 75/224 (33%), Gaps = 42/224 (18%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSL------------------------ANLYQK 43
            H+NIV  +G       +Y+  E    G L                              
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 44  YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLA--TTTND 93
             L+   +  +  Q+  G+ +L  ++ VHR++   N+LV           GLA    ++ 
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 94  V-KSFEGTPF---WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQAL 148
                        W+APE  +L    Y + +D+WS G  + E+ +    PY  +      
Sbjct: 227 NYVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284

Query: 149 FR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           ++ I  G     P   + +    +  C   +   RP+   L   
Sbjct: 285 YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.8 bits (168), Expect = 4e-14
 Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 18/165 (10%)

Query: 43  KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDV 94
           K  L+   +  Y+ Q+  G+ +L  R  +HR++   NIL+           GLA      
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246

Query: 95  KSFEGT-----PF-WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQA 147
             +        P  W+APE   + +  Y + +D+WS G  + E+ +    PY  ++  + 
Sbjct: 247 PDYVRKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304

Query: 148 LFR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
             R +  G     P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 305 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 66.1 bits (161), Expect = 3e-13
 Identities = 29/136 (21%), Positives = 44/136 (32%), Gaps = 49/136 (36%)

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS------------HLEDMQALF--- 149
           + EV  L  +GY   ADIWS  C   E+ T    +             H+  +  L    
Sbjct: 261 SLEV--LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKV 318

Query: 150 ----------------------RIGRGKLPSVPNSL----------SRDARDFILKCLQV 177
                                  I + K   +   L          +    DF+L  L++
Sbjct: 319 PRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLEL 378

Query: 178 NPNDRPTAAQLMEHPF 193
            P  R TAA+ + HP+
Sbjct: 379 IPEKRATAAECLRHPW 394

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 64.3 bits (157), Expect = 1e-12
 Identities = 36/150 (24%), Positives = 62/150 (41%), Gaps = 33/150 (22%)

Query: 11  NIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-----KYH-LSDSQVSSYTRQILNGLTY 64
            IV         N L +  E++      NLY       +  +S +    + +Q+   L +
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY----NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172

Query: 65  LHER--NVVHREIKCANILVDASGLATTTNDVK-------SFEG--------TPFWVAPE 107
           L     +++H ++K  NIL+         + +K          G        + F+ +PE
Sbjct: 173 LATPELSIIHCDLKPENILLCNPK----RSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPE 228

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
           V  L    Y L+ D+WSLGC ++EM T +P
Sbjct: 229 V--LLGMPYDLAIDMWSLGCILVEMHTGEP 256

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 46.6 bits (111), Expect = 2e-06
 Identities = 9/28 (32%), Positives = 14/28 (50%)

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           D IL+ L  +P  R      ++H F K+
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFFKK 378

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 60.3 bits (147), Expect = 3e-11
 Identities = 53/235 (22%), Positives = 86/235 (36%), Gaps = 67/235 (28%)

Query: 5   SQFEHDNIVQYIG--TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSY-----TRQ 57
           S   H N+++  G      E RL ++   +  GS+A       L +   S        RQ
Sbjct: 82  SMAVHRNLLRLRGFCMTPTE-RLLVY-PYMANGSVA-----SCLRERPESQPPLDWPKRQ 134

Query: 58  -----ILNGLTYLHER---NVVHREIKCANILVDAS--------GLATTTNDVKS----- 96
                   GL YLH+     ++HR++K ANIL+D          GLA   +   +     
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194

Query: 97  FEGTPFWVAPEVVNLKNNGYGLS------ADIWSLGCTVLEMLTHQPPY----SHLEDMQ 146
             GT   +APE        Y  +       D++  G  +LE++T Q  +       +D  
Sbjct: 195 VRGTIGHIAPE--------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 147 ALFR-----IGRGKL-----PSVPNSLSRD-ARDFI---LKCLQVNPNDRPTAAQ 187
            L       +   KL       +  +   +     I   L C Q +P +RP  ++
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 53.7 bits (128), Expect = 6e-09
 Identities = 18/118 (15%), Positives = 37/118 (31%), Gaps = 4/118 (3%)

Query: 21  DENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER-NVVHREIKCAN 79
            +++L+I LE    G      +    S +   S   Q+   L          HR++   N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 80  ILVDASGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP 137
           +L+  + L        +  G    +    + +    Y LS           ++   + 
Sbjct: 193 VLLKKTSLKKLH---YTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 46.2 bits (110), Expect = 2e-06
 Identities = 41/185 (22%), Positives = 72/185 (38%), Gaps = 38/185 (20%)

Query: 13  VQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNV 70
           V Y G E   N   + ++L+   SL +L        S   V+   +Q+L  +  +HE+++
Sbjct: 71  VYYFGQEGLHN--VLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 127

Query: 71  VHREIKCANILVDAS-------------GLAT-----TTN------DVKSFEGTPFWVAP 106
           V+R+IK  N L+                G+        T       + K+  GT  +++ 
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS- 186

Query: 107 EVVNLKNNGYGLS--ADIWSLGCTVLEMLTHQPPYSHLE---DMQALFRIGRGKLPSVPN 161
             +N  + G   S   D+ +LG   +  L    P+  L+   + Q   RIG  K  +   
Sbjct: 187 --IN-THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243

Query: 162 SLSRD 166
            L   
Sbjct: 244 ELCAG 248

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 46.3 bits (110), Expect = 2e-06
 Identities = 36/187 (19%), Positives = 68/187 (36%), Gaps = 33/187 (17%)

Query: 13  VQYIGTEKDENRLYIFLELVKKG-SLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERN 69
               G      + Y F+ + + G  L  +Y+      S   V   + +IL+ L Y+HE  
Sbjct: 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE 172

Query: 70  VVHREIKCANILVDAS----------GLAT-----------TTNDVKSFEGTPFWVAPEV 108
            VH +IK +N+L++            GLA              +  +  +GT  + +   
Sbjct: 173 YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTS--- 229

Query: 109 VNLKNNGYGLS--ADIWSLGCTVLEMLTHQPPYSHLE---DMQALFRIGRGKLPSVPNSL 163
           ++  +NG   S   D+  LG  +++ LT   P+             +I   +  +     
Sbjct: 230 IDA-HNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDK 288

Query: 164 SRDARDF 170
              A + 
Sbjct: 289 CFPAANA 295

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 45.8 bits (108), Expect = 3e-06
 Identities = 43/183 (23%), Positives = 74/183 (40%), Gaps = 42/183 (22%)

Query: 13  VQYIGTEKDENRLYIFLELVKKGSLANL--YQKYHLSDSQVSSYTRQILNGLTYLHERNV 70
           V++ G E D N   + ++L+   SL +L  +    LS   V     Q++N + ++H ++ 
Sbjct: 68  VRWFGVEGDYN--VLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124

Query: 71  VHREIKCANILVDASGLATTTNDV-------------------------KSFEGTPFWVA 105
           +HR+IK  N L+   GL    N V                         K+  GT  + +
Sbjct: 125 LHRDIKPDNFLM---GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181

Query: 106 PEVVNLKNNGYGLS--ADIWSLGCTVLEMLTHQPPYSHLE---DMQALFRIGRGKLPSVP 160
              VN  + G   S   D+ SLG  ++  L    P+  L+     Q   +I   K+ +  
Sbjct: 182 ---VN-THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237

Query: 161 NSL 163
            +L
Sbjct: 238 EAL 240

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 44.7 bits (106), Expect = 6e-06
 Identities = 40/176 (22%), Positives = 69/176 (39%), Gaps = 42/176 (23%)

Query: 13  VQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNV 70
           +++ G E D N   + +EL+   SL +L+       S   V     Q+++ + Y+H +N 
Sbjct: 70  IRWCGAEGDYN--VMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 126

Query: 71  VHREIKCANILVDASGLATTTNDV-------------------------KSFEGTPFWVA 105
           +HR++K  N L+   GL    N V                         K+  GT  + +
Sbjct: 127 IHRDVKPDNFLM---GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183

Query: 106 PEVVNLKNNGYGLS--ADIWSLGCTVLEMLTHQPPYSHLE---DMQALFRIGRGKL 156
              +N  + G   S   D+ SLG  ++       P+  L+     Q   RI   K+
Sbjct: 184 ---IN-THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 43.2 bits (102), Expect = 2e-05
 Identities = 32/139 (23%), Positives = 54/139 (38%), Gaps = 29/139 (20%)

Query: 13  VQYIGTEKDENRLYIFLELVKKG-SLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNV 70
               G  + + R Y F+ + + G  L  +  +      S V     ++L+ L Y+HE   
Sbjct: 113 FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEY 172

Query: 71  VHREIKCANILVDAS----------GLAT-----------TTNDVKSFEGTPFWVAPEVV 109
           VH +IK AN+L+             GL+              N  K   GT  + +   +
Sbjct: 173 VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS---L 229

Query: 110 NLKNNGYGLS--ADIWSLG 126
           +  + G  LS  +D+  LG
Sbjct: 230 DA-HKGVALSRRSDVEILG 247

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.0 bits (99), Expect = 5e-05
 Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 38/175 (21%)

Query: 13  VQYIGTEKDENRLYIFLELVKKGSLANL--YQKYHLSDSQVSSYTRQILNGLTYLHERNV 70
           V Y G     N   + LEL+   SL +L        S   V     Q+++ + Y+H +N+
Sbjct: 70  VYYFGPCGKYN--AMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126

Query: 71  VHREIKCANILVDAS-------------GLAT-----TTN------DVKSFEGTPFWVAP 106
           ++R++K  N L+                 LA       T       + KS  GT  +++ 
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS- 185

Query: 107 EVVNLKNNGYGLS--ADIWSLGCTVLEMLTHQPPYSHLED---MQALFRIGRGKL 156
             +N  + G   S   D+ +LG   +  L    P+  L+     +   +IG  K 
Sbjct: 186 --IN-THLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 5e-05
 Identities = 40/233 (17%), Positives = 73/233 (31%), Gaps = 74/233 (31%)

Query: 4   FSQFEHDNIVQYIGTEKDENRLY-IFLELVKKGSLANLYQK---------YHLSDSQVSS 53
            S+ E D+I+    ++   +    +F  L+ K     + QK         Y    S + +
Sbjct: 46  LSKEEIDHIIM---SKDAVSGTLRLFWTLLSKQE--EMVQKFVEEVLRINYKFLMSPIKT 100

Query: 54  YTRQ-ILNGLTYLHERNVVHR-----------------EIKCA--------NILVD---A 84
             RQ  +    Y+ +R+ ++                  +++ A        N+L+D    
Sbjct: 101 EQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160

Query: 85  SG---LATTT-NDVK---SFEGTPFWV------APEVV--NLKNNGYGLSADIWSLGCTV 129
           SG   +A       K     +   FW+      +PE V   L+     L   I     + 
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQK----LLYQIDPNWTSR 216

Query: 130 LEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSL--------SRDARDFILKC 174
            +          +  +QA  R    K     N L        ++    F L C
Sbjct: 217 SD--HSSNIKLRIHSIQAELRR-LLKSKPYENCLLVLLNVQNAKAWNAFNLSC 266

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 42.0 bits (99), Expect = 6e-05
 Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 30/117 (25%)

Query: 36  SLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS------- 85
           SL +         LS+  V     ++L+ L +LHE   VH  +   NI VD         
Sbjct: 143 SLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTL 202

Query: 86  ---GLAT-----------TTNDVKSFEGTPFWVAPEVVNLKNNGYGLS--ADIWSLG 126
              G A                    EG   +++   ++L + G G S  +D+ SLG
Sbjct: 203 AGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFIS---MDL-HKGCGPSRRSDLQSLG 255

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	201
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.84
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.58
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.26
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.24
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.79
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.52
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.43
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.37
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.34
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.84
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.79
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.56
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.11
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.08
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	95.4
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.28
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	94.8
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	94.69
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	93.86
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	92.96
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	90.95
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	88.51
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	87.71
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	86.65
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	86.21
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	82.91
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	82.68

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.9e-55  Score=329.98  Aligned_cols=194  Identities=30%  Similarity=0.589  Sum_probs=173.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      +|++++||||+++++++.+++..|+||||++||+|.+++.+.++++.++..++.||+.||+|||++||+||||||+|||+
T Consensus       124 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl  203 (346)
T 4fih_A          124 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL  203 (346)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE
Confidence            57889999999999999999999999999999999999998889999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|.+++.++.            ...+||+.|+|||++  .+..++.++||||+||++|+|++|+.||.+....+....
T Consensus       204 ~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl--~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~  281 (346)
T 4fih_A          204 THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI--SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM  281 (346)
T ss_dssp             CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHH--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence            998877766643            235689999999998  456789999999999999999999999998887777777


Q ss_pred             hhcCCCCC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          151 IGRGKLPS--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       151 ~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      +.....+.  .+..+++++++||.+||+.||++|||++|+++||||++..
T Consensus       282 i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          282 IRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            66554433  3456899999999999999999999999999999998753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.5e-55  Score=330.83  Aligned_cols=194  Identities=27%  Similarity=0.533  Sum_probs=177.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++||||+++++++.+++..|+||||++||+|.+++...   .+++.+++.++.||+.||+|||++||+||||||+|
T Consensus        76 il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N  155 (350)
T 4b9d_A           76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQN  155 (350)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGG
T ss_pred             HHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHH
Confidence            578899999999999999999999999999999999999643   27899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           80 ILVDASGLATTTNDVKS------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ||++.+|.+++.+++..            ..||+.|+|||++  .+..++.++||||+||++|+|++|+.||......+.
T Consensus       156 ILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l--~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~  233 (350)
T 4b9d_A          156 IFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC--ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL  233 (350)
T ss_dssp             EEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             EEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHH--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence            99999998888776422            3489999999998  456788999999999999999999999999888888


Q ss_pred             HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          148 LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ..++..+..+..+..+++++++||.+||+.||++|||++|+++||||++..
T Consensus       234 ~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          234 VLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            888888888888889999999999999999999999999999999998654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3e-54  Score=320.00  Aligned_cols=193  Identities=28%  Similarity=0.426  Sum_probs=173.3

Q ss_pred             cccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            2 FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      .+|++++||||+++++++.+++..++||||++||+|.+++++. .+++.++..++.||+.||+|||++||+||||||+||
T Consensus        78 ~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI  157 (304)
T 3ubd_A           78 DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI  157 (304)
T ss_dssp             CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred             HHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHe
Confidence            3689999999999999999999999999999999999999764 599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      |++.+|.+++.++.            ....||+.|+|||++  .+..++.++|+||+||++|+|++|+.||.+....+..
T Consensus       158 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~--~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~  235 (304)
T 3ubd_A          158 LLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV--NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM  235 (304)
T ss_dssp             EECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHH--HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             EEcCCCCEEecccccceeccCCCccccccccCcccCCHHHh--ccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH
Confidence            99999877766642            234689999999998  4567889999999999999999999999988888877


Q ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccCc
Q 046714          149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKRP  197 (201)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~~  197 (201)
                      ..+.... ..++..+++++++|+.+||+.||++|||     ++|+++||||+..
T Consensus       236 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          236 TMILKAK-LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHcCC-CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            7776655 3677889999999999999999999998     5899999999863

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.2e-54  Score=322.22  Aligned_cols=192  Identities=28%  Similarity=0.495  Sum_probs=172.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++++++..|+||||++||+|.+++++. .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus        85 il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNIL  164 (311)
T 4aw0_A           85 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL  164 (311)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeE
Confidence            588999999999999999999999999999999999999764 5999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc--------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           82 VDASGLATTTNDV--------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        82 l~~~g~~~~~~~~--------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ++.+|.+++.++.              .+.+||+.|+|||++  .+..++.++|+||+||++|+|++|+.||......+.
T Consensus       165 l~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl--~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~  242 (311)
T 4aw0_A          165 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI  242 (311)
T ss_dssp             ECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHH--HHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHH--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9988877666542              234689999999998  456688999999999999999999999998888777


Q ss_pred             HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhH------HhcCccccCc
Q 046714          148 LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQ------LMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~------il~~~~~~~~  197 (201)
                      ..++..... .++..+++++++|+.+||+.||++|||++|      +++||||+..
T Consensus       243 ~~~i~~~~~-~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          243 FAKIIKLEY-DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             HHHHHHTCC-CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHcCCC-CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            777776653 678889999999999999999999999998      5899999763

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.7e-54  Score=315.56  Aligned_cols=194  Identities=24%  Similarity=0.392  Sum_probs=166.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++..++||||+ +|+|.+++.+ +.+++.++..++.||+.||+|||++||+||||||+||+
T Consensus        66 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NIL  144 (275)
T 3hyh_A           66 YLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLL  144 (275)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEE
T ss_pred             HHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeE
Confidence            578899999999999999999999999999 5699888865 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           82 VDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        82 l~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      ++.+|.+++.++..           ...||+.|+|||++. .....+.++||||+||++|+|++|+.||...........
T Consensus       145 l~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~-~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~  223 (275)
T 3hyh_A          145 LDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKN  223 (275)
T ss_dssp             ECTTCCEEECCSSCC---------------CTTSCHHHHS-SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhc-CCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            99988877766532           345899999999983 223346899999999999999999999988777666666


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      +..+. ..++..+++++++|+.+||+.||++|||++|+++||||+..++
T Consensus       224 i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p  271 (275)
T 3hyh_A          224 ISNGV-YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLP  271 (275)
T ss_dssp             HHHTC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCC
T ss_pred             HHcCC-CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccCCC
Confidence            66554 4677889999999999999999999999999999999987765

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.5e-54  Score=330.31  Aligned_cols=194  Identities=30%  Similarity=0.589  Sum_probs=174.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      +|++++||||+++++++.+++.+|+||||+.||+|.++++...+++.++..++.||+.||+|||++||+||||||+|||+
T Consensus       201 il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl  280 (423)
T 4fie_A          201 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL  280 (423)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE
T ss_pred             HHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE
Confidence            57889999999999999999999999999999999999998889999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|.+++.+++            ...+||+.|+|||++  .+..++.++|||||||++|+|++|+.||.+....+....
T Consensus       281 ~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl--~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~  358 (423)
T 4fie_A          281 THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI--SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM  358 (423)
T ss_dssp             CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHH--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence            998887776653            234589999999998  456789999999999999999999999998887777777


Q ss_pred             hhcCCCC--CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          151 IGRGKLP--SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       151 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      +.....+  ..+..+++++++||.+||+.||++|||++|+++||||++..
T Consensus       359 i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          359 IRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            6655433  33457899999999999999999999999999999998653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.5e-53  Score=312.80  Aligned_cols=191  Identities=28%  Similarity=0.561  Sum_probs=161.7

Q ss_pred             ccccCCCcceeccceeeee----CCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcC--ccccCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD----ENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERN--VVHREI   75 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~dl   75 (201)
                      +|++++||||+++++++.+    ++.+++||||++||+|.+++++. .+++..+..++.||+.||+|||++|  |+||||
T Consensus        78 il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDl  157 (290)
T 3fpq_A           78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL  157 (290)
T ss_dssp             HHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCC
T ss_pred             HHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEeccc
Confidence            5789999999999999875    35689999999999999999764 5999999999999999999999998  999999


Q ss_pred             CCCcEEEcc-CCceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           76 KCANILVDA-SGLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        76 ~p~nill~~-~g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      ||+|||++. +|.+++.+++          ....||+.|+|||++.   ..++.++|||||||++|+|++|+.||.+...
T Consensus       158 Kp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~---~~y~~~~DiwSlGvilyelltg~~Pf~~~~~  234 (290)
T 3fpq_A          158 KCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQN  234 (290)
T ss_dssp             CGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred             ChhheeEECCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence            999999975 6777666643          2345899999999973   3588999999999999999999999976544


Q ss_pred             HH-HHHHhhcCCCC-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          145 MQ-ALFRIGRGKLP-SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       145 ~~-~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      .. ....+..+..+ ..+...++++++|+.+||+.||++|||++|+++||||++
T Consensus       235 ~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          235 AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            44 34444444332 355668899999999999999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.5e-53  Score=316.73  Aligned_cols=193  Identities=27%  Similarity=0.446  Sum_probs=167.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++.+++||||++||+|.+++++. .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus       103 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL  182 (336)
T 4g3f_A          103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVL  182 (336)
T ss_dssp             TTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEE
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEE
Confidence            688999999999999999999999999999999999999764 5999999999999999999999999999999999999


Q ss_pred             EccCCc-eeeecCcc-----------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           82 VDASGL-ATTTNDVK-----------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        82 l~~~g~-~~~~~~~~-----------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      ++.+|. +++.++..                 ...||+.|+|||++  .+..++.++||||+||++|+|++|+.||....
T Consensus       183 l~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~--~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~  260 (336)
T 4g3f_A          183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV--MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF  260 (336)
T ss_dssp             ECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred             EeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHH--CCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence            998874 66665431                 13589999999998  45678899999999999999999999998765


Q ss_pred             HHHHHHHhhcCCC--CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHH-------------hcCccccCc
Q 046714          144 DMQALFRIGRGKL--PSVPNSLSRDARDFILKCLQVNPNDRPTAAQL-------------MEHPFVKRP  197 (201)
Q Consensus       144 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~i-------------l~~~~~~~~  197 (201)
                      .......+.....  ..++..+++.+.+++.+||+.||.+|||+.|+             ++|||+.+.
T Consensus       261 ~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          261 RGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             CSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            5555555554433  24677899999999999999999999999997             579998653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.1e-51  Score=304.18  Aligned_cols=185  Identities=24%  Similarity=0.464  Sum_probs=168.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--------------CCCHHHHHHHHHHHHHHHHHHhhc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--------------HLSDSQVSSYTRQILNGLTYLHER   68 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lh~~   68 (201)
                      +|++++||||+++++++.+++..++||||+++|+|.+++++.              .+++.++..++.||+.||+|||++
T Consensus        68 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~  147 (299)
T 4asz_A           68 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ  147 (299)
T ss_dssp             HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            588999999999999999999999999999999999999753              389999999999999999999999


Q ss_pred             CccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh
Q 046714           69 NVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT  134 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~  134 (201)
                      +|+||||||+|||++.++.+++.++..+              ..+|+.|+|||.+  .+..++.++|||||||++|||+|
T Consensus       148 ~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~--~~~~~~~k~DVwS~Gvvl~Ellt  225 (299)
T 4asz_A          148 HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSLGVVLWEIFT  225 (299)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHH--cCCCCCchhhHHHHHHHHHHHHc
Confidence            9999999999999999988887775421              2367889999998  45678999999999999999998


Q ss_pred             -CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          135 -HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       135 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                       |+.||......+....+..+..+..+..+++++.+|+.+||+.+|++|||++++.
T Consensus       226 ~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          226 YGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             TTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence             8999999988888888888888888999999999999999999999999999984

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=303.82  Aligned_cols=187  Identities=21%  Similarity=0.399  Sum_probs=168.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc----------------CCCHHHHHHHHHHHHHHHHHHh
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY----------------HLSDSQVSSYTRQILNGLTYLH   66 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh   66 (201)
                      +|++++||||+++++++.+++..++||||+++|+|.+++++.                ++++.++..++.||+.||+|||
T Consensus        96 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH  175 (329)
T 4aoj_A           96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA  175 (329)
T ss_dssp             HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence            588999999999999999999999999999999999998652                3889999999999999999999


Q ss_pred             hcCccccCCCCCcEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHH
Q 046714           67 ERNVVHREIKCANILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEM  132 (201)
Q Consensus        67 ~~~i~H~dl~p~nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l  132 (201)
                      +++|+||||||+|||++.++.+++.++..              ...+|+.|+|||.+  .+..++.++|||||||++|||
T Consensus       176 ~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~--~~~~~~~~sDvwS~Gvvl~El  253 (329)
T 4aoj_A          176 GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI--LYRKFTTESDVWSFGVVLWEI  253 (329)
T ss_dssp             HTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHH--TTCCCCHHHHHHHHHHHHHHH
T ss_pred             cCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhh--cCCCCCccccccchHHHHHHH
Confidence            99999999999999999988877776532              23467889999998  466789999999999999999


Q ss_pred             Hh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          133 LT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       133 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +| |+.||......+....+..+..+..+..+++++.+++.+||+.+|++|||++|++++
T Consensus       254 lt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          254 FTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HTTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HcCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            99 899999988888888888888888899999999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.6e-50  Score=300.33  Aligned_cols=187  Identities=20%  Similarity=0.368  Sum_probs=168.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----------------YHLSDSQVSSYTRQILNGLTYL   65 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~l   65 (201)
                      +|++++||||++++|++.+++..++||||+++|+|.+++..                 ..+++.++..++.||+.||+||
T Consensus        82 il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL  161 (308)
T 4gt4_A           82 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL  161 (308)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence            57889999999999999999999999999999999999964                 2388999999999999999999


Q ss_pred             hhcCccccCCCCCcEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHH
Q 046714           66 HERNVVHREIKCANILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE  131 (201)
Q Consensus        66 h~~~i~H~dl~p~nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~  131 (201)
                      |+++|+||||||+|||++.++.+++.+++-              ...||+.|+|||.+  .+..++.++||||||+++||
T Consensus       162 H~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l--~~~~~s~ksDVwSfGvvl~E  239 (308)
T 4gt4_A          162 SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAI--MYGKFSIDSDIWSYGVVLWE  239 (308)
T ss_dssp             HHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHH
T ss_pred             HhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHH--hCCCCCccchhhhHHHHHHH
Confidence            999999999999999999887777766432              23467889999998  45678999999999999999


Q ss_pred             HHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          132 MLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       132 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      |+| |+.||.+....+....+..+.....+..+++.+.+++.+||+.+|++|||+.||+++
T Consensus       240 l~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          240 VFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            998 899999998888888888888888899999999999999999999999999999774

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-49  Score=294.34  Aligned_cols=187  Identities=25%  Similarity=0.494  Sum_probs=155.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+ +..++||||+++|+|.+++..  ..+++.++..++.||+.||+|||+++|+||||||+||
T Consensus        85 il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NI  163 (307)
T 3omv_A           85 VLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNI  163 (307)
T ss_dssp             HHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSE
T ss_pred             HHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHE
Confidence            5889999999999998865 458999999999999999965  3599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc--------------ccccCcccccccccccC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLK-NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |++.++.+++.++.-              ...||+.|+|||.+... ...++.++|||||||++|||+||+.||.+....
T Consensus       164 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~  243 (307)
T 3omv_A          164 FLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR  243 (307)
T ss_dssp             EEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred             EECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH
Confidence            999887776665432              23588999999998433 335789999999999999999999999876554


Q ss_pred             HHHHHh-hcCC----CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRI-GRGK----LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~-~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ...... ..+.    .+..+..+++.+.+++.+||+.+|++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          244 DQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             HHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             HHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            444333 2222    23456678999999999999999999999998743

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.1e-49  Score=299.62  Aligned_cols=192  Identities=26%  Similarity=0.372  Sum_probs=154.5

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|+++ +||||+++++++.+++..++||||++|++|.++++  .+++.++..++.||+.||+|||++||+||||||+|||
T Consensus        72 ~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiL  149 (361)
T 4f9c_A           72 CLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFL  149 (361)
T ss_dssp             HHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeE
Confidence            35556 69999999999999999999999999999999985  4899999999999999999999999999999999999


Q ss_pred             EccC-CceeeecCcc----------------------------------------ccccCcccccccccccCCCCCcchh
Q 046714           82 VDAS-GLATTTNDVK----------------------------------------SFEGTPFWVAPEVVNLKNNGYGLSA  120 (201)
Q Consensus        82 l~~~-g~~~~~~~~~----------------------------------------~~~~~~~~~aPE~~~~~~~~~~~~~  120 (201)
                      ++.+ |..++.+++.                                        ...||+.|+|||++. ....++.++
T Consensus       150 l~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~y~~~~  228 (361)
T 4f9c_A          150 YNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT-KCPNQTTAI  228 (361)
T ss_dssp             EETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHT-TCSCCCTHH
T ss_pred             EeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHc-CCCCCCCcc
Confidence            9865 5554444321                                        235899999999983 344578999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCc-hHHHHHHHhhc----------------------------------------------
Q 046714          121 DIWSLGCTVLEMLTHQPPYSHL-EDMQALFRIGR----------------------------------------------  153 (201)
Q Consensus       121 Dv~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~----------------------------------------------  153 (201)
                      ||||+||++|+|++|+.||... +.......+..                                              
T Consensus       229 DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~  308 (361)
T 4f9c_A          229 DMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKL  308 (361)
T ss_dssp             HHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---------
T ss_pred             chhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccc
Confidence            9999999999999999998433 22222211100                                              


Q ss_pred             -------CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          154 -------GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       154 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                             ......+..+++++.+|+.+||+.||++|+|++|+++||||++.
T Consensus       309 ~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          309 TSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             -------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                   00011234678999999999999999999999999999999864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.6e-49  Score=295.34  Aligned_cols=190  Identities=24%  Similarity=0.410  Sum_probs=155.1

Q ss_pred             ccccCCCcceeccceeeeeCC------------eEEEEEEecCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHh
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN------------RLYIFLELVKKGSLANLYQKYH----LSDSQVSSYTRQILNGLTYLH   66 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~------------~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~i~~~l~~lh   66 (201)
                      +|++++||||+++++++.+.+            ..|++|||+.+++|.+++....    .+...++.++.||++||+|||
T Consensus        56 il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH  135 (299)
T 4g31_A           56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH  135 (299)
T ss_dssp             HHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH
Confidence            578999999999999987644            3699999999999999998654    455668899999999999999


Q ss_pred             hcCccccCCCCCcEEEccCCceeeecCcc------------------------ccccCcccccccccccCCCCCcchhhH
Q 046714           67 ERNVVHREIKCANILVDASGLATTTNDVK------------------------SFEGTPFWVAPEVVNLKNNGYGLSADI  122 (201)
Q Consensus        67 ~~~i~H~dl~p~nill~~~g~~~~~~~~~------------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv  122 (201)
                      ++||+||||||+|||++.+|.+++.+++.                        ...||+.|+|||++  .+..++.++||
T Consensus       136 ~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~--~~~~y~~~~Di  213 (299)
T 4g31_A          136 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI--HGNSYSHKVDI  213 (299)
T ss_dssp             HTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHH--TTCCCCTHHHH
T ss_pred             HCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHH--cCCCCCCHHHH
Confidence            99999999999999999998887776542                        13589999999998  45678999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCchH-HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          123 WSLGCTVLEMLTHQPPYSHLED-MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       123 ~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ||+||++|+|++   ||..... ......+.....+......++...+|+.+||+.+|++|||+.|+++||||+..
T Consensus       214 wSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          214 FSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            999999999996   7765432 23333344444443344456778899999999999999999999999999863

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-48  Score=313.05  Aligned_cols=192  Identities=28%  Similarity=0.385  Sum_probs=166.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +++.++||||+++++++++++.+|+||||+.||+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus       245 ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNIL  324 (689)
T 3v5w_A          245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL  324 (689)
T ss_dssp             HHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred             HHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeE
Confidence            457789999999999999999999999999999999999764 4999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHH
Q 046714           82 VDASGLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE---DMQAL  148 (201)
Q Consensus        82 l~~~g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---~~~~~  148 (201)
                      ++.+|.+++.+++          .+.+||+.|+|||++. .+..++.++|+||+||++|+|++|+.||....   .....
T Consensus       325 ld~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~-~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~  403 (689)
T 3v5w_A          325 LDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID  403 (689)
T ss_dssp             ECTTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHS-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH
T ss_pred             EeCCCCEEecccceeeecCCCCCCCccCCcCccCHHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            9999887776643          2456999999999983 34568899999999999999999999996532   22233


Q ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccC
Q 046714          149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKR  196 (201)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~  196 (201)
                      ..+. .....++..+++++++||.+||+.||.+|++     ++|+++||||+.
T Consensus       404 ~~i~-~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          404 RMTL-TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             HHHH-HCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             Hhhc-CCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            3333 3345678889999999999999999999998     799999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-48  Score=300.99  Aligned_cols=193  Identities=26%  Similarity=0.453  Sum_probs=160.5

Q ss_pred             ccccCCCcceeccceeeee------CCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD------ENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREI   75 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl   75 (201)
                      +|++++||||+++++++..      .+..|+||||+.| +|.+++.+ +++++..+..++.||+.||+|||++||+||||
T Consensus       106 il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDl  184 (398)
T 4b99_A          106 ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDL  184 (398)
T ss_dssp             HHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred             HHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCc
Confidence            5788999999999998764      3678999999965 79898865 45999999999999999999999999999999


Q ss_pred             CCCcEEEccCCceeeecCc----------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCC
Q 046714           76 KCANILVDASGLATTTNDV----------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY  139 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~~~----------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  139 (201)
                      ||+|||++.+|..++.++.                ....||+.|+|||++. ....++.++||||+||++|+|++|+.||
T Consensus       185 KP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~-~~~~~~~~~DiWSlG~il~ell~G~~pF  263 (398)
T 4b99_A          185 KPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML-SLHEYTQAIDLWSVGCIFGEMLARRQLF  263 (398)
T ss_dssp             CGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHT-TCSCCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred             CccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhc-CCCCCCChhheehhHHHHHHHHHCCCCC
Confidence            9999999998877666543                2346899999999972 3445789999999999999999999999


Q ss_pred             CCchHHHHHHHhhcCC--C--------------------C--------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          140 SHLEDMQALFRIGRGK--L--------------------P--------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       140 ~~~~~~~~~~~~~~~~--~--------------------~--------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                      .+....+....+....  .                    +        .....+++++.+||.+||+.||++|||++|+|
T Consensus       264 ~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L  343 (398)
T 4b99_A          264 PGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL  343 (398)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             CCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence            8877666655542110  0                    0        01134688999999999999999999999999


Q ss_pred             cCccccCc
Q 046714          190 EHPFVKRP  197 (201)
Q Consensus       190 ~~~~~~~~  197 (201)
                      +||||++.
T Consensus       344 ~Hp~f~~~  351 (398)
T 4b99_A          344 RHPFLAKY  351 (398)
T ss_dssp             TSGGGTTT
T ss_pred             cCHhhCcC
Confidence            99999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-47  Score=306.74  Aligned_cols=194  Identities=28%  Similarity=0.435  Sum_probs=169.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++.++++|||+.||+|.+++..  ..+++.++..++.||+.||+|||++||+||||||+||
T Consensus       207 il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Ni  286 (573)
T 3uto_A          207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI  286 (573)
T ss_dssp             HHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhc
Confidence            57889999999999999999999999999999999998853  4599999999999999999999999999999999999


Q ss_pred             EEccC--CceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           81 LVDAS--GLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~~~--g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +++.+  |.+++.++.           ....||+.|+|||++  .+..++.++||||+||++|+|++|+.||.+....+.
T Consensus       287 ll~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~--~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~  364 (573)
T 3uto_A          287 MFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET  364 (573)
T ss_dssp             EESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHH--TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             cccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHh--CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence            99854  555555543           234589999999998  456788999999999999999999999999888888


Q ss_pred             HHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          148 LFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       148 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ...+......   ..+..+++++++||.+||+.||.+|||++|+++||||+...
T Consensus       365 ~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          365 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             HHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            7777655432   23456899999999999999999999999999999998653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1e-47  Score=291.02  Aligned_cols=187  Identities=24%  Similarity=0.477  Sum_probs=161.0

Q ss_pred             ccccCCC-cceeccceeeeeC-CeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHH
Q 046714            3 SFSQFEH-DNIVQYIGTEKDE-NRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLT   63 (201)
Q Consensus         3 ~l~~l~h-~~I~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~   63 (201)
                      +|++++| |||++++|+|... +..++||||+++|+|.++++..                 .+++..+..++.||+.||+
T Consensus       120 il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~  199 (353)
T 4ase_A          120 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME  199 (353)
T ss_dssp             HHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHH
Confidence            4677766 8999999998764 5689999999999999999642                 2789999999999999999


Q ss_pred             HHhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHH
Q 046714           64 YLHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV  129 (201)
Q Consensus        64 ~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l  129 (201)
                      |||+++|+||||||+|||++.++.+++.++..+              ..+|+.|+|||.+  .+..++.++|||||||++
T Consensus       200 yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l--~~~~y~~ksDVwS~Gv~l  277 (353)
T 4ase_A          200 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLL  277 (353)
T ss_dssp             HHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH--HHCCCCHHHHHHHHHHHH
T ss_pred             hHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHH--hcCCCCCcccEeehHHHH
Confidence            999999999999999999999888877765422              2367789999998  456789999999999999


Q ss_pred             HHHHh-CCCCCCCch-HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          130 LEMLT-HQPPYSHLE-DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       130 ~~l~~-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      |||+| |+.||.+.. .......+..+..+..+..+++++.+++.+||+.+|++|||+.|+++|
T Consensus       278 ~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          278 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            99998 999998764 344445566677778888999999999999999999999999999987

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.3e-46  Score=275.85  Aligned_cols=195  Identities=33%  Similarity=0.619  Sum_probs=169.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.+++....+++..+..++.|++.||+|||++|++|+||||+||++
T Consensus        70 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~  149 (297)
T 3fxz_A           70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL  149 (297)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE
Confidence            46789999999999999999999999999999999999998889999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|.+++.+...            ...+++.|+|||.+  .+..++.++||||+|+++|+|++|+.||...........
T Consensus       150 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  227 (297)
T 3fxz_A          150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL  227 (297)
T ss_dssp             CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHH--HCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhh--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9888777766431            23478889999998  455678999999999999999999999988766655555


Q ss_pred             hhcCCC--CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          151 IGRGKL--PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       151 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      +.....  ...+..+++.+.+++.+||+.+|.+|||++|+++||||+...+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          228 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             HHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence            433322  2345678999999999999999999999999999999987543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.4e-45  Score=276.99  Aligned_cols=194  Identities=26%  Similarity=0.455  Sum_probs=169.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+.+..++||||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+
T Consensus        67 ~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIl  146 (328)
T 3fe3_A           67 IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL  146 (328)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEE
Confidence            46789999999999999999999999999999999998865 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           82 VDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        82 l~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      ++.+|.+++.+..           ....+++.|+|||.+. .....+.++||||+|+++|+|++|+.||.+.........
T Consensus       147 l~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  225 (328)
T 3fe3_A          147 LDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER  225 (328)
T ss_dssp             ECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHH-TCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EcCCCCEEEeeccCceecCCCCccccccCCcceeCccccc-CCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9998877776643           2345788999999983 233345899999999999999999999998887777777


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      +..+.. ..+..+++++.+++.+||+.+|.+|||++|+++||||+...
T Consensus       226 i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          226 VLRGKY-RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHCCC-CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHhCCC-CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            666543 56777899999999999999999999999999999998643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.2e-44  Score=271.58  Aligned_cols=191  Identities=28%  Similarity=0.467  Sum_probs=168.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+.+..++||||+.|++|.+++.+. .+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        58 ~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl  137 (337)
T 1o6l_A           58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM  137 (337)
T ss_dssp             HHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             HHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEE
Confidence            467899999999999999999999999999999999988754 5899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...||+.|+|||.+  .+..++.++|+||+|+++|+|++|+.||..........
T Consensus       138 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~  215 (337)
T 1o6l_A          138 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE  215 (337)
T ss_dssp             ECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGG--SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhh--cCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH
Confidence            99988777765431            23478889999998  45667899999999999999999999998877766666


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKR  196 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~  196 (201)
                      .+.... ..++..+++++.+++.+||+.+|++||     +++++++||||+.
T Consensus       216 ~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          216 LILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            665543 356778999999999999999999999     9999999999975

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3e-44  Score=269.88  Aligned_cols=191  Identities=26%  Similarity=0.487  Sum_probs=170.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..++||||+.|++|.+++.+. .+++..+..++.||+.||+|||++|++|+||||+||+
T Consensus        59 ~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl  138 (318)
T 1fot_A           59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL  138 (318)
T ss_dssp             HHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred             HHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEE
Confidence            467899999999999999999999999999999999998764 5999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           82 VDASGLATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        82 l~~~g~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      ++.+|.+++.+..         ....||+.|+|||.+  .+..++.++|+||+|+++|+|++|+.||...........+.
T Consensus       139 l~~~g~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  216 (318)
T 1fot_A          139 LDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVV--STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL  216 (318)
T ss_dssp             ECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHH--TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             EcCCCCEEEeecCcceecCCccccccCCccccCHhHh--cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9998877776643         234588999999998  45667899999999999999999999998887777776666


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccC
Q 046714          153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKR  196 (201)
Q Consensus       153 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~  196 (201)
                      ... ..++..+++++.+++.+||+.+|.+|+     +++++++||||+.
T Consensus       217 ~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          217 NAE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             HCC-CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             hCC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            554 356778999999999999999999999     9999999999985

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3e-44  Score=274.00  Aligned_cols=193  Identities=28%  Similarity=0.451  Sum_probs=167.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+.+..++||||+.|++|.+++... .+++..+..++.||+.||+|||+.||+|+||||+||+
T Consensus        68 il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIl  147 (361)
T 2yab_A           68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM  147 (361)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence            478899999999999999999999999999999999999764 4999999999999999999999999999999999999


Q ss_pred             EccCC----ceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           82 VDASG----LATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        82 l~~~g----~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ++.++    .+++.+..           ....|++.|+|||.+  .+..++.++|+||+|+++|+|++|..||.+....+
T Consensus       148 l~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~  225 (361)
T 2yab_A          148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE  225 (361)
T ss_dssp             ESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred             EeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHH--cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            98776    34554432           234578899999998  45567899999999999999999999998887777


Q ss_pred             HHHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          147 ALFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       147 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ....+......   ..+..+++.+++|+.+||..+|.+|||++|+++||||+..
T Consensus       226 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          226 TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            77766655432   1235688999999999999999999999999999999853

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.6e-44  Score=278.48  Aligned_cols=196  Identities=27%  Similarity=0.465  Sum_probs=159.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.+++..   ..+++..+..++.||+.||+|||++||+|+||||+|
T Consensus        79 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N  158 (389)
T 3gni_B           79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASH  158 (389)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             HHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            46789999999999999999999999999999999999876   459999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc-------------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Q 046714           80 ILVDASGLATTTNDVK-------------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS  140 (201)
Q Consensus        80 ill~~~g~~~~~~~~~-------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  140 (201)
                      |+++.+|.+++.+...                   ...+++.|+|||.+......++.++||||+||++|+|++|+.||.
T Consensus       159 Ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  238 (389)
T 3gni_B          159 ILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK  238 (389)
T ss_dssp             EEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             EEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            9999888776665421                   124677899999984333578899999999999999999999997


Q ss_pred             CchHHHHHHHhhcCCC---------------------------------------------CCCCCCCCHHHHHHHHHHh
Q 046714          141 HLEDMQALFRIGRGKL---------------------------------------------PSVPNSLSRDARDFILKCL  175 (201)
Q Consensus       141 ~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~li~~~l  175 (201)
                      +............+..                                             ...+..+++.+.+|+.+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  318 (389)
T 3gni_B          239 DMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL  318 (389)
T ss_dssp             TCCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHT
T ss_pred             CCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHh
Confidence            6544333332221111                                             1234567889999999999


Q ss_pred             hcCCCCCCCHhHHhcCccccCcC
Q 046714          176 QVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       176 ~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      +.||++|||++|+++||||+...
T Consensus       319 ~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          319 QRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             CSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             hcCcccCCCHHHHhcCHHHHHHh
Confidence            99999999999999999998643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=274.95  Aligned_cols=191  Identities=26%  Similarity=0.482  Sum_probs=167.8

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      |+++ +||||+++++++.+.+..++||||+.|++|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        77 l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIL  156 (353)
T 3txo_A           77 LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVL  156 (353)
T ss_dssp             HHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             HHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEE
Confidence            4445 799999999999999999999999999999998876 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...||+.|+|||.+  .+..++.++|+||+|+++|+|++|+.||......+...
T Consensus       157 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~  234 (353)
T 3txo_A          157 LDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL--QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE  234 (353)
T ss_dssp             ECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHH--HHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ECCCCCEEEccccceeecccCCccccccCCCcCeEChhhc--CCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99998887776532            23478899999998  44567889999999999999999999999888877777


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH------hHHhcCccccCc
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA------AQLMEHPFVKRP  197 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~------~~il~~~~~~~~  197 (201)
                      .+..... .++..+++.+.+++.+||+.+|.+||++      +++++||||+..
T Consensus       235 ~i~~~~~-~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          235 AILNDEV-VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHHCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHcCCC-CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            7766543 5677899999999999999999999998      899999999863

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.7e-45  Score=270.75  Aligned_cols=188  Identities=22%  Similarity=0.323  Sum_probs=148.2

Q ss_pred             ccccCCCcceeccceeeeeCC----eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc--------Cc
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER--------NV   70 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------~i   70 (201)
                      ++.+++||||+++++++.+++    ..++||||+++|+|.++++..+++++.+.+++.|++.||+|||++        +|
T Consensus        50 ~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~I  129 (303)
T 3hmm_A           50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI  129 (303)
T ss_dssp             TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCE
T ss_pred             HHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCE
Confidence            467899999999999998654    579999999999999999999999999999999999999999977        89


Q ss_pred             cccCCCCCcEEEccCCceeeecCcc----------------ccccCcccccccccccC----CCCCcchhhHHHHHHHHH
Q 046714           71 VHREIKCANILVDASGLATTTNDVK----------------SFEGTPFWVAPEVVNLK----NNGYGLSADIWSLGCTVL  130 (201)
Q Consensus        71 ~H~dl~p~nill~~~g~~~~~~~~~----------------~~~~~~~~~aPE~~~~~----~~~~~~~~Dv~slG~~l~  130 (201)
                      +||||||+|||++.+|.+++.++.-                ...||+.|+|||.+...    ...++.++|||||||++|
T Consensus       130 iHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~  209 (303)
T 3hmm_A          130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW  209 (303)
T ss_dssp             ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH
T ss_pred             eeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHH
Confidence            9999999999999998877776542                13489999999998432    113678999999999999


Q ss_pred             HHHhCCCCCCCc---------------hHHHHHHHhh-cCCCCCCCCC-----CCHHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          131 EMLTHQPPYSHL---------------EDMQALFRIG-RGKLPSVPNS-----LSRDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       131 ~l~~g~~p~~~~---------------~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                      ||+||..|+...               ........+. ....+.++..     .+..+.+++.+||+.||++|||+.|++
T Consensus       210 El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~  289 (303)
T 3hmm_A          210 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK  289 (303)
T ss_dssp             HHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHH
T ss_pred             HHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHH
Confidence            999997655311               1112222222 2333444432     234688999999999999999999987


Q ss_pred             c
Q 046714          190 E  190 (201)
Q Consensus       190 ~  190 (201)
                      +
T Consensus       290 ~  290 (303)
T 3hmm_A          290 K  290 (303)
T ss_dssp             H
T ss_pred             H
Confidence            6

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.3e-44  Score=270.68  Aligned_cols=191  Identities=27%  Similarity=0.447  Sum_probs=170.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+.+..++||||+.|++|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        94 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl  173 (350)
T 1rdq_E           94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL  173 (350)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEE
Confidence            57889999999999999999999999999999999999876 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           82 VDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        82 l~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      ++.+|.+++.+...         ...||+.|+|||.+  .+..++.++|+||||+++|+|++|+.||...........+.
T Consensus       174 l~~~g~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  251 (350)
T 1rdq_E          174 IDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV  251 (350)
T ss_dssp             ECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ECCCCCEEEcccccceeccCCcccccCCccccCHHHh--cCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH
Confidence            99988777766432         34578899999998  45567899999999999999999999998887777777776


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccC
Q 046714          153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKR  196 (201)
Q Consensus       153 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~  196 (201)
                      .+. ..++..+++.+.+++.+||+.+|.+||+     ++++++||||+.
T Consensus       252 ~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          252 SGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HCC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             cCC-CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            654 3567789999999999999999999998     999999999975

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.8e-44  Score=277.86  Aligned_cols=192  Identities=28%  Similarity=0.479  Sum_probs=165.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+++..++||||+.|++|.+.+... .+++..+..++.||+.||+|||++||+|+||||+||+
T Consensus        63 il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIl  142 (444)
T 3soa_A           63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLL  142 (444)
T ss_dssp             HHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEE
T ss_pred             HHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence            567899999999999999999999999999999999988654 5999999999999999999999999999999999999


Q ss_pred             Ecc---CCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           82 VDA---SGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        82 l~~---~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ++.   ++.+++.+..            ....|++.|+|||.+  .+..++.++||||+|+++|+|++|+.||......+
T Consensus       143 l~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l--~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~  220 (444)
T 3soa_A          143 LASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL--RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR  220 (444)
T ss_dssp             ESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHh--cCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH
Confidence            984   3455554432            123578899999998  45568899999999999999999999998888777


Q ss_pred             HHHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          147 ALFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       147 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ....+..+...   .....+++++.+++.+||+.||.+|||++|+++||||+.
T Consensus       221 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          221 LYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            77776655432   223568999999999999999999999999999999964

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.4e-43  Score=266.76  Aligned_cols=193  Identities=32%  Similarity=0.632  Sum_probs=168.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++||||+++++++...+..++||||+.+++|.+++....+++..+..++.|++.||+|||+.|++|+||||+||++
T Consensus        95 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll  174 (321)
T 2c30_A           95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL  174 (321)
T ss_dssp             HHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence            57889999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|.+++.+..            ....+++.|+|||.+  .+..++.++||||||+++|+|++|+.||...........
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~  252 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI--SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR  252 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            988877666543            123478889999998  455678999999999999999999999988777666666


Q ss_pred             hhcCCCCCC--CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          151 IGRGKLPSV--PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       151 ~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      +.....+..  ...+++.+.+++.+||+.+|++|||++++++||||++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          253 LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             HHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             HhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence            555443332  34578999999999999999999999999999999764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.2e-44  Score=270.78  Aligned_cols=188  Identities=28%  Similarity=0.517  Sum_probs=166.9

Q ss_pred             CCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccC
Q 046714            7 FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDAS   85 (201)
Q Consensus         7 l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~   85 (201)
                      .+||||+++++++.+.+..++||||+.|++|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus        75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~  154 (345)
T 1xjd_A           75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD  154 (345)
T ss_dssp             TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred             CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC
Confidence            4899999999999999999999999999999999876 459999999999999999999999999999999999999998


Q ss_pred             CceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhc
Q 046714           86 GLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR  153 (201)
Q Consensus        86 g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  153 (201)
                      |.+++.+..            ....||+.|+|||.+  .+..++.++|+||+|+++|+|++|+.||...........+..
T Consensus       155 g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~  232 (345)
T 1xjd_A          155 GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL--LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM  232 (345)
T ss_dssp             SCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCEEEeEChhhhhcccCCCcccCCCCCcccCChhhh--cCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            877766543            233578899999998  455688999999999999999999999988877777766655


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHh-HHhcCccccCc
Q 046714          154 GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAA-QLMEHPFVKRP  197 (201)
Q Consensus       154 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~-~il~~~~~~~~  197 (201)
                      .. +.++..+++++.+++.+||+.+|++||++. ++++||||+..
T Consensus       233 ~~-~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          233 DN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             CC-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             CC-CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            53 466778999999999999999999999998 99999999763

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-44  Score=270.53  Aligned_cols=194  Identities=23%  Similarity=0.351  Sum_probs=166.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+.+..++||||+.+++|.+++...  .+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        54 ~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NI  133 (321)
T 1tki_A           54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI  133 (321)
T ss_dssp             HHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHE
Confidence            467899999999999999999999999999999999999764  489999999999999999999999999999999999


Q ss_pred             EEcc--CCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           81 LVDA--SGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~~--~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +++.  ++..++.+...           ...+++.|+|||.+  .+..++.++|+||+|+++|+|++|..||........
T Consensus       134 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  211 (321)
T 1tki_A          134 IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH--QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI  211 (321)
T ss_dssp             EESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHH--TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             EEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHh--cCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH
Confidence            9987  56666555432           23378889999998  445678999999999999999999999988877777


Q ss_pred             HHHhhcCCCCCC---CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          148 LFRIGRGKLPSV---PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       148 ~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ...+........   ...+++++.+++.+||..+|.+|||++|+++||||++..
T Consensus       212 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            766665543221   246899999999999999999999999999999998653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.6e-44  Score=275.58  Aligned_cols=195  Identities=26%  Similarity=0.401  Sum_probs=168.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++||||+++++++.+++..++||||+.|++|.++++...+++..+..++.||+.||+|||++||+||||||+||++
T Consensus       122 il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl  201 (410)
T 3v8s_A          122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL  201 (410)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE
Confidence            46778999999999999999999999999999999999998889999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc-------------ccccCcccccccccccCCC--CCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           83 DASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNN--GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        83 ~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +.+|.+++.+...             ...||+.|+|||++.....  .++.++|+||||+++|+|++|+.||........
T Consensus       202 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~  281 (410)
T 3v8s_A          202 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT  281 (410)
T ss_dssp             CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH
Confidence            9988777665431             3458899999999843221  277899999999999999999999988877777


Q ss_pred             HHHhhcCC---CCCCCCCCCHHHHHHHHHHhhcCCCC--CCCHhHHhcCccccCc
Q 046714          148 LFRIGRGK---LPSVPNSLSRDARDFILKCLQVNPND--RPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~--R~t~~~il~~~~~~~~  197 (201)
                      ...+....   .......+++++++|+.+||+.+|.+  |++++|+++||||+..
T Consensus       282 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          282 YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            66665431   11223468999999999999998988  9999999999999863

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.5e-44  Score=273.16  Aligned_cols=194  Identities=22%  Similarity=0.373  Sum_probs=161.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+++..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        62 ~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl  140 (336)
T 3h4j_B           62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL  140 (336)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEE
T ss_pred             HHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEE
Confidence            478899999999999999999999999999 5688887754 56999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           82 VDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        82 l~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      ++.+|.+++.+..           ....|++.|+|||.+. .....++++||||+|+++|+|++|+.||...........
T Consensus       141 l~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~  219 (336)
T 3h4j_B          141 LDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK  219 (336)
T ss_dssp             ECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSC-CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC
T ss_pred             EcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHc-CCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            9999887776643           2334788999999983 222347899999999999999999999976433222211


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      + .......+..+++.+.+++.+||+.||.+|||++|+++||||+...+
T Consensus       220 i-~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  267 (336)
T 3h4j_B          220 V-NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP  267 (336)
T ss_dssp             C-CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred             H-HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence            1 12223556778999999999999999999999999999999987543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.9e-43  Score=267.16  Aligned_cols=190  Identities=25%  Similarity=0.446  Sum_probs=167.7

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      |.++ +||||+++++.+.+.+..++||||+.|++|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+||+
T Consensus        74 l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl  153 (353)
T 2i0e_A           74 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM  153 (353)
T ss_dssp             HTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             HHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEE
Confidence            4555 799999999999999999999999999999999876 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+..            ....||+.|+|||.+  .+..++.++|+||||+++|+|++|+.||......+...
T Consensus       154 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~  231 (353)
T 2i0e_A          154 LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ  231 (353)
T ss_dssp             ECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHH--TTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EcCCCcEEEEeCCcccccccCCcccccccCCccccChhhh--cCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            9998877776543            234478899999998  45667899999999999999999999999887777776


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKR  196 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~  196 (201)
                      .+.... ..++..+++++.+++.+||+.+|.+||+     ++++++||||+.
T Consensus       232 ~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          232 SIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHHhCC-CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            666554 3567789999999999999999999994     699999999975

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.2e-43  Score=266.27  Aligned_cols=191  Identities=28%  Similarity=0.466  Sum_probs=168.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++..++||||+.+++|.+++... .+++..+..++.||+.||+|||++|++|+||||+||+
T Consensus        74 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nil  153 (327)
T 3a62_A           74 ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIM  153 (327)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEE
T ss_pred             HHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeE
Confidence            467889999999999999999999999999999999998754 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...|++.|+|||.+  .+..++.++|+||||+++|+|++|+.||..........
T Consensus       154 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  231 (327)
T 3a62_A          154 LNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEIL--MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID  231 (327)
T ss_dssp             ECTTSCEEECCCSCC----------CTTSSCCTTSCHHHH--TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             ECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhC--cCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            99988777766432            23478889999998  45567899999999999999999999998887777666


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKR  196 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~  196 (201)
                      .+.... ..++..+++.+.+++.+||+.+|.+||     +++++++||||+.
T Consensus       232 ~i~~~~-~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          232 KILKCK-LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             HHHHTC-CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HHHhCC-CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            665544 356678899999999999999999999     8899999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.6e-43  Score=272.57  Aligned_cols=187  Identities=31%  Similarity=0.565  Sum_probs=160.3

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG   86 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g   86 (201)
                      +||||+++++++.+++..++||||+.+++|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+||+++.+|
T Consensus       111 ~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g  190 (396)
T 4dc2_A          111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG  190 (396)
T ss_dssp             TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS
T ss_pred             CCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC
Confidence            899999999999999999999999999999998876 4599999999999999999999999999999999999999998


Q ss_pred             ceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHH
Q 046714           87 LATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE--------DMQ  146 (201)
Q Consensus        87 ~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~  146 (201)
                      .+++.+..            ....||+.|+|||++  .+..++.++|+||+|+++|+|++|+.||....        ...
T Consensus       191 ~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l--~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~  268 (396)
T 4dc2_A          191 HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL--RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED  268 (396)
T ss_dssp             CEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHH
T ss_pred             CEEEeecceeeecccCCCccccccCCcccCCchhh--cCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHH
Confidence            77776543            234578899999998  45678899999999999999999999995321        112


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH------hHHhcCccccC
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA------AQLMEHPFVKR  196 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~------~~il~~~~~~~  196 (201)
                      ............++..+++++.+++.+||+.+|.+|+++      +|+++||||+.
T Consensus       269 ~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          269 YLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             HHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            222333333456788899999999999999999999984      79999999975

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=266.73  Aligned_cols=193  Identities=27%  Similarity=0.458  Sum_probs=164.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+.+..++||||+.+++|.+++... .+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        67 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl  146 (326)
T 2y0a_A           67 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM  146 (326)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEE
Confidence            467899999999999999999999999999999999998754 4899999999999999999999999999999999999


Q ss_pred             EccCC----ceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           82 VDASG----LATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        82 l~~~g----~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ++.++    .+++.+..           ....+++.|+|||.+  .+..++.++|+||+|+++|+|++|..||......+
T Consensus       147 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  224 (326)
T 2y0a_A          147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE  224 (326)
T ss_dssp             ESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred             EecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceee--cCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence            98876    44554432           223478889999998  45567899999999999999999999998877666


Q ss_pred             HHHHhhcCCCCC---CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          147 ALFRIGRGKLPS---VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       147 ~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ....+.......   ....+++.+.+++.+||+.+|.+|||++++++||||+..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          225 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            665554433221   224678999999999999999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.5e-43  Score=260.22  Aligned_cols=193  Identities=30%  Similarity=0.490  Sum_probs=161.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..++||||+.+ +|.+++..  .++++..+..++.|++.||+|||++|++|+||||+||
T Consensus        53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  131 (288)
T 1ob3_A           53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL  131 (288)
T ss_dssp             GGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             HHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            57889999999999999999999999999987 99998875  4589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|.+++.+...            ...+++.|+|||.+. ....++.++|+||+|+++|+|++|+.||.........
T Consensus       132 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  210 (288)
T 1ob3_A          132 LINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM-GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL  210 (288)
T ss_dssp             EECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EEcCCCCEEEeECccccccCccccccccccccccccCchhee-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999998887776431            234688899999983 3445789999999999999999999999887665554


Q ss_pred             HHhhcC---C-C------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          149 FRIGRG---K-L------------------------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       149 ~~~~~~---~-~------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ..+...   . .                        ......+++++.+++.+||+.||++|||++|+++||||++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          211 MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             HHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            443210   0 0                        01124578999999999999999999999999999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=264.24  Aligned_cols=194  Identities=28%  Similarity=0.495  Sum_probs=162.8

Q ss_pred             ccccCCCcceeccceeeee--CCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+  .+..++||||+.+++|.+++....+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            4678999999999999987  56899999999999998887777799999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc------------cccccCcccccccccccCCC-CCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           81 LVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNN-GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +++.+|.+++.+..            ....+++.|+|||.+..... ..+.++|+||||+++|+|++|+.||........
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            99998877766543            12347888999999843222 147889999999999999999999988766555


Q ss_pred             HHHhhcCCCC-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          148 LFRIGRGKLP-SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       148 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ...+...... .....+++.+.+++.+||+.+|++|||++|+++||||++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            5554433322 223468899999999999999999999999999999964

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.5e-43  Score=268.03  Aligned_cols=191  Identities=27%  Similarity=0.419  Sum_probs=168.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      .++.++||||+++++.+.+.+..++||||+.|++|.+++.+. .+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        92 ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl  171 (373)
T 2r5t_A           92 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL  171 (373)
T ss_dssp             CBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             HHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence            367899999999999999999999999999999999988764 5999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+..            ....||+.|+|||.+  .+..++.++|+||||+++|+|++|..||......+...
T Consensus       172 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~  249 (373)
T 2r5t_A          172 LDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVL--HKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD  249 (373)
T ss_dssp             ECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH
T ss_pred             ECCCCCEEEeeCccccccccCCCccccccCCccccCHHHh--CCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            9998877766543            234578899999998  45668899999999999999999999998887777777


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH----hHHhcCccccC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA----AQLMEHPFVKR  196 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~----~~il~~~~~~~  196 (201)
                      .+.... ..++..+++.+.+++.+||+.+|.+|+++    +++++||||+.
T Consensus       250 ~i~~~~-~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          250 NILNKP-LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHHHSC-CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHHhcc-cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            766554 35677899999999999999999999986    69999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.8e-44  Score=267.80  Aligned_cols=196  Identities=23%  Similarity=0.398  Sum_probs=162.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.+++... .+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus        58 ~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl  137 (323)
T 3tki_A           58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL  137 (323)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEE
Confidence            467889999999999999999999999999999999988765 4999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           82 VDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        82 l~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ++.+|.+++.+...              ...+++.|+|||.+. .....+.++||||+|+++|+|++|+.||........
T Consensus       138 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  216 (323)
T 3tki_A          138 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ  216 (323)
T ss_dssp             ECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHH-CSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH
T ss_pred             EeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhc-cCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence            99988777665432              234788899999983 233347899999999999999999999976543211


Q ss_pred             -HHH-hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          148 -LFR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       148 -~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                       ... ............+++.+.+++.+||+.+|.+|||++|+++||||+....
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          217 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             HHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence             222 2222222334568999999999999999999999999999999987654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.6e-43  Score=274.14  Aligned_cols=193  Identities=26%  Similarity=0.449  Sum_probs=170.0

Q ss_pred             cccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCc
Q 046714            2 FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCAN   79 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~n   79 (201)
                      .+|++++||||+++++++.+.+..++||||+.+++|.+++.. ..+++..+..++.||+.||+|||+ .||+|+||||+|
T Consensus       200 ~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~N  279 (446)
T 4ejn_A          200 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN  279 (446)
T ss_dssp             -CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGG
T ss_pred             HHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHH
Confidence            367889999999999999999999999999999999998865 458999999999999999999998 899999999999


Q ss_pred             EEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           80 ILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        80 ill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+++.+|.+++.+...            ...||+.|+|||.+  .+..++.++||||||+++|+|++|+.||........
T Consensus       280 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~  357 (446)
T 4ejn_A          280 LMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL  357 (446)
T ss_dssp             EEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHH--HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhc--CCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH
Confidence            9999988777766432            23478899999998  456688999999999999999999999988877776


Q ss_pred             HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          148 LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                      ...+.... ..++..+++++.+++.+||+.+|.+||     |++|+++||||+..
T Consensus       358 ~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          358 FELILMEE-IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHhCC-CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            66665544 356778999999999999999999999     99999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.1e-43  Score=267.12  Aligned_cols=190  Identities=31%  Similarity=0.552  Sum_probs=161.3

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++ +||||+++++++.+.+..++||||+.+++|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        63 l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl  142 (345)
T 3a8x_A           63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL  142 (345)
T ss_dssp             HHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             HHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence            4455 899999999999999999999999999999998876 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc-------
Q 046714           82 VDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL-------  142 (201)
Q Consensus        82 l~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-------  142 (201)
                      ++.+|.+++.+..            ....||+.|+|||.+  .+..++.++|+||+||++|+|++|+.||...       
T Consensus       143 l~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  220 (345)
T 3a8x_A          143 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL--RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD  220 (345)
T ss_dssp             ECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----
T ss_pred             ECCCCCEEEEeccccccccCCCCcccccCCCccccCcccc--CCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc
Confidence            9999877766542            223578899999998  4566789999999999999999999999642       


Q ss_pred             --hHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH------hHHhcCccccC
Q 046714          143 --EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA------AQLMEHPFVKR  196 (201)
Q Consensus       143 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~------~~il~~~~~~~  196 (201)
                        ........+.. ....++..+++.+.+++.+||+.+|.+||++      +++++||||+.
T Consensus       221 ~~~~~~~~~~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          221 QNTEDYLFQVILE-KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             --CHHHHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             cccHHHHHHHHHc-CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence              11222223333 3346778899999999999999999999995      89999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-43  Score=269.88  Aligned_cols=192  Identities=27%  Similarity=0.469  Sum_probs=164.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.+.+... .+++..+..++.||+.||+|||++||+|+||||+||+
T Consensus        81 il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIl  160 (362)
T 2bdw_A           81 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLL  160 (362)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred             HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEE
Confidence            467899999999999999999999999999999999988654 4899999999999999999999999999999999999


Q ss_pred             EccCC---ceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           82 VDASG---LATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        82 l~~~g---~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ++.++   .+++.+..           ....+++.|+|||.+  .+..++.++||||+|+++|+|++|+.||........
T Consensus       161 l~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~  238 (362)
T 2bdw_A          161 LASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL--KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL  238 (362)
T ss_dssp             ESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHH--ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            98653   34454432           124578899999998  455678999999999999999999999988877777


Q ss_pred             HHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          148 LFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       148 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ...+..+...   .....+++++.+++.+||+.+|.+|||++++++||||..
T Consensus       239 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          239 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            6666555432   122467999999999999999999999999999999964

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2e-43  Score=260.92  Aligned_cols=193  Identities=28%  Similarity=0.519  Sum_probs=168.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..+++|||+.+++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+
T Consensus        62 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nil  141 (279)
T 3fdn_A           62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL  141 (279)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEE
T ss_pred             HHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEE
Confidence            46789999999999999999999999999999999998876 45899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 046714           82 VDASGLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI  151 (201)
Q Consensus        82 l~~~g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  151 (201)
                      ++.+|.+++.+..          ....+++.|+|||.+  .+...+.++||||+|+++|++++|+.||...........+
T Consensus       142 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  219 (279)
T 3fdn_A          142 LGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI  219 (279)
T ss_dssp             ECTTSCEEECSCCEESCC--------CCCCTTCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EcCCCCEEEEeccccccCCcccccccCCCCCccCHhHh--ccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence            9999887776643          223478889999998  4556788999999999999999999999887776666555


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .... ...+..+++.+.+++.+||+.+|.+|||++|+++||||+...
T Consensus       220 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          220 SRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHTC-CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HhCC-CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence            5443 356777899999999999999999999999999999998654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.1e-43  Score=264.70  Aligned_cols=195  Identities=29%  Similarity=0.478  Sum_probs=160.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++..++||||+.+ +|.+++...  ++++..+..++.|++.||+|||++|++|+||||+||
T Consensus        72 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NI  150 (311)
T 3niz_A           72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL  150 (311)
T ss_dssp             HHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhE
Confidence            46789999999999999999999999999986 888877654  389999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|.+++.+...            ...+++.|+|||.+. ....++.++||||+|+++|+|++|+.||......+..
T Consensus       151 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  229 (311)
T 3niz_A          151 LINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLM-GSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL  229 (311)
T ss_dssp             EECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH
T ss_pred             EECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhc-CCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            999988777766432            224678899999983 3456789999999999999999999999765544443


Q ss_pred             HHhhc---CCCC--------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          149 FRIGR---GKLP--------------------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       149 ~~~~~---~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      ..+..   ...+                          .....+++++.+|+.+||+.||++|||++|+++||||+...+
T Consensus       230 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          230 PKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             HHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             HHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            33211   1110                          012346788999999999999999999999999999997654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.2e-43  Score=267.76  Aligned_cols=191  Identities=28%  Similarity=0.473  Sum_probs=159.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.+.+...     .+++..+..++.||+.||+|||++|++|+||||
T Consensus        79 ~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp  158 (351)
T 3c0i_A           79 ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKP  158 (351)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             HHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCh
Confidence            467889999999999999999999999999999998877542     389999999999999999999999999999999


Q ss_pred             CcEEEccCCc---eeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc
Q 046714           78 ANILVDASGL---ATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL  142 (201)
Q Consensus        78 ~nill~~~g~---~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  142 (201)
                      +||+++.++.   +++.+..            ....+++.|+|||.+  .+..++.++||||+|+++|+|++|+.||...
T Consensus       159 ~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (351)
T 3c0i_A          159 HCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV--KREPYGKPVDVWGCGVILFILLSGCLPFYGT  236 (351)
T ss_dssp             GGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             HHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHH--cCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence            9999986543   4444331            123578899999998  4556789999999999999999999999875


Q ss_pred             hHHHHHHHhhcCCCCCC---CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          143 EDMQALFRIGRGKLPSV---PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       143 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      .. .....+..+.....   +..+++.+.+++.+||+.+|++|||+.++++||||+.
T Consensus       237 ~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          237 KE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             HH-HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HH-HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            43 33444444433221   2468899999999999999999999999999999975

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.1e-43  Score=276.61  Aligned_cols=194  Identities=27%  Similarity=0.428  Sum_probs=168.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+.+..++||||+.+++|.+++.+. .+++..+..++.||+.||+|||++|++|+||||+||+
T Consensus        69 ~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIl  148 (476)
T 2y94_A           69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL  148 (476)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEE
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEE
Confidence            478899999999999999999999999999999999998754 4999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           82 VDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        82 l~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      ++.+|.+++.+..           ....+++.|+|||.+. .....+.++|+||+|+++|+|++|+.||...........
T Consensus       149 l~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~  227 (476)
T 2y94_A          149 LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS-GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK  227 (476)
T ss_dssp             ECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHT-TCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH
T ss_pred             EecCCCeEEEeccchhhccccccccccCCCcCeEChhhcc-CCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence            9998877666542           2345788999999983 233347899999999999999999999988776666666


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      +..+. ...+..+++.+.+++.+||+.+|.+|||++++++||||+...
T Consensus       228 i~~~~-~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          228 ICDGI-FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             HHTTC-CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             HhcCC-cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            65554 355677899999999999999999999999999999998754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5e-43  Score=268.90  Aligned_cols=194  Identities=25%  Similarity=0.482  Sum_probs=165.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+.+..++||||+.|++|.+++... .+++..+..++.||+.||+|||++||+|+||||+||+
T Consensus        68 il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl  147 (384)
T 4fr4_A           68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNIL  147 (384)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeE
Confidence            577899999999999999999999999999999999999865 5999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc-----------cccccCcccccccccccC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCc---hHHH
Q 046714           82 VDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLK-NNGYGLSADIWSLGCTVLEMLTHQPPYSHL---EDMQ  146 (201)
Q Consensus        82 l~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~---~~~~  146 (201)
                      ++.+|.+++.+..           ....||+.|+|||.+... +..++.++|+|||||++|+|++|+.||...   ....
T Consensus       148 l~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~  227 (384)
T 4fr4_A          148 LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE  227 (384)
T ss_dssp             ECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH
T ss_pred             ECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH
Confidence            9998877766543           234588899999998432 345789999999999999999999999643   2223


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-HhHHhcCccccCc
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-AAQLMEHPFVKRP  197 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-~~~il~~~~~~~~  197 (201)
                      ....+. .....++..+++.+.+++.+||+.+|.+||+ ++++++||||+..
T Consensus       228 ~~~~~~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          228 IVHTFE-TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             HHHHHH-HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             HHHHHh-hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            333333 3344667789999999999999999999998 9999999999753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.9e-43  Score=259.06  Aligned_cols=195  Identities=26%  Similarity=0.479  Sum_probs=166.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil  138 (277)
T 3f3z_A           59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFL  138 (277)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEE
Confidence            46789999999999999999999999999999999998765 44899999999999999999999999999999999999


Q ss_pred             E---ccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           82 V---DASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        82 l---~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +   +.++.+++.+..           ....+++.|+|||.+.   ..++.++|+||+|+++|++++|+.||........
T Consensus       139 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  215 (277)
T 3f3z_A          139 FLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE---GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV  215 (277)
T ss_dssp             ESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT---TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhc---ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH
Confidence            9   666666555432           2334788899999973   2378999999999999999999999998877777


Q ss_pred             HHHhhcCCCCCCC---CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCCC
Q 046714          148 LFRIGRGKLPSVP---NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQT  200 (201)
Q Consensus       148 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~~  200 (201)
                      ...+..+......   ..+++.+.+++.+||+.+|.+|||+.++++||||++..+.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~  271 (277)
T 3f3z_A          216 MLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS  271 (277)
T ss_dssp             HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred             HHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence            7776665443222   2678999999999999999999999999999999876543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.5e-43  Score=263.57  Aligned_cols=195  Identities=29%  Similarity=0.459  Sum_probs=162.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcCccccCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-------HLSDSQVSSYTRQILNGLTYLHERNVVHREI   75 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl   75 (201)
                      +|++++||||+++++++.+++..++||||+.+ +|.+++...       .+++..+..++.||+.||+|||++|++|+||
T Consensus        56 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dl  134 (317)
T 2pmi_A           56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL  134 (317)
T ss_dssp             HHTTCCBTTBCCEEEEECCTTEEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             HHHhcCCCCcceEEEEEEECCeEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence            57889999999999999999999999999985 999988643       4899999999999999999999999999999


Q ss_pred             CCCcEEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           76 KCANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      ||+||+++.+|.+++.+...            ...+++.|+|||.+. ....++.++||||+|+++|+|++|+.||....
T Consensus       135 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  213 (317)
T 2pmi_A          135 KPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM-GSRTYSTSIDIWSCGCILAEMITGKPLFPGTN  213 (317)
T ss_dssp             CGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999988777765432            234678899999983 33467899999999999999999999998876


Q ss_pred             HHHHHHHhhcC--CC-------------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          144 DMQALFRIGRG--KL-------------------------------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       144 ~~~~~~~~~~~--~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..+....+...  ..                               +.....+++++.+|+.+||+.+|.+|||++|+++
T Consensus       214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          214 DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             HHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            66555443210  00                               0112357889999999999999999999999999


Q ss_pred             CccccCcCC
Q 046714          191 HPFVKRPLQ  199 (201)
Q Consensus       191 ~~~~~~~~~  199 (201)
                      ||||++...
T Consensus       294 hp~f~~~~~  302 (317)
T 2pmi_A          294 HPWFAEYYH  302 (317)
T ss_dssp             SGGGGGGCC
T ss_pred             Chhhhcccc
Confidence            999987654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.2e-43  Score=266.38  Aligned_cols=194  Identities=27%  Similarity=0.419  Sum_probs=154.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus        69 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nil  148 (361)
T 3uc3_A           69 NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTL  148 (361)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEE
T ss_pred             HHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence            46788999999999999999999999999999999998865 45999999999999999999999999999999999999


Q ss_pred             EccCCc--eeeecCc-----------cccccCcccccccccccCCCCC-cchhhHHHHHHHHHHHHhCCCCCCCchH---
Q 046714           82 VDASGL--ATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGY-GLSADIWSLGCTVLEMLTHQPPYSHLED---  144 (201)
Q Consensus        82 l~~~g~--~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~---  144 (201)
                      ++.++.  +++.+..           ....+++.|+|||.+.  +..+ +.++||||+|+++|+|++|+.||.....   
T Consensus       149 l~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~  226 (361)
T 3uc3_A          149 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD  226 (361)
T ss_dssp             ECSSSSCCEEECCCCCC---------------CTTSCHHHHH--CSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC
T ss_pred             EcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhc--CCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH
Confidence            987764  5555543           2234788999999983  3334 4559999999999999999999976432   


Q ss_pred             -HHHHHHhhcCCC-CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          145 -MQALFRIGRGKL-PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       145 -~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                       ......+..... ......+++.+.+|+.+||+.+|++|||++|+++||||....
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          227 YRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence             223333332222 122335789999999999999999999999999999997654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-43  Score=268.22  Aligned_cols=197  Identities=28%  Similarity=0.458  Sum_probs=163.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---------------------------------------
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---------------------------------------   43 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---------------------------------------   43 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.+++..                                       
T Consensus        81 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (345)
T 3hko_A           81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRES  160 (345)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEE
T ss_pred             HHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            46788999999999999999999999999999999998841                                       


Q ss_pred             --cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC--ceeeecCc----------------cccccCccc
Q 046714           44 --YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG--LATTTNDV----------------KSFEGTPFW  103 (201)
Q Consensus        44 --~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g--~~~~~~~~----------------~~~~~~~~~  103 (201)
                        ..+++..++.++.|++.||+|||++|++|+||||+||+++.++  .+++.+..                ....+++.|
T Consensus       161 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y  240 (345)
T 3hko_A          161 LDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF  240 (345)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGG
T ss_pred             ccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccc
Confidence              1135777889999999999999999999999999999998765  45555432                123478889


Q ss_pred             ccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCCCCC---CCCCCHHHHHHHHHHhhcCCC
Q 046714          104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV---PNSLSRDARDFILKCLQVNPN  180 (201)
Q Consensus       104 ~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~  180 (201)
                      +|||.+......++.++||||||+++|+|++|+.||......+....+........   ...+++.+.+++.+||+.+|.
T Consensus       241 ~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             CCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred             cCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence            99999854456788999999999999999999999998877777766655443222   224789999999999999999


Q ss_pred             CCCCHhHHhcCccccCcCC
Q 046714          181 DRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       181 ~R~t~~~il~~~~~~~~~~  199 (201)
                      +|||+.++++||||+....
T Consensus       321 ~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          321 ERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             TSCCHHHHHHSHHHHTTSS
T ss_pred             HCCCHHHHhcChhhccChH
Confidence            9999999999999987653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-42  Score=255.90  Aligned_cols=192  Identities=26%  Similarity=0.430  Sum_probs=159.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      +|++++||||+++++++.+.+..++||||+.+++|.+++..     ..+++..+..++.|++.||+|||++|++|+||||
T Consensus        73 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp  152 (285)
T 3is5_A           73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKP  152 (285)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred             HHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCH
Confidence            47889999999999999999999999999999999998743     3599999999999999999999999999999999


Q ss_pred             CcEEEcc---CCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           78 ANILVDA---SGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        78 ~nill~~---~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      +||+++.   ++.+++.+...           ...+++.|+|||.+.   ..++.++|+||+|+++|+|++|+.||....
T Consensus       153 ~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~il~~ll~g~~pf~~~~  229 (285)
T 3is5_A          153 ENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK---RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS  229 (285)
T ss_dssp             GGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT---TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc---cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence            9999953   45555554422           234678899999973   357899999999999999999999998877


Q ss_pred             HHHHHHHhhcCCC--CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          144 DMQALFRIGRGKL--PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       144 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .............  ......+++.+.+++.+||+.+|++|||++|+++||||++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          230 LEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             HHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             HHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence            6665555433322  22234478999999999999999999999999999999863

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.9e-43  Score=263.39  Aligned_cols=195  Identities=28%  Similarity=0.450  Sum_probs=146.2

Q ss_pred             ccccCC-CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFE-HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +++++. ||||+++++++.+++..++||||+.+++|.+++... .+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        58 ~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI  137 (325)
T 3kn6_A           58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL  137 (325)
T ss_dssp             HHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHE
Confidence            345665 999999999999999999999999999999998765 499999999999999999999999999999999999


Q ss_pred             EEccCC---ceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH-
Q 046714           81 LVDASG---LATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED-  144 (201)
Q Consensus        81 ll~~~g---~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-  144 (201)
                      +++.++   .+++.+..            ....+++.|+|||.+  .+..++.++||||+|+++|+|++|+.||..... 
T Consensus       138 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  215 (325)
T 3kn6_A          138 LFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL--NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRS  215 (325)
T ss_dssp             EEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-----
T ss_pred             EEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHh--cCCCCCCccchHHHHHHHHHHHhCCCCCCCCccc
Confidence            998665   44444432            123357889999998  456688999999999999999999999976432 


Q ss_pred             ------HHHHHHhhcCCCCCC---CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          145 ------MQALFRIGRGKLPSV---PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       145 ------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                            .+....+..+.....   +..+++++.+++.+||+.+|.+|||++++++||||+...+
T Consensus       216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          216 LTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             --CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             cccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence                  334444444433211   1357899999999999999999999999999999987644

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.4e-43  Score=272.70  Aligned_cols=194  Identities=24%  Similarity=0.396  Sum_probs=167.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.+++.+  ..+++..+..++.||+.||+|||+.||+||||||+||
T Consensus       127 il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NI  206 (437)
T 4aw2_A          127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI  206 (437)
T ss_dssp             HHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             HHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHe
Confidence            46778999999999999999999999999999999999976  4599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-------------ccccCccccccccccc---CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           81 LVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNL---KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      +++.+|.+++.+...             ...||+.|+|||++..   ....++.++|+||+|+++|+|++|+.||.....
T Consensus       207 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~  286 (437)
T 4aw2_A          207 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL  286 (437)
T ss_dssp             EECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             eEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence            999988777766432             2458899999999841   245678999999999999999999999988877


Q ss_pred             HHHHHHhhc----CCCCCCCCCCCHHHHHHHHHHhhcCCCC--CCCHhHHhcCccccC
Q 046714          145 MQALFRIGR----GKLPSVPNSLSRDARDFILKCLQVNPND--RPTAAQLMEHPFVKR  196 (201)
Q Consensus       145 ~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~--R~t~~~il~~~~~~~  196 (201)
                      .+....+..    ...+.....+++++++|+++||+.+|++  |++++|+++||||+.
T Consensus       287 ~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          287 VETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             HHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             hHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence            766666543    2334444568999999999999888888  999999999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-43  Score=267.82  Aligned_cols=193  Identities=26%  Similarity=0.456  Sum_probs=165.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+.+..++||||+.+++|.+++...  .+++..+..++.||+.||+|||++|++|+||||+||
T Consensus       101 il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NI  180 (387)
T 1kob_A          101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENI  180 (387)
T ss_dssp             HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHe
Confidence            578899999999999999999999999999999999998654  489999999999999999999999999999999999


Q ss_pred             EEccC--CceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           81 LVDAS--GLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~~~--g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +++.+  +.+++.+...           ...+|+.|+|||.+  .+..++.++||||+|+++|+|++|..||........
T Consensus       181 ll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~  258 (387)
T 1kob_A          181 MCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV--DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET  258 (387)
T ss_dssp             EESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHH--TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             EEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhc--cCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH
Confidence            99743  4455554321           23478889999998  456688999999999999999999999988777666


Q ss_pred             HHHhhcCCC---CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGRGKL---PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+.....   ......+++++.+++.+||+.+|.+|||++|+++||||+..
T Consensus       259 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          259 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence            666554432   23345689999999999999999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.3e-43  Score=258.24  Aligned_cols=193  Identities=28%  Similarity=0.478  Sum_probs=168.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..+++|||+.+++|.+++... .+++..+..++.|++.||+|||++|++|+||+|+||+
T Consensus        67 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil  146 (284)
T 2vgo_A           67 IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLL  146 (284)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred             HHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence            467889999999999999999999999999999999988754 5899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 046714           82 VDASGLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI  151 (201)
Q Consensus        82 l~~~g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  151 (201)
                      ++.+|.+++.+..          ....+++.|+|||.+  .+..++.++|+||+|+++|++++|..||...........+
T Consensus       147 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  224 (284)
T 2vgo_A          147 MGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMI--EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI  224 (284)
T ss_dssp             ECTTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHH--TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EcCCCCEEEecccccccCcccccccccCCCCcCCHHHh--ccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH
Confidence            9988877766543          123467889999998  4556789999999999999999999999887766666555


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .... ..++..+++.+.+++.+||+.+|.+|||++++++||||+...
T Consensus       225 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          225 VNVD-LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             HTTC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             hccc-cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            5443 356677899999999999999999999999999999998654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.6e-42  Score=256.61  Aligned_cols=195  Identities=27%  Similarity=0.455  Sum_probs=165.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+++..+++|||+.+++|.+.+.. ..+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus        58 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil  137 (284)
T 3kk8_A           58 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLL  137 (284)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             HHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEE
Confidence            46788999999999999999999999999999999887765 45899999999999999999999999999999999999


Q ss_pred             EccCCc---eeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           82 VDASGL---ATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        82 l~~~g~---~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ++.++.   .++.+..           ....+++.|+|||.+  .+..++.++|+||+|+++|++++|+.||........
T Consensus       138 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  215 (284)
T 3kk8_A          138 LASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL--KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL  215 (284)
T ss_dssp             ESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhh--cCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH
Confidence            976543   4444432           124578889999998  455678999999999999999999999988877776


Q ss_pred             HHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          148 LFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       148 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      ...+......   .....+++.+.+++.+||+.+|.+|||++|+++||||+...+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          216 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            6665544332   223568899999999999999999999999999999987543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.4e-42  Score=257.97  Aligned_cols=193  Identities=27%  Similarity=0.442  Sum_probs=156.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..++||||+.+ ++.+.+..  ..+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        54 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Ni  132 (292)
T 3o0g_A           54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL  132 (292)
T ss_dssp             HHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             HHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            57889999999999999999999999999987 56555543  4599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCC-CCchHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY-SHLEDMQA  147 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~-~~~~~~~~  147 (201)
                      +++.+|.+++.+...            ...+++.|+|||.+. ....++.++|+||+|+++|+|++|..|+ ........
T Consensus       133 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~  211 (292)
T 3o0g_A          133 LINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF-GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ  211 (292)
T ss_dssp             EECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHT-TCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred             EEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHc-CCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence            999988777765432            234678899999983 3344789999999999999999987774 44444444


Q ss_pred             HHHhhc---C-------------------------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGR---G-------------------------KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~---~-------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+..   .                         ........+++.+.+++.+||+.||++|||++|+++||||+.-
T Consensus       212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence            333321   0                         0011223578899999999999999999999999999999874

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.2e-42  Score=256.00  Aligned_cols=192  Identities=24%  Similarity=0.408  Sum_probs=157.1

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      +.++ +||||+++++++.+++..++||||+++++|.+++..     ..+++..+..++.||+.||+|||++|++|+||||
T Consensus        64 ~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp  143 (289)
T 1x8b_A           64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKP  143 (289)
T ss_dssp             HHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             HHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCH
Confidence            3455 899999999999999999999999999999999875     3489999999999999999999999999999999


Q ss_pred             CcEEEccCC-------------------ceeeecCc--------cccccCcccccccccccCCCCCcchhhHHHHHHHHH
Q 046714           78 ANILVDASG-------------------LATTTNDV--------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVL  130 (201)
Q Consensus        78 ~nill~~~g-------------------~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~  130 (201)
                      +||+++.+|                   ..++.+..        ....+++.|+|||.+. .....+.++||||||+++|
T Consensus       144 ~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~Di~slG~il~  222 (289)
T 1x8b_A          144 SNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQ-ENYTHLPKADIFALALTVV  222 (289)
T ss_dssp             GGEEEC--------------------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHT-TCCTTHHHHHHHHHHHHHH
T ss_pred             HHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCccccCCCccccChhHhc-CCCCCCchhhHHHHHHHHH
Confidence            999998544                   33443322        2344788899999983 3446678999999999999


Q ss_pred             HHHhCCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          131 EMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       131 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      ++++|..++.....   ...+..+..+..+..+++.+.+++.+||+.+|.+|||+.++++||||+....
T Consensus       223 ~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  288 (289)
T 1x8b_A          223 CAAGAEPLPRNGDQ---WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR  288 (289)
T ss_dssp             HHTTCCCCCSSSHH---HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-----
T ss_pred             HHhcCCCCCcchhH---HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhcc
Confidence            99999887755433   3445556667778889999999999999999999999999999999987653

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.7e-43  Score=260.62  Aligned_cols=194  Identities=37%  Similarity=0.688  Sum_probs=173.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.+++....+++..+..++.|++.||++||+.|++|+||+|+||++
T Consensus        73 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~  152 (303)
T 3a7i_A           73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL  152 (303)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE
Confidence            46788999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|.+++.+...            ...+++.|+|||.+  .+..++.++|+||||+++|++++|+.||...........
T Consensus       153 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  230 (303)
T 3a7i_A          153 SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL  230 (303)
T ss_dssp             CTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             CCCCCEEEeecccceecCccccccCccCCCcCccCHHHH--hcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH
Confidence            9888776665421            23467889999998  455678899999999999999999999988877777766


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      +.....+..+..+++.+.+++.+||+.+|.+|||++++++||||....
T Consensus       231 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          231 IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             HHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             hhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            666777777888999999999999999999999999999999996544

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=263.96  Aligned_cols=195  Identities=27%  Similarity=0.422  Sum_probs=161.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+.+..++||||+.+++|.+++... .+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus       101 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  180 (349)
T 2w4o_A          101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLL  180 (349)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             HHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEE
Confidence            467899999999999999999999999999999999988764 4899999999999999999999999999999999999


Q ss_pred             Ecc---CCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-
Q 046714           82 VDA---SGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ-  146 (201)
Q Consensus        82 l~~---~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-  146 (201)
                      ++.   ++.+++.+..           ....+++.|+|||.+  .+..++.++||||||+++|+|++|+.||....... 
T Consensus       181 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  258 (349)
T 2w4o_A          181 YATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL--RGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF  258 (349)
T ss_dssp             ESSSSTTCCEEECCCC----------------CGGGSCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH
T ss_pred             EecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHh--cCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH
Confidence            975   5666655543           123478889999998  45568899999999999999999999997665443 


Q ss_pred             HHHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          147 ALFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       147 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      ....+......   .....++..+.+++.+||+.+|++|||+.|+++||||+....
T Consensus       259 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          259 MFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             HHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             HHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence            33344433222   234568999999999999999999999999999999987543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.8e-43  Score=258.28  Aligned_cols=195  Identities=27%  Similarity=0.549  Sum_probs=145.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+.+..++++||+.+++|.+++...  .+++..+..++.|++.||+|||++|++|+||+|+||
T Consensus        64 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni  143 (278)
T 3cok_A           64 IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNL  143 (278)
T ss_dssp             HHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGE
T ss_pred             HHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            467899999999999999999999999999999999999864  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|.+++.+...            ...+++.|+|||.+  .+..++.++|+||+|+++|++++|+.||.........
T Consensus       144 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  221 (278)
T 3cok_A          144 LLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA--TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL  221 (278)
T ss_dssp             EECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---
T ss_pred             EEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH
Confidence            999888777665432            23367789999997  4556788999999999999999999999776544444


Q ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCCC
Q 046714          149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQT  200 (201)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~~  200 (201)
                      ....... ...+..++..+.+++.+||+.+|++|||++++++||||+....+
T Consensus       222 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  272 (278)
T 3cok_A          222 NKVVLAD-YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST  272 (278)
T ss_dssp             --CCSSC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-----
T ss_pred             HHHhhcc-cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCCc
Confidence            3333222 24566789999999999999999999999999999999876543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.8e-43  Score=267.80  Aligned_cols=193  Identities=24%  Similarity=0.382  Sum_probs=164.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+.+..++||||+++++|.+++...  .+++..+..++.||+.||+|||+.||+|+||||+||
T Consensus       139 ~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  218 (373)
T 2x4f_A          139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENI  218 (373)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHE
Confidence            578899999999999999999999999999999999988643  489999999999999999999999999999999999


Q ss_pred             EEc--cCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           81 LVD--ASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~--~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ++.  .++.+++.+..           ....+++.|+|||.+  ....++.++||||||+++|+|++|+.||........
T Consensus       219 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  296 (373)
T 2x4f_A          219 LCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV--NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET  296 (373)
T ss_dssp             EEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHH--TTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             EEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhc--cCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            994  44555554432           123478899999998  455678999999999999999999999988877777


Q ss_pred             HHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+......   .....+++++.+|+.+||+.+|.+|||++|+++||||+..
T Consensus       297 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          297 LNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            6666554332   2235689999999999999999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.3e-42  Score=254.74  Aligned_cols=195  Identities=27%  Similarity=0.427  Sum_probs=162.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..++++||+.+++|.+++... .+++..+..++.|++.||+|||++|++|+||+|+||+
T Consensus        64 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil  143 (276)
T 2h6d_A           64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL  143 (276)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEE
T ss_pred             HHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEE
Confidence            467889999999999999999999999999999999998754 5899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           82 VDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        82 l~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      ++.+|.+++.+...           ...+++.|+|||.+. .....+.++|+||+|+++|++++|+.||...........
T Consensus       144 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  222 (276)
T 2h6d_A          144 LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS-GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK  222 (276)
T ss_dssp             ECTTSCEEECCCCGGGCCCC-------------CCTGGGT-TSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ECCCCCEEEeecccccccCCCcceecccCCccccCHHHHc-CCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence            99988777665432           223677899999983 223346899999999999999999999988766666555


Q ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          151 IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      +.... ...+..++..+.+++.+||+.+|.+|||++++++||||++..+
T Consensus       223 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~  270 (276)
T 2h6d_A          223 IRGGV-FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP  270 (276)
T ss_dssp             HHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             hhcCc-ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence            54443 3456778999999999999999999999999999999988764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.1e-42  Score=260.30  Aligned_cols=193  Identities=28%  Similarity=0.446  Sum_probs=165.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.+++... .+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        68 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl  147 (321)
T 2a2a_A           68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIM  147 (321)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEE
Confidence            467899999999999999999999999999999999999764 4899999999999999999999999999999999999


Q ss_pred             EccCC----ceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           82 VDASG----LATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        82 l~~~g----~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ++.+|    .+++.+..           ....+++.|+|||.+  .+..++.++|+||+|+++|+|++|+.||......+
T Consensus       148 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  225 (321)
T 2a2a_A          148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE  225 (321)
T ss_dssp             ESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred             EecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccc--cCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            98877    45555432           223478889999998  45567899999999999999999999998877766


Q ss_pred             HHHHhhcCCCCC---CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          147 ALFRIGRGKLPS---VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       147 ~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ....+.......   ....+++.+.+++.+||+.+|.+|||++++++||||+..
T Consensus       226 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          226 TLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             HHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             HHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            666655443321   225688999999999999999999999999999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=260.62  Aligned_cols=188  Identities=26%  Similarity=0.424  Sum_probs=160.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCC-CHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKG-SLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+.+..++|||++.++ +|.+++... .+++..+..++.||+.||+|||++|++|+||||+||
T Consensus        82 ~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI  161 (335)
T 3dls_A           82 ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENI  161 (335)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             HHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHE
Confidence            578899999999999999999999999998666 999998875 499999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           81 LVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      +++.+|.+++.+...           ...+++.|+|||.+. .....+.++||||||+++|+|++|+.||.....     
T Consensus       162 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----  235 (335)
T 3dls_A          162 VIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----  235 (335)
T ss_dssp             EECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHT-TCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----
T ss_pred             EEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhc-CCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----
Confidence            999988777766432           233788999999983 222337899999999999999999999976432     


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                        ........+..+++++.+++.+||+.+|++|||++++++||||+++.
T Consensus       236 --~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          236 --TVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             --GTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             --HHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence              11222344566899999999999999999999999999999998764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.4e-43  Score=269.05  Aligned_cols=192  Identities=28%  Similarity=0.478  Sum_probs=159.5

Q ss_pred             ccccCC-CcceeccceeeeeCC--eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFE-HDNIVQYIGTEKDEN--RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|+++. ||||+++++++...+  ..++||||+.+ +|.+++....+++..+..++.||+.||+|||+.||+||||||+|
T Consensus        61 ~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N  139 (388)
T 3oz6_A           61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSN  139 (388)
T ss_dssp             HHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHHhccCCCCCCeeeeEEecCCCCEEEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHH
Confidence            356676 999999999997544  68999999985 99999988889999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc---------------------------------cccCcccccccccccCCCCCcchhhHHHHH
Q 046714           80 ILVDASGLATTTNDVKS---------------------------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLG  126 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~---------------------------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG  126 (201)
                      |+++.+|.+++.++...                                 ..+|+.|+|||.+. ....++.++||||+|
T Consensus       140 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlG  218 (388)
T 3oz6_A          140 ILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKGIDMWSLG  218 (388)
T ss_dssp             EEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHT-TCCCCCTHHHHHHHH
T ss_pred             eEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhc-CCCCCCChhhHHHHH
Confidence            99999887766654321                                 35788899999983 335688999999999


Q ss_pred             HHHHHHHhCCCCCCCchHHHHHHHhhcCC-CC---------------------------------------------CCC
Q 046714          127 CTVLEMLTHQPPYSHLEDMQALFRIGRGK-LP---------------------------------------------SVP  160 (201)
Q Consensus       127 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------------------------~~~  160 (201)
                      |++|+|++|+.||.+.........+.... .+                                             ..+
T Consensus       219 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (388)
T 3oz6_A          219 CILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK  298 (388)
T ss_dssp             HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTT
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccccc
Confidence            99999999999998876665554432100 00                                             011


Q ss_pred             CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          161 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       161 ~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ..+++++.+|+.+||+.||.+|||++|+++||||+.
T Consensus       299 ~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~  334 (388)
T 3oz6_A          299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI  334 (388)
T ss_dssp             CCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTT
T ss_pred             ccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHH
Confidence            257889999999999999999999999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=260.74  Aligned_cols=195  Identities=26%  Similarity=0.480  Sum_probs=160.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil  134 (311)
T 4agu_A           55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENIL  134 (311)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEE
Confidence            46789999999999999999999999999999999988875 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...++..|+|||.+. ....++.++|+||+|+++|++++|+.||......+...
T Consensus       135 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  213 (311)
T 4agu_A          135 ITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV-GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY  213 (311)
T ss_dssp             ECTTSCEEECCCTTCEECC------------GGGCCHHHHH-TCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHh-cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99888777665432            234677899999983 34567899999999999999999999998876655443


Q ss_pred             HhhcC---------------------CCCCC---------CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          150 RIGRG---------------------KLPSV---------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       150 ~~~~~---------------------~~~~~---------~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .+...                     ..+..         ...+++.+.+++.+||+.+|.+|||++|+++||||+...
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          214 LIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             HHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence            32210                     00000         135788899999999999999999999999999998753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=261.09  Aligned_cols=195  Identities=25%  Similarity=0.397  Sum_probs=160.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++..++||||+.+ +|.+++...  .+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus        53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NI  131 (324)
T 3mtl_A           53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL  131 (324)
T ss_dssp             HHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGE
T ss_pred             HHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHE
Confidence            47889999999999999999999999999986 898888754  389999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|.+++.+...            ...+++.|+|||.+. ....++.++||||+|+++|+|++|+.||......+..
T Consensus       132 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  210 (324)
T 3mtl_A          132 LINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILL-GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL  210 (324)
T ss_dssp             EECTTCCEEECSSSEEECC------------CGGGCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EECCCCCEEEccCcccccccCCccccccccCcccccChhhhc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999988877766432            223578899999983 3456789999999999999999999999887665555


Q ss_pred             HHhhc---CCCCC--------------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          149 FRIGR---GKLPS--------------------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       149 ~~~~~---~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      ..+..   .....                          ....+++++.+|+.+||+.||.+|||++|+++||||+...+
T Consensus       211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          211 HFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             HHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             HHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            44322   11000                          11246788999999999999999999999999999986543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.6e-42  Score=255.71  Aligned_cols=194  Identities=28%  Similarity=0.478  Sum_probs=165.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..+++|||+.+++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl  138 (304)
T 2jam_A           59 VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLL  138 (304)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCE
T ss_pred             HHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence            46789999999999999999999999999999999998865 45899999999999999999999999999999999999


Q ss_pred             E---ccCCceeeecCccc----------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           82 V---DASGLATTTNDVKS----------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        82 l---~~~g~~~~~~~~~~----------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +   +.++..++.+....          ..+++.|+|||.+  .+..++.++|+||+|+++|++++|+.||.........
T Consensus       139 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  216 (304)
T 2jam_A          139 YLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVL--AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF  216 (304)
T ss_dssp             ESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTB--SSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             EecCCCCCCEEEccCCcceecCCCccccccCCCCccChHHh--ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            9   56666666554321          2367889999998  4566889999999999999999999999887776666


Q ss_pred             HHhhcCCC---CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          149 FRIGRGKL---PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       149 ~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ..+..+..   ...+..+++.+.+++.+||+.+|.+|||++++++||||+...
T Consensus       217 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          217 EKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            66555432   234467899999999999999999999999999999997653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-42  Score=261.72  Aligned_cols=194  Identities=25%  Similarity=0.425  Sum_probs=157.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++..++||||+.+ +|.+++... .+++..+..++.||+.||+|||++|++|+||||+||+
T Consensus        86 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIl  164 (329)
T 3gbz_A           86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLL  164 (329)
T ss_dssp             HGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEE
Confidence            57889999999999999999999999999986 999988765 4999999999999999999999999999999999999


Q ss_pred             EccC-----CceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           82 VDAS-----GLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        82 l~~~-----g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      ++.+     +.+++.+..            ....+++.|+|||.+. ....++.++||||+|+++|+|++|+.||.....
T Consensus       165 l~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  243 (329)
T 3gbz_A          165 LSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILL-GSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE  243 (329)
T ss_dssp             EEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhc-CCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence            9543     335555532            1233588899999983 334578999999999999999999999988766


Q ss_pred             HHHHHHhhcC--CCC---------------CC------------CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          145 MQALFRIGRG--KLP---------------SV------------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       145 ~~~~~~~~~~--~~~---------------~~------------~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      .+....+...  ...               .+            +..+++++.+|+.+||+.||.+|||++|+++||||+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  323 (329)
T 3gbz_A          244 IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS  323 (329)
T ss_dssp             HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             HHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccC
Confidence            6655544221  000               00            112678999999999999999999999999999998


Q ss_pred             CcC
Q 046714          196 RPL  198 (201)
Q Consensus       196 ~~~  198 (201)
                      ...
T Consensus       324 ~~~  326 (329)
T 3gbz_A          324 HND  326 (329)
T ss_dssp             SSC
T ss_pred             CCC
Confidence            753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.4e-42  Score=255.52  Aligned_cols=193  Identities=28%  Similarity=0.551  Sum_probs=167.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+++..+++|||+.+++|.+++... .+++..+..++.|++.||+|||++|++|+||+|+||+
T Consensus        68 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil  147 (294)
T 2rku_A           68 IHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF  147 (294)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEE
Confidence            467899999999999999999999999999999999988764 5999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...+++.|+|||.+  .+...+.++|+||+|+++|+|++|+.||......+...
T Consensus       148 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  225 (294)
T 2rku_A          148 LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL--SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL  225 (294)
T ss_dssp             ECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHH--TTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             EcCCCCEEEEeccCceecccCccccccccCCCCcCCcchh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99888776665422            23467789999998  45567889999999999999999999998877666665


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .+.... ...+..+++.+.+++.+||+.+|++|||++++++||||+...
T Consensus       226 ~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          226 RIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             HHHTTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHhhcc-CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence            555443 356778899999999999999999999999999999997653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=267.88  Aligned_cols=194  Identities=29%  Similarity=0.426  Sum_probs=164.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|.+++||||+++++++.+.+..++||||+.|++|.+++.+.  .+++..+..++.||+.||+|||++||+||||||+||
T Consensus       114 il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NI  193 (412)
T 2vd5_A          114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNI  193 (412)
T ss_dssp             HHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             HHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHe
Confidence            466789999999999999999999999999999999999763  599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-------------ccccCcccccccccccC-----CCCCcchhhHHHHHHHHHHHHhCCCCCCCc
Q 046714           81 LVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLK-----NNGYGLSADIWSLGCTVLEMLTHQPPYSHL  142 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  142 (201)
                      +++.+|.+++.+...             ...||+.|+|||.+...     ...++.++|+|||||++|+|++|+.||...
T Consensus       194 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  273 (412)
T 2vd5_A          194 LLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD  273 (412)
T ss_dssp             EECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             eecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence            999988777665431             24588999999998421     345789999999999999999999999887


Q ss_pred             hHHHHHHHhhc----CCCCCCCCCCCHHHHHHHHHHhhcCCCCC---CCHhHHhcCccccCc
Q 046714          143 EDMQALFRIGR----GKLPSVPNSLSRDARDFILKCLQVNPNDR---PTAAQLMEHPFVKRP  197 (201)
Q Consensus       143 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~R---~t~~~il~~~~~~~~  197 (201)
                      ...+....+..    ...+..+..+++++++++++||+ +|.+|   ++++++++||||+..
T Consensus       274 ~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          274 STAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             SHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence            77666655543    22344456799999999999999 89998   599999999999753

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.1e-42  Score=256.91  Aligned_cols=196  Identities=28%  Similarity=0.515  Sum_probs=170.6

Q ss_pred             ccccCCCcceeccceeee--eCCeEEEEEEecCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcC-----c
Q 046714            3 SFSQFEHDNIVQYIGTEK--DENRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQILNGLTYLHERN-----V   70 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~~-----i   70 (201)
                      ++++++||||+++++++.  ..+..++||||+.+++|.+++...     .+++..++.++.|++.||+|||+.|     +
T Consensus        58 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~i  137 (279)
T 2w5a_A           58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV  137 (279)
T ss_dssp             HHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------
T ss_pred             HHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCee
Confidence            467889999999999875  467899999999999999998653     2899999999999999999999999     9


Q ss_pred             cccCCCCCcEEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCC
Q 046714           71 VHREIKCANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPP  138 (201)
Q Consensus        71 ~H~dl~p~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p  138 (201)
                      +|+||+|+||+++.+|.+++.+...            ...+++.|+|||.+  .+..++.++|+||||+++|++++|+.|
T Consensus       138 vH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p  215 (279)
T 2w5a_A          138 LHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM--NRMSYNEKSDIWSLGCLLYELCALMPP  215 (279)
T ss_dssp             CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHH--HCC-CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             EEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHh--ccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence            9999999999999998877766432            12367889999998  345678999999999999999999999


Q ss_pred             CCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCCC
Q 046714          139 YSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQT  200 (201)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~~  200 (201)
                      |...........+..+..+..+..+++.+.+++.+||+.+|.+|||++++++|+|+.++-++
T Consensus       216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  277 (279)
T 2w5a_A          216 FTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH  277 (279)
T ss_dssp             SCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGSC
T ss_pred             CcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhccc
Confidence            99888777777777777777888899999999999999999999999999999999988654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.1e-42  Score=260.83  Aligned_cols=193  Identities=28%  Similarity=0.550  Sum_probs=168.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..+++|||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus        94 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl  173 (335)
T 2owb_A           94 IHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF  173 (335)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             HHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEE
Confidence            46789999999999999999999999999999999998876 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...++..|+|||.+  .+..++.++|+||||+++|+|++|+.||......+...
T Consensus       174 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  251 (335)
T 2owb_A          174 LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVL--SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL  251 (335)
T ss_dssp             ECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHH--HTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             EcCCCCEEEeeccCceecccCcccccccCCCccccCHHHh--ccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH
Confidence            99988776665432            23467789999998  45567889999999999999999999998876666655


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .+.... ...+..+++.+.+++.+||+.+|++|||++|+++||||+...
T Consensus       252 ~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          252 RIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             HHHHTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHhcCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence            555443 356678899999999999999999999999999999998654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-42  Score=257.21  Aligned_cols=191  Identities=27%  Similarity=0.460  Sum_probs=156.4

Q ss_pred             ccCCCcceeccceeeeeCC-----eEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            5 SQFEHDNIVQYIGTEKDEN-----RLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      ++++||||+++++++....     ..++++|++.+ +|.+++....   +++..+..++.|++.||+|||++|++|+|||
T Consensus        69 ~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk  147 (308)
T 3g33_A           69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK  147 (308)
T ss_dssp             HHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             hhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            3456999999999998765     58999999975 9999987654   8999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           77 CANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |+||+++.+|.+++.+...           ...+++.|+|||.+  .+..++.++||||+|+++|+|++|+.||......
T Consensus       148 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  225 (308)
T 3g33_A          148 PENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA  225 (308)
T ss_dssp             TTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHH--HTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred             HHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHH--cCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999988877776532           23468889999998  4556789999999999999999999999887766


Q ss_pred             HHHHHhhcC--CC--C----------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          146 QALFRIGRG--KL--P----------------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       146 ~~~~~~~~~--~~--~----------------------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .....+...  ..  .                      .....+++.+.+++.+||+.||.+|||++|+++||||+...
T Consensus       226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          226 DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            665554221  00  0                      01235788999999999999999999999999999998754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.3e-42  Score=271.69  Aligned_cols=191  Identities=29%  Similarity=0.546  Sum_probs=164.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+.+..++||||+.+++|.+.+.. ..+++..+..++.||+.||+|||++||+|+||||+||+
T Consensus        89 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil  168 (494)
T 3lij_A           89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLL  168 (494)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEE
Confidence            57889999999999999999999999999999999887754 46999999999999999999999999999999999999


Q ss_pred             EccCC---ceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           82 VDASG---LATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        82 l~~~g---~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ++..+   .+++.+..           ....+++.|+|||.+.   ..++.++||||+|+++|+|++|..||......+.
T Consensus       169 ~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  245 (494)
T 3lij_A          169 LESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR---KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI  245 (494)
T ss_dssp             ESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            97643   34444432           2345788999999973   3578999999999999999999999998888777


Q ss_pred             HHHhhcCCCCC---CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          148 LFRIGRGKLPS---VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       148 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ...+..+....   .+..+++.+.+++.+||+.+|.+|||++++++||||+.
T Consensus       246 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          246 LRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             HHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             HHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            77766554432   23568999999999999999999999999999999975

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3e-42  Score=254.11  Aligned_cols=197  Identities=23%  Similarity=0.392  Sum_probs=161.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+++..++|+||+.+++|.+++... .+++..+..++.|++.||+|||++|++|+||+|+||+
T Consensus        58 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil  137 (276)
T 2yex_A           58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL  137 (276)
T ss_dssp             HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEE
Confidence            467889999999999999999999999999999999988754 5899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-
Q 046714           82 VDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ-  146 (201)
Q Consensus        82 l~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-  146 (201)
                      ++.+|..++.+...              ...+++.|+|||.+. .....+.++|+||+|+++|++++|+.||....... 
T Consensus       138 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  216 (276)
T 2yex_A          138 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ  216 (276)
T ss_dssp             ECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGT-CSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH
T ss_pred             EccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHh-cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence            99888776655321              234678899999983 22334789999999999999999999997654321 


Q ss_pred             HHHHhhc-CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCCC
Q 046714          147 ALFRIGR-GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQT  200 (201)
Q Consensus       147 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~~  200 (201)
                      ....... .........+++.+.+++.+||+.+|.+|||++|+++||||+++...
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          217 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             HHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             HHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence            2222222 11222335689999999999999999999999999999999988754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.4e-42  Score=256.84  Aligned_cols=195  Identities=34%  Similarity=0.649  Sum_probs=160.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHhhcCcccc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---------YHLSDSQVSSYTRQILNGLTYLHERNVVHR   73 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~   73 (201)
                      ++++++||||+++++++...+..++||||+.+++|.+++..         ..+++..+..++.|++.||+|||++|++|+
T Consensus        66 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  145 (303)
T 2vwi_A           66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR  145 (303)
T ss_dssp             CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence            57889999999999999999999999999999999999863         338999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceeeecCc-----------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCC
Q 046714           74 EIKCANILVDASGLATTTNDV-----------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        74 dl~p~nill~~~g~~~~~~~~-----------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                      ||+|+||+++.+|.+++.+..                 ....+++.|+|||.+. ....++.++|+||||+++|++++|+
T Consensus       146 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~  224 (303)
T 2vwi_A          146 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGA  224 (303)
T ss_dssp             CCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHH-HHHCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhc-cccCCCchhhHHHHHHHHHHHHhCC
Confidence            999999999998877766542                 1234778899999973 2245788999999999999999999


Q ss_pred             CCCCCchHHHHHHHhhcCCCC---------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          137 PPYSHLEDMQALFRIGRGKLP---------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .||.................+         .....+++.+.+++.+||+.+|.+|||++++++||||+...
T Consensus       225 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          225 APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             CTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             CCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            999876554444433333222         23356788999999999999999999999999999998653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.5e-42  Score=261.06  Aligned_cols=195  Identities=34%  Similarity=0.634  Sum_probs=166.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++..++||||+.| +|.+++..  ..+++..+..++.|++.||+|||++|++|+||||+||
T Consensus       107 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  185 (348)
T 1u5q_A          107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI  185 (348)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred             HHHhCCCCCEeeEEEEEEECCeEEEEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence            46789999999999999999999999999985 88887753  4599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc--------cccccCccccccccccc-CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 046714           81 LVDASGLATTTNDV--------KSFEGTPFWVAPEVVNL-KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI  151 (201)
Q Consensus        81 ll~~~g~~~~~~~~--------~~~~~~~~~~aPE~~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  151 (201)
                      +++.+|.+++.+..        ....+++.|+|||.+.. ....++.++||||||+++|+|++|+.||...........+
T Consensus       186 ll~~~~~~kL~DfG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  265 (348)
T 1u5q_A          186 LLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  265 (348)
T ss_dssp             EEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             EECCCCCEEEeeccCceecCCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            99998877766543        23457889999999732 2456788999999999999999999999887766666555


Q ss_pred             hcCCCCC-CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          152 GRGKLPS-VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       152 ~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .....+. .+..+++.+.+++.+||+.+|++|||++++++||||....
T Consensus       266 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          266 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence            5444433 3456899999999999999999999999999999987654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.2e-42  Score=272.34  Aligned_cols=193  Identities=26%  Similarity=0.473  Sum_probs=166.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++..++||||+.+++|.+++.. ..+++..+..++.||+.||+|||++||+|+||||+||+
T Consensus        99 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil  178 (504)
T 3q5i_A           99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL  178 (504)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEE
Confidence            57789999999999999999999999999999999888765 45999999999999999999999999999999999999


Q ss_pred             EccCC---ceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           82 VDASG---LATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        82 l~~~g---~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ++.+|   .+++.+..           ....+++.|+|||.+.   ..++.++||||+|+++|+|++|..||......+.
T Consensus       179 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  255 (504)
T 3q5i_A          179 LENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK---KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI  255 (504)
T ss_dssp             ESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc---cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            98775   24444432           2345788999999973   3578999999999999999999999999888777


Q ss_pred             HHHhhcCCCCC---CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          148 LFRIGRGKLPS---VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       148 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ...+..+....   .+..+++++.+++.+||+.+|.+|||++|+++||||+...
T Consensus       256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          256 IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             HHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            77776654422   1256899999999999999999999999999999997644

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.2e-42  Score=257.98  Aligned_cols=194  Identities=28%  Similarity=0.463  Sum_probs=155.6

Q ss_pred             ccc-CCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            4 FSQ-FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~-l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      |++ ++||||+++++++.+++..++||||+.+++|.+++... .+++..+..++.||+.||+|||++|++|+||||+||+
T Consensus        64 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil  143 (316)
T 2ac3_A           64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL  143 (316)
T ss_dssp             HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             HHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEE
Confidence            444 57999999999999999999999999999999998764 5899999999999999999999999999999999999


Q ss_pred             EccCCc---eeeecCcc-------------------ccccCcccccccccccC---CCCCcchhhHHHHHHHHHHHHhCC
Q 046714           82 VDASGL---ATTTNDVK-------------------SFEGTPFWVAPEVVNLK---NNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        82 l~~~g~---~~~~~~~~-------------------~~~~~~~~~aPE~~~~~---~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                      ++.++.   +++.+...                   ...+++.|+|||.+...   ...++.++||||+|+++|+|++|+
T Consensus       144 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~  223 (316)
T 2ac3_A          144 CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY  223 (316)
T ss_dssp             ESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSS
T ss_pred             EccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCC
Confidence            987764   45544321                   12378889999998321   134678999999999999999999


Q ss_pred             CCCCCch---------------HHHHHHHhhcCCCCCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          137 PPYSHLE---------------DMQALFRIGRGKLPSVP----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       137 ~p~~~~~---------------~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .||....               .......+..... .++    ..+++.+.+++.+||+.||.+|||++|+++||||+..
T Consensus       224 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          224 PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             CSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             CCCcccccccccccccccchhHHHHHHHHHhccCc-ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            9997642               1223333333332 222    3578999999999999999999999999999999864


Q ss_pred             C
Q 046714          198 L  198 (201)
Q Consensus       198 ~  198 (201)
                      .
T Consensus       303 ~  303 (316)
T 2ac3_A          303 A  303 (316)
T ss_dssp             -
T ss_pred             C
Confidence            3

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.6e-42  Score=253.49  Aligned_cols=192  Identities=27%  Similarity=0.524  Sum_probs=159.1

Q ss_pred             ccccCCCcceeccceeeee----CCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcC--ccccCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD----ENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERN--VVHREI   75 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~dl   75 (201)
                      +|++++||||+++++++..    .+..++||||+.+++|.+++.. ..++...+..++.|++.||+|||+.|  ++|+||
T Consensus        78 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~di  157 (290)
T 1t4h_A           78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL  157 (290)
T ss_dssp             HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCC
T ss_pred             HHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCC
Confidence            5788999999999998875    4568999999999999999986 45999999999999999999999999  999999


Q ss_pred             CCCcEEEc-cCCceeeecCcc----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           76 KCANILVD-ASGLATTTNDVK----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        76 ~p~nill~-~~g~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      ||+||+++ .+|.+++.+...          ...+++.|+|||.+.   ..++.++|+||+|+++|++++|+.||.....
T Consensus       158 kp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  234 (290)
T 1t4h_A          158 KCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQN  234 (290)
T ss_dssp             CGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred             CHHHEEEECCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHh---ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc
Confidence            99999997 666666655432          234788899999873   3478999999999999999999999987544


Q ss_pred             HHH-HHHhhcCCC-CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          145 MQA-LFRIGRGKL-PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       145 ~~~-~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ... ......+.. ...+...++.+.+++.+||+.+|.+|||++++++||||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          235 AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            333 333333322 23455678899999999999999999999999999999864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.1e-42  Score=275.85  Aligned_cols=192  Identities=28%  Similarity=0.441  Sum_probs=164.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++||||+++++++.+.+..++||||+.|++|.+++...+   +++..+..++.||+.||+|||++||+||||||+|
T Consensus       237 iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeN  316 (576)
T 2acx_A          237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPEN  316 (576)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchhe
Confidence            5778999999999999999999999999999999999987643   8999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch---HH
Q 046714           80 ILVDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE---DM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---~~  145 (201)
                      |+++.+|.+++.+..           ....||+.|+|||.+  .+..++.++|+||+|+++|+|++|+.||....   ..
T Consensus       317 ILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl--~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~  394 (576)
T 2acx_A          317 ILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR  394 (576)
T ss_dssp             EEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHH--TTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH
T ss_pred             EEEeCCCCeEEEecccceecccCccccccCCCccccCHHHH--cCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH
Confidence            999998877766543           234578899999998  45568899999999999999999999997642   12


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccC
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKR  196 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~  196 (201)
                      .............++..+++++.+++.+||+.+|.+||     +++|+++||||+.
T Consensus       395 ~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          395 EEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            22223222334466788999999999999999999999     8999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-41  Score=259.73  Aligned_cols=193  Identities=29%  Similarity=0.509  Sum_probs=162.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhc-CccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHER-NVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++..++||||+.+++|.+++... .+++..+..++.|++.||+|||+. |++|+||||+||
T Consensus        84 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Ni  163 (360)
T 3eqc_A           84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI  163 (360)
T ss_dssp             GGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGE
T ss_pred             HHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHE
Confidence            678899999999999999999999999999999999998764 599999999999999999999996 999999999999


Q ss_pred             EEccCCceeeecCcc----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH-
Q 046714           81 LVDASGLATTTNDVK----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF-  149 (201)
Q Consensus        81 ll~~~g~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-  149 (201)
                      +++.+|.+++.+...          ...+++.|+|||.+  .+..++.++||||+|+++|+|++|+.||.......... 
T Consensus       164 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  241 (360)
T 3eqc_A          164 LVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM  241 (360)
T ss_dssp             EECTTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHH--TTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHH
T ss_pred             EECCCCCEEEEECCCCcccccccccCCCCCCCeECHHHH--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999998887776542          23578899999998  45678899999999999999999999997654433211 


Q ss_pred             -----------------------------------------HhhcCCCCC-CCCCCCHHHHHHHHHHhhcCCCCCCCHhH
Q 046714          150 -----------------------------------------RIGRGKLPS-VPNSLSRDARDFILKCLQVNPNDRPTAAQ  187 (201)
Q Consensus       150 -----------------------------------------~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~t~~~  187 (201)
                                                               .+.....+. ....++.++.+|+.+||+.+|.+|||++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  321 (360)
T 3eqc_A          242 FGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ  321 (360)
T ss_dssp             HC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred             hcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHH
Confidence                                                     111222222 23347889999999999999999999999


Q ss_pred             HhcCccccCc
Q 046714          188 LMEHPFVKRP  197 (201)
Q Consensus       188 il~~~~~~~~  197 (201)
                      +++||||+..
T Consensus       322 ll~hp~~~~~  331 (360)
T 3eqc_A          322 LMVHAFIKRS  331 (360)
T ss_dssp             HHTSHHHHHH
T ss_pred             HhhChHhhcc
Confidence            9999999753

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=9.6e-42  Score=254.46  Aligned_cols=197  Identities=36%  Similarity=0.679  Sum_probs=167.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..++|+||+.+++|.+++..  ..+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus        69 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni  148 (302)
T 2j7t_A           69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNV  148 (302)
T ss_dssp             HHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred             HHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHE
Confidence            46788999999999999999999999999999999998865  4599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc------------cccccCccccccccccc---CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           81 LVDASGLATTTNDV------------KSFEGTPFWVAPEVVNL---KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      +++.+|.+++.+..            ....+++.|+|||.+..   ....++.++|+||||+++|+|++|+.||......
T Consensus       149 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  228 (302)
T 2j7t_A          149 LMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM  228 (302)
T ss_dssp             EECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred             EECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence            99998888777643            22357888999998731   2456788999999999999999999999887776


Q ss_pred             HHHHHhhcCCCCC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          146 QALFRIGRGKLPS--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       146 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      ...........+.  .+..++..+.+++.+||+.+|.+|||++++++||||+....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          229 RVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             HHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             HHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            6666655544432  34568899999999999999999999999999999987543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.3e-42  Score=271.21  Aligned_cols=193  Identities=31%  Similarity=0.532  Sum_probs=164.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+.+..++|+||+.+++|.+.+.. ..+++..+..++.||+.||+|||++||+|+||||+||+
T Consensus        74 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil  153 (486)
T 3mwu_A           74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENIL  153 (486)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             HHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEE
Confidence            57789999999999999999999999999999999887754 55999999999999999999999999999999999999


Q ss_pred             Ecc---CCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           82 VDA---SGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        82 l~~---~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ++.   ++.+++.+..           ....+++.|+|||.+.   ..++.++||||+|+++|+|++|+.||......+.
T Consensus       154 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  230 (486)
T 3mwu_A          154 LESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR---GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI  230 (486)
T ss_dssp             ESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGG---SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            964   3345555432           2234788999999983   2478999999999999999999999998887777


Q ss_pred             HHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          148 LFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       148 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ...+..+...   ..+..+++.+++++.+||+.+|.+|||+.++++||||+...
T Consensus       231 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          231 LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            7776655433   22346889999999999999999999999999999997643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-42  Score=262.54  Aligned_cols=193  Identities=23%  Similarity=0.442  Sum_probs=161.6

Q ss_pred             ccccCCCcceeccceeeeeCC------eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN------RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +|++++||||+++++++...+      ..++||||+ +++|.++++...+++..+..++.||+.||+|||+.|++|+|||
T Consensus        77 ~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk  155 (367)
T 1cm8_A           77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK  155 (367)
T ss_dssp             HHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             HHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcC
Confidence            467899999999999988763      469999999 7799999998889999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           77 CANILVDASGLATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+||+++.+|.+++.+..         ....+++.|+|||.+. ....++.++|+||+||++++|++|+.||.+......
T Consensus       156 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  234 (367)
T 1cm8_A          156 PGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ  234 (367)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHH-TTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             HHHEEEcCCCCEEEEeeecccccccccCcCcCCCCcCCHHHHh-CCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999998877766543         2345788899999983 335688999999999999999999999987765554


Q ss_pred             HHHhhc------------------------------CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGR------------------------------GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+..                              ..........++.+.+|+.+||+.||.+|||++++++||||+..
T Consensus       235 l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence            433321                              01112234678999999999999999999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.2e-42  Score=261.24  Aligned_cols=193  Identities=30%  Similarity=0.560  Sum_probs=164.2

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++ +||||+++++++...+..++||||+.+++|.+++... .+++..+..++.||+.||.|||+.|++|+||||+||+
T Consensus       153 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl  232 (365)
T 2y7j_A          153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL  232 (365)
T ss_dssp             HHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            4555 7999999999999999999999999999999998764 5999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc-----------cccccCcccccccccccC----CCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           82 VDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLK----NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        82 l~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ++.+|..++.+..           ....+++.|+|||.+...    ...++.++||||||+++|+|++|+.||.......
T Consensus       233 ~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  312 (365)
T 2y7j_A          233 LDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL  312 (365)
T ss_dssp             ECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH
Confidence            9998877666543           223478889999997422    2357889999999999999999999998877666


Q ss_pred             HHHHhhcCCCCCC---CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          147 ALFRIGRGKLPSV---PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       147 ~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ....+..+.....   +..+++.+.+++.+||+.+|++|||++++++||||++
T Consensus       313 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          313 MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            6665555443221   2467889999999999999999999999999999974

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.6e-41  Score=276.99  Aligned_cols=190  Identities=25%  Similarity=0.447  Sum_probs=169.4

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      |.++ +||+|+++++++.+.+..++||||+.+++|.++++. ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus       395 l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NIL  474 (674)
T 3pfq_A          395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM  474 (674)
T ss_dssp             HTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEE
T ss_pred             HHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEE
Confidence            4444 799999999999999999999999999999999876 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.++.            ....||+.|+|||++  .+..++.++|+||||+++|+|++|+.||......+...
T Consensus       475 l~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l--~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~  552 (674)
T 3pfq_A          475 LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII--AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ  552 (674)
T ss_dssp             ECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHH--TCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhh--cCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            9998877776543            234578999999998  45678999999999999999999999999988877777


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCH-----hHHhcCccccC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTA-----AQLMEHPFVKR  196 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~-----~~il~~~~~~~  196 (201)
                      .+.... ..++..+++++.+|+.+||+.+|.+|+++     +++++||||+.
T Consensus       553 ~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          553 SIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             HHHSSC-CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             HHHhCC-CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            776654 46778899999999999999999999998     99999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.8e-42  Score=261.58  Aligned_cols=190  Identities=34%  Similarity=0.521  Sum_probs=156.8

Q ss_pred             ccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            5 SQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         5 ~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      .++ +||||+++++++.+++..++||||+.|++|.+++.+. .+++..+..++.||+.||+|||++|++|+||||+||++
T Consensus        70 ~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~  149 (342)
T 2qr7_A           70 LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY  149 (342)
T ss_dssp             HHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             HHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEE
Confidence            344 7999999999999999999999999999999988764 48999999999999999999999999999999999998


Q ss_pred             ccC-C---ceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc---h
Q 046714           83 DAS-G---LATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL---E  143 (201)
Q Consensus        83 ~~~-g---~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~---~  143 (201)
                      ... |   ..++.+..            ....+++.|+|||.+  .+..++.++|+||+|+++|+|++|..||...   .
T Consensus       150 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~  227 (342)
T 2qr7_A          150 VDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL--ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT  227 (342)
T ss_dssp             SSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHH--HHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC
T ss_pred             ecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHh--cCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC
Confidence            543 2   23443322            234468889999998  3445788999999999999999999999752   3


Q ss_pred             HHHHHHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          144 DMQALFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       144 ~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ..+....+..+...   ..+..+++.+.+++.+||+.||++|||++++++||||..
T Consensus       228 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          228 PEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            34444455444332   234678999999999999999999999999999999964

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=252.64  Aligned_cols=197  Identities=38%  Similarity=0.685  Sum_probs=162.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY----HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++||||+++++++.+.+..++++||+.+++|.+++...    .+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus        72 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~  151 (295)
T 2clq_A           72 LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGD  151 (295)
T ss_dssp             HHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             HHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChh
Confidence            467889999999999999999999999999999999998764    3668889999999999999999999999999999


Q ss_pred             cEEEcc-CCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           79 NILVDA-SGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        79 nill~~-~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      ||+++. +|.+++.+..            ....+++.|+|||.+......++.++|+||||+++|+|++|+.||......
T Consensus       152 Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  231 (295)
T 2clq_A          152 NVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP  231 (295)
T ss_dssp             GEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH
T ss_pred             hEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch
Confidence            999987 6666655532            123467889999998433344788999999999999999999999654322


Q ss_pred             --HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          146 --QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       146 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                        ...........+..+..+++.+.+++.+||+.+|++|||++++++||||+....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          232 QAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             HHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             hHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence              222223334455677889999999999999999999999999999999987654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=254.95  Aligned_cols=194  Identities=36%  Similarity=0.681  Sum_probs=166.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+.+..+++|||+.+++|.+++..  ..+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus        77 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Ni  156 (314)
T 3com_A           77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNI  156 (314)
T ss_dssp             HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             HHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHE
Confidence            46789999999999999999999999999999999999863  4599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|.+++.+...            ...+++.|+|||.+  .+..++.++|+||||+++|+|++|+.||.........
T Consensus       157 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  234 (314)
T 3com_A          157 LLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI--QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI  234 (314)
T ss_dssp             EECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHH--SSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             EECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhc--CCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            999888776665421            23467789999998  4556789999999999999999999999887666555


Q ss_pred             HHhhcCCCCC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          149 FRIGRGKLPS--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       149 ~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ........+.  .+..+++.+.+++.+||..+|.+|||++++++||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          235 FMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            5544433322  3455789999999999999999999999999999998764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9e-42  Score=255.86  Aligned_cols=184  Identities=30%  Similarity=0.442  Sum_probs=154.3

Q ss_pred             CCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEcc
Q 046714            7 FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA   84 (201)
Q Consensus         7 l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~   84 (201)
                      .+||||+++++++.+++..++||||+ +++|.+++...  .+++..++.++.|++.||+|||+.||+|+||||+||+++.
T Consensus       114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~  192 (311)
T 3p1a_A          114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP  192 (311)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECG
T ss_pred             cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC
Confidence            48999999999999999999999999 55898887653  4999999999999999999999999999999999999998


Q ss_pred             CCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhc
Q 046714           85 SGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGR  153 (201)
Q Consensus        85 ~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  153 (201)
                      +|.+++.+...           ...+++.|+|||.+.  + .++.++||||+|+++|++++|..++.......   .+..
T Consensus       193 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~  266 (311)
T 3p1a_A          193 RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ--G-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ  266 (311)
T ss_dssp             GGCEEECCCTTCEECC------CCCCCGGGCCGGGGG--T-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT
T ss_pred             CCCEEEccceeeeecccCCCCcccCCCccccCHhHhc--C-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc
Confidence            88777766432           234788999999973  2 57899999999999999999977665543322   2222


Q ss_pred             CC-CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          154 GK-LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       154 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .. .+..+..+++.+.+++.+||+.+|++|||++|+++||||++|
T Consensus       267 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~p  311 (311)
T 3p1a_A          267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP  311 (311)
T ss_dssp             TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSCC
T ss_pred             cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccCC
Confidence            22 223456689999999999999999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.3e-42  Score=272.31  Aligned_cols=192  Identities=27%  Similarity=0.483  Sum_probs=165.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+.+..++|+||+.+++|.+.+.. ..+++..+..++.||+.||+|||++|++|+||||+||+
T Consensus        79 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil  158 (484)
T 3nyv_A           79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLL  158 (484)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEE
Confidence            57889999999999999999999999999999999998865 45999999999999999999999999999999999999


Q ss_pred             Ec---cCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           82 VD---ASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        82 l~---~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ++   .++.+++.+..           ....+++.|+|||.+.  + .++.++||||+|+++|+|++|+.||......+.
T Consensus       159 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  235 (484)
T 3nyv_A          159 LESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH--G-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI  235 (484)
T ss_dssp             ESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHH--T-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeec--C-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            94   45666665542           1234788999999983  2 578999999999999999999999999888777


Q ss_pred             HHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+..+...   ..+..+++.+++++.+||+.+|.+|||++|+++||||+..
T Consensus       236 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          236 LKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             HHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             HHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            7777665432   2234689999999999999999999999999999999754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-41  Score=252.53  Aligned_cols=193  Identities=28%  Similarity=0.501  Sum_probs=158.2

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc-CccccCCCC
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHER-NVVHREIKC   77 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~p   77 (201)
                      ++.++||||+++++++.+++..++||||+.+ +|.+++..     ..+++..+..++.|++.||+|||++ |++|+||||
T Consensus        60 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp  138 (290)
T 3fme_A           60 MRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP  138 (290)
T ss_dssp             HTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSG
T ss_pred             HHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCH
Confidence            6788999999999999999999999999986 88777653     3599999999999999999999998 999999999


Q ss_pred             CcEEEccCCceeeecCcc-----------ccccCccccccccccc--CCCCCcchhhHHHHHHHHHHHHhCCCCCCCc-h
Q 046714           78 ANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNL--KNNGYGLSADIWSLGCTVLEMLTHQPPYSHL-E  143 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~--~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~  143 (201)
                      +||+++.++.+++.+...           ...+++.|+|||.+..  ....++.++|+||+|+++|++++|+.||... .
T Consensus       139 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  218 (290)
T 3fme_A          139 SNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT  218 (290)
T ss_dssp             GGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC
T ss_pred             HHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc
Confidence            999999988777766432           1247888999999731  3456788999999999999999999999763 3


Q ss_pred             HHHHHHHh-hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          144 DMQALFRI-GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       144 ~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ........ ...........+++.+.+++.+||+.+|++|||++|+++||||+..
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          219 PFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             HHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             hHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            33333333 3333333445789999999999999999999999999999999754

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.3e-42  Score=263.98  Aligned_cols=191  Identities=26%  Similarity=0.436  Sum_probs=153.8

Q ss_pred             ccCCCcceeccceeeee----CCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            5 SQFEHDNIVQYIGTEKD----ENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      +..+||||+++++++..    .+..++||||+.|++|.+++...   .+++..+..++.||+.||+|||+.||+|+||||
T Consensus       110 ~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp  189 (400)
T 1nxk_A          110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP  189 (400)
T ss_dssp             HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCc
Confidence            45689999999999876    66789999999999999999764   389999999999999999999999999999999


Q ss_pred             CcEEEcc---CCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           78 ANILVDA---SGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        78 ~nill~~---~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      +||+++.   +|.+++.++.           ....+|+.|+|||.+  .+..++.++|||||||++|+|++|+.||....
T Consensus       190 ~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  267 (400)
T 1nxk_A          190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_dssp             GGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGS--CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred             ceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhc--CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            9999987   5666665543           223468889999998  45678899999999999999999999996543


Q ss_pred             HHH----HHHHhhcCCC---CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          144 DMQ----ALFRIGRGKL---PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       144 ~~~----~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...    ....+..+..   ......+++++.+|+.+||+.+|.+|||++++++||||...
T Consensus       268 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          268 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             TCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             cccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            211    1122222221   12235689999999999999999999999999999999754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.5e-42  Score=259.14  Aligned_cols=190  Identities=22%  Similarity=0.392  Sum_probs=154.3

Q ss_pred             ccccCCCcceeccceeeeeCC---------------------------------------------------------eE
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN---------------------------------------------------------RL   25 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~---------------------------------------------------------~~   25 (201)
                      +|++++||||+++++++.+.+                                                         ..
T Consensus        57 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  136 (332)
T 3qd2_B           57 ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYL  136 (332)
T ss_dssp             HHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------------CCCEE
T ss_pred             HHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceE
Confidence            578899999999999886543                                                         38


Q ss_pred             EEEEEecCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCcc------
Q 046714           26 YIFLELVKKGSLANLYQKYH----LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVK------   95 (201)
Q Consensus        26 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~------   95 (201)
                      +++|||+.+++|.+++....    .+...++.++.|++.||+|||++|++|+||||+||+++.+|.+++.+...      
T Consensus       137 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  216 (332)
T 3qd2_B          137 YIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ  216 (332)
T ss_dssp             EEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSC
T ss_pred             EEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccccc
Confidence            99999999999999998643    56667899999999999999999999999999999999888776665432      


Q ss_pred             ------------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCCC
Q 046714           96 ------------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP  157 (201)
Q Consensus        96 ------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  157 (201)
                                        ...+++.|+|||.+  .+..++.++|+||+|+++|+|++|..|+.  ..............+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~~~~~~--~~~~~~~~~~~~~~~  292 (332)
T 3qd2_B          217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI--HGNNYSHKVDIFSLGLILFELLYSFSTQM--ERVRIITDVRNLKFP  292 (332)
T ss_dssp             C--------------CCCSCC-CGGGSCHHHH--HCCCCCTHHHHHHHHHHHHHHHSCCCCHH--HHHHHHHHHHTTCCC
T ss_pred             chhhccccccccccccccccCCCcCccChHHh--cCCCCcchhhHHHHHHHHHHHHHcCCChh--HHHHHHHHhhccCCC
Confidence                              13478889999998  45567899999999999999999876542  222333334444444


Q ss_pred             CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       158 ~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ......++.+.+++.+||+.+|.+|||++|+++||||+.
T Consensus       293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence            334456788899999999999999999999999999985

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.3e-42  Score=261.03  Aligned_cols=186  Identities=28%  Similarity=0.434  Sum_probs=152.7

Q ss_pred             CCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEc
Q 046714            7 FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD   83 (201)
Q Consensus         7 l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~   83 (201)
                      ++||||+++++++...+..++|||++ +++|.+++....   ++...+..++.||+.||+|||++||+|+||||+||+++
T Consensus        93 ~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  171 (360)
T 3llt_A           93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLD  171 (360)
T ss_dssp             TTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred             CCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEc
Confidence            45999999999999999999999999 889999997654   89999999999999999999999999999999999997


Q ss_pred             c-------------------------CCceeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHHHHH
Q 046714           84 A-------------------------SGLATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV  129 (201)
Q Consensus        84 ~-------------------------~g~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l  129 (201)
                      .                         ++.+++.+..         ....+++.|+|||.+  .+..++.++||||+||++
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVI--LNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHH--TTCCCCTTHHHHHHHHHH
T ss_pred             cccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHH--cCCCCCCccchHHHHHHH
Confidence            5                         4555555432         234478889999998  455688999999999999


Q ss_pred             HHHHhCCCCCCCchHHHHHHHhhcCCCC---------------------------------------------CCCCCCC
Q 046714          130 LEMLTHQPPYSHLEDMQALFRIGRGKLP---------------------------------------------SVPNSLS  164 (201)
Q Consensus       130 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~  164 (201)
                      |+|++|+.||......+....+.....+                                             ......+
T Consensus       250 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (360)
T 3llt_A          250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH  329 (360)
T ss_dssp             HHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred             HHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence            9999999999877665554433221110                                             0001123


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       165 ~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      +.+.+|+.+||+.||.+|||++|+++||||+
T Consensus       330 ~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          330 ELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            6788999999999999999999999999996

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-41  Score=270.71  Aligned_cols=191  Identities=25%  Similarity=0.438  Sum_probs=164.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      +|++++||||+++++++.+.+..++||||+.|++|.+++...     .+++..+..++.||+.||+|||++||+|+||||
T Consensus       238 iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP  317 (543)
T 3c4z_A          238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKP  317 (543)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCCh
Confidence            467889999999999999999999999999999999998653     499999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch--
Q 046714           78 ANILVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE--  143 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--  143 (201)
                      +||+++.+|.+++.+..            ....||+.|+|||.+  .+..++.++|+|||||++|+|++|+.||....  
T Consensus       318 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l--~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~  395 (543)
T 3c4z_A          318 ENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL--LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK  395 (543)
T ss_dssp             GGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC
T ss_pred             HHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhh--cCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc
Confidence            99999998877766542            123688999999998  45678899999999999999999999997642  


Q ss_pred             --HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccC
Q 046714          144 --DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKR  196 (201)
Q Consensus       144 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~  196 (201)
                        .......+... ...++..+++.+.+++.+||+.+|.+||+     ++++++||||+.
T Consensus       396 ~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          396 VENKELKQRVLEQ-AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             CCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             hhHHHHHHHHhhc-ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence              23333334333 34567789999999999999999999996     489999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.4e-42  Score=260.86  Aligned_cols=194  Identities=28%  Similarity=0.503  Sum_probs=160.1

Q ss_pred             ccccCCCcceeccceeeeeC-----CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE-----NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      +|++++||||+++++++...     ...++++|++.+ +|.++++...+++..+..++.|++.||+|||++|++|+||||
T Consensus        78 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  156 (364)
T 3qyz_A           78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKP  156 (364)
T ss_dssp             HHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCh
Confidence            56789999999999998765     468999999986 999999988899999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc
Q 046714           78 ANILVDASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL  142 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  142 (201)
                      +||+++.+|.+++.+...               ...+++.|+|||.+. ....++.++||||+|+++|+|++|+.||...
T Consensus       157 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~  235 (364)
T 3qyz_A          157 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  235 (364)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHH-TBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhc-CCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence            999999988776665431               235788899999862 4455789999999999999999999999776


Q ss_pred             hHHHHHHHhhc---C----------------------CCC-----CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          143 EDMQALFRIGR---G----------------------KLP-----SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       143 ~~~~~~~~~~~---~----------------------~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                      ...+....+..   .                      ...     .....+++++.+|+.+||+.+|.+|||++|+++||
T Consensus       236 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  315 (364)
T 3qyz_A          236 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  315 (364)
T ss_dssp             SGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence            54443333211   0                      000     11245788999999999999999999999999999


Q ss_pred             cccCcC
Q 046714          193 FVKRPL  198 (201)
Q Consensus       193 ~~~~~~  198 (201)
                      ||++..
T Consensus       316 ~~~~~~  321 (364)
T 3qyz_A          316 YLEQYY  321 (364)
T ss_dssp             GGTTTC
T ss_pred             chhhcc
Confidence            998753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=259.28  Aligned_cols=193  Identities=27%  Similarity=0.421  Sum_probs=160.7

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      |+++ +||||+++++++.+++..++||||+.+++|.+++.. ..+++..+..++.||+.||+|||++||+|+||||+||+
T Consensus       112 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIl  191 (355)
T 1vzo_A          112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL  191 (355)
T ss_dssp             HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             HHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence            4556 699999999999999999999999999999999875 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc-------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch----H
Q 046714           82 VDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE----D  144 (201)
Q Consensus        82 l~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----~  144 (201)
                      ++.+|.+++.+...             ...+++.|+|||.+......++.++||||||+++|+|++|+.||....    .
T Consensus       192 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  271 (355)
T 1vzo_A          192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ  271 (355)
T ss_dssp             ECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH
T ss_pred             ECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH
Confidence            99988777665431             234788999999984334557889999999999999999999996432    2


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                      ......+. ...+..+..+++.+.+++.+||..+|.+||     |++++++||||+..
T Consensus       272 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          272 AEISRRIL-KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             HHHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHh-ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            22222333 234566778999999999999999999999     99999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.2e-42  Score=259.66  Aligned_cols=194  Identities=32%  Similarity=0.561  Sum_probs=161.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.++... .++++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        77 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil  156 (331)
T 4aaa_A           77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENIL  156 (331)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             HHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEE
Confidence            46789999999999999999999999999999888888654 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|.+++.+...            ...+++.|+|||.+. ....++.++||||+|+++|+|++|+.||..........
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  235 (331)
T 4aaa_A          157 VSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLV-GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY  235 (331)
T ss_dssp             ECTTSCEEECCCTTC------------CCCCCTTCCHHHHT-TCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EcCCCcEEEEeCCCceeecCCccccCCCcCCccccCccccc-CCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            99988777766432            234678899999983 33467899999999999999999999998876555443


Q ss_pred             HhhcC---------------------CCCCC---------CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          150 RIGRG---------------------KLPSV---------PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       150 ~~~~~---------------------~~~~~---------~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .+...                     ..+..         ...+++.+.+++.+||+.+|.+|||++|+++||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          236 HIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             HHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            32210                     00111         12578899999999999999999999999999999753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.5e-41  Score=251.21  Aligned_cols=193  Identities=28%  Similarity=0.458  Sum_probs=163.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..+++|||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+
T Consensus        61 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil  140 (283)
T 3bhy_A           61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIM  140 (283)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEE
Confidence            46788999999999999999999999999999999999865 45999999999999999999999999999999999999


Q ss_pred             EccCC----ceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           82 VDASG----LATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        82 l~~~g----~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ++.++    .+++.+...           ...+++.|+|||.+  .+..++.++|+||||+++|++++|+.||.......
T Consensus       141 ~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  218 (283)
T 3bhy_A          141 LLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGETKQE  218 (283)
T ss_dssp             ESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             EecCCCCCCceEEEecccceeccCCCcccccCCCcCccCccee--cCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH
Confidence            98776    455554321           23367889999998  45567899999999999999999999998877766


Q ss_pred             HHHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          147 ALFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       147 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ....+......   .....+++.+.+++.+||+.+|.+|||+.++++||||+..
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          219 TLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            66555443322   1225678999999999999999999999999999999753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=252.41  Aligned_cols=195  Identities=23%  Similarity=0.462  Sum_probs=161.9

Q ss_pred             ccccCCCcceeccceee--eeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTE--KDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~--~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      ++++++||||+++++++  .+.+..++||||+.++ |.+++..   ..+++..+..++.|++.||+|||++|++|+||||
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp  137 (305)
T 2wtk_C           59 LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKP  137 (305)
T ss_dssp             HHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             HHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCc
Confidence            47889999999999998  4456789999999885 7776654   3489999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           78 ANILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      +||+++.+|..++.+...              ...+++.|+|||.+.......+.++|+||+|+++|++++|+.||....
T Consensus       138 ~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  217 (305)
T 2wtk_C          138 GNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN  217 (305)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence            999999888776655321              233678899999984333445789999999999999999999998877


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          144 DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      .......+.... ...+..+++.+.+++.+||..+|.+|||++++++||||+....
T Consensus       218 ~~~~~~~i~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          218 IYKLFENIGKGS-YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHHHHHHHHHCC-CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             HHHHHHHHhcCC-CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            766666655553 3566788999999999999999999999999999999986543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3e-41  Score=252.77  Aligned_cols=192  Identities=31%  Similarity=0.547  Sum_probs=164.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHhhcC--ccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH----LSDSQVSSYTRQILNGLTYLHERN--VVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~i~~~l~~lh~~~--i~H~dl~   76 (201)
                      +|++++||||+++++++.+.+..++||||+.+++|.+++...+    +++..++.++.|++.||+|||++|  ++|+|||
T Consensus        87 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dik  166 (309)
T 3p86_A           87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLK  166 (309)
T ss_dssp             HHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCC
T ss_pred             HHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCC
Confidence            4778999999999999999999999999999999999997654    899999999999999999999999  9999999


Q ss_pred             CCcEEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           77 CANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      |+||+++.+|.+++.+...            ...+++.|+|||.+  .+..++.++||||||+++|++++|+.||.....
T Consensus       167 p~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~  244 (309)
T 3p86_A          167 SPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL--RDEPSNEKSDVYSFGVILWELATLQQPWGNLNP  244 (309)
T ss_dssp             GGGEEECTTCCEEECCCC-----------------CCTTSCHHHH--TTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred             hhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhh--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999998877766532            23478889999998  455678999999999999999999999988877


Q ss_pred             HHHHHHhh-cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc--CccccC
Q 046714          145 MQALFRIG-RGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME--HPFVKR  196 (201)
Q Consensus       145 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~--~~~~~~  196 (201)
                      ......+. .......+..+++.+.+++.+||+.+|.+|||++++++  .++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          245 AQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            66655543 44555778889999999999999999999999999987  455544

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.7e-41  Score=251.63  Aligned_cols=196  Identities=30%  Similarity=0.494  Sum_probs=165.4

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++ +||||+++++++.+++..++||||+.+++|.+++... .+++..+..++.|++.||+|||+.|++|+||+|+||+
T Consensus        77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil  156 (298)
T 1phk_A           77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL  156 (298)
T ss_dssp             HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE
Confidence            4566 4999999999999999999999999999999998764 5899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc-----------ccccCccccccccccc----CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           82 VDASGLATTTNDVK-----------SFEGTPFWVAPEVVNL----KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        82 l~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~----~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ++.+|.+++.+...           ...+++.|+|||.+..    ....++.++|+||||+++|+|++|+.||.......
T Consensus       157 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  236 (298)
T 1phk_A          157 LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  236 (298)
T ss_dssp             ECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH
Confidence            99988776665431           2346788999998732    23457889999999999999999999998877666


Q ss_pred             HHHHhhcCCCCC---CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          147 ALFRIGRGKLPS---VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       147 ~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      ....+.......   ....+++.+.+++.+||+.+|.+|||++++++||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          237 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             HHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence            665555443322   22467899999999999999999999999999999997654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-41  Score=248.69  Aligned_cols=187  Identities=21%  Similarity=0.425  Sum_probs=165.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..+++|||+.+++|.+++....  +++..+..++.|++.||+|||+.|++|+||||+||
T Consensus        58 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Ni  137 (269)
T 4hcu_A           58 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC  137 (269)
T ss_dssp             HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             HHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheE
Confidence            5778999999999999999999999999999999999997543  89999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.++.+++.+....             ..+++.|+|||.+  ....++.++|+||+|+++|++++ |+.||.......
T Consensus       138 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~  215 (269)
T 4hcu_A          138 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  215 (269)
T ss_dssp             EECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EEcCCCCEEeccccccccccccccccccCcccccccCCHHHh--cCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence            9998887777664321             2245579999998  45568899999999999999999 999999988888


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ....+........+...++.+.+++.+||+.+|++|||+.+++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          216 VVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            888887777777788899999999999999999999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.3e-41  Score=260.47  Aligned_cols=187  Identities=24%  Similarity=0.448  Sum_probs=163.8

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLTY   64 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~   64 (201)
                      +|+++ +||||+++++++.+.+..++||||+.+++|.+++...                 .++...++.++.||+.||+|
T Consensus       139 ~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~  218 (370)
T 2psq_A          139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY  218 (370)
T ss_dssp             HHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence            45677 8999999999999999999999999999999999764                 27889999999999999999


Q ss_pred             HhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHH
Q 046714           65 LHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVL  130 (201)
Q Consensus        65 lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~  130 (201)
                      ||++||+|+||||+||+++.+|.+++.++...              ..+++.|+|||.+  .+..++.++||||||+++|
T Consensus       219 LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DvwslG~il~  296 (370)
T 2psq_A          219 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMW  296 (370)
T ss_dssp             HHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH--HTCCCCHHHHHHHHHHHHH
T ss_pred             HHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHh--cCCCCCcHHHHHHHHHHHH
Confidence            99999999999999999999888777664321              1245679999998  4566889999999999999


Q ss_pred             HHHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          131 EMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       131 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +|++ |..||......+....+..+.....+..+++.+.+++.+||+.+|.+|||+.|++++
T Consensus       297 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          297 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999 999998887777777777777777888899999999999999999999999999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=255.31  Aligned_cols=186  Identities=23%  Similarity=0.430  Sum_probs=165.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++..++||||+.+++|.++++..  .+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus       103 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI  182 (325)
T 3kul_A          103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNV  182 (325)
T ss_dssp             HHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             HHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceE
Confidence            578899999999999999999999999999999999999653  599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc---------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           81 LVDASGLATTTNDVKSF---------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~---------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      +++.+|.+++.+.....               .+++.|+|||.+  .+..++.++||||||+++|++++ |+.||.....
T Consensus       183 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~  260 (325)
T 3kul_A          183 LVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI--AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN  260 (325)
T ss_dssp             EECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHH--HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred             EECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHh--cCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence            99998877776643221               134569999998  44567899999999999999999 9999999888


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ......+..+.....+..+++.+.+++.+||..+|.+|||+.++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          261 RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            8888888877777788889999999999999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-41  Score=256.99  Aligned_cols=193  Identities=24%  Similarity=0.436  Sum_probs=160.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+.+..++||||+.+ +|.+++....  +++..+..++.|++.||+|||+.|++|+||||+||
T Consensus        65 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  143 (346)
T 1ua2_A           65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL  143 (346)
T ss_dssp             HHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             HHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHE
Confidence            46788999999999999999999999999987 8988887643  88999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.+|.+++.+...            ...+++.|+|||.+. ....++.++|+||+|+++|+|++|..||.........
T Consensus       144 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~  222 (346)
T 1ua2_A          144 LLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF-GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL  222 (346)
T ss_dssp             EECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHT-TCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             EEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhh-CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            999998877766432            234678899999983 3345789999999999999999999999887766655


Q ss_pred             HHhhcC--CC-----CC--------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          149 FRIGRG--KL-----PS--------------------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       149 ~~~~~~--~~-----~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ..+...  ..     +.                    ....+++.+.+++.+||+.+|.+|||++|+++||||+..
T Consensus       223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence            443221  00     00                    014567899999999999999999999999999999764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.6e-42  Score=261.58  Aligned_cols=190  Identities=26%  Similarity=0.418  Sum_probs=166.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcCccccC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--------HLSDSQVSSYTRQILNGLTYLHERNVVHRE   74 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d   74 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.+++...        .+++..++.++.||+.||+|||++||+|||
T Consensus       127 ~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD  206 (367)
T 3l9p_A          127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD  206 (367)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             HHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence            467889999999999999999999999999999999999764        289999999999999999999999999999


Q ss_pred             CCCCcEEEccCC---ceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CC
Q 046714           75 IKCANILVDASG---LATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQ  136 (201)
Q Consensus        75 l~p~nill~~~g---~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~  136 (201)
                      |||+||+++.+|   .+++.++..              ...+++.|+|||.+  .+..++.++|||||||++|+|++ |.
T Consensus       207 lkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DvwslG~il~ellt~g~  284 (367)
T 3l9p_A          207 IAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGY  284 (367)
T ss_dssp             CCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHh--cCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            999999999654   355555321              22357789999998  45568899999999999999998 99


Q ss_pred             CCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          137 PPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .||......+....+..+.....+..+++.+.+++.+||+.+|.+|||+.+++++.++
T Consensus       285 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          285 MPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            9999988888888888877777888899999999999999999999999999987643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.3e-41  Score=254.72  Aligned_cols=195  Identities=22%  Similarity=0.429  Sum_probs=161.0

Q ss_pred             ccccCCCcceeccceeeeeCCeE------EEEEEecCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRL------YIFLELVKKGSLANLYQKY-------HLSDSQVSSYTRQILNGLTYLHERN   69 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~   69 (201)
                      ++++++||||+++++++...+..      ++++||+.+++|.+++...       .+++..++.++.|++.||+|||++|
T Consensus        78 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~  157 (323)
T 3qup_A           78 CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN  157 (323)
T ss_dssp             HHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC
Confidence            47889999999999999877654      9999999999999988543       4899999999999999999999999


Q ss_pred             ccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-
Q 046714           70 VVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-  134 (201)
Q Consensus        70 i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-  134 (201)
                      ++|+||||+||+++.+|.+++.+....              ..+++.|+|||.+  .+..++.++||||||+++|++++ 
T Consensus       158 ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~~  235 (323)
T 3qup_A          158 FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESL--ADNLYTVHSDVWAFGVTMWEIMTR  235 (323)
T ss_dssp             CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhh--cCCCCCCccchhhHHHHHHHHHhC
Confidence            999999999999999988777665322              1245579999998  45568899999999999999999 


Q ss_pred             CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-------HhHHhcCccccCcCC
Q 046714          135 HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-------AAQLMEHPFVKRPLQ  199 (201)
Q Consensus       135 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-------~~~il~~~~~~~~~~  199 (201)
                      |+.||...........+........+..+++.+.+++.+||+.+|++|||       ++++++|+|+....+
T Consensus       236 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          236 GQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             CCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence            99999988777777777777777778889999999999999999999999       788899999877554

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.6e-41  Score=255.81  Aligned_cols=193  Identities=25%  Similarity=0.445  Sum_probs=156.3

Q ss_pred             ccccCCCcceeccceeeee--------CCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccc
Q 046714            3 SFSQFEHDNIVQYIGTEKD--------ENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVH   72 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H   72 (201)
                      +|++++||||+++++++..        .+..++||||+.+ +|.+.+..  ..+++..+..++.|++.||+|||++|++|
T Consensus        69 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH  147 (351)
T 3mi9_A           69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILH  147 (351)
T ss_dssp             HHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeC
Confidence            4678899999999999887        4568999999987 77777654  35999999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceeeecCcc----------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCC
Q 046714           73 REIKCANILVDASGLATTTNDVK----------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        73 ~dl~p~nill~~~g~~~~~~~~~----------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                      +||||+||+++.+|.+++.+...                ...+++.|+|||.+. ....++.++||||+|+++|+|++|+
T Consensus       148 ~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~  226 (351)
T 3mi9_A          148 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL-GERDYGPPIDLWGAGCIMAEMWTRS  226 (351)
T ss_dssp             CCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhc-CCCCCCcHhHHHHHHHHHHHHHhCC
Confidence            99999999999888777665431                223578899999982 3455789999999999999999999


Q ss_pred             CCCCCchHHHHHHHhhc---CCCCCCCCC----------------------------CCHHHHHHHHHHhhcCCCCCCCH
Q 046714          137 PPYSHLEDMQALFRIGR---GKLPSVPNS----------------------------LSRDARDFILKCLQVNPNDRPTA  185 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~---~~~~~~~~~----------------------------~~~~~~~li~~~l~~~p~~R~t~  185 (201)
                      .||...........+..   ...+.....                            .++.+.+|+.+||+.||++|||+
T Consensus       227 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  306 (351)
T 3mi9_A          227 PIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS  306 (351)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             CCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH
Confidence            99988766555544322   111111111                            26779999999999999999999


Q ss_pred             hHHhcCccccCc
Q 046714          186 AQLMEHPFVKRP  197 (201)
Q Consensus       186 ~~il~~~~~~~~  197 (201)
                      +|+++||||+..
T Consensus       307 ~e~l~hp~f~~~  318 (351)
T 3mi9_A          307 DDALNHDFFWSD  318 (351)
T ss_dssp             HHHHTSGGGGSS
T ss_pred             HHHhCCCCcCCC
Confidence            999999999764

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.6e-42  Score=269.32  Aligned_cols=190  Identities=25%  Similarity=0.465  Sum_probs=153.7

Q ss_pred             ccccCCCcceeccceeeeeC------CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE------NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +|++++||||+++++++...      +..++||||+.+ ++.+.+.. .+++..+..++.||+.||+|||+.||+|||||
T Consensus       114 ~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlk  191 (464)
T 3ttj_A          114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  191 (464)
T ss_dssp             HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             HHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            57789999999999998765      357999999987 56666654 48999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           77 CANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |+||+++.+|.+++.+...           ...+|+.|+|||.+  .+..++.++||||+||++|+|++|+.||.+....
T Consensus       192 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~  269 (464)
T 3ttj_A          192 PSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI  269 (464)
T ss_dssp             GGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             hHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHH--cCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999998877766532           24578889999998  4557889999999999999999999999887665


Q ss_pred             HHHHHhhcCC---------------------CCCCC---------CC-----------CCHHHHHHHHHHhhcCCCCCCC
Q 046714          146 QALFRIGRGK---------------------LPSVP---------NS-----------LSRDARDFILKCLQVNPNDRPT  184 (201)
Q Consensus       146 ~~~~~~~~~~---------------------~~~~~---------~~-----------~~~~~~~li~~~l~~~p~~R~t  184 (201)
                      +....+....                     .+...         ..           .++++.+|+.+||+.||++|||
T Consensus       270 ~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t  349 (464)
T 3ttj_A          270 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS  349 (464)
T ss_dssp             HHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred             HHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC
Confidence            5554432210                     00000         00           1456899999999999999999


Q ss_pred             HhHHhcCccccC
Q 046714          185 AAQLMEHPFVKR  196 (201)
Q Consensus       185 ~~~il~~~~~~~  196 (201)
                      ++|+++||||+.
T Consensus       350 a~e~L~Hp~~~~  361 (464)
T 3ttj_A          350 VDDALQHPYINV  361 (464)
T ss_dssp             HHHHHTSTTTGG
T ss_pred             HHHHhcChhhhh
Confidence            999999999974

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-41  Score=263.75  Aligned_cols=194  Identities=30%  Similarity=0.486  Sum_probs=152.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++..+ ..++||||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus       193 ~l~~l~hpniv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl  271 (419)
T 3i6u_A          193 ILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL  271 (419)
T ss_dssp             HHHHCCCTTBCCCCEEEESS-EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHHhCCCCCEeeEEEEEecC-ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEE
Confidence            57789999999999998654 57899999999999888765 45999999999999999999999999999999999999


Q ss_pred             EccCC---ceeeecCc-----------cccccCccccccccccc-CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-
Q 046714           82 VDASG---LATTTNDV-----------KSFEGTPFWVAPEVVNL-KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-  145 (201)
Q Consensus        82 l~~~g---~~~~~~~~-----------~~~~~~~~~~aPE~~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-  145 (201)
                      ++.++   .+++.+..           ....+++.|+|||.+.. ....++.++|+||+|+++|+|++|+.||...... 
T Consensus       272 l~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  351 (419)
T 3i6u_A          272 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV  351 (419)
T ss_dssp             ESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred             EecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence            97544   35555432           12347889999999732 2356788999999999999999999999764332 


Q ss_pred             HHHHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          146 QALFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       146 ~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .....+..+...   ..+..+++.+.+++.+||+.+|++|||++|+++||||+..
T Consensus       352 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          352 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             HHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            222223333222   2235688999999999999999999999999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.2e-41  Score=260.37  Aligned_cols=194  Identities=27%  Similarity=0.428  Sum_probs=154.7

Q ss_pred             ccccCCCcceeccceeeeeCC------eEEEEEEecCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcCccc
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN------RLYIFLELVKKGSLANLYQ----KYHLSDSQVSSYTRQILNGLTYLHERNVVH   72 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H   72 (201)
                      +|++++||||+++++++...+      ..++||||+.++.+.....    ...+++..+..++.||+.||+|||++||+|
T Consensus        85 il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH  164 (394)
T 4e7w_A           85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICH  164 (394)
T ss_dssp             HHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence            578899999999999986543      3889999998844333322    345999999999999999999999999999


Q ss_pred             cCCCCCcEEEc-cCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Q 046714           73 REIKCANILVD-ASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS  140 (201)
Q Consensus        73 ~dl~p~nill~-~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  140 (201)
                      |||||+||+++ .+|.+++.+...           ...+++.|+|||.+. ....++.++||||+||++|+|++|+.||.
T Consensus       165 rDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~  243 (394)
T 4e7w_A          165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIF-GATNYTTNIDIWSTGCVMAELMQGQPLFP  243 (394)
T ss_dssp             SCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHc-CCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999998 677666655432           234678899999983 34457899999999999999999999998


Q ss_pred             CchHHHHHHHhhcC-------------------CCC---------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          141 HLEDMQALFRIGRG-------------------KLP---------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       141 ~~~~~~~~~~~~~~-------------------~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                      +....+....+...                   ..+         .++...++++.+|+.+||+.+|.+|||+.|+++||
T Consensus       244 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  323 (394)
T 4e7w_A          244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP  323 (394)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence            87665554443210                   111         12345789999999999999999999999999999


Q ss_pred             cccCc
Q 046714          193 FVKRP  197 (201)
Q Consensus       193 ~~~~~  197 (201)
                      ||++.
T Consensus       324 ~f~~~  328 (394)
T 4e7w_A          324 FFDEL  328 (394)
T ss_dssp             GGSTT
T ss_pred             hhhhh
Confidence            99864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.4e-41  Score=257.00  Aligned_cols=194  Identities=24%  Similarity=0.443  Sum_probs=163.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHH------HHh---cCCCHHHHHHHHHHHHHHHHHHhh-cCccc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL------YQK---YHLSDSQVSSYTRQILNGLTYLHE-RNVVH   72 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~---~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H   72 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.++      +..   ..+++..+..++.|++.||+|||+ .|++|
T Consensus        96 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H  175 (348)
T 2pml_X           96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH  175 (348)
T ss_dssp             HHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred             HHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEee
Confidence            47889999999999999999999999999999999998      554   458999999999999999999999 99999


Q ss_pred             cCCCCCcEEEccCCceeeecCcc----------ccccCcccccccccccCCCCCcc-hhhHHHHHHHHHHHHhCCCCCCC
Q 046714           73 REIKCANILVDASGLATTTNDVK----------SFEGTPFWVAPEVVNLKNNGYGL-SADIWSLGCTVLEMLTHQPPYSH  141 (201)
Q Consensus        73 ~dl~p~nill~~~g~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~  141 (201)
                      +||+|+||+++.+|.+++.+...          ...++..|+|||.+. ....++. ++|+||+|+++|++++|+.||..
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  254 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFS-NESSYNGAKVDIWSLGICLYVMFYNVVPFSL  254 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGS-SCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCChHhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhc-CCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999988777665432          234778899999983 2224455 99999999999999999999987


Q ss_pred             chH-HHHHHHhhcCCCCCCC-------------------CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          142 LED-MQALFRIGRGKLPSVP-------------------NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       142 ~~~-~~~~~~~~~~~~~~~~-------------------~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ... .+....+..... ..+                   ..+++.+.+++.+||+.+|.+|||++++++||||+...
T Consensus       255 ~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          255 KISLVELFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             SSCSHHHHHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             CCcHHHHHHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            655 555555544432 233                   56889999999999999999999999999999998753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.4e-41  Score=254.35  Aligned_cols=192  Identities=26%  Similarity=0.440  Sum_probs=162.0

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++ .||||+++++++.+.+..++||||+.+++|.+++..   ..+++..++.++.|++.||+|||++|++|+||||+|
T Consensus        82 l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~N  161 (327)
T 3lm5_A           82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQN  161 (327)
T ss_dssp             HHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             HHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHH
Confidence            4455 569999999999999999999999999999998754   348999999999999999999999999999999999


Q ss_pred             EEEcc---CCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           80 ILVDA---SGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~---~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |+++.   +|.+++.+..           ....+++.|+|||.+  ....++.++|+||||+++|+|++|+.||......
T Consensus       162 Il~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  239 (327)
T 3lm5_A          162 ILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL--NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ  239 (327)
T ss_dssp             EEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeee--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Confidence            99987   5666665532           223478899999998  4556789999999999999999999999887766


Q ss_pred             HHHHHhhcCC---CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          146 QALFRIGRGK---LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       146 ~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .....+....   .......+++.+.+++.+||+.+|.+|||++++++||||+..
T Consensus       240 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          240 ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             HHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            6655544332   233445689999999999999999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.1e-41  Score=259.08  Aligned_cols=186  Identities=23%  Similarity=0.446  Sum_probs=164.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++..++||||+++++|.+++...  .++...+..++.|++.||+|||++|++|+||||+||
T Consensus       165 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni  244 (377)
T 3cbl_A          165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNC  244 (377)
T ss_dssp             HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             HHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHE
Confidence            578899999999999999999999999999999999998754  389999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc--------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVKSF--------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~--------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      +++.+|.+++.+.....              .++..|+|||.+  ....++.++||||||+++|++++ |..||......
T Consensus       245 l~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~  322 (377)
T 3cbl_A          245 LVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL--NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ  322 (377)
T ss_dssp             EECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH
T ss_pred             EEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999887777653211              124569999998  34567899999999999999998 99999988877


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+..+.....+..+++.+.+++.+||+.+|++|||++++++
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          323 QTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            777777777777778889999999999999999999999999875

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.8e-41  Score=259.07  Aligned_cols=192  Identities=24%  Similarity=0.437  Sum_probs=155.7

Q ss_pred             ccccCCCcceeccceeeee--------------------------------------CCeEEEEEEecCCCCHHHHHHh-
Q 046714            3 SFSQFEHDNIVQYIGTEKD--------------------------------------ENRLYIFLELVKKGSLANLYQK-   43 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~--------------------------------------~~~~~lv~e~~~~~~L~~~~~~-   43 (201)
                      +|++++||||+++++++..                                      ....++||||+.+ +|.+.+.. 
T Consensus        53 il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~  131 (383)
T 3eb0_A           53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSF  131 (383)
T ss_dssp             HHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHH
T ss_pred             HHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHH
Confidence            5788999999999999843                                      3448899999986 88776653 


Q ss_pred             ----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEc-cCCceeeecCcc-----------ccccCccccccc
Q 046714           44 ----YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-ASGLATTTNDVK-----------SFEGTPFWVAPE  107 (201)
Q Consensus        44 ----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~-~~g~~~~~~~~~-----------~~~~~~~~~aPE  107 (201)
                          ..+++..+..++.||+.||+|||+.||+|+||||+||+++ .+|.+++.+...           ...+++.|+|||
T Consensus       132 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE  211 (383)
T 3eb0_A          132 IRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPE  211 (383)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHH
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHH
Confidence                4599999999999999999999999999999999999998 466565555322           234677899999


Q ss_pred             ccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcC-------------------CCC---------CC
Q 046714          108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG-------------------KLP---------SV  159 (201)
Q Consensus       108 ~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~~---------~~  159 (201)
                      .+. ....++.++||||+||++|+|++|+.||.+....+....+...                   ..+         .+
T Consensus       212 ~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (383)
T 3eb0_A          212 LML-GATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL  290 (383)
T ss_dssp             HHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHS
T ss_pred             Hhc-CCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhC
Confidence            973 3445789999999999999999999999887666555443210                   000         13


Q ss_pred             CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          160 PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       160 ~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      +...++.+.+|+.+||+.+|++|||+.|+++||||+.
T Consensus       291 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence            4567889999999999999999999999999999974

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.7e-41  Score=252.82  Aligned_cols=195  Identities=34%  Similarity=0.661  Sum_probs=161.3

Q ss_pred             cccC-CCcceeccceeeee------CCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCcccc
Q 046714            4 FSQF-EHDNIVQYIGTEKD------ENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHR   73 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~   73 (201)
                      ++++ +||||+++++++..      .+..++||||+.+++|.+++..   ..+++..+..++.||+.||+|||+.|++|+
T Consensus        74 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  153 (326)
T 2x7f_A           74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHR  153 (326)
T ss_dssp             HHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            4556 79999999999887      4678999999999999999975   358999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceeeecCcc------------ccccCcccccccccccC---CCCCcchhhHHHHHHHHHHHHhCCCC
Q 046714           74 EIKCANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLK---NNGYGLSADIWSLGCTVLEMLTHQPP  138 (201)
Q Consensus        74 dl~p~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p  138 (201)
                      ||+|+||+++.+|.+++.+...            ...+++.|+|||.+...   ...++.++||||||+++|+|++|..|
T Consensus       154 dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  233 (326)
T 2x7f_A          154 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP  233 (326)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCT
T ss_pred             CCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCC
Confidence            9999999999988777766432            22367889999998321   44578899999999999999999999


Q ss_pred             CCCchHHHHHHHhhcCCCC-CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          139 YSHLEDMQALFRIGRGKLP-SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      |...........+.....+ .....+++.+.+++.+||..+|.+|||++++++||||+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          234 LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             TTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             CCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            9887766665555444333 23556899999999999999999999999999999998653

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.6e-40  Score=244.07  Aligned_cols=188  Identities=21%  Similarity=0.440  Sum_probs=160.2

Q ss_pred             ccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcC--ccccCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERN--VVHREI   75 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~--i~H~dl   75 (201)
                      ++++++||||+++++++.+.  +..+++|||+.+++|.+++....   +++..+..++.|++.||+|||+.|  ++|+||
T Consensus        60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~di  139 (271)
T 3kmu_A           60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHAL  139 (271)
T ss_dssp             GGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCC
T ss_pred             HHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCC
Confidence            67899999999999999887  78899999999999999998654   899999999999999999999999  999999


Q ss_pred             CCCcEEEccCCceeeecC-------ccccccCcccccccccccCC-CCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           76 KCANILVDASGLATTTND-------VKSFEGTPFWVAPEVVNLKN-NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~~-------~~~~~~~~~~~aPE~~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ||+||+++.+|..++.+.       .....+++.|+|||.+.... ...+.++||||+|+++|++++|+.||........
T Consensus       140 kp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  219 (271)
T 3kmu_A          140 NSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI  219 (271)
T ss_dssp             SGGGEEECTTSCEEEEGGGSCCTTSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH
T ss_pred             ccceEEEcCCcceeEEeccceeeecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH
Confidence            999999999887766432       12344788899999984321 2234589999999999999999999988776666


Q ss_pred             HHHh-hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          148 LFRI-GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       148 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .... .....+..+..+++.+.+++.+||+.+|++|||++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          220 GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            5544 345556778889999999999999999999999999975

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.5e-41  Score=247.52  Aligned_cols=187  Identities=23%  Similarity=0.442  Sum_probs=165.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.+++...  .+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus        56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Ni  135 (268)
T 3sxs_A           56 TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNC  135 (268)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGE
T ss_pred             HHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceE
Confidence            467889999999999999999999999999999999998764  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.+|.+++.+....             ..+++.|+|||.+  .+..++.++|+||+|+++|++++ |+.||.......
T Consensus       136 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  213 (268)
T 3sxs_A          136 LVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF--HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE  213 (268)
T ss_dssp             EECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHH--HHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             EECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHH--hccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH
Confidence            9999887776654321             1234569999998  45567889999999999999999 999999888888


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .............+...++.+.+++.+||+.+|.+|||+.+++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          214 VVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            877777777777788889999999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7e-41  Score=247.74  Aligned_cols=187  Identities=21%  Similarity=0.432  Sum_probs=166.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.+++..  ..+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        72 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Ni  151 (283)
T 3gen_A           72 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC  151 (283)
T ss_dssp             HHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred             HHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceE
Confidence            46789999999999999999999999999999999999975  5599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.+|.+++.+....             ..+++.|+|||.+  .+..++.++|+||+|+++|++++ |+.||.......
T Consensus       152 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~  229 (283)
T 3gen_A          152 LVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE  229 (283)
T ss_dssp             EECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHH--HHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCccCcccCCHHHh--ccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH
Confidence            9999988777665322             2245679999998  34567899999999999999998 999999888888


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ....+........+...++.+.+++.+||+.+|.+|||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          230 TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            888887777777788889999999999999999999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.6e-41  Score=259.66  Aligned_cols=193  Identities=26%  Similarity=0.429  Sum_probs=153.4

Q ss_pred             ccccCCCcceeccceeeeeC------CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE------NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +|++++||||+++++++...      +..++++|++ +++|.++++...+++..+..++.||+.||+|||+.|++|+|||
T Consensus        81 ~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlk  159 (367)
T 2fst_X           81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK  159 (367)
T ss_dssp             HHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             HHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence            46789999999999998754      5679999999 6699999988889999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           77 CANILVDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+||+++.+|.+++.+...         ...++..|+|||.+. ....++.++||||+||++|+|++|+.||.+......
T Consensus       160 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  238 (367)
T 2fst_X          160 PSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ  238 (367)
T ss_dssp             GGGEEECTTCCEEECC---------------CCCTTCCHHHHT-TCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             HhhEEECCCCCEEEeeccccccccccCCCcCcCcCccChHHHc-CCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999988777766432         245788899999983 335678999999999999999999999988766554


Q ss_pred             HHHhhcC----------------------CCCC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGRG----------------------KLPS--------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~----------------------~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+...                      ..+.        .....++.+.+|+.+||+.||.+|||++|+++||||+.-
T Consensus       239 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          239 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             HHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence            4333210                      0000        113467889999999999999999999999999999863

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-41  Score=257.43  Aligned_cols=187  Identities=25%  Similarity=0.459  Sum_probs=165.8

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-----------------CCHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----------------LSDSQVSSYTRQILNGLTY   64 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------------~~~~~~~~~~~~i~~~l~~   64 (201)
                      +++++ +||||+++++++.+++..++||||+.+++|.+++....                 +++..++.++.||+.||+|
T Consensus       127 ~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~  206 (382)
T 3tt0_A          127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY  206 (382)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence            35566 89999999999999999999999999999999997643                 8999999999999999999


Q ss_pred             HhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHH
Q 046714           65 LHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVL  130 (201)
Q Consensus        65 lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~  130 (201)
                      ||++|++|+||||+||+++.+|.+++.+....              ..+++.|+|||.+  .+..++.++||||||+++|
T Consensus       207 LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwslG~il~  284 (382)
T 3tt0_A          207 LASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLW  284 (382)
T ss_dssp             HHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH--HSCCCCHHHHHHHHHHHHH
T ss_pred             HHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHh--cCCCCCchhHHHHHHHHHH
Confidence            99999999999999999999888777665322              1245679999998  4567889999999999999


Q ss_pred             HHHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          131 EMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       131 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ++++ |..||......+....+..+.....+..+++++.+++.+||+.+|++|||+++++++
T Consensus       285 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          285 EIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999 999999888888887787777778888999999999999999999999999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9e-41  Score=258.74  Aligned_cols=193  Identities=25%  Similarity=0.392  Sum_probs=149.2

Q ss_pred             ccccCCCcceeccceeeee--CCeEEEEEEecCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHhhcCc
Q 046714            3 SFSQFEHDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKY----------HLSDSQVSSYTRQILNGLTYLHERNV   70 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lh~~~i   70 (201)
                      +|++++||||+++++++..  ....++||||+.+ +|.+++...          .+++..++.++.||+.||+|||++||
T Consensus        71 ~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i  149 (405)
T 3rgf_A           71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWV  149 (405)
T ss_dssp             HHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            5778999999999999954  6789999999976 888877521          38999999999999999999999999


Q ss_pred             cccCCCCCcEEE----ccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHH
Q 046714           71 VHREIKCANILV----DASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE  131 (201)
Q Consensus        71 ~H~dl~p~nill----~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~  131 (201)
                      +|+||||+||++    +.+|.+++.+...               ...+|+.|+|||.+. ....++.++||||+||++|+
T Consensus       150 vH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlG~il~e  228 (405)
T 3rgf_A          150 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL-GARHYTKAIDIWAIGCIFAE  228 (405)
T ss_dssp             CCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHT-TCCSCCHHHHHHHHHHHHHH
T ss_pred             eCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhc-CCCcccchhhhHHHHHHHHH
Confidence            999999999999    5556666665432               234688899999983 33458899999999999999


Q ss_pred             HHhCCCCCCCchHH---------HHHHHhh---cCCCCC----------------------------------CCCCCCH
Q 046714          132 MLTHQPPYSHLEDM---------QALFRIG---RGKLPS----------------------------------VPNSLSR  165 (201)
Q Consensus       132 l~~g~~p~~~~~~~---------~~~~~~~---~~~~~~----------------------------------~~~~~~~  165 (201)
                      |++|+.||......         .....+.   ......                                  .....++
T Consensus       229 ll~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (405)
T 3rgf_A          229 LLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS  308 (405)
T ss_dssp             HHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTS
T ss_pred             HHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCH
Confidence            99999999654321         1111111   000000                                  0112367


Q ss_pred             HHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          166 DARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       166 ~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .+.+|+.+||+.||.+|||++|+++||||++.
T Consensus       309 ~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~  340 (405)
T 3rgf_A          309 KAFHLLQKLLTMDPIKRITSEQAMQDPYFLED  340 (405)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence            88999999999999999999999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-40  Score=252.93  Aligned_cols=187  Identities=22%  Similarity=0.429  Sum_probs=165.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-------------------------cCCCHHHHHHHHHH
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-------------------------YHLSDSQVSSYTRQ   57 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-------------------------~~~~~~~~~~~~~~   57 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.+++..                         ..+++.+++.++.|
T Consensus       103 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  182 (343)
T 1luf_A          103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ  182 (343)
T ss_dssp             HHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred             HHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHH
Confidence            47789999999999999999999999999999999999976                         45899999999999


Q ss_pred             HHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHH
Q 046714           58 ILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIW  123 (201)
Q Consensus        58 i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~  123 (201)
                      |+.||+|||++|++|+||||+||+++.+|.+++.+...              ...+++.|+|||.+  .+..++.++|+|
T Consensus       183 i~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~  260 (343)
T 1luf_A          183 VAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI--FYNRYTTESDVW  260 (343)
T ss_dssp             HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH--HHCCCCHHHHHH
T ss_pred             HHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh--ccCCcCcccccH
Confidence            99999999999999999999999999888777766431              12356779999998  345688999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          124 SLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       124 slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      |||+++|+|++ |..||......+....+..+.....+..+++.+.+++.+||+.+|.+|||+.+++++
T Consensus       261 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          261 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            99999999999 999999888878777777777777888899999999999999999999999998763

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.4e-40  Score=259.49  Aligned_cols=193  Identities=26%  Similarity=0.433  Sum_probs=151.5

Q ss_pred             ccccCCCcceeccceeeeeC-----CeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE-----NRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +|++++||||+++++++...     +..++|||++.+ +|.++++... +++..+..++.||+.||+|||+.||+|||||
T Consensus        78 ~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlk  156 (432)
T 3n9x_A           78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLK  156 (432)
T ss_dssp             HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             HHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            57789999999999998876     579999999975 9999988654 9999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCc----------------------------------cccccCcccccccccccCCCCCcchhhH
Q 046714           77 CANILVDASGLATTTNDV----------------------------------KSFEGTPFWVAPEVVNLKNNGYGLSADI  122 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~----------------------------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv  122 (201)
                      |+||+++.+|.+++.+..                                  ....+|+.|+|||.+ .....++.++||
T Consensus       157 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~-~~~~~~~~~~Di  235 (432)
T 3n9x_A          157 PANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDI  235 (432)
T ss_dssp             GGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHH-TTCSCCCTHHHH
T ss_pred             HHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHH-hcCCCCCccccc
Confidence            999999988776665542                                  234568889999986 245568999999


Q ss_pred             HHHHHHHHHHHhCCCC-----------CCCch-----------------HHHHHHHh-----------------------
Q 046714          123 WSLGCTVLEMLTHQPP-----------YSHLE-----------------DMQALFRI-----------------------  151 (201)
Q Consensus       123 ~slG~~l~~l~~g~~p-----------~~~~~-----------------~~~~~~~~-----------------------  151 (201)
                      ||+||++|+|++|..|           |.+..                 .......+                       
T Consensus       236 wSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~  315 (432)
T 3n9x_A          236 WSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY  315 (432)
T ss_dssp             HHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHH
T ss_pred             chHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHH
Confidence            9999999999985433           33321                 01111000                       


Q ss_pred             hcCCCCC-------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          152 GRGKLPS-------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       152 ~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .......       ....+++++.+|+.+||+.||.+|||++|+++||||+..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  368 (432)
T 3n9x_A          316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV  368 (432)
T ss_dssp             HHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred             HHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence            0000000       113578999999999999999999999999999999874

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.9e-41  Score=260.09  Aligned_cols=191  Identities=27%  Similarity=0.446  Sum_probs=155.5

Q ss_pred             cCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            6 QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         6 ~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ..+|+||+++++.+...+..+++||++.+ +|.+++....   +++..+..++.||+.||+|||++||+|+||||+||++
T Consensus       155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl  233 (429)
T 3kvw_A          155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL  233 (429)
T ss_dssp             TTSCSCBCCEEEEEEETTEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE
T ss_pred             ccCCcCEEEEEeecccCCeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence            34789999999999999999999999965 9999887643   8999999999999999999999999999999999999


Q ss_pred             ccCCc--eeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 046714           83 DASGL--ATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI  151 (201)
Q Consensus        83 ~~~g~--~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  151 (201)
                      +.+|.  +++.++..         ...+++.|+|||.+  .+..++.++|||||||++|+|++|+.||......+....+
T Consensus       234 ~~~~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i  311 (429)
T 3kvw_A          234 KQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVI--LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM  311 (429)
T ss_dssp             SSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHH--HTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ccCCCcceEEeecccceecCCcccccCCCCCccChHHH--hCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            98876  56655432         34578889999998  4556789999999999999999999999887665554433


Q ss_pred             hcC--C--------------------CC------------------------------------CCCCCCCHHHHHHHHH
Q 046714          152 GRG--K--------------------LP------------------------------------SVPNSLSRDARDFILK  173 (201)
Q Consensus       152 ~~~--~--------------------~~------------------------------------~~~~~~~~~~~~li~~  173 (201)
                      ...  .                    .+                                    .++...++.+.+|+.+
T Consensus       312 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~  391 (429)
T 3kvw_A          312 IELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQ  391 (429)
T ss_dssp             HHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHH
T ss_pred             HHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHH
Confidence            210  0                    00                                    0112347889999999


Q ss_pred             HhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          174 CLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       174 ~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      ||+.||++|||++|+++||||++..+
T Consensus       392 ~L~~dP~~Rpta~e~L~Hpw~~~~~~  417 (429)
T 3kvw_A          392 CLEWDPAVRMTPGQALRHPWLRRRLP  417 (429)
T ss_dssp             HTCSSTTTSCCHHHHHTSTTTC----
T ss_pred             HCCCChhhCCCHHHHhCChhhccCCC
Confidence            99999999999999999999998764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.3e-41  Score=252.76  Aligned_cols=192  Identities=24%  Similarity=0.400  Sum_probs=161.9

Q ss_pred             ccccCCCcceeccceeeeeCC----eEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      ++++++||||+++++++....    ..++||||+.+++|.+++... .+++..++.++.|++.||+|||++|++|+||||
T Consensus        65 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp  144 (311)
T 3ork_A           65 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP  144 (311)
T ss_dssp             TCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred             HHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence            578899999999999987654    349999999999999998754 599999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCccc---------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc
Q 046714           78 ANILVDASGLATTTNDVKS---------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL  142 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~~---------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  142 (201)
                      +||+++.+|.+++.+....               ..+++.|+|||.+  .+..++.++||||||+++|+|++|+.||...
T Consensus       145 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  222 (311)
T 3ork_A          145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTGEPPFTGD  222 (311)
T ss_dssp             GGEEEETTSCEEECCCSCC------------------CCTTCCHHHH--HTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             HHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHh--cCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999888777665321               2368889999998  4557889999999999999999999999887


Q ss_pred             hHHHHHHHhhcCCCCC---CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          143 EDMQALFRIGRGKLPS---VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       143 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ................   ....+++.+.+++.+||+.+|.+||+..+++.++|++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          223 SPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             SHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            7766655544433221   23468999999999999999999999999999999863

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=252.86  Aligned_cols=193  Identities=23%  Similarity=0.450  Sum_probs=155.8

Q ss_pred             ccccCCC--cceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEH--DNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h--~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++|  |||+++++++.+++..++|||+ .+++|.+++... .+++.++..++.|++.||+|||+.||+|+||||+|
T Consensus        60 ~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~N  138 (343)
T 3dbq_A           60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN  138 (343)
T ss_dssp             HHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             HHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence            3566776  9999999999999999999995 566999998765 48999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc--------------ccccCccccccccccc---------CCCCCcchhhHHHHHHHHHHHHhCC
Q 046714           80 ILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNL---------KNNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        80 ill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~---------~~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                      |+++ +|.+++.+...              ...+++.|+|||.+..         ....++.++||||||+++|+|++|+
T Consensus       139 Ill~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~  217 (343)
T 3dbq_A          139 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK  217 (343)
T ss_dssp             EEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSS
T ss_pred             EEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCC
Confidence            9997 45555554321              2347889999999742         1256788999999999999999999


Q ss_pred             CCCCCchH-HHHHHHh-hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          137 PPYSHLED-MQALFRI-GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       137 ~p~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .||..... ....... ........+...++.+.+++.+||+.+|.+|||+.|+++||||+..
T Consensus       218 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          218 TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             CTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            99976432 2333333 3334446677788999999999999999999999999999999753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.4e-40  Score=248.56  Aligned_cols=191  Identities=30%  Similarity=0.512  Sum_probs=158.7

Q ss_pred             ccCCCcceeccceeee-----eCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            5 SQFEHDNIVQYIGTEK-----DENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      ++++||||+++++++.     .....++++||+.+ +|.+++...   .+++..+..++.|++.||+|||+.|++|+|||
T Consensus        69 ~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlk  147 (326)
T 1blx_A           69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK  147 (326)
T ss_dssp             HHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             hccCCCCeEeeeeeeeecccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence            3458999999999987     55678999999985 999998764   38999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           77 CANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |+||+++.+|.+++.+...           ...++..|+|||.+  .+..++.++||||||+++|++++|+.||......
T Consensus       148 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  225 (326)
T 1blx_A          148 PQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV  225 (326)
T ss_dssp             GGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             HHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHH--hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence            9999999988777765432           23467889999998  4456789999999999999999999999887665


Q ss_pred             HHHHHhhcC--------------------------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          146 QALFRIGRG--------------------------KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       146 ~~~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .....+...                          ....+...+++.+.+++.+||+.+|.+|||+.++++||||+...
T Consensus       226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          226 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence            555443210                          00123356789999999999999999999999999999998643

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1e-40  Score=254.02  Aligned_cols=194  Identities=27%  Similarity=0.501  Sum_probs=159.7

Q ss_pred             ccccCCCcceeccceeeeeC-----CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE-----NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      ++++++||||+++++++...     +..++++||+.+ +|.+++....+++..+..++.|++.||+|||++|++|+||||
T Consensus        62 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp  140 (353)
T 2b9h_A           62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKP  140 (353)
T ss_dssp             HHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred             HHHhCcCCCcCCeeeeecccccCccceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence            46788999999999987764     678999999975 999999888899999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCccc----------------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC
Q 046714           78 ANILVDASGLATTTNDVKS----------------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH  135 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~~----------------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g  135 (201)
                      +||+++.+|.+++.+....                      ..+++.|+|||.+. ....++.++|+||||+++|+|++|
T Consensus       141 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g  219 (353)
T 2b9h_A          141 SNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML-TSAKYSRAMDVWSCGCILAELFLR  219 (353)
T ss_dssp             GGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHH-SCCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             HHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeec-cCCCccchhhHHHHHHHHHHHHhC
Confidence            9999998887766654321                      24678899999872 345678999999999999999999


Q ss_pred             CCCCCCchHHHHHHHhhc--CC---------------------CC--------CCCCCCCHHHHHHHHHHhhcCCCCCCC
Q 046714          136 QPPYSHLEDMQALFRIGR--GK---------------------LP--------SVPNSLSRDARDFILKCLQVNPNDRPT  184 (201)
Q Consensus       136 ~~p~~~~~~~~~~~~~~~--~~---------------------~~--------~~~~~~~~~~~~li~~~l~~~p~~R~t  184 (201)
                      +.||...........+..  +.                     .+        .....+++.+.+++.+||+.||++|||
T Consensus       220 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  299 (353)
T 2b9h_A          220 RPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT  299 (353)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred             CCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC
Confidence            999987765444332210  00                     00        012367889999999999999999999


Q ss_pred             HhHHhcCccccCcC
Q 046714          185 AAQLMEHPFVKRPL  198 (201)
Q Consensus       185 ~~~il~~~~~~~~~  198 (201)
                      ++++++||||+...
T Consensus       300 ~~ell~hp~~~~~~  313 (353)
T 2b9h_A          300 AKEALEHPYLQTYH  313 (353)
T ss_dssp             HHHHHTSGGGTTTC
T ss_pred             HHHHhcCccccccC
Confidence            99999999998643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.6e-42  Score=263.70  Aligned_cols=187  Identities=18%  Similarity=0.187  Sum_probs=148.8

Q ss_pred             ccccCCCcceeccc-------eeeeeCC-----------------eEEEEEEecCCCCHHHHHHhc-CCCH-------HH
Q 046714            3 SFSQFEHDNIVQYI-------GTEKDEN-----------------RLYIFLELVKKGSLANLYQKY-HLSD-------SQ   50 (201)
Q Consensus         3 ~l~~l~h~~I~~~~-------~~~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~-~~~~-------~~   50 (201)
                      +|++++||||++++       +++.+.+                 ..+++|||+ +++|.+++... .+++       ..
T Consensus       129 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~  207 (377)
T 3byv_A          129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHA  207 (377)
T ss_dssp             GSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHH
T ss_pred             hccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHH
Confidence            57788999999998       6666553                 388999999 56999998753 2444       78


Q ss_pred             HHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCcc---------ccccCcccccccccccC---------
Q 046714           51 VSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVK---------SFEGTPFWVAPEVVNLK---------  112 (201)
Q Consensus        51 ~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~---------  112 (201)
                      +..++.||+.||+|||++||+|+||||+||+++.+|.+++.++..         ...| +.|+|||.+...         
T Consensus       208 ~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~  286 (377)
T 3byv_A          208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDR  286 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccc
Confidence            888999999999999999999999999999999998887776532         2335 889999998322         


Q ss_pred             CCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       113 ~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                      ...++.++||||||+++|+|++|+.||...........+.     .....+++.+.+++.+||+.+|.+|||+.|+++||
T Consensus       287 ~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  361 (377)
T 3byv_A          287 RTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF-----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP  361 (377)
T ss_dssp             EEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG-----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSH
T ss_pred             cccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh-----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhCh
Confidence            0267899999999999999999999997654333222222     12357899999999999999999999999999999


Q ss_pred             cccC
Q 046714          193 FVKR  196 (201)
Q Consensus       193 ~~~~  196 (201)
                      ||+.
T Consensus       362 ~f~~  365 (377)
T 3byv_A          362 EYEQ  365 (377)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-40  Score=261.35  Aligned_cols=193  Identities=26%  Similarity=0.456  Sum_probs=150.2

Q ss_pred             ccccCCCcceeccceeeeeC-----CeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE-----NRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +|++++||||+++++++...     +..++|||++. ++|.+++.... +++..+..++.||+.||+|||+.||+|||||
T Consensus       105 ~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlK  183 (458)
T 3rp9_A          105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLK  183 (458)
T ss_dssp             HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred             HHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence            57789999999999998543     57899999985 48999887654 9999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCccc---------------------------------------cccCcccccccccccCCCCCc
Q 046714           77 CANILVDASGLATTTNDVKS---------------------------------------FEGTPFWVAPEVVNLKNNGYG  117 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~~---------------------------------------~~~~~~~~aPE~~~~~~~~~~  117 (201)
                      |+||+++.+|.+++.++...                                       ..+|+.|+|||.+ .....++
T Consensus       184 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~~~  262 (458)
T 3rp9_A          184 PANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI-LLQENYT  262 (458)
T ss_dssp             GGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHH-TTCCCCC
T ss_pred             hhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHh-hCCCCCC
Confidence            99999999887776654321                                       2358889999986 2455689


Q ss_pred             chhhHHHHHHHHHHHHh-----------CCCCCCCchH--------------------HHHHHHhh--------------
Q 046714          118 LSADIWSLGCTVLEMLT-----------HQPPYSHLED--------------------MQALFRIG--------------  152 (201)
Q Consensus       118 ~~~Dv~slG~~l~~l~~-----------g~~p~~~~~~--------------------~~~~~~~~--------------  152 (201)
                      .++|||||||++|+|++           |+.+|.+...                    ......+.              
T Consensus       263 ~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~  342 (458)
T 3rp9_A          263 EAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL  342 (458)
T ss_dssp             THHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTS
T ss_pred             cHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhc
Confidence            99999999999999998           6666654321                    11111100              


Q ss_pred             ---------cC-------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          153 ---------RG-------KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       153 ---------~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                               ..       .........++++.+|+.+||+.||++|||++|+++||||+..
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          343 EKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             SCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence                     00       0001123468999999999999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-40  Score=247.18  Aligned_cols=189  Identities=25%  Similarity=0.430  Sum_probs=159.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.+++... .+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus        64 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil  143 (294)
T 4eqm_A           64 NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNIL  143 (294)
T ss_dssp             HHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             HHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence            467899999999999999999999999999999999998765 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           82 VDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        82 l~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      ++.+|.+++.+....             ..+++.|+|||.+  .+..++.++|+||+|+++|++++|+.||.........
T Consensus       144 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  221 (294)
T 4eqm_A          144 IDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA--KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA  221 (294)
T ss_dssp             ECTTSCEEECCCSSSTTC-------------CCSSCCHHHH--HTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH
T ss_pred             ECCCCCEEEEeCCCccccccccccccCccccCccccCHhHh--cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            999988777664321             2368889999998  4556788999999999999999999999888776665


Q ss_pred             HHhhcCCCCC----CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcc
Q 046714          149 FRIGRGKLPS----VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF  193 (201)
Q Consensus       149 ~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~  193 (201)
                      ........+.    ....+++.+.+++.+||+.+|.+||+..+.+.++|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          222 IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             HHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             HHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence            5555444433    35678999999999999999999995555554443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.8e-41  Score=251.43  Aligned_cols=187  Identities=25%  Similarity=0.433  Sum_probs=163.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-------------------------CCCHHHHHHHHHH
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-------------------------HLSDSQVSSYTRQ   57 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------------------~~~~~~~~~~~~~   57 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.+++...                         .+++..++.++.|
T Consensus        79 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  158 (314)
T 2ivs_A           79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ  158 (314)
T ss_dssp             HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHH
T ss_pred             HHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHH
Confidence            478899999999999999999999999999999999999753                         2788999999999


Q ss_pred             HHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHH
Q 046714           58 ILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIW  123 (201)
Q Consensus        58 i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~  123 (201)
                      ++.||+|||++|++|+||||+||+++.+|.+++.+....              ..+++.|+|||.+  .+..++.++|+|
T Consensus       159 i~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~  236 (314)
T 2ivs_A          159 ISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL--FDHIYTTQSDVW  236 (314)
T ss_dssp             HHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHH--HHCEECHHHHHH
T ss_pred             HHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhh--cCCCcCchhhHH
Confidence            999999999999999999999999998887766654321              2245679999998  345678999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          124 SLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       124 slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      |+|+++|+|++ |..||...........+........+..+++.+.+++.+||+.+|.+|||+++++++
T Consensus       237 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          237 SFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999 999998877766766677776777788899999999999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.6e-41  Score=251.89  Aligned_cols=194  Identities=30%  Similarity=0.492  Sum_probs=156.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++..++ .++||||+.+++|.+++... .+++..+..++.||+.||+|||++|++|+||||+||+
T Consensus        68 ~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl  146 (322)
T 2ycf_A           68 ILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL  146 (322)
T ss_dssp             HHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            467889999999999987765 89999999999999988654 5999999999999999999999999999999999999


Q ss_pred             EccCCc---eeeecCccc-----------cccCccccccccccc-CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-
Q 046714           82 VDASGL---ATTTNDVKS-----------FEGTPFWVAPEVVNL-KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM-  145 (201)
Q Consensus        82 l~~~g~---~~~~~~~~~-----------~~~~~~~~aPE~~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-  145 (201)
                      ++.++.   +++.+....           ..+++.|+|||.+.. ....++.++|+||||+++|++++|..||...... 
T Consensus       147 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  226 (322)
T 2ycf_A          147 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV  226 (322)
T ss_dssp             ESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS
T ss_pred             EecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH
Confidence            987653   555554321           236888999998732 3456788999999999999999999999764322 


Q ss_pred             HHHHHhhcCCC---CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          146 QALFRIGRGKL---PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       146 ~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .....+..+..   +..+..+++.+.+++.+||+.+|.+|||++++++||||+..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          227 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             CHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             HHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            12222222222   22235688999999999999999999999999999999863

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4e-41  Score=257.95  Aligned_cols=191  Identities=24%  Similarity=0.412  Sum_probs=154.6

Q ss_pred             ccccCCCcceeccceeeeeCC------eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN------RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      ++++++||||+++++++...+      ..++||||+.+ +|.+.+. ..+++..+..++.||+.||+|||++|++|+|||
T Consensus        77 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk  154 (371)
T 2xrw_A           77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  154 (371)
T ss_dssp             HHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             HHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence            467889999999999988765      78999999986 7888876 458999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           77 CANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |+||+++.+|.+++.+...           ...+++.|+|||.+  .+..++.++||||+|+++|+|++|+.||.+....
T Consensus       155 p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  232 (371)
T 2xrw_A          155 PSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI  232 (371)
T ss_dssp             GGGEEECTTSCEEECCCCC----------------CTTCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHh--cCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999988877766432           23467889999998  4456889999999999999999999999887766


Q ss_pred             HHHHHhhcCCCC---------------------CCC--------------C------CCCHHHHHHHHHHhhcCCCCCCC
Q 046714          146 QALFRIGRGKLP---------------------SVP--------------N------SLSRDARDFILKCLQVNPNDRPT  184 (201)
Q Consensus       146 ~~~~~~~~~~~~---------------------~~~--------------~------~~~~~~~~li~~~l~~~p~~R~t  184 (201)
                      .....+......                     ...              .      ..++.+.+|+.+||+.||.+|||
T Consensus       233 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t  312 (371)
T 2xrw_A          233 DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS  312 (371)
T ss_dssp             HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred             HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC
Confidence            665554332111                     000              0      01467899999999999999999


Q ss_pred             HhHHhcCccccCc
Q 046714          185 AAQLMEHPFVKRP  197 (201)
Q Consensus       185 ~~~il~~~~~~~~  197 (201)
                      ++|+++||||+.-
T Consensus       313 ~~e~l~hp~~~~~  325 (371)
T 2xrw_A          313 VDEALQHPYINVW  325 (371)
T ss_dssp             HHHHHHSHHHHTT
T ss_pred             HHHHhCCcchhhh
Confidence            9999999999753

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8.7e-41  Score=256.10  Aligned_cols=192  Identities=26%  Similarity=0.442  Sum_probs=158.8

Q ss_pred             ccccCCCcceeccceeeeeCCeE------EEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRL------YIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      ++++++||||+++++++...+..      +++|||+.+ +|.+++.. .+++..+..++.|++.||+|||+.|++|+|||
T Consensus        94 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  171 (371)
T 4exu_A           94 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLK  171 (371)
T ss_dssp             HHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCE-EHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             HHHhcCCCCchhhhhheeccCCcccceeEEEEEccccc-cHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcC
Confidence            46788999999999999887654      999999975 88887643 48999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           77 CANILVDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+||+++.+|.+++.+...         ...+++.|+|||.+. ....++.++||||+|+++|+|++|+.||......+.
T Consensus       172 p~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  250 (371)
T 4exu_A          172 PGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ  250 (371)
T ss_dssp             GGGEEECTTCCEEECSTTCC--------CTTCCCTTSCHHHHS-CCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             HHHeEECCCCCEEEEecCcccccccCcCCcccCccccCHHHhc-CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            9999999998877776532         245788899999983 335678999999999999999999999988765554


Q ss_pred             HHHhhcCC-------------------------C-----CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGRGK-------------------------L-----PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~~-------------------------~-----~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+....                         .     ......+++.+.+|+.+||+.+|.+|||++|+++||||+..
T Consensus       251 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          251 LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             HHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence            44432100                         0     01123568999999999999999999999999999999853

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.5e-40  Score=250.72  Aligned_cols=187  Identities=24%  Similarity=0.454  Sum_probs=164.4

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLTY   64 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~   64 (201)
                      +++++ +||||+++++++.+.+..++||||+.+++|.+++...                 .+++..++.++.||+.||+|
T Consensus        78 ~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~  157 (327)
T 1fvr_A           78 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY  157 (327)
T ss_dssp             HHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence            46788 8999999999999999999999999999999999754                 48999999999999999999


Q ss_pred             HhhcCccccCCCCCcEEEccCCceeeecCccc-----------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHH
Q 046714           65 LHERNVVHREIKCANILVDASGLATTTNDVKS-----------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML  133 (201)
Q Consensus        65 lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~-----------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~  133 (201)
                      ||++|++|+||||+||+++.+|.+++.+....           ..+++.|+|||.+  .+..++.++|+||||+++|+|+
T Consensus       158 LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ell  235 (327)
T 1fvr_A          158 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV  235 (327)
T ss_dssp             HHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHH--HHCEECHHHHHHHHHHHHHHHH
T ss_pred             HHhCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhh--ccccCCchhcchHHHHHHHHHH
Confidence            99999999999999999998887776654321           2246679999998  4456789999999999999999


Q ss_pred             h-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          134 T-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       134 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      + |+.||...........+..+.....+..+++.+.+++.+||+.+|.+|||+++++++
T Consensus       236 t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          236 SLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             TTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8 999999888877777777776667778899999999999999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.5e-40  Score=254.85  Aligned_cols=186  Identities=23%  Similarity=0.447  Sum_probs=159.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.+++...  .+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        99 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  178 (373)
T 2qol_A           99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI  178 (373)
T ss_dssp             HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             HHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceE
Confidence            578899999999999999999999999999999999999764  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc---------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           81 LVDASGLATTTNDVKSF---------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~---------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      +++.++.+++.+.....               .++..|+|||.+  .+..++.++||||||+++|++++ |+.||.....
T Consensus       179 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~  256 (373)
T 2qol_A          179 LINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI--AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN  256 (373)
T ss_dssp             EECTTCCEEECCC----------------------CTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred             EEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhh--ccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999887776643211               124569999998  44568899999999999999998 9999988877


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .+....+..+.....+..++..+.+++.+||+.+|.+|||++++++
T Consensus       257 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          257 QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            7777777666555667788999999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.5e-40  Score=248.15  Aligned_cols=187  Identities=22%  Similarity=0.407  Sum_probs=164.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHhhcCcc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----------YHLSDSQVSSYTRQILNGLTYLHERNVV   71 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lh~~~i~   71 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.+++..           ..++...+..++.|++.||+|||++|++
T Consensus        81 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  160 (322)
T 1p4o_A           81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV  160 (322)
T ss_dssp             HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            57889999999999999999999999999999999999865           2368999999999999999999999999


Q ss_pred             ccCCCCCcEEEccCCceeeecCcccc--------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CC
Q 046714           72 HREIKCANILVDASGLATTTNDVKSF--------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQ  136 (201)
Q Consensus        72 H~dl~p~nill~~~g~~~~~~~~~~~--------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~  136 (201)
                      |+||||+||+++.+|.+++.+.....              .+++.|+|||.+  .+..++.++|+||+|+++|++++ |.
T Consensus       161 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~  238 (322)
T 1p4o_A          161 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAE  238 (322)
T ss_dssp             CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred             cCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhh--ccCCCCchhhHHHHHHHHHHHHhcCC
Confidence            99999999999999887776653221              235679999997  44567899999999999999999 89


Q ss_pred             CCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          137 PPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .||...........+..+.....+..+++.+.+++.+||+.+|.+|||+.+++++
T Consensus       239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          239 QPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            9999888777777777777777788899999999999999999999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.9e-40  Score=245.92  Aligned_cols=194  Identities=30%  Similarity=0.517  Sum_probs=162.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+.+..++++|++.+++|.+++.. ..+++..+..++.|++.||++||++|++|+||+|+||+
T Consensus        74 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl  153 (287)
T 2wei_A           74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENIL  153 (287)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEE
Confidence            46789999999999999999999999999999999887754 46999999999999999999999999999999999999


Q ss_pred             EccCC---ceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           82 VDASG---LATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        82 l~~~g---~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ++.++   .+++.+...           ...+++.|+|||.+.  + .++.++|+||||+++|++++|+.||........
T Consensus       154 v~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (287)
T 2wei_A          154 LESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR--G-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI  230 (287)
T ss_dssp             ESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHT--T-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhc--C-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            97643   355554321           112566799999973  2 378899999999999999999999988877776


Q ss_pred             HHHhhcCCCCC---CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          148 LFRIGRGKLPS---VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       148 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      ...+..+....   ....+++.+.+++.+||+.+|.+|||++++++||||++...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          231 LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             HHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             HHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence            66665554321   12467899999999999999999999999999999986543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-40  Score=243.06  Aligned_cols=187  Identities=21%  Similarity=0.415  Sum_probs=164.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..+++|||+.+++|.+++...  .+++..+..++.|++.||++||++|++|+||+|+||
T Consensus        56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni  135 (267)
T 3t9t_A           56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC  135 (267)
T ss_dssp             HHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred             HHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheE
Confidence            467899999999999999999999999999999999999764  389999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.++.+++.+....             ..++..|+|||.+  .+..++.++|+||+|+++|++++ |+.||.......
T Consensus       136 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  213 (267)
T 3t9t_A          136 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  213 (267)
T ss_dssp             EECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EECCCCCEEEcccccccccccccccccccccccccccChhhh--cCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH
Confidence            9998887776654321             2245679999998  44567899999999999999999 899999887777


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ....+..+.....+...++.+.+++.+||+.+|.+|||+.+++++
T Consensus       214 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          214 VVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            777777776667777889999999999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.6e-40  Score=245.74  Aligned_cols=186  Identities=26%  Similarity=0.469  Sum_probs=158.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++. ++..++||||+.+++|.+++...  .+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus        69 ~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  147 (281)
T 1mp8_A           69 TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV  147 (281)
T ss_dssp             HHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             HHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHE
Confidence            467899999999999985 45688999999999999999754  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.+|.+++.+....             ..+++.|+|||.+  ....++.++|+||+|+++|++++ |..||......+
T Consensus       148 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~  225 (281)
T 1mp8_A          148 LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  225 (281)
T ss_dssp             EEEETTEEEECC-------------------CCGGGCCHHHH--HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             EECCCCCEEECccccccccCcccccccccCCCcccccChhhc--ccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH
Confidence            9998887776664321             1245679999998  34567899999999999999997 999998877767


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ....+........+..+++.+.+++.+||..+|.+|||+.+++++
T Consensus       226 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          226 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            777777776677788899999999999999999999999998763

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.7e-40  Score=244.63  Aligned_cols=192  Identities=25%  Similarity=0.412  Sum_probs=152.5

Q ss_pred             ccccCCCcceeccceeeee-------------CCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhh
Q 046714            3 SFSQFEHDNIVQYIGTEKD-------------ENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHE   67 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~   67 (201)
                      ++++++||||+++++++.+             .+..+++|||+.+++|.+++...+  +++..++.++.|++.||+|||+
T Consensus        55 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~  134 (303)
T 1zy4_A           55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS  134 (303)
T ss_dssp             HHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh
Confidence            4788999999999998765             457899999999999999997543  7888999999999999999999


Q ss_pred             cCccccCCCCCcEEEccCCceeeecCcc--------------------------ccccCcccccccccccCCCCCcchhh
Q 046714           68 RNVVHREIKCANILVDASGLATTTNDVK--------------------------SFEGTPFWVAPEVVNLKNNGYGLSAD  121 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g~~~~~~~~~--------------------------~~~~~~~~~aPE~~~~~~~~~~~~~D  121 (201)
                      +|++|+||||+||+++.+|..++.+...                          ...+++.|+|||.+. ....++.++|
T Consensus       135 ~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~D  213 (303)
T 1zy4_A          135 QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD-GTGHYNEKID  213 (303)
T ss_dssp             TTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHT-SCSCCCTHHH
T ss_pred             CCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCccccc-CCCCCcchhh
Confidence            9999999999999999888776665432                          123677899999983 2345789999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCch-HHHHHHHhhcC---CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          122 IWSLGCTVLEMLTHQPPYSHLE-DMQALFRIGRG---KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       122 v~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      +||+|+++|+|++   ||.... .......+...   ..+.++...++.+.+++.+||+.+|.+|||++++++||||+..
T Consensus       214 i~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          214 MYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            9999999999998   554432 22333333222   2234455677889999999999999999999999999999865


Q ss_pred             C
Q 046714          198 L  198 (201)
Q Consensus       198 ~  198 (201)
                      .
T Consensus       291 ~  291 (303)
T 1zy4_A          291 H  291 (303)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.1e-40  Score=253.81  Aligned_cols=193  Identities=22%  Similarity=0.438  Sum_probs=155.2

Q ss_pred             ccccCC--CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFE--HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~--h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++  ||||+++++++..++..++||| +.+++|.+++... .+++..+..++.||+.||+|||++||+|+||||+|
T Consensus       107 ~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~N  185 (390)
T 2zmd_A          107 YLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN  185 (390)
T ss_dssp             HHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGG
T ss_pred             HHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence            355665  5999999999999999999999 4577999998764 48899999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCc--------------cccccCcccccccccccC---------CCCCcchhhHHHHHHHHHHHHhCC
Q 046714           80 ILVDASGLATTTNDV--------------KSFEGTPFWVAPEVVNLK---------NNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        80 ill~~~g~~~~~~~~--------------~~~~~~~~~~aPE~~~~~---------~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                      |++++ |.+++.++.              ....+++.|+|||.+...         ...++.++||||||+++|+|++|+
T Consensus       186 Ill~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~  264 (390)
T 2zmd_A          186 FLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK  264 (390)
T ss_dssp             EEESS-SCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSS
T ss_pred             EEEEC-CeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCC
Confidence            99964 555555432              123478899999998421         235788999999999999999999


Q ss_pred             CCCCCch-HHHHHHHhhc-CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          137 PPYSHLE-DMQALFRIGR-GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       137 ~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .||.... .......+.. ......+...++.+.+++.+||+.+|.+|||+.|+++||||+..
T Consensus       265 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          265 TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            9997653 2233333333 33335566778999999999999999999999999999999753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.7e-40  Score=259.15  Aligned_cols=186  Identities=26%  Similarity=0.485  Sum_probs=163.3

Q ss_pred             ccccCCCcceeccceeeeeCC-eEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN-RLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      +|++++||||+++++++...+ ..++||||+.+++|.+++...+   ++...+..++.|++.||+|||++|++|+||||+
T Consensus       239 ~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~  318 (450)
T 1k9a_A          239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR  318 (450)
T ss_dssp             HHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             HHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence            578899999999999987665 7999999999999999997643   689999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCccc---------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH
Q 046714           79 NILVDASGLATTTNDVKS---------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQAL  148 (201)
Q Consensus        79 nill~~~g~~~~~~~~~~---------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~  148 (201)
                      ||+++.+|.+++.+....         ..++..|+|||.+  ....++.++||||||+++|+|++ |+.||......+..
T Consensus       319 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~  396 (450)
T 1k9a_A          319 NVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV  396 (450)
T ss_dssp             GEEECTTSCEEECCCTTCEECC------CCCTTTSCHHHH--HSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH
T ss_pred             hEEECCCCCEEEeeCCCcccccccccCCCCCcceeCHHHh--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            999999888777765321         2346679999998  45668899999999999999998 99999887777777


Q ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..+..+.....+..+++.+.+++.+||..+|.+|||+.++++
T Consensus       397 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          397 PRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            777777777788899999999999999999999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.9e-40  Score=253.37  Aligned_cols=194  Identities=27%  Similarity=0.444  Sum_probs=156.6

Q ss_pred             ccccCCCcceeccceeeee-----CCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD-----ENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREI   75 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl   75 (201)
                      +|++++||||+++++++..     ....++||||+.+ +|.+++...  .+++..+..++.||+.||+|||++|++|+||
T Consensus        82 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl  160 (362)
T 3pg1_A           82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDL  160 (362)
T ss_dssp             HHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             HHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCC
Confidence            4678999999999999854     3468999999985 888877654  4899999999999999999999999999999


Q ss_pred             CCCcEEEccCCceeeecCccc-----------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           76 KCANILVDASGLATTTNDVKS-----------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~~~~~-----------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      ||+||+++.+|.+++.+....           ..+++.|+|||.+. ....++.++|+||+|+++|++++|+.||.....
T Consensus       161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          161 HPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             CGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHT-TCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhc-CCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            999999999888777665322           23677899999983 335678999999999999999999999987665


Q ss_pred             HHHHHHhhc-----------------------CCCC--------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcc
Q 046714          145 MQALFRIGR-----------------------GKLP--------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF  193 (201)
Q Consensus       145 ~~~~~~~~~-----------------------~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~  193 (201)
                      ......+..                       ....        ......++.+.+++.+||+.+|.+|||++|+++|||
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  319 (362)
T 3pg1_A          240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY  319 (362)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence            554443321                       1111        112356888999999999999999999999999999


Q ss_pred             ccCcC
Q 046714          194 VKRPL  198 (201)
Q Consensus       194 ~~~~~  198 (201)
                      |+...
T Consensus       320 f~~~~  324 (362)
T 3pg1_A          320 FESLF  324 (362)
T ss_dssp             GTTTC
T ss_pred             hhhcc
Confidence            98753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.8e-40  Score=243.04  Aligned_cols=187  Identities=23%  Similarity=0.510  Sum_probs=157.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcC---ccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERN---VVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.+++..+++|||+.+++|.+++....+++..+..++.|++.||+|||++|   ++|+||||+|
T Consensus        59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~N  138 (271)
T 3dtc_A           59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN  138 (271)
T ss_dssp             HHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGG
T ss_pred             HHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHH
Confidence            4677899999999999999999999999999999999998888999999999999999999999999   8999999999


Q ss_pred             EEEcc--------CCceeeecCcc----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Q 046714           80 ILVDA--------SGLATTTNDVK----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH  141 (201)
Q Consensus        80 ill~~--------~g~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  141 (201)
                      |+++.        ++.+++.+...          ...+++.|+|||.+  .+..++.++|+||+|+++|++++|+.||..
T Consensus       139 il~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  216 (271)
T 3dtc_A          139 ILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVI--RASMFSKGSDVWSYGVLLWELLTGEVPFRG  216 (271)
T ss_dssp             EEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHHHH--HHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             EEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHHHh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99986        44455554322          23478889999998  455678999999999999999999999988


Q ss_pred             chHHHHHHHhhc-CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          142 LEDMQALFRIGR-GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       142 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ............ ......+..+++.+.+++.+||+.+|.+|||+.|++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          217 IDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             SCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            776666555443 33345677889999999999999999999999999864

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=249.16  Aligned_cols=193  Identities=27%  Similarity=0.456  Sum_probs=156.9

Q ss_pred             ccccCCCcceeccceeee--------------eCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc
Q 046714            3 SFSQFEHDNIVQYIGTEK--------------DENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER   68 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   68 (201)
                      ++++++||||+++++++.              +.+..++||||+.+ +|.+++....+++..+..++.|++.||+|||++
T Consensus        61 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  139 (320)
T 2i6l_A           61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA  139 (320)
T ss_dssp             HHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSE-EHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCC-CHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhC
Confidence            477899999999999874              44678999999985 999999888899999999999999999999999


Q ss_pred             CccccCCCCCcEEEcc-CCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHH
Q 046714           69 NVVHREIKCANILVDA-SGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEM  132 (201)
Q Consensus        69 ~i~H~dl~p~nill~~-~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l  132 (201)
                      |++|+||||+||+++. ++.+++.+...               ...++..|+|||.+. ....++.++|+||||+++|++
T Consensus       140 ~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~el  218 (320)
T 2i6l_A          140 NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEM  218 (320)
T ss_dssp             TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHH-CTTCCCHHHHHHHHHHHHHHH
T ss_pred             CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhc-CcccCCchhhhHhHHHHHHHH
Confidence            9999999999999974 44555544321               122467799999873 345678999999999999999


Q ss_pred             HhCCCCCCCchHHHHHHHhhcCCC-----------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCC
Q 046714          133 LTHQPPYSHLEDMQALFRIGRGKL-----------------------------PSVPNSLSRDARDFILKCLQVNPNDRP  183 (201)
Q Consensus       133 ~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~  183 (201)
                      ++|+.||...........+.....                             ......+++.+.+++.+||+.+|.+||
T Consensus       219 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  298 (320)
T 2i6l_A          219 LTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL  298 (320)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSC
T ss_pred             HhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccC
Confidence            999999987765554433322110                             012245789999999999999999999


Q ss_pred             CHhHHhcCccccCc
Q 046714          184 TAAQLMEHPFVKRP  197 (201)
Q Consensus       184 t~~~il~~~~~~~~  197 (201)
                      |++++++||||+..
T Consensus       299 t~~ell~hp~~~~~  312 (320)
T 2i6l_A          299 TAEEALSHPYMSIY  312 (320)
T ss_dssp             CHHHHHTSHHHHTT
T ss_pred             CHHHHhCCcccccc
Confidence            99999999999853

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.3e-40  Score=249.91  Aligned_cols=195  Identities=26%  Similarity=0.444  Sum_probs=153.9

Q ss_pred             ccccCC-Ccceeccceeeee--CCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFE-HDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++ ||||+++++++.+  ....+++|||+.+++|.++++.  +++..+..++.|++.||+|||++|++|+||||+|
T Consensus        83 ~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N  160 (330)
T 3nsz_A           83 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN  160 (330)
T ss_dssp             HHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             HHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence            456676 9999999999988  6678999999999999998765  8999999999999999999999999999999999


Q ss_pred             EEEccCC-ceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc-hHHH
Q 046714           80 ILVDASG-LATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL-EDMQ  146 (201)
Q Consensus        80 ill~~~g-~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~~  146 (201)
                      |+++.++ .+++.+...           ...++..|+|||.+. ....++.++||||+|+++|+|++|+.||... ....
T Consensus       161 il~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~  239 (330)
T 3nsz_A          161 VMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD  239 (330)
T ss_dssp             EEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred             EEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhc-CCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH
Confidence            9999776 455554321           234677899999982 3356789999999999999999999998432 2211


Q ss_pred             HHHHh-------------hcCC-----------------------CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          147 ALFRI-------------GRGK-----------------------LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       147 ~~~~~-------------~~~~-----------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ....+             ....                       ....+..+++++.+|+.+||+.+|.+|||++|+++
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          240 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11110             0000                       01112237899999999999999999999999999


Q ss_pred             CccccCcCCC
Q 046714          191 HPFVKRPLQT  200 (201)
Q Consensus       191 ~~~~~~~~~~  200 (201)
                      ||||+.....
T Consensus       320 hp~f~~~~~~  329 (330)
T 3nsz_A          320 HPYFYTVVKD  329 (330)
T ss_dssp             SGGGTTCC--
T ss_pred             CccHhhhccC
Confidence            9999987654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.8e-40  Score=250.95  Aligned_cols=192  Identities=26%  Similarity=0.448  Sum_probs=157.7

Q ss_pred             ccccCCCcceeccceeeeeCCe------EEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENR------LYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      ++++++||||+++++++...+.      .+++|||+.+ +|.+++.. .+++..+..++.||+.||+|||++|++|+|||
T Consensus        76 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlk  153 (353)
T 3coi_A           76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLK  153 (353)
T ss_dssp             HHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSE-EGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred             HHHhcCCCCcccHhheEecccccccceeEEEEeccccC-CHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            4678899999999999987654      4999999975 88877654 48999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           77 CANILVDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+||+++.+|.+++.+...         ...+++.|+|||.+. ....++.++|+||+|+++|+|++|+.||......+.
T Consensus       154 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  232 (353)
T 3coi_A          154 PGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ  232 (353)
T ss_dssp             GGGEEECTTCCEEECSTTCTTC--------CCSBCCSCHHHHS-CCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH
T ss_pred             HHHEeECCCCcEEEeecccccCCCCCccccccCcCcCCHHHHh-CcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999998887776532         234688899999983 335678999999999999999999999987655444


Q ss_pred             HHHhhc------------------------------CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGR------------------------------GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+..                              .........+++.+.+++.+||+.+|.+|||++++++||||+..
T Consensus       233 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          233 LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             HHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            333211                              11122345678999999999999999999999999999999853

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-39  Score=246.85  Aligned_cols=187  Identities=25%  Similarity=0.434  Sum_probs=163.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.+++...  .+++..++.++.|++.||+|||++|++|+||||+||
T Consensus        99 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI  178 (333)
T 1mqb_A           99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI  178 (333)
T ss_dssp             HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             HHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheE
Confidence            467899999999999999999999999999999999999763  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc---------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           81 LVDASGLATTTNDVKSF---------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~---------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      +++.+|.+++.+.....               .++..|+|||.+  .+..++.++||||||+++|++++ |+.||.....
T Consensus       179 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~  256 (333)
T 1mqb_A          179 LVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI--SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN  256 (333)
T ss_dssp             EECTTCCEEECCCCC-----------------CCCGGGSCHHHH--HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             EECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhc--ccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence            99998877776643211               134579999998  45567899999999999999999 9999988877


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .+....+..+.....+..+++.+.+++.+||+.+|.+|||+.++++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          257 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77777777766666777899999999999999999999999998763

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.2e-40  Score=257.58  Aligned_cols=193  Identities=24%  Similarity=0.377  Sum_probs=153.1

Q ss_pred             ccccCCCcceeccceeeeeC------CeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCcc
Q 046714            3 SFSQFEHDNIVQYIGTEKDE------NRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVV   71 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~   71 (201)
                      +|++++||||+++++++...      ...++||||+.+ ++.+++..     ..+++..+..++.||+.||+|||++||+
T Consensus       100 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv  178 (420)
T 1j1b_A          100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC  178 (420)
T ss_dssp             HHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred             HHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            57889999999999987542      246799999987 77666542     4599999999999999999999999999


Q ss_pred             ccCCCCCcEEEccCC-ceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCC
Q 046714           72 HREIKCANILVDASG-LATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY  139 (201)
Q Consensus        72 H~dl~p~nill~~~g-~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  139 (201)
                      |+||||+||+++.++ .+++.++..           ...+++.|+|||.+. ....++.++||||+||++|+|++|+.||
T Consensus       179 HrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlG~il~ell~G~~pf  257 (420)
T 1j1b_A          179 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF-GATDYTSSIDVWSAGCVLAELLLGQPIF  257 (420)
T ss_dssp             CSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHc-CCCCCCchhhhHHHHHHHHHHHhCCCCC
Confidence            999999999999653 445554321           234688899999983 3346889999999999999999999999


Q ss_pred             CCchHHHHHHHhhcC-------------------CCCC---------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          140 SHLEDMQALFRIGRG-------------------KLPS---------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       140 ~~~~~~~~~~~~~~~-------------------~~~~---------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .+....+....+...                   ..+.         ++...++++.+|+.+||+.+|.+|||++|+++|
T Consensus       258 ~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          258 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             CCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            887655544333210                   0111         234568899999999999999999999999999


Q ss_pred             ccccCc
Q 046714          192 PFVKRP  197 (201)
Q Consensus       192 ~~~~~~  197 (201)
                      |||+..
T Consensus       338 p~f~~~  343 (420)
T 1j1b_A          338 SFFDEL  343 (420)
T ss_dssp             GGGGGG
T ss_pred             Hhhccc
Confidence            999753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.6e-40  Score=243.89  Aligned_cols=185  Identities=23%  Similarity=0.423  Sum_probs=161.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++ ..+..++|+||+.+++|.+++...+ +++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        71 ~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil  149 (291)
T 1xbb_A           71 VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL  149 (291)
T ss_dssp             HHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEE
Confidence            46789999999999999 5667899999999999999998754 999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCccc---------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           82 VDASGLATTTNDVKS---------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        82 l~~~g~~~~~~~~~~---------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      ++.+|.+++.+....               ..+++.|+|||.+  .+..++.++|+||||+++|++++ |+.||......
T Consensus       150 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~  227 (291)
T 1xbb_A          150 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS  227 (291)
T ss_dssp             EEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             EeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHh--ccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            998887766654321               1134679999998  34567889999999999999999 99999988887


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+..+..+..+..+++.+.+++.+||+.+|.+|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          228 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            777777777777788889999999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.1e-40  Score=249.77  Aligned_cols=186  Identities=24%  Similarity=0.409  Sum_probs=160.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+ +..++|+||+.+++|.+++...  .+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus        68 ~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Ni  146 (325)
T 3kex_A           68 AIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNV  146 (325)
T ss_dssp             HHHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTE
T ss_pred             HHhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheE
Confidence            4678899999999999864 5688999999999999998753  589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      +++.+|.+++.+....              ..++..|+|||.+  .+..++.++|+||+|+++|++++ |+.||......
T Consensus       147 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  224 (325)
T 3kex_A          147 LLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI--HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA  224 (325)
T ss_dssp             EESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT
T ss_pred             EECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHh--ccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH
Confidence            9999887777664321              2245679999998  44568899999999999999999 99999887776


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .....+........+..++..+.+++.+||..+|.+|||+.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          225 EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7766777776677778889999999999999999999999999875

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-40  Score=252.05  Aligned_cols=192  Identities=27%  Similarity=0.430  Sum_probs=139.4

Q ss_pred             cccCCCcceeccceeeee----CCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            4 FSQFEHDNIVQYIGTEKD----ENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      ++.++||||+++++++..    ++..++||||+.+++|.+++...   .+++..++.++.|++.||+|||++|++|+|||
T Consensus        76 ~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlk  155 (336)
T 3fhr_A           76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVK  155 (336)
T ss_dssp             HHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             HHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            456789999999999876    45689999999999999999765   48999999999999999999999999999999


Q ss_pred             CCcEEEccC---CceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           77 CANILVDAS---GLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        77 p~nill~~~---g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      |+||+++.+   +.+++.+..          ....+++.|+|||.+  .+..++.++|+||+|+++|++++|+.||....
T Consensus       156 p~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (336)
T 3fhr_A          156 PENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVL--GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT  233 (336)
T ss_dssp             GGGEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             HHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhh--CCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            999999764   335555432          223467889999997  45667889999999999999999999997654


Q ss_pred             HHHHHH----Hhhc---CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          144 DMQALF----RIGR---GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       144 ~~~~~~----~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ......    .+..   .........+++.+.+++.+||+.+|.+|||++|+++||||++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          234 GQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             chhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            433211    1111   11122235689999999999999999999999999999999864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.7e-40  Score=257.55  Aligned_cols=185  Identities=24%  Similarity=0.505  Sum_probs=162.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++||||+++++++. .+..++||||+.+++|.++++..   .++...+..++.||+.||+|||++|++|+||||+|
T Consensus       236 ~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N  314 (454)
T 1qcf_A          236 VMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN  314 (454)
T ss_dssp             HHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGG
T ss_pred             HHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence            578899999999999987 56689999999999999999743   58999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.++.+++.++...             ..++..|+|||.+  ....++.++||||||+++|+|++ |+.||.+....
T Consensus       315 ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~  392 (454)
T 1qcf_A          315 ILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP  392 (454)
T ss_dssp             EEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHh--ccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999988877765322             1234579999998  34568899999999999999999 99999988887


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +....+..+.....+..+++.+.+++.+||..+|++|||++++++
T Consensus       393 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          393 EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            877777777666778889999999999999999999999999865

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.4e-40  Score=244.67  Aligned_cols=186  Identities=22%  Similarity=0.372  Sum_probs=154.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.+++...+  +++..+..++.|++.||+|||++|++|+||||+||
T Consensus        65 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI  144 (289)
T 4fvq_A           65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNI  144 (289)
T ss_dssp             HHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             HHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceE
Confidence            4778999999999999999999999999999999999997654  99999999999999999999999999999999999


Q ss_pred             EEccCCc--------eeeecCccc--------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC-CCCCCCch
Q 046714           81 LVDASGL--------ATTTNDVKS--------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLE  143 (201)
Q Consensus        81 ll~~~g~--------~~~~~~~~~--------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~  143 (201)
                      +++.++.        +++.+....        ..+++.|+|||.+. ....++.++||||+|+++|+|++| ..|+....
T Consensus       145 ll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~  223 (289)
T 4fvq_A          145 LLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSGGDKPLSALD  223 (289)
T ss_dssp             EEEECCBGGGTBCCEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHH-CGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             EEecCCcccccccceeeeccCcccccccCccccCCcCcccCHHHhC-CCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence            9998876        555554332        22577899999983 235678999999999999999995 55555554


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          144 DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ..........  ....+...++.+.+++.+||+.+|.+|||+.+++++
T Consensus       224 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          224 SQRKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHHHHHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4443333322  335566678899999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.2e-40  Score=248.33  Aligned_cols=190  Identities=25%  Similarity=0.418  Sum_probs=164.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--------CCHHHHHHHHHHHHHHHHHHhhcCccccC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--------LSDSQVSSYTRQILNGLTYLHERNVVHRE   74 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~i~~~l~~lh~~~i~H~d   74 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.+++....        +++..++.++.|++.||+|||+.|++|+|
T Consensus        86 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~d  165 (327)
T 2yfx_A           86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRD  165 (327)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             HHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCc
Confidence            4678899999999999999999999999999999999997642        88999999999999999999999999999


Q ss_pred             CCCCcEEEccCC---ceeeecCc--------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CC
Q 046714           75 IKCANILVDASG---LATTTNDV--------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQ  136 (201)
Q Consensus        75 l~p~nill~~~g---~~~~~~~~--------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~  136 (201)
                      |||+||+++.+|   .+++.+..              ....+++.|+|||.+  .+..++.++||||||+++|+|++ |+
T Consensus       166 lkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~  243 (327)
T 2yfx_A          166 IAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGY  243 (327)
T ss_dssp             CCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHh--cCCCCCchhhHHHHHHHHHHHHcCCC
Confidence            999999998543   35554432              122356789999998  34567899999999999999998 99


Q ss_pred             CCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          137 PPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      .||...........+..+.....+..+++.+.+++.+||+.+|.+|||+.+++++.++
T Consensus       244 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          244 MPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            9998887777777777777777788899999999999999999999999999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-40  Score=245.02  Aligned_cols=187  Identities=25%  Similarity=0.400  Sum_probs=162.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++ ..+..++||||+.+++|.+++..  ..+++..+..++.|++.||++||+.|++|+||+|+||
T Consensus        63 ~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  141 (287)
T 1u59_A           63 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV  141 (287)
T ss_dssp             HHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             HHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheE
Confidence            46788999999999999 45568999999999999999854  3489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc---------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           81 LVDASGLATTTNDVKS---------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~---------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      +++.+|.+++.+....               ..+++.|+|||.+  .+..++.++|+||+|+++|++++ |+.||.....
T Consensus       142 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  219 (287)
T 1u59_A          142 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  219 (287)
T ss_dssp             EEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHH--HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred             EEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHh--ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9998887666554211               1235679999998  34567899999999999999998 9999988877


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                      .+....+..+..+..+..+++.+.+++.+||..+|.+|||+.+++++.
T Consensus       220 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          220 PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            777777777777788889999999999999999999999999998763

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.7e-40  Score=248.71  Aligned_cols=186  Identities=21%  Similarity=0.392  Sum_probs=161.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++ .++++|++.+++|.+++...  .+++..++.++.|++.||+|||++|++|+||||+||
T Consensus        70 ~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NI  148 (327)
T 3poz_A           70 VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV  148 (327)
T ss_dssp             HHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             HHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheE
Confidence            467899999999999998765 77899999999999998763  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      +++.+|.+++.++..              ...++..|+|||.+  .+..++.++||||||+++|++++ |+.||......
T Consensus       149 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  226 (327)
T 3poz_A          149 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  226 (327)
T ss_dssp             EEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             EECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHh--ccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH
Confidence            999988877766432              12246679999998  45678899999999999999999 99999887776


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .....+..+.....+..++..+.+++.+||+.+|.+|||+.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          227 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             GHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            6666666666667778899999999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=248.53  Aligned_cols=183  Identities=23%  Similarity=0.449  Sum_probs=153.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.++++.  ..+++.++..++.|++.||+|||++|++|+||||+||
T Consensus        60 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Ni  139 (310)
T 3s95_A           60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNC  139 (310)
T ss_dssp             HHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred             HHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeE
Confidence            57889999999999999999999999999999999999986  4589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc--------------------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh
Q 046714           81 LVDASGLATTTNDVK--------------------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT  134 (201)
Q Consensus        81 ll~~~g~~~~~~~~~--------------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~  134 (201)
                      +++.+|.+++.+...                          ...|++.|+|||.+  .+..++.++||||+|+++|++++
T Consensus       140 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~  217 (310)
T 3s95_A          140 LVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI--NGRSYDEKVDVFSFGIVLCEIIG  217 (310)
T ss_dssp             EECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             EECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHh--cCCCCCcHHHHHHHHHHHHHHhc
Confidence            999988777665432                          23478889999998  45678899999999999999999


Q ss_pred             CCCCCCCchHHHH-----HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          135 HQPPYSHLEDMQA-----LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       135 g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      |..|+........     ......   ...+..+++.+.+++.+||+.+|++|||++++++
T Consensus       218 g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          218 RVNADPDYLPRTMDFGLNVRGFLD---RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             TCCSSTTTSCBCTTSSBCHHHHHH---HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCcchhhhHHHHhhhhhcccc---ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            9998865321100     000111   1235678899999999999999999999999876

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.2e-40  Score=243.54  Aligned_cols=186  Identities=25%  Similarity=0.448  Sum_probs=162.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.+++...   .+++..+..++.|++.||+|||+.|++|+||||+|
T Consensus        62 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~N  141 (288)
T 3kfa_A           62 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN  141 (288)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGG
T ss_pred             HHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcce
Confidence            467899999999999999999999999999999999999763   38999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.+|.+++.+....             ..+++.|+|||.+  .+..++.++|+||+|+++|++++ |..||......
T Consensus       142 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~  219 (288)
T 3kfa_A          142 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  219 (288)
T ss_dssp             EEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99998887777664322             1135569999998  44567899999999999999999 99999887776


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+........+..+++.+.+++.+||..+|.+|||++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          220 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            666667666667778889999999999999999999999999876

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.6e-40  Score=248.31  Aligned_cols=187  Identities=24%  Similarity=0.447  Sum_probs=162.7

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-----------------CCHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----------------LSDSQVSSYTRQILNGLTY   64 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------------~~~~~~~~~~~~i~~~l~~   64 (201)
                      +++++ +||||+++++++.+.+..++||||+.+++|.+++....                 +++..++.++.||+.||+|
T Consensus        93 ~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~  172 (334)
T 2pvf_A           93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY  172 (334)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence            35566 89999999999999999999999999999999997542                 7889999999999999999


Q ss_pred             HhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHH
Q 046714           65 LHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVL  130 (201)
Q Consensus        65 lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~  130 (201)
                      ||++|++|+||||+||+++.+|.+++.+....              ..+++.|+|||.+  .+..++.++||||+|+++|
T Consensus       173 LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~  250 (334)
T 2pvf_A          173 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL--FDRVYTHQSDVWSFGVLMW  250 (334)
T ss_dssp             HHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHH--HHCEECHHHHHHHHHHHHH
T ss_pred             HHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHh--cCCCcChHHHHHHHHHHHH
Confidence            99999999999999999998887777654321              1245679999997  3456789999999999999


Q ss_pred             HHHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          131 EMLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       131 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ++++ |..||......+....+..+.....+..+++.+.+++.+||..+|.+|||+.+++++
T Consensus       251 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          251 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999 999998887777777777776677788899999999999999999999999999764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=243.51  Aligned_cols=193  Identities=30%  Similarity=0.526  Sum_probs=156.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhc-CccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHER-NVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~p~n   79 (201)
                      +++.++||||+++++++.+++..++||||+ ++.+..+...  ..+++..+..++.|++.||+|||++ |++|+||+|+|
T Consensus        77 ~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~N  155 (318)
T 2dyl_A           77 VLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN  155 (318)
T ss_dssp             HHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGG
T ss_pred             HHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHH
Confidence            467789999999999999999999999999 5566666653  4599999999999999999999996 99999999999


Q ss_pred             EEEccCCceeeecCccc-----------cccCccccccccccc---CCCCCcchhhHHHHHHHHHHHHhCCCCCCCc-hH
Q 046714           80 ILVDASGLATTTNDVKS-----------FEGTPFWVAPEVVNL---KNNGYGLSADIWSLGCTVLEMLTHQPPYSHL-ED  144 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-----------~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~  144 (201)
                      |+++.+|.+++.+....           ..+++.|+|||.+..   ....++.++||||+|+++|+|++|+.||... ..
T Consensus       156 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  235 (318)
T 2dyl_A          156 ILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD  235 (318)
T ss_dssp             EEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             EEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc
Confidence            99999888777664322           246788999999842   2345778999999999999999999999763 34


Q ss_pred             HHHHHHhhcCCCCCCC--CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          145 MQALFRIGRGKLPSVP--NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ............+..+  ..+++.+.+++.+||+.+|.+|||++++++||||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          236 FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             HHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            4445555544444443  357899999999999999999999999999999974

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=245.85  Aligned_cols=185  Identities=21%  Similarity=0.388  Sum_probs=161.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++ .+++++++.+++|.+++...  .+++..++.++.|++.||+|||++|++|+||||+||
T Consensus        70 ~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI  148 (327)
T 3lzb_A           70 VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV  148 (327)
T ss_dssp             HHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             HHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHE
Confidence            578899999999999998765 78899999999999998753  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      +++.+|.+++.+....              ..+++.|+|||.+  .+..++.++||||||+++|++++ |+.||......
T Consensus       149 l~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~  226 (327)
T 3lzb_A          149 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  226 (327)
T ss_dssp             EEEETTEEEECCTTC----------------CCCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             EEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHH--cCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence            9999887777664322              1235579999998  45668899999999999999999 99999888777


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+........+..++..+.+++.+||..+|.+|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          227 EISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             GHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            777777777667778889999999999999999999999999976

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.4e-40  Score=260.59  Aligned_cols=186  Identities=25%  Similarity=0.445  Sum_probs=162.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++||||+++++++.+.+..++||||+.+++|.+++...   .+++..+..++.||+.||+|||++||+|+||||+|
T Consensus       269 ~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N  348 (495)
T 1opk_A          269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARN  348 (495)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             HHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence            577899999999999999999999999999999999999753   38999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.++.+++.++...             ..++..|+|||.+  ....++.++||||||+++|+|++ |..||......
T Consensus       349 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~  426 (495)
T 1opk_A          349 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  426 (495)
T ss_dssp             EEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHH--HHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHH--hcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence            99998877776654321             1234579999998  34567899999999999999999 99999887776


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+..+.....+..+++.+.+++.+||+.+|.+|||+.++++
T Consensus       427 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          427 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            666667777666778889999999999999999999999999976

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=7.8e-40  Score=249.71  Aligned_cols=193  Identities=24%  Similarity=0.374  Sum_probs=153.0

Q ss_pred             cccCCCcceeccceeeeeCCe-------EEEEEEecCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHh--hcC
Q 046714            4 FSQFEHDNIVQYIGTEKDENR-------LYIFLELVKKGSLANLYQ-----KYHLSDSQVSSYTRQILNGLTYLH--ERN   69 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~-------~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lh--~~~   69 (201)
                      +++++||||+++++++...+.       .++||||+.+ +|.+.+.     ...+++..+..++.|++.||.|||  +.|
T Consensus        73 l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~  151 (360)
T 3e3p_A           73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN  151 (360)
T ss_dssp             HHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC
T ss_pred             HHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            466799999999999876433       8899999987 5544433     234899999999999999999999  999


Q ss_pred             ccccCCCCCcEEEcc-CCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCC
Q 046714           70 VVHREIKCANILVDA-SGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        70 i~H~dl~p~nill~~-~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      ++|+||||+||+++. +|.+++.+...           ...+++.|+|||.+. ....++.++||||||+++|+|++|+.
T Consensus       152 ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~Di~slG~il~ell~g~~  230 (360)
T 3e3p_A          152 VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIF-GNQHYTTAVDIWSVGCIFAEMMLGEP  230 (360)
T ss_dssp             CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHc-CCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            999999999999996 67666665432           234678899999972 34457899999999999999999999


Q ss_pred             CCCCchHHHHHHHhhcCC-------------------------------CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHh
Q 046714          138 PYSHLEDMQALFRIGRGK-------------------------------LPSVPNSLSRDARDFILKCLQVNPNDRPTAA  186 (201)
Q Consensus       138 p~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~  186 (201)
                      ||...........+....                               .+......++++.+|+.+||+.+|.+|||+.
T Consensus       231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  310 (360)
T 3e3p_A          231 IFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY  310 (360)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHH
Confidence            998876655554432100                               0112223567899999999999999999999


Q ss_pred             HHhcCccccCcC
Q 046714          187 QLMEHPFVKRPL  198 (201)
Q Consensus       187 ~il~~~~~~~~~  198 (201)
                      |+++||||++..
T Consensus       311 e~l~hp~f~~~~  322 (360)
T 3e3p_A          311 EALCHPYFDELH  322 (360)
T ss_dssp             HHTTSGGGGGGG
T ss_pred             HHhcCccccccC
Confidence            999999998653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.8e-41  Score=257.54  Aligned_cols=191  Identities=13%  Similarity=0.119  Sum_probs=139.8

Q ss_pred             cccCCCcceeccc-------eeeeeC-----------------CeEEEEEEecCCCCHHHHHHhc--CCCHHHH------
Q 046714            4 FSQFEHDNIVQYI-------GTEKDE-----------------NRLYIFLELVKKGSLANLYQKY--HLSDSQV------   51 (201)
Q Consensus         4 l~~l~h~~I~~~~-------~~~~~~-----------------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~------   51 (201)
                      |++ +||||++++       +++...                 ...++||||+. ++|.+++...  .++...+      
T Consensus       119 l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk  196 (371)
T 3q60_A          119 LLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILAL  196 (371)
T ss_dssp             HHC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHH
T ss_pred             hcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhH
Confidence            455 799988755       444433                 33799999998 6999999753  3555555      


Q ss_pred             HHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhH
Q 046714           52 SSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADI  122 (201)
Q Consensus        52 ~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv  122 (201)
                      ..++.||+.||+|||++||+|+||||+||+++.+|.+++.++..         ...+++.|+|||.+......++.++||
T Consensus       197 ~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Di  276 (371)
T 3q60_A          197 HILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNA  276 (371)
T ss_dssp             HHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccH
Confidence            67779999999999999999999999999999998887776542         234568899999984333678999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCchHHHH--HHH---h---hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          123 WSLGCTVLEMLTHQPPYSHLEDMQA--LFR---I---GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       123 ~slG~~l~~l~~g~~p~~~~~~~~~--~~~---~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ||||+++|+|++|+.||........  ...   .   ...........+++.+.+++.+||+.+|++|||++++++||||
T Consensus       277 wSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  356 (371)
T 3q60_A          277 WQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF  356 (371)
T ss_dssp             HHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence            9999999999999999976532110  000   0   0011111224689999999999999999999999999999999


Q ss_pred             cC
Q 046714          195 KR  196 (201)
Q Consensus       195 ~~  196 (201)
                      +.
T Consensus       357 ~~  358 (371)
T 3q60_A          357 LQ  358 (371)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.3e-40  Score=251.68  Aligned_cols=187  Identities=24%  Similarity=0.481  Sum_probs=157.2

Q ss_pred             ccccC-CCcceeccceeeeeCC-eEEEEEEecCCCCHHHHHHhcC-----------------------------------
Q 046714            3 SFSQF-EHDNIVQYIGTEKDEN-RLYIFLELVKKGSLANLYQKYH-----------------------------------   45 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~-----------------------------------   45 (201)
                      +++++ +||||+++++++.+.+ ..++||||+.+++|.+++....                                   
T Consensus        78 ~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (359)
T 3vhe_A           78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSIT  157 (359)
T ss_dssp             HHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------
T ss_pred             HHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccC
Confidence            35566 7999999999988765 4899999999999999997542                                   


Q ss_pred             --------------------------------CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecC
Q 046714           46 --------------------------------LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTND   93 (201)
Q Consensus        46 --------------------------------~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~   93 (201)
                                                      +++..++.++.|++.||+|||++|++|+||||+||+++.++.+++.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Df  237 (359)
T 3vhe_A          158 SSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF  237 (359)
T ss_dssp             --------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             ccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEec
Confidence                                            788999999999999999999999999999999999998887777654


Q ss_pred             ccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCch-HHHHHHHhhcCCCC
Q 046714           94 VKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLE-DMQALFRIGRGKLP  157 (201)
Q Consensus        94 ~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~-~~~~~~~~~~~~~~  157 (201)
                      ...              ..+++.|+|||.+  .+..++.++||||||+++|+|++ |+.||.... ..........+...
T Consensus       238 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~  315 (359)
T 3vhe_A          238 GLARDIYKDPDYVRKGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM  315 (359)
T ss_dssp             GGGSCTTSCTTCEEC--CEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC
T ss_pred             cceeeecccccchhccccCCCceeEChhhh--cCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC
Confidence            322              2256679999998  35667899999999999999998 999997754 33344445555566


Q ss_pred             CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          158 SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       158 ~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ..+..+++.+.+++.+||+.+|.+|||++++++|
T Consensus       316 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          316 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            7778899999999999999999999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-39  Score=250.05  Aligned_cols=187  Identities=20%  Similarity=0.411  Sum_probs=158.1

Q ss_pred             ccccCCCcceeccceeee-eCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEK-DENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++. .++..++||||+.+++|.++++..  .+++..+..++.||+.||+|||++|++|+||||+|
T Consensus       143 il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  222 (373)
T 3c1x_A          143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN  222 (373)
T ss_dssp             TSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             HHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchhe
Confidence            688999999999999865 456789999999999999999754  38889999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc----------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCc
Q 046714           80 ILVDASGLATTTNDVKS----------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHL  142 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~----------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~  142 (201)
                      |+++.+|.+++.++...                ..+++.|+|||.+  .+..++.++||||||+++|++++ |..||...
T Consensus       223 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~  300 (373)
T 3c1x_A          223 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  300 (373)
T ss_dssp             EEECTTCCEEECCC---------------------CCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             EEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHh--cCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence            99999887777664321                1245579999998  45567899999999999999999 78888776


Q ss_pred             hHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          143 EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ...+....+..+.....+..+++.+.+++.+||+.+|.+|||+.+++++
T Consensus       301 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          301 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6555555666666666778899999999999999999999999998763

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.2e-40  Score=241.82  Aligned_cols=186  Identities=24%  Similarity=0.432  Sum_probs=158.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.++ ..+++|||+.+++|.+++...  .+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        66 ~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni  144 (281)
T 3cc6_A           66 IMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNI  144 (281)
T ss_dssp             HHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred             HHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceE
Confidence            46778999999999998765 468999999999999999764  389999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.+|.+++.+....             ..+++.|+|||.+  .+..++.++|+||||+++|++++ |+.||.......
T Consensus       145 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~  222 (281)
T 3cc6_A          145 LVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI--NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD  222 (281)
T ss_dssp             EEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG
T ss_pred             EECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhh--ccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH
Confidence            9999887776654321             2245679999998  45567899999999999999998 999998766656


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ....+........+..+++.+.+++.+||..+|.+|||+.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          223 VIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            666666666666777899999999999999999999999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-40  Score=248.52  Aligned_cols=188  Identities=21%  Similarity=0.374  Sum_probs=158.3

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC------------------------CCHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH------------------------LSDSQVSSYTRQ   57 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------------~~~~~~~~~~~~   57 (201)
                      +|+++ +||||+++++++.+.+..++||||+.+++|.+++....                        +++..++.++.|
T Consensus       101 ~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  180 (344)
T 1rjb_A          101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ  180 (344)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHH
T ss_pred             HHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHH
Confidence            45677 89999999999999999999999999999999997532                        688999999999


Q ss_pred             HHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHH
Q 046714           58 ILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIW  123 (201)
Q Consensus        58 i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~  123 (201)
                      |+.||+|||++|++|+||||+||+++.+|.+++.+....              ..+++.|+|||.+  .+..++.++|||
T Consensus       181 i~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~  258 (344)
T 1rjb_A          181 VAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL--FEGIYTIKSDVW  258 (344)
T ss_dssp             HHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH--HHCCCCHHHHHH
T ss_pred             HHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh--ccCCCChhHhHH
Confidence            999999999999999999999999999887777664322              1245679999997  345688999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCchHHHHH-HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          124 SLGCTVLEMLT-HQPPYSHLEDMQAL-FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       124 slG~~l~~l~~-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                      |||+++|+|++ |..||......... ..+..+.....+..+++.+.+++.+||+.+|.+|||+.+++++-
T Consensus       259 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          259 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            99999999998 99999776543333 33444445566778899999999999999999999999998753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.6e-39  Score=241.88  Aligned_cols=186  Identities=25%  Similarity=0.426  Sum_probs=154.8

Q ss_pred             ccccCCCcceeccceeeee--CCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      +|++++||||+++++++..  ....++||||+.+++|.+++....  +++..+..++.|++.||+|||+.|++|+||||+
T Consensus        64 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~  143 (295)
T 3ugc_A           64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR  143 (295)
T ss_dssp             HHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             HHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHh
Confidence            5788999999999999865  356899999999999999997643  899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCccc---------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           79 NILVDASGLATTTNDVKS---------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        79 nill~~~g~~~~~~~~~~---------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      ||+++.++.+++.+....               ..++..|+|||.+  .+..++.++||||+|+++|++++|..|+....
T Consensus       144 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~  221 (295)
T 3ugc_A          144 NILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPP  221 (295)
T ss_dssp             GEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH
T ss_pred             hEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHh--cCCCCChHHHHHHHHHHHHHHHhcccccCCCh
Confidence            999999887777664322               1234559999998  45568899999999999999999999886543


Q ss_pred             HH----------------HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          144 DM----------------QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       144 ~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..                ..............+..+++.+.+++.+||+.+|++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          222 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            22                222333445555667889999999999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.7e-39  Score=241.89  Aligned_cols=186  Identities=21%  Similarity=0.426  Sum_probs=159.3

Q ss_pred             ccccCCCcceeccceee-eeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTE-KDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++ ..++..+++|||+.+++|.+++...  .++...+..++.|++.||+|||++|++|+||||+|
T Consensus        79 ~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~N  158 (298)
T 3f66_A           79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARN  158 (298)
T ss_dssp             HHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             HHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchhe
Confidence            57889999999999985 4566889999999999999999753  38999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc----------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCc
Q 046714           80 ILVDASGLATTTNDVKS----------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHL  142 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~----------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~  142 (201)
                      |+++.+|.+++.+....                ..+++.|+|||.+  .+..++.++|+||+|+++|++++ |..||...
T Consensus       159 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  236 (298)
T 3f66_A          159 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  236 (298)
T ss_dssp             EEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             EEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHh--cCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence            99999887777664321                2245679999998  45567899999999999999999 67777777


Q ss_pred             hHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          143 EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ...........+.....+..+++.+.+++.+||+.+|.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          237 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            666666666767666777889999999999999999999999999876

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-39  Score=240.56  Aligned_cols=186  Identities=25%  Similarity=0.474  Sum_probs=160.1

Q ss_pred             ccccCCCcceeccceeeeeC-CeEEEEEEecCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE-NRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++||||+++++++.+. +..++++||+.+++|.+++...+   +++..+..++.|++.||+|||++|++|+||||+
T Consensus        67 ~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~  146 (278)
T 1byg_A           67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR  146 (278)
T ss_dssp             HHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             HHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcc
Confidence            57889999999999986544 57899999999999999987643   899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH
Q 046714           79 NILVDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQAL  148 (201)
Q Consensus        79 nill~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~  148 (201)
                      ||+++.+|.+++.+...         ...+++.|+|||.+  .+..++.++|+||||+++|++++ |+.||.........
T Consensus       147 Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  224 (278)
T 1byg_A          147 NVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV  224 (278)
T ss_dssp             GEEECTTSCEEECCCCC------------CCTTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred             eEEEeCCCcEEEeeccccccccccccCCCccccccCHHHh--CCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999988777766432         12356779999998  45567899999999999999998 99999887766676


Q ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..+..+.....+..+++.+.+++.+||..+|.+|||+.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          225 PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            677777667778889999999999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=9.4e-40  Score=246.37  Aligned_cols=194  Identities=28%  Similarity=0.488  Sum_probs=145.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHhhc-CccccCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ------KYHLSDSQVSSYTRQILNGLTYLHER-NVVHREI   75 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~------~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl   75 (201)
                      +++.++||||+++++++.+++..++||||+.+ +|.+++.      ...+++..+..++.|++.||.|||+. |++|+||
T Consensus        74 ~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dl  152 (327)
T 3aln_A           74 VMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDI  152 (327)
T ss_dssp             HHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCC
T ss_pred             HHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCC
Confidence            46788999999999999999999999999987 8888775      34589999999999999999999999 9999999


Q ss_pred             CCCcEEEccCCceeeecCccc-----------cccCccccccccccc--CCCCCcchhhHHHHHHHHHHHHhCCCCCCCc
Q 046714           76 KCANILVDASGLATTTNDVKS-----------FEGTPFWVAPEVVNL--KNNGYGLSADIWSLGCTVLEMLTHQPPYSHL  142 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~~~~~-----------~~~~~~~~aPE~~~~--~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  142 (201)
                      ||+||+++.+|.+++.+....           ..+++.|+|||.+..  .+..++.++|+||||+++|+|++|+.||...
T Consensus       153 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (327)
T 3aln_A          153 KPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW  232 (327)
T ss_dssp             CGGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred             CHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            999999999888777664322           246788999999732  2345788999999999999999999999875


Q ss_pred             hHH-HHHHHhhcCCCCCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          143 EDM-QALFRIGRGKLPSVP----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       143 ~~~-~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ... ........+..+.++    ..+++.+.+++.+||+.+|.+|||+.++++||||...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          233 NSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             -------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             chHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            432 222222333322222    4578999999999999999999999999999999754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-39  Score=245.39  Aligned_cols=188  Identities=24%  Similarity=0.328  Sum_probs=149.5

Q ss_pred             ccccCCCcceeccceeeeeCC----eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc----------
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER----------   68 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~----------   68 (201)
                      +|++++||||+++++++.+..    ..++||||+.+++|.++++...+++..+..++.|++.||+|||+.          
T Consensus        71 ~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~  150 (322)
T 3soc_A           71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKP  150 (322)
T ss_dssp             TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEEC
T ss_pred             HHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCC
Confidence            578899999999999998754    479999999999999999988899999999999999999999999          


Q ss_pred             CccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccC---CCCCcchhhHHHHHHHHHH
Q 046714           69 NVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLK---NNGYGLSADIWSLGCTVLE  131 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~---~~~~~~~~Dv~slG~~l~~  131 (201)
                      |++|+||||+||+++.++.+++.+....              ..+++.|+|||.+...   ...++.++||||||+++|+
T Consensus       151 ~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~e  230 (322)
T 3soc_A          151 AISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE  230 (322)
T ss_dssp             EEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHH
Confidence            9999999999999999887777664322              3478889999998422   1345678999999999999


Q ss_pred             HHhCCCCCCCch----------------HHHHHHHhhc-CCCCCCCCC-----CCHHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          132 MLTHQPPYSHLE----------------DMQALFRIGR-GKLPSVPNS-----LSRDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       132 l~~g~~p~~~~~----------------~~~~~~~~~~-~~~~~~~~~-----~~~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                      |++|+.||....                .......... ...+..+..     .++.+.+++.+||+.+|++|||+++++
T Consensus       231 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell  310 (322)
T 3soc_A          231 LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG  310 (322)
T ss_dssp             HHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999985421                1112222222 222222221     234599999999999999999999997


Q ss_pred             c
Q 046714          190 E  190 (201)
Q Consensus       190 ~  190 (201)
                      +
T Consensus       311 ~  311 (322)
T 3soc_A          311 E  311 (322)
T ss_dssp             H
T ss_pred             H
Confidence            6

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=261.56  Aligned_cols=185  Identities=25%  Similarity=0.409  Sum_probs=162.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+ +..++||||+.+++|.+++..  ..+++..+..++.||+.||+|||++||+|+||||+||
T Consensus       389 il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI  467 (613)
T 2ozo_A          389 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNV  467 (613)
T ss_dssp             HHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             HHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHE
Confidence            5788999999999999987 458999999999999999864  3489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcccc---------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           81 LVDASGLATTTNDVKSF---------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~~---------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      +++.++.+++.++....               .+++.|+|||.+  ....++.++||||||+++|+|++ |+.||.....
T Consensus       468 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~--~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~  545 (613)
T 2ozo_A          468 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  545 (613)
T ss_dssp             EEEETTEEEECCCSTTTTCC--------------CCTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred             EEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhh--cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence            99998887777653221               123579999998  44568899999999999999998 9999998888


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .+....+..+.....+..+++.+.+++.+||..+|.+|||++++++
T Consensus       546 ~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          546 PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8888888888777888899999999999999999999999999854

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.3e-39  Score=246.31  Aligned_cols=188  Identities=22%  Similarity=0.347  Sum_probs=150.9

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEcc
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDA   84 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~   84 (201)
                      .|++|+++++++.+.+..++||||+ +++|.+++...   .+++..+..++.|++.||+|||++|++|+||||+||+++.
T Consensus        75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~  153 (339)
T 1z57_A           75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQ  153 (339)
T ss_dssp             CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC
T ss_pred             CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEec
Confidence            3446999999999999999999999 77999998765   3889999999999999999999999999999999999987


Q ss_pred             -------------------CCceeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCC
Q 046714           85 -------------------SGLATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        85 -------------------~g~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                                         ++.+++.+..         ....+++.|+|||.+  .+..++.++|+||||+++|++++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~  231 (339)
T 1z57_A          154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVI--LALGWSQPCDVWSIGCILIEYYLGF  231 (339)
T ss_dssp             CCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHH--TTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cccccccCCccccccccccCCCceEeeCcccccCccccccccCCccccChHHh--hCCCCCcchhhHHHHHHHHHHHhCC
Confidence                               3344444432         234578889999998  4556889999999999999999999


Q ss_pred             CCCCCchHHHHHHHhhc--CCCC-----------------------------------------CCCCCCCHHHHHHHHH
Q 046714          137 PPYSHLEDMQALFRIGR--GKLP-----------------------------------------SVPNSLSRDARDFILK  173 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~--~~~~-----------------------------------------~~~~~~~~~~~~li~~  173 (201)
                      .||......+....+..  +..+                                         ......++.+.+++.+
T Consensus       232 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  311 (339)
T 1z57_A          232 TVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK  311 (339)
T ss_dssp             CSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH
Confidence            99987665444332211  1000                                         0112235678899999


Q ss_pred             HhhcCCCCCCCHhHHhcCccccCcC
Q 046714          174 CLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       174 ~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ||+.+|.+|||++|+++||||+...
T Consensus       312 ~L~~dP~~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          312 MLEYDPAKRITLREALKHPFFDLLK  336 (339)
T ss_dssp             HTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred             HhCcCcccccCHHHHhcCHHHHHHh
Confidence            9999999999999999999998654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.4e-39  Score=255.21  Aligned_cols=190  Identities=25%  Similarity=0.461  Sum_probs=163.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++||||+++++++.+ +..++||||+.+++|.+++..   ..+++..+..++.|++.||+|||++|++|+||||+|
T Consensus       232 ~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~N  310 (452)
T 1fmk_A          232 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN  310 (452)
T ss_dssp             HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             HHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhh
Confidence            5778999999999999876 668999999999999999964   348999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.++.+++.+....             ..++..|+|||.+  ....++.++||||||+++|++++ |+.||.+....
T Consensus       311 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~  388 (452)
T 1fmk_A          311 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  388 (452)
T ss_dssp             EEECGGGCEEECCCCTTC--------------CCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             EEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHH--hcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence            99998887777664322             1234679999998  34568899999999999999999 99999988887


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc--Ccccc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME--HPFVK  195 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~--~~~~~  195 (201)
                      +....+..+.....+..+++.+.+++.+||+.+|++|||++++++  ..++.
T Consensus       389 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          389 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            888777777777778889999999999999999999999999876  34444

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=247.71  Aligned_cols=191  Identities=23%  Similarity=0.393  Sum_probs=151.2

Q ss_pred             ccccCCCcceeccceeeeeCC--eEEEEEEecCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN--RLYIFLELVKKGSLANLYQKYH----LSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +|++++||||+++++++...+  ..++||||+.+++|.+++....    +++..++.++.|++.||+|||++|++|+|||
T Consensus        60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk  139 (319)
T 4euu_A           60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK  139 (319)
T ss_dssp             HHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             HHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence            577899999999999988765  7899999999999999997533    8999999999999999999999999999999


Q ss_pred             CCcEEE----ccCCceeeecCc-----------cccccCccccccccccc------CCCCCcchhhHHHHHHHHHHHHhC
Q 046714           77 CANILV----DASGLATTTNDV-----------KSFEGTPFWVAPEVVNL------KNNGYGLSADIWSLGCTVLEMLTH  135 (201)
Q Consensus        77 p~nill----~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~------~~~~~~~~~Dv~slG~~l~~l~~g  135 (201)
                      |+||++    +.++.+++.+..           ....+++.|+|||.+..      .+..++.++||||||+++|+|++|
T Consensus       140 p~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g  219 (319)
T 4euu_A          140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG  219 (319)
T ss_dssp             GGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHS
T ss_pred             HHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhC
Confidence            999998    555545554432           22347889999998731      145678999999999999999999


Q ss_pred             CCCCCCc----hHHHHHHHhhcCCCC------------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhH
Q 046714          136 QPPYSHL----EDMQALFRIGRGKLP------------------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQ  187 (201)
Q Consensus       136 ~~p~~~~----~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~  187 (201)
                      +.||...    ........+..+...                        .+...+++.+.+++.+||+.||++|||++|
T Consensus       220 ~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~e  299 (319)
T 4euu_A          220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ  299 (319)
T ss_dssp             SCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred             CCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHH
Confidence            9999632    223333333322211                        112234567889999999999999999999


Q ss_pred             HhcCcc
Q 046714          188 LMEHPF  193 (201)
Q Consensus       188 il~~~~  193 (201)
                      +++||-
T Consensus       300 ll~h~~  305 (319)
T 4euu_A          300 FFAETS  305 (319)
T ss_dssp             HHHHHH
T ss_pred             hhhccH
Confidence            999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.9e-39  Score=237.82  Aligned_cols=186  Identities=23%  Similarity=0.392  Sum_probs=154.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcC--ccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERN--VVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~dl~p~   78 (201)
                      ++++++||||+++++++.+..  +++|||+.+++|.+.+...  .+++..+..++.|++.||+|||+.|  ++|+||||+
T Consensus        76 ~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~  153 (287)
T 4f0f_A           76 IMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSP  153 (287)
T ss_dssp             HHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGG
T ss_pred             HHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcc
Confidence            477899999999999997766  6999999999999888543  4899999999999999999999999  999999999


Q ss_pred             cEEEccCCc-----eeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           79 NILVDASGL-----ATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        79 nill~~~g~-----~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      ||+++.++.     +++.+..         ....+++.|+|||.+......++.++|+||+|+++|++++|+.||.....
T Consensus       154 Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  233 (287)
T 4f0f_A          154 NIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY  233 (287)
T ss_dssp             GEEESCCCTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             eEEEeccCCCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence            999987664     5555542         22447888999999844455678899999999999999999999976532


Q ss_pred             HHH--HHH-hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQA--LFR-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~--~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ...  ... ......+..+..+++.+.+++.+||+.+|.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          234 GKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            222  222 3345556677889999999999999999999999999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=244.01  Aligned_cols=184  Identities=24%  Similarity=0.465  Sum_probs=149.1

Q ss_pred             CCcceeccceeeeeCCeEEEEEEe-cCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEc-c
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLEL-VKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD-A   84 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~-~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~-~   84 (201)
                      +||||+++++++.+.+..++++|+ +.+++|.+++... .+++..++.++.|++.||+|||+.|++|+||||+||+++ .
T Consensus        96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~  175 (312)
T 2iwi_A           96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLR  175 (312)
T ss_dssp             CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETT
T ss_pred             CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCC
Confidence            899999999999999999999999 7889999998764 499999999999999999999999999999999999998 6


Q ss_pred             CCceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcC
Q 046714           85 SGLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG  154 (201)
Q Consensus        85 ~g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  154 (201)
                      +|.+++.+..          ....++..|+|||.+. .....+.++|+||+|+++|++++|+.||......      .. 
T Consensus       176 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~-  247 (312)
T 2iwi_A          176 RGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWIS-RHQYHALPATVWSLGILLYDMVCGDIPFERDQEI------LE-  247 (312)
T ss_dssp             TTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHH-HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------HH-
T ss_pred             CCeEEEEEcchhhhcccCcccccCCcccccCceeee-cCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH------hh-
Confidence            7766655542          2234678899999973 2333356899999999999999999999764321      11 


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       155 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      ....++..++..+.+++.+||+.+|++|||++|+++||||+...+
T Consensus       248 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          248 AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence            223456778999999999999999999999999999999997643

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.4e-39  Score=242.76  Aligned_cols=187  Identities=21%  Similarity=0.396  Sum_probs=159.9

Q ss_pred             ccccCCCcceeccceeeeeCC-----eEEEEEEecCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN-----RLYIFLELVKKGSLANLYQK-------YHLSDSQVSSYTRQILNGLTYLHERNV   70 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~i   70 (201)
                      ++++++||||+++++++.+.+     ..++++||+.+++|.+++..       ..+++..++.++.|++.||.|||++|+
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  168 (313)
T 3brb_A           89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF  168 (313)
T ss_dssp             HHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             HHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            467899999999999988754     35999999999999999842       348999999999999999999999999


Q ss_pred             cccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-C
Q 046714           71 VHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-H  135 (201)
Q Consensus        71 ~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g  135 (201)
                      +|+||||+||+++.+|.+++.+....              ..+++.|+|||.+  .+..++.++|+||||+++|+|++ |
T Consensus       169 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g  246 (313)
T 3brb_A          169 LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRG  246 (313)
T ss_dssp             CCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHH--HSSCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             ccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhh--cCCCccchhhhHHHHHHHHHHHhcC
Confidence            99999999999999887777664322              1245679999998  45668899999999999999999 8


Q ss_pred             CCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          136 QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       136 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ..||...........+..+.....+..+++.+.+++.+||..+|.+|||+.+++++
T Consensus       247 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          247 MTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99998877777777777777777788899999999999999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.8e-39  Score=240.75  Aligned_cols=187  Identities=22%  Similarity=0.458  Sum_probs=157.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+.+..++++||+.+++|.+++...+  +++..+..++.|++.||+|||+.|++|+||||+||
T Consensus        82 ~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NI  161 (319)
T 2y4i_B           82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNV  161 (319)
T ss_dssp             GGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTE
T ss_pred             HHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhE
Confidence            5788999999999999999999999999999999999997654  89999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-----------------ccccCcccccccccccC-------CCCCcchhhHHHHHHHHHHHHhCC
Q 046714           81 LVDASGLATTTNDVK-----------------SFEGTPFWVAPEVVNLK-------NNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-----------------~~~~~~~~~aPE~~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                      +++ +|.+++.+...                 ...+++.|+|||.+...       ...++.++||||||+++|++++|+
T Consensus       162 l~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~  240 (319)
T 2y4i_B          162 FYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE  240 (319)
T ss_dssp             EEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             EEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCC
Confidence            998 45554444321                 12367789999998431       235688999999999999999999


Q ss_pred             CCCCCchHHHHHHHhhcCCCCCCC-CCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          137 PPYSHLEDMQALFRIGRGKLPSVP-NSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .||...........+..+..+... ..+++.+.+++.+||..+|.+|||+.++++
T Consensus       241 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          241 WPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             CSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             CCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            999888777776666655554433 368899999999999999999999999976

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.4e-39  Score=243.77  Aligned_cols=187  Identities=24%  Similarity=0.403  Sum_probs=156.9

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-------------------CCCHHHHHHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-------------------HLSDSQVSSYTRQILNGL   62 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------------~~~~~~~~~~~~~i~~~l   62 (201)
                      +++++ +||||+++++++.+++..++||||+.+++|.+++...                   .+++..++.++.|++.||
T Consensus        79 ~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l  158 (313)
T 1t46_A           79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM  158 (313)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHH
T ss_pred             HHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHH
Confidence            45677 8999999999999999999999999999999998754                   289999999999999999


Q ss_pred             HHHhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHH
Q 046714           63 TYLHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT  128 (201)
Q Consensus        63 ~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~  128 (201)
                      +|||++|++|+||||+||+++.++.+++.+....              ..+++.|+|||.+  .+..++.++|+||||++
T Consensus       159 ~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~i  236 (313)
T 1t46_A          159 AFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI--FNCVYTFESDVWSYGIF  236 (313)
T ss_dssp             HHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH--HHCCCCHHHHHHHHHHH
T ss_pred             HHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHh--cCCCCChHHHHHHHHHH
Confidence            9999999999999999999999887777654321              1235579999997  35568899999999999


Q ss_pred             HHHHHh-CCCCCCCchHHHHH-HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          129 VLEMLT-HQPPYSHLEDMQAL-FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       129 l~~l~~-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +|+|++ |+.||......... ...........+..+++.+.+++.+||+.+|.+|||+++++++
T Consensus       237 l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            999999 99999775433332 3333444445567789999999999999999999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.6e-39  Score=244.49  Aligned_cols=187  Identities=26%  Similarity=0.453  Sum_probs=156.1

Q ss_pred             cccCC--CcceeccceeeeeCCeEEEEEEecCC-CCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            4 FSQFE--HDNIVQYIGTEKDENRLYIFLELVKK-GSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         4 l~~l~--h~~I~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +++++  ||||+++++++.+++..++++|++.+ ++|.+++.. ..+++..+..++.|++.||+|||++|++|+||||+|
T Consensus       100 l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N  179 (320)
T 3a99_A          100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN  179 (320)
T ss_dssp             HHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             HHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHH
Confidence            44554  69999999999999999999999975 799998875 458999999999999999999999999999999999


Q ss_pred             EEEc-cCCceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           80 ILVD-ASGLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        80 ill~-~~g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      |+++ .+|.+++.+..          ....+++.|+|||.+. .....+.++|+||||+++|++++|+.||......   
T Consensus       180 Ill~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---  255 (320)
T 3a99_A          180 ILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---  255 (320)
T ss_dssp             EEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHH-HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---
T ss_pred             EEEeCCCCCEEEeeCccccccccccccCCCCCccCCChHHhc-cCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh---
Confidence            9998 56666665543          2234788899999983 2333478899999999999999999999764321   


Q ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                         ... ....+..+++.+.+++.+||+.+|++|||++++++||||+...
T Consensus       256 ---~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          256 ---IRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             ---HHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ---hcc-cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence               111 2345667899999999999999999999999999999998764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-39  Score=239.13  Aligned_cols=186  Identities=23%  Similarity=0.413  Sum_probs=158.5

Q ss_pred             ccccCCCcceeccceeeeeCCeE-EEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRL-YIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~-~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.+.+.. ++++||+.+++|.+++..  ..+++..+..++.|++.||+|||++|++|+||||+|
T Consensus        75 ~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~N  154 (298)
T 3pls_A           75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARN  154 (298)
T ss_dssp             HHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             HHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence            47789999999999999876654 999999999999999976  348999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc----------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCc
Q 046714           80 ILVDASGLATTTNDVKS----------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHL  142 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~----------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~  142 (201)
                      |+++.+|.+++.+....                ..+++.|+|||.+  .+..++.++|+||+|+++|++++ +..||...
T Consensus       155 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~  232 (298)
T 3pls_A          155 CMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL--QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI  232 (298)
T ss_dssp             EEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHH--TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             EEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhh--ccCCCChhhchhhHHHHHHHHhhCCCCCCccC
Confidence            99999987777664322                2245679999998  45668899999999999999999 55556666


Q ss_pred             hHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          143 EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ........+........+..+++.+.+++.+||+.+|.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          233 DPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            666666666666666777889999999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.3e-39  Score=262.74  Aligned_cols=185  Identities=24%  Similarity=0.424  Sum_probs=163.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.++ ..++||||+.+++|.++++... +++..+..++.||+.||+|||++||+|+||||+||+
T Consensus       423 il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NIL  501 (635)
T 4fl3_A          423 VMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL  501 (635)
T ss_dssp             HHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             HHHhCCCCCEeeEEEEEecC-CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEE
Confidence            57789999999999999754 5789999999999999997654 999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCccc---------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           82 VDASGLATTTNDVKS---------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        82 l~~~g~~~~~~~~~~---------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      ++.++.+++.++...               ..+++.|+|||.+  ....++.++||||||+++|+|++ |+.||......
T Consensus       502 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~--~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~  579 (635)
T 4fl3_A          502 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS  579 (635)
T ss_dssp             EEETTEEEECCTTHHHHTTC-------------CGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             EeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhh--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999988777665321               1134679999998  45568899999999999999998 99999998888


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +....+..+.....+..+++++.+++.+||..+|++|||++++++
T Consensus       580 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          580 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            888888888888888899999999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.5e-39  Score=238.13  Aligned_cols=185  Identities=24%  Similarity=0.472  Sum_probs=159.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++||||+++++++.+ +..+++|||+.+++|.+++...   .+++..+..++.|++.||+|||++|++|+||||+|
T Consensus        61 ~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N  139 (279)
T 1qpc_A           61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN  139 (279)
T ss_dssp             HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             HHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhh
Confidence            4678999999999999875 4589999999999999998643   59999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.+|.+++.+....             ..++..|+|||.+  .+..++.++|+||||+++|++++ |+.||......
T Consensus       140 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  217 (279)
T 1qpc_A          140 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP  217 (279)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHH--HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             EEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhh--ccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH
Confidence            99998887766654321             1245579999998  34567889999999999999999 99999888777


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +....+..+.....+..+++.+.+++.+||..+|++|||++++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          218 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            777777777666777889999999999999999999999999876

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-38  Score=239.25  Aligned_cols=193  Identities=23%  Similarity=0.444  Sum_probs=154.5

Q ss_pred             cccCC--CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            4 FSQFE--HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         4 l~~l~--h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +++++  ||||+++++++.+++..+++||+ .+++|.+++... .+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        80 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI  158 (313)
T 3cek_A           80 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF  158 (313)
T ss_dssp             HHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             HHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccE
Confidence            45566  59999999999999999999994 567999998764 489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc--------------ccccCcccccccccccC---------CCCCcchhhHHHHHHHHHHHHhCCC
Q 046714           81 LVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLK---------NNGYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        81 ll~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~---------~~~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      ++++ |.+++.+...              ...+++.|+|||.+...         ...++.++||||||+++|+|++|+.
T Consensus       159 l~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~  237 (313)
T 3cek_A          159 LIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT  237 (313)
T ss_dssp             EEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             EEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCC
Confidence            9964 5555554321              22468889999998421         2457889999999999999999999


Q ss_pred             CCCCchH-HHHHHHh-hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          138 PYSHLED-MQALFRI-GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       138 p~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ||..... ....... .......++...++.+.+++.+||+.+|.+|||++++++||||+...
T Consensus       238 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          238 PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             TTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             chhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            9976532 2222232 23333456677789999999999999999999999999999998753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.9e-39  Score=242.20  Aligned_cols=186  Identities=25%  Similarity=0.468  Sum_probs=157.4

Q ss_pred             ccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+.  ...++||||+.+++|.+++...++++..++.++.|++.||+|||+.|++|+||||+||
T Consensus        86 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Ni  165 (318)
T 3lxp_A           86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNV  165 (318)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             HHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheE
Confidence            46789999999999999874  6789999999999999999988899999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc---------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVKS---------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~---------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      +++.++.+++.+....               ..++..|+|||.+  .+..++.++||||+|+++|++++|..||......
T Consensus       166 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~  243 (318)
T 3lxp_A          166 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK  243 (318)
T ss_dssp             EECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH
T ss_pred             EEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHh--cCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh
Confidence            9999887776654321               2245669999998  4556789999999999999999999998654322


Q ss_pred             ---------------HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 ---------------QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                                     ..............+..+++.+.+++.+||+.+|.+|||++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          244 FLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                           122233445555677889999999999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-39  Score=250.17  Aligned_cols=193  Identities=28%  Similarity=0.458  Sum_probs=148.5

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|+++ +||||+++++++.+.+..+++||++.+ +|.+++....  .....+..++.||+.||+|||+.||+||||||+|
T Consensus        70 ~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~N  148 (432)
T 3p23_A           70 LLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHN  148 (432)
T ss_dssp             HHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTS
T ss_pred             HHHhccCCCCcCeEEEEEecCCEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHH
Confidence            35566 799999999999999999999999975 9999997654  5555678999999999999999999999999999


Q ss_pred             EEEccC---Cc--eeeecCc---------------cccccCcccccccccccC-CCCCcchhhHHHHHHHHHHHHh-CCC
Q 046714           80 ILVDAS---GL--ATTTNDV---------------KSFEGTPFWVAPEVVNLK-NNGYGLSADIWSLGCTVLEMLT-HQP  137 (201)
Q Consensus        80 ill~~~---g~--~~~~~~~---------------~~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slG~~l~~l~~-g~~  137 (201)
                      |+++.+   |.  +++.+..               ....||+.|+|||.+... ...++.++||||+||++|++++ |..
T Consensus       149 Ill~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~  228 (432)
T 3p23_A          149 ILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH  228 (432)
T ss_dssp             EEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCB
T ss_pred             EEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCC
Confidence            999532   21  2233321               123478999999998422 4556789999999999999999 999


Q ss_pred             CCCCchHHHHHHHhhcCCCCC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          138 PYSHLEDMQALFRIGRGKLPS--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       138 p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ||...................  .....+..+.+++.+||+.+|.+|||++++++||||..
T Consensus       229 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          229 PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             TTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             CcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            997654443333222222211  12234556889999999999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.6e-39  Score=251.08  Aligned_cols=193  Identities=29%  Similarity=0.457  Sum_probs=144.2

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCC--------HHHHHHHHHHHHHHHHHHhhcCccccC
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLS--------DSQVSSYTRQILNGLTYLHERNVVHRE   74 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~i~~~l~~lh~~~i~H~d   74 (201)
                      |+++ +||||+++++++.+++..++||||+.+ +|.+++......        +..++.++.||+.||+|||++||+|+|
T Consensus        62 l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD  140 (434)
T 2rio_A           62 LTESDDHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRD  140 (434)
T ss_dssp             HHHHTTSTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHhccCCCCcCeEEEEEecCCeEEEEEecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccC
Confidence            4444 899999999999999999999999965 999999865422        223567999999999999999999999


Q ss_pred             CCCCcEEEccCC-------------ceeeecCc----------------cccccCcccccccccccC-----CCCCcchh
Q 046714           75 IKCANILVDASG-------------LATTTNDV----------------KSFEGTPFWVAPEVVNLK-----NNGYGLSA  120 (201)
Q Consensus        75 l~p~nill~~~g-------------~~~~~~~~----------------~~~~~~~~~~aPE~~~~~-----~~~~~~~~  120 (201)
                      |||+||+++.+|             .+++.+..                ....+++.|+|||.+...     ...++.++
T Consensus       141 Lkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~  220 (434)
T 2rio_A          141 LKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI  220 (434)
T ss_dssp             CSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHH
T ss_pred             CChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhh
Confidence            999999997543             33333321                123578899999998431     25678999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCCchHHHHHHHhhcCCCCCC----CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          121 DIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPSV----PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       121 Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      ||||+||++|++++ |+.||.................+..    +..+++++.+++.+||+.+|.+|||+.++++||||.
T Consensus       221 DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~  300 (434)
T 2rio_A          221 DIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW  300 (434)
T ss_dssp             HHHHHHHHHHHHHTTSCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             hhHhHHHHHHHHHhCCCCCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence            99999999999999 9999976543322111111111111    113457899999999999999999999999999997


Q ss_pred             Cc
Q 046714          196 RP  197 (201)
Q Consensus       196 ~~  197 (201)
                      ..
T Consensus       301 ~~  302 (434)
T 2rio_A          301 PK  302 (434)
T ss_dssp             CH
T ss_pred             Cc
Confidence            53

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=247.54  Aligned_cols=185  Identities=19%  Similarity=0.254  Sum_probs=148.7

Q ss_pred             ccccCCCcceeccceeeee----CCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD----ENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      .+++++||||+++++++..    .+..++||||+ +++|.+++... .+++..++.++.||+.||+|||++|++|+||||
T Consensus       101 ~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  179 (345)
T 2v62_A          101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKA  179 (345)
T ss_dssp             HHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             hhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCH
Confidence            3567899999999999888    77899999999 88999998754 599999999999999999999999999999999


Q ss_pred             CcEEEccCC--ceeeecCcc-------------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCC
Q 046714           78 ANILVDASG--LATTTNDVK-------------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        78 ~nill~~~g--~~~~~~~~~-------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                      +||+++.++  .+++.+...                   ...+++.|+|||.+  .+..++.++||||||+++|+|++|+
T Consensus       180 ~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~g~  257 (345)
T 2v62_A          180 ANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH--KGVALSRRSDVEILGYCMLRWLCGK  257 (345)
T ss_dssp             GGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH--HTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             HHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHh--cCCCCCchhhHHHHHHHHHHHHhCC
Confidence            999998776  666555322                   23478889999998  4556899999999999999999999


Q ss_pred             CCCCCc-hHHHHHHH---hhcCCCCC------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          137 PPYSHL-EDMQALFR---IGRGKLPS------VPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       137 ~p~~~~-~~~~~~~~---~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .||... ........   ......+.      ....+++.+.+++.+||+.+|++|||++++++
T Consensus       258 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          258 LPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             CTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            999542 11111111   11111111      11268899999999999999999999999865

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.4e-38  Score=236.99  Aligned_cols=186  Identities=25%  Similarity=0.340  Sum_probs=153.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      ++++++||||+++++++.+++..++++||+.+++|.+++... .+++..+..++.|++.||+|||+.|++|+||+|+||+
T Consensus        87 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl  166 (309)
T 2h34_A           87 TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENIL  166 (309)
T ss_dssp             HHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEE
Confidence            477899999999999999999999999999999999998764 4999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc-------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           82 VDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        82 l~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      ++.+|.+++.+...             ...+++.|+|||.+  .+..++.++|+||||+++|++++|+.||.........
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  244 (309)
T 2h34_A          167 VSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF--SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG  244 (309)
T ss_dssp             ECTTSCEEECSCCC----------------CCGGGCCGGGT--CC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH
T ss_pred             EcCCCCEEEecCccCccccccccccccccCCCcCccCHHHH--cCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH
Confidence            99888777665431             23467789999998  4556788999999999999999999999887665443


Q ss_pred             HHhhcCCC--CCCCCCCCHHHHHHHHHHhhcCCCCCC-CHhHHhc
Q 046714          149 FRIGRGKL--PSVPNSLSRDARDFILKCLQVNPNDRP-TAAQLME  190 (201)
Q Consensus       149 ~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~-t~~~il~  190 (201)
                      ..+.....  ...+..+++.+.+++.+||+.+|++|| |++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          245 AHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            33332221  234567899999999999999999999 8888765

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.1e-39  Score=245.78  Aligned_cols=188  Identities=24%  Similarity=0.400  Sum_probs=148.9

Q ss_pred             CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHh--hcCccccCCCCCcEEEc
Q 046714            9 HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLH--ERNVVHREIKCANILVD   83 (201)
Q Consensus         9 h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh--~~~i~H~dl~p~nill~   83 (201)
                      |++|+++++.+...+..++||||+.+ +|.+++...   ++++..+..++.|++.||.|||  +.||+|+||||+||+++
T Consensus       115 ~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~  193 (382)
T 2vx3_A          115 KYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLC  193 (382)
T ss_dssp             GGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEES
T ss_pred             ceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEe
Confidence            44699999999999999999999976 999998764   4899999999999999999999  57999999999999995


Q ss_pred             c--CCceeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           84 A--SGLATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        84 ~--~g~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      .  ++.+++.+..         ....+++.|+|||.+  .+..++.++|||||||++|+|++|+.||......+....+.
T Consensus       194 ~~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~  271 (382)
T 2vx3_A          194 NPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV  271 (382)
T ss_dssp             STTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cCCCCcEEEEeccCceecccccccccCCccccChHHH--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            4  5556555543         234578889999998  45568899999999999999999999998876655544432


Q ss_pred             cCC--CC---------------CCC------------------CC----------------------------CCHHHHH
Q 046714          153 RGK--LP---------------SVP------------------NS----------------------------LSRDARD  169 (201)
Q Consensus       153 ~~~--~~---------------~~~------------------~~----------------------------~~~~~~~  169 (201)
                      ...  .+               .++                  ..                            ..+.+.+
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  351 (382)
T 2vx3_A          272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD  351 (382)
T ss_dssp             HHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHH
T ss_pred             HHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHH
Confidence            110  00               000                  00                            0136889


Q ss_pred             HHHHHhhcCCCCCCCHhHHhcCccccCcCC
Q 046714          170 FILKCLQVNPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       170 li~~~l~~~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      |+.+||+.||++|||++|+++||||++..+
T Consensus       352 li~~mL~~dP~~Rpta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          352 LILRMLDYDPKTRIQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTTSGGGCC---
T ss_pred             HHHHhcCCChhhCCCHHHHhcCcccccCCC
Confidence            999999999999999999999999987653

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=238.30  Aligned_cols=184  Identities=24%  Similarity=0.527  Sum_probs=154.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHhh---cCccccCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH----LSDSQVSSYTRQILNGLTYLHE---RNVVHREI   75 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~i~~~l~~lh~---~~i~H~dl   75 (201)
                      +|++++||||+++++++.+.  .++||||+.+++|.+++....    ++...+..++.|++.||+|||+   +|++|+||
T Consensus        54 ~l~~l~hp~iv~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dl  131 (307)
T 2eva_A           54 QLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDL  131 (307)
T ss_dssp             HHHHCCCTTBCCEEEBCTTT--TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCC
T ss_pred             HHhcCCCCCcCeEEEEEcCC--cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCC
Confidence            46788999999999988754  789999999999999997643    7889999999999999999999   89999999


Q ss_pred             CCCcEEEccCCc-eeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc--h
Q 046714           76 KCANILVDASGL-ATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL--E  143 (201)
Q Consensus        76 ~p~nill~~~g~-~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~--~  143 (201)
                      ||+||+++.+|. +++.+...         ...+++.|+|||.+  .+..++.++||||||+++|++++|+.||...  .
T Consensus       132 kp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  209 (307)
T 2eva_A          132 KPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVF--EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP  209 (307)
T ss_dssp             SGGGEEEETTTTEEEECCCCC------------CCTTSSCHHHH--TCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS
T ss_pred             ChhHEEEeCCCCEEEEcccccccccccccccCCCCCceEChhhh--CCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc
Confidence            999999998876 45555432         23478889999998  4557889999999999999999999999754  2


Q ss_pred             HHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          144 DMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..........+..+..+..+++.+.+++.+||+.+|.+|||++++++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          210 AFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             HHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            33334445556666777889999999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.6e-39  Score=238.77  Aligned_cols=186  Identities=26%  Similarity=0.473  Sum_probs=154.2

Q ss_pred             ccccCCCcceeccceeeeeC--CeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      +|++++||||+++++++.+.  +..+++|||+.+++|.+++...  .+++..+..++.|++.||+|||++|++|+||||+
T Consensus        76 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~  155 (302)
T 4e5w_A           76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR  155 (302)
T ss_dssp             HHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchh
Confidence            46789999999999999876  6689999999999999998543  4899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc-
Q 046714           79 NILVDASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL-  142 (201)
Q Consensus        79 nill~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-  142 (201)
                      ||+++.+|.+++.+...               ...++..|+|||.+  .+..++.++|+||+|+++|++++|..|+... 
T Consensus       156 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  233 (302)
T 4e5w_A          156 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL--MQSKFYIASDVWSFGVTLHELLTYCDSDSSPM  233 (302)
T ss_dssp             GEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred             eEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeee--cCCCCCcchhHHHHHHHHHHHHHccCCCcchh
Confidence            99999888776665432               12355669999998  4556789999999999999999998875322 


Q ss_pred             --------------hHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          143 --------------EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       143 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                                    ...........+.....+..+++.+.+++.+||+.+|.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          234 ALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             hHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                          222333444555556677889999999999999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.8e-39  Score=244.15  Aligned_cols=191  Identities=20%  Similarity=0.340  Sum_probs=149.8

Q ss_pred             cccCCCcc------eeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccC
Q 046714            4 FSQFEHDN------IVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHRE   74 (201)
Q Consensus         4 l~~l~h~~------I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d   74 (201)
                      +++++|++      |+.+++++...+..++||||+. +++.+.+...   .+++..+..++.||+.||+|||++||+|+|
T Consensus        70 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~D  148 (355)
T 2eu9_A           70 LKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTD  148 (355)
T ss_dssp             HHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred             HHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence            44455554      9999999999999999999995 4776766543   489999999999999999999999999999


Q ss_pred             CCCCcEEE-------------------ccCCceeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHH
Q 046714           75 IKCANILV-------------------DASGLATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLG  126 (201)
Q Consensus        75 l~p~nill-------------------~~~g~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG  126 (201)
                      |||+||++                   +.++.+++.+..         ....+++.|+|||.+  .+..++.++|+||||
T Consensus       149 lkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG  226 (355)
T 2eu9_A          149 LKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVI--LELGWAQPCDVWSIG  226 (355)
T ss_dssp             CCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHH--TTCCCCTHHHHHHHH
T ss_pred             CCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeee--ecCCCCCccchHHHH
Confidence            99999999                   444555555432         234578889999998  455688999999999


Q ss_pred             HHHHHHHhCCCCCCCchHHHHHHHhhc--CCCC-----------------------------------------CCCCCC
Q 046714          127 CTVLEMLTHQPPYSHLEDMQALFRIGR--GKLP-----------------------------------------SVPNSL  163 (201)
Q Consensus       127 ~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~-----------------------------------------~~~~~~  163 (201)
                      +++|+|++|+.||...........+..  +..+                                         ......
T Consensus       227 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (355)
T 2eu9_A          227 CILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE  306 (355)
T ss_dssp             HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHH
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchh
Confidence            999999999999987665544333211  1100                                         001112


Q ss_pred             CHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          164 SRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       164 ~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      +..+.+|+.+||+.+|.+|||++|+++||||+..
T Consensus       307 ~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL  340 (355)
T ss_dssp             HHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred             HHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence            4578899999999999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.2e-39  Score=246.85  Aligned_cols=185  Identities=16%  Similarity=0.260  Sum_probs=147.8

Q ss_pred             ccccCCCcceeccceeeeeC----CeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE----NRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      .+++++||||+++++++...    ...++||||+ +++|.+++...  .+++..+..++.||+.||+|||++||+|+|||
T Consensus       101 ~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlk  179 (364)
T 3op5_A          101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIK  179 (364)
T ss_dssp             HHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             HHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCC
Confidence            35788999999999998765    4589999999 88999999764  49999999999999999999999999999999


Q ss_pred             CCcEEEc--cCCceeeecCccc-------------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC
Q 046714           77 CANILVD--ASGLATTTNDVKS-------------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH  135 (201)
Q Consensus        77 p~nill~--~~g~~~~~~~~~~-------------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g  135 (201)
                      |+||+++  .++.+++.++...                   ..+|+.|+|||.+  .+..++.++||||||+++|+|++|
T Consensus       180 p~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~~l~el~~g  257 (364)
T 3op5_A          180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH--NGVAPSRRGDLEILGYCMIQWLTG  257 (364)
T ss_dssp             GGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             HHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh--CCCCCCchhhHHHHHHHHHHHHhC
Confidence            9999998  6666666554321                   2378899999998  455689999999999999999999


Q ss_pred             CCCCCCchHHHH-HHHhh---cCCCC------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          136 QPPYSHLEDMQA-LFRIG---RGKLP------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       136 ~~p~~~~~~~~~-~~~~~---~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +.||........ .....   .....      .....+++++.+++..||..+|.+|||++++++
T Consensus       258 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          258 HLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             CCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            999975321111 11000   00000      012467899999999999999999999998865

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.3e-39  Score=256.06  Aligned_cols=186  Identities=26%  Similarity=0.461  Sum_probs=162.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++||||+++++++.+ +..++||||+.+++|.++++.   ..+++..++.++.||+.||+|||++||+|+||||+|
T Consensus       315 ~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N  393 (535)
T 2h8h_A          315 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN  393 (535)
T ss_dssp             HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             HHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhh
Confidence            5788999999999999876 668999999999999999964   348999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      |+++.++.+++.++...             ..++..|+|||.+  ....++.++||||||+++|+|++ |+.||......
T Consensus       394 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~  471 (535)
T 2h8h_A          394 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  471 (535)
T ss_dssp             EEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH
T ss_pred             EEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHh--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99998887777765322             1234679999998  34568899999999999999999 99999988887


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +....+..+.....+..+++.+.++|.+||..+|++|||++++++.
T Consensus       472 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          472 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8877777777667788899999999999999999999999998763

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4e-39  Score=241.65  Aligned_cols=187  Identities=24%  Similarity=0.465  Sum_probs=156.0

Q ss_pred             ccccC-CCcceeccceeeeeCC-eEEEEEEecCCCCHHHHHHhcC-----------------CCHHHHHHHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDEN-RLYIFLELVKKGSLANLYQKYH-----------------LSDSQVSSYTRQILNGLT   63 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~-----------------~~~~~~~~~~~~i~~~l~   63 (201)
                      +++++ +||||+++++++...+ ..++++||+.+++|.+++....                 +++..+..++.|++.||+
T Consensus        83 ~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~  162 (316)
T 2xir_A           83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME  162 (316)
T ss_dssp             HHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHH
T ss_pred             HHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHH
Confidence            35566 6999999999988754 5899999999999999997643                 788999999999999999


Q ss_pred             HHhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHH
Q 046714           64 YLHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTV  129 (201)
Q Consensus        64 ~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l  129 (201)
                      |||+.|++|+||||+||+++.+|.+++.+....              ..+++.|+|||.+  .+..++.++|+||+|+++
T Consensus       163 ~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il  240 (316)
T 2xir_A          163 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLL  240 (316)
T ss_dssp             HHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH--HHCCCCHHHHHHHHHHHH
T ss_pred             HHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhh--ccccccchhHHHHHHHHH
Confidence            999999999999999999998887777664321              2245679999998  455678999999999999


Q ss_pred             HHHHh-CCCCCCCchH-HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          130 LEMLT-HQPPYSHLED-MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       130 ~~l~~-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      |++++ |+.||..... ......+..+.....+..+++.+.+++.+||+.+|.+|||+.+++++
T Consensus       241 ~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          241 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99998 9999976543 33334445555556677889999999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.5e-40  Score=246.71  Aligned_cols=188  Identities=24%  Similarity=0.370  Sum_probs=150.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      ++++++||||+++++++.+++..++||||+.+++|.+++...     .+++..+..++.|++.||+|||++|++|+||||
T Consensus        88 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp  167 (321)
T 2qkw_B           88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKS  167 (321)
T ss_dssp             GGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCS
T ss_pred             HHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCH
Confidence            578899999999999999999999999999999999988653     388999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           78 ANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      +||+++.+|.+++.+....              ..+++.|+|||.+  .+..++.++||||||+++|++++|+.||....
T Consensus       168 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~g~~p~~~~~  245 (321)
T 2qkw_B          168 INILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF--IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL  245 (321)
T ss_dssp             TTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHH--HHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred             HHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHh--cCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence            9999999887776654321              2267789999998  34567899999999999999999999986432


Q ss_pred             HHH------H-HHHhhcCCC-----C----CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          144 DMQ------A-LFRIGRGKL-----P----SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       144 ~~~------~-~~~~~~~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                      ...      . .........     +    ..+...+..+.+++.+||+.+|++|||+.+++++-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            111      0 011111111     1    11223456788999999999999999999998764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.6e-39  Score=241.14  Aligned_cols=187  Identities=25%  Similarity=0.451  Sum_probs=156.1

Q ss_pred             ccccCCCcceeccceeee--eCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEK--DENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++||||+++++++.  +.+..++||||+.+++|.+++..  ..+++..++.++.|++.||+|||+.|++|+||||+
T Consensus        77 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~  156 (327)
T 3lxl_A           77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAAR  156 (327)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             HHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChh
Confidence            577899999999999886  45678999999999999999875  34999999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCccc---------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           79 NILVDASGLATTTNDVKS---------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        79 nill~~~g~~~~~~~~~~---------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      ||+++.+|.+++.+....               ..++..|+|||.+  .+..++.++||||||+++|++++|..||....
T Consensus       157 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~  234 (327)
T 3lxl_A          157 NILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL--SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS  234 (327)
T ss_dssp             GEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred             hEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHh--ccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence            999999887766654321               2255669999998  45567899999999999999999999986543


Q ss_pred             HH---------------HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          144 DM---------------QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       144 ~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ..               ........+.....+..+++.+.+++.+||+.+|.+|||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          235 AEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            32               2333344555566778899999999999999999999999999653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-38  Score=237.45  Aligned_cols=182  Identities=23%  Similarity=0.382  Sum_probs=145.2

Q ss_pred             ccCCCcceeccceeeee----CCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            5 SQFEHDNIVQYIGTEKD----ENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      +.++||||+++++++..    .+..++||||+.+++|.+++...   .+++..+..++.|++.||+|||++|++|+||||
T Consensus        66 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp  145 (299)
T 3m2w_A           66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP  145 (299)
T ss_dssp             HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence            56789999999999887    67899999999999999999765   399999999999999999999999999999999


Q ss_pred             CcEEEcc---CCceeeecCccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcC
Q 046714           78 ANILVDA---SGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG  154 (201)
Q Consensus        78 ~nill~~---~g~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  154 (201)
                      +||+++.   ++.+++.+......            ..+..++.++|+||+|+++|+|++|+.||...............
T Consensus       146 ~Nil~~~~~~~~~~kl~Dfg~a~~------------~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  213 (299)
T 3m2w_A          146 ENLLYTSKRPNAILKLTDFGFAKE------------TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR  213 (299)
T ss_dssp             GGEEESSSSTTCCEEECCCTTCEE------------CTTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS
T ss_pred             HHEEEecCCCCCcEEEeccccccc------------cccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH
Confidence            9999998   56666666543211            13456788999999999999999999999775543332111111


Q ss_pred             ---CCCCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          155 ---KLPSVP----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       155 ---~~~~~~----~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                         .....+    ..+++++.+++.+||+.+|.+|||++|+++||||+...
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence               111112    46789999999999999999999999999999997653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.3e-38  Score=235.69  Aligned_cols=184  Identities=17%  Similarity=0.220  Sum_probs=150.3

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++ +|+||+++++++.+....++++||+ +++|.+++...  .+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        59 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NI  137 (298)
T 1csn_A           59 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF  137 (298)
T ss_dssp             HHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred             HHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence            4556 7999999999999999999999999 88999999853  489999999999999999999999999999999999


Q ss_pred             EEccCCc-----eeeecCc-------------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCC
Q 046714           81 LVDASGL-----ATTTNDV-------------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        81 ll~~~g~-----~~~~~~~-------------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                      +++.+|.     +++.+..                   ....+++.|+|||.+  .+..++.++||||||+++|++++|+
T Consensus       138 l~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~  215 (298)
T 1csn_A          138 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGS  215 (298)
T ss_dssp             EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             EeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhh--cCCCCChHHHHHHHHHHHHHHHcCC
Confidence            9987654     5555432                   123477889999998  4556789999999999999999999


Q ss_pred             CCCCCch---HHHHHHHh----hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          137 PPYSHLE---DMQALFRI----GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       137 ~p~~~~~---~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .||....   .......+    .....+.....+++.+.+++.+||+.+|.+|||++++++
T Consensus       216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          216 LPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             CTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            9997632   22222222    122222334578999999999999999999999999865

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.2e-38  Score=235.11  Aligned_cols=187  Identities=24%  Similarity=0.537  Sum_probs=150.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||++++++. ..+..++||||+.+++|.+++..  ..+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus        73 ~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Ni  151 (289)
T 3og7_A           73 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNI  151 (289)
T ss_dssp             HHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             HHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence            57889999999999965 45568999999999999999854  3489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc--------------ccccCccccccccccc-CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNL-KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~-~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      +++.+|.+++.+...              ...+++.|+|||.+.. ....++.++||||+|+++|++++|+.||......
T Consensus       152 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  231 (289)
T 3og7_A          152 FLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR  231 (289)
T ss_dssp             EEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH
T ss_pred             EECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH
Confidence            999988777665432              1246888999999842 2456788999999999999999999999875444


Q ss_pred             HHHHH-hhcCC----CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFR-IGRGK----LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~-~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..... ...+.    .......+++.+.+++.+||+.+|.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          232 DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            43333 22222    22344578899999999999999999999999976

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.1e-39  Score=249.11  Aligned_cols=186  Identities=27%  Similarity=0.423  Sum_probs=143.0

Q ss_pred             CCcceeccceeee----eCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc-CccccCCCCCc
Q 046714            8 EHDNIVQYIGTEK----DENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHER-NVVHREIKCAN   79 (201)
Q Consensus         8 ~h~~I~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~p~n   79 (201)
                      .||||+++++.+.    +....++||||+.+ ++.+.+..   .++++..++.++.||+.||+|||++ ||+|+||||+|
T Consensus        99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N  177 (397)
T 1wak_A           99 NREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN  177 (397)
T ss_dssp             GGGGBCCEEEEEEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred             CcceeeeeecceeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence            3889999999987    55689999999955 66665543   3499999999999999999999998 99999999999


Q ss_pred             EEEccCC-------------------------------------------------ceeeecCc---------cccccCc
Q 046714           80 ILVDASG-------------------------------------------------LATTTNDV---------KSFEGTP  101 (201)
Q Consensus        80 ill~~~g-------------------------------------------------~~~~~~~~---------~~~~~~~  101 (201)
                      |+++.+|                                                 .+++.+..         ....+|+
T Consensus       178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~  257 (397)
T 1wak_A          178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTR  257 (397)
T ss_dssp             EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCG
T ss_pred             eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCC
Confidence            9998765                                                 34444332         2344788


Q ss_pred             ccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHhh--cCCCC----------------
Q 046714          102 FWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE------DMQALFRIG--RGKLP----------------  157 (201)
Q Consensus       102 ~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~--~~~~~----------------  157 (201)
                      .|+|||.+  .+..++.++|||||||++|+|++|+.||....      .......+.  .+..+                
T Consensus       258 ~y~aPE~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  335 (397)
T 1wak_A          258 QYRSLEVL--IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK  335 (397)
T ss_dssp             GGCCHHHH--HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred             cccCChhh--cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence            99999998  45568899999999999999999999996432      111111110  01000                


Q ss_pred             -----------------------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          158 -----------------------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       158 -----------------------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                                             ..+...++.+.+|+.+||+.+|++|||++|+++||||+.
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                                   112223456889999999999999999999999999974

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.8e-39  Score=242.99  Aligned_cols=186  Identities=22%  Similarity=0.432  Sum_probs=155.0

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---------------CCCHHHHHHHHHHHHHHHHHHh
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---------------HLSDSQVSSYTRQILNGLTYLH   66 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~lh   66 (201)
                      +++++ +||||+++++++.+.+..++||||+.+++|.+++...               .+++..+..++.|++.||+|||
T Consensus       102 ~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  181 (333)
T 2i1m_A          102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA  181 (333)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh
Confidence            45677 8999999999999999999999999999999998642               3789999999999999999999


Q ss_pred             hcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHH
Q 046714           67 ERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEM  132 (201)
Q Consensus        67 ~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l  132 (201)
                      ++|++|+||||+||+++.++.+++.+....              ..+++.|+|||.+  .+..++.++||||||+++|+|
T Consensus       182 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el  259 (333)
T 2i1m_A          182 SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI--FDCVYTVQSDVWSYGILLWEI  259 (333)
T ss_dssp             HTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHH
T ss_pred             cCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHh--ccCCCChHHHHHHHHHHHHHH
Confidence            999999999999999998877766654321              2245679999997  345678999999999999999


Q ss_pred             Hh-CCCCCCCchHHHHHH-HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          133 LT-HQPPYSHLEDMQALF-RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       133 ~~-g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ++ |..||.......... ..........+...++.+.+++.+||+.+|.+|||++++++
T Consensus       260 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          260 FSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             TTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            98 999997754333332 33334444566778999999999999999999999999976

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.5e-38  Score=234.02  Aligned_cols=187  Identities=29%  Similarity=0.576  Sum_probs=153.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      ++++++||||+++++++.+.+..+++|||+.+++|.+++..     ..+++..++.++.|++.||+|||+.|++|+||+|
T Consensus        85 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p  164 (310)
T 2wqm_A           85 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKP  164 (310)
T ss_dssp             HHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred             HHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcH
Confidence            46789999999999999999999999999999999998864     3489999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch--
Q 046714           78 ANILVDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE--  143 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--  143 (201)
                      +||+++.+|.+++.+...            ...+++.|+|||.+  .+..++.++|+||||+++|++++|..||....  
T Consensus       165 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  242 (310)
T 2wqm_A          165 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN  242 (310)
T ss_dssp             GGEEECTTSCEEECCC------------------CCSSCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC
T ss_pred             HHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHh--CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh
Confidence            999999988777665432            22467789999998  45567899999999999999999999996532  


Q ss_pred             HHHHHHHhhcCCCCCC-CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          144 DMQALFRIGRGKLPSV-PNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       144 ~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      .......+.....+.. ...+++.+.+++.+||..+|.+|||+.++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          243 LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            2233334444433333 36689999999999999999999999998763

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=239.12  Aligned_cols=189  Identities=22%  Similarity=0.363  Sum_probs=151.0

Q ss_pred             ccccCCCcceeccceeeee----CCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcCcccc
Q 046714            3 SFSQFEHDNIVQYIGTEKD----ENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERNVVHR   73 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~   73 (201)
                      ++++++||||+++++++..    .+..++|+||+.+++|.+++..     ..+++..++.++.|++.||+|||++|++|+
T Consensus        79 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~  158 (317)
T 2buj_A           79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHR  158 (317)
T ss_dssp             HHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            4678999999999999873    4578999999999999998875     348999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceeeecCccc---------------------cccCcccccccccccC-CCCCcchhhHHHHHHHHHH
Q 046714           74 EIKCANILVDASGLATTTNDVKS---------------------FEGTPFWVAPEVVNLK-NNGYGLSADIWSLGCTVLE  131 (201)
Q Consensus        74 dl~p~nill~~~g~~~~~~~~~~---------------------~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slG~~l~~  131 (201)
                      ||||+||+++.+|.+++.+....                     ..+++.|+|||.+... ...++.++||||||+++|+
T Consensus       159 dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e  238 (317)
T 2buj_A          159 DLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA  238 (317)
T ss_dssp             CCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHH
Confidence            99999999999888777665421                     1247889999997322 1236789999999999999


Q ss_pred             HHhCCCCCCCchHH--HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          132 MLTHQPPYSHLEDM--QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       132 l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +++|+.||......  ..............+..+++.+.+++.+||+.+|.+|||+++++++
T Consensus       239 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          239 MMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            99999998542111  1111222222233445689999999999999999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.2e-38  Score=256.92  Aligned_cols=185  Identities=26%  Similarity=0.468  Sum_probs=161.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+ +..++||||+.+++|.++++..  .+++..+..++.|++.||+|||++|++|+||||+||
T Consensus       444 ~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NI  522 (656)
T 2j0j_A          444 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV  522 (656)
T ss_dssp             HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             HHHhCCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhE
Confidence            4678899999999999854 5689999999999999999754  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.+|.+++.+....             ..+++.|+|||.+  .+..++.++||||||+++|++++ |..||.+....+
T Consensus       523 Ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  600 (656)
T 2j0j_A          523 LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  600 (656)
T ss_dssp             EEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHh--cCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            9999887777665322             1234679999998  34568899999999999999997 999999888878


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ....+..+.....+..+++.+.+++.+||..+|.+|||+.++++
T Consensus       601 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          601 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            87777777777788899999999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.3e-39  Score=244.08  Aligned_cols=188  Identities=22%  Similarity=0.305  Sum_probs=150.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHhhc---CccccC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----LSDSQVSSYTRQILNGLTYLHER---NVVHRE   74 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~i~~~l~~lh~~---~i~H~d   74 (201)
                      ++++++||||+++++++.+.+..++||||+.+++|.+++....     +++..+..++.|++.||+|||+.   |++|+|
T Consensus        80 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~D  159 (326)
T 3uim_A           80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRD  159 (326)
T ss_dssp             GGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCC
T ss_pred             HHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Confidence            5788999999999999999999999999999999999997543     89999999999999999999999   999999


Q ss_pred             CCCCcEEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Q 046714           75 IKCANILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH  141 (201)
Q Consensus        75 l~p~nill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  141 (201)
                      |||+||+++.++.+++.+....             ..+++.|+|||.+  .+..++.++||||+|+++|+|++|+.||..
T Consensus       160 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~  237 (326)
T 3uim_A          160 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL--STGKSSEKTDVFGYGVMLLELITGQRAFDL  237 (326)
T ss_dssp             CSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHH--HHSEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred             CchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHh--ccCCCCccccchhHHHHHHHHHhCCCcccc
Confidence            9999999999887776654321             2378889999998  345678999999999999999999999952


Q ss_pred             chH--------HHHHHHhhcC-CC---------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          142 LED--------MQALFRIGRG-KL---------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       142 ~~~--------~~~~~~~~~~-~~---------~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                      ...        .......... ..         ...+...++.+.+++.+||+.+|.+|||+.+++++-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  306 (326)
T 3uim_A          238 ARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML  306 (326)
T ss_dssp             HHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             cccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence            111        1111111111 00         011122346789999999999999999999998863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.5e-39  Score=244.69  Aligned_cols=189  Identities=24%  Similarity=0.425  Sum_probs=146.0

Q ss_pred             CCcceeccceeeeeCC----eEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc-CccccCCCCCc
Q 046714            8 EHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHER-NVVHREIKCAN   79 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~p~n   79 (201)
                      .||||+++++++...+    ..++++|++ +++|.+++..   .++++..+..++.||+.||+|||++ |++|+||||+|
T Consensus        84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~N  162 (373)
T 1q8y_A           84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN  162 (373)
T ss_dssp             HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred             ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHH
Confidence            4899999999988654    789999999 7799999875   3489999999999999999999998 99999999999


Q ss_pred             EEEccCC------ceeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           80 ILVDASG------LATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        80 ill~~~g------~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      |+++.+|      .+++.+..         ....+++.|+|||.+  .+..++.++||||||+++|+|++|+.||.....
T Consensus       163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  240 (373)
T 1q8y_A          163 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEG  240 (373)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHH--HTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             eEEeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHH--hCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence            9995332      34444332         234578899999998  455678999999999999999999999975431


Q ss_pred             ------HHHHHHhhc--CC---------------------------------------CCCCCCCCCHHHHHHHHHHhhc
Q 046714          145 ------MQALFRIGR--GK---------------------------------------LPSVPNSLSRDARDFILKCLQV  177 (201)
Q Consensus       145 ------~~~~~~~~~--~~---------------------------------------~~~~~~~~~~~~~~li~~~l~~  177 (201)
                            ......+..  +.                                       ...++..+++.+.+|+.+||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  320 (373)
T 1q8y_A          241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  320 (373)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence                  111111110  00                                       0112234467888999999999


Q ss_pred             CCCCCCCHhHHhcCccccCcCC
Q 046714          178 NPNDRPTAAQLMEHPFVKRPLQ  199 (201)
Q Consensus       178 ~p~~R~t~~~il~~~~~~~~~~  199 (201)
                      ||.+|||++|+++||||+....
T Consensus       321 dP~~Rpt~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          321 DPRKRADAGGLVNHPWLKDTLG  342 (373)
T ss_dssp             STTTCBCHHHHHTCGGGTTCTT
T ss_pred             CccccCCHHHHhhChhhhcccC
Confidence            9999999999999999998654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.7e-38  Score=238.77  Aligned_cols=184  Identities=20%  Similarity=0.267  Sum_probs=148.9

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +++++ +||||+++++++.+++..++||||+ +++|.+++..  ..+++..+..++.|++.||+|||+.|++|+||||+|
T Consensus        57 ~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N  135 (330)
T 2izr_A           57 FYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPEN  135 (330)
T ss_dssp             HHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence            45677 8999999999999999999999999 8899999985  469999999999999999999999999999999999


Q ss_pred             EEEccCCc-----eeeecCc-------------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC
Q 046714           80 ILVDASGL-----ATTTNDV-------------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH  135 (201)
Q Consensus        80 ill~~~g~-----~~~~~~~-------------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g  135 (201)
                      |+++.+|.     +++.+..                   ....||+.|+|||.+  .+..++.++|+||||+++|+|++|
T Consensus       136 ill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~ell~g  213 (330)
T 2izr_A          136 FLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTH--LGKEQSRRDDLEALGHMFMYFLRG  213 (330)
T ss_dssp             EEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred             eeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHH--cCCCCCchhHHHHHHHHHHHHhcC
Confidence            99988765     5555432                   234578899999998  456678999999999999999999


Q ss_pred             CCCCCCch---HHHHHHHhhcCC----CCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          136 QPPYSHLE---DMQALFRIGRGK----LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       136 ~~p~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +.||....   ..+....+....    ........+ ++.+++.+||..+|.+||+++++++
T Consensus       214 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          214 SLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             SCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            99997632   222222221111    111122344 9999999999999999999998865

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4e-38  Score=233.68  Aligned_cols=185  Identities=26%  Similarity=0.472  Sum_probs=156.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++ .++++||+.+++|.+++..  ..+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        74 ~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Ni  152 (291)
T 1u46_A           74 AMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL  152 (291)
T ss_dssp             HHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             HHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheE
Confidence            467889999999999998766 7899999999999998875  3499999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           81 LVDASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      +++.+|.+++.+...               ...++..|+|||.+  .+..++.++|+||||+++|++++ |+.||.....
T Consensus       153 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~  230 (291)
T 1u46_A          153 LLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG  230 (291)
T ss_dssp             EEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             EEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhh--cCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH
Confidence            999888776665432               12245579999998  44567899999999999999999 9999988777


Q ss_pred             HHHHHHhhcC-CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQALFRIGRG-KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ......+... .....+..+++.+.+++.+||..+|.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          231 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            6666665433 334556678999999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.3e-38  Score=233.29  Aligned_cols=186  Identities=23%  Similarity=0.417  Sum_probs=153.7

Q ss_pred             ccccCCCcceeccceeeee----------------CCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHH
Q 046714            3 SFSQFEHDNIVQYIGTEKD----------------ENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLT   63 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~   63 (201)
                      ++++++||||+++++++..                .+..+++|||+.+++|.+++...   .+++..++.++.|++.||+
T Consensus        57 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~  136 (284)
T 2a19_B           57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVD  136 (284)
T ss_dssp             HHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence            4678899999999998764                45689999999999999999653   4899999999999999999


Q ss_pred             HHhhcCccccCCCCCcEEEccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHH
Q 046714           64 YLHERNVVHREIKCANILVDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEM  132 (201)
Q Consensus        64 ~lh~~~i~H~dl~p~nill~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l  132 (201)
                      |||++|++|+||||+||+++.++.+++.+..           ....+++.|+|||.+  .+..++.++|+||||+++|+|
T Consensus       137 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~~l  214 (284)
T 2a19_B          137 YIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQI--SSQDYGKEVDLYALGLILAEL  214 (284)
T ss_dssp             HHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHH--HCSCCCTHHHHHHHHHHHHHH
T ss_pred             HHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhh--ccCCCcchhhhHHHHHHHHHH
Confidence            9999999999999999999988877666542           123477889999998  455678999999999999999


Q ss_pred             HhCCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          133 LTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       133 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      ++|..|+...  ..........   ..+..+++.+.+++.+||..+|.+|||+.+++++.+.-
T Consensus       215 ~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          215 LHVCDTAFET--SKFFTDLRDG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             HSCCSSHHHH--HHHHHHHHTT---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcCCcchhH--HHHHHHhhcc---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            9998877432  2222223222   34567889999999999999999999999999987643

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.2e-38  Score=234.57  Aligned_cols=185  Identities=24%  Similarity=0.430  Sum_probs=146.4

Q ss_pred             cCCCcceeccceeeee----CCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHh--------hcCcccc
Q 046714            6 QFEHDNIVQYIGTEKD----ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH--------ERNVVHR   73 (201)
Q Consensus         6 ~l~h~~I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~~i~H~   73 (201)
                      +++||||+++++++..    .+..++||||+.+++|.++++...+++..+..++.|++.||+|||        +.|++|+
T Consensus        58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~  137 (301)
T 3q4u_A           58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHR  137 (301)
T ss_dssp             CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECS
T ss_pred             hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecC
Confidence            4899999999998654    356899999999999999998888999999999999999999999        9999999


Q ss_pred             CCCCCcEEEccCCceeeecCcc----------------ccccCcccccccccccCCC----CCcchhhHHHHHHHHHHHH
Q 046714           74 EIKCANILVDASGLATTTNDVK----------------SFEGTPFWVAPEVVNLKNN----GYGLSADIWSLGCTVLEML  133 (201)
Q Consensus        74 dl~p~nill~~~g~~~~~~~~~----------------~~~~~~~~~aPE~~~~~~~----~~~~~~Dv~slG~~l~~l~  133 (201)
                      ||||+||+++.++.+++.+...                ...+++.|+|||.+.....    .++.++||||+|+++|+|+
T Consensus       138 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~  217 (301)
T 3q4u_A          138 DLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA  217 (301)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHH
Confidence            9999999999888777665432                1257889999999843211    3457999999999999999


Q ss_pred             hC----------CCCCCCch----HHHHHHHh--hcCCCCCCCC-----CCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          134 TH----------QPPYSHLE----DMQALFRI--GRGKLPSVPN-----SLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       134 ~g----------~~p~~~~~----~~~~~~~~--~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +|          ..||....    ........  .....+..+.     ..++.+.+++.+||+.+|++|||++++++
T Consensus       218 tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          218 RRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             hhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            99          78874421    11222221  2222223322     24567999999999999999999999975

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-37  Score=234.43  Aligned_cols=187  Identities=26%  Similarity=0.395  Sum_probs=147.2

Q ss_pred             ccCCCcceeccceeeeeC----CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc--------Cccc
Q 046714            5 SQFEHDNIVQYIGTEKDE----NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER--------NVVH   72 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------~i~H   72 (201)
                      ..++||||+++++++...    +..++||||+.+++|.++++...+++..+..++.|++.||+|||++        |++|
T Consensus        86 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH  165 (337)
T 3mdy_A           86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH  165 (337)
T ss_dssp             TTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEEC
T ss_pred             HhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEe
Confidence            346999999999998887    7899999999999999999988899999999999999999999998        9999


Q ss_pred             cCCCCCcEEEccCCceeeecCcc----------------ccccCcccccccccccCCCCC----cchhhHHHHHHHHHHH
Q 046714           73 REIKCANILVDASGLATTTNDVK----------------SFEGTPFWVAPEVVNLKNNGY----GLSADIWSLGCTVLEM  132 (201)
Q Consensus        73 ~dl~p~nill~~~g~~~~~~~~~----------------~~~~~~~~~aPE~~~~~~~~~----~~~~Dv~slG~~l~~l  132 (201)
                      +||||+||+++.+|.+++.+...                ...+++.|+|||.+.......    +.++||||||+++|+|
T Consensus       166 ~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el  245 (337)
T 3mdy_A          166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV  245 (337)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHH
T ss_pred             cccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHH
Confidence            99999999999888777766432                235788999999984322111    1249999999999999


Q ss_pred             HhC----------CCCCCCch-----HHHHHHHh-hcCCCCCCCC-----CCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          133 LTH----------QPPYSHLE-----DMQALFRI-GRGKLPSVPN-----SLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       133 ~~g----------~~p~~~~~-----~~~~~~~~-~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ++|          ..||....     ........ .....+..+.     .+++.+.+++.+||+.+|.+|||+++++++
T Consensus       246 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          246 ARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            999          66664321     11111111 2222233332     455679999999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.9e-38  Score=237.17  Aligned_cols=186  Identities=25%  Similarity=0.375  Sum_probs=150.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK----YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++||||+++++++.+.+..+++|||+.+++|.+++..    ..+++..+..++.|++.||+|||+.|++|+||||+
T Consensus        83 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~  162 (307)
T 2nru_A           83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSA  162 (307)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             HHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHH
Confidence            46788999999999999999999999999999999999863    24899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           79 NILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        79 nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      ||+++.+|.+++.+...              ...+++.|+|||.+.   ..++.++|+||||+++|++++|..||.....
T Consensus       163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT---TEECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc---CCCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            99999888776665431              234678899999973   2478899999999999999999999975432


Q ss_pred             HH----HHHHh----------hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          145 MQ----ALFRI----------GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       145 ~~----~~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ..    .....          ........+...++.+.+++.+||+.+|.+|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          240 PQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            11    11111          1112222333455778999999999999999999999863

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=234.82  Aligned_cols=186  Identities=25%  Similarity=0.425  Sum_probs=151.4

Q ss_pred             ccccCCCcceeccceeeeeCC--eEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN--RLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++||||+++++++...+  ..++|+||+.+++|.+++....  +++..++.++.|++.||++||+.|++|+||||+
T Consensus        95 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~  174 (326)
T 2w1i_A           95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR  174 (326)
T ss_dssp             HHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             HHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcc
Confidence            477899999999999887654  7899999999999999997643  899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCccc---------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           79 NILVDASGLATTTNDVKS---------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        79 nill~~~g~~~~~~~~~~---------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      ||+++.+|.+++.+....               ..++..|+|||.+  .+..++.++||||||+++|++++|..|+....
T Consensus       175 NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  252 (326)
T 2w1i_A          175 NILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPP  252 (326)
T ss_dssp             GEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH
T ss_pred             eEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhh--cCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH
Confidence            999998887766654211               2244569999998  34567899999999999999999998876432


Q ss_pred             HH----------------HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          144 DM----------------QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       144 ~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ..                .....+........+..+++.+.+++.+||+.+|.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          253 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            11                112223334445567789999999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=236.68  Aligned_cols=185  Identities=20%  Similarity=0.263  Sum_probs=147.1

Q ss_pred             ccccCCCcceec---------------cceeeee-CCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHH
Q 046714            3 SFSQFEHDNIVQ---------------YIGTEKD-ENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLT   63 (201)
Q Consensus         3 ~l~~l~h~~I~~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~   63 (201)
                      ++++++||||++               +++++.. ++..++||||+ +++|.+++..   ..+++..+..++.||+.||+
T Consensus        95 ~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~  173 (352)
T 2jii_A           95 FFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALE  173 (352)
T ss_dssp             HHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHH
Confidence            466778988887               5666665 67899999999 8899999986   45999999999999999999


Q ss_pred             HHhhcCccccCCCCCcEEEccCC--ceeeecCcc-------------------ccccCcccccccccccCCCCCcchhhH
Q 046714           64 YLHERNVVHREIKCANILVDASG--LATTTNDVK-------------------SFEGTPFWVAPEVVNLKNNGYGLSADI  122 (201)
Q Consensus        64 ~lh~~~i~H~dl~p~nill~~~g--~~~~~~~~~-------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv  122 (201)
                      |||++|++|+||||+||+++.++  .+++.+...                   ...+++.|+|||.+  .+..++.++||
T Consensus       174 ~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di  251 (352)
T 2jii_A          174 FLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH--KGCGPSRRSDL  251 (352)
T ss_dssp             HHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH--TTCCCCHHHHH
T ss_pred             HHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH--ccCCCCchhhH
Confidence            99999999999999999999887  555554321                   12578889999998  45568899999


Q ss_pred             HHHHHHHHHHHhCCCCCCCch-HHHHHHHh---hcCCCCCCC------CCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          123 WSLGCTVLEMLTHQPPYSHLE-DMQALFRI---GRGKLPSVP------NSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       123 ~slG~~l~~l~~g~~p~~~~~-~~~~~~~~---~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ||||+++|+|++|+.||.... ........   .......+.      ..+++.+.+++.+||+.+|++|||++++++
T Consensus       252 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          252 QSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            999999999999999997653 21211111   111112221      256899999999999999999999999865

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3e-37  Score=229.37  Aligned_cols=185  Identities=16%  Similarity=0.220  Sum_probs=146.7

Q ss_pred             ccccCCCcceeccceee-eeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTE-KDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++|++++..++.+ .+.+..+++|||+ +++|.+++..  ..+++..+..++.|++.||+|||++|++|+||||+|
T Consensus        57 ~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N  135 (296)
T 4hgt_A           57 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN  135 (296)
T ss_dssp             HHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             HHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence            45677888877776655 6677889999999 8899999874  459999999999999999999999999999999999


Q ss_pred             EEE---ccCCceeeecCcc-------------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCC
Q 046714           80 ILV---DASGLATTTNDVK-------------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        80 ill---~~~g~~~~~~~~~-------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      |++   +.++.+++.+...                   ...+++.|+|||.+  .+..++.++||||+|+++|++++|+.
T Consensus       136 Il~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~  213 (296)
T 4hgt_A          136 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSL  213 (296)
T ss_dssp             EEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             eeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHh--cCCCCCchhHHHHHHHHHHHHhcCCC
Confidence            999   6666665554321                   23478889999998  45568899999999999999999999


Q ss_pred             CCCCchH-------HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          138 PYSHLED-------MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       138 p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ||.....       ..................+++.+.+++.+||+.+|++|||++++++
T Consensus       214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          214 PWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             CCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            9965321       1111111122222233567899999999999999999999999876

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=234.95  Aligned_cols=194  Identities=22%  Similarity=0.306  Sum_probs=147.1

Q ss_pred             cccCCCcceeccceeee-----eCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc---------C
Q 046714            4 FSQFEHDNIVQYIGTEK-----DENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER---------N   69 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---------~   69 (201)
                      ++.++||||+++++.+.     ....+++||||+++++|.++++....++..+..++.|++.||+|||+.         |
T Consensus        61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~  140 (336)
T 3g2f_A           61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA  140 (336)
T ss_dssp             STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC
T ss_pred             HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccc
Confidence            55789999999998543     234678999999999999999988889999999999999999999999         9


Q ss_pred             ccccCCCCCcEEEccCCceeeecCccc--------------------cccCcccccccccccCC-----CCCcchhhHHH
Q 046714           70 VVHREIKCANILVDASGLATTTNDVKS--------------------FEGTPFWVAPEVVNLKN-----NGYGLSADIWS  124 (201)
Q Consensus        70 i~H~dl~p~nill~~~g~~~~~~~~~~--------------------~~~~~~~~aPE~~~~~~-----~~~~~~~Dv~s  124 (201)
                      ++|+||||+||+++.+|.+++.++...                    ..+++.|+|||.+....     ..++.++||||
T Consensus       141 ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diws  220 (336)
T 3g2f_A          141 ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA  220 (336)
T ss_dssp             EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHH
T ss_pred             eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHH
Confidence            999999999999999887776654322                    24788999999984211     34567899999


Q ss_pred             HHHHHHHHHhCCCCCCCch-----------------HHHHHH--HhhcCCCCCCCCC------CCHHHHHHHHHHhhcCC
Q 046714          125 LGCTVLEMLTHQPPYSHLE-----------------DMQALF--RIGRGKLPSVPNS------LSRDARDFILKCLQVNP  179 (201)
Q Consensus       125 lG~~l~~l~~g~~p~~~~~-----------------~~~~~~--~~~~~~~~~~~~~------~~~~~~~li~~~l~~~p  179 (201)
                      ||+++|+|++|..|+....                 ......  .......+.++..      .++.+.+++.+||+.+|
T Consensus       221 lG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  300 (336)
T 3g2f_A          221 LGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA  300 (336)
T ss_dssp             HHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSG
T ss_pred             HHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCCh
Confidence            9999999999976652211                 011111  1122223333333      33479999999999999


Q ss_pred             CCCCCHhHHhc------CccccCc
Q 046714          180 NDRPTAAQLME------HPFVKRP  197 (201)
Q Consensus       180 ~~R~t~~~il~------~~~~~~~  197 (201)
                      ++|||++|+++      ++|-+..
T Consensus       301 ~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          301 EARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             GGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             hhCcchHHHHHHHHHHHHHHHhcc
Confidence            99999999944      5665544

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.2e-37  Score=227.43  Aligned_cols=185  Identities=17%  Similarity=0.229  Sum_probs=145.7

Q ss_pred             ccccCCCcceeccceee-eeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTE-KDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++|+++++.++.+ ...+..+++|||+ +++|.+++..  ..+++..+..++.|++.||+|||++|++|+||||+|
T Consensus        57 ~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N  135 (296)
T 3uzp_A           57 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN  135 (296)
T ss_dssp             HHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             HHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence            45678888877666654 5677889999999 8899999973  459999999999999999999999999999999999


Q ss_pred             EEEc---cCCceeeecCc-------------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCC
Q 046714           80 ILVD---ASGLATTTNDV-------------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        80 ill~---~~g~~~~~~~~-------------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      |+++   .++.+++.+..                   ....+++.|+|||.+  .+..++.++||||||+++|++++|+.
T Consensus       136 Il~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~slG~il~~l~~g~~  213 (296)
T 3uzp_A          136 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSL  213 (296)
T ss_dssp             EEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             eEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhh--cCCCCCcchhhHHHHHHHHHHHhCCC
Confidence            9994   66655555432                   223478889999998  45568899999999999999999999


Q ss_pred             CCCCchH-------HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          138 PYSHLED-------MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       138 p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ||.....       ..................+++.+.+++.+||+.+|.+|||++++++
T Consensus       214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          214 PWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             CCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            9975321       1111112222222234568999999999999999999999998865

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.2e-38  Score=252.91  Aligned_cols=192  Identities=20%  Similarity=0.330  Sum_probs=150.2

Q ss_pred             ccccCCCcceeccceeeee------CCeEEEEEEecCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhcCccc
Q 046714            3 SFSQFEHDNIVQYIGTEKD------ENRLYIFLELVKKGSLANLYQKY----HLSDSQVSSYTRQILNGLTYLHERNVVH   72 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~H   72 (201)
                      +|++++||||+++++++..      ++..++||||+.+++|.+++...    ++++..++.++.|++.||+|||+.|++|
T Consensus        65 iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVH  144 (676)
T 3qa8_A           65 IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIH  144 (676)
T ss_dssp             HHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCC
T ss_pred             HHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            5678899999999998765      67789999999999999999763    4899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCc---eeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCC
Q 046714           73 REIKCANILVDASGL---ATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPP  138 (201)
Q Consensus        73 ~dl~p~nill~~~g~---~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p  138 (201)
                      +||+|+||+++.+|.   +++.+..           ....+++.|+|||.+  .+..++.++|+||+|+++|++++|..|
T Consensus       145 rDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l--~~~~~s~ksDIwSLGviLyeLltG~~P  222 (676)
T 3qa8_A          145 RDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL--EQKKYTVTVDYWSFGTLAFECITGFRP  222 (676)
T ss_dssp             CCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSS--CCSCCSTTHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHh--ccCCCCchhHHHHHHHHHHHHHHCCCC
Confidence            999999999997653   3343322           223478889999998  456788999999999999999999999


Q ss_pred             CCCchHHHHHHH---------hh-----cC---------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          139 YSHLEDMQALFR---------IG-----RG---------KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       139 ~~~~~~~~~~~~---------~~-----~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      |........+..         ..     .+         ........+++.+.+++.+||..+|++|||++++++||||+
T Consensus       223 f~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~  302 (676)
T 3qa8_A          223 FLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ  302 (676)
T ss_dssp             CCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred             CCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence            965432221100         00     00         00112233567899999999999999999999999999986


Q ss_pred             C
Q 046714          196 R  196 (201)
Q Consensus       196 ~  196 (201)
                      .
T Consensus       303 ~  303 (676)
T 3qa8_A          303 A  303 (676)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.9e-37  Score=232.53  Aligned_cols=185  Identities=24%  Similarity=0.395  Sum_probs=133.9

Q ss_pred             ccccCC-Ccceeccceeee--------eCCeEEEEEEecCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcC
Q 046714            3 SFSQFE-HDNIVQYIGTEK--------DENRLYIFLELVKKGSLANLYQK----YHLSDSQVSSYTRQILNGLTYLHERN   69 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~   69 (201)
                      +++++. ||||+++++++.        .....++++||+.| +|.+++..    ..+++..++.++.||+.||+|||+.|
T Consensus        78 ~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  156 (337)
T 3ll6_A           78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK  156 (337)
T ss_dssp             HHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred             HHHHhccCCChhhccccccccccccccCCceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            355664 999999999984        34568999999975 89888754    34999999999999999999999999


Q ss_pred             --ccccCCCCCcEEEccCCceeeecCccc------------------------cccCccccccccccc-CCCCCcchhhH
Q 046714           70 --VVHREIKCANILVDASGLATTTNDVKS------------------------FEGTPFWVAPEVVNL-KNNGYGLSADI  122 (201)
Q Consensus        70 --i~H~dl~p~nill~~~g~~~~~~~~~~------------------------~~~~~~~~aPE~~~~-~~~~~~~~~Dv  122 (201)
                        ++|+||||+||+++.+|.+++.+....                        ..+++.|+|||.+.. .+..++.++||
T Consensus       157 ~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv  236 (337)
T 3ll6_A          157 PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI  236 (337)
T ss_dssp             SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHH
T ss_pred             CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhH
Confidence              999999999999999887777664321                        236778999999732 35567889999


Q ss_pred             HHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          123 WSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       123 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ||||+++|+|++|+.||...........   ..........+..+.+++.+||+.+|.+|||+++++++
T Consensus       237 ~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          237 WALGCILYLLCFRQHPFEDGAKLRIVNG---KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             HHHHHHHHHHHHSSCCC---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcchhHHHhhcC---cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999976544333222   12223345677889999999999999999999999876

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.2e-37  Score=231.45  Aligned_cols=186  Identities=25%  Similarity=0.394  Sum_probs=148.2

Q ss_pred             cCCCcceeccceeeeeCC----eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHh--------hcCcccc
Q 046714            6 QFEHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH--------ERNVVHR   73 (201)
Q Consensus         6 ~l~h~~I~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~~i~H~   73 (201)
                      +++||||+++++++...+    ..++||||+.+++|.+++.+..+++..++.++.|++.||+|||        +.|++|+
T Consensus        92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~  171 (342)
T 1b6c_B           92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR  171 (342)
T ss_dssp             CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred             hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeC
Confidence            389999999999998876    7899999999999999999888999999999999999999999        8999999


Q ss_pred             CCCCCcEEEccCCceeeecCc----------------cccccCcccccccccccCCC----CCcchhhHHHHHHHHHHHH
Q 046714           74 EIKCANILVDASGLATTTNDV----------------KSFEGTPFWVAPEVVNLKNN----GYGLSADIWSLGCTVLEML  133 (201)
Q Consensus        74 dl~p~nill~~~g~~~~~~~~----------------~~~~~~~~~~aPE~~~~~~~----~~~~~~Dv~slG~~l~~l~  133 (201)
                      ||||+||+++.+|.+++.+..                ....+++.|+|||.+.....    .++.++||||||+++|+|+
T Consensus       172 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~  251 (342)
T 1b6c_B          172 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA  251 (342)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence            999999999988877666542                12347888999999843211    2347899999999999999


Q ss_pred             hC----------CCCCCCch-----HHHHHHHhhc-CCCCCCCC-----CCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          134 TH----------QPPYSHLE-----DMQALFRIGR-GKLPSVPN-----SLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       134 ~g----------~~p~~~~~-----~~~~~~~~~~-~~~~~~~~-----~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +|          ..||....     .......+.. ...+..+.     ..+..+.+++.+||+.+|.+|||+++++++
T Consensus       252 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             hccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            99          77885531     2222222222 22233332     234578999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.3e-38  Score=241.46  Aligned_cols=188  Identities=23%  Similarity=0.398  Sum_probs=147.6

Q ss_pred             ccccCCCcceeccceeeeeCC--eEEEEEEecCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN--RLYIFLELVKKGSLANLYQKYH----LSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +|++++||||+++++++.+.+  ..++||||+.+++|.+++....    +++..++.++.||+.||+|||++||+|+|||
T Consensus        60 ~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  139 (396)
T 4eut_A           60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIK  139 (396)
T ss_dssp             HHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             HHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcC
Confidence            577899999999999988765  7899999999999999987532    8999999999999999999999999999999


Q ss_pred             CCcEEE----ccCCceeeecCc-----------cccccCcccccccccccC------CCCCcchhhHHHHHHHHHHHHhC
Q 046714           77 CANILV----DASGLATTTNDV-----------KSFEGTPFWVAPEVVNLK------NNGYGLSADIWSLGCTVLEMLTH  135 (201)
Q Consensus        77 p~nill----~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~------~~~~~~~~Dv~slG~~l~~l~~g  135 (201)
                      |+||++    +.++.+++.+..           ....+++.|+|||.+...      ...++.++||||||+++|+|++|
T Consensus       140 p~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg  219 (396)
T 4eut_A          140 PGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG  219 (396)
T ss_dssp             GGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred             HHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHC
Confidence            999998    555545554432           234478899999997321      14567899999999999999999


Q ss_pred             CCCCCCc----hHHHHHHHhhcCCCCC------------------------CCCCCCHHHHHHHHHHhhcCCCCCCCHhH
Q 046714          136 QPPYSHL----EDMQALFRIGRGKLPS------------------------VPNSLSRDARDFILKCLQVNPNDRPTAAQ  187 (201)
Q Consensus       136 ~~p~~~~----~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~R~t~~~  187 (201)
                      +.||...    ...+....+..+..+.                        +...+++.+.+++.+||+.||++|||+++
T Consensus       220 ~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e  299 (396)
T 4eut_A          220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ  299 (396)
T ss_dssp             SCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred             CCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence            9999532    2233444443332211                        11234567889999999999999999999


Q ss_pred             Hhc
Q 046714          188 LME  190 (201)
Q Consensus       188 il~  190 (201)
                      +++
T Consensus       300 ~l~  302 (396)
T 4eut_A          300 FFA  302 (396)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            855

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=8.7e-37  Score=226.22  Aligned_cols=169  Identities=14%  Similarity=0.157  Sum_probs=138.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      ++++++||||+++++++.+++..++||||+.|++|.++++.+ ....++..++.|++.||+|||++|++|+||||+||++
T Consensus        84 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll  162 (286)
T 3uqc_A           84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV  162 (286)
T ss_dssp             HHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred             HHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE
Confidence            467899999999999999999999999999999999999764 4666789999999999999999999999999999999


Q ss_pred             ccCCceeeecCccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH---HhhcCCCC--
Q 046714           83 DASGLATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF---RIGRGKLP--  157 (201)
Q Consensus        83 ~~~g~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~--  157 (201)
                      +.+|.+++.        +..|++         .++.++||||||+++|+|++|+.||..........   ........  
T Consensus       163 ~~~g~~kl~--------~~~~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  225 (286)
T 3uqc_A          163 SIDGDVVLA--------YPATMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP  225 (286)
T ss_dssp             ETTSCEEEC--------SCCCCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCH
T ss_pred             cCCCCEEEE--------eccccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCCh
Confidence            999887765        223333         36789999999999999999999997654322110   00011111  


Q ss_pred             -CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          158 -SVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       158 -~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                       .....+++.+.+++.+||+.||.+| |++++++
T Consensus       226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence             1235688999999999999999999 9999876

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1e-35  Score=234.34  Aligned_cols=185  Identities=17%  Similarity=0.243  Sum_probs=145.9

Q ss_pred             ccccCCCc-ceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHD-NIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~-~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +++.++|+ +|..+..++...+..++||||+ +++|.+++..  ..+++..++.++.||+.||+|||++||+|+||||+|
T Consensus        55 il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~N  133 (483)
T 3sv0_A           55 IYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN  133 (483)
T ss_dssp             HHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcce
Confidence            45667774 5556666677788899999999 8899999974  459999999999999999999999999999999999


Q ss_pred             EEE---ccCCceeeecCcc-------------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCC
Q 046714           80 ILV---DASGLATTTNDVK-------------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        80 ill---~~~g~~~~~~~~~-------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      |++   +.++.+++.++..                   ...++..|+|||.+  .+..++.++||||||+++|+|++|+.
T Consensus       134 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~s~~sDvwSlGvil~elltG~~  211 (483)
T 3sv0_A          134 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTH--LGIEQSRRDDLESLGYVLMYFLRGSL  211 (483)
T ss_dssp             EEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             EEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHh--cCCCCChHHHHHHHHHHHHHHHhCCC
Confidence            999   4666555554321                   34478889999998  45668899999999999999999999


Q ss_pred             CCCCchH---HHHHHHh----hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          138 PYSHLED---MQALFRI----GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       138 p~~~~~~---~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ||.....   ......+    .......+...+++++.+++.+||+.+|.+||+++++++
T Consensus       212 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          212 PWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             TTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            9976432   2222221    122222333568899999999999999999999998765

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.4e-35  Score=226.82  Aligned_cols=178  Identities=16%  Similarity=0.151  Sum_probs=142.1

Q ss_pred             ccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK------YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ....|+||+++++.+..++..++||||+.+++|.+++..      ..+++..+..++.||+.||+|||++||+||||||+
T Consensus       122 ~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~  201 (365)
T 3e7e_A          122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD  201 (365)
T ss_dssp             CGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGG
T ss_pred             hhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHH
Confidence            344599999999999999999999999999999999963      34999999999999999999999999999999999


Q ss_pred             cEEEcc-----------CCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHH
Q 046714           79 NILVDA-----------SGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML  133 (201)
Q Consensus        79 nill~~-----------~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~  133 (201)
                      ||+++.           ++.+++.++..              ...||+.|+|||.+  .+..++.++||||||+++|+|+
T Consensus       202 NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~ell  279 (365)
T 3e7e_A          202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML--SNKPWNYQIDYFGVAATVYCML  279 (365)
T ss_dssp             GEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH--TTCCBSTHHHHHHHHHHHHHHH
T ss_pred             HEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh--cCCCCCccccHHHHHHHHHHHH
Confidence            999988           66666665432              23478899999998  4556899999999999999999


Q ss_pred             hCCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          134 THQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       134 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                      +|+.||........   .........  ..++.+.+++..|++.+|.+|++..+.+
T Consensus       280 tg~~pf~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l  330 (365)
T 3e7e_A          280 FGTYMKVKNEGGEC---KPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLL  330 (365)
T ss_dssp             HSSCCCEEEETTEE---EECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred             hCCCccccCCCCce---eechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHH
Confidence            99999854322110   011111111  2467789999999999999996544433

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6e-36  Score=226.40  Aligned_cols=179  Identities=16%  Similarity=0.186  Sum_probs=136.5

Q ss_pred             Ccceeccceeeee-------------CCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHh-hcCccccC
Q 046714            9 HDNIVQYIGTEKD-------------ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH-ERNVVHRE   74 (201)
Q Consensus         9 h~~I~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~d   74 (201)
                      ||||+++++++.+             .+..++||||+.+|++.+.+.+..+++..++.++.||+.||+||| +.||+|||
T Consensus       108 hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrD  187 (336)
T 2vuw_A          108 PPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRD  187 (336)
T ss_dssp             CHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSC
T ss_pred             cHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECC
Confidence            6666666666665             788999999999987766666667899999999999999999999 99999999


Q ss_pred             CCCCcEEEccCC--------------------ceeeecCccc-------cccCcccccccccccCCCCCcchhhHHHHHH
Q 046714           75 IKCANILVDASG--------------------LATTTNDVKS-------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGC  127 (201)
Q Consensus        75 l~p~nill~~~g--------------------~~~~~~~~~~-------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~  127 (201)
                      |||+||+++.+|                    .+++.++...       ..||+.|+|||.+.  +.. +.++||||+|+
T Consensus       188 lKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~--g~~-~~~~Diwsl~~  264 (336)
T 2vuw_A          188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT--GDG-DYQFDIYRLMK  264 (336)
T ss_dssp             CCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGC--CCS-SHHHHHHHHHH
T ss_pred             CCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhc--CCC-ccceehhhhhC
Confidence            999999999887                    5666655322       34788999999983  333 78999999877


Q ss_pred             H-HHHHHhCCCCCCCchH-HHHHHHhhcC-CC-----CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHh-cCcccc
Q 046714          128 T-VLEMLTHQPPYSHLED-MQALFRIGRG-KL-----PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM-EHPFVK  195 (201)
Q Consensus       128 ~-l~~l~~g~~p~~~~~~-~~~~~~~~~~-~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il-~~~~~~  195 (201)
                      + .+++++|..||..... ......+... ..     ...+..+++++.+|+.+||+++     |++|++ +||||+
T Consensus       265 ~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          265 KENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             CCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            7 6678889988854321 1111222211 11     1112346788999999999976     999999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-35  Score=241.92  Aligned_cols=178  Identities=24%  Similarity=0.329  Sum_probs=142.1

Q ss_pred             ccccCCCcceeccceeeeeCCe-----EEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDENR-----LYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      +|++++||||+++++++...+.     .++||||+.|++|.+++.. .+++.++..++.||+.||+|||++||+|+||||
T Consensus       132 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp  210 (681)
T 2pzi_A          132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKP  210 (681)
T ss_dssp             GGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             HHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccCh
Confidence            5789999999999999987665     7999999999999988766 799999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecC--------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           78 ANILVDASGLATTTND--------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        78 ~nill~~~g~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      +||+++.+ .+++.++        .....||+.|+|||.+..   ..+.++||||||+++|+|++|..||.....     
T Consensus       211 ~NIll~~~-~~kl~DFG~a~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~-----  281 (681)
T 2pzi_A          211 ENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYV-----  281 (681)
T ss_dssp             GGEEECSS-CEEECCCTTCEETTCCSCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEEC-----
T ss_pred             HHeEEeCC-cEEEEecccchhcccCCccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCccccc-----
Confidence            99999875 4444443        234458899999999832   248899999999999999999888764211     


Q ss_pred             HhhcCCCCC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          150 RIGRGKLPS--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       150 ~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                          ...+.  .....++.+.+++.+||+.+|.+||+..+.+.++|+
T Consensus       282 ----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          282 ----DGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             ----SSCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ----ccccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence                00110  011235789999999999999999998888888765

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4e-35  Score=227.51  Aligned_cols=166  Identities=19%  Similarity=0.222  Sum_probs=134.2

Q ss_pred             eEEEEEEecCCCCHHHHHH--------hcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCcc
Q 046714           24 RLYIFLELVKKGSLANLYQ--------KYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVK   95 (201)
Q Consensus        24 ~~~lv~e~~~~~~L~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~   95 (201)
                      .++++|+.+. ++|.++++        ...+++..+..++.|++.||+|||++||+||||||+||+++.+|.+++.++..
T Consensus       179 ~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~  257 (413)
T 3dzo_A          179 SRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH  257 (413)
T ss_dssp             SEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGG
T ss_pred             ceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccc
Confidence            4677777774 59999885        22377888999999999999999999999999999999999998887776543


Q ss_pred             ---------ccccCccccccccccc--------CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCCCC
Q 046714           96 ---------SFEGTPFWVAPEVVNL--------KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPS  158 (201)
Q Consensus        96 ---------~~~~~~~~~aPE~~~~--------~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  158 (201)
                               ...| +.|+|||.+..        ....++.++|||||||++|+|++|+.||...........+...    
T Consensus       258 a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~----  332 (413)
T 3dzo_A          258 LVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS----  332 (413)
T ss_dssp             CEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSS----
T ss_pred             eeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhh----
Confidence                     2346 88999999731        2334678999999999999999999999776543332222221    


Q ss_pred             CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       159 ~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                       ...+++.+.+++.+||+.+|++|||+.++++||||+.
T Consensus       333 -~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          333 -CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             -CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             -cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence             2367899999999999999999999999999999975

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=9.4e-29  Score=198.26  Aligned_cols=127  Identities=12%  Similarity=0.103  Sum_probs=95.2

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcC-CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|+++ .|+||+++++++++++..||||||++|++|.+++.+.+ ++..   +++.||+.||+|+|++||+||||||+||
T Consensus       294 ~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNI  370 (569)
T 4azs_A          294 FLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNV  370 (569)
T ss_dssp             HHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGE
T ss_pred             HHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhE
Confidence            47777 79999999999999999999999999999999998765 5543   5889999999999999999999999999


Q ss_pred             EEccCCceeeecCccc------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC
Q 046714           81 LVDASGLATTTNDVKS------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH  135 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g  135 (201)
                      |++.+|.+++.+++..            ..||+.|+|||++.  + ....++|+|++|++++.+.++
T Consensus       371 LL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~--g-~~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          371 MVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFA--E-NKSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             EECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC--------------------CCCCTT
T ss_pred             EECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhC--C-CCCCcccccccccchhhhccc
Confidence            9999998888876522            23678899999983  2 356789999999988766544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.84  E-value=2.8e-22  Score=159.98  Aligned_cols=128  Identities=13%  Similarity=0.120  Sum_probs=104.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      +|++++||||+++..++.+.+..++||||+++++|.++++.       +..++.|+++||+|||++||+|+||||+||++
T Consensus       392 il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl  464 (540)
T 3en9_A          392 YLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF  464 (540)
T ss_dssp             HHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE
T ss_pred             HHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE
Confidence            57789999999766666677778999999999999999776       66899999999999999999999999999999


Q ss_pred             ccCCceeeecCcc-------------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCC
Q 046714           83 DASGLATTTNDVK-------------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY  139 (201)
Q Consensus        83 ~~~g~~~~~~~~~-------------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  139 (201)
                      +.  .+++.++..                   ...+|+.|+|||.+......++..+|+|+...-..+-+.++.+|
T Consensus       465 ~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          465 DK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             SS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            87  444444321                   33478889999998543355677889999988888877776655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.58  E-value=6.1e-16  Score=114.03  Aligned_cols=94  Identities=14%  Similarity=0.083  Sum_probs=73.7

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEc
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD   83 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~   83 (201)
                      |++++  | +++.+++.. +..++||||++|++|.+ +.     ......++.|++.||++||+.|++|+||||+||+++
T Consensus       158 l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-----~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~  227 (282)
T 1zar_A          158 LQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR-----VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS  227 (282)
T ss_dssp             HHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred             HHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc-----hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE
Confidence            45566  5 677776544 45699999999999987 32     233557999999999999999999999999999999


Q ss_pred             cCCceeeecCccccccCccccccccc
Q 046714           84 ASGLATTTNDVKSFEGTPFWVAPEVV  109 (201)
Q Consensus        84 ~~g~~~~~~~~~~~~~~~~~~aPE~~  109 (201)
                       +|.+++.+.... ..+..+.|||.+
T Consensus       228 -~~~vkl~DFG~a-~~~~~~~a~e~l  251 (282)
T 1zar_A          228 -EEGIWIIDFPQS-VEVGEEGWREIL  251 (282)
T ss_dssp             -TTEEEECCCTTC-EETTSTTHHHHH
T ss_pred             -CCcEEEEECCCC-eECCCCCHHHHH
Confidence             888777766543 355667888886

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.26  E-value=1.7e-12  Score=94.42  Aligned_cols=83  Identities=14%  Similarity=0.191  Sum_probs=59.9

Q ss_pred             cccCCCcce--eccceeeeeCCeEEEEEEecCC-C----CHHHHHHhcCCCHHHHHHHHHHHHHHHHHHh-hcCccccCC
Q 046714            4 FSQFEHDNI--VQYIGTEKDENRLYIFLELVKK-G----SLANLYQKYHLSDSQVSSYTRQILNGLTYLH-ERNVVHREI   75 (201)
Q Consensus         4 l~~l~h~~I--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~dl   75 (201)
                      |+++.|++|  +.+++.    +..++||||+.+ |    +|.++...  .++..+..++.|++.+|.+|| +.|++|+||
T Consensus       124 l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDl  197 (258)
T 1zth_A          124 LERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADL  197 (258)
T ss_dssp             HHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred             HHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence            455666654  222322    346899999942 3    77766433  235567899999999999999 999999999


Q ss_pred             CCCcEEEccCCceeeecCc
Q 046714           76 KCANILVDASGLATTTNDV   94 (201)
Q Consensus        76 ~p~nill~~~g~~~~~~~~   94 (201)
                      ||+||+++.  .+.+.+..
T Consensus       198 kp~NILl~~--~~~liDFG  214 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMG  214 (258)
T ss_dssp             STTSEEESS--SEEECCCT
T ss_pred             CHHHEEEcC--cEEEEECc
Confidence            999999987  45555544

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.24  E-value=8.7e-13  Score=100.47  Aligned_cols=74  Identities=16%  Similarity=0.168  Sum_probs=56.2

Q ss_pred             CCcceeccceeeeeC------CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            8 EHDNIVQYIGTEKDE------NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      .|+|+.++++.....      +..++||||+.|.+|.++.     ..+....+..|++.+|.+||+.|++||||||.|||
T Consensus       163 E~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~-----~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          163 EFAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVS-----SVPDPASLYADLIALILRLAKHGLIHGDFNEFNIL  237 (397)
T ss_dssp             HHHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCC-----CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred             HHHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhc-----ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEE
Confidence            366776665432211      1236999999998886542     22345678899999999999999999999999999


Q ss_pred             EccCC
Q 046714           82 VDASG   86 (201)
Q Consensus        82 l~~~g   86 (201)
                      ++.+|
T Consensus       238 l~~dg  242 (397)
T 4gyi_A          238 IREEK  242 (397)
T ss_dssp             EEEEE
T ss_pred             EeCCC
Confidence            98876

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.79  E-value=9.3e-09  Score=74.62  Aligned_cols=55  Identities=5%  Similarity=0.093  Sum_probs=44.1

Q ss_pred             CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhh
Q 046714            9 HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHE   67 (201)
Q Consensus         9 h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   67 (201)
                      +..+.++++++.+.+..++|||+++|.+|.+...    +......++.++..++..||+
T Consensus        69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~  123 (263)
T 3tm0_A           69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCeEEEEEecCCceEEEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhC
Confidence            5678889999999999999999999999876521    222344778899999999998

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.52  E-value=4.8e-06  Score=58.08  Aligned_cols=135  Identities=19%  Similarity=0.107  Sum_probs=91.1

Q ss_pred             CCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCcEEEccCCceeeecCccccccCccccccccccc
Q 046714           35 GSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCANILVDASGLATTTNDVKSFEGTPFWVAPEVVNL  111 (201)
Q Consensus        35 ~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~nill~~~g~~~~~~~~~~~~~~~~~~aPE~~~~  111 (201)
                      -+|.++++.  .+++++++|.++.|.+.++.-+-. +.-...=+.|..|++..+|.+......+. .....+.+||..  
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~~~s~-~~~~~~~~pe~~--  109 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAPAADD-AGEPPPVAGKLG--  109 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECCC-------------CCS--
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccccccc-ccccCCCChhhc--
Confidence            378898875  459999999999999999877632 11123445578999999999887754422 234457789875  


Q ss_pred             CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhc--------------
Q 046714          112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQV--------------  177 (201)
Q Consensus       112 ~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--------------  177 (201)
                       ....+.+.=|||||+++|.-+--..|                  +..+..+++.+.+||..|..-              
T Consensus       110 -~~~~te~~~IysLG~tLY~ALDygL~------------------e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~  170 (229)
T 2yle_A          110 -YSQCMETEVIESLGIIIYKALDYGLK------------------ENEERELSPPLEQLIDHMANTVEADGSNDEGYEAA  170 (229)
T ss_dssp             -SSSSCHHHHHHHHHHHHHHHHTTTCC------------------TTEEECCCHHHHHHHHHHTTCCC------------
T ss_pred             -cccchHHHHHHHHHHHHHHHhhcCCC------------------cccchhhCHHHHHHHHHHHhccccccccccccccc
Confidence             24556789999999999987753221                  233456889999999988755              


Q ss_pred             -----------CCCCCCCHhHHhcC
Q 046714          178 -----------NPNDRPTAAQLMEH  191 (201)
Q Consensus       178 -----------~p~~R~t~~~il~~  191 (201)
                                 .+..|.++++|++.
T Consensus       171 ~eg~~d~~~~~~~~~~~sl~~Vi~~  195 (229)
T 2yle_A          171 EEGLGDEDEKRKISAIRSYRDVMKL  195 (229)
T ss_dssp             --------CCSCCCCCCSHHHHHHH
T ss_pred             ccccccccccccccCcCCHHHHHHH
Confidence                       34688999988763

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.43  E-value=1.5e-07  Score=67.84  Aligned_cols=50  Identities=16%  Similarity=0.222  Sum_probs=34.2

Q ss_pred             eeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhc
Q 046714           12 IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHER   68 (201)
Q Consensus        12 I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   68 (201)
                      +.+++++..+++..++|||+++|.++.  ..  ...   ...++.++...+..||+.
T Consensus        77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~  126 (264)
T 1nd4_A           77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTL  126 (264)
T ss_dssp             BCCEEEEEECSSCEEEEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTS
T ss_pred             CCeEEEeccCCCCCEEEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCC
Confidence            556888888888899999999998884  11  112   224566666667777653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.37  E-value=1.8e-07  Score=69.41  Aligned_cols=115  Identities=15%  Similarity=0.173  Sum_probs=74.0

Q ss_pred             eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhh------------------------------------
Q 046714           24 RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHE------------------------------------   67 (201)
Q Consensus        24 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~------------------------------------   67 (201)
                      ..++||++++|.++.+... ..++..+...++.+++..+..||+                                    
T Consensus        90 ~~~~vm~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP  168 (304)
T ss_dssp             CSCEEEECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred             cceEEEcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence            4588999999988865322 236777777888888888888875                                    


Q ss_pred             ----------------------cCccccCCCCCcEEEcc--CCceeeecCccccccCcc--------c---cccccccc-
Q 046714           68 ----------------------RNVVHREIKCANILVDA--SGLATTTNDVKSFEGTPF--------W---VAPEVVNL-  111 (201)
Q Consensus        68 ----------------------~~i~H~dl~p~nill~~--~g~~~~~~~~~~~~~~~~--------~---~aPE~~~~-  111 (201)
                                            ..++|+|++|.||+++.  ++...+.+......+.+.        .   ..|+.... 
T Consensus       169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHH
Confidence                                  13699999999999998  444444443332222221        1   22222110 


Q ss_pred             -C--CCC--------CcchhhHHHHHHHHHHHHhCCCCC
Q 046714          112 -K--NNG--------YGLSADIWSLGCTVLEMLTHQPPY  139 (201)
Q Consensus       112 -~--~~~--------~~~~~Dv~slG~~l~~l~~g~~p~  139 (201)
                       .  +..        .....+.|+++.+++.+.+|..+|
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             0  010        011258999999999999997655

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.34  E-value=5.7e-07  Score=68.21  Aligned_cols=58  Identities=14%  Similarity=0.172  Sum_probs=44.3

Q ss_pred             CcceeccceeeeeC---CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhh
Q 046714            9 HDNIVQYIGTEKDE---NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHE   67 (201)
Q Consensus         9 h~~I~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   67 (201)
                      +..+++++.++.+.   +..++|||+++|.++.+.. -..++..+...++.+++.+|..||+
T Consensus        97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A           97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhC
Confidence            44577888888776   4589999999997774311 1236788888899999999999996

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.84  E-value=5.8e-05  Score=54.69  Aligned_cols=80  Identities=11%  Similarity=0.144  Sum_probs=54.4

Q ss_pred             eeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhh------------------------
Q 046714           12 IVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHE------------------------   67 (201)
Q Consensus        12 I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~------------------------   67 (201)
                      +.++++++.+.+..++|||+++|.++.+.....   ......+..++...+..||.                        
T Consensus        82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~  158 (272)
T 4gkh_A           82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMN  158 (272)
T ss_dssp             CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHH
T ss_pred             cCeEEEEEEECCeEEEEEEeeCCccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHH
Confidence            667888888999999999999998887654431   11223344444444444442                        


Q ss_pred             ----------------------------------cCccccCCCCCcEEEccCCceeeecCc
Q 046714           68 ----------------------------------RNVVHREIKCANILVDASGLATTTNDV   94 (201)
Q Consensus        68 ----------------------------------~~i~H~dl~p~nill~~~g~~~~~~~~   94 (201)
                                                        ..++|+|+.+.||+++.++...+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe  219 (272)
T 4gkh_A          159 NGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVG  219 (272)
T ss_dssp             TTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCT
T ss_pred             HhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECc
Confidence                                              126899999999999877655555433

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.56  E-value=0.00032  Score=51.88  Aligned_cols=54  Identities=19%  Similarity=0.129  Sum_probs=29.9

Q ss_pred             eeccceeee-eCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHh
Q 046714           12 IVQYIGTEK-DENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH   66 (201)
Q Consensus        12 I~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   66 (201)
                      +.+.+.+.. ..+..+++||+++|.++.+..- ..++..+...++.++...+..||
T Consensus        74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH  128 (306)
T 3tdw_A           74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELS  128 (306)
T ss_dssp             CCCEEEEEECTTSCEEEEEECCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCeEeecccCCCceEEEEeccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHh
Confidence            455555553 4556789999999988865311 11333344444444444444444

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.08  E-value=0.00032  Score=52.91  Aligned_cols=25  Identities=8%  Similarity=0.116  Sum_probs=18.6

Q ss_pred             cCccccCCCCCcEEEccCCceeeec
Q 046714           68 RNVVHREIKCANILVDASGLATTTN   92 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g~~~~~~   92 (201)
                      ..++|+|+++.||++++++...+.+
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vID  246 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLD  246 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECC
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEc
Confidence            4689999999999998543344444

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=95.40  E-value=0.042  Score=40.83  Aligned_cols=27  Identities=19%  Similarity=0.154  Sum_probs=19.9

Q ss_pred             cCccccCCCCCcEEEccC----CceeeecCc
Q 046714           68 RNVVHREIKCANILVDAS----GLATTTNDV   94 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~----g~~~~~~~~   94 (201)
                      ..++|||+++.||+++.+    +...+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~  213 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQ  213 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCT
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCC
Confidence            469999999999999864    444445433

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.28  E-value=0.027  Score=41.80  Aligned_cols=27  Identities=15%  Similarity=0.139  Sum_probs=20.9

Q ss_pred             cCccccCCCCCcEEEccCCceeeecCc
Q 046714           68 RNVVHREIKCANILVDASGLATTTNDV   94 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g~~~~~~~~   94 (201)
                      .+++|+|+++.||+++.++...+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe  248 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLD  248 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCT
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehh
Confidence            579999999999999766655555443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=94.80  E-value=0.4  Score=33.46  Aligned_cols=115  Identities=7%  Similarity=-0.019  Sum_probs=73.1

Q ss_pred             CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHH-HHhhcCccccCCCCCcEEEccCC
Q 046714            8 EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLT-YLHERNVVHREIKCANILVDASG   86 (201)
Q Consensus         8 ~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~-~lh~~~i~H~dl~p~nill~~~g   86 (201)
                      .||+.  -..+-.+++.+.+.++.-.+..-...++  .++....++++..|+.... +++  .-+|--++|+|++++.++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--~~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~NL~f~~~~  121 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--KTTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPENLMFNRAL  121 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--TSCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGGGEEECTTC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--hcCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCceEEEeCCC
Confidence            46666  2344456666666666653333333333  4789999999999998766 443  446778999999999999


Q ss_pred             ceeeecCccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Q 046714           87 LATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS  140 (201)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  140 (201)
                      .+.+...     |-..-++|..       .+..-=.-.+=|++..++.++..|.
T Consensus       122 ~p~i~hR-----Gi~~~lpP~e-------~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          122 EPFFLHV-----GVKESLPPDE-------WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             CEEESCC-----EETTTBSSCS-------CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             cEEEEEc-----CCcccCCCCC-------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            8876633     3333334432       2233334456677788888877763

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=94.69  E-value=0.16  Score=35.29  Aligned_cols=117  Identities=8%  Similarity=0.023  Sum_probs=73.5

Q ss_pred             CCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEccCC
Q 046714            7 FEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASG   86 (201)
Q Consensus         7 l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~~~g   86 (201)
                      ..||+.++. .+-.+++.+.+.++.-.  ....+-.-...+....++++..|+....+++  .-+|--++|+|++++.++
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~~  116 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIKSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRDG  116 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGGGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTTS
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHHhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCCC
Confidence            457777765 55566665555555543  2222222233788899999999998775544  346778999999999999


Q ss_pred             ceeeecCccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Q 046714           87 LATTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS  140 (201)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  140 (201)
                      .+.....+     -..-++|.       ..+...=.-.+=|++..+++++..|.
T Consensus       117 ~p~i~~RG-----ik~~l~P~-------~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          117 LPIAKTRG-----LQNVVDPL-------PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CEEESCCE-----ETTTBSCC-------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CEEEEEcc-----CccCCCCC-------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            87665332     22222332       22333344456677888888888773

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=93.86  E-value=0.044  Score=42.24  Aligned_cols=69  Identities=10%  Similarity=0.152  Sum_probs=39.3

Q ss_pred             hhcCccccCCCCCcEEEccCCceeeecCccccccCc-------------ccccccccccCC-CCCcchhhHHHHHHHHHH
Q 046714           66 HERNVVHREIKCANILVDASGLATTTNDVKSFEGTP-------------FWVAPEVVNLKN-NGYGLSADIWSLGCTVLE  131 (201)
Q Consensus        66 h~~~i~H~dl~p~nill~~~g~~~~~~~~~~~~~~~-------------~~~aPE~~~~~~-~~~~~~~Dv~slG~~l~~  131 (201)
                      +...++|||++|.||+++.++ ..+.+......|.+             .|.+|+...... .......++...+..++.
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            356799999999999998877 55555433333332             245555431111 111223455566666666


Q ss_pred             HHhC
Q 046714          132 MLTH  135 (201)
Q Consensus       132 l~~g  135 (201)
                      .+.+
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=92.96  E-value=0.2  Score=36.61  Aligned_cols=23  Identities=17%  Similarity=0.202  Sum_probs=16.6

Q ss_pred             CccccCCCCCcEEEccCCceeeec
Q 046714           69 NVVHREIKCANILVDASGLATTTN   92 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~g~~~~~~   92 (201)
                      .++|+|+.+.||+.+ +|...+.+
T Consensus       174 ~l~HgDl~~~Nil~~-~~~~~lID  196 (301)
T 3dxq_A          174 AACHCDPLCENFLDT-GERMWIVD  196 (301)
T ss_dssp             EEECSCCCGGGEEEC-SSCEEECC
T ss_pred             eeeccCCCcCCEEEC-CCCEEEEe
Confidence            479999999999954 44344444

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=90.95  E-value=0.075  Score=39.17  Aligned_cols=26  Identities=15%  Similarity=0.210  Sum_probs=20.1

Q ss_pred             cCccccCCCCCcEEEccCCceeeecC
Q 046714           68 RNVVHREIKCANILVDASGLATTTND   93 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g~~~~~~~   93 (201)
                      .+++|+|+++.||+++.++...+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf  212 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDF  212 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCC
T ss_pred             cccCCCCCCccCEEEeCCceEEEecc
Confidence            46899999999999987655445443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=88.51  E-value=0.53  Score=34.62  Aligned_cols=16  Identities=25%  Similarity=0.250  Sum_probs=14.6

Q ss_pred             cCccccCCCCCcEEEc
Q 046714           68 RNVVHREIKCANILVD   83 (201)
Q Consensus        68 ~~i~H~dl~p~nill~   83 (201)
                      ..++|||+++.||+++
T Consensus       195 ~~l~HgD~~~~Nil~~  210 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR  210 (328)
T ss_dssp             CEECCSSCSGGGEEES
T ss_pred             eeeeeCCCCcccEeEc
Confidence            4589999999999998

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=87.71  E-value=0.43  Score=35.62  Aligned_cols=26  Identities=19%  Similarity=0.212  Sum_probs=20.4

Q ss_pred             cCccccCCCCCcEEEccCCceeeecC
Q 046714           68 RNVVHREIKCANILVDASGLATTTND   93 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g~~~~~~~   93 (201)
                      ..++|+|+.+.||+++.++...+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~  231 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDW  231 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEEC
Confidence            36899999999999987665555544

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=86.65  E-value=0.63  Score=35.36  Aligned_cols=20  Identities=10%  Similarity=0.391  Sum_probs=17.1

Q ss_pred             hcCccccCCCCCcEEEccCC
Q 046714           67 ERNVVHREIKCANILVDASG   86 (201)
Q Consensus        67 ~~~i~H~dl~p~nill~~~g   86 (201)
                      ...++|||+.+.||+++.++
T Consensus       226 ~~~L~HGDl~~~Nil~~~~~  245 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEHE  245 (397)
T ss_dssp             CCEEECSCCSGGGEEECSSC
T ss_pred             CCceeeCCCCcCcEEEeCCC
Confidence            35799999999999998765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=86.21  E-value=0.82  Score=33.03  Aligned_cols=20  Identities=20%  Similarity=0.358  Sum_probs=17.8

Q ss_pred             CccccCCCCCcEEEccCCce
Q 046714           69 NVVHREIKCANILVDASGLA   88 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~g~~   88 (201)
                      .++|||+.+.||+++.+|..
T Consensus       189 ~LvHGDlw~gNvl~~~~g~~  208 (288)
T 3f7w_A          189 ARIHGDLWNGNVLWQDDGAV  208 (288)
T ss_dssp             EEECSCCSGGGEEEETTEEE
T ss_pred             eeeecCCCCCcEEEcCCCeE
Confidence            58999999999999988853

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=82.91  E-value=1  Score=33.88  Aligned_cols=18  Identities=17%  Similarity=0.263  Sum_probs=15.4

Q ss_pred             CccccCCCCCcEEEccCC
Q 046714           69 NVVHREIKCANILVDASG   86 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~g   86 (201)
                      .++|+|+++.||+++.++
T Consensus       213 ~l~HgDl~~~Nil~~~~~  230 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC  230 (369)
T ss_dssp             EEECSCCCGGGEEECC-C
T ss_pred             EEEeCCCCcccEEecCCc
Confidence            589999999999998665

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	201
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-62
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-61
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-60
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-57
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-54
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-54
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-54
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-54
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-53
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-53
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-52
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-50
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-50
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-49
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-48
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-47
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-46
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-46
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-46
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-46
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-44
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-44
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-44
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-44
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-43
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-43
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-42
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-41
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-41
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-40
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-40
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-40
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-40
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-40
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-39
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-36
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-35
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-11

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  194 bits (495), Expect = 1e-62
 Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 11/208 (5%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLT 63
            +  H N +QY G    E+  ++ +E     +       K  L + ++++ T   L GL 
Sbjct: 70  QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTNDVKSFEGTPFWVAPEVVNLKNNG 115
           YLH  N++HR++K  NIL+           G A+      SF GTP+W+APEV+   + G
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEG 189

Query: 116 -YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNS-LSRDARDFILK 173
            Y    D+WSLG T +E+   +PP  ++  M AL+ I + + P++ +   S   R+F+  
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249

Query: 174 CLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           CLQ  P DRPT+  L++H FV R    +
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPT 277

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 5e-61
 Identities = 72/211 (34%), Positives = 115/211 (54%), Gaps = 19/211 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGL 62
           +  +H NIV+ +     EN L+I +E    G++  +  +    L++SQ+    +Q L+ L
Sbjct: 64  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 123

Query: 63  TYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVV- 109
            YLH+  ++HR++K  NIL    G               T     SF GTP+W+APEVV 
Sbjct: 124 NYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183

Query: 110 --NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSR 165
               K+  Y   AD+WSLG T++EM   +PP+  L  M+ L +I + + P++  P+  S 
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 243

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           + +DF+ KCL+ N + R T +QL++HPFV  
Sbjct: 244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 5e-60
 Identities = 63/211 (29%), Positives = 109/211 (51%), Gaps = 16/211 (7%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTY 64
            + ++ NIV Y+ +    + L++ +E +  GSL ++  +  + + Q+++  R+ L  L +
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEF 131

Query: 65  LHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNLK 112
           LH   V+HR+IK  NIL+   G            +    +   +  GTP+W+APE   + 
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE--VVT 189

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV--PNSLSRDARDF 170
              YG   DIWSLG   +EM+  +PPY +   ++AL+ I     P +  P  LS   RDF
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249

Query: 171 ILKCLQVNPNDRPTAAQLMEHPFVKRPLQTS 201
           + +CL ++   R +A +L++H F+K     S
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-59
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 14/202 (6%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
           S   H NI++  G   D  R+Y+ LE    G++    QK     + + ++Y  ++ N L+
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTNDVK--SFEGTPFWVAPEVVNLKN 113
           Y H + V+HR+IK  N+L+ ++        G +      +  +  GT  ++ PE+  ++ 
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM--IEG 178

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILK 173
             +    D+WSLG    E L  +PP+      +   RI R +    P+ ++  ARD I +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-FPDFVTEGARDLISR 237

Query: 174 CLQVNPNDRPTAAQLMEHPFVK 195
            L+ NP+ RP   +++EHP++ 
Sbjct: 238 LLKHNPSQRPMLREVLEHPWIT 259

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 5e-57
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 26/214 (12%)

Query: 5   SQFEHDNIVQYI--GTEKDENRLYIFLELVKKGSLANLYQKY-----HLSDSQVSSYTRQ 57
            + +H NIV+Y     ++    LYI +E  + G LA++  K      +L +  V     Q
Sbjct: 58  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117

Query: 58  ILNGLTYLHERN-----VVHREIKCANILVDASG------------LATTTNDVKSFEGT 100
           +   L   H R+     V+HR++K AN+ +D               L   T+  K+F GT
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT 177

Query: 101 PFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVP 160
           P++++PE   +    Y   +DIWSLGC + E+    PP++     +   +I  GK   +P
Sbjct: 178 PYYMSPEQ--MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 235

Query: 161 NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
              S +  + I + L +    RP+  +++E+P +
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  176 bits (446), Expect = 8e-55
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 20/209 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGL 62
           +Q  H  ++      +D+  + + LE +  G L +      Y +S+++V +Y RQ   GL
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140

Query: 63  TYLHERNVVHREIKCANILVDAS----------GLATTTND---VKSFEGTPFWVAPEVV 109
            ++HE ++VH +IK  NI+ +            GLAT  N    VK    T  + APE+ 
Sbjct: 141 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI- 199

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSRD 166
            +     G   D+W++G     +L+   P++  +D++ L  + R          +S+S +
Sbjct: 200 -VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258

Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           A+DFI   LQ  P  R T    +EHP++K
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLK 287

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 2e-54
 Identities = 45/212 (21%), Positives = 85/212 (40%), Gaps = 18/212 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLT 63
               H+N+V++ G  ++ N  Y+FLE    G L + +     + +     +  Q++ G+ 
Sbjct: 58  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 117

Query: 64  YLHERNVVHREIKCANILVDASG--------------LATTTNDVKSFEGTPFWVAPEVV 109
           YLH   + HR+IK  N+L+D                        +    GT  +VAPE++
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI--GRGKLPSVPNSLSRDA 167
             +   +    D+WS G  +  ML  + P+    D    +     +    +    +    
Sbjct: 178 K-RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236

Query: 168 RDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
              + K L  NP+ R T   + +  +  +PL+
Sbjct: 237 LALLHKILVENPSARITIPDIKKDRWYNKPLK 268

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  174 bits (441), Expect = 4e-54
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 20/210 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGL 62
           S   H  +V      +D+N + +  E +  G L       H  +S+ +   Y RQ+  GL
Sbjct: 78  SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 137

Query: 63  TYLHERNVVHREIKCANILVDA-------------SGLATTTNDVKSFEGTPFWVAPEVV 109
            ++HE N VH ++K  NI+                +        VK   GT  + APEV 
Sbjct: 138 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV- 196

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSRD 166
             +    G   D+WS+G     +L+   P+    D + L  +         S  + +S D
Sbjct: 197 -AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255

Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
            +DFI K L  +PN R T  Q +EHP++  
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTP 285

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 4e-54
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 23/211 (10%)

Query: 5   SQFEHDNIVQYIG----TEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQIL 59
              +H NIV++      T K +  + +  EL+  G+L    +++  +    + S+ RQIL
Sbjct: 63  KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 122

Query: 60  NGLTYLHERN--VVHREIKCANILVDAS---------GLATTTND--VKSFEGTPFWVAP 106
            GL +LH R   ++HR++KC NI +            GLAT       K+  GTP ++AP
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAP 182

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR-IGRGKLP-SVPNSLS 164
           E+       Y  S D+++ G  +LEM T + PYS  ++   ++R +  G  P S      
Sbjct: 183 EMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
            + ++ I  C++ N ++R +   L+ H F +
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 7e-54
 Identities = 44/209 (21%), Positives = 95/209 (45%), Gaps = 23/209 (11%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
            +  H NI+ ++G      +L I  +  +  SL +            ++    RQ   G+
Sbjct: 59  RKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117

Query: 63  TYLHERNVVHREIKCANILVDAS--------GLA------TTTNDVKSFEGTPFWVAPEV 108
            YLH ++++HR++K  NI +           GLA      + ++  +   G+  W+APEV
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 109 VNLKNNG-YGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK-----LPSVPNS 162
           + +++   Y   +D+++ G  + E++T Q PYS++ +   +  +         L  V ++
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237

Query: 163 LSRDARDFILKCLQVNPNDRPTAAQLMEH 191
             +  +  + +CL+   ++RP   Q++  
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  171 bits (433), Expect = 8e-54
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)

Query: 8   EHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLH 66
            H NI+Q   T +     ++  +L+KKG L + L +K  LS+ +     R +L  +  LH
Sbjct: 68  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 127

Query: 67  ERNVVHREIKCANILVDASG-----------LATTTNDVKSFEGTPFWVAPEVV----NL 111
           + N+VHR++K  NIL+D                     ++   GTP ++APE++    N 
Sbjct: 128 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 187

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSRDAR 168
            + GYG   D+WS G  +  +L   PP+ H + M  L  I  G         +  S   +
Sbjct: 188 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 247

Query: 169 DFILKCLQVNPNDRPTAAQLMEHPFVKR 196
           D + + L V P  R TA + + HPF ++
Sbjct: 248 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-53
 Identities = 45/213 (21%), Positives = 91/213 (42%), Gaps = 20/213 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGL 62
           +   H NI+    + +    L +  E +    +        + L++ ++ SY  Q+   L
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115

Query: 63  TYLHERNVVHREIKCANILVDAS----------GLA---TTTNDVKSFEGTPFWVAPEVV 109
            +LH  N+ H +I+  NI+              G A      ++ +     P + APEV 
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV- 174

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSRD 166
             +++    + D+WSLG  V  +L+   P+    + Q +  I   +          +S +
Sbjct: 175 -HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
           A DF+ + L      R TA++ ++HP++K+ ++
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 6e-53
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 18/207 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
           S+ +H   V+   T +D+ +LY  L   K G L    +K     ++    YT +I++ L 
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122

Query: 64  YLHERNVVHREIKCANILVDASGLA--------------TTTNDVKSFEGTPFWVAPEVV 109
           YLH + ++HR++K  NIL++                   +      SF GT  +V+PE+ 
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL- 181

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARD 169
            L       S+D+W+LGC + +++   PP+    +     +I + +    P      ARD
Sbjct: 182 -LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARD 239

Query: 170 FILKCLQVNPNDRPTAAQLMEHPFVKR 196
            + K L ++   R    ++  +  +K 
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  168 bits (426), Expect = 2e-52
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 20/209 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLT 63
            + +H NIV      +    LY+ ++LV  G L + + +K   ++   S    Q+L+ + 
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 121

Query: 64  YLHERNVVHREIKCANILVDAS-----------GLATTTND---VKSFEGTPFWVAPEVV 109
           YLH+  +VHR++K  N+L  +            GL+   +    + +  GTP +VAPEV 
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV- 180

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSRD 166
            L    Y  + D WS+G     +L   PP+    D +   +I + +        + +S  
Sbjct: 181 -LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239

Query: 167 ARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
           A+DFI   ++ +P  R T  Q ++HP++ 
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIA 268

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-50
 Identities = 46/201 (22%), Positives = 86/201 (42%), Gaps = 16/201 (7%)

Query: 5   SQFEHDNIVQYIGT-EKDENRLYIFLELVKKGSLANLYQKYH---LSDSQVSSYTRQILN 60
           +Q  H N+VQ +G   +++  LYI  E + KGSL +  +      L    +  ++  +  
Sbjct: 55  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114

Query: 61  GLTYLHERNVVHREIKCANILVDASGLA---------TTTNDVKSFEGTPFWVAPEVVNL 111
            + YL   N VHR++   N+LV    +A           ++   + +    W APE   L
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA--L 172

Query: 112 KNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDF 170
           +   +   +D+WS G  + E+ +  + PY  +     + R+ +G     P+       + 
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 232

Query: 171 ILKCLQVNPNDRPTAAQLMEH 191
           +  C  ++   RP+  QL E 
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQ 253

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 5e-50
 Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 17/204 (8%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTY 64
            +EH  +     T + +  L+  +E +  G L   +   +    S+ + Y  +I+ GL +
Sbjct: 59  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118

Query: 65  LHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNLK 112
           LH + +V+R++K  NIL+D  G                     +F GTP ++APE+  L 
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI--LL 176

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL 172
              Y  S D WS G  + EML  Q P+   ++ +    I     P  P  L ++A+D ++
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLV 235

Query: 173 KCLQVNPNDRPTAA-QLMEHPFVK 195
           K     P  R      + +HP  +
Sbjct: 236 KLFVREPEKRLGVRGDIRQHPLFR 259

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 1e-49
 Identities = 59/247 (23%), Positives = 100/247 (40%), Gaps = 57/247 (23%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLT 63
            +     IV + G    +  + I +E +  GSL  + +K   + +  +   +  ++ GLT
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLT 118

Query: 64  YLHERN-VVHREIKCANILVDAS--------GLATTTND--VKSFEGTPFWVAPEVVNLK 112
           YL E++ ++HR++K +NILV++         G++    D    SF GT  +++PE   L+
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPER--LQ 176

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPY---SHLEDMQALFRIGRGKLPSVP--------- 160
              Y + +DIWS+G +++EM   + P       E          G     P         
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 161 -------------------------------NSLSRDARDFILKCLQVNPNDRPTAAQLM 189
                                             S + +DF+ KCL  NP +R    QLM
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296

Query: 190 EHPFVKR 196
            H F+KR
Sbjct: 297 VHAFIKR 303

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 5e-48
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 30/220 (13%)

Query: 8   EHDNIVQYIGT----EKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILN 60
           +  +IV+ +            L I +E +  G L +  Q       ++ + S   + I  
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122

Query: 61  GLTYLHERNVVHREIKCANILVDA--------------SGLATTTNDVKSFEGTPFWVAP 106
            + YLH  N+ HR++K  N+L  +              +   T+ N + +   TP++VAP
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY------SHLEDMQALFRIGRGKLPSVP 160
           EV  L    Y  S D+WSLG  +  +L   PP+      +    M+   R+G+ + P+  
Sbjct: 183 EV--LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240

Query: 161 NS-LSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQ 199
            S +S + +  I   L+  P  R T  + M HP++ +  +
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 2e-47
 Identities = 45/209 (21%), Positives = 84/209 (40%), Gaps = 23/209 (11%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLT 63
            Q ++  IV+ IG  + E+   + +E+ + G L   L Q  H+ D  +     Q+  G+ 
Sbjct: 63  QQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121

Query: 64  YLHERNVVHREIKCANILVDASGLA---------------TTTNDVKSFEGTPFWVAPEV 108
           YL E N VHR++   N+L+     A                        +    W APE 
Sbjct: 122 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA 167
             +    +   +D+WS G  + E  ++ Q PY  ++  +    + +G+    P    R+ 
Sbjct: 182 --INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 239

Query: 168 RDFILKCLQVNPNDRPTAAQL---MEHPF 193
            D +  C   +  +RP  A +   + + +
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-46
 Identities = 47/203 (23%), Positives = 91/203 (44%), Gaps = 21/203 (10%)

Query: 6   QFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGLT 63
                 +++ +   +  +   + LE  +       +  ++  L +    S+  Q+L  + 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 64  YLHERNVVHREIKCANILVDAS---------GLATTTND--VKSFEGTPFWVAPEVVNLK 112
           + H   V+HR+IK  NIL+D +         G      D     F+GT  +  PE +   
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR-Y 183

Query: 113 NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFIL 172
           +  +G SA +WSLG  + +M+    P+ H E++       RG++      +S + +  I 
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII------RGQVF-FRQRVSSECQHLIR 236

Query: 173 KCLQVNPNDRPTAAQLMEHPFVK 195
            CL + P+DRPT  ++  HP+++
Sbjct: 237 WCLALRPSDRPTFEEIQNHPWMQ 259

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-46
 Identities = 39/203 (19%), Positives = 75/203 (36%), Gaps = 18/203 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL--YQKYHLSDSQVSSYTRQILNGL 62
               H+ +VQ  G    +  ++I  E +  G L N     ++     Q+    + +   +
Sbjct: 54  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 113

Query: 63  TYLHERNVVHREIKCANILVDASGLA-------------TTTNDVKSFEGTPFWVAPEVV 109
            YL  +  +HR++   N LV+  G+                       +    W  PEV 
Sbjct: 114 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV- 172

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
            L  + +   +DIW+ G  + E+ +  + PY    + +    I +G     P+  S    
Sbjct: 173 -LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 231

Query: 169 DFILKCLQVNPNDRPTAAQLMEH 191
             +  C     ++RPT   L+ +
Sbjct: 232 TIMYSCWHEKADERPTFKILLSN 254

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-46
 Identities = 39/203 (19%), Positives = 77/203 (37%), Gaps = 18/203 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGL 62
            +  H  +VQ  G   ++  + +  E ++ G L++  +      +   +      +  G+
Sbjct: 55  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM 114

Query: 63  TYLHERNVVHREIKCANILVDASGLA-------------TTTNDVKSFEGTPFWVAPEVV 109
            YL E  V+HR++   N LV  + +                       +    W +PEV 
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV- 173

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
               + Y   +D+WS G  + E+ +  + PY +  + + +  I  G     P   S    
Sbjct: 174 -FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 232

Query: 169 DFILKCLQVNPNDRPTAAQLMEH 191
             +  C +  P DRP  ++L+  
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQ 255

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-46
 Identities = 47/212 (22%), Positives = 84/212 (39%), Gaps = 24/212 (11%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNGL 62
            Q ++  IV+ IG  + E  L + +E+   G L      ++  +  S V+    Q+  G+
Sbjct: 64  HQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122

Query: 63  TYLHERNVVHREIKCANILVDASGLA---------------TTTNDVKSFEGTPFWVAPE 107
            YL E+N VHR++   N+L+     A               +      + +    W APE
Sbjct: 123 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
              +    +   +D+WS G T+ E L++ Q PY  ++  + +  I +GK    P     +
Sbjct: 183 C--INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 240

Query: 167 ARDFILKCLQVNPNDRPTAAQL---MEHPFVK 195
               +  C      DRP    +   M   +  
Sbjct: 241 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  152 bits (386), Expect = 7e-46
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 19/209 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLT 63
           S  +   IV         ++L   L+L+  G L  +L Q    S++ +  Y  +I+ GL 
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 64  YLHERNVVHREIKCANILVDAS--------GLATTTNDVKS--FEGTPFWVAPEVVNLKN 113
           ++H R VV+R++K ANIL+D          GLA   +  K     GT  ++APEV+  K 
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKG 180

Query: 114 NGYGLSADIWSLGCTVLEMLTHQPPYSH--LEDMQALFRIGRGKLPSVPNSLSRDARDFI 171
             Y  SAD +SLGC + ++L    P+     +D   + R+       +P+S S + R  +
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 240

Query: 172 LKCLQVNPNDRPT-----AAQLMEHPFVK 195
              LQ + N R       A ++ E PF +
Sbjct: 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFR 269

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-45
 Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 21/210 (10%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLY-QKYHLSDSQVSSYTRQILNGLT 63
            + +H N++      +++  + + LELV  G L +   +K  L++ + + + +QILNG+ 
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127

Query: 64  YLHERNVVHREIKCANILVDASGLATTTNDVKSFE---------------GTPFWVAPEV 108
           YLH   + H ++K  NI++    +      +  F                GTP +VAPE+
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSR 165
             +     GL AD+WS+G     +L+   P+      + L  +            ++ S 
Sbjct: 188 --VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
            A+DFI + L  +P  R T    ++HP++K
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  150 bits (379), Expect = 3e-45
 Identities = 48/206 (23%), Positives = 92/206 (44%), Gaps = 18/206 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL-YQKYHLSDSQVSSYTRQILNGLT 63
           S   H  I++  GT +D  ++++ ++ ++ G L +L  +     +     Y  ++   L 
Sbjct: 59  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 118

Query: 64  YLHERNVVHREIKCANILVDASGLA---------TTTNDVKSFEGTPFWVAPEVVNLKNN 114
           YLH +++++R++K  NIL+D +G              +   +  GTP ++APEV  +   
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEV--VSTK 176

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKC 174
            Y  S D WS G  + EML    P+     M+   +I   +L   P   + D +D + + 
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR-FPPFFNEDVKDLLSRL 235

Query: 175 LQVNPNDR-----PTAAQLMEHPFVK 195
           +  + + R          +  HP+ K
Sbjct: 236 ITRDLSQRLGNLQNGTEDVKNHPWFK 261

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 3e-44
 Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 19/203 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGL 62
            QF+H +IV+ IG    EN ++I +EL   G L +  Q     L  + +  Y  Q+   L
Sbjct: 63  RQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121

Query: 63  TYLHERNVVHREIKCANILVDASGLATTTNDVKS-------------FEGTPFWVAPEVV 109
            YL  +  VHR+I   N+LV ++      +   S              +    W+APE  
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES- 180

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDAR 168
            +    +  ++D+W  G  + E+L H   P+  +++   + RI  G+   +P +      
Sbjct: 181 -INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 239

Query: 169 DFILKCLQVNPNDRPTAAQLMEH 191
             + KC   +P+ RP   +L   
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQ 262

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  146 bits (368), Expect = 5e-44
 Identities = 46/214 (21%), Positives = 86/214 (40%), Gaps = 25/214 (11%)

Query: 5   SQFEHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQIL 59
           +   H  IV    T + E       YI +E V   +L ++      ++  +         
Sbjct: 62  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121

Query: 60  NGLTYLHERNVVHREIKCANILVDA---------------SGLATTTNDVKSFEGTPFWV 104
             L + H+  ++HR++K ANI++ A               +    +     +  GT  ++
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLP---SVPN 161
           +PE    + +     +D++SLGC + E+LT +PP++    +   ++  R       +   
Sbjct: 182 SPEQ--ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239

Query: 162 SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
            LS D    +LK L  NP +R   A  M    V+
Sbjct: 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 5e-44
 Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 23/209 (11%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNG 61
            Q +H  +V+       E  +YI  E ++ GSL +  +      L+ +++     QI  G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 62  LTYLHERNVVHREIKCANILVDASGL-------------ATTTNDVKSFEGTPFWVAPEV 108
           + ++ ERN +HR+++ ANILV  +                      +  +    W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA 167
             +    + + +D+WS G  + E++TH + PY  + + + +  + RG     P++   + 
Sbjct: 182 --INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239

Query: 168 RDFILKCLQVNPNDRPTAAQLM---EHPF 193
              +  C +  P DRPT   L    E  F
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 6e-44
 Identities = 38/223 (17%), Positives = 75/223 (33%), Gaps = 42/223 (18%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH----------------------- 45
           H+NIV  +G       +Y+  E    G L N  +                          
Sbjct: 100 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159

Query: 46  -LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLA--------------TT 90
            L+   +  +  Q+  G+ +L  ++ VHR++   N+LV    +               + 
Sbjct: 160 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219

Query: 91  TNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALF 149
                +      W+APE  +L    Y + +D+WS G  + E+ +    PY  +      +
Sbjct: 220 YVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277

Query: 150 RIGRGKL-PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           ++ +       P   + +    +  C   +   RP+   L   
Sbjct: 278 KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 7e-44
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 22/206 (10%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
              +H N+++  G       + +  EL   GSL +  +K+  H     +S Y  Q+  G+
Sbjct: 66  HSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 63  TYLHERNVVHREIKCANILVDASGLA---------------TTTNDVKSFEGTPFWVAPE 107
            YL  +  +HR++   N+L+    L                      +  +    W APE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGR-GKLPSVPNSLSR 165
              LK   +  ++D W  G T+ EM T+ Q P+  L   Q L +I + G+    P    +
Sbjct: 185 S--LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 242

Query: 166 DARDFILKCLQVNPNDRPTAAQLMEH 191
           D  + +++C    P DRPT   L + 
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 9e-44
 Identities = 57/235 (24%), Positives = 90/235 (38%), Gaps = 46/235 (19%)

Query: 5   SQFEHDNIVQYIG-----TEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQ 57
             FEH N+V+            E +L +  E V +     L +     +    +     Q
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 58  ILNGLTYLHERNVVHREIKCANILVDASG-----------LATTTNDVKSFEGTPFWVAP 106
           +L GL +LH   VVHR++K  NILV +SG           + +    + S   T ++ AP
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 107 EVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK----------- 155
           EV  L  + Y    D+WS+GC   EM   +P +    D+  L +I               
Sbjct: 185 EV--LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 156 ---------------LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                          +      +    +D +LKCL  NP  R +A   + HP+ +
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  144 bits (365), Expect = 3e-43
 Identities = 45/207 (21%), Positives = 85/207 (41%), Gaps = 22/207 (10%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGL 62
            QF+H N++   G       + I  E ++ GSL +  ++     +  Q+    R I  G+
Sbjct: 82  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141

Query: 63  TYLHERNVVHREIKCANILVDASGLA-----------------TTTNDVKSFEGTPFWVA 105
            YL + N VHR++   NILV+++ +                   T       +    W A
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLS 164
           PE   ++   +  ++D+WS G  + E++++ + PY  + +   +  I +      P    
Sbjct: 202 PEA--IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEH 191
                 +L C Q + N RP   Q++  
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 3e-43
 Identities = 46/231 (19%), Positives = 86/231 (37%), Gaps = 41/231 (17%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ-KYHLSDSQVSSYTRQILNGLT 63
            +  H NI+  +     ++ + +  + ++      +      L+ S + +Y    L GL 
Sbjct: 55  QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 114

Query: 64  YLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL 111
           YLH+  ++HR++K  N+L+D +G              +          T ++ APE++  
Sbjct: 115 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF- 173

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRG----------------- 154
               YG+  D+W++GC + E+L   P      D+  L RI                    
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 155 ----------KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                      L  + ++   D  D I      NP  R TA Q ++  +  
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 4e-43
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 22/209 (10%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLTYLHE 67
              +V      + E +L++ L+ +  G L   L Q+   ++ +V  Y  +I+  L +LH+
Sbjct: 88  SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147

Query: 68  RNVVHREIKCANILVDASG-------------LATTTNDVKSFEGTPFWVAPEVVNLKNN 114
             +++R+IK  NIL+D++G             +A  T     F GT  ++AP++V   ++
Sbjct: 148 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 207

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKL---PSVPNSLSRDARDFI 171
           G+  + D WSLG  + E+LT   P++   +  +   I R  L   P  P  +S  A+D I
Sbjct: 208 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 267

Query: 172 LKCLQVNPNDRP-----TAAQLMEHPFVK 195
            + L  +P  R       A ++ EH F +
Sbjct: 268 QRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 1e-42
 Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 22/212 (10%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNG 61
            +  H+ +VQ      +E  +YI  E + KGSL +  +     +L   Q+     QI +G
Sbjct: 67  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125

Query: 62  LTYLHERNVVHREIKCANILVDASGLA-------------TTTNDVKSFEGTPFWVAPEV 108
           + Y+   N VHR+++ ANILV  + +                    +  +    W APE 
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA 167
                  + + +D+WS G  + E+ T  + PY  + + + L ++ RG     P       
Sbjct: 186 --ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 243

Query: 168 RDFILKCLQVNPNDRPTAAQLME--HPFVKRP 197
            D + +C +  P +RPT   L      +    
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 4e-42
 Identities = 56/233 (24%), Positives = 90/233 (38%), Gaps = 43/233 (18%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGL 62
            +  H NIV+ +     EN+LY+  E + +     +       +    + SY  Q+L GL
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115

Query: 63  TYLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVN 110
            + H   V+HR++K  N+L++  G                         T ++ APE++ 
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL- 174

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK--------------- 155
           L    Y  + DIWSLGC   EM+T +  +    ++  LFRI R                 
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 156 -------------LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                           V   L  D R  + + L  +PN R +A   + HPF +
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 2e-41
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 21/209 (10%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLT 63
               H  +       +  +RL   +E    G L   L ++   ++ +   Y  +I++ L 
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119

Query: 64  YLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL 111
           YLH R+VV+R+IK  N+++D  G              +    +K+F GTP ++APEV  L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV--L 177

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFI 171
           ++N YG + D W LG  + EM+  + P+ + +  +    I   ++   P +LS +A+  +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-FPRTLSPEAKSLL 236

Query: 172 LKCLQVNPNDRP-----TAAQLMEHPFVK 195
              L+ +P  R       A ++MEH F  
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-41
 Identities = 45/212 (21%), Positives = 87/212 (41%), Gaps = 31/212 (14%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----------------LSDSQV 51
           H NI+  +G  +    LY+ +E    G+L +  +K                   LS  Q+
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 52  SSYTRQILNGLTYLHERNVVHREIKCANILVDAS--------GLATTTNDV---KSFEGT 100
             +   +  G+ YL ++  +HR++   NILV  +        GL+               
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 189

Query: 101 PFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSV 159
             W+A E   L  + Y  ++D+WS G  + E+++    PY  +   +   ++ +G     
Sbjct: 190 VRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247

Query: 160 PNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
           P +   +  D + +C +  P +RP+ AQ++  
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  138 bits (348), Expect = 8e-41
 Identities = 41/226 (18%), Positives = 82/226 (36%), Gaps = 42/226 (18%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH------------------- 45
           ++F++ NIV+ +G       + +  E +  G L    +                      
Sbjct: 71  AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 46  ------LSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLA----------- 88
                 LS ++     RQ+  G+ YL ER  VHR++   N LV  + +            
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 89  ---TTTNDVKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ-PPYSHLED 144
                     +      W+ PE   +  N Y   +D+W+ G  + E+ ++   PY  +  
Sbjct: 191 YSADYYKADGNDAIPIRWMPPES--IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248

Query: 145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
            + ++ +  G + + P +   +  + +  C    P DRP+   +  
Sbjct: 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-40
 Identities = 44/225 (19%), Positives = 84/225 (37%), Gaps = 34/225 (15%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-----------LSDSQVSS 53
            +F   ++V+ +G         + +EL+ +G L +  +               S S++  
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 54  YTRQILNGLTYLHERNVVHREIKCANILVDASGLA--------------TTTNDVKSFEG 99
              +I +G+ YL+    VHR++   N +V                               
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 100 TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRGKLPS 158
              W++PE   LK+  +   +D+WS G  + E+ T  + PY  L + Q L  +  G L  
Sbjct: 198 PVRWMSPES--LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255

Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAAQLME------HPFVKRP 197
            P++      + +  C Q NP  RP+  +++        P  +  
Sbjct: 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-40
 Identities = 39/207 (18%), Positives = 81/207 (39%), Gaps = 22/207 (10%)

Query: 5   SQFEHDNIVQYIGT-EKDENRLYIFLELVKKGSLANLY--QKYHLSDSQVSSYTRQILNG 61
             F H N++  +G   + E    + L  +K G L N    + ++ +   +  +  Q+  G
Sbjct: 83  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142

Query: 62  LTYLHERNVVHREIKCANILVDASGLA----------------TTTNDVKSFEGTPFWVA 105
           + +L  +  VHR++   N ++D                      + ++    +    W+A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLS 164
            E   L+   +   +D+WS G  + E++T   PPY  +        + +G+    P    
Sbjct: 203 LES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 260

Query: 165 RDARDFILKCLQVNPNDRPTAAQLMEH 191
               + +LKC       RP+ ++L+  
Sbjct: 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-40
 Identities = 47/215 (21%), Positives = 79/215 (36%), Gaps = 34/215 (15%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQV 51
           H NI+  +G    +  LY+ +E   KG+L    Q                    LS   +
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137

Query: 52  SSYTRQILNGLTYLHERNVVHREIKCANILVDASGL--------------ATTTNDVKSF 97
            S   Q+  G+ YL  +  +HR++   N+LV    +                      + 
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197

Query: 98  EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKL 156
                W+APE   L +  Y   +D+WS G  + E+ T    PY  +   +    +  G  
Sbjct: 198 RLPVKWMAPEA--LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 255

Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
              P++ + +    +  C    P+ RPT  QL+E 
Sbjct: 256 MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  136 bits (343), Expect = 3e-40
 Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 42/232 (18%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANL-YQKYHLSDSQVSSYTRQILNGLT 63
            + +H NIV+       + RL +  E + +     L   +  L      S+  Q+LNG+ 
Sbjct: 55  KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 64  YLHERNVVHREIKCANILVDASG------------LATTTNDVKSFEGTPFWVAPEVVNL 111
           Y H+R V+HR++K  N+L++  G                         T ++ AP+V+ +
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL-M 173

Query: 112 KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK---------------- 155
            +  Y  + DIWS+GC   EM+   P +  + +   L RI R                  
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233

Query: 156 ------------LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                         S    L     D + K L+++PN R TA Q +EH + K
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 3e-40
 Identities = 48/213 (22%), Positives = 85/213 (39%), Gaps = 22/213 (10%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGL 62
            QF H NI++  G       + I  E ++ G+L    ++     S  Q+    R I  G+
Sbjct: 64  GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 63  TYLHERNVVHREIKCANILVDASGLA---------------TTTNDVKSFEGTPFWVAPE 107
            YL   N VHR++   NILV+++ +                  T      +    W APE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRD 166
              +    +  ++D+WS G  + E++T+ + PY  L + + +  I  G     P      
Sbjct: 184 A--ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241

Query: 167 ARDFILKCLQVNPNDRPTAAQLME--HPFVKRP 197
               +++C Q     RP  A ++      ++ P
Sbjct: 242 IYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 4e-40
 Identities = 38/204 (18%), Positives = 86/204 (42%), Gaps = 20/204 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGL 62
           +  ++ ++ + +G       + +  +L+  G L +  +++  ++    + ++  QI  G+
Sbjct: 66  ASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 63  TYLHERNVVHREIKCANILVDASGLA--------------TTTNDVKSFEGTPFWVAPEV 108
            YL +R +VHR++   N+LV                          +  +    W+A E 
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA 167
             + +  Y   +D+WS G TV E++T    PY  +   +    + +G+    P   + D 
Sbjct: 185 --ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242

Query: 168 RDFILKCLQVNPNDRPTAAQLMEH 191
              ++KC  ++ + RP   +L+  
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIE 266

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (344), Expect = 8e-40
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 18/206 (8%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLAN-LYQKYHLSDSQVSSYTRQILNGLT 63
                  +V+   + KD + LY+ +E V  G + + L +    S+     Y  QI+    
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155

Query: 64  YLHERNVVHREIKCANILVDASGLATTT---------NDVKSFEGTPFWVAPEVVNLKNN 114
           YLH  ++++R++K  N+L+D  G    T             +  GTP  +APE+  + + 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEI--ILSK 213

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKC 174
           GY  + D W+LG  + EM    PP+   + +Q   +I  GK+   P+  S D +D +   
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR-FPSHFSSDLKDLLRNL 272

Query: 175 LQVNPNDR-----PTAAQLMEHPFVK 195
           LQV+   R          +  H +  
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWFA 298

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (336), Expect = 4e-39
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 19/203 (9%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQ---KYHLSDSQVSSYTRQILNG 61
            + +H N+VQ +G    E   YI  E +  G+L +  +   +  +S   +     QI + 
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127

Query: 62  LTYLHERNVVHREIKCANILVDASGLA-------------TTTNDVKSFEGTPFWVAPEV 108
           + YL ++N +HR++   N LV  + L               T       +    W APE 
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187

Query: 109 VNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDMQALFRIGRGKLPSVPNSLSRDA 167
             L  N + + +D+W+ G  + E+ T+   PY  ++  Q    + +      P       
Sbjct: 188 --LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245

Query: 168 RDFILKCLQVNPNDRPTAAQLME 190
            + +  C Q NP+DRP+ A++ +
Sbjct: 246 YELMRACWQWNPSDRPSFAEIHQ 268

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 9e-39
 Identities = 53/241 (21%), Positives = 82/241 (34%), Gaps = 51/241 (21%)

Query: 5   SQFEHDNIVQYI------GTEKDENRLYIFLELVKKGSLANLYQ----KYHLSDSQVSSY 54
            + +H NIV+        G +KDE  L + L+ V +            K  L    V  Y
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127

Query: 55  TRQILNGLTYLHERNVVHREIKCANILVDASGLATTTND------------VKSFEGTPF 102
             Q+   L Y+H   + HR+IK  N+L+D         D              S+  + +
Sbjct: 128 MYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187

Query: 103 WVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI----------- 151
           + APE++      Y  S D+WS GC + E+L  QP +     +  L  I           
Sbjct: 188 YRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

Query: 152 --------GRGKLPSVPN---------SLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
                      K P +               +A     + L+  P  R T  +   H F 
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

Query: 195 K 195
            
Sbjct: 307 D 307

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-38
 Identities = 41/217 (18%), Positives = 78/217 (35%), Gaps = 37/217 (17%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-------------------LSDS 49
           H NIV  +G         +  E    G L N  ++                     L   
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 50  QVSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKSFE----------- 98
            + S++ Q+  G+ +L  +N +HR++   NIL+    +    +   + +           
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 99  ---GTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRG 154
                  W+APE   + N  Y   +D+WS G  + E+ +    PY  +      +++ + 
Sbjct: 206 NARLPVKWMAPES--IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263

Query: 155 KL-PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
                 P     +  D +  C   +P  RPT  Q+++
Sbjct: 264 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (323), Expect = 3e-37
 Identities = 30/224 (13%), Positives = 68/224 (30%), Gaps = 35/224 (15%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLTYLHE 67
              I        + +   + +EL+         +     S   V     Q+++ + Y+H 
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 68  RNVVHREIKCANILVDASGLA----------------------TTTNDVKSFEGTPFWVA 105
           +N +HR++K  N L+                                + K+  GT  + +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

Query: 106 PEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK-------LPS 158
                          D+ SLG  ++       P+  L+      +  R         +  
Sbjct: 182 INT--HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 159 VPNSLSRDARDFILKCLQVNPNDRPTAA---QLMEHPFVKRPLQ 199
           +      +   ++  C  +  +D+P  +   QL  + F ++   
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 4e-37
 Identities = 56/242 (23%), Positives = 100/242 (41%), Gaps = 52/242 (21%)

Query: 5   SQFEHDNIVQYIG-----TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQIL 59
            +F H+NI+         T +    +Y+   L+    L  L +  HLS+  +  +  QIL
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG-ADLYKLLKTQHLSNDHICYFLYQIL 119

Query: 60  NGLTYLHERNVVHREIKCANILVDASGLA---------------TTTNDVKSFEGTPFWV 104
            GL Y+H  NV+HR++K +N+L++ +                    T  +  +  T ++ 
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI------------- 151
           APE++   + GY  S DIWS+GC + EML+++P +     +  L  I             
Sbjct: 180 APEIML-NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 152 -----------------GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV 194
                             +     +  +    A D + K L  NP+ R    Q + HP++
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

Query: 195 KR 196
           ++
Sbjct: 299 EQ 300

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-36
 Identities = 48/247 (19%), Positives = 83/247 (33%), Gaps = 57/247 (23%)

Query: 5   SQFEHDNIVQYIGT--------EKDENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYT 55
              +H+N+V  I           + +  +Y+  +  +              + S++    
Sbjct: 64  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123

Query: 56  RQILNGLTYLHERNVVHREIKCANILVDAS--------GLA--------TTTNDVKSFEG 99
           + +LNGL Y+H   ++HR++K AN+L+           GLA        +  N   +   
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 100 TPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSV 159
           T ++  PE++ L    YG   D+W  GC + EM T  P      +   L  I +      
Sbjct: 184 TLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 160 PN-------------------------------SLSRDARDFILKCLQVNPNDRPTAAQL 188
           P                                     A D I K L ++P  R  +   
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

Query: 189 MEHPFVK 195
           + H F  
Sbjct: 303 LNHDFFW 309

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 3e-36
 Identities = 48/239 (20%), Positives = 87/239 (36%), Gaps = 53/239 (22%)

Query: 5   SQFEHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILN 60
               H+NI+ +I  +  +N    +L++  +  + GSL +   +Y ++   +        +
Sbjct: 52  VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTAS 111

Query: 61  GLTYLHE--------RNVVHREIKCANILVDASGLA----------------TTTNDVKS 96
           GL +LH           + HR++K  NILV  +G                  T       
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171

Query: 97  FEGTPFWVAPEV----VNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF--- 149
             GT  ++APEV    +N+K+      ADI+++G    E+          ED Q  +   
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231

Query: 150 -------------RIGRGKLPSVPNSLS-----RDARDFILKCLQVNPNDRPTAAQLME 190
                           +   P++PN        R     + +C   N   R TA ++ +
Sbjct: 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 8e-36
 Identities = 46/236 (19%), Positives = 92/236 (38%), Gaps = 47/236 (19%)

Query: 5   SQFEHDNIVQYIGTEKDENRL------YIFLELVKKGSLANLYQKYHLSDSQVSSYTRQI 58
               H+N++  +     +  L      Y+ +  +    L  L +   L + ++     Q+
Sbjct: 72  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQFLVYQM 130

Query: 59  LNGLTYLHERNVVHREIKCANILVDASGLA---------TTTNDVKSFEGTPFWVAPEVV 109
           L GL Y+H   ++HR++K  N+ V+                 +++  +  T ++ APEV+
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVI 190

Query: 110 NLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK-------------- 155
            L    Y  + DIWS+GC + EM+T +  +   + +  L  I +                
Sbjct: 191 -LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249

Query: 156 ----------------LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                             S+  + S  A + + K L ++   R TA + + HP+ +
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  125 bits (315), Expect = 1e-35
 Identities = 49/238 (20%), Positives = 89/238 (37%), Gaps = 54/238 (22%)

Query: 9   HDNIVQYIGT--EKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLH 66
             NI+       +       +  E V       LYQ   L+D  +  Y  +IL  L Y H
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCH 146

Query: 67  ERNVVHREIKCANILVDAS---------GLATTTNDVKSFE---GTPFWVAPEVVNLKNN 114
              ++HR++K  N+++D           GLA   +  + +     + ++  PE + +   
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE-LLVDYQ 205

Query: 115 GYGLSADIWSLGCTVLEMLTHQPPY----SHLEDMQALFRI------------------- 151
            Y  S D+WSLGC +  M+  + P+     + + +  + ++                   
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 152 --------------GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                          R       + +S +A DF+ K L+ +   R TA + MEHP+  
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-35
 Identities = 45/217 (20%), Positives = 84/217 (38%), Gaps = 36/217 (16%)

Query: 9   HDNIVQYIG-TEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQ 50
           H N+V  +G   K    L + +E  K G+L+   +                    L+   
Sbjct: 76  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 51  VSSYTRQILNGLTYLHERNVVHREIKCANILVDASGLA--------------TTTNDVKS 96
           +  Y+ Q+  G+ +L  R  +HR++   NIL+    +                       
Sbjct: 136 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 97  FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFR-IGRG 154
                 W+APE   + +  Y + +D+WS G  + E+ +    PY  ++  +   R +  G
Sbjct: 196 ARLPLKWMAPET--IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 253

Query: 155 KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH 191
                P+  + +    +L C    P+ RPT ++L+EH
Sbjct: 254 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 1e-34
 Identities = 53/232 (22%), Positives = 84/232 (36%), Gaps = 41/232 (17%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLA-NLYQKYHLSDSQVSSYTRQILNGLT 63
            + +H NIV+       + +L +  E   +            L    V S+  Q+L GL 
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 64  YLHERNVVHREIKCANILVDASG-----------LATTTNDVKSFEGTPFWVAPEVVNLK 112
           + H RNV+HR++K  N+L++ +G                    S E    W  P  V   
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 113 NNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQALFRIGRG----------------- 154
              Y  S D+WS GC   E+    +P +   +    L RI R                  
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 155 -----------KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK 195
                       L +V   L+   RD +   L+ NP  R +A + ++HP+  
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 3e-34
 Identities = 50/236 (21%), Positives = 95/236 (40%), Gaps = 45/236 (19%)

Query: 5   SQFEHDNIVQYIG-----TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQIL 59
              +H+N++  +         +E      +  +    L N+ +   L+D  V     QIL
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131

Query: 60  NGLTYLHERNVVHREIKCANILVDASGL---------ATTTNDVKSFEGTPFWVAPEVVN 110
            GL Y+H  +++HR++K +N+ V+               T +++  +  T ++ APE++ 
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM- 190

Query: 111 LKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGK--------------- 155
           L    Y  + DIWS+GC + E+LT +  +   + +  L  I R                 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250

Query: 156 ---------------LPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR 196
                            +V    +  A D + K L ++ + R TAAQ + H +  +
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  113 bits (284), Expect = 2e-31
 Identities = 32/214 (14%), Positives = 64/214 (29%), Gaps = 34/214 (15%)

Query: 9   HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYH-LSDSQVSSYTRQILNGLTYLHE 67
              I       ++     + ++L+       L       S   V+   +Q+L  +  +HE
Sbjct: 60  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 68  RNVVHREIKCANILVDAS-------------GLATTTND-----------VKSFEGTPFW 103
           +++V+R+IK  N L+                G+     D            K+  GT  +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 104 VAPEVVNLKNNGYGLSADIWSLGCTVLEMLT---HQPPYSHLEDMQALFRIGRGK----L 156
           ++               D+ +LG   +  L             + Q   RIG  K    L
Sbjct: 180 MSINT--HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 157 PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME 190
             +      +   ++     +  +  P    L  
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-30
 Identities = 46/249 (18%), Positives = 93/249 (37%), Gaps = 62/249 (24%)

Query: 5   SQFEHDNIVQYIG------TEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQI 58
               H NI+  +       T ++   +Y+ +EL+       +  +      ++S    Q+
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--DHERMSYLLYQM 128

Query: 59  LNGLTYLHERNVVHREIKCANILVDASG-----------LATTTNDVKSFEGTPFWVAPE 107
           L G+ +LH   ++HR++K +NI+V +              A T+  +  +  T ++ APE
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188

Query: 108 VVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIGRGKLPSVP------- 160
              +   GY  + DIWS+GC + EM+ H+  +   + +    ++        P       
Sbjct: 189 --VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 161 ----------------------------------NSLSRDARDFILKCLQVNPNDRPTAA 186
                                                +  ARD + K L ++P  R +  
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306

Query: 187 QLMEHPFVK 195
             ++HP++ 
Sbjct: 307 DALQHPYIN 315

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  101 bits (251), Expect = 3e-26
 Identities = 52/261 (19%), Positives = 97/261 (37%), Gaps = 71/261 (27%)

Query: 7   FEHDNIVQYI--GTEKDENRLYIFLELVKKG----SLANLYQKYHLSDSQVSSYTRQILN 60
              ++I++ +     K  N +++ +     G    +L   Y+   +    V   ++Q+L 
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 61  GLTYLH-ERNVVHREIKCANILVDASGLATTTNDVKSFE---------------GTPFWV 104
           GL Y+H    ++H +IK  N+L++          +K  +                T  + 
Sbjct: 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 105 APEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPY------SHLEDMQALFRIGR--GKL 156
           +PEV  L    +G  ADIWS  C + E++T    +      S+ +D   + +I    G+L
Sbjct: 197 SPEV--LLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 157 PS---------------------------------------VPNSLSRDARDFILKCLQV 177
           PS                                            +++  DF+   LQ+
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 178 NPNDRPTAAQLMEHPFVKRPL 198
           +P  R  A  L+ HP++K  L
Sbjct: 315 DPRKRADAGGLVNHPWLKDTL 335

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 58.6 bits (141), Expect = 1e-11
 Identities = 19/137 (13%), Positives = 42/137 (30%), Gaps = 24/137 (17%)

Query: 5   SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTY 64
            + +   + +            + +EL+    L  +  +              IL  +  
Sbjct: 69  QKLQGLAVPKVY----AWEGNAVLMELIDAKELYRVRVENPDE------VLDMILEEVAK 118

Query: 65  LHERNVVHREIKCANILVDAS-------GLATTTNDVKSFEGTPFWVAPEVVNLK---NN 114
            + R +VH ++   N+LV            +    +    E     +  +V N+    + 
Sbjct: 119 FYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWRE----ILERDVRNIITYFSR 174

Query: 115 GYGLSADIWSLGCTVLE 131
            Y    DI S    +L+
Sbjct: 175 TYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	201
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.55
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.29
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.56
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	94.86
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	92.89
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	83.7

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-54  Score=311.98  Aligned_cols=192  Identities=29%  Similarity=0.521  Sum_probs=171.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++..++||||+++|+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        59 il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nil  138 (263)
T d2j4za1          59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL  138 (263)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             HHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccce
Confidence            57889999999999999999999999999999999999876 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 046714           82 VDASGLATTTNDVK----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI  151 (201)
Q Consensus        82 l~~~g~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  151 (201)
                      ++.+|..++.++..          ...||+.|+|||.+  .+..++.++||||+||++|+|++|+.||......+....+
T Consensus       139 l~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~--~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i  216 (263)
T d2j4za1         139 LGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI  216 (263)
T ss_dssp             ECTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             ecCCCCEeecccceeeecCCCcccccCCCCcccCHHHH--cCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            99988877766432          23478899999998  4556789999999999999999999999888777777666


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .... ..++..+++++++|+.+||+.+|++|||++|+++||||+..
T Consensus       217 ~~~~-~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         217 SRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HTTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HcCC-CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            5554 46778899999999999999999999999999999999764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=313.29  Aligned_cols=194  Identities=33%  Similarity=0.627  Sum_probs=170.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILV   82 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill   82 (201)
                      +|++++||||+++++++.+++..++||||+.|++|.+++.++++++.++..++.||+.||+|||++||+||||||+||++
T Consensus        70 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl  149 (293)
T d1yhwa1          70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL  149 (293)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE
Confidence            57889999999999999999999999999999999999988889999999999999999999999999999999999999


Q ss_pred             ccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Q 046714           83 DASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFR  150 (201)
Q Consensus        83 ~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~  150 (201)
                      +.+|.+++.+++            ....||+.|+|||.+  .+..++.++||||+||++|+|++|+.||.+.........
T Consensus       150 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~  227 (293)
T d1yhwa1         150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL  227 (293)
T ss_dssp             CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHH--SSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             CCCCcEeeccchhheeeccccccccccccCCCccChhhh--cCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH
Confidence            988877666543            233488999999998  456678999999999999999999999988776666655


Q ss_pred             hhcCCC--CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          151 IGRGKL--PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       151 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      +.....  ...+..+++.+++|+.+||+.+|++|||++|+++||||+...
T Consensus       228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             HHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence            544332  244567899999999999999999999999999999997543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=309.73  Aligned_cols=197  Identities=23%  Similarity=0.409  Sum_probs=165.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++..++||||+++++|.+++++. .+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        56 ~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NIL  135 (271)
T d1nvra_          56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL  135 (271)
T ss_dssp             HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             HHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEE
Confidence            578999999999999999999999999999999999998754 4999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc--------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           82 VDASGLATTTNDV--------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        82 l~~~g~~~~~~~~--------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ++.+|.+++.++.              ....||+.|+|||.+. .....+.++||||+||++|+|++|+.||........
T Consensus       136 l~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~  214 (271)
T d1nvra_         136 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ  214 (271)
T ss_dssp             ECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHH-CSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH
T ss_pred             ECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhc-CCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH
Confidence            9988777666543              2345889999999983 233346789999999999999999999976543222


Q ss_pred             HH-H-hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcCCC
Q 046714          148 LF-R-IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPLQT  200 (201)
Q Consensus       148 ~~-~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~~~  200 (201)
                      .. . ............+++++.+|+.+||+.+|++|||++|+++||||+++++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~k  269 (271)
T d1nvra_         215 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  269 (271)
T ss_dssp             HHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             HHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCCCC
Confidence            22 2 22222233345789999999999999999999999999999999998864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=306.50  Aligned_cols=196  Identities=36%  Similarity=0.655  Sum_probs=171.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++..++||||+++++|.+++.+  .++++.++..++.||+.||+|||++||+||||||+||
T Consensus        62 il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NI  141 (288)
T d2jfla1          62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNI  141 (288)
T ss_dssp             HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             HHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhhe
Confidence            57889999999999999999999999999999999998754  3499999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc------------ccccCccccccccccc---CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVK------------SFEGTPFWVAPEVVNL---KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      +++.+|.+++.++..            ...||+.|+|||.+..   ....++.++||||+||++|+|++|+.||.+....
T Consensus       142 ll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~  221 (288)
T d2jfla1         142 LFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM  221 (288)
T ss_dssp             EECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred             eECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH
Confidence            999998887776542            3458899999999742   2345788999999999999999999999888777


Q ss_pred             HHHHHhhcCCCCC--CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          146 QALFRIGRGKLPS--VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       146 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      +....+.....+.  .+..+++++++|+.+||+.||++|||++|+++||||+...
T Consensus       222 ~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~  276 (288)
T d2jfla1         222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS  276 (288)
T ss_dssp             GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred             HHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            7777766655433  3567899999999999999999999999999999998643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-52  Score=301.59  Aligned_cols=190  Identities=29%  Similarity=0.558  Sum_probs=162.4

Q ss_pred             ccccCCCcceeccceeeee--CCeEEEEEEecCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcC-----c
Q 046714            3 SFSQFEHDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQK-----YHLSDSQVSSYTRQILNGLTYLHERN-----V   70 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~-----i   70 (201)
                      +|++++||||+++++++.+  .+..++||||+++|+|.+++.+     ..+++..++.++.||+.||+|||++|     |
T Consensus        56 il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~I  135 (269)
T d2java1          56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV  135 (269)
T ss_dssp             HTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-----
T ss_pred             HHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCE
Confidence            5789999999999999865  4568999999999999998853     34999999999999999999999976     9


Q ss_pred             cccCCCCCcEEEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCC
Q 046714           71 VHREIKCANILVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPP  138 (201)
Q Consensus        71 ~H~dl~p~nill~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p  138 (201)
                      +||||||+||+++.+|.+++.++.            ....||+.|+|||.+  .+..++.++|||||||++|+|++|+.|
T Consensus       136 iHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l--~~~~~~~~~DIwSlGvilyel~tg~~P  213 (269)
T d2java1         136 LHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM--NRMSYNEKSDIWSLGCLLYELCALMPP  213 (269)
T ss_dssp             ----CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             EeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHH--cCCCCChHHHHHhhCHHHHHHhhCCCC
Confidence            999999999999999887776532            234578999999998  456688999999999999999999999


Q ss_pred             CCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          139 YSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      |......+....+..+..+..+..+++++.+|+.+||+.||++|||++|+++|||+
T Consensus       214 f~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         214 FTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            99888888888888888778888999999999999999999999999999999995

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-51  Score=305.09  Aligned_cols=196  Identities=34%  Similarity=0.613  Sum_probs=170.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++..++||||+.+++|..++.. .++++..+..++.||+.||+|||++||+||||||+||+
T Consensus        68 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NIL  147 (309)
T d1u5ra_          68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL  147 (309)
T ss_dssp             HHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred             HHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEE
Confidence            57899999999999999999999999999999988776554 56999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc--------cccccCcccccccccccC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           82 VDASGLATTTNDV--------KSFEGTPFWVAPEVVNLK-NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        82 l~~~g~~~~~~~~--------~~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      ++.+|.+++.+++        ....||+.|+|||.+... ...++.++||||+||++|+|++|+.||.+....+....+.
T Consensus       148 l~~~~~~Kl~DFG~a~~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~  227 (309)
T d1u5ra_         148 LSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA  227 (309)
T ss_dssp             EETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             ECCCCCEEEeecccccccCCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            9998877776653        334589999999998432 3457889999999999999999999998887777777766


Q ss_pred             cCCCCCC-CCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          153 RGKLPSV-PNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       153 ~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .+..+.. +..+++.+.+|+.+||+.||.+|||++|+++||||....
T Consensus       228 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             HSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             hCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            6555443 456899999999999999999999999999999997654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.4e-51  Score=301.99  Aligned_cols=193  Identities=26%  Similarity=0.455  Sum_probs=164.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++..++||||++|++|.+++.+. .+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        60 il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil  139 (307)
T d1a06a_          60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLL  139 (307)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEeccccee
Confidence            578999999999999999999999999999999999998764 5999999999999999999999999999999999999


Q ss_pred             Ec---cCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           82 VD---ASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        82 l~---~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +.   .+|.+++.+++           ....||+.|+|||.+  .+..++.++||||+||++|+|++|+.||.+....+.
T Consensus       140 ~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~--~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~  217 (307)
T d1a06a_         140 YYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL--AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL  217 (307)
T ss_dssp             ESSSSTTCCEEECCC------------------CTTSCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHH--cCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence            95   35555555532           234588999999998  455678999999999999999999999998877777


Q ss_pred             HHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+......   ..+..+++++.+|+.+||+.+|++|||++|+++||||+..
T Consensus       218 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            7666655432   3346789999999999999999999999999999999753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=297.96  Aligned_cols=190  Identities=28%  Similarity=0.551  Sum_probs=160.5

Q ss_pred             ccccCCCcceeccceeeee----CCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcC--ccccCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD----ENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERN--VVHREI   75 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~dl   75 (201)
                      +|++++||||+++++++.+    ++.+++||||+++++|.+++.+. .+++..+..++.||+.||+|||++|  |+||||
T Consensus        61 il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDi  140 (270)
T d1t4ha_          61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL  140 (270)
T ss_dssp             HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCC
T ss_pred             HHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCc
Confidence            5889999999999999875    35689999999999999998764 5999999999999999999999998  999999


Q ss_pred             CCCcEEEcc-CCceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           76 KCANILVDA-SGLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        76 ~p~nill~~-~g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      ||+||++++ +|.+++.++.          ....||+.|+|||.+.   ..++.++||||+||++|+|++|+.||.+...
T Consensus       141 Kp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~---~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~  217 (270)
T d1t4ha_         141 KCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQN  217 (270)
T ss_dssp             CGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG---TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred             ChhhceeeCCCCCEEEeecCcceeccCCccCCcccCccccCHHHhC---CCCCCcCchhhHHHHHHHHHHCCCCCCCccc
Confidence            999999964 6666666532          2345899999999983   3478999999999999999999999977644


Q ss_pred             HH-HHHHhhcCCC-CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcccc
Q 046714          145 MQ-ALFRIGRGKL-PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVK  195 (201)
Q Consensus       145 ~~-~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~  195 (201)
                      .. ....+..+.. ..++...++++.+++.+||+.+|++|||++|+++||||+
T Consensus       218 ~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         218 AAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            44 3444444433 245566889999999999999999999999999999996

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=302.83  Aligned_cols=192  Identities=28%  Similarity=0.488  Sum_probs=169.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++..++||||++|++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+
T Consensus        61 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIl  140 (288)
T d1uu3a_          61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL  140 (288)
T ss_dssp             HHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccc
Confidence            57889999999999999999999999999999999998875 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           82 VDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        82 l~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      ++.+|.+++.++..              ...||+.|+|||++  .+..++.++||||+||++|+|++|+.||........
T Consensus       141 l~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~--~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~  218 (288)
T d1uu3a_         141 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL--TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI  218 (288)
T ss_dssp             ECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHH--HTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             cCCCceEEecccccceecccCCcccccccccCCccccCceee--ccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH
Confidence            99987776665431              23488999999998  455678999999999999999999999998877777


Q ss_pred             HHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhH------HhcCccccCc
Q 046714          148 LFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQ------LMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~------il~~~~~~~~  197 (201)
                      ...+.... ..++..+++++++||.+||+.||++|||++|      +++||||+..
T Consensus       219 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         219 FQKIIKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             HHHHHTTC-CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHcCC-CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            77766654 4677889999999999999999999999998      5889999764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-50  Score=300.74  Aligned_cols=191  Identities=28%  Similarity=0.465  Sum_probs=171.2

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++..++||||++||+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+||+
T Consensus        58 il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIL  137 (337)
T d1o6la_          58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM  137 (337)
T ss_dssp             HHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             HHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeE
Confidence            578999999999999999999999999999999999988764 5999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|..++.++..            ...||+.|+|||++  .+..++.++|+||+||++|+|++|+.||..........
T Consensus       138 l~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~--~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~  215 (337)
T d1o6la_         138 LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL--EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE  215 (337)
T ss_dssp             ECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGG--SSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhc--cCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH
Confidence            99998877766432            24478999999998  45678999999999999999999999999888777776


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKR  196 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~  196 (201)
                      .+.... ..++..+++++++||.+||+.||.+|++     ++|+++||||+.
T Consensus       216 ~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         216 LILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHhcCC-CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence            666654 4678889999999999999999999994     899999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.5e-50  Score=297.11  Aligned_cols=192  Identities=27%  Similarity=0.492  Sum_probs=171.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++..++||||+.|++|..++... .+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        57 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIL  136 (316)
T d1fota_          57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL  136 (316)
T ss_dssp             HHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred             HHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchhee
Confidence            578899999999999999999999999999999999988764 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           82 VDASGLATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        82 l~~~g~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      ++.+|.+++.+++         ....||+.|+|||.+  .+..++.++||||+||++|+|++|+.||......+....+.
T Consensus       137 l~~~g~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l--~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~  214 (316)
T d1fota_         137 LDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVV--STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL  214 (316)
T ss_dssp             ECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHH--TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             EcCCCCEEEecCccceEeccccccccCcccccCHHHH--cCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH
Confidence            9999887777643         235589999999998  45667899999999999999999999999988877777776


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       153 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                      .+.. .++..+++++.+++.+||+.+|.+|+     |++++++||||+..
T Consensus       215 ~~~~-~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         215 NAEL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             HCCC-CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             cCCC-CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            6643 56778999999999999999999996     99999999999863

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-50  Score=299.48  Aligned_cols=194  Identities=30%  Similarity=0.522  Sum_probs=160.5

Q ss_pred             cccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCc
Q 046714            2 FSFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCAN   79 (201)
Q Consensus         2 ~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~n   79 (201)
                      .+|++++||||+++++++.+++..++||||+.|++|.+++.+. .+++..+..++.|++.||.|||+ +||+||||||+|
T Consensus        56 ~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~N  135 (322)
T d1s9ja_          56 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN  135 (322)
T ss_dssp             GGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred             HHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHH
Confidence            3689999999999999999999999999999999999998754 59999999999999999999997 599999999999


Q ss_pred             EEEccCCceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH--
Q 046714           80 ILVDASGLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA--  147 (201)
Q Consensus        80 ill~~~g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--  147 (201)
                      |+++.+|.+++.+++          ....||+.|+|||.+  .+..++.++||||+||++|+|++|+.||........  
T Consensus       136 ILl~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl--~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~  213 (322)
T d1s9ja_         136 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL  213 (322)
T ss_dssp             EEECTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHH--HCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHH
T ss_pred             eeECCCCCEEEeeCCCccccCCCccccccCCccccCchHH--cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            999999888877654          235689999999998  456789999999999999999999999965432111  


Q ss_pred             ----------------------------------------HHHhhcCCCCCCC-CCCCHHHHHHHHHHhhcCCCCCCCHh
Q 046714          148 ----------------------------------------LFRIGRGKLPSVP-NSLSRDARDFILKCLQVNPNDRPTAA  186 (201)
Q Consensus       148 ----------------------------------------~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~  186 (201)
                                                              .........+..+ ..+++++.+|+.+||+.||++|||++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~  293 (322)
T d1s9ja_         214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK  293 (322)
T ss_dssp             HC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence                                                    0111111111222 23578999999999999999999999


Q ss_pred             HHhcCccccCc
Q 046714          187 QLMEHPFVKRP  197 (201)
Q Consensus       187 ~il~~~~~~~~  197 (201)
                      |+++||||++.
T Consensus       294 e~L~Hpf~~~~  304 (322)
T d1s9ja_         294 QLMVHAFIKRS  304 (322)
T ss_dssp             HHHTSHHHHHH
T ss_pred             HHhhCHhhCcC
Confidence            99999999753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-50  Score=296.70  Aligned_cols=193  Identities=27%  Similarity=0.470  Sum_probs=166.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++..++||||+++++|.+++.+. .+++..++.++.|++.||+|||++||+||||||+||+
T Consensus        66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nil  145 (293)
T d1jksa_          66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIM  145 (293)
T ss_dssp             HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEE
Confidence            478899999999999999999999999999999999998764 5999999999999999999999999999999999999


Q ss_pred             EccCCc----eeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Q 046714           82 VDASGL----ATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQ  146 (201)
Q Consensus        82 l~~~g~----~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  146 (201)
                      ++.+|.    +++.+..           ....+++.|+|||.+  .+..++.++||||+||++|+|++|+.||.+....+
T Consensus       146 l~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~--~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~  223 (293)
T d1jksa_         146 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE  223 (293)
T ss_dssp             ESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHH--cCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH
Confidence            987653    3443322           234578889999998  45567899999999999999999999999888777


Q ss_pred             HHHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          147 ALFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       147 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ....+......   ..+..+++.+.+||.+||+.+|++|||++|+++||||+..
T Consensus       224 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         224 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            77776655432   2235689999999999999999999999999999999853

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.4e-50  Score=302.24  Aligned_cols=193  Identities=26%  Similarity=0.456  Sum_probs=168.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++..++||||++|++|.+.+...  ++++.+++.++.||+.||+|||++||+||||||+||
T Consensus        79 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NI  158 (352)
T d1koba_          79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENI  158 (352)
T ss_dssp             HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccc
Confidence            578999999999999999999999999999999999877543  489999999999999999999999999999999999


Q ss_pred             EEc--cCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           81 LVD--ASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~--~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |++  .+|.+++.+++.           ...+++.|+|||.+  .+..++.++||||+||++|+|++|+.||.+......
T Consensus       159 Ll~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~  236 (352)
T d1koba_         159 MCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV--DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET  236 (352)
T ss_dssp             EESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHH--TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             cccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHH--cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            997  456666655432           23478889999998  556789999999999999999999999998888777


Q ss_pred             HHHhhcCCC---CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGRGKL---PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ...+.....   ...+..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       237 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            777665443   23446789999999999999999999999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.7e-50  Score=292.53  Aligned_cols=195  Identities=30%  Similarity=0.512  Sum_probs=167.5

Q ss_pred             ccccCC-CcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFE-HDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++ ||||+++++++.+++..++||||+++++|.++++. +++++..+..++.||+.||+|||++||+||||||+||
T Consensus        62 ~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Ni  141 (277)
T d1phka_          62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENI  141 (277)
T ss_dssp             HHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             HHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceE
Confidence            466776 99999999999999999999999999999999965 4599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc-----------cccccCccccccccccc----CCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           81 LVDASGLATTTNDV-----------KSFEGTPFWVAPEVVNL----KNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~----~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      +++.+|..++.+..           ....||+.|.|||.+..    ....++.++||||+||++|+|++|+.||......
T Consensus       142 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~  221 (277)
T d1phka_         142 LLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM  221 (277)
T ss_dssp             EECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence            99988877666542           22447888999999842    1334678999999999999999999999998877


Q ss_pred             HHHHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          146 QALFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       146 ~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      .....+..+...   .....+|+++++|+.+||+.+|++|||++|+++||||++-
T Consensus       222 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         222 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            777666655432   2334789999999999999999999999999999999863

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7e-50  Score=301.39  Aligned_cols=194  Identities=28%  Similarity=0.430  Sum_probs=167.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++..++||||++||+|.+++.+  +.+++..+..++.||+.||+|||++||+||||||+||
T Consensus        76 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NI  155 (350)
T d1koaa2          76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI  155 (350)
T ss_dssp             HHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHe
Confidence            57889999999999999999999999999999999999843  3599999999999999999999999999999999999


Q ss_pred             EEcc--CCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           81 LVDA--SGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~~--~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +++.  +|.+++.+++.           ...||+.|+|||++  .+..++.++||||+||++|+|++|+.||.+....+.
T Consensus       156 ll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~--~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~  233 (350)
T d1koaa2         156 MFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET  233 (350)
T ss_dssp             EESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHH--HTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             eeccCCCCeEEEeecchheecccccccceecCcccccCHHHH--cCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence            9964  45566655432           23478999999998  456678999999999999999999999998877777


Q ss_pred             HHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          148 LFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       148 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ...+......   .....+++++++||.+||+.||++|||++|+++||||+...
T Consensus       234 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         234 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            7776654432   22346899999999999999999999999999999998653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.9e-49  Score=298.86  Aligned_cols=193  Identities=28%  Similarity=0.411  Sum_probs=166.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +++.++||||+++++++.+++..++||||+.|++|.+++.+. .+++..+..++.||+.||+|||++|++||||||+|||
T Consensus        60 ~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NIL  139 (364)
T d1omwa3          60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL  139 (364)
T ss_dssp             HHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeE
Confidence            467789999999999999999999999999999999998754 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHH
Q 046714           82 VDASGLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED--MQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~  149 (201)
                      ++.+|.+++.+++          ....||+.|+|||.+. .+..++.++||||+||++|+|++|+.||.....  .....
T Consensus       140 l~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~-~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~  218 (364)
T d1omwa3         140 LDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ-KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID  218 (364)
T ss_dssp             ECSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHS-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH
T ss_pred             EcCCCcEEEeeeceeeecCCCcccccccccccchhHHhh-cCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9998877776643          2345899999999983 355678999999999999999999999976432  22333


Q ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCC-----HhHHhcCccccC
Q 046714          150 RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPT-----AAQLMEHPFVKR  196 (201)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t-----~~~il~~~~~~~  196 (201)
                      ..........+..+++++++||.+||+.||++|||     ++|+++||||+.
T Consensus       219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            34444455677889999999999999999999999     799999999985

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=295.47  Aligned_cols=189  Identities=28%  Similarity=0.513  Sum_probs=168.6

Q ss_pred             ccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEc
Q 046714            5 SQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD   83 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~   83 (201)
                      .+++||||+++++++.+++..++||||+.+|+|.+++... .+++.++..++.||+.||+|||++|++||||||+|||++
T Consensus        58 ~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~  137 (320)
T d1xjda_          58 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD  137 (320)
T ss_dssp             HHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred             HhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec
Confidence            4689999999999999999999999999999999999764 599999999999999999999999999999999999999


Q ss_pred             cCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHh
Q 046714           84 ASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRI  151 (201)
Q Consensus        84 ~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  151 (201)
                      .+|.+++.+.+.            ...||+.|+|||.+  .+..++.++||||+||++|+|++|+.||.+.........+
T Consensus       138 ~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i  215 (320)
T d1xjda_         138 KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL--LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI  215 (320)
T ss_dssp             TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCceeccccchhhhcccccccccccCCCCCcCCHHHH--cCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            988776665432            23478899999998  4567889999999999999999999999988877777766


Q ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHh-HHhcCccccC
Q 046714          152 GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAA-QLMEHPFVKR  196 (201)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~-~il~~~~~~~  196 (201)
                      .... +.++..+++++.+|+.+||+.+|.+|||++ ++++||||++
T Consensus       216 ~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         216 RMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             HHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HcCC-CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            6554 577888999999999999999999999996 8999999976

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-48  Score=294.96  Aligned_cols=192  Identities=27%  Similarity=0.444  Sum_probs=171.1

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+.+..++|+||+.+++|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        94 il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NIL  173 (350)
T d1rdqe_          94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL  173 (350)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcc
Confidence            57899999999999999999999999999999999998865 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHhh
Q 046714           82 VDASGLATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALFRIG  152 (201)
Q Consensus        82 l~~~g~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  152 (201)
                      ++.+|.+++.+++         ....||+.|+|||.+  .+..++.++||||+||++|+|++|+.||.+.........+.
T Consensus       174 l~~~g~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~--~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~  251 (350)
T d1rdqe_         174 IDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV  251 (350)
T ss_dssp             ECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHH--TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cCCCCCEEeeeceeeeecccccccccCccccCCHHHH--cCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh
Confidence            9999887776643         234588999999998  45667899999999999999999999999887777777766


Q ss_pred             cCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccCc
Q 046714          153 RGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKRP  197 (201)
Q Consensus       153 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~~  197 (201)
                      ... ...+..+++++.+++.+||+.||.+|+     |++++++||||+..
T Consensus       252 ~~~-~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         252 SGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HCC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             cCC-CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence            654 356778999999999999999999994     99999999999753

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=290.09  Aligned_cols=190  Identities=23%  Similarity=0.437  Sum_probs=166.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.++ ..++||||+++|+|.+++.+. .+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        61 il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nil  139 (277)
T d1xbba_          61 VMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL  139 (277)
T ss_dssp             HHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             HHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhc
Confidence            57899999999999999765 568999999999999998764 4999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           82 VDASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        82 l~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      ++.+|.+++.++..               ...+++.|+|||.+  .+..++.++||||||+++|++++ |+.||.+....
T Consensus       140 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l--~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~  217 (277)
T d1xbba_         140 LVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS  217 (277)
T ss_dssp             EEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             ccccCcccccchhhhhhccccccccccccccCCCceecCchhh--cCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH
Confidence            99888776655431               12367789999998  45567899999999999999998 89999998888


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHH---hcCcccc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL---MEHPFVK  195 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~i---l~~~~~~  195 (201)
                      +....+..+..+..+..+++++.+++.+||+.+|++|||++++   |+++|++
T Consensus       218 ~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         218 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            8888888888888899999999999999999999999999998   4566653

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-49  Score=294.05  Aligned_cols=194  Identities=22%  Similarity=0.352  Sum_probs=166.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++.+++||||++|++|.+++...  .+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        54 il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NI  133 (321)
T d1tkia_          54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI  133 (321)
T ss_dssp             HHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccce
Confidence            578899999999999999999999999999999999999754  489999999999999999999999999999999999


Q ss_pred             EEccCC--ceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           81 LVDASG--LATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        81 ll~~~g--~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      +++.++  ..++.++.           ....+++.|+|||.+  .+..++.++||||+||++|+|++|+.||......+.
T Consensus       134 ll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~--~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~  211 (321)
T d1tkia_         134 IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH--QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI  211 (321)
T ss_dssp             EESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHH--TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             eecCCCceEEEEcccchhhccccCCcccccccccccccchhc--cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH
Confidence            998654  33333322           123367889999997  456688999999999999999999999999888777


Q ss_pred             HHHhhcCCCCC---CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          148 LFRIGRGKLPS---VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       148 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ...+.......   .+..+++++++|+.+||+.||++|||++|+++||||++..
T Consensus       212 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  265 (321)
T d1tkia_         212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence            77776654322   2246899999999999999999999999999999997653

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-48  Score=287.26  Aligned_cols=187  Identities=24%  Similarity=0.448  Sum_probs=165.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++..++||||+++|+|.+++...  .+++.++..++.||+.||+|||++|++||||||+||
T Consensus        80 ~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NI  159 (299)
T d1jpaa_          80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNI  159 (299)
T ss_dssp             HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             HHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceE
Confidence            578999999999999999999999999999999999988763  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-----------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCc
Q 046714           81 LVDASGLATTTNDVKS-----------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHL  142 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-----------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~  142 (201)
                      |++.+|.+++.+++..                 ..+++.|+|||.+  .+..++.++|||||||++|+|+| |+.||.+.
T Consensus       160 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~  237 (299)
T d1jpaa_         160 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVMSYGERPYWDM  237 (299)
T ss_dssp             EECTTCCEEECCC-----------------------CGGGSCHHHH--HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             EECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHH--hcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence            9999988877765421                 2246789999998  45568899999999999999998 89999998


Q ss_pred             hHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          143 EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ...+....+..+..+..+..+++.+.+++.+||+.+|.+|||+.|+++.
T Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         238 TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            8888888888887778888999999999999999999999999998764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-49  Score=290.82  Aligned_cols=193  Identities=24%  Similarity=0.419  Sum_probs=161.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+++..++||||+.++++..+... ..+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        53 il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIl  132 (299)
T d1ua2a_          53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL  132 (299)
T ss_dssp             HHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             HHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEE
Confidence            57889999999999999999999999999999777666654 34899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|..++.++..            ...+|+.|+|||.+. ....++.++||||+||++|+|++|..||......+...
T Consensus       133 i~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~  211 (299)
T d1ua2a_         133 LDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF-GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT  211 (299)
T ss_dssp             ECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHT-TCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             ecCCCccccccCccccccCCCcccccceecChhhccHHHHc-cCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH
Confidence            99998887766432            234788899999983 34567899999999999999999999998877766655


Q ss_pred             HhhcC--C--C---C------------C--------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          150 RIGRG--K--L---P------------S--------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       150 ~~~~~--~--~---~------------~--------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      .+...  .  .   +            .        .....++++.+|+.+||+.||++|||++|+++||||++
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         212 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             HHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             HHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence            44211  0  0   0            0        01246789999999999999999999999999999974

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-49  Score=288.82  Aligned_cols=190  Identities=25%  Similarity=0.410  Sum_probs=166.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.++ ..++||||+++|+|.+++..  ..+++..+..++.||+.||+|||++|++||||||+||
T Consensus        62 il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Ni  140 (285)
T d1u59a_          62 IMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV  140 (285)
T ss_dssp             HHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             HHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhhe
Confidence            57889999999999998764 57899999999999998754  3599999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           81 LVDASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      +++.+|.+++.++..               ...+++.|+|||.+  ....++.++||||||+++|+++| |+.||.+...
T Consensus       141 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~  218 (285)
T d1u59a_         141 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  218 (285)
T ss_dssp             EEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHH--HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred             eeccCCceeeccchhhhcccccccccccccccccCccccChHHH--hCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH
Confidence            999988777666431               12357789999998  44568899999999999999998 9999998887


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHH---hcCcccc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQL---MEHPFVK  195 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~i---l~~~~~~  195 (201)
                      .+....+..+..+..+..+++++.+++.+||+.+|++|||+.++   |+++|+.
T Consensus       219 ~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         219 PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            78888888888888899999999999999999999999999988   5677764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-48  Score=281.79  Aligned_cols=187  Identities=21%  Similarity=0.421  Sum_probs=163.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||++++|++.+++..++||||+++|+|.+++...  .+++..+..++.||+.||+|||+++|+||||||+||
T Consensus        53 ~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Ni  132 (263)
T d1sm2a_          53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC  132 (263)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGE
T ss_pred             HHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhhe
Confidence            467899999999999999999999999999999999998653  488999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.++.+++.++...             ..+++.|+|||.+  .+..++.++||||||+++|++++ |+.||......+
T Consensus       133 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~  210 (263)
T d1sm2a_         133 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  210 (263)
T ss_dssp             EECGGGCEEECSCC------------------CTTSCCHHHH--TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH
T ss_pred             eecCCCCeEecccchheeccCCCceeecceecCcccCChHHh--cCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH
Confidence            9999888777665321             2367789999998  45568999999999999999999 577777777777


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ....+..+..+..+..+++++.+++.+||+.+|++|||++|++++
T Consensus       211 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         211 VVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            777777777778888899999999999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=280.39  Aligned_cols=188  Identities=24%  Similarity=0.509  Sum_probs=156.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+ +..++||||+++|+|.+++...  .+++..+..++.||++||+|||++||+||||||+||
T Consensus        57 ~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~Ni  135 (276)
T d1uwha_          57 VLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNI  135 (276)
T ss_dssp             HHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             HHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHE
Confidence            5789999999999998754 5579999999999999999653  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc--------------ccccCcccccccccccC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLK-NNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      +++.++.+++.++..              ...||+.|+|||.+... ...++.++||||||+++|+|++|+.||.+....
T Consensus       136 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~  215 (276)
T d1uwha_         136 FLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR  215 (276)
T ss_dssp             EEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred             EEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH
Confidence            999998877766432              23478889999998533 234789999999999999999999999876544


Q ss_pred             HHHHH-hhcCCC----CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          146 QALFR-IGRGKL----PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       146 ~~~~~-~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ..... +..+..    ...+..+++++.+++.+||..+|.+|||++|++++
T Consensus       216 ~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            44333 332222    24566789999999999999999999999999876

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=276.81  Aligned_cols=187  Identities=21%  Similarity=0.432  Sum_probs=167.6

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++++++||||+++++++.+++..++||||+.+|+|.+++..  ..+++..+.+++.|+++||+|||++||+||||||+||
T Consensus        52 ~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Ni  131 (258)
T d1k2pa_          52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC  131 (258)
T ss_dssp             HHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGE
T ss_pred             HHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeE
Confidence            57889999999999999999999999999999999998654  4589999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.++.+++.+....             ..+++.|+|||.+  ....++.++||||||+++|+|+| |+.||......+
T Consensus       132 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~  209 (258)
T d1k2pa_         132 LVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE  209 (258)
T ss_dssp             EECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred             EEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHh--cCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence            9999888777664321             3367779999998  45567899999999999999998 899999998888


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ....+..+.....+...++.+.+|+.+||+.+|++|||++++++|
T Consensus       210 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         210 TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            888888888888889999999999999999999999999999886

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-48  Score=289.67  Aligned_cols=192  Identities=25%  Similarity=0.416  Sum_probs=154.3

Q ss_pred             ccCCCcceeccceeeee----CCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            5 SQFEHDNIVQYIGTEKD----ENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         5 ~~l~h~~I~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      +..+||||+++++++.+    ++.+++||||++||+|.+++.+.   .+++.++..++.||+.||+|||++||+||||||
T Consensus        60 ~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp  139 (335)
T d2ozaa1          60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP  139 (335)
T ss_dssp             HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             HhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccc
Confidence            45689999999999876    46789999999999999999764   489999999999999999999999999999999


Q ss_pred             CcEEEccC---CceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           78 ANILVDAS---GLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        78 ~nill~~~---g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      +||+++.+   +.+++.++.           ....||+.|+|||.+  .+..++.++||||+||++|+|++|+.||.+..
T Consensus       140 ~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~  217 (335)
T d2ozaa1         140 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  217 (335)
T ss_dssp             GGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCC--CGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred             cccccccccccccccccccceeeeccCCCccccccCCcccCCcHHH--cCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence            99999863   344444432           234589999999998  45668899999999999999999999997654


Q ss_pred             HHHHHHHh---hcCCCCCCC----CCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          144 DMQALFRI---GRGKLPSVP----NSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       144 ~~~~~~~~---~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      .......+   .......++    ..+++++.+|+.+||+.+|++|||++|+++||||++..
T Consensus       218 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         218 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             CC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             HHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            33322221   111111222    25789999999999999999999999999999997654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=286.92  Aligned_cols=187  Identities=21%  Similarity=0.391  Sum_probs=160.5

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc------------------------CCCHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY------------------------HLSDSQVSSYTRQ   57 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------------------------~~~~~~~~~~~~~   57 (201)
                      +|+++ +||||+++++++.+.+..++||||+++|+|.++++..                        .+++..++.++.|
T Consensus        93 ~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  172 (325)
T d1rjba_          93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ  172 (325)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHH
T ss_pred             HHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHH
Confidence            35566 8999999999999999999999999999999998653                        2788999999999


Q ss_pred             HHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHH
Q 046714           58 ILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIW  123 (201)
Q Consensus        58 i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~  123 (201)
                      |+.||+|||++||+||||||+||+++.+|.+++.++..+              ..+|+.|+|||.+  .+..++.++|||
T Consensus       173 i~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~~~~~Diw  250 (325)
T d1rjba_         173 VAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL--FEGIYTIKSDVW  250 (325)
T ss_dssp             HHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH--HHCCCCHHHHHH
T ss_pred             HHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH--cCCCCCcceecc
Confidence            999999999999999999999999999988877775422              2257789999998  456688999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCchHHHHHH-HhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          124 SLGCTVLEMLT-HQPPYSHLEDMQALF-RIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       124 slG~~l~~l~~-g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ||||++|+|++ |+.||.+........ .+..+..+..+..+++++++|+.+||+.+|++|||++|+++|
T Consensus       251 S~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         251 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999998 899998765444433 344555667788899999999999999999999999999875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=278.90  Aligned_cols=194  Identities=29%  Similarity=0.504  Sum_probs=158.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++..++||||+.++.+......  .++++..+..++.||+.||+|||++||+||||||+||
T Consensus        54 il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNI  133 (298)
T d1gz8a_          54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL  133 (298)
T ss_dssp             HHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             HHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchhe
Confidence            57899999999999999999999999999977444433332  3499999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           81 LVDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        81 ll~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +++.++..++.++.            ....+++.|+|||.+. .....+.++|+||+|+++|+|++|+.||.........
T Consensus       134 l~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~-~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~  212 (298)
T d1gz8a_         134 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL-GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL  212 (298)
T ss_dssp             EECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             eecccCcceeccCCcceeccCCcccceeecccceeeehhhhc-cccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH
Confidence            99988877766543            2235788999999873 4445688999999999999999999999887666655


Q ss_pred             HHhhcC--CC---------------CC-----------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          149 FRIGRG--KL---------------PS-----------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       149 ~~~~~~--~~---------------~~-----------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ..+...  ..               ..           ....+++++.+|+.+||+.||++|||++|+++||||++.
T Consensus       213 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         213 FRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             HHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            443210  00               00           012467889999999999999999999999999999764

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=280.06  Aligned_cols=187  Identities=26%  Similarity=0.456  Sum_probs=155.8

Q ss_pred             cccCC--CcceeccceeeeeCCeEEEEEEecCC-CCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            4 FSQFE--HDNIVQYIGTEKDENRLYIFLELVKK-GSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         4 l~~l~--h~~I~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      |++++  ||||+++++++.+++..++||||+.+ +++.+++.+ ..+++.+++.++.||+.||+|||++||+||||||+|
T Consensus        61 l~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~N  140 (273)
T d1xwsa_          61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN  140 (273)
T ss_dssp             HHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             HHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccc
Confidence            45555  89999999999999999999999976 577787765 459999999999999999999999999999999999


Q ss_pred             EEEccC-CceeeecCc----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           80 ILVDAS-GLATTTNDV----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        80 ill~~~-g~~~~~~~~----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      |+++.+ +.+++.+++          ....||+.|+|||.+. .....+.++||||+||++|+|++|+.||.....    
T Consensus       141 Ill~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~-~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----  215 (273)
T d1xwsa_         141 ILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----  215 (273)
T ss_dssp             EEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHH-HSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred             eEEecCCCeEEECccccceecccccccccccCCCcCCHHHHc-CCCCCCcccccccceeeehhHhhCCCCCCCchH----
Confidence            999854 455555432          2345889999999983 233456789999999999999999999976432    


Q ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                        +... ...++..+|+++++|+.+||+.||++|||++|+++||||++..
T Consensus       216 --i~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         216 --IIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             --HHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             --Hhhc-ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence              2222 2356678999999999999999999999999999999998753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.6e-47  Score=279.28  Aligned_cols=186  Identities=24%  Similarity=0.428  Sum_probs=161.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++||||+++++++.+++..+++|||+.+|+|.+++.+.   .+++..+..++.||+.||+|||++||+||||||+|
T Consensus        66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~N  145 (287)
T d1opja_          66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARN  145 (287)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             HHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCe
Confidence            578899999999999999999999999999999999998753   48999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcccc-------------ccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCC-CCCchHH
Q 046714           80 ILVDASGLATTTNDVKSF-------------EGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPP-YSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~~-------------~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p-~~~~~~~  145 (201)
                      ||++.+|.+++.+++.+.             .+++.|+|||.+  .+..++.++||||||+++|+|++|..| +......
T Consensus       146 ILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~  223 (287)
T d1opja_         146 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  223 (287)
T ss_dssp             EEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHH--HHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             EEECCCCcEEEccccceeecCCCCceeeccccccccccChHHH--cCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH
Confidence            999999888877654321             246679999998  455688999999999999999996555 5555666


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .....+..+..+..+..+++.+.+|+.+||+.+|++|||++|+++
T Consensus       224 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            666666677777888899999999999999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-47  Score=280.45  Aligned_cols=192  Identities=29%  Similarity=0.491  Sum_probs=157.5

Q ss_pred             cccCCCcceeccceeeee-----CCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            4 FSQFEHDNIVQYIGTEKD-----ENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      |+.++||||+++++++..     ....++++|++.++.+......  ..+++..++.++.|++.||+|||++||+|||||
T Consensus        64 l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiK  143 (305)
T d1blxa_          64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK  143 (305)
T ss_dssp             HHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             HhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCC
Confidence            445689999999999863     3568999999998766544433  348999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           77 CANILVDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |+|||++.+|..++.+..           ....||+.|+|||.+  .+..++.++||||+||++|+|++|+.||......
T Consensus       144 p~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~--~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~  221 (305)
T d1blxa_         144 PQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV  221 (305)
T ss_dssp             GGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHH--TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchh--cCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH
Confidence            999999998877766543           234578999999998  4567899999999999999999999999887766


Q ss_pred             HHHHHhhcC--------------------------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          146 QALFRIGRG--------------------------KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       146 ~~~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      +....+...                          ....+...+++.+.+|+.+||++||++|||++|+++||||++.
T Consensus       222 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         222 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            655443210                          0012344678899999999999999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=279.66  Aligned_cols=190  Identities=25%  Similarity=0.488  Sum_probs=163.8

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++||||+++++++.+ +..++||||+.+|+|.+++..   ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus        61 ~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~N  139 (272)
T d1qpca_          61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN  139 (272)
T ss_dssp             HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             HHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhh
Confidence            5788999999999998765 457899999999999987643   348999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCcc-------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC-CCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~~  145 (201)
                      |+++.++.+++.++..             ...+++.|+|||.+  ....++.++||||||+++|+|+|| ..|+......
T Consensus       140 Ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~--~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~  217 (272)
T d1qpca_         140 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP  217 (272)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHH--HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             eeeecccceeeccccceEEccCCccccccccCCcccccChHHH--hCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH
Confidence            9999988777765432             22367789999998  345678999999999999999995 5566677777


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc--Ccccc
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME--HPFVK  195 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~--~~~~~  195 (201)
                      +....+..+..+..+..+++++.+|+.+||+.+|++|||++++++  ++||.
T Consensus       218 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         218 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            777778788778888899999999999999999999999999988  78875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.7e-46  Score=276.63  Aligned_cols=193  Identities=30%  Similarity=0.483  Sum_probs=160.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++.+.+++..++++|++.++.+..+.+. +.+++..+..++.||+.||+|||+.||+||||||+||+
T Consensus        53 il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIl  132 (286)
T d1ob3a_          53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL  132 (286)
T ss_dssp             GGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             HHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceee
Confidence            68899999999999999999999999999988777666654 45999999999999999999999999999999999999


Q ss_pred             EccCCceeeecCc------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Q 046714           82 VDASGLATTTNDV------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQALF  149 (201)
Q Consensus        82 l~~~g~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  149 (201)
                      ++.+|..++.+..            ....+++.|.|||.+. ....++.++|+||+|+++|+|++|+.||.+....+...
T Consensus       133 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~  211 (286)
T d1ob3a_         133 INREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM-GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM  211 (286)
T ss_dssp             ECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHT-TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EcCCCCEEecccccceecccCccccceecccchhhhHHHHh-CCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999888777643            1234677899999983 44567899999999999999999999998876655554


Q ss_pred             Hhhc--CCC--------------------------CCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccC
Q 046714          150 RIGR--GKL--------------------------PSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKR  196 (201)
Q Consensus       150 ~~~~--~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~  196 (201)
                      ++..  +..                          .......++.+.+|+.+||+.||++|||++|+++||||++
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            4321  000                          0123456889999999999999999999999999999985

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=274.65  Aligned_cols=186  Identities=26%  Similarity=0.465  Sum_probs=162.3

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++. ++..++||||+.+++|.+++...  .+++..++.++.||+.||+|||++|++||||||+||
T Consensus        61 ~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NI  139 (273)
T d1mp8a_          61 TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV  139 (273)
T ss_dssp             HHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             HHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhhe
Confidence            578899999999999986 46689999999999999987543  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHH
Q 046714           81 LVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQ  146 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~  146 (201)
                      +++.++.+++.++..             ...+++.|+|||.+  ....++.++||||||+++|+|++ |..||......+
T Consensus       140 ll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l--~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~  217 (273)
T d1mp8a_         140 LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  217 (273)
T ss_dssp             EEEETTEEEECC-------------------CCGGGCCHHHH--HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             eecCCCcEEEccchhheeccCCcceeccceecCcccchhhHh--ccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH
Confidence            999988777766432             12357789999998  45567899999999999999998 899999888888


Q ss_pred             HHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          147 ALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ....+..+..+..+..+++.+.+|+.+||+.+|++|||++|++++
T Consensus       218 ~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         218 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            888888888888899999999999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=271.66  Aligned_cols=186  Identities=25%  Similarity=0.435  Sum_probs=162.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||++++|++.+.+..++++||+.++++.+++...  .+++.++..++.||+.|++|||+++|+||||||+||
T Consensus        62 il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NI  141 (283)
T d1mqba_          62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI  141 (283)
T ss_dssp             HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             HHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceE
Confidence            578899999999999999999999999999999999887653  489999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCccc---------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC-CCCCCCchH
Q 046714           81 LVDASGLATTTNDVKS---------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~~---------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~  144 (201)
                      |++.++.+++.++...               ..+|+.|+|||.+  .+..++.++||||||+++|+|+++ ..|+.....
T Consensus       142 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l--~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~  219 (283)
T d1mqba_         142 LVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI--SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN  219 (283)
T ss_dssp             EECTTCCEEECCCCC-----------------CCCGGGSCHHHH--HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             EECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHH--ccCCCCCcccccccHHHHHHHHhCCCCccccCCH
Confidence            9999988877764321               2357789999998  456788999999999999999995 455666666


Q ss_pred             HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .+....+..+..+..+..+++.+.+++.+||+.+|++|||+.|+++
T Consensus       220 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         220 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            6777777778778888899999999999999999999999999876

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=272.04  Aligned_cols=187  Identities=24%  Similarity=0.468  Sum_probs=163.0

Q ss_pred             ccccCCCcceeccceeeee-CCeEEEEEEecCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD-ENRLYIFLELVKKGSLANLYQKY---HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      ++++++||||+++++++.+ ++..++||||+++|+|.+++.+.   .+++..+..++.||+.||+|||+++++|+||||+
T Consensus        53 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~  132 (262)
T d1byga_          53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR  132 (262)
T ss_dssp             HHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             HHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchH
Confidence            5789999999999998854 56689999999999999998653   3899999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHH
Q 046714           79 NILVDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDMQAL  148 (201)
Q Consensus        79 nill~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~  148 (201)
                      ||+++.+|.+++.+...         ...++..|+|||.+  .+..++.++||||||+++|+|++ |+.||......+..
T Consensus       133 Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l--~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~  210 (262)
T d1byga_         133 NVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV  210 (262)
T ss_dssp             GEEECTTSCEEECCCCC------------CCTTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred             hheecCCCCEeecccccceecCCCCccccccccCCChHHH--hCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence            99999998877765432         23357789999998  34568999999999999999998 78899888877888


Q ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          149 FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ..+..+..++.+..+++++++++.+||..||++|||+.+++++
T Consensus       211 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         211 PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            8888888889999999999999999999999999999999763

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=278.30  Aligned_cols=193  Identities=23%  Similarity=0.442  Sum_probs=160.9

Q ss_pred             ccccCCCcceeccceeeeeCC------eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN------RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +|++++||||+++++++...+      ..++||||+ +.+|..+.+..++++..++.++.||+.||+|||++||+|||||
T Consensus        70 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiK  148 (346)
T d1cm8a_          70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK  148 (346)
T ss_dssp             HHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             HHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccC
Confidence            578899999999999998654      579999999 5589888888889999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCc---------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH
Q 046714           77 CANILVDASGLATTTNDV---------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQA  147 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~---------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~  147 (201)
                      |+||+++.+|..++.++.         ....+++.|+|||.+. .....+.++||||+||++|+|++|+.||........
T Consensus       149 p~NIL~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~  227 (346)
T d1cm8a_         149 PGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ  227 (346)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHH-TTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             cchhhcccccccccccccceeccCCccccccccccccCHHHHc-CCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH
Confidence            999999998877666543         2355788999999983 345678999999999999999999999987665444


Q ss_pred             HHHhhc------------------------------CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          148 LFRIGR------------------------------GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       148 ~~~~~~------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ......                              ..........++.+.+|+.+||+.||++|||++|+++||||++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            332211                              00112334678999999999999999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-46  Score=271.58  Aligned_cols=193  Identities=25%  Similarity=0.452  Sum_probs=164.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK---YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++||||+++++++.+ +..++||||+.+|+|.+++..   ..+++.+++.++.||+.||+|||++|++||||||+|
T Consensus        65 ~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~N  143 (285)
T d1fmka3          65 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAAN  143 (285)
T ss_dssp             HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             HHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceE
Confidence            4788999999999999865 457899999999999988753   358999999999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc-------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC-CCCCCCchHH
Q 046714           80 ILVDASGLATTTNDVKS-------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-QPPYSHLEDM  145 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~-------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~~  145 (201)
                      |+++.+|.+++.+....             ..+++.|+|||.+  ....++.++||||||+++|+|++| +.|+......
T Consensus       144 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~  221 (285)
T d1fmka3         144 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA--LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  221 (285)
T ss_dssp             EEECGGGCEEECCCCTTC--------------CCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             EEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHH--hCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH
Confidence            99999887777664422             2367789999998  456678999999999999999995 5555666666


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc--CccccCcC
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME--HPFVKRPL  198 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~--~~~~~~~~  198 (201)
                      +....+..+.....+..+++++++++.+||+.+|++|||++++++  ++||....
T Consensus       222 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         222 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            677777777777888899999999999999999999999999987  78886543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.3e-46  Score=272.75  Aligned_cols=190  Identities=24%  Similarity=0.407  Sum_probs=153.9

Q ss_pred             ccccCCCcceeccceeeeeCC----eEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      +|++++||||+++++++...+    .+++||||++|++|.+++... .+++.++..++.||+.||+|||++||+||||||
T Consensus        60 ~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP  139 (277)
T d1o6ya_          60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP  139 (277)
T ss_dssp             HHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             HHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccC
Confidence            578899999999999987653    489999999999999988654 599999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCc---------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc
Q 046714           78 ANILVDASGLATTTNDV---------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL  142 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~---------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  142 (201)
                      +||+++.++...+.+..               ....||+.|+|||.+  .+..++.++||||+||++|+|++|+.||...
T Consensus       140 ~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~--~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  217 (277)
T d1o6ya_         140 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTGEPPFTGD  217 (277)
T ss_dssp             GGEEEETTSCEEECCCTTCEECC----------------TTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHH--cCCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence            99999988766554321               123478999999998  4567889999999999999999999999988


Q ss_pred             hHHHHHHHhhcCCCC---CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccc
Q 046714          143 EDMQALFRIGRGKLP---SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFV  194 (201)
Q Consensus       143 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~  194 (201)
                      ...+...+.......   .....+|+.+.+++.+||+.||.+||+..+.+.++|.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         218 SPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             SHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            777776665544332   3356789999999999999999999954444555654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=272.12  Aligned_cols=185  Identities=25%  Similarity=0.466  Sum_probs=164.2

Q ss_pred             cccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHH
Q 046714            4 FSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLTYL   65 (201)
Q Consensus         4 l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~l   65 (201)
                      ++++ +||||+++++++.+++..++||||+.+|+|.+++...                 .+++.+++.++.||+.||+||
T Consensus        72 l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl  151 (299)
T d1fgka_          72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL  151 (299)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHh
Confidence            3444 8999999999999999999999999999999999643                 279999999999999999999


Q ss_pred             hhcCccccCCCCCcEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHH
Q 046714           66 HERNVVHREIKCANILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLE  131 (201)
Q Consensus        66 h~~~i~H~dl~p~nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~  131 (201)
                      |++|++||||||+||+++.+|..++.+...              ...+++.|+|||.+  .+..++.++||||||+++|+
T Consensus       152 H~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l--~~~~y~~k~DiwS~Gvvl~e  229 (299)
T d1fgka_         152 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWE  229 (299)
T ss_dssp             HHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH--HHCCCCHHHHHHHHHHHHHH
T ss_pred             hhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHh--cCCCCCchhhhHHhHHHHHH
Confidence            999999999999999999998877665421              23467789999998  44678999999999999999


Q ss_pred             HHh-CCCCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          132 MLT-HQPPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       132 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      |++ |..||.+.........+..+..+..+..+++++.+|+.+||+.+|++|||+.|+++
T Consensus       230 ll~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         230 IFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            998 79999888888887778888888889999999999999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-45  Score=273.41  Aligned_cols=194  Identities=26%  Similarity=0.418  Sum_probs=161.8

Q ss_pred             ccccCCC-cceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEH-DNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h-~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++| |||+++++++.+.+..++++||+.+++|.+++... .+++..+..++.||+.||+|||++|++||||||+||
T Consensus        81 il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Ni  160 (322)
T d1vzoa_          81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI  160 (322)
T ss_dssp             HHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             HHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccce
Confidence            4678877 79999999999999999999999999999998765 488999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc-------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--
Q 046714           81 LVDASGLATTTNDVK-------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM--  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~-------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--  145 (201)
                      +++.+|.+++.++..             ...+++.|++||.+......++.++||||+||++|+|++|+.||......  
T Consensus       161 ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~  240 (322)
T d1vzoa_         161 LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS  240 (322)
T ss_dssp             EECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred             eecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999998777666432             23367889999998555556788999999999999999999999654322  


Q ss_pred             -HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCC-----CHhHHhcCccccC
Q 046714          146 -QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRP-----TAAQLMEHPFVKR  196 (201)
Q Consensus       146 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~~il~~~~~~~  196 (201)
                       ....+......+..+..+++++.+|+.+||+++|.+||     |++|+++||||++
T Consensus       241 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         241 QAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence             22222233334566778999999999999999999999     5899999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-45  Score=270.90  Aligned_cols=187  Identities=23%  Similarity=0.446  Sum_probs=165.2

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLTY   64 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~   64 (201)
                      +|+++ +||||+++++++.+++..++||||+.+|+|.+++++.                 .+++..+..++.||+.||.|
T Consensus        63 ~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~  142 (309)
T d1fvra_          63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY  142 (309)
T ss_dssp             HHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHh
Confidence            57787 7999999999999999999999999999999998643                 38999999999999999999


Q ss_pred             HhhcCccccCCCCCcEEEccCCceeeecCcc-----------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHH
Q 046714           65 LHERNVVHREIKCANILVDASGLATTTNDVK-----------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEML  133 (201)
Q Consensus        65 lh~~~i~H~dl~p~nill~~~g~~~~~~~~~-----------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~  133 (201)
                      +|++|++||||||+||+++.++.+++.+...           ...++..|+|||.+  ....++.++||||||+++|+|+
T Consensus       143 lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l--~~~~~~~~sDvwSfGvil~ell  220 (309)
T d1fvra_         143 LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV  220 (309)
T ss_dssp             HHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHH--HHCEECHHHHHHHHHHHHHHHH
T ss_pred             hhcCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHh--ccCCCCccceeehhHHHHHHHH
Confidence            9999999999999999999887776665432           23477889999998  4556789999999999999999


Q ss_pred             hCC-CCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          134 THQ-PPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       134 ~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +|. .||......+....+..+..+..+..+++++.+|+.+||+.+|++|||+++++++
T Consensus       221 ~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         221 SLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             TTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            965 6788888888888888888888889999999999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=273.47  Aligned_cols=186  Identities=21%  Similarity=0.392  Sum_probs=161.7

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.+++ .++++|++.+++|.+.+...  .+++..+..++.||+.||+|||++||+||||||+||
T Consensus        64 ~l~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NI  142 (317)
T d1xkka_          64 VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV  142 (317)
T ss_dssp             HHHHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             HHHhCCCCCEeeEEEEEecCC-eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcc
Confidence            578899999999999998764 57788999999998887654  499999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchHH
Q 046714           81 LVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLEDM  145 (201)
Q Consensus        81 ll~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~  145 (201)
                      +++.++.+++.+++.              ...+|+.|+|||.+  .+..++.++||||||+++|+|+| |+.||.+....
T Consensus       143 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l--~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~  220 (317)
T d1xkka_         143 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  220 (317)
T ss_dssp             EEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred             eeCCCCCeEeeccccceecccccccccccccccCccccChHHH--hcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence            999998877766431              12367889999998  44568999999999999999998 89999887777


Q ss_pred             HHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          146 QALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      +....+..+..+..+..+++.+.+++.+||+.+|.+|||+.|++++
T Consensus       221 ~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         221 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             GHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            7777777777778888999999999999999999999999999876

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=272.25  Aligned_cols=195  Identities=27%  Similarity=0.462  Sum_probs=157.6

Q ss_pred             ccccCCCcceeccceeeeeCC----eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCA   78 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~   78 (201)
                      +|++++||||+++++++....    ..+++++++.+++|.++++.+++++..+..++.|++.||+|||++||+||||||+
T Consensus        59 il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~  138 (345)
T d1pmea_          59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS  138 (345)
T ss_dssp             HHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             HHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcc
Confidence            578899999999999987653    2345556677889999999889999999999999999999999999999999999


Q ss_pred             cEEEccCCceeeecCc---------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCch
Q 046714           79 NILVDASGLATTTNDV---------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLE  143 (201)
Q Consensus        79 nill~~~g~~~~~~~~---------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  143 (201)
                      ||+++.+|..++.++.               ....+++.|+|||.+. ....++.++|+||+||++|+|++|+.||....
T Consensus       139 NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~  217 (345)
T d1pmea_         139 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  217 (345)
T ss_dssp             GEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTT-TBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             eEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhh-cCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence            9999998877766543               1233678899999973 44567889999999999999999999997765


Q ss_pred             HHHHHHHhhc-------------------------CCCC-----CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCcc
Q 046714          144 DMQALFRIGR-------------------------GKLP-----SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPF  193 (201)
Q Consensus       144 ~~~~~~~~~~-------------------------~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~  193 (201)
                      ..........                         ....     .....+++++.+|+.+||+.||.+|||++|+++|||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf  297 (345)
T d1pmea_         218 YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  297 (345)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             HHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            4433322210                         0000     112356788999999999999999999999999999


Q ss_pred             ccCcC
Q 046714          194 VKRPL  198 (201)
Q Consensus       194 ~~~~~  198 (201)
                      |++..
T Consensus       298 ~~~~~  302 (345)
T d1pmea_         298 LEQYY  302 (345)
T ss_dssp             GTTTC
T ss_pred             hccCC
Confidence            98544

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-44  Score=267.14  Aligned_cols=186  Identities=22%  Similarity=0.440  Sum_probs=166.0

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-------------------------CCCHHHHHHHHHH
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-------------------------HLSDSQVSSYTRQ   57 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------------------~~~~~~~~~~~~~   57 (201)
                      +|++++||||+++++++.+.+..++++||+.+++|.+++...                         .+++..+..++.|
T Consensus        69 il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  148 (301)
T d1lufa_          69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ  148 (301)
T ss_dssp             HHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred             HHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHH
Confidence            578999999999999999999999999999999999998642                         2788899999999


Q ss_pred             HHHHHHHHhhcCccccCCCCCcEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHH
Q 046714           58 ILNGLTYLHERNVVHREIKCANILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIW  123 (201)
Q Consensus        58 i~~~l~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~  123 (201)
                      ++.||+|||+++++||||||+||+++.++.+++.+++.              ...+++.|+|||.+  .+..++.++|||
T Consensus       149 i~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~t~ksDVw  226 (301)
T d1lufa_         149 VAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI--FYNRYTTESDVW  226 (301)
T ss_dssp             HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH--HHCCCCHHHHHH
T ss_pred             HHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH--ccCCCChhhhhc
Confidence            99999999999999999999999999988877766432              23366789999998  456788999999


Q ss_pred             HHHHHHHHHHhCC-CCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          124 SLGCTVLEMLTHQ-PPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       124 slG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      |||+++|+|++|. .||......+....+..+..+..+..+++++.+++.+||+.+|++|||+.|+++
T Consensus       227 S~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         227 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999985 688888888888888888888889999999999999999999999999999965

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=264.83  Aligned_cols=185  Identities=26%  Similarity=0.485  Sum_probs=157.9

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      +|++++||||+++++++.++ ..++||||+.++++.+++..  ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus        64 ~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NI  142 (273)
T d1u46a_          64 AMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL  142 (273)
T ss_dssp             HHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             HHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHh
Confidence            47889999999999999764 56899999999999987754  3499999999999999999999999999999999999


Q ss_pred             EEccCCceeeecCcc---------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh-CCCCCCCchH
Q 046714           81 LVDASGLATTTNDVK---------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT-HQPPYSHLED  144 (201)
Q Consensus        81 ll~~~g~~~~~~~~~---------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~  144 (201)
                      +++.++.+++.++..               ...++..|+|||.+  .+..++.++||||||+++|+|++ |+.||.+...
T Consensus       143 ll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~  220 (273)
T d1u46a_         143 LLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG  220 (273)
T ss_dssp             EEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHH--HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             ccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHH--hCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH
Confidence            999887776665431               12255679999998  45678899999999999999998 8999998888


Q ss_pred             HHHHHHhhc-CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          145 MQALFRIGR-GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       145 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      .+....+.. +..++.+..+++.+.+++.+||..+|++|||+.++++
T Consensus       221 ~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         221 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            777777644 3455677889999999999999999999999999863

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=272.93  Aligned_cols=194  Identities=25%  Similarity=0.364  Sum_probs=153.4

Q ss_pred             ccccCCCcceeccceeeeeC------CeEEEEEEecCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcCccc
Q 046714            3 SFSQFEHDNIVQYIGTEKDE------NRLYIFLELVKKGSLANLYQ----KYHLSDSQVSSYTRQILNGLTYLHERNVVH   72 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H   72 (201)
                      +|++++||||+++++++...      ...++||||+.++.+..+..    ...+++..++.++.||+.||+|||++||+|
T Consensus        66 il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiH  145 (350)
T d1q5ka_          66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH  145 (350)
T ss_dssp             HHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             HHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Confidence            57889999999999998543      35789999998754333322    234999999999999999999999999999


Q ss_pred             cCCCCCcEEEccCC-ceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Q 046714           73 REIKCANILVDASG-LATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYS  140 (201)
Q Consensus        73 ~dl~p~nill~~~g-~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  140 (201)
                      |||||+||+++.+| .+++.++.           ....+++.|+|||.+ .....++.++||||+||++|+|++|+.||.
T Consensus       146 rDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~~DIwSlG~il~el~~g~~pf~  224 (350)
T d1q5ka_         146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELLLGQPIFP  224 (350)
T ss_dssp             CCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHH-TTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred             cCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHh-hcccCCCcceeecccceEEEehhhCCCCCC
Confidence            99999999999775 45555432           223478889999987 345568899999999999999999999998


Q ss_pred             CchHHHHHHHhhc-------------------CCCC---------CCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCc
Q 046714          141 HLEDMQALFRIGR-------------------GKLP---------SVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHP  192 (201)
Q Consensus       141 ~~~~~~~~~~~~~-------------------~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~  192 (201)
                      .....+....+..                   ...+         ......++++.+|+.+||+.||++|||+.|+++||
T Consensus       225 ~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  304 (350)
T d1q5ka_         225 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  304 (350)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence            7766555444321                   0000         11234788999999999999999999999999999


Q ss_pred             cccCc
Q 046714          193 FVKRP  197 (201)
Q Consensus       193 ~~~~~  197 (201)
                      ||++.
T Consensus       305 ~f~~~  309 (350)
T d1q5ka_         305 FFDEL  309 (350)
T ss_dssp             GGGGG
T ss_pred             hhccc
Confidence            99753

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=271.95  Aligned_cols=194  Identities=25%  Similarity=0.377  Sum_probs=157.9

Q ss_pred             ccccCCCcceeccceeeeeC-----CeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKDE-----NRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKC   77 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p   77 (201)
                      +|++++||||+++++++...     ...+++++++.+++|.+++..+++++..++.++.||+.||+|||++||+||||||
T Consensus        70 il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp  149 (348)
T d2gfsa1          70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP  149 (348)
T ss_dssp             HHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred             HHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCC
Confidence            57889999999999998643     3346667778899999999888899999999999999999999999999999999


Q ss_pred             CcEEEccCCceeeecCcc---------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH
Q 046714           78 ANILVDASGLATTTNDVK---------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDMQAL  148 (201)
Q Consensus        78 ~nill~~~g~~~~~~~~~---------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  148 (201)
                      +||+++.+|..++.+...         ...+++.|+|||.+. .....+.++|+||+||++|+|++|+.||.+.......
T Consensus       150 ~NILi~~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~-~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~  228 (348)
T d2gfsa1         150 SNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL  228 (348)
T ss_dssp             GGEEECTTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHT-TCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccchhcccCcccccccccccccCchhhc-CCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999998877665432         234677799999872 4445688999999999999999999999876655444


Q ss_pred             HHhhcCC----------------------CCC--------CCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCc
Q 046714          149 FRIGRGK----------------------LPS--------VPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRP  197 (201)
Q Consensus       149 ~~~~~~~----------------------~~~--------~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~  197 (201)
                      ..+....                      ...        ....+++.+.+||.+||+.||++|||++|+++||||++.
T Consensus       229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         229 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            3332110                      000        123578899999999999999999999999999999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=261.37  Aligned_cols=195  Identities=27%  Similarity=0.397  Sum_probs=157.5

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEE
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANIL   81 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nil   81 (201)
                      +|++++||||+++++++.+....+++++++.++++..++... .+++..+..++.|++.||+|||++||+||||||+||+
T Consensus        54 il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIl  133 (292)
T d1unla_          54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL  133 (292)
T ss_dssp             HHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccc
Confidence            578999999999999999999999999999998888887654 4899999999999999999999999999999999999


Q ss_pred             EccCCceeeecCcc------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCc-hHHHHH
Q 046714           82 VDASGLATTTNDVK------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHL-EDMQAL  148 (201)
Q Consensus        82 l~~~g~~~~~~~~~------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~~~~  148 (201)
                      ++.++..++.++..            ...+++.|.|||.+. ....++.++||||+||++|+|++|+.||... ...+..
T Consensus       134 i~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~  212 (292)
T d1unla_         134 INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF-GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL  212 (292)
T ss_dssp             ECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHT-TCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH
T ss_pred             cccCCceeeeecchhhcccCCCccceeeccccchhhhhHhc-cCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH
Confidence            99887766655432            122556789999873 3445689999999999999999999986433 333333


Q ss_pred             HHhhc----------------------------CCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcCccccCcC
Q 046714          149 FRIGR----------------------------GKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       149 ~~~~~----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ..+..                            ..........++.+.+|+.+||+.||++|||++|+++||||++-.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             HHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             HHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            22210                            011122345678999999999999999999999999999998754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-44  Score=265.63  Aligned_cols=193  Identities=24%  Similarity=0.418  Sum_probs=152.2

Q ss_pred             ccccCCCcceeccceeeee--------CCeEEEEEEecCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHhhcCcccc
Q 046714            3 SFSQFEHDNIVQYIGTEKD--------ENRLYIFLELVKKGSLANLYQK-YHLSDSQVSSYTRQILNGLTYLHERNVVHR   73 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~   73 (201)
                      +|++++||||+++++++..        ++..+++||++.++.+...... ..+++..++.++.|++.||+|||++||+||
T Consensus        62 il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHr  141 (318)
T d3blha1          62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHR  141 (318)
T ss_dssp             HHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEec
Confidence            5789999999999998765        3468999999988665544333 348999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceeeecCc----------------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCC
Q 046714           74 EIKCANILVDASGLATTTNDV----------------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        74 dl~p~nill~~~g~~~~~~~~----------------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      ||||+||+++.+|.+++.+..                ....+|+.|+|||.+. ....++.++||||+||++|+|++|+.
T Consensus       142 DlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~-~~~~~~~k~DiwSlGvil~el~~g~~  220 (318)
T d3blha1         142 DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL-GERDYGPPIDLWGAGCIMAEMWTRSP  220 (318)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHT-TCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHc-CCCCCCcHHHcccCCceeeeHhhCCC
Confidence            999999999988776655432                1234788999999983 34467899999999999999999999


Q ss_pred             CCCCchHHHHHHHhhc---CCCCCCCC----------------------------CCCHHHHHHHHHHhhcCCCCCCCHh
Q 046714          138 PYSHLEDMQALFRIGR---GKLPSVPN----------------------------SLSRDARDFILKCLQVNPNDRPTAA  186 (201)
Q Consensus       138 p~~~~~~~~~~~~~~~---~~~~~~~~----------------------------~~~~~~~~li~~~l~~~p~~R~t~~  186 (201)
                      ||.+.........+..   ...+....                            ..++.+.+|+.+||+.||++|||++
T Consensus       221 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~  300 (318)
T d3blha1         221 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD  300 (318)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             CCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence            9987766555444321   11111000                            1356778999999999999999999


Q ss_pred             HHhcCccccC
Q 046714          187 QLMEHPFVKR  196 (201)
Q Consensus       187 ~il~~~~~~~  196 (201)
                      |+++||||+.
T Consensus       301 elL~Hpff~~  310 (318)
T d3blha1         301 DALNHDFFWS  310 (318)
T ss_dssp             HHHHSGGGSS
T ss_pred             HHHcChhhcc
Confidence            9999999985

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=263.84  Aligned_cols=187  Identities=19%  Similarity=0.370  Sum_probs=157.9

Q ss_pred             ccccCCCcceeccceeeee-CCeEEEEEEecCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQYIGTEKD-ENRLYIFLELVKKGSLANLYQKYH--LSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|++++||||++++|++.+ ++..++||||+.+++|.+++....  .++..+..++.|++.||.|||+.+|+||||||+|
T Consensus        81 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~N  160 (311)
T d1r0pa_          81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN  160 (311)
T ss_dssp             HHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             HHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHh
Confidence            5789999999999999765 568999999999999999987544  7788899999999999999999999999999999


Q ss_pred             EEEccCCceeeecCccc----------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCC-c
Q 046714           80 ILVDASGLATTTNDVKS----------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSH-L  142 (201)
Q Consensus        80 ill~~~g~~~~~~~~~~----------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~  142 (201)
                      |+++.++.+++.+++..                ..+++.|+|||.+  ....++.++||||||+++|++++|..||.. .
T Consensus       161 ILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~  238 (311)
T d1r0pa_         161 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  238 (311)
T ss_dssp             EEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHH--HHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred             EeECCCCCEEEecccchhhccccccccceecccccccccccChHHH--hcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence            99999888877664311                2356789999997  445679999999999999999997776654 3


Q ss_pred             hHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          143 EDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      ...+....+..+..+..+..+++.+.+++.+||..+|++|||+.|++++
T Consensus       239 ~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         239 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ----CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            4445556667777778888999999999999999999999999999887

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=262.68  Aligned_cols=192  Identities=22%  Similarity=0.405  Sum_probs=169.4

Q ss_pred             ccccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHhhcCcc
Q 046714            3 SFSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-----------HLSDSQVSSYTRQILNGLTYLHERNVV   71 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~lh~~~i~   71 (201)
                      ++++++||||+++++++..++..++||||+.+|+|.+++...           .++...+..++.|++.||.|||+++|+
T Consensus        76 il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~iv  155 (308)
T d1p4oa_          76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV  155 (308)
T ss_dssp             HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence            578999999999999999999999999999999999988532           268889999999999999999999999


Q ss_pred             ccCCCCCcEEEccCCceeeecCccc--------------cccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhC-C
Q 046714           72 HREIKCANILVDASGLATTTNDVKS--------------FEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTH-Q  136 (201)
Q Consensus        72 H~dl~p~nill~~~g~~~~~~~~~~--------------~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g-~  136 (201)
                      ||||||+||+++.++.+++.+.+.+              ..+++.|+|||.+  .+..++.++||||||+++|+|++| .
T Consensus       156 HrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l--~~~~~~~~~Dv~S~G~il~El~t~~~  233 (308)
T d1p4oa_         156 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAE  233 (308)
T ss_dssp             CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred             eceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHH--ccCCCCcccccccHHHHHHHHHhCCC
Confidence            9999999999999988877765322              2367889999998  455678899999999999999997 5


Q ss_pred             CCCCCchHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc------CccccC
Q 046714          137 PPYSHLEDMQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME------HPFVKR  196 (201)
Q Consensus       137 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~------~~~~~~  196 (201)
                      .||.+....+....+..+..+..+..+++.+.+++.+||+.+|.+|||++++++      +|+|++
T Consensus       234 ~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         234 QPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            888888888888888888888888999999999999999999999999999987      666654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-43  Score=261.09  Aligned_cols=183  Identities=24%  Similarity=0.462  Sum_probs=153.6

Q ss_pred             CCCcceeccceeeeeC-CeEEEEEEecCCCCHHHHHHhc-----------------CCCHHHHHHHHHHHHHHHHHHhhc
Q 046714            7 FEHDNIVQYIGTEKDE-NRLYIFLELVKKGSLANLYQKY-----------------HLSDSQVSSYTRQILNGLTYLHER   68 (201)
Q Consensus         7 l~h~~I~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~lh~~   68 (201)
                      .+||||+.+++++... +..+++|||+++|+|.++++..                 .+++.+++.++.||+.||+|||++
T Consensus        74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~  153 (299)
T d1ywna1          74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR  153 (299)
T ss_dssp             CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4689999999987654 5689999999999999998642                 278899999999999999999999


Q ss_pred             CccccCCCCCcEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHh
Q 046714           69 NVVHREIKCANILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLT  134 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~  134 (201)
                      ||+||||||+||+++.+|.+++.+++.              ...||+.|+|||.+  .+..++.++||||+||++|+|++
T Consensus       154 ~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l--~~~~~~~~sDiwS~Gvil~ellt  231 (299)
T d1ywna1         154 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI--FDRVYTIQSDVWSFGVLLWEIFS  231 (299)
T ss_dssp             TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH--HHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHh--hcCCCCcccceeehHHHHHHHHh
Confidence            999999999999999888777766431              23477889999998  45678899999999999999998


Q ss_pred             C-CCCCCCchH-HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhcC
Q 046714          135 H-QPPYSHLED-MQALFRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLMEH  191 (201)
Q Consensus       135 g-~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~~  191 (201)
                      | ..||..... ......+..+..+..+..+++++.+++.+||+.+|++|||++|+++|
T Consensus       232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         232 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             TSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6 567876543 33444456667778888899999999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-43  Score=260.93  Aligned_cols=186  Identities=24%  Similarity=0.408  Sum_probs=156.3

Q ss_pred             ccccC-CCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc-------------------CCCHHHHHHHHHHHHHHH
Q 046714            3 SFSQF-EHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY-------------------HLSDSQVSSYTRQILNGL   62 (201)
Q Consensus         3 ~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------------~~~~~~~~~~~~~i~~~l   62 (201)
                      +++++ +||||+++++++.+++..+++|||+.+++|.+++.+.                   .+++..+..++.||+.||
T Consensus        79 ~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl  158 (311)
T d1t46a_          79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM  158 (311)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHH
T ss_pred             HHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHH
Confidence            34556 6999999999999999999999999999999998653                   388899999999999999


Q ss_pred             HHHhhcCccccCCCCCcEEEccCCceeeecCcc--------------ccccCcccccccccccCCCCCcchhhHHHHHHH
Q 046714           63 TYLHERNVVHREIKCANILVDASGLATTTNDVK--------------SFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCT  128 (201)
Q Consensus        63 ~~lh~~~i~H~dl~p~nill~~~g~~~~~~~~~--------------~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~  128 (201)
                      +|||++|++||||||+||+++.++..++.+...              ...+++.|+|||.+  ....++.++||||||++
T Consensus       159 ~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DIwS~G~~  236 (311)
T d1t46a_         159 AFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI--FNCVYTFESDVWSYGIF  236 (311)
T ss_dssp             HHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH--HHCCCCHHHHHHHHHHH
T ss_pred             HHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHh--cCCCCCCcccccchHHH
Confidence            999999999999999999999887766655321              23467889999998  34567899999999999


Q ss_pred             HHHHHh-CCCCCCCchHHHHH-HHhhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          129 VLEMLT-HQPPYSHLEDMQAL-FRIGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       129 l~~l~~-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      +|+|++ |..||......+.. ..+..+..+..+...++.+.+|+.+||+.+|++|||++|+++
T Consensus       237 l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999998 66667665443433 334556666777889999999999999999999999999885

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-43  Score=266.85  Aligned_cols=191  Identities=24%  Similarity=0.418  Sum_probs=150.5

Q ss_pred             ccccCCCcceeccceeeee------CCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCC
Q 046714            3 SFSQFEHDNIVQYIGTEKD------ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIK   76 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~   76 (201)
                      +|++++||||+++++++..      .+..++||||+.++.+ +.+. ..+++..++.++.||+.||+|||++||+|+|||
T Consensus        69 il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~~-~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlK  146 (355)
T d2b1pa1          69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-QVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK  146 (355)
T ss_dssp             HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-HHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             HHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHH-Hhhh-cCCCHHHHHHHHHHHHHHHHHhhhcccccccCC
Confidence            5788999999999999864      3678999999987544 4433 458999999999999999999999999999999


Q ss_pred             CCcEEEccCCceeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Q 046714           77 CANILVDASGLATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLEDM  145 (201)
Q Consensus        77 p~nill~~~g~~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  145 (201)
                      |+||+++.++..++.+..           ....+|+.|+|||.+  .+..+++++||||+||++++|++|+.||......
T Consensus       147 P~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l--~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~  224 (355)
T d2b1pa1         147 PSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI  224 (355)
T ss_dssp             GGGEEECTTCCEEECCCCC---------------CCTTCCHHHH--TTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ccccccccccceeeechhhhhccccccccccccccccccChhhh--cCCCCCCCcccccccchHHHHhhCCCCCCCCCHH
Confidence            999999998877665542           223478899999998  4567889999999999999999999999776554


Q ss_pred             HHHHHhhc----------------------CCCCCC-------------------CCCCCHHHHHHHHHHhhcCCCCCCC
Q 046714          146 QALFRIGR----------------------GKLPSV-------------------PNSLSRDARDFILKCLQVNPNDRPT  184 (201)
Q Consensus       146 ~~~~~~~~----------------------~~~~~~-------------------~~~~~~~~~~li~~~l~~~p~~R~t  184 (201)
                      ....++..                      ......                   ....++++.+|+.+||..||++|||
T Consensus       225 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t  304 (355)
T d2b1pa1         225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS  304 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred             HHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC
Confidence            44333211                      100000                   0113567889999999999999999


Q ss_pred             HhHHhcCccccCc
Q 046714          185 AAQLMEHPFVKRP  197 (201)
Q Consensus       185 ~~~il~~~~~~~~  197 (201)
                      ++|+|+||||+..
T Consensus       305 a~elL~Hpw~~~~  317 (355)
T d2b1pa1         305 VDDALQHPYINVW  317 (355)
T ss_dssp             HHHHHTSTTTGGG
T ss_pred             HHHHhcCcccCCC
Confidence            9999999999863

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.3e-43  Score=262.08  Aligned_cols=193  Identities=27%  Similarity=0.444  Sum_probs=151.3

Q ss_pred             ccccCC-Ccceeccceeeee--CCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFE-HDNIVQYIGTEKD--ENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~-h~~I~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      +|+++. ||||+++++++..  .+..++||||+.+++|..+.+  .+++..+..++.||+.||+|||++||+||||||+|
T Consensus        82 il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~--~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~N  159 (328)
T d3bqca1          82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN  159 (328)
T ss_dssp             HHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             HHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcccccccccccc
Confidence            467775 9999999999874  456899999999999977643  49999999999999999999999999999999999


Q ss_pred             EEEccCCc-eeeecCc-----------cccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH-HH
Q 046714           80 ILVDASGL-ATTTNDV-----------KSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED-MQ  146 (201)
Q Consensus        80 ill~~~g~-~~~~~~~-----------~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~  146 (201)
                      ||++.++. .++.++.           ....+|+.|+|||.+. ....++.++|+||+||++|++++|+.||..... ..
T Consensus       160 ILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~  238 (328)
T d3bqca1         160 VMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV-DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD  238 (328)
T ss_dssp             EEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHT-TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred             eEEcCCCCeeeecccccceeccCCCcccccccCccccCccccc-CCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH
Confidence            99987653 4444432           2334678899999973 345578999999999999999999999865432 11


Q ss_pred             HHHHhh----------------cC--------------------CCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHhc
Q 046714          147 ALFRIG----------------RG--------------------KLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLME  190 (201)
Q Consensus       147 ~~~~~~----------------~~--------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il~  190 (201)
                      ....+.                ..                    ........+++++.+||.+||+.||++|||++|+|+
T Consensus       239 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111100                00                    000112346789999999999999999999999999


Q ss_pred             CccccCcC
Q 046714          191 HPFVKRPL  198 (201)
Q Consensus       191 ~~~~~~~~  198 (201)
                      ||||+...
T Consensus       319 Hp~F~~v~  326 (328)
T d3bqca1         319 HPYFYTVV  326 (328)
T ss_dssp             SGGGTTSC
T ss_pred             CcccCCCC
Confidence            99999754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-41  Score=249.54  Aligned_cols=188  Identities=23%  Similarity=0.327  Sum_probs=147.0

Q ss_pred             ccccCCCcceeccceeeeeCC----eEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhh--------cCc
Q 046714            3 SFSQFEHDNIVQYIGTEKDEN----RLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHE--------RNV   70 (201)
Q Consensus         3 ~l~~l~h~~I~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--------~~i   70 (201)
                      .+++++||||+++++++.+++    ..++||||+++++|.+++++.++++..+..++.|++.||+|+|.        +||
T Consensus        50 ~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~I  129 (303)
T d1vjya_          50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI  129 (303)
T ss_dssp             TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEE
T ss_pred             HHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCe
Confidence            457889999999999988654    58999999999999999999899999999999999999999996        599


Q ss_pred             cccCCCCCcEEEccCCceeeecCc----------------cccccCcccccccccccCC----CCCcchhhHHHHHHHHH
Q 046714           71 VHREIKCANILVDASGLATTTNDV----------------KSFEGTPFWVAPEVVNLKN----NGYGLSADIWSLGCTVL  130 (201)
Q Consensus        71 ~H~dl~p~nill~~~g~~~~~~~~----------------~~~~~~~~~~aPE~~~~~~----~~~~~~~Dv~slG~~l~  130 (201)
                      +||||||+||+++.+|.+++.++.                ....||+.|+|||.+....    ..++.++|||||||++|
T Consensus       130 vHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~  209 (303)
T d1vjya_         130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW  209 (303)
T ss_dssp             ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH
T ss_pred             eccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHH
Confidence            999999999999999888776643                1234789999999984221    12567999999999999


Q ss_pred             HHHhCCCCCCCch---------------HHHHHHHh-hcCCCCCCCCCC-----CHHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          131 EMLTHQPPYSHLE---------------DMQALFRI-GRGKLPSVPNSL-----SRDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       131 ~l~~g~~p~~~~~---------------~~~~~~~~-~~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                      +|++|..|+....               ........ .....+.++...     ...+.+++.+||+.+|++|||+.|++
T Consensus       210 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~  289 (303)
T d1vjya_         210 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK  289 (303)
T ss_dssp             HHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHH
T ss_pred             HHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHH
Confidence            9999987763211               11122122 222223333322     24588999999999999999999987


Q ss_pred             c
Q 046714          190 E  190 (201)
Q Consensus       190 ~  190 (201)
                      +
T Consensus       290 ~  290 (303)
T d1vjya_         290 K  290 (303)
T ss_dssp             H
T ss_pred             H
Confidence            6

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-38  Score=236.27  Aligned_cols=192  Identities=16%  Similarity=0.233  Sum_probs=143.2

Q ss_pred             ccccCCCcceecc-ceeeeeCCeEEEEEEecCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCc
Q 046714            3 SFSQFEHDNIVQY-IGTEKDENRLYIFLELVKKGSLANLYQK--YHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCAN   79 (201)
Q Consensus         3 ~l~~l~h~~I~~~-~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~n   79 (201)
                      ++++++|+|++.. .+++.+++..++||||+.+ ++.+.+..  ..+++..+..++.|++.||+|||++||+||||||+|
T Consensus        55 i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~N  133 (299)
T d1ckia_          55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN  133 (299)
T ss_dssp             HHHHSTTSTTCCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             HHHHccCCCcccEEEEEEecCCEEEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhh
Confidence            4677887775554 5556778889999999955 67666543  459999999999999999999999999999999999


Q ss_pred             EEEccC---CceeeecC-------------------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCC
Q 046714           80 ILVDAS---GLATTTND-------------------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQP  137 (201)
Q Consensus        80 ill~~~---g~~~~~~~-------------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  137 (201)
                      |+++..   +.+++.++                   .....||+.|+|||.+  .+..++.++|||||||++|+|++|+.
T Consensus       134 Il~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~~l~el~tg~~  211 (299)
T d1ckia_         134 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSL  211 (299)
T ss_dssp             EEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHH--TTBCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHH--hCCCCCChhhEEecCHHHHHHHhCCC
Confidence            997532   22332222                   1233588999999998  45668999999999999999999999


Q ss_pred             CCCCchHHHHHHH-------hhcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhH---HhcCccccCc
Q 046714          138 PYSHLEDMQALFR-------IGRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQ---LMEHPFVKRP  197 (201)
Q Consensus       138 p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~---il~~~~~~~~  197 (201)
                      ||...........       ......+.....+|+++.+++.+||+.+|++||++++   +++++|.+..
T Consensus       212 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         212 PWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             TTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             cccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            9976543332211       1122223345678999999999999999999999875   4667765443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.3e-37  Score=229.48  Aligned_cols=183  Identities=17%  Similarity=0.237  Sum_probs=144.9

Q ss_pred             cccCCC-cceeccceeeeeCCeEEEEEEecCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcE
Q 046714            4 FSQFEH-DNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKY--HLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANI   80 (201)
Q Consensus         4 l~~l~h-~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~ni   80 (201)
                      ++.++| +||+.+++++..+...++|||++ +++|.+++...  .++...+..++.|++.||+|||++||+||||||+||
T Consensus        54 ~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Ni  132 (293)
T d1csna_          54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF  132 (293)
T ss_dssp             HHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred             HHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccce
Confidence            456665 89999999999999999999999 56999988653  499999999999999999999999999999999999


Q ss_pred             EEcc-----CCceeeecC-------------------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCC
Q 046714           81 LVDA-----SGLATTTND-------------------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQ  136 (201)
Q Consensus        81 ll~~-----~g~~~~~~~-------------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~  136 (201)
                      +++.     ++.+++.++                   .....||+.|+|||.+  .+..++.++|+||+|+++|+|++|+
T Consensus       133 li~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~--~~~~~~~~~DiwSlG~~l~elltg~  210 (293)
T d1csna_         133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGS  210 (293)
T ss_dssp             EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH--TTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             eecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHh--cCCCCChHHHHHHhhHHHHHHHhCC
Confidence            9964     233333322                   1234589999999998  4567899999999999999999999


Q ss_pred             CCCCCch---HHHHHHHh----hcCCCCCCCCCCCHHHHHHHHHHhhcCCCCCCCHhHHh
Q 046714          137 PPYSHLE---DMQALFRI----GRGKLPSVPNSLSRDARDFILKCLQVNPNDRPTAAQLM  189 (201)
Q Consensus       137 ~p~~~~~---~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~~il  189 (201)
                      .||....   .......+    .......+...+|+++.+++..|+..+|++||+.+.+.
T Consensus       211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         211 LPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             CTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             CcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence            9996432   22222221    12222334567899999999999999999999977654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-36  Score=230.75  Aligned_cols=190  Identities=23%  Similarity=0.397  Sum_probs=135.4

Q ss_pred             CCCcceeccceeeeeC--CeEEEEEEecCCCCHHH-HHH---hcCCCHHHHHHHHHHHHHHHHHHhh-cCccccCCCCCc
Q 046714            7 FEHDNIVQYIGTEKDE--NRLYIFLELVKKGSLAN-LYQ---KYHLSDSQVSSYTRQILNGLTYLHE-RNVVHREIKCAN   79 (201)
Q Consensus         7 l~h~~I~~~~~~~~~~--~~~~lv~e~~~~~~L~~-~~~---~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~p~n   79 (201)
                      +.|+||+++++++...  ...++++++...+.... ...   ...+++..+..++.||+.|++|||+ .||+||||||+|
T Consensus        77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N  156 (362)
T d1q8ya_          77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN  156 (362)
T ss_dssp             HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred             cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence            4578999999987653  45666666665544322 222   2348999999999999999999998 899999999999


Q ss_pred             EEEccCCc------eeeecC---------ccccccCcccccccccccCCCCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Q 046714           80 ILVDASGL------ATTTND---------VKSFEGTPFWVAPEVVNLKNNGYGLSADIWSLGCTVLEMLTHQPPYSHLED  144 (201)
Q Consensus        80 ill~~~g~------~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  144 (201)
                      |+++.+|.      .++.+.         .....+++.|+|||.+  ....++.++|+||+||++++|++|+.||.....
T Consensus       157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         157 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHH--HTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             eeeeccCcccccceeeEeecccccccccccccccccccccChhhc--cccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence            99976542      222221         2334578899999998  355678999999999999999999999964332


Q ss_pred             HH------HHHHh--hcC------------------------CC---------------CCCCCCCCHHHHHHHHHHhhc
Q 046714          145 MQ------ALFRI--GRG------------------------KL---------------PSVPNSLSRDARDFILKCLQV  177 (201)
Q Consensus       145 ~~------~~~~~--~~~------------------------~~---------------~~~~~~~~~~~~~li~~~l~~  177 (201)
                      ..      .....  ..+                        ..               .......++++.+|+.+||++
T Consensus       235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  314 (362)
T d1q8ya_         235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  314 (362)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence            11      11000  000                        00               011123456789999999999


Q ss_pred             CCCCCCCHhHHhcCccccCcC
Q 046714          178 NPNDRPTAAQLMEHPFVKRPL  198 (201)
Q Consensus       178 ~p~~R~t~~~il~~~~~~~~~  198 (201)
                      ||.+|||++|+|+||||++..
T Consensus       315 dP~~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         315 DPRKRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             STTTCBCHHHHHTCGGGTTCT
T ss_pred             ChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999998653

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.55  E-value=3e-16  Score=107.56  Aligned_cols=80  Identities=16%  Similarity=0.225  Sum_probs=62.7

Q ss_pred             cccCCCcceeccceeeeeCCeEEEEEEecCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcCccccCCCCCcEEEc
Q 046714            4 FSQFEHDNIVQYIGTEKDENRLYIFLELVKKGSLANLYQKYHLSDSQVSSYTRQILNGLTYLHERNVVHREIKCANILVD   83 (201)
Q Consensus         4 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~p~nill~   83 (201)
                      +.++.|++++..++...    .+++||++.+..+.+      ++...+..++.|++.++++||++|++|+||||+||+++
T Consensus        68 l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~  137 (191)
T d1zara2          68 LQKLQGLAVPKVYAWEG----NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS  137 (191)
T ss_dssp             HHHTTTSSSCCEEEEET----TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred             HHHccCCCcceEEEecC----CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee
Confidence            45678888887765532    279999998865532      45566778999999999999999999999999999999


Q ss_pred             cCCceeeecCc
Q 046714           84 ASGLATTTNDV   94 (201)
Q Consensus        84 ~~g~~~~~~~~   94 (201)
                      ++|. .+.++.
T Consensus       138 ~~~~-~liDFG  147 (191)
T d1zara2         138 EEGI-WIIDFP  147 (191)
T ss_dssp             TTEE-EECCCT
T ss_pred             CCCE-EEEECC
Confidence            7764 445444

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.29  E-value=0.00022  Score=49.56  Aligned_cols=29  Identities=3%  Similarity=0.030  Sum_probs=23.7

Q ss_pred             eeccceeeeeCCeEEEEEEecCCCCHHHH
Q 046714           12 IVQYIGTEKDENRLYIFLELVKKGSLANL   40 (201)
Q Consensus        12 I~~~~~~~~~~~~~~lv~e~~~~~~L~~~   40 (201)
                      +.+++.+..+++..++||+++.|.++.+.
T Consensus        72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~  100 (263)
T d1j7la_          72 VPKVLHFERHDGWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             CCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred             CCcEEEEEecCCceEEEEEeccccccccc
Confidence            56677788888999999999999877543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.56  E-value=0.00082  Score=46.32  Aligned_cols=26  Identities=15%  Similarity=0.221  Sum_probs=21.5

Q ss_pred             eeccceeeeeCCeEEEEEEecCCCCH
Q 046714           12 IVQYIGTEKDENRLYIFLELVKKGSL   37 (201)
Q Consensus        12 I~~~~~~~~~~~~~~lv~e~~~~~~L   37 (201)
                      +.+++....+++..+++|++++|.++
T Consensus        68 vP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          68 CAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             BCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             CCceeeecccccceEEEEEeeecccc
Confidence            56677788888889999999988665

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=94.86  E-value=0.024  Score=41.55  Aligned_cols=19  Identities=11%  Similarity=0.382  Sum_probs=16.7

Q ss_pred             CccccCCCCCcEEEccCCc
Q 046714           69 NVVHREIKCANILVDASGL   87 (201)
Q Consensus        69 ~i~H~dl~p~nill~~~g~   87 (201)
                      .++|||++|.|||++.++.
T Consensus       224 ~LiHGDl~~gNIlv~~~~~  242 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHET  242 (392)
T ss_dssp             EEECSCCCGGGEEECSSCE
T ss_pred             ceeccCCcCCceeEcCCce
Confidence            5899999999999987763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=92.89  E-value=0.0092  Score=42.29  Aligned_cols=27  Identities=15%  Similarity=0.188  Sum_probs=21.8

Q ss_pred             cCccccCCCCCcEEEccCCceeeecCc
Q 046714           68 RNVVHREIKCANILVDASGLATTTNDV   94 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~~g~~~~~~~~   94 (201)
                      .|++|+|+.++||+++.++...+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~  209 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFY  209 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCT
T ss_pred             cccccCCcchhhhhcccccceeEeccc
Confidence            579999999999999988765555544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=83.70  E-value=0.42  Score=33.63  Aligned_cols=17  Identities=24%  Similarity=0.229  Sum_probs=15.0

Q ss_pred             cCccccCCCCCcEEEcc
Q 046714           68 RNVVHREIKCANILVDA   84 (201)
Q Consensus        68 ~~i~H~dl~p~nill~~   84 (201)
                      .+++|+|+++.||++++
T Consensus       192 ~~liHgDlh~~NvL~~~  208 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRD  208 (325)
T ss_dssp             CEECCSSCSGGGEEESS
T ss_pred             ceeecCCCCcccEEEeC
Confidence            36899999999999974